{"PMC7531792": [], "PMC7321019": [], "eb1c07c57a33eb156201f316b43646ad31711970": [["frailty tools to predict worse outcomes in both community and emergency settings (5, 6) , should be used to identify frailty among older adults.", [["frailty", "DISEASE", 117, 124], ["frailty tools", "PROBLEM", 0, 13]]], ["The mortality of COVID-19 is also correlated with its health-care burden.", [["COVID", "TEST", 17, 22]]], ["Therefore, preventive measures should be taken to reduce the risk of death due to this disease, e.g., early detection of frail older adults at risk of COVID-19.", [["death", "DISEASE", 69, 74], ["preventive measures", "TREATMENT", 11, 30], ["death", "PROBLEM", 69, 74], ["this disease", "PROBLEM", 82, 94], ["COVID", "TEST", 151, 156]]], ["The elderly should also be encouraged to adopt precautions against the virus, such as washing hands frequently, checking body temperature daily, wearing masks, keeping their hands away from their faces, staying away from people with signs of illness, and maintaining close contact with local health officials and strong social support.", [["body", "ANATOMY", 121, 125], ["illness", "DISEASE", 242, 249], ["body", "ORGANISM_SUBDIVISION", 121, 125], ["people", "SPECIES", 221, 227], ["precautions", "TREATMENT", 47, 58], ["the virus", "PROBLEM", 67, 76], ["masks", "TREATMENT", 153, 158], ["illness", "PROBLEM", 242, 249]]], ["These measures are essential for protecting the frail older adults and mitigating the severity of patient outcomes.", [["patient", "ORGANISM", 98, 105], ["patient", "SPECIES", 98, 105]]]], "3b05296a3d936880e2aa2f0b51a0de80e1cbf797": [["Newer vaccines with more efficient manufacturing processes, enhanced efficacy, and cross-protection against multiple strains would improve preparedness.", [["Newer vaccines", "TREATMENT", 0, 14], ["cross-protection", "TREATMENT", 83, 99], ["multiple strains", "PROBLEM", 108, 124]]], ["Reverse genetics technology has provided one such method, and emerging gene-based vaccines offer another approach that reduces dependence on egg-based production and human exposure to pathogenic viruses.", [["human", "ORGANISM", 166, 171], ["human", "SPECIES", 166, 171], ["human", "SPECIES", 166, 171], ["emerging gene-based vaccines", "TREATMENT", 62, 90], ["another approach", "TREATMENT", 97, 113], ["dependence on egg", "PROBLEM", 127, 144], ["pathogenic viruses", "PROBLEM", 184, 202]]], ["Gene-based vaccines also provide rapid manufacturing, enhanced precision and versatility, and the capacity to protect against a broad range of viral subtypes.", [["Gene-based vaccines", "TREATMENT", 0, 19], ["rapid manufacturing", "TREATMENT", 33, 52], ["the capacity", "PROBLEM", 94, 106], ["viral subtypes", "PROBLEM", 143, 157], ["viral subtypes", "OBSERVATION", 143, 157]]], ["Vectors for these vaccines include replication-defective viruses, bacterial vectors, and DNA.", [["DNA", "CELLULAR_COMPONENT", 89, 92], ["Vectors", "TREATMENT", 0, 7], ["these vaccines", "TREATMENT", 12, 26], ["replication", "TREATMENT", 35, 46], ["defective viruses", "PROBLEM", 47, 64], ["bacterial vectors", "TREATMENT", 66, 83], ["DNA", "PROBLEM", 89, 92], ["defective viruses", "OBSERVATION", 47, 64], ["bacterial vectors", "OBSERVATION", 66, 83]]], ["Here we review the features of gene-based vaccination that may facilitate the control of HPAI H5N1 in poultry, and highlight the development of a hemagglutinin-based multivalent DNA vaccine that confers protection in mice and chickens.INTRODUCTIONSevere outbreaks of highly pathogenic avian influenza A (HPAI) H5N1 (HPAI H5N1) in birds throughout Asia, Africa, and Europe have resulted in human deaths, raising concern about its potential for adaptation to humans.", [["H5N1", "DISEASE", 94, 98], ["avian influenza A (HPAI) H5N1", "DISEASE", 285, 314], ["HPAI H5N1", "DISEASE", 316, 325], ["deaths", "DISEASE", 395, 401], ["HPAI H5N1", "ORGANISM", 89, 98], ["DNA", "CELLULAR_COMPONENT", 178, 181], ["mice", "ORGANISM", 217, 221], ["chickens", "ORGANISM", 226, 234], ["highly pathogenic", "ORGANISM", 267, 284], ["avian influenza A (HPAI) H5N1", "ORGANISM", 285, 314], ["HPAI H5N1", "ORGANISM", 316, 325], ["human", "ORGANISM", 389, 394], ["humans", "ORGANISM", 457, 463], ["HPAI H5N1", "SPECIES", 89, 98], ["mice", "SPECIES", 217, 221], ["chickens", "SPECIES", 226, 234], ["avian influenza A", "SPECIES", 285, 302], ["HPAI) H5N1", "SPECIES", 304, 314], ["HPAI H5N1", "SPECIES", 316, 325], ["human", "SPECIES", 389, 394], ["humans", "SPECIES", 457, 463], ["HPAI H5N1", "SPECIES", 89, 98], ["mice", "SPECIES", 217, 221], ["chickens", "SPECIES", 226, 234], ["HPAI", "SPECIES", 304, 308], ["human", "SPECIES", 389, 394], ["humans", "SPECIES", 457, 463], ["gene-based vaccination", "TREATMENT", 31, 53], ["HPAI H5N1", "TREATMENT", 89, 98], ["a hemagglutinin-based multivalent DNA vaccine", "TREATMENT", 144, 189], ["highly pathogenic avian influenza A (HPAI) H5N1 (HPAI H5N1", "PROBLEM", 267, 325], ["human deaths", "PROBLEM", 389, 401]]], ["In addition, the virus has affected the poultry industry, leading to culling of flocks and major economic losses.", [["the virus", "PROBLEM", 13, 22], ["culling of flocks", "PROBLEM", 69, 86], ["major economic losses", "PROBLEM", 91, 112], ["virus", "OBSERVATION", 17, 22], ["major", "OBSERVATION_MODIFIER", 91, 96], ["economic losses", "OBSERVATION", 97, 112]]], ["From 1997 to 2007, more than 250 million birds have been killed or culled, compared with only 23 million in the previous 40 yr (Capua and Alexander, 2004 ; Food and Agriculture Organization of the United Nations, 2006; Peiris et al., 2007) .", [["birds", "ORGANISM", 41, 46]]], ["The economic impact of HPAI H5N1 outbreaks in Asia has exceeded $575 million (World Health Organization, 2005) .", [["H5N1", "DISEASE", 28, 32], ["HPAI H5N1", "ORGANISM", 23, 32], ["HPAI H5N1", "SPECIES", 23, 32], ["HPAI", "OBSERVATION_MODIFIER", 23, 27], ["H5N1", "OBSERVATION", 28, 32]]], ["The direct costs from the death or destruction of poultry and agriculture are amplified by indirect costs, which include a significant impact on tourism and commerce.", [["death", "DISEASE", 26, 31], ["the death", "PROBLEM", 22, 31], ["destruction of poultry and agriculture", "PROBLEM", 35, 73], ["destruction", "OBSERVATION", 35, 46], ["significant", "OBSERVATION_MODIFIER", 123, 134], ["impact", "OBSERVATION_MODIFIER", 135, 141]]], ["Dissemination results primarily from the movement of the virus through infected poultry, poultry products, and contaminated fomites, but migratory birds have also served as secondary vectors for the virus, rapidly spreading HPAI to Asia, Europe, and Africa (Mcleod et al., 2005) .", [["fomites", "ANATOMY", 124, 131], ["infected poultry", "DISEASE", 71, 87], ["HPAI", "DISEASE", 224, 228], ["birds", "ORGANISM", 147, 152], ["poultry", "SPECIES", 80, 87], ["the virus", "PROBLEM", 53, 62], ["poultry products", "TREATMENT", 89, 105], ["contaminated fomites", "PROBLEM", 111, 131], ["the virus", "PROBLEM", 195, 204]]], ["Historically, avian influenza viruses have rarely infected humans, although the HPAI H7 and H9 subtypes have increasingly caused human infections (Fouchier et al., 2004; Taubenberger et al., 2007) .", [["influenza viruses", "DISEASE", 20, 37], ["infections", "DISEASE", 135, 145], ["avian influenza viruses", "ORGANISM", 14, 37], ["humans", "ORGANISM", 59, 65], ["HPAI H7", "ORGANISM", 80, 87], ["H9 subtypes", "ORGANISM", 92, 103], ["human", "ORGANISM", 129, 134], ["avian influenza viruses", "SPECIES", 14, 37], ["humans", "SPECIES", 59, 65], ["human", "SPECIES", 129, 134], ["humans", "SPECIES", 59, 65], ["HPAI H7", "SPECIES", 80, 87], ["human", "SPECIES", 129, 134], ["avian influenza viruses", "PROBLEM", 14, 37], ["the HPAI H7", "PROBLEM", 76, 87], ["human infections", "PROBLEM", 129, 145], ["influenza viruses", "OBSERVATION", 20, 37], ["infections", "OBSERVATION", 135, 145]]], ["However, H5N1 viruses killed 6 out of 18 infected people in the Hong Kong severe acute respiratory syndrome outbreak in 1997 (Capua and Alexander, 2006; Cinatl et al., 2007b) .", [["acute respiratory syndrome", "DISEASE", 81, 107], ["H5N1 viruses", "ORGANISM", 9, 21], ["people", "ORGANISM", 50, 56], ["people", "SPECIES", 50, 56], ["H5N1 viruses", "SPECIES", 9, 21], ["Hong Kong severe acute respiratory syndrome outbreak", "SPECIES", 64, 116], ["H5N1 viruses", "PROBLEM", 9, 21], ["severe acute respiratory syndrome", "PROBLEM", 74, 107], ["severe", "OBSERVATION_MODIFIER", 74, 80], ["acute", "OBSERVATION_MODIFIER", 81, 86], ["respiratory syndrome", "OBSERVATION", 87, 107]]], ["In addition, there is evidence that US poultry workers, swine, swine farmers, and veterinarians have been infected with avian influenza virus (Gray, 2008) .", [["avian influenza virus", "DISEASE", 120, 141], ["avian influenza virus", "ORGANISM", 120, 141], ["swine", "SPECIES", 56, 61], ["swine", "SPECIES", 63, 68], ["avian influenza virus", "SPECIES", 120, 141], ["swine", "SPECIES", 56, 61], ["swine", "SPECIES", 63, 68], ["avian influenza virus", "PROBLEM", 120, 141]]], ["Such zoonotic infections raise the concern that human hosts may facilitate viral reassortment and the creation of new subtypes.", [["zoonotic infections", "DISEASE", 5, 24], ["human", "ORGANISM", 48, 53], ["human", "SPECIES", 48, 53], ["human", "SPECIES", 48, 53], ["Such zoonotic infections", "PROBLEM", 0, 24], ["human hosts", "TREATMENT", 48, 59], ["viral reassortment", "TREATMENT", 75, 93], ["zoonotic", "OBSERVATION_MODIFIER", 5, 13], ["infections", "OBSERVATION", 14, 24], ["new", "OBSERVATION_MODIFIER", 114, 117]]], ["It has long been hypothesized that swine serve as \"mixing vessels\" between human and avian influenza, as supported by the finding that the pig trachea contains receptors for both human and avian influenza viruses (Ito et al., 1998; Van Reeth, 2007) .", [["vessels", "ANATOMY", 58, 65], ["trachea", "ANATOMY", 143, 150], ["influenza", "DISEASE", 91, 100], ["influenza viruses", "DISEASE", 195, 212], ["vessels", "TISSUE", 58, 65], ["human", "ORGANISM", 75, 80], ["avian influenza", "ORGANISM", 85, 100], ["pig", "ORGANISM", 139, 142], ["trachea", "ORGAN", 143, 150], ["human", "ORGANISM", 179, 184], ["avian influenza viruses", "ORGANISM", 189, 212], ["swine", "SPECIES", 35, 40], ["human", "SPECIES", 75, 80], ["avian influenza", "SPECIES", 85, 100], ["pig", "SPECIES", 139, 142], ["human", "SPECIES", 179, 184], ["avian influenza", "SPECIES", 189, 204], ["swine", "SPECIES", 35, 40], ["human", "SPECIES", 75, 80], ["pig", "SPECIES", 139, 142], ["human", "SPECIES", 179, 184], ["human and avian influenza", "PROBLEM", 75, 100], ["both human and avian influenza viruses", "PROBLEM", 174, 212], ["trachea", "ANATOMY", 143, 150]]], ["An exchange of genes between these 2 viruses might grant the highly pathogenic avian virus transmissibility in humans, which could potentially result in a novel pandemic strain.", [["avian virus transmissibility", "DISEASE", 79, 107], ["avian virus", "ORGANISM", 79, 90], ["humans", "ORGANISM", 111, 117], ["avian virus", "SPECIES", 79, 90], ["humans", "SPECIES", 111, 117], ["humans", "SPECIES", 111, 117], ["An exchange of genes", "TREATMENT", 0, 20], ["these 2 viruses", "TREATMENT", 29, 44], ["a novel pandemic strain", "PROBLEM", 153, 176], ["pathogenic avian", "OBSERVATION", 68, 84], ["virus transmissibility", "OBSERVATION", 85, 107], ["pandemic strain", "OBSERVATION", 161, 176]]], ["However, the speculation that swine serve as intermediates between human and avian influenza has yet to be proven; no human seasonal strain containing swine influenza genes has yet been isolated.", [["influenza", "DISEASE", 83, 92], ["swine", "ORGANISM", 30, 35], ["human", "ORGANISM", 67, 72], ["avian influenza", "ORGANISM", 77, 92], ["human", "ORGANISM", 118, 123], ["swine influenza", "ORGANISM", 151, 166], ["swine influenza genes", "DNA", 151, 172], ["swine", "SPECIES", 30, 35], ["human", "SPECIES", 67, 72], ["avian influenza", "SPECIES", 77, 92], ["human", "SPECIES", 118, 123], ["swine", "SPECIES", 151, 156], ["swine", "SPECIES", 30, 35], ["human", "SPECIES", 67, 72], ["human", "SPECIES", 118, 123], ["swine", "SPECIES", 151, 156], ["intermediates between human and avian influenza", "PROBLEM", 45, 92], ["human seasonal strain containing swine influenza genes", "PROBLEM", 118, 172]]], ["Evidence suggests that there are strong barriers preventing the infection of pigs by influenza viruses in other species, and major genetic events would have to take place for an avian virus to gain transmissibility in humans via swine (Kuiken et al., 2006; Van Reeth, 2007) .INTRODUCTIONWhether human pandemics have avian origins is debatable (Vana and Westover, 2008) , but HPAI H5N1 poses a significant threat for a human pandemic as it continues to affect poultry populations.", [["infection", "DISEASE", 64, 73], ["influenza viruses", "DISEASE", 85, 102], ["HPAI H5N1", "DISEASE", 375, 384], ["pigs", "ORGANISM", 77, 81], ["influenza viruses", "ORGANISM", 85, 102], ["humans", "ORGANISM", 218, 224], ["human", "ORGANISM", 295, 300], ["HPAI H5N1", "ORGANISM", 375, 384], ["human", "ORGANISM", 418, 423], ["pigs", "SPECIES", 77, 81], ["humans", "SPECIES", 218, 224], ["swine", "SPECIES", 229, 234], ["human", "SPECIES", 295, 300], ["HPAI H5N1", "SPECIES", 375, 384], ["human", "SPECIES", 418, 423], ["pigs", "SPECIES", 77, 81], ["humans", "SPECIES", 218, 224], ["swine", "SPECIES", 229, 234], ["human", "SPECIES", 295, 300], ["HPAI H5N1", "SPECIES", 375, 384], ["human", "SPECIES", 418, 423], ["the infection of pigs", "PROBLEM", 60, 81], ["influenza viruses in other species", "PROBLEM", 85, 119], ["an avian virus", "PROBLEM", 175, 189], ["a human pandemic", "PROBLEM", 416, 432], ["strong", "OBSERVATION_MODIFIER", 33, 39], ["infection", "OBSERVATION", 64, 73]]], ["Presently, the most effective means of controlling a potential pandemic virus in humans is vaccination, but vaccines are also an effective tool in the control of avian influenza in poultry when combined with adequate biosecurity.Influenza VirusesInfluenza viruses come in 3 different types: A, B, and C. Type A demonstrates the ability to infect a wide host range, potentially resulting in epidemics and pandemics.", [["avian influenza", "DISEASE", 162, 177], ["Influenza viruses", "DISEASE", 246, 263], ["humans", "ORGANISM", 81, 87], ["avian", "ORGANISM", 162, 167], ["Influenza Viruses", "ORGANISM", 229, 246], ["B", "GENE_OR_GENE_PRODUCT", 294, 295], ["humans", "SPECIES", 81, 87], ["avian influenza", "SPECIES", 162, 177], ["Influenza", "SPECIES", 229, 238], ["Influenza", "SPECIES", 246, 255], ["humans", "SPECIES", 81, 87], ["poultry", "SPECIES", 181, 188], ["C. Type A", "SPECIES", 301, 310], ["a potential pandemic virus", "PROBLEM", 51, 77], ["vaccination", "TREATMENT", 91, 102], ["vaccines", "TREATMENT", 108, 116], ["avian influenza", "PROBLEM", 162, 177], ["Influenza VirusesInfluenza viruses", "PROBLEM", 229, 263], ["epidemics", "PROBLEM", 390, 399], ["pandemics", "PROBLEM", 404, 413], ["pandemic virus", "OBSERVATION", 63, 77]]], ["Type A influenza viruses have a large number of subtypes and are identified by their surface glycoproteins, consisting of 1 of 16 hemagglutinins (HA) and 1 of 9 neuraminidases.", [["surface", "ANATOMY", 85, 92], ["influenza viruses", "DISEASE", 7, 24], ["Type A influenza viruses", "ORGANISM", 0, 24], ["neuraminidases", "GENE_OR_GENE_PRODUCT", 161, 175], ["surface glycoproteins", "PROTEIN", 85, 106], ["hemagglutinins", "PROTEIN", 130, 144], ["HA", "PROTEIN", 146, 148], ["neuraminidases", "PROTEIN", 161, 175], ["Type A influenza viruses", "SPECIES", 0, 24], ["Type A influenza viruses", "PROBLEM", 0, 24], ["16 hemagglutinins (HA)", "TREATMENT", 127, 149], ["influenza viruses", "OBSERVATION", 7, 24], ["large", "OBSERVATION_MODIFIER", 32, 37], ["number", "OBSERVATION_MODIFIER", 38, 44]]], ["Hence, the H5N1 subtype contains H5 HA and N1 neuraminidase.", [["H5 HA", "ORGANISM", 33, 38], ["N1 neuraminidase", "GENE_OR_GENE_PRODUCT", 43, 59], ["H5 HA", "PROTEIN", 33, 38], ["N1 neuraminidase", "PROTEIN", 43, 59], ["the H5N1 subtype", "PROBLEM", 7, 23], ["H5 HA", "TREATMENT", 33, 38], ["N1 neuraminidase", "TREATMENT", 43, 59], ["H5N1", "OBSERVATION", 11, 15], ["N1 neuraminidase", "OBSERVATION", 43, 59]]], ["An effective vaccine for influenza A must induce humoral immunity, particularly neutralizing antibodies, against these glycoproteins, primarily the HA component.", [["influenza A", "ORGANISM", 25, 36], ["neutralizing antibodies", "PROTEIN", 80, 103], ["glycoproteins", "PROTEIN", 119, 132], ["influenza A", "SPECIES", 25, 36], ["An effective vaccine", "TREATMENT", 0, 20], ["influenza", "PROBLEM", 25, 34], ["humoral immunity", "PROBLEM", 49, 65], ["neutralizing antibodies", "PROBLEM", 80, 103], ["these glycoproteins", "PROBLEM", 113, 132], ["the HA component", "PROBLEM", 144, 160]]], ["Vaccines are subtype specific, although cross-reactivity between the strains of the same subtype is occasionally seen.", [["Vaccines", "TREATMENT", 0, 8]]], ["However, vaccines generated against one subtype do not neutralize a different subtype.Influenza VirusesVaccine development for avian influenza is particularly challenging because of frequent, unpredictable changes in viral structure via antigenic drift and antigenic shift (Tosh and Poland, 2008) .", [["Influenza VirusesVaccine", "DISEASE", 86, 110], ["avian influenza", "DISEASE", 127, 142], ["Influenza VirusesVaccine", "ORGANISM", 86, 110], ["avian influenza", "ORGANISM", 127, 142], ["Influenza", "SPECIES", 86, 95], ["avian influenza", "SPECIES", 127, 142], ["vaccines", "TREATMENT", 9, 17], ["Influenza VirusesVaccine development", "TREATMENT", 86, 122], ["avian influenza", "PROBLEM", 127, 142], ["unpredictable changes in viral structure", "PROBLEM", 192, 232], ["antigenic drift", "PROBLEM", 237, 252], ["viral structure", "OBSERVATION", 217, 232], ["antigenic drift", "OBSERVATION", 237, 252]]], ["Antigenic drift refers to minor, gradual changes to the surface antigens through high rates of point mutations, a consequence of the error-prone RNA-dependent RNA polymerase of the virus.", [["surface", "ANATOMY", 56, 63], ["surface antigens", "PROTEIN", 56, 72], ["error-prone RNA-dependent RNA polymerase", "PROTEIN", 133, 173], ["Antigenic drift", "PROBLEM", 0, 15], ["gradual changes", "PROBLEM", 33, 48], ["the surface antigens", "TEST", 52, 72], ["point mutations", "PROBLEM", 95, 110], ["the error-prone RNA", "TEST", 129, 148], ["the virus", "PROBLEM", 177, 186], ["drift", "OBSERVATION", 10, 15]]], ["Antigenic shift is a drastic change that results from a reassortment of genes via the coinfection of 2 influenza viruses in one host (Capua and Alexander, 2006; van den Berg et al., 2008) .", [["influenza viruses", "DISEASE", 103, 120], ["2 influenza viruses", "ORGANISM", 101, 120], ["Antigenic shift", "PROBLEM", 0, 15], ["a drastic change", "PROBLEM", 19, 35], ["2 influenza viruses", "PROBLEM", 101, 120], ["drastic", "OBSERVATION_MODIFIER", 21, 28], ["coinfection", "OBSERVATION", 86, 97]]], ["In reassortment, the unique, segmented nature of influenza viruses allows for the mixing and matching of genes, causing major changes in the viral structure and potentially the creation of a novel subtype.", [["influenza viruses", "DISEASE", 49, 66], ["influenza viruses", "ORGANISM", 49, 66], ["influenza viruses", "PROBLEM", 49, 66], ["the mixing and matching of genes", "PROBLEM", 78, 110], ["major changes in the viral structure", "PROBLEM", 120, 156], ["a novel subtype", "PROBLEM", 189, 204], ["influenza viruses", "OBSERVATION", 49, 66], ["viral structure", "OBSERVATION", 141, 156]]], ["In fact, direct transfer of virus from one host type to a different host type has been established in canine species with equine influenza H3N8 (Crawford et al., 2005) .", [["influenza H3N8", "DISEASE", 129, 143], ["canine", "ORGANISM", 102, 108], ["equine influenza H3N8", "ORGANISM", 122, 143], ["canine", "SPECIES", 102, 108], ["equine influenza H3N8", "SPECIES", 122, 143], ["canine", "SPECIES", 102, 108], ["equine influenza H3N8", "SPECIES", 122, 143], ["virus", "PROBLEM", 28, 33], ["equine influenza H3N8", "TREATMENT", 122, 143]]], ["Antigenic drift is responsible for seasonal epidemics of influenza, whereas antigenic shift is associated with more serious consequences, such as a pandemic, because no previous immunity exists for a novel subtype.Current VaccinesBecause of the high propensity of influenza viruses for mutation, vaccines must continually be updated to keep pace with the variation in surface antigens.", [["surface", "ANATOMY", 368, 375], ["influenza", "DISEASE", 57, 66], ["influenza viruses", "DISEASE", 264, 281], ["influenza viruses", "ORGANISM", 264, 281], ["surface antigens", "GENE_OR_GENE_PRODUCT", 368, 384], ["surface antigens", "PROTEIN", 368, 384], ["Antigenic drift", "PROBLEM", 0, 15], ["influenza", "PROBLEM", 57, 66], ["a pandemic", "PROBLEM", 146, 156], ["a novel subtype", "PROBLEM", 198, 213], ["influenza viruses", "PROBLEM", 264, 281], ["mutation", "PROBLEM", 286, 294], ["vaccines", "TREATMENT", 296, 304], ["drift", "OBSERVATION", 10, 15], ["responsible for", "UNCERTAINTY", 19, 34], ["influenza", "OBSERVATION", 57, 66]]], ["For a vaccine to be licensed by the Animal and Plant Health Inspection Service of the USDA, it must meet standards in 4 criteria: 1) purity (exclusively desired compounds, consistent in production), 2) safety (no harmful effects on the host or environment), 3) efficacy (quantified standards of protection), and 4) potency (protection in a variety of conditions, reasonable dosages; Myers and Morgan, 2003; Swayne, 2008) .", [["a vaccine", "TREATMENT", 4, 13]]], ["The majority of currently available influenza vaccines for poultry are inactivated whole-virus vaccines, which are produced by rendering a live virus harmless through a series of physical or chemical processes (Qiao et al., 2006; Cinatl et al., 2007a; Marangon et al., 2008) .", [["whole-virus", "ORGANISM", 83, 94], ["poultry", "SPECIES", 59, 66], ["influenza vaccines", "TREATMENT", 36, 54], ["poultry", "TREATMENT", 59, 66], ["whole-virus vaccines", "TREATMENT", 83, 103]]], ["In these processes, a wild-type donor virus is coinfected in embryonated eggs with an egg-adapted influenza strain.", [["eggs", "ANATOMY", 73, 77], ["influenza", "DISEASE", 98, 107], ["wild-type donor virus", "ORGANISM", 22, 43], ["egg", "ORGANISM_SUBDIVISION", 86, 89], ["a wild-type donor virus", "PROBLEM", 20, 43], ["embryonated eggs", "PROBLEM", 61, 77], ["an egg", "TEST", 83, 89], ["adapted influenza strain", "PROBLEM", 90, 114], ["influenza", "OBSERVATION", 98, 107]]], ["Clones are then screened until a reassortant is identified that has the appropriate HA profile of the pathogenic strain, yet is adapted for growth in eggs.", [["eggs", "ANATOMY", 150, 154], ["Clones", "CELL", 0, 6], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 150, 154], ["the pathogenic strain", "PROBLEM", 98, 119], ["growth in eggs", "PROBLEM", 140, 154]]], ["The seed strain is then rendered noninfectious by treatment with formaldehyde or \u03b2-propriolactone (Webby and Sandbulte, 2008) .", [["formaldehyde", "CHEMICAL", 65, 77], ["\u03b2-propriolactone", "CHEMICAL", 81, 97], ["formaldehyde", "CHEMICAL", 65, 77], ["\u03b2-propriolactone", "CHEMICAL", 81, 97], ["Webby", "CHEMICAL", 99, 104], ["formaldehyde", "SIMPLE_CHEMICAL", 65, 77], ["\u03b2-propriolactone", "SIMPLE_CHEMICAL", 81, 97], ["The seed strain", "PROBLEM", 0, 15], ["formaldehyde", "TREATMENT", 65, 77], ["\u03b2-propriolactone", "TREATMENT", 81, 97], ["noninfectious", "OBSERVATION", 33, 46]]], ["These vaccines elicit an immune response in a variety of poultry species and do not pose any dangers to the host because an inactivated virus cannot replicate; however, they must also be administered in multiple doses to achieve a neutralizing titer.", [["These vaccines", "TREATMENT", 0, 14], ["poultry species", "PROBLEM", 57, 72], ["an inactivated virus", "PROBLEM", 121, 141], ["a neutralizing titer", "TREATMENT", 229, 249]]], ["So far, inactivated wholevirus vaccines have been shown in clinical trials to be very effective in protecting both poultry and humans against highly pathogenic influenza viruses, especially when administered with an oil-in-water adjuvant such as MF59 (Leroux-Roels et al., 2007; Bernstein et al., 2008) .", [["influenza viruses", "DISEASE", 160, 177], ["MF59", "CHEMICAL", 246, 250], ["wholevirus vaccines", "ORGANISM", 20, 39], ["humans", "ORGANISM", 127, 133], ["influenza viruses", "ORGANISM", 160, 177], ["MF59", "SIMPLE_CHEMICAL", 246, 250], ["humans", "SPECIES", 127, 133], ["poultry", "SPECIES", 115, 122], ["humans", "SPECIES", 127, 133], ["inactivated wholevirus vaccines", "TREATMENT", 8, 39], ["highly pathogenic influenza viruses", "PROBLEM", 142, 177], ["an oil-in-water adjuvant", "TREATMENT", 213, 237]]], ["However, it is important to note that in poultry, the vaccine may only protect against disease, and birds may shed variable quantities of virus, depending on individual responses and the homology between the vaccine strain and the HA of the challenge strain.", [["birds", "ORGANISM", 100, 105], ["poultry", "SPECIES", 41, 48], ["the vaccine", "TREATMENT", 50, 61], ["disease", "PROBLEM", 87, 94], ["variable quantities of virus", "PROBLEM", 115, 143], ["the vaccine strain", "TREATMENT", 204, 222], ["the challenge strain", "PROBLEM", 237, 257]]], ["In 2004, the USDA approved the development of a vaccine bank to produce up to 40 million doses of inactivated H5N2, H5N9, H7N2, and H7N3 vaccines for poultry (Becker, 2004) .Current VaccinesA serious concern with inactivated vaccines is the lack of efficiency in production and the exposure of laboratory personnel to pathogenic viruses.", [["VaccinesA", "CHEMICAL", 182, 191], ["H5N2", "ORGANISM", 110, 114], ["H7N3 vaccines", "ORGANISM", 132, 145], ["H5N9", "SPECIES", 116, 120], ["H7N2", "SPECIES", 122, 126], ["H7N3", "SPECIES", 132, 136], ["poultry", "SPECIES", 150, 157], ["a vaccine bank", "TREATMENT", 46, 60], ["inactivated H5N2", "TREATMENT", 98, 114], ["H5N9", "TREATMENT", 116, 120], ["H7N2", "TREATMENT", 122, 126], ["H7N3 vaccines", "TREATMENT", 132, 145], ["Current VaccinesA", "TREATMENT", 174, 191], ["inactivated vaccines", "TREATMENT", 213, 233], ["pathogenic viruses", "PROBLEM", 318, 336]]], ["These vaccines use viruses that are grown in embryonated eggs, a process that requires large biocontainment facilities for highly pathogenic viruses.", [["eggs", "ANATOMY", 57, 61], ["These vaccines", "TREATMENT", 0, 14], ["viruses", "TREATMENT", 19, 26], ["embryonated eggs", "PROBLEM", 45, 61], ["large biocontainment facilities", "TREATMENT", 87, 118], ["highly pathogenic viruses", "PROBLEM", 123, 148], ["embryonated eggs", "OBSERVATION", 45, 61], ["large", "OBSERVATION_MODIFIER", 87, 92]]], ["Manipulation and handling of these wild-type avian influenza viruses involve high levels of biosafety requirements, and it usually takes at least 6 mo to produce an inactivated vaccine by using this method (Liu et al., 2006; Wright, 2008) .", [["influenza viruses", "DISEASE", 51, 68], ["wild-type", "ORGANISM", 35, 44], ["avian influenza viruses", "ORGANISM", 45, 68], ["avian influenza viruses", "SPECIES", 45, 68], ["Manipulation", "TREATMENT", 0, 12], ["type avian influenza viruses", "PROBLEM", 40, 68], ["an inactivated vaccine", "TREATMENT", 162, 184]]], ["These severely limited time constraints are a serious concern for preparedness for large outbreaks.", [["large outbreaks", "PROBLEM", 83, 98], ["severely", "OBSERVATION_MODIFIER", 6, 14], ["large", "OBSERVATION_MODIFIER", 83, 88], ["outbreaks", "OBSERVATION", 89, 98]]], ["Thus, research efforts have been accelerated to develop new production methods and alternative strategies to reduce production time while continuing to elicit safe, sufficient immune responses.Reverse GeneticsReverse genetics technology represents a substantial improvement in generating inactivated and live attenuated vaccine prototype strains.", [["new production methods", "TREATMENT", 56, 78], ["alternative strategies", "TREATMENT", 83, 105], ["live attenuated vaccine prototype strains", "TREATMENT", 304, 345], ["substantial", "OBSERVATION_MODIFIER", 250, 261], ["improvement", "OBSERVATION_MODIFIER", 262, 273]]], ["Reverse genetics was initially used to investigate influenza pathogenesis by the selective modification of genes to observe their effects on behavior and phenotype (Ahringer, 2006) .", [["influenza", "DISEASE", 51, 60], ["influenza pathogenesis", "PROBLEM", 51, 73]]], ["This technique was used to attenuate viruses through directed mutation of internal genes or the removal of virulence factors in highly pathogenic strains (Subbarao and Katz, 2004) .", [["internal genes", "DNA", 74, 88], ["virulence factors", "PROTEIN", 107, 124], ["This technique", "TREATMENT", 0, 14], ["viruses", "PROBLEM", 37, 44], ["internal genes", "TREATMENT", 74, 88], ["the removal", "TREATMENT", 92, 103], ["virulence factors", "PROBLEM", 107, 124]]], ["For virus attenuation, this method is more efficient, precise, and versatile than developing a seed strain via the traditional method of attenuation, which requires multiple passages of a virus in eggs until the virus loses virulence.", [["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 197, 201], ["virus attenuation", "PROBLEM", 4, 21], ["a seed strain", "PROBLEM", 93, 106], ["a virus in eggs", "TREATMENT", 186, 201], ["the virus loses virulence", "PROBLEM", 208, 233], ["virus attenuation", "OBSERVATION", 4, 21], ["more efficient", "OBSERVATION_MODIFIER", 38, 52], ["attenuation", "OBSERVATION_MODIFIER", 137, 148], ["multiple", "OBSERVATION_MODIFIER", 165, 173]]], ["Reverse genetics also enables the generation of replication-competent virus from cloned plasmid DNA (Subbarao et al., 2003; Subbarao and Katz, 2004; Song et al., 2008; Webby and Sandbulte, 2008) .", [["plasmid", "ANATOMY", 88, 95], ["DNA", "CELLULAR_COMPONENT", 96, 99], ["cloned plasmid DNA", "DNA", 81, 99], ["replication", "TREATMENT", 48, 59], ["competent virus", "PROBLEM", 60, 75]]], ["Such vaccines have been evaluated for immunogenicity and efficacy against avian influenza in swine, equines, and poultry (Quinlivan et al., 2005; Richt et al., 2006; Webster et al., 2006; van den Berg et al., 2008) .", [["avian influenza", "DISEASE", 74, 89], ["avian influenza", "ORGANISM", 74, 89], ["swine", "ORGANISM", 93, 98], ["avian influenza", "SPECIES", 74, 89], ["swine", "SPECIES", 93, 98], ["swine", "SPECIES", 93, 98], ["Such vaccines", "TREATMENT", 0, 13], ["immunogenicity", "PROBLEM", 38, 52], ["avian influenza", "PROBLEM", 74, 89]]], ["These are not considered gene-based vaccines but traditional vaccines with an alternative production method, and therefore will not be discussed further.", [["gene-based vaccines", "TREATMENT", 25, 44], ["traditional vaccines", "TREATMENT", 49, 69], ["an alternative production method", "TREATMENT", 75, 107], ["not considered", "UNCERTAINTY", 10, 24]]], ["However, reverse genetics technology bridges the concept of traditional and modern gene-based vaccines.GENE-BASED VACCINESGene-based vaccines differ from traditional vaccines in their ability to allow selective expression of viral gene products in immunized subjects, and they have emerged as a promising new approach to vaccination.", [["viral gene products", "PROTEIN", 225, 244], ["traditional and modern gene-based vaccines", "TREATMENT", 60, 102], ["BASED VACCINESGene-based vaccines", "TREATMENT", 108, 141], ["traditional vaccines", "TREATMENT", 154, 174], ["viral gene products", "TREATMENT", 225, 244]]], ["An essential component is the vector that permits the delivery of a gene encoding the immunogen in vivo rather than injecting preformed virions or viral proteins, as is done conventionally.", [["virions", "ANATOMY", 136, 143], ["viral proteins", "PROTEIN", 147, 161], ["a gene encoding the immunogen", "TREATMENT", 66, 95], ["viral proteins", "PROBLEM", 147, 161], ["essential", "OBSERVATION_MODIFIER", 3, 12], ["component", "OBSERVATION_MODIFIER", 13, 22]]], ["It aims to elicit immune protection by manipulating viral genes to maximize safety and immunogenicity while allowing for cell culture-based production.", [["cell", "ANATOMY", 121, 125], ["cell", "CELL", 121, 125], ["viral genes", "DNA", 52, 63], ["immune protection", "TREATMENT", 18, 35], ["manipulating viral genes", "TREATMENT", 39, 63], ["cell culture", "TEST", 121, 133]]], ["In some instances, production can be much more efficient; vaccines can be generated in as little as 4 mo and on a large scale.", [["vaccines", "TREATMENT", 58, 66], ["a large scale", "TREATMENT", 112, 125]]], ["More important, shorter production times accelerate the process of vaccine deployment after a new pathogen is identified.", [["vaccine deployment", "TREATMENT", 67, 85], ["a new pathogen", "PROBLEM", 92, 106], ["new", "OBSERVATION_MODIFIER", 94, 97], ["pathogen", "OBSERVATION", 98, 106]]], ["The vaccines are designed to be free of contaminants and to maximize safety; in most cases, they cannot replicate within eukaryotic cells, and virulence genes can be removed to mitigate any risks posed by reassortment with field strains.", [["cells", "ANATOMY", 132, 137], ["cells", "CELL", 132, 137], ["eukaryotic cells", "CELL_TYPE", 121, 137], ["virulence genes", "DNA", 143, 158], ["The vaccines", "TREATMENT", 0, 12]]], ["In addition, gene-based vaccines can be tailored to target specific virus field strains because pro-duction schedules allow for the incorporation of newly emerging threats (Swayne, 2008; Wright, 2008) .", [["gene-based vaccines", "TREATMENT", 13, 32], ["target specific virus field strains", "PROBLEM", 52, 87], ["pro-duction schedules", "TREATMENT", 96, 117]]], ["Here, we briefly review 3 types of gene-based vaccines: virus vector-based vaccines, bacterial vector-based vaccines, and DNA vaccines.Virus Vector-Based VaccinesVirus vectors deliver genes encoding protective proteins to the vaccinated host, preferably in replicationdefective viruses.", [["DNA", "CELLULAR_COMPONENT", 122, 125], ["Virus Vector-Based VaccinesVirus vectors", "DNA", 135, 175], ["protective proteins", "PROTEIN", 199, 218], ["gene-based vaccines", "TREATMENT", 35, 54], ["virus vector", "TREATMENT", 56, 68], ["based vaccines", "TREATMENT", 69, 83], ["bacterial vector", "TREATMENT", 85, 101], ["based vaccines", "TREATMENT", 102, 116], ["DNA vaccines", "TREATMENT", 122, 134], ["Virus Vector", "TREATMENT", 135, 147], ["Based VaccinesVirus vectors", "TREATMENT", 148, 175], ["encoding protective proteins", "TREATMENT", 190, 218], ["the vaccinated host", "TREATMENT", 222, 241]]], ["Protective genes (e.g., HA for influenza A) along with enhancer-promoter and terminator regulatory sequences, are inserted into the viral vector nucleotide sequences.", [["nucleotide", "CHEMICAL", 145, 155], ["nucleotide", "CHEMICAL", 145, 155], ["HA for influenza A", "GENE_OR_GENE_PRODUCT", 24, 42], ["HA", "DNA", 24, 26], ["enhancer-promoter and terminator regulatory sequences", "DNA", 55, 108], ["viral vector nucleotide sequences", "DNA", 132, 165], ["HA", "PROBLEM", 24, 26], ["influenza", "PROBLEM", 31, 40], ["enhancer-promoter and terminator regulatory sequences", "TREATMENT", 55, 108]]], ["When the viral vector vaccine is injected, the inserted influenza proteins are expressed, and they induce cellular responses, humoral immune responses, or both to influenza virus.", [["cellular", "ANATOMY", 106, 114], ["influenza virus", "DISEASE", 163, 178], ["cellular", "CELL", 106, 114], ["influenza virus", "ORGANISM", 163, 178], ["influenza proteins", "PROTEIN", 56, 74], ["influenza virus", "SPECIES", 163, 178], ["the viral vector vaccine", "TREATMENT", 5, 29], ["the inserted influenza proteins", "PROBLEM", 43, 74], ["influenza virus", "PROBLEM", 163, 178]]], ["These vaccines are readily manufactured under good manufacturing processes.", [["These vaccines", "TREATMENT", 0, 14], ["good manufacturing", "OBSERVATION", 46, 64]]], ["Currently, canarypox virus vector vaccines are licensed for use against rabies and leukemia in cats, as well as West Nile virus and influenza in horses (Poulet et al., 2007) .Virus Vector-Based VaccinesOne viral vectored vaccine has been licensed for use in poultry.", [["leukemia", "ANATOMY", 83, 91], ["rabies and leukemia", "DISEASE", 72, 91], ["West Nile virus", "DISEASE", 112, 127], ["influenza", "DISEASE", 132, 141], ["canarypox virus", "ORGANISM", 11, 26], ["rabies", "ORGANISM", 72, 78], ["leukemia", "CANCER", 83, 91], ["cats", "ORGANISM", 95, 99], ["West Nile virus", "ORGANISM", 112, 127], ["rabies", "SPECIES", 72, 78], ["cats", "SPECIES", 95, 99], ["Nile virus", "SPECIES", 117, 127], ["canarypox virus", "SPECIES", 11, 26], ["rabies", "SPECIES", 72, 78], ["West Nile virus", "SPECIES", 112, 127], ["poultry", "SPECIES", 258, 265], ["canarypox virus vector vaccines", "TREATMENT", 11, 42], ["rabies", "PROBLEM", 72, 78], ["leukemia in cats", "PROBLEM", 83, 99], ["West Nile virus", "PROBLEM", 112, 127], ["influenza", "PROBLEM", 132, 141], ["Virus Vector", "TREATMENT", 175, 187], ["Based Vaccines", "TREATMENT", 188, 202], ["One viral vectored vaccine", "TREATMENT", 202, 228], ["leukemia", "OBSERVATION", 83, 91]]], ["The Merial recombinant fowlpox virus AI-H5 (rFP-AI-H5; Merial Limited, Duluth, GA), also known as Trovac AI-H5, is administered in the hatchery, which improves biosecurity and quality control and allows for coadministration with other routinely used vaccines as well as for protection at a younger age (Bublot et al., 2006; van den Berg et al., 2008) .", [["fowlpox virus AI-H5", "CHEMICAL", 23, 42], ["rFP-AI-H5", "CHEMICAL", 44, 53], ["GA", "CHEMICAL", 79, 81], ["Trovac AI-H5", "CHEMICAL", 98, 110], ["fowlpox virus", "ORGANISM", 23, 36], ["AI-H5", "ORGANISM", 37, 42], ["rFP", "ORGANISM", 44, 47], ["Duluth", "SIMPLE_CHEMICAL", 71, 77], ["GA", "SIMPLE_CHEMICAL", 79, 81], ["Trovac AI-H5", "ORGANISM", 98, 110], ["fowlpox virus AI-H5 (rFP-AI-H5", "SPECIES", 23, 53], ["Trovac AI-H5", "SPECIES", 98, 110], ["The Merial recombinant fowlpox virus AI", "TEST", 0, 39], ["H5", "PROBLEM", 40, 42], ["rFP", "TEST", 44, 47], ["AI", "TEST", 48, 50], ["H5", "PROBLEM", 51, 53], ["Trovac AI", "TREATMENT", 98, 107], ["coadministration", "TREATMENT", 207, 223], ["vaccines", "TREATMENT", 250, 258], ["fowlpox virus", "OBSERVATION", 23, 36]]], ["In addition, strategies for differentiating infected from vaccinated animals are readily used with existing serological tests (van den Berg et al., 2008) .", [["differentiating infected from vaccinated animals", "PROBLEM", 28, 76], ["existing serological tests", "TEST", 99, 125]]], ["Although only licensed for chickens, this vaccine has also shown good immunogenicity and protection in other domestic avian and mammalian species, such as ducks and cats (Karaca et al., 2005; Steensels et al., 2007) .Virus Vector-Based VaccinesOther viral vector vaccines based on recombinant Newcastle disease viruses (NDV) and recombinant adenoviruses have been developed and may qualify for licensure.", [["Newcastle disease viruses", "DISEASE", 293, 318], ["chickens", "ORGANISM", 27, 35], ["ducks", "ORGANISM", 155, 160], ["cats", "ORGANISM", 165, 169], ["recombinant", "ORGANISM", 281, 292], ["Newcastle disease viruses", "ORGANISM", 293, 318], ["NDV", "ORGANISM", 320, 323], ["adenoviruses", "ORGANISM", 341, 353], ["chickens", "SPECIES", 27, 35], ["ducks", "SPECIES", 155, 160], ["cats", "SPECIES", 165, 169], ["chickens", "SPECIES", 27, 35], ["Newcastle disease viruses", "SPECIES", 293, 318], ["NDV", "SPECIES", 320, 323], ["chickens", "PROBLEM", 27, 35], ["this vaccine", "TREATMENT", 37, 49], ["mammalian species", "PROBLEM", 128, 145], ["Virus Vector", "TREATMENT", 217, 229], ["Based VaccinesOther viral vector vaccines", "TREATMENT", 230, 271], ["recombinant Newcastle disease viruses (NDV", "TREATMENT", 281, 323], ["recombinant adenoviruses", "TREATMENT", 329, 353], ["good", "OBSERVATION_MODIFIER", 65, 69], ["immunogenicity", "OBSERVATION", 70, 84], ["mammalian species", "OBSERVATION", 128, 145]]], ["Newcastle disease is caused by avian paramyxovirus I and may result in a very high mortality rate in poultry, depending on the pathotype, but avirulent NDV strains are commonly used as live vaccines.", [["Newcastle disease", "DISEASE", 0, 17], ["avian paramyxovirus I", "DISEASE", 31, 52], ["avian paramyxovirus I", "ORGANISM", 31, 52], ["NDV strains", "ORGANISM", 152, 163], ["avian paramyxovirus", "SPECIES", 31, 50], ["NDV", "SPECIES", 152, 155], ["avian paramyxovirus I", "SPECIES", 31, 52], ["NDV", "SPECIES", 152, 155], ["Newcastle disease", "PROBLEM", 0, 17], ["avian paramyxovirus I", "PROBLEM", 31, 52], ["a very high mortality rate", "PROBLEM", 71, 97], ["the pathotype", "PROBLEM", 123, 136], ["avirulent NDV strains", "PROBLEM", 142, 163], ["live vaccines", "TREATMENT", 185, 198], ["disease", "OBSERVATION", 10, 17], ["avian paramyxovirus", "OBSERVATION", 31, 50]]], ["Newcastle disease virus vaccines are produced at a lower cost and greater yield than inactivated vaccines, and can be administered through aerosol sprays, drinking water, or eye drops, reducing the cost of administration (Ge et al., 2007) .", [["eye", "ANATOMY", 174, 177], ["Newcastle disease", "DISEASE", 0, 17], ["Newcastle disease virus", "ORGANISM", 0, 23], ["eye", "ORGAN", 174, 177], ["Newcastle disease virus", "SPECIES", 0, 23], ["Newcastle disease virus vaccines", "PROBLEM", 0, 32], ["inactivated vaccines", "TREATMENT", 85, 105], ["aerosol sprays", "TREATMENT", 139, 153], ["eye drops", "TREATMENT", 174, 183]]], ["Bivalent NDV-H5 vaccines engineered by reverse genetics have shown protection against lethal challenges of both NDV and HPAI (Veits et al., 2006; Ge et al., 2007) .Virus Vector-Based VaccinesRecombinant, replication-defective adenoviral (rAd) vectors have also been developed for avian influenza and other varieties of pathogens.", [["HPAI", "DISEASE", 120, 124], ["avian influenza", "DISEASE", 280, 295], ["NDV-H5", "ORGANISM", 9, 15], ["NDV", "ORGANISM", 112, 115], ["adenoviral", "ORGANISM", 226, 236], ["rAd", "ORGANISM", 238, 241], ["avian influenza", "ORGANISM", 280, 295], ["replication-defective adenoviral (rAd) vectors", "DNA", 204, 250], ["NDV", "SPECIES", 112, 115], ["avian influenza", "SPECIES", 280, 295], ["NDV-H5", "SPECIES", 9, 15], ["NDV", "SPECIES", 112, 115], ["Bivalent NDV", "TREATMENT", 0, 12], ["H5 vaccines", "TREATMENT", 13, 24], ["Virus Vector", "TREATMENT", 164, 176], ["Based VaccinesRecombinant", "TREATMENT", 177, 202], ["replication-defective adenoviral (rAd) vectors", "TREATMENT", 204, 250], ["influenza", "PROBLEM", 286, 295], ["pathogens", "PROBLEM", 319, 328], ["pathogens", "OBSERVATION", 319, 328]]], ["A human rAd5 vector encoding an avian influenza H7 HA elicits protective immunity against avian influenza with a single dose in chickens.", [["HA", "CHEMICAL", 51, 53], ["avian influenza", "DISEASE", 90, 105], ["human", "ORGANISM", 2, 7], ["rAd5", "GENE_OR_GENE_PRODUCT", 8, 12], ["avian influenza H7 HA", "ORGANISM", 32, 53], ["avian influenza", "ORGANISM", 90, 105], ["chickens", "ORGANISM", 128, 136], ["human rAd5 vector", "DNA", 2, 19], ["human", "SPECIES", 2, 7], ["avian influenza H7", "SPECIES", 32, 50], ["avian influenza", "SPECIES", 90, 105], ["chickens", "SPECIES", 128, 136], ["human", "SPECIES", 2, 7], ["chickens", "SPECIES", 128, 136], ["A human rAd5 vector", "TREATMENT", 0, 19], ["an avian influenza H7 HA elicits", "TREATMENT", 29, 61], ["influenza", "PROBLEM", 96, 105]]], ["This vaccine can be injected in ovo in conjunction with another adenoviral vector encoding an H5 HA, eliciting robust antibody responses against both H5 and H7 proteins (Toro et al., 2008) .", [["adenoviral", "ORGANISM", 64, 74], ["H5 HA", "ORGANISM", 94, 99], ["H5 HA", "PROTEIN", 94, 99], ["H5 and H7 proteins", "PROTEIN", 150, 168], ["This vaccine", "TREATMENT", 0, 12], ["another adenoviral vector", "TREATMENT", 56, 81], ["an H5 HA", "PROBLEM", 91, 99]]], ["Replication-defective adenoviral-based vaccines efficiently stimulate cellular and humoral responses and allow the incorporation of multiple HA genes, raising the possibility of protection against multiple strains of AI.", [["cellular", "ANATOMY", 70, 78], ["adenoviral", "ORGANISM", 22, 32], ["cellular", "CELL", 70, 78], ["HA", "GENE_OR_GENE_PRODUCT", 141, 143], ["HA genes", "DNA", 141, 149], ["Replication-defective adenoviral-based vaccines", "TREATMENT", 0, 47], ["multiple HA genes", "PROBLEM", 132, 149], ["multiple strains of AI", "PROBLEM", 197, 219]]], ["In fact, experimental DNA prime-rAd boost vaccines were found to induce stronger T-cell responses than coldadapted live attenuated vaccines in mice, and to confer protection against a variety of influenza subtypes, including highly pathogenic H5N1 viruses (Lo et al., 2008) .", [["T-cell", "ANATOMY", 81, 87], ["influenza", "DISEASE", 195, 204], ["H5N1 viruses", "DISEASE", 243, 255], ["DNA", "CELLULAR_COMPONENT", 22, 25], ["T-cell", "CELL", 81, 87], ["mice", "ORGANISM", 143, 147], ["H5N1 viruses", "ORGANISM", 243, 255], ["mice", "SPECIES", 143, 147], ["mice", "SPECIES", 143, 147], ["experimental DNA prime", "PROBLEM", 9, 31], ["rAd boost vaccines", "TREATMENT", 32, 50], ["attenuated vaccines", "TREATMENT", 120, 139], ["protection", "TREATMENT", 163, 173], ["influenza subtypes", "PROBLEM", 195, 213], ["highly pathogenic H5N1 viruses", "PROBLEM", 225, 255]]], ["These findings suggest that viral gene-based vaccination may be able to elicit heterosubtypic immunity (Het-I).", [["viral gene", "DNA", 28, 38], ["viral gene-based vaccination", "TREATMENT", 28, 56]]], ["Heterosubtypic immunity denotes a broader range of immunity that protects against multiple subtypes of influenza A, rather than multiple strains of one subtype, and is the basis for the development of universal flu vaccines.", [["influenza A", "DISEASE", 103, 114], ["influenza A", "ORGANISM", 103, 114], ["influenza A", "PROBLEM", 103, 114], ["universal flu vaccines", "TREATMENT", 201, 223], ["influenza", "OBSERVATION", 103, 112], ["one subtype", "OBSERVATION_MODIFIER", 148, 159]]], ["Usually induced by infection with wild-type viruses, Het-I reduces morbidity and mortality and promotes rapid viral clearance.", [["infection", "DISEASE", 19, 28], ["Het-I", "CHEMICAL", 53, 58], ["wild-type viruses", "ORGANISM", 34, 51], ["Het-I", "ORGANISM", 53, 58], ["infection", "PROBLEM", 19, 28], ["type viruses", "PROBLEM", 39, 51], ["morbidity", "PROBLEM", 67, 76], ["rapid viral clearance", "PROBLEM", 104, 125], ["infection", "OBSERVATION", 19, 28], ["rapid", "OBSERVATION_MODIFIER", 104, 109], ["viral clearance", "OBSERVATION", 110, 125]]], ["Comparative studies in mice have shown that an experimental DNA prime-rAd boost regimen may induce an Het-I response more readily than current licensed inactivated or live attenuated vaccines (Lo et al., 2008) .", [["mice", "ORGANISM", 23, 27], ["DNA", "CELLULAR_COMPONENT", 60, 63], ["Het-I", "GENE_OR_GENE_PRODUCT", 102, 107], ["mice", "SPECIES", 23, 27], ["mice", "SPECIES", 23, 27], ["Comparative studies", "TEST", 0, 19], ["an experimental DNA prime", "TREATMENT", 44, 69], ["rAd boost regimen", "TREATMENT", 70, 87], ["live attenuated vaccines", "TREATMENT", 167, 191]]], ["Although this effect has been observed in mice, whether it can apply to other species, including humans, remains unknown.Virus Vector-Based VaccinesOne limitation of vectored virus vaccines is that maternal antibodies or preimmunity resulting from natural infections may neutralize the viral vector and possibly affect its efficacy.", [["infections", "DISEASE", 256, 266], ["mice", "ORGANISM", 42, 46], ["humans", "ORGANISM", 97, 103], ["maternal antibodies", "PROTEIN", 198, 217], ["mice", "SPECIES", 42, 46], ["humans", "SPECIES", 97, 103], ["mice", "SPECIES", 42, 46], ["humans", "SPECIES", 97, 103], ["vectored virus", "SPECIES", 166, 180], ["Virus Vector", "TREATMENT", 121, 133], ["Based Vaccines", "TREATMENT", 134, 148], ["vectored virus vaccines", "TREATMENT", 166, 189], ["maternal antibodies", "PROBLEM", 198, 217], ["preimmunity", "PROBLEM", 221, 232], ["natural infections", "PROBLEM", 248, 266], ["the viral vector", "PROBLEM", 282, 298], ["vectored virus", "OBSERVATION", 166, 180], ["infections", "OBSERVATION", 256, 266]]], ["However, vaccines can be constructed with rare serotypes, chimeric viruses, or adjuvants to avoid or overcome maternal antibodies, and could be administered early in life to avoid other forms of preimmunity.", [["maternal antibodies", "PROTEIN", 110, 129], ["vaccines", "TREATMENT", 9, 17], ["rare serotypes", "PROBLEM", 42, 56], ["chimeric viruses", "PROBLEM", 58, 74], ["adjuvants", "TREATMENT", 79, 88], ["maternal antibodies", "PROBLEM", 110, 129]]], ["Nonetheless, enhancing these vaccines relies heavily on choosing and developing the most appropriate vector to deliver viral proteins and elicit protective immunity in the host.Bacterial Vector-Based VaccinesIn addition to viruses, recombinant bacteria have been investigated as a possible vector for influenza vaccines.", [["viral proteins", "PROTEIN", 119, 133], ["enhancing these vaccines", "TREATMENT", 13, 37], ["viral proteins", "TREATMENT", 119, 133], ["Bacterial Vector-Based Vaccines", "TREATMENT", 177, 208], ["viruses", "PROBLEM", 223, 230], ["recombinant bacteria", "PROBLEM", 232, 252], ["influenza vaccines", "TREATMENT", 301, 319], ["viruses", "OBSERVATION", 223, 230]]], ["The concepts are similar to virus vectors; genes from a target pathogen are inserted into bacteria, which are then used to deliver them into the host to stimulate an immune response.", [["virus vectors", "TREATMENT", 28, 41], ["a target pathogen", "PROBLEM", 54, 71], ["immune response", "OBSERVATION", 166, 181]]], ["Bacterial vectors are advantageous because they are relatively inexpensive, well-suited for large-scale production, and can be administered orally (Shata et al., 2000; Parsa and Pfeifer, 2007) .", [["Bacterial vectors", "TREATMENT", 0, 17], ["vectors", "OBSERVATION", 10, 17]]], ["In addition, bacterial vectors inherently trigger an immune response and naturally stimulate the activity of antigen-presenting cells (Matzinger, 1994; Banchereau and Steinman, 1998; Paglia et al., 1998; Shata et al., 2000; Parsa and Pfeifer, 2007) .", [["antigen-presenting cells", "ANATOMY", 109, 133], ["cells", "CELL", 128, 133], ["antigen-presenting cells", "CELL_TYPE", 109, 133], ["bacterial vectors", "TREATMENT", 13, 30], ["bacterial vectors", "OBSERVATION", 13, 30]]], ["With precise dosages and delivery, bacterial vectors may provide their own natural adjuvant, and could possibly be used in conjunction with viral vaccines to boost immune responses.", [["precise dosages", "TREATMENT", 5, 20], ["delivery", "TREATMENT", 25, 33], ["bacterial vectors", "TREATMENT", 35, 52], ["viral vaccines", "TREATMENT", 140, 154]]], ["Despite these various advantages, bacterial vectors may encounter more obstacles because of their larger size, which limits gene transfer rates, as well as the large numbers of bacterial antigens that might compete with the recombinant vaccine antigen for immunogenicity.", [["bacterial antigens", "PROTEIN", 177, 195], ["recombinant vaccine antigen", "PROTEIN", 224, 251], ["these various advantages", "TREATMENT", 8, 32], ["bacterial vectors", "TREATMENT", 34, 51], ["bacterial antigens", "PROBLEM", 177, 195], ["the recombinant vaccine antigen", "TREATMENT", 220, 251], ["larger", "OBSERVATION_MODIFIER", 98, 104], ["size", "OBSERVATION_MODIFIER", 105, 109], ["large", "OBSERVATION_MODIFIER", 160, 165], ["bacterial antigens", "OBSERVATION", 177, 195]]], ["In addition, there is a risk of endotoxin and exotoxin release if the bacteria is not attenuated properly, which could result in mild reactions, such as food poisoning, or severe adverse events, such as septic shock (Parsa and Pfeifer, 2007) .", [["endotoxin", "CHEMICAL", 32, 41], ["food poisoning", "DISEASE", 153, 167], ["septic shock", "DISEASE", 203, 215], ["endotoxin", "SIMPLE_CHEMICAL", 32, 41], ["exotoxin", "GENE_OR_GENE_PRODUCT", 46, 54], ["endotoxin", "TREATMENT", 32, 41], ["exotoxin release", "TREATMENT", 46, 62], ["the bacteria", "PROBLEM", 66, 78], ["mild reactions", "PROBLEM", 129, 143], ["food poisoning", "PROBLEM", 153, 167], ["severe adverse events", "PROBLEM", 172, 193], ["septic shock", "PROBLEM", 203, 215], ["mild", "OBSERVATION_MODIFIER", 129, 133], ["reactions", "OBSERVATION", 134, 143], ["severe", "OBSERVATION_MODIFIER", 172, 178], ["septic shock", "OBSERVATION", 203, 215]]], ["These reactions can be reduced by choosing strains lacking particular toxins or by counteracting them with antibiotics.", [["These reactions", "PROBLEM", 0, 15], ["antibiotics", "TREATMENT", 107, 118]]], ["Examples of common bacterial vectors are Salmonella, Bacille Calmette-Guerin, Listeria monocytogenes, and Shigella.", [["Salmonella", "ORGANISM", 41, 51], ["Bacille Calmette-Guerin", "ORGANISM", 53, 76], ["Listeria monocytogenes", "ORGANISM", 78, 100], ["Shigella.", "ORGANISM", 106, 115], ["Listeria monocytogenes", "SPECIES", 78, 100], ["Listeria monocytogenes", "SPECIES", 78, 100], ["common bacterial vectors", "PROBLEM", 12, 36], ["Salmonella", "PROBLEM", 41, 51], ["Bacille Calmette", "TEST", 53, 69], ["Guerin", "PROBLEM", 70, 76], ["Listeria monocytogenes", "PROBLEM", 78, 100], ["Shigella", "PROBLEM", 106, 114], ["common bacterial", "ANATOMY", 12, 28], ["Bacille Calmette", "OBSERVATION", 53, 69], ["Guerin", "ANATOMY", 70, 76], ["Listeria monocytogenes", "OBSERVATION", 78, 100], ["Shigella", "OBSERVATION_MODIFIER", 106, 114]]], ["For avian influenza, attenuated salmonella vectors expressing universally conserved avian influenza ionchannel proteins M2 or M2e have recently been shown to provide broad protection against low-pathogenic influenza challenges (Hargis et al., 2008; van den Berg et al., 2008) .", [["avian influenza", "DISEASE", 4, 19], ["influenza", "DISEASE", 206, 215], ["avian influenza", "ORGANISM", 4, 19], ["salmonella vectors", "ORGANISM", 32, 50], ["avian influenza", "ORGANISM", 84, 99], ["ionchannel proteins M2", "GENE_OR_GENE_PRODUCT", 100, 122], ["M2e", "GENE_OR_GENE_PRODUCT", 126, 129], ["avian influenza ionchannel proteins", "PROTEIN", 84, 119], ["M2", "PROTEIN", 120, 122], ["M2e", "PROTEIN", 126, 129], ["avian influenza", "SPECIES", 4, 19], ["avian influenza ionchannel", "SPECIES", 84, 110], ["avian influenza", "PROBLEM", 4, 19], ["attenuated salmonella vectors", "TREATMENT", 21, 50], ["broad protection", "TREATMENT", 166, 182], ["low-pathogenic influenza challenges", "PROBLEM", 191, 226], ["influenza", "OBSERVATION", 10, 19]]], ["However, this vector did not prevent mortality in lethal challenges of HPAI.", [["HPAI", "DISEASE", 71, 75], ["HPAI", "ORGANISM", 71, 75], ["HPAI", "SPECIES", 71, 75], ["HPAI", "PROBLEM", 71, 75], ["HPAI", "OBSERVATION", 71, 75]]], ["Although bacterial vectors have potential for gene-based vaccine delivery, their advanced development has proven more challenging than the development of DNA or viral vectors, and few have been used in poultry.DNA VaccinesDeoxyribonucleic acid vaccines have received much attention since they were first reported to induce protective immune responses.", [["Deoxyribonucleic acid", "CHEMICAL", 222, 243], ["DNA", "CELLULAR_COMPONENT", 154, 157], ["DNA", "CELLULAR_COMPONENT", 210, 213], ["Deoxyribonucleic acid", "SIMPLE_CHEMICAL", 222, 243], ["bacterial vectors", "TREATMENT", 9, 26], ["gene-based vaccine delivery", "TREATMENT", 46, 73], ["DNA", "PROBLEM", 154, 157], ["viral vectors", "TREATMENT", 161, 174], ["DNA Vaccines", "TREATMENT", 210, 222], ["Deoxyribonucleic acid vaccines", "TREATMENT", 222, 252], ["bacterial vectors", "OBSERVATION", 9, 26], ["viral vectors", "OBSERVATION", 161, 174]]], ["Viral genes are cloned into eukaryotic expression vectors and inserted into DNA plasmids, which are used to transform Escherichia coli.", [["plasmids", "ANATOMY", 80, 88], ["DNA", "CELLULAR_COMPONENT", 76, 79], ["Escherichia coli", "ORGANISM", 118, 134], ["Viral genes", "DNA", 0, 11], ["eukaryotic expression vectors", "DNA", 28, 57], ["DNA plasmids", "DNA", 76, 88], ["Escherichia coli", "SPECIES", 118, 134], ["Escherichia coli", "SPECIES", 118, 134], ["Viral genes", "PROBLEM", 0, 11], ["eukaryotic expression vectors", "TREATMENT", 28, 57], ["DNA plasmids", "TREATMENT", 76, 88], ["transform Escherichia coli", "PROBLEM", 108, 134], ["Escherichia coli", "OBSERVATION", 118, 134]]], ["The resulting DNA is purified and administered intramuscularly or intradermally.", [["intramuscularly", "ANATOMY", 47, 62], ["intradermally", "ANATOMY", 66, 79], ["DNA", "CELLULAR_COMPONENT", 14, 17], ["The resulting DNA", "PROBLEM", 0, 17]]], ["The DNA is then processed by antigen-presenting cells that produce the viral proteins with their own transcription or translation mechanisms.", [["cells", "ANATOMY", 48, 53], ["DNA", "CELLULAR_COMPONENT", 4, 7], ["cells", "CELL", 48, 53], ["antigen-presenting cells", "CELL_TYPE", 29, 53], ["viral proteins", "PROTEIN", 71, 85], ["the viral proteins", "PROBLEM", 67, 85], ["viral proteins", "OBSERVATION", 71, 85]]], ["The viral proteins are then processed through the proteasome and presented on MHC class I and II molecules, where they are detected by the immune system, triggering both cellular and humoral immune responses.", [["immune system", "ANATOMY", 139, 152], ["cellular", "ANATOMY", 170, 178], ["MHC class I", "GENE_OR_GENE_PRODUCT", 78, 89], ["cellular", "CELL", 170, 178], ["viral proteins", "PROTEIN", 4, 18], ["proteasome", "PROTEIN", 50, 60], ["MHC class I and II molecules", "PROTEIN", 78, 106], ["The viral proteins", "PROBLEM", 0, 18], ["the proteasome", "TREATMENT", 46, 60], ["viral proteins", "OBSERVATION", 4, 18], ["humoral immune", "OBSERVATION", 183, 197]]], ["Encoding highly conserved sequences from influenza, such as the nucleoprotein or M2, may induce cross-reactive responses against different kinds of influenza viruses.", [["influenza", "DISEASE", 41, 50], ["influenza viruses", "DISEASE", 148, 165], ["M2", "GENE_OR_GENE_PRODUCT", 81, 83], ["influenza viruses", "ORGANISM", 148, 165], ["M2", "PROTEIN", 81, 83], ["influenza", "PROBLEM", 41, 50], ["influenza viruses", "PROBLEM", 148, 165], ["influenza viruses", "OBSERVATION", 148, 165]]], ["Deoxyribonucleic acid vaccines are safer than conventional vaccines because they are noninfectious and do not replicate in mammalian cells.", [["cells", "ANATOMY", 133, 138], ["Deoxyribonucleic acid", "CHEMICAL", 0, 21], ["Deoxyribonucleic acid", "SIMPLE_CHEMICAL", 0, 21], ["mammalian cells", "CELL", 123, 138], ["mammalian cells", "CELL_TYPE", 123, 138], ["Deoxyribonucleic acid vaccines", "TREATMENT", 0, 30], ["conventional vaccines", "TREATMENT", 46, 67], ["noninfectious", "PROBLEM", 85, 98], ["noninfectious", "OBSERVATION", 85, 98], ["mammalian cells", "OBSERVATION", 123, 138]]], ["There is no risk of contracting disease from the vaccine, and negative responses to other vectors are avoided, including preimmunity to the vector.", [["contracting disease", "PROBLEM", 20, 39], ["the vaccine", "TREATMENT", 45, 56], ["no risk of", "UNCERTAINTY", 9, 19], ["contracting disease", "OBSERVATION", 20, 39]]], ["Unlike virus vectors, there are no immune responses against a DNA plasmid vector.", [["DNA", "CELLULAR_COMPONENT", 62, 65], ["DNA plasmid vector", "DNA", 62, 80], ["Unlike virus vectors", "PROBLEM", 0, 20], ["immune responses", "PROBLEM", 35, 51], ["a DNA plasmid vector", "TREATMENT", 60, 80], ["virus vectors", "OBSERVATION", 7, 20], ["no", "UNCERTAINTY", 32, 34]]], ["This also means that the vaccine can be administered safely and effectively in multiple doses to boost immunity until desired levels are achieved.", [["the vaccine", "TREATMENT", 21, 32]]], ["In addition, the manufacture of DNA plasmid within E. coli is fast and efficient, and allows the production of highly pure and stable vaccines to be scaled up (Cinatl et al., 2007a; van den Berg et al., 2008) .", [["DNA", "CELLULAR_COMPONENT", 32, 35], ["E. coli", "ORGANISM", 51, 58], ["DNA plasmid", "DNA", 32, 43], ["E. coli", "SPECIES", 51, 58], ["E. coli", "SPECIES", 51, 58], ["DNA plasmid", "PROBLEM", 32, 43], ["E. coli", "PROBLEM", 51, 58], ["E. coli", "OBSERVATION", 51, 58]]], ["Deoxyribonucleic acid vaccine technology is expensive relative to other vaccines because the doses required to elicit immunity are relatively large, but ongoing research is addressing concerns about both the strength of immunogenicity and the cost-effectiveness.", [["Deoxyribonucleic acid", "CHEMICAL", 0, 21], ["Deoxyribonucleic acid", "SIMPLE_CHEMICAL", 0, 21], ["Deoxyribonucleic acid vaccine technology", "TREATMENT", 0, 40], ["other vaccines", "TREATMENT", 66, 80], ["large", "OBSERVATION_MODIFIER", 142, 147]]], ["However, it is clear that an effective DNA vaccine offers several significant advantages in its great versatility, safety, stability, ease of production, storage, and delivery.DNA VaccinesDeoxyribonucleic acid vaccines are already currently available for commercial use against other types of pathogens.", [["Deoxyribonucleic acid", "CHEMICAL", 188, 209], ["DNA", "CELLULAR_COMPONENT", 39, 42], ["DNA", "CELLULAR_COMPONENT", 176, 179], ["Deoxyribonucleic acid", "SIMPLE_CHEMICAL", 188, 209], ["an effective DNA vaccine", "TREATMENT", 26, 50], ["delivery", "TREATMENT", 167, 175], ["DNA Vaccines", "TREATMENT", 176, 188], ["Deoxyribonucleic acid vaccines", "TREATMENT", 188, 218], ["pathogens", "PROBLEM", 293, 302], ["pathogens", "OBSERVATION", 293, 302]]], ["Wyeth Fort Dodge Laboratories (Fort Dodge, IA), in conjunction with the Centers for Disease Control and Prevention (Atlanta, GA), developed a DNA vaccine to protect horses from West Nile virus, and this became the first DNA vaccine licensed by the USDA (Holl and Redding, 2005; Dauphin and Zientara, 2007) .", [["DNA", "CELLULAR_COMPONENT", 142, 145], ["horses", "ORGANISM", 165, 171], ["West Nile virus", "ORGANISM", 177, 192], ["DNA", "CELLULAR_COMPONENT", 220, 223], ["West Nile virus", "SPECIES", 177, 192], ["West Nile virus", "SPECIES", 177, 192], ["Disease Control", "TREATMENT", 84, 99], ["a DNA vaccine", "TREATMENT", 140, 153], ["West Nile virus", "PROBLEM", 177, 192]]], ["Shortly afterward, another DNA vaccine developed by Swiss-based Novartis Animal Health (Basel, Switzerland) received approval to protect salmon against infectious hematopoietic necrosis virus (Lorenzen and LaPatra, 2005; Vical Inc., 2005) .", [["infectious hematopoietic necrosis", "DISEASE", 152, 185], ["DNA", "CELLULAR_COMPONENT", 27, 30], ["salmon", "ORGANISM", 137, 143], ["salmon", "SPECIES", 137, 143], ["infectious hematopoietic necrosis virus", "SPECIES", 152, 191], ["another DNA vaccine", "TREATMENT", 19, 38], ["infectious hematopoietic necrosis virus", "PROBLEM", 152, 191], ["necrosis", "OBSERVATION", 177, 185]]], ["In addition, the Merial Memorial Sloan-Kettering Cancer Center (New York, NY) and the Animal Medical Center (New York, NY) developed a DNA vaccine that is licensed to treat and prevent canine melanoma (Bergman, 2007; Merial, 2007) .", [["melanoma", "ANATOMY", 192, 200], ["Cancer", "DISEASE", 49, 55], ["canine melanoma", "DISEASE", 185, 200], ["DNA", "CELLULAR_COMPONENT", 135, 138], ["canine", "ORGANISM", 185, 191], ["melanoma", "CANCER", 192, 200], ["canine", "SPECIES", 185, 191], ["a DNA vaccine", "TREATMENT", 133, 146], ["canine melanoma", "PROBLEM", 185, 200], ["Cancer", "OBSERVATION", 49, 55], ["melanoma", "OBSERVATION", 192, 200]]], ["Regarding influenza, DNA vaccines elicit protective responses in several different animal models, such as the mouse, chicken, and ferret; however, no DNA vaccines are currently licensed for protection against influenza virus.A Polyvalent DNA Vaccine for Avian InfluenzaWe have recently developed an effective trivalent DNA vaccine that elicits broad protection against different H5N1 sublineages in poultry (Rao et al., 2008a) .", [["influenza", "DISEASE", 10, 19], ["influenza virus", "DISEASE", 209, 224], ["InfluenzaWe", "CHEMICAL", 260, 271], ["DNA", "CELLULAR_COMPONENT", 21, 24], ["mouse", "ORGANISM", 110, 115], ["chicken", "ORGANISM", 117, 124], ["ferret", "ORGANISM", 130, 136], ["DNA", "CELLULAR_COMPONENT", 150, 153], ["influenza virus", "ORGANISM", 209, 224], ["DNA", "CELLULAR_COMPONENT", 238, 241], ["Avian InfluenzaWe", "ORGANISM", 254, 271], ["DNA", "CELLULAR_COMPONENT", 319, 322], ["H5N1", "ORGANISM", 379, 383], ["mouse", "SPECIES", 110, 115], ["chicken", "SPECIES", 117, 124], ["ferret", "SPECIES", 130, 136], ["influenza virus", "SPECIES", 209, 224], ["mouse", "SPECIES", 110, 115], ["chicken", "SPECIES", 117, 124], ["ferret", "SPECIES", 130, 136], ["influenza virus", "SPECIES", 209, 224], ["influenza", "PROBLEM", 10, 19], ["DNA vaccines", "TREATMENT", 21, 33], ["DNA vaccines", "TREATMENT", 150, 162], ["influenza virus", "PROBLEM", 209, 224], ["A Polyvalent DNA Vaccine", "TREATMENT", 225, 249], ["an effective trivalent DNA vaccine", "TREATMENT", 296, 330], ["broad protection", "TREATMENT", 344, 360]]], ["It encodes HA proteins from 3 different H5N1 strains: A/Indonesia/05/2005, A/Anhui/1/2005, and A/Vietnam/1203/2004 (Rao et al., 2008b) .", [["HA", "GENE_OR_GENE_PRODUCT", 11, 13], ["HA proteins", "PROTEIN", 11, 22], ["A/Indonesia/05/2005, A/Anhui/1/2005", "SPECIES", 54, 89], ["A/Vietnam/1203/2004", "SPECIES", 95, 114]]], ["The vaccine was developed by first comparing and evaluating different DNA vaccine regimens in mice.", [["DNA", "CELLULAR_COMPONENT", 70, 73], ["mice", "ORGANISM", 94, 98], ["mice", "SPECIES", 94, 98], ["mice", "SPECIES", 94, 98], ["The vaccine", "TREATMENT", 0, 11], ["different DNA vaccine regimens", "TREATMENT", 60, 90]]], ["High-level expression and immunogenicity vectors were used to encode HA from 10 different strains of influenza virus.", [["influenza virus", "DISEASE", 101, 116], ["HA", "GENE_OR_GENE_PRODUCT", 69, 71], ["influenza virus", "ORGANISM", 101, 116], ["influenza virus", "SPECIES", 101, 116], ["influenza virus", "SPECIES", 101, 116], ["High-level expression", "TREATMENT", 0, 21], ["immunogenicity vectors", "TREATMENT", 26, 48], ["encode HA", "PROBLEM", 62, 71], ["influenza virus", "PROBLEM", 101, 116], ["influenza virus", "OBSERVATION", 101, 116]]], ["In this study, various monovalent and multivalent vaccines conferred protection against a lethal strain of H5N1 A/ Vietnam/1203/2004.", [["H5N1 A", "ORGANISM", 107, 113], ["H5N1 A/ Vietnam/1203/2004", "SPECIES", 107, 132], ["this study", "TEST", 3, 13], ["various monovalent", "TREATMENT", 15, 33], ["multivalent vaccines", "TREATMENT", 38, 58]]], ["In chickens, a multivalent H5 HA DNA vaccine elicited broad, robust responses against matched and unmatched challenge strains with as little as two 5-\u03bcg doses.", [["chickens", "ORGANISM", 3, 11], ["DNA", "CELLULAR_COMPONENT", 33, 36], ["chickens", "SPECIES", 3, 11], ["chickens", "SPECIES", 3, 11], ["H5", "SPECIES", 27, 29], ["a multivalent H5 HA DNA vaccine", "TREATMENT", 13, 44]]], ["This vaccine can be administered intradermally or subcutaneously with the CO 2 -powered, needle-free Agro-Jet device, developed by MIT Canada Inc. (2008) .", [["intradermally", "ANATOMY", 33, 46], ["subcutaneously", "ANATOMY", 50, 64], ["CO", "CHEMICAL", 74, 76], ["This vaccine", "TREATMENT", 0, 12], ["the CO", "TEST", 70, 76], ["needle-free Agro-Jet device", "TREATMENT", 89, 116]]], ["The vaccine effectively generates an immune response that neutralizes the avian influenza virus in chickens and prevents productive replication in the host (Rao et al., 2008b) .", [["influenza virus", "DISEASE", 80, 95], ["avian influenza virus", "ORGANISM", 74, 95], ["chickens", "ORGANISM", 99, 107], ["avian influenza virus", "SPECIES", 74, 95], ["chickens", "SPECIES", 99, 107], ["avian influenza virus", "SPECIES", 74, 95], ["chickens", "SPECIES", 99, 107], ["The vaccine", "TREATMENT", 0, 11], ["the avian influenza virus", "PROBLEM", 70, 95], ["productive", "OBSERVATION_MODIFIER", 121, 131]]], ["Although DNA vaccines are generally considered an expensive strategy, the reduction of effective dose (<5 \u03bcg), along with the capability of the Agro-Jet to deliver rapid repeated injections make this DNA vaccine cost-effective and practical for use in poultry.ConclusionsMajor outbreaks of highly pathogenic avian influenza and the imminent threat of a pandemic highlight the need for effective vaccines as a means for control and prevention.", [["avian influenza", "DISEASE", 308, 323], ["DNA", "CELLULAR_COMPONENT", 9, 12], ["DNA", "CELLULAR_COMPONENT", 200, 203], ["avian influenza", "ORGANISM", 308, 323], ["avian influenza", "SPECIES", 308, 323], ["poultry", "SPECIES", 252, 259], ["DNA vaccines", "TREATMENT", 9, 21], ["an expensive strategy", "TREATMENT", 47, 68], ["the Agro-Jet", "TREATMENT", 140, 152], ["rapid repeated injections", "TREATMENT", 164, 189], ["this DNA vaccine", "TREATMENT", 195, 211], ["highly pathogenic avian influenza", "PROBLEM", 290, 323], ["effective vaccines", "TREATMENT", 385, 403], ["highly", "OBSERVATION_MODIFIER", 290, 296], ["pathogenic avian influenza", "OBSERVATION", 297, 323]]], ["The vast majority of current vaccines are inactivated whole-virus vaccines produced in eggs.", [["eggs", "ANATOMY", 87, 91], ["whole-virus", "ORGANISM", 54, 65], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 87, 91], ["current vaccines", "TREATMENT", 21, 37], ["whole-virus vaccines", "TREATMENT", 54, 74]]], ["This production method is limited by the availability of embryonated eggs and by its lack of versatility in quickly altering antigenic composition to respond effectively to a rapidly changing field virus.", [["eggs", "ANATOMY", 69, 73], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 69, 73], ["embryonated eggs", "TREATMENT", 57, 73], ["a rapidly changing field virus", "PROBLEM", 173, 203]]], ["Thus, newer vaccines with more efficient production technologies are needed for a more timely response to severe outbreaks.", [["newer vaccines", "TREATMENT", 6, 20], ["more efficient production technologies", "TREATMENT", 26, 64], ["severe outbreaks", "PROBLEM", 106, 122], ["severe", "OBSERVATION_MODIFIER", 106, 112], ["outbreaks", "OBSERVATION", 113, 122]]], ["Genebased vaccines have emerged as viable candidates to meet these challenges.", [["Genebased vaccines", "TREATMENT", 0, 18]]], ["Not only can they be produced at a much faster rate and on a larger scale by using safe cell-based production methods, but they can also exhibit the potential for enhanced efficacy against a broader range of influenza strains by stimulating both cellular and humoral responses.", [["cell", "ANATOMY", 88, 92], ["cellular", "ANATOMY", 246, 254], ["influenza", "DISEASE", 208, 217], ["cell", "CELL", 88, 92], ["influenza strains", "ORGANISM", 208, 225], ["cellular", "CELL", 246, 254], ["a larger scale", "TREATMENT", 59, 73], ["safe cell-based production methods", "TREATMENT", 83, 117], ["enhanced efficacy", "PROBLEM", 163, 180], ["influenza strains", "PROBLEM", 208, 225]]], ["New gene-based technologies include replication-defective viral and bacterial vectors and DNA vaccines.", [["DNA", "CELLULAR_COMPONENT", 90, 93], ["New gene-based technologies", "PROBLEM", 0, 27], ["replication", "TREATMENT", 36, 47], ["defective viral and bacterial vectors", "TREATMENT", 48, 85], ["DNA vaccines", "TREATMENT", 90, 102], ["defective viral", "OBSERVATION", 48, 63], ["bacterial vectors", "OBSERVATION", 68, 85]]], ["Each demonstrates advantages over conventional vaccines, but they continue to face specific challenges, such as variable immunogenicity and cost of production, which may limit their widespread use.", [["conventional vaccines", "TREATMENT", 34, 55]]], ["A multivalent DNA vaccine that elicits protection in both mice and chickens at low doses now shows promise, and it represents an attractive candidate for licensure and use in poultry.", [["DNA", "CELLULAR_COMPONENT", 14, 17], ["mice", "ORGANISM", 58, 62], ["chickens", "ORGANISM", 67, 75], ["mice", "SPECIES", 58, 62], ["chickens", "SPECIES", 67, 75], ["mice", "SPECIES", 58, 62], ["chickens", "SPECIES", 67, 75], ["poultry", "SPECIES", 175, 182], ["A multivalent DNA vaccine", "TREATMENT", 0, 25]]], ["Gene-based vaccine technologies represent an advance in animal influenza vaccine development that provide a viable alternative to existing eggbased and inactivated viral vaccines.", [["Gene-based vaccine technologies", "TREATMENT", 0, 31], ["animal influenza vaccine", "TREATMENT", 56, 80], ["existing eggbased and inactivated viral vaccines", "TREATMENT", 130, 178]]]], "a40b532f470598966311e6402f995d2551cd5d15": [["IntroductionWith the emergence of the recent COVID-19 outbreak, several contact-tracing applications have been proposed to alert users if they have come in close contact with someone who Mohammad Al-Zinati mhzinati@just.edu.jo Extended author information available on the last page of the article. tested positive for COVID-19.", [["COVID", "TEST", 318, 323]]], ["For instance, Google and Apple launched a joint COVID-19 tracing tool for iOS and Android that employs Bluetooth technology to alert users if they have come in close contact with someone who has tested positive for COVID- 19 .", [["a joint COVID", "TEST", 40, 53], ["tracing tool", "TEST", 57, 69], ["COVID", "TEST", 215, 220], ["joint", "ANATOMY", 42, 47]]], ["The government of Singapore, China, and Austria also launched similar applications for contact tracing.IntroductionNevertheless, none of the proposed applications has considered the possibility of a contaminated environment and its role in transmitting the disease.", [["contact tracing", "TEST", 87, 102], ["a contaminated environment", "PROBLEM", 197, 223], ["the disease", "PROBLEM", 253, 264], ["disease", "OBSERVATION", 257, 264]]], ["According to a recent report from the world health organization [56] , it is vital to include environmental sampling as part of the comprehensive outbreak investigation and combine environmental sampling with the results of COVID-19 patient investigations.", [["patient", "ORGANISM", 233, 240], ["patient", "SPECIES", 233, 240], ["COVID", "TREATMENT", 224, 229], ["patient investigations", "TEST", 233, 255]]], ["Nonetheless, the suggested protocol for sampling the environment is limited to the hospitals and other health care facilities that have a high possibility of being contaminated with the virus.", [["the virus", "PROBLEM", 182, 191]]], ["Other possibly contaminated areas of the environment, such as grocery stores, service areas, and workplaces, are not considered.", [["possibly", "UNCERTAINTY", 6, 14], ["contaminated", "OBSERVATION_MODIFIER", 15, 27], ["areas", "OBSERVATION_MODIFIER", 28, 33], ["not considered", "UNCERTAINTY", 113, 127]]], ["As the proposed framework in this paper is able to identify and localize such infected areas, it can provide a tool for epidemiological investigation teams that supports the efficient sampling of the environment to detect potential threats.", [["such infected areas", "PROBLEM", 73, 92], ["infected", "OBSERVATION", 78, 86]]], ["Effective localization of these threats can help in applying the required actions or the appropriate quarantine necessary to contain the spread of the infection promptly.IntroductionOver the past years, researchers and practitioners have made significant efforts to develop effective biosurveillance systems.", [["infection", "DISEASE", 151, 160], ["the appropriate quarantine", "TREATMENT", 85, 111], ["the infection", "PROBLEM", 147, 160], ["effective biosurveillance systems", "TREATMENT", 274, 307], ["infection", "OBSERVATION", 151, 160]]], ["Research findings suggest that effective biosurveillance systems largely support appropriate responses to biological incidents and alleviate their threats [36, 37] .IntroductionRapid Syndrome Validation Project (RSVP) [4] , Real-Time Outbreak Disease Surveillance (RODS) [51] , BioSense [17] , and Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE) [13] are examples of popular real-world biosurveillance systems that rely on monitoring information combined from from various sources.", [["effective biosurveillance systems", "TREATMENT", 31, 64], ["IntroductionRapid Syndrome", "PROBLEM", 165, 191]]], ["Nevertheless, according to the Centers for Disease Control and Prevention (CDC), many countries are still incapable of implementing and deploying effective biosurveillance systems due to several economic and technological factors [18] .IntroductionTo overcome this limitation, researchers investigated building scalable and reliable biosurveillance systems that integrate the use of wearable sensors technologies with mobileedge and cloud computing platforms [2, 3, 50] .", [["Disease Control", "TREATMENT", 43, 58], ["effective biosurveillance systems", "TREATMENT", 146, 179], ["wearable sensors technologies", "TREATMENT", 383, 412]]], ["However, none of these systems is capable of localizing the origin of biological threats.IntroductionIn this paper, we propose a reorganizing biosurveillance framework for the localization of biological infections.", [["infections", "DISEASE", 203, 213], ["a reorganizing biosurveillance framework", "TREATMENT", 127, 167], ["biological infections", "PROBLEM", 192, 213], ["infections", "OBSERVATION", 203, 213]]], ["The framework is organized as a hierarchy of agent-based infrastructural elements.", [["agent-based infrastructural elements", "DNA", 45, 81], ["infrastructural elements", "OBSERVATION", 57, 81]]], ["At the lower-level, wearable biosensors and personal smartphones continuously monitor and analyze the humans' vital signs.", [["humans", "ORGANISM", 102, 108], ["humans", "SPECIES", 102, 108], ["humans", "SPECIES", 102, 108], ["personal smartphones", "TEST", 44, 64], ["the humans' vital signs", "TEST", 98, 121]]], ["At the higher-level, a hierarchy of software agents deployed on fog nodes are responsible for aggregating monitoring data within their assigned regions and detecting potential threats.", [["fog nodes", "MULTI-TISSUE_STRUCTURE", 64, 73], ["fog nodes", "PROBLEM", 64, 73], ["aggregating monitoring data", "TEST", 94, 121], ["fog nodes", "OBSERVATION", 64, 73]]], ["Moreover, the framework provides an adaptive multi-agent system for reorganizing the monitored environment structure to cope with the evolving dynamics and to alleviate the consequences of the static hosting infrastructure.IntroductionWe organize the rest of this paper as follows.", [["an adaptive multi-agent system", "TREATMENT", 33, 63]]], ["In Section 4, we present the reorganization mechanism.", [["reorganization mechanism", "OBSERVATION", 29, 53]]], ["Finally, we conclude the paper and give future work directions in Section 6.IntroductionEarly detection and immediate response to bioterrorism attacks and disease outbreaks are among the highest priorities in today's modern societies and represent a significant issue at the national security level [25] .", [["bioterrorism attacks", "PROBLEM", 130, 150], ["disease outbreaks", "PROBLEM", 155, 172]]], ["Dealing with emerging epidemics and bioterrorism attacks requires real-time tracking of infectious diseases, continuous surveillance, and very fast, highly accurate data analysis [21] .", [["infectious diseases", "DISEASE", 88, 107], ["bioterrorism attacks", "PROBLEM", 36, 56], ["infectious diseases", "PROBLEM", 88, 107], ["continuous surveillance", "TEST", 109, 132]]], ["An efficient biosurveillance system would have the benefit of enhancing the quality of healthcare, reducing healthcare costs, and controlling disease outbreaks.", [["An efficient biosurveillance system", "TREATMENT", 0, 35], ["controlling disease outbreaks", "PROBLEM", 130, 159]]], ["Traditional biosurveillance systems depend on analyzing data collected about epidemic diseases (Syndromic Surveillance Systems), data collected from medical lab tests (Laboratory Surveillance Systems), or through environmental monitoring (Environmental Surveillance Systems).", [["Traditional biosurveillance systems", "TREATMENT", 0, 35], ["analyzing data", "TEST", 46, 60], ["epidemic diseases", "PROBLEM", 77, 94], ["medical lab tests", "TEST", 149, 166], ["environmental monitoring", "TEST", 213, 237]]], ["Recently, with the remarkable advancements in smart healthcare technology, several edge computing, and IoT-based frameworks have been proposed for biosurveillance.", [["IoT-based frameworks", "TREATMENT", 103, 123], ["biosurveillance", "TREATMENT", 147, 162]]], ["In the following subsections, we discuss the main research efforts in each category.Syndromic surveillance systemsSeveral systems have been developed in recent years to gather and analyze syndromic data obtained from patient records and social media about major epidemic diseases such as influenza-like illness, West Nile virus, Ebola virus, Zika virus, et.", [["influenza-like illness", "DISEASE", 288, 310], ["West Nile virus", "DISEASE", 312, 327], ["Ebola virus", "DISEASE", 329, 340], ["patient", "ORGANISM", 217, 224], ["West Nile virus", "ORGANISM", 312, 327], ["Ebola virus", "ORGANISM", 329, 340], ["Zika virus", "ORGANISM", 342, 352], ["patient", "SPECIES", 217, 224], ["West Nile virus", "SPECIES", 312, 327], ["Ebola virus", "SPECIES", 329, 340], ["Zika virus", "SPECIES", 342, 352], ["West Nile virus", "SPECIES", 312, 327], ["Ebola virus", "SPECIES", 329, 340], ["Zika virus", "SPECIES", 342, 352], ["Syndromic surveillance systems", "PROBLEM", 84, 114], ["major epidemic diseases", "PROBLEM", 256, 279], ["influenza", "PROBLEM", 288, 297], ["West Nile virus", "PROBLEM", 312, 327], ["Ebola virus", "PROBLEM", 329, 340], ["Zika virus", "PROBLEM", 342, 352]]], ["These systems work by analyzing the gathered data to extract distinctive patterns that characterize well-known health threats [16, 20] .Syndromic surveillance systemsPopular examples of these systems include BioSense [17] , Real-Time Outbreak Disease Surveillance (RODS) [51] , Rapid Syndrome Validation Project (RSVP) [4] , New York City syndromic surveillance systems [24] , Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE) [13] , National Bioterrorism Syndromic Surveillance Demonstration Program (NBSSD) [29] , Oak Ridge Bio-surveillance Toolkit (ORBiT) [41] , Integrated Forecast and Early Enteric Outbreak (INFERNO) [34] ,and the CDC's Early Aberration Reporting System (EARS) [27] .Syndromic surveillance systemsDespite their exciting results, syndromic surveillance systems require access to patients' private health records [30] .", [["patients", "ORGANISM", 848, 856], ["patients", "SPECIES", 848, 856], ["Syndromic surveillance systems", "PROBLEM", 136, 166], ["BioSense", "TEST", 208, 216], ["Rapid Syndrome", "PROBLEM", 278, 292], ["the CDC", "TEST", 680, 687], ["Syndromic surveillance systems", "PROBLEM", 737, 767], ["syndromic surveillance systems", "PROBLEM", 799, 829], ["ORBiT", "ANATOMY", 599, 604], ["Enteric", "ANATOMY", 643, 650]]], ["Finally, there is no evidence that they can work well for global surveillance.", [["global surveillance", "TEST", 58, 77], ["no evidence", "UNCERTAINTY", 18, 29]]], ["An interesting discussion about the challenges of syndromic surveillance systems is given in [8] .Laboratory surveillance systemsMedical lab tests provide a reliable source of information about infection cases.", [["infection", "DISEASE", 194, 203], ["syndromic surveillance systems", "TREATMENT", 50, 80], ["Laboratory surveillance systems", "TEST", 98, 129], ["Medical lab tests", "TEST", 129, 146], ["infection cases", "PROBLEM", 194, 209]]], ["Therefore, laboratory surveillance systems work by combining accurate and confirmed test results to detect possible infection outbreaks.", [["infection", "DISEASE", 116, 125], ["laboratory surveillance systems", "TEST", 11, 42], ["infection outbreaks", "PROBLEM", 116, 135], ["possible", "UNCERTAINTY", 107, 115], ["infection", "OBSERVATION", 116, 125]]], ["For laboratory surveillance systems to operate, it is necessary to create a network of specialized medical labs that are capable of sharing and exchanging test results about a specific health security threat.Laboratory surveillance systemsFor example, the California Department of Health Services (CDHS) deployed an automated laboratory-based disease reporting system [10] .", [["laboratory surveillance systems", "TEST", 4, 35], ["specialized medical labs", "TEST", 87, 111], ["Laboratory surveillance systems", "TEST", 208, 239]]], ["Moreover, a cloud computing-based hospital automated laboratory reporting system was proposed in [55] to efficiently exchange medical laboratory test results about infectious diseases.Laboratory surveillance systemsIt is important to note here that laboratory surveillance systems can be combined with syndromic surveillance systems to increase the accuracy of disease outbreak detection.", [["infectious diseases", "DISEASE", 164, 183], ["medical laboratory test", "TEST", 126, 149], ["infectious diseases", "PROBLEM", 164, 183], ["Laboratory surveillance systems", "TEST", 184, 215], ["laboratory surveillance systems", "TEST", 249, 280], ["syndromic surveillance systems", "TEST", 302, 332], ["disease outbreak detection", "PROBLEM", 361, 387]]], ["Nevertheless, laboratory surveillance systems require a considerable amount of time to operate and produce useful results.", [["laboratory surveillance systems", "TEST", 14, 45]]], ["As such, they are not fit to meet the timely response requirement in case of biological attacks.", [["biological attacks", "PROBLEM", 77, 95]]], ["Furthermore, as these systems work as unified networks, the varying capacities of member labs and their different information sharing regulations greatly influence the overall effectiveness of threat detection efforts [54] .Environmental biosurveillance systemsDue to the privacy issues of personal health information, several efforts have investigated using data collected by specialized environmental sensors distributed over different areas of the monitored environment [19, 28] .Environmental biosurveillance systemsBiowatch is an example of an environmental biosurveillance system that uses a network of aerosol sensors deployed in 31 major US cities [42] .", [["member labs", "TEST", 82, 93], ["an environmental biosurveillance system", "TREATMENT", 546, 585], ["aerosol sensors", "TREATMENT", 609, 624]]], ["In [61] , Yang et al. proposed a similar system that uses a wireless sensor network for the real-time monitoring of CO concentration.", [["CO", "CHEMICAL", 116, 118], ["sensor network", "MULTI-TISSUE_STRUCTURE", 69, 83], ["CO", "SIMPLE_CHEMICAL", 116, 118], ["a wireless sensor network", "TREATMENT", 58, 83], ["CO concentration", "TREATMENT", 116, 132]]], ["The system employs a low-frequency modulation method to improve the detection accuracy based on the CO concentration readings collected by the specialized sensors.Environmental biosurveillance systemsAs discussed above, environmental biosurveillance systems do not violate the privacy of humans as they do not rely on any personal data.", [["CO", "CHEMICAL", 100, 102], ["CO", "SIMPLE_CHEMICAL", 100, 102], ["humans", "ORGANISM", 288, 294], ["humans", "SPECIES", 288, 294], ["humans", "SPECIES", 288, 294], ["a low-frequency modulation method", "TREATMENT", 19, 52], ["the detection accuracy", "TEST", 64, 86], ["the CO concentration readings", "TEST", 96, 125], ["environmental biosurveillance systems", "TREATMENT", 220, 257]]], ["However, their installation, operation, and maintenance costs are relatively high, and their coverages are only limited to the locations where the sensors are deployed.IoT-based surveillance systemsThe rapid developments in the area of the Internet of Things (IoT) and their integration with fog, edge, and cloud computing technologies provide an ideal platform for a new generation of advanced surveillance systems.", [["operation", "TREATMENT", 29, 38], ["maintenance costs", "TREATMENT", 44, 61], ["advanced surveillance systems", "TREATMENT", 386, 415], ["relatively", "OBSERVATION_MODIFIER", 66, 76], ["high", "OBSERVATION_MODIFIER", 77, 81], ["rapid", "OBSERVATION_MODIFIER", 202, 207]]], ["In these systems, IoT based sensors and other edge devices collect and initially process raw data.", [["IoT based sensors", "TREATMENT", 18, 35], ["other edge devices", "TREATMENT", 40, 58]]], ["After that, they transmit the initially processed data to nearby fog devices that are capable of performing further processing.", [["further processing", "TREATMENT", 108, 126]]], ["Ultimately, fog nodes send the aggregated data to cloud computing platforms that implement more in-depth analysis and events correlation to extract useful health information.IoT-based surveillance systemsFor instance, Salahuddin et al. [43] proposed a health care system based on an edge computing model.", [["fog nodes", "MULTI-TISSUE_STRUCTURE", 12, 21], ["fog nodes", "PROBLEM", 12, 21], ["depth analysis", "TEST", 99, 113], ["a health care system", "TREATMENT", 250, 270], ["fog nodes", "OBSERVATION", 12, 21]]], ["In their model, they define an edge layer composed of smart edge gateway devices serving as a bridge between a wireless sensor network and a public connected network.", [["edge layer", "ANATOMY", 31, 41], ["network", "MULTI-TISSUE_STRUCTURE", 158, 165], ["smart edge gateway devices", "TREATMENT", 54, 80], ["a wireless sensor network", "TREATMENT", 109, 134], ["a public connected network", "TREATMENT", 139, 165], ["edge", "OBSERVATION_MODIFIER", 31, 35], ["layer", "OBSERVATION_MODIFIER", 36, 41]]], ["The used edge devices can analyze data and issue appropriate warnings in case of emergency conditions.", [["The used edge devices", "TREATMENT", 0, 21]]], ["Besides, several other research efforts have focused on addressing scalability and performance issues resulting from the massively collected data [1, 32, 35, 38-40, 57, 60] , and on enhancing the security level through addressing privacy-related issues of these systems [1, 31] .IoT-based surveillance systemsIn addition to the above-discussed frameworks, recent studies have investigated the possibility of utilizing recent advances in IoT-Based bio-sensors, fog, and cloud computing to implement a variety of health monitoring systems.", [["the massively collected data", "TEST", 117, 145], ["recent studies", "TEST", 356, 370]]], ["Table 1 provides a summary of these studies.", [["these studies", "TEST", 30, 43]]], ["As illustrated in the table, most of these systems use a combination of bio-sensors, fog, and cloud computing technologies to gather and aggregate health information.", [["bio-sensors", "TREATMENT", 72, 83]]], ["The collected data is then used to classify and monitor the infection status of individual people with specific diseases.", [["infection", "DISEASE", 60, 69], ["people", "ORGANISM", 91, 97], ["people", "SPECIES", 91, 97], ["The collected data", "TEST", 0, 18], ["the infection", "PROBLEM", 56, 69], ["specific diseases", "PROBLEM", 103, 120], ["infection", "OBSERVATION", 60, 69]]], ["Despite the effectiveness of the proposed systems in classifying the type of infection for individual cases, none of these systems propose a mechanism to localize the origin of these infections.", [["infection", "DISEASE", 77, 86], ["infections", "DISEASE", 183, 193], ["the proposed systems", "TREATMENT", 29, 49], ["infection", "PROBLEM", 77, 86], ["these infections", "PROBLEM", 177, 193], ["infection", "OBSERVATION", 77, 86], ["infections", "OBSERVATION", 183, 193]]], ["Localization of threat origins becomes very important in the case of purposeful biological attacks.", [["purposeful biological attacks", "PROBLEM", 69, 98], ["threat", "OBSERVATION", 16, 22]]], ["Furthermore, all of the proposed systems rely on the existing static base station infrastructure that is fixed at predefined locations.", [["fixed", "OBSERVATION_MODIFIER", 105, 110]]], ["Nevertheless, in the case of biological attacks, the monitored environment becomes highly dynamic, and some areas might become overloaded while other regions might become empty.", [["biological attacks", "PROBLEM", 29, 47], ["overloaded", "OBSERVATION", 127, 137], ["empty", "OBSERVATION", 171, 176]]], ["Extending the existing systems to adapt to the highly dynamic nature of the monitored environment is a challenging task that still needs further investigation.IoT-based surveillance systemsIn this paper, we present a reorganizing biosurveillance framework for the detection and localization of biological threats.", [["further investigation", "TEST", 137, 158], ["the detection", "TEST", 260, 273]]], ["We organize the elements of the proposed framework in a hierarchical architecture.", [["hierarchical architecture", "OBSERVATION", 56, 81]]], ["At the lower-level, wearable sensors continuously monitor and analyze humans vital signs.", [["humans", "ORGANISM", 70, 76], ["humans", "SPECIES", 70, 76], ["humans", "SPECIES", 70, 76], ["wearable sensors", "TEST", 20, 36], ["analyze humans vital signs", "TEST", 62, 88]]], ["At the higher-levels, a hierarchy of fog nodes aggregate and process monitoring data to detect possible infections.", [["infections", "DISEASE", 104, 114], ["fog nodes", "MULTI-TISSUE_STRUCTURE", 37, 46], ["fog nodes aggregate", "PROBLEM", 37, 56], ["monitoring data", "TEST", 69, 84], ["infections", "PROBLEM", 104, 114], ["fog nodes", "OBSERVATION", 37, 46], ["infections", "OBSERVATION", 104, 114]]], ["The choice of fog computing platforms allows for future extension of the framework to support real-time proactive system for warning population close to infectious threats and guide them to safe places in case of emergencies.", [["fog computing platforms", "TEST", 14, 37]]], ["Although traditional fixed base stations host our fog nodes, the framework continuously reorganizes the monitored environment structure to cope with the evolving environmental conditions.The initial framework for biological threats localizationIn this section, we present our initial framework for the localization of biological infections that we built by extending our earlier framework that is presented in [5] .", [["infections", "DISEASE", 329, 339], ["fog nodes", "MULTI-TISSUE_STRUCTURE", 50, 59], ["biological threats localization", "TEST", 213, 244], ["biological infections", "PROBLEM", 318, 339], ["fog nodes", "OBSERVATION", 50, 59], ["infections", "OBSERVATION", 329, 339]]], ["After that, we explain the limitations of our earlier framework and address the need for its extension to overcome its current limitations.Architecture of the frameworkAs depicted in Fig. 1 , we define the proposed Framework as a hierarchy of infrastructural computing elements.", [["infrastructural computing elements", "DNA", 243, 277], ["Fig", "OBSERVATION", 183, 186]]], ["At the lower level, wearable sensors continuously measure the vital signs of monitored humans.", [["humans", "ORGANISM", 87, 93], ["humans", "SPECIES", 87, 93], ["humans", "SPECIES", 87, 93], ["wearable sensors", "TEST", 20, 36], ["the vital signs", "TEST", 58, 73], ["lower", "ANATOMY_MODIFIER", 7, 12]]], ["The readings are then captured and initially processed at the edge by personal agents hosted on the accompanying smartphones to detect possible abnormalities.", [["abnormalities", "PROBLEM", 144, 157], ["possible", "UNCERTAINTY", 135, 143], ["abnormalities", "OBSERVATION", 144, 157]]], ["As such, we are proposing to utilize ubiquitous smartphone devices and existing base stations infrastructure to deploy our framework and implement its functionalities.", [["ubiquitous smartphone devices", "TREATMENT", 37, 66], ["existing base stations infrastructure", "TREATMENT", 71, 108]]], ["Tech companies recently started to incorporate smartphone accessories, such as earbuds and smartwatches, with biosensors that can easily capture several vital signs and transmit them to an attached smartphone.Architecture of the frameworkAs we are utilizing the existing base station infrastructure, we partition the environment into a set of smaller areas named cells.", [["cells", "ANATOMY", 363, 368], ["cells", "CELL", 363, 368], ["smartphone accessories", "TREATMENT", 47, 69], ["biosensors", "TREATMENT", 110, 120], ["smaller", "OBSERVATION_MODIFIER", 343, 350]]], ["The cell size is defined by the district that is covered by the base station.", [["cell", "ANATOMY", 4, 8], ["cell", "CELL", 4, 8], ["cell", "OBSERVATION_MODIFIER", 4, 8], ["size", "OBSERVATION_MODIFIER", 9, 13], ["district", "OBSERVATION", 32, 40], ["base", "ANATOMY_MODIFIER", 64, 68]]], ["Moreover, we assign each cell a Cell Manager agent that is responsible for collecting monitoring data within its cell.", [["cell", "ANATOMY", 25, 29], ["Cell", "ANATOMY", 32, 36], ["cell", "ANATOMY", 113, 117], ["cell", "CELL", 25, 29], ["Cell", "CELL", 32, 36], ["cell", "CELL", 113, 117], ["collecting monitoring data", "TEST", 75, 101]]], ["The cell manager periodically sends the aggregated data to the corresponding higher-level Regional Manager agent that combines the received data to detect potential threats within its region.Architecture of the frameworkIt is important to note here that cell and regional managers can be deployed on any distributed computational platforms.", [["cell", "ANATOMY", 4, 8], ["cell", "ANATOMY", 254, 258], ["cell", "CELL", 4, 8], ["cell", "CELL", 254, 258], ["potential threats within its region", "PROBLEM", 155, 190]]], ["However, the choice of a fog computing platform allows for future extension of the framework to support real-time proactive system for warning population close to infectious threats and guide them to safe places.Architecture of the frameworkAs the environment might contain multiple infected areas, it is necessary to cluster cells with related infection information into the same regions.", [["cells", "ANATOMY", 326, 331], ["infection", "DISEASE", 345, 354], ["cells", "CELL", 326, 331], ["warning population", "PROBLEM", 135, 153], ["multiple infected areas", "PROBLEM", 274, 297], ["related infection", "PROBLEM", 337, 354], ["multiple", "OBSERVATION_MODIFIER", 274, 282], ["infected", "OBSERVATION", 283, 291], ["infection", "OBSERVATION", 345, 354]]], ["To this end, we define the Coordinator agent to oversee the distribution of cells within regions and redistributes them again when necessary to create regions with focused information.", [["cells", "ANATOMY", 76, 81], ["cells", "CELL", 76, 81]]], ["The effect of latency issues between the coordinator and regional managers are marginal to the work of the coordinator.", [["latency issues", "PROBLEM", 14, 28], ["latency", "OBSERVATION_MODIFIER", 14, 21]]], ["Moreover, aIdentifying infected areasWhile performing their daily chores, monitored humans might navigate different cells of the environment.", [["cells", "ANATOMY", 116, 121], ["humans", "ORGANISM", 84, 90], ["cells", "CELL", 116, 121], ["humans", "SPECIES", 84, 90], ["humans", "SPECIES", 84, 90], ["infected", "OBSERVATION_MODIFIER", 23, 31]]], ["Once a human passes by a biologically infected area, he will become infected.", [["human", "ORGANISM", 7, 12], ["human", "SPECIES", 7, 12], ["human", "SPECIES", 7, 12], ["a biologically infected area", "PROBLEM", 23, 51], ["infected", "PROBLEM", 68, 76], ["infected", "OBSERVATION", 68, 76]]], ["Nevertheless, abnormal vital signs will not immediately appear.", [["abnormal vital signs", "PROBLEM", 14, 34]]], ["Instead, they will reveal after a variable amount of time that depends on the strength of their immunity systems.Identifying infected areasAs more infected humans cross a cell, there is a higher possibility for this cell to be infected.", [["cell", "ANATOMY", 171, 175], ["cell", "ANATOMY", 216, 220], ["humans", "ORGANISM", 156, 162], ["cell", "CELL", 171, 175], ["cell", "CELL", 216, 220], ["humans", "SPECIES", 156, 162], ["humans", "SPECIES", 156, 162], ["infected areas", "PROBLEM", 125, 139], ["this cell", "PROBLEM", 211, 220], ["infected", "PROBLEM", 227, 235], ["infected", "OBSERVATION", 125, 133], ["infected", "OBSERVATION", 147, 155], ["higher possibility for", "UNCERTAINTY", 188, 210], ["infected", "OBSERVATION", 227, 235]]], ["In the same manner, as more non-infected humans cross a cell, there is a lower possibility for this cell to be contaminated.", [["cell", "ANATOMY", 56, 60], ["cell", "ANATOMY", 100, 104], ["humans", "ORGANISM", 41, 47], ["cell", "CELL", 56, 60], ["cell", "CELL", 100, 104], ["humans", "SPECIES", 41, 47], ["humans", "SPECIES", 41, 47], ["this cell", "PROBLEM", 95, 104], ["lower possibility for", "UNCERTAINTY", 73, 94], ["contaminated", "OBSERVATION", 111, 123]]], ["Also, as more humans get infected without crossing a specific cell, it is more likely that this cell is not contaminated.Identifying infected areasTo decide the likelihood of a cell of being contaminated, we use the observations mentioned above to assess the similarity between the traversal information of a specified cell and the infection patterns of humans who traversed that cell.", [["cell", "ANATOMY", 62, 66], ["cell", "ANATOMY", 96, 100], ["cell", "ANATOMY", 177, 181], ["cell", "ANATOMY", 319, 323], ["cell", "ANATOMY", 380, 384], ["infection", "DISEASE", 332, 341], ["humans", "ORGANISM", 14, 20], ["cell", "CELL", 62, 66], ["cell", "CELL", 96, 100], ["cell", "CELL", 177, 181], ["cell", "CELL", 319, 323], ["humans", "ORGANISM", 354, 360], ["cell", "CELL", 380, 384], ["humans", "SPECIES", 14, 20], ["humans", "SPECIES", 354, 360], ["humans", "SPECIES", 14, 20], ["humans", "SPECIES", 354, 360], ["this cell", "PROBLEM", 91, 100], ["infected areas", "PROBLEM", 133, 147], ["the observations", "TEST", 212, 228], ["the infection patterns of humans", "PROBLEM", 328, 360], ["more likely", "UNCERTAINTY", 74, 85], ["infected", "OBSERVATION", 133, 141], ["infection", "OBSERVATION", 332, 341]]], ["As the traversal information of a specified cell is more similar to the infection pattern, the specified cells are more likely to be infected.", [["cell", "ANATOMY", 44, 48], ["cells", "ANATOMY", 105, 110], ["infection", "DISEASE", 72, 81], ["cell", "CELL", 44, 48], ["cells", "CELL", 105, 110], ["a specified cell", "PROBLEM", 32, 48], ["the infection pattern", "PROBLEM", 68, 89], ["infected", "PROBLEM", 133, 141], ["infection", "OBSERVATION", 72, 81], ["more likely to be", "UNCERTAINTY", 115, 132], ["infected", "OBSERVATION", 133, 141]]], ["In our framework, we consider the computed Jaccard similarity as the suspiciousness score of the cell for being infected, and we calculate it as follows:Identifying infected areaswhere, I T (C) is the number of infected persons who navigated C, I U (C) is the number of infected persons who did not navigate C, and N T (C) is the number of not infected persons who navigated C. The regional managers continuously compute ordered lists of cells in their regions according to their Suspiciousness scores.", [["cell", "ANATOMY", 97, 101], ["cells", "ANATOMY", 438, 443], ["cell", "CELL", 97, 101], ["persons", "ORGANISM", 220, 227], ["persons", "ORGANISM", 279, 286], ["persons", "ORGANISM", 353, 360], ["cells", "CELL", 438, 443], ["persons", "SPECIES", 220, 227], ["persons", "SPECIES", 279, 286], ["persons", "SPECIES", 353, 360], ["infected", "PROBLEM", 112, 120], ["infected", "OBSERVATION", 112, 120], ["infected", "OBSERVATION", 165, 173]]], ["The higher the order of a cell, the more likely it is infected.Identifying infected areasFor instance, Fig. 2 illustrates an example of a monitored environment with 9 equallysized cells and three monitored humans.", [["cell", "ANATOMY", 26, 30], ["cells", "ANATOMY", 180, 185], ["cell", "CELL", 26, 30], ["cells", "CELL", 180, 185], ["humans", "ORGANISM", 206, 212], ["equallysized cells", "CELL_TYPE", 167, 185], ["humans", "SPECIES", 206, 212], ["humans", "SPECIES", 206, 212], ["infected", "PROBLEM", 54, 62], ["infected areas", "PROBLEM", 75, 89], ["9 equallysized cells", "TREATMENT", 165, 185], ["more likely", "UNCERTAINTY", 36, 47], ["infected", "OBSERVATION", 54, 62], ["infected", "OBSERVATION", 75, 83]]], ["The spot highlighted in yellow inside cell 5 represents an infected area.", [["cell", "ANATOMY", 38, 42], ["area", "ANATOMY", 68, 72], ["cell 5", "CELL", 38, 44], ["The spot", "PROBLEM", 0, 8], ["an infected area", "PROBLEM", 56, 72], ["spot", "OBSERVATION_MODIFIER", 4, 8], ["yellow", "OBSERVATION_MODIFIER", 24, 30], ["inside cell 5", "OBSERVATION", 31, 44], ["infected", "OBSERVATION_MODIFIER", 59, 67], ["area", "OBSERVATION_MODIFIER", 68, 72]]], ["As a human passes an infected area, he will become infected (a 1 and a 2 ) after a variable incubation time.", [["human", "ORGANISM", 5, 10], ["human", "SPECIES", 5, 10], ["human", "SPECIES", 5, 10], ["an infected area", "PROBLEM", 18, 34], ["infected", "PROBLEM", 51, 59], ["a variable incubation time", "TREATMENT", 81, 107], ["infected", "OBSERVATION", 21, 29], ["infected", "OBSERVATION", 51, 59]]], ["On the other hand, other humans who do not pass infected areas (a 3 ) will not be infected (represented by green dashed lines).", [["humans", "ORGANISM", 25, 31], ["lines", "CELL", 120, 125], ["green dashed lines", "CELL_LINE", 107, 125], ["humans", "SPECIES", 25, 31], ["humans", "SPECIES", 25, 31], ["infected", "OBSERVATION", 48, 56], ["infected", "OBSERVATION", 82, 90]]], ["Table 2 illustrates the results of suspicion scores computed for all cells using (1).", [["cells", "ANATOMY", 69, 74], ["cells", "CELL", 69, 74], ["suspicion scores", "TEST", 35, 51]]], ["As can be seen from the results, cell 5 has the highest suspicion score and, as such, has the highest possibility of containing an infected area.", [["cell", "ANATOMY", 33, 37], ["cell 5", "CELL", 33, 39], ["an infected area", "PROBLEM", 128, 144], ["infected", "OBSERVATION", 131, 139]]], ["These results conform to the actual infected area, as shown in Fig. 2.Multiple-threat detectionIn the case of the existence of multiple infected areas in the environment, it is common that variant numbers of humans cross different infected areas.", [["humans", "ORGANISM", 208, 214], ["humans", "SPECIES", 208, 214], ["humans", "SPECIES", 208, 214], ["multiple infected areas in the environment", "PROBLEM", 127, 169], ["infected", "OBSERVATION", 36, 44], ["threat", "OBSERVATION", 79, 85], ["multiple", "OBSERVATION_MODIFIER", 127, 135], ["infected", "OBSERVATION_MODIFIER", 136, 144], ["areas", "OBSERVATION", 145, 150], ["cross different", "OBSERVATION_MODIFIER", 215, 230], ["infected", "OBSERVATION", 231, 239]]], ["Therefore, infected areas with a relatively small number of crossing humans will be ranked low in the suspiciousness list.", [["humans", "ORGANISM", 69, 75], ["humans", "SPECIES", 69, 75], ["humans", "SPECIES", 69, 75], ["infected areas", "PROBLEM", 11, 25], ["infected", "OBSERVATION_MODIFIER", 11, 19], ["areas", "OBSERVATION_MODIFIER", 20, 25], ["relatively", "OBSERVATION_MODIFIER", 33, 43], ["small", "OBSERVATION_MODIFIER", 44, 49], ["number", "OBSERVATION_MODIFIER", 50, 56], ["crossing", "OBSERVATION", 60, 68]]], ["The problem becomes more visible as the variance in the number of humans crossing different infected areas increases.Multiple-threat detectionThe framework solves the issue of the variant distribution of humans across the monitored environment by grouping cells related to the same threat inside the same region.", [["cells", "ANATOMY", 256, 261], ["humans", "ORGANISM", 66, 72], ["humans", "ORGANISM", 204, 210], ["cells", "CELL", 256, 261], ["humans", "SPECIES", 66, 72], ["humans", "SPECIES", 204, 210], ["humans", "SPECIES", 66, 72], ["humans", "SPECIES", 204, 210], ["more visible", "OBSERVATION_MODIFIER", 20, 32], ["number", "OBSERVATION_MODIFIER", 56, 62], ["different", "OBSERVATION_MODIFIER", 82, 91], ["infected", "OBSERVATION_MODIFIER", 92, 100], ["areas", "OBSERVATION_MODIFIER", 101, 106], ["increases", "OBSERVATION_MODIFIER", 107, 116]]], ["To this end, the cell managers gather infection information from monitored humans within their areas.", [["cell", "ANATOMY", 17, 21], ["infection", "DISEASE", 38, 47], ["cell", "CELL", 17, 21], ["humans", "ORGANISM", 75, 81], ["humans", "SPECIES", 75, 81], ["humans", "SPECIES", 75, 81]]], ["Finally, they pass the calculated measures to the coordinator that rearranges the regions to group related cells within the same regions.", [["cells", "ANATOMY", 107, 112], ["cells", "CELL", 107, 112], ["related cells", "OBSERVATION", 99, 112]]], ["The region managers can then use the newly formed regions to localize biological threats within each region.", [["biological threats", "OBSERVATION", 70, 88]]], ["Detailed information on measuring the distance between monitoring information and creating focused regions can be found in [5] .Limitations of the initial framework and motivations for extensionThe proposed framework assumes a fixed cell size.", [["cell", "ANATOMY", 233, 237], ["cell", "CELL", 233, 237], ["extension", "TEST", 185, 194], ["a fixed cell size", "PROBLEM", 225, 242], ["fixed cell", "OBSERVATION", 227, 237], ["size", "OBSERVATION_MODIFIER", 238, 242]]], ["However, it is evident through experiments that the cell size significantly impacts the effectiveness of the framework.", [["cell", "ANATOMY", 52, 56], ["cell", "CELL", 52, 56], ["the cell size", "PROBLEM", 48, 61], ["cell", "OBSERVATION_MODIFIER", 52, 56], ["size", "OBSERVATION_MODIFIER", 57, 61], ["significantly", "OBSERVATION_MODIFIER", 62, 75]]], ["A larger cell size causes monitored humans to cross cells that contain infection threats but without actually crossing the particular infected portion of the cell.", [["cell", "ANATOMY", 9, 13], ["cells", "ANATOMY", 52, 57], ["cell", "ANATOMY", 158, 162], ["infection", "DISEASE", 71, 80], ["cell", "CELL", 9, 13], ["humans", "ORGANISM", 36, 42], ["cells", "CELL", 52, 57], ["cell", "CELL", 158, 162], ["humans", "SPECIES", 36, 42], ["humans", "SPECIES", 36, 42], ["A larger cell size", "PROBLEM", 0, 18], ["infection threats", "PROBLEM", 71, 88], ["larger", "OBSERVATION_MODIFIER", 2, 8], ["cell", "OBSERVATION", 9, 13], ["size", "OBSERVATION_MODIFIER", 14, 18], ["cross cells", "OBSERVATION_MODIFIER", 46, 57], ["infection", "OBSERVATION", 71, 80], ["particular", "OBSERVATION_MODIFIER", 123, 133], ["infected", "OBSERVATION", 134, 142], ["cell", "ANATOMY", 158, 162]]], ["Hence, the monitoring agent will mark the cell as clear of infections while it is infected.", [["cell", "ANATOMY", 42, 46], ["infections", "DISEASE", 59, 69], ["cell", "CELL", 42, 46], ["the monitoring agent", "TREATMENT", 7, 27], ["infections", "PROBLEM", 59, 69], ["infected", "PROBLEM", 82, 90], ["infections", "OBSERVATION", 59, 69], ["infected", "OBSERVATION", 82, 90]]], ["The wrong specification of cell status will negatively impact the accuracy of the results.Limitations of the initial framework and motivations for extensionOn the other hand, using a smaller cell size results in an additional number of cells.", [["cell", "ANATOMY", 27, 31], ["cell", "ANATOMY", 191, 195], ["cells", "ANATOMY", 236, 241], ["cell", "CELL", 27, 31], ["cell", "CELL", 191, 195], ["cells", "CELL", 236, 241], ["a smaller cell size", "TEST", 181, 200], ["size", "OBSERVATION_MODIFIER", 196, 200]]], ["In this case, infected areas might span more cells, and the same problem starts to appear.Limitations of the initial framework and motivations for extensionMoreover, minimizing the cell size improves the accuracy of the results to a specific limit.", [["cells", "ANATOMY", 45, 50], ["cell", "ANATOMY", 181, 185], ["cells", "CELL", 45, 50], ["cell", "CELL", 181, 185], ["infected areas", "PROBLEM", 14, 28], ["extension", "TEST", 147, 156], ["infected", "OBSERVATION", 14, 22], ["more cells", "OBSERVATION_MODIFIER", 40, 50], ["size", "OBSERVATION_MODIFIER", 186, 190]]], ["Further minimization of cell size will negatively affect the accuracy of the framework, as indicated by the results.", [["cell", "ANATOMY", 24, 28], ["cell", "CELL", 24, 28], ["cell size", "TREATMENT", 24, 33], ["cell", "OBSERVATION", 24, 28], ["size", "OBSERVATION_MODIFIER", 29, 33]]], ["This effect is related to the additional number of cells that results in noise in the collected monitoring information.Limitations of the initial framework and motivations for extensionIt is important to mention here that the continuous evolving conditions of the moving humans and the randomness of biological attacks make it impossible to define an optimal cell size in advance.", [["cells", "ANATOMY", 51, 56], ["cell", "ANATOMY", 359, 363], ["cells", "CELL", 51, 56], ["humans", "ORGANISM", 271, 277], ["cell", "CELL", 359, 363], ["humans", "SPECIES", 271, 277], ["humans", "SPECIES", 271, 277], ["extension", "TEST", 176, 185], ["an optimal cell size", "TREATMENT", 348, 368], ["size", "OBSERVATION_MODIFIER", 364, 368]]], ["Given the previously mentioned conflicting objectives, there is a crucial need for developing a reorganizing technique that adjusts the cell size to adapt to the evolving nature of the monitored environment.A Reorganizing biosurveillance frameworkWe start this section by providing an overview of the proposed framework, and then we present its re-organization methods.General overviewThe re-organization process starts by gathering the monitoring information from the personal agents.", [["cell", "ANATOMY", 136, 140], ["cell", "CELL", 136, 140], ["a reorganizing technique", "TREATMENT", 94, 118], ["the cell size", "TREATMENT", 132, 145], ["this section", "TREATMENT", 256, 268], ["size", "OBSERVATION_MODIFIER", 141, 145]]], ["As discussed in Section 3, personal agents continuously capture the recorded vital signs and process them to detect any abnormality.", [["personal agents", "TREATMENT", 27, 42], ["the recorded vital signs", "TEST", 64, 88], ["any abnormality", "PROBLEM", 116, 131]]], ["After that, the cell managers periodically aggregate monitoring information from Personal agents within their cells.", [["cell", "ANATOMY", 16, 20], ["cells", "ANATOMY", 110, 115], ["cell", "CELL", 16, 20], ["cells", "CELL", 110, 115]]], ["Periodically, the Coordinator regularly oversees the distribution of cells over regions and re-distribute them, if necessary, to improve the accuracy of the framework.", [["cells", "ANATOMY", 69, 74], ["cells", "CELL", 69, 74]]], ["After receiving the aggregated monitoring-information, regional managers use the information within their regions to find a cell structure setting that improves the effectiveness of localizing infected areas.", [["cell", "ANATOMY", 124, 128], ["cell", "CELL", 124, 128], ["the aggregated monitoring", "TEST", 16, 41], ["localizing infected areas", "PROBLEM", 182, 207], ["infected", "OBSERVATION", 193, 201]]], ["For this sake, the regional manager progressively splits the identified suspicious cells into a set of smaller cells to find a cell structure setting that improves the overall accuracy of the framework.", [["cells", "ANATOMY", 83, 88], ["cells", "ANATOMY", 111, 116], ["cell", "ANATOMY", 127, 131], ["cells", "CELL", 83, 88], ["cells", "CELL", 111, 116], ["cell", "CELL", 127, 131], ["suspicious cells", "PROBLEM", 72, 88], ["smaller cells", "PROBLEM", 103, 116], ["suspicious cells", "OBSERVATION", 72, 88], ["cell structure", "OBSERVATION", 127, 141]]], ["As the information of the monitored environment continuously evolves, the framework regularly repeats the re-organization process to cope with the dynamic nature of the environment.General overviewOur initial framework description in [5] contains detailed information on the process of re-organizing cells across regions.", [["cells", "ANATOMY", 300, 305], ["cells", "CELL", 300, 305], ["re-organizing cells", "CELL_TYPE", 286, 305], ["re-organizing cells across regions", "PROBLEM", 286, 320], ["re-organizing cells", "OBSERVATION", 286, 305]]], ["In this section, we focus our discussion on the process of re-organizing the cells within each region to find its best cell structure settings.Re-organization within the regionAt initialization time, the monitored environment is initially divided into a set of cells.", [["cells", "ANATOMY", 77, 82], ["cell", "ANATOMY", 119, 123], ["cells", "ANATOMY", 261, 266], ["cells", "CELL", 77, 82], ["cell", "CELL", 119, 123], ["cells", "CELL", 261, 266], ["re-organizing the cells", "TREATMENT", 59, 82], ["best cell structure", "OBSERVATION", 114, 133]]], ["The original cell size is defined by the maximum area that can be covered by the base station that hosts the cell manager.", [["cell", "ANATOMY", 13, 17], ["cell", "ANATOMY", 109, 113], ["cell", "CELL", 13, 17], ["cell", "CELL", 109, 113], ["original cell", "OBSERVATION", 4, 17], ["size", "OBSERVATION_MODIFIER", 18, 22], ["maximum", "OBSERVATION_MODIFIER", 41, 48], ["area", "OBSERVATION_MODIFIER", 49, 53], ["cell manager", "OBSERVATION", 109, 121]]], ["To improve the accuracy of the framework, the regional manager periodically re-organizes the cell structure settings within its region.", [["cell", "ANATOMY", 93, 97], ["cell", "CELL", 93, 97], ["cell structure", "OBSERVATION", 93, 107]]], ["Algorithm 1 illustrates the re-organization process.Re-organization within the regionIn the remainder of this section, we use the case study in Fig. 3 to illustrate the various steps of the re-organization algorithm.", [["Algorithm", "TEST", 0, 9], ["the re-organization process", "PROBLEM", 24, 51], ["the case study", "TEST", 126, 140], ["the re-organization algorithm", "TEST", 186, 215], ["re-organization process", "OBSERVATION", 28, 51]]], ["Figure 3 presents an example of a monitored environment that consists of 32 equally sized cells organized into two regions according to the technique discussed in Section 3.", [["cells", "ANATOMY", 90, 95], ["cells", "CELL", 90, 95]]], ["Each regional manager is responsible for individually implementing Algorithm 1 to re-organize the cell structure settings within its region.Fig.", [["cell", "ANATOMY", 98, 102], ["cell", "CELL", 98, 102], ["cell structure", "OBSERVATION", 98, 112]]], ["3 A monitored environment that consists of 32 cells organized into two regionsRegion 1 contains a single infected area (highlighted in yellow) that spans cells 2, 10, and 18.", [["cells", "ANATOMY", 46, 51], ["area", "ANATOMY", 114, 118], ["cells", "ANATOMY", 154, 159], ["cells", "CELL", 46, 51], ["cells", "CELL", 154, 159], ["a single infected area", "PROBLEM", 96, 118], ["regions", "ANATOMY_MODIFIER", 71, 78], ["single", "OBSERVATION_MODIFIER", 98, 104], ["infected", "OBSERVATION_MODIFIER", 105, 113], ["area", "OBSERVATION_MODIFIER", 114, 118], ["yellow", "OBSERVATION_MODIFIER", 135, 141]]], ["In the same manner, region 2 has one infected area that spans cells 22 and 23.", [["area", "ANATOMY", 46, 50], ["cells", "ANATOMY", 62, 67], ["cells", "CELL", 62, 67], ["one", "OBSERVATION_MODIFIER", 33, 36], ["infected", "OBSERVATION", 37, 45]]], ["As humans pass any of the infected areas, there will become infected after a variable amount of time.", [["humans", "ORGANISM", 3, 9], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["the infected areas", "PROBLEM", 22, 40], ["infected", "OBSERVATION_MODIFIER", 26, 34], ["areas", "OBSERVATION", 35, 40], ["infected", "OBSERVATION", 60, 68]]], ["A red dashed line represents the traversal path of an infected human.", [["red dashed line", "CELL", 2, 17], ["human", "ORGANISM", 63, 68], ["red dashed line", "CELL_LINE", 2, 17], ["human", "SPECIES", 63, 68], ["human", "SPECIES", 63, 68], ["A red dashed line", "TREATMENT", 0, 17], ["an infected human", "PROBLEM", 51, 68], ["red", "OBSERVATION_MODIFIER", 2, 5], ["dashed line", "OBSERVATION", 6, 17], ["traversal", "OBSERVATION_MODIFIER", 33, 42], ["path", "OBSERVATION_MODIFIER", 43, 47], ["infected human", "OBSERVATION", 54, 68]]], ["The yellow circle on the path represents the point in time when the personal agent first detects the infection state.", [["infection", "DISEASE", 101, 110], ["the infection state", "PROBLEM", 97, 116], ["yellow circle", "OBSERVATION", 4, 17], ["infection", "OBSERVATION", 101, 110]]], ["On the other hand, solid green lines represent the traversal paths of non-infected humans.Fig.", [["solid green lines", "ANATOMY", 19, 36], ["solid green lines", "CELL", 19, 36], ["humans", "ORGANISM", 83, 89], ["solid green lines", "CELL_LINE", 19, 36], ["humans", "SPECIES", 83, 89], ["humans", "SPECIES", 83, 89], ["solid green lines", "PROBLEM", 19, 36], ["hand", "ANATOMY", 13, 17], ["solid", "OBSERVATION", 19, 24], ["green lines", "OBSERVATION", 25, 36], ["traversal paths", "OBSERVATION", 51, 66], ["non-infected humans", "OBSERVATION", 70, 89]]], ["3 A monitored environment that consists of 32 cells organized into two regionsThe regional manager starts by using the original cell structure settings in its region to compute the suspicion ranking ( ) of the cells within its territory (see Algorithm 1 (line 3)).", [["cells", "ANATOMY", 46, 51], ["cell", "ANATOMY", 128, 132], ["cells", "ANATOMY", 210, 215], ["cells", "CELL", 46, 51], ["cell", "CELL", 128, 132], ["cells", "CELL", 210, 215], ["regions", "ANATOMY_MODIFIER", 71, 78]]], ["Table 3 illustrates the results of the suspicion calculation using the original 32 cell-structure.", [["cell", "ANATOMY", 83, 87], ["cell", "CELL", 83, 87], ["the suspicion calculation", "TEST", 35, 60], ["32 cell", "OBSERVATION_MODIFIER", 80, 87]]], ["As shown in the results, cell (10) is ranked as the most suspicious cell in region 1 with a suspicion score of 0.8333 followed by cells (2, 18, 9, 11, 17, 25, 3) .", [["cell", "ANATOMY", 25, 29], ["cell", "ANATOMY", 68, 72], ["cells", "ANATOMY", 130, 135], ["cell", "CELL", 25, 29], ["cell", "CELL", 68, 72], ["cells", "CELL", 130, 135], ["a suspicion score", "TEST", 90, 107], ["cells", "TEST", 130, 135]]], ["On the other hand, cell (23) is ranked as the top suspicious cell in region 2 with a suspicion score of 0.75 followed by cells (30, 31, 4, 12, 13, 14, 15, 32, 22 ).", [["cell", "ANATOMY", 19, 23], ["cell", "ANATOMY", 61, 65], ["cells", "ANATOMY", 121, 126], ["cell", "CELL", 19, 23], ["cell", "CELL", 61, 65], ["cells", "CELL", 121, 126], ["a suspicion score", "TEST", 83, 100], ["cells", "TEST", 121, 126], ["suspicious cell", "OBSERVATION", 50, 65]]], ["The results in Table 3 show that the maximum reached suspicion rank in region 1 is 7 while the maximum rank in region 2 is 5.Fig.", [["maximum", "OBSERVATION_MODIFIER", 95, 102]]], ["3 A monitored environment that consists of 32 cells organized into two regionsAs the reorganization process will generate a large number of cells, it is not feasible to display the suspicion ranking results using a table.", [["cells", "ANATOMY", 46, 51], ["cells", "ANATOMY", 140, 145], ["cells", "CELL", 46, 51], ["cells", "CELL", 140, 145], ["regions", "ANATOMY_MODIFIER", 71, 78], ["large", "OBSERVATION_MODIFIER", 124, 129]]], ["Therefore, we demonstrate the suspicion ranks using a colored map, as depicted in Fig. 4 .", [["a colored map", "TEST", 52, 65]]], ["The cells colored in dark red represent the most suspicious cells, while less suspicious cells have brighter colors.", [["cells", "ANATOMY", 4, 9], ["cells", "ANATOMY", 60, 65], ["cells", "ANATOMY", 89, 94], ["cells", "CELL", 4, 9], ["cells", "CELL", 60, 65], ["cells", "CELL", 89, 94], ["the most suspicious cells", "PROBLEM", 40, 65], ["cells colored", "OBSERVATION", 4, 17], ["dark red", "OBSERVATION_MODIFIER", 21, 29], ["most suspicious", "OBSERVATION_MODIFIER", 44, 59], ["cells", "OBSERVATION", 60, 65], ["brighter colors", "OBSERVATION", 100, 115]]], ["After that, the regional manager progressively splits each infected cell into four equally sized cells (see Algorithm 1 (line 6)).", [["cell", "ANATOMY", 68, 72], ["cells", "ANATOMY", 97, 102], ["cell", "CELL", 68, 72], ["cells", "CELL", 97, 102], ["infected cell", "OBSERVATION", 59, 72]]], ["Then, it uses the new cell structure settings (C RG ) to compute the suspicion rank of the new cells ( ) (see Algorithm 1 (line 8)).", [["cell", "ANATOMY", 22, 26], ["cells", "ANATOMY", 95, 100], ["cell", "CELL", 22, 26], ["cells", "CELL", 95, 100]]], ["In case the new highest reached is larger than the old one, the regional manager repeats the split process (Algorithm 1 (line 5 to 11)).", [["Algorithm", "TEST", 108, 117], ["new", "OBSERVATION_MODIFIER", 12, 15], ["highest", "OBSERVATION_MODIFIER", 16, 23], ["larger", "OBSERVATION_MODIFIER", 35, 41]]], ["The regional manager continues to split infected cells until the obtained highest reached rank (\u03a9) becomes lower than its previous value(\u03a9 ).", [["cells", "ANATOMY", 49, 54], ["cells", "CELL", 49, 54], ["infected cells", "CELL_TYPE", 40, 54], ["split infected cells", "PROBLEM", 34, 54], ["infected cells", "OBSERVATION", 40, 54], ["lower", "OBSERVATION_MODIFIER", 107, 112]]], ["Figure 5 shows the two regions after the first split operation.", [["the first split operation", "TREATMENT", 37, 62], ["operation", "OBSERVATION", 53, 62]]], ["As illustrated in the figure, the regional manager split each infected cell into four equally sized cells, and computes the suspicion scores and ranks accordingly.", [["cell", "ANATOMY", 71, 75], ["cells", "ANATOMY", 100, 105], ["cell", "CELL", 71, 75], ["cells", "CELL", 100, 105], ["the suspicion scores", "TEST", 120, 140], ["infected cell", "OBSERVATION", 62, 75]]], ["For instance, cell 10 is ranked as the most suspicious cell when using the original cell structure.", [["cell", "ANATOMY", 14, 18], ["cell", "ANATOMY", 55, 59], ["cell", "ANATOMY", 84, 88], ["cell", "CELL", 14, 18], ["cell", "CELL", 55, 59], ["cell", "CELL", 84, 88], ["original cell structure", "OBSERVATION", 75, 98]]], ["After the first split, cells 10.3 and 10.4 are listed as most suspicious (colored in dark red), and cells 18.1 and 18.2 are ranked second.", [["cells", "ANATOMY", 23, 28], ["cells", "ANATOMY", 100, 105], ["cells", "CELL", 23, 28], ["cells", "CELL", 100, 105], ["cells", "TEST", 23, 28], ["cells", "TEST", 100, 105]]], ["Cell 18.3 is originally part of cell 18 that was initially ranked second.", [["Cell", "ANATOMY", 0, 4], ["cell", "ANATOMY", 32, 36], ["Cell", "CELL", 0, 4], ["cell 18", "CELL", 32, 39], ["Cell", "TEST", 0, 4]]], ["Nevertheless, cell 18.3 is not identified suspicious after splitting the cells.", [["cell", "ANATOMY", 14, 18], ["cells", "ANATOMY", 73, 78], ["cell", "CELL", 14, 18], ["cells", "CELL", 73, 78], ["cell", "TEST", 14, 18]]], ["This observation conforms with the actual span of the infected area, which does not cover cell 18.3.", [["area", "ANATOMY", 63, 67], ["cell", "ANATOMY", 90, 94], ["cell", "CELL", 90, 94], ["This observation", "TEST", 0, 16], ["infected", "OBSERVATION", 54, 62]]], ["Therefore, minimizing cell size helps in excluding non-infected territories that are included in the case of large cell size and consequently makes the framework more precise.Fig.", [["cell", "ANATOMY", 22, 26], ["cell", "ANATOMY", 115, 119], ["cell", "CELL", 22, 26], ["cell", "CELL", 115, 119], ["minimizing cell size", "PROBLEM", 11, 31], ["large cell size", "PROBLEM", 109, 124], ["minimizing cell", "OBSERVATION", 11, 26], ["size", "OBSERVATION_MODIFIER", 27, 31], ["non-infected territories", "OBSERVATION", 51, 75], ["large", "OBSERVATION_MODIFIER", 109, 114], ["cell", "OBSERVATION", 115, 119], ["size", "OBSERVATION_MODIFIER", 120, 124]]], ["3 A monitored environment that consists of 32 cells organized into two regionsAfter the first split of infected cells (level-1), the highest reached ranks in regions 1 and 2 are 7 and 5, respectively.", [["cells", "ANATOMY", 46, 51], ["cells", "ANATOMY", 112, 117], ["cells", "CELL", 46, 51], ["cells", "CELL", 112, 117], ["infected cells", "CELL_TYPE", 103, 117], ["infected cells", "PROBLEM", 103, 117], ["regions", "ANATOMY_MODIFIER", 71, 78], ["infected cells", "OBSERVATION", 103, 117], ["highest", "OBSERVATION_MODIFIER", 133, 140], ["regions", "ANATOMY_MODIFIER", 158, 165]]], ["As the highest reached ranks for the two regions are equal to the previous ranks at level-0 (i.e., before splitting), the regional managers further split (level-2) the infected cells within both regions.", [["cells", "ANATOMY", 177, 182], ["cells", "CELL", 177, 182], ["infected cells", "CELL_TYPE", 168, 182], ["the infected cells", "PROBLEM", 164, 182], ["highest", "OBSERVATION_MODIFIER", 7, 14], ["equal", "OBSERVATION_MODIFIER", 53, 58], ["infected cells", "OBSERVATION", 168, 182], ["both", "ANATOMY_MODIFIER", 190, 194], ["regions", "ANATOMY_MODIFIER", 195, 202]]], ["As can be noticed, the area of suspicious cells is narrowed down to better match the infected areas.", [["cells", "ANATOMY", 42, 47], ["cells", "CELL", 42, 47], ["suspicious cells", "CELL_TYPE", 31, 47], ["suspicious cells", "PROBLEM", 31, 47], ["suspicious cells", "OBSERVATION", 31, 47], ["narrowed", "OBSERVATION_MODIFIER", 51, 59], ["infected", "OBSERVATION_MODIFIER", 85, 93], ["areas", "OBSERVATION_MODIFIER", 94, 99]]], ["As can be noticed from the figure, the gradients in the suspicion rank of cells in region 2 become very small.", [["cells", "ANATOMY", 74, 79], ["cells", "CELL", 74, 79], ["gradients", "OBSERVATION_MODIFIER", 39, 48], ["very", "OBSERVATION_MODIFIER", 99, 103], ["small", "OBSERVATION_MODIFIER", 104, 109]]], ["This convergence in results indicates that all suspicious cells have the same or close degree of suspiciousness.", [["cells", "ANATOMY", 58, 63], ["suspiciousness", "DISEASE", 97, 111], ["cells", "CELL", 58, 63], ["all suspicious cells", "PROBLEM", 43, 63], ["suspiciousness", "PROBLEM", 97, 111]]], ["Consequently, using this cell structure wastes the improvement in efficiency gained by the split process.Fig.", [["cell", "ANATOMY", 25, 29], ["cell", "CELL", 25, 29], ["this cell structure wastes", "TREATMENT", 20, 46], ["the split process", "PROBLEM", 87, 104], ["improvement", "OBSERVATION_MODIFIER", 51, 62], ["efficiency", "OBSERVATION_MODIFIER", 66, 76], ["split process", "OBSERVATION", 91, 104]]], ["3 A monitored environment that consists of 32 cells organized into two regionsAs the previous highest rank in region 2 is larger than the new one, the split process in region 2 will be reverted to level-1.", [["cells", "ANATOMY", 46, 51], ["cells", "CELL", 46, 51], ["region 2", "DNA", 110, 118], ["regions", "ANATOMY_MODIFIER", 71, 78], ["larger", "OBSERVATION_MODIFIER", 122, 128], ["new", "OBSERVATION_MODIFIER", 138, 141], ["split", "OBSERVATION_MODIFIER", 151, 156], ["process", "OBSERVATION", 157, 164]]], ["Therefore, the regional manager considers the suspicion scores and ranks computed according to the cell structure of level-1.", [["cell", "ANATOMY", 99, 103], ["cell", "CELL", 99, 103], ["the suspicion scores", "TEST", 42, 62]]], ["On the other hand, the regional manager at region 1 further splits its cells to level-3 and computes the suspicion ranks accordingly (see Fig. 7 ).Fig.", [["cells", "ANATOMY", 71, 76], ["cells", "CELL", 71, 76]]], ["3 A monitored environment that consists of 32 cells organized into two regionsAccording to the results given in Fig. 7 , the highest reached rank in region 1 using the structure of level-3 is 4.", [["cells", "ANATOMY", 46, 51], ["cells", "CELL", 46, 51], ["regions", "ANATOMY_MODIFIER", 71, 78], ["highest", "OBSERVATION_MODIFIER", 125, 132]]], ["As such, the regional manager reverts the cell structure to level-2, and the reorganization process stops at this level.", [["cell", "ANATOMY", 42, 46], ["cell", "CELL", 42, 46], ["cell structure", "OBSERVATION", 42, 56], ["reorganization", "OBSERVATION_MODIFIER", 77, 91], ["process", "OBSERVATION", 92, 99]]], ["Figure 8 captures the final cell structure settings after completing the reorganization process.", [["cell", "ANATOMY", 28, 32], ["cell", "CELL", 28, 32], ["the reorganization process", "TREATMENT", 69, 95], ["final cell", "OBSERVATION", 22, 32], ["reorganization process", "OBSERVATION", 73, 95]]], ["As illustrated in Fig. 8 , the most suspicious areas in region 1 are mainly focused within cell 10 and the lower parts of cell 2.", [["cell", "ANATOMY", 91, 95], ["lower parts", "ANATOMY", 107, 118], ["cell", "ANATOMY", 122, 126], ["cell 10", "CELL", 91, 98], ["cell 2", "CELL", 122, 128], ["most", "OBSERVATION_MODIFIER", 31, 35], ["suspicious", "OBSERVATION_MODIFIER", 36, 46], ["areas", "OBSERVATION", 47, 52], ["region", "ANATOMY_MODIFIER", 56, 62], ["mainly", "OBSERVATION_MODIFIER", 69, 75], ["focused", "OBSERVATION_MODIFIER", 76, 83], ["within cell", "OBSERVATION", 84, 95], ["lower parts", "ANATOMY_MODIFIER", 107, 118], ["of cell", "ANATOMY_MODIFIER", 119, 126]]], ["Furthermore, the figure shows that the structure of the identified infected cells adapts to the actual spread of the infection and the infected humans' traversal information.", [["cells", "ANATOMY", 76, 81], ["infection", "DISEASE", 117, 126], ["cells", "CELL", 76, 81], ["humans", "ORGANISM", 144, 150], ["infected cells", "CELL_TYPE", 67, 81], ["humans", "SPECIES", 144, 150], ["humans", "SPECIES", 144, 150], ["infected cells", "PROBLEM", 67, 81], ["the infection", "PROBLEM", 113, 126], ["infected cells", "OBSERVATION", 67, 81], ["spread", "OBSERVATION_MODIFIER", 103, 109], ["infection", "OBSERVATION", 117, 126], ["infected", "OBSERVATION_MODIFIER", 135, 143]]], ["Overall, the framework gives more precise results for region 1 in comparison to region 2.", [["region 1", "DNA", 54, 62]]], ["The improved accuracy in this example is expected as region 1 includes a larger number of monitored humans that generate added monitoring information.", [["humans", "ORGANISM", 100, 106], ["humans", "SPECIES", 100, 106], ["humans", "SPECIES", 100, 106], ["improved", "OBSERVATION_MODIFIER", 4, 12], ["accuracy", "OBSERVATION_MODIFIER", 13, 21], ["larger", "OBSERVATION_MODIFIER", 73, 79], ["number", "OBSERVATION_MODIFIER", 80, 86]]], ["We start by presenting the experimental settings and the evaluation metrics.", [["the evaluation metrics", "TEST", 53, 75]]], ["Then, we discuss the collected results.Experiment settingWe implemented and integrated our framework using DIVAs 4 [6] , a framework for the quick construction of agent-based simulation systems.", [["the quick construction of agent", "TREATMENT", 137, 168]]], ["Using the environment editing system integrated with DIVAs 4, we built a virtual city that consists of buildings, streets, trees, and other environmental objects.", [["DIVAs", "TREATMENT", 53, 58]]], ["In all of our experiments, we fixed the simulated environment dimensions to 8000X8000 meters that we initially partitioned into 256 cells.Experiment settingMoreover, we defined a circular biologically infected area at the center of the virtual city.", [["cells", "ANATOMY", 132, 137], ["cells", "CELL", 132, 137], ["256 cells", "CELL_LINE", 128, 137], ["a circular biologically infected area", "PROBLEM", 177, 214], ["circular", "OBSERVATION_MODIFIER", 179, 187], ["biologically", "OBSERVATION_MODIFIER", 188, 200], ["infected", "OBSERVATION", 201, 209]]], ["We run the simulation scenarios using infected areas with a radius of 100, 200, 300, and 400 meters and with 1000, 2000, and 3000 simulated humans.", [["humans", "ORGANISM", 140, 146], ["humans", "SPECIES", 140, 146], ["humans", "SPECIES", 140, 146], ["infected", "OBSERVATION_MODIFIER", 38, 46], ["areas", "OBSERVATION_MODIFIER", 47, 52]]], ["At the start of the simulation, none of the simulated humans is infected.", [["humans", "ORGANISM", 54, 60], ["humans", "SPECIES", 54, 60], ["humans", "SPECIES", 54, 60], ["infected", "OBSERVATION", 64, 72]]], ["Nevertheless, as any of the humans crosses the infected area, he will become infected after a variable amount of time.", [["humans", "ORGANISM", 28, 34], ["humans", "SPECIES", 28, 34], ["humans", "SPECIES", 28, 34], ["infected", "PROBLEM", 77, 85], ["infected", "OBSERVATION", 47, 55], ["infected", "OBSERVATION", 77, 85]]], ["The incubation period depends on the strength of the immunity level for the infected human.", [["human", "ORGANISM", 85, 90], ["human", "SPECIES", 85, 90], ["human", "SPECIES", 85, 90], ["the infected human", "PROBLEM", 72, 90], ["infected", "OBSERVATION", 76, 84]]], ["For this sake, we assign a random immunity level values for each of our simulated humans that range from 1 to 5.", [["humans", "ORGANISM", 82, 88], ["humans", "SPECIES", 82, 88], ["humans", "SPECIES", 82, 88], ["a random immunity level values", "TEST", 25, 55]]], ["The higher the value, the longer the time it takes the infection signs to appear.Experiment settingFor each combination of the above settings, we ran the simulation scenario 10 times.", [["infection", "DISEASE", 55, 64], ["the infection signs", "PROBLEM", 51, 70], ["the above settings", "TREATMENT", 123, 141], ["higher", "OBSERVATION_MODIFIER", 4, 10], ["infection", "OBSERVATION", 55, 64]]], ["The results show that the percentage of the inspected environment increases as the threat radius increases.", [["environment", "OBSERVATION_MODIFIER", 54, 65], ["increases", "OBSERVATION_MODIFIER", 66, 75], ["threat", "OBSERVATION_MODIFIER", 83, 89], ["radius", "OBSERVATION_MODIFIER", 90, 96], ["increases", "OBSERVATION_MODIFIER", 97, 106]]], ["This increment is expected as the increase in the threat radius increases the overall infected area.", [["the increase in the threat radius", "PROBLEM", 30, 63], ["increase", "OBSERVATION_MODIFIER", 34, 42], ["threat", "OBSERVATION_MODIFIER", 50, 56], ["radius", "OBSERVATION_MODIFIER", 57, 63], ["increases", "OBSERVATION_MODIFIER", 64, 73], ["overall", "OBSERVATION_MODIFIER", 78, 85], ["infected", "OBSERVATION", 86, 94]]], ["Figure 9 also shows that with any number of monitored humans, the rate of inspected environment significantly drops from level (0) to level (2) .", [["humans", "ORGANISM", 54, 60], ["humans", "SPECIES", 54, 60], ["humans", "SPECIES", 54, 60]]], ["After level (2), the decrease becomes marginal.", [["decrease", "OBSERVATION_MODIFIER", 21, 29], ["marginal", "OBSERVATION_MODIFIER", 38, 46]]], ["Minimizing the size of the cell will result in adding new cells in the environment.", [["cell", "ANATOMY", 27, 31], ["cells", "ANATOMY", 58, 63], ["cell", "CELL", 27, 31], ["cells", "CELL", 58, 63], ["size", "OBSERVATION_MODIFIER", 15, 19], ["cell", "OBSERVATION", 27, 31]]], ["This addition will cause the monitored humans to traverse more cells.", [["cells", "ANATOMY", 63, 68], ["humans", "ORGANISM", 39, 45], ["cells", "CELL", 63, 68], ["humans", "SPECIES", 39, 45], ["humans", "SPECIES", 39, 45]]], ["As not all of the newly created cells are infected, crossing these cells will result in collecting false pieces of evidence that affects the accuracy of the model.", [["cells", "ANATOMY", 32, 37], ["cells", "ANATOMY", 67, 72], ["cells", "CELL", 32, 37], ["cells", "CELL", 67, 72], ["the newly created cells", "PROBLEM", 14, 37], ["infected", "PROBLEM", 42, 50], ["infected", "OBSERVATION", 42, 50], ["false pieces", "OBSERVATION", 99, 111]]], ["We can notice the same effect when using more monitored humans in the environment.", [["humans", "ORGANISM", 56, 62], ["humans", "SPECIES", 56, 62], ["humans", "SPECIES", 56, 62]]], ["Although monitoring more humans provides more pieces of evidence, there is a higher chance for those humans to navigate more cells that might not be infected.", [["cells", "ANATOMY", 125, 130], ["humans", "ORGANISM", 25, 31], ["humans", "ORGANISM", 101, 107], ["cells", "CELL", 125, 130], ["humans", "SPECIES", 25, 31], ["humans", "SPECIES", 101, 107], ["humans", "SPECIES", 25, 31], ["humans", "SPECIES", 101, 107], ["might not be", "UNCERTAINTY", 136, 148], ["infected", "OBSERVATION", 149, 157]]], ["Consequently, the benefits gained by monitoring more humans will be lost.", [["humans", "ORGANISM", 53, 59], ["humans", "SPECIES", 53, 59], ["humans", "SPECIES", 53, 59]]], ["For instance, in case of a threat radius of 100, the minimum inspected percentage with 1000 is 0.102% and is achieved at level (5) .", [["percentage", "OBSERVATION_MODIFIER", 71, 81]]], ["In the case of using 2000 humans, the rate drops to 0.0621% and then increases again to 0.0709% in the case of 3000 humans.", [["humans", "ORGANISM", 26, 32], ["humans", "ORGANISM", 116, 122], ["humans", "SPECIES", 26, 32], ["humans", "SPECIES", 116, 122], ["humans", "SPECIES", 26, 32], ["humans", "SPECIES", 116, 122], ["the rate", "TEST", 34, 42]]], ["Despite the slight increase in the percentage of the inspected environment in case of the 3000 humans, the recorded results are comparable to the case of 2000 humans.Results & evaluationThe results in Fig. 9 also show that the minimum percentage in case of the 100 infection radius occurs at levels (5) and (6) .", [["infection", "DISEASE", 265, 274], ["humans", "ORGANISM", 95, 101], ["humans", "ORGANISM", 159, 165], ["humans", "SPECIES", 95, 101], ["humans", "SPECIES", 159, 165], ["humans", "SPECIES", 95, 101], ["humans", "SPECIES", 159, 165], ["evaluation", "TEST", 176, 186], ["the 100 infection radius", "PROBLEM", 257, 281], ["slight", "OBSERVATION_MODIFIER", 12, 18], ["increase", "OBSERVATION_MODIFIER", 19, 27], ["infection", "OBSERVATION", 265, 274]]], ["However, in the case of the 200 infection radius, the minimum percentage occurs at level (4).", [["infection", "DISEASE", 32, 41], ["the 200 infection radius", "PROBLEM", 24, 48], ["infection", "OBSERVATION", 32, 41]]], ["As we can notice from the results, the optimal cell size increases as the size of the infected area increases.Results & evaluationAs the size of the infected area increases, there is a higher possibility of not traversing all infected cells in the environment.", [["cell", "ANATOMY", 47, 51], ["area", "ANATOMY", 95, 99], ["area", "ANATOMY", 158, 162], ["cells", "ANATOMY", 235, 240], ["cell", "CELL", 47, 51], ["cells", "CELL", 235, 240], ["infected cells", "CELL_TYPE", 226, 240], ["the infected area", "PROBLEM", 82, 99], ["evaluation", "TEST", 120, 130], ["the infected area", "PROBLEM", 145, 162], ["size", "OBSERVATION_MODIFIER", 52, 56], ["increases", "OBSERVATION_MODIFIER", 57, 66], ["size", "OBSERVATION_MODIFIER", 74, 78], ["infected", "OBSERVATION_MODIFIER", 86, 94], ["area", "OBSERVATION_MODIFIER", 95, 99], ["increases", "OBSERVATION_MODIFIER", 100, 109], ["size", "OBSERVATION_MODIFIER", 137, 141], ["infected", "OBSERVATION_MODIFIER", 149, 157], ["area", "OBSERVATION_MODIFIER", 158, 162], ["increases", "OBSERVATION_MODIFIER", 163, 172], ["higher possibility of", "UNCERTAINTY", 185, 206], ["infected cells", "OBSERVATION", 226, 240]]], ["Consequently, the framework will not be able to identify all infected cells.", [["cells", "ANATOMY", 70, 75], ["cells", "CELL", 70, 75], ["infected cells", "CELL_TYPE", 61, 75], ["all infected cells", "PROBLEM", 57, 75], ["infected cells", "OBSERVATION", 61, 75]]], ["Figure 10 captures this behavior and shows the percentage of false negatives with a threat radius of 300 and 400 and using 1000, 2000, and 3000 monitored humans.", [["humans", "ORGANISM", 154, 160], ["humans", "SPECIES", 154, 160], ["humans", "SPECIES", 154, 160], ["false negatives", "OBSERVATION", 61, 76]]], ["As can be seen in the Figure, with an infection radius of 300 or 400, the framework is unable to identify all infected cells in the environment.", [["cells", "ANATOMY", 119, 124], ["infection", "DISEASE", 38, 47], ["cells", "CELL", 119, 124], ["infected cells", "CELL_TYPE", 110, 124], ["an infection radius", "PROBLEM", 35, 54], ["infection", "OBSERVATION", 38, 47], ["infected cells", "OBSERVATION", 110, 124]]], ["Nevertheless, as the cell size decreases, the percentage of false negatives also decreases.", [["cell", "ANATOMY", 21, 25], ["cell", "CELL", 21, 25], ["the cell size", "TEST", 17, 30], ["false negatives", "TEST", 60, 75], ["size", "OBSERVATION_MODIFIER", 26, 30], ["decreases", "OBSERVATION_MODIFIER", 31, 40], ["percentage", "OBSERVATION_MODIFIER", 46, 56], ["false negatives", "OBSERVATION", 60, 75], ["decreases", "OBSERVATION_MODIFIER", 81, 90]]], ["Yet, in case of monitoring more number of humans, the percentage of false negatives also deceases.", [["humans", "ORGANISM", 42, 48], ["humans", "SPECIES", 42, 48], ["humans", "SPECIES", 42, 48], ["false negatives", "OBSERVATION", 68, 83]]], ["For instance, the percentage of false negatives will drop to zero percent starting from level (3) in case of monitoring 3000 humans (see Fig. 10c ).", [["humans", "ORGANISM", 125, 131], ["humans", "SPECIES", 125, 131], ["humans", "SPECIES", 125, 131], ["false negatives", "PROBLEM", 32, 47], ["false negatives", "OBSERVATION", 32, 47]]], ["Although monitoring more humans might slightly affect the accuracy of the framework as discussed above, it will result in a higher chance of covering more infected areas.", [["humans", "ORGANISM", 25, 31], ["humans", "SPECIES", 25, 31], ["humans", "SPECIES", 25, 31], ["infected", "OBSERVATION", 155, 163]]], ["Consequently, it helps in minimizing the percentage of false negatives and in enhancing the reliability of the framework.Results & evaluationThe results in Fig. 10 also show that, with an infection radius of 300 and 400 meters, the false negative rates in case of 1000 monitored humans are higher than the false negative rates with 2000 or 3000 humans.", [["infection", "DISEASE", 188, 197], ["humans", "ORGANISM", 279, 285], ["humans", "ORGANISM", 345, 351], ["humans", "SPECIES", 279, 285], ["humans", "SPECIES", 345, 351], ["humans", "SPECIES", 279, 285], ["humans", "SPECIES", 345, 351], ["evaluation", "TEST", 131, 141], ["an infection radius", "TEST", 185, 204], ["the false negative rates", "TEST", 228, 252], ["false negatives", "OBSERVATION", 55, 70], ["infection", "OBSERVATION", 188, 197]]], ["This fact explains why the percentage of the inspected Fig. 10 Percentage of false negatives with a threat radius of 300 and 400 and using 1000, 2000, and 3000 monitored humans environment with 1000 humans is less than the percentage when tracking 2000 and 3000 humans (see Fig. 9g -l).", [["humans", "ORGANISM", 170, 176], ["humans", "ORGANISM", 199, 205], ["humans", "ORGANISM", 262, 268], ["humans", "SPECIES", 170, 176], ["humans", "SPECIES", 199, 205], ["humans", "SPECIES", 262, 268], ["humans", "SPECIES", 170, 176], ["humans", "SPECIES", 199, 205], ["humans", "SPECIES", 262, 268], ["a threat radius", "TEST", 98, 113], ["false negatives", "OBSERVATION", 77, 92]]], ["Figure 11 shows the percentage of false-positive cases generated by the framework.", [["Figure", "TEST", 0, 6]]], ["As the cases of 300 and 400 meters infection radius have loss percentages, we restrict the results to the experiments with 100 and 200 meters infection radius.", [["infection", "DISEASE", 35, 44], ["infection", "DISEASE", 142, 151], ["loss percentages", "PROBLEM", 57, 73]]], ["Furthermore, the percentages of false-positives initially remain low and then start to increase as the level increases for any number of monitored humans.", [["humans", "ORGANISM", 147, 153], ["humans", "SPECIES", 147, 153], ["humans", "SPECIES", 147, 153], ["false-positives", "TEST", 32, 47], ["false", "OBSERVATION", 32, 37]]], ["This increment is expected as the higher levels result in more cells in the environment.", [["cells", "ANATOMY", 63, 68], ["cells", "CELL", 63, 68], ["more cells", "OBSERVATION_MODIFIER", 58, 68]]], ["Accordingly, monitored humans traverse more cells, that might not be infected.", [["cells", "ANATOMY", 44, 49], ["humans", "ORGANISM", 23, 29], ["cells", "CELL", 44, 49], ["humans", "SPECIES", 23, 29], ["humans", "SPECIES", 23, 29], ["might not be", "UNCERTAINTY", 56, 68], ["infected", "OBSERVATION", 69, 77]]], ["Therefore, the number of false-positives increases.Results & evaluationThe results in Fig. 11 also show that with an infection radius of 100 meters, tracking 1000 humans results in a very high percentage of false-positives in comparison to tracking 2000 and 3000 humans for the same infection radius (see Fig. 11a ,b, and c).", [["infection", "DISEASE", 117, 126], ["infection", "DISEASE", 283, 292], ["humans", "ORGANISM", 163, 169], ["humans", "ORGANISM", 263, 269], ["humans", "SPECIES", 163, 169], ["humans", "SPECIES", 263, 269], ["humans", "SPECIES", 163, 169], ["humans", "SPECIES", 263, 269], ["evaluation", "TEST", 61, 71], ["an infection radius", "PROBLEM", 114, 133], ["the same infection radius", "PROBLEM", 274, 299], ["false", "OBSERVATION", 25, 30], ["positives", "OBSERVATION", 31, 40], ["increases", "OBSERVATION_MODIFIER", 41, 50], ["infection", "OBSERVATION", 117, 126], ["infection", "OBSERVATION", 283, 292]]], ["As discussed earlier, monitoring a larger number of humans provides more pieces of evidence and enhances the accuracy of the framework.", [["humans", "ORGANISM", 52, 58], ["humans", "SPECIES", 52, 58], ["humans", "SPECIES", 52, 58], ["larger", "OBSERVATION_MODIFIER", 35, 41]]], ["The percentage of false-positives becomes higher in the case of small infection areas, as in the case of the 100 meter infection radius.", [["infection", "DISEASE", 70, 79], ["infection", "DISEASE", 119, 128], ["false-positives", "PROBLEM", 18, 33], ["small infection areas", "PROBLEM", 64, 85], ["the 100 meter infection radius", "PROBLEM", 105, 135], ["percentage", "OBSERVATION_MODIFIER", 4, 14], ["false", "OBSERVATION", 18, 23], ["positives", "OBSERVATION", 24, 33], ["higher", "OBSERVATION_MODIFIER", 42, 48], ["small", "OBSERVATION_MODIFIER", 64, 69], ["infection", "OBSERVATION", 70, 79], ["infection", "OBSERVATION", 119, 128]]], ["This raise in falsepositives happens because smaller infected areas have a lower chance of being covered by a small number of humans.Results & evaluationNevertheless, the results in Fig. 11 show that with an infection radius of 100 meters, monitoring 2000 humans results in more false-positives in comparison to the case of 3000 humans.", [["infection", "DISEASE", 208, 217], ["humans", "ORGANISM", 126, 132], ["humans", "ORGANISM", 256, 262], ["humans", "ORGANISM", 329, 335], ["humans", "SPECIES", 126, 132], ["humans", "SPECIES", 256, 262], ["humans", "SPECIES", 329, 335], ["humans", "SPECIES", 126, 132], ["humans", "SPECIES", 256, 262], ["humans", "SPECIES", 329, 335], ["smaller infected areas", "PROBLEM", 45, 67], ["Results & evaluation", "TEST", 133, 153], ["an infection radius", "PROBLEM", 205, 224], ["smaller", "OBSERVATION_MODIFIER", 45, 52], ["infected", "OBSERVATION", 53, 61], ["lower chance", "OBSERVATION_MODIFIER", 75, 87], ["small", "OBSERVATION_MODIFIER", 110, 115], ["number", "OBSERVATION_MODIFIER", 116, 122], ["infection", "OBSERVATION", 208, 217]]], ["On the other hand, in case of the 200 meters infection radius, the percentage of false-positives in case of monitoring 3000 humans is higher than the case of 2000 humans.", [["infection", "DISEASE", 45, 54], ["humans", "ORGANISM", 124, 130], ["humans", "ORGANISM", 163, 169], ["humans", "SPECIES", 124, 130], ["humans", "SPECIES", 163, 169], ["humans", "SPECIES", 124, 130], ["humans", "SPECIES", 163, 169], ["the 200 meters infection radius", "PROBLEM", 30, 61]]], ["In the case of the 200 meters infection radius, the environment has a larger number of infected cells in comparison to the 100 meters infection radius.", [["cells", "ANATOMY", 96, 101], ["infection", "DISEASE", 30, 39], ["infection", "DISEASE", 134, 143], ["cells", "CELL", 96, 101], ["infected cells", "CELL_TYPE", 87, 101], ["the 200 meters infection radius", "PROBLEM", 15, 46], ["infected cells", "PROBLEM", 87, 101], ["larger", "OBSERVATION_MODIFIER", 70, 76], ["number", "OBSERVATION_MODIFIER", 77, 83], ["infected cells", "OBSERVATION", 87, 101], ["infection", "OBSERVATION", 134, 143]]], ["Hence, monitoring more humans results in more false positives as these humans have higher chances of traversing more infected cells.Results & evaluationOverall, we can notice from the results that the proposed framework maintained the lowest percentage of inspected areas.", [["cells", "ANATOMY", 126, 131], ["humans", "ORGANISM", 23, 29], ["humans", "ORGANISM", 71, 77], ["cells", "CELL", 126, 131], ["infected cells", "CELL_TYPE", 117, 131], ["humans", "SPECIES", 23, 29], ["humans", "SPECIES", 71, 77], ["humans", "SPECIES", 23, 29], ["humans", "SPECIES", 71, 77], ["traversing more infected cells", "PROBLEM", 101, 131], ["infected cells", "OBSERVATION", 117, 131], ["lowest", "OBSERVATION_MODIFIER", 235, 241], ["percentage", "OBSERVATION_MODIFIER", 242, 252]]], ["Furthermore, the results show that the framework dynamically reorganizes the cell partitioning to minimize the loss and false-positive rates.Conclusion and future workIn this paper, we presented a reorganizing biosurveillance framework for the precise detection of biological threats using fog and mobile edge computing support.", [["cell", "ANATOMY", 77, 81], ["cell", "CELL", 77, 81], ["the cell partitioning", "TREATMENT", 73, 94], ["the loss and false-positive rates", "PROBLEM", 107, 140], ["mobile edge computing support", "TREATMENT", 298, 327], ["cell partitioning", "OBSERVATION", 77, 94], ["positive rates", "OBSERVATION", 126, 140]]], ["In the proposed framework, a hierarchy of fog nodes are responsible for aggregating monitoring data within their regions and detecting potential threats.", [["fog nodes", "MULTI-TISSUE_STRUCTURE", 42, 51], ["fog nodes", "PROBLEM", 42, 51], ["aggregating monitoring data", "TEST", 72, 99], ["fog nodes", "OBSERVATION", 42, 51]]], ["Although fog nodes are deployed on a fixed base station infrastructure, the framework provides an efficient technique for reorganizing the monitored environment structure to adapt to the evolving environmental conditions and to overcome the limitations of the static base station infrastructure.", [["fog nodes", "ANATOMY", 9, 18], ["fog nodes", "MULTI-TISSUE_STRUCTURE", 9, 18], ["fog nodes", "PROBLEM", 9, 18], ["an efficient technique", "TREATMENT", 95, 117], ["fog nodes", "OBSERVATION", 9, 18]]], ["The proposed framework is implemented and assessed in DIVAs 4, a framework for the rapid development of multi-agent simulation systems.", [["multi-agent simulation systems", "TREATMENT", 104, 134]]], ["Evaluation results illustrate the ability of the framework to localize biological threats and detect infected areas.", [["Evaluation", "TEST", 0, 10], ["infected areas", "PROBLEM", 101, 115], ["infected", "OBSERVATION", 101, 109]]], ["Moreover, the results show the effectiveness of the reorganization mechanisms in adjusting the environment structure to cope with the evolving environmental conditions.", [["the reorganization mechanisms", "TREATMENT", 48, 77], ["environmental conditions", "OBSERVATION", 143, 167]]], ["As clearly noticed in the presented experimental results, the framework's main limitation is its inability to identify infected areas not covered by infected humans.", [["humans", "ORGANISM", 158, 164], ["humans", "SPECIES", 158, 164], ["humans", "SPECIES", 158, 164], ["infected areas", "PROBLEM", 119, 133], ["infected", "OBSERVATION", 119, 127], ["infected", "OBSERVATION", 149, 157]]], ["In our future work, we are intending to investigate advanced techniques to anticipate these areas using information from neighboring infected areas.", [["advanced techniques", "TREATMENT", 52, 71], ["infected", "OBSERVATION", 133, 141]]], ["Such methods are vital to improve the accuracy of the framework and minimize the loss rate.", [["the loss rate", "PROBLEM", 77, 90]]], ["Additionally, we intend to investigate the impact of the re-organization process on the performance of the framework.", [["re-organization", "OBSERVATION", 57, 72]]]], "c9dda11349e49ff819f07d1ae24c8a782a1dc6fa": [["IntroductionFrom an external point of view, the asset management (buy side) industry is a well-suited industry to apply machine learning as large amount of data are available thanks to the revolution of electronic trading and the methodical collection of data by asset managers or their acquisition from data providers.", [["the asset management", "TREATMENT", 44, 64], ["electronic trading", "TREATMENT", 203, 221]]], ["In addition, machine based decision can help reducing emotional bias and taking rational and systematic investment choices (Kahneman 2011).", [["rational and systematic investment choices", "TREATMENT", 80, 122]]], ["However, to date, the buy side industry is still largely relying on old and traditional methods to make investment decisions and in particular to choose portfolio allocation and hedging strategies.", [["hedging strategies", "TREATMENT", 178, 196]]], ["This is in sharp contrast with the ubiquitous usage of deep reinforcement learning (DRL) in other industries and in particular its use for solving challenging tasks like autonomous driving (Wang, Jia, and Weng 2018) , learning Copyright c 2020, Association for the Advancement of Artificial Intelligence (www.aaai.org).", [["deep reinforcement", "TREATMENT", 55, 73], ["deep reinforcement", "OBSERVATION", 55, 73]]], ["All rights reserved. advanced locomotion and manipulation skills from raw sensory inputs Levine et al. 2016; Schulman et al. 2015; Schulman et al. 2017; Lillicrap et al. 2015) or on a more conceptual side for reaching supra human level in popular games like Atari (Mnih et al. 2013) , Go Silver et al. 2017 It therefore makes sense to investigate if DRL can help help in financial planning and in particular in creating augmented asset managers.", [["human", "ORGANISM", 224, 229], ["human", "SPECIES", 224, 229], ["advanced locomotion", "PROBLEM", 21, 40]]], ["To narrow down our problem, we are specifically interested in finding hedging strategies for a risky asset.", [["narrow", "OBSERVATION_MODIFIER", 3, 9]]], ["To make things concrete and more illustrative, we represent this risky asset in our experiment with the MSCI World index that captures large and mid cap securities across 23 developed financial markets.", [["large and mid cap securities", "PROBLEM", 135, 163], ["large", "OBSERVATION_MODIFIER", 135, 140], ["mid cap", "OBSERVATION_MODIFIER", 145, 152]]], ["The targeted hedging strategies are on purpose different in nature and spirit.", [["The targeted hedging strategies", "TREATMENT", 0, 31]]], ["Financial planning is therefore critical for deciding the appropriate timing when to add and remove these hedging strategies.Related worksAt first, reinforcement learning was not used in portfolio allocation.", [["these hedging strategies", "TREATMENT", 100, 124], ["reinforcement learning", "TREATMENT", 148, 170]]], ["Armed with the forecast, an augmented asset manager could solve its financial planning problem to decide the optimal portfolio allocations.", [["an augmented asset manager", "TREATMENT", 25, 51]]], ["However, this initial usage of machine learning contains multiple caveats.", [["machine learning", "TREATMENT", 31, 47], ["multiple", "OBSERVATION_MODIFIER", 57, 65], ["caveats", "OBSERVATION", 66, 73]]], ["First, there is no guarantee that the forecast is reliable in the near future.", [["no", "UNCERTAINTY", 16, 18]]], ["Third, there is no consideration of online learning to adapt to changing environment as well as the incorporation of transaction costs.", [["no consideration of", "UNCERTAINTY", 16, 35]]], ["A second stream of research around deep reinforcement learning has emerged to address these points (Jiang and Liang 2016; Jiang, Xu, and Liang 2017; Liang et al. 2018; Yu et al. 2019; Wang and Zhou 2019; Liu et al. 2020; Ye et al. 2020; Xiong et al. 2019; Benhamou et al. 2020) .", [["research around deep reinforcement", "TREATMENT", 19, 53], ["stream", "OBSERVATION_MODIFIER", 9, 15]]], ["However, these works, except (Ye et al. 2020) and (Benhamou et al. 2020 ) rely only on time series of open high low close prices, which are known to be very noisy.", [["open high low close prices", "TREATMENT", 102, 128]]], ["Thirdly, except (Benhamou et al. 2020), they rely on a single reward function and do not measure the impact of the reward function.", [["reward function", "OBSERVATION", 115, 130]]], ["Technically, we create two sub-networks: one fed with direct observations (past prices and standard deviation) and another one with contextual information (level of risk aversion in financial markets, early warning indicators for future recession, corporate earnings etc...).Contributions\u2022 One day lag between price observation and action.", [["price observation", "TEST", 310, 327]]], ["This one day lag makes the RL problem more realistic but also more challenging.Contributions\u2022 The walk-forward procedure.", [["the RL problem", "PROBLEM", 23, 37], ["The walk-forward procedure", "TREATMENT", 94, 120]]], ["We present a new methodology in DRL model evaluation referred to as walk forward analysis that iteratively trains and tests the model on extending data-set.", [["DRL model evaluation", "TEST", 32, 52]]], ["This allows validating that selected hyper parameters work well over time and that the resulting model is stable over time.Contributions\u2022 Model leverage.", [["stable", "OBSERVATION_MODIFIER", 106, 112], ["Model leverage", "OBSERVATION", 138, 152]]], ["Not only do we do a multi inputs network, we also do a multi outputs network to compute at the same time the percentage in each hedging strategy and the overall leverage.", [["inputs network", "MULTI-TISSUE_STRUCTURE", 26, 40]]], ["This is a nice feature of this DRL model as it incorporates by design a leverage mechanism.ContributionsTo make sure the leverage is in line with the asset manager objective, we cap the leverage to the maximum authorized leverage, which is in our case 3.", [["this DRL model", "TREATMENT", 26, 40]]], ["This byproduct of the method is another key difference with standard financial methods like Markwitz that do not care about leverage and only give a percentage for the hedging portfolio allocation.Background and mathematical formulationIn standard reinforcement learning, models are based on Markov Decision Process (MDP) (Sutton and Barto 2018) .", [["mathematical formulationIn standard reinforcement learning", "TREATMENT", 212, 270]]], ["A Markov decision process is defined as a tuple M = (X , A, p, r) where: \u2022 X is the state space, \u2022 A is the action space, \u2022 p(y|x, a) is the transition probability such that p(y|x, a) = P(x t+1 = y|x t = x, a t = a), \u2022 r(x, a, y) is the reward of transition (x, a, y).Background and mathematical formulationMDP assumes that the we know all the states of the environment and have all the information to make the optimal decision in every state.", [["MDP", "SIMPLE_CHEMICAL", 307, 310], ["the transition probability", "TEST", 137, 163], ["t", "TEST", 200, 201], ["transition", "TEST", 247, 257]]], ["The Markov property in addition implies that knowing the current state is sufficient.", [["The Markov property", "TREATMENT", 0, 19], ["Markov property", "OBSERVATION", 4, 19]]], ["In practice to avoid large dimension and the curse of dimension, it is useful to reduce this set and take only a subset of these past observations with j < n past observations, such that 0 < i 1 < . . . < i j and i k \u2208 N is an integer.", [["large dimension", "OBSERVATION_MODIFIER", 21, 36]]], ["In the case of a trading framework, regular observations are past prices observed over a lag period \u03b4 = (0 < i 1 < . . . < i j ).ObservationsTo renormalize data, we rather use past returns computed as r t = p k t p k t\u22121 \u2212 1 where p k t is the price at time t of the asset k.", [["k t", "TEST", 215, 218]]], ["To give information about regime changes, our trading agent receives also empirical standard deviation computed over a sliding estimation window denoted by d as followsObservationsThis setting with two layers (past returns and past volatilities) is quite different from the one presented in (Jiang and Liang 2016; Jiang, Xu, and Liang 2017; Liang et al. 2018 ) that uses different layers representing closing, open high low prices.", [["regime changes", "TREATMENT", 26, 40], ["a sliding estimation window", "TREATMENT", 117, 144], ["open high low prices", "TREATMENT", 410, 430]]], ["First, high low information does not make sense for portfolio strategies that are only evaluated daily, which is the case of all the funds.", [["portfolio strategies", "TREATMENT", 52, 72]]], ["Secondly, open high low prices tend to be highly correlated creating some noise in the inputs.", [["open high low prices", "TREATMENT", 10, 30], ["high low", "OBSERVATION_MODIFIER", 15, 23]]], ["The latter information is like for regular observations motivated by the stylized fact that standard deviations are useful features to detect crisis.", [["crisis", "PROBLEM", 142, 148]]], ["The contextualObservationsof contextual states C t implies in particular that we will use 1D convolutions should we use convolutional layers.", [["1D convolutions", "TREATMENT", 90, 105]]], ["All in all, observations that are augmented observations, write asObservationsthat will feed the two sub-networks of our global network.ActionIn our deep reinforcement learning the augmented asset manager trading agent needs to decide at each period in which hedging strategy it invests.", [["global network", "MULTI-TISSUE_STRUCTURE", 121, 135], ["deep reinforcement", "OBSERVATION", 149, 167]]], ["The augmented asset manager can invest in l strategies that can be simple strategies or strategies that are also done by asset management agent.", [["l strategies", "TREATMENT", 42, 54], ["simple strategies", "TREATMENT", 67, 84], ["asset management agent", "TREATMENT", 121, 143]]], ["To cope with reality, the agent will only be able to act after one period.", [["the agent", "TREATMENT", 22, 31]]], ["As it has access to l potential hedging strategies, the output is a l dimension vector that provides how much it invest in each hedging strategy.", [["l potential hedging strategies", "TREATMENT", 20, 50], ["the output", "TEST", 52, 62], ["a l dimension vector", "TREATMENT", 66, 86], ["output", "OBSERVATION_MODIFIER", 56, 62], ["l dimension", "OBSERVATION_MODIFIER", 68, 79]]], ["For our deep network, this means that the last layer is a softmax layer to ensure that portfolio weights are between 0 and 100% and sum to 1, denoted by (p 1 t , ..., p l t ).", [["deep network", "MULTI-TISSUE_STRUCTURE", 8, 20], ["a softmax layer", "TREATMENT", 56, 71], ["portfolio weights", "TEST", 87, 104], ["deep", "ANATOMY_MODIFIER", 8, 12]]], ["In addition, to include leverage, our deep network has a second output which is the overall leverage that is between 0 and a maximum leverage value (in our experiment 3), denoted by lvg t .", [["deep network", "MULTI-TISSUE_STRUCTURE", 38, 50], ["a second output", "TEST", 55, 70], ["deep", "ANATOMY_MODIFIER", 38, 42]]], ["Hence the final allocation is given by lvg t \u00d7 (p 1 t , ..., p l t ).RewardThere are multiple choices for our reward and it's a key point for the asset manager to decide the reward corresponding to his her risk profile.Reward\u2022 A straightforward reward function is to compute the final net performance of the combination of our portfolio computed as the value of our portfolio at the last train date t T over the initial value of the portfolio t 0 minus one:Reward\u2022 Another natural reward function is to compute the Sharpe ratio.", [["multiple", "OBSERVATION_MODIFIER", 85, 93]]], ["This annualized Sharpe ratio computed from daily data is defined as the ratio of the annualized return over the annualized volatility \u00b5/\u03c3.", [["This annualized Sharpe ratio", "TEST", 0, 28]]], ["The intuition of the Sharpe ratio is to account for risk when comparing returns with risk is represented by volatility.Reward\u2022 The last reward we are interested in is the Sortino ratio.", [["Sortino", "GENE_OR_GENE_PRODUCT", 171, 178], ["the Sharpe ratio", "TEST", 17, 33]]], ["Hence the downside standard deviation is computed byConvolutional networkThe similarities with image recognition (where pixels are stored in 3 different matrices representing red, green and blue image) enable us using convolution networks for our deep neural network.", [["neural network", "ANATOMY", 252, 266], ["neural network", "MULTI-TISSUE_STRUCTURE", 252, 266], ["image recognition", "TEST", 95, 112], ["red, green and blue image", "PROBLEM", 175, 200], ["our deep neural network", "PROBLEM", 243, 266], ["deep", "ANATOMY_MODIFIER", 247, 251], ["neural network", "OBSERVATION", 252, 266]]], ["The analogy goes even further as it is well known in image recognition that convolutional networks achieve strong performances thanks to their capacity to extract meaningful features and to have very limited parameters hence avoiding over-fitting.", [["convolutional networks", "MULTI-TISSUE_STRUCTURE", 76, 98]]], ["We use a convolution layer with a convolution window or kernel with a single row and a resulting vertical stride of 1.", [["a convolution layer", "TREATMENT", 7, 26], ["a convolution window", "TREATMENT", 32, 52]]], ["This particularity enables us to avoid mixing data from different strategies.", [["mixing data", "PROBLEM", 39, 50], ["different strategies", "TREATMENT", 56, 76]]], ["Recall that in convolution network, the stride parameter controls how the filter convolves around our input.", [["convolution network", "MULTI-TISSUE_STRUCTURE", 15, 34], ["the stride parameter", "TREATMENT", 36, 56], ["the filter", "TREATMENT", 70, 80]]], ["Likewise the size of the window also referred to as the kernel size controls how the filter applies to data.", [["the filter", "TREATMENT", 81, 91], ["size", "OBSERVATION_MODIFIER", 13, 17], ["size", "OBSERVATION_MODIFIER", 63, 67]]], ["Because of this peculiarity, we can interpret our 2-D convolution as an iteration over a 1-D convolution network for each variable.Multi inputs and outputsWe display in figure 2 the architecture of our network.", [["a 1-D convolution network", "TREATMENT", 87, 112], ["Multi inputs", "TEST", 131, 143], ["outputs", "OBSERVATION_MODIFIER", 148, 155]]], ["Because we feed our network with both data from the strategies to select but also contextual information, our network is a multiple inputs network.Multi inputs and outputsFigure 2: network architecture obtained via tensorflow plotmodel function.", [["inputs network", "MULTI-TISSUE_STRUCTURE", 132, 146], ["network architecture", "MULTI-TISSUE_STRUCTURE", 181, 201], ["Multi inputs", "TEST", 147, 159], ["outputs", "OBSERVATION_MODIFIER", 164, 171]]], ["Our network is very different from standard DRL networks that have single inputs and outputs.", [["DRL networks", "DNA", 44, 56], ["very different", "OBSERVATION_MODIFIER", 15, 29]]], ["Contextual information introduces a second input while the leverage adds a second output Additionally, as we want from these inputs to provide not only percentage in the different hedging strategies (with a softmax activation of a dense layer) but also the overall leverage (with a dense layer with one single ouput neurons), we also have a multi outputs network.", [["ouput neurons", "ANATOMY", 310, 323], ["neurons", "CELL", 316, 323]]], ["Additional hyperparameters that are used in the network as L2 regularization with a coefficient of 1e-8.Adversarial Policy GradientTo learn the parameters of our network depicted in 2, we use a modified policy gradient algorithm called adversarial as we introduce noise in the data as suggested in (Liang et al. 2018) ..", [["Additional hyperparameters", "TREATMENT", 0, 26], ["L2 regularization", "TREATMENT", 59, 76], ["a modified policy gradient algorithm", "TREATMENT", 192, 228], ["L2", "ANATOMY", 59, 61]]], ["This is somehow similar to drop out in deep networks where we randomly pertubate the network by randomly removing some neurons to make it more robust and less prone to overfitting.", [["neurons", "ANATOMY", 119, 126], ["neurons", "CELL", 119, 126], ["some neurons", "TREATMENT", 114, 126], ["deep", "ANATOMY_MODIFIER", 39, 43]]], ["A policy is a mapping from the observation space to the action space, \u03c0 : O \u2192 A. To achieve this, a policy is specified by a deep network with a set of parameters \u03b8.", [["a mapping", "TEST", 12, 21]]], ["The action is a vector function of the observation given the parameters: a t = \u03c0 \u03b8 (o t ).", [["the observation", "TEST", 35, 50]]], ["The performance metric of \u03c0 \u03b8 for time interval [0, t] is defined as the corresponding total reward function of the interval J [0,t] (\u03c0 \u03b8 ) = R o 1 , \u03c0 \u03b8 (o 1 ), \u00b7 \u00b7 \u00b7 , o t , \u03c0 \u03b8 (o t ), o t+1 .", [["\u03c0 \u03b8", "PROTEIN", 26, 29], ["t", "TEST", 130, 131], ["\u03b8", "TEST", 136, 137], ["\u03b8", "TEST", 152, 153], ["\u00b7", "TEST", 162, 163], ["\u00b7", "TEST", 164, 165], ["\u00b7", "TEST", 166, 167], ["t", "TEST", 172, 173]]], ["After random initialization, the parameters are continuously updated along the gradient direction with a learning rate \u03bb: \u03b8 \u2212\u2192 \u03b8 + \u03bb\u2207 \u03b8 J [0,t] (\u03c0 \u03b8 ).", [["\u03b8", "PROTEIN", 122, 123], ["\u03b8", "PROTEIN", 127, 128], ["a learning rate", "TEST", 103, 118]]], ["The gradient ascent optimization is done with standard Adam (short for Adaptive Moment Estimation) optimizer to have the benefit of adaptive gradient descent with root mean square propagation (Kingma and Ba 2014).", [["root", "ANATOMY", 163, 167], ["The gradient ascent optimization", "TEST", 0, 32], ["Adaptive Moment Estimation) optimizer", "TREATMENT", 71, 108], ["adaptive gradient descent", "TREATMENT", 132, 157], ["gradient", "OBSERVATION_MODIFIER", 4, 12]]], ["The whole process is summarized in algorithm 1. for however many updates in D do end while 17: until convergence In our gradient ascent, we use a learning rate of 0.01, an adversarial Gaussian noise with a standard deviation of 0.002.", [["a learning rate", "TEST", 144, 159], ["an adversarial Gaussian noise", "PROBLEM", 169, 198], ["gradient ascent", "OBSERVATION_MODIFIER", 120, 135]]], ["We do up to 500 maximum iterations with an early stop condition if on the train set, there is no improvement over the last 50 iterations.Walk forward analysisIn machine learning, the standard approach is to do k-fold cross validation as shown in figure 3.", [["Walk forward analysis", "TEST", 137, 158], ["k-fold cross validation", "TREATMENT", 210, 233], ["no", "UNCERTAINTY", 94, 96], ["improvement", "OBSERVATION_MODIFIER", 97, 108]]], ["Rather, we can take sliding test set and take past data as training data as show in the two sub-figures on the right of figure 4.", [["sliding test", "TEST", 20, 32], ["training data", "TEST", 59, 72], ["right", "ANATOMY_MODIFIER", 111, 116]]], ["To ensure some stability, we favor to add incrementally new data in the training set, at each new step.", [["some", "OBSERVATION_MODIFIER", 10, 14], ["stability", "OBSERVATION", 15, 24]]], ["The negative effect of using extending training data set is to adapt slowly to new information.", [["extending training data", "TEST", 29, 52], ["negative effect", "OBSERVATION_MODIFIER", 4, 19]]], ["Last but not least, as the test set is always after the train set, walk forward analysis gives less steps compared to cross validation.", [["the test set", "TEST", 23, 35], ["walk forward analysis", "TEST", 67, 88], ["cross validation", "TEST", 118, 134]]], ["In practice for our data set, we train our models from 2000 We are interested in planing a hedging strategy for a risky asset.", [["a hedging strategy", "TREATMENT", 89, 107]]], ["The hedging strategies are 4 SG-CIB proprietary systematic strategies further described below .Data-set descriptionSystematic strategies are similar to asset managers that invest in financial markets according to an adaptive, predefined trading rule.", [["The hedging strategies", "TREATMENT", 0, 22]]], ["Here, we use 4 SG CIB proprietary 'hedging strategies', that tend to perform when stock markets are down:Data-set description\u2022 Directional hedges -react to small negative return in equities, \u2022 Gap risk hedges -perform well in sudden market crashes,Data-set description\u2022 Proxy hedges -tend to perform in some market configurations, like for example when highly indebted stocks under-perform other stocks, \u2022 Duration hedges -invest in bond market, a classical diversifier to equity risk in finance.Data-set descriptionThe underlying financial instruments vary from put options, listed futures, single stocks, to government bonds.", [["Directional hedges", "TEST", 127, 145], ["Gap risk hedges", "PROBLEM", 193, 208], ["small", "OBSERVATION_MODIFIER", 156, 161], ["negative", "OBSERVATION", 162, 170], ["financial instruments", "OBSERVATION", 531, 552]]], ["The challenge consists in balancing cost versus benefits.Data-set descriptionIn practice, asset managers have to decide how much of these hedging strategies are needed on top of an existing portfolio to achieve a better risk reward.", [["these hedging strategies", "TREATMENT", 132, 156]]], ["The decision making process is often based on contextual information, such as the economic and geopolitical environment, the level of risk aversion among investors and other correlation regimes.", [["risk aversion", "TREATMENT", 134, 147]]], ["The contextual information is modelled by a large range of features :Data-set description\u2022 the level of risk aversion in financial markets, or market sentiment, measured as an indicator varying between 0 for maximum risk aversion and 1 for maximum risk appetite,Data-set description\u2022 the bond/equity historical correlation, a classical expost measure of the diversification benefits of a duration hedge, measured on a 1-month, 3-month and 1-year rolling window,Data-set description\u2022 The credit spreads of global corporate -investment grade, high yield, in Europe and in the US -known to be an early indicator of potential economic tensions,Data-set description\u2022 The equity implied volatility, a measure if the 'fear factor' in financial market,Data-set description\u2022 The spread between the yield of Italian government bonds and the German government bond, a measure of potential tensions in the European Union,Data-set description\u2022 The US Treasury slope, a classical early indicator for US recession,Data-set description\u2022 And some more financial variables, often used as a gauge for global trade and activity: the dollar, the level of rates in the US, the estimated earnings per shares (EPS).Data-set descriptionA cross validation step selects the most relevant features.Data-set descriptionIn the present case, the first three features are selected.", [["EPS", "DISEASE", 1186, 1189], ["maximum risk appetite", "PROBLEM", 240, 261], ["high yield", "PROBLEM", 541, 551], ["The US", "TEST", 931, 937], ["US recession", "PROBLEM", 986, 998], ["Data", "TEST", 1191, 1195], ["global", "OBSERVATION_MODIFIER", 505, 511], ["corporate", "OBSERVATION_MODIFIER", 512, 521], ["high yield", "OBSERVATION_MODIFIER", 541, 551], ["volatility", "OBSERVATION_MODIFIER", 681, 691]]], ["They are taken into account dynamically to penalise solutions with a high turnover rate.Evaluation metricsAsset managers use a wide range of metrics to evaluate the success of their investment decision.", [["a high turnover rate", "TREATMENT", 67, 87], ["Evaluation metrics", "TEST", 88, 106]]], ["The metrics we are interested in for our hedging problem are listed below:Evaluation metrics\u2022 annualized return defined as the average annualized compounded return,Evaluation metrics\u2022 annualized daily based Sharpe ratio defined as the ratio of the annualized return over the annualized daily based volatility \u00b5/\u03c3,Evaluation metrics\u2022 Sortino ratio computed as the ratio of the annualized return overt the downside standard deviation,Evaluation metrics\u2022 maximum drawdown (max DD) computed as the maximum of all daily drawdowns.", [["Sortino", "SIMPLE_CHEMICAL", 333, 340], ["Evaluation metrics", "TEST", 164, 182], ["Evaluation", "TEST", 313, 323], ["Sortino ratio", "TEST", 333, 346], ["Evaluation metrics", "TEST", 432, 450], ["standard deviation", "OBSERVATION", 413, 431]]], ["The daily drawdown is computed as the ratio of the difference between the running maximum of the portfolio value (RM T = max t=0..T (P t ) ) and the portfolio value over the running maximum of the portfolio value.", [["the portfolio value", "TEST", 145, 164]]], ["Hence DD T = (RM T \u2212 P T )/RM T and M DD T = max t=0..T (DD t ).", [["T", "TEST", 23, 24]]], ["It is the maximum loss in return that an investor will incur if she/he invested at the worst time (at peak).BaselinePure risky asset This first evaluation is to compare our portfolio composed only of the risky asset (in our case, the MSCI world index) with the one augmented by the trading agent and composed of the risky asset and the hedging overlay.", [["the maximum loss", "PROBLEM", 6, 22], ["This first evaluation", "TEST", 133, 154], ["maximum", "OBSERVATION_MODIFIER", 10, 17], ["loss", "OBSERVATION_MODIFIER", 18, 22]]], ["Hence the Markowitz portfolio consists in maximizing the expected return for a given level of risk, represented by a given variance.", [["the Markowitz portfolio", "TREATMENT", 6, 29]]], ["Using dual optimization, this is also equivalent to minimize variance for a given expected return, which is solved by standard quadratic programming optimization.", [["dual optimization", "TREATMENT", 6, 23], ["standard quadratic programming optimization", "TREATMENT", 118, 161]]], ["Let w = (w 1 , ..., w l ) be the allocation weights with 1 \u2265 w i \u2265 0 for i = 0...l, which is summarized by 1 \u2265 w \u2265 0, with the additional constraints that these weights sum to 1: l i=1 w i = 1.", [["the allocation weights", "TEST", 29, 51], ["these weights", "TEST", 155, 168]]], ["Let \u00b5 = (\u00b5 1 , ..., \u00b5 l ) T be the expected returns for our l strategies and \u03a3 the matrix of variance covariances of the l strategies' returns.", [["our l strategies", "TREATMENT", 56, 72]]], ["The Markowitz optimization problem to solve that is done by standard quadratic programming is the following:BaselineThe Markowitz portfolio is a good benchmark very often used in portfolio theory as it allows investors to construct more efficient portfolios by controlling the variance of their strategies.", [["The Markowitz optimization problem", "TREATMENT", 0, 34]]], ["One of the famous critic of this theory is that it controls the variance (and then the standard deviation) of the portfolio but it doesn't allow controlling a better risk indicator which is the downside standard deviation (representing the potential loss that may arise from risk compared to a minimum acceptable return).", [["the potential loss", "PROBLEM", 236, 254]]], ["In other words, an investor prefers a portfolio with less risk for a given level of return and will only take on high-risk investments if he can expect a larger reward.BaselineFollow the winner This is a simple strategy that consists in selecting the hedging strategy that was the best performer in the past year.", [["high-risk investments", "TREATMENT", 113, 134], ["the hedging strategy", "TREATMENT", 247, 267]]], ["If there is some persistence over time of the hedging strategies' performance, this simple methodology works well.", [["some", "OBSERVATION_MODIFIER", 12, 16], ["persistence", "OBSERVATION_MODIFIER", 17, 28]]], ["It assumes that there is some mean reversion in strategies' performance, meaning that strategies tend to perform equally well on long term and mean revert around their trend.", [["some mean reversion in strategies' performance", "PROBLEM", 25, 71], ["some", "OBSERVATION_MODIFIER", 25, 29], ["mean reversion", "OBSERVATION", 30, 44]]], ["Hence if a strategy did not perform well in the past, and if there is mean reversion, there is a lot of chance that this strategy will recover with its pairs.", [["mean reversion", "PROBLEM", 70, 84]]], ["We compare the performance of the following 5 models: DRL model based on convolutional networks with contextual states (Sentiment indicator, 6 month correlation between equity and bonds and credit main index), same DRL model without contextual states, follow the winner, follow the loser and Markowitz portfolio.", [["DRL model", "TEST", 54, 63]]], ["To make figures readable, we first show the two DRL models, with the risky asset and clearly see the impact of contextual information as the DRL model (in orange) is well above the green curve (the same model without contextual information) and is also well above the risky asset position alone (the blue curve).", [["the blue curve", "TEST", 296, 310]]], ["We finally plot the two best performers: the DRL and the Follow the Winner model, emphasizing that the difference between DRL and Follow the Winner is mostly in years 2018 to 2020 that exhibit regime changes, with in particular the recent Covid crisis.Results and discussionOut of these 5 models, only DRL and Follow the winner are able to provide significant net performance increase compared to the risky asset alone thanks to an efficient hedging strategy over the 2007 to 2020 period.", [["significant net performance increase", "PROBLEM", 348, 384], ["crisis", "OBSERVATION", 245, 251]]], ["The DRL model is in addition able to better adapt to the Covid crisis and to have better efficiency in net return but also Sharpe and Sortino figure 5 , we can remark that the DRL model has a tendency to move away from the blue curve (the risky asset) continuously and increasingly whereas the follow the winner model has moved away from the blue curve in 2015 and 2016 and tends to remain in parallel after this period, indicating that there is no continuous improvement of the model.", [["the blue curve", "TEST", 219, 233], ["the blue curve", "TEST", 338, 352], ["no", "UNCERTAINTY", 446, 448]]], ["The growing divergence of the DRL from the blue curve is a positive sign of its regular performance whci is illustrated in numbers in table 1.Results and discussionMoreover, when comparing the weights obtained by the different models (figures 6, 7, and 8), we see that the bad performance of Markowitz can be a consequence of its diversification as it takes each year a non null position in the four hedging strategies and tends to change this allocation quite frequently.", [["Markowitz", "DISEASE", 292, 301], ["DRL", "DNA", 30, 33], ["the blue curve", "TEST", 39, 53], ["the weights", "TEST", 189, 200], ["growing", "OBSERVATION_MODIFIER", 4, 11], ["divergence", "OBSERVATION_MODIFIER", 12, 22]]], ["The rapid change of allocation is a sign of unstability of this method (which is a well known drawback of Markowitz).Results and discussionIn contrast, DRL and Follow the winner models tends to choose only one or two strategies, in a stock picking manner.", [["rapid", "OBSERVATION_MODIFIER", 4, 9], ["change", "OBSERVATION_MODIFIER", 10, 16]]], ["DRL model tends to choose mostly duration hedge and is able to dynamically adapt its behavior over the last 3 years and to better manage the Covid crisis with a mix allocation between duration and proxy hedge.Results and discussionIn terms of the smallest maximum drawdown, the follow the loser model is able to significantly reduce maximum drawdown but at the price of a lower return, Sharpe and Sortino ratios.", [["Sortino", "SIMPLE_CHEMICAL", 397, 404], ["the Covid crisis", "PROBLEM", 137, 153], ["Sortino ratios", "TEST", 397, 411], ["smallest", "OBSERVATION_MODIFIER", 247, 255], ["maximum", "OBSERVATION_MODIFIER", 256, 263]]], ["Removing contextual information deteriorates model performances significantly and is illustrated by the difference in term of return, Sharpe, Sortino ratio and maximum drawdown between the DRL and the DRL no context model.", [["Sortino ratio", "TEST", 142, 155]]], ["It is the worst performer over the last 3 and 5 years because of this lack of adaptation.Results and discussionFor all models, we use the walk forward analysis as described earlier.", [["the walk forward analysis", "TEST", 134, 159], ["worst", "OBSERVATION_MODIFIER", 10, 15]]], ["We then train the model from 2000 to end of 2007 and use the best model on the test set in 2008 and etc ...", [["the test", "TEST", 75, 83]]], ["This process ensures that we detect models that are unstable overtime and is similar in spirit to delayed online training.", [["unstable", "OBSERVATION_MODIFIER", 52, 60]]], ["We also provide in table 2 different configurations (adversarial training, use of context, and use of day lag), which leads to a total of 16 models.", [["adversarial training", "TREATMENT", 53, 73]]], ["The frist 8 models are the ones with a daylag sorted in order of decreasing performance.", [["decreasing", "OBSERVATION_MODIFIER", 65, 75]]], ["The best model is the one with a reward in net profit, adversarial training, use of context information with a total performance of 81.8 %.", [["adversarial training", "TREATMENT", 55, 75], ["a total performance", "TEST", 109, 128]]], ["These models are theoreticall and not considered as they do not cope with reality.Impact of contextIn table 2, we provide a list of 16 models based on the following choices: the choice of the reward function (net profit or Sortino), the use of adversarial training with noise in data or not, the use of contextual states, and the use of day lag between observations and actions.", [["adversarial training", "TREATMENT", 244, 264]]], ["We see that the best DRL model with the day-lag turnover constraint is the one using convolutional networks, adversarial training, contextual states and net profit reward function.", [["adversarial training", "TREATMENT", 109, 129]]], ["These 4 parameters are meaningful for our DRL model and change model performance substantially as illustrated by the table with a difference between model 1 (the best model) and model 8 (the worst model) of 129.5 % (=81.8 % -(-47.7 %)).Impact of contextTo measure the impact of the contextual information for our best model, we can measure it simply by doing the difference between model 1 and model 6 (as there are the same model except the presence or absence of contextual information).", [["our DRL model", "TEST", 38, 51]]], ["We find a significant impact as it accounts for 111.4 % (=81.8 % -(-29.5 %)).", [["significant", "OBSERVATION_MODIFIER", 10, 21]]], ["It is quite intuitive that adding a context should improve the model as we provide more meaningful information to the model.Impact of one day lagOur model accounts for the fact that asset managers cannot immediately change their position at the close of the financial markets.", [["one day", "OBSERVATION_MODIFIER", 134, 141]]], ["It is not surprising that a delayed action (with one period lag) after observation makes the learning process more challenging for the DRL agent as influence of variables tends to decrease with time.", [["the DRL agent", "TREATMENT", 131, 144], ["not surprising", "UNCERTAINTY", 6, 20]]], ["Surprisingly, this salient modeling characteristic is ignored in existing literature (Jiang, Xu, and Liang 2017; Liang et al. 2018; Yu et al. 2019; Wang and Zhou 2019; Liu et al. 2020; Ye et al. 2020; .Future workAs nice as this work is, there is room for improvement as we have only tested a few possible hyper-parameters for our convolutional networks and could play with more layers, other design choice like combination of max pooling layers (like in image recognition) and ways to create more predictive contextual information.ConclusionIn this paper, we address the challenging task of financial planning in a noisy and self adapting environment with sequential, non-stationary and non-homogeneous observations.", [["convolutional networks", "MULTI-TISSUE_STRUCTURE", 331, 353], ["hyper-parameters", "PROBLEM", 306, 322], ["max pooling layers", "TREATMENT", 427, 445], ["financial planning", "TREATMENT", 592, 610]]], ["Our approach is based on deep reinforcement learning using contextual information thanks to a second subnetwork.", [["deep reinforcement learning", "TREATMENT", 25, 52]]], ["We also show that the additional constraint of a delayed action following observations has a substantial impact that should not be overlooked.", [["should not be", "UNCERTAINTY", 117, 130]]], ["We introduce the novel concept of walk forward analysis to test the robustness of the deep RL model.", [["walk forward analysis", "TEST", 34, 55], ["deep", "ANATOMY_MODIFIER", 86, 90], ["RL model", "OBSERVATION", 91, 99]]], ["This is very important for regime changing environments that cannot be evaluated with a simple train validation test procedure, neither a k-fold cross validation as it ignores the strong chronological feature of observations.", [["a simple train validation test procedure", "TEST", 86, 126], ["a k-fold cross validation", "TREATMENT", 136, 161]]], ["For our trading agent, we take not only past performances of portfolio strategies over different rolling period, but also standard deviations to provide predictive variables for regime changes.", [["regime changes", "TREATMENT", 178, 192]]], ["Augmented states with contextual information make a big difference in the model and help the agent learning more efficiently in a noisy environment.", [["a big difference in the model", "PROBLEM", 50, 79]]], ["Last but not least, it is quite important to fine tune the numerous hyper-parameters of the contextual based DRL model, namely the various lags (lags period for the sub network fed by portfolio strategies past returns, lags period for common contextual features referred to as the common features in the paper), standard deviation period, learning rate, etc...ConclusionDespite the efficiency of contextual based DRL models, there is room for improvement.", [["common contextual features", "PROBLEM", 235, 261], ["learning rate", "TEST", 339, 352], ["numerous", "OBSERVATION_MODIFIER", 59, 67], ["hyper", "OBSERVATION", 68, 73], ["efficiency", "OBSERVATION_MODIFIER", 382, 392]]], ["For large stocks, like tech stocks, sentiment information based on social media activity could also be relevant.", [["large", "OBSERVATION_MODIFIER", 4, 9], ["stocks", "OBSERVATION", 10, 16]]]], "PMC7301891": [["IntroductionEpidemiology mainly deals with the infectious diseases and predicts their occurrence, transmission as well as control in a population.", [["infectious diseases", "DISEASE", 47, 66], ["the infectious diseases", "PROBLEM", 43, 66], ["infectious", "OBSERVATION", 47, 57]]], ["It identifies the factors responsible for disease spread, facilitates treatment quality and health services, provides necessary measures for prevention, treatment, planning in order to improve the efficiency and effectiveness of health services [1].", [["disease spread", "PROBLEM", 42, 56], ["prevention", "TREATMENT", 141, 151], ["treatment", "TREATMENT", 153, 162], ["responsible for", "UNCERTAINTY", 26, 41]]], ["HIV is a retrovirus which is discovered in 1981 in USA among the gay community causes an AIDS a severe life intimidating ailment.", [["AIDS", "DISEASE", 89, 93], ["HIV", "ORGANISM", 0, 3], ["retrovirus", "ORGANISM", 9, 19], ["HIV", "SPECIES", 0, 3], ["HIV", "SPECIES", 0, 3], ["HIV", "PROBLEM", 0, 3], ["a retrovirus", "PROBLEM", 7, 19], ["retrovirus", "OBSERVATION", 9, 19]]], ["At present, there is no vaccine or cure for AIDS, that makes it an incurable disease with high mortality rate (there are almost 25 million deaths by AIDS per year worldwide), also it spread quickly affecting about 14,000 new case/day.", [["AIDS", "DISEASE", 44, 48], ["deaths", "DISEASE", 139, 145], ["AIDS", "DISEASE", 149, 153], ["vaccine", "TREATMENT", 24, 31], ["AIDS", "PROBLEM", 44, 48], ["an incurable disease", "PROBLEM", 64, 84], ["high mortality rate", "PROBLEM", 90, 109], ["no", "UNCERTAINTY", 21, 23], ["incurable", "OBSERVATION_MODIFIER", 67, 76]]], ["The time duration for HIV to develop AIDS mostly lasts from 6 months to 15 year.", [["AIDS", "DISEASE", 37, 41], ["HIV", "ORGANISM", 22, 25], ["HIV", "SPECIES", 22, 25], ["HIV", "SPECIES", 22, 25], ["HIV", "PROBLEM", 22, 25], ["AIDS", "PROBLEM", 37, 41]]], ["The virus destructs CD4+ T-cells ending of loss of cell mediated immunity, thus makes the immune system susceptible to cancers and various infectious diseases.", [["CD4+ T-cells", "ANATOMY", 20, 32], ["cell", "ANATOMY", 51, 55], ["immune system", "ANATOMY", 90, 103], ["cancers", "ANATOMY", 119, 126], ["cancers", "DISEASE", 119, 126], ["infectious diseases", "DISEASE", 139, 158], ["CD4", "GENE_OR_GENE_PRODUCT", 20, 23], ["cell", "CELL", 51, 55], ["cancers", "CANCER", 119, 126], ["CD4", "PROTEIN", 20, 23], ["T-cells", "CELL_TYPE", 25, 32], ["The virus destructs CD4", "TEST", 0, 23], ["loss of cell mediated immunity", "PROBLEM", 43, 73], ["cancers", "PROBLEM", 119, 126], ["various infectious diseases", "PROBLEM", 131, 158], ["virus", "OBSERVATION", 4, 9], ["loss", "OBSERVATION_MODIFIER", 43, 47], ["cell mediated immunity", "OBSERVATION", 51, 73], ["infectious", "OBSERVATION_MODIFIER", 139, 149]]], ["The routes of transmission of HIV virus are unprotected sexual intercourse, through blood by sharing contaminated needles or infected blood transfusion, from mother to her child during pregnancy i.e., vertical transmission [2].IntroductionMathematical models act as a tool which the researchers have extensively used in the epidemiology of HIV/AIDS to get the understanding of the major contributing factors in a given epidemic.", [["blood", "ANATOMY", 84, 89], ["blood", "ANATOMY", 134, 139], ["HIV virus", "DISEASE", 30, 39], ["HIV/AIDS", "DISEASE", 340, 348], ["HIV virus", "ORGANISM", 30, 39], ["blood", "ORGANISM_SUBSTANCE", 84, 89], ["blood", "ORGANISM_SUBSTANCE", 134, 139], ["HIV", "ORGANISM", 340, 343], ["HIV virus", "SPECIES", 30, 39], ["HIV virus", "SPECIES", 30, 39], ["HIV", "SPECIES", 340, 343], ["HIV virus", "PROBLEM", 30, 39], ["infected blood transfusion", "TREATMENT", 125, 151], ["HIV/AIDS", "TREATMENT", 340, 348], ["epidemic", "PROBLEM", 419, 427]]], ["Zafar et al.[3] fractionally studied the HIV/AIDS epidemics with three solution approaches namely Adams-Bashforth Moulton method, Grunwald Letnikov approach and Grunwald Letnikov approach with binomial coefficients.", [["HIV/AIDS", "DISEASE", 41, 49], ["HIV", "ORGANISM", 41, 44], ["HIV", "SPECIES", 41, 44], ["the HIV/AIDS epidemics", "PROBLEM", 37, 59], ["three solution approaches", "TREATMENT", 65, 90], ["Moulton method", "TREATMENT", 114, 128], ["Grunwald Letnikov approach", "TREATMENT", 130, 156], ["Grunwald Letnikov approach", "TREATMENT", 161, 187]]], ["In their study, they have analyzed the model and obtained the necessary conditions for the existence and stability of both the equilibria.", [["their study", "TEST", 3, 14], ["stability", "OBSERVATION_MODIFIER", 105, 114], ["equilibria", "OBSERVATION", 127, 137]]], ["They have shown that the system is stable if R0<1 and if R0>1, then system becomes unstable and endemic equilibrium exists which behaves as an attractor.", [["R0", "TEST", 57, 59], ["unstable", "PROBLEM", 83, 91], ["endemic equilibrium", "PROBLEM", 96, 115], ["stable", "OBSERVATION_MODIFIER", 35, 41], ["unstable", "OBSERVATION_MODIFIER", 83, 91]]], ["Wang et al.[4] studied a delayed fractional order SIR model with saturated incidence and treatment functions.", [["treatment functions", "TREATMENT", 89, 108]]], ["They have provided the sufficient conditions that guarantee the existence of equilibria and discussed the global stability results for both disease-free equilibrium as well as endemic equilibrium by constructing a suitable Lyapunov functions.", [["both disease-free equilibrium", "PROBLEM", 135, 164], ["endemic equilibrium", "PROBLEM", 176, 195]]], ["Almeida [5] in his paper studied a fractional SEIR epidemic model in presence of treatment.", [["treatment", "TREATMENT", 81, 90]]], ["Further, he proved the local stability for both equilibria.", [["equilibria", "OBSERVATION", 48, 58]]], ["Carvalho et al.[6] provided a HIV/HCV coinfection fractional order model to understand the impact of HIV viral load on the coinfection.", [["HIV/HCV coinfection", "DISEASE", 30, 49], ["coinfection", "DISEASE", 123, 134], ["HIV", "ORGANISM", 30, 33], ["HCV", "ORGANISM", 34, 37], ["HIV", "ORGANISM", 101, 104], ["HIV", "SPECIES", 30, 33], ["HCV", "SPECIES", 34, 37], ["HIV", "SPECIES", 101, 104], ["a HIV/HCV coinfection fractional order model", "TREATMENT", 28, 72], ["HIV viral load", "PROBLEM", 101, 115], ["the coinfection", "PROBLEM", 119, 134], ["coinfection", "OBSERVATION", 123, 134]]], ["Their main motive in the model was to provide good fits to real data from patients suffering from several diseases such as HIV, HCV, dengue fever and many more.", [["HIV, HCV, dengue fever", "DISEASE", 123, 145], ["patients", "ORGANISM", 74, 82], ["HIV", "ORGANISM", 123, 126], ["HCV", "ORGANISM", 128, 131], ["patients", "SPECIES", 74, 82], ["HIV", "SPECIES", 123, 126], ["HIV", "SPECIES", 123, 126], ["HCV", "SPECIES", 128, 131], ["several diseases", "PROBLEM", 98, 114], ["HIV", "PROBLEM", 123, 126], ["HCV", "PROBLEM", 128, 131], ["dengue fever", "PROBLEM", 133, 145]]], ["They have numerically suggested that the HIV viral load impacts impressively the severity of the HCV infection.", [["HCV infection", "DISEASE", 97, 110], ["HIV", "ORGANISM", 41, 44], ["HCV", "ORGANISM", 97, 100], ["HIV", "SPECIES", 41, 44], ["HCV", "SPECIES", 97, 100], ["the HIV viral load", "PROBLEM", 37, 55], ["the HCV infection", "PROBLEM", 93, 110], ["HCV", "OBSERVATION_MODIFIER", 97, 100], ["infection", "OBSERVATION", 101, 110]]], ["Also, by their results they showed that the treatment efficacy is also influential over the natural progression of HCV on the HIV/HCV coinfection.", [["HCV", "DISEASE", 115, 118], ["HIV/HCV coinfection", "DISEASE", 126, 145], ["HCV", "ORGANISM", 115, 118], ["HIV/HCV", "ORGANISM", 126, 133], ["HIV", "SPECIES", 126, 129], ["HCV", "SPECIES", 115, 118], ["HIV", "SPECIES", 126, 129], ["HCV", "SPECIES", 130, 133], ["the treatment efficacy", "TREATMENT", 40, 62], ["HCV", "PROBLEM", 115, 118], ["the HIV/HCV coinfection", "PROBLEM", 122, 145], ["HCV", "OBSERVATION", 115, 118], ["HCV coinfection", "OBSERVATION", 130, 145]]], ["Recently, Kheiri and Jafari [7] analysed a multi-patch HIV/AIDS epidemic model with fractional order derivatives and investigated the effect of human movement on the spread of HIV/AIDS epidemic among patches.", [["HIV/AIDS", "DISEASE", 55, 63], ["HIV/AIDS", "DISEASE", 176, 184], ["human", "ORGANISM", 144, 149], ["HIV", "ORGANISM", 176, 179], ["human", "SPECIES", 144, 149], ["HIV", "SPECIES", 55, 58], ["human", "SPECIES", 144, 149], ["HIV", "SPECIES", 176, 179], ["a multi-patch HIV", "TREATMENT", 41, 58], ["fractional order derivatives", "TREATMENT", 84, 112], ["human movement", "PROBLEM", 144, 158], ["HIV", "PROBLEM", 176, 179]]], ["They derived the basic reproduction number R0 of the model and studied the local as well as global stability of the equilibria on the basis of R0 .", [["global", "OBSERVATION_MODIFIER", 92, 98], ["stability", "OBSERVATION", 99, 108]]], ["They have shown that the system is stable if R0<1 and it becomes unstable if R0>1.", [["stable", "OBSERVATION_MODIFIER", 35, 41]]], ["They also obtained the sufficient conditions under which the endemic equilibrium is unique and globally asymptotically stable.", [["stable", "OBSERVATION_MODIFIER", 119, 125]]], ["Besides this, they formulated a fractional optimal control problem in which the state and co-state equations are given in term of the left fractional derivatives.", [["a fractional optimal control problem", "TREATMENT", 30, 66], ["co-state equations", "TEST", 90, 108], ["the left fractional derivatives", "TREATMENT", 130, 161], ["left", "ANATOMY_MODIFIER", 134, 138], ["fractional derivatives", "OBSERVATION", 139, 161]]], ["They incorporated in the model time dependent controls in order to control the spread of HIV/AIDS epidemics.", [["HIV/AIDS", "DISEASE", 89, 97], ["HIV", "ORGANISM", 89, 92], ["HIV", "SPECIES", 89, 92], ["HIV/AIDS epidemics", "PROBLEM", 89, 107]]], ["They also derived the necessary conditions for the fractional optimal control in their proposed model.", [["the fractional optimal control", "TREATMENT", 47, 77]]], ["The effect of varying the fractional order on the disease spread is also studied in their model.", [["the disease spread", "PROBLEM", 46, 64], ["varying", "OBSERVATION_MODIFIER", 14, 21], ["disease", "OBSERVATION", 50, 57]]], ["Researchers have continuously studied the fractional order models of HIV disease dynamics and provided many well-known mathematical techniques for the solution of these models for the dynamics of HIV epidemics [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19].", [["HIV disease", "DISEASE", 69, 80], ["HIV epidemics", "DISEASE", 196, 209], ["HIV", "ORGANISM", 196, 199], ["[9]", "SIMPLE_CHEMICAL", 215, 218], ["[10]", "SIMPLE_CHEMICAL", 220, 224], ["[11], [12], [13], [14], [15], [16], [17], [18]", "SIMPLE_CHEMICAL", 226, 272], ["HIV", "SPECIES", 69, 72], ["HIV", "SPECIES", 69, 72], ["HIV", "SPECIES", 196, 199], ["HIV disease dynamics", "PROBLEM", 69, 89], ["the solution of these models", "TREATMENT", 147, 175], ["HIV epidemics", "PROBLEM", 196, 209]]], ["Besides this, a number of studies on fractional order modeling of other infectious diseases can be found in the literature [20], [21], [22], [23].", [["infectious diseases", "DISEASE", 72, 91], ["[21]", "SIMPLE_CHEMICAL", 129, 133], ["[22]", "SIMPLE_CHEMICAL", 135, 139], ["other infectious diseases", "PROBLEM", 66, 91], ["infectious", "OBSERVATION", 72, 82]]], ["The fractional order derivative not only find its application on modeling infectious diseases but in other fields as well like vibration equation [24] and so on.IntroductionThe optimal control theory is developing fast and its various applications are extensively used in many fields of science and engineering [25].", [["infectious diseases", "DISEASE", 74, 93], ["The fractional order derivative", "TREATMENT", 0, 31], ["modeling infectious diseases", "PROBLEM", 65, 93], ["vibration equation", "TEST", 127, 145], ["infectious", "OBSERVATION", 74, 84]]], ["This theory for linear systems has been highly improved [26], however, the nonlinear optimal control problem (OCP) has become a strong topic and should be deeper investigated [27], [28].", [["highly", "OBSERVATION_MODIFIER", 40, 46], ["improved", "OBSERVATION_MODIFIER", 47, 55]]], ["Jajarmi and Baleanu [29] proposed a new approach based on the modal series method and eigenvalue decomposition technique to solve a class of nonlinear optimal control problems.", [["a new approach", "TREATMENT", 34, 48], ["the modal series method", "TREATMENT", 58, 81], ["eigenvalue decomposition technique", "TREATMENT", 86, 120], ["nonlinear optimal control problems", "PROBLEM", 141, 175]]], ["Jajarmi et al. [30] proposed a new approach for the optimal control of time-varying delay systems with external persistent matched disturbances.", [["a new approach", "TREATMENT", 29, 43], ["varying delay systems", "PROBLEM", 76, 97], ["external persistent matched disturbances", "PROBLEM", 103, 143]]], ["In their internal model principle, they converted original time-delay model with disturbance into an augmented system without any disturbance.", [["disturbance into an augmented system", "PROBLEM", 81, 117], ["any disturbance", "PROBLEM", 126, 141], ["internal", "ANATOMY_MODIFIER", 9, 17]]], ["Then, they selected a quadratic performance index for the augmented system to form an undisturbed time-delay optimal control problem.", [["a quadratic performance index", "TEST", 20, 49], ["the augmented system", "TREATMENT", 54, 74], ["undisturbed", "OBSERVATION", 86, 97]]], ["At the end they finally provided a fast iterative algorithm for the latter advance-delay boundary value problem.", [["a fast iterative algorithm", "TREATMENT", 33, 59], ["delay boundary value problem", "PROBLEM", 83, 111]]], ["They also investigated the convergence of the new iterative technique.IntroductionThe purpose of dealing with fractional order systems is the memory and hereditary properties which are the complex behavioral patterns of biological systems gives us more realistic way to model HIV/AIDS systems.", [["hereditary", "DISEASE", 153, 163], ["HIV/AIDS", "DISEASE", 276, 284], ["HIV", "ORGANISM", 276, 279], ["HIV", "SPECIES", 276, 279], ["the new iterative technique", "TREATMENT", 42, 69], ["fractional order systems", "TREATMENT", 110, 134], ["hereditary properties", "PROBLEM", 153, 174], ["model HIV/AIDS systems", "PROBLEM", 270, 292]]], ["Also, the hereditary property describes the genetic profile along with age and status of the immune system.", [["immune system", "ANATOMY", 93, 106], ["immune system", "ANATOMICAL_SYSTEM", 93, 106]]], ["Because of such properties fractional order calculus have found wide applications to model dynamics processes in many well-known fields of science, engineering, biology, medicine and many other [31], [32].", [["such properties fractional order calculus", "PROBLEM", 11, 52], ["model dynamics processes", "PROBLEM", 85, 109], ["calculus", "OBSERVATION", 44, 52]]], ["Saeedian et al.[33] formulated SIR epidemic model with the inclusion of memory effect and studied its behavior along the memory effect on the disease spread with the help of fractional derivatives.", [["memory effect", "PROBLEM", 72, 85], ["the disease spread", "PROBLEM", 138, 156], ["fractional derivatives", "TREATMENT", 174, 196], ["disease", "OBSERVATION", 142, 149]]], ["Rihan [34] provided a class of fractional order differential models of biological systems with memory, such as dynamics of tumor-immune system and dynamics of HIV infection of CD4+ T cells.IntroductionCommunicable diseases have been a cause of global concern throughout the history of mankind.", [["tumor", "ANATOMY", 123, 128], ["CD4+ T cells", "ANATOMY", 176, 188], ["Rihan", "CHEMICAL", 0, 5], ["tumor", "DISEASE", 123, 128], ["HIV infection", "DISEASE", 159, 172], ["IntroductionCommunicable diseases", "DISEASE", 189, 222], ["tumor", "CANCER", 123, 128], ["HIV", "ORGANISM", 159, 162], ["CD4", "GENE_OR_GENE_PRODUCT", 176, 179], ["CD4+ T cells", "CELL_TYPE", 176, 188], ["HIV", "SPECIES", 159, 162], ["HIV infection", "PROBLEM", 159, 172], ["CD4+ T cells", "PROBLEM", 176, 188], ["IntroductionCommunicable diseases", "PROBLEM", 189, 222], ["tumor", "OBSERVATION", 123, 128]]], ["Its outbreak severely affects the morbidity and the mortality rates across the globe.", [["the morbidity", "PROBLEM", 30, 43], ["outbreak", "OBSERVATION_MODIFIER", 4, 12], ["severely", "OBSERVATION_MODIFIER", 13, 21], ["morbidity", "OBSERVATION_MODIFIER", 34, 43], ["globe", "ANATOMY", 79, 84]]], ["It is therefore important to implement the control measures to prevent and control the disease spread among the populations.", [["the control measures", "TREATMENT", 39, 59], ["the disease spread", "PROBLEM", 83, 101], ["disease", "OBSERVATION", 87, 94]]], ["Kheiri and Jafari [35] formulated a fractional optimal control epidemic model of HIV/AIDS with random testing and contact tracing.", [["HIV/AIDS", "DISEASE", 81, 89], ["HIV", "ORGANISM", 81, 84], ["HIV", "SPECIES", 81, 84], ["HIV", "SPECIES", 81, 84], ["HIV/AIDS", "PROBLEM", 81, 89], ["random testing", "TEST", 95, 109], ["contact tracing", "TEST", 114, 129]]], ["In their model, they have incorporated the control measures of condom use and antiretroviral therapy for the control of spread of HIV/AIDS in the susceptible population.", [["HIV/AIDS", "DISEASE", 130, 138], ["HIV", "ORGANISM", 130, 133], ["HIV", "SPECIES", 130, 133], ["condom use", "TREATMENT", 63, 73], ["antiretroviral therapy", "TREATMENT", 78, 100], ["HIV", "PROBLEM", 130, 133], ["AIDS", "PROBLEM", 134, 138]]], ["They have presented a Forward-Backword sweep numerical method based on Adams-Bashforth-Moulton method for the solution of their model.", [["the solution of their model", "TREATMENT", 106, 133]]], ["Agrawal [36] formulated a fractional optimal control problem by using the Reimann-Liouville fractional derivatives and presented a numerical method for its solution.", [["a fractional optimal control problem", "TREATMENT", 24, 60], ["the Reimann", "TREATMENT", 70, 81], ["Liouville fractional derivatives", "TREATMENT", 82, 114], ["a numerical method", "TREATMENT", 129, 147], ["its solution", "TREATMENT", 152, 164]]], ["Bashir et al.[37] presented a fractional optimal control for a kinetic model and provided a numerical scheme for its solution.IntroductionGoing by the antecedents, we have seen clearly that modeling of physical and real-life scenarios with the fractional order derivatives is much more accurate when compared with the integer order cases.", [["a fractional optimal control", "TREATMENT", 28, 56], ["a numerical scheme", "TREATMENT", 90, 108], ["its solution", "TREATMENT", 113, 125], ["the fractional order derivatives", "TREATMENT", 240, 272]]], ["This assertion has been demonstrated a number of research papers, monographs and books, see for example [38], [39], [40], [41].", [["[39]", "SIMPLE_CHEMICAL", 110, 114], ["[40]", "SIMPLE_CHEMICAL", 116, 120]]], ["In view of these achievements, we are motivated in this research work by modeling the control and analysis of SEI1I2R dynamics of HIV disease transmission using the Caputo fractional order operator which is most suited for modeling the biological and physical facts [42], [43], [44], [45], [46], [47].", [["HIV disease", "DISEASE", 130, 141], ["HIV", "ORGANISM", 130, 133], ["[43]", "SIMPLE_CHEMICAL", 272, 276], ["[44]", "SIMPLE_CHEMICAL", 278, 282], ["[45]", "SIMPLE_CHEMICAL", 284, 288], ["HIV", "SPECIES", 130, 133], ["HIV disease transmission", "PROBLEM", 130, 154], ["the Caputo fractional order operator", "TREATMENT", 161, 197]]], ["The choice of using the Caputo derivative is due to the fact that, if the given function is a constant, then the Caputo derivative of that function gives zero.", [["the Caputo derivative", "TREATMENT", 20, 41]]], ["Primarily, the Caputo operator computes an ordinary differential equation, followed by a fractional integral to obtain the desired order of fractional derivative.", [["Caputo operator", "DNA", 15, 30], ["a fractional integral", "TREATMENT", 87, 108], ["fractional derivative", "TREATMENT", 140, 161]]], ["More importantly, the Caputo fractional differential equation (FDO) permits the use of local initial conditions to be included in the derivation of the model.IntroductionIn the present paper, we propose and analyze a fractional optimal control problem, in which the state and co-state equations are given in terms of the Caputo fractional derivatives.", [["Caputo fractional derivatives", "SIMPLE_CHEMICAL", 321, 350], ["the Caputo fractional differential equation", "TEST", 18, 61], ["local initial conditions", "TREATMENT", 87, 111], ["a fractional optimal control problem", "TREATMENT", 215, 251], ["co-state equations", "TEST", 276, 294], ["the Caputo fractional derivatives", "TREATMENT", 317, 350]]], ["This approach simplifies the use of fractional numerical methods to solve the state and co-state equations.", [["fractional numerical methods", "TREATMENT", 36, 64]]], ["Fractional optimal control problems can be regarded as a generalization of classic optimal control problems for which the dynamics of the control system are described by fractional differential equations.", [["Fractional optimal control problems", "PROBLEM", 0, 35], ["classic optimal control problems", "PROBLEM", 75, 107]]], ["We incorporate into the model time dependent controls such as condom use for exposed individuals, treatment for infected female sex workers, awareness about the disease among unaware infectives and behavioral change for susceptibles in order to reduce the risk of the spread of HIV/AIDS disease.", [["HIV/AIDS disease", "DISEASE", 278, 294], ["HIV", "ORGANISM", 278, 281], ["HIV", "SPECIES", 278, 281], ["HIV", "SPECIES", 278, 281], ["treatment", "TREATMENT", 98, 107], ["the disease", "PROBLEM", 157, 168], ["behavioral change", "PROBLEM", 198, 215], ["HIV/AIDS disease", "PROBLEM", 278, 294]]], ["Conditions for fractional optimal control of the disease are derived and the state and co-state equations are characterized by Caputo fractional derivatives.", [["Caputo fractional derivatives", "SIMPLE_CHEMICAL", 127, 156], ["the disease", "PROBLEM", 45, 56], ["co-state equations", "TEST", 87, 105], ["Caputo fractional derivatives", "TREATMENT", 127, 156], ["disease", "OBSERVATION", 49, 56]]], ["Furthermore, the efficacy of order of fractional derivative, the control strategies and the value of objective functional is investigated.IntroductionThe structure of the paper is designed as: in the next Section 2, some preliminary results required for the formulation of mathematical model is provided.", [["fractional derivative", "TREATMENT", 38, 59], ["the control strategies", "TREATMENT", 61, 83]]], ["Development of the proposed mathematical model and its well-posedness is discussed in Section 3.", [["mathematical model", "OBSERVATION", 28, 46]]], ["In Section 4, we discuss the mathematical analysis of the proposed fractional order SEI1I2R epidemic model along with equilibrium points and the stability of equilibrium points.", [["the mathematical analysis", "TEST", 25, 50], ["stability", "OBSERVATION_MODIFIER", 145, 154], ["equilibrium points", "OBSERVATION", 158, 176]]], ["In Section 5, the fractional optimal control problem is formulated and discussed.", [["the fractional optimal control problem", "TREATMENT", 14, 52]]], ["Also, in this Section, the necessary conditions for the optimality of proposed fractional optimal control problem is provided.", [["proposed fractional optimal control problem", "TREATMENT", 70, 113]]], ["Furthermore, in Section 6, application of the generalized Adams-Bashforth-Moulton method is performed on the proposed model and the numerical simulations are done to validate the analytical studies.", [["the generalized Adams", "TEST", 42, 63], ["Moulton method", "TREATMENT", 74, 88], ["the numerical simulations", "TEST", 128, 153], ["the analytical studies", "TEST", 175, 197]]], ["In Section 7, numerical results are given to illustrate the capability of generalized Adams-Bashforth-Moulton method and the behavior of the obtained solutions is also discussed in this section.", [["Moulton method", "TREATMENT", 102, 116]]], ["Finally, Section 8 concludes all the major findings of the present research study.Mathematical preliminariesResearchers have continuously extended the definitions of fractional order derivatives like the Riemann-Liouville, the Caputo, Caputo-Fabrizio, Atangana-Baleanu, the Grunwald-Letnikov, the Weyl, the Marchaud, the Riesz, and the Miller and Ross [48], [49], [50], [51], [52].", [["the present research study", "TEST", 55, 81], ["fractional order derivatives", "TREATMENT", 166, 194], ["the Riemann", "TREATMENT", 200, 211], ["Caputo", "TEST", 235, 241], ["Atangana", "TEST", 252, 260]]], ["Recently, many new definitions of fractional derivative [53] have hugely evolved, going from the derivatives with nonsingular kernel and new Riemann-Liouville fractional derivative without singular kernel to the two-parameter derivatives with non-singular and non-local kernel [54], [55], [56].Mathematical preliminaries", [["nonsingular kernel", "TREATMENT", 114, 132], ["new Riemann-Liouville fractional derivative", "TREATMENT", 137, 180], ["new", "OBSERVATION_MODIFIER", 15, 18]]]], "ae05907bbddcbe93390b53dbc70950339cccb46a": [["MyocardiumThe myocardium is the muscular layer of the heart.", [["myocardium", "ANATOMY", 14, 24], ["muscular layer", "ANATOMY", 32, 46], ["heart", "ANATOMY", 54, 59], ["myocardium", "MULTI-TISSUE_STRUCTURE", 14, 24], ["muscular layer", "TISSUE", 32, 46], ["heart", "ORGAN", 54, 59], ["myocardium", "ANATOMY", 14, 24], ["muscular", "ANATOMY_MODIFIER", 32, 40], ["layer", "ANATOMY_MODIFIER", 41, 46], ["heart", "ANATOMY", 54, 59]]], ["It consists of cardiac muscle cells (cardiac myocytes [also known as cardiac rhabdomyocytes] or cardiomyocytes) arranged in overlapping spiral patterns.", [["cardiac muscle cells", "ANATOMY", 15, 35], ["cardiac myocytes", "ANATOMY", 37, 53], ["cardiac rhabdomyocytes", "ANATOMY", 69, 91], ["cardiomyocytes", "ANATOMY", 96, 110], ["cardiac muscle cells", "CELL", 15, 35], ["cardiac myocytes", "CELL", 37, 53], ["cardiac rhabdomyocytes", "CELL", 69, 91], ["cardiomyocytes", "CELL", 96, 110], ["cardiac muscle cells", "CELL_TYPE", 15, 35], ["cardiac myocytes", "CELL_TYPE", 37, 53], ["cardiac rhabdomyocytes", "CELL_TYPE", 69, 91], ["cardiomyocytes", "CELL_TYPE", 96, 110], ["cardiac muscle cells", "PROBLEM", 15, 35], ["cardiac rhabdomyocytes", "PROBLEM", 69, 91], ["cardiomyocytes", "PROBLEM", 96, 110], ["cardiac muscle", "ANATOMY", 15, 29], ["cells", "OBSERVATION", 30, 35], ["cardiac myocytes", "ANATOMY", 37, 53], ["cardiomyocytes", "ANATOMY", 96, 110], ["overlapping", "OBSERVATION_MODIFIER", 124, 135], ["spiral patterns", "OBSERVATION", 136, 151]]], ["These sheets of cells are anchored to the fibrous skeleton of the heart, which surrounds the atrioventricular valves and the origins of the aorta and pulmonary artery.", [["cells", "ANATOMY", 16, 21], ["fibrous skeleton", "ANATOMY", 42, 58], ["heart", "ANATOMY", 66, 71], ["atrioventricular valves", "ANATOMY", 93, 116], ["aorta", "ANATOMY", 140, 145], ["pulmonary artery", "ANATOMY", 150, 166], ["cells", "CELL", 16, 21], ["fibrous skeleton", "TISSUE", 42, 58], ["heart", "ORGAN", 66, 71], ["atrioventricular valves", "MULTI-TISSUE_STRUCTURE", 93, 116], ["aorta", "MULTI-TISSUE_STRUCTURE", 140, 145], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 150, 166], ["cells", "OBSERVATION", 16, 21], ["fibrous", "OBSERVATION", 42, 49], ["skeleton", "ANATOMY_MODIFIER", 50, 58], ["heart", "ANATOMY", 66, 71], ["atrioventricular valves", "ANATOMY", 93, 116], ["origins", "ANATOMY_MODIFIER", 125, 132], ["aorta", "ANATOMY", 140, 145], ["pulmonary artery", "ANATOMY", 150, 166]]], ["The myocardial thickness is related to the pressure present in each chamber; thus the atria are thin walled and the ventricles are thicker.", [["myocardial", "ANATOMY", 4, 14], ["atria", "ANATOMY", 86, 91], ["ventricles", "ANATOMY", 116, 126], ["myocardial", "MULTI-TISSUE_STRUCTURE", 4, 14], ["atria", "MULTI-TISSUE_STRUCTURE", 86, 91], ["ventricles", "MULTI-TISSUE_STRUCTURE", 116, 126], ["the pressure", "TEST", 39, 51], ["myocardial", "ANATOMY", 4, 14], ["thickness", "OBSERVATION_MODIFIER", 15, 24], ["pressure", "OBSERVATION_MODIFIER", 43, 51], ["chamber", "ANATOMY_MODIFIER", 68, 75], ["atria", "ANATOMY", 86, 91], ["thin", "OBSERVATION_MODIFIER", 96, 100], ["walled", "OBSERVATION", 101, 107], ["ventricles", "ANATOMY", 116, 126], ["thicker", "OBSERVATION", 131, 138]]], ["In adult animals, the thickness of the left ventricular free wall is approximately threefold that of the right ventricle, measured in a transverse section across the middle of the ventricles, because the pressure is greater in the systemic circulation than in the pulmonary circuit.MyocardiumThe arterial supply to the heart is the left and right coronary arteries, which arise from the aorta at the sinus of Valsalva behind the left and right cusps of the aortic valves.", [["left ventricular free wall", "ANATOMY", 39, 65], ["right ventricle", "ANATOMY", 105, 120], ["ventricles", "ANATOMY", 180, 190], ["pulmonary", "ANATOMY", 264, 273], ["arterial", "ANATOMY", 296, 304], ["heart", "ANATOMY", 319, 324], ["left", "ANATOMY", 332, 336], ["right coronary arteries", "ANATOMY", 341, 364], ["aorta", "ANATOMY", 387, 392], ["sinus", "ANATOMY", 400, 405], ["left", "ANATOMY", 429, 433], ["right cusps", "ANATOMY", 438, 449], ["aortic valves", "ANATOMY", 457, 470], ["left ventricular", "MULTI-TISSUE_STRUCTURE", 39, 55], ["free wall", "MULTI-TISSUE_STRUCTURE", 56, 65], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 105, 120], ["ventricles", "MULTI-TISSUE_STRUCTURE", 180, 190], ["pulmonary", "ORGAN", 264, 273], ["arterial", "MULTI-TISSUE_STRUCTURE", 296, 304], ["heart", "ORGAN", 319, 324], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 347, 364], ["aorta", "MULTI-TISSUE_STRUCTURE", 387, 392], ["sinus", "ORGAN", 400, 405], ["aortic valves", "MULTI-TISSUE_STRUCTURE", 457, 470], ["the pressure", "TEST", 200, 212], ["adult", "OBSERVATION_MODIFIER", 3, 8], ["animals", "OBSERVATION", 9, 16], ["thickness", "OBSERVATION_MODIFIER", 22, 31], ["left ventricular", "ANATOMY", 39, 55], ["free", "ANATOMY_MODIFIER", 56, 60], ["wall", "ANATOMY_MODIFIER", 61, 65], ["approximately", "OBSERVATION_MODIFIER", 69, 82], ["threefold", "OBSERVATION", 83, 92], ["right ventricle", "ANATOMY", 105, 120], ["transverse", "OBSERVATION_MODIFIER", 136, 146], ["middle", "ANATOMY_MODIFIER", 166, 172], ["ventricles", "ANATOMY", 180, 190], ["pressure", "OBSERVATION_MODIFIER", 204, 212], ["greater", "OBSERVATION_MODIFIER", 216, 223], ["systemic", "OBSERVATION_MODIFIER", 231, 239], ["circulation", "OBSERVATION_MODIFIER", 240, 251], ["pulmonary circuit", "ANATOMY", 264, 281], ["arterial", "ANATOMY", 296, 304], ["heart", "ANATOMY", 319, 324], ["left", "ANATOMY_MODIFIER", 332, 336], ["right coronary arteries", "ANATOMY", 341, 364], ["aorta", "ANATOMY", 387, 392], ["sinus of Valsalva", "ANATOMY", 400, 417], ["left", "ANATOMY_MODIFIER", 429, 433], ["right", "ANATOMY_MODIFIER", 438, 443], ["cusps", "ANATOMY_MODIFIER", 444, 449], ["aortic valves", "ANATOMY", 457, 470]]], ["The arteries course over the heart in the subepicardium and give off perforating intramyocardial arteries that supply a rich capillary bed throughout the myocardium.", [["arteries", "ANATOMY", 4, 12], ["heart", "ANATOMY", 29, 34], ["subepicardium", "ANATOMY", 42, 55], ["intramyocardial arteries", "ANATOMY", 81, 105], ["capillary bed", "ANATOMY", 125, 138], ["myocardium", "ANATOMY", 154, 164], ["arteries", "MULTI-TISSUE_STRUCTURE", 4, 12], ["heart", "ORGAN", 29, 34], ["subepicardium", "CANCER", 42, 55], ["intramyocardial arteries", "MULTI-TISSUE_STRUCTURE", 81, 105], ["capillary bed", "TISSUE", 125, 138], ["myocardium", "MULTI-TISSUE_STRUCTURE", 154, 164], ["arteries", "ANATOMY", 4, 12], ["heart", "ANATOMY", 29, 34], ["subepicardium", "ANATOMY", 42, 55], ["perforating", "OBSERVATION", 69, 80], ["intramyocardial arteries", "ANATOMY", 81, 105], ["rich", "OBSERVATION_MODIFIER", 120, 124], ["capillary", "ANATOMY_MODIFIER", 125, 134], ["myocardium", "ANATOMY", 154, 164]]], ["Extensive anastomoses occur between the capillaries that tend to run parallel to the elongated cardiac muscle cells.", [["capillaries", "ANATOMY", 40, 51], ["cardiac muscle cells", "ANATOMY", 95, 115], ["capillaries", "TISSUE", 40, 51], ["cardiac muscle cells", "CELL", 95, 115], ["elongated cardiac muscle cells", "CELL_TYPE", 85, 115], ["Extensive anastomoses", "PROBLEM", 0, 21], ["anastomoses", "OBSERVATION", 10, 21], ["capillaries", "ANATOMY", 40, 51], ["elongated", "OBSERVATION", 85, 94], ["cardiac muscle", "ANATOMY", 95, 109], ["cells", "OBSERVATION", 110, 115]]], ["The ratio of the area of capillaries to that of muscle cells is approximately 1 : 1, a fact evident when the myocardium is viewed histologically in cross section.", [["capillaries", "ANATOMY", 25, 36], ["muscle cells", "ANATOMY", 48, 60], ["myocardium", "ANATOMY", 109, 119], ["capillaries", "TISSUE", 25, 36], ["muscle cells", "CELL", 48, 60], ["myocardium", "ORGAN", 109, 119], ["muscle cells", "CELL_TYPE", 48, 60], ["The ratio", "TEST", 0, 9], ["area", "OBSERVATION_MODIFIER", 17, 21], ["capillaries", "OBSERVATION", 25, 36], ["muscle cells", "ANATOMY", 48, 60], ["myocardium", "ANATOMY", 109, 119]]], ["Cardiac myocytes are dependent on oxidative phosphorylation for energy requirements.", [["Cardiac myocytes", "ANATOMY", 0, 16], ["Cardiac myocytes", "CELL", 0, 16], ["Cardiac myocytes", "CELL_TYPE", 0, 16], ["oxidative phosphorylation", "TREATMENT", 34, 59], ["energy requirements", "TREATMENT", 64, 83], ["myocytes", "ANATOMY", 8, 16], ["dependent", "OBSERVATION_MODIFIER", 21, 30], ["oxidative phosphorylation", "OBSERVATION", 34, 59]]], ["This requires a constant supply of oxygen delivered by coronary arteries.Cardiac Conduction SystemThe heart is a muscular four-chamber pump that simultaneously supplies blood to the pulmonary and systemic circulatory beds (see .", [["coronary arteries", "ANATOMY", 55, 72], ["Cardiac", "ANATOMY", 73, 80], ["heart", "ANATOMY", 102, 107], ["muscular", "ANATOMY", 113, 121], ["blood", "ANATOMY", 169, 174], ["pulmonary", "ANATOMY", 182, 191], ["oxygen", "CHEMICAL", 35, 41], ["oxygen", "CHEMICAL", 35, 41], ["oxygen", "SIMPLE_CHEMICAL", 35, 41], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 55, 72], ["heart", "ORGAN", 102, 107], ["blood", "ORGANISM_SUBSTANCE", 169, 174], ["pulmonary", "ORGAN", 182, 191], ["a constant supply of oxygen", "TREATMENT", 14, 41], ["systemic circulatory beds", "TREATMENT", 196, 221], ["coronary arteries", "ANATOMY", 55, 72], ["Conduction System", "ANATOMY", 81, 98], ["heart", "ANATOMY", 102, 107], ["muscular", "OBSERVATION", 113, 121], ["chamber pump", "OBSERVATION", 127, 139], ["pulmonary", "ANATOMY", 182, 191], ["systemic", "ANATOMY", 196, 204], ["circulatory beds", "OBSERVATION", 205, 221]]], ["Mechanical pumping is composed of sequential contraction (systole) and relaxation (diastole) that must be preceded by an electrophysiologic process that triggers a coordinated chronologic sequence of electrical events that result in muscle contractions.", [["muscle", "ANATOMY", 233, 239], ["muscle contractions", "DISEASE", 233, 252], ["muscle", "ORGAN", 233, 239], ["Mechanical pumping", "TREATMENT", 0, 18], ["an electrophysiologic process", "PROBLEM", 118, 147], ["muscle contractions", "PROBLEM", 233, 252], ["pumping", "OBSERVATION", 11, 18], ["muscle contractions", "OBSERVATION", 233, 252]]], ["This electrophysiologic process is made possible by a network of 561.e2 interventricular septum, and (3) the right and left bundle branches that descend on each side of the muscular interventricular septum and eventually ramify in the ventricular myocardium as the Purkinje fiber network.", [[".e2 interventricular septum", "ANATOMY", 68, 95], ["right", "ANATOMY", 109, 114], ["left bundle branches", "ANATOMY", 119, 139], ["muscular interventricular septum", "ANATOMY", 173, 205], ["ventricular myocardium", "ANATOMY", 235, 257], ["Purkinje fiber network", "ANATOMY", 265, 287], ["interventricular septum", "TISSUE", 72, 95], ["muscular interventricular septum", "MULTI-TISSUE_STRUCTURE", 173, 205], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 235, 257], ["Purkinje fiber network", "MULTI-TISSUE_STRUCTURE", 265, 287], ["interventricular septum", "ANATOMY", 72, 95], ["right", "ANATOMY_MODIFIER", 109, 114], ["left", "ANATOMY_MODIFIER", 119, 123], ["bundle", "ANATOMY_MODIFIER", 124, 130], ["branches", "ANATOMY_MODIFIER", 131, 139], ["descend", "ANATOMY_MODIFIER", 145, 152], ["muscular interventricular septum", "ANATOMY", 173, 205], ["ventricular myocardium", "ANATOMY", 235, 257], ["Purkinje fiber", "OBSERVATION", 265, 279]]], ["The major pacemaker of the cardiac conduction system is the SAN.", [["cardiac conduction system", "ANATOMY", 27, 52], ["SAN", "ANATOMY", 60, 63], ["cardiac", "ORGAN", 27, 34], ["SAN", "MULTI-TISSUE_STRUCTURE", 60, 63], ["The major pacemaker", "TREATMENT", 0, 19], ["major", "OBSERVATION_MODIFIER", 4, 9], ["pacemaker", "OBSERVATION", 10, 19], ["cardiac", "ANATOMY", 27, 34], ["conduction system", "OBSERVATION", 35, 52]]], ["This disk-shaped structure lies between the wall of the cranial vena cava and the external wall of the right auricular appendage.", [["wall", "ANATOMY", 44, 48], ["cranial vena cava", "ANATOMY", 56, 73], ["external wall", "ANATOMY", 82, 95], ["right auricular appendage", "ANATOMY", 103, 128], ["wall", "TISSUE", 44, 48], ["cranial vena cava", "MULTI-TISSUE_STRUCTURE", 56, 73], ["external wall", "MULTI-TISSUE_STRUCTURE", 82, 95], ["auricular appendage", "MULTI-TISSUE_STRUCTURE", 109, 128], ["This disk-shaped structure", "PROBLEM", 0, 26], ["disk", "OBSERVATION_MODIFIER", 5, 9], ["shaped", "OBSERVATION_MODIFIER", 10, 16], ["structure", "OBSERVATION", 17, 26], ["wall", "ANATOMY_MODIFIER", 44, 48], ["cranial vena cava", "ANATOMY", 56, 73], ["external", "ANATOMY_MODIFIER", 82, 90], ["wall", "ANATOMY_MODIFIER", 91, 95], ["right auricular appendage", "ANATOMY", 103, 128]]], ["Four internodal pathways connect the SAN with the AVN.", [["SAN", "ANATOMY", 37, 40], ["AVN", "DISEASE", 50, 53], ["SAN", "MULTI-TISSUE_STRUCTURE", 37, 40], ["the AVN", "PROBLEM", 46, 53], ["internodal pathways", "OBSERVATION", 5, 24], ["AVN", "OBSERVATION", 50, 53]]], ["The AVN is present in the wall of the right atrium dorsal to the septal cusp of the tricuspid valve.", [["wall", "ANATOMY", 26, 30], ["right atrium dorsal", "ANATOMY", 38, 57], ["septal cusp", "ANATOMY", 65, 76], ["tricuspid valve", "ANATOMY", 84, 99], ["AVN", "DISEASE", 4, 7], ["AVN", "CANCER", 4, 7], ["wall", "TISSUE", 26, 30], ["atrium dorsal", "MULTI-TISSUE_STRUCTURE", 44, 57], ["septal cusp", "MULTI-TISSUE_STRUCTURE", 65, 76], ["tricuspid valve", "PATHOLOGICAL_FORMATION", 84, 99], ["The AVN", "TREATMENT", 0, 7], ["AVN", "OBSERVATION", 4, 7], ["wall", "ANATOMY_MODIFIER", 26, 30], ["right atrium", "ANATOMY", 38, 50], ["dorsal", "ANATOMY_MODIFIER", 51, 57], ["septal", "ANATOMY_MODIFIER", 65, 71], ["cusp", "ANATOMY_MODIFIER", 72, 76], ["tricuspid valve", "ANATOMY", 84, 99]]], ["For the atria to be electrically insulated from the ventricles so that an unwarranted ectopic conduction wave will not activate the ventricles (or vice versa) and disrupt the synchronous events of the cardiac cycle, a fibrous cardiac skeleton composed of a layer of dense collagen (central fibrous body [CFB] ), as well as occasional plates of chondroid and osseous metaplasia, separates the atrial from the ventricular myocardium.", [["atria", "ANATOMY", 8, 13], ["ventricles", "ANATOMY", 52, 62], ["ventricles", "ANATOMY", 132, 142], ["cardiac", "ANATOMY", 201, 208], ["fibrous cardiac skeleton", "ANATOMY", 218, 242], ["fibrous body", "ANATOMY", 290, 302], ["chondroid", "ANATOMY", 344, 353], ["osseous metaplasia", "ANATOMY", 358, 376], ["atrial", "ANATOMY", 392, 398], ["ventricular myocardium", "ANATOMY", 408, 430], ["atria", "MULTI-TISSUE_STRUCTURE", 8, 13], ["ventricles", "MULTI-TISSUE_STRUCTURE", 52, 62], ["ventricles", "MULTI-TISSUE_STRUCTURE", 132, 142], ["cardiac", "ORGAN", 201, 208], ["collagen", "GENE_OR_GENE_PRODUCT", 272, 280], ["central fibrous body", "TISSUE", 282, 302], ["chondroid", "TISSUE", 344, 353], ["osseous metaplasia", "CANCER", 358, 376], ["atrial", "MULTI-TISSUE_STRUCTURE", 392, 398], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 408, 430], ["collagen", "PROTEIN", 272, 280], ["an unwarranted ectopic conduction wave", "PROBLEM", 71, 109], ["a fibrous cardiac skeleton", "PROBLEM", 216, 242], ["dense collagen (central fibrous body [CFB", "PROBLEM", 266, 307], ["occasional plates of chondroid and osseous metaplasia", "PROBLEM", 323, 376], ["atria", "ANATOMY", 8, 13], ["ventricles", "ANATOMY", 52, 62], ["ventricles", "ANATOMY", 132, 142], ["synchronous", "OBSERVATION", 175, 186], ["cardiac", "ANATOMY", 201, 208], ["fibrous", "OBSERVATION", 218, 225], ["cardiac skeleton", "ANATOMY", 226, 242], ["layer", "OBSERVATION_MODIFIER", 257, 262], ["dense", "OBSERVATION_MODIFIER", 266, 271], ["collagen", "OBSERVATION_MODIFIER", 272, 280], ["central", "OBSERVATION_MODIFIER", 282, 289], ["fibrous body", "OBSERVATION", 290, 302], ["occasional", "OBSERVATION_MODIFIER", 323, 333], ["plates", "OBSERVATION_MODIFIER", 334, 340], ["chondroid", "OBSERVATION_MODIFIER", 344, 353], ["osseous", "ANATOMY", 358, 365], ["metaplasia", "OBSERVATION", 366, 376], ["atrial", "ANATOMY", 392, 398], ["ventricular myocardium", "ANATOMY", 408, 430]]], ["This skeleton forms two fibrous rings around the AV orifices and the aortic and pulmonic orifices.", [["skeleton", "ANATOMY", 5, 13], ["fibrous rings", "ANATOMY", 24, 37], ["AV orifices", "ANATOMY", 49, 60], ["aortic", "ANATOMY", 69, 75], ["pulmonic orifices", "ANATOMY", 80, 97], ["fibrous rings", "TISSUE", 24, 37], ["AV orifices", "MULTI-TISSUE_STRUCTURE", 49, 60], ["aortic", "MULTI-TISSUE_STRUCTURE", 69, 75], ["pulmonic orifices", "MULTI-TISSUE_STRUCTURE", 80, 97], ["skeleton", "ANATOMY", 5, 13], ["two", "OBSERVATION_MODIFIER", 20, 23], ["fibrous rings", "OBSERVATION", 24, 37], ["AV", "ANATOMY", 49, 51], ["orifices", "ANATOMY_MODIFIER", 52, 60], ["aortic", "ANATOMY", 69, 75], ["pulmonic", "ANATOMY", 80, 88], ["orifices", "ANATOMY_MODIFIER", 89, 97]]], ["Conduction fibers arising from the AVN, known as the bundle of His or AV bundle, pierce through the CFB into the ventricles and continue along the subendocardium of the interventricular septum.", [["Conduction fibers", "ANATOMY", 0, 17], ["AVN", "ANATOMY", 35, 38], ["AV bundle", "ANATOMY", 70, 79], ["ventricles", "ANATOMY", 113, 123], ["subendocardium", "ANATOMY", 147, 161], ["interventricular septum", "ANATOMY", 169, 192], ["AVN", "DISEASE", 35, 38], ["His", "CHEMICAL", 63, 66], ["Conduction fibers", "CELLULAR_COMPONENT", 0, 17], ["AVN", "CANCER", 35, 38], ["His", "GENE_OR_GENE_PRODUCT", 63, 66], ["ventricles", "MULTI-TISSUE_STRUCTURE", 113, 123], ["subendocardium", "MULTI-TISSUE_STRUCTURE", 147, 161], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 169, 192], ["CFB", "PROTEIN", 100, 103], ["Conduction fibers", "PROBLEM", 0, 17], ["the AVN", "PROBLEM", 31, 38], ["AVN", "OBSERVATION", 35, 38], ["bundle", "ANATOMY_MODIFIER", 53, 59], ["AV bundle", "ANATOMY", 70, 79], ["CFB", "OBSERVATION", 100, 103], ["ventricles", "ANATOMY", 113, 123], ["subendocardium", "ANATOMY_MODIFIER", 147, 161], ["interventricular septum", "ANATOMY", 169, 192]]], ["The AV bundle then splits into the right and left bundle branches, which further split and ramify into many other smaller branches that blend into the ventricular myocardium.", [["AV bundle", "ANATOMY", 4, 13], ["right", "ANATOMY", 35, 40], ["left bundle branches", "ANATOMY", 45, 65], ["ventricular myocardium", "ANATOMY", 151, 173], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 151, 173], ["AV bundle", "ANATOMY", 4, 13], ["right", "ANATOMY_MODIFIER", 35, 40], ["left", "ANATOMY_MODIFIER", 45, 49], ["bundle", "ANATOMY_MODIFIER", 50, 56], ["branches", "ANATOMY_MODIFIER", 57, 65], ["split", "OBSERVATION_MODIFIER", 81, 86], ["smaller", "OBSERVATION_MODIFIER", 114, 121], ["branches", "ANATOMY_MODIFIER", 122, 130], ["ventricular myocardium", "ANATOMY", 151, 173]]], ["Purkinje fibers constitute the AV bundle and downstream conduction pathways.Endocardium and Heart ValvesThe endocardium is the innermost layer of the heart and lines the chambers and extends over projecting structures such as the valves, chordae tendineae, and papillary muscles.", [["Purkinje fibers", "ANATOMY", 0, 15], ["AV bundle", "ANATOMY", 31, 40], ["Endocardium", "ANATOMY", 76, 87], ["Heart Valves", "ANATOMY", 92, 104], ["endocardium", "ANATOMY", 108, 119], ["innermost layer", "ANATOMY", 127, 142], ["heart", "ANATOMY", 150, 155], ["projecting structures", "ANATOMY", 196, 217], ["valves", "ANATOMY", 230, 236], ["chordae tendineae", "ANATOMY", 238, 255], ["papillary muscles", "ANATOMY", 261, 278], ["Purkinje fibers", "CELLULAR_COMPONENT", 0, 15], ["endocardium", "MULTI-TISSUE_STRUCTURE", 108, 119], ["heart", "ORGAN", 150, 155], ["structures", "TISSUE", 207, 217], ["valves", "TISSUE", 230, 236], ["chordae tendineae", "TISSUE", 238, 255], ["papillary muscles", "TISSUE", 261, 278], ["Endocardium and Heart Valves", "PROBLEM", 76, 104], ["AV bundle", "ANATOMY", 31, 40], ["downstream conduction", "OBSERVATION", 45, 66], ["Heart Valves", "ANATOMY", 92, 104], ["endocardium", "ANATOMY", 108, 119], ["innermost", "ANATOMY_MODIFIER", 127, 136], ["layer", "ANATOMY_MODIFIER", 137, 142], ["heart", "ANATOMY", 150, 155], ["lines", "OBSERVATION", 160, 165], ["chambers", "OBSERVATION_MODIFIER", 170, 178], ["valves", "ANATOMY", 230, 236], ["chordae tendineae", "ANATOMY", 238, 255], ["papillary muscles", "ANATOMY", 261, 278]]], ["The endocardium of the atria is thicker than that of the ventricles and thus normally appears white to gray on gross examination.", [["endocardium", "ANATOMY", 4, 15], ["atria", "ANATOMY", 23, 28], ["ventricles", "ANATOMY", 57, 67], ["endocardium", "MULTI-TISSUE_STRUCTURE", 4, 15], ["atria", "MULTI-TISSUE_STRUCTURE", 23, 28], ["ventricles", "MULTI-TISSUE_STRUCTURE", 57, 67], ["gross examination", "TEST", 111, 128], ["endocardium", "ANATOMY_MODIFIER", 4, 15], ["atria", "ANATOMY", 23, 28], ["thicker", "OBSERVATION", 32, 39], ["ventricles", "ANATOMY", 57, 67], ["white", "OBSERVATION_MODIFIER", 94, 99]]], ["The surface of the endocardium is endothelium that lies on a thin layer of vascularized connective tissue; the subendocardial layer contains blood vessels, nerves, and connective tissue.", [["surface", "ANATOMY", 4, 11], ["endocardium", "ANATOMY", 19, 30], ["endothelium", "ANATOMY", 34, 45], ["connective tissue", "ANATOMY", 88, 105], ["subendocardial layer", "ANATOMY", 111, 131], ["blood vessels", "ANATOMY", 141, 154], ["nerves", "ANATOMY", 156, 162], ["connective tissue", "ANATOMY", 168, 185], ["surface", "CELLULAR_COMPONENT", 4, 11], ["endocardium", "TISSUE", 19, 30], ["endothelium", "TISSUE", 34, 45], ["connective tissue", "TISSUE", 88, 105], ["subendocardial layer", "TISSUE", 111, 131], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 141, 154], ["nerves", "TISSUE", 156, 162], ["connective tissue", "TISSUE", 168, 185], ["a thin layer of vascularized connective tissue", "PROBLEM", 59, 105], ["blood vessels, nerves, and connective tissue", "PROBLEM", 141, 185], ["surface", "ANATOMY_MODIFIER", 4, 11], ["endocardium", "ANATOMY", 19, 30], ["endothelium", "OBSERVATION", 34, 45], ["thin", "OBSERVATION_MODIFIER", 61, 65], ["layer", "OBSERVATION_MODIFIER", 66, 71], ["vascularized", "OBSERVATION_MODIFIER", 75, 87], ["connective tissue", "OBSERVATION", 88, 105], ["subendocardial", "ANATOMY_MODIFIER", 111, 125], ["layer", "ANATOMY_MODIFIER", 126, 131], ["blood vessels", "ANATOMY", 141, 154], ["nerves", "ANATOMY", 156, 162], ["connective tissue", "OBSERVATION", 168, 185]]], ["Purkinje fibers are distributed in the subendocardium throughout both ventricles.", [["Purkinje fibers", "ANATOMY", 0, 15], ["subendocardium", "ANATOMY", 39, 53], ["ventricles", "ANATOMY", 70, 80], ["Purkinje fibers", "CELLULAR_COMPONENT", 0, 15], ["subendocardium", "TISSUE", 39, 53], ["ventricles", "MULTI-TISSUE_STRUCTURE", 70, 80], ["subendocardium", "ANATOMY_MODIFIER", 39, 53], ["both", "ANATOMY_MODIFIER", 65, 69], ["ventricles", "ANATOMY", 70, 80]]], ["The heart valves (tricuspid valve [right AV valve] , mitral valve [left AV valve], aortic valve, and pulmonary valve) are attached to fibrous rings and have thin avascular cusps.", [["heart valves", "ANATOMY", 4, 16], ["tricuspid valve", "ANATOMY", 18, 33], ["right AV valve", "ANATOMY", 35, 49], ["mitral valve", "ANATOMY", 53, 65], ["left AV valve", "ANATOMY", 67, 80], ["aortic valve", "ANATOMY", 83, 95], ["pulmonary valve", "ANATOMY", 101, 116], ["fibrous rings", "ANATOMY", 134, 147], ["avascular cusps", "ANATOMY", 162, 177], ["heart valves", "MULTI-TISSUE_STRUCTURE", 4, 16], ["valve", "MULTI-TISSUE_STRUCTURE", 44, 49], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 83, 95], ["pulmonary valve", "MULTI-TISSUE_STRUCTURE", 101, 116], ["avascular cusps", "PATHOLOGICAL_FORMATION", 162, 177], ["The heart valves", "TREATMENT", 0, 16], ["tricuspid valve", "TREATMENT", 18, 33], ["right AV valve", "TREATMENT", 35, 49], ["mitral valve", "TREATMENT", 53, 65], ["left AV valve", "TREATMENT", 67, 80], ["aortic valve", "TREATMENT", 83, 95], ["pulmonary valve", "TREATMENT", 101, 116], ["thin avascular cusps", "PROBLEM", 157, 177], ["heart valves", "ANATOMY", 4, 16], ["tricuspid valve", "ANATOMY", 18, 33], ["right", "ANATOMY_MODIFIER", 35, 40], ["AV valve", "ANATOMY", 41, 49], ["mitral valve", "ANATOMY", 53, 65], ["left", "ANATOMY_MODIFIER", 67, 71], ["AV valve", "ANATOMY", 72, 80], ["aortic valve", "ANATOMY", 83, 95], ["pulmonary valve", "ANATOMY", 101, 116], ["fibrous rings", "OBSERVATION", 134, 147], ["thin", "OBSERVATION_MODIFIER", 157, 161], ["avascular cusps", "OBSERVATION", 162, 177]]], ["The valves open and close to regulate blood flow through the heart.", [["valves", "ANATOMY", 4, 10], ["blood", "ANATOMY", 38, 43], ["heart", "ANATOMY", 61, 66], ["valves", "TISSUE", 4, 10], ["blood", "ORGANISM_SUBSTANCE", 38, 43], ["heart", "ORGAN", 61, 66], ["The valves", "TREATMENT", 0, 10], ["valves", "ANATOMY", 4, 10], ["open", "OBSERVATION", 11, 15], ["heart", "ANATOMY", 61, 66]]], ["During embryogenesis, endocardial cushions (mesenchymal tissue covered by endothelium) are precursors of the valve cusps.", [["endocardial cushions", "ANATOMY", 22, 42], ["mesenchymal tissue", "ANATOMY", 44, 62], ["endothelium", "ANATOMY", 74, 85], ["valve cusps", "ANATOMY", 109, 120], ["endocardial cushions", "TISSUE", 22, 42], ["mesenchymal tissue", "TISSUE", 44, 62], ["endothelium", "TISSUE", 74, 85], ["valve cusps", "MULTI-TISSUE_STRUCTURE", 109, 120], ["endocardial cushions (mesenchymal tissue", "TREATMENT", 22, 62], ["endocardial", "ANATOMY", 22, 33], ["cushions", "ANATOMY_MODIFIER", 34, 42], ["mesenchymal tissue", "OBSERVATION", 44, 62], ["endothelium", "ANATOMY", 74, 85], ["valve", "ANATOMY", 109, 114], ["cusps", "ANATOMY_MODIFIER", 115, 120]]], ["By remodeling, growth, and elongation, the cushions become thin mature cusps composed of connective tissue with an endothelial covering.Pericardium and EpicardiumThe pericardium, which normally contains a small amount of clear, serous fluid, is composed of an outer fibrous component and an inner serous layer, which form the sac surrounding the heart.", [["cushions", "ANATOMY", 43, 51], ["connective tissue", "ANATOMY", 89, 106], ["endothelial", "ANATOMY", 115, 126], ["Pericardium", "ANATOMY", 136, 147], ["pericardium", "ANATOMY", 166, 177], ["serous fluid", "ANATOMY", 228, 240], ["outer fibrous component", "ANATOMY", 260, 283], ["inner serous layer", "ANATOMY", 291, 309], ["sac", "ANATOMY", 326, 329], ["heart", "ANATOMY", 346, 351], ["connective tissue", "TISSUE", 89, 106], ["endothelial", "TISSUE", 115, 126], ["Epicardium", "CANCER", 152, 162], ["pericardium", "ORGAN", 166, 177], ["serous fluid", "ORGANISM_SUBSTANCE", 228, 240], ["inner serous layer", "TISSUE", 291, 309], ["sac", "TISSUE", 326, 329], ["heart", "ORGAN", 346, 351], ["elongation", "PROBLEM", 27, 37], ["thin mature cusps", "PROBLEM", 59, 76], ["connective tissue", "PROBLEM", 89, 106], ["serous fluid", "PROBLEM", 228, 240], ["an outer fibrous component", "PROBLEM", 257, 283], ["an inner serous layer", "PROBLEM", 288, 309], ["growth", "OBSERVATION_MODIFIER", 15, 21], ["elongation", "OBSERVATION_MODIFIER", 27, 37], ["thin", "OBSERVATION_MODIFIER", 59, 63], ["mature", "OBSERVATION_MODIFIER", 64, 70], ["cusps", "OBSERVATION", 71, 76], ["connective tissue", "OBSERVATION", 89, 106], ["endothelial", "ANATOMY", 115, 126], ["Epicardium", "ANATOMY", 152, 162], ["pericardium", "ANATOMY", 166, 177], ["small", "OBSERVATION_MODIFIER", 205, 210], ["amount", "OBSERVATION_MODIFIER", 211, 217], ["clear", "OBSERVATION_MODIFIER", 221, 226], ["serous", "OBSERVATION_MODIFIER", 228, 234], ["fluid", "OBSERVATION", 235, 240], ["outer", "OBSERVATION_MODIFIER", 260, 265], ["fibrous", "OBSERVATION_MODIFIER", 266, 273], ["component", "OBSERVATION_MODIFIER", 274, 283], ["inner", "OBSERVATION_MODIFIER", 291, 296], ["serous", "OBSERVATION_MODIFIER", 297, 303], ["layer", "OBSERVATION_MODIFIER", 304, 309], ["sac", "ANATOMY_MODIFIER", 326, 329], ["heart", "ANATOMY", 346, 351]]], ["The outer component is continuous with the mediastinal pleura.", [["outer component", "ANATOMY", 4, 19], ["mediastinal pleura", "ANATOMY", 43, 61], ["mediastinal pleura", "MULTI-TISSUE_STRUCTURE", 43, 61], ["outer", "OBSERVATION_MODIFIER", 4, 9], ["component", "OBSERVATION_MODIFIER", 10, 19], ["continuous", "OBSERVATION_MODIFIER", 23, 33], ["mediastinal", "ANATOMY", 43, 54], ["pleura", "ANATOMY", 55, 61]]], ["The base of the fibrous pericardium surrounds and blends with the adventitia of the greater arteries and veins exiting and entering the heart.", [["fibrous pericardium", "ANATOMY", 16, 35], ["adventitia", "ANATOMY", 66, 76], ["arteries", "ANATOMY", 92, 100], ["veins", "ANATOMY", 105, 110], ["heart", "ANATOMY", 136, 141], ["fibrous pericardium", "TISSUE", 16, 35], ["adventitia", "TISSUE", 66, 76], ["arteries", "MULTI-TISSUE_STRUCTURE", 92, 100], ["veins", "MULTI-TISSUE_STRUCTURE", 105, 110], ["heart", "ORGAN", 136, 141], ["base", "ANATOMY_MODIFIER", 4, 8], ["fibrous pericardium", "ANATOMY", 16, 35], ["blends", "OBSERVATION_MODIFIER", 50, 56], ["adventitia", "ANATOMY_MODIFIER", 66, 76], ["greater arteries", "ANATOMY", 84, 100], ["veins", "ANATOMY", 105, 110], ["heart", "ANATOMY", 136, 141]]], ["The serous pericardium forms a closed sac surrounding the heart and the roots of the great vessels.Pericardium and EpicardiumThe epicardium (also known as visceral pericardium), the outermost layer of the heart, is continuous at the cardiac base with the parietal pericardium.", [["serous pericardium", "ANATOMY", 4, 22], ["sac", "ANATOMY", 38, 41], ["heart", "ANATOMY", 58, 63], ["roots", "ANATOMY", 72, 77], ["great vessels", "ANATOMY", 85, 98], ["Pericardium", "ANATOMY", 99, 110], ["epicardium", "ANATOMY", 129, 139], ["visceral pericardium", "ANATOMY", 155, 175], ["outermost layer", "ANATOMY", 182, 197], ["heart", "ANATOMY", 205, 210], ["cardiac base", "ANATOMY", 233, 245], ["parietal pericardium", "ANATOMY", 255, 275], ["serous pericardium", "MULTI-TISSUE_STRUCTURE", 4, 22], ["sac", "TISSUE", 38, 41], ["heart", "ORGAN", 58, 63], ["roots", "ORGAN", 72, 77], ["great vessels", "MULTI-TISSUE_STRUCTURE", 85, 98], ["Epicardium", "CANCER", 115, 125], ["epicardium", "MULTI-TISSUE_STRUCTURE", 129, 139], ["visceral pericardium", "MULTI-TISSUE_STRUCTURE", 155, 175], ["outermost layer", "TISSUE", 182, 197], ["heart", "ORGAN", 205, 210], ["cardiac", "ORGAN", 233, 240], ["parietal pericardium", "MULTI-TISSUE_STRUCTURE", 255, 275], ["serous", "OBSERVATION", 4, 10], ["pericardium", "ANATOMY", 11, 22], ["closed", "OBSERVATION", 31, 37], ["sac", "OBSERVATION_MODIFIER", 38, 41], ["heart", "ANATOMY", 58, 63], ["roots", "ANATOMY_MODIFIER", 72, 77], ["great vessels", "ANATOMY", 85, 98], ["Epicardium", "ANATOMY", 115, 125], ["epicardium", "ANATOMY", 129, 139], ["visceral pericardium", "ANATOMY", 155, 175], ["outermost", "ANATOMY_MODIFIER", 182, 191], ["layer", "ANATOMY_MODIFIER", 192, 197], ["heart", "ANATOMY", 205, 210], ["cardiac", "ANATOMY", 233, 240], ["base", "ANATOMY_MODIFIER", 241, 245], ["parietal", "ANATOMY_MODIFIER", 255, 263], ["pericardium", "ANATOMY", 264, 275]]], ["The parietal pericardium is fused with the fibrous pericardium.", [["parietal pericardium", "ANATOMY", 4, 24], ["fibrous pericardium", "ANATOMY", 43, 62], ["parietal pericardium", "MULTI-TISSUE_STRUCTURE", 4, 24], ["fibrous pericardium", "TISSUE", 43, 62], ["parietal", "ANATOMY_MODIFIER", 4, 12], ["pericardium", "ANATOMY", 13, 24], ["fused", "OBSERVATION", 28, 33], ["fibrous", "OBSERVATION", 43, 50], ["pericardium", "ANATOMY", 51, 62]]], ["The entire inner surface of the pericardial cavity is covered by mesothelium.", [["inner surface", "ANATOMY", 11, 24], ["pericardial cavity", "ANATOMY", 32, 50], ["mesothelium", "ANATOMY", 65, 76], ["inner surface", "MULTI-TISSUE_STRUCTURE", 11, 24], ["pericardial cavity", "MULTI-TISSUE_STRUCTURE", 32, 50], ["mesothelium", "TISSUE", 65, 76], ["entire", "OBSERVATION_MODIFIER", 4, 10], ["inner", "OBSERVATION_MODIFIER", 11, 16], ["surface", "OBSERVATION_MODIFIER", 17, 24], ["pericardial", "ANATOMY", 32, 43], ["cavity", "OBSERVATION", 44, 50], ["mesothelium", "OBSERVATION", 65, 76]]], ["The subepicardial layer is attached to the myocardium and consists of a thin layer of fibrous connective tissue, variable but generally abundant amounts (in well-nourished animals) of adipose tissue, and numerous blood vessels, lymphatic vessels, and nerves. special conducting fibers that are collectively referred to as the cardiac conduction system.", [["subepicardial layer", "ANATOMY", 4, 23], ["myocardium", "ANATOMY", 43, 53], ["fibrous connective tissue", "ANATOMY", 86, 111], ["adipose tissue", "ANATOMY", 184, 198], ["blood vessels", "ANATOMY", 213, 226], ["lymphatic vessels", "ANATOMY", 228, 245], ["nerves", "ANATOMY", 251, 257], ["fibers", "ANATOMY", 278, 284], ["cardiac", "ANATOMY", 326, 333], ["subepicardial layer", "TISSUE", 4, 23], ["myocardium", "ORGAN", 43, 53], ["fibrous connective tissue", "TISSUE", 86, 111], ["adipose tissue", "TISSUE", 184, 198], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 213, 226], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 228, 245], ["nerves", "MULTI-TISSUE_STRUCTURE", 251, 257], ["fibers", "CELL", 278, 284], ["a thin layer of fibrous connective tissue", "PROBLEM", 70, 111], ["adipose tissue", "PROBLEM", 184, 198], ["special conducting fibers", "PROBLEM", 259, 284], ["subepicardial", "ANATOMY_MODIFIER", 4, 17], ["layer", "ANATOMY_MODIFIER", 18, 23], ["myocardium", "ANATOMY", 43, 53], ["thin", "OBSERVATION_MODIFIER", 72, 76], ["layer", "OBSERVATION_MODIFIER", 77, 82], ["fibrous connective tissue", "OBSERVATION", 86, 111], ["variable", "OBSERVATION_MODIFIER", 113, 121], ["generally", "OBSERVATION_MODIFIER", 126, 135], ["abundant", "OBSERVATION_MODIFIER", 136, 144], ["amounts", "OBSERVATION_MODIFIER", 145, 152], ["adipose tissue", "ANATOMY", 184, 198], ["numerous", "OBSERVATION_MODIFIER", 204, 212], ["blood vessels", "ANATOMY", 213, 226], ["lymphatic vessels", "ANATOMY", 228, 245], ["nerves", "ANATOMY", 251, 257], ["cardiac", "ANATOMY", 326, 333]]], ["The cardiac conduction system is infrequently examined in animals because it is a labor-intensive process.", [["cardiac", "ANATOMY", 4, 11], ["cardiac", "ORGAN", 4, 11], ["a labor", "PROBLEM", 80, 87], ["cardiac", "ANATOMY", 4, 11], ["conduction system", "OBSERVATION", 12, 29], ["labor", "OBSERVATION", 82, 87]]], ["Exceptions are cases with documented electrocardiographic alterations of undetermined origin.", [["documented electrocardiographic alterations", "PROBLEM", 26, 69], ["undetermined origin", "OBSERVATION_MODIFIER", 73, 92]]], ["Components include (1) the sinoatrial node (SAN) at the junction of the cranial vena cava and the right atrium, (2) the atrioventricular node (AVN) located above the septal leaflet of the tricuspid valve and the atrioventricular (AV) bundle traversing the lower atrial septum onto the dorsal portion of the muscular myocardium, and epicardium are evenly innervated, whereas the ventricles are considerably less innervated, with epicardium more densely populated by neural tissue than the endocardium.Endocardium and Heart ValvesThe endocardium, lining the atrium and ventricles, consists of a continuous endothelium, subendothelium, and subendocardium.", [["sinoatrial node", "ANATOMY", 27, 42], ["SAN", "ANATOMY", 44, 47], ["cranial vena cava", "ANATOMY", 72, 89], ["right atrium", "ANATOMY", 98, 110], ["atrioventricular node", "ANATOMY", 120, 141], ["AVN", "ANATOMY", 143, 146], ["septal leaflet", "ANATOMY", 166, 180], ["tricuspid valve", "ANATOMY", 188, 203], ["atrioventricular (AV) bundle", "ANATOMY", 212, 240], ["lower atrial septum", "ANATOMY", 256, 275], ["dorsal portion", "ANATOMY", 285, 299], ["muscular myocardium", "ANATOMY", 307, 326], ["epicardium", "ANATOMY", 332, 342], ["ventricles", "ANATOMY", 378, 388], ["epicardium", "ANATOMY", 428, 438], ["neural tissue", "ANATOMY", 465, 478], ["endocardium", "ANATOMY", 488, 499], ["Endocardium", "ANATOMY", 500, 511], ["Heart Valves", "ANATOMY", 516, 528], ["endocardium", "ANATOMY", 532, 543], ["atrium", "ANATOMY", 556, 562], ["ventricles", "ANATOMY", 567, 577], ["endothelium", "ANATOMY", 604, 615], ["subendothelium", "ANATOMY", 617, 631], ["subendocardium", "ANATOMY", 637, 651], ["sinoatrial node", "MULTI-TISSUE_STRUCTURE", 27, 42], ["SAN", "MULTI-TISSUE_STRUCTURE", 44, 47], ["cranial vena cava", "MULTI-TISSUE_STRUCTURE", 72, 89], ["right atrium", "MULTI-TISSUE_STRUCTURE", 98, 110], ["atrioventricular node", "MULTI-TISSUE_STRUCTURE", 120, 141], ["AVN", "MULTI-TISSUE_STRUCTURE", 143, 146], ["septal leaflet", "MULTI-TISSUE_STRUCTURE", 166, 180], ["tricuspid valve", "MULTI-TISSUE_STRUCTURE", 188, 203], ["atrioventricular", "MULTI-TISSUE_STRUCTURE", 212, 228], ["atrial septum", "MULTI-TISSUE_STRUCTURE", 262, 275], ["muscular myocardium", "TISSUE", 307, 326], ["epicardium", "MULTI-TISSUE_STRUCTURE", 332, 342], ["ventricles", "MULTI-TISSUE_STRUCTURE", 378, 388], ["epicardium", "TISSUE", 428, 438], ["neural tissue", "TISSUE", 465, 478], ["endocardium", "MULTI-TISSUE_STRUCTURE", 488, 499], ["endocardium", "MULTI-TISSUE_STRUCTURE", 532, 543], ["atrium", "MULTI-TISSUE_STRUCTURE", 556, 562], ["ventricles", "MULTI-TISSUE_STRUCTURE", 567, 577], ["endothelium", "TISSUE", 604, 615], ["subendothelium", "TISSUE", 617, 631], ["subendocardium", "TISSUE", 637, 651], ["subendothelium", "CELL_TYPE", 617, 631], ["the sinoatrial node (SAN", "PROBLEM", 23, 47], ["the atrioventricular node (AVN)", "PROBLEM", 116, 147], ["Endocardium and Heart Valves", "PROBLEM", 500, 528], ["sinoatrial", "ANATOMY", 27, 37], ["node", "OBSERVATION", 38, 42], ["junction", "ANATOMY_MODIFIER", 56, 64], ["cranial vena cava", "ANATOMY", 72, 89], ["right atrium", "ANATOMY", 98, 110], ["atrioventricular node", "ANATOMY", 120, 141], ["AVN", "OBSERVATION", 143, 146], ["septal", "ANATOMY_MODIFIER", 166, 172], ["leaflet", "ANATOMY_MODIFIER", 173, 180], ["tricuspid valve", "ANATOMY", 188, 203], ["atrioventricular", "ANATOMY_MODIFIER", 212, 228], ["AV", "ANATOMY_MODIFIER", 230, 232], ["bundle", "ANATOMY_MODIFIER", 234, 240], ["lower", "ANATOMY_MODIFIER", 256, 261], ["atrial septum", "ANATOMY", 262, 275], ["dorsal", "ANATOMY_MODIFIER", 285, 291], ["portion", "ANATOMY_MODIFIER", 292, 299], ["muscular myocardium", "ANATOMY", 307, 326], ["epicardium", "ANATOMY", 332, 342], ["evenly", "OBSERVATION_MODIFIER", 347, 353], ["innervated", "OBSERVATION", 354, 364], ["ventricles", "ANATOMY", 378, 388], ["considerably", "OBSERVATION_MODIFIER", 393, 405], ["less", "OBSERVATION_MODIFIER", 406, 410], ["epicardium", "ANATOMY", 428, 438], ["more", "OBSERVATION_MODIFIER", 439, 443], ["densely", "OBSERVATION_MODIFIER", 444, 451], ["populated", "OBSERVATION", 452, 461], ["neural tissue", "OBSERVATION", 465, 478], ["endocardium", "ANATOMY", 488, 499], ["Heart Valves", "ANATOMY", 516, 528], ["endocardium", "ANATOMY", 532, 543], ["lining", "ANATOMY_MODIFIER", 545, 551], ["atrium", "ANATOMY", 556, 562], ["ventricles", "ANATOMY", 567, 577], ["continuous", "OBSERVATION_MODIFIER", 593, 603], ["endothelium", "OBSERVATION", 604, 615], ["subendothelium", "OBSERVATION_MODIFIER", 617, 631], ["subendocardium", "ANATOMY", 637, 651]]], ["The subendothelial layer contains dense irregular fibroblasts intermixed with collagen and elastic fibers and occasional smooth muscle cells.", [["subendothelial layer", "ANATOMY", 4, 24], ["fibroblasts", "ANATOMY", 50, 61], ["elastic fibers", "ANATOMY", 91, 105], ["smooth muscle cells", "ANATOMY", 121, 140], ["subendothelial layer", "TISSUE", 4, 24], ["fibroblasts", "CELL", 50, 61], ["collagen", "GENE_OR_GENE_PRODUCT", 78, 86], ["elastic fibers", "CELLULAR_COMPONENT", 91, 105], ["smooth muscle cells", "CELL", 121, 140], ["dense irregular fibroblasts", "CELL_TYPE", 34, 61], ["collagen", "PROTEIN", 78, 86], ["occasional smooth muscle cells", "CELL_TYPE", 110, 140], ["dense irregular fibroblasts", "PROBLEM", 34, 61], ["collagen and elastic fibers", "TREATMENT", 78, 105], ["occasional smooth muscle cells", "PROBLEM", 110, 140], ["subendothelial", "ANATOMY_MODIFIER", 4, 18], ["layer", "ANATOMY_MODIFIER", 19, 24], ["dense", "OBSERVATION_MODIFIER", 34, 39], ["irregular", "OBSERVATION_MODIFIER", 40, 49], ["fibroblasts intermixed", "OBSERVATION", 50, 72], ["collagen", "OBSERVATION_MODIFIER", 78, 86], ["elastic fibers", "OBSERVATION", 91, 105], ["occasional", "OBSERVATION_MODIFIER", 110, 120], ["smooth muscle cells", "OBSERVATION", 121, 140]]], ["Elastic fibers are abundant within the subendocardium of the atria.", [["Elastic fibers", "ANATOMY", 0, 14], ["subendocardium", "ANATOMY", 39, 53], ["atria", "ANATOMY", 61, 66], ["Elastic fibers", "CELLULAR_COMPONENT", 0, 14], ["subendocardium", "MULTI-TISSUE_STRUCTURE", 39, 53], ["atria", "MULTI-TISSUE_STRUCTURE", 61, 66], ["Elastic fibers", "TREATMENT", 0, 14], ["fibers", "OBSERVATION", 8, 14], ["abundant", "OBSERVATION_MODIFIER", 19, 27], ["subendocardium", "ANATOMY_MODIFIER", 39, 53], ["atria", "ANATOMY", 61, 66]]], ["The subendocardial layer contains vascular structures, elastic and collagen bands, and fibroblasts and is continuous with the myocardium.", [["subendocardial layer", "ANATOMY", 4, 24], ["vascular structures", "ANATOMY", 34, 53], ["fibroblasts", "ANATOMY", 87, 98], ["myocardium", "ANATOMY", 126, 136], ["subendocardial layer", "TISSUE", 4, 24], ["vascular structures", "TISSUE", 34, 53], ["collagen", "GENE_OR_GENE_PRODUCT", 67, 75], ["fibroblasts", "CELL", 87, 98], ["myocardium", "MULTI-TISSUE_STRUCTURE", 126, 136], ["fibroblasts", "CELL_TYPE", 87, 98], ["elastic and collagen bands", "PROBLEM", 55, 81], ["subendocardial", "ANATOMY_MODIFIER", 4, 18], ["layer", "ANATOMY_MODIFIER", 19, 24], ["vascular structures", "ANATOMY", 34, 53], ["elastic", "OBSERVATION_MODIFIER", 55, 62], ["collagen bands", "OBSERVATION", 67, 81], ["fibroblasts", "OBSERVATION", 87, 98], ["myocardium", "ANATOMY", 126, 136]]], ["Purkinje fibers are located in the subendocardium.", [["Purkinje fibers", "ANATOMY", 0, 15], ["subendocardium", "ANATOMY", 35, 49], ["Purkinje fibers", "CELLULAR_COMPONENT", 0, 15], ["subendocardium", "TISSUE", 35, 49], ["subendocardium", "ANATOMY", 35, 49]]], ["The heart valves are poorly vascularized, endocardial folds covered by endothelium.", [["heart valves", "ANATOMY", 4, 16], ["endocardial folds", "ANATOMY", 42, 59], ["endothelium", "ANATOMY", 71, 82], ["heart valves", "MULTI-TISSUE_STRUCTURE", 4, 16], ["endocardial folds", "TISSUE", 42, 59], ["endothelium", "TISSUE", 71, 82], ["poorly vascularized", "PROBLEM", 21, 40], ["heart valves", "ANATOMY", 4, 16], ["poorly", "OBSERVATION_MODIFIER", 21, 27], ["vascularized", "OBSERVATION", 28, 40], ["endocardial folds", "OBSERVATION", 42, 59], ["endothelium", "OBSERVATION", 71, 82]]], ["The subendothelial layer is composed of fibroblasts with abundant elastic and collagen fibers.", [["subendothelial layer", "ANATOMY", 4, 24], ["fibroblasts", "ANATOMY", 40, 51], ["collagen fibers", "ANATOMY", 78, 93], ["subendothelial layer", "TISSUE", 4, 24], ["fibroblasts", "CELL", 40, 51], ["collagen", "GENE_OR_GENE_PRODUCT", 78, 86], ["fibers", "CELLULAR_COMPONENT", 87, 93], ["fibroblasts", "CELL_TYPE", 40, 51], ["fibroblasts", "PROBLEM", 40, 51], ["abundant elastic and collagen fibers", "TREATMENT", 57, 93], ["subendothelial", "ANATOMY_MODIFIER", 4, 18], ["layer", "OBSERVATION_MODIFIER", 19, 24], ["fibroblasts", "OBSERVATION", 40, 51], ["abundant", "OBSERVATION_MODIFIER", 57, 65], ["elastic", "OBSERVATION_MODIFIER", 66, 73], ["collagen fibers", "OBSERVATION", 78, 93]]], ["The AV valves (AVVs) consist of a layer of stratum spongiosum and stratum fibrosum.", [["AV valves", "ANATOMY", 4, 13], ["AVVs", "ANATOMY", 15, 19], ["stratum spongiosum", "ANATOMY", 43, 61], ["stratum fibrosum", "ANATOMY", 66, 82], ["AV valves", "MULTI-TISSUE_STRUCTURE", 4, 13], ["AVVs", "MULTI-TISSUE_STRUCTURE", 15, 19], ["stratum spongiosum", "TISSUE", 43, 61], ["stratum fibrosum", "CANCER", 66, 82], ["The AV valves", "TREATMENT", 0, 13], ["stratum fibrosum", "PROBLEM", 66, 82], ["AV valves", "ANATOMY", 4, 13], ["layer", "OBSERVATION_MODIFIER", 34, 39], ["stratum spongiosum", "ANATOMY", 43, 61], ["stratum fibrosum", "OBSERVATION", 66, 82]]], ["The stratum spongiosum consists of loosely arranged fibroblasts with moderate amounts of collagen and elastin fibers and vascular structures.", [["stratum spongiosum", "ANATOMY", 4, 22], ["fibroblasts", "ANATOMY", 52, 63], ["fibers", "ANATOMY", 110, 116], ["vascular structures", "ANATOMY", 121, 140], ["stratum spongiosum", "CANCER", 4, 22], ["fibroblasts", "CELL", 52, 63], ["collagen", "GENE_OR_GENE_PRODUCT", 89, 97], ["elastin fibers", "CELLULAR_COMPONENT", 102, 116], ["vascular structures", "TISSUE", 121, 140], ["loosely arranged fibroblasts", "CELL_TYPE", 35, 63], ["collagen", "PROTEIN", 89, 97], ["loosely arranged fibroblasts", "PROBLEM", 35, 63], ["collagen and elastin fibers", "TREATMENT", 89, 116], ["stratum spongiosum", "ANATOMY", 4, 22], ["loosely", "OBSERVATION_MODIFIER", 35, 42], ["fibroblasts", "OBSERVATION", 52, 63], ["moderate", "OBSERVATION_MODIFIER", 69, 77], ["amounts", "OBSERVATION_MODIFIER", 78, 85], ["collagen", "OBSERVATION", 89, 97], ["elastin fibers", "OBSERVATION", 102, 116], ["vascular structures", "ANATOMY", 121, 140]]], ["The stratum fibrosis contains fibroblasts and collagen, which are continuous with the annulus fibrosis and chordae tendineae.Pericardium and EpicardiumThe pericardial sac is composed of parietal and visceral pericardium, both of which are covered by mesothelium.", [["stratum", "ANATOMY", 4, 11], ["fibroblasts", "ANATOMY", 30, 41], ["annulus", "ANATOMY", 86, 93], ["chordae tendineae", "ANATOMY", 107, 124], ["Pericardium", "ANATOMY", 125, 136], ["pericardial sac", "ANATOMY", 155, 170], ["parietal", "ANATOMY", 186, 194], ["visceral pericardium", "ANATOMY", 199, 219], ["mesothelium", "ANATOMY", 250, 261], ["fibrosis", "DISEASE", 12, 20], ["fibrosis", "DISEASE", 94, 102], ["stratum", "TISSUE", 4, 11], ["fibroblasts", "CELL", 30, 41], ["collagen", "GENE_OR_GENE_PRODUCT", 46, 54], ["annulus", "TISSUE", 86, 93], ["Epicardium", "CANCER", 141, 151], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 155, 170], ["parietal", "MULTI-TISSUE_STRUCTURE", 186, 194], ["visceral pericardium", "TISSUE", 199, 219], ["mesothelium", "TISSUE", 250, 261], ["fibroblasts", "CELL_TYPE", 30, 41], ["collagen", "PROTEIN", 46, 54], ["The stratum fibrosis", "PROBLEM", 0, 20], ["fibroblasts", "PROBLEM", 30, 41], ["the annulus fibrosis", "PROBLEM", 82, 102], ["chordae tendineae", "PROBLEM", 107, 124], ["stratum", "OBSERVATION_MODIFIER", 4, 11], ["fibrosis", "OBSERVATION", 12, 20], ["fibroblasts", "OBSERVATION", 30, 41], ["collagen", "OBSERVATION_MODIFIER", 46, 54], ["annulus", "ANATOMY_MODIFIER", 86, 93], ["fibrosis", "OBSERVATION", 94, 102], ["chordae tendineae", "OBSERVATION", 107, 124], ["Epicardium", "ANATOMY", 141, 151], ["pericardial", "ANATOMY", 155, 166], ["sac", "ANATOMY_MODIFIER", 167, 170], ["parietal", "ANATOMY_MODIFIER", 186, 194], ["visceral pericardium", "ANATOMY", 199, 219], ["both", "ANATOMY_MODIFIER", 221, 225], ["mesothelium", "OBSERVATION", 250, 261]]], ["Beneath the visceral approximately at the level of the annuli of the aortic and mitral valves B2) , to become the left and right bundle branches.", [["visceral", "ANATOMY", 12, 20], ["annuli", "ANATOMY", 55, 61], ["aortic", "ANATOMY", 69, 75], ["mitral valves", "ANATOMY", 80, 93], ["left", "ANATOMY", 114, 118], ["right bundle branches", "ANATOMY", 123, 144], ["visceral", "TISSUE", 12, 20], ["annuli", "MULTI-TISSUE_STRUCTURE", 55, 61], ["aortic", "MULTI-TISSUE_STRUCTURE", 69, 75], ["visceral", "ANATOMY", 12, 20], ["annuli", "ANATOMY_MODIFIER", 55, 61], ["aortic", "ANATOMY", 69, 75], ["mitral valves", "ANATOMY", 80, 93], ["left", "ANATOMY_MODIFIER", 114, 118], ["right", "ANATOMY_MODIFIER", 123, 128], ["bundle", "ANATOMY_MODIFIER", 129, 135], ["branches", "ANATOMY_MODIFIER", 136, 144]]], ["The size of an AV bundle myofiber progressively enlarges, and its cytomorphology transitions from a pale eosinophilic, small and thin (AVN-like morphology) myofiber to a pale eosinophilic, foamy to waxy, large, and somewhat rectangular myofiber that lacks crossstriations (a Purkinje-like cellular morphology) ( Fig. 10-4, C) .Pericardium and EpicardiumAutonomic Nervous System.", [["AV bundle myofiber", "ANATOMY", 15, 33], ["myofiber", "ANATOMY", 156, 164], ["pale eosinophilic", "ANATOMY", 170, 187], ["myofiber", "ANATOMY", 236, 244], ["Purkinje", "ANATOMY", 275, 283], ["cellular", "ANATOMY", 289, 297], ["myofiber", "CELLULAR_COMPONENT", 25, 33], ["myofiber", "TISSUE", 156, 164], ["myofiber", "TISSUE", 236, 244], ["cellular", "CELL", 289, 297], ["an AV bundle myofiber progressively enlarges", "PROBLEM", 12, 56], ["its cytomorphology transitions", "PROBLEM", 62, 92], ["a pale eosinophilic", "PROBLEM", 98, 117], ["small and thin (AVN", "PROBLEM", 119, 138], ["a pale eosinophilic", "PROBLEM", 168, 187], ["Fig.", "TEST", 312, 316], ["Pericardium and EpicardiumAutonomic Nervous System", "PROBLEM", 327, 377], ["size", "OBSERVATION_MODIFIER", 4, 8], ["AV", "ANATOMY", 15, 17], ["bundle", "ANATOMY_MODIFIER", 18, 24], ["myofiber", "ANATOMY", 25, 33], ["progressively", "OBSERVATION_MODIFIER", 34, 47], ["enlarges", "OBSERVATION", 48, 56], ["pale", "OBSERVATION_MODIFIER", 100, 104], ["eosinophilic", "OBSERVATION_MODIFIER", 105, 117], ["small", "OBSERVATION_MODIFIER", 119, 124], ["thin", "OBSERVATION_MODIFIER", 129, 133], ["like morphology", "OBSERVATION_MODIFIER", 139, 154], ["myofiber", "ANATOMY", 156, 164], ["pale", "OBSERVATION_MODIFIER", 170, 174], ["eosinophilic", "OBSERVATION", 175, 187], ["foamy", "OBSERVATION_MODIFIER", 189, 194], ["large", "OBSERVATION_MODIFIER", 204, 209], ["somewhat", "OBSERVATION_MODIFIER", 215, 223], ["rectangular myofiber", "OBSERVATION", 224, 244], ["EpicardiumAutonomic Nervous", "ANATOMY", 343, 370]]], ["The nerve supply to the heart is autonomic and includes sympathetic, parasympathetic, and nonadrenergic noncholinergic innervation.", [["nerve", "ANATOMY", 4, 9], ["heart", "ANATOMY", 24, 29], ["nerve", "MULTI-TISSUE_STRUCTURE", 4, 9], ["heart", "ORGAN", 24, 29], ["nonadrenergic noncholinergic innervation", "TISSUE", 90, 130], ["autonomic", "PROBLEM", 33, 42], ["sympathetic, parasympathetic, and nonadrenergic noncholinergic innervation", "PROBLEM", 56, 130], ["nerve", "ANATOMY", 4, 9], ["heart", "ANATOMY", 24, 29], ["autonomic", "OBSERVATION", 33, 42], ["nonadrenergic noncholinergic innervation", "OBSERVATION", 90, 130]]], ["Histologically, large nerves can be seen in the epicardium and adjacent to the coronary blood vessels, whereas special staining techniques are required for demonstration of neural tissue elsewhere.", [["nerves", "ANATOMY", 22, 28], ["epicardium", "ANATOMY", 48, 58], ["coronary blood vessels", "ANATOMY", 79, 101], ["neural tissue", "ANATOMY", 173, 186], ["nerves", "MULTI-TISSUE_STRUCTURE", 22, 28], ["epicardium", "TISSUE", 48, 58], ["coronary blood vessels", "MULTI-TISSUE_STRUCTURE", 79, 101], ["neural tissue", "TISSUE", 173, 186], ["special staining techniques", "TEST", 111, 138], ["neural tissue", "PROBLEM", 173, 186], ["large", "OBSERVATION_MODIFIER", 16, 21], ["nerves", "OBSERVATION", 22, 28], ["epicardium", "ANATOMY", 48, 58], ["coronary blood vessels", "ANATOMY", 79, 101], ["neural tissue", "OBSERVATION", 173, 186]]], ["Electron microscopy and immunohistochemistry allow differentiation between sympathetic and parasympathetic nerves that are otherwise indistinguishable with H&E stain.", [["parasympathetic nerves", "ANATOMY", 91, 113], ["sympathetic", "ANATOMICAL_SYSTEM", 75, 86], ["parasympathetic nerves", "MULTI-TISSUE_STRUCTURE", 91, 113], ["Electron microscopy", "TEST", 0, 19], ["immunohistochemistry", "TEST", 24, 44], ["sympathetic and parasympathetic nerves", "PROBLEM", 75, 113], ["H&E stain", "TEST", 156, 165], ["parasympathetic nerves", "ANATOMY", 91, 113]]], ["Preganglionic parasympathetic fibers pass to the heart through the cardiac branch of the vagal nerve and synapse with parasympathetic ganglionic neurons.", [["parasympathetic fibers", "ANATOMY", 14, 36], ["heart", "ANATOMY", 49, 54], ["cardiac branch", "ANATOMY", 67, 81], ["vagal nerve", "ANATOMY", 89, 100], ["synapse", "ANATOMY", 105, 112], ["parasympathetic ganglionic neurons", "ANATOMY", 118, 152], ["parasympathetic fibers", "CELL", 14, 36], ["heart", "ORGAN", 49, 54], ["cardiac branch", "MULTI-TISSUE_STRUCTURE", 67, 81], ["vagal nerve", "MULTI-TISSUE_STRUCTURE", 89, 100], ["synapse", "CELLULAR_COMPONENT", 105, 112], ["parasympathetic ganglionic neurons", "CELL", 118, 152], ["parasympathetic ganglionic neurons", "CELL_TYPE", 118, 152], ["parasympathetic ganglionic neurons", "PROBLEM", 118, 152], ["parasympathetic fibers", "OBSERVATION", 14, 36], ["heart", "ANATOMY", 49, 54], ["cardiac", "ANATOMY", 67, 74], ["branch", "ANATOMY_MODIFIER", 75, 81], ["vagal nerve", "ANATOMY", 89, 100], ["parasympathetic", "OBSERVATION", 118, 133], ["ganglionic neurons", "OBSERVATION", 134, 152]]], ["Postganglionic neurons are distributed to the SAN and AVN, as well as to atrial and, to a much lesser extent, ventricular myocardium (however, the ventricular conduction system is well supplied by cholinergic innervation).", [["Postganglionic neurons", "ANATOMY", 0, 22], ["SAN", "ANATOMY", 46, 49], ["AVN", "ANATOMY", 54, 57], ["atrial", "ANATOMY", 73, 79], ["ventricular myocardium", "ANATOMY", 110, 132], ["ventricular", "ANATOMY", 147, 158], ["Postganglionic neurons", "CELL", 0, 22], ["SAN", "MULTI-TISSUE_STRUCTURE", 46, 49], ["AVN", "MULTI-TISSUE_STRUCTURE", 54, 57], ["atrial", "MULTI-TISSUE_STRUCTURE", 73, 79], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 110, 132], ["ventricular", "ORGAN", 147, 158], ["cholinergic innervation", "MULTI-TISSUE_STRUCTURE", 197, 220], ["Postganglionic neurons", "CELL_TYPE", 0, 22], ["Postganglionic neurons", "PROBLEM", 0, 22], ["AVN", "PROBLEM", 54, 57], ["neurons", "ANATOMY", 15, 22], ["AVN", "OBSERVATION", 54, 57], ["atrial", "ANATOMY", 73, 79], ["lesser", "OBSERVATION_MODIFIER", 95, 101], ["extent", "OBSERVATION_MODIFIER", 102, 108], ["ventricular myocardium", "ANATOMY", 110, 132], ["ventricular conduction", "ANATOMY", 147, 169]]], ["Postganglionic sympathetic fibers arising from the cervicothoracic and middle cervical ganglia intensely innervate the SAN and AVN and, to a lesser extent, the AV bundle.", [["sympathetic fibers", "ANATOMY", 15, 33], ["cervicothoracic", "ANATOMY", 51, 66], ["middle cervical ganglia", "ANATOMY", 71, 94], ["SAN", "ANATOMY", 119, 122], ["AV bundle", "ANATOMY", 160, 169], ["AVN", "DISEASE", 127, 130], ["sympathetic fibers", "MULTI-TISSUE_STRUCTURE", 15, 33], ["cervicothoracic", "ORGAN", 51, 66], ["cervical ganglia", "MULTI-TISSUE_STRUCTURE", 78, 94], ["SAN", "MULTI-TISSUE_STRUCTURE", 119, 122], ["Postganglionic sympathetic fibers", "PROBLEM", 0, 33], ["AVN", "PROBLEM", 127, 130], ["sympathetic fibers", "OBSERVATION", 15, 33], ["cervicothoracic", "ANATOMY", 51, 66], ["middle", "ANATOMY_MODIFIER", 71, 77], ["cervical ganglia", "ANATOMY", 78, 94], ["SAN", "OBSERVATION_MODIFIER", 119, 122], ["AVN", "OBSERVATION", 127, 130], ["lesser", "OBSERVATION_MODIFIER", 141, 147], ["extent", "OBSERVATION_MODIFIER", 148, 154], ["AV", "ANATOMY", 160, 162], ["bundle", "ANATOMY_MODIFIER", 163, 169]]], ["The atrial endocardium, (2).", [["atrial endocardium", "ANATOMY", 4, 22], ["atrial endocardium", "MULTI-TISSUE_STRUCTURE", 4, 22], ["atrial endocardium", "ANATOMY", 4, 22]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["A1, Higher magnification.", [["A1", "PROTEIN", 0, 2], ["Higher magnification", "OBSERVATION", 4, 24]]], ["Haphazardly oriented myofibers are embedded within abundant loose collagenous and elastic connective tissue.", [["myofibers", "ANATOMY", 21, 30], ["collagenous", "ANATOMY", 66, 77], ["connective tissue", "ANATOMY", 90, 107], ["myofibers", "CELL", 21, 30], ["collagenous", "TISSUE", 66, 77], ["elastic connective tissue", "TISSUE", 82, 107], ["abundant loose collagenous and elastic connective tissue", "PROBLEM", 51, 107], ["myofibers", "ANATOMY", 21, 30], ["abundant", "OBSERVATION_MODIFIER", 51, 59], ["loose collagenous", "OBSERVATION", 60, 77], ["elastic connective tissue", "OBSERVATION", 82, 107]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["A2, Higher magnification.", [["A2", "GENE_OR_GENE_PRODUCT", 0, 2], ["A2", "PROTEIN", 0, 2], ["A2", "PROBLEM", 0, 2], ["Higher magnification", "OBSERVATION", 4, 24]]], ["Nodal myofibers have discrete cell borders, a moderate amount of wavy sarcoplasm, and an elongated nucleus.", [["Nodal myofibers", "ANATOMY", 0, 15], ["cell", "ANATOMY", 30, 34], ["wavy sarcoplasm", "ANATOMY", 65, 80], ["nucleus", "ANATOMY", 99, 106], ["Nodal myofibers", "CELL", 0, 15], ["cell", "CELL", 30, 34], ["sarcoplasm", "CANCER", 70, 80], ["nucleus", "CELLULAR_COMPONENT", 99, 106], ["Nodal myofibers", "CELL_TYPE", 0, 15], ["Nodal myofibers", "PROBLEM", 0, 15], ["a moderate amount of wavy sarcoplasm", "PROBLEM", 44, 80], ["an elongated nucleus", "PROBLEM", 86, 106], ["myofibers", "ANATOMY", 6, 15], ["discrete", "OBSERVATION_MODIFIER", 21, 29], ["cell borders", "OBSERVATION", 30, 42], ["moderate", "OBSERVATION_MODIFIER", 46, 54], ["amount", "OBSERVATION_MODIFIER", 55, 61], ["wavy sarcoplasm", "OBSERVATION", 65, 80], ["elongated", "OBSERVATION_MODIFIER", 89, 98], ["nucleus", "OBSERVATION_MODIFIER", 99, 106]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["B, Atrioventricular (AV) node, goat.", [["AV) node", "ANATOMY", 21, 29], ["B", "GENE_OR_GENE_PRODUCT", 0, 1], ["Atrioventricular", "MULTI-TISSUE_STRUCTURE", 3, 19], ["node", "MULTI-TISSUE_STRUCTURE", 25, 29], ["goat", "SPECIES", 31, 35], ["Atrioventricular (AV) node", "PROBLEM", 3, 29], ["Atrioventricular", "ANATOMY", 3, 19], ["AV", "ANATOMY", 21, 23], ["node", "OBSERVATION", 25, 29]]], ["The AV node (1) is composed of interconnecting nodal myofibers that are supported by loose collagenous and elastic fibrous stroma.", [["AV node", "ANATOMY", 4, 11], ["nodal myofibers", "ANATOMY", 47, 62], ["collagenous", "ANATOMY", 91, 102], ["fibrous stroma", "ANATOMY", 115, 129], ["AV node", "MULTI-TISSUE_STRUCTURE", 4, 11], ["nodal myofibers", "MULTI-TISSUE_STRUCTURE", 47, 62], ["collagenous", "TISSUE", 91, 102], ["elastic fibrous stroma", "TISSUE", 107, 129], ["interconnecting nodal myofibers", "PROBLEM", 31, 62], ["loose collagenous and elastic fibrous stroma", "PROBLEM", 85, 129], ["AV", "ANATOMY", 4, 6], ["node", "OBSERVATION", 7, 11], ["interconnecting", "OBSERVATION_MODIFIER", 31, 46], ["nodal myofibers", "OBSERVATION", 47, 62], ["loose", "OBSERVATION_MODIFIER", 85, 90], ["collagenous", "OBSERVATION_MODIFIER", 91, 102], ["elastic", "OBSERVATION_MODIFIER", 107, 114], ["fibrous stroma", "OBSERVATION", 115, 129]]], ["The node is embedded in adipose tissue (2).", [["node", "ANATOMY", 4, 8], ["adipose tissue", "ANATOMY", 24, 38], ["node", "MULTI-TISSUE_STRUCTURE", 4, 8], ["adipose tissue", "TISSUE", 24, 38], ["node", "OBSERVATION", 4, 8], ["adipose tissue", "OBSERVATION", 24, 38]]], ["Note that in this illustration the AV node (1) is a poorly demarcated region (see B1 for greater detail) that is elongated (flattened) from top to bottom and that it and its surrounding adipose tissue are positioned adjacent to the cardiac fibrous skeleton (arrows) that has undergone focal chondroid metaplasia (3).", [["AV node", "ANATOMY", 35, 42], ["adipose tissue", "ANATOMY", 186, 200], ["cardiac fibrous skeleton", "ANATOMY", 232, 256], ["focal chondroid metaplasia", "ANATOMY", 285, 311], ["AV node", "MULTI-TISSUE_STRUCTURE", 35, 42], ["adipose tissue", "TISSUE", 186, 200], ["cardiac fibrous skeleton", "TISSUE", 232, 256], ["chondroid metaplasia", "CANCER", 291, 311], ["B1", "PROTEIN", 82, 84], ["a poorly demarcated region", "PROBLEM", 50, 76], ["elongated", "PROBLEM", 113, 122], ["focal chondroid metaplasia", "PROBLEM", 285, 311], ["AV", "ANATOMY", 35, 37], ["node", "OBSERVATION", 38, 42], ["poorly demarcated", "OBSERVATION_MODIFIER", 52, 69], ["elongated", "OBSERVATION_MODIFIER", 113, 122], ["flattened", "OBSERVATION_MODIFIER", 124, 133], ["top to bottom", "OBSERVATION_MODIFIER", 140, 153], ["adipose tissue", "OBSERVATION", 186, 200], ["cardiac", "ANATOMY", 232, 239], ["fibrous", "ANATOMY_MODIFIER", 240, 247], ["skeleton", "ANATOMY", 248, 256], ["focal", "OBSERVATION_MODIFIER", 285, 290], ["chondroid", "OBSERVATION_MODIFIER", 291, 300], ["metaplasia", "OBSERVATION", 301, 311]]], ["The position and overall shape of the AV node in a histologic section is dependent on the plane of section.", [["AV node", "ANATOMY", 38, 45], ["AV node", "MULTI-TISSUE_STRUCTURE", 38, 45], ["position", "OBSERVATION_MODIFIER", 4, 12], ["overall", "OBSERVATION_MODIFIER", 17, 24], ["shape", "OBSERVATION_MODIFIER", 25, 30], ["AV", "ANATOMY", 38, 40], ["node", "OBSERVATION", 41, 45], ["dependent", "OBSERVATION_MODIFIER", 73, 82]]], ["Endocardium (arrowhead).", [["Endocardium", "ANATOMY", 0, 11]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["B1, AV node, goat.", [["AV node", "ANATOMY", 4, 11], ["B1", "GENE_OR_GENE_PRODUCT", 0, 2], ["AV node", "MULTI-TISSUE_STRUCTURE", 4, 11], ["B1", "PROTEIN", 0, 2], ["goat", "SPECIES", 13, 17], ["goat", "SPECIES", 13, 17], ["AV", "ANATOMY", 4, 6], ["node", "OBSERVATION", 7, 11], ["goat", "ANATOMY", 13, 17]]], ["In this higher magnification of B, AV nodal myofibers have a characteristic pale eosinophilic and thin sarcoplasm, with abundance of distinct striations and a short oval to elongated nucleus with dispersed chromatin.", [["AV nodal myofibers", "ANATOMY", 35, 53], ["pale eosinophilic", "ANATOMY", 76, 93], ["sarcoplasm", "ANATOMY", 103, 113], ["nucleus", "ANATOMY", 183, 190], ["chromatin", "ANATOMY", 206, 215], ["B", "GENE_OR_GENE_PRODUCT", 32, 33], ["nodal myofibers", "MULTI-TISSUE_STRUCTURE", 38, 53], ["sarcoplasm", "CANCER", 103, 113], ["nucleus", "CELLULAR_COMPONENT", 183, 190], ["chromatin", "CELLULAR_COMPONENT", 206, 215], ["AV nodal myofibers", "CELL_TYPE", 35, 53], ["chromatin", "DNA", 206, 215], ["a characteristic pale eosinophilic", "PROBLEM", 59, 93], ["thin sarcoplasm", "PROBLEM", 98, 113], ["distinct striations", "PROBLEM", 133, 152], ["a short oval to elongated nucleus", "PROBLEM", 157, 190], ["nodal myofibers", "ANATOMY", 38, 53], ["pale", "OBSERVATION_MODIFIER", 76, 80], ["eosinophilic", "OBSERVATION", 81, 93], ["thin sarcoplasm", "OBSERVATION", 98, 113], ["distinct striations", "OBSERVATION", 133, 152], ["short oval", "OBSERVATION_MODIFIER", 159, 169], ["elongated", "OBSERVATION_MODIFIER", 173, 182], ["nucleus", "OBSERVATION_MODIFIER", 183, 190], ["dispersed chromatin", "OBSERVATION", 196, 215]]], ["An autonomic myelinated nerve is present in the AV node (arrow).", [["autonomic myelinated nerve", "ANATOMY", 3, 29], ["AV node", "ANATOMY", 48, 55], ["myelinated nerve", "MULTI-TISSUE_STRUCTURE", 13, 29], ["AV node", "MULTI-TISSUE_STRUCTURE", 48, 55], ["An autonomic myelinated nerve", "PROBLEM", 0, 29], ["autonomic", "OBSERVATION", 3, 12], ["myelinated nerve", "OBSERVATION", 13, 29], ["AV", "ANATOMY", 48, 50], ["node", "OBSERVATION", 51, 55]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["C, AV bundle, goat.", [["C", "GENE_OR_GENE_PRODUCT", 0, 1], ["goat", "ORGANISM", 14, 18], ["goat", "SPECIES", 14, 18], ["AV bundle", "ANATOMY", 3, 12], ["goat", "ANATOMY", 14, 18]]], ["The AV bundle (1) travels diagonally through the center of the figure from the lower left to the upper right margins.", [["AV bundle", "ANATOMY", 4, 13], ["upper right margins", "ANATOMY", 97, 116], ["AV", "ANATOMY", 4, 6], ["bundle", "ANATOMY_MODIFIER", 7, 13], ["lower", "ANATOMY_MODIFIER", 79, 84], ["left", "ANATOMY_MODIFIER", 85, 89], ["upper", "ANATOMY_MODIFIER", 97, 102], ["right", "ANATOMY_MODIFIER", 103, 108], ["margins", "ANATOMY_MODIFIER", 109, 116]]], ["It is formed by an interweaving pseudosyncytium of cardiac myofibers supported by a loose to dense intervening collagenous stroma (see C1 for greater detail) and may be surrounded by adipose tissue (2).", [["cardiac myofibers", "ANATOMY", 51, 68], ["collagenous stroma", "ANATOMY", 111, 129], ["adipose tissue", "ANATOMY", 183, 197], ["cardiac myofibers", "TISSUE", 51, 68], ["collagenous stroma", "TISSUE", 111, 129], ["adipose tissue", "TISSUE", 183, 197], ["cardiac myofibers", "CELL_TYPE", 51, 68], ["cardiac myofibers", "TREATMENT", 51, 68], ["a loose to dense intervening collagenous stroma", "PROBLEM", 82, 129], ["cardiac myofibers", "ANATOMY", 51, 68], ["loose", "OBSERVATION_MODIFIER", 84, 89], ["dense", "OBSERVATION_MODIFIER", 93, 98], ["collagenous stroma", "OBSERVATION", 111, 129], ["may be", "UNCERTAINTY", 162, 168], ["adipose tissue", "OBSERVATION", 183, 197]]], ["Cardiac cartilaginous skeleton (3).", [["Cardiac cartilaginous skeleton", "ANATOMY", 0, 30], ["cartilaginous", "ANATOMY_MODIFIER", 8, 21], ["skeleton", "ANATOMY", 22, 30]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["C1, Higher magnification.", [["C1", "GENE_OR_GENE_PRODUCT", 0, 2], ["Higher magnification", "OBSERVATION", 4, 24]]], ["The AV bundle myofibers of the pseudosyncytium have moderate to large, pale eosinophilic sarcoplasm with prominent striations and large nuclei with fine stippled chromatin.FunctionThe primary function of the cardiovascular and lymphatic systems is to maintain an adequate and steady supply of nutrients to and facilitate the removal of waste products from all organs and tissues of the body.", [["AV bundle myofibers", "ANATOMY", 4, 23], ["pseudosyncytium", "ANATOMY", 31, 46], ["eosinophilic sarcoplasm", "ANATOMY", 76, 99], ["nuclei", "ANATOMY", 136, 142], ["chromatin", "ANATOMY", 162, 171], ["cardiovascular", "ANATOMY", 208, 222], ["lymphatic systems", "ANATOMY", 227, 244], ["organs", "ANATOMY", 360, 366], ["tissues", "ANATOMY", 371, 378], ["body", "ANATOMY", 386, 390], ["pseudosyncytium", "CANCER", 31, 46], ["nuclei", "CELLULAR_COMPONENT", 136, 142], ["chromatin", "CELLULAR_COMPONENT", 162, 171], ["cardiovascular", "ANATOMICAL_SYSTEM", 208, 222], ["lymphatic systems", "MULTI-TISSUE_STRUCTURE", 227, 244], ["organs", "ORGAN", 360, 366], ["tissues", "TISSUE", 371, 378], ["body", "ORGANISM_SUBDIVISION", 386, 390], ["AV bundle myofibers", "CELL_TYPE", 4, 23], ["chromatin", "DNA", 162, 171], ["moderate to large, pale eosinophilic sarcoplasm", "PROBLEM", 52, 99], ["prominent striations", "PROBLEM", 105, 125], ["large nuclei with fine stippled chromatin", "PROBLEM", 130, 171], ["the removal of waste products", "TREATMENT", 321, 350], ["AV", "ANATOMY", 4, 6], ["bundle", "ANATOMY_MODIFIER", 7, 13], ["myofibers", "ANATOMY", 14, 23], ["moderate", "OBSERVATION_MODIFIER", 52, 60], ["large", "OBSERVATION_MODIFIER", 64, 69], ["pale", "OBSERVATION_MODIFIER", 71, 75], ["eosinophilic sarcoplasm", "OBSERVATION", 76, 99], ["prominent", "OBSERVATION_MODIFIER", 105, 114], ["striations", "OBSERVATION_MODIFIER", 115, 125], ["large", "OBSERVATION_MODIFIER", 130, 135], ["nuclei", "OBSERVATION_MODIFIER", 136, 142], ["fine", "OBSERVATION_MODIFIER", 148, 152], ["stippled chromatin", "OBSERVATION", 153, 171], ["lymphatic", "ANATOMY", 227, 236], ["body", "ANATOMY", 386, 390]]], ["Cardiac myocytes provide the force of contraction; the conduction system and the nervous system control the flow and volume.MyocardiumThe results of normal cardiac function include the maintenance of adequate blood flow, called cardiac output, to peripheral tissues that provide delivery of oxygen and nutrients, the removal of carbon dioxide and other metabolic waste products, the distribution of hormones and other cellular regulators, and the maintenance of adequate thermoregulation and glomerular filtration pressure (urine output).", [["Cardiac myocytes", "ANATOMY", 0, 16], ["conduction system", "ANATOMY", 55, 72], ["nervous system", "ANATOMY", 81, 95], ["cardiac", "ANATOMY", 156, 163], ["blood", "ANATOMY", 209, 214], ["cardiac", "ANATOMY", 228, 235], ["peripheral tissues", "ANATOMY", 247, 265], ["cellular", "ANATOMY", 418, 426], ["glomerular", "ANATOMY", 492, 502], ["urine", "ANATOMY", 524, 529], ["oxygen", "CHEMICAL", 291, 297], ["carbon dioxide", "CHEMICAL", 328, 342], ["oxygen", "CHEMICAL", 291, 297], ["carbon dioxide", "CHEMICAL", 328, 342], ["Cardiac myocytes", "CELL", 0, 16], ["nervous system", "ANATOMICAL_SYSTEM", 81, 95], ["cardiac", "ORGAN", 156, 163], ["blood", "ORGANISM_SUBSTANCE", 209, 214], ["cardiac", "ORGAN", 228, 235], ["peripheral tissues", "TISSUE", 247, 265], ["oxygen", "SIMPLE_CHEMICAL", 291, 297], ["carbon dioxide", "SIMPLE_CHEMICAL", 328, 342], ["cellular", "CELL", 418, 426], ["glomerular", "TISSUE", 492, 502], ["urine", "ORGANISM_SUBSTANCE", 524, 529], ["cardiac output", "TEST", 228, 242], ["delivery of oxygen", "TREATMENT", 279, 297], ["nutrients", "TREATMENT", 302, 311], ["the removal of carbon dioxide", "TREATMENT", 313, 342], ["other metabolic waste products", "TREATMENT", 347, 377], ["glomerular filtration pressure", "TEST", 492, 522], ["urine output", "TEST", 524, 536], ["myocytes", "ANATOMY", 8, 16], ["flow", "OBSERVATION", 108, 112], ["normal", "OBSERVATION", 149, 155], ["cardiac", "ANATOMY", 156, 163], ["cardiac", "ANATOMY", 228, 235], ["output", "OBSERVATION", 236, 242], ["peripheral tissues", "ANATOMY", 247, 265], ["metabolic waste", "OBSERVATION", 353, 368]]], ["The normal heart has a threefold to fivefold functional reserve capacity, but this capacity can eventually be lost in cardiac disease and the result is impaired function.Cardiac Conduction SystemCells of the cardiac conduction system are modified cardiac myofibers that are able to spontaneously depolarize, which is also called autoexcitation, and function to (1) coordinate the sequence of events required for efficient ventricular filling during diastole and ejection during systole and (2) maintain the pressure in the pulmonary and systemic circuits (see E- Fig. 10-2) .Cardiac Conduction SystemDepolarization of the membrane of these pacemaker cells is due to a transiently increased rapid permeability to sodium ions and a slightly longer lasting increase in permeability to calcium ions that results in their influx into the myofiber sarcoplasm, thus changing the membrane potential (see Chapter 14) .", [["heart", "ANATOMY", 11, 16], ["cardiac", "ANATOMY", 118, 125], ["Cardiac", "ANATOMY", 170, 177], ["cardiac conduction system", "ANATOMY", 208, 233], ["cardiac myofibers", "ANATOMY", 247, 264], ["ventricular", "ANATOMY", 422, 433], ["pulmonary", "ANATOMY", 523, 532], ["Cardiac", "ANATOMY", 575, 582], ["membrane", "ANATOMY", 622, 630], ["pacemaker cells", "ANATOMY", 640, 655], ["myofiber sarcoplasm", "ANATOMY", 833, 852], ["membrane", "ANATOMY", 872, 880], ["cardiac disease", "DISEASE", 118, 133], ["sodium ions", "CHEMICAL", 712, 723], ["calcium", "CHEMICAL", 782, 789], ["sodium", "CHEMICAL", 712, 718], ["calcium", "CHEMICAL", 782, 789], ["heart", "ORGAN", 11, 16], ["cardiac", "ORGAN", 118, 125], ["cardiac", "ORGAN", 208, 215], ["cardiac myofibers", "TISSUE", 247, 264], ["ventricular", "MULTI-TISSUE_STRUCTURE", 422, 433], ["pulmonary", "ORGAN", 523, 532], ["membrane", "CELLULAR_COMPONENT", 622, 630], ["pacemaker cells", "CELL", 640, 655], ["sodium ions", "SIMPLE_CHEMICAL", 712, 723], ["calcium ions", "SIMPLE_CHEMICAL", 782, 794], ["myofiber sarcoplasm", "CELLULAR_COMPONENT", 833, 852], ["membrane", "CELLULAR_COMPONENT", 872, 880], ["pacemaker cells", "CELL_TYPE", 640, 655], ["cardiac disease", "PROBLEM", 118, 133], ["impaired function", "PROBLEM", 152, 169], ["the pressure", "TEST", 503, 515], ["systemic circuits", "TREATMENT", 537, 554], ["these pacemaker cells", "TREATMENT", 634, 655], ["a transiently increased rapid permeability to sodium ions", "PROBLEM", 666, 723], ["a slightly longer lasting increase in permeability to calcium ions", "PROBLEM", 728, 794], ["normal", "OBSERVATION", 4, 10], ["heart", "ANATOMY", 11, 16], ["reserve capacity", "OBSERVATION", 56, 72], ["cardiac", "ANATOMY", 118, 125], ["disease", "OBSERVATION", 126, 133], ["impaired", "OBSERVATION", 152, 160], ["Conduction SystemCells", "OBSERVATION", 178, 200], ["cardiac conduction", "ANATOMY", 208, 226], ["myofibers", "OBSERVATION", 255, 264], ["pressure", "OBSERVATION_MODIFIER", 507, 515], ["pulmonary", "ANATOMY", 523, 532], ["systemic circuits", "ANATOMY", 537, 554], ["Conduction SystemDepolarization", "OBSERVATION", 583, 614], ["pacemaker cells", "OBSERVATION", 640, 655], ["transiently", "OBSERVATION_MODIFIER", 668, 679], ["increased", "OBSERVATION_MODIFIER", 680, 689], ["rapid", "OBSERVATION_MODIFIER", 690, 695], ["permeability", "OBSERVATION", 696, 708], ["myofiber sarcoplasm", "ANATOMY", 833, 852]]], ["As this transient permeability is lost, membranal potassium channels open, and rapid outward potassium flux results in myofiber membranal hyperpolarization (along with sodium and calcium efflux), ultimately bringing the membrane potential back to a \"normal\" steady state (resting potential).", [["myofiber", "ANATOMY", 119, 127], ["membrane", "ANATOMY", 220, 228], ["potassium", "CHEMICAL", 50, 59], ["potassium", "CHEMICAL", 93, 102], ["sodium", "CHEMICAL", 168, 174], ["calcium", "CHEMICAL", 179, 186], ["potassium", "CHEMICAL", 50, 59], ["potassium", "CHEMICAL", 93, 102], ["sodium", "CHEMICAL", 168, 174], ["calcium", "CHEMICAL", 179, 186], ["potassium", "SIMPLE_CHEMICAL", 93, 102], ["sodium", "SIMPLE_CHEMICAL", 168, 174], ["calcium", "SIMPLE_CHEMICAL", 179, 186], ["membrane", "CELLULAR_COMPONENT", 220, 228], ["membranal potassium channels", "PROTEIN", 40, 68], ["this transient permeability", "PROBLEM", 3, 30], ["membranal potassium channels", "TEST", 40, 68], ["rapid outward potassium flux", "TEST", 79, 107], ["myofiber membranal hyperpolarization", "PROBLEM", 119, 155], ["sodium and calcium efflux", "TREATMENT", 168, 193], ["myofiber", "ANATOMY", 119, 127], ["membranal hyperpolarization", "OBSERVATION", 128, 155]]], ["During this period of time (refractory period), the myocyte cannot depolarize again because of a special conformation of membrane sodium channels that is transiently lost with depolarization and regained only with hyperpolarization.", [["myocyte", "ANATOMY", 52, 59], ["membrane", "ANATOMY", 121, 129], ["sodium", "CHEMICAL", 130, 136], ["sodium", "CHEMICAL", 130, 136], ["myocyte", "CELL", 52, 59], ["membrane", "CELLULAR_COMPONENT", 121, 129], ["sodium", "SIMPLE_CHEMICAL", 130, 136], ["membrane sodium channels", "PROTEIN", 121, 145], ["membrane sodium channels", "PROBLEM", 121, 145], ["myocyte", "ANATOMY", 52, 59]]], ["Intrinsically, the resting membrane potential of pacemaker cells is more positive than that of contracting cardiomyocytes and slightly more negative than the membrane threshold potential.", [["membrane", "ANATOMY", 27, 35], ["pacemaker cells", "ANATOMY", 49, 64], ["cardiomyocytes", "ANATOMY", 107, 121], ["membrane", "ANATOMY", 158, 166], ["resting membrane", "CELLULAR_COMPONENT", 19, 35], ["pacemaker cells", "CELL", 49, 64], ["cardiomyocytes", "CELL", 107, 121], ["membrane", "CELLULAR_COMPONENT", 158, 166], ["pacemaker cells", "CELL_TYPE", 49, 64], ["contracting cardiomyocytes", "CELL_TYPE", 95, 121], ["pacemaker cells", "PROBLEM", 49, 64], ["contracting cardiomyocytes", "PROBLEM", 95, 121], ["pacemaker cells", "OBSERVATION", 49, 64], ["cardiomyocytes", "ANATOMY", 107, 121], ["membrane threshold", "OBSERVATION_MODIFIER", 158, 176]]], ["This difference is due to leakiness of the pacemaker cell membrane to sodium and calcium ions and a steady low-grade influx of these ions.Cardiac Conduction SystemOnce one pacemaker cell depolarizes, a wave of depolarization propagates through the surrounding myocytes because these cells are connected to each other by special membranal pores (gap junctions), which allow for ionic exchange between adjacent cells.", [["pacemaker cell membrane", "ANATOMY", 43, 66], ["Cardiac", "ANATOMY", 138, 145], ["pacemaker cell", "ANATOMY", 172, 186], ["myocytes", "ANATOMY", 260, 268], ["cells", "ANATOMY", 283, 288], ["membranal pores", "ANATOMY", 328, 343], ["gap junctions", "ANATOMY", 345, 358], ["cells", "ANATOMY", 409, 414], ["sodium", "CHEMICAL", 70, 76], ["calcium", "CHEMICAL", 81, 88], ["sodium", "CHEMICAL", 70, 76], ["calcium", "CHEMICAL", 81, 88], ["pacemaker cell membrane", "CELLULAR_COMPONENT", 43, 66], ["sodium", "SIMPLE_CHEMICAL", 70, 76], ["calcium ions", "SIMPLE_CHEMICAL", 81, 93], ["pacemaker cell", "CELL", 172, 186], ["myocytes", "CELL", 260, 268], ["cells", "CELL", 283, 288], ["gap junctions", "CELLULAR_COMPONENT", 345, 358], ["cells", "CELL", 409, 414], ["adjacent cells", "CELL_TYPE", 400, 414], ["leakiness of the pacemaker cell membrane", "PROBLEM", 26, 66], ["sodium", "TEST", 70, 76], ["calcium ions", "TEST", 81, 93], ["a steady low-grade influx of these ions", "PROBLEM", 98, 137], ["a wave of depolarization", "PROBLEM", 200, 224], ["these cells", "PROBLEM", 277, 288], ["ionic exchange between adjacent cells", "TREATMENT", 377, 414], ["due to", "UNCERTAINTY", 19, 25], ["leakiness", "OBSERVATION", 26, 35], ["pacemaker cell membrane", "OBSERVATION", 43, 66], ["steady", "OBSERVATION_MODIFIER", 100, 106], ["low-grade", "OBSERVATION_MODIFIER", 107, 116], ["influx", "OBSERVATION_MODIFIER", 117, 123], ["ions", "OBSERVATION", 133, 137], ["Conduction SystemOnce", "OBSERVATION", 146, 167], ["pacemaker cell depolarizes", "OBSERVATION", 172, 198], ["myocytes", "ANATOMY", 260, 268], ["gap junctions", "OBSERVATION", 345, 358]]], ["The number of gap junctions between cells of the conduction system is therefore a property that affects conduction velocity.", [["gap junctions", "ANATOMY", 14, 27], ["cells", "ANATOMY", 36, 41], ["conduction system", "ANATOMY", 49, 66], ["gap junctions", "CELLULAR_COMPONENT", 14, 27], ["cells", "CELL", 36, 41], ["number", "OBSERVATION_MODIFIER", 4, 10], ["gap junctions", "OBSERVATION", 14, 27], ["conduction system", "OBSERVATION", 49, 66], ["conduction velocity", "OBSERVATION", 104, 123]]], ["Because the heart cycle must be strictly coordinated so that both atria and both ventricles contract and relax at the same time, and atrial contraction occurs simultaneous to the late ventricular relaxation, the depolarization wave has to be conducted fast at certain points along the conduction pathway and slower at others.", [["heart", "ANATOMY", 12, 17], ["atria", "ANATOMY", 66, 71], ["ventricles", "ANATOMY", 81, 91], ["atrial", "ANATOMY", 133, 139], ["ventricular", "ANATOMY", 184, 195], ["heart", "ORGAN", 12, 17], ["atria", "MULTI-TISSUE_STRUCTURE", 66, 71], ["ventricles", "MULTI-TISSUE_STRUCTURE", 81, 91], ["atrial", "MULTI-TISSUE_STRUCTURE", 133, 139], ["ventricular", "MULTI-TISSUE_STRUCTURE", 184, 195], ["atrial contraction", "PROBLEM", 133, 151], ["the depolarization wave", "PROBLEM", 208, 231], ["heart", "ANATOMY", 12, 17], ["atria", "ANATOMY", 66, 71], ["both ventricles", "ANATOMY", 76, 91], ["atrial", "ANATOMY", 133, 139], ["contraction", "OBSERVATION", 140, 151], ["late ventricular relaxation", "OBSERVATION", 179, 206], ["slower", "OBSERVATION_MODIFIER", 308, 314]]], ["Therefore, at different anatomic regions along the conduction pathway, the degree of cellto-cell interaction dictates a slightly different cellular morphology.Cardiac Conduction SystemWhen an electric signal (a propagating depolarization front) is generated in the sinoatrial node (SAN) and spreads throughout the atria from cell to cell and eventually reaches the atrioventricular node (AVN), it is also conveyed through the specialized internodal conducting fibers.", [["cellto-cell", "ANATOMY", 85, 96], ["cellular", "ANATOMY", 139, 147], ["Cardiac", "ANATOMY", 159, 166], ["sinoatrial node", "ANATOMY", 265, 280], ["SAN", "ANATOMY", 282, 285], ["atria", "ANATOMY", 314, 319], ["cell", "ANATOMY", 325, 329], ["cell", "ANATOMY", 333, 337], ["atrioventricular node", "ANATOMY", 365, 386], ["AVN", "ANATOMY", 388, 391], ["internodal conducting fibers", "ANATOMY", 438, 466], ["cellto-cell", "CELL", 85, 96], ["cellular", "CELL", 139, 147], ["sinoatrial node", "MULTI-TISSUE_STRUCTURE", 265, 280], ["SAN", "MULTI-TISSUE_STRUCTURE", 282, 285], ["atria", "MULTI-TISSUE_STRUCTURE", 314, 319], ["cell", "CELL", 325, 329], ["cell", "CELL", 333, 337], ["atrioventricular node", "MULTI-TISSUE_STRUCTURE", 365, 386], ["AVN", "MULTI-TISSUE_STRUCTURE", 388, 391], ["fibers", "CELLULAR_COMPONENT", 460, 466], ["cellto-cell interaction", "PROBLEM", 85, 108], ["anatomic", "ANATOMY_MODIFIER", 24, 32], ["regions", "ANATOMY_MODIFIER", 33, 40], ["conduction pathway", "OBSERVATION", 51, 69], ["degree", "OBSERVATION_MODIFIER", 75, 81], ["cell interaction", "OBSERVATION", 92, 108], ["slightly", "OBSERVATION_MODIFIER", 120, 128], ["different", "OBSERVATION_MODIFIER", 129, 138], ["cellular morphology", "OBSERVATION", 139, 158], ["Conduction SystemWhen", "OBSERVATION", 167, 188], ["electric", "OBSERVATION_MODIFIER", 192, 200], ["sinoatrial node", "ANATOMY", 265, 280], ["atria", "ANATOMY", 314, 319], ["cell to cell", "OBSERVATION", 325, 337], ["atrioventricular node", "ANATOMY", 365, 386], ["AVN", "OBSERVATION", 388, 391], ["internodal", "OBSERVATION_MODIFIER", 438, 448]]], ["The conduction in these fibers is approximately mesothelium is a thin layer of fibrous connective tissue, adipocytes, and vascular structures.", [["fibers", "ANATOMY", 24, 30], ["mesothelium", "ANATOMY", 48, 59], ["fibrous connective tissue", "ANATOMY", 79, 104], ["adipocytes", "ANATOMY", 106, 116], ["vascular structures", "ANATOMY", 122, 141], ["fibers", "CELLULAR_COMPONENT", 24, 30], ["mesothelium", "TISSUE", 48, 59], ["fibrous connective tissue", "TISSUE", 79, 104], ["adipocytes", "TISSUE", 106, 116], ["vascular structures", "TISSUE", 122, 141], ["adipocytes", "CELL_TYPE", 106, 116], ["a thin layer of fibrous connective tissue", "PROBLEM", 63, 104], ["conduction", "OBSERVATION", 4, 14], ["fibers", "ANATOMY_MODIFIER", 24, 30], ["approximately", "OBSERVATION_MODIFIER", 34, 47], ["mesothelium", "OBSERVATION", 48, 59], ["thin", "OBSERVATION_MODIFIER", 65, 69], ["layer", "OBSERVATION_MODIFIER", 70, 75], ["fibrous connective tissue", "OBSERVATION", 79, 104], ["adipocytes", "ANATOMY", 106, 116], ["vascular", "ANATOMY", 122, 130], ["structures", "ANATOMY_MODIFIER", 131, 141]]], ["This organization forms the subepicardium and interdigitates with the myocardium.", [["subepicardium", "ANATOMY", 28, 41], ["myocardium", "ANATOMY", 70, 80], ["subepicardium", "CANCER", 28, 41], ["myocardium", "ORGAN", 70, 80], ["subepicardium", "ANATOMY", 28, 41], ["myocardium", "ANATOMY", 70, 80]]], ["The parietal pericardium is composed of an inner layer of mesothelium that interdigitates with the dense connective tissue forming the outer pericardial sac.Blood and Lymphatic Vascular SystemsThe overall design of the blood and lymphatic vessels is similar, except that luminal diameter, wall thickness, and the presence of other anatomic features, such as valves, vary between the different segments.", [["parietal pericardium", "ANATOMY", 4, 24], ["inner layer", "ANATOMY", 43, 54], ["mesothelium", "ANATOMY", 58, 69], ["connective tissue", "ANATOMY", 105, 122], ["outer pericardial sac", "ANATOMY", 135, 156], ["Blood", "ANATOMY", 157, 162], ["blood", "ANATOMY", 219, 224], ["lymphatic vessels", "ANATOMY", 229, 246], ["luminal", "ANATOMY", 271, 278], ["wall", "ANATOMY", 289, 293], ["luminal", "CHEMICAL", 271, 278], ["parietal pericardium", "MULTI-TISSUE_STRUCTURE", 4, 24], ["inner layer", "TISSUE", 43, 54], ["mesothelium", "TISSUE", 58, 69], ["connective tissue", "TISSUE", 105, 122], ["outer pericardial sac", "TISSUE", 135, 156], ["Blood", "ORGANISM_SUBSTANCE", 157, 162], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 167, 185], ["blood", "ORGANISM_SUBSTANCE", 219, 224], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 229, 246], ["luminal", "TISSUE", 271, 278], ["wall", "TISSUE", 289, 293], ["valves", "PATHOLOGICAL_FORMATION", 358, 364], ["an inner layer of mesothelium", "PROBLEM", 40, 69], ["the dense connective tissue", "PROBLEM", 95, 122], ["Blood", "TEST", 157, 162], ["other anatomic features", "PROBLEM", 325, 348], ["valves", "TREATMENT", 358, 364], ["parietal", "ANATOMY_MODIFIER", 4, 12], ["pericardium", "ANATOMY", 13, 24], ["inner", "OBSERVATION_MODIFIER", 43, 48], ["layer", "OBSERVATION_MODIFIER", 49, 54], ["mesothelium", "OBSERVATION", 58, 69], ["dense", "OBSERVATION_MODIFIER", 99, 104], ["connective tissue", "OBSERVATION", 105, 122], ["outer", "ANATOMY_MODIFIER", 135, 140], ["pericardial sac", "ANATOMY", 141, 156], ["Lymphatic", "OBSERVATION", 167, 176], ["Vascular Systems", "ANATOMY", 177, 193], ["overall", "OBSERVATION_MODIFIER", 197, 204], ["blood", "ANATOMY", 219, 224], ["lymphatic vessels", "ANATOMY", 229, 246], ["similar", "OBSERVATION_MODIFIER", 250, 257], ["luminal", "ANATOMY_MODIFIER", 271, 278], ["diameter", "OBSERVATION_MODIFIER", 279, 287], ["wall", "OBSERVATION_MODIFIER", 289, 293], ["thickness", "OBSERVATION_MODIFIER", 294, 303], ["anatomic features", "OBSERVATION", 331, 348], ["valves", "OBSERVATION", 358, 364], ["different", "OBSERVATION_MODIFIER", 383, 392], ["segments", "OBSERVATION_MODIFIER", 393, 401]]], ["The luminal surface of all vessels is lined by longitudinally aligned endothelial cells covering a basal lamina.", [["luminal surface", "ANATOMY", 4, 19], ["vessels", "ANATOMY", 27, 34], ["endothelial cells", "ANATOMY", 70, 87], ["basal lamina", "ANATOMY", 99, 111], ["luminal", "CHEMICAL", 4, 11], ["luminal surface", "CELLULAR_COMPONENT", 4, 19], ["vessels", "MULTI-TISSUE_STRUCTURE", 27, 34], ["endothelial cells", "CELL", 70, 87], ["basal lamina", "CELLULAR_COMPONENT", 99, 111], ["longitudinally aligned endothelial cells", "CELL_TYPE", 47, 87], ["longitudinally aligned endothelial cells", "PROBLEM", 47, 87], ["luminal", "ANATOMY_MODIFIER", 4, 11], ["surface", "ANATOMY_MODIFIER", 12, 19], ["all vessels", "ANATOMY", 23, 34], ["lined", "OBSERVATION", 38, 43], ["longitudinally", "OBSERVATION_MODIFIER", 47, 61], ["aligned", "OBSERVATION_MODIFIER", 62, 69], ["endothelial cells", "OBSERVATION", 70, 87], ["basal", "ANATOMY_MODIFIER", 99, 104], ["lamina", "ANATOMY", 105, 111]]], ["Vessel walls are divided into three layers or tunics: intima, media, and adventitia.", [["Vessel walls", "ANATOMY", 0, 12], ["tunics", "ANATOMY", 46, 52], ["intima", "ANATOMY", 54, 60], ["adventitia", "ANATOMY", 73, 83], ["Vessel walls", "MULTI-TISSUE_STRUCTURE", 0, 12], ["layers", "TISSUE", 36, 42], ["intima", "TISSUE", 54, 60], ["adventitia", "TISSUE", 73, 83], ["intima, media, and adventitia", "PROBLEM", 54, 83], ["walls", "ANATOMY_MODIFIER", 7, 12], ["layers", "OBSERVATION_MODIFIER", 36, 42], ["intima", "ANATOMY", 54, 60], ["media", "ANATOMY", 62, 67], ["adventitia", "ANATOMY", 73, 83]]], ["However, some of the layers can be absent or all of the layers can be thinned in some segments of the vascular system, depending on the intravascular pressures.", [["vascular system", "ANATOMY", 102, 117], ["intravascular", "ANATOMY", 136, 149], ["layers", "TISSUE", 21, 27], ["layers", "TISSUE", 56, 62], ["vascular system", "MULTI-TISSUE_STRUCTURE", 102, 117], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 136, 149], ["the intravascular pressures", "TEST", 132, 159], ["layers", "OBSERVATION_MODIFIER", 21, 27], ["absent", "OBSERVATION", 35, 41], ["all", "OBSERVATION_MODIFIER", 45, 48], ["layers", "OBSERVATION_MODIFIER", 56, 62], ["thinned", "OBSERVATION", 70, 77], ["some segments", "ANATOMY_MODIFIER", 81, 94], ["vascular system", "ANATOMY", 102, 117], ["intravascular pressures", "OBSERVATION", 136, 159]]], ["The large elastic arteries such as the aorta have (1) an intima composed of endothelium and subendothelial connective tissue; (2) a very thick tunica media composed of fenestrated elastic laminae with interposed smooth muscle cells and ground substance and bordered internally by the internal elastic lamina and externally by the external elastic lamina; and (3) an outer tunica adventitia layer composed of collagen and elastic fibers and connective tissue cells with penetrating blood vessels, termed the vasa vasorum, supplying nutrients to the adventitia and the outer half of the media.", [["elastic arteries", "ANATOMY", 10, 26], ["aorta", "ANATOMY", 39, 44], ["intima", "ANATOMY", 57, 63], ["endothelium", "ANATOMY", 76, 87], ["subendothelial connective tissue", "ANATOMY", 92, 124], ["elastic laminae", "ANATOMY", 180, 195], ["smooth muscle cells", "ANATOMY", 212, 231], ["internal elastic lamina", "ANATOMY", 284, 307], ["external elastic lamina", "ANATOMY", 330, 353], ["tunica adventitia layer", "ANATOMY", 372, 395], ["elastic fibers", "ANATOMY", 421, 435], ["connective tissue cells", "ANATOMY", 440, 463], ["blood vessels", "ANATOMY", 481, 494], ["vasa vasorum", "ANATOMY", 507, 519], ["adventitia", "ANATOMY", 548, 558], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 10, 26], ["aorta", "MULTI-TISSUE_STRUCTURE", 39, 44], ["intima", "TISSUE", 57, 63], ["endothelium", "TISSUE", 76, 87], ["subendothelial connective tissue", "TISSUE", 92, 124], ["elastic laminae", "TISSUE", 180, 195], ["smooth muscle cells", "CELL", 212, 231], ["elastic lamina", "TISSUE", 293, 307], ["elastic lamina", "TISSUE", 339, 353], ["outer tunica adventitia layer", "TISSUE", 366, 395], ["collagen", "GENE_OR_GENE_PRODUCT", 408, 416], ["elastic fibers", "CELLULAR_COMPONENT", 421, 435], ["connective tissue cells", "CELL", 440, 463], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 481, 494], ["vasa vasorum", "MULTI-TISSUE_STRUCTURE", 507, 519], ["adventitia", "TISSUE", 548, 558], ["interposed smooth muscle cells", "CELL_TYPE", 201, 231], ["collagen", "PROTEIN", 408, 416], ["connective tissue cells", "CELL_TYPE", 440, 463], ["vasa vasorum", "SPECIES", 507, 519], ["vasa vasorum", "SPECIES", 507, 519], ["subendothelial connective tissue", "PROBLEM", 92, 124], ["a very thick tunica media", "PROBLEM", 130, 155], ["fenestrated elastic laminae", "TREATMENT", 168, 195], ["interposed smooth muscle cells", "PROBLEM", 201, 231], ["an outer tunica adventitia layer", "TREATMENT", 363, 395], ["collagen and elastic fibers and connective tissue cells", "TREATMENT", 408, 463], ["penetrating blood vessels", "PROBLEM", 469, 494], ["large", "OBSERVATION_MODIFIER", 4, 9], ["elastic", "OBSERVATION", 10, 17], ["arteries", "ANATOMY", 18, 26], ["aorta", "ANATOMY", 39, 44], ["intima", "OBSERVATION", 57, 63], ["endothelium", "OBSERVATION", 76, 87], ["subendothelial", "ANATOMY_MODIFIER", 92, 106], ["connective tissue", "OBSERVATION", 107, 124], ["very", "OBSERVATION_MODIFIER", 132, 136], ["thick", "OBSERVATION", 137, 142], ["tunica media", "ANATOMY", 143, 155], ["fenestrated", "ANATOMY_MODIFIER", 168, 179], ["elastic", "ANATOMY_MODIFIER", 180, 187], ["laminae", "ANATOMY_MODIFIER", 188, 195], ["interposed", "ANATOMY_MODIFIER", 201, 211], ["smooth muscle cells", "OBSERVATION", 212, 231], ["ground substance", "OBSERVATION", 236, 252], ["internal", "ANATOMY_MODIFIER", 284, 292], ["elastic", "ANATOMY_MODIFIER", 293, 300], ["lamina", "ANATOMY_MODIFIER", 301, 307], ["externally", "ANATOMY_MODIFIER", 312, 322], ["external elastic lamina", "ANATOMY", 330, 353], ["outer", "ANATOMY_MODIFIER", 366, 371], ["tunica adventitia", "ANATOMY", 372, 389], ["layer", "OBSERVATION_MODIFIER", 390, 395], ["collagen", "OBSERVATION", 408, 416], ["elastic fibers", "OBSERVATION", 421, 435], ["connective tissue cells", "OBSERVATION", 440, 463], ["penetrating blood vessels", "OBSERVATION", 469, 494], ["vasa vasorum", "ANATOMY", 507, 519], ["adventitia", "ANATOMY", 548, 558], ["outer", "ANATOMY_MODIFIER", 567, 572], ["media", "ANATOMY", 585, 590]]], ["In muscular arteries and arterioles, the tunica media is largely composed of smooth muscle cells arranged in a circumferential pattern.", [["muscular arteries", "ANATOMY", 3, 20], ["arterioles", "ANATOMY", 25, 35], ["smooth muscle cells", "ANATOMY", 77, 96], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 3, 20], ["arterioles", "MULTI-TISSUE_STRUCTURE", 25, 35], ["smooth muscle cells", "CELL", 77, 96], ["smooth muscle cells", "CELL_TYPE", 77, 96], ["muscular arteries", "ANATOMY", 3, 20], ["arterioles", "ANATOMY", 25, 35], ["tunica media", "ANATOMY", 41, 53], ["smooth muscle cells", "OBSERVATION", 77, 96], ["circumferential", "OBSERVATION_MODIFIER", 111, 126], ["pattern", "OBSERVATION_MODIFIER", 127, 134]]], ["Arterioles are the smallest arterial channels and are generally less than 100 \u00b5m in diameter and with one to three layers of smooth muscle cells in the tunica media.Blood and Lymphatic Vascular SystemsCapillaries are 5 to 10 \u00b5m in diameter, and their endothelium is one of three types: (1) continuous, (2) fenestrated (as in the endocrine glands), or (3) porous (as in renal glomeruli).", [["Arterioles", "ANATOMY", 0, 10], ["arterial", "ANATOMY", 28, 36], ["smooth muscle cells", "ANATOMY", 125, 144], ["Blood", "ANATOMY", 165, 170], ["Lymphatic Vascular SystemsCapillaries", "ANATOMY", 175, 212], ["endothelium", "ANATOMY", 251, 262], ["endocrine glands", "ANATOMY", 329, 345], ["renal glomeruli", "ANATOMY", 369, 384], ["Arterioles", "CANCER", 0, 10], ["arterial", "MULTI-TISSUE_STRUCTURE", 28, 36], ["smooth muscle cells", "CELL", 125, 144], ["tunica", "TISSUE", 152, 158], ["Blood", "ORGANISM_SUBSTANCE", 165, 170], ["Lymphatic Vascular SystemsCapillaries", "CANCER", 175, 212], ["endothelium", "TISSUE", 251, 262], ["endocrine glands", "ORGAN", 329, 345], ["renal glomeruli", "MULTI-TISSUE_STRUCTURE", 369, 384], ["smooth muscle cells", "CELL_TYPE", 125, 144], ["Blood", "TEST", 165, 170], ["Lymphatic Vascular SystemsCapillaries", "TEST", 175, 212], ["smallest", "OBSERVATION_MODIFIER", 19, 27], ["arterial channels", "ANATOMY", 28, 45], ["generally", "OBSERVATION_MODIFIER", 54, 63], ["less", "OBSERVATION_MODIFIER", 64, 68], ["diameter", "OBSERVATION_MODIFIER", 84, 92], ["layers", "OBSERVATION_MODIFIER", 115, 121], ["smooth muscle cells", "OBSERVATION", 125, 144], ["tunica media", "ANATOMY", 152, 164], ["Lymphatic", "ANATOMY_MODIFIER", 175, 184], ["Vascular", "ANATOMY", 185, 193], ["SystemsCapillaries", "OBSERVATION", 194, 212], ["5 to 10 \u00b5m", "OBSERVATION_MODIFIER", 217, 227], ["diameter", "OBSERVATION_MODIFIER", 231, 239], ["endothelium", "ANATOMY", 251, 262], ["one", "OBSERVATION_MODIFIER", 266, 269], ["endocrine glands", "ANATOMY", 329, 345], ["renal glomeruli", "ANATOMY", 369, 384]]], ["The endothelium rests on an external lamina surrounded by pericytes.", [["endothelium", "ANATOMY", 4, 15], ["external lamina", "ANATOMY", 28, 43], ["pericytes", "ANATOMY", 58, 67], ["endothelium", "TISSUE", 4, 15], ["lamina", "TISSUE", 37, 43], ["pericytes", "CELL", 58, 67], ["pericytes", "CELL_TYPE", 58, 67], ["endothelium", "OBSERVATION", 4, 15], ["external", "ANATOMY_MODIFIER", 28, 36], ["lamina", "ANATOMY_MODIFIER", 37, 43], ["pericytes", "OBSERVATION", 58, 67]]], ["Pericytes are located abluminally to capillaries and postcapillary venules and because of their location, contractility, and cytoskeletal proteins may play a role in regulating capillary and venular blood flow.", [["Pericytes", "ANATOMY", 0, 9], ["abluminally", "ANATOMY", 22, 33], ["capillaries", "ANATOMY", 37, 48], ["postcapillary venules", "ANATOMY", 53, 74], ["cytoskeletal", "ANATOMY", 125, 137], ["capillary", "ANATOMY", 177, 186], ["venular blood", "ANATOMY", 191, 204], ["Pericytes", "GENE_OR_GENE_PRODUCT", 0, 9], ["capillaries", "TISSUE", 37, 48], ["postcapillary venules", "TISSUE", 53, 74], ["cytoskeletal", "CELLULAR_COMPONENT", 125, 137], ["capillary", "TISSUE", 177, 186], ["venular blood", "MULTI-TISSUE_STRUCTURE", 191, 204], ["postcapillary venules", "CELL_TYPE", 53, 74], ["cytoskeletal proteins", "PROTEIN", 125, 146], ["Pericytes", "PROBLEM", 0, 9], ["venular blood flow", "TEST", 191, 209], ["capillaries", "ANATOMY_MODIFIER", 37, 48], ["postcapillary venules", "OBSERVATION", 53, 74], ["contractility", "OBSERVATION_MODIFIER", 106, 119], ["cytoskeletal proteins", "OBSERVATION", 125, 146], ["capillary", "ANATOMY_MODIFIER", 177, 186], ["venular blood", "ANATOMY", 191, 204]]], ["Lesions of the endothelium might not be evident by light microscopy, and electron microscopy is required for characterization.Blood and Lymphatic Vascular SystemsVeins have thin walls in relation to their luminal size compared with those of arteries, in which blood pressure is greater.", [["endothelium", "ANATOMY", 15, 26], ["Blood", "ANATOMY", 126, 131], ["Vascular", "ANATOMY", 146, 154], ["luminal", "ANATOMY", 205, 212], ["arteries", "ANATOMY", 241, 249], ["blood", "ANATOMY", 260, 265], ["luminal", "CHEMICAL", 205, 212], ["endothelium", "TISSUE", 15, 26], ["Blood", "ORGANISM_SUBSTANCE", 126, 131], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 136, 154], ["walls", "IMMATERIAL_ANATOMICAL_ENTITY", 178, 183], ["luminal", "MULTI-TISSUE_STRUCTURE", 205, 212], ["arteries", "MULTI-TISSUE_STRUCTURE", 241, 249], ["blood", "ORGANISM_SUBSTANCE", 260, 265], ["Lesions of the endothelium", "PROBLEM", 0, 26], ["light microscopy", "TEST", 51, 67], ["electron microscopy", "TEST", 73, 92], ["Blood", "TEST", 126, 131], ["thin walls", "PROBLEM", 173, 183], ["blood pressure", "TEST", 260, 274], ["endothelium", "ANATOMY", 15, 26], ["might not be evident", "UNCERTAINTY", 27, 47], ["Lymphatic", "ANATOMY_MODIFIER", 136, 145], ["Vascular SystemsVeins", "ANATOMY", 146, 167], ["thin", "OBSERVATION_MODIFIER", 173, 177], ["walls", "OBSERVATION_MODIFIER", 178, 183], ["luminal", "ANATOMY_MODIFIER", 205, 212], ["size", "OBSERVATION_MODIFIER", 213, 217], ["arteries", "ANATOMY", 241, 249], ["pressure", "OBSERVATION_MODIFIER", 266, 274], ["greater", "OBSERVATION_MODIFIER", 278, 285]]], ["The adventitia is the thickest layer.", [["adventitia", "ANATOMY", 4, 14], ["thickest layer", "ANATOMY", 22, 36], ["adventitia", "MULTI-TISSUE_STRUCTURE", 4, 14], ["adventitia", "ANATOMY", 4, 14], ["thickest", "OBSERVATION_MODIFIER", 22, 30], ["layer", "OBSERVATION_MODIFIER", 31, 36]]], ["Valves are present to prevent retrograde blood flow (i.e., away from the heart).Blood and Lymphatic Vascular SystemsLymphatic capillaries lack a basal lamina.", [["Valves", "ANATOMY", 0, 6], ["blood", "ANATOMY", 41, 46], ["heart", "ANATOMY", 73, 78], ["Blood", "ANATOMY", 80, 85], ["Lymphatic Vascular SystemsLymphatic capillaries", "ANATOMY", 90, 137], ["basal lamina", "ANATOMY", 145, 157], ["blood", "ORGANISM_SUBSTANCE", 41, 46], ["heart", "ORGAN", 73, 78], ["Blood", "ORGANISM_SUBSTANCE", 80, 85], ["Lymphatic Vascular SystemsLymphatic capillaries", "TISSUE", 90, 137], ["basal lamina", "CELLULAR_COMPONENT", 145, 157], ["Valves", "TREATMENT", 0, 6], ["retrograde blood flow", "TEST", 30, 51], ["Blood", "TEST", 80, 85], ["blood flow", "OBSERVATION", 41, 51], ["heart", "ANATOMY", 73, 78], ["Lymphatic", "ANATOMY_MODIFIER", 90, 99], ["Vascular", "ANATOMY", 100, 108], ["SystemsLymphatic capillaries", "OBSERVATION", 109, 137], ["basal", "ANATOMY_MODIFIER", 145, 150], ["lamina", "ANATOMY", 151, 157]]], ["Large lymphatic vessels are similar in structure to veins and generally have large lumina, thin walls, and a greater number of intimal valves but contain lymph.Blood and Lymphatic Vascular SystemsThe morphology of large arteries, veins, microvasculature, and lymphatic vessels is described in Chapter 2 and is not discussed further in this chapter.Necropsy Assessment of Heart and Vascular StructuresFor information on this topic, see E-Appendix 10-1 and E-Figs.", [["lymphatic vessels", "ANATOMY", 6, 23], ["veins", "ANATOMY", 52, 57], ["lumina", "ANATOMY", 83, 89], ["thin walls", "ANATOMY", 91, 101], ["intimal valves", "ANATOMY", 127, 141], ["lymph", "ANATOMY", 154, 159], ["Blood", "ANATOMY", 160, 165], ["arteries", "ANATOMY", 220, 228], ["veins", "ANATOMY", 230, 235], ["microvasculature", "ANATOMY", 237, 253], ["lymphatic vessels", "ANATOMY", 259, 276], ["Heart", "ANATOMY", 371, 376], ["Vascular", "ANATOMY", 381, 389], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 6, 23], ["veins", "MULTI-TISSUE_STRUCTURE", 52, 57], ["lumina", "MULTI-TISSUE_STRUCTURE", 83, 89], ["intimal valves", "TISSUE", 127, 141], ["lymph", "ORGAN", 154, 159], ["Blood", "ORGANISM_SUBSTANCE", 160, 165], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 170, 188], ["large arteries", "MULTI-TISSUE_STRUCTURE", 214, 228], ["veins", "MULTI-TISSUE_STRUCTURE", 230, 235], ["microvasculature", "TISSUE", 237, 253], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 259, 276], ["Heart", "ORGAN", 371, 376], ["Vascular", "MULTI-TISSUE_STRUCTURE", 381, 389], ["Large lymphatic vessels", "PROBLEM", 0, 23], ["large lumina, thin walls", "PROBLEM", 77, 101], ["Blood", "TEST", 160, 165], ["large arteries, veins, microvasculature, and lymphatic vessels", "PROBLEM", 214, 276], ["Necropsy Assessment", "TEST", 348, 367], ["Appendix", "TEST", 437, 445], ["lymphatic vessels", "ANATOMY", 6, 23], ["veins", "ANATOMY", 52, 57], ["large", "OBSERVATION_MODIFIER", 77, 82], ["lumina", "OBSERVATION", 83, 89], ["thin", "OBSERVATION_MODIFIER", 91, 95], ["walls", "OBSERVATION_MODIFIER", 96, 101], ["greater", "OBSERVATION_MODIFIER", 109, 116], ["number", "OBSERVATION_MODIFIER", 117, 123], ["intimal valves", "OBSERVATION", 127, 141], ["lymph", "OBSERVATION", 154, 159], ["Lymphatic", "OBSERVATION", 170, 179], ["Vascular Systems", "ANATOMY", 180, 196], ["morphology", "OBSERVATION_MODIFIER", 200, 210], ["large arteries", "ANATOMY", 214, 228], ["veins", "ANATOMY", 230, 235], ["microvasculature", "ANATOMY", 237, 253], ["lymphatic vessels", "ANATOMY", 259, 276], ["Heart", "ANATOMY", 371, 376], ["Vascular", "ANATOMY", 381, 389], ["Appendix", "ANATOMY", 437, 445]]], ["10-5 and 10-6 at www.expertconsult.com.565.e1CHAPTER 10 Cardiovascular System and Lymphatic Vessels E- Figure 10 -5 Postmortem \"Chicken Fat\" Arterial Cast, Dog.", [["Arterial", "ANATOMY", 141, 149], ["Chicken", "SPECIES", 128, 135], ["Lymphatic Vessels", "ANATOMY", 82, 99], ["Arterial", "ANATOMY", 141, 149], ["Cast", "OBSERVATION", 150, 154]]], ["Note how the clot conforms to the shape of the lumens of the vessels from which it was removed.", [["clot", "ANATOMY", 13, 17], ["lumens", "ANATOMY", 47, 53], ["vessels", "ANATOMY", 61, 68], ["clot", "ORGANISM_SUBSTANCE", 13, 17], ["lumens", "TISSUE", 47, 53], ["vessels", "MULTI-TISSUE_STRUCTURE", 61, 68], ["the clot", "PROBLEM", 9, 17], ["clot", "OBSERVATION", 13, 17], ["shape", "OBSERVATION_MODIFIER", 34, 39], ["lumens", "ANATOMY_MODIFIER", 47, 53], ["vessels", "ANATOMY", 61, 68]]], ["Chicken fat clots consist primarily of clotted plasma and fibrin and other proteins of the coagulation cascade.", [["fat clots", "ANATOMY", 8, 17], ["plasma", "ANATOMY", 47, 53], ["Chicken", "ORGANISM", 0, 7], ["fat clots", "ORGANISM_SUBSTANCE", 8, 17], ["plasma", "ORGANISM_SUBSTANCE", 47, 53], ["fibrin", "GENE_OR_GENE_PRODUCT", 58, 64], ["fibrin", "PROTEIN", 58, 64], ["Chicken", "SPECIES", 0, 7], ["Chicken", "SPECIES", 0, 7], ["Chicken fat clots", "PROBLEM", 0, 17], ["clotted plasma", "TREATMENT", 39, 53], ["fibrin", "TREATMENT", 58, 64], ["the coagulation cascade", "TREATMENT", 87, 110], ["clots", "OBSERVATION", 12, 17], ["clotted plasma", "OBSERVATION", 39, 53], ["fibrin", "OBSERVATION", 58, 64], ["coagulation cascade", "OBSERVATION", 91, 110]]], ["They are often indicative of anemia; however, in all animals their formation by the separation of the red blood cells from the rest of the components of blood depends on the erythrocyte sedimentation rate (ESR).", [["red blood cells", "ANATOMY", 102, 117], ["blood", "ANATOMY", 153, 158], ["erythrocyte", "ANATOMY", 174, 185], ["anemia", "DISEASE", 29, 35], ["red blood cells", "CELL", 102, 117], ["blood", "ORGANISM_SUBSTANCE", 153, 158], ["erythrocyte", "CELL", 174, 185], ["red blood cells", "CELL_TYPE", 102, 117], ["anemia", "PROBLEM", 29, 35], ["the red blood cells", "TEST", 98, 117], ["the erythrocyte sedimentation rate", "TEST", 170, 204], ["ESR", "TEST", 206, 209], ["often indicative of", "UNCERTAINTY", 9, 28], ["anemia", "OBSERVATION", 29, 35]]], ["Separation can occur in all animals in response to systemic inflammation, which increases the ESR, but the horse normally has a high ESR because equine erythrocytes clump together in rouleau formation, which increases the ESR.", [["erythrocytes", "ANATOMY", 152, 164], ["rouleau", "ANATOMY", 183, 190], ["inflammation", "DISEASE", 60, 72], ["horse", "ORGANISM", 107, 112], ["equine", "ORGANISM", 145, 151], ["erythrocytes", "CELL", 152, 164], ["rouleau", "TISSUE", 183, 190], ["equine erythrocytes", "CELL_TYPE", 145, 164], ["ESR", "PROTEIN", 222, 225], ["systemic inflammation", "PROBLEM", 51, 72], ["the ESR", "TEST", 90, 97], ["a high ESR", "PROBLEM", 126, 136], ["equine erythrocytes clump", "PROBLEM", 145, 170], ["rouleau formation", "PROBLEM", 183, 200], ["the ESR", "TEST", 218, 225], ["systemic", "OBSERVATION_MODIFIER", 51, 59], ["inflammation", "OBSERVATION", 60, 72], ["erythrocytes clump", "OBSERVATION", 152, 170], ["rouleau formation", "OBSERVATION", 183, 200]]], ["Thus, depending on the ESR, postmortem clots may be pale white to yellow (\"chicken fat\" clot) or shiny red (\"currant jelly\" clot) or sometimes a mixture.", [["postmortem clots", "ANATOMY", 28, 44], ["fat", "ANATOMY", 83, 86], ["clot", "ANATOMY", 88, 92], ["clot", "ANATOMY", 124, 128], ["clots", "ORGANISM_SUBSTANCE", 39, 44], ["chicken", "ORGANISM", 75, 82], ["fat", "TISSUE", 83, 86], ["clot", "ORGANISM_SUBSTANCE", 88, 92], ["clot", "ORGANISM_SUBSTANCE", 124, 128], ["chicken", "SPECIES", 75, 82], ["chicken", "SPECIES", 75, 82], ["the ESR", "TEST", 19, 26], ["postmortem clots", "PROBLEM", 28, 44], ["pale white to yellow (\"chicken fat\" clot", "PROBLEM", 52, 92], ["shiny red (\"currant jelly\" clot", "PROBLEM", 97, 128], ["clot", "OBSERVATION", 124, 128]]], ["(E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresOccasionally, normal features in animal hearts can be misinterpreted as lesions.", [["Heart", "ANATOMY", 40, 45], ["Vascular", "ANATOMY", 50, 58], ["hearts", "ANATOMY", 109, 115], ["lesions", "ANATOMY", 141, 148], ["Heart", "ORGAN", 40, 45], ["Vascular", "MULTI-TISSUE_STRUCTURE", 50, 58], ["hearts", "ORGAN", 109, 115], ["lesions", "PATHOLOGICAL_FORMATION", 141, 148], ["E-Appendix", "TEST", 1, 11], ["Necropsy Assessment", "TEST", 17, 36], ["lesions", "PROBLEM", 141, 148], ["Appendix", "ANATOMY", 3, 11], ["Heart", "ANATOMY", 40, 45], ["Vascular", "ANATOMY", 50, 58], ["normal", "OBSERVATION", 83, 89], ["hearts", "ANATOMY", 109, 115], ["lesions", "OBSERVATION", 141, 148]]], ["The epicardial lymphatic vessels, especially in cattle, can appear as prominent white streaks that could be interpreted as areas of necrosis.", [["epicardial lymphatic vessels", "ANATOMY", 4, 32], ["necrosis", "DISEASE", 132, 140], ["epicardial lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 4, 32], ["cattle", "SPECIES", 48, 54], ["cattle", "SPECIES", 48, 54], ["prominent white streaks", "PROBLEM", 70, 93], ["necrosis", "PROBLEM", 132, 140], ["epicardial", "ANATOMY_MODIFIER", 4, 14], ["lymphatic vessels", "ANATOMY", 15, 32], ["prominent", "OBSERVATION_MODIFIER", 70, 79], ["white streaks", "OBSERVATION", 80, 93], ["necrosis", "OBSERVATION", 132, 140]]], ["The septal cusp of the tricuspid valve in dogs is normally rather tightly attached to the ventricular septum.", [["septal cusp", "ANATOMY", 4, 15], ["tricuspid valve", "ANATOMY", 23, 38], ["ventricular septum", "ANATOMY", 90, 108], ["septal cusp", "MULTI-TISSUE_STRUCTURE", 4, 15], ["tricuspid valve", "PATHOLOGICAL_FORMATION", 23, 38], ["dogs", "ORGANISM", 42, 46], ["ventricular septum", "MULTI-TISSUE_STRUCTURE", 90, 108], ["dogs", "SPECIES", 42, 46], ["septal", "ANATOMY_MODIFIER", 4, 10], ["cusp", "ANATOMY_MODIFIER", 11, 15], ["tricuspid valve", "ANATOMY", 23, 38], ["dogs", "OBSERVATION", 42, 46], ["ventricular septum", "ANATOMY", 90, 108]]], ["In young ruminants up to 2 to 3 weeks of age, the ductus arteriosus and foramen ovale can be probed patent, but unless the openings are large, no significant shunting of blood is likely to occur during life.", [["ductus arteriosus", "ANATOMY", 50, 67], ["blood", "ANATOMY", 170, 175], ["ductus arteriosus and foramen ovale", "DISEASE", 50, 85], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 50, 67], ["blood", "ORGANISM_SUBSTANCE", 170, 175], ["the ductus arteriosus", "PROBLEM", 46, 67], ["foramen ovale", "PROBLEM", 72, 85], ["significant shunting of blood", "PROBLEM", 146, 175], ["ductus arteriosus", "ANATOMY", 50, 67], ["foramen ovale", "ANATOMY", 72, 85], ["patent", "OBSERVATION", 100, 106], ["large", "OBSERVATION_MODIFIER", 136, 141], ["no", "UNCERTAINTY", 143, 145], ["significant", "OBSERVATION_MODIFIER", 146, 157], ["shunting", "OBSERVATION", 158, 166]]], ["The overall shape of normal hearts can vary from the elongated conical profile in the horse to the somewhat rounded shape in the dog.", [["hearts", "ANATOMY", 28, 34], ["hearts", "ORGAN", 28, 34], ["horse", "ORGANISM_SUBDIVISION", 86, 91], ["dog", "ORGANISM", 129, 132], ["horse", "SPECIES", 86, 91], ["dog", "SPECIES", 129, 132], ["overall", "OBSERVATION_MODIFIER", 4, 11], ["shape", "OBSERVATION_MODIFIER", 12, 17], ["normal", "OBSERVATION", 21, 27], ["hearts", "ANATOMY", 28, 34], ["elongated", "OBSERVATION_MODIFIER", 53, 62], ["conical", "OBSERVATION_MODIFIER", 63, 70], ["profile", "OBSERVATION_MODIFIER", 71, 78], ["somewhat", "OBSERVATION_MODIFIER", 99, 107], ["rounded", "OBSERVATION_MODIFIER", 108, 115], ["shape", "OBSERVATION_MODIFIER", 116, 121], ["dog", "ANATOMY", 129, 132]]], ["Cardiac weights vary greatly among species and breeds; pigs have relatively small hearts (approximately 0.3% of body weight), and dogs have relatively large hearts (from 0.75% of body weight in nonathletic breeds to 1.25% in athletic breeds).E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresPostmortem alterations in hearts and vascular structures must be recognized and correctly interpreted.", [["Cardiac", "ANATOMY", 0, 7], ["hearts", "ANATOMY", 82, 88], ["body", "ANATOMY", 112, 116], ["hearts", "ANATOMY", 157, 163], ["body", "ANATOMY", 179, 183], ["Heart", "ANATOMY", 281, 286], ["Vascular", "ANATOMY", 291, 299], ["hearts", "ANATOMY", 336, 342], ["vascular structures", "ANATOMY", 347, 366], ["Cardiac", "ORGAN", 0, 7], ["pigs", "ORGANISM", 55, 59], ["hearts", "ORGAN", 82, 88], ["body", "ORGANISM_SUBDIVISION", 112, 116], ["dogs", "ORGANISM", 130, 134], ["hearts", "ORGAN", 157, 163], ["body", "ORGANISM_SUBDIVISION", 179, 183], ["Heart", "ORGAN", 281, 286], ["Vascular", "MULTI-TISSUE_STRUCTURE", 291, 299], ["hearts", "MULTI-TISSUE_STRUCTURE", 336, 342], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 347, 366], ["pigs", "SPECIES", 55, 59], ["dogs", "SPECIES", 130, 134], ["pigs", "SPECIES", 55, 59], ["Cardiac weights", "TEST", 0, 15], ["body weight", "TEST", 112, 123], ["body weight in nonathletic breeds", "TREATMENT", 179, 212], ["E-Appendix", "TEST", 242, 252], ["Necropsy Assessment", "TEST", 258, 277], ["Postmortem alterations in hearts and vascular structures", "PROBLEM", 310, 366], ["small", "OBSERVATION_MODIFIER", 76, 81], ["hearts", "ANATOMY", 82, 88], ["relatively", "OBSERVATION_MODIFIER", 140, 150], ["large", "OBSERVATION", 151, 156], ["hearts", "ANATOMY", 157, 163], ["Appendix", "ANATOMY", 244, 252], ["Heart", "ANATOMY", 281, 286], ["Vascular", "ANATOMY", 291, 299], ["alterations", "OBSERVATION", 321, 332], ["hearts", "ANATOMY", 336, 342], ["vascular", "ANATOMY", 347, 355]]], ["Rigor mortis occurs in myocardium much as in skeletal muscles and produces contracted, rigid ventricular walls, which empties the more muscular left ventricle.", [["myocardium", "ANATOMY", 23, 33], ["skeletal muscles", "ANATOMY", 45, 61], ["ventricular walls", "ANATOMY", 93, 110], ["muscular left ventricle", "ANATOMY", 135, 158], ["myocardium", "ORGAN", 23, 33], ["skeletal muscles", "ORGAN", 45, 61], ["ventricular walls", "MULTI-TISSUE_STRUCTURE", 93, 110], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 144, 158], ["Rigor mortis", "PROBLEM", 0, 12], ["contracted, rigid ventricular walls", "PROBLEM", 75, 110], ["mortis", "OBSERVATION", 6, 12], ["myocardium", "ANATOMY", 23, 33], ["skeletal muscles", "ANATOMY", 45, 61], ["contracted", "OBSERVATION", 75, 85], ["rigid ventricular", "ANATOMY", 87, 104], ["walls", "ANATOMY_MODIFIER", 105, 110], ["muscular", "ANATOMY_MODIFIER", 135, 143], ["left ventricle", "ANATOMY", 144, 158]]], ["After rigor passes, the ventricular walls relax.E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresPostmortem blood clotting produces red (\"currant jelly\") clots in the atria, right ventricle, and large vessels at the base of the heart.", [["ventricular walls", "ANATOMY", 24, 41], ["Heart", "ANATOMY", 87, 92], ["Vascular", "ANATOMY", 97, 105], ["blood", "ANATOMY", 127, 132], ["jelly", "ANATOMY", 165, 170], ["clots", "ANATOMY", 173, 178], ["atria", "ANATOMY", 186, 191], ["right ventricle", "ANATOMY", 193, 208], ["vessels", "ANATOMY", 220, 227], ["heart", "ANATOMY", 247, 252], ["ventricular walls", "MULTI-TISSUE_STRUCTURE", 24, 41], ["Heart", "ORGAN", 87, 92], ["Vascular", "MULTI-TISSUE_STRUCTURE", 97, 105], ["blood", "ORGANISM_SUBSTANCE", 127, 132], ["clots", "ORGANISM_SUBSTANCE", 173, 178], ["atria", "MULTI-TISSUE_STRUCTURE", 186, 191], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 193, 208], ["large vessels", "MULTI-TISSUE_STRUCTURE", 214, 227], ["heart", "ORGAN", 247, 252], ["E", "TEST", 48, 49], ["Appendix", "TEST", 50, 58], ["Necropsy Assessment", "TEST", 64, 83], ["blood clotting", "TEST", 127, 141], ["red (\"currant jelly\"", "PROBLEM", 151, 171], ["clots in the atria, right ventricle", "PROBLEM", 173, 208], ["ventricular", "ANATOMY", 24, 35], ["walls", "ANATOMY_MODIFIER", 36, 41], ["Appendix", "ANATOMY", 50, 58], ["Heart", "ANATOMY", 87, 92], ["Vascular", "ANATOMY", 97, 105], ["blood clotting", "OBSERVATION", 127, 141], ["clots", "OBSERVATION", 173, 178], ["atria", "ANATOMY", 186, 191], ["right ventricle", "ANATOMY", 193, 208], ["large", "OBSERVATION_MODIFIER", 214, 219], ["vessels", "OBSERVATION", 220, 227], ["base", "ANATOMY_MODIFIER", 235, 239], ["heart", "ANATOMY", 247, 252]]], ["Postmortem blood clots are found in these anatomic structures because they lack contractile elements (large vessels) or have less muscle mass (atria, right ventricle) to undergo contraction during rigor mortis.", [["Postmortem blood clots", "ANATOMY", 0, 22], ["anatomic structures", "ANATOMY", 42, 61], ["contractile", "ANATOMY", 80, 91], ["vessels", "ANATOMY", 108, 115], ["muscle mass", "ANATOMY", 130, 141], ["atria", "ANATOMY", 143, 148], ["right ventricle", "ANATOMY", 150, 165], ["blood", "ORGANISM_SUBSTANCE", 11, 16], ["clots", "ORGANISM_SUBSTANCE", 17, 22], ["anatomic structures", "TISSUE", 42, 61], ["vessels", "MULTI-TISSUE_STRUCTURE", 108, 115], ["muscle", "ORGAN", 130, 136], ["atria", "MULTI-TISSUE_STRUCTURE", 143, 148], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 150, 165], ["Postmortem blood clots", "PROBLEM", 0, 22], ["less muscle mass", "PROBLEM", 125, 141], ["contraction during rigor mortis", "PROBLEM", 178, 209], ["blood", "ANATOMY", 11, 16], ["clots", "OBSERVATION", 17, 22], ["contractile elements", "OBSERVATION", 80, 100], ["large", "OBSERVATION_MODIFIER", 102, 107], ["vessels", "ANATOMY", 108, 115], ["less", "OBSERVATION_MODIFIER", 125, 129], ["muscle", "ANATOMY", 130, 136], ["mass", "OBSERVATION", 137, 141], ["atria", "ANATOMY", 143, 148], ["right ventricle", "ANATOMY", 150, 165], ["contraction", "OBSERVATION", 178, 189], ["rigor mortis", "OBSERVATION", 197, 209]]], ["In postmortem evaluations of the heart, it is important to note the presence (or absence) of blood clots in the ventricles and their appearance (\"currant jelly\" vs. \"chicken fat\") (E- Fig. 10-5 ).E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresUnder normal conditions, because of its larger chamber volume and thinner walls, a blood clot will be found in the right ventricle, whereas little or no blood clot will be found in the left ventricle because of its smaller chamber volume and thicker walls.", [["heart", "ANATOMY", 33, 38], ["blood clots", "ANATOMY", 93, 104], ["ventricles", "ANATOMY", 112, 122], ["fat", "ANATOMY", 174, 177], ["Heart", "ANATOMY", 235, 240], ["Vascular", "ANATOMY", 245, 253], ["walls", "ANATOMY", 338, 343], ["blood clot", "ANATOMY", 347, 357], ["right ventricle", "ANATOMY", 379, 394], ["blood clot", "ANATOMY", 417, 427], ["left ventricle", "ANATOMY", 449, 463], ["heart", "ORGAN", 33, 38], ["blood", "ORGANISM_SUBSTANCE", 93, 98], ["clots", "ORGANISM_SUBSTANCE", 99, 104], ["ventricles", "MULTI-TISSUE_STRUCTURE", 112, 122], ["chicken", "ORGANISM", 166, 173], ["fat", "TISSUE", 174, 177], ["Heart", "ORGAN", 235, 240], ["Vascular", "MULTI-TISSUE_STRUCTURE", 245, 253], ["blood clot", "ORGANISM_SUBSTANCE", 347, 357], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 379, 394], ["blood", "ORGANISM_SUBSTANCE", 417, 422], ["clot", "ORGANISM_SUBSTANCE", 423, 427], ["ventricle", "MULTI-TISSUE_STRUCTURE", 454, 463], ["chicken", "SPECIES", 166, 173], ["chicken", "SPECIES", 166, 173], ["postmortem evaluations", "TEST", 3, 25], ["blood clots in the ventricles", "PROBLEM", 93, 122], ["\"chicken fat\"", "PROBLEM", 165, 178], ["E-Appendix", "TEST", 196, 206], ["Necropsy Assessment", "TEST", 212, 231], ["a blood clot", "PROBLEM", 345, 357], ["blood clot", "PROBLEM", 417, 427], ["heart", "ANATOMY", 33, 38], ["blood", "ANATOMY", 93, 98], ["clots", "OBSERVATION", 99, 104], ["ventricles", "ANATOMY", 112, 122], ["Heart", "ANATOMY", 235, 240], ["Vascular", "ANATOMY", 245, 253], ["normal", "OBSERVATION", 270, 276], ["larger", "OBSERVATION_MODIFIER", 304, 310], ["chamber volume", "OBSERVATION", 311, 325], ["thinner", "OBSERVATION_MODIFIER", 330, 337], ["walls", "OBSERVATION_MODIFIER", 338, 343], ["blood", "ANATOMY", 347, 352], ["clot", "OBSERVATION", 353, 357], ["right ventricle", "ANATOMY", 379, 394], ["clot", "OBSERVATION", 423, 427], ["left ventricle", "ANATOMY", 449, 463], ["smaller", "OBSERVATION_MODIFIER", 479, 486], ["chamber volume", "OBSERVATION", 487, 501], ["thicker", "OBSERVATION_MODIFIER", 506, 513], ["walls", "OBSERVATION_MODIFIER", 514, 519]]], ["Animals with prolonged heart disease may lack adequate glycogen reserves in cardiac myocytes.", [["heart", "ANATOMY", 23, 28], ["cardiac myocytes", "ANATOMY", 76, 92], ["heart disease", "DISEASE", 23, 36], ["Animals", "ORGANISM", 0, 7], ["heart", "ORGAN", 23, 28], ["glycogen", "SIMPLE_CHEMICAL", 55, 63], ["cardiac myocytes", "CELL", 76, 92], ["cardiac myocytes", "CELL_TYPE", 76, 92], ["prolonged heart disease", "PROBLEM", 13, 36], ["heart", "ANATOMY", 23, 28], ["disease", "OBSERVATION", 29, 36], ["glycogen reserves", "OBSERVATION", 55, 72], ["cardiac myocytes", "ANATOMY", 76, 92]]], ["As a result, the ventricular chambers may fail to contract during rigor mortis, allowing a blood clot to form in the left ventricle.E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresOccasionally, pale \"chicken fat\" clots that contain reduced numbers of erythrocytes form in animals with severe anemia, systemic inflammatory disease, leukemia, or after prolonged agonal periods.", [["ventricular chambers", "ANATOMY", 17, 37], ["blood clot", "ANATOMY", 91, 101], ["left ventricle", "ANATOMY", 117, 131], ["Heart", "ANATOMY", 171, 176], ["Vascular", "ANATOMY", 181, 189], ["fat\" clots", "ANATOMY", 228, 238], ["erythrocytes", "ANATOMY", 271, 283], ["leukemia", "ANATOMY", 351, 359], ["anemia", "DISEASE", 312, 318], ["systemic inflammatory disease", "DISEASE", 320, 349], ["leukemia", "DISEASE", 351, 359], ["ventricular chambers", "MULTI-TISSUE_STRUCTURE", 17, 37], ["blood", "ORGANISM_SUBSTANCE", 91, 96], ["clot", "ORGANISM_SUBSTANCE", 97, 101], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 117, 131], ["Heart", "ORGAN", 171, 176], ["Vascular", "MULTI-TISSUE_STRUCTURE", 181, 189], ["chicken", "ORGANISM", 220, 227], ["fat", "TISSUE", 228, 231], ["clots", "ORGANISM_SUBSTANCE", 233, 238], ["erythrocytes", "CELL", 271, 283], ["leukemia", "CANCER", 351, 359], ["erythrocytes", "CELL_TYPE", 271, 283], ["chicken", "SPECIES", 220, 227], ["chicken", "SPECIES", 220, 227], ["the ventricular chambers", "TREATMENT", 13, 37], ["rigor mortis", "PROBLEM", 66, 78], ["a blood clot", "PROBLEM", 89, 101], ["E", "TEST", 132, 133], ["Appendix", "TEST", 134, 142], ["Necropsy Assessment", "TEST", 148, 167], ["Heart and Vascular StructuresOccasionally", "PROBLEM", 171, 212], ["pale \"chicken fat\" clots", "PROBLEM", 214, 238], ["reduced numbers of erythrocytes", "PROBLEM", 252, 283], ["severe anemia", "PROBLEM", 305, 318], ["systemic inflammatory disease", "PROBLEM", 320, 349], ["leukemia", "PROBLEM", 351, 359], ["prolonged agonal periods", "PROBLEM", 370, 394], ["ventricular", "ANATOMY", 17, 28], ["blood clot", "OBSERVATION", 91, 101], ["left ventricle", "ANATOMY", 117, 131], ["Appendix", "ANATOMY", 134, 142], ["Heart", "ANATOMY", 171, 176], ["Vascular StructuresOccasionally", "ANATOMY", 181, 212], ["pale", "OBSERVATION_MODIFIER", 214, 218], ["reduced", "OBSERVATION_MODIFIER", 252, 259], ["numbers", "OBSERVATION_MODIFIER", 260, 267], ["erythrocytes", "OBSERVATION", 271, 283], ["severe", "OBSERVATION_MODIFIER", 305, 311], ["anemia", "OBSERVATION", 312, 318], ["systemic", "OBSERVATION_MODIFIER", 320, 328], ["inflammatory disease", "OBSERVATION", 329, 349], ["leukemia", "OBSERVATION", 351, 359]]], ["Horses more often have pale clots because of a rapid erythrocyte sedimentation rate termed rouleaux formation.", [["pale clots", "ANATOMY", 23, 33], ["erythrocyte", "ANATOMY", 53, 64], ["clots", "ORGANISM_SUBSTANCE", 28, 33], ["erythrocyte", "CELL", 53, 64], ["rouleaux", "SIMPLE_CHEMICAL", 91, 99], ["pale clots", "PROBLEM", 23, 33], ["a rapid erythrocyte sedimentation rate termed rouleaux formation", "PROBLEM", 45, 109], ["pale", "OBSERVATION_MODIFIER", 23, 27], ["clots", "OBSERVATION", 28, 33], ["rouleaux formation", "OBSERVATION", 91, 109]]], ["Postmortem lysis of erythrocytes followed by imbibition of hemoglobin produces diffuse red staining of the endocardium and epicardium and simulates the appearance of hemorrhage.E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresUsually 12 to 24 hours after death, erythrocytes lyse, and the resultant imbibition of hemoglobin produces red discoloration of the normally white intima of blood vessels.", [["erythrocytes", "ANATOMY", 20, 32], ["endocardium", "ANATOMY", 107, 118], ["epicardium", "ANATOMY", 123, 133], ["Heart", "ANATOMY", 216, 221], ["Vascular", "ANATOMY", 226, 234], ["erythrocytes", "ANATOMY", 281, 293], ["white intima", "ANATOMY", 386, 398], ["blood vessels", "ANATOMY", 402, 415], ["hemorrhage", "DISEASE", 166, 176], ["death", "DISEASE", 274, 279], ["erythrocytes", "CELL", 20, 32], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 59, 69], ["endocardium", "MULTI-TISSUE_STRUCTURE", 107, 118], ["epicardium", "MULTI-TISSUE_STRUCTURE", 123, 133], ["Heart", "ORGAN", 216, 221], ["Vascular", "MULTI-TISSUE_STRUCTURE", 226, 234], ["erythrocytes", "CELL", 281, 293], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 332, 342], ["intima", "TISSUE", 392, 398], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 402, 415], ["erythrocytes", "CELL_TYPE", 20, 32], ["hemoglobin", "PROTEIN", 59, 69], ["erythrocytes", "CELL_TYPE", 281, 293], ["hemoglobin", "PROTEIN", 332, 342], ["Postmortem lysis of erythrocytes", "TREATMENT", 0, 32], ["imbibition of hemoglobin", "TEST", 45, 69], ["diffuse red staining of the endocardium and epicardium", "PROBLEM", 79, 133], ["hemorrhage", "PROBLEM", 166, 176], ["E", "TEST", 177, 178], ["Appendix", "TEST", 179, 187], ["Necropsy Assessment", "TEST", 193, 212], ["death", "PROBLEM", 274, 279], ["erythrocytes lyse", "TEST", 281, 298], ["the resultant imbibition of hemoglobin", "PROBLEM", 304, 342], ["red discoloration", "PROBLEM", 352, 369], ["erythrocytes", "ANATOMY", 20, 32], ["diffuse", "OBSERVATION_MODIFIER", 79, 86], ["red staining", "OBSERVATION", 87, 99], ["endocardium", "ANATOMY", 107, 118], ["epicardium", "ANATOMY", 123, 133], ["hemorrhage", "OBSERVATION", 166, 176], ["Appendix", "ANATOMY", 179, 187], ["Heart", "ANATOMY", 216, 221], ["Vascular", "ANATOMY", 226, 234], ["erythrocytes lyse", "OBSERVATION", 281, 298], ["resultant", "OBSERVATION_MODIFIER", 308, 317], ["imbibition", "OBSERVATION_MODIFIER", 318, 328], ["discoloration", "OBSERVATION_MODIFIER", 356, 369], ["normally", "OBSERVATION_MODIFIER", 377, 385], ["white", "OBSERVATION_MODIFIER", 386, 391], ["intima", "OBSERVATION", 392, 398], ["blood vessels", "ANATOMY", 402, 415]]], ["Postmortem clotting must be differentiated from thrombosis.", [["Postmortem", "ANATOMY", 0, 10], ["thrombosis", "DISEASE", 48, 58], ["Postmortem clotting", "PROBLEM", 0, 19], ["thrombosis", "PROBLEM", 48, 58], ["clotting", "OBSERVATION", 11, 19], ["thrombosis", "OBSERVATION", 48, 58]]], ["Postmortem clots, found in veins and large elastic arteries as red \"currant jelly\" type or occasionally as pale \"chicken fat\" type, are readily removed by traction or gentle flushing at necropsy, in contrast to thrombi, which are adherent.", [["Postmortem clots", "ANATOMY", 0, 16], ["veins", "ANATOMY", 27, 32], ["elastic arteries", "ANATOMY", 43, 59], ["fat", "ANATOMY", 121, 124], ["thrombi", "ANATOMY", 211, 218], ["thrombi", "DISEASE", 211, 218], ["clots", "ORGANISM_SUBSTANCE", 11, 16], ["veins", "MULTI-TISSUE_STRUCTURE", 27, 32], ["elastic arteries", "TISSUE", 43, 59], ["chicken", "ORGANISM", 113, 120], ["fat", "TISSUE", 121, 124], ["thrombi", "PATHOLOGICAL_FORMATION", 211, 218], ["chicken", "SPECIES", 113, 120], ["Postmortem clots", "PROBLEM", 0, 16], ["large elastic arteries", "PROBLEM", 37, 59], ["gentle flushing at necropsy", "TREATMENT", 167, 194], ["thrombi", "PROBLEM", 211, 218], ["clots", "OBSERVATION", 11, 16], ["veins", "ANATOMY", 27, 32], ["large", "OBSERVATION_MODIFIER", 37, 42], ["elastic", "OBSERVATION", 43, 50], ["arteries", "ANATOMY", 51, 59], ["pale", "OBSERVATION_MODIFIER", 107, 111], ["thrombi", "OBSERVATION", 211, 218], ["adherent", "OBSERVATION_MODIFIER", 230, 238]]], ["Postmortem contraction of muscular arteries because of rigor mortis extrudes blood.", [["Postmortem", "ANATOMY", 0, 10], ["muscular arteries", "ANATOMY", 26, 43], ["blood", "ANATOMY", 77, 82], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 26, 43], ["blood", "ORGANISM_SUBSTANCE", 77, 82], ["Postmortem contraction of muscular arteries", "PROBLEM", 0, 43], ["rigor mortis extrudes blood", "PROBLEM", 55, 82], ["contraction", "OBSERVATION", 11, 22], ["muscular arteries", "ANATOMY", 26, 43], ["rigor mortis", "OBSERVATION", 55, 67]]], ["Microscopically, these muscular arteries are devoid of blood, and their internal elastic lamina is wavy in cross sections of the contacted vessel.E-Appendix 10-1 Necropsy Assessment of Heart and Vascular StructuresOther potentially misleading findings at necropsy of young dogs and horses include diffuse or patchy myocardial pallor that subsequently fails to correlate with any detectable microscopic alterations.", [["muscular arteries", "ANATOMY", 23, 40], ["blood", "ANATOMY", 55, 60], ["elastic lamina", "ANATOMY", 81, 95], ["sections", "ANATOMY", 113, 121], ["vessel", "ANATOMY", 139, 145], ["Heart", "ANATOMY", 185, 190], ["Vascular", "ANATOMY", 195, 203], ["myocardial", "ANATOMY", 315, 325], ["myocardial pallor", "DISEASE", 315, 332], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 23, 40], ["blood", "ORGANISM_SUBSTANCE", 55, 60], ["elastic lamina", "CELLULAR_COMPONENT", 81, 95], ["vessel", "MULTI-TISSUE_STRUCTURE", 139, 145], ["Heart", "ORGAN", 185, 190], ["Vascular", "MULTI-TISSUE_STRUCTURE", 195, 203], ["dogs", "ORGANISM", 273, 277], ["horses", "ORGANISM", 282, 288], ["myocardial", "MULTI-TISSUE_STRUCTURE", 315, 325], ["dogs", "SPECIES", 273, 277], ["blood", "TEST", 55, 60], ["E", "TEST", 146, 147], ["Appendix", "TEST", 148, 156], ["Necropsy Assessment", "TEST", 162, 181], ["diffuse or patchy myocardial pallor", "PROBLEM", 297, 332], ["any detectable microscopic alterations", "PROBLEM", 375, 413], ["muscular arteries", "ANATOMY", 23, 40], ["blood", "OBSERVATION", 55, 60], ["internal", "OBSERVATION_MODIFIER", 72, 80], ["elastic", "OBSERVATION_MODIFIER", 81, 88], ["lamina", "OBSERVATION_MODIFIER", 89, 95], ["wavy", "OBSERVATION_MODIFIER", 99, 103], ["cross sections", "OBSERVATION_MODIFIER", 107, 121], ["vessel", "ANATOMY", 139, 145], ["Appendix", "ANATOMY", 148, 156], ["Heart", "ANATOMY", 185, 190], ["Vascular", "ANATOMY", 195, 203], ["diffuse", "OBSERVATION_MODIFIER", 297, 304], ["patchy", "OBSERVATION_MODIFIER", 308, 314], ["myocardial", "ANATOMY", 315, 325], ["pallor", "OBSERVATION", 326, 332]]], ["Also, the intracardiac injection of euthanasia solution and other substances can cause hemopericardium and myocardial pallor from tissue dissolution and from crystalline deposits at the site of solution deposition (E- Fig. 10-6 ).E-Appendix 10-2 Examination of the Cardiovascular and Lymphatic Systems at Necropsy and Tissue Sampling for Histopathologic EvaluationIt has been stated that there are as many ways to open and evaluate the heart as there are pathologists!", [["intracardiac", "ANATOMY", 10, 22], ["hemopericardium", "ANATOMY", 87, 102], ["myocardial", "ANATOMY", 107, 117], ["tissue", "ANATOMY", 130, 136], ["Cardiovascular", "ANATOMY", 265, 279], ["Tissue", "ANATOMY", 318, 324], ["heart", "ANATOMY", 436, 441], ["hemopericardium", "DISEASE", 87, 102], ["myocardial pallor", "DISEASE", 107, 124], ["hemopericardium", "SIMPLE_CHEMICAL", 87, 102], ["myocardial", "MULTI-TISSUE_STRUCTURE", 107, 117], ["tissue", "TISSUE", 130, 136], ["Cardiovascular", "MULTI-TISSUE_STRUCTURE", 265, 279], ["Lymphatic", "MULTI-TISSUE_STRUCTURE", 284, 293], ["Tissue", "TISSUE", 318, 324], ["heart", "ORGAN", 436, 441], ["euthanasia solution", "TREATMENT", 36, 55], ["hemopericardium", "PROBLEM", 87, 102], ["myocardial pallor from tissue dissolution", "PROBLEM", 107, 148], ["crystalline deposits", "PROBLEM", 158, 178], ["Examination", "TEST", 246, 257], ["Tissue Sampling", "TEST", 318, 333], ["Histopathologic Evaluation", "TEST", 338, 364], ["intracardiac", "ANATOMY", 10, 22], ["hemopericardium", "OBSERVATION", 87, 102], ["myocardial", "ANATOMY", 107, 117], ["pallor", "OBSERVATION", 118, 124], ["tissue dissolution", "OBSERVATION", 130, 148], ["crystalline deposits", "OBSERVATION", 158, 178], ["solution deposition", "OBSERVATION", 194, 213], ["Cardiovascular", "ANATOMY", 265, 279], ["Lymphatic Systems", "ANATOMY", 284, 301], ["heart", "ANATOMY", 436, 441]]], ["Your goal is to use a consistent method, which allows examination of the entire heart and its associated vascular structures.E-Appendix 10-2 Examination of the Cardiovascular and Lymphatic Systems at Necropsy and Tissue Sampling for Histopathologic Evaluation1.", [["heart", "ANATOMY", 80, 85], ["vascular structures", "ANATOMY", 105, 124], ["Cardiovascular", "ANATOMY", 160, 174], ["Tissue", "ANATOMY", 213, 219], ["heart", "ORGAN", 80, 85], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 105, 124], ["Cardiovascular", "MULTI-TISSUE_STRUCTURE", 160, 174], ["Lymphatic", "MULTI-TISSUE_STRUCTURE", 179, 188], ["Tissue", "TISSUE", 213, 219], ["examination", "TEST", 54, 65], ["Appendix", "TEST", 127, 135], ["Tissue Sampling", "TEST", 213, 228], ["Histopathologic Evaluation1", "TEST", 233, 260], ["entire", "ANATOMY_MODIFIER", 73, 79], ["heart", "ANATOMY", 80, 85], ["vascular structures", "ANATOMY", 105, 124], ["Appendix", "ANATOMY", 127, 135], ["Cardiovascular", "ANATOMY", 160, 174], ["Lymphatic Systems", "ANATOMY", 179, 196]]], ["First evaluate the pluck-both in situ and then after removal.", [["the pluck", "TREATMENT", 15, 24], ["removal", "TREATMENT", 53, 60]]], ["If possible, carefully open the pericardial sac and observe the quantity and quality of the pericardial fluid.", [["pericardial sac", "ANATOMY", 32, 47], ["pericardial fluid", "ANATOMY", 92, 109], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 32, 47], ["pericardial fluid", "MULTI-TISSUE_STRUCTURE", 92, 109], ["the pericardial fluid", "PROBLEM", 88, 109], ["pericardial", "ANATOMY", 32, 43], ["sac", "OBSERVATION", 44, 47], ["pericardial", "ANATOMY", 92, 103], ["fluid", "OBSERVATION", 104, 109]]], ["If the fluid appears abnormal, now is the time to take samples for bacterial isolation.", [["fluid", "ANATOMY", 7, 12], ["samples", "ANATOMY", 55, 62], ["fluid", "ORGANISM_SUBSTANCE", 7, 12], ["the fluid", "PROBLEM", 3, 12], ["abnormal", "PROBLEM", 21, 29], ["bacterial isolation", "TREATMENT", 67, 86], ["fluid", "OBSERVATION", 7, 12], ["abnormal", "OBSERVATION_MODIFIER", 21, 29]]], ["Remove the heart from the lungs and place the heart so that the auricles are facing you.", [["heart", "ANATOMY", 11, 16], ["lungs", "ANATOMY", 26, 31], ["heart", "ANATOMY", 46, 51], ["auricles", "ANATOMY", 64, 72], ["heart", "ORGAN", 11, 16], ["lungs", "ORGAN", 26, 31], ["heart", "ORGAN", 46, 51], ["auricles", "CANCER", 64, 72], ["heart", "ANATOMY", 11, 16], ["lungs", "ANATOMY", 26, 31], ["heart", "ANATOMY", 46, 51], ["auricles", "ANATOMY", 64, 72]]], ["This is an excellent time to look at the pulmonary arteries for thrombi.", [["pulmonary arteries", "ANATOMY", 41, 59], ["thrombi", "ANATOMY", 64, 71], ["thrombi", "DISEASE", 64, 71], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 41, 59], ["thrombi", "PROBLEM", 64, 71], ["pulmonary arteries", "ANATOMY", 41, 59], ["thrombi", "OBSERVATION", 64, 71]]], ["Once the heart and lungs are separated, it can be difficult to locate a thrombus.", [["heart", "ANATOMY", 9, 14], ["lungs", "ANATOMY", 19, 24], ["thrombus", "ANATOMY", 72, 80], ["thrombus", "DISEASE", 72, 80], ["heart", "ORGAN", 9, 14], ["lungs", "ORGAN", 19, 24], ["thrombus", "PATHOLOGICAL_FORMATION", 72, 80], ["a thrombus", "PROBLEM", 70, 80], ["heart", "ANATOMY", 9, 14], ["lungs", "ANATOMY", 19, 24], ["thrombus", "OBSERVATION", 72, 80]]], ["Note: The more vascular structures you leave attached to the heart, the easier you will find dissection.", [["vascular structures", "ANATOMY", 15, 34], ["heart", "ANATOMY", 61, 66], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 15, 34], ["heart", "ORGAN", 61, 66], ["dissection", "PROBLEM", 93, 103], ["vascular", "ANATOMY", 15, 23], ["heart", "ANATOMY", 61, 66], ["dissection", "OBSERVATION", 93, 103]]], ["Open the right atrium and remove any clotted blood using a transverse incision.", [["right atrium", "ANATOMY", 9, 21], ["blood", "ANATOMY", 45, 50], ["atrium", "MULTI-TISSUE_STRUCTURE", 15, 21], ["blood", "ORGANISM_SUBSTANCE", 45, 50], ["any clotted blood", "PROBLEM", 33, 50], ["a transverse incision", "TREATMENT", 57, 78], ["right atrium", "ANATOMY", 9, 21], ["clotted", "OBSERVATION", 37, 44], ["transverse", "OBSERVATION_MODIFIER", 59, 69], ["incision", "OBSERVATION", 70, 78]]], ["Assess the tricuspid valve by looking down into the lumen of the right ventricle.", [["tricuspid valve", "ANATOMY", 11, 26], ["lumen", "ANATOMY", 52, 57], ["right ventricle", "ANATOMY", 65, 80], ["tricuspid valve", "PATHOLOGICAL_FORMATION", 11, 26], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 52, 57], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 65, 80], ["tricuspid valve", "ANATOMY", 11, 26], ["lumen", "ANATOMY_MODIFIER", 52, 57], ["right ventricle", "ANATOMY", 65, 80]]], ["Open the right ventricle.", [["right ventricle", "ANATOMY", 9, 24], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 9, 24], ["right ventricle", "ANATOMY", 9, 24]]], ["Start by cutting through the atrioventricular valve nearest the septum.", [["atrioventricular valve", "ANATOMY", 29, 51], ["septum", "ANATOMY", 64, 70], ["atrioventricular valve", "MULTI-TISSUE_STRUCTURE", 29, 51], ["septum", "MULTI-TISSUE_STRUCTURE", 64, 70], ["atrioventricular valve", "ANATOMY", 29, 51], ["septum", "ANATOMY", 64, 70]]], ["Then with either scissors or a knife, using the ventricular septum as your guide, follow the septal wall to the pulmonary artery.", [["ventricular septum", "ANATOMY", 48, 66], ["septal wall", "ANATOMY", 93, 104], ["pulmonary artery", "ANATOMY", 112, 128], ["ventricular septum", "MULTI-TISSUE_STRUCTURE", 48, 66], ["septal wall", "MULTI-TISSUE_STRUCTURE", 93, 104], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 112, 128], ["scissors", "TREATMENT", 17, 25], ["a knife", "TREATMENT", 29, 36], ["ventricular septum", "ANATOMY", 48, 66], ["septal", "ANATOMY_MODIFIER", 93, 99], ["wall", "ANATOMY_MODIFIER", 100, 104], ["pulmonary artery", "ANATOMY", 112, 128]]], ["Evaluate the tricuspid and pulmonic valves, thickness of the right ventricle, and endocardium.", [["tricuspid", "ANATOMY", 13, 22], ["pulmonic valves", "ANATOMY", 27, 42], ["right ventricle", "ANATOMY", 61, 76], ["endocardium", "ANATOMY", 82, 93], ["tricuspid", "MULTI-TISSUE_STRUCTURE", 13, 22], ["pulmonic valves", "MULTI-TISSUE_STRUCTURE", 27, 42], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 61, 76], ["endocardium", "MULTI-TISSUE_STRUCTURE", 82, 93], ["tricuspid", "OBSERVATION", 13, 22], ["pulmonic valves", "ANATOMY", 27, 42], ["thickness", "OBSERVATION_MODIFIER", 44, 53], ["right ventricle", "ANATOMY", 61, 76], ["endocardium", "ANATOMY", 82, 93]]], ["Open the left auricle in the same manner as the right auricle.E-Appendix 10-2 Examination of the Cardiovascular and Lymphatic Systems at Necropsy and Tissue Sampling for Histopathologic EvaluationRemove blood clots and examine the mitral valve.", [["left auricle", "ANATOMY", 9, 21], ["right auricle", "ANATOMY", 48, 61], ["Cardiovascular", "ANATOMY", 97, 111], ["Tissue", "ANATOMY", 150, 156], ["blood clots", "ANATOMY", 203, 214], ["mitral valve", "ANATOMY", 231, 243], ["auricle", "ORGAN", 14, 21], ["auricle", "ORGAN", 54, 61], ["Cardiovascular", "MULTI-TISSUE_STRUCTURE", 97, 111], ["Lymphatic", "MULTI-TISSUE_STRUCTURE", 116, 125], ["Tissue", "TISSUE", 150, 156], ["blood", "ORGANISM_SUBSTANCE", 203, 208], ["clots", "ORGANISM_SUBSTANCE", 209, 214], ["mitral valve", "PATHOLOGICAL_FORMATION", 231, 243], ["Appendix", "TEST", 64, 72], ["Tissue Sampling", "TEST", 150, 165], ["Histopathologic EvaluationRemove blood clots", "TEST", 170, 214], ["the mitral valve", "TREATMENT", 227, 243], ["left", "ANATOMY_MODIFIER", 9, 13], ["auricle", "ANATOMY", 14, 21], ["right", "ANATOMY_MODIFIER", 48, 53], ["auricle", "ANATOMY", 54, 61], ["Appendix", "ANATOMY", 64, 72], ["Cardiovascular", "ANATOMY", 97, 111], ["Lymphatic Systems", "ANATOMY", 116, 133], ["mitral valve", "ANATOMY", 231, 243]]], ["Now is the time to evaluate the functionality of the mitral valve.", [["mitral valve", "ANATOMY", 53, 65], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 53, 65], ["mitral valve", "ANATOMY", 53, 65]]], ["By using water (from the tap), you can evaluate whether or not the mitral valve closes completely.", [["mitral valve", "ANATOMY", 67, 79], ["mitral valve", "PATHOLOGICAL_FORMATION", 67, 79], ["the tap", "TREATMENT", 21, 28], ["mitral valve", "ANATOMY", 67, 79]]], ["This is also the perfect time to look for a ruptured chordae tendineae.", [["chordae tendineae", "ANATOMY", 53, 70], ["chordae tendineae", "DISEASE", 53, 70], ["a ruptured chordae tendineae", "PROBLEM", 42, 70], ["ruptured", "OBSERVATION", 44, 52], ["chordae tendineae", "OBSERVATION", 53, 70]]], ["By starting midway between the left ventricle, insert your knife and cut to the apex.", [["left ventricle", "ANATOMY", 31, 45], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 31, 45], ["your knife", "TREATMENT", 54, 64], ["left ventricle", "ANATOMY", 31, 45], ["apex", "ANATOMY_MODIFIER", 80, 84]]], ["Remove blood, and examine the mitral valve.", [["blood", "ANATOMY", 7, 12], ["mitral valve", "ANATOMY", 30, 42], ["blood", "ORGANISM_SUBSTANCE", 7, 12], ["mitral valve", "PATHOLOGICAL_FORMATION", 30, 42], ["the mitral valve", "TREATMENT", 26, 42], ["mitral valve", "ANATOMY", 30, 42]]], ["Then make a \"window\" and exit out the aortic outflow.", [["aortic", "ANATOMY", 38, 44], ["aortic outflow", "MULTI-TISSUE_STRUCTURE", 38, 52], ["a \"window\"", "TREATMENT", 10, 20], ["aortic", "ANATOMY", 38, 44], ["outflow", "ANATOMY_MODIFIER", 45, 52]]], ["Note: This is the time when people usually stop-that is, before they examine the aortic valves and outflow.", [["aortic", "ANATOMY", 81, 87], ["people", "ORGANISM", 28, 34], ["aortic valves", "MULTI-TISSUE_STRUCTURE", 81, 94], ["people", "SPECIES", 28, 34], ["aortic valves", "ANATOMY", 81, 94], ["outflow", "ANATOMY_MODIFIER", 99, 106]]], ["Examine the aortic valves, papillary muscles, endocardium, and mitral valve.", [["aortic valves", "ANATOMY", 12, 25], ["papillary muscles", "ANATOMY", 27, 44], ["endocardium", "ANATOMY", 46, 57], ["mitral valve", "ANATOMY", 63, 75], ["aortic valves", "TISSUE", 12, 25], ["papillary muscles", "TISSUE", 27, 44], ["endocardium", "MULTI-TISSUE_STRUCTURE", 46, 57], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 63, 75], ["aortic valves", "ANATOMY", 12, 25], ["papillary muscles", "ANATOMY", 27, 44], ["endocardium", "ANATOMY", 46, 57], ["mitral valve", "ANATOMY", 63, 75]]], ["By using string, you can measure the diameter of the aortic valve and pulmonic valves.", [["aortic valve", "ANATOMY", 53, 65], ["pulmonic valves", "ANATOMY", 70, 85], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 53, 65], ["pulmonic valves", "MULTI-TISSUE_STRUCTURE", 70, 85], ["aortic valve", "ANATOMY", 53, 65], ["pulmonic valves", "ANATOMY", 70, 85]]], ["They should be roughly similar in length.", [["roughly", "OBSERVATION_MODIFIER", 15, 22], ["similar", "OBSERVATION_MODIFIER", 23, 30]]], ["Measure the left and right ventricular free wall.", [["left", "ANATOMY", 12, 16], ["right ventricular free wall", "ANATOMY", 21, 48], ["ventricular free wall", "MULTI-TISSUE_STRUCTURE", 27, 48], ["left", "ANATOMY_MODIFIER", 12, 16], ["right ventricular", "ANATOMY", 21, 38], ["free", "ANATOMY_MODIFIER", 39, 43], ["wall", "ANATOMY_MODIFIER", 44, 48]]], ["Be sure to consistently measure at the same place and not include the thickness of the papillary muscles.", [["papillary muscles", "ANATOMY", 87, 104], ["papillary muscles", "TISSUE", 87, 104], ["papillary muscles", "ANATOMY", 87, 104]]], ["Remember that the normal measurement should be roughly 3 : 1 for left to right measurement.", [["normal", "OBSERVATION", 18, 24], ["right", "ANATOMY_MODIFIER", 73, 78]]], ["Always remember to examine the following: pericardial sac and contents, epicardial surface, and myocardium-left, right, and papillary muscles, valves (all four), endocardium, pulmonary and aortic outflow, and intimal surfaces.", [["pericardial sac", "ANATOMY", 42, 57], ["epicardial surface", "ANATOMY", 72, 90], ["myocardium", "ANATOMY", 96, 106], ["left", "ANATOMY", 107, 111], ["right", "ANATOMY", 113, 118], ["papillary muscles", "ANATOMY", 124, 141], ["valves", "ANATOMY", 143, 149], ["endocardium", "ANATOMY", 162, 173], ["pulmonary", "ANATOMY", 175, 184], ["aortic", "ANATOMY", 189, 195], ["intimal surfaces", "ANATOMY", 209, 225], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 42, 57], ["epicardial surface", "TISSUE", 72, 90], ["myocardium", "MULTI-TISSUE_STRUCTURE", 96, 106], ["papillary muscles", "TISSUE", 124, 141], ["valves", "MULTI-TISSUE_STRUCTURE", 143, 149], ["endocardium", "MULTI-TISSUE_STRUCTURE", 162, 173], ["pulmonary", "MULTI-TISSUE_STRUCTURE", 175, 184], ["aortic outflow", "MULTI-TISSUE_STRUCTURE", 189, 203], ["intimal surfaces", "TISSUE", 209, 225], ["pericardial sac and contents, epicardial surface, and myocardium-left, right, and papillary muscles, valves (all four), endocardium, pulmonary and aortic outflow, and intimal surfaces", "PROBLEM", 42, 225], ["pericardial", "ANATOMY", 42, 53], ["sac", "OBSERVATION", 54, 57], ["contents", "OBSERVATION", 62, 70], ["epicardial", "ANATOMY", 72, 82], ["surface", "ANATOMY_MODIFIER", 83, 90], ["myocardium", "ANATOMY", 96, 106], ["left", "ANATOMY_MODIFIER", 107, 111], ["right", "ANATOMY_MODIFIER", 113, 118], ["papillary muscles", "ANATOMY", 124, 141], ["valves", "OBSERVATION", 143, 149], ["endocardium", "ANATOMY", 162, 173], ["pulmonary", "ANATOMY", 175, 184], ["aortic", "ANATOMY", 189, 195], ["outflow", "ANATOMY_MODIFIER", 196, 203], ["intimal", "OBSERVATION_MODIFIER", 209, 216], ["surfaces", "OBSERVATION_MODIFIER", 217, 225]]], ["If you do this, you will be a successful cardiac pathologist.", [["cardiac", "ANATOMY", 41, 48], ["cardiac pathologist", "CANCER", 41, 60]]], ["Now all you have to do is know what abnormalities are significant.E-Appendix 10-2 Examination of the Cardiovascular and Lymphatic Systems at Necropsy and Tissue Sampling for Histopathologic EvaluationAfter fixation for at least 24 hours, tissue samples should be removed from standard heart sites for histopathologic evaluation (see E- Fig. 10-7) .", [["Cardiovascular", "ANATOMY", 101, 115], ["Tissue", "ANATOMY", 154, 160], ["tissue samples", "ANATOMY", 238, 252], ["heart sites", "ANATOMY", 285, 296], ["Cardiovascular", "MULTI-TISSUE_STRUCTURE", 101, 115], ["Lymphatic", "MULTI-TISSUE_STRUCTURE", 120, 129], ["Tissue", "TISSUE", 154, 160], ["tissue samples", "CANCER", 238, 252], ["heart sites", "MULTI-TISSUE_STRUCTURE", 285, 296], ["what abnormalities", "PROBLEM", 31, 49], ["Appendix", "TEST", 68, 76], ["Tissue Sampling", "TEST", 154, 169], ["Histopathologic EvaluationAfter fixation", "TREATMENT", 174, 214], ["tissue samples", "TEST", 238, 252], ["histopathologic evaluation", "TEST", 301, 327], ["significant", "OBSERVATION_MODIFIER", 54, 65], ["Appendix", "ANATOMY", 68, 76], ["Cardiovascular", "ANATOMY", 101, 115], ["Lymphatic Systems", "ANATOMY", 120, 137], ["heart", "ANATOMY", 285, 290]]], ["If gross lesions are apparent, representative samples should be taken of those lesions.", [["gross lesions", "ANATOMY", 3, 16], ["samples", "ANATOMY", 46, 53], ["lesions", "ANATOMY", 79, 86], ["gross lesions", "CANCER", 3, 16], ["samples", "CANCER", 46, 53], ["lesions", "PATHOLOGICAL_FORMATION", 79, 86], ["gross lesions", "PROBLEM", 3, 16], ["those lesions", "PROBLEM", 73, 86], ["gross", "OBSERVATION_MODIFIER", 3, 8], ["lesions", "OBSERVATION", 9, 16], ["lesions", "OBSERVATION", 79, 86]]], ["In small-sized hearts, the fixed specimen is bisected perpendicular to the long axis of the septum to provide a sample for histopathologic study that includes sections of all four chambers and interventricular and interatrial septa.E-Appendix 10-2 Examination of the Cardiovascular and Lymphatic Systems at Necropsy and Tissue Sampling for Histopathologic EvaluationSpecial sampling procedures are available for comprehensive evaluation of the cardiac conduction tissue.565.e3CHAPTER 10 Cardiovascular System and Lymphatic Vessels Left ventricle D repolarization, and shortens the refractory period.", [["hearts", "ANATOMY", 15, 21], ["specimen", "ANATOMY", 33, 41], ["septum", "ANATOMY", 92, 98], ["sample", "ANATOMY", 112, 118], ["sections", "ANATOMY", 159, 167], ["interventricular", "ANATOMY", 193, 209], ["interatrial septa", "ANATOMY", 214, 231], ["Cardiovascular", "ANATOMY", 267, 281], ["Tissue", "ANATOMY", 320, 326], ["cardiac conduction tissue", "ANATOMY", 444, 469], ["Cardiovascular", "ANATOMY", 487, 501], ["Left ventricle", "ANATOMY", 531, 545], ["hearts", "ORGAN", 15, 21], ["septum", "MULTI-TISSUE_STRUCTURE", 92, 98], ["interventricular", "MULTI-TISSUE_STRUCTURE", 193, 209], ["interatrial septa", "TISSUE", 214, 231], ["Cardiovascular", "MULTI-TISSUE_STRUCTURE", 267, 281], ["Lymphatic", "MULTI-TISSUE_STRUCTURE", 286, 295], ["cardiac conduction tissue", "TISSUE", 444, 469], ["histopathologic study", "TEST", 123, 144], ["interventricular and interatrial septa", "PROBLEM", 193, 231], ["Appendix", "TEST", 234, 242], ["Tissue Sampling", "TEST", 320, 335], ["Histopathologic Evaluation", "TEST", 340, 366], ["Special sampling procedures", "TEST", 366, 393], ["comprehensive evaluation", "TEST", 412, 436], ["Left ventricle D repolarization", "PROBLEM", 531, 562], ["small", "OBSERVATION_MODIFIER", 3, 8], ["sized", "OBSERVATION_MODIFIER", 9, 14], ["hearts", "ANATOMY", 15, 21], ["fixed", "OBSERVATION_MODIFIER", 27, 32], ["specimen", "OBSERVATION", 33, 41], ["bisected", "OBSERVATION_MODIFIER", 45, 53], ["perpendicular", "OBSERVATION_MODIFIER", 54, 67], ["long axis", "ANATOMY_MODIFIER", 75, 84], ["septum", "ANATOMY", 92, 98], ["interventricular", "ANATOMY_MODIFIER", 193, 209], ["interatrial septa", "ANATOMY", 214, 231], ["Appendix", "ANATOMY", 234, 242], ["Cardiovascular", "ANATOMY", 267, 281], ["Lymphatic Systems", "ANATOMY", 286, 303], ["cardiac", "ANATOMY", 444, 451], ["conduction tissue", "OBSERVATION", 452, 469], ["Cardiovascular System", "ANATOMY", 487, 508], ["Lymphatic Vessels", "ANATOMY", 513, 530], ["Left ventricle", "ANATOMY", 531, 545], ["D repolarization", "OBSERVATION", 546, 562], ["shortens", "OBSERVATION_MODIFIER", 568, 576], ["refractory", "OBSERVATION_MODIFIER", 581, 591]]], ["Therefore adrenergic agonists are said to be positive chronotropes, inotropes, dromotropes, and lusitropes, whereas parasympathetic agonists have the opposite effects.", [["lusitropes", "SIMPLE_CHEMICAL", 96, 106], ["adrenergic agonists", "TREATMENT", 10, 29], ["positive chronotropes", "PROBLEM", 45, 66], ["inotropes", "TREATMENT", 68, 77], ["dromotropes", "TREATMENT", 79, 90], ["lusitropes", "TREATMENT", 96, 106], ["parasympathetic agonists", "TREATMENT", 116, 140]]], ["Heart rate is primarily regulated by opposing effects of adrenergic and cholinergic nerve terminals on the SAN and at the same time by modulation of conduction velocity of the AVN and AV bundle.", [["Heart", "ANATOMY", 0, 5], ["nerve terminals", "ANATOMY", 84, 99], ["SAN", "ANATOMY", 107, 110], ["AVN", "ANATOMY", 176, 179], ["AV bundle", "ANATOMY", 184, 193], ["Heart", "ORGAN", 0, 5], ["adrenergic", "CELL", 57, 67], ["nerve terminals", "MULTI-TISSUE_STRUCTURE", 84, 99], ["SAN", "MULTI-TISSUE_STRUCTURE", 107, 110], ["AVN", "GENE_OR_GENE_PRODUCT", 176, 179], ["Heart rate", "TEST", 0, 10], ["adrenergic and cholinergic nerve terminals", "PROBLEM", 57, 99], ["the AVN", "PROBLEM", 172, 179], ["adrenergic", "OBSERVATION", 57, 67], ["cholinergic nerve", "OBSERVATION", 72, 89], ["conduction velocity", "OBSERVATION", 149, 168], ["AVN", "OBSERVATION", 176, 179], ["AV", "ANATOMY", 184, 186], ["bundle", "ANATOMY_MODIFIER", 187, 193]]], ["Physiologically, the force of contraction represents the sum of interactions between myocardial contractility, which is positively modulated by adrenergic nerve terminals that act on \u03b2 1 receptors on ventricular myocardial myofibers (positive inotropic effect), and by the volume of blood that is present in the ventricles just before contraction (preload), as well as by the resistance in front of which contraction actually takes place (afterload).Endocardium and Heart ValvesThe endocardium lines the myocardium and contains Purkinje nerve fibers, which transmit a rhythmic action potential throughout the myocardium leading to contraction.", [["myocardial", "ANATOMY", 85, 95], ["nerve terminals", "ANATOMY", 155, 170], ["ventricular myocardial myofibers", "ANATOMY", 200, 232], ["blood", "ANATOMY", 283, 288], ["ventricles", "ANATOMY", 312, 322], ["Endocardium", "ANATOMY", 450, 461], ["Heart Valves", "ANATOMY", 466, 478], ["endocardium lines", "ANATOMY", 482, 499], ["myocardium", "ANATOMY", 504, 514], ["Purkinje nerve fibers", "ANATOMY", 528, 549], ["myocardium", "ANATOMY", 609, 619], ["myocardial", "MULTI-TISSUE_STRUCTURE", 85, 95], ["\u03b2 1 receptors", "GENE_OR_GENE_PRODUCT", 183, 196], ["ventricular myocardial myofibers", "TISSUE", 200, 232], ["blood", "ORGANISM_SUBSTANCE", 283, 288], ["ventricles", "MULTI-TISSUE_STRUCTURE", 312, 322], ["endocardium lines", "CELL", 482, 499], ["myocardium", "ORGAN", 504, 514], ["Purkinje nerve fibers", "TISSUE", 528, 549], ["myocardium", "ORGAN", 609, 619], ["\u03b2 1 receptors", "PROTEIN", 183, 196], ["ventricular myocardial myofibers", "CELL_TYPE", 200, 232], ["Purkinje nerve fibers", "CELL_TYPE", 528, 549], ["ventricular myocardial myofibers", "PROBLEM", 200, 232], ["preload", "TEST", 348, 355], ["Endocardium and Heart Valves", "PROBLEM", 450, 478], ["Purkinje nerve fibers", "PROBLEM", 528, 549], ["contraction", "PROBLEM", 631, 642], ["contraction", "OBSERVATION", 30, 41], ["myocardial contractility", "ANATOMY", 85, 109], ["adrenergic nerve", "OBSERVATION", 144, 160], ["ventricular", "ANATOMY", 200, 211], ["myocardial myofibers", "ANATOMY", 212, 232], ["inotropic effect", "OBSERVATION", 243, 259], ["blood", "ANATOMY", 283, 288], ["ventricles", "ANATOMY", 312, 322], ["Heart Valves", "ANATOMY", 466, 478], ["endocardium", "ANATOMY", 482, 493], ["lines", "OBSERVATION", 494, 499], ["myocardium", "ANATOMY", 504, 514], ["Purkinje nerve fibers", "OBSERVATION", 528, 549], ["rhythmic", "OBSERVATION_MODIFIER", 568, 576], ["myocardium", "ANATOMY", 609, 619]]], ["The endocardium is lined by endothelial cells, which modulate many aspects of normal hemostasis.", [["endocardium", "ANATOMY", 4, 15], ["endothelial cells", "ANATOMY", 28, 45], ["endocardium", "MULTI-TISSUE_STRUCTURE", 4, 15], ["endothelial cells", "CELL", 28, 45], ["endothelial cells", "CELL_TYPE", 28, 45], ["endocardium", "ANATOMY", 4, 15], ["lined", "OBSERVATION", 19, 24], ["endothelial cells", "OBSERVATION", 28, 45], ["normal hemostasis", "OBSERVATION", 78, 95]]], ["In normal states, the endothelial cells are antithrombotic, preventing circulating cells from attaching and thus allowing normal flow of blood through the heart and blood vessels.", [["endothelial cells", "ANATOMY", 22, 39], ["cells", "ANATOMY", 83, 88], ["blood", "ANATOMY", 137, 142], ["heart", "ANATOMY", 155, 160], ["blood vessels", "ANATOMY", 165, 178], ["endothelial cells", "CELL", 22, 39], ["cells", "CELL", 83, 88], ["blood", "ORGANISM_SUBSTANCE", 137, 142], ["heart", "ORGAN", 155, 160], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 165, 178], ["endothelial cells", "CELL_TYPE", 22, 39], ["circulating cells", "CELL_TYPE", 71, 88], ["the endothelial cells", "PROBLEM", 18, 39], ["antithrombotic", "TREATMENT", 44, 58], ["circulating cells", "PROBLEM", 71, 88], ["normal", "OBSERVATION", 3, 9], ["endothelial cells", "OBSERVATION", 22, 39], ["antithrombotic", "OBSERVATION_MODIFIER", 44, 58], ["circulating cells", "OBSERVATION", 71, 88], ["flow", "OBSERVATION_MODIFIER", 129, 133], ["heart", "ANATOMY", 155, 160], ["blood vessels", "ANATOMY", 165, 178]]], ["The endocardium is continuous with the endothelium of blood and lymphatic vessels.", [["endocardium", "ANATOMY", 4, 15], ["endothelium", "ANATOMY", 39, 50], ["blood", "ANATOMY", 54, 59], ["lymphatic vessels", "ANATOMY", 64, 81], ["endocardium", "MULTI-TISSUE_STRUCTURE", 4, 15], ["endothelium", "TISSUE", 39, 50], ["blood", "ORGANISM_SUBSTANCE", 54, 59], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 64, 81], ["endocardium", "ANATOMY", 4, 15], ["continuous", "OBSERVATION", 19, 29], ["endothelium", "OBSERVATION", 39, 50], ["blood", "ANATOMY", 54, 59], ["lymphatic vessels", "ANATOMY", 64, 81]]], ["Normal flow of blood through the heart depends on functional valves (see Chapter 2).", [["blood", "ANATOMY", 15, 20], ["heart", "ANATOMY", 33, 38], ["blood", "ORGANISM_SUBSTANCE", 15, 20], ["heart", "ORGAN", 33, 38], ["functional valves", "TREATMENT", 50, 67], ["flow", "OBSERVATION", 7, 11], ["heart", "ANATOMY", 33, 38], ["functional valves", "OBSERVATION", 50, 67]]], ["Properly functioning valves serve as one-way valves, allowing blood either to flow from one chamber to another (through AVVs) or to exit from the heart and enter either the pulmonary circulation (pulmonic valve) or the systemic circulation (aortic valve).Pericardium and EpicardiumThe pericardium contains a small amount of serous fluid, which allows frictionless cardiac movement of the mesothelial surfaces of the pericardium and epicardium on each other.", [["blood", "ANATOMY", 62, 67], ["heart", "ANATOMY", 146, 151], ["pulmonary", "ANATOMY", 173, 182], ["pulmonic valve", "ANATOMY", 196, 210], ["aortic valve", "ANATOMY", 241, 253], ["Pericardium", "ANATOMY", 255, 266], ["pericardium", "ANATOMY", 285, 296], ["serous fluid", "ANATOMY", 324, 336], ["cardiac", "ANATOMY", 364, 371], ["mesothelial surfaces", "ANATOMY", 388, 408], ["pericardium", "ANATOMY", 416, 427], ["epicardium", "ANATOMY", 432, 442], ["valves", "MULTI-TISSUE_STRUCTURE", 21, 27], ["valves", "PATHOLOGICAL_FORMATION", 45, 51], ["blood", "ORGANISM_SUBSTANCE", 62, 67], ["heart", "ORGAN", 146, 151], ["pulmonary", "ORGAN", 173, 182], ["pulmonic valve", "MULTI-TISSUE_STRUCTURE", 196, 210], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 241, 253], ["Epicardium", "CANCER", 271, 281], ["pericardium", "ORGAN", 285, 296], ["serous fluid", "ORGANISM_SUBSTANCE", 324, 336], ["mesothelial surfaces", "TISSUE", 388, 408], ["pericardium", "TISSUE", 416, 427], ["epicardium", "MULTI-TISSUE_STRUCTURE", 432, 442], ["Properly functioning valves", "TREATMENT", 0, 27], ["a small amount of serous fluid", "PROBLEM", 306, 336], ["functioning valves", "OBSERVATION", 9, 27], ["valves", "OBSERVATION", 45, 51], ["heart", "ANATOMY", 146, 151], ["pulmonary circulation", "ANATOMY", 173, 194], ["pulmonic valve", "ANATOMY", 196, 210], ["systemic circulation", "ANATOMY", 219, 239], ["aortic valve", "ANATOMY", 241, 253], ["Epicardium", "ANATOMY", 271, 281], ["pericardium", "ANATOMY", 285, 296], ["small", "OBSERVATION_MODIFIER", 308, 313], ["amount", "OBSERVATION_MODIFIER", 314, 320], ["serous fluid", "OBSERVATION", 324, 336], ["movement", "OBSERVATION_MODIFIER", 372, 380], ["mesothelial", "ANATOMY_MODIFIER", 388, 399], ["surfaces", "ANATOMY_MODIFIER", 400, 408], ["pericardium", "ANATOMY", 416, 427], ["epicardium", "ANATOMY", 432, 442]]], ["The pericardial sac can adapt to changes in the heart size provided adequate time.", [["pericardial sac", "ANATOMY", 4, 19], ["heart", "ANATOMY", 48, 53], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 4, 19], ["heart", "ORGAN", 48, 53], ["pericardial", "ANATOMY", 4, 15], ["sac", "OBSERVATION", 16, 19], ["heart", "ANATOMY", 48, 53], ["size", "OBSERVATION_MODIFIER", 54, 58]]], ["The pericardium functions to provide a protective environment for cardiac function.", [["pericardium", "ANATOMY", 4, 15], ["cardiac", "ANATOMY", 66, 73], ["pericardium", "ORGAN", 4, 15], ["cardiac", "ORGAN", 66, 73], ["a protective environment", "TREATMENT", 37, 61], ["cardiac function", "TEST", 66, 82], ["pericardium", "ANATOMY", 4, 15]]], ["Rapid, abnormal filling with blood (hemopericardium), fluid (hydropericardium), or exudate (suppurative pericarditis) can result in compression of the heart (cardiac tamponade), particularly the large veins, right atrium, and right ventricle.", [["blood", "ANATOMY", 29, 34], ["hemopericardium", "ANATOMY", 36, 51], ["fluid", "ANATOMY", 54, 59], ["hydropericardium", "ANATOMY", 61, 77], ["exudate", "ANATOMY", 83, 90], ["heart", "ANATOMY", 151, 156], ["cardiac", "ANATOMY", 158, 165], ["veins", "ANATOMY", 201, 206], ["right atrium", "ANATOMY", 208, 220], ["right ventricle", "ANATOMY", 226, 241], ["suppurative pericarditis", "DISEASE", 92, 116], ["compression of the heart", "DISEASE", 132, 156], ["cardiac tamponade", "DISEASE", 158, 175], ["blood", "ORGANISM_SUBSTANCE", 29, 34], ["hemopericardium", "CANCER", 36, 51], ["fluid", "ORGANISM_SUBSTANCE", 54, 59], ["heart", "ORGAN", 151, 156], ["cardiac", "ORGAN", 158, 165], ["veins", "MULTI-TISSUE_STRUCTURE", 201, 206], ["right atrium", "MULTI-TISSUE_STRUCTURE", 208, 220], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 226, 241], ["Rapid, abnormal filling with blood (hemopericardium", "PROBLEM", 0, 51], ["fluid (hydropericardium)", "PROBLEM", 54, 78], ["exudate", "PROBLEM", 83, 90], ["suppurative pericarditis", "PROBLEM", 92, 116], ["compression of the heart (cardiac tamponade", "PROBLEM", 132, 175], ["abnormal", "OBSERVATION_MODIFIER", 7, 15], ["filling", "OBSERVATION_MODIFIER", 16, 23], ["hemopericardium", "OBSERVATION_MODIFIER", 36, 51], ["fluid", "OBSERVATION_MODIFIER", 54, 59], ["exudate", "OBSERVATION_MODIFIER", 83, 90], ["suppurative", "OBSERVATION_MODIFIER", 92, 103], ["pericarditis", "OBSERVATION", 104, 116], ["compression", "OBSERVATION", 132, 143], ["heart", "ANATOMY", 151, 156], ["cardiac", "ANATOMY", 158, 165], ["tamponade", "OBSERVATION", 166, 175], ["large veins", "ANATOMY", 195, 206], ["right atrium", "ANATOMY", 208, 220], ["right ventricle", "ANATOMY", 226, 241]]], ["Animals can survive without a pericardial sac.Blood and Lymphatic Vascular SystemsBlood and lymphatic vessels have several important functions.", [["pericardial sac", "ANATOMY", 30, 45], ["Blood", "ANATOMY", 46, 51], ["Lymphatic Vascular", "ANATOMY", 56, 74], ["Blood", "ANATOMY", 82, 87], ["lymphatic vessels", "ANATOMY", 92, 109], ["Animals", "ORGANISM", 0, 7], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 30, 45], ["Blood", "ORGANISM_SUBSTANCE", 46, 51], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 56, 74], ["Blood", "ORGANISM_SUBSTANCE", 82, 87], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 92, 109], ["Blood", "TEST", 46, 51], ["pericardial", "ANATOMY", 30, 41], ["sac", "OBSERVATION", 42, 45], ["Lymphatic", "ANATOMY_MODIFIER", 56, 65], ["Vascular", "ANATOMY", 66, 74], ["lymphatic vessels", "ANATOMY", 92, 109]]], ["Blood vessels regulate the differential distribution of blood flow to tissues.", [["Blood vessels", "ANATOMY", 0, 13], ["blood", "ANATOMY", 56, 61], ["tissues", "ANATOMY", 70, 77], ["Blood vessels", "MULTI-TISSUE_STRUCTURE", 0, 13], ["blood", "ORGANISM_SUBSTANCE", 56, 61], ["tissues", "TISSUE", 70, 77], ["Blood vessels", "TEST", 0, 13], ["blood flow to tissues", "PROBLEM", 56, 77], ["vessels", "ANATOMY", 6, 13], ["differential", "OBSERVATION_MODIFIER", 27, 39], ["distribution", "OBSERVATION_MODIFIER", 40, 52], ["blood flow", "OBSERVATION", 56, 66]]], ["Blood vessels actively synthesize and secrete vasoactive substances that regulate vascular tone and antithrombotic substances, which maintain the fluidity of the blood.", [["Blood vessels", "ANATOMY", 0, 13], ["vascular", "ANATOMY", 82, 90], ["blood", "ANATOMY", 162, 167], ["Blood vessels", "MULTI-TISSUE_STRUCTURE", 0, 13], ["vascular", "MULTI-TISSUE_STRUCTURE", 82, 90], ["blood", "ORGANISM_SUBSTANCE", 162, 167], ["Blood vessels actively synthesize", "PROBLEM", 0, 33], ["secrete vasoactive substances", "TREATMENT", 38, 67], ["antithrombotic substances", "TREATMENT", 100, 125], ["vessels", "ANATOMY", 6, 13], ["vasoactive substances", "OBSERVATION", 46, 67], ["vascular", "ANATOMY", 82, 90], ["antithrombotic substances", "OBSERVATION", 100, 125], ["blood", "ANATOMY", 162, 167]]], ["Blood and lymphatic vessels play an important role in transporting and controlling inflammation and thrombosis.", [["Blood", "ANATOMY", 0, 5], ["lymphatic vessels", "ANATOMY", 10, 27], ["inflammation", "DISEASE", 83, 95], ["thrombosis", "DISEASE", 100, 110], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 10, 27], ["Blood", "TEST", 0, 5], ["inflammation", "PROBLEM", 83, 95], ["thrombosis", "PROBLEM", 100, 110], ["lymphatic vessels", "ANATOMY", 10, 27], ["inflammation", "OBSERVATION", 83, 95], ["thrombosis", "OBSERVATION", 100, 110]]], ["Blood and lymphatic vessels also constitute an important pathway for disease dissemination through transport of bacteria and tumor cells to distant sites.Dysfunction/Responses to InjuryCommon pathophysiologic responses of the cardiovascular system to injury are listed in Box 10-1 and shown in E- Fig. 10-8 .", [["Blood", "ANATOMY", 0, 5], ["lymphatic vessels", "ANATOMY", 10, 27], ["tumor cells", "ANATOMY", 125, 136], ["sites", "ANATOMY", 148, 153], ["cardiovascular system", "ANATOMY", 226, 247], ["tumor", "DISEASE", 125, 130], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 10, 27], ["tumor cells", "CELL", 125, 136], ["cardiovascular", "ANATOMICAL_SYSTEM", 226, 240], ["system", "ANATOMICAL_SYSTEM", 241, 247], ["tumor cells", "CELL_TYPE", 125, 136], ["Blood", "TEST", 0, 5], ["disease dissemination", "PROBLEM", 69, 90], ["bacteria", "PROBLEM", 112, 120], ["tumor cells", "PROBLEM", 125, 136], ["Dysfunction", "PROBLEM", 154, 165], ["InjuryCommon pathophysiologic responses", "PROBLEM", 179, 218], ["injury", "PROBLEM", 251, 257], ["lymphatic vessels", "ANATOMY", 10, 27], ["tumor cells", "OBSERVATION", 125, 136], ["cardiovascular system", "ANATOMY", 226, 247], ["injury", "OBSERVATION", 251, 257]]], ["The specific diseases that result from these responses are discussed in greater detail in the sections covering diseases that occur in all domestic animal species or that are unique to one species. three times faster than that of the atrial myofibers.", [["sections", "ANATOMY", 94, 102], ["atrial myofibers", "ANATOMY", 234, 250], ["atrial myofibers", "TISSUE", 234, 250], ["atrial myofibers", "CELL_TYPE", 234, 250], ["The specific diseases", "PROBLEM", 0, 21], ["atrial myofibers", "ANATOMY", 234, 250]]], ["By conveying the signal through these fibers, both atria can contract simultaneously and in a coordinated manner that allows the process of pushing of blood into the ventricles.", [["fibers", "ANATOMY", 38, 44], ["atria", "ANATOMY", 51, 56], ["blood", "ANATOMY", 151, 156], ["ventricles", "ANATOMY", 166, 176], ["fibers", "CELLULAR_COMPONENT", 38, 44], ["atria", "MULTI-TISSUE_STRUCTURE", 51, 56], ["blood", "ORGANISM_SUBSTANCE", 151, 156], ["ventricles", "MULTI-TISSUE_STRUCTURE", 166, 176], ["both atria", "ANATOMY", 46, 56], ["ventricles", "ANATOMY", 166, 176]]], ["Correlating with their special fast conducting function, these cells have a Purkinje-like morphology.", [["cells", "ANATOMY", 63, 68], ["Purkinje", "ANATOMY", 76, 84], ["cells", "CELL", 63, 68]]], ["The conduction velocity is then slowed down when propagating through the AVN.", [["AVN", "DISEASE", 73, 76], ["The conduction velocity", "TEST", 0, 23], ["the AVN", "PROBLEM", 69, 76], ["conduction velocity", "OBSERVATION", 4, 23], ["AVN", "OBSERVATION", 73, 76]]], ["The time it takes to conduct the signal through the AVN and penetrating AV bundles is approximately four times longer than the time it takes for it to be conducted from the SAN to the AVN.", [["AV bundles", "ANATOMY", 72, 82], ["AVN", "DISEASE", 52, 55], ["AVN", "DISEASE", 184, 187], ["AV bundles", "MULTI-TISSUE_STRUCTURE", 72, 82], ["SAN", "MULTI-TISSUE_STRUCTURE", 173, 176], ["the AVN", "PROBLEM", 48, 55], ["penetrating AV bundles", "TREATMENT", 60, 82], ["AVN", "OBSERVATION", 52, 55], ["AV", "ANATOMY", 72, 74], ["bundles", "ANATOMY_MODIFIER", 75, 82], ["AVN", "OBSERVATION", 184, 187]]], ["This delay in conduction serves to empty the atria from blood before the ventricles start to contract.", [["atria", "ANATOMY", 45, 50], ["blood", "ANATOMY", 56, 61], ["ventricles", "ANATOMY", 73, 83], ["atria", "MULTI-TISSUE_STRUCTURE", 45, 50], ["blood", "ORGANISM_SUBSTANCE", 56, 61], ["ventricles", "MULTI-TISSUE_STRUCTURE", 73, 83], ["This delay", "PROBLEM", 0, 10], ["atria", "ANATOMY", 45, 50], ["ventricles", "ANATOMY", 73, 83]]], ["It also contributes to the unidirectional blood flow between the atria and the ventricles, above and beyond the similar role played by the atrioventricular valves (AVVs).Dysfunction/Responses to InjuryFinally, the signal is delivered through the AV bundle, bundle branches, and Purkinje fibers in a velocity approximately 150 times faster than that of the AVN.", [["blood", "ANATOMY", 42, 47], ["atria", "ANATOMY", 65, 70], ["ventricles", "ANATOMY", 79, 89], ["atrioventricular valves", "ANATOMY", 139, 162], ["AVVs", "ANATOMY", 164, 168], ["AV bundle", "ANATOMY", 246, 255], ["bundle branches", "ANATOMY", 257, 272], ["Purkinje fibers", "ANATOMY", 278, 293], ["AVN", "DISEASE", 356, 359], ["blood", "ORGANISM_SUBSTANCE", 42, 47], ["atria", "MULTI-TISSUE_STRUCTURE", 65, 70], ["ventricles", "MULTI-TISSUE_STRUCTURE", 79, 89], ["atrioventricular valves", "MULTI-TISSUE_STRUCTURE", 139, 162], ["Purkinje fibers", "CELLULAR_COMPONENT", 278, 293], ["Purkinje fibers", "CELL_TYPE", 278, 293], ["the unidirectional blood flow between the atria and the ventricles", "PROBLEM", 23, 89], ["Dysfunction", "PROBLEM", 170, 181], ["a velocity", "TEST", 297, 307], ["the AVN", "PROBLEM", 352, 359], ["unidirectional blood flow", "OBSERVATION", 27, 52], ["atria", "ANATOMY", 65, 70], ["ventricles", "ANATOMY", 79, 89], ["atrioventricular valves", "ANATOMY", 139, 162], ["AV bundle", "ANATOMY", 246, 255], ["bundle branches", "ANATOMY", 257, 272], ["Purkinje fibers", "OBSERVATION", 278, 293], ["velocity", "OBSERVATION_MODIFIER", 299, 307], ["AVN", "OBSERVATION", 356, 359]]], ["The bundle branches run along the subendocardium of the interventricular septum and free ventricular walls and give rise to Purkinje fibers that supply the myocardium in a subendocardial-to-epicardial direction.", [["bundle branches", "ANATOMY", 4, 19], ["subendocardium", "ANATOMY", 34, 48], ["interventricular septum", "ANATOMY", 56, 79], ["ventricular walls", "ANATOMY", 89, 106], ["Purkinje fibers", "ANATOMY", 124, 139], ["myocardium", "ANATOMY", 156, 166], ["subendocardial", "ANATOMY", 172, 186], ["epicardial", "ANATOMY", 190, 200], ["subendocardium", "TISSUE", 34, 48], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 56, 79], ["ventricular walls", "PATHOLOGICAL_FORMATION", 89, 106], ["Purkinje fibers", "CELLULAR_COMPONENT", 124, 139], ["myocardium", "ORGAN", 156, 166], ["epicardial", "MULTI-TISSUE_STRUCTURE", 190, 200], ["bundle", "ANATOMY_MODIFIER", 4, 10], ["branches", "ANATOMY_MODIFIER", 11, 19], ["subendocardium", "ANATOMY_MODIFIER", 34, 48], ["interventricular septum", "ANATOMY", 56, 79], ["free ventricular", "ANATOMY", 84, 100], ["walls", "ANATOMY_MODIFIER", 101, 106], ["Purkinje fibers", "OBSERVATION", 124, 139], ["myocardium", "ANATOMY", 156, 166], ["subendocardial", "ANATOMY_MODIFIER", 172, 186], ["epicardial direction", "ANATOMY_MODIFIER", 190, 210]]], ["This organization allows for a rapid and synchronous contraction of both ventricles at an order that ultimately enables blood to be \"squeezed\" from apex to base, toward both outflow tracts.Dysfunction/Responses to InjuryCardiac myofibers have a unique property of intrinsic coupling of the electrical stimulation with mechanical contraction, which is fundamental for cardiac function.", [["ventricles", "ANATOMY", 73, 83], ["blood", "ANATOMY", 120, 125], ["outflow tracts", "ANATOMY", 174, 188], ["InjuryCardiac myofibers", "ANATOMY", 214, 237], ["cardiac", "ANATOMY", 367, 374], ["ventricles", "MULTI-TISSUE_STRUCTURE", 73, 83], ["blood", "ORGANISM_SUBSTANCE", 120, 125], ["outflow tracts", "MULTI-TISSUE_STRUCTURE", 174, 188], ["InjuryCardiac myofibers", "CELL", 214, 237], ["cardiac", "ORGAN", 367, 374], ["InjuryCardiac myofibers", "CELL_TYPE", 214, 237], ["a rapid and synchronous contraction of both ventricles", "PROBLEM", 29, 83], ["Dysfunction", "PROBLEM", 189, 200], ["InjuryCardiac myofibers", "PROBLEM", 214, 237], ["the electrical stimulation", "TREATMENT", 286, 312], ["mechanical contraction", "TREATMENT", 318, 340], ["rapid", "OBSERVATION_MODIFIER", 31, 36], ["both ventricles", "ANATOMY", 68, 83], ["apex", "ANATOMY_MODIFIER", 148, 152], ["base", "ANATOMY_MODIFIER", 156, 160], ["both", "ANATOMY_MODIFIER", 169, 173], ["outflow tracts", "ANATOMY", 174, 188], ["mechanical contraction", "OBSERVATION", 318, 340]]], ["Diastole starts immediately at the end of ventricular contraction, as the cardiac muscle (myocardium) starts to relax.", [["ventricular", "ANATOMY", 42, 53], ["cardiac muscle", "ANATOMY", 74, 88], ["myocardium", "ANATOMY", 90, 100], ["ventricular", "MULTI-TISSUE_STRUCTURE", 42, 53], ["cardiac muscle", "TISSUE", 74, 88], ["myocardium", "MULTI-TISSUE_STRUCTURE", 90, 100], ["Diastole", "PROBLEM", 0, 8], ["ventricular contraction", "OBSERVATION", 42, 65], ["cardiac muscle", "ANATOMY", 74, 88], ["myocardium", "ANATOMY", 90, 100]]], ["For a brief moment, relaxation leads to a rapid fall in ventricular pressure, without change in ventricular volume as the AVVs are still sealed off (isovolumetric relaxation).", [["ventricular", "ANATOMY", 56, 67], ["ventricular", "ANATOMY", 96, 107], ["AVVs", "ANATOMY", 122, 126], ["ventricular", "MULTI-TISSUE_STRUCTURE", 56, 67], ["ventricular", "MULTI-TISSUE_STRUCTURE", 96, 107], ["a rapid fall", "PROBLEM", 40, 52], ["ventricular pressure", "TEST", 56, 76], ["change in ventricular volume", "PROBLEM", 86, 114], ["isovolumetric relaxation", "TREATMENT", 149, 173], ["rapid", "OBSERVATION_MODIFIER", 42, 47], ["fall", "OBSERVATION", 48, 52], ["ventricular", "ANATOMY", 56, 67], ["pressure", "OBSERVATION_MODIFIER", 68, 76], ["without", "UNCERTAINTY", 78, 85], ["change", "OBSERVATION_MODIFIER", 86, 92], ["ventricular volume", "OBSERVATION", 96, 114]]], ["Because of the fall in ventricular pressure, the blood that has pooled in the atria during systole, along with incoming blood that constantly flows from systemic and pulmonary veins through the atria, pushes the AVV open and rapidly and passively fills the ventricles (rapid-filling phase).", [["ventricular", "ANATOMY", 23, 34], ["blood", "ANATOMY", 49, 54], ["atria", "ANATOMY", 78, 83], ["blood", "ANATOMY", 120, 125], ["pulmonary veins", "ANATOMY", 166, 181], ["atria", "ANATOMY", 194, 199], ["AVV", "ANATOMY", 212, 215], ["ventricles", "ANATOMY", 257, 267], ["ventricular", "MULTI-TISSUE_STRUCTURE", 23, 34], ["blood", "ORGANISM_SUBSTANCE", 49, 54], ["atria", "MULTI-TISSUE_STRUCTURE", 78, 83], ["blood", "ORGANISM_SUBSTANCE", 120, 125], ["pulmonary veins", "MULTI-TISSUE_STRUCTURE", 166, 181], ["atria", "MULTI-TISSUE_STRUCTURE", 194, 199], ["ventricles", "MULTI-TISSUE_STRUCTURE", 257, 267], ["the fall", "PROBLEM", 11, 19], ["ventricular pressure", "TEST", 23, 43], ["the blood", "PROBLEM", 45, 54], ["incoming blood", "PROBLEM", 111, 125], ["fall", "OBSERVATION", 15, 19], ["ventricular", "ANATOMY", 23, 34], ["pressure", "OBSERVATION_MODIFIER", 35, 43], ["atria", "ANATOMY", 78, 83], ["systemic", "OBSERVATION", 153, 161], ["pulmonary veins", "ANATOMY", 166, 181], ["atria", "ANATOMY", 194, 199], ["AVV", "OBSERVATION_MODIFIER", 212, 215], ["open", "OBSERVATION", 216, 220], ["rapidly", "OBSERVATION_MODIFIER", 225, 232], ["ventricles", "ANATOMY", 257, 267], ["rapid", "OBSERVATION_MODIFIER", 269, 274], ["filling phase", "OBSERVATION", 275, 288]]], ["Next, because of the resultant pressure rise in the ventricles, the flow of blood that continues to enter the ventricles through the atria abruptly ends (diastasis phase).", [["ventricles", "ANATOMY", 52, 62], ["blood", "ANATOMY", 76, 81], ["ventricles", "ANATOMY", 110, 120], ["atria", "ANATOMY", 133, 138], ["ventricles", "MULTI-TISSUE_STRUCTURE", 52, 62], ["blood", "ORGANISM_SUBSTANCE", 76, 81], ["ventricles", "MULTI-TISSUE_STRUCTURE", 110, 120], ["atria", "MULTI-TISSUE_STRUCTURE", 133, 138], ["the resultant pressure rise in the ventricles", "PROBLEM", 17, 62], ["the flow of blood", "PROBLEM", 64, 81], ["diastasis phase", "PROBLEM", 154, 169], ["resultant", "OBSERVATION_MODIFIER", 21, 30], ["pressure", "OBSERVATION", 31, 39], ["rise", "OBSERVATION_MODIFIER", 40, 44], ["ventricles", "ANATOMY", 52, 62], ["flow", "OBSERVATION_MODIFIER", 68, 72], ["ventricles", "ANATOMY", 110, 120], ["atria", "ANATOMY", 133, 138], ["diastasis", "OBSERVATION_MODIFIER", 154, 163], ["phase", "OBSERVATION_MODIFIER", 164, 169]]], ["The last phase of diastole is active contraction of the atria, which pushes blood into the (now somewhat less compliant) ventricles and further raises their pressure (\"atrial kick\").Dysfunction/Responses to InjuryIn systole, the myocardium contracts, leading to a rapid increase in intraventricular pressure.", [["atria", "ANATOMY", 56, 61], ["blood", "ANATOMY", 76, 81], ["ventricles", "ANATOMY", 121, 131], ["atrial", "ANATOMY", 168, 174], ["myocardium", "ANATOMY", 229, 239], ["intraventricular", "ANATOMY", 282, 298], ["atria", "MULTI-TISSUE_STRUCTURE", 56, 61], ["blood", "ORGANISM_SUBSTANCE", 76, 81], ["ventricles", "MULTI-TISSUE_STRUCTURE", 121, 131], ["myocardium", "MULTI-TISSUE_STRUCTURE", 229, 239], ["active contraction of the atria", "PROBLEM", 30, 61], ["somewhat less compliant) ventricles", "PROBLEM", 96, 131], ["their pressure (\"atrial kick\"", "PROBLEM", 151, 180], ["Dysfunction", "PROBLEM", 182, 193], ["InjuryIn systole", "PROBLEM", 207, 223], ["a rapid increase in intraventricular pressure", "PROBLEM", 262, 307], ["active", "OBSERVATION_MODIFIER", 30, 36], ["contraction", "OBSERVATION", 37, 48], ["atria", "ANATOMY", 56, 61], ["less compliant", "OBSERVATION_MODIFIER", 105, 119], ["ventricles", "ANATOMY", 121, 131], ["pressure", "OBSERVATION_MODIFIER", 157, 165], ["myocardium", "ANATOMY", 229, 239], ["rapid", "OBSERVATION_MODIFIER", 264, 269], ["increase", "OBSERVATION_MODIFIER", 270, 278], ["intraventricular pressure", "OBSERVATION", 282, 307]]], ["Because the aortic and pulmonary valves are shut during diastole, the sudden rise in pressure leads to closure of the AVVs.", [["aortic", "ANATOMY", 12, 18], ["pulmonary valves", "ANATOMY", 23, 39], ["AVVs", "ANATOMY", 118, 122], ["aortic", "MULTI-TISSUE_STRUCTURE", 12, 18], ["pulmonary valves", "MULTI-TISSUE_STRUCTURE", 23, 39], ["AVVs", "PATHOLOGICAL_FORMATION", 118, 122], ["pulmonary valves", "TREATMENT", 23, 39], ["the sudden rise", "PROBLEM", 66, 81], ["closure", "TREATMENT", 103, 110], ["the AVVs", "PROBLEM", 114, 122], ["aortic", "ANATOMY", 12, 18], ["pulmonary valves", "ANATOMY", 23, 39], ["sudden", "OBSERVATION_MODIFIER", 70, 76], ["rise", "OBSERVATION_MODIFIER", 77, 81], ["pressure", "OBSERVATION_MODIFIER", 85, 93], ["closure", "OBSERVATION_MODIFIER", 103, 110]]], ["In this brief period, which is termed isovolumetric contraction, the change in ventricular pressure has not led to a change in ventricular volume because the blood had not yet been ejected into the aorta and pulmonary arteries.", [["ventricular", "ANATOMY", 79, 90], ["ventricular", "ANATOMY", 127, 138], ["blood", "ANATOMY", 158, 163], ["aorta", "ANATOMY", 198, 203], ["pulmonary arteries", "ANATOMY", 208, 226], ["ventricular", "MULTI-TISSUE_STRUCTURE", 79, 90], ["ventricular", "MULTI-TISSUE_STRUCTURE", 127, 138], ["blood", "ORGANISM_SUBSTANCE", 158, 163], ["aorta", "MULTI-TISSUE_STRUCTURE", 198, 203], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 208, 226], ["termed isovolumetric contraction", "PROBLEM", 31, 63], ["the change in ventricular pressure", "PROBLEM", 65, 99], ["a change in ventricular volume", "PROBLEM", 115, 145], ["the blood", "TEST", 154, 163], ["isovolumetric contraction", "OBSERVATION", 38, 63], ["change", "OBSERVATION_MODIFIER", 69, 75], ["ventricular", "ANATOMY", 79, 90], ["pressure", "OBSERVATION_MODIFIER", 91, 99], ["change", "OBSERVATION_MODIFIER", 117, 123], ["ventricular volume", "OBSERVATION", 127, 145], ["aorta", "ANATOMY", 198, 203], ["pulmonary arteries", "ANATOMY", 208, 226]]], ["When the pressure in the ventricles exceeds the pressure in the great arteries, the aortic and pulmonary valves (semilunar valves) open and the ejection of the blood through the right and left side outflow tracts ensues (ejection phase).", [["ventricles", "ANATOMY", 25, 35], ["great arteries", "ANATOMY", 64, 78], ["aortic", "ANATOMY", 84, 90], ["pulmonary valves", "ANATOMY", 95, 111], ["semilunar valves", "ANATOMY", 113, 129], ["blood", "ANATOMY", 160, 165], ["right", "ANATOMY", 178, 183], ["left side outflow tracts", "ANATOMY", 188, 212], ["ventricles", "MULTI-TISSUE_STRUCTURE", 25, 35], ["great arteries", "MULTI-TISSUE_STRUCTURE", 64, 78], ["aortic", "MULTI-TISSUE_STRUCTURE", 84, 90], ["pulmonary valves", "MULTI-TISSUE_STRUCTURE", 95, 111], ["semilunar valves", "MULTI-TISSUE_STRUCTURE", 113, 129], ["blood", "ORGANISM_SUBSTANCE", 160, 165], ["right", "ORGANISM_SUBDIVISION", 178, 183], ["the pressure", "TEST", 5, 17], ["semilunar valves)", "TREATMENT", 113, 130], ["pressure", "OBSERVATION_MODIFIER", 9, 17], ["ventricles", "ANATOMY", 25, 35], ["pressure", "OBSERVATION_MODIFIER", 48, 56], ["great arteries", "ANATOMY", 64, 78], ["aortic", "ANATOMY", 84, 90], ["pulmonary valves", "ANATOMY", 95, 111], ["semilunar valves", "ANATOMY", 113, 129], ["ejection", "OBSERVATION", 144, 152], ["right", "ANATOMY_MODIFIER", 178, 183], ["left", "ANATOMY_MODIFIER", 188, 192], ["outflow tracts", "ANATOMY", 198, 212], ["ejection phase", "OBSERVATION", 221, 235]]], ["Simultaneously with the ejection phase, the atria relax, atrial pressure falls, and blood enters the atria and pools within it passively.Dysfunction/Responses to InjuryAn additional level of complexity is brought about by the innervation of the autonomous nervous system (ANS).", [["atria", "ANATOMY", 44, 49], ["atrial", "ANATOMY", 57, 63], ["blood", "ANATOMY", 84, 89], ["atria", "ANATOMY", 101, 106], ["autonomous nervous system", "ANATOMY", 245, 270], ["atria", "MULTI-TISSUE_STRUCTURE", 44, 49], ["atrial", "MULTI-TISSUE_STRUCTURE", 57, 63], ["blood", "ORGANISM_SUBSTANCE", 84, 89], ["atria", "MULTI-TISSUE_STRUCTURE", 101, 106], ["autonomous nervous system", "ANATOMICAL_SYSTEM", 245, 270], ["ANS", "ANATOMICAL_SYSTEM", 272, 275], ["the ejection phase", "TEST", 20, 38], ["atrial pressure falls", "PROBLEM", 57, 78], ["Dysfunction", "PROBLEM", 137, 148], ["atria", "ANATOMY", 44, 49], ["atrial", "ANATOMY", 57, 63], ["pressure falls", "OBSERVATION", 64, 78], ["atria", "ANATOMY", 101, 106], ["pools", "OBSERVATION_MODIFIER", 111, 116], ["autonomous nervous", "ANATOMY", 245, 263]]], ["In general, the ANS influences heart rate (chronotropy), alters the rate of conduction (dromotropy), and controls myocardial contractility (inotropy) and the rate of mechanical relaxation (lusitropy).", [["heart", "ANATOMY", 31, 36], ["myocardial", "ANATOMY", 114, 124], ["heart", "ORGAN", 31, 36], ["myocardial", "MULTI-TISSUE_STRUCTURE", 114, 124], ["mechanical relaxation (lusitropy", "TREATMENT", 166, 198], ["mechanical relaxation", "OBSERVATION", 166, 187]]], ["Parasympathetic postganglionic nerve terminals secrete acetylcholine that affects muscarinic (M2) receptors, whereas sympathetic postganglionic nerve terminals secrete norepinephrine that predominantly acts on the \u03b2 1 -adrenergic receptors.", [["postganglionic nerve terminals", "ANATOMY", 16, 46], ["sympathetic postganglionic nerve terminals", "ANATOMY", 117, 159], ["acetylcholine", "CHEMICAL", 55, 68], ["norepinephrine", "CHEMICAL", 168, 182], ["acetylcholine", "CHEMICAL", 55, 68], ["norepinephrine", "CHEMICAL", 168, 182], ["nerve terminals", "MULTI-TISSUE_STRUCTURE", 31, 46], ["acetylcholine", "SIMPLE_CHEMICAL", 55, 68], ["muscarinic (M2) receptors", "GENE_OR_GENE_PRODUCT", 82, 107], ["nerve terminals", "MULTI-TISSUE_STRUCTURE", 144, 159], ["norepinephrine", "SIMPLE_CHEMICAL", 168, 182], ["\u03b2 1 -adrenergic receptors", "GENE_OR_GENE_PRODUCT", 214, 239], ["muscarinic (M2) receptors", "PROTEIN", 82, 107], ["\u03b2 1 -adrenergic receptors", "PROTEIN", 214, 239], ["Parasympathetic postganglionic nerve terminals", "PROBLEM", 0, 46], ["sympathetic postganglionic nerve terminals secrete norepinephrine", "PROBLEM", 117, 182], ["postganglionic", "ANATOMY_MODIFIER", 16, 30], ["nerve", "ANATOMY", 31, 36], ["sympathetic", "ANATOMY_MODIFIER", 117, 128], ["postganglionic nerve", "ANATOMY", 129, 149]]], ["The latter, when stimulated by catecholamines, lead to a chain of intracellular events that increases calcium influx, increases the magnitude of potassium and chloride 566.e1 CHAPTER 10 Cardiovascular System and Lymphatic Vessels The properties of the arterial system can be described by the total arterial compliance, the peripheral resistance, and the characteristic impedance.", [["intracellular", "ANATOMY", 66, 79], ["arterial system", "ANATOMY", 252, 267], ["arterial", "ANATOMY", 298, 306], ["catecholamines", "CHEMICAL", 31, 45], ["calcium", "CHEMICAL", 102, 109], ["potassium", "CHEMICAL", 145, 154], ["chloride", "CHEMICAL", 159, 167], ["catecholamines", "CHEMICAL", 31, 45], ["calcium", "CHEMICAL", 102, 109], ["potassium", "CHEMICAL", 145, 154], ["chloride", "CHEMICAL", 159, 167], ["catecholamines", "SIMPLE_CHEMICAL", 31, 45], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 66, 79], ["calcium", "SIMPLE_CHEMICAL", 102, 109], ["potassium", "SIMPLE_CHEMICAL", 145, 154], ["chloride", "SIMPLE_CHEMICAL", 159, 167], ["arterial system", "MULTI-TISSUE_STRUCTURE", 252, 267], ["arterial", "MULTI-TISSUE_STRUCTURE", 298, 306], ["intracellular events", "PROBLEM", 66, 86], ["calcium influx", "PROBLEM", 102, 116], ["potassium", "TEST", 145, 154], ["chloride", "TEST", 159, 167], ["Cardiovascular System", "ANATOMY", 186, 207], ["Lymphatic Vessels", "ANATOMY", 212, 229], ["arterial system", "ANATOMY", 252, 267], ["total", "OBSERVATION_MODIFIER", 292, 297], ["arterial compliance", "OBSERVATION", 298, 317], ["peripheral resistance", "OBSERVATION", 323, 344], ["impedance", "OBSERVATION_MODIFIER", 369, 378]]], ["Total arterial compliance corresponds to the elastic properties of arteries (i.e., aorta) and reflects change in volume from a given change in pressure.", [["arterial", "ANATOMY", 6, 14], ["arteries", "ANATOMY", 67, 75], ["aorta", "ANATOMY", 83, 88], ["arterial", "MULTI-TISSUE_STRUCTURE", 6, 14], ["arteries", "MULTI-TISSUE_STRUCTURE", 67, 75], ["aorta", "MULTI-TISSUE_STRUCTURE", 83, 88], ["Total arterial compliance", "TREATMENT", 0, 25], ["change in volume", "PROBLEM", 103, 119], ["pressure", "TEST", 143, 151], ["arterial", "ANATOMY", 6, 14], ["compliance", "OBSERVATION", 15, 25], ["elastic", "OBSERVATION", 45, 52], ["arteries", "ANATOMY", 67, 75], ["aorta", "ANATOMY", 83, 88], ["change", "OBSERVATION_MODIFIER", 103, 109], ["volume", "OBSERVATION_MODIFIER", 113, 119], ["pressure", "OBSERVATION_MODIFIER", 143, 151]]], ["Peripheral resistance is largely determined by small arteries and arterioles and involves steady (nonpulsatile) flow.", [["small arteries", "ANATOMY", 47, 61], ["arterioles", "ANATOMY", 66, 76], ["arteries", "MULTI-TISSUE_STRUCTURE", 53, 61], ["arterioles", "MULTI-TISSUE_STRUCTURE", 66, 76], ["Peripheral resistance", "TEST", 0, 21], ["resistance", "OBSERVATION", 11, 21], ["small arteries", "ANATOMY", 47, 61], ["arterioles", "ANATOMY", 66, 76], ["steady", "OBSERVATION_MODIFIER", 90, 96], ["nonpulsatile", "OBSERVATION_MODIFIER", 98, 110], ["flow", "OBSERVATION_MODIFIER", 112, 116]]], ["Characteristic impedance is the opposition to pulsatile flow.Dysfunction/Responses to InjuryLeft ventricular (LV) afterload is increased by an increase in peripheral resistance and characteristic impedance and a decrease in total arterial compliance.", [["ventricular", "ANATOMY", 97, 108], ["LV", "ANATOMY", 110, 112], ["arterial", "ANATOMY", 230, 238], ["InjuryLeft ventricular", "MULTI-TISSUE_STRUCTURE", 86, 108], ["LV", "MULTI-TISSUE_STRUCTURE", 110, 112], ["peripheral", "TISSUE", 155, 165], ["arterial", "MULTI-TISSUE_STRUCTURE", 230, 238], ["Characteristic impedance", "PROBLEM", 0, 24], ["Dysfunction", "PROBLEM", 61, 72], ["InjuryLeft ventricular (LV) afterload", "PROBLEM", 86, 123], ["an increase in peripheral resistance", "PROBLEM", 140, 176], ["characteristic impedance", "PROBLEM", 181, 205], ["total arterial compliance", "TREATMENT", 224, 249], ["pulsatile flow", "OBSERVATION", 46, 60], ["InjuryLeft ventricular", "ANATOMY", 86, 108], ["LV", "ANATOMY", 110, 112], ["increased", "OBSERVATION_MODIFIER", 127, 136], ["increase", "OBSERVATION_MODIFIER", 143, 151], ["peripheral resistance", "OBSERVATION", 155, 176], ["characteristic impedance", "OBSERVATION", 181, 205], ["decrease", "OBSERVATION_MODIFIER", 212, 220], ["total arterial compliance", "OBSERVATION", 224, 249]]], ["Subsequently, the left ventricle ejects into a stiff vasculature, increasing both the energetic cost to maintain blood flow and myocardial oxygen consumption (MVO 2 ).", [["left ventricle", "ANATOMY", 18, 32], ["vasculature", "ANATOMY", 53, 64], ["blood", "ANATOMY", 113, 118], ["myocardial", "ANATOMY", 128, 138], ["oxygen", "CHEMICAL", 139, 145], ["oxygen", "CHEMICAL", 139, 145], ["ventricle", "MULTI-TISSUE_STRUCTURE", 23, 32], ["vasculature", "MULTI-TISSUE_STRUCTURE", 53, 64], ["blood", "ORGANISM_SUBSTANCE", 113, 118], ["myocardial", "MULTI-TISSUE_STRUCTURE", 128, 138], ["oxygen", "SIMPLE_CHEMICAL", 139, 145], ["blood flow", "TEST", 113, 123], ["myocardial oxygen consumption", "TEST", 128, 157], ["MVO", "TEST", 159, 162], ["left ventricle", "ANATOMY", 18, 32], ["stiff vasculature", "OBSERVATION", 47, 64], ["increasing", "OBSERVATION_MODIFIER", 66, 76], ["energetic cost", "OBSERVATION", 86, 100], ["myocardial", "ANATOMY", 128, 138], ["oxygen consumption", "OBSERVATION", 139, 157]]], ["Characteristic impedance, a property of the proximal aorta, increases whenever the stiffness of the aorta increases or its radius becomes smaller.", [["proximal aorta", "ANATOMY", 44, 58], ["aorta", "ANATOMY", 100, 105], ["aorta", "MULTI-TISSUE_STRUCTURE", 53, 58], ["aorta", "MULTI-TISSUE_STRUCTURE", 100, 105], ["Characteristic impedance", "PROBLEM", 0, 24], ["impedance", "OBSERVATION", 15, 24], ["proximal", "ANATOMY_MODIFIER", 44, 52], ["aorta", "ANATOMY", 53, 58], ["increases", "OBSERVATION_MODIFIER", 60, 69], ["stiffness", "OBSERVATION_MODIFIER", 83, 92], ["aorta", "ANATOMY", 100, 105], ["increases", "OBSERVATION_MODIFIER", 106, 115], ["radius", "OBSERVATION_MODIFIER", 123, 129], ["smaller", "OBSERVATION_MODIFIER", 138, 145]]], ["Peripheral resistance has a greater effect on ventricular performance than does characteristic impedance or compliance.Systolic and Diastolic Heart FailureSystolic heart failure is characterized by normal filling of the ventricle and a decrease in the forward stroke volume (SV).", [["ventricular", "ANATOMY", 46, 57], ["Heart", "ANATOMY", 142, 147], ["heart", "ANATOMY", 164, 169], ["ventricle", "ANATOMY", 220, 229], ["heart failure", "DISEASE", 164, 177], ["stroke", "DISEASE", 260, 266], ["ventricular", "MULTI-TISSUE_STRUCTURE", 46, 57], ["heart", "ORGAN", 164, 169], ["ventricle", "MULTI-TISSUE_STRUCTURE", 220, 229], ["Peripheral resistance", "TEST", 0, 21], ["Systolic", "TEST", 119, 127], ["Diastolic Heart FailureSystolic heart failure", "PROBLEM", 132, 177], ["normal filling of the ventricle", "PROBLEM", 198, 229], ["a decrease in the forward stroke volume", "PROBLEM", 234, 273], ["resistance", "OBSERVATION", 11, 21], ["greater", "OBSERVATION_MODIFIER", 28, 35], ["effect", "OBSERVATION_MODIFIER", 36, 42], ["ventricular", "ANATOMY", 46, 57], ["Diastolic", "ANATOMY_MODIFIER", 132, 141], ["Heart", "ANATOMY", 142, 147], ["FailureSystolic", "ANATOMY_MODIFIER", 148, 163], ["heart", "ANATOMY", 164, 169], ["failure", "OBSERVATION", 170, 177], ["normal", "OBSERVATION", 198, 204], ["filling", "OBSERVATION_MODIFIER", 205, 212], ["ventricle", "ANATOMY", 220, 229], ["decrease", "OBSERVATION_MODIFIER", 236, 244], ["forward", "OBSERVATION_MODIFIER", 252, 259], ["stroke volume", "OBSERVATION", 260, 273]]], ["The decrease inPathophysiology of Heart FailureHeart failure is a progressive clinical syndrome in which impaired pumping decreases ventricular ejection and impedes venous return.", [["Heart", "ANATOMY", 34, 39], ["Heart", "ANATOMY", 47, 52], ["ventricular", "ANATOMY", 132, 143], ["venous", "ANATOMY", 165, 171], ["Heart Failure", "DISEASE", 34, 47], ["Heart failure", "DISEASE", 47, 60], ["Heart", "ORGAN", 34, 39], ["ventricular", "MULTI-TISSUE_STRUCTURE", 132, 143], ["venous", "MULTI-TISSUE_STRUCTURE", 165, 171], ["Heart Failure", "PROBLEM", 34, 47], ["Heart failure", "PROBLEM", 47, 60], ["a progressive clinical syndrome", "PROBLEM", 64, 95], ["impaired pumping", "PROBLEM", 105, 121], ["ventricular ejection", "PROBLEM", 132, 152], ["decrease", "OBSERVATION_MODIFIER", 4, 12], ["Heart", "ANATOMY", 34, 39], ["Failure", "OBSERVATION", 40, 47], ["Heart", "ANATOMY", 47, 52], ["failure", "OBSERVATION", 53, 60], ["progressive", "OBSERVATION_MODIFIER", 66, 77], ["impaired", "OBSERVATION_MODIFIER", 105, 113], ["pumping", "OBSERVATION_MODIFIER", 114, 121], ["decreases", "OBSERVATION_MODIFIER", 122, 131], ["ventricular ejection", "OBSERVATION", 132, 152], ["venous", "ANATOMY", 165, 171]]], ["The heart fails either by decreased blood pumping into the aorta and/or pulmonary artery to maintain arterial pressure (low-output heart failure) or by an inability to adequately empty the venous reservoirs (congestive heart failure) (see Box 10-1).", [["heart", "ANATOMY", 4, 9], ["blood", "ANATOMY", 36, 41], ["aorta", "ANATOMY", 59, 64], ["pulmonary artery", "ANATOMY", 72, 88], ["arterial", "ANATOMY", 101, 109], ["heart", "ANATOMY", 131, 136], ["venous", "ANATOMY", 189, 195], ["heart", "ANATOMY", 219, 224], ["low-output heart failure", "DISEASE", 120, 144], ["congestive heart failure", "DISEASE", 208, 232], ["heart", "ORGAN", 4, 9], ["blood", "ORGANISM_SUBSTANCE", 36, 41], ["aorta", "MULTI-TISSUE_STRUCTURE", 59, 64], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 72, 88], ["arterial", "MULTI-TISSUE_STRUCTURE", 101, 109], ["heart", "ORGAN", 131, 136], ["venous", "MULTI-TISSUE_STRUCTURE", 189, 195], ["heart", "ORGAN", 219, 224], ["decreased blood pumping into the aorta", "PROBLEM", 26, 64], ["arterial pressure", "TEST", 101, 118], ["low-output heart failure", "PROBLEM", 120, 144], ["an inability to adequately empty the venous reservoirs", "PROBLEM", 152, 206], ["congestive heart failure", "PROBLEM", 208, 232], ["heart", "ANATOMY", 4, 9], ["decreased", "OBSERVATION", 26, 35], ["blood pumping", "OBSERVATION", 36, 49], ["aorta", "ANATOMY", 59, 64], ["pulmonary artery", "ANATOMY", 72, 88], ["arterial", "ANATOMY_MODIFIER", 101, 109], ["pressure", "OBSERVATION_MODIFIER", 110, 118], ["low", "OBSERVATION_MODIFIER", 120, 123], ["heart", "ANATOMY", 131, 136], ["failure", "OBSERVATION", 137, 144], ["venous", "ANATOMY", 189, 195], ["reservoirs", "OBSERVATION", 196, 206], ["congestive", "OBSERVATION_MODIFIER", 208, 218], ["heart", "ANATOMY", 219, 224], ["failure", "OBSERVATION", 225, 232]]], ["Anamnestic signs of low cardiac output include depression, lethargy, syncope, and hypotension, and those of congestion include ascites, pleural effusion, and pulmonary edema.Syndromes of Cardiac Failure or Decompensation: Congestive Heart FailureCongestive heart failure can be right-sided, left-sided, or bilateral and can occur with cardiac dilation and/or hypertrophy ( Fig. 10-5 ).", [["cardiac", "ANATOMY", 24, 31], ["ascites", "ANATOMY", 127, 134], ["pleural", "ANATOMY", 136, 143], ["pulmonary", "ANATOMY", 158, 167], ["Cardiac", "ANATOMY", 187, 194], ["Heart", "ANATOMY", 233, 238], ["heart", "ANATOMY", 257, 262], ["cardiac", "ANATOMY", 335, 342], ["low cardiac output", "DISEASE", 20, 38], ["depression", "DISEASE", 47, 57], ["lethargy", "DISEASE", 59, 67], ["syncope", "DISEASE", 69, 76], ["hypotension", "DISEASE", 82, 93], ["congestion", "DISEASE", 108, 118], ["ascites", "DISEASE", 127, 134], ["pleural effusion", "DISEASE", 136, 152], ["pulmonary edema", "DISEASE", 158, 173], ["Cardiac Failure", "DISEASE", 187, 202], ["Decompensation", "DISEASE", 206, 220], ["Heart FailureCongestive heart failure", "DISEASE", 233, 270], ["cardiac dilation", "DISEASE", 335, 351], ["hypertrophy", "DISEASE", 359, 370], ["cardiac", "ORGAN", 24, 31], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 158, 173], ["heart", "ORGAN", 257, 262], ["cardiac", "ORGAN", 335, 342], ["Anamnestic signs", "TEST", 0, 16], ["low cardiac output", "PROBLEM", 20, 38], ["depression", "PROBLEM", 47, 57], ["lethargy", "PROBLEM", 59, 67], ["syncope", "PROBLEM", 69, 76], ["hypotension", "PROBLEM", 82, 93], ["congestion", "PROBLEM", 108, 118], ["ascites", "PROBLEM", 127, 134], ["pleural effusion", "PROBLEM", 136, 152], ["pulmonary edema", "PROBLEM", 158, 173], ["Syndromes", "PROBLEM", 174, 183], ["Cardiac Failure", "PROBLEM", 187, 202], ["Decompensation", "PROBLEM", 206, 220], ["Congestive Heart FailureCongestive heart failure", "PROBLEM", 222, 270], ["cardiac dilation", "PROBLEM", 335, 351], ["hypertrophy", "PROBLEM", 359, 370], ["low cardiac output", "OBSERVATION", 20, 38], ["depression", "OBSERVATION", 47, 57], ["lethargy", "OBSERVATION", 59, 67], ["syncope", "OBSERVATION", 69, 76], ["hypotension", "OBSERVATION", 82, 93], ["congestion", "OBSERVATION", 108, 118], ["ascites", "OBSERVATION", 127, 134], ["pleural", "ANATOMY", 136, 143], ["effusion", "OBSERVATION", 144, 152], ["pulmonary", "ANATOMY", 158, 167], ["edema", "OBSERVATION", 168, 173], ["Cardiac", "ANATOMY", 187, 194], ["Failure", "OBSERVATION", 195, 202], ["Decompensation", "OBSERVATION", 206, 220], ["Congestive", "OBSERVATION_MODIFIER", 222, 232], ["Heart", "ANATOMY", 233, 238], ["FailureCongestive", "ANATOMY_MODIFIER", 239, 256], ["heart", "ANATOMY", 257, 262], ["failure", "OBSERVATION", 263, 270], ["right", "ANATOMY_MODIFIER", 278, 283], ["sided", "ANATOMY_MODIFIER", 284, 289], ["left", "ANATOMY_MODIFIER", 291, 295], ["sided", "ANATOMY_MODIFIER", 296, 301], ["bilateral", "ANATOMY_MODIFIER", 306, 315], ["cardiac", "ANATOMY", 335, 342], ["dilation", "OBSERVATION", 343, 351], ["hypertrophy", "OBSERVATION", 359, 370]]], ["Right-sided congestive heart failure is associated with signs of congestion in the systemic circulation (i.e., ascites and peripheral edema [Figs.", [["heart", "ANATOMY", 23, 28], ["ascites", "ANATOMY", 111, 118], ["peripheral edema", "ANATOMY", 123, 139], ["congestive heart failure", "DISEASE", 12, 36], ["congestion", "DISEASE", 65, 75], ["ascites", "DISEASE", 111, 118], ["peripheral edema", "DISEASE", 123, 139], ["heart", "ORGAN", 23, 28], ["peripheral edema", "PATHOLOGICAL_FORMATION", 123, 139], ["Right-sided congestive heart failure", "PROBLEM", 0, 36], ["congestion in the systemic circulation", "PROBLEM", 65, 103], ["ascites", "PROBLEM", 111, 118], ["peripheral edema", "PROBLEM", 123, 139], ["sided", "ANATOMY_MODIFIER", 6, 11], ["congestive", "OBSERVATION", 12, 22], ["heart", "ANATOMY", 23, 28], ["failure", "OBSERVATION", 29, 36], ["congestion", "OBSERVATION", 65, 75], ["systemic circulation", "ANATOMY", 83, 103], ["ascites", "OBSERVATION", 111, 118], ["peripheral", "ANATOMY_MODIFIER", 123, 133], ["edema", "OBSERVATION", 134, 139]]], ["10-6 and 10-7]), whereas left-sided congestive heart failure causes signs of congestion in the pulmonary circulation (i.e., pulmonary edema and dyspnea).", [["heart", "ANATOMY", 47, 52], ["pulmonary", "ANATOMY", 95, 104], ["pulmonary", "ANATOMY", 124, 133], ["heart failure", "DISEASE", 47, 60], ["congestion", "DISEASE", 77, 87], ["pulmonary edema", "DISEASE", 124, 139], ["dyspnea", "DISEASE", 144, 151], ["heart", "ORGAN", 47, 52], ["pulmonary", "ORGAN", 95, 104], ["pulmonary", "ORGAN", 124, 133], ["left-sided congestive heart failure", "PROBLEM", 25, 60], ["congestion in the pulmonary circulation", "PROBLEM", 77, 116], ["pulmonary edema", "PROBLEM", 124, 139], ["dyspnea", "PROBLEM", 144, 151], ["left", "ANATOMY_MODIFIER", 25, 29], ["sided", "ANATOMY_MODIFIER", 30, 35], ["congestive", "OBSERVATION", 36, 46], ["heart", "ANATOMY", 47, 52], ["failure", "OBSERVATION", 53, 60], ["congestion", "OBSERVATION", 77, 87], ["pulmonary circulation", "ANATOMY", 95, 116], ["pulmonary", "ANATOMY", 124, 133], ["edema", "OBSERVATION", 134, 139], ["dyspnea", "OBSERVATION", 144, 151]]], ["In small animals, pleural effusion is usually associated with bilateral congestive heart failure.Syndromes of Cardiac Failure or Decompensation: Congestive Heart FailureHeart failure may result from an inability of the heart to eject blood adequately (systolic failure), from inadequate ventricular filling (diastolic failure), or both.", [["pleural effusion", "ANATOMY", 18, 34], ["heart", "ANATOMY", 83, 88], ["Cardiac", "ANATOMY", 110, 117], ["Heart", "ANATOMY", 156, 161], ["Heart", "ANATOMY", 169, 174], ["heart", "ANATOMY", 219, 224], ["blood", "ANATOMY", 234, 239], ["ventricular", "ANATOMY", 287, 298], ["pleural effusion", "DISEASE", 18, 34], ["congestive heart failure", "DISEASE", 72, 96], ["Cardiac Failure", "DISEASE", 110, 125], ["Decompensation", "DISEASE", 129, 143], ["Congestive Heart Failure", "DISEASE", 145, 169], ["Heart failure", "DISEASE", 169, 182], ["systolic failure", "DISEASE", 252, 268], ["diastolic failure", "DISEASE", 308, 325], ["pleural", "ORGAN", 18, 25], ["heart", "ORGAN", 83, 88], ["Heart", "ORGAN", 169, 174], ["heart", "ORGAN", 219, 224], ["blood", "ORGANISM_SUBSTANCE", 234, 239], ["ventricular", "MULTI-TISSUE_STRUCTURE", 287, 298], ["pleural effusion", "PROBLEM", 18, 34], ["bilateral congestive heart failure", "PROBLEM", 62, 96], ["Syndromes", "PROBLEM", 97, 106], ["Cardiac Failure", "PROBLEM", 110, 125], ["Decompensation", "PROBLEM", 129, 143], ["Congestive Heart Failure", "PROBLEM", 145, 169], ["Heart failure", "PROBLEM", 169, 182], ["systolic failure", "PROBLEM", 252, 268], ["inadequate ventricular filling", "PROBLEM", 276, 306], ["diastolic failure)", "PROBLEM", 308, 326], ["small", "OBSERVATION_MODIFIER", 3, 8], ["animals", "OBSERVATION_MODIFIER", 9, 16], ["pleural", "ANATOMY", 18, 25], ["effusion", "OBSERVATION", 26, 34], ["usually associated with", "UNCERTAINTY", 38, 61], ["bilateral", "ANATOMY_MODIFIER", 62, 71], ["congestive", "OBSERVATION_MODIFIER", 72, 82], ["heart", "ANATOMY", 83, 88], ["failure", "OBSERVATION", 89, 96], ["Cardiac", "ANATOMY", 110, 117], ["Failure", "OBSERVATION", 118, 125], ["Decompensation", "OBSERVATION", 129, 143], ["Congestive", "OBSERVATION_MODIFIER", 145, 155], ["Heart", "ANATOMY", 156, 161], ["Failure", "OBSERVATION", 162, 169], ["failure", "OBSERVATION", 175, 182], ["heart", "ANATOMY", 219, 224], ["failure", "OBSERVATION", 261, 268], ["ventricular filling", "OBSERVATION", 287, 306], ["diastolic failure", "OBSERVATION", 308, 325]]], ["The resultant reduction in stroke volume (SV) leads to a decrease in cardiac output (CO) and a decrease in arterial blood pressure.Indices of Cardiac FunctionArterial blood pressure (ABP) ~ CO \u00d7 Z (where Z is the aortic input impedance) and CO = SV \u00d7 heart rate (HR).", [["cardiac", "ANATOMY", 69, 76], ["arterial", "ANATOMY", 107, 115], ["blood", "ANATOMY", 116, 121], ["Cardiac", "ANATOMY", 142, 149], ["blood", "ANATOMY", 167, 172], ["aortic", "ANATOMY", 213, 219], ["heart", "ANATOMY", 251, 256], ["stroke", "DISEASE", 27, 33], ["decrease in cardiac output", "DISEASE", 57, 83], ["cardiac", "ORGAN", 69, 76], ["arterial", "MULTI-TISSUE_STRUCTURE", 107, 115], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["blood", "ORGANISM_SUBSTANCE", 167, 172], ["aortic", "MULTI-TISSUE_STRUCTURE", 213, 219], ["heart", "ORGAN", 251, 256], ["The resultant reduction in stroke volume", "PROBLEM", 0, 40], ["a decrease in cardiac output", "PROBLEM", 55, 83], ["arterial blood pressure", "TEST", 107, 130], ["Cardiac FunctionArterial blood pressure", "TEST", 142, 181], ["ABP", "TEST", 183, 186], ["the aortic input impedance", "TEST", 209, 235], ["CO", "TEST", 241, 243], ["SV", "TEST", 246, 248], ["heart rate", "TEST", 251, 261], ["HR", "TEST", 263, 265], ["resultant", "OBSERVATION_MODIFIER", 4, 13], ["reduction", "OBSERVATION_MODIFIER", 14, 23], ["stroke volume", "OBSERVATION", 27, 40], ["decrease", "OBSERVATION_MODIFIER", 57, 65], ["cardiac", "ANATOMY", 69, 76], ["output", "OBSERVATION_MODIFIER", 77, 83], ["decrease", "OBSERVATION_MODIFIER", 95, 103], ["arterial blood", "ANATOMY", 107, 121], ["pressure", "OBSERVATION_MODIFIER", 122, 130], ["Cardiac", "ANATOMY", 142, 149], ["FunctionArterial", "ANATOMY_MODIFIER", 150, 166], ["aortic", "ANATOMY", 213, 219], ["heart", "ANATOMY", 251, 256]]], ["Increases in HR increase CO linearly until a plateau is reached, at which point further increases in HR will decrease CO because of decreased diastolic filling (the Frank-Starling law of the heart).", [["heart", "ANATOMY", 191, 196], ["CO", "CHEMICAL", 25, 27], ["CO", "CHEMICAL", 118, 120], ["CO", "SIMPLE_CHEMICAL", 25, 27], ["heart", "ORGAN", 191, 196], ["HR", "TEST", 101, 103], ["CO", "TEST", 118, 120], ["decreased diastolic filling", "PROBLEM", 132, 159], ["increase", "OBSERVATION_MODIFIER", 16, 24], ["increases", "OBSERVATION_MODIFIER", 88, 97], ["decreased", "OBSERVATION", 132, 141], ["diastolic filling", "OBSERVATION", 142, 159], ["heart", "ANATOMY", 191, 196]]], ["Contractility and the two coupling factors, preload and afterload, primarily determine SV.", [["Contractility", "PROBLEM", 0, 13], ["the two coupling factors", "PROBLEM", 18, 42], ["preload", "TEST", 44, 51], ["afterload", "TEST", 56, 65]]], ["The latter increases with increases in preload and contractility and decreases in afterload.", [["preload", "TEST", 39, 46], ["contractility", "TEST", 51, 64], ["afterload", "TEST", 82, 91], ["latter", "OBSERVATION_MODIFIER", 4, 10], ["increases", "OBSERVATION_MODIFIER", 11, 20], ["increases", "OBSERVATION_MODIFIER", 26, 35], ["decreases", "OBSERVATION_MODIFIER", 69, 78], ["afterload", "OBSERVATION_MODIFIER", 82, 91]]], ["Preload reflects the degree of ventricular filling just before contraction.", [["ventricular", "ANATOMY", 31, 42], ["ventricular", "MULTI-TISSUE_STRUCTURE", 31, 42], ["Preload", "TEST", 0, 7], ["ventricular filling", "PROBLEM", 31, 50], ["degree", "OBSERVATION_MODIFIER", 21, 27], ["ventricular", "ANATOMY", 31, 42], ["filling", "OBSERVATION", 43, 50]]], ["End diastolic volume (EDV) can estimate preload.", [["End diastolic volume", "TEST", 0, 20], ["EDV", "TEST", 22, 25], ["preload", "TEST", 40, 47], ["diastolic volume", "OBSERVATION", 4, 20]]], ["The force opposing ventricular ejection is termed afterload.", [["ventricular", "ANATOMY", 19, 30], ["ventricular", "MULTI-TISSUE_STRUCTURE", 19, 30], ["ventricular", "ANATOMY", 19, 30], ["ejection", "OBSERVATION", 31, 39], ["termed afterload", "OBSERVATION", 43, 59]]], ["Aortic input impedance best describes the opposition that the ventricle encounters at the time of ejection.", [["Aortic", "ANATOMY", 0, 6], ["ventricle", "ANATOMY", 62, 71], ["Aortic", "MULTI-TISSUE_STRUCTURE", 0, 6], ["ventricle", "MULTI-TISSUE_STRUCTURE", 62, 71], ["Aortic input impedance", "TREATMENT", 0, 22], ["ventricle", "ANATOMY", 62, 71], ["ejection", "OBSERVATION", 98, 106]]], ["An increase in afterload communicates itself to the ventricles during systole by increasing wall stress.", [["ventricles", "ANATOMY", 52, 62], ["wall", "ANATOMY", 92, 96], ["ventricles", "MULTI-TISSUE_STRUCTURE", 52, 62], ["wall", "IMMATERIAL_ANATOMICAL_ENTITY", 92, 96], ["An increase in afterload", "PROBLEM", 0, 24], ["increasing wall stress", "PROBLEM", 81, 103], ["increase", "OBSERVATION_MODIFIER", 3, 11], ["afterload", "OBSERVATION", 15, 24], ["ventricles", "ANATOMY", 52, 62], ["increasing", "OBSERVATION_MODIFIER", 81, 91], ["wall stress", "OBSERVATION", 92, 103]]], ["Contractility is a change in the heart's ability to do work when the preload, afterload, and HR are kept constant.", [["heart", "ANATOMY", 33, 38], ["Contractility", "DISEASE", 0, 13], ["heart", "ORGAN", 33, 38], ["a change in the heart's ability", "PROBLEM", 17, 48], ["the preload", "TEST", 65, 76], ["afterload", "TEST", 78, 87], ["HR", "TEST", 93, 95], ["change", "OBSERVATION_MODIFIER", 19, 25], ["heart", "ANATOMY", 33, 38]]], ["Diastolic ventricular filling, ventricular wall motion abnormalities, space-occupying lesions, and arrhythmias also affect SV.", [["ventricular", "ANATOMY", 10, 21], ["ventricular wall", "ANATOMY", 31, 47], ["space-occupying lesions", "ANATOMY", 70, 93], ["arrhythmias", "DISEASE", 99, 110], ["Diastolic ventricular", "MULTI-TISSUE_STRUCTURE", 0, 21], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 31, 47], ["space-occupying lesions", "PATHOLOGICAL_FORMATION", 70, 93], ["Diastolic ventricular filling", "PROBLEM", 0, 29], ["ventricular wall motion abnormalities", "PROBLEM", 31, 68], ["space-occupying lesions", "PROBLEM", 70, 93], ["arrhythmias", "PROBLEM", 99, 110], ["ventricular", "ANATOMY", 10, 21], ["filling", "OBSERVATION", 22, 29], ["ventricular", "ANATOMY", 31, 42], ["wall", "ANATOMY_MODIFIER", 43, 47], ["motion abnormalities", "OBSERVATION", 48, 68], ["space", "OBSERVATION_MODIFIER", 70, 75], ["occupying", "OBSERVATION_MODIFIER", 76, 85], ["lesions", "OBSERVATION", 86, 93], ["arrhythmias", "OBSERVATION", 99, 110]]], ["Fig. 10-9 ), pulmonic stenosis (see Fig. 10 -32), \"brisket disease\" (\"high-altitude disease\") in cattle (see Fig. 10 -7), and chronic alveolar emphysema (\"heaves\") in horses (see Fig. 9 -13) (right-sided congestive heart failure).", [["pulmonic", "ANATOMY", 13, 21], ["alveolar", "ANATOMY", 134, 142], ["heaves", "ANATOMY", 155, 161], ["heart", "ANATOMY", 215, 220], ["pulmonic stenosis", "DISEASE", 13, 30], ["brisket disease", "DISEASE", 51, 66], ["high-altitude disease", "DISEASE", 70, 91], ["alveolar emphysema", "DISEASE", 134, 152], ["congestive heart failure", "DISEASE", 204, 228], ["pulmonic", "ORGAN", 13, 21], ["alveolar emphysema", "PATHOLOGICAL_FORMATION", 134, 152], ["heart", "ORGAN", 215, 220], ["cattle", "SPECIES", 97, 103], ["cattle", "SPECIES", 97, 103], ["pulmonic stenosis", "PROBLEM", 13, 30], ["brisket disease\"", "PROBLEM", 51, 67], ["high-altitude disease\"", "PROBLEM", 70, 92], ["chronic alveolar emphysema", "PROBLEM", 126, 152], ["\"heaves\"", "PROBLEM", 154, 162], ["right-sided congestive heart failure", "PROBLEM", 192, 228], ["pulmonic", "ANATOMY", 13, 21], ["stenosis", "OBSERVATION", 22, 30], ["altitude disease", "OBSERVATION", 75, 91], ["chronic", "OBSERVATION_MODIFIER", 126, 133], ["alveolar", "ANATOMY_MODIFIER", 134, 142], ["emphysema", "OBSERVATION", 143, 152], ["right", "ANATOMY_MODIFIER", 192, 197], ["sided", "ANATOMY_MODIFIER", 198, 203], ["congestive", "OBSERVATION", 204, 214], ["heart", "ANATOMY", 215, 220], ["failure", "OBSERVATION", 221, 228]]], ["Leaking valves, an abnormal communication between the systemic and pulmonary circulations, or high-output states (e.g., hyperthyroidism) usually result in increased ventricular volume (increased preload).", [["pulmonary circulations", "ANATOMY", 67, 89], ["ventricular", "ANATOMY", 165, 176], ["hyperthyroidism", "DISEASE", 120, 135], ["valves", "MULTI-TISSUE_STRUCTURE", 8, 14], ["pulmonary circulations", "MULTI-TISSUE_STRUCTURE", 67, 89], ["ventricular", "MULTI-TISSUE_STRUCTURE", 165, 176], ["Leaking valves", "PROBLEM", 0, 14], ["an abnormal communication between the systemic and pulmonary circulations", "PROBLEM", 16, 89], ["high-output states", "PROBLEM", 94, 112], ["hyperthyroidism", "PROBLEM", 120, 135], ["increased ventricular volume", "PROBLEM", 155, 183], ["valves", "OBSERVATION", 8, 14], ["abnormal", "OBSERVATION_MODIFIER", 19, 27], ["communication", "OBSERVATION", 28, 41], ["systemic", "OBSERVATION_MODIFIER", 54, 62], ["pulmonary circulations", "ANATOMY", 67, 89], ["high", "OBSERVATION_MODIFIER", 94, 98], ["output states", "OBSERVATION", 99, 112], ["hyperthyroidism", "OBSERVATION", 120, 135], ["increased", "OBSERVATION_MODIFIER", 155, 164], ["ventricular volume", "OBSERVATION", 165, 183], ["increased preload", "OBSERVATION", 185, 202]]], ["Decrease in contractility lowers the SV, CO, and ABP and negates the heart's ability to compensate for the decrease in CO.", [["heart", "ANATOMY", 69, 74], ["CO", "CHEMICAL", 41, 43], ["CO", "CHEMICAL", 119, 121], ["CO", "SIMPLE_CHEMICAL", 41, 43], ["ABP", "GENE_OR_GENE_PRODUCT", 49, 52], ["heart", "ORGAN", 69, 74], ["CO", "SIMPLE_CHEMICAL", 119, 121], ["ABP", "PROTEIN", 49, 52], ["CO", "TEST", 41, 43], ["ABP", "TEST", 49, 52], ["the decrease in CO", "PROBLEM", 103, 121], ["contractility", "OBSERVATION", 12, 25], ["lowers", "OBSERVATION_MODIFIER", 26, 32], ["SV", "ANATOMY", 37, 39], ["heart", "ANATOMY", 69, 74], ["decrease", "OBSERVATION_MODIFIER", 107, 115]]], ["Diastolic heart failure is characterized by improper filling of ventricles.", [["heart", "ANATOMY", 10, 15], ["ventricles", "ANATOMY", 64, 74], ["Diastolic heart failure", "DISEASE", 0, 23], ["heart", "ORGAN", 10, 15], ["ventricles", "MULTI-TISSUE_STRUCTURE", 64, 74], ["Diastolic heart failure", "PROBLEM", 0, 23], ["improper filling of ventricles", "PROBLEM", 44, 74], ["heart", "ANATOMY", 10, 15], ["failure", "OBSERVATION", 16, 23], ["improper", "OBSERVATION_MODIFIER", 44, 52], ["filling", "OBSERVATION", 53, 60], ["ventricles", "ANATOMY", 64, 74]]], ["This dysfunction may be caused by an impaired energy ventricular relaxation, myocardial dysfunction, obstruction to ventricular filling, or pericardial abnormalities (Box 10-3).Concentric HypertrophyIn pressure overload states, the increase in resistance to ejected blood leads to compensatory dilation (concentric hypertrophy).", [["ventricular", "ANATOMY", 53, 64], ["myocardial", "ANATOMY", 77, 87], ["ventricular", "ANATOMY", 116, 127], ["pericardial", "ANATOMY", 140, 151], ["blood", "ANATOMY", 266, 271], ["myocardial dysfunction", "DISEASE", 77, 99], ["obstruction", "DISEASE", 101, 112], ["ventricular filling", "DISEASE", 116, 135], ["pericardial abnormalities", "DISEASE", 140, 165], ["hypertrophy", "DISEASE", 315, 326], ["ventricular", "MULTI-TISSUE_STRUCTURE", 53, 64], ["myocardial", "MULTI-TISSUE_STRUCTURE", 77, 87], ["ventricular", "MULTI-TISSUE_STRUCTURE", 116, 127], ["pericardial", "ORGAN", 140, 151], ["Box 10-3", "GENE_OR_GENE_PRODUCT", 167, 175], ["blood", "ORGANISM_SUBSTANCE", 266, 271], ["This dysfunction", "PROBLEM", 0, 16], ["an impaired energy ventricular relaxation", "PROBLEM", 34, 75], ["myocardial dysfunction", "PROBLEM", 77, 99], ["obstruction to ventricular filling", "PROBLEM", 101, 135], ["pericardial abnormalities", "PROBLEM", 140, 165], ["Concentric HypertrophyIn pressure overload", "PROBLEM", 177, 219], ["ejected blood", "PROBLEM", 258, 271], ["compensatory dilation", "PROBLEM", 281, 302], ["concentric hypertrophy)", "PROBLEM", 304, 327], ["may be caused", "UNCERTAINTY", 17, 30], ["impaired", "OBSERVATION_MODIFIER", 37, 45], ["energy ventricular relaxation", "OBSERVATION", 46, 75], ["myocardial", "ANATOMY", 77, 87], ["dysfunction", "OBSERVATION", 88, 99], ["obstruction", "OBSERVATION", 101, 112], ["ventricular", "ANATOMY", 116, 127], ["filling", "OBSERVATION", 128, 135], ["pericardial", "ANATOMY", 140, 151], ["abnormalities", "OBSERVATION", 152, 165], ["HypertrophyIn", "OBSERVATION_MODIFIER", 188, 201], ["pressure overload", "OBSERVATION", 202, 219], ["increase", "OBSERVATION_MODIFIER", 232, 240], ["resistance", "OBSERVATION_MODIFIER", 244, 254], ["compensatory", "OBSERVATION_MODIFIER", 281, 293], ["dilation", "OBSERVATION", 294, 302], ["concentric", "OBSERVATION_MODIFIER", 304, 314], ["hypertrophy", "OBSERVATION", 315, 326]]], ["Chamber dilation in turn helps to overcome the increased resistance and to maintain SV at the expense of MVO 2 , which eventually will lead to myocardial failure.Concentric HypertrophyLV wall stress LV pressure LV radius LV wall thickness = \u00d7 2Concentric HypertrophyFrom the previous equation, it can be depicted that decreased wall stress can be achieved by decreasing LV radius and/or by increasing LV wall thickness.", [["myocardial", "ANATOMY", 143, 153], ["wall", "ANATOMY", 187, 191], ["LV", "ANATOMY", 199, 201], ["LV wall", "ANATOMY", 221, 228], ["wall", "ANATOMY", 328, 332], ["LV", "ANATOMY", 370, 372], ["LV wall", "ANATOMY", 401, 408], ["MVO", "DISEASE", 105, 108], ["myocardial failure", "DISEASE", 143, 161], ["myocardial", "MULTI-TISSUE_STRUCTURE", 143, 153], ["HypertrophyLV wall", "TISSUE", 173, 191], ["wall", "TISSUE", 328, 332], ["LV wall", "TISSUE", 401, 408], ["Chamber dilation", "TREATMENT", 0, 16], ["the increased resistance", "PROBLEM", 43, 67], ["myocardial failure", "PROBLEM", 143, 161], ["Concentric HypertrophyLV wall stress", "PROBLEM", 162, 198], ["LV pressure", "TEST", 199, 210], ["LV wall thickness", "TEST", 221, 238], ["decreased wall stress", "PROBLEM", 318, 339], ["increasing LV wall thickness", "PROBLEM", 390, 418], ["dilation", "OBSERVATION", 8, 16], ["increased", "OBSERVATION_MODIFIER", 47, 56], ["resistance", "OBSERVATION", 57, 67], ["myocardial", "ANATOMY", 143, 153], ["failure", "OBSERVATION", 154, 161], ["HypertrophyLV", "OBSERVATION", 173, 186], ["wall", "ANATOMY_MODIFIER", 187, 191], ["stress", "OBSERVATION", 192, 198], ["LV", "ANATOMY_MODIFIER", 199, 201], ["pressure LV", "ANATOMY", 202, 213], ["radius", "ANATOMY_MODIFIER", 214, 220], ["LV", "ANATOMY", 221, 223], ["wall", "ANATOMY_MODIFIER", 224, 228], ["thickness", "OBSERVATION_MODIFIER", 229, 238], ["decreasing", "OBSERVATION_MODIFIER", 359, 369], ["LV radius", "OBSERVATION", 370, 379], ["increasing", "OBSERVATION_MODIFIER", 390, 400], ["LV", "ANATOMY", 401, 403], ["wall", "ANATOMY_MODIFIER", 404, 408], ["thickness", "OBSERVATION_MODIFIER", 409, 418]]], ["With a sustained pressure overload, the ventricular muscle adapts by undergoing concentric hypertrophy, which leads to an increase in wall thickness at the expense of a decrease in chamber size (decrease in ventricular radius), thus returning ventricular wall stress toward normal and increasing contractility.", [["ventricular muscle", "ANATOMY", 40, 58], ["wall", "ANATOMY", 134, 138], ["ventricular", "ANATOMY", 207, 218], ["ventricular wall", "ANATOMY", 243, 259], ["hypertrophy", "DISEASE", 91, 102], ["ventricular muscle", "TISSUE", 40, 58], ["wall", "TISSUE", 134, 138], ["ventricular radius", "MULTI-TISSUE_STRUCTURE", 207, 225], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 243, 259], ["a sustained pressure overload", "PROBLEM", 5, 34], ["concentric hypertrophy", "PROBLEM", 80, 102], ["an increase in wall thickness", "PROBLEM", 119, 148], ["a decrease in chamber size", "PROBLEM", 167, 193], ["sustained", "OBSERVATION_MODIFIER", 7, 16], ["pressure overload", "OBSERVATION", 17, 34], ["ventricular muscle", "ANATOMY", 40, 58], ["concentric", "OBSERVATION_MODIFIER", 80, 90], ["hypertrophy", "OBSERVATION", 91, 102], ["increase", "OBSERVATION_MODIFIER", 122, 130], ["wall", "OBSERVATION_MODIFIER", 134, 138], ["thickness", "OBSERVATION_MODIFIER", 139, 148], ["expense", "OBSERVATION_MODIFIER", 156, 163], ["decrease", "OBSERVATION_MODIFIER", 169, 177], ["chamber", "OBSERVATION_MODIFIER", 181, 188], ["size", "OBSERVATION_MODIFIER", 189, 193], ["decrease", "OBSERVATION_MODIFIER", 195, 203], ["ventricular radius", "ANATOMY", 207, 225], ["ventricular wall", "ANATOMY", 243, 259], ["normal", "OBSERVATION", 274, 280], ["increasing", "OBSERVATION_MODIFIER", 285, 295], ["contractility", "OBSERVATION_MODIFIER", 296, 309]]], ["The SV may result from a decreased contractility (myocardial failure), from a primary increase in ventricular pressure (pressure overload), or or from an increase in ventricular volume (volume overload) (Box 10-2).", [["myocardial", "ANATOMY", 50, 60], ["ventricular", "ANATOMY", 98, 109], ["ventricular", "ANATOMY", 166, 177], ["myocardial failure", "DISEASE", 50, 68], ["SV", "MULTI-TISSUE_STRUCTURE", 4, 6], ["myocardial", "MULTI-TISSUE_STRUCTURE", 50, 60], ["ventricular", "MULTI-TISSUE_STRUCTURE", 98, 109], ["ventricular", "MULTI-TISSUE_STRUCTURE", 166, 177], ["a decreased contractility (myocardial failure", "PROBLEM", 23, 68], ["a primary increase in ventricular pressure (pressure overload", "PROBLEM", 76, 137], ["an increase in ventricular volume (volume overload", "PROBLEM", 151, 201], ["SV", "ANATOMY", 4, 6], ["decreased contractility", "OBSERVATION", 25, 48], ["myocardial failure", "OBSERVATION", 50, 68], ["primary", "OBSERVATION_MODIFIER", 78, 85], ["increase", "OBSERVATION_MODIFIER", 86, 94], ["ventricular", "ANATOMY", 98, 109], ["pressure", "OBSERVATION_MODIFIER", 110, 118], ["pressure overload", "OBSERVATION", 120, 137], ["increase", "OBSERVATION_MODIFIER", 154, 162], ["ventricular", "ANATOMY", 166, 177], ["volume", "OBSERVATION_MODIFIER", 178, 184], ["volume overload", "OBSERVATION", 186, 201]]], ["Myocardial failure may be primary (e.g., dilated cardiomyopathy) or may occur secondary to chronic volume or pressure overload.", [["Myocardial", "ANATOMY", 0, 10], ["Myocardial failure", "DISEASE", 0, 18], ["dilated cardiomyopathy", "DISEASE", 41, 63], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["Myocardial failure", "PROBLEM", 0, 18], ["dilated cardiomyopathy", "PROBLEM", 41, 63], ["chronic volume", "PROBLEM", 91, 105], ["pressure overload", "PROBLEM", 109, 126], ["failure", "OBSERVATION", 11, 18], ["may be", "UNCERTAINTY", 19, 25], ["dilated", "OBSERVATION_MODIFIER", 41, 48], ["cardiomyopathy", "OBSERVATION", 49, 63], ["chronic", "OBSERVATION_MODIFIER", 91, 98], ["volume", "OBSERVATION", 99, 105], ["pressure overload", "OBSERVATION", 109, 126]]], ["The most common causes for pressure overload in domestic animals are subaortic stenosis and hypertension (left-sided congestive heart determinant of early ventricular filling; adrenergic stimulation increases the rate of relaxation, improving relaxation to a greater extent than it improves contractility.", [["subaortic", "ANATOMY", 69, 78], ["heart", "ANATOMY", 128, 133], ["ventricular", "ANATOMY", 155, 166], ["pressure overload", "DISEASE", 27, 44], ["subaortic stenosis", "DISEASE", 69, 87], ["hypertension", "DISEASE", 92, 104], ["subaortic", "MULTI-TISSUE_STRUCTURE", 69, 78], ["heart", "ORGAN", 128, 133], ["ventricular", "MULTI-TISSUE_STRUCTURE", 155, 166], ["pressure overload", "PROBLEM", 27, 44], ["subaortic stenosis", "PROBLEM", 69, 87], ["hypertension (left-sided congestive heart determinant", "PROBLEM", 92, 145], ["early ventricular filling", "PROBLEM", 149, 174], ["adrenergic stimulation", "TREATMENT", 176, 198], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["pressure overload", "OBSERVATION", 27, 44], ["subaortic", "OBSERVATION_MODIFIER", 69, 78], ["stenosis", "OBSERVATION", 79, 87], ["hypertension", "OBSERVATION", 92, 104], ["left", "ANATOMY_MODIFIER", 106, 110], ["sided", "ANATOMY_MODIFIER", 111, 116], ["congestive", "OBSERVATION", 117, 127], ["heart", "ANATOMY", 128, 133], ["early", "OBSERVATION_MODIFIER", 149, 154], ["ventricular filling", "OBSERVATION", 155, 174], ["adrenergic stimulation", "OBSERVATION", 176, 198], ["greater extent", "OBSERVATION_MODIFIER", 259, 273]]], ["Tachycardia shortens the duration of the diastasis.", [["Tachycardia", "DISEASE", 0, 11], ["diastasis", "DISEASE", 41, 50], ["Tachycardia", "PROBLEM", 0, 11], ["the diastasis", "PROBLEM", 37, 50], ["diastasis", "OBSERVATION", 41, 50]]], ["Loss of atrial contraction is one reason why dogs with dilated cardiomyopathy or myxomatous valvular degeneration develop heart failure when the atria start to fibrillate.", [["atrial", "ANATOMY", 8, 14], ["myxomatous valvular", "ANATOMY", 81, 100], ["heart", "ANATOMY", 122, 127], ["atria", "ANATOMY", 145, 150], ["atrial contraction", "DISEASE", 8, 26], ["dilated cardiomyopathy", "DISEASE", 55, 77], ["myxomatous valvular degeneration", "DISEASE", 81, 113], ["heart failure", "DISEASE", 122, 135], ["atrial", "MULTI-TISSUE_STRUCTURE", 8, 14], ["dogs", "ORGANISM", 45, 49], ["valvular", "ORGAN", 92, 100], ["heart", "ORGAN", 122, 127], ["atria", "ORGAN", 145, 150], ["dogs", "SPECIES", 45, 49], ["Loss of atrial contraction", "PROBLEM", 0, 26], ["dilated cardiomyopathy", "PROBLEM", 55, 77], ["myxomatous valvular degeneration", "PROBLEM", 81, 113], ["heart failure", "PROBLEM", 122, 135], ["fibrillate", "PROBLEM", 160, 170], ["atrial", "ANATOMY", 8, 14], ["contraction", "OBSERVATION", 15, 26], ["dilated", "OBSERVATION_MODIFIER", 55, 62], ["cardiomyopathy", "OBSERVATION", 63, 77], ["myxomatous", "OBSERVATION", 81, 91], ["valvular", "ANATOMY", 92, 100], ["degeneration", "OBSERVATION", 101, 113], ["heart", "ANATOMY", 122, 127], ["failure", "OBSERVATION", 128, 135], ["atria", "ANATOMY", 145, 150]]], ["Asynchronous relaxation (decrease in the uniformity of relaxation) of the left ventricle may be observed in cats with restrictive cardiomyopathy.", [["left ventricle", "ANATOMY", 74, 88], ["restrictive cardiomyopathy", "DISEASE", 118, 144], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 74, 88], ["cats", "ORGANISM", 108, 112], ["Asynchronous relaxation", "PROBLEM", 0, 23], ["restrictive cardiomyopathy", "PROBLEM", 118, 144], ["relaxation", "OBSERVATION_MODIFIER", 13, 23], ["decrease", "OBSERVATION_MODIFIER", 25, 33], ["uniformity", "OBSERVATION_MODIFIER", 41, 51], ["relaxation", "OBSERVATION_MODIFIER", 55, 65], ["left ventricle", "ANATOMY", 74, 88], ["may be observed", "UNCERTAINTY", 89, 104], ["restrictive", "OBSERVATION_MODIFIER", 118, 129], ["cardiomyopathy", "OBSERVATION", 130, 144]]], ["LV hypertrophy decreases LV compliance and leads to poor diastolic function because of an increase in cardiomyocyte size, collagen formation, and wall thickening.", [["LV", "ANATOMY", 0, 2], ["LV", "ANATOMY", 25, 27], ["cardiomyocyte", "ANATOMY", 102, 115], ["wall", "ANATOMY", 146, 150], ["LV hypertrophy", "DISEASE", 0, 14], ["LV", "MULTI-TISSUE_STRUCTURE", 0, 2], ["LV", "MULTI-TISSUE_STRUCTURE", 25, 27], ["cardiomyocyte", "CELL", 102, 115], ["collagen", "GENE_OR_GENE_PRODUCT", 122, 130], ["wall", "TISSUE", 146, 150], ["collagen", "PROTEIN", 122, 130], ["LV hypertrophy", "PROBLEM", 0, 14], ["poor diastolic function", "PROBLEM", 52, 75], ["an increase in cardiomyocyte size", "PROBLEM", 87, 120], ["collagen formation", "PROBLEM", 122, 140], ["wall thickening", "PROBLEM", 146, 161], ["hypertrophy", "OBSERVATION", 3, 14], ["LV compliance", "OBSERVATION", 25, 38], ["increase", "OBSERVATION_MODIFIER", 90, 98], ["cardiomyocyte", "ANATOMY", 102, 115], ["size", "OBSERVATION_MODIFIER", 116, 120], ["collagen formation", "OBSERVATION", 122, 140], ["wall", "ANATOMY_MODIFIER", 146, 150], ["thickening", "OBSERVATION", 151, 161]]], ["Constrictive pericardial disease or cardiac tamponade impose their mechanical properties on those of the ventricle during the final phases of diastole.", [["pericardial", "ANATOMY", 13, 24], ["cardiac", "ANATOMY", 36, 43], ["ventricle", "ANATOMY", 105, 114], ["Constrictive pericardial disease", "DISEASE", 0, 32], ["cardiac tamponade", "DISEASE", 36, 53], ["pericardial", "ORGAN", 13, 24], ["cardiac", "ORGAN", 36, 43], ["ventricle", "MULTI-TISSUE_STRUCTURE", 105, 114], ["Constrictive pericardial disease", "PROBLEM", 0, 32], ["cardiac tamponade", "PROBLEM", 36, 53], ["pericardial", "ANATOMY", 13, 24], ["disease", "OBSERVATION", 25, 32], ["cardiac", "ANATOMY", 36, 43], ["tamponade", "OBSERVATION", 44, 53], ["mechanical properties", "OBSERVATION", 67, 88], ["ventricle", "ANATOMY", 105, 114], ["diastole", "OBSERVATION", 142, 150]]], ["Hence, diastolic dysfunction results from abnormal relaxation (early diastole), abnormal compliance (early to late diastole), or external constraint by the pericardium (tamponade).Neuroendocrine Compensatory Mechanisms in Heart FailureHeart failure results in chronic activation of neuroendocrine compensatory mechanisms to restore and maintain ABP.", [["pericardium", "ANATOMY", 156, 167], ["Neuroendocrine", "ANATOMY", 180, 194], ["Heart", "ANATOMY", 222, 227], ["Heart", "ANATOMY", 235, 240], ["neuroendocrine", "ANATOMY", 282, 296], ["diastolic dysfunction", "DISEASE", 7, 28], ["tamponade", "DISEASE", 169, 178], ["Heart Failure", "DISEASE", 222, 235], ["Heart failure", "DISEASE", 235, 248], ["pericardium", "ORGAN", 156, 167], ["Neuroendocrine", "ORGAN", 180, 194], ["Heart", "ORGAN", 235, 240], ["neuroendocrine", "CELL", 282, 296], ["ABP", "GENE_OR_GENE_PRODUCT", 345, 348], ["ABP", "PROTEIN", 345, 348], ["diastolic dysfunction", "PROBLEM", 7, 28], ["abnormal relaxation", "PROBLEM", 42, 61], ["abnormal compliance", "PROBLEM", 80, 99], ["tamponade", "PROBLEM", 169, 178], ["Neuroendocrine Compensatory Mechanisms", "PROBLEM", 180, 218], ["Heart Failure", "PROBLEM", 222, 235], ["Heart failure", "PROBLEM", 235, 248], ["neuroendocrine compensatory mechanisms", "TREATMENT", 282, 320], ["ABP", "TEST", 345, 348], ["diastolic dysfunction", "OBSERVATION", 7, 28], ["abnormal", "OBSERVATION_MODIFIER", 42, 50], ["relaxation", "OBSERVATION_MODIFIER", 51, 61], ["abnormal", "OBSERVATION_MODIFIER", 80, 88], ["compliance", "OBSERVATION_MODIFIER", 89, 99], ["external constraint", "OBSERVATION", 129, 148], ["pericardium", "ANATOMY", 156, 167], ["tamponade", "OBSERVATION", 169, 178], ["Heart", "ANATOMY", 222, 227], ["Failure", "OBSERVATION", 228, 235], ["failure", "OBSERVATION", 241, 248], ["chronic", "OBSERVATION_MODIFIER", 260, 267], ["neuroendocrine compensatory", "OBSERVATION", 282, 309]]], ["High-pressure baroreceptors in the aortic arch and carotid sinus, mechanoreceptors in the ventricular myocardium, volume receptors in the atria and great veins, and the juxtaglomerular apparatus in the kidneys can sense alteration in ABP that results from a diminished CO.", [["aortic arch", "ANATOMY", 35, 46], ["carotid sinus", "ANATOMY", 51, 64], ["mechanoreceptors", "ANATOMY", 66, 82], ["ventricular myocardium", "ANATOMY", 90, 112], ["atria", "ANATOMY", 138, 143], ["great veins", "ANATOMY", 148, 159], ["juxtaglomerular apparatus", "ANATOMY", 169, 194], ["kidneys", "ANATOMY", 202, 209], ["CO", "CHEMICAL", 269, 271], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 35, 46], ["carotid sinus", "MULTI-TISSUE_STRUCTURE", 51, 64], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 90, 112], ["atria", "MULTI-TISSUE_STRUCTURE", 138, 143], ["great veins", "MULTI-TISSUE_STRUCTURE", 148, 159], ["juxtaglomerular apparatus", "IMMATERIAL_ANATOMICAL_ENTITY", 169, 194], ["kidneys", "ORGAN", 202, 209], ["ABP", "GENE_OR_GENE_PRODUCT", 234, 237], ["CO", "SIMPLE_CHEMICAL", 269, 271], ["ABP", "PROTEIN", 234, 237], ["High-pressure baroreceptors", "TREATMENT", 0, 27], ["ABP", "TEST", 234, 237], ["a diminished CO", "PROBLEM", 256, 271], ["pressure baroreceptors", "OBSERVATION", 5, 27], ["aortic arch", "ANATOMY", 35, 46], ["carotid sinus", "ANATOMY", 51, 64], ["mechanoreceptors", "ANATOMY_MODIFIER", 66, 82], ["ventricular myocardium", "ANATOMY", 90, 112], ["volume receptors", "OBSERVATION", 114, 130], ["atria", "ANATOMY", 138, 143], ["great veins", "ANATOMY", 148, 159], ["juxtaglomerular", "ANATOMY", 169, 184], ["kidneys", "ANATOMY", 202, 209], ["diminished", "OBSERVATION_MODIFIER", 258, 268]]], ["A reactive neuroendocrine activation decreases parasympathetic drive (immediate and short-lived) and increases sympathetic drive (slow but long-lasting), causing vasoconstriction (increasing arterial impedance) and tachycardia.", [["neuroendocrine", "ANATOMY", 11, 25], ["arterial", "ANATOMY", 191, 199], ["tachycardia", "DISEASE", 215, 226], ["neuroendocrine", "CELL", 11, 25], ["arterial", "MULTI-TISSUE_STRUCTURE", 191, 199], ["A reactive neuroendocrine activation", "PROBLEM", 0, 36], ["increases sympathetic drive", "PROBLEM", 101, 128], ["vasoconstriction", "PROBLEM", 162, 178], ["increasing arterial impedance)", "PROBLEM", 180, 210], ["tachycardia", "PROBLEM", 215, 226], ["reactive", "OBSERVATION_MODIFIER", 2, 10], ["neuroendocrine activation", "OBSERVATION", 11, 36], ["decreases", "OBSERVATION_MODIFIER", 37, 46], ["parasympathetic drive", "OBSERVATION", 47, 68], ["sympathetic drive", "OBSERVATION", 111, 128], ["vasoconstriction", "OBSERVATION", 162, 178], ["arterial", "ANATOMY", 191, 199], ["tachycardia", "OBSERVATION", 215, 226]]], ["A decrease in renal blood flow leads to renin-angiotensin-aldosterone system (RAAS) activation, contributing to vasoconstriction and sodium and water retention (increases the circulating volume).", [["renal blood", "ANATOMY", 14, 25], ["angiotensin", "CHEMICAL", 46, 57], ["aldosterone", "CHEMICAL", 58, 69], ["sodium", "CHEMICAL", 133, 139], ["aldosterone", "CHEMICAL", 58, 69], ["sodium", "CHEMICAL", 133, 139], ["renal", "ORGAN", 14, 19], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["renin-angiotensin-aldosterone system", "GENE_OR_GENE_PRODUCT", 40, 76], ["RAAS", "GENE_OR_GENE_PRODUCT", 78, 82], ["sodium", "SIMPLE_CHEMICAL", 133, 139], ["water", "SIMPLE_CHEMICAL", 144, 149], ["renin", "PROTEIN", 40, 45], ["A decrease in renal blood flow leads", "PROBLEM", 0, 36], ["renin", "TEST", 40, 45], ["angiotensin-aldosterone system", "TREATMENT", 46, 76], ["vasoconstriction", "PROBLEM", 112, 128], ["sodium and water retention", "PROBLEM", 133, 159], ["the circulating volume)", "TREATMENT", 171, 194], ["decrease", "OBSERVATION_MODIFIER", 2, 10], ["renal", "ANATOMY", 14, 19], ["blood flow", "OBSERVATION", 20, 30], ["vasoconstriction", "OBSERVATION", 112, 128], ["water retention", "OBSERVATION", 144, 159]]], ["To maintain ABP, the cardiovascular system allows the venous pressure to increase and redistributes CO, maintaining blood flow mostly to essential organs.", [["cardiovascular system", "ANATOMY", 21, 42], ["venous", "ANATOMY", 54, 60], ["blood", "ANATOMY", 116, 121], ["organs", "ANATOMY", 147, 153], ["CO", "CHEMICAL", 100, 102], ["ABP", "GENE_OR_GENE_PRODUCT", 12, 15], ["cardiovascular", "ANATOMICAL_SYSTEM", 21, 35], ["system", "ANATOMICAL_SYSTEM", 36, 42], ["venous", "MULTI-TISSUE_STRUCTURE", 54, 60], ["CO", "SIMPLE_CHEMICAL", 100, 102], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["organs", "ORGAN", 147, 153], ["ABP", "PROTEIN", 12, 15], ["ABP", "TEST", 12, 15], ["the cardiovascular system", "TEST", 17, 42], ["the venous pressure", "TEST", 50, 69], ["CO", "TEST", 100, 102], ["blood flow", "TEST", 116, 126], ["venous", "ANATOMY", 54, 60], ["pressure", "OBSERVATION", 61, 69], ["organs", "ANATOMY", 147, 153]]], ["The cardiomyocytes also undergo changes to adapt to ventricular dysfunction, initially by performing extra work (stable hyperfunction) but over a long period these cardiomyocytes die (exhaustion and progressive cardiosclerosis phase).", [["cardiomyocytes", "ANATOMY", 4, 18], ["ventricular", "ANATOMY", 52, 63], ["cardiomyocytes", "ANATOMY", 164, 178], ["ventricular dysfunction", "DISEASE", 52, 75], ["hyperfunction", "DISEASE", 120, 133], ["cardiosclerosis", "DISEASE", 211, 226], ["cardiomyocytes", "CELL", 4, 18], ["ventricular", "MULTI-TISSUE_STRUCTURE", 52, 63], ["cardiomyocytes", "CELL", 164, 178], ["cardiomyocytes", "CELL_TYPE", 4, 18], ["ventricular dysfunction", "PROBLEM", 52, 75], ["exhaustion", "PROBLEM", 184, 194], ["progressive cardiosclerosis phase", "PROBLEM", 199, 232], ["cardiomyocytes", "ANATOMY", 4, 18], ["ventricular", "ANATOMY", 52, 63], ["dysfunction", "OBSERVATION", 64, 75], ["cardiomyocytes", "ANATOMY", 164, 178], ["progressive", "OBSERVATION_MODIFIER", 199, 210], ["cardiosclerosis phase", "OBSERVATION", 211, 232]]], ["The net effect of neuroendocrine activation is vasoconstriction, sodium and water retention, LV hypertrophy, and coronary and peripheral vessel remodeling.Role of Catecholamines in the Progression of Heart FailureDogs with congestive heart failure have increased norepinephrine (NE) concentrations secondary to NE \"spillover\" into plasma, and they have decreased uptake by adrenergic nerve endings.", [["neuroendocrine", "ANATOMY", 18, 32], ["LV", "ANATOMY", 93, 95], ["coronary", "ANATOMY", 113, 121], ["peripheral vessel", "ANATOMY", 126, 143], ["Heart", "ANATOMY", 200, 205], ["heart", "ANATOMY", 234, 239], ["plasma", "ANATOMY", 331, 337], ["adrenergic nerve endings", "ANATOMY", 373, 397], ["sodium", "CHEMICAL", 65, 71], ["LV hypertrophy", "DISEASE", 93, 107], ["Catecholamines", "CHEMICAL", 163, 177], ["congestive heart failure", "DISEASE", 223, 247], ["norepinephrine", "CHEMICAL", 263, 277], ["NE", "CHEMICAL", 279, 281], ["NE", "CHEMICAL", 311, 313], ["sodium", "CHEMICAL", 65, 71], ["Catecholamines", "CHEMICAL", 163, 177], ["norepinephrine", "CHEMICAL", 263, 277], ["neuroendocrine", "CELL", 18, 32], ["sodium", "SIMPLE_CHEMICAL", 65, 71], ["water", "SIMPLE_CHEMICAL", 76, 81], ["LV", "MULTI-TISSUE_STRUCTURE", 93, 95], ["coronary", "MULTI-TISSUE_STRUCTURE", 113, 121], ["peripheral vessel", "MULTI-TISSUE_STRUCTURE", 126, 143], ["heart", "ORGAN", 234, 239], ["norepinephrine", "SIMPLE_CHEMICAL", 263, 277], ["NE", "SIMPLE_CHEMICAL", 279, 281], ["NE", "SIMPLE_CHEMICAL", 311, 313], ["plasma", "ORGANISM_SUBSTANCE", 331, 337], ["nerve endings", "MULTI-TISSUE_STRUCTURE", 384, 397], ["neuroendocrine activation", "PROBLEM", 18, 43], ["vasoconstriction", "PROBLEM", 47, 63], ["sodium and water retention", "PROBLEM", 65, 91], ["LV hypertrophy", "PROBLEM", 93, 107], ["coronary and peripheral vessel remodeling", "PROBLEM", 113, 154], ["Catecholamines", "TREATMENT", 163, 177], ["Heart FailureDogs", "PROBLEM", 200, 217], ["congestive heart failure", "PROBLEM", 223, 247], ["norepinephrine (NE) concentrations", "TREATMENT", 263, 297], ["NE \"spillover", "PROBLEM", 311, 324], ["decreased uptake by adrenergic nerve endings", "PROBLEM", 353, 397], ["net effect", "OBSERVATION_MODIFIER", 4, 14], ["neuroendocrine activation", "OBSERVATION", 18, 43], ["water retention", "OBSERVATION", 76, 91], ["LV", "ANATOMY", 93, 95], ["hypertrophy", "OBSERVATION", 96, 107], ["coronary", "ANATOMY", 113, 121], ["peripheral", "ANATOMY_MODIFIER", 126, 136], ["vessel", "ANATOMY", 137, 143], ["remodeling", "OBSERVATION", 144, 154], ["Catecholamines", "OBSERVATION", 163, 177], ["Heart", "ANATOMY", 200, 205], ["FailureDogs", "OBSERVATION", 206, 217], ["congestive", "OBSERVATION", 223, 233], ["heart", "ANATOMY", 234, 239], ["failure", "OBSERVATION", 240, 247], ["increased", "OBSERVATION_MODIFIER", 253, 262], ["norepinephrine", "OBSERVATION_MODIFIER", 263, 277], ["decreased", "OBSERVATION_MODIFIER", 353, 362], ["uptake", "OBSERVATION", 363, 369], ["adrenergic nerve", "ANATOMY", 373, 389]]], ["Despite the increase in the plasma concentration of NE, there is depletion of NE from the atria and ventricles (secondary to \u03b2-adrenoreceptor downregulation), which blunts the response to sympathetic activation.", [["plasma", "ANATOMY", 28, 34], ["atria", "ANATOMY", 90, 95], ["ventricles", "ANATOMY", 100, 110], ["NE", "CHEMICAL", 52, 54], ["NE", "CHEMICAL", 78, 80], ["plasma", "ORGANISM_SUBSTANCE", 28, 34], ["NE", "SIMPLE_CHEMICAL", 52, 54], ["NE", "SIMPLE_CHEMICAL", 78, 80], ["atria", "MULTI-TISSUE_STRUCTURE", 90, 95], ["ventricles", "MULTI-TISSUE_STRUCTURE", 100, 110], ["\u03b2-adrenoreceptor", "GENE_OR_GENE_PRODUCT", 125, 141], ["NE", "PROTEIN", 52, 54], ["NE", "PROTEIN", 78, 80], ["\u03b2-adrenoreceptor", "PROTEIN", 125, 141], ["the plasma concentration of NE", "TREATMENT", 24, 54], ["depletion of NE from the atria and ventricles", "PROBLEM", 65, 110], ["\u03b2-adrenoreceptor downregulation", "PROBLEM", 125, 156], ["sympathetic activation", "PROBLEM", 188, 210], ["increase", "OBSERVATION_MODIFIER", 12, 20], ["depletion", "OBSERVATION", 65, 74], ["NE", "OBSERVATION", 78, 80], ["atria", "ANATOMY", 90, 95], ["ventricles", "ANATOMY", 100, 110], ["\u03b2-adrenoreceptor downregulation", "OBSERVATION", 125, 156], ["sympathetic activation", "OBSERVATION", 188, 210]]], ["In normal hearts, the ratio of \u03b2 1 to \u03b2 2 receptors is approximately 80 : 20, whereas in failing hearts, it approaches 60 : 40.", [["hearts", "ANATOMY", 10, 16], ["hearts", "ANATOMY", 97, 103], ["hearts", "ORGAN", 10, 16], ["\u03b2 1", "GENE_OR_GENE_PRODUCT", 31, 34], ["\u03b2 2 receptors", "GENE_OR_GENE_PRODUCT", 38, 51], ["hearts", "ORGAN", 97, 103], ["\u03b2 1", "PROTEIN", 31, 34], ["\u03b2 2 receptors", "PROTEIN", 38, 51], ["the ratio", "TEST", 18, 27], ["normal", "OBSERVATION", 3, 9], ["hearts", "ANATOMY", 10, 16], ["hearts", "ANATOMY", 97, 103]]], ["The decrease in NE stores and the changes in adrenoreceptors lead to a decrease in the contractile response of the myocardial cells and in a positive chronotropic response (increased HR).", [["myocardial cells", "ANATOMY", 115, 131], ["NE", "CHEMICAL", 16, 18], ["NE", "SIMPLE_CHEMICAL", 16, 18], ["adrenoreceptors", "SIMPLE_CHEMICAL", 45, 60], ["myocardial cells", "CELL", 115, 131], ["NE", "PROTEIN", 16, 18], ["adrenoreceptors", "PROTEIN", 45, 60], ["myocardial cells", "CELL_TYPE", 115, 131], ["The decrease in NE stores", "PROBLEM", 0, 25], ["the changes in adrenoreceptors", "PROBLEM", 30, 60], ["a decrease", "PROBLEM", 69, 79], ["the myocardial cells", "PROBLEM", 111, 131], ["a positive chronotropic response", "PROBLEM", 139, 171], ["decrease", "OBSERVATION_MODIFIER", 4, 12], ["NE stores", "OBSERVATION", 16, 25], ["decrease", "OBSERVATION_MODIFIER", 71, 79], ["contractile response", "OBSERVATION", 87, 107], ["myocardial cells", "ANATOMY", 115, 131], ["positive chronotropic response", "OBSERVATION", 141, 171]]], ["Chronic adrenergic stimulation also leads to an increase in afterload and MVO 2 , development of ventricular arrhythmias, and progression to left ventricular dysfunction.Role of Baroreceptors in the Progression of Heart FailureBaroreflex control is altered during congestive heart failure.", [["ventricular", "ANATOMY", 97, 108], ["left ventricular", "ANATOMY", 141, 157], ["Heart", "ANATOMY", 214, 219], ["heart", "ANATOMY", 275, 280], ["MVO", "DISEASE", 74, 77], ["ventricular arrhythmias", "DISEASE", 97, 120], ["left ventricular dysfunction", "DISEASE", 141, 169], ["congestive heart failure", "DISEASE", 264, 288], ["ventricular", "MULTI-TISSUE_STRUCTURE", 97, 108], ["left ventricular", "MULTI-TISSUE_STRUCTURE", 141, 157], ["Baroreceptors", "GENE_OR_GENE_PRODUCT", 178, 191], ["Heart", "ORGAN", 214, 219], ["heart", "ORGAN", 275, 280], ["Chronic adrenergic stimulation", "TREATMENT", 0, 30], ["afterload and MVO", "TREATMENT", 60, 77], ["ventricular arrhythmias", "PROBLEM", 97, 120], ["left ventricular dysfunction", "PROBLEM", 141, 169], ["Baroreceptors", "TREATMENT", 178, 191], ["Heart FailureBaroreflex control", "TREATMENT", 214, 245], ["congestive heart failure", "PROBLEM", 264, 288], ["adrenergic stimulation", "OBSERVATION", 8, 30], ["increase", "OBSERVATION_MODIFIER", 48, 56], ["afterload", "OBSERVATION", 60, 69], ["ventricular", "ANATOMY", 97, 108], ["arrhythmias", "OBSERVATION", 109, 120], ["left ventricular", "ANATOMY", 141, 157], ["dysfunction", "OBSERVATION", 158, 169], ["Progression", "OBSERVATION_MODIFIER", 199, 210], ["Heart", "ANATOMY", 214, 219], ["FailureBaroreflex", "OBSERVATION", 220, 237], ["congestive", "OBSERVATION_MODIFIER", 264, 274], ["heart", "ANATOMY", 275, 280], ["failure", "OBSERVATION", 281, 288]]], ["Normally, an increase in atrial pressure (volume overload) stimulates atrial stretch receptors, inhibits the release of antidiuretic hormone (ADH), decreases sympathetic activity, and increases renal blood hypertrophied ventricle is prone to ischemia, which leads to fibrosis and an increase in collagen content that interferes with diastolic filling, decreasing preload and SV.", [["atrial", "ANATOMY", 25, 31], ["atrial", "ANATOMY", 70, 76], ["renal blood hypertrophied ventricle", "ANATOMY", 194, 229], ["ischemia", "DISEASE", 242, 250], ["fibrosis", "DISEASE", 267, 275], ["atrial", "MULTI-TISSUE_STRUCTURE", 25, 31], ["antidiuretic hormone", "GENE_OR_GENE_PRODUCT", 120, 140], ["ADH", "GENE_OR_GENE_PRODUCT", 142, 145], ["renal blood hypertrophied ventricle", "MULTI-TISSUE_STRUCTURE", 194, 229], ["collagen", "GENE_OR_GENE_PRODUCT", 295, 303], ["atrial stretch receptors", "PROTEIN", 70, 94], ["collagen", "PROTEIN", 295, 303], ["an increase in atrial pressure (volume overload", "PROBLEM", 10, 57], ["atrial stretch receptors", "PROBLEM", 70, 94], ["antidiuretic hormone (ADH)", "PROBLEM", 120, 146], ["decreases sympathetic activity", "PROBLEM", 148, 178], ["increases renal blood hypertrophied ventricle", "PROBLEM", 184, 229], ["ischemia", "PROBLEM", 242, 250], ["fibrosis", "PROBLEM", 267, 275], ["an increase in collagen content", "PROBLEM", 280, 311], ["diastolic filling", "PROBLEM", 333, 350], ["decreasing preload", "PROBLEM", 352, 370], ["increase", "OBSERVATION_MODIFIER", 13, 21], ["atrial", "ANATOMY", 25, 31], ["pressure", "OBSERVATION_MODIFIER", 32, 40], ["volume overload", "OBSERVATION", 42, 57], ["atrial", "ANATOMY", 70, 76], ["antidiuretic hormone", "OBSERVATION", 120, 140], ["sympathetic activity", "OBSERVATION", 158, 178], ["renal", "ANATOMY", 194, 199], ["blood", "ANATOMY_MODIFIER", 200, 205], ["hypertrophied ventricle", "ANATOMY", 206, 229], ["ischemia", "OBSERVATION", 242, 250], ["fibrosis", "OBSERVATION", 267, 275], ["increase", "OBSERVATION_MODIFIER", 283, 291], ["collagen content", "OBSERVATION", 295, 311], ["diastolic filling", "OBSERVATION", 333, 350], ["decreasing", "OBSERVATION_MODIFIER", 352, 362], ["preload", "OBSERVATION_MODIFIER", 363, 370], ["SV", "ANATOMY", 375, 377]]], ["Therefore, in the end both systolic and diastolic dysfunction occur.Eccentric HypertrophyIn volume overload, the increase in chamber size occurs as a result of the need to accommodate a large ventricular EDV.", [["ventricular", "ANATOMY", 192, 203], ["systolic and diastolic dysfunction", "DISEASE", 27, 61], ["Hypertrophy", "DISEASE", 78, 89], ["volume overload", "DISEASE", 92, 107], ["ventricular", "MULTI-TISSUE_STRUCTURE", 192, 203], ["diastolic dysfunction", "PROBLEM", 40, 61], ["Eccentric Hypertrophy", "PROBLEM", 68, 89], ["volume overload", "PROBLEM", 92, 107], ["the increase in chamber size", "PROBLEM", 109, 137], ["a large ventricular EDV", "PROBLEM", 184, 207], ["systolic", "OBSERVATION_MODIFIER", 27, 35], ["diastolic dysfunction", "OBSERVATION", 40, 61], ["Hypertrophy", "OBSERVATION", 78, 89], ["volume overload", "OBSERVATION", 92, 107], ["increase", "OBSERVATION_MODIFIER", 113, 121], ["chamber", "OBSERVATION_MODIFIER", 125, 132], ["size", "OBSERVATION_MODIFIER", 133, 137], ["large", "OBSERVATION_MODIFIER", 186, 191], ["ventricular", "ANATOMY", 192, 203], ["EDV", "OBSERVATION", 204, 207]]], ["Dilation of the ventricle by increasing the EDV leads to a lesser increase in wall stress than in pressure overload, and it subsequently results in ventricular eccentric hypertrophy in order to normalize wall stress.", [["ventricle", "ANATOMY", 16, 25], ["wall", "ANATOMY", 78, 82], ["ventricular", "ANATOMY", 148, 159], ["wall", "ANATOMY", 204, 208], ["ventricular eccentric hypertrophy", "DISEASE", 148, 181], ["ventricle", "MULTI-TISSUE_STRUCTURE", 16, 25], ["wall", "TISSUE", 78, 82], ["wall", "TISSUE", 204, 208], ["Dilation of the ventricle", "PROBLEM", 0, 25], ["a lesser increase in wall stress", "PROBLEM", 57, 89], ["pressure overload", "PROBLEM", 98, 115], ["ventricular eccentric hypertrophy", "PROBLEM", 148, 181], ["wall stress", "PROBLEM", 204, 215], ["ventricle", "ANATOMY", 16, 25], ["increasing", "OBSERVATION_MODIFIER", 29, 39], ["EDV", "OBSERVATION", 44, 47], ["lesser", "OBSERVATION_MODIFIER", 59, 65], ["increase", "OBSERVATION_MODIFIER", 66, 74], ["wall stress", "OBSERVATION", 78, 89], ["pressure overload", "OBSERVATION", 98, 115], ["ventricular", "ANATOMY", 148, 159], ["eccentric", "OBSERVATION_MODIFIER", 160, 169], ["hypertrophy", "OBSERVATION", 170, 181], ["wall stress", "OBSERVATION", 204, 215]]], ["Volume overload is marked by an eccentric hypertrophy with a mild increase in wall thickness in the face of a large increase in LV radius.Eccentric HypertrophyDiastole can be divided into four phases: (1) isovolumic relaxation (aortic valve closure to mitral valve opening), (2) rapid early mitral inflow (rapid filling phase during which most of ventricular filling occurs), (3) diastasis (slow filling phase during which little change occurs in ventricular volume and pressure), and (4) atrial contraction (atrial systole that actively pumps blood to the ventricle).", [["wall", "ANATOMY", 78, 82], ["LV", "ANATOMY", 128, 130], ["aortic valve", "ANATOMY", 228, 240], ["mitral valve", "ANATOMY", 252, 264], ["mitral", "ANATOMY", 291, 297], ["ventricular", "ANATOMY", 347, 358], ["ventricular", "ANATOMY", 447, 458], ["atrial", "ANATOMY", 489, 495], ["atrial", "ANATOMY", 509, 515], ["blood", "ANATOMY", 544, 549], ["ventricle", "ANATOMY", 557, 566], ["Volume overload", "DISEASE", 0, 15], ["hypertrophy", "DISEASE", 42, 53], ["diastasis", "DISEASE", 380, 389], ["wall", "TISSUE", 78, 82], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 228, 240], ["mitral", "MULTI-TISSUE_STRUCTURE", 291, 297], ["ventricular", "MULTI-TISSUE_STRUCTURE", 347, 358], ["ventricular", "MULTI-TISSUE_STRUCTURE", 447, 458], ["atrial", "MULTI-TISSUE_STRUCTURE", 489, 495], ["atrial", "MULTI-TISSUE_STRUCTURE", 509, 515], ["blood", "ORGANISM_SUBSTANCE", 544, 549], ["ventricle", "MULTI-TISSUE_STRUCTURE", 557, 566], ["Volume overload", "PROBLEM", 0, 15], ["an eccentric hypertrophy", "PROBLEM", 29, 53], ["a mild increase in wall thickness", "PROBLEM", 59, 92], ["a large increase in LV radius", "PROBLEM", 108, 137], ["Eccentric HypertrophyDiastole", "PROBLEM", 138, 167], ["isovolumic relaxation", "TREATMENT", 205, 226], ["aortic valve closure", "TREATMENT", 228, 248], ["mitral valve opening", "TREATMENT", 252, 272], ["rapid early mitral inflow (rapid filling phase", "PROBLEM", 279, 325], ["diastasis (slow filling phase", "PROBLEM", 380, 409], ["ventricular volume", "TEST", 447, 465], ["(4) atrial contraction (atrial systole", "PROBLEM", 485, 523], ["overload", "OBSERVATION", 7, 15], ["marked", "OBSERVATION_MODIFIER", 19, 25], ["eccentric", "OBSERVATION_MODIFIER", 32, 41], ["hypertrophy", "OBSERVATION", 42, 53], ["mild", "OBSERVATION_MODIFIER", 61, 65], ["increase", "OBSERVATION_MODIFIER", 66, 74], ["wall", "ANATOMY_MODIFIER", 78, 82], ["thickness", "OBSERVATION_MODIFIER", 83, 92], ["face", "ANATOMY_MODIFIER", 100, 104], ["large", "OBSERVATION_MODIFIER", 110, 115], ["increase", "OBSERVATION_MODIFIER", 116, 124], ["LV", "ANATOMY", 128, 130], ["radius", "ANATOMY_MODIFIER", 131, 137], ["aortic valve", "ANATOMY", 228, 240], ["closure", "OBSERVATION", 241, 248], ["mitral valve", "ANATOMY", 252, 264], ["mitral", "OBSERVATION", 291, 297], ["inflow", "ANATOMY_MODIFIER", 298, 304], ["filling phase", "OBSERVATION", 312, 325], ["diastasis", "OBSERVATION", 380, 389], ["ventricular", "ANATOMY", 447, 458], ["pressure", "OBSERVATION_MODIFIER", 470, 478], ["atrial contraction", "ANATOMY", 489, 507], ["atrial systole", "ANATOMY", 509, 523], ["ventricle", "ANATOMY", 557, 566]]], ["Diastolic ventricular filling takes place during the second through fourth phases.", [["ventricular", "ANATOMY", 10, 21], ["Diastolic ventricular", "MULTI-TISSUE_STRUCTURE", 0, 21], ["Diastolic ventricular filling", "PROBLEM", 0, 29], ["ventricular", "ANATOMY", 10, 21], ["filling", "OBSERVATION", 22, 29]]], ["Relaxation (phase 1) is a dynamic, energydependent process. \u03b2-Adrenergic stimulation improves relaxation, whereas ischemia, asynchrony of relaxation, an increase in afterload, ventricular hypertrophy, and abnormal calcium fluxes in the myocardial cells delay relaxation.", [["ventricular", "ANATOMY", 176, 187], ["myocardial cells", "ANATOMY", 236, 252], ["ischemia", "DISEASE", 114, 122], ["ventricular hypertrophy", "DISEASE", 176, 199], ["calcium", "CHEMICAL", 214, 221], ["calcium", "CHEMICAL", 214, 221], ["\u03b2-Adrenergic", "GENE_OR_GENE_PRODUCT", 60, 72], ["ventricular", "MULTI-TISSUE_STRUCTURE", 176, 187], ["calcium", "SIMPLE_CHEMICAL", 214, 221], ["myocardial cells", "CELL", 236, 252], ["myocardial cells", "CELL_TYPE", 236, 252], ["a dynamic, energydependent process", "PROBLEM", 24, 58], ["Adrenergic stimulation", "TREATMENT", 62, 84], ["ischemia", "PROBLEM", 114, 122], ["asynchrony of relaxation", "PROBLEM", 124, 148], ["an increase in afterload", "PROBLEM", 150, 174], ["ventricular hypertrophy", "PROBLEM", 176, 199], ["abnormal calcium fluxes", "PROBLEM", 205, 228], ["the myocardial cells delay relaxation", "PROBLEM", 232, 269], ["Adrenergic stimulation", "OBSERVATION", 62, 84], ["increase", "OBSERVATION_MODIFIER", 153, 161], ["afterload", "OBSERVATION", 165, 174], ["ventricular", "ANATOMY", 176, 187], ["hypertrophy", "OBSERVATION", 188, 199], ["abnormal", "OBSERVATION_MODIFIER", 205, 213], ["calcium fluxes", "OBSERVATION", 214, 228], ["myocardial cells", "ANATOMY", 236, 252]]], ["Ventricular compliance (phases 2 through 4) is the ability of the heart to fill passively.", [["Ventricular", "ANATOMY", 0, 11], ["heart", "ANATOMY", 66, 71], ["Ventricular", "MULTI-TISSUE_STRUCTURE", 0, 11], ["heart", "ORGAN", 66, 71], ["heart", "ANATOMY", 66, 71]]], ["Ventricular compliance is determined by volume, geometry, and the tissue characteristics of the ventricular wall.", [["Ventricular", "ANATOMY", 0, 11], ["tissue", "ANATOMY", 66, 72], ["ventricular wall", "ANATOMY", 96, 112], ["Ventricular", "MULTI-TISSUE_STRUCTURE", 0, 11], ["tissue", "TISSUE", 66, 72], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 96, 112], ["Ventricular compliance", "TEST", 0, 22], ["compliance", "OBSERVATION", 12, 22], ["volume", "OBSERVATION", 40, 46], ["geometry", "OBSERVATION_MODIFIER", 48, 56], ["ventricular", "ANATOMY", 96, 107], ["wall", "ANATOMY_MODIFIER", 108, 112]]], ["Ventricular compliance decreases with an increase in filling pressure and intrinsic myocardial stiffness (e.g., infiltrative diseases, fibrosis, and ischemia), with hypertrophy and cardiac tamponade.", [["Ventricular", "ANATOMY", 0, 11], ["myocardial", "ANATOMY", 84, 94], ["cardiac", "ANATOMY", 181, 188], ["myocardial stiffness", "DISEASE", 84, 104], ["fibrosis", "DISEASE", 135, 143], ["ischemia", "DISEASE", 149, 157], ["hypertrophy", "DISEASE", 165, 176], ["cardiac tamponade", "DISEASE", 181, 198], ["Ventricular", "MULTI-TISSUE_STRUCTURE", 0, 11], ["myocardial", "MULTI-TISSUE_STRUCTURE", 84, 94], ["cardiac", "ORGAN", 181, 188], ["Ventricular compliance decreases", "PROBLEM", 0, 32], ["an increase in filling pressure", "PROBLEM", 38, 69], ["intrinsic myocardial stiffness", "PROBLEM", 74, 104], ["infiltrative diseases", "PROBLEM", 112, 133], ["fibrosis", "PROBLEM", 135, 143], ["ischemia", "PROBLEM", 149, 157], ["hypertrophy", "PROBLEM", 165, 176], ["cardiac tamponade", "PROBLEM", 181, 198], ["compliance", "OBSERVATION", 12, 22], ["decreases", "OBSERVATION_MODIFIER", 23, 32], ["increase", "OBSERVATION_MODIFIER", 41, 49], ["filling pressure", "OBSERVATION", 53, 69], ["intrinsic myocardial stiffness", "OBSERVATION", 74, 104], ["infiltrative", "OBSERVATION_MODIFIER", 112, 124], ["fibrosis", "OBSERVATION", 135, 143], ["ischemia", "OBSERVATION", 149, 157], ["hypertrophy", "OBSERVATION", 165, 176], ["cardiac", "ANATOMY", 181, 188], ["tamponade", "OBSERVATION", 189, 198]]], ["Lusitropy comprises the relaxation and filling phases.", [["Lusitropy", "CHEMICAL", 0, 9], ["Lusitropy", "TREATMENT", 0, 9], ["filling phases", "OBSERVATION", 39, 53]]], ["Ventricular filling may be affected by several factors, including isovolumic relaxation rate, synchrony between atrial kick and ventricular relaxation, compliance, and atrioventricular pressure gradient.", [["Ventricular", "ANATOMY", 0, 11], ["atrial", "ANATOMY", 112, 118], ["ventricular", "ANATOMY", 128, 139], ["atrioventricular", "ANATOMY", 168, 184], ["Ventricular", "MULTI-TISSUE_STRUCTURE", 0, 11], ["atrial", "MULTI-TISSUE_STRUCTURE", 112, 118], ["ventricular", "MULTI-TISSUE_STRUCTURE", 128, 139], ["Ventricular filling", "PROBLEM", 0, 19], ["isovolumic relaxation rate", "PROBLEM", 66, 92], ["atrial kick", "TEST", 112, 123], ["ventricular relaxation", "TREATMENT", 128, 150], ["atrioventricular pressure gradient", "TEST", 168, 202], ["filling", "OBSERVATION", 12, 19], ["may be", "UNCERTAINTY", 20, 26], ["isovolumic relaxation", "OBSERVATION", 66, 87], ["atrial", "ANATOMY", 112, 118], ["ventricular relaxation", "ANATOMY", 128, 150], ["atrioventricular", "OBSERVATION", 168, 184], ["pressure gradient", "OBSERVATION", 185, 202]]], ["The latter is the driving force for ventricular filling (which is mostly affected by intravascular volume and the degree of vasodilatation).", [["ventricular", "ANATOMY", 36, 47], ["intravascular", "ANATOMY", 85, 98], ["ventricular", "MULTI-TISSUE_STRUCTURE", 36, 47], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 85, 98], ["ventricular filling", "PROBLEM", 36, 55], ["intravascular volume", "TEST", 85, 105], ["vasodilatation", "PROBLEM", 124, 138], ["ventricular", "ANATOMY", 36, 47], ["filling", "OBSERVATION", 48, 55], ["vasodilatation", "OBSERVATION", 124, 138]]], ["The isovolumic relaxation rate is also an importantPERICARDIAL ABNORMALITIES\u2022 Constrictive disease \u2022 Cardiac tamponade Box 10-3 Mechanisms Leading to Diastolic Heart Failure diastolic function.", [["Cardiac", "ANATOMY", 101, 108], ["Heart", "ANATOMY", 160, 165], ["Constrictive disease", "DISEASE", 78, 98], ["Cardiac tamponade", "DISEASE", 101, 118], ["The isovolumic relaxation rate", "TREATMENT", 0, 30], ["PERICARDIAL ABNORMALITIES", "PROBLEM", 51, 76], ["Constrictive disease", "PROBLEM", 78, 98], ["Cardiac tamponade Box", "PROBLEM", 101, 122], ["Diastolic Heart Failure diastolic function", "PROBLEM", 150, 192], ["isovolumic relaxation", "OBSERVATION", 4, 25], ["ABNORMALITIES", "OBSERVATION", 63, 76], ["Constrictive", "OBSERVATION_MODIFIER", 78, 90], ["disease", "OBSERVATION", 91, 98], ["Cardiac", "ANATOMY", 101, 108], ["tamponade", "OBSERVATION", 109, 118], ["Diastolic", "ANATOMY_MODIFIER", 150, 159], ["Heart", "ANATOMY", 160, 165], ["Failure", "OBSERVATION", 166, 173], ["diastolic function", "OBSERVATION", 174, 192]]], ["When early interstitial fibrosis progresses to individuation of cardiac myocytes (with progression of hypertrophy), both systolic and diastolic functions are impaired.", [["interstitial", "ANATOMY", 11, 23], ["cardiac myocytes", "ANATOMY", 64, 80], ["fibrosis", "DISEASE", 24, 32], ["hypertrophy", "DISEASE", 102, 113], ["interstitial", "IMMATERIAL_ANATOMICAL_ENTITY", 11, 23], ["cardiac myocytes", "CELL", 64, 80], ["early interstitial fibrosis", "PROBLEM", 5, 32], ["cardiac myocytes", "PROBLEM", 64, 80], ["hypertrophy", "PROBLEM", 102, 113], ["both systolic and diastolic functions", "TEST", 116, 153], ["early", "OBSERVATION_MODIFIER", 5, 10], ["interstitial", "ANATOMY_MODIFIER", 11, 23], ["fibrosis", "OBSERVATION", 24, 32], ["cardiac myocytes", "ANATOMY", 64, 80], ["hypertrophy", "OBSERVATION", 102, 113], ["systolic", "OBSERVATION_MODIFIER", 121, 129], ["diastolic functions", "OBSERVATION", 134, 153], ["impaired", "OBSERVATION_MODIFIER", 158, 166]]], ["Therefore congestive heart failure is a progressive and irreversible disease with myocardial cell death and functional myocardial failure that ultimately leads to death.", [["heart", "ANATOMY", 21, 26], ["myocardial cell", "ANATOMY", 82, 97], ["myocardial", "ANATOMY", 119, 129], ["congestive heart failure", "DISEASE", 10, 34], ["myocardial cell death", "DISEASE", 82, 103], ["myocardial failure", "DISEASE", 119, 137], ["death", "DISEASE", 163, 168], ["heart", "ORGAN", 21, 26], ["myocardial cell", "CELL", 82, 97], ["myocardial", "MULTI-TISSUE_STRUCTURE", 119, 129], ["congestive heart failure", "PROBLEM", 10, 34], ["a progressive and irreversible disease", "PROBLEM", 38, 76], ["myocardial cell death", "PROBLEM", 82, 103], ["functional myocardial failure", "PROBLEM", 108, 137], ["death", "PROBLEM", 163, 168], ["congestive", "OBSERVATION", 10, 20], ["heart", "ANATOMY", 21, 26], ["failure", "OBSERVATION", 27, 34], ["progressive", "OBSERVATION_MODIFIER", 40, 51], ["irreversible", "OBSERVATION_MODIFIER", 56, 68], ["disease", "OBSERVATION", 69, 76], ["myocardial cell death", "OBSERVATION", 82, 103], ["functional myocardial failure", "OBSERVATION", 108, 137]]], ["The cycles resulting in progressive left heart failure are detailed in Fig. 10 -8.Cardiac SyncopeCardiac syncope, an acute expression of cardiac disease, is characterized clinically by collapse, loss of consciousness, and extreme changes in heart rate and blood pressure, and with or without demonstrable lesions.", [["left heart", "ANATOMY", 36, 46], ["Cardiac", "ANATOMY", 82, 89], ["cardiac", "ANATOMY", 137, 144], ["heart", "ANATOMY", 241, 246], ["blood", "ANATOMY", 256, 261], ["lesions", "ANATOMY", 305, 312], ["left heart failure", "DISEASE", 36, 54], ["Cardiac SyncopeCardiac syncope", "DISEASE", 82, 112], ["cardiac disease", "DISEASE", 137, 152], ["loss of consciousness", "DISEASE", 195, 216], ["heart", "ORGAN", 41, 46], ["cardiac", "ORGAN", 137, 144], ["heart", "ORGAN", 241, 246], ["blood", "ORGANISM_SUBSTANCE", 256, 261], ["lesions", "PATHOLOGICAL_FORMATION", 305, 312], ["progressive left heart failure", "PROBLEM", 24, 54], ["Cardiac SyncopeCardiac syncope", "PROBLEM", 82, 112], ["cardiac disease", "PROBLEM", 137, 152], ["collapse", "PROBLEM", 185, 193], ["loss of consciousness", "PROBLEM", 195, 216], ["extreme changes in heart rate", "PROBLEM", 222, 251], ["blood pressure", "TEST", 256, 270], ["demonstrable lesions", "PROBLEM", 292, 312], ["progressive", "OBSERVATION_MODIFIER", 24, 35], ["left", "ANATOMY_MODIFIER", 36, 40], ["heart", "ANATOMY", 41, 46], ["failure", "OBSERVATION", 47, 54], ["SyncopeCardiac", "OBSERVATION_MODIFIER", 90, 104], ["syncope", "OBSERVATION", 105, 112], ["acute", "OBSERVATION_MODIFIER", 117, 122], ["cardiac", "ANATOMY", 137, 144], ["disease", "OBSERVATION", 145, 152], ["collapse", "OBSERVATION", 185, 193], ["heart", "ANATOMY", 241, 246], ["without", "UNCERTAINTY", 284, 291], ["lesions", "OBSERVATION", 305, 312]]], ["Syncope can be caused by massive myocardial necrosis, ventricular fibrillation, heart block, arrhythmias, and reflex cardiac inhibition (e.g., that associated with high intestinal blockage).Types of Heart FailureA wide variety of experimental animal models of heart failure exist (E-Clinical Diagnostic ProceduresFor information on this topic, see E-Appendix 10-3 at www.expertconsult.com.Responses to Injury: MyocardiumCommon responses of the myocardium to injury are listed in Box 10-4.Disturbances of CirculationHemorrhage: Trauma (Physical Injury).", [["myocardial", "ANATOMY", 33, 43], ["ventricular", "ANATOMY", 54, 65], ["heart", "ANATOMY", 80, 85], ["cardiac", "ANATOMY", 117, 124], ["intestinal", "ANATOMY", 169, 179], ["heart", "ANATOMY", 260, 265], ["myocardium", "ANATOMY", 444, 454], ["Syncope", "DISEASE", 0, 7], ["myocardial necrosis", "DISEASE", 33, 52], ["ventricular fibrillation", "DISEASE", 54, 78], ["heart block", "DISEASE", 80, 91], ["arrhythmias", "DISEASE", 93, 104], ["Heart FailureA", "DISEASE", 199, 213], ["heart failure", "DISEASE", 260, 273], ["Injury", "DISEASE", 402, 408], ["CirculationHemorrhage", "DISEASE", 504, 525], ["Trauma", "DISEASE", 527, 533], ["Injury", "DISEASE", 544, 550], ["myocardial", "MULTI-TISSUE_STRUCTURE", 33, 43], ["ventricular", "MULTI-TISSUE_STRUCTURE", 54, 65], ["heart", "ORGAN", 80, 85], ["cardiac", "ORGAN", 117, 124], ["intestinal", "ORGAN", 169, 179], ["heart", "ORGAN", 260, 265], ["myocardium", "ORGAN", 444, 454], ["Box 10-4", "DNA", 479, 487], ["Syncope", "PROBLEM", 0, 7], ["massive myocardial necrosis", "PROBLEM", 25, 52], ["ventricular fibrillation", "PROBLEM", 54, 78], ["heart block", "PROBLEM", 80, 91], ["arrhythmias", "PROBLEM", 93, 104], ["reflex cardiac inhibition", "PROBLEM", 110, 135], ["high intestinal blockage", "PROBLEM", 164, 188], ["Heart FailureA", "PROBLEM", 199, 213], ["heart failure", "PROBLEM", 260, 273], ["Injury", "PROBLEM", 402, 408], ["injury", "PROBLEM", 458, 464], ["Disturbances of CirculationHemorrhage", "PROBLEM", 488, 525], ["Trauma (Physical Injury", "PROBLEM", 527, 550], ["massive", "OBSERVATION_MODIFIER", 25, 32], ["myocardial", "ANATOMY", 33, 43], ["necrosis", "OBSERVATION", 44, 52], ["ventricular", "ANATOMY", 54, 65], ["fibrillation", "OBSERVATION", 66, 78], ["heart", "ANATOMY", 80, 85], ["block", "OBSERVATION", 86, 91], ["arrhythmias", "OBSERVATION", 93, 104], ["intestinal", "ANATOMY", 169, 179], ["blockage", "OBSERVATION", 180, 188], ["Heart", "ANATOMY", 199, 204], ["FailureA", "OBSERVATION", 205, 213], ["heart", "ANATOMY", 260, 265], ["failure", "OBSERVATION", 266, 273], ["myocardium", "ANATOMY", 444, 454], ["injury", "OBSERVATION", 458, 464], ["Circulation", "OBSERVATION_MODIFIER", 504, 515], ["Hemorrhage", "OBSERVATION", 515, 525], ["Trauma", "OBSERVATION", 527, 533]]], ["See section on Disorders of Domestic Animals: Myocardium, Disturbances of Circulation, Hemorrhage: Trauma (Physical Injury).Disturbances of GrowthMyocardial Hypertrophy.", [["Hemorrhage", "DISEASE", 87, 97], ["Trauma", "DISEASE", 99, 105], ["Physical Injury", "DISEASE", 107, 122], ["GrowthMyocardial Hypertrophy", "DISEASE", 140, 168], ["Disturbances of Circulation", "PROBLEM", 58, 85], ["Hemorrhage", "PROBLEM", 87, 97], ["Trauma (Physical Injury", "PROBLEM", 99, 122], ["GrowthMyocardial Hypertrophy", "PROBLEM", 140, 168], ["Myocardium", "ANATOMY", 46, 56], ["Circulation", "ANATOMY", 74, 85], ["Hemorrhage", "OBSERVATION", 87, 97], ["GrowthMyocardial Hypertrophy", "OBSERVATION", 140, 168]]], ["See the discussion on hypertrophy in Chapter 1.Disturbances of GrowthHypertrophy of the myocardium represents an increase in muscle mass, which is the result of an increase in the size of cardiac muscle cells .", [["myocardium", "ANATOMY", 88, 98], ["muscle mass", "ANATOMY", 125, 136], ["cardiac muscle cells", "ANATOMY", 188, 208], ["hypertrophy", "DISEASE", 22, 33], ["myocardium", "MULTI-TISSUE_STRUCTURE", 88, 98], ["muscle", "ORGAN", 125, 131], ["cardiac muscle cells", "CELL", 188, 208], ["cardiac muscle cells", "CELL_TYPE", 188, 208], ["hypertrophy", "PROBLEM", 22, 33], ["GrowthHypertrophy of the myocardium", "PROBLEM", 63, 98], ["an increase in muscle mass", "PROBLEM", 110, 136], ["an increase in the size of cardiac muscle cells", "PROBLEM", 161, 208], ["hypertrophy", "OBSERVATION", 22, 33], ["GrowthHypertrophy", "OBSERVATION", 63, 80], ["myocardium", "ANATOMY", 88, 98], ["increase", "OBSERVATION_MODIFIER", 113, 121], ["muscle", "ANATOMY", 125, 131], ["mass", "OBSERVATION", 132, 136], ["increase", "OBSERVATION_MODIFIER", 164, 172], ["size", "OBSERVATION_MODIFIER", 180, 184], ["cardiac muscle", "ANATOMY", 188, 202], ["cells", "OBSERVATION", 203, 208]]], ["Two anatomic forms of hypertrophy are recognized.", [["hypertrophy", "DISEASE", 22, 33], ["hypertrophy", "PROBLEM", 22, 33], ["anatomic", "OBSERVATION_MODIFIER", 4, 12], ["hypertrophy", "OBSERVATION", 22, 33]]], ["Eccentric hypertrophy results in a heart with enlarged ventricular chambers and walls of normal to somewhat decreased thickness.", [["heart", "ANATOMY", 35, 40], ["ventricular chambers", "ANATOMY", 55, 75], ["hypertrophy", "DISEASE", 10, 21], ["heart", "ORGAN", 35, 40], ["ventricular chambers", "MULTI-TISSUE_STRUCTURE", 55, 75], ["Eccentric hypertrophy", "PROBLEM", 0, 21], ["somewhat decreased thickness", "PROBLEM", 99, 127], ["hypertrophy", "OBSERVATION", 10, 21], ["heart", "ANATOMY", 35, 40], ["enlarged", "OBSERVATION", 46, 54], ["ventricular", "ANATOMY", 55, 66], ["chambers", "ANATOMY_MODIFIER", 67, 75], ["walls", "ANATOMY_MODIFIER", 80, 85], ["normal", "OBSERVATION", 89, 95], ["somewhat", "OBSERVATION_MODIFIER", 99, 107], ["decreased", "OBSERVATION_MODIFIER", 108, 117], ["thickness", "OBSERVATION_MODIFIER", 118, 127]]], ["Volume-overload hypertrophy is characterized by new sarcomeres being assembled in series within sarcomeres resulting in increased length of myofibers.", [["sarcomeres", "ANATOMY", 52, 62], ["sarcomeres", "ANATOMY", 96, 106], ["myofibers", "ANATOMY", 140, 149], ["hypertrophy", "DISEASE", 16, 27], ["sarcomeres", "CELLULAR_COMPONENT", 52, 62], ["sarcomeres", "CELLULAR_COMPONENT", 96, 106], ["myofibers", "CELLULAR_COMPONENT", 140, 149], ["Volume-overload hypertrophy", "PROBLEM", 0, 27], ["new sarcomeres", "PROBLEM", 48, 62], ["increased length of myofibers", "PROBLEM", 120, 149], ["overload", "OBSERVATION_MODIFIER", 7, 15], ["hypertrophy", "OBSERVATION", 16, 27], ["new", "OBSERVATION_MODIFIER", 48, 51], ["sarcomeres", "OBSERVATION", 52, 62], ["increased", "OBSERVATION_MODIFIER", 120, 129], ["length", "OBSERVATION_MODIFIER", 130, 136], ["myofibers", "ANATOMY", 140, 149]]], ["In concentric hypertrophy, the heart is characterized by small ventricular chambers and thick walls.", [["heart", "ANATOMY", 31, 36], ["ventricular", "ANATOMY", 63, 74], ["hypertrophy", "DISEASE", 14, 25], ["heart", "ORGAN", 31, 36], ["ventricular chambers", "MULTI-TISSUE_STRUCTURE", 63, 83], ["thick walls", "TISSUE", 88, 99], ["concentric hypertrophy", "PROBLEM", 3, 25], ["small ventricular chambers and thick walls", "PROBLEM", 57, 99], ["concentric", "OBSERVATION_MODIFIER", 3, 13], ["hypertrophy", "OBSERVATION", 14, 25], ["heart", "ANATOMY", 31, 36], ["small", "OBSERVATION_MODIFIER", 57, 62], ["ventricular chambers", "OBSERVATION", 63, 83], ["thick", "OBSERVATION_MODIFIER", 88, 93], ["walls", "OBSERVATION_MODIFIER", 94, 99]]], ["Pressure-overload hypertrophy is the result of the formation of new sarcomeres assembled predominantly in parallel to the long axes of cells resulting in an increase in thickness of the myofiber.", [["sarcomeres", "ANATOMY", 68, 78], ["cells", "ANATOMY", 135, 140], ["myofiber", "ANATOMY", 186, 194], ["hypertrophy", "DISEASE", 18, 29], ["sarcomeres", "CELLULAR_COMPONENT", 68, 78], ["cells", "CELL", 135, 140], ["myofiber", "CELLULAR_COMPONENT", 186, 194], ["Pressure-overload hypertrophy", "PROBLEM", 0, 29], ["new sarcomeres", "PROBLEM", 64, 78], ["an increase in thickness of the myofiber", "PROBLEM", 154, 194], ["overload", "OBSERVATION_MODIFIER", 9, 17], ["hypertrophy", "OBSERVATION", 18, 29], ["new", "OBSERVATION_MODIFIER", 64, 67], ["sarcomeres", "OBSERVATION", 68, 78], ["predominantly", "OBSERVATION_MODIFIER", 89, 102], ["long axes", "OBSERVATION_MODIFIER", 122, 131], ["increase", "OBSERVATION_MODIFIER", 157, 165], ["thickness", "OBSERVATION_MODIFIER", 169, 178], ["myofiber", "ANATOMY", 186, 194]]], ["Some cats with hyperthyroidism have a cardiac hypertrophy that is mediated by enhanced production of myocardial contractile proteins under the influence of increased concentration of circulating thyroid hormones ( Fig. 10-10) .", [["cardiac", "ANATOMY", 38, 45], ["myocardial", "ANATOMY", 101, 111], ["hyperthyroidism", "DISEASE", 15, 30], ["cardiac hypertrophy", "DISEASE", 38, 57], ["cats", "ORGANISM", 5, 9], ["cardiac", "ORGAN", 38, 45], ["myocardial contractile proteins", "GENE_OR_GENE_PRODUCT", 101, 132], ["thyroid", "ORGAN", 195, 202], ["myocardial contractile proteins", "PROTEIN", 101, 132], ["cats", "SPECIES", 5, 9], ["Some cats", "PROBLEM", 0, 9], ["hyperthyroidism", "PROBLEM", 15, 30], ["a cardiac hypertrophy", "PROBLEM", 36, 57], ["myocardial contractile proteins", "PROBLEM", 101, 132], ["increased concentration of circulating thyroid hormones", "PROBLEM", 156, 211], ["cats", "OBSERVATION", 5, 9], ["hyperthyroidism", "OBSERVATION", 15, 30], ["cardiac", "ANATOMY", 38, 45], ["hypertrophy", "OBSERVATION", 46, 57], ["myocardial contractile proteins", "OBSERVATION", 101, 132], ["increased", "OBSERVATION_MODIFIER", 156, 165], ["concentration", "OBSERVATION_MODIFIER", 166, 179], ["thyroid", "ANATOMY", 195, 202]]], ["The hypertrophy is reversible on return to euthyroidism.Disturbances of GrowthThree stages of myocardial hypertrophy are recognizable: (1) initiation, (2) stable hyperfunction, and (3) deterioration of function associated with degeneration of hypertrophied myocytes.", [["myocardial", "ANATOMY", 94, 104], ["hypertrophied myocytes", "ANATOMY", 243, 265], ["hypertrophy", "DISEASE", 4, 15], ["euthyroidism", "DISEASE", 43, 55], ["myocardial hypertrophy", "DISEASE", 94, 116], ["hyperfunction", "DISEASE", 162, 175], ["myocardial", "MULTI-TISSUE_STRUCTURE", 94, 104], ["myocytes", "CELL", 257, 265], ["The hypertrophy", "PROBLEM", 0, 15], ["euthyroidism", "PROBLEM", 43, 55], ["myocardial hypertrophy", "PROBLEM", 94, 116], ["stable hyperfunction, and (3) deterioration of function", "PROBLEM", 155, 210], ["degeneration of hypertrophied myocytes", "PROBLEM", 227, 265], ["hypertrophy", "OBSERVATION", 4, 15], ["reversible", "OBSERVATION_MODIFIER", 19, 29], ["euthyroidism", "OBSERVATION", 43, 55], ["myocardial", "ANATOMY", 94, 104], ["hypertrophy", "OBSERVATION", 105, 116], ["stable", "OBSERVATION_MODIFIER", 155, 161], ["hyperfunction", "OBSERVATION", 162, 175], ["degeneration", "OBSERVATION", 227, 239], ["hypertrophied myocytes", "OBSERVATION", 243, 265]]], ["Microscopically, in myocardial hypertrophy, the myocytes are enlarged and have large nuclei ( Fig. 10-11 ).Disturbances of GrowthPhysiologic Atrophy.", [["myocardial", "ANATOMY", 20, 30], ["myocytes", "ANATOMY", 48, 56], ["nuclei", "ANATOMY", 85, 91], ["myocardial hypertrophy", "DISEASE", 20, 42], ["Atrophy", "DISEASE", 141, 148], ["myocardial", "MULTI-TISSUE_STRUCTURE", 20, 30], ["myocytes", "CELL", 48, 56], ["nuclei", "CELLULAR_COMPONENT", 85, 91], ["myocardial hypertrophy", "PROBLEM", 20, 42], ["large nuclei", "PROBLEM", 79, 91], ["Fig.", "TEST", 94, 98], ["GrowthPhysiologic Atrophy", "PROBLEM", 123, 148], ["myocardial", "ANATOMY", 20, 30], ["hypertrophy", "OBSERVATION", 31, 42], ["myocytes", "ANATOMY", 48, 56], ["enlarged", "OBSERVATION_MODIFIER", 61, 69], ["large", "OBSERVATION_MODIFIER", 79, 84], ["nuclei", "OBSERVATION_MODIFIER", 85, 91], ["GrowthPhysiologic Atrophy", "OBSERVATION", 123, 148]]], ["Physiologic atrophy of heart muscle may occur in confined animals and also occurs as a result of flow and the glomerular filtration rate.", [["heart muscle", "ANATOMY", 23, 35], ["glomerular", "ANATOMY", 110, 120], ["atrophy", "DISEASE", 12, 19], ["heart muscle", "DISEASE", 23, 35], ["heart muscle", "ORGAN", 23, 35], ["glomerular", "TISSUE", 110, 120], ["Physiologic atrophy of heart muscle", "PROBLEM", 0, 35], ["the glomerular filtration rate", "TEST", 106, 136], ["atrophy", "OBSERVATION", 12, 19], ["heart muscle", "ANATOMY", 23, 35], ["flow", "OBSERVATION", 97, 101], ["glomerular filtration", "OBSERVATION", 110, 131]]], ["During congestive heart failure, atrial and arterial receptors have a decreased response to stimulation, and baroreceptor function is impaired.", [["heart", "ANATOMY", 18, 23], ["atrial", "ANATOMY", 33, 39], ["arterial", "ANATOMY", 44, 52], ["congestive heart failure", "DISEASE", 7, 31], ["heart", "ORGAN", 18, 23], ["atrial", "MULTI-TISSUE_STRUCTURE", 33, 39], ["arterial", "MULTI-TISSUE_STRUCTURE", 44, 52], ["atrial and arterial receptors", "PROTEIN", 33, 62], ["congestive heart failure", "PROBLEM", 7, 31], ["atrial and arterial receptors", "PROBLEM", 33, 62], ["baroreceptor function", "TEST", 109, 130], ["congestive", "OBSERVATION", 7, 17], ["heart", "ANATOMY", 18, 23], ["failure", "OBSERVATION", 24, 31], ["atrial", "ANATOMY", 33, 39], ["arterial", "ANATOMY_MODIFIER", 44, 52], ["decreased", "OBSERVATION_MODIFIER", 70, 79], ["response to stimulation", "OBSERVATION", 80, 103], ["impaired", "OBSERVATION_MODIFIER", 134, 142]]], ["The overall effect is a decrease in parasympathetic activity and subsequent impaired restraint on the SAN, which results in a higher HR and decreased HR variability.Role of Renin-Angiotensin-Aldosterone System in the Progression of Heart FailureIn congestive heart failure, renin is continuously released in the juxtaglomerular apparatus of the kidneys secondary to the low CO.", [["SAN", "ANATOMY", 102, 105], ["Heart", "ANATOMY", 232, 237], ["heart", "ANATOMY", 259, 264], ["juxtaglomerular apparatus", "ANATOMY", 312, 337], ["kidneys", "ANATOMY", 345, 352], ["Angiotensin", "CHEMICAL", 179, 190], ["Aldosterone", "CHEMICAL", 191, 202], ["congestive heart failure", "DISEASE", 248, 272], ["Aldosterone", "CHEMICAL", 191, 202], ["CO", "CHEMICAL", 374, 376], ["parasympathetic", "ANATOMICAL_SYSTEM", 36, 51], ["SAN", "MULTI-TISSUE_STRUCTURE", 102, 105], ["Renin-Angiotensin-Aldosterone", "GENE_OR_GENE_PRODUCT", 173, 202], ["heart", "ORGAN", 259, 264], ["renin", "GENE_OR_GENE_PRODUCT", 274, 279], ["juxtaglomerular apparatus", "MULTI-TISSUE_STRUCTURE", 312, 337], ["kidneys", "ORGAN", 345, 352], ["renin", "PROTEIN", 274, 279], ["a decrease in parasympathetic activity", "PROBLEM", 22, 60], ["a higher HR", "PROBLEM", 124, 135], ["decreased HR variability", "PROBLEM", 140, 164], ["Renin-Angiotensin", "TREATMENT", 173, 190], ["Aldosterone System", "TREATMENT", 191, 209], ["Heart FailureIn congestive heart failure", "PROBLEM", 232, 272], ["renin", "PROBLEM", 274, 279], ["the low CO", "PROBLEM", 366, 376], ["overall", "OBSERVATION_MODIFIER", 4, 11], ["effect", "OBSERVATION_MODIFIER", 12, 18], ["decrease", "OBSERVATION_MODIFIER", 24, 32], ["parasympathetic activity", "OBSERVATION", 36, 60], ["impaired", "OBSERVATION_MODIFIER", 76, 84], ["restraint", "OBSERVATION", 85, 94], ["decreased", "OBSERVATION_MODIFIER", 140, 149], ["HR variability", "OBSERVATION", 150, 164], ["Heart", "ANATOMY", 232, 237], ["FailureIn", "ANATOMY_MODIFIER", 238, 247], ["congestive", "OBSERVATION", 248, 258], ["heart", "ANATOMY", 259, 264], ["failure", "OBSERVATION", 265, 272], ["renin", "OBSERVATION", 274, 279], ["juxtaglomerular", "ANATOMY_MODIFIER", 312, 327], ["kidneys", "ANATOMY", 345, 352], ["low", "OBSERVATION_MODIFIER", 370, 373]]], ["Consequently, perpetuation of angiotensin II (AGII) effects leads to a vicious cycle that contributes to further declines in ventricular function.", [["ventricular", "ANATOMY", 125, 136], ["angiotensin II", "CHEMICAL", 30, 44], ["angiotensin II", "GENE_OR_GENE_PRODUCT", 30, 44], ["AGII", "GENE_OR_GENE_PRODUCT", 46, 50], ["ventricular", "MULTI-TISSUE_STRUCTURE", 125, 136], ["angiotensin II", "PROTEIN", 30, 44], ["angiotensin II (AGII) effects", "PROBLEM", 30, 59], ["a vicious cycle", "PROBLEM", 69, 84], ["further declines in ventricular function", "PROBLEM", 105, 145], ["ventricular", "ANATOMY", 125, 136]]], ["These include AGII-mediated increase in afterload, increase in MVO 2 , and increase in preload (through a decrease in venous capacity).", [["venous", "ANATOMY", 118, 124], ["AGII", "SIMPLE_CHEMICAL", 14, 18], ["venous", "MULTI-TISSUE_STRUCTURE", 118, 124], ["AGII", "PROTEIN", 14, 18], ["AGII", "PROBLEM", 14, 18], ["afterload", "TREATMENT", 40, 49], ["MVO", "TEST", 63, 66], ["preload", "TEST", 87, 94], ["a decrease in venous capacity", "PROBLEM", 104, 133], ["increase", "OBSERVATION_MODIFIER", 28, 36], ["afterload", "OBSERVATION", 40, 49], ["increase", "OBSERVATION_MODIFIER", 51, 59], ["MVO", "OBSERVATION", 63, 66], ["increase", "OBSERVATION_MODIFIER", 75, 83], ["decrease", "OBSERVATION_MODIFIER", 106, 114], ["venous", "ANATOMY", 118, 124]]], ["AGII also stimulates the release of ADH and aldosterone (both contribute to total body water retention); the latter contributes to baroreceptor dysfunction, increased stiffness and decreased compliance of the arterial system, and increased Mg and K excretion.", [["body", "ANATOMY", 82, 86], ["arterial system", "ANATOMY", 209, 224], ["AGII", "CHEMICAL", 0, 4], ["aldosterone", "CHEMICAL", 44, 55], ["baroreceptor dysfunction", "DISEASE", 131, 155], ["Mg", "CHEMICAL", 240, 242], ["K", "CHEMICAL", 247, 248], ["aldosterone", "CHEMICAL", 44, 55], ["Mg", "CHEMICAL", 240, 242], ["K", "CHEMICAL", 247, 248], ["AGII", "SIMPLE_CHEMICAL", 0, 4], ["ADH", "GENE_OR_GENE_PRODUCT", 36, 39], ["aldosterone", "SIMPLE_CHEMICAL", 44, 55], ["body", "ORGANISM_SUBDIVISION", 82, 86], ["arterial", "MULTI-TISSUE_STRUCTURE", 209, 217], ["Mg", "SIMPLE_CHEMICAL", 240, 242], ["K", "SIMPLE_CHEMICAL", 247, 248], ["ADH", "PROBLEM", 36, 39], ["aldosterone", "TREATMENT", 44, 55], ["total body water retention", "TREATMENT", 76, 102], ["baroreceptor dysfunction", "PROBLEM", 131, 155], ["increased stiffness", "PROBLEM", 157, 176], ["decreased compliance of the arterial system", "PROBLEM", 181, 224], ["increased Mg", "PROBLEM", 230, 242], ["K excretion", "TEST", 247, 258], ["baroreceptor dysfunction", "OBSERVATION", 131, 155], ["increased", "OBSERVATION_MODIFIER", 157, 166], ["stiffness", "OBSERVATION_MODIFIER", 167, 176], ["decreased compliance", "OBSERVATION", 181, 201], ["arterial system", "ANATOMY", 209, 224], ["increased", "OBSERVATION_MODIFIER", 230, 239]]], ["Increases in plasma aldosterone are associated with an inflammatory response that is thought to lead to intramural coronary artery remodeling and fibrosis.", [["plasma", "ANATOMY", 13, 19], ["intramural coronary artery", "ANATOMY", 104, 130], ["aldosterone", "CHEMICAL", 20, 31], ["fibrosis", "DISEASE", 146, 154], ["aldosterone", "CHEMICAL", 20, 31], ["plasma", "ORGANISM_SUBSTANCE", 13, 19], ["aldosterone", "GENE_OR_GENE_PRODUCT", 20, 31], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 115, 130], ["Increases in plasma aldosterone", "PROBLEM", 0, 31], ["an inflammatory response", "PROBLEM", 52, 76], ["intramural coronary artery remodeling", "PROBLEM", 104, 141], ["fibrosis", "PROBLEM", 146, 154], ["plasma aldosterone", "OBSERVATION", 13, 31], ["inflammatory", "OBSERVATION", 55, 67], ["thought to lead to", "UNCERTAINTY", 85, 103], ["intramural", "ANATOMY_MODIFIER", 104, 114], ["coronary artery", "ANATOMY", 115, 130], ["remodeling", "OBSERVATION", 131, 141], ["fibrosis", "OBSERVATION", 146, 154]]], ["AGII stimulates growth factors, promoting remodeling in the vessels and myocardium (reduced NO synthesis or by increasing local angiotensin-converting enzyme breakdown of bradykinin).", [["vessels", "ANATOMY", 60, 67], ["myocardium", "ANATOMY", 72, 82], ["AGII", "CHEMICAL", 0, 4], ["NO", "CHEMICAL", 92, 94], ["angiotensin", "CHEMICAL", 128, 139], ["bradykinin", "CHEMICAL", 171, 181], ["NO", "CHEMICAL", 92, 94], ["bradykinin", "CHEMICAL", 171, 181], ["AGII", "SIMPLE_CHEMICAL", 0, 4], ["vessels", "MULTI-TISSUE_STRUCTURE", 60, 67], ["myocardium", "MULTI-TISSUE_STRUCTURE", 72, 82], ["NO", "SIMPLE_CHEMICAL", 92, 94], ["angiotensin-converting enzyme", "GENE_OR_GENE_PRODUCT", 128, 157], ["bradykinin", "SIMPLE_CHEMICAL", 171, 181], ["AGII", "PROTEIN", 0, 4], ["growth factors", "PROTEIN", 16, 30], ["angiotensin-converting enzyme", "PROTEIN", 128, 157], ["growth factors", "PROBLEM", 16, 30], ["promoting remodeling in the vessels and myocardium", "PROBLEM", 32, 82], ["synthesis", "PROBLEM", 95, 104], ["increasing local angiotensin", "TREATMENT", 111, 139], ["enzyme breakdown of bradykinin", "PROBLEM", 151, 181], ["growth", "OBSERVATION_MODIFIER", 16, 22], ["remodeling", "OBSERVATION", 42, 52], ["vessels", "ANATOMY", 60, 67], ["myocardium", "ANATOMY", 72, 82]]], ["Consequently, vascular remodeling (i.e., smooth muscle hyperplasia, hypertrophy, and apoptosis) results in structural changes that further decrease the compliance of the arterial system.", [["vascular", "ANATOMY", 14, 22], ["smooth muscle", "ANATOMY", 41, 54], ["arterial system", "ANATOMY", 170, 185], ["muscle hyperplasia", "DISEASE", 48, 66], ["hypertrophy", "DISEASE", 68, 79], ["vascular", "MULTI-TISSUE_STRUCTURE", 14, 22], ["smooth muscle", "TISSUE", 41, 54], ["arterial system", "MULTI-TISSUE_STRUCTURE", 170, 185], ["vascular remodeling", "PROBLEM", 14, 33], ["smooth muscle hyperplasia", "PROBLEM", 41, 66], ["hypertrophy", "PROBLEM", 68, 79], ["apoptosis", "PROBLEM", 85, 94], ["structural changes", "PROBLEM", 107, 125], ["vascular", "ANATOMY", 14, 22], ["remodeling", "OBSERVATION", 23, 33], ["smooth", "OBSERVATION_MODIFIER", 41, 47], ["muscle", "ANATOMY", 48, 54], ["hyperplasia", "OBSERVATION", 55, 66], ["hypertrophy", "OBSERVATION", 68, 79], ["arterial system", "ANATOMY", 170, 185]]], ["AGII has a key role in the development of pathologic hypertrophy, exerting cytotoxic effects on the myocardium, causing myocyte necrosis, and contributing to myocardial loss.Role of Natriuretic Peptides and Nitric Oxide in the Progression of Heart FailureThe natriuretic peptides are counterregulatory hormones involved in volume homeostasis and cardiovascular remodeling, and they promote natriuresis, diuresis, peripheral vasodilatation, and inhibition of the RAAS.", [["myocardium", "ANATOMY", 100, 110], ["myocyte", "ANATOMY", 120, 127], ["myocardial", "ANATOMY", 158, 168], ["Heart", "ANATOMY", 242, 247], ["cardiovascular", "ANATOMY", 346, 360], ["AGII", "CHEMICAL", 0, 4], ["hypertrophy", "DISEASE", 53, 64], ["necrosis", "DISEASE", 128, 136], ["myocardial loss", "DISEASE", 158, 173], ["Nitric Oxide", "CHEMICAL", 207, 219], ["Heart Failure", "DISEASE", 242, 255], ["Nitric Oxide", "CHEMICAL", 207, 219], ["AGII", "GENE_OR_GENE_PRODUCT", 0, 4], ["myocardium", "ORGAN", 100, 110], ["myocyte", "CELL", 120, 127], ["myocardial", "MULTI-TISSUE_STRUCTURE", 158, 168], ["Nitric Oxide", "SIMPLE_CHEMICAL", 207, 219], ["natriuretic peptides", "GENE_OR_GENE_PRODUCT", 259, 279], ["cardiovascular", "ANATOMICAL_SYSTEM", 346, 360], ["peripheral", "TISSUE", 413, 423], ["RAAS", "GENE_OR_GENE_PRODUCT", 462, 466], ["AGII", "PROTEIN", 0, 4], ["RAAS", "PROTEIN", 462, 466], ["pathologic hypertrophy", "PROBLEM", 42, 64], ["cytotoxic effects on the myocardium", "PROBLEM", 75, 110], ["myocyte necrosis", "PROBLEM", 120, 136], ["myocardial loss", "PROBLEM", 158, 173], ["Natriuretic Peptides", "TREATMENT", 182, 202], ["Nitric Oxide", "TREATMENT", 207, 219], ["Heart Failure", "PROBLEM", 242, 255], ["The natriuretic peptides", "TEST", 255, 279], ["counterregulatory hormones", "PROBLEM", 284, 310], ["volume homeostasis", "PROBLEM", 323, 341], ["cardiovascular remodeling", "PROBLEM", 346, 371], ["natriuresis", "TREATMENT", 390, 401], ["diuresis", "TREATMENT", 403, 411], ["peripheral vasodilatation", "TREATMENT", 413, 438], ["inhibition of the RAAS", "TREATMENT", 444, 466], ["pathologic", "OBSERVATION_MODIFIER", 42, 52], ["hypertrophy", "OBSERVATION", 53, 64], ["cytotoxic effects", "OBSERVATION", 75, 92], ["myocardium", "ANATOMY", 100, 110], ["causing", "UNCERTAINTY", 112, 119], ["myocyte", "ANATOMY", 120, 127], ["necrosis", "OBSERVATION", 128, 136], ["myocardial loss", "OBSERVATION", 158, 173], ["Heart", "ANATOMY", 242, 247], ["Failure", "OBSERVATION", 248, 255], ["volume homeostasis", "OBSERVATION", 323, 341], ["cardiovascular remodeling", "OBSERVATION", 346, 371], ["natriuresis", "OBSERVATION", 390, 401], ["peripheral vasodilatation", "OBSERVATION", 413, 438]]], ["They consist of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendraspis natriuretic peptides (DNP), and urodilatin.", [["DNP", "CHEMICAL", 150, 153], ["urodilatin", "CHEMICAL", 160, 170], ["urodilatin", "CHEMICAL", 160, 170], ["atrial natriuretic peptide", "GENE_OR_GENE_PRODUCT", 16, 42], ["ANP", "GENE_OR_GENE_PRODUCT", 44, 47], ["brain natriuretic peptide", "GENE_OR_GENE_PRODUCT", 50, 75], ["BNP", "GENE_OR_GENE_PRODUCT", 77, 80], ["C-type natriuretic peptide", "GENE_OR_GENE_PRODUCT", 83, 109], ["CNP", "GENE_OR_GENE_PRODUCT", 111, 114], ["dendraspis natriuretic peptides", "GENE_OR_GENE_PRODUCT", 117, 148], ["DNP", "SIMPLE_CHEMICAL", 150, 153], ["urodilatin", "SIMPLE_CHEMICAL", 160, 170], ["atrial natriuretic peptide", "TREATMENT", 16, 42], ["ANP", "TEST", 44, 47], ["brain natriuretic peptide", "TEST", 50, 75], ["BNP", "TEST", 77, 80], ["C-type natriuretic peptide", "PROBLEM", 83, 109], ["dendraspis natriuretic peptides", "PROBLEM", 117, 148], ["urodilatin", "TREATMENT", 160, 170], ["atrial", "ANATOMY", 16, 22]]], ["Despite the natriuretic peptides' beneficial effects during congestive heart failure, their release is overridden by the release of agents that cause vasoconstriction and sodium and water retention.", [["heart", "ANATOMY", 71, 76], ["congestive heart failure", "DISEASE", 60, 84], ["sodium", "CHEMICAL", 171, 177], ["sodium", "CHEMICAL", 171, 177], ["heart", "ORGAN", 71, 76], ["sodium", "SIMPLE_CHEMICAL", 171, 177], ["water", "SIMPLE_CHEMICAL", 182, 187], ["the natriuretic peptides", "TREATMENT", 8, 32], ["congestive heart failure", "PROBLEM", 60, 84], ["agents", "TREATMENT", 132, 138], ["vasoconstriction", "PROBLEM", 150, 166], ["sodium and water retention", "PROBLEM", 171, 197], ["heart", "ANATOMY", 71, 76], ["failure", "OBSERVATION", 77, 84], ["water retention", "OBSERVATION", 182, 197]]], ["NO regulates cardiac function through both vascular-dependent (coronary vessel tone, thrombogenicity, proliferative and inflammatory properties, and cellular cross-talk that supports angiogenesis) and vascularindependent (effects on several aspects of cardiomyocyte contractility, from the fine regulation of excitation-contraction coupling to modulation of autonomic signaling and mitochondrial respiration) effects.", [["cardiac", "ANATOMY", 13, 20], ["vascular", "ANATOMY", 43, 51], ["coronary vessel", "ANATOMY", 63, 78], ["cellular", "ANATOMY", 149, 157], ["cardiomyocyte", "ANATOMY", 252, 265], ["mitochondrial", "ANATOMY", 382, 395], ["NO", "CHEMICAL", 0, 2], ["NO", "CHEMICAL", 0, 2], ["NO", "SIMPLE_CHEMICAL", 0, 2], ["cardiac", "ORGAN", 13, 20], ["vascular", "MULTI-TISSUE_STRUCTURE", 43, 51], ["coronary vessel", "MULTI-TISSUE_STRUCTURE", 63, 78], ["cellular", "CELL", 149, 157], ["cardiomyocyte", "CELL", 252, 265], ["mitochondrial", "CELLULAR_COMPONENT", 382, 395], ["thrombogenicity", "PROBLEM", 85, 100], ["proliferative and inflammatory properties", "PROBLEM", 102, 143], ["angiogenesis", "PROBLEM", 183, 195], ["cardiomyocyte contractility", "PROBLEM", 252, 279], ["contraction coupling", "TREATMENT", 320, 340], ["autonomic signaling", "PROBLEM", 358, 377], ["mitochondrial respiration) effects", "PROBLEM", 382, 416], ["cardiac", "ANATOMY", 13, 20], ["function", "OBSERVATION", 21, 29], ["vascular", "ANATOMY", 43, 51], ["dependent", "OBSERVATION", 52, 61], ["coronary vessel", "ANATOMY", 63, 78], ["thrombogenicity", "OBSERVATION", 85, 100], ["proliferative", "OBSERVATION_MODIFIER", 102, 115], ["inflammatory", "OBSERVATION_MODIFIER", 120, 132]]], ["Overall, NO may play an important compensatory role in congestive heart failure during resting conditions by antagonizing neuroendocrine vasoconstrictive forces.Summary of Pathophysiology of Heart FailureIn summary, long-term overload-induced cardiac hypertrophy is accompanied by myocardial cell death and cardiac fibrosis (i.e., cardiomyopathy of overload).", [["heart", "ANATOMY", 66, 71], ["neuroendocrine", "ANATOMY", 122, 136], ["cardiac", "ANATOMY", 243, 250], ["myocardial cell", "ANATOMY", 281, 296], ["cardiac", "ANATOMY", 307, 314], ["NO", "CHEMICAL", 9, 11], ["congestive heart failure", "DISEASE", 55, 79], ["cardiac hypertrophy", "DISEASE", 243, 262], ["myocardial cell death", "DISEASE", 281, 302], ["cardiac fibrosis", "DISEASE", 307, 323], ["cardiomyopathy", "DISEASE", 331, 345], ["overload", "DISEASE", 349, 357], ["NO", "CHEMICAL", 9, 11], ["NO", "SIMPLE_CHEMICAL", 9, 11], ["heart", "ORGAN", 66, 71], ["neuroendocrine", "CELL", 122, 136], ["cardiac", "ORGAN", 243, 250], ["myocardial cell", "CELL", 281, 296], ["cardiac", "ORGAN", 307, 314], ["congestive heart failure", "PROBLEM", 55, 79], ["long-term overload", "PROBLEM", 216, 234], ["cardiac hypertrophy", "PROBLEM", 243, 262], ["myocardial cell death", "PROBLEM", 281, 302], ["cardiac fibrosis", "PROBLEM", 307, 323], ["cardiomyopathy of overload", "PROBLEM", 331, 357], ["NO may play", "UNCERTAINTY", 9, 20], ["congestive", "OBSERVATION_MODIFIER", 55, 65], ["heart", "ANATOMY", 66, 71], ["failure", "OBSERVATION", 72, 79], ["vasoconstrictive forces", "OBSERVATION", 137, 160], ["Heart", "ANATOMY", 191, 196], ["overload", "OBSERVATION", 226, 234], ["cardiac", "ANATOMY", 243, 250], ["hypertrophy", "OBSERVATION", 251, 262], ["myocardial cell death", "OBSERVATION", 281, 302], ["cardiac", "ANATOMY", 307, 314], ["fibrosis", "OBSERVATION", 315, 323], ["overload", "OBSERVATION", 349, 357]]], ["The hypertrophied ventricle outstrips its blood supply.", [["hypertrophied ventricle", "ANATOMY", 4, 27], ["blood", "ANATOMY", 42, 47], ["hypertrophied ventricle", "MULTI-TISSUE_STRUCTURE", 4, 27], ["blood", "ORGANISM_SUBSTANCE", 42, 47], ["hypertrophied", "OBSERVATION", 4, 17], ["ventricle", "ANATOMY", 18, 27], ["blood supply", "OBSERVATION", 42, 54]]], ["The relative decrease in oxygen delivery worsens the increased MVO 2 demand.", [["oxygen", "CHEMICAL", 25, 31], ["oxygen", "CHEMICAL", 25, 31], ["oxygen", "SIMPLE_CHEMICAL", 25, 31], ["oxygen delivery", "TREATMENT", 25, 40], ["the increased MVO 2 demand", "PROBLEM", 49, 75], ["relative", "OBSERVATION_MODIFIER", 4, 12], ["decrease", "OBSERVATION_MODIFIER", 13, 21], ["oxygen delivery", "OBSERVATION", 25, 40], ["increased", "OBSERVATION_MODIFIER", 53, 62], ["MVO", "OBSERVATION", 63, 66]]], ["The ischemia resulting from hypertrophy and stretching beyond certain limits decreases contractile strength and eventually leads to loss of contractile proteins within these cells or loss of these cells.", [["contractile", "ANATOMY", 140, 151], ["cells", "ANATOMY", 174, 179], ["cells", "ANATOMY", 197, 202], ["ischemia", "DISEASE", 4, 12], ["hypertrophy", "DISEASE", 28, 39], ["cells", "CELL", 174, 179], ["cells", "CELL", 197, 202], ["contractile proteins", "PROTEIN", 140, 160], ["The ischemia", "PROBLEM", 0, 12], ["hypertrophy", "PROBLEM", 28, 39], ["stretching", "PROBLEM", 44, 54], ["contractile strength", "PROBLEM", 87, 107], ["contractile proteins within these cells", "PROBLEM", 140, 179], ["loss of these cells", "PROBLEM", 183, 202], ["ischemia", "OBSERVATION", 4, 12], ["hypertrophy", "OBSERVATION", 28, 39], ["stretching", "OBSERVATION_MODIFIER", 44, 54], ["contractile strength", "OBSERVATION", 87, 107], ["contractile proteins", "OBSERVATION", 140, 160], ["loss", "OBSERVATION_MODIFIER", 183, 187], ["these cells", "OBSERVATION", 191, 202]]], ["These processes result in atrophy of the affected myocardium and lead to the development of multifocal myocardial fibrosis and atrophy, which consequently interferes with 570.e1 CHAPTER 10 Cardiovascular System and Lymphatic Vessels E-E-Appendix 10-3 Clinical Diagnostic ProceduresThe array of diagnostic tools available to the veterinarian to detect and evaluate changes in cases of cardiac disease has increased dramatically in the past several decades as many procedures have been adapted from use in human medicine.", [["myocardium", "ANATOMY", 50, 60], ["myocardial", "ANATOMY", 103, 113], ["cardiac", "ANATOMY", 384, 391], ["atrophy of the affected myocardium", "DISEASE", 26, 60], ["myocardial fibrosis", "DISEASE", 103, 122], ["atrophy", "DISEASE", 127, 134], ["cardiac disease", "DISEASE", 384, 399], ["myocardium", "ORGAN", 50, 60], ["myocardial", "MULTI-TISSUE_STRUCTURE", 103, 113], ["cardiac", "ORGAN", 384, 391], ["human", "ORGANISM", 504, 509], ["human", "SPECIES", 504, 509], ["human", "SPECIES", 504, 509], ["atrophy of the affected myocardium", "PROBLEM", 26, 60], ["multifocal myocardial fibrosis", "PROBLEM", 92, 122], ["atrophy", "PROBLEM", 127, 134], ["Lymphatic Vessels E-E-Appendix", "TEST", 215, 245], ["diagnostic tools", "TEST", 294, 310], ["cardiac disease", "PROBLEM", 384, 399], ["human medicine", "TREATMENT", 504, 518], ["atrophy", "OBSERVATION", 26, 33], ["affected myocardium", "ANATOMY", 41, 60], ["multifocal", "OBSERVATION_MODIFIER", 92, 102], ["myocardial", "ANATOMY", 103, 113], ["fibrosis", "OBSERVATION", 114, 122], ["atrophy", "OBSERVATION", 127, 134], ["Lymphatic Vessels", "ANATOMY", 215, 232], ["cardiac", "ANATOMY", 384, 391], ["disease", "OBSERVATION", 392, 399], ["increased", "OBSERVATION_MODIFIER", 404, 413], ["dramatically", "OBSERVATION_MODIFIER", 414, 426]]], ["Procedures include physical examination, radiography, electrocardiography, echocardiography, angiocardiography, and cardiac catheterization.", [["cardiac", "ANATOMY", 116, 123], ["cardiac", "ORGAN", 116, 123], ["physical examination", "TEST", 19, 39], ["radiography", "TEST", 41, 52], ["electrocardiography", "TEST", 54, 73], ["echocardiography", "TEST", 75, 91], ["angiocardiography", "TEST", 93, 110], ["cardiac catheterization", "TEST", 116, 139], ["cardiac", "ANATOMY", 116, 123], ["catheterization", "OBSERVATION", 124, 139]]], ["Cardiac myocardial damage can be detected by increased activity of serum enzymes and isoenzymes, such as creatine kinase (CK), lactate dehydrogenase (LDH), troponin T (TnT), troponin I (TnI), and aspartate aminotransferase (AST), which are specifically leaked from injured cardiac muscle cells.", [["Cardiac", "ANATOMY", 0, 7], ["myocardial", "ANATOMY", 8, 18], ["serum", "ANATOMY", 67, 72], ["cardiac muscle cells", "ANATOMY", 273, 293], ["Cardiac myocardial damage", "DISEASE", 0, 25], ["creatine", "CHEMICAL", 105, 113], ["lactate", "CHEMICAL", 127, 134], ["aspartate", "CHEMICAL", 196, 205], ["creatine", "CHEMICAL", 105, 113], ["lactate", "CHEMICAL", 127, 134], ["aspartate", "CHEMICAL", 196, 205], ["Cardiac", "TISSUE", 0, 7], ["myocardial", "MULTI-TISSUE_STRUCTURE", 8, 18], ["serum", "ORGANISM_SUBSTANCE", 67, 72], ["creatine kinase", "GENE_OR_GENE_PRODUCT", 105, 120], ["CK", "GENE_OR_GENE_PRODUCT", 122, 124], ["lactate dehydrogenase", "GENE_OR_GENE_PRODUCT", 127, 148], ["LDH", "GENE_OR_GENE_PRODUCT", 150, 153], ["troponin T", "GENE_OR_GENE_PRODUCT", 156, 166], ["TnT", "GENE_OR_GENE_PRODUCT", 168, 171], ["troponin I", "GENE_OR_GENE_PRODUCT", 174, 184], ["TnI", "GENE_OR_GENE_PRODUCT", 186, 189], ["aspartate aminotransferase", "GENE_OR_GENE_PRODUCT", 196, 222], ["AST", "SIMPLE_CHEMICAL", 224, 227], ["cardiac muscle cells", "CELL", 273, 293], ["serum enzymes", "PROTEIN", 67, 80], ["isoenzymes", "PROTEIN", 85, 95], ["creatine kinase", "PROTEIN", 105, 120], ["CK", "PROTEIN", 122, 124], ["lactate dehydrogenase", "PROTEIN", 127, 148], ["LDH", "PROTEIN", 150, 153], ["troponin T", "PROTEIN", 156, 166], ["TnT", "PROTEIN", 168, 171], ["troponin I", "PROTEIN", 174, 184], ["TnI", "PROTEIN", 186, 189], ["aspartate aminotransferase", "PROTEIN", 196, 222], ["AST", "PROTEIN", 224, 227], ["injured cardiac muscle cells", "CELL_TYPE", 265, 293], ["Cardiac myocardial damage", "PROBLEM", 0, 25], ["serum enzymes", "TEST", 67, 80], ["isoenzymes", "TEST", 85, 95], ["creatine kinase", "TEST", 105, 120], ["CK", "TEST", 122, 124], ["lactate dehydrogenase", "TEST", 127, 148], ["LDH", "TEST", 150, 153], ["troponin T", "TEST", 156, 166], ["TnT", "TEST", 168, 171], ["troponin I", "TEST", 174, 184], ["TnI", "TEST", 186, 189], ["aspartate aminotransferase (AST", "TEST", 196, 227], ["myocardial", "ANATOMY", 8, 18], ["damage", "OBSERVATION", 19, 25], ["injured", "OBSERVATION", 265, 272], ["cardiac muscle", "ANATOMY", 273, 287], ["cells", "OBSERVATION", 288, 293]]], ["Also, increased plasma concentrations of plasma natriuretic peptides (A type [atrial] ANP and B type [brain BNP) may indicate cardiac disease.", [["plasma", "ANATOMY", 16, 22], ["plasma", "ANATOMY", 41, 47], ["brain", "ANATOMY", 102, 107], ["cardiac", "ANATOMY", 126, 133], ["cardiac disease", "DISEASE", 126, 141], ["plasma", "ORGANISM_SUBSTANCE", 16, 22], ["plasma", "ORGANISM_SUBSTANCE", 41, 47], ["natriuretic peptides", "GENE_OR_GENE_PRODUCT", 48, 68], ["A type [atrial] ANP", "GENE_OR_GENE_PRODUCT", 70, 89], ["B type", "GENE_OR_GENE_PRODUCT", 94, 100], ["brain", "ORGAN", 102, 107], ["BNP", "GENE_OR_GENE_PRODUCT", 108, 111], ["cardiac", "ORGAN", 126, 133], ["increased plasma concentrations of plasma natriuretic peptides", "PROBLEM", 6, 68], ["A type [atrial] ANP and B type [brain BNP", "PROBLEM", 70, 111], ["cardiac disease", "PROBLEM", 126, 141], ["increased", "OBSERVATION_MODIFIER", 6, 15], ["plasma concentrations", "OBSERVATION_MODIFIER", 16, 37], ["plasma natriuretic peptides", "OBSERVATION", 41, 68], ["atrial", "ANATOMY", 78, 84], ["may indicate", "UNCERTAINTY", 113, 125], ["cardiac", "ANATOMY", 126, 133], ["disease", "OBSERVATION", 134, 141]]], ["These hormones are synthesized and released by cardiac muscle cells in increased amounts during cardiac dysfunction.", [["cardiac muscle cells", "ANATOMY", 47, 67], ["cardiac", "ANATOMY", 96, 103], ["cardiac dysfunction", "DISEASE", 96, 115], ["cardiac muscle cells", "CELL", 47, 67], ["cardiac", "ORGAN", 96, 103], ["cardiac muscle cells", "CELL_TYPE", 47, 67], ["increased amounts during cardiac dysfunction", "PROBLEM", 71, 115], ["cardiac muscle", "ANATOMY", 47, 61], ["increased", "OBSERVATION_MODIFIER", 71, 80], ["amounts", "OBSERVATION_MODIFIER", 81, 88], ["cardiac", "ANATOMY", 96, 103], ["dysfunction", "OBSERVATION", 104, 115]]], ["In research studies of cardiac diseases in animals, endomyocardial biopsies have been used to assess the light microscopic and ultrastructural alterations during the course of the disease. decompensation of cardiac myocytes in chronic congestive heart failure (see Fig. 10 -5, A).", [["cardiac", "ANATOMY", 23, 30], ["endomyocardial biopsies", "ANATOMY", 52, 75], ["cardiac myocytes", "ANATOMY", 207, 223], ["heart", "ANATOMY", 246, 251], ["cardiac diseases", "DISEASE", 23, 39], ["decompensation", "DISEASE", 189, 203], ["congestive heart failure", "DISEASE", 235, 259], ["cardiac", "ORGAN", 23, 30], ["endomyocardial biopsies", "MULTI-TISSUE_STRUCTURE", 52, 75], ["cardiac myocytes", "CELL", 207, 223], ["heart", "ORGAN", 246, 251], ["cardiac diseases", "PROBLEM", 23, 39], ["endomyocardial biopsies", "TEST", 52, 75], ["the light microscopic and ultrastructural alterations", "PROBLEM", 101, 154], ["the disease", "PROBLEM", 176, 187], ["decompensation", "PROBLEM", 189, 203], ["cardiac myocytes", "PROBLEM", 207, 223], ["chronic congestive heart failure", "PROBLEM", 227, 259], ["cardiac", "ANATOMY", 23, 30], ["diseases", "OBSERVATION", 31, 39], ["ultrastructural alterations", "OBSERVATION", 127, 154], ["disease", "OBSERVATION", 180, 187], ["cardiac myocytes", "ANATOMY", 207, 223], ["chronic", "OBSERVATION_MODIFIER", 227, 234], ["congestive", "OBSERVATION_MODIFIER", 235, 245], ["heart", "ANATOMY", 246, 251], ["failure", "OBSERVATION", 252, 259]]], ["Initially, these myocytes respond through hypertrophy with increased contractile force according to the Frank-Starling phenomenon.", [["myocytes", "ANATOMY", 17, 25], ["hypertrophy", "DISEASE", 42, 53], ["myocytes", "CELL", 17, 25], ["hypertrophy", "PROBLEM", 42, 53], ["increased contractile force", "PROBLEM", 59, 86], ["myocytes", "ANATOMY", 17, 25], ["hypertrophy", "OBSERVATION", 42, 53], ["increased", "OBSERVATION_MODIFIER", 59, 68], ["contractile force", "OBSERVATION", 69, 86], ["Starling phenomenon", "OBSERVATION", 110, 129]]], ["However, stretching beyond certain limits decreases contractile strength and eventually leads to loss of contractile proteins within these cells or loss of these cells resulting in atrophy of the affected myocardium (see Fig. 10 -9).E-Appendix 10-3 Clinical Diagnostic ProceduresNeoplastic Transformation.", [["contractile", "ANATOMY", 105, 116], ["cells", "ANATOMY", 139, 144], ["cells", "ANATOMY", 162, 167], ["myocardium", "ANATOMY", 205, 215], ["atrophy of the affected myocardium", "DISEASE", 181, 215], ["Neoplastic Transformation", "DISEASE", 279, 304], ["cells", "CELL", 139, 144], ["cells", "CELL", 162, 167], ["myocardium", "ORGAN", 205, 215], ["contractile proteins", "PROTEIN", 105, 125], ["contractile strength", "PROBLEM", 52, 72], ["loss of contractile proteins within these cells", "PROBLEM", 97, 144], ["loss of these cells", "PROBLEM", 148, 167], ["atrophy of the affected myocardium", "PROBLEM", 181, 215], ["Neoplastic Transformation", "PROBLEM", 279, 304], ["contractile strength", "OBSERVATION", 52, 72], ["contractile proteins", "OBSERVATION", 105, 125], ["loss", "OBSERVATION_MODIFIER", 148, 152], ["these cells", "OBSERVATION", 156, 167], ["atrophy", "OBSERVATION", 181, 188], ["affected myocardium", "ANATOMY", 196, 215], ["Appendix", "ANATOMY", 235, 243], ["Neoplastic Transformation", "OBSERVATION", 279, 304]]], ["See Chapter 6 for a discussion of the mechanisms involved in neoplastic transformation.", [["neoplastic", "ANATOMY", 61, 71], ["neoplastic transformation", "PROBLEM", 61, 86], ["neoplastic transformation", "OBSERVATION", 61, 86]]], ["Rhabdomyomas and rhabdomyosarcomas are primary tumors that originate from the myocardium in domestic animals.", [["Rhabdomyomas", "ANATOMY", 0, 12], ["rhabdomyosarcomas", "ANATOMY", 17, 34], ["primary tumors", "ANATOMY", 39, 53], ["myocardium", "ANATOMY", 78, 88], ["Rhabdomyomas", "DISEASE", 0, 12], ["rhabdomyosarcomas", "DISEASE", 17, 34], ["primary tumors", "DISEASE", 39, 53], ["Rhabdomyomas", "CANCER", 0, 12], ["rhabdomyosarcomas", "CANCER", 17, 34], ["tumors", "CANCER", 47, 53], ["myocardium", "ORGAN", 78, 88], ["Rhabdomyomas", "PROBLEM", 0, 12], ["rhabdomyosarcomas", "PROBLEM", 17, 34], ["primary tumors", "PROBLEM", 39, 53], ["rhabdomyosarcomas", "OBSERVATION", 17, 34], ["primary", "OBSERVATION_MODIFIER", 39, 46], ["tumors", "OBSERVATION", 47, 53], ["myocardium", "ANATOMY", 78, 88]]], ["Fibrosarcomas also occur rarely.", [["Fibrosarcomas", "ANATOMY", 0, 13], ["Fibrosarcomas", "DISEASE", 0, 13], ["Fibrosarcomas", "CANCER", 0, 13], ["Fibrosarcomas", "PROBLEM", 0, 13]]], ["Numerous types of secondary tumors, such asDISTURBANCES OF GROWTHAtrophy (dilation) Hypertrophy Agenesis (aplasia), hypoplasia, dysplasia (dysgenesis) Developmental errors, congenital anomalies Neoplasia (neoplastic transformation)INFLAMMATIONBox 10-4 Responses of the Myocardium to Injury myocardial inflammation with secondary necrosis because both lesions have substantial leukocytic infiltration.", [["tumors", "ANATOMY", 28, 34], ["neoplastic", "ANATOMY", 205, 215], ["Myocardium", "ANATOMY", 269, 279], ["myocardial", "ANATOMY", 290, 300], ["lesions", "ANATOMY", 351, 358], ["leukocytic", "ANATOMY", 376, 386], ["secondary tumors", "DISEASE", 18, 34], ["Hypertrophy Agenesis", "DISEASE", 84, 104], ["aplasia", "DISEASE", 106, 113], ["hypoplasia", "DISEASE", 116, 126], ["dysplasia", "DISEASE", 128, 137], ["dysgenesis", "DISEASE", 139, 149], ["Developmental errors", "DISEASE", 151, 171], ["congenital anomalies Neoplasia", "DISEASE", 173, 203], ["Injury myocardial inflammation", "DISEASE", 283, 313], ["necrosis", "DISEASE", 329, 337], ["tumors", "CANCER", 28, 34], ["dysplasia", "PATHOLOGICAL_FORMATION", 128, 137], ["myocardial", "MULTI-TISSUE_STRUCTURE", 290, 300], ["lesions", "PATHOLOGICAL_FORMATION", 351, 358], ["leukocytic", "CELL", 376, 386], ["secondary tumors", "PROBLEM", 18, 34], ["GROWTHAtrophy (dilation)", "PROBLEM", 59, 83], ["Hypertrophy Agenesis (aplasia)", "PROBLEM", 84, 114], ["hypoplasia", "PROBLEM", 116, 126], ["dysplasia (dysgenesis)", "PROBLEM", 128, 150], ["Developmental errors", "PROBLEM", 151, 171], ["congenital anomalies Neoplasia", "PROBLEM", 173, 203], ["neoplastic transformation", "PROBLEM", 205, 230], ["Injury myocardial inflammation", "PROBLEM", 283, 313], ["secondary necrosis", "PROBLEM", 319, 337], ["both lesions", "PROBLEM", 346, 358], ["substantial leukocytic infiltration", "PROBLEM", 364, 399], ["secondary", "OBSERVATION_MODIFIER", 18, 27], ["tumors", "OBSERVATION", 28, 34], ["dilation", "OBSERVATION", 74, 82], ["Hypertrophy", "OBSERVATION_MODIFIER", 84, 95], ["Agenesis", "OBSERVATION", 96, 104], ["aplasia", "OBSERVATION", 106, 113], ["hypoplasia", "OBSERVATION", 116, 126], ["dysplasia", "OBSERVATION", 128, 137], ["congenital", "OBSERVATION_MODIFIER", 173, 183], ["anomalies", "OBSERVATION_MODIFIER", 184, 193], ["Neoplasia", "OBSERVATION", 194, 203], ["neoplastic", "OBSERVATION_MODIFIER", 205, 215], ["Myocardium", "ANATOMY", 269, 279], ["Injury", "OBSERVATION", 283, 289], ["myocardial", "ANATOMY", 290, 300], ["inflammation", "OBSERVATION", 301, 313], ["secondary", "OBSERVATION_MODIFIER", 319, 328], ["necrosis", "OBSERVATION", 329, 337], ["lesions", "OBSERVATION", 351, 358], ["substantial", "OBSERVATION_MODIFIER", 364, 375], ["leukocytic infiltration", "OBSERVATION", 376, 399]]], ["Some animals that die peracutely from cardiac failure lack detectable microscopic alterations and are presumed to have suffered from an arrhythmic episode resulting in syncope.", [["cardiac", "ANATOMY", 38, 45], ["cardiac failure", "DISEASE", 38, 53], ["syncope", "DISEASE", 168, 175], ["animals", "ORGANISM", 5, 12], ["cardiac", "ORGAN", 38, 45], ["cardiac failure", "PROBLEM", 38, 53], ["microscopic alterations", "PROBLEM", 70, 93], ["an arrhythmic episode", "PROBLEM", 133, 154], ["syncope", "PROBLEM", 168, 175], ["cardiac", "ANATOMY", 38, 45], ["failure", "OBSERVATION", 46, 53], ["arrhythmic", "OBSERVATION", 136, 146], ["syncope", "OBSERVATION", 168, 175]]], ["Hearts with long-standing myocardial damage have foci of fibrosis, regardless of the cause of the loss of myocytes.", [["Hearts", "ANATOMY", 0, 6], ["myocardial", "ANATOMY", 26, 36], ["foci", "ANATOMY", 49, 53], ["myocytes", "ANATOMY", 106, 114], ["myocardial damage", "DISEASE", 26, 43], ["fibrosis", "DISEASE", 57, 65], ["myocardial", "MULTI-TISSUE_STRUCTURE", 26, 36], ["myocytes", "CELL", 106, 114], ["long-standing myocardial damage", "PROBLEM", 12, 43], ["fibrosis", "PROBLEM", 57, 65], ["the loss of myocytes", "PROBLEM", 94, 114], ["long", "OBSERVATION_MODIFIER", 12, 16], ["myocardial", "ANATOMY", 26, 36], ["damage", "OBSERVATION", 37, 43], ["foci", "OBSERVATION", 49, 53], ["fibrosis", "OBSERVATION", 57, 65], ["loss", "OBSERVATION", 98, 102], ["myocytes", "ANATOMY", 106, 114]]], ["Correlation between the severity of clinical cardiac disease and the severity of myocardial injury can be poor: A small lesion at a critical site, such as a portion of the conduction system, can be fatal, whereas a widespread myocardial lesion, such as myocarditis, can be asymptomatic.INFLAMMATIONCardiac myofibers can respond to toxins in a variety of waysapoptosis, myofibrillar lysis, and coagulation necrosis are but a few mechanisms that may result from toxic exposure.", [["cardiac", "ANATOMY", 45, 52], ["myocardial", "ANATOMY", 81, 91], ["lesion", "ANATOMY", 120, 126], ["site", "ANATOMY", 141, 145], ["conduction system", "ANATOMY", 172, 189], ["myocardial lesion", "ANATOMY", 226, 243], ["myofibers", "ANATOMY", 306, 315], ["myofibrillar", "ANATOMY", 369, 381], ["cardiac disease", "DISEASE", 45, 60], ["myocardial injury", "DISEASE", 81, 98], ["myocardial lesion", "DISEASE", 226, 243], ["myocarditis", "DISEASE", 253, 264], ["waysapoptosis", "DISEASE", 354, 367], ["coagulation necrosis", "DISEASE", 393, 413], ["cardiac", "ORGAN", 45, 52], ["myocardial", "MULTI-TISSUE_STRUCTURE", 81, 91], ["lesion", "CANCER", 120, 126], ["myocardial lesion", "PATHOLOGICAL_FORMATION", 226, 243], ["myofibers", "CELL", 306, 315], ["myofibrillar", "CELLULAR_COMPONENT", 369, 381], ["clinical cardiac disease", "PROBLEM", 36, 60], ["myocardial injury", "PROBLEM", 81, 98], ["A small lesion", "PROBLEM", 112, 126], ["a widespread myocardial lesion", "PROBLEM", 213, 243], ["myocarditis", "PROBLEM", 253, 264], ["asymptomatic", "PROBLEM", 273, 285], ["INFLAMMATIONCardiac myofibers", "PROBLEM", 286, 315], ["toxins", "PROBLEM", 331, 337], ["waysapoptosis", "PROBLEM", 354, 367], ["myofibrillar lysis", "PROBLEM", 369, 387], ["coagulation necrosis", "PROBLEM", 393, 413], ["toxic exposure", "PROBLEM", 460, 474], ["cardiac", "ANATOMY", 45, 52], ["disease", "OBSERVATION", 53, 60], ["myocardial", "ANATOMY", 81, 91], ["injury", "OBSERVATION", 92, 98], ["small", "OBSERVATION_MODIFIER", 114, 119], ["lesion", "OBSERVATION", 120, 126], ["critical site", "OBSERVATION_MODIFIER", 132, 145], ["conduction system", "OBSERVATION", 172, 189], ["can be", "UNCERTAINTY", 191, 197], ["fatal", "OBSERVATION_MODIFIER", 198, 203], ["widespread", "OBSERVATION_MODIFIER", 215, 225], ["myocardial", "ANATOMY", 226, 236], ["lesion", "OBSERVATION", 237, 243], ["myocarditis", "OBSERVATION", 253, 264], ["myofibrillar lysis", "OBSERVATION", 369, 387], ["coagulation", "OBSERVATION_MODIFIER", 393, 404], ["necrosis", "OBSERVATION", 405, 413], ["toxic", "OBSERVATION_MODIFIER", 460, 465]]], ["A long list of toxins are responsible for causing myocardial injury; some of the most frequently observed current examples are ionophore toxicity in horses and ruminants, vitamin E-selenium deficiency in the young of many species, \"heart-brain syndrome\" of dogs (see Fig. 10 -82), anthracycline toxicity in dogs, and gossypol toxicosis in pigs (Box 10-5).", [["myocardial", "ANATOMY", 50, 60], ["heart", "ANATOMY", 232, 237], ["brain", "ANATOMY", 238, 243], ["myocardial injury", "DISEASE", 50, 67], ["ionophore", "CHEMICAL", 127, 136], ["toxicity", "DISEASE", 137, 145], ["vitamin E-selenium", "CHEMICAL", 171, 189], ["heart-brain syndrome", "DISEASE", 232, 252], ["anthracycline", "CHEMICAL", 281, 294], ["toxicity", "DISEASE", 295, 303], ["gossypol", "CHEMICAL", 317, 325], ["toxicosis", "DISEASE", 326, 335], ["ionophore", "CHEMICAL", 127, 136], ["vitamin E", "CHEMICAL", 171, 180], ["selenium", "CHEMICAL", 181, 189], ["anthracycline", "CHEMICAL", 281, 294], ["gossypol", "CHEMICAL", 317, 325], ["myocardial", "MULTI-TISSUE_STRUCTURE", 50, 60], ["ionophore", "SIMPLE_CHEMICAL", 127, 136], ["horses", "ORGANISM_SUBDIVISION", 149, 155], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 171, 189], ["heart", "ORGAN", 232, 237], ["brain", "ORGAN", 238, 243], ["dogs", "ORGANISM", 257, 261], ["anthracycline", "SIMPLE_CHEMICAL", 281, 294], ["dogs", "ORGANISM", 307, 311], ["gossypol", "SIMPLE_CHEMICAL", 317, 325], ["pigs", "ORGANISM", 339, 343], ["Box 10-5", "ORGANISM", 345, 353], ["dogs", "SPECIES", 257, 261], ["dogs", "SPECIES", 307, 311], ["pigs", "SPECIES", 339, 343], ["pigs", "SPECIES", 339, 343], ["toxins", "PROBLEM", 15, 21], ["myocardial injury", "PROBLEM", 50, 67], ["ionophore toxicity in horses", "PROBLEM", 127, 155], ["vitamin E", "TREATMENT", 171, 180], ["selenium deficiency", "PROBLEM", 181, 200], ["many species", "PROBLEM", 217, 229], ["heart-brain syndrome", "PROBLEM", 232, 252], ["dogs", "PROBLEM", 257, 261], ["anthracycline toxicity in dogs", "PROBLEM", 281, 311], ["gossypol toxicosis", "PROBLEM", 317, 335], ["myocardial", "ANATOMY", 50, 60], ["injury", "OBSERVATION", 61, 67], ["selenium deficiency", "OBSERVATION", 181, 200], ["species", "OBSERVATION", 222, 229], ["heart", "ANATOMY", 232, 237], ["brain", "ANATOMY", 238, 243], ["syndrome", "OBSERVATION", 244, 252], ["gossypol toxicosis", "OBSERVATION", 317, 335]]], ["In various localized areas throughout the world, numerous deaths in ruminants have resulted from consumption of poisonous plants such as Acacia georginae and Dichapetalum cymosum.INFLAMMATIONCardiotoxicity has emerged as a significant clinical entity in veterinary medicine in recent years with the growing use of antineoplastic drugs in small animal practice and the widespread use of growth promotants in ruminants (see Fig. 10 -49).", [["antineoplastic", "ANATOMY", 314, 328], ["deaths", "DISEASE", 58, 64], ["Acacia georginae", "ORGANISM", 137, 153], ["Dichapetalum cymosum.", "ORGANISM", 158, 179], ["Acacia georginae", "SPECIES", 137, 153], ["Dichapetalum cymosum.", "SPECIES", 158, 179], ["Acacia georginae", "SPECIES", 137, 153], ["Dichapetalum cymosum.", "SPECIES", 158, 179], ["poisonous plants", "PROBLEM", 112, 128], ["Acacia georginae", "TREATMENT", 137, 153], ["INFLAMMATIONCardiotoxicity", "PROBLEM", 179, 205], ["antineoplastic drugs", "TREATMENT", 314, 334], ["growth promotants", "PROBLEM", 386, 403], ["various", "OBSERVATION_MODIFIER", 3, 10], ["localized", "OBSERVATION_MODIFIER", 11, 20], ["areas", "OBSERVATION_MODIFIER", 21, 26], ["numerous", "OBSERVATION_MODIFIER", 49, 57], ["deaths", "OBSERVATION", 58, 64], ["poisonous plants", "OBSERVATION", 112, 128], ["Acacia georginae", "OBSERVATION", 137, 153], ["significant", "OBSERVATION_MODIFIER", 223, 234], ["widespread", "OBSERVATION_MODIFIER", 368, 378]]], ["The mechanisms of cardiotoxicities include (1) exaggerated pharmacologic action of drugs acting on cardiovascular tissues, (2) exposure to substances that depress myocardial function, (3) direct injury of cardiac muscle cells by chemicals, and (4) hypersensitivity reactions.INFLAMMATIONOncotic Necrosis.", [["cardiovascular tissues", "ANATOMY", 99, 121], ["myocardial", "ANATOMY", 163, 173], ["cardiac muscle cells", "ANATOMY", 205, 225], ["cardiotoxicities", "DISEASE", 18, 34], ["hypersensitivity", "DISEASE", 248, 264], ["Necrosis", "DISEASE", 295, 303], ["cardiovascular tissues", "TISSUE", 99, 121], ["myocardial", "MULTI-TISSUE_STRUCTURE", 163, 173], ["cardiac muscle cells", "CELL", 205, 225], ["cardiac muscle cells", "CELL_TYPE", 205, 225], ["drugs", "TREATMENT", 83, 88], ["depress myocardial function", "PROBLEM", 155, 182], ["direct injury of cardiac muscle cells", "PROBLEM", 188, 225], ["hypersensitivity reactions", "PROBLEM", 248, 274], ["INFLAMMATIONOncotic Necrosis", "PROBLEM", 275, 303], ["cardiovascular tissues", "ANATOMY", 99, 121], ["cardiac muscle", "ANATOMY", 205, 219], ["Necrosis", "OBSERVATION", 295, 303]]], ["Necrosis of cardiac muscle cells is generally followed by leukocytic invasion and phagocytosis of sarcoplasmic debris ( Fig. 10-13 ; also see .", [["cardiac muscle cells", "ANATOMY", 12, 32], ["leukocytic", "ANATOMY", 58, 68], ["sarcoplasmic debris", "ANATOMY", 98, 117], ["Necrosis", "DISEASE", 0, 8], ["cardiac muscle", "DISEASE", 12, 26], ["cardiac muscle cells", "CELL", 12, 32], ["leukocytic", "CELL", 58, 68], ["sarcoplasmic debris", "CELLULAR_COMPONENT", 98, 117], ["cardiac muscle cells", "CELL_TYPE", 12, 32], ["Necrosis of cardiac muscle cells", "PROBLEM", 0, 32], ["leukocytic invasion", "PROBLEM", 58, 77], ["sarcoplasmic debris", "PROBLEM", 98, 117], ["cardiac muscle", "ANATOMY", 12, 26], ["leukocytic invasion", "OBSERVATION", 58, 77], ["phagocytosis", "OBSERVATION_MODIFIER", 82, 94], ["sarcoplasmic debris", "OBSERVATION", 98, 117]]], ["The end result is persistence of collapsed sarcolemmal \"tubes\" of basal lamina surrounded by condensed interstitial stroma and vessels.", [["sarcolemmal", "ANATOMY", 43, 54], ["tubes", "ANATOMY", 56, 61], ["basal lamina", "ANATOMY", 66, 78], ["interstitial stroma", "ANATOMY", 103, 122], ["vessels", "ANATOMY", 127, 134], ["sarcolemmal", "CELLULAR_COMPONENT", 43, 54], ["tubes", "TISSUE", 56, 61], ["basal lamina", "CELLULAR_COMPONENT", 66, 78], ["interstitial stroma", "TISSUE", 103, 122], ["vessels", "MULTI-TISSUE_STRUCTURE", 127, 134], ["collapsed sarcolemmal \"tubes", "PROBLEM", 33, 61], ["condensed interstitial stroma and vessels", "PROBLEM", 93, 134], ["persistence", "OBSERVATION_MODIFIER", 18, 29], ["collapsed", "OBSERVATION_MODIFIER", 33, 42], ["sarcolemmal \"tubes", "OBSERVATION", 43, 61], ["basal", "ANATOMY_MODIFIER", 66, 71], ["lamina", "ANATOMY_MODIFIER", 72, 78], ["condensed", "OBSERVATION_MODIFIER", 93, 102], ["interstitial stroma", "OBSERVATION", 103, 122], ["vessels", "ANATOMY", 127, 134]]], ["Lesions with severe disruption of the myocardium have residual changes of fibroblastic proliferation and collagen deposition to form scar tissue.", [["myocardium", "ANATOMY", 38, 48], ["fibroblastic", "ANATOMY", 74, 86], ["scar tissue", "ANATOMY", 133, 144], ["myocardium", "MULTI-TISSUE_STRUCTURE", 38, 48], ["fibroblastic", "CELL", 74, 86], ["collagen", "GENE_OR_GENE_PRODUCT", 105, 113], ["scar tissue", "TISSUE", 133, 144], ["collagen", "PROTEIN", 105, 113], ["Lesions", "PROBLEM", 0, 7], ["severe disruption of the myocardium", "PROBLEM", 13, 48], ["fibroblastic proliferation", "PROBLEM", 74, 100], ["collagen deposition", "TREATMENT", 105, 124], ["scar tissue", "PROBLEM", 133, 144], ["severe", "OBSERVATION_MODIFIER", 13, 19], ["disruption", "OBSERVATION", 20, 30], ["myocardium", "ANATOMY", 38, 48], ["residual", "OBSERVATION_MODIFIER", 54, 62], ["fibroblastic proliferation", "OBSERVATION", 74, 100], ["collagen deposition", "OBSERVATION", 105, 124], ["scar tissue", "OBSERVATION", 133, 144]]], ["Regeneration of cardiac muscle cells generally does not occur, except in less evolved animals, such as amphibians and fish, and in certain inbred mouse strains.", [["cardiac muscle cells", "ANATOMY", 16, 36], ["cardiac muscle cells", "CELL", 16, 36], ["fish", "ORGANISM_SUBDIVISION", 118, 122], ["mouse", "ORGANISM", 146, 151], ["cardiac muscle cells", "CELL_TYPE", 16, 36], ["mouse", "SPECIES", 146, 151], ["mouse", "SPECIES", 146, 151], ["Regeneration of cardiac muscle cells", "PROBLEM", 0, 36], ["cardiac muscle", "ANATOMY", 16, 30]]], ["The continual contraction of intact cardiac muscle cells impairs the mechanisms for regeneration.", [["cardiac muscle cells", "ANATOMY", 36, 56], ["cardiac muscle cells", "CELL", 36, 56], ["cardiac muscle cells", "CELL_TYPE", 36, 56], ["intact cardiac muscle cells", "PROBLEM", 29, 56], ["regeneration", "PROBLEM", 84, 96], ["contraction", "OBSERVATION_MODIFIER", 14, 25], ["intact", "OBSERVATION", 29, 35], ["cardiac muscle", "ANATOMY", 36, 50], ["cells", "OBSERVATION", 51, 56]]], ["Also, lymphosarcomas, metastasize to the myocardium and are discussed in this chapter and other chapters of this book.", [["lymphosarcomas", "ANATOMY", 6, 20], ["myocardium", "ANATOMY", 41, 51], ["lymphosarcomas", "DISEASE", 6, 20], ["lymphosarcomas", "CANCER", 6, 20], ["myocardium", "ORGAN", 41, 51], ["lymphosarcomas", "PROBLEM", 6, 20], ["metastasize to the myocardium", "PROBLEM", 22, 51], ["lymphosarcomas", "OBSERVATION", 6, 20], ["metastasize", "OBSERVATION", 22, 33], ["myocardium", "ANATOMY", 41, 51]]], ["Hemangiosarcomas are tumors of blood vessels of the myocardium of the right atrium and are discussed later.Cell Degeneration and DeathSublethal cardiac muscle cell injuries include lipofuscinosis, fatty degeneration, myocytolysis, and vacuolar degeneration ( Fig. 10-12 ; see Chapter 1).", [["Hemangiosarcomas", "ANATOMY", 0, 16], ["tumors", "ANATOMY", 21, 27], ["blood vessels", "ANATOMY", 31, 44], ["myocardium", "ANATOMY", 52, 62], ["right atrium", "ANATOMY", 70, 82], ["Cell", "ANATOMY", 107, 111], ["DeathSublethal cardiac muscle cell", "ANATOMY", 129, 163], ["vacuolar", "ANATOMY", 235, 243], ["Hemangiosarcomas", "DISEASE", 0, 16], ["tumors", "DISEASE", 21, 27], ["cardiac muscle cell injuries", "DISEASE", 144, 172], ["lipofuscinosis", "DISEASE", 181, 195], ["fatty degeneration", "DISEASE", 197, 215], ["myocytolysis", "DISEASE", 217, 229], ["vacuolar degeneration", "DISEASE", 235, 256], ["Hemangiosarcomas", "CANCER", 0, 16], ["tumors", "CANCER", 21, 27], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 31, 44], ["myocardium", "ORGAN", 52, 62], ["right atrium", "MULTI-TISSUE_STRUCTURE", 70, 82], ["Cell", "CELL", 107, 111], ["cardiac muscle cell", "CELL", 144, 163], ["fatty", "TISSUE", 197, 202], ["vacuolar", "CELLULAR_COMPONENT", 235, 243], ["Hemangiosarcomas", "PROBLEM", 0, 16], ["tumors of blood vessels", "PROBLEM", 21, 44], ["Cell Degeneration", "PROBLEM", 107, 124], ["DeathSublethal cardiac muscle cell injuries", "PROBLEM", 129, 172], ["lipofuscinosis", "PROBLEM", 181, 195], ["fatty degeneration", "PROBLEM", 197, 215], ["myocytolysis", "PROBLEM", 217, 229], ["vacuolar degeneration", "PROBLEM", 235, 256], ["tumors", "OBSERVATION", 21, 27], ["blood vessels", "OBSERVATION", 31, 44], ["myocardium", "ANATOMY", 52, 62], ["right atrium", "ANATOMY", 70, 82], ["Degeneration", "OBSERVATION", 112, 124], ["cardiac", "ANATOMY", 144, 151], ["muscle cell injuries", "OBSERVATION", 152, 172], ["lipofuscinosis", "OBSERVATION", 181, 195], ["fatty degeneration", "OBSERVATION", 197, 215], ["vacuolar degeneration", "OBSERVATION", 235, 256]]], ["Histopathologic study of sections of the myocardium is substantially limited with respect to specific diagnoses and only rarely can an etiologic diagnosis be made from the morphologic alterations.", [["sections", "ANATOMY", 25, 33], ["myocardium", "ANATOMY", 41, 51], ["sections", "MULTI-TISSUE_STRUCTURE", 25, 33], ["myocardium", "MULTI-TISSUE_STRUCTURE", 41, 51], ["Histopathologic study", "TEST", 0, 21], ["the morphologic alterations", "PROBLEM", 168, 195], ["myocardium", "ANATOMY", 41, 51]]], ["This inadequacy exists because the spectrum of pathologic reactions is limited, and many agents that damage the heart produce similar lesions.", [["heart", "ANATOMY", 112, 117], ["lesions", "ANATOMY", 134, 141], ["heart", "ORGAN", 112, 117], ["lesions", "CANCER", 134, 141], ["pathologic reactions", "PROBLEM", 47, 67], ["similar lesions", "PROBLEM", 126, 141], ["pathologic", "OBSERVATION", 47, 57], ["heart", "ANATOMY", 112, 117], ["similar", "OBSERVATION_MODIFIER", 126, 133], ["lesions", "OBSERVATION", 134, 141]]], ["Myocardial necrosis can be confused with These conditions include cardiac development, ischemic injury, several types of experimentally induced heart failure (ischemiareperfusion, hypoxia, and pressure-overload hypertrophy), and cardiotoxicity.", [["Myocardial", "ANATOMY", 0, 10], ["cardiac", "ANATOMY", 66, 73], ["heart", "ANATOMY", 144, 149], ["Myocardial necrosis", "DISEASE", 0, 19], ["cardiac development", "DISEASE", 66, 85], ["ischemic injury", "DISEASE", 87, 102], ["heart failure", "DISEASE", 144, 157], ["ischemiareperfusion", "DISEASE", 159, 178], ["hypoxia", "DISEASE", 180, 187], ["hypertrophy", "DISEASE", 211, 222], ["cardiotoxicity", "DISEASE", 229, 243], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["cardiac", "ORGAN", 66, 73], ["heart", "ORGAN", 144, 149], ["Myocardial necrosis", "PROBLEM", 0, 19], ["These conditions", "PROBLEM", 41, 57], ["cardiac development", "PROBLEM", 66, 85], ["ischemic injury", "PROBLEM", 87, 102], ["experimentally induced heart failure", "PROBLEM", 121, 157], ["ischemiareperfusion", "PROBLEM", 159, 178], ["hypoxia", "PROBLEM", 180, 187], ["pressure-overload hypertrophy", "PROBLEM", 193, 222], ["cardiotoxicity", "PROBLEM", 229, 243], ["necrosis", "OBSERVATION", 11, 19], ["ischemic", "OBSERVATION_MODIFIER", 87, 95], ["injury", "OBSERVATION", 96, 102], ["heart", "ANATOMY", 144, 149], ["failure", "OBSERVATION", 150, 157], ["hypoxia", "OBSERVATION_MODIFIER", 180, 187], ["pressure", "OBSERVATION_MODIFIER", 193, 201], ["overload", "OBSERVATION_MODIFIER", 202, 210], ["hypertrophy", "OBSERVATION", 211, 222]]], ["In some cell systems, apoptosis can be triggered by the presence of excessive amounts of oxygen free radicals.", [["cell systems", "ANATOMY", 8, 20], ["oxygen", "CHEMICAL", 89, 95], ["oxygen", "CHEMICAL", 89, 95], ["cell", "CELL", 8, 12], ["oxygen free radicals", "SIMPLE_CHEMICAL", 89, 109], ["apoptosis", "PROBLEM", 22, 31], ["oxygen free radicals", "TREATMENT", 89, 109], ["cell systems", "OBSERVATION", 8, 20], ["excessive", "OBSERVATION_MODIFIER", 68, 77], ["amounts", "OBSERVATION_MODIFIER", 78, 85]]], ["Cells dying by apoptosis shrink and form apoptotic bodies.", [["Cells", "ANATOMY", 0, 5], ["bodies", "ANATOMY", 51, 57], ["Cells", "CELL", 0, 5], ["apoptotic bodies", "CELLULAR_COMPONENT", 41, 57], ["apoptotic bodies", "PROBLEM", 41, 57], ["apoptosis shrink", "OBSERVATION", 15, 31], ["apoptotic bodies", "OBSERVATION", 41, 57]]], ["In contrast to cell death by necrosis, apoptosis is not accompanied by an inflammatory reaction and fibrosis.Cell Degeneration and DeathFatty Infiltration.", [["cell", "ANATOMY", 15, 19], ["Cell", "ANATOMY", 109, 113], ["death", "DISEASE", 20, 25], ["necrosis", "DISEASE", 29, 37], ["fibrosis", "DISEASE", 100, 108], ["cell", "CELL", 15, 19], ["Cell", "CELL", 109, 113], ["necrosis", "PROBLEM", 29, 37], ["apoptosis", "PROBLEM", 39, 48], ["an inflammatory reaction", "PROBLEM", 71, 95], ["fibrosis", "PROBLEM", 100, 108], ["Cell Degeneration", "PROBLEM", 109, 126], ["DeathFatty Infiltration", "PROBLEM", 131, 154], ["cell death", "OBSERVATION", 15, 25], ["necrosis", "OBSERVATION", 29, 37], ["not accompanied", "UNCERTAINTY", 52, 67], ["inflammatory", "OBSERVATION_MODIFIER", 74, 86], ["reaction", "OBSERVATION", 87, 95], ["fibrosis", "OBSERVATION", 100, 108], ["Degeneration", "OBSERVATION", 114, 126], ["DeathFatty", "OBSERVATION_MODIFIER", 131, 141], ["Infiltration", "OBSERVATION", 142, 154]]], ["Fatty infiltration is the presence of increased numbers of lipocytes interposed between myocardial fibers.", [["lipocytes", "ANATOMY", 59, 68], ["myocardial fibers", "ANATOMY", 88, 105], ["Fatty infiltration", "DISEASE", 0, 18], ["lipocytes", "GENE_OR_GENE_PRODUCT", 59, 68], ["myocardial fibers", "TISSUE", 88, 105], ["Fatty infiltration", "PROBLEM", 0, 18], ["increased numbers of lipocytes", "PROBLEM", 38, 68], ["infiltration", "OBSERVATION", 6, 18], ["increased", "OBSERVATION_MODIFIER", 38, 47], ["numbers", "OBSERVATION_MODIFIER", 48, 55], ["lipocytes", "OBSERVATION", 59, 68], ["myocardial", "ANATOMY", 88, 98], ["fibers", "ANATOMY_MODIFIER", 99, 105]]], ["The lesion is associated with obesity and age and appears as abundant epicardial and myocardial deposits of adipose tissue.", [["lesion", "ANATOMY", 4, 10], ["epicardial", "ANATOMY", 70, 80], ["myocardial", "ANATOMY", 85, 95], ["adipose tissue", "ANATOMY", 108, 122], ["obesity", "DISEASE", 30, 37], ["epicardial", "MULTI-TISSUE_STRUCTURE", 70, 80], ["myocardial deposits", "TISSUE", 85, 104], ["adipose tissue", "TISSUE", 108, 122], ["The lesion", "PROBLEM", 0, 10], ["obesity", "PROBLEM", 30, 37], ["abundant epicardial and myocardial deposits of adipose tissue", "PROBLEM", 61, 122], ["lesion", "OBSERVATION", 4, 10], ["associated with", "UNCERTAINTY", 14, 29], ["obesity", "OBSERVATION", 30, 37], ["abundant", "OBSERVATION_MODIFIER", 61, 69], ["epicardial", "ANATOMY", 70, 80], ["myocardial", "ANATOMY", 85, 95], ["deposits", "OBSERVATION", 96, 104], ["adipose tissue", "OBSERVATION", 108, 122]]], ["Grossly, the myocardium has irregular layers of adipose tissue infiltrating normal myocardium.", [["myocardium", "ANATOMY", 13, 23], ["irregular layers", "ANATOMY", 28, 44], ["adipose tissue", "ANATOMY", 48, 62], ["myocardium", "ANATOMY", 83, 93], ["myocardium", "MULTI-TISSUE_STRUCTURE", 13, 23], ["irregular layers", "TISSUE", 28, 44], ["adipose tissue", "TISSUE", 48, 62], ["normal myocardium", "TISSUE", 76, 93], ["irregular layers of adipose tissue", "PROBLEM", 28, 62], ["myocardium", "ANATOMY", 13, 23], ["irregular", "OBSERVATION_MODIFIER", 28, 37], ["layers", "OBSERVATION_MODIFIER", 38, 44], ["adipose tissue", "OBSERVATION", 48, 62], ["infiltrating", "OBSERVATION_MODIFIER", 63, 75], ["normal myocardium", "OBSERVATION", 76, 93]]], ["The atria and right ventricle are most often affected.Cell Degeneration and DeathFatty Degeneration.", [["atria", "ANATOMY", 4, 9], ["right ventricle", "ANATOMY", 14, 29], ["Cell", "ANATOMY", 54, 58], ["atria", "MULTI-TISSUE_STRUCTURE", 4, 9], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 14, 29], ["Cell", "CELL", 54, 58], ["Cell Degeneration", "PROBLEM", 54, 71], ["DeathFatty Degeneration", "PROBLEM", 76, 99], ["atria", "ANATOMY", 4, 9], ["right ventricle", "ANATOMY", 14, 29], ["Degeneration", "OBSERVATION", 59, 71], ["DeathFatty Degeneration", "OBSERVATION", 76, 99]]], ["Fatty degeneration (fatty change) is the accumulation of abundant lipid droplets in the sarcoplasm of myocytes.", [["lipid droplets", "ANATOMY", 66, 80], ["sarcoplasm", "ANATOMY", 88, 98], ["myocytes", "ANATOMY", 102, 110], ["Fatty degeneration", "DISEASE", 0, 18], ["fatty change", "DISEASE", 20, 32], ["Fatty", "TISSUE", 0, 5], ["lipid droplets", "CELLULAR_COMPONENT", 66, 80], ["myocytes", "CELL", 102, 110], ["Fatty degeneration (fatty change", "PROBLEM", 0, 32], ["abundant lipid droplets", "PROBLEM", 57, 80], ["degeneration", "OBSERVATION", 6, 18], ["fatty change", "OBSERVATION", 20, 32], ["accumulation", "OBSERVATION_MODIFIER", 41, 53], ["abundant", "OBSERVATION_MODIFIER", 57, 65], ["lipid droplets", "OBSERVATION", 66, 80], ["sarcoplasm", "ANATOMY", 88, 98], ["myocytes", "ANATOMY", 102, 110]]], ["Microscopically, affected myocytes have numerous variably sized spherical droplets that appear as empty vacuoles in paraffin sections but stain positively for lipids with lipid-soluble stains in frozen sections.", [["myocytes", "ANATOMY", 26, 34], ["vacuoles", "ANATOMY", 104, 112], ["paraffin sections", "ANATOMY", 116, 133], ["sections", "ANATOMY", 202, 210], ["myocytes", "CELL", 26, 34], ["vacuoles", "CELLULAR_COMPONENT", 104, 112], ["lipids", "SIMPLE_CHEMICAL", 159, 165], ["lipid", "SIMPLE_CHEMICAL", 171, 176], ["affected myocytes", "PROBLEM", 17, 34], ["numerous variably sized spherical droplets", "PROBLEM", 40, 82], ["stain", "TEST", 138, 143], ["lipids", "TEST", 159, 165], ["lipid-soluble stains", "TEST", 171, 191], ["frozen sections", "TEST", 195, 210], ["myocytes", "ANATOMY", 26, 34], ["numerous", "OBSERVATION_MODIFIER", 40, 48], ["variably", "OBSERVATION_MODIFIER", 49, 57], ["sized", "OBSERVATION_MODIFIER", 58, 63], ["spherical droplets", "OBSERVATION", 64, 82], ["empty vacuoles", "OBSERVATION", 98, 112], ["paraffin sections", "OBSERVATION_MODIFIER", 116, 133]]], ["This lesion occurs with systemic disorders, such as severe anemia, toxemia, and copper deficiency, but is seen much less often in the heart than in the liver and kidneys (also see Chapter 1).Cell Degeneration and DeathHydropic Degeneration.", [["lesion", "ANATOMY", 5, 11], ["heart", "ANATOMY", 134, 139], ["liver", "ANATOMY", 152, 157], ["kidneys", "ANATOMY", 162, 169], ["Cell", "ANATOMY", 191, 195], ["systemic disorders", "DISEASE", 24, 42], ["anemia", "DISEASE", 59, 65], ["toxemia", "DISEASE", 67, 74], ["copper deficiency", "DISEASE", 80, 97], ["DeathHydropic Degeneration", "DISEASE", 213, 239], ["copper", "CHEMICAL", 80, 86], ["copper", "SIMPLE_CHEMICAL", 80, 86], ["heart", "ORGAN", 134, 139], ["liver", "ORGAN", 152, 157], ["kidneys", "ORGAN", 162, 169], ["Cell", "CELL", 191, 195], ["This lesion", "PROBLEM", 0, 11], ["systemic disorders", "PROBLEM", 24, 42], ["severe anemia", "PROBLEM", 52, 65], ["toxemia", "PROBLEM", 67, 74], ["copper deficiency", "PROBLEM", 80, 97], ["Cell Degeneration", "PROBLEM", 191, 208], ["DeathHydropic Degeneration", "PROBLEM", 213, 239], ["lesion", "OBSERVATION", 5, 11], ["systemic disorders", "OBSERVATION", 24, 42], ["severe", "OBSERVATION_MODIFIER", 52, 58], ["anemia", "OBSERVATION", 59, 65], ["toxemia", "OBSERVATION", 67, 74], ["copper deficiency", "OBSERVATION", 80, 97], ["heart", "ANATOMY", 134, 139], ["liver", "ANATOMY", 152, 157], ["kidneys", "ANATOMY", 162, 169], ["Degeneration", "OBSERVATION", 196, 208], ["DeathHydropic Degeneration", "OBSERVATION", 213, 239]]], ["Hydropic degeneration, a distinctive microscopic alteration in cardiac muscle cells, is associated with chronic administration of anthracyclines, a group of antineoplastic drugs.", [["cardiac muscle cells", "ANATOMY", 63, 83], ["antineoplastic", "ANATOMY", 157, 171], ["Hydropic degeneration", "DISEASE", 0, 21], ["cardiac muscle", "DISEASE", 63, 77], ["anthracyclines", "CHEMICAL", 130, 144], ["anthracyclines", "CHEMICAL", 130, 144], ["cardiac muscle cells", "CELL", 63, 83], ["anthracyclines", "SIMPLE_CHEMICAL", 130, 144], ["cardiac muscle cells", "CELL_TYPE", 63, 83], ["Hydropic degeneration", "PROBLEM", 0, 21], ["a distinctive microscopic alteration in cardiac muscle cells", "PROBLEM", 23, 83], ["anthracyclines", "TREATMENT", 130, 144], ["antineoplastic drugs", "TREATMENT", 157, 177], ["degeneration", "OBSERVATION", 9, 21], ["distinctive", "OBSERVATION_MODIFIER", 25, 36], ["microscopic", "OBSERVATION_MODIFIER", 37, 48], ["alteration", "OBSERVATION", 49, 59], ["cardiac muscle", "ANATOMY", 63, 77], ["cells", "OBSERVATION", 78, 83], ["chronic", "OBSERVATION_MODIFIER", 104, 111]]], ["Chronic passive congestion with ascites and cardiac dilation may result (E-Figs.", [["ascites", "ANATOMY", 32, 39], ["cardiac", "ANATOMY", 44, 51], ["ascites", "DISEASE", 32, 39], ["cardiac dilation", "DISEASE", 44, 60], ["cardiac", "ORGAN", 44, 51], ["Chronic passive congestion", "PROBLEM", 0, 26], ["ascites", "PROBLEM", 32, 39], ["cardiac dilation", "PROBLEM", 44, 60], ["passive", "OBSERVATION_MODIFIER", 8, 15], ["congestion", "OBSERVATION", 16, 26], ["ascites", "OBSERVATION", 32, 39], ["cardiac", "ANATOMY", 44, 51], ["dilation", "OBSERVATION", 52, 60]]], ["Affected fibers have extensive vacuolization of sarcoplasm that is initiated by distention of elements of sarcoplasmic reticulum and eventually ends in lysis of contractile material (E-Figs.", [["fibers", "ANATOMY", 9, 15], ["sarcoplasm", "ANATOMY", 48, 58], ["sarcoplasmic reticulum", "ANATOMY", 106, 128], ["contractile material", "ANATOMY", 161, 181], ["fibers", "CELLULAR_COMPONENT", 9, 15], ["sarcoplasm", "CANCER", 48, 58], ["sarcoplasmic reticulum", "CELLULAR_COMPONENT", 106, 128], ["contractile material", "CELLULAR_COMPONENT", 161, 181], ["Affected fibers", "PROBLEM", 0, 15], ["extensive vacuolization of sarcoplasm", "PROBLEM", 21, 58], ["sarcoplasmic reticulum", "PROBLEM", 106, 128], ["contractile material", "TEST", 161, 181], ["extensive", "OBSERVATION_MODIFIER", 21, 30], ["vacuolization", "OBSERVATION", 31, 44], ["sarcoplasm", "ANATOMY", 48, 58], ["distention", "OBSERVATION", 80, 90], ["sarcoplasmic reticulum", "OBSERVATION", 106, 128], ["lysis", "OBSERVATION_MODIFIER", 152, 157], ["contractile material", "OBSERVATION", 161, 181]]], ["10-12 and 10-13).Cell Degeneration and DeathHydropic degeneration of cardiac muscle cells may also result from drug-induced injury to mitochondria.", [["Cell", "ANATOMY", 17, 21], ["cardiac muscle cells", "ANATOMY", 69, 89], ["mitochondria", "ANATOMY", 134, 146], ["Cell", "CELL", 17, 21], ["cardiac muscle cells", "CELL", 69, 89], ["mitochondria", "CELLULAR_COMPONENT", 134, 146], ["cardiac muscle cells", "CELL_TYPE", 69, 89], ["Cell Degeneration", "PROBLEM", 17, 34], ["DeathHydropic degeneration of cardiac muscle cells", "PROBLEM", 39, 89], ["drug-induced injury to mitochondria", "PROBLEM", 111, 146], ["Degeneration", "OBSERVATION", 22, 34], ["DeathHydropic", "OBSERVATION_MODIFIER", 39, 52], ["degeneration", "OBSERVATION", 53, 65], ["cardiac muscle", "ANATOMY", 69, 83], ["injury", "OBSERVATION", 124, 130]]], ["Antiretroviral drugs, such as nucleoside reverse transcriptase inhibitors (zidovudine or AZT), are linked to this distinctive lesion.", [["lesion", "ANATOMY", 126, 132], ["nucleoside", "CHEMICAL", 30, 40], ["zidovudine", "CHEMICAL", 75, 85], ["AZT", "CHEMICAL", 89, 92], ["nucleoside", "CHEMICAL", 30, 40], ["zidovudine", "CHEMICAL", 75, 85], ["AZT", "CHEMICAL", 89, 92], ["nucleoside reverse transcriptase", "GENE_OR_GENE_PRODUCT", 30, 62], ["zidovudine", "SIMPLE_CHEMICAL", 75, 85], ["AZT", "SIMPLE_CHEMICAL", 89, 92], ["lesion", "CANCER", 126, 132], ["nucleoside reverse transcriptase", "PROTEIN", 30, 62], ["Antiretroviral drugs", "TREATMENT", 0, 20], ["nucleoside reverse transcriptase inhibitors", "TREATMENT", 30, 73], ["zidovudine", "TREATMENT", 75, 85], ["AZT)", "TREATMENT", 89, 93], ["this distinctive lesion", "PROBLEM", 109, 132], ["distinctive", "OBSERVATION_MODIFIER", 114, 125], ["lesion", "OBSERVATION", 126, 132]]], ["Scattered cardiac muscle cells appear swollen with pale sarcoplasm by light microscopy.", [["cardiac muscle cells", "ANATOMY", 10, 30], ["pale sarcoplasm", "ANATOMY", 51, 66], ["cardiac muscle cells", "CELL", 10, 30], ["sarcoplasm", "ORGANISM_SUBSTANCE", 56, 66], ["cardiac muscle cells", "CELL_TYPE", 10, 30], ["Scattered cardiac muscle cells", "PROBLEM", 0, 30], ["swollen", "PROBLEM", 38, 45], ["pale sarcoplasm", "PROBLEM", 51, 66], ["light microscopy", "TEST", 70, 86], ["cardiac", "ANATOMY", 10, 17], ["muscle cells", "ANATOMY", 18, 30], ["swollen", "OBSERVATION", 38, 45], ["pale sarcoplasm", "OBSERVATION", 51, 66]]], ["Electron microscopy reveals extensive mitochondrial swelling and disruption of cristae with subsequent formation of myelin figures from the membrane debris of damaged mitochondria.", [["mitochondrial", "ANATOMY", 38, 51], ["cristae", "ANATOMY", 79, 86], ["myelin", "ANATOMY", 116, 122], ["membrane debris", "ANATOMY", 140, 155], ["mitochondria", "ANATOMY", 167, 179], ["mitochondrial swelling", "DISEASE", 38, 60], ["mitochondrial", "CELLULAR_COMPONENT", 38, 51], ["cristae", "CELLULAR_COMPONENT", 79, 86], ["myelin", "CELLULAR_COMPONENT", 116, 122], ["membrane debris", "CELLULAR_COMPONENT", 140, 155], ["mitochondria", "CELLULAR_COMPONENT", 167, 179], ["Electron microscopy", "TEST", 0, 19], ["extensive mitochondrial swelling", "PROBLEM", 28, 60], ["disruption of cristae", "PROBLEM", 65, 86], ["myelin figures", "PROBLEM", 116, 130], ["the membrane debris", "PROBLEM", 136, 155], ["damaged mitochondria", "PROBLEM", 159, 179], ["extensive", "OBSERVATION_MODIFIER", 28, 37], ["mitochondrial swelling", "OBSERVATION", 38, 60], ["cristae", "OBSERVATION_MODIFIER", 79, 86], ["myelin figures", "OBSERVATION", 116, 130], ["membrane debris", "OBSERVATION", 140, 155], ["damaged mitochondria", "OBSERVATION", 159, 179]]], ["Myofibrillar Degeneration.", [["Myofibrillar", "ANATOMY", 0, 12], ["Myofibrillar Degeneration", "DISEASE", 0, 25], ["Myofibrillar Degeneration", "PROBLEM", 0, 25], ["Degeneration", "OBSERVATION", 13, 25]]], ["Myofibrillar degeneration (myocytolysis) represents a distinctive sublethal injury of cardiac muscle cells.", [["Myofibrillar", "ANATOMY", 0, 12], ["cardiac muscle cells", "ANATOMY", 86, 106], ["Myofibrillar degeneration", "DISEASE", 0, 25], ["myocytolysis", "DISEASE", 27, 39], ["injury of cardiac muscle", "DISEASE", 76, 100], ["cardiac muscle cells", "CELL", 86, 106], ["cardiac muscle cells", "CELL_TYPE", 86, 106], ["Myofibrillar degeneration (myocytolysis)", "PROBLEM", 0, 40], ["a distinctive sublethal injury of cardiac muscle cells", "PROBLEM", 52, 106], ["degeneration", "OBSERVATION", 13, 25], ["distinctive", "OBSERVATION_MODIFIER", 54, 65], ["sublethal", "OBSERVATION_MODIFIER", 66, 75], ["injury", "OBSERVATION", 76, 82], ["cardiac muscle", "ANATOMY", 86, 100], ["cells", "OBSERVATION", 101, 106]]], ["Affected fibers have pale eosinophilic sarcoplasm and lack cross-striations.", [["fibers", "ANATOMY", 9, 15], ["eosinophilic sarcoplasm", "ANATOMY", 26, 49], ["fibers", "CELLULAR_COMPONENT", 9, 15], ["Affected fibers", "PROBLEM", 0, 15], ["pale eosinophilic sarcoplasm", "PROBLEM", 21, 49], ["lack cross-striations", "PROBLEM", 54, 75], ["pale", "OBSERVATION_MODIFIER", 21, 25], ["eosinophilic sarcoplasm", "OBSERVATION", 26, 49], ["lack cross-striations", "OBSERVATION", 54, 75]]], ["Ultrastructurally, myofibrils have a variable extent of dissolution (myofibrillar lysis).", [["myofibrils", "ANATOMY", 19, 29], ["myofibrillar", "ANATOMY", 69, 81], ["myofibrils", "CELLULAR_COMPONENT", 19, 29], ["myofibrillar", "CELLULAR_COMPONENT", 69, 81], ["myofibrils", "CELL_TYPE", 19, 29], ["myofibrillar lysis", "TREATMENT", 69, 87], ["variable extent", "OBSERVATION_MODIFIER", 37, 52], ["myofibrillar lysis", "OBSERVATION", 69, 87]]], ["This lesion has been described in furazolidone cardiotoxicity in birds and potassium deficiency in rats.Cell Degeneration and DeathLipofuscinosis.", [["lesion", "ANATOMY", 5, 11], ["Cell", "ANATOMY", 104, 108], ["furazolidone", "CHEMICAL", 34, 46], ["cardiotoxicity", "DISEASE", 47, 61], ["potassium", "CHEMICAL", 75, 84], ["furazolidone", "CHEMICAL", 34, 46], ["potassium", "CHEMICAL", 75, 84], ["furazolidone", "SIMPLE_CHEMICAL", 34, 46], ["birds", "ORGANISM", 65, 70], ["potassium", "SIMPLE_CHEMICAL", 75, 84], ["rats", "ORGANISM", 99, 103], ["Cell", "CELL", 104, 108], ["rats", "SPECIES", 99, 103], ["This lesion", "PROBLEM", 0, 11], ["furazolidone cardiotoxicity", "TREATMENT", 34, 61], ["potassium deficiency in rats", "PROBLEM", 75, 103], ["Cell Degeneration", "PROBLEM", 104, 121], ["DeathLipofuscinosis", "PROBLEM", 126, 145], ["lesion", "OBSERVATION", 5, 11], ["furazolidone", "OBSERVATION_MODIFIER", 34, 46], ["cardiotoxicity", "OBSERVATION", 47, 61], ["potassium deficiency", "OBSERVATION", 75, 95], ["Degeneration", "OBSERVATION", 109, 121]]], ["Lipofuscinosis (brown atrophy) of the myocardium occurs in aged animals and in animals with severe cachexia, but it also has been described as a hereditary lesion in healthy Ayrshire cattle.", [["myocardium", "ANATOMY", 38, 48], ["lesion", "ANATOMY", 156, 162], ["Lipofuscinosis", "DISEASE", 0, 14], ["brown atrophy", "DISEASE", 16, 29], ["cachexia", "DISEASE", 99, 107], ["hereditary lesion", "DISEASE", 145, 162], ["brown", "ORGANISM_SUBDIVISION", 16, 21], ["myocardium", "ORGAN", 38, 48], ["cachexia", "CANCER", 99, 107], ["Ayrshire cattle", "ORGANISM", 174, 189], ["cattle", "SPECIES", 183, 189], ["Ayrshire cattle", "SPECIES", 174, 189], ["Lipofuscinosis (brown atrophy", "PROBLEM", 0, 29], ["the myocardium", "PROBLEM", 34, 48], ["severe cachexia", "PROBLEM", 92, 107], ["a hereditary lesion", "PROBLEM", 143, 162], ["brown atrophy", "OBSERVATION", 16, 29], ["myocardium", "ANATOMY", 38, 48], ["severe", "OBSERVATION_MODIFIER", 92, 98], ["cachexia", "OBSERVATION", 99, 107], ["hereditary", "OBSERVATION_MODIFIER", 145, 155], ["lesion", "OBSERVATION", 156, 162]]], ["Severely affected hearts appear brown and microscopically have clusters of yellow-brown granules at the nuclear poles of myocytes.", [["hearts", "ANATOMY", 18, 24], ["granules", "ANATOMY", 88, 96], ["nuclear poles", "ANATOMY", 104, 117], ["myocytes", "ANATOMY", 121, 129], ["hearts", "ORGAN", 18, 24], ["granules", "ORGANISM_SUBSTANCE", 88, 96], ["nuclear poles", "CELLULAR_COMPONENT", 104, 117], ["myocytes", "CELL", 121, 129], ["Severely affected hearts", "PROBLEM", 0, 24], ["yellow-brown granules", "PROBLEM", 75, 96], ["hearts", "ANATOMY", 18, 24], ["brown", "OBSERVATION", 32, 37], ["clusters", "OBSERVATION_MODIFIER", 63, 71], ["yellow", "OBSERVATION_MODIFIER", 75, 81], ["brown granules", "OBSERVATION", 82, 96], ["nuclear poles", "ANATOMY_MODIFIER", 104, 117], ["myocytes", "ANATOMY", 121, 129]]], ["These granules represent intralysosomal accumulation of membranous and amorphous debris (residual bodies).Cell Degeneration and DeathMineralization.", [["granules", "ANATOMY", 6, 14], ["intralysosomal", "ANATOMY", 25, 39], ["membranous", "ANATOMY", 56, 66], ["bodies", "ANATOMY", 98, 104], ["Cell", "ANATOMY", 106, 110], ["granules", "CELLULAR_COMPONENT", 6, 14], ["membranous", "CELLULAR_COMPONENT", 56, 66], ["Cell", "CELL", 106, 110], ["intralysosomal accumulation of membranous and amorphous debris (residual bodies)", "PROBLEM", 25, 105], ["Cell Degeneration", "PROBLEM", 106, 123], ["DeathMineralization", "PROBLEM", 128, 147], ["intralysosomal accumulation", "OBSERVATION", 25, 52], ["membranous", "OBSERVATION_MODIFIER", 56, 66], ["amorphous", "OBSERVATION_MODIFIER", 71, 80], ["debris", "OBSERVATION", 81, 87], ["residual bodies", "OBSERVATION", 89, 104], ["Degeneration", "OBSERVATION", 111, 123], ["DeathMineralization", "OBSERVATION", 128, 147]]], ["Myocardial mineralization (calcium) is a prominent feature in several diseases, such as hereditary calcinosis in mice, cardiomyopathy in hamsters, vitamin E-selenium in hearts of neonatal animals and more often in avian hearts, a limited amount of myocyte regeneration has been reported.", [["Myocardial", "ANATOMY", 0, 10], ["hearts", "ANATOMY", 169, 175], ["hearts", "ANATOMY", 220, 226], ["myocyte", "ANATOMY", 248, 255], ["calcium", "CHEMICAL", 27, 34], ["hereditary calcinosis", "DISEASE", 88, 109], ["cardiomyopathy", "DISEASE", 119, 133], ["vitamin E-selenium", "CHEMICAL", 147, 165], ["calcium", "CHEMICAL", 27, 34], ["vitamin E", "CHEMICAL", 147, 156], ["selenium", "CHEMICAL", 157, 165], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["calcium", "SIMPLE_CHEMICAL", 27, 34], ["mice", "ORGANISM", 113, 117], ["hamsters", "ORGANISM", 137, 145], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 147, 165], ["hearts", "ORGAN", 169, 175], ["avian", "ORGANISM", 214, 219], ["hearts", "ORGAN", 220, 226], ["myocyte", "CELL", 248, 255], ["mice", "SPECIES", 113, 117], ["hamsters", "SPECIES", 137, 145], ["mice", "SPECIES", 113, 117], ["hamsters", "SPECIES", 137, 145], ["Myocardial mineralization", "PROBLEM", 0, 25], ["calcium", "TEST", 27, 34], ["a prominent feature", "PROBLEM", 39, 58], ["several diseases", "PROBLEM", 62, 78], ["hereditary calcinosis in mice", "PROBLEM", 88, 117], ["cardiomyopathy in hamsters", "PROBLEM", 119, 145], ["vitamin E", "TREATMENT", 147, 156], ["neonatal animals", "PROBLEM", 179, 195], ["myocyte regeneration", "PROBLEM", 248, 268], ["mineralization", "OBSERVATION", 11, 25], ["prominent", "OBSERVATION_MODIFIER", 41, 50], ["several", "OBSERVATION_MODIFIER", 62, 69], ["diseases", "OBSERVATION", 70, 78], ["hereditary", "OBSERVATION_MODIFIER", 88, 98], ["calcinosis", "OBSERVATION", 99, 109], ["cardiomyopathy", "OBSERVATION", 119, 133], ["hearts", "ANATOMY", 169, 175], ["hearts", "ANATOMY", 220, 226], ["myocyte regeneration", "OBSERVATION", 248, 268]]], ["Hyperplasia of myocytes is a normal component of cardiac growth in fetal development and during the first few weeks of life.", [["myocytes", "ANATOMY", 15, 23], ["cardiac", "ANATOMY", 49, 56], ["fetal", "ANATOMY", 67, 72], ["Hyperplasia", "DISEASE", 0, 11], ["myocytes", "CELL", 15, 23], ["cardiac", "ORGAN", 49, 56], ["fetal", "ANATOMICAL_SYSTEM", 67, 72], ["Hyperplasia of myocytes", "PROBLEM", 0, 23], ["cardiac growth", "PROBLEM", 49, 63], ["myocytes", "ANATOMY", 15, 23], ["normal", "OBSERVATION_MODIFIER", 29, 35], ["component", "OBSERVATION_MODIFIER", 36, 45], ["cardiac", "ANATOMY", 49, 56], ["growth", "OBSERVATION_MODIFIER", 57, 63], ["fetal development", "OBSERVATION_MODIFIER", 67, 84]]], ["Thereafter, proliferation ceases and \"normal growth\" is the result of hypertrophy until cell size normal for each species is reached.", [["cell", "ANATOMY", 88, 92], ["hypertrophy", "DISEASE", 70, 81], ["cell", "CELL", 88, 92], ["proliferation ceases", "PROBLEM", 12, 32], ["hypertrophy", "PROBLEM", 70, 81], ["growth", "OBSERVATION_MODIFIER", 45, 51], ["hypertrophy", "OBSERVATION", 70, 81], ["size", "OBSERVATION_MODIFIER", 93, 97]]], ["Recent studies indicate that stem cells exist in adult animal and human hearts, and with myocardial injury, these cells may differentiate into cardiac muscle cells.", [["stem cells", "ANATOMY", 29, 39], ["hearts", "ANATOMY", 72, 78], ["myocardial", "ANATOMY", 89, 99], ["cells", "ANATOMY", 114, 119], ["cardiac muscle cells", "ANATOMY", 143, 163], ["myocardial injury", "DISEASE", 89, 106], ["stem cells", "CELL", 29, 39], ["human", "ORGANISM", 66, 71], ["hearts", "ORGAN", 72, 78], ["myocardial", "MULTI-TISSUE_STRUCTURE", 89, 99], ["cells", "CELL", 114, 119], ["cardiac muscle cells", "CELL", 143, 163], ["stem cells", "CELL_TYPE", 29, 39], ["cardiac muscle cells", "CELL_TYPE", 143, 163], ["human", "SPECIES", 66, 71], ["human", "SPECIES", 66, 71], ["Recent studies", "TEST", 0, 14], ["stem cells", "PROBLEM", 29, 39], ["myocardial injury", "PROBLEM", 89, 106], ["these cells", "PROBLEM", 108, 119], ["stem cells", "OBSERVATION", 29, 39], ["human hearts", "ANATOMY", 66, 78], ["myocardial", "ANATOMY", 89, 99], ["injury", "OBSERVATION", 100, 106], ["cardiac muscle", "ANATOMY", 143, 157], ["cells", "OBSERVATION", 158, 163]]], ["However, the extent of myocyte regeneration is probably minimal.Cell Degeneration and DeathApoptosis.", [["myocyte", "ANATOMY", 23, 30], ["Cell", "ANATOMY", 64, 68], ["myocyte", "CELL", 23, 30], ["Cell", "CELL", 64, 68], ["myocyte regeneration", "PROBLEM", 23, 43], ["Cell Degeneration", "PROBLEM", 64, 81], ["DeathApoptosis", "PROBLEM", 86, 100], ["extent", "OBSERVATION_MODIFIER", 13, 19], ["myocyte regeneration", "OBSERVATION", 23, 43], ["probably", "UNCERTAINTY", 47, 55], ["minimal", "OBSERVATION_MODIFIER", 56, 63], ["Degeneration", "OBSERVATION", 69, 81]]], ["Apoptosis (programmed cell death of cardiac myocytes) is increasingly recognized for its role in the development ofPHYSICAL INJURIES AND SHOCKCentral nervous system lesions and trauma (\"heart-brain syndrome\"), gastric dilation and volvulus, stress, overexertion, electrical defibrillation, hemorrhagic shock These myocytes have features of coagulation necrosis and have relaxed rather than hypercontracted contractile elements.PHYSICAL INJURIES AND SHOCKWithin 24 to 48 hours after injury, necrotic areas are infiltrated by inflammatory cells, mainly macrophages and a few neutrophils; these phagocytose and lyse the necrotic cellular debris (E- Fig. 10 -17).", [["cell", "ANATOMY", 22, 26], ["cardiac myocytes", "ANATOMY", 36, 52], ["SHOCKCentral nervous system lesions", "ANATOMY", 137, 172], ["heart", "ANATOMY", 186, 191], ["brain", "ANATOMY", 192, 197], ["gastric", "ANATOMY", 210, 217], ["myocytes", "ANATOMY", 314, 322], ["necrotic areas", "ANATOMY", 490, 504], ["inflammatory cells", "ANATOMY", 524, 542], ["macrophages", "ANATOMY", 551, 562], ["neutrophils", "ANATOMY", 573, 584], ["necrotic cellular debris", "ANATOMY", 617, 641], ["Apoptosis", "DISEASE", 0, 9], ["SHOCKCentral nervous system lesions", "DISEASE", 137, 172], ["trauma", "DISEASE", 177, 183], ["heart-brain syndrome", "DISEASE", 186, 206], ["gastric dilation", "DISEASE", 210, 226], ["volvulus", "DISEASE", 231, 239], ["overexertion", "DISEASE", 249, 261], ["hemorrhagic shock", "DISEASE", 290, 307], ["necrosis", "DISEASE", 352, 360], ["necrotic", "DISEASE", 490, 498], ["necrotic", "DISEASE", 617, 625], ["cell", "CELL", 22, 26], ["cardiac myocytes", "CELL", 36, 52], ["SHOCKCentral nervous system lesions", "CANCER", 137, 172], ["heart", "ORGAN", 186, 191], ["brain", "ORGAN", 192, 197], ["gastric", "ORGAN", 210, 217], ["myocytes", "CELL", 314, 322], ["necrotic areas", "PATHOLOGICAL_FORMATION", 490, 504], ["inflammatory cells", "CELL", 524, 542], ["macrophages", "CELL", 551, 562], ["neutrophils", "CELL", 573, 584], ["necrotic cellular debris", "TISSUE", 617, 641], ["hypercontracted contractile elements", "DNA", 390, 426], ["inflammatory cells", "CELL_TYPE", 524, 542], ["macrophages", "CELL_TYPE", 551, 562], ["neutrophils", "CELL_TYPE", 573, 584], ["phagocytose", "CELL_TYPE", 592, 603], ["Apoptosis (programmed cell death of cardiac myocytes", "PROBLEM", 0, 52], ["PHYSICAL INJURIES", "PROBLEM", 115, 132], ["SHOCKCentral nervous system lesions", "PROBLEM", 137, 172], ["trauma (\"heart-brain syndrome\"", "PROBLEM", 177, 207], ["gastric dilation", "PROBLEM", 210, 226], ["volvulus", "PROBLEM", 231, 239], ["stress", "PROBLEM", 241, 247], ["overexertion", "PROBLEM", 249, 261], ["electrical defibrillation", "TREATMENT", 263, 288], ["hemorrhagic shock", "PROBLEM", 290, 307], ["coagulation necrosis", "PROBLEM", 340, 360], ["PHYSICAL INJURIES", "PROBLEM", 427, 444], ["injury", "PROBLEM", 482, 488], ["necrotic areas", "PROBLEM", 490, 504], ["inflammatory cells", "PROBLEM", 524, 542], ["mainly macrophages", "PROBLEM", 544, 562], ["a few neutrophils", "PROBLEM", 567, 584], ["these phagocytose", "TEST", 586, 603], ["lyse the necrotic cellular debris", "PROBLEM", 608, 641], ["cardiac myocytes", "ANATOMY", 36, 52], ["INJURIES", "OBSERVATION", 124, 132], ["nervous system", "ANATOMY", 150, 164], ["lesions", "OBSERVATION", 165, 172], ["heart", "ANATOMY", 186, 191], ["brain", "ANATOMY", 192, 197], ["syndrome", "OBSERVATION", 198, 206], ["gastric", "ANATOMY", 210, 217], ["dilation", "OBSERVATION", 218, 226], ["volvulus", "OBSERVATION", 231, 239], ["electrical defibrillation", "OBSERVATION", 263, 288], ["hemorrhagic", "OBSERVATION_MODIFIER", 290, 301], ["shock", "OBSERVATION", 302, 307], ["myocytes", "ANATOMY", 314, 322], ["coagulation", "OBSERVATION_MODIFIER", 340, 351], ["necrosis", "OBSERVATION", 352, 360], ["contractile elements", "OBSERVATION", 406, 426], ["INJURIES", "OBSERVATION", 436, 444], ["necrotic", "OBSERVATION_MODIFIER", 490, 498], ["infiltrated", "OBSERVATION", 509, 520], ["inflammatory cells", "OBSERVATION", 524, 542], ["macrophages", "OBSERVATION_MODIFIER", 551, 562], ["few", "OBSERVATION_MODIFIER", 569, 572], ["neutrophils", "OBSERVATION_MODIFIER", 573, 584], ["phagocytose", "OBSERVATION_MODIFIER", 592, 603], ["necrotic", "OBSERVATION_MODIFIER", 617, 625], ["cellular debris", "OBSERVATION", 626, 641]]], ["In early stages of healing of necrosis, it is often difficult to distinguish the lesions from those found in some types of myocarditis (see later discussion).", [["lesions", "ANATOMY", 81, 88], ["necrosis", "DISEASE", 30, 38], ["myocarditis", "DISEASE", 123, 134], ["lesions", "PATHOLOGICAL_FORMATION", 81, 88], ["necrosis", "PROBLEM", 30, 38], ["the lesions", "PROBLEM", 77, 88], ["myocarditis", "PROBLEM", 123, 134], ["early stages", "OBSERVATION_MODIFIER", 3, 15], ["healing", "OBSERVATION_MODIFIER", 19, 26], ["necrosis", "OBSERVATION", 30, 38], ["lesions", "OBSERVATION", 81, 88], ["some types", "OBSERVATION_MODIFIER", 109, 119], ["myocarditis", "OBSERVATION", 123, 134]]], ["Later, when necrosis has progressed somewhat, lesions consist of persistent stromal tissue (interstitial fibroblasts, collagen, and capillaries) and empty \"tubes\" of basal laminae formerly occupied by necrotic myocytes (see Chapter 15).", [["lesions", "ANATOMY", 46, 53], ["stromal tissue", "ANATOMY", 76, 90], ["interstitial fibroblasts", "ANATOMY", 92, 116], ["capillaries", "ANATOMY", 132, 143], ["tubes", "ANATOMY", 156, 161], ["basal laminae", "ANATOMY", 166, 179], ["necrotic myocytes", "ANATOMY", 201, 218], ["necrosis", "DISEASE", 12, 20], ["necrotic", "DISEASE", 201, 209], ["lesions", "PATHOLOGICAL_FORMATION", 46, 53], ["stromal tissue", "TISSUE", 76, 90], ["interstitial fibroblasts", "CELL", 92, 116], ["collagen", "GENE_OR_GENE_PRODUCT", 118, 126], ["capillaries", "TISSUE", 132, 143], ["tubes", "TISSUE", 156, 161], ["basal laminae", "CELLULAR_COMPONENT", 166, 179], ["necrotic myocytes", "TISSUE", 201, 218], ["interstitial fibroblasts", "CELL_TYPE", 92, 116], ["collagen", "PROTEIN", 118, 126], ["necrotic myocytes", "CELL_TYPE", 201, 218], ["necrosis", "PROBLEM", 12, 20], ["lesions", "PROBLEM", 46, 53], ["persistent stromal tissue (interstitial fibroblasts", "PROBLEM", 65, 116], ["empty \"tubes", "TREATMENT", 149, 161], ["necrotic myocytes", "PROBLEM", 201, 218], ["necrosis", "OBSERVATION", 12, 20], ["progressed", "OBSERVATION_MODIFIER", 25, 35], ["somewhat", "OBSERVATION_MODIFIER", 36, 44], ["lesions", "OBSERVATION", 46, 53], ["persistent", "OBSERVATION_MODIFIER", 65, 75], ["stromal tissue", "OBSERVATION", 76, 90], ["interstitial fibroblasts", "OBSERVATION", 92, 116], ["collagen", "OBSERVATION_MODIFIER", 118, 126], ["capillaries", "ANATOMY", 132, 143], ["empty \"tubes", "OBSERVATION", 149, 161], ["basal", "ANATOMY_MODIFIER", 166, 171], ["laminae", "ANATOMY_MODIFIER", 172, 179], ["necrotic myocytes", "OBSERVATION", 201, 218]]], ["The healing phase is characterized by proliferation of connective tissue cells (fibroblasts) (Fig. 10-18 ) and by deposition of connective tissue products (collagen and elastic tissue and acid mucopolysaccharides).", [["connective tissue cells", "ANATOMY", 55, 78], ["fibroblasts", "ANATOMY", 80, 91], ["connective tissue", "ANATOMY", 128, 145], ["elastic tissue", "ANATOMY", 169, 183], ["connective tissue cells", "CELL", 55, 78], ["fibroblasts", "CELL", 80, 91], ["connective tissue products", "TISSUE", 128, 154], ["collagen", "GENE_OR_GENE_PRODUCT", 156, 164], ["elastic tissue", "TISSUE", 169, 183], ["mucopolysaccharides", "SIMPLE_CHEMICAL", 193, 212], ["connective tissue cells", "CELL_TYPE", 55, 78], ["fibroblasts", "CELL_TYPE", 80, 91], ["connective tissue products", "PROTEIN", 128, 154], ["collagen", "PROTEIN", 156, 164], ["The healing phase", "TEST", 0, 17], ["connective tissue cells", "PROBLEM", 55, 78], ["Fig.", "TEST", 94, 98], ["connective tissue products", "TREATMENT", 128, 154], ["collagen and elastic tissue and acid mucopolysaccharides", "TREATMENT", 156, 212], ["healing phase", "OBSERVATION_MODIFIER", 4, 17], ["proliferation", "OBSERVATION_MODIFIER", 38, 51], ["connective tissue cells", "OBSERVATION", 55, 78], ["connective tissue", "ANATOMY", 128, 145], ["elastic tissue", "OBSERVATION_MODIFIER", 169, 183]]], ["Grossly, these areas with healing of myocardial necrosis appear as white, firm, contracted scars.PHYSICAL INJURIES AND SHOCKThe outcome of myocardial necrosis varies, depending on the extent of the damage: \u2022 Many animals die unexpectedly of acute cardiac failure if the myocardial damage is extensive. \u2022 Early deaths from necrosis-related arrhythmias also occur when cardiac conduction is disrupted. \u2022 Some cases eventually develop cardiac decompensation and die with cardiac dilation, scarring, and lesions of chronic congestive failure.PHYSICAL INJURIES AND SHOCKHearts with minimal damage have only microscopically detectable myocardial fibrosis when death eventually occurs from other diseases.InflammationMyocarditis.", [["myocardial", "ANATOMY", 37, 47], ["scars", "ANATOMY", 91, 96], ["myocardial", "ANATOMY", 139, 149], ["cardiac", "ANATOMY", 247, 254], ["myocardial", "ANATOMY", 270, 280], ["cardiac", "ANATOMY", 367, 374], ["cardiac", "ANATOMY", 432, 439], ["cardiac", "ANATOMY", 468, 475], ["lesions", "ANATOMY", 500, 507], ["myocardial", "ANATOMY", 629, 639], ["myocardial necrosis", "DISEASE", 37, 56], ["myocardial necrosis", "DISEASE", 139, 158], ["cardiac failure", "DISEASE", 247, 262], ["myocardial damage", "DISEASE", 270, 287], ["deaths", "DISEASE", 310, 316], ["necrosis", "DISEASE", 322, 330], ["arrhythmias", "DISEASE", 339, 350], ["cardiac decompensation", "DISEASE", 432, 454], ["cardiac dilation", "DISEASE", 468, 484], ["scarring", "DISEASE", 486, 494], ["congestive failure", "DISEASE", 519, 537], ["myocardial fibrosis", "DISEASE", 629, 648], ["death", "DISEASE", 654, 659], ["Myocarditis", "DISEASE", 710, 721], ["myocardial", "MULTI-TISSUE_STRUCTURE", 37, 47], ["scars", "PATHOLOGICAL_FORMATION", 91, 96], ["myocardial", "MULTI-TISSUE_STRUCTURE", 139, 149], ["cardiac", "ORGAN", 247, 254], ["myocardial", "MULTI-TISSUE_STRUCTURE", 270, 280], ["cardiac", "ORGAN", 367, 374], ["cardiac", "ORGAN", 432, 439], ["cardiac", "ORGAN", 468, 475], ["lesions", "PATHOLOGICAL_FORMATION", 500, 507], ["myocardial", "MULTI-TISSUE_STRUCTURE", 629, 639], ["myocardial necrosis", "PROBLEM", 37, 56], ["white, firm, contracted scars", "PROBLEM", 67, 96], ["PHYSICAL INJURIES", "PROBLEM", 97, 114], ["myocardial necrosis varies", "PROBLEM", 139, 165], ["acute cardiac failure", "PROBLEM", 241, 262], ["the myocardial damage", "PROBLEM", 266, 287], ["Early deaths", "PROBLEM", 304, 316], ["necrosis", "PROBLEM", 322, 330], ["arrhythmias", "PROBLEM", 339, 350], ["cardiac decompensation", "PROBLEM", 432, 454], ["cardiac dilation", "PROBLEM", 468, 484], ["scarring", "PROBLEM", 486, 494], ["lesions", "PROBLEM", 500, 507], ["chronic congestive failure", "PROBLEM", 511, 537], ["PHYSICAL INJURIES", "PROBLEM", 538, 555], ["SHOCKHearts", "PROBLEM", 560, 571], ["minimal damage", "PROBLEM", 577, 591], ["microscopically detectable myocardial fibrosis", "PROBLEM", 602, 648], ["death", "PROBLEM", 654, 659], ["other diseases", "PROBLEM", 683, 697], ["InflammationMyocarditis", "PROBLEM", 698, 721], ["areas", "OBSERVATION_MODIFIER", 15, 20], ["healing", "OBSERVATION_MODIFIER", 26, 33], ["myocardial", "ANATOMY", 37, 47], ["necrosis", "OBSERVATION", 48, 56], ["white", "OBSERVATION_MODIFIER", 67, 72], ["firm", "OBSERVATION_MODIFIER", 74, 78], ["contracted", "OBSERVATION_MODIFIER", 80, 90], ["scars", "OBSERVATION", 91, 96], ["INJURIES", "OBSERVATION", 106, 114], ["myocardial", "ANATOMY", 139, 149], ["necrosis", "OBSERVATION", 150, 158], ["acute", "OBSERVATION_MODIFIER", 241, 246], ["cardiac", "ANATOMY", 247, 254], ["failure", "OBSERVATION", 255, 262], ["myocardial", "ANATOMY", 270, 280], ["damage", "OBSERVATION", 281, 287], ["extensive", "OBSERVATION_MODIFIER", 291, 300], ["necrosis", "OBSERVATION", 322, 330], ["arrhythmias", "OBSERVATION", 339, 350], ["conduction", "OBSERVATION", 375, 385], ["cardiac", "ANATOMY", 432, 439], ["decompensation", "OBSERVATION", 440, 454], ["cardiac", "ANATOMY", 468, 475], ["dilation", "OBSERVATION", 476, 484], ["scarring", "OBSERVATION", 486, 494], ["lesions", "OBSERVATION_MODIFIER", 500, 507], ["chronic", "OBSERVATION_MODIFIER", 511, 518], ["congestive", "OBSERVATION_MODIFIER", 519, 529], ["failure", "OBSERVATION", 530, 537], ["INJURIES", "OBSERVATION", 547, 555], ["minimal", "OBSERVATION_MODIFIER", 577, 584], ["damage", "OBSERVATION", 585, 591], ["microscopically", "OBSERVATION_MODIFIER", 602, 617], ["detectable", "OBSERVATION_MODIFIER", 618, 628], ["myocardial", "ANATOMY", 629, 639], ["fibrosis", "OBSERVATION", 640, 648], ["Myocarditis", "OBSERVATION", 710, 721]]], ["The various infectious diseases that cause myocarditis in animals are summarized in Box 10-6.", [["infectious diseases", "DISEASE", 12, 31], ["myocarditis", "DISEASE", 43, 54], ["The various infectious diseases", "PROBLEM", 0, 31], ["myocarditis", "PROBLEM", 43, 54], ["various", "OBSERVATION_MODIFIER", 4, 11], ["infectious", "OBSERVATION", 12, 22], ["myocarditis", "OBSERVATION", 43, 54]]], ["Myocarditis generally deficiency in sheep and cattle ( Fig. 10-15 ), vitamin D toxicity in several species, calcinogenic plant toxicosis in cattle (\"Manchester wasting disease\"), and spontaneous myocardial calcification in aged rats and guinea pigs.InflammationMyocardial Necrosis.", [["myocardial", "ANATOMY", 195, 205], ["Myocardial", "ANATOMY", 261, 271], ["Myocarditis", "DISEASE", 0, 11], ["vitamin D", "CHEMICAL", 69, 78], ["toxicity", "DISEASE", 79, 87], ["toxicosis", "DISEASE", 127, 136], ["wasting disease", "DISEASE", 160, 175], ["myocardial calcification", "DISEASE", 195, 219], ["vitamin D", "CHEMICAL", 69, 78], ["sheep", "ORGANISM", 36, 41], ["vitamin D", "SIMPLE_CHEMICAL", 69, 78], ["cattle", "ORGANISM", 140, 146], ["myocardial", "MULTI-TISSUE_STRUCTURE", 195, 205], ["rats", "ORGANISM", 228, 232], ["guinea pigs", "ORGANISM", 237, 248], ["sheep", "SPECIES", 36, 41], ["cattle", "SPECIES", 46, 52], ["cattle", "SPECIES", 140, 146], ["rats", "SPECIES", 228, 232], ["guinea pigs", "SPECIES", 237, 248], ["sheep", "SPECIES", 36, 41], ["cattle", "SPECIES", 46, 52], ["cattle", "SPECIES", 140, 146], ["guinea pigs", "SPECIES", 237, 248], ["Myocarditis", "PROBLEM", 0, 11], ["deficiency in sheep", "PROBLEM", 22, 41], ["cattle ( Fig.", "TEST", 46, 59], ["vitamin D toxicity", "PROBLEM", 69, 87], ["several species", "PROBLEM", 91, 106], ["calcinogenic plant toxicosis", "PROBLEM", 108, 136], ["Manchester wasting disease\"", "PROBLEM", 149, 176], ["spontaneous myocardial calcification", "PROBLEM", 183, 219], ["guinea pigs", "TREATMENT", 237, 248], ["InflammationMyocardial Necrosis", "PROBLEM", 249, 280], ["deficiency", "OBSERVATION", 22, 32], ["plant toxicosis", "OBSERVATION", 121, 136], ["spontaneous", "OBSERVATION_MODIFIER", 183, 194], ["myocardial", "ANATOMY", 195, 205], ["calcification", "OBSERVATION", 206, 219], ["Myocardial", "ANATOMY", 261, 271], ["Necrosis", "OBSERVATION", 272, 280]]], ["Myocardial necrosis can result from a number of causes, including nutritional deficiencies, chemical and plant toxins, ischemia, metabolic disorders, heritable diseases, and physical injuries (see Box 10-5).", [["Myocardial", "ANATOMY", 0, 10], ["Myocardial necrosis", "DISEASE", 0, 19], ["nutritional deficiencies", "DISEASE", 66, 90], ["ischemia", "DISEASE", 119, 127], ["metabolic disorders", "DISEASE", 129, 148], ["heritable diseases", "DISEASE", 150, 168], ["physical injuries", "DISEASE", 174, 191], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["Myocardial necrosis", "PROBLEM", 0, 19], ["nutritional deficiencies", "PROBLEM", 66, 90], ["chemical and plant toxins", "PROBLEM", 92, 117], ["ischemia", "PROBLEM", 119, 127], ["metabolic disorders", "PROBLEM", 129, 148], ["heritable diseases", "PROBLEM", 150, 168], ["physical injuries", "PROBLEM", 174, 191], ["necrosis", "OBSERVATION", 11, 19], ["nutritional deficiencies", "OBSERVATION", 66, 90], ["ischemia", "OBSERVATION", 119, 127], ["metabolic disorders", "OBSERVATION", 129, 148], ["heritable", "OBSERVATION_MODIFIER", 150, 159], ["diseases", "OBSERVATION", 160, 168]]], ["Grossly, affected areas appear pale initially, and some progress to prominent yellow to white (see Fig. 10 -49), dry areas made gritty by dystrophic mineralization.", [["dystrophic mineralization", "DISEASE", 138, 163], ["affected areas", "PROBLEM", 9, 23], ["prominent yellow to white", "PROBLEM", 68, 93], ["dystrophic mineralization", "PROBLEM", 138, 163], ["affected", "OBSERVATION_MODIFIER", 9, 17], ["pale", "OBSERVATION", 31, 35], ["prominent", "OBSERVATION_MODIFIER", 68, 77], ["yellow", "OBSERVATION_MODIFIER", 78, 84], ["dystrophic", "OBSERVATION_MODIFIER", 138, 148], ["mineralization", "OBSERVATION", 149, 163]]], ["The lesions are focal, multifocal, or diffuse.", [["lesions", "ANATOMY", 4, 11], ["lesions", "CANCER", 4, 11], ["The lesions", "PROBLEM", 0, 11], ["lesions", "OBSERVATION", 4, 11], ["focal", "OBSERVATION_MODIFIER", 16, 21], ["multifocal", "OBSERVATION_MODIFIER", 23, 33], ["diffuse", "OBSERVATION_MODIFIER", 38, 45]]], ["The most frequent sites of focal lesions are the left ventricular papillary muscles and the subendocardial myocardium, especially when such lesions are related to transient reduction of vascular perfusion.", [["sites", "ANATOMY", 18, 23], ["focal lesions", "ANATOMY", 27, 40], ["left ventricular papillary muscles", "ANATOMY", 49, 83], ["subendocardial myocardium", "ANATOMY", 92, 117], ["lesions", "ANATOMY", 140, 147], ["vascular", "ANATOMY", 186, 194], ["focal lesions", "PATHOLOGICAL_FORMATION", 27, 40], ["ventricular papillary muscles", "TISSUE", 54, 83], ["subendocardial myocardium", "TISSUE", 92, 117], ["lesions", "PATHOLOGICAL_FORMATION", 140, 147], ["vascular", "MULTI-TISSUE_STRUCTURE", 186, 194], ["focal lesions", "PROBLEM", 27, 40], ["such lesions", "PROBLEM", 135, 147], ["transient reduction of vascular perfusion", "PROBLEM", 163, 204], ["most", "OBSERVATION_MODIFIER", 4, 8], ["frequent", "OBSERVATION_MODIFIER", 9, 17], ["focal", "OBSERVATION_MODIFIER", 27, 32], ["lesions", "OBSERVATION", 33, 40], ["left ventricular", "ANATOMY", 49, 65], ["papillary muscles", "ANATOMY", 66, 83], ["subendocardial myocardium", "ANATOMY", 92, 117], ["lesions", "OBSERVATION", 140, 147], ["transient", "OBSERVATION_MODIFIER", 163, 172], ["reduction", "OBSERVATION_MODIFIER", 173, 182], ["vascular perfusion", "OBSERVATION", 186, 204]]], ["These lesions can be overlooked at necropsy unless multiple incisions are made in the ventricular myocardium.", [["lesions", "ANATOMY", 6, 13], ["ventricular myocardium", "ANATOMY", 86, 108], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 86, 108], ["These lesions", "PROBLEM", 0, 13], ["multiple incisions", "PROBLEM", 51, 69], ["lesions", "OBSERVATION", 6, 13], ["multiple", "OBSERVATION_MODIFIER", 51, 59], ["incisions", "OBSERVATION", 60, 69], ["ventricular myocardium", "ANATOMY", 86, 108]]], ["In diseases with diffuse cardiac necrosis, such as white muscle disease of calves and lambs due to vitamin Eselenium deficiency, the discrete white lesions can be readily observed beneath the epicardial and endocardial surfaces ( Fig. 10-16) .InflammationMicroscopically, the appearance depends on the age of the lesions.", [["cardiac", "ANATOMY", 25, 32], ["white muscle", "ANATOMY", 51, 63], ["white lesions", "ANATOMY", 142, 155], ["epicardial", "ANATOMY", 192, 202], ["endocardial surfaces", "ANATOMY", 207, 227], ["lesions", "ANATOMY", 313, 320], ["cardiac necrosis", "DISEASE", 25, 41], ["white muscle disease", "DISEASE", 51, 71], ["vitamin Eselenium", "CHEMICAL", 99, 116], ["Inflammation", "DISEASE", 243, 255], ["vitamin Eselenium", "CHEMICAL", 99, 116], ["cardiac", "ORGAN", 25, 32], ["muscle", "ORGAN", 57, 63], ["calves", "ORGANISM", 75, 81], ["lambs", "ORGANISM_SUBDIVISION", 86, 91], ["vitamin Eselenium", "SIMPLE_CHEMICAL", 99, 116], ["white lesions", "PATHOLOGICAL_FORMATION", 142, 155], ["epicardial", "TISSUE", 192, 202], ["endocardial surfaces", "TISSUE", 207, 227], ["lesions", "PATHOLOGICAL_FORMATION", 313, 320], ["calves", "SPECIES", 75, 81], ["diffuse cardiac necrosis", "PROBLEM", 17, 41], ["white muscle disease of calves", "PROBLEM", 51, 81], ["vitamin Eselenium deficiency", "PROBLEM", 99, 127], ["the discrete white lesions", "PROBLEM", 129, 155], ["Inflammation", "PROBLEM", 243, 255], ["the lesions", "PROBLEM", 309, 320], ["diseases", "OBSERVATION", 3, 11], ["diffuse", "OBSERVATION_MODIFIER", 17, 24], ["cardiac", "ANATOMY", 25, 32], ["necrosis", "OBSERVATION", 33, 41], ["white muscle disease", "OBSERVATION", 51, 71], ["calves", "ANATOMY", 75, 81], ["Eselenium deficiency", "OBSERVATION", 107, 127], ["discrete", "OBSERVATION_MODIFIER", 133, 141], ["white", "OBSERVATION_MODIFIER", 142, 147], ["lesions", "OBSERVATION", 148, 155], ["epicardial", "ANATOMY", 192, 202], ["endocardial", "ANATOMY", 207, 218], ["surfaces", "ANATOMY_MODIFIER", 219, 227], ["lesions", "OBSERVATION", 313, 320]]], ["Fibers in areas of recent necrosis often appear swollen and hypereosinophilic (hyaline necrosis).", [["Fibers", "ANATOMY", 0, 6], ["necrosis", "DISEASE", 26, 34], ["hypereosinophilic", "DISEASE", 60, 77], ["necrosis", "DISEASE", 87, 95], ["Fibers", "MULTI-TISSUE_STRUCTURE", 0, 6], ["recent necrosis", "PROBLEM", 19, 34], ["swollen", "PROBLEM", 48, 55], ["hypereosinophilic (hyaline necrosis", "PROBLEM", 60, 95], ["areas", "OBSERVATION_MODIFIER", 10, 15], ["necrosis", "OBSERVATION", 26, 34], ["swollen", "OBSERVATION_MODIFIER", 48, 55], ["hypereosinophilic", "OBSERVATION", 60, 77], ["hyaline", "OBSERVATION_MODIFIER", 79, 86], ["necrosis", "OBSERVATION", 87, 95]]], ["Striations are indistinct, and nuclei are pyknotic.", [["nuclei", "ANATOMY", 31, 37], ["nuclei", "CELLULAR_COMPONENT", 31, 37], ["pyknotic", "PROBLEM", 42, 50], ["indistinct", "OBSERVATION_MODIFIER", 15, 25], ["nuclei", "ANATOMY", 31, 37], ["pyknotic", "OBSERVATION_MODIFIER", 42, 50]]], ["Necrotic fibers often have scattered basophilic granules ( Fig. 10-17 ) that represent calcified mitochondria and can be confirmed by electron microscopy (E- Fig. 10-15 ).", [["Necrotic fibers", "ANATOMY", 0, 15], ["basophilic granules", "ANATOMY", 37, 56], ["mitochondria", "ANATOMY", 97, 109], ["Necrotic fibers", "CELL", 0, 15], ["basophilic granules", "CELLULAR_COMPONENT", 37, 56], ["mitochondria", "CELLULAR_COMPONENT", 97, 109], ["Necrotic fibers", "PROBLEM", 0, 15], ["scattered basophilic granules", "PROBLEM", 27, 56], ["calcified mitochondria", "PROBLEM", 87, 109], ["electron microscopy", "TEST", 134, 153], ["scattered", "OBSERVATION_MODIFIER", 27, 36], ["basophilic granules", "OBSERVATION", 37, 56], ["calcified", "OBSERVATION_MODIFIER", 87, 96], ["mitochondria", "OBSERVATION", 97, 109]]], ["In a second pattern of necrosis, affected myocytes have a \"shredded\" appearance because of hypercontraction and the formation of multiple transversely oriented bars of disrupted contractile material (often termed contraction band necrosis) (E- Fig. 10-16) .", [["myocytes", "ANATOMY", 42, 50], ["contractile material", "ANATOMY", 178, 198], ["necrosis", "DISEASE", 23, 31], ["hypercontraction", "DISEASE", 91, 107], ["necrosis", "DISEASE", 230, 238], ["myocytes", "CELL", 42, 50], ["contractile material", "TISSUE", 178, 198], ["necrosis", "PROBLEM", 23, 31], ["affected myocytes", "PROBLEM", 33, 50], ["hypercontraction", "PROBLEM", 91, 107], ["disrupted contractile material", "PROBLEM", 168, 198], ["contraction band necrosis", "PROBLEM", 213, 238], ["necrosis", "OBSERVATION", 23, 31], ["myocytes", "ANATOMY", 42, 50], ["hypercontraction", "OBSERVATION", 91, 107], ["multiple", "OBSERVATION_MODIFIER", 129, 137], ["transversely", "OBSERVATION_MODIFIER", 138, 150], ["oriented", "OBSERVATION_MODIFIER", 151, 159], ["bars", "OBSERVATION_MODIFIER", 160, 164], ["disrupted contractile material", "OBSERVATION", 168, 198], ["contraction", "OBSERVATION_MODIFIER", 213, 224], ["band", "OBSERVATION_MODIFIER", 225, 229], ["necrosis", "OBSERVATION", 230, 238]]], ["A third pattern is seen in necrotic myocytes in large areas of ischemic necrosis (infarcts). is the result of infections spread hematogenously to the myocardium and occurs in various systemic diseases.", [["necrotic myocytes", "ANATOMY", 27, 44], ["infarcts", "ANATOMY", 82, 90], ["myocardium", "ANATOMY", 150, 160], ["necrotic", "DISEASE", 27, 35], ["ischemic necrosis", "DISEASE", 63, 80], ["infarcts", "DISEASE", 82, 90], ["infections", "DISEASE", 110, 120], ["hematogenously to the myocardium", "DISEASE", 128, 160], ["necrotic myocytes", "CELL", 27, 44], ["myocardium", "ORGAN", 150, 160], ["necrotic myocytes", "CELL_TYPE", 27, 44], ["necrotic myocytes", "PROBLEM", 27, 44], ["ischemic necrosis (infarcts)", "PROBLEM", 63, 91], ["infections", "PROBLEM", 110, 120], ["various systemic diseases", "PROBLEM", 175, 200], ["necrotic", "OBSERVATION_MODIFIER", 27, 35], ["myocytes", "OBSERVATION", 36, 44], ["large", "OBSERVATION_MODIFIER", 48, 53], ["areas", "OBSERVATION_MODIFIER", 54, 59], ["ischemic", "OBSERVATION_MODIFIER", 63, 71], ["necrosis", "OBSERVATION", 72, 80], ["infarcts", "OBSERVATION", 82, 90], ["infections", "OBSERVATION", 110, 120], ["myocardium", "ANATOMY", 150, 160], ["various", "OBSERVATION_MODIFIER", 175, 182], ["systemic diseases", "OBSERVATION", 183, 200]]], ["Infrequently, the heart is the primary location in affected animals and responsible for death.", [["heart", "ANATOMY", 18, 23], ["death", "DISEASE", 88, 93], ["heart", "ORGAN", 18, 23], ["death", "PROBLEM", 88, 93], ["heart", "ANATOMY", 18, 23]]], ["Types of inflammation provoked by infectious agents that produce myocarditis include suppurative, necrotizing, hemorrhagic, lymphocytic, and eosinophilic.", [["lymphocytic", "ANATOMY", 124, 135], ["inflammation", "DISEASE", 9, 21], ["myocarditis", "DISEASE", 65, 76], ["hemorrhagic", "DISEASE", 111, 122], ["inflammation", "PROBLEM", 9, 21], ["infectious agents", "TREATMENT", 34, 51], ["myocarditis", "PROBLEM", 65, 76], ["suppurative", "PROBLEM", 85, 96], ["necrotizing", "PROBLEM", 98, 109], ["hemorrhagic", "PROBLEM", 111, 122], ["lymphocytic", "PROBLEM", 124, 135], ["eosinophilic", "PROBLEM", 141, 153], ["inflammation", "OBSERVATION", 9, 21], ["infectious", "OBSERVATION", 34, 44], ["myocarditis", "OBSERVATION", 65, 76], ["suppurative", "OBSERVATION_MODIFIER", 85, 96], ["necrotizing", "OBSERVATION_MODIFIER", 98, 109], ["hemorrhagic", "OBSERVATION_MODIFIER", 111, 122], ["lymphocytic", "OBSERVATION", 124, 135], ["eosinophilic", "OBSERVATION_MODIFIER", 141, 153]]], ["Suppurative myocarditis results from localization of pyogenic bacteria in the myocardium ( Fig. 10-19 ) that are trapped in thromboemboli most commonly originating from vegetative valvular endocarditis on the mitral and aortic valves.", [["myocardium", "ANATOMY", 78, 88], ["thromboemboli", "ANATOMY", 124, 137], ["valvular", "ANATOMY", 180, 188], ["mitral", "ANATOMY", 209, 215], ["aortic", "ANATOMY", 220, 226], ["myocarditis", "DISEASE", 12, 23], ["thromboemboli", "DISEASE", 124, 137], ["valvular endocarditis", "DISEASE", 180, 201], ["myocardium", "ORGAN", 78, 88], ["valvular", "PATHOLOGICAL_FORMATION", 180, 188], ["mitral", "MULTI-TISSUE_STRUCTURE", 209, 215], ["aortic valves", "MULTI-TISSUE_STRUCTURE", 220, 233], ["Suppurative myocarditis", "PROBLEM", 0, 23], ["pyogenic bacteria in the myocardium", "PROBLEM", 53, 88], ["thromboemboli", "PROBLEM", 124, 137], ["vegetative valvular endocarditis", "PROBLEM", 169, 201], ["myocarditis", "OBSERVATION", 12, 23], ["pyogenic", "OBSERVATION_MODIFIER", 53, 61], ["bacteria", "OBSERVATION", 62, 70], ["myocardium", "ANATOMY", 78, 88], ["thromboemboli", "OBSERVATION", 124, 137], ["vegetative valvular endocarditis", "OBSERVATION", 169, 201], ["mitral", "ANATOMY", 209, 215], ["aortic valves", "ANATOMY", 220, 233]]], ["Septic infarcts with pale, disseminated lesions may be grossly evident in the myocardium.", [["disseminated lesions", "ANATOMY", 27, 47], ["myocardium", "ANATOMY", 78, 88], ["Septic infarcts", "DISEASE", 0, 15], ["lesions", "PATHOLOGICAL_FORMATION", 40, 47], ["myocardium", "ORGAN", 78, 88], ["Septic infarcts", "PROBLEM", 0, 15], ["pale, disseminated lesions", "PROBLEM", 21, 47], ["infarcts", "OBSERVATION", 7, 15], ["pale", "OBSERVATION_MODIFIER", 21, 25], ["disseminated", "OBSERVATION_MODIFIER", 27, 39], ["lesions", "OBSERVATION", 40, 47], ["myocardium", "ANATOMY", 78, 88]]], ["These foci consist of neutrophils and necrotic myocytes that form abscesses.InflammationThe pathogenesis and expected outcome of cases of myocarditis remain an important area of research because of the severity of this lesion in cardiac failure in human beings.", [["foci", "ANATOMY", 6, 10], ["neutrophils", "ANATOMY", 22, 33], ["necrotic myocytes", "ANATOMY", 38, 55], ["abscesses", "ANATOMY", 66, 75], ["lesion", "ANATOMY", 219, 225], ["cardiac", "ANATOMY", 229, 236], ["necrotic", "DISEASE", 38, 46], ["abscesses", "DISEASE", 66, 75], ["Inflammation", "DISEASE", 76, 88], ["myocarditis", "DISEASE", 138, 149], ["cardiac failure", "DISEASE", 229, 244], ["neutrophils", "CELL", 22, 33], ["necrotic myocytes", "CELL", 38, 55], ["abscesses", "PATHOLOGICAL_FORMATION", 66, 75], ["cardiac", "ORGAN", 229, 236], ["human", "ORGANISM", 248, 253], ["neutrophils", "CELL_TYPE", 22, 33], ["necrotic myocytes", "CELL_TYPE", 38, 55], ["human", "SPECIES", 248, 253], ["human", "SPECIES", 248, 253], ["These foci", "PROBLEM", 0, 10], ["neutrophils", "PROBLEM", 22, 33], ["necrotic myocytes", "PROBLEM", 38, 55], ["abscesses", "PROBLEM", 66, 75], ["Inflammation", "PROBLEM", 76, 88], ["myocarditis", "PROBLEM", 138, 149], ["this lesion", "PROBLEM", 214, 225], ["cardiac failure", "PROBLEM", 229, 244], ["foci", "OBSERVATION", 6, 10], ["neutrophils", "OBSERVATION", 22, 33], ["necrotic myocytes", "OBSERVATION", 38, 55], ["abscesses", "OBSERVATION", 66, 75], ["myocarditis", "OBSERVATION", 138, 149], ["lesion", "OBSERVATION", 219, 225], ["cardiac", "ANATOMY", 229, 236], ["failure", "OBSERVATION", 237, 244]]], ["The sequelae to A B myocarditis include (1) complete resolution of lesions, (2) scattered residual myocardial scars, or (3) progressive myocardial damage with acute or, in some cases, chronic cardiac failure as secondary dilated (congestive) cardiomyopathy.", [["lesions", "ANATOMY", 67, 74], ["myocardial", "ANATOMY", 99, 109], ["myocardial", "ANATOMY", 136, 146], ["cardiac", "ANATOMY", 192, 199], ["myocarditis", "DISEASE", 20, 31], ["myocardial scars", "DISEASE", 99, 115], ["myocardial damage", "DISEASE", 136, 153], ["cardiac failure", "DISEASE", 192, 207], ["congestive) cardiomyopathy", "DISEASE", 230, 256], ["lesions", "PATHOLOGICAL_FORMATION", 67, 74], ["myocardial scars", "PATHOLOGICAL_FORMATION", 99, 115], ["myocardial", "MULTI-TISSUE_STRUCTURE", 136, 146], ["cardiac", "ORGAN", 192, 199], ["A B myocarditis", "PROBLEM", 16, 31], ["lesions", "PROBLEM", 67, 74], ["scattered residual myocardial scars", "PROBLEM", 80, 115], ["progressive myocardial damage", "PROBLEM", 124, 153], ["chronic cardiac failure", "PROBLEM", 184, 207], ["secondary dilated (congestive) cardiomyopathy", "PROBLEM", 211, 256], ["sequelae", "OBSERVATION", 4, 12], ["myocarditis", "OBSERVATION", 20, 31], ["resolution", "OBSERVATION_MODIFIER", 53, 63], ["lesions", "OBSERVATION", 67, 74], ["scattered", "OBSERVATION_MODIFIER", 80, 89], ["residual", "OBSERVATION_MODIFIER", 90, 98], ["myocardial", "ANATOMY", 99, 109], ["scars", "OBSERVATION", 110, 115], ["progressive", "OBSERVATION_MODIFIER", 124, 135], ["myocardial", "ANATOMY", 136, 146], ["damage", "OBSERVATION", 147, 153], ["acute", "OBSERVATION_MODIFIER", 159, 164], ["chronic", "OBSERVATION_MODIFIER", 184, 191], ["cardiac", "ANATOMY", 192, 199], ["failure", "OBSERVATION", 200, 207], ["dilated", "OBSERVATION", 221, 228], ["congestive", "OBSERVATION_MODIFIER", 230, 240], ["cardiomyopathy", "OBSERVATION", 242, 256]]], ["In experimental studies of myocarditis induced in mice by coxsackie B virus, the severity of myocarditis was influenced by the virulence of the virus and mouse strain and was enhanced by host factors such as young age, male sex, pregnancy, poor nutrition, whole-body ionizing radiation, cold environmental temperatures, alcohol ingestion, exercise, and cortisone administration.", [["myocarditis", "DISEASE", 27, 38], ["myocarditis", "DISEASE", 93, 104], ["alcohol", "CHEMICAL", 320, 327], ["cortisone", "CHEMICAL", 353, 362], ["alcohol", "CHEMICAL", 320, 327], ["cortisone", "CHEMICAL", 353, 362], ["mice", "ORGANISM", 50, 54], ["coxsackie B virus", "ORGANISM", 58, 75], ["mouse", "ORGANISM", 154, 159], ["alcohol", "SIMPLE_CHEMICAL", 320, 327], ["cortisone", "SIMPLE_CHEMICAL", 353, 362], ["mice", "SPECIES", 50, 54], ["coxsackie B virus", "SPECIES", 58, 75], ["mouse", "SPECIES", 154, 159], ["mice", "SPECIES", 50, 54], ["coxsackie B virus", "SPECIES", 58, 75], ["mouse", "SPECIES", 154, 159], ["myocarditis", "PROBLEM", 27, 38], ["coxsackie B virus", "PROBLEM", 58, 75], ["myocarditis", "PROBLEM", 93, 104], ["the virus", "PROBLEM", 140, 149], ["mouse strain", "PROBLEM", 154, 166], ["poor nutrition", "PROBLEM", 240, 254], ["whole-body ionizing radiation", "TREATMENT", 256, 285], ["exercise", "TREATMENT", 339, 347], ["cortisone administration", "TREATMENT", 353, 377], ["myocarditis", "OBSERVATION", 27, 38], ["myocarditis", "OBSERVATION", 93, 104]]], ["Much of the myocardial damage in coxsackie B virus infection is induced by immunologic reactions (with T lymphocyte involvement) rather than by direct viral injury.Responses to Injury: Cardiac Conduction SystemIn domestic animals, injury of the cardiac conduction system involves forms of cell degeneration and death, inflammation, andEosinophilic myocarditisBox 10-6 Diseases that Cause Myocarditis in Animals fibrosis.", [["myocardial", "ANATOMY", 12, 22], ["T lymphocyte", "ANATOMY", 103, 115], ["Cardiac", "ANATOMY", 185, 192], ["cardiac conduction system", "ANATOMY", 245, 270], ["cell", "ANATOMY", 289, 293], ["myocardial damage", "DISEASE", 12, 29], ["coxsackie B", "CHEMICAL", 33, 44], ["infection", "DISEASE", 51, 60], ["viral injury", "DISEASE", 151, 163], ["Injury", "DISEASE", 177, 183], ["death", "DISEASE", 311, 316], ["inflammation", "DISEASE", 318, 330], ["myocarditis", "DISEASE", 348, 359], ["Myocarditis", "DISEASE", 388, 399], ["fibrosis", "DISEASE", 411, 419], ["myocardial", "MULTI-TISSUE_STRUCTURE", 12, 22], ["coxsackie B virus", "ORGANISM", 33, 50], ["T lymphocyte", "CELL", 103, 115], ["cardiac", "ORGAN", 245, 252], ["cell", "CELL", 289, 293], ["coxsackie B virus", "SPECIES", 33, 50], ["coxsackie B virus", "SPECIES", 33, 50], ["the myocardial damage", "PROBLEM", 8, 29], ["coxsackie B virus infection", "PROBLEM", 33, 60], ["immunologic reactions", "PROBLEM", 75, 96], ["T lymphocyte involvement", "PROBLEM", 103, 127], ["direct viral injury", "PROBLEM", 144, 163], ["Injury", "PROBLEM", 177, 183], ["Cardiac Conduction", "TEST", 185, 203], ["injury of the cardiac conduction system", "PROBLEM", 231, 270], ["cell degeneration", "PROBLEM", 289, 306], ["death", "PROBLEM", 311, 316], ["inflammation", "PROBLEM", 318, 330], ["Eosinophilic myocarditisBox", "PROBLEM", 335, 362], ["Myocarditis", "PROBLEM", 388, 399], ["Animals fibrosis", "PROBLEM", 403, 419], ["myocardial", "ANATOMY", 12, 22], ["damage", "OBSERVATION", 23, 29], ["virus infection", "OBSERVATION", 45, 60], ["viral injury", "OBSERVATION", 151, 163], ["Cardiac", "ANATOMY", 185, 192], ["injury", "OBSERVATION", 231, 237], ["cardiac conduction", "ANATOMY", 245, 263], ["cell degeneration", "OBSERVATION", 289, 306], ["inflammation", "OBSERVATION", 318, 330], ["Eosinophilic myocarditis", "OBSERVATION", 335, 359], ["Myocarditis", "OBSERVATION", 388, 399], ["Animals", "OBSERVATION_MODIFIER", 403, 410], ["fibrosis", "OBSERVATION", 411, 419]]], ["The response to injury of the conduction system is poorly documented because histopathology of the conduction system is labor-intensive and rarely performed.", [["conduction system", "ANATOMY", 30, 47], ["injury of the conduction system", "PROBLEM", 16, 47], ["labor", "PROBLEM", 120, 125], ["injury", "OBSERVATION", 16, 22]]], ["In rare cases in which histopathology and electrocardiographic studies were available, atrial and/or ventricular origin of arrhythmia was associated with inflammation, degeneration, and fibrosis along the cardiac conduction system ( Fig. 10-20 ).Disturbances of CirculationHemorrhage.", [["atrial", "ANATOMY", 87, 93], ["ventricular", "ANATOMY", 101, 112], ["cardiac", "ANATOMY", 205, 212], ["arrhythmia", "DISEASE", 123, 133], ["inflammation", "DISEASE", 154, 166], ["fibrosis", "DISEASE", 186, 194], ["CirculationHemorrhage", "DISEASE", 262, 283], ["atrial", "MULTI-TISSUE_STRUCTURE", 87, 93], ["ventricular", "MULTI-TISSUE_STRUCTURE", 101, 112], ["cardiac", "ORGAN", 205, 212], ["electrocardiographic studies", "TEST", 42, 70], ["atrial and/or ventricular origin of arrhythmia", "PROBLEM", 87, 133], ["inflammation", "PROBLEM", 154, 166], ["degeneration", "PROBLEM", 168, 180], ["fibrosis", "PROBLEM", 186, 194], ["Disturbances of CirculationHemorrhage", "PROBLEM", 246, 283], ["ventricular origin", "ANATOMY", 101, 119], ["arrhythmia", "OBSERVATION", 123, 133], ["associated with", "UNCERTAINTY", 138, 153], ["inflammation", "OBSERVATION", 154, 166], ["degeneration", "OBSERVATION", 168, 180], ["fibrosis", "OBSERVATION", 186, 194], ["cardiac conduction", "ANATOMY", 205, 223], ["CirculationHemorrhage", "OBSERVATION", 262, 283]]], ["Endocardial hemorrhages are commonly seen and may be the result of trauma or septicemias, especially those with endotoxins, or can occur agonally at death .", [["Endocardial", "ANATOMY", 0, 11], ["Endocardial hemorrhages", "DISEASE", 0, 23], ["trauma", "DISEASE", 67, 73], ["septicemias", "DISEASE", 77, 88], ["death", "DISEASE", 149, 154], ["Endocardial hemorrhages", "PROBLEM", 0, 23], ["trauma", "PROBLEM", 67, 73], ["septicemias", "PROBLEM", 77, 88], ["hemorrhages", "OBSERVATION", 12, 23], ["may be the result of", "UNCERTAINTY", 46, 66], ["trauma", "OBSERVATION", 67, 73]]], ["See the previous sections on the Pericardium and Epicardium and the Myocardium and Box 10-4 and also Chapter 2.Disturbances of GrowthValvular Anomalies and Dysplasia.", [["sections", "ANATOMY", 17, 25], ["Pericardium", "ANATOMY", 33, 44], ["GrowthValvular Anomalies", "DISEASE", 127, 151], ["Dysplasia", "DISEASE", 156, 165], ["Pericardium", "CANCER", 33, 44], ["Epicardium", "CANCER", 49, 59], ["GrowthValvular Anomalies", "PROBLEM", 127, 151], ["Dysplasia", "PROBLEM", 156, 165], ["Pericardium", "ANATOMY", 33, 44], ["Epicardium", "ANATOMY", 49, 59], ["Myocardium", "ANATOMY", 68, 78], ["GrowthValvular", "ANATOMY", 127, 141], ["Anomalies", "OBSERVATION", 142, 151], ["Dysplasia", "OBSERVATION", 156, 165]]], ["See the discussion on valvular anomalies and dysplasia in the section on Disorders of Domestic Animals, Developmental Errors/Congenital Anomalies: Endocardium and Heart Valves.Cellular Degeneration and DeathSee Chapter 1 for discussion of the causes of cell injury, irreversible cell injury and cell death, and chronic cell injury and cell adaptations.InflammationSee Chapters 3 and 5 for discussion of the processes and mechanisms of acute and chronic inflammation.Disturbances of CirculationHemorrhage.", [["valvular", "ANATOMY", 22, 30], ["Heart", "ANATOMY", 163, 168], ["Cellular", "ANATOMY", 176, 184], ["cell", "ANATOMY", 253, 257], ["cell", "ANATOMY", 279, 283], ["cell", "ANATOMY", 295, 299], ["cell", "ANATOMY", 319, 323], ["cell", "ANATOMY", 335, 339], ["valvular anomalies", "DISEASE", 22, 40], ["dysplasia", "DISEASE", 45, 54], ["Developmental Errors", "DISEASE", 104, 124], ["Congenital Anomalies", "DISEASE", 125, 145], ["death", "DISEASE", 300, 305], ["Inflammation", "DISEASE", 352, 364], ["inflammation", "DISEASE", 453, 465], ["CirculationHemorrhage", "DISEASE", 482, 503], ["valvular", "PATHOLOGICAL_FORMATION", 22, 30], ["dysplasia", "PATHOLOGICAL_FORMATION", 45, 54], ["cell", "CELL", 253, 257], ["cell", "CELL", 279, 283], ["cell", "CELL", 295, 299], ["cell", "CELL", 319, 323], ["cell", "CELL", 335, 339], ["valvular anomalies", "PROBLEM", 22, 40], ["dysplasia", "PROBLEM", 45, 54], ["Congenital Anomalies", "PROBLEM", 125, 145], ["Endocardium and Heart Valves", "TREATMENT", 147, 175], ["Cellular Degeneration", "PROBLEM", 176, 197], ["cell injury", "PROBLEM", 253, 264], ["irreversible cell injury", "PROBLEM", 266, 290], ["cell death", "PROBLEM", 295, 305], ["chronic cell injury", "PROBLEM", 311, 330], ["cell adaptations", "PROBLEM", 335, 351], ["Inflammation", "PROBLEM", 352, 364], ["acute and chronic inflammation", "PROBLEM", 435, 465], ["CirculationHemorrhage", "PROBLEM", 482, 503], ["valvular", "ANATOMY", 22, 30], ["anomalies", "OBSERVATION", 31, 40], ["dysplasia", "OBSERVATION", 45, 54], ["Congenital Anomalies", "OBSERVATION", 125, 145], ["Endocardium", "ANATOMY", 147, 158], ["Heart Valves", "ANATOMY", 163, 175], ["Degeneration", "OBSERVATION", 185, 197], ["cell injury", "OBSERVATION", 253, 264], ["irreversible cell injury", "OBSERVATION", 266, 290], ["cell death", "OBSERVATION", 295, 305], ["chronic cell injury", "OBSERVATION", 311, 330], ["cell adaptations", "OBSERVATION", 335, 351], ["acute", "OBSERVATION_MODIFIER", 435, 440], ["chronic", "OBSERVATION_MODIFIER", 445, 452], ["inflammation", "OBSERVATION", 453, 465], ["Circulation", "OBSERVATION_MODIFIER", 482, 493], ["Hemorrhage", "OBSERVATION", 493, 503]]], ["See section on Disorders of Domestic Animals, Disorders of Domestic Animals: Pericardium and Epicardium, Disturbances of Circulation, Hemorrhage.", [["Hemorrhage", "DISEASE", 134, 144], ["Pericardium and Epicardium, Disturbances of Circulation", "PROBLEM", 77, 132], ["Hemorrhage", "PROBLEM", 134, 144], ["Pericardium", "ANATOMY", 77, 88], ["Epicardium", "ANATOMY", 93, 103], ["Circulation", "OBSERVATION_MODIFIER", 121, 132], ["Hemorrhage", "OBSERVATION", 134, 144]]], ["Effusions.", [["Effusions", "PROBLEM", 0, 9]]], ["See section on Disorders of Domestic Animals, Disorders of Domestic Animals: Pericardium and Epicardium, Disturbances of Circulation, Hemopericardium and Hydropericardium.Responses to Injury: Blood and Lymphatic Vascular SystemsThe responses of blood and lymphatic vessels to injury involve a complex interaction among the cellular and noncellular elements of the vessel wall and the cellular and noncellular elements of the blood.", [["Blood", "ANATOMY", 192, 197], ["Vascular", "ANATOMY", 212, 220], ["blood", "ANATOMY", 245, 250], ["lymphatic vessels", "ANATOMY", 255, 272], ["cellular", "ANATOMY", 323, 331], ["noncellular", "ANATOMY", 336, 347], ["vessel wall", "ANATOMY", 364, 375], ["cellular", "ANATOMY", 384, 392], ["noncellular", "ANATOMY", 397, 408], ["blood", "ANATOMY", 425, 430], ["Injury", "DISEASE", 184, 190], ["Blood", "ORGANISM_SUBSTANCE", 192, 197], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 202, 220], ["blood", "ORGANISM_SUBSTANCE", 245, 250], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 255, 272], ["cellular", "CELL", 323, 331], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 364, 375], ["cellular", "CELL", 384, 392], ["blood", "ORGANISM_SUBSTANCE", 425, 430], ["cellular and noncellular elements", "DNA", 323, 356], ["cellular and noncellular elements", "DNA", 384, 417], ["Pericardium and Epicardium, Disturbances of Circulation", "PROBLEM", 77, 132], ["Hemopericardium", "PROBLEM", 134, 149], ["Hydropericardium", "PROBLEM", 154, 170], ["Injury", "PROBLEM", 184, 190], ["injury", "PROBLEM", 276, 282], ["a complex interaction", "PROBLEM", 291, 312], ["the cellular and noncellular elements of the blood", "PROBLEM", 380, 430], ["Pericardium", "ANATOMY", 77, 88], ["Epicardium", "ANATOMY", 93, 103], ["Circulation", "OBSERVATION_MODIFIER", 121, 132], ["Hemopericardium", "OBSERVATION", 134, 149], ["Hydropericardium", "OBSERVATION_MODIFIER", 154, 170], ["Injury", "OBSERVATION", 184, 190], ["Blood", "ANATOMY", 192, 197], ["Lymphatic", "ANATOMY_MODIFIER", 202, 211], ["Vascular", "ANATOMY", 212, 220], ["blood", "ANATOMY", 245, 250], ["lymphatic vessels", "ANATOMY", 255, 272], ["injury", "OBSERVATION", 276, 282], ["complex", "OBSERVATION_MODIFIER", 293, 300], ["interaction", "OBSERVATION", 301, 312], ["cellular", "OBSERVATION_MODIFIER", 323, 331], ["noncellular", "ANATOMY_MODIFIER", 336, 347], ["elements", "ANATOMY_MODIFIER", 348, 356], ["vessel", "ANATOMY", 364, 370], ["wall", "ANATOMY_MODIFIER", 371, 375], ["cellular", "OBSERVATION_MODIFIER", 384, 392], ["noncellular elements", "OBSERVATION", 397, 417], ["blood", "ANATOMY", 425, 430]]], ["The key cells of vessels in these reactions are endothelial cells and smooth muscle cells.", [["cells", "ANATOMY", 8, 13], ["vessels", "ANATOMY", 17, 24], ["endothelial cells", "ANATOMY", 48, 65], ["smooth muscle cells", "ANATOMY", 70, 89], ["cells", "CELL", 8, 13], ["vessels", "MULTI-TISSUE_STRUCTURE", 17, 24], ["endothelial cells", "CELL", 48, 65], ["smooth muscle cells", "CELL", 70, 89], ["endothelial cells", "CELL_TYPE", 48, 65], ["smooth muscle cells", "CELL_TYPE", 70, 89], ["key cells", "OBSERVATION", 4, 13], ["vessels", "ANATOMY", 17, 24], ["endothelial cells", "OBSERVATION", 48, 65], ["smooth muscle cells", "OBSERVATION", 70, 89]]], ["Endothelial cells are metabolically active and provide a thromboresistant monolayer at the interface of blood and the vessel wall unless damaged.", [["Endothelial cells", "ANATOMY", 0, 17], ["monolayer", "ANATOMY", 74, 83], ["blood", "ANATOMY", 104, 109], ["vessel wall", "ANATOMY", 118, 129], ["Endothelial cells", "CELL", 0, 17], ["monolayer", "CELL", 74, 83], ["blood", "ORGANISM_SUBSTANCE", 104, 109], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 118, 129], ["Endothelial cells", "CELL_TYPE", 0, 17], ["Endothelial cells", "TEST", 0, 17], ["a thromboresistant monolayer", "PROBLEM", 55, 83], ["metabolically", "OBSERVATION_MODIFIER", 22, 35], ["active", "OBSERVATION_MODIFIER", 36, 42], ["thromboresistant monolayer", "OBSERVATION", 57, 83], ["blood", "ANATOMY", 104, 109], ["vessel", "ANATOMY", 118, 124], ["wall", "ANATOMY_MODIFIER", 125, 129], ["damaged", "OBSERVATION", 137, 144]]], ["Endothelial cells play an important role in fluid distribution, inflammation, angiogenesis, and hemostasis (see Chapters 2 and 3).", [["Endothelial cells", "ANATOMY", 0, 17], ["fluid", "ANATOMY", 44, 49], ["inflammation", "DISEASE", 64, 76], ["Endothelial cells", "CELL", 0, 17], ["fluid", "ORGANISM_SUBSTANCE", 44, 49], ["Endothelial cells", "CELL_TYPE", 0, 17], ["Endothelial cells", "PROBLEM", 0, 17], ["inflammation", "PROBLEM", 64, 76], ["angiogenesis", "PROBLEM", 78, 90], ["hemostasis", "TEST", 96, 106], ["fluid distribution", "OBSERVATION", 44, 62], ["inflammation", "OBSERVATION", 64, 76]]], ["Responses of blood vessels to a variety of toxins are listed in E-Box 10-1.Responses to Injury: Blood and Lymphatic Vascular SystemsKey functions of endothelial cells include prostacyclin production, macromolecular transport, and recruitment of inflammatory cells.", [["blood vessels", "ANATOMY", 13, 26], ["Blood", "ANATOMY", 96, 101], ["Vascular", "ANATOMY", 116, 124], ["endothelial cells", "ANATOMY", 149, 166], ["inflammatory cells", "ANATOMY", 245, 263], ["Injury", "DISEASE", 88, 94], ["prostacyclin", "CHEMICAL", 175, 187], ["prostacyclin", "CHEMICAL", 175, 187], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 13, 26], ["E-Box 10-1", "GENE_OR_GENE_PRODUCT", 64, 74], ["Blood", "ORGANISM_SUBSTANCE", 96, 101], ["Vascular", "MULTI-TISSUE_STRUCTURE", 116, 124], ["endothelial cells", "CELL", 149, 166], ["prostacyclin", "SIMPLE_CHEMICAL", 175, 187], ["cells", "CELL", 258, 263], ["E-Box 10-1", "DNA", 64, 74], ["endothelial cells", "CELL_TYPE", 149, 166], ["inflammatory cells", "CELL_TYPE", 245, 263], ["Injury", "PROBLEM", 88, 94], ["Blood", "TEST", 96, 101], ["endothelial cells", "PROBLEM", 149, 166], ["prostacyclin production", "PROBLEM", 175, 198], ["macromolecular transport", "TREATMENT", 200, 224], ["inflammatory cells", "PROBLEM", 245, 263], ["blood vessels", "ANATOMY", 13, 26], ["Blood", "ANATOMY", 96, 101], ["Lymphatic", "ANATOMY_MODIFIER", 106, 115], ["Vascular", "ANATOMY", 116, 124], ["endothelial cells", "OBSERVATION", 149, 166], ["prostacyclin production", "OBSERVATION", 175, 198], ["inflammatory cells", "OBSERVATION", 245, 263]]], ["Injury of endothelial cells is followed by separation from the underlying basement membrane and increased permeability to movement of plasma proteins into the subendothelium.", [["endothelial cells", "ANATOMY", 10, 27], ["basement membrane", "ANATOMY", 74, 91], ["plasma", "ANATOMY", 134, 140], ["subendothelium", "ANATOMY", 159, 173], ["endothelial cells", "CELL", 10, 27], ["basement membrane", "CELLULAR_COMPONENT", 74, 91], ["plasma", "ORGANISM_SUBSTANCE", 134, 140], ["subendothelium", "CELLULAR_COMPONENT", 159, 173], ["endothelial cells", "CELL_TYPE", 10, 27], ["plasma proteins", "PROTEIN", 134, 149], ["subendothelium", "CELL_TYPE", 159, 173], ["Injury of endothelial cells", "PROBLEM", 0, 27], ["increased permeability", "PROBLEM", 96, 118], ["plasma proteins", "TEST", 134, 149], ["endothelial cells", "OBSERVATION", 10, 27], ["basement", "ANATOMY_MODIFIER", 74, 82], ["membrane", "ANATOMY_MODIFIER", 83, 91], ["increased", "OBSERVATION_MODIFIER", 96, 105], ["permeability", "OBSERVATION", 106, 118], ["subendothelium", "ANATOMY_MODIFIER", 159, 173]]], ["Necrosis of endothelium exposes subendothelial collagen and elicits thrombus formation.", [["endothelium", "ANATOMY", 12, 23], ["subendothelial", "ANATOMY", 32, 46], ["thrombus", "ANATOMY", 68, 76], ["thrombus", "DISEASE", 68, 76], ["endothelium", "TISSUE", 12, 23], ["subendothelial", "CELLULAR_COMPONENT", 32, 46], ["collagen", "GENE_OR_GENE_PRODUCT", 47, 55], ["thrombus", "PATHOLOGICAL_FORMATION", 68, 76], ["subendothelial collagen", "PROTEIN", 32, 55], ["Necrosis of endothelium", "PROBLEM", 0, 23], ["subendothelial collagen", "TREATMENT", 32, 55], ["thrombus formation", "PROBLEM", 68, 86], ["endothelium", "OBSERVATION", 12, 23], ["subendothelial collagen", "OBSERVATION", 32, 55], ["thrombus", "OBSERVATION", 68, 76]]], ["Endothelial cells at the margin of denuded areas proliferate and re-endothelialize the damaged area.", [["Endothelial cells", "ANATOMY", 0, 17], ["area", "ANATOMY", 95, 99], ["Endothelial cells", "CELL", 0, 17], ["Endothelial cells", "CELL_TYPE", 0, 17], ["Endothelial cells", "PROBLEM", 0, 17], ["denuded areas proliferate", "PROBLEM", 35, 60], ["the damaged area", "PROBLEM", 83, 99], ["margin", "OBSERVATION_MODIFIER", 25, 31], ["denuded", "OBSERVATION_MODIFIER", 35, 42], ["areas", "OBSERVATION_MODIFIER", 43, 48], ["proliferate", "OBSERVATION_MODIFIER", 49, 60], ["damaged", "OBSERVATION_MODIFIER", 87, 94], ["area", "OBSERVATION_MODIFIER", 95, 99]]], ["The arterial intima has regional differences in the uptake of macromolecules, as well as other unique structural and functional features that result in lesionprone areas of the vasculature.", [["arterial intima", "ANATOMY", 4, 19], ["vasculature", "ANATOMY", 177, 188], ["arterial intima", "MULTI-TISSUE_STRUCTURE", 4, 19], ["vasculature", "MULTI-TISSUE_STRUCTURE", 177, 188], ["the uptake of macromolecules", "PROBLEM", 48, 76], ["arterial", "ANATOMY_MODIFIER", 4, 12], ["intima", "ANATOMY", 13, 19], ["regional", "OBSERVATION_MODIFIER", 24, 32], ["differences", "OBSERVATION_MODIFIER", 33, 44], ["uptake of macromolecules", "OBSERVATION", 52, 76], ["functional features", "OBSERVATION", 117, 136], ["vasculature", "ANATOMY", 177, 188]]], ["Bilirubin staining of the intima results in yellow discoloration in jaundiced animals ( Fig. 10-23) .Responses to Injury: Blood and Lymphatic Vascular SystemsThe other major cellular component of vessels involved in reaction to injury is the smooth muscle cell.", [["intima", "ANATOMY", 26, 32], ["Blood", "ANATOMY", 122, 127], ["Vascular", "ANATOMY", 142, 150], ["cellular", "ANATOMY", 174, 182], ["vessels", "ANATOMY", 196, 203], ["smooth muscle cell", "ANATOMY", 242, 260], ["Injury", "DISEASE", 114, 120], ["Bilirubin", "CHEMICAL", 0, 9], ["Bilirubin", "SIMPLE_CHEMICAL", 0, 9], ["intima", "TISSUE", 26, 32], ["Blood", "ORGANISM_SUBSTANCE", 122, 127], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 132, 150], ["cellular", "CELL", 174, 182], ["vessels", "MULTI-TISSUE_STRUCTURE", 196, 203], ["smooth muscle cell", "CELL", 242, 260], ["smooth muscle cell", "CELL_TYPE", 242, 260], ["Bilirubin staining", "TEST", 0, 18], ["yellow discoloration", "PROBLEM", 44, 64], ["jaundiced animals", "PROBLEM", 68, 85], ["injury", "PROBLEM", 228, 234], ["intima", "ANATOMY", 26, 32], ["yellow discoloration", "OBSERVATION", 44, 64], ["jaundiced", "OBSERVATION_MODIFIER", 68, 77], ["Injury", "OBSERVATION", 114, 120], ["Blood", "ANATOMY", 122, 127], ["Lymphatic", "ANATOMY_MODIFIER", 132, 141], ["Vascular", "ANATOMY", 142, 150], ["vessels", "ANATOMY", 196, 203], ["injury", "OBSERVATION", 228, 234], ["smooth muscle cell", "OBSERVATION", 242, 260]]], ["These cells have important functions, including production of extracellular components, such as collagen, elastin, and proteoglycans; maintenance of vascular tone; monocyte recruitment; lipoprotein metabolism; production of bioactive lipids, such as prostaglandins; and formation of oxygenfree radicals.", [["cells", "ANATOMY", 6, 11], ["extracellular components", "ANATOMY", 62, 86], ["vascular", "ANATOMY", 149, 157], ["monocyte", "ANATOMY", 164, 172], ["prostaglandins", "CHEMICAL", 250, 264], ["prostaglandins", "CHEMICAL", 250, 264], ["cells", "CELL", 6, 11], ["extracellular components", "CELLULAR_COMPONENT", 62, 86], ["collagen", "GENE_OR_GENE_PRODUCT", 96, 104], ["elastin", "GENE_OR_GENE_PRODUCT", 106, 113], ["proteoglycans", "GENE_OR_GENE_PRODUCT", 119, 132], ["vascular", "MULTI-TISSUE_STRUCTURE", 149, 157], ["monocyte", "CELL", 164, 172], ["lipoprotein", "SIMPLE_CHEMICAL", 186, 197], ["lipids", "SIMPLE_CHEMICAL", 234, 240], ["prostaglandins", "SIMPLE_CHEMICAL", 250, 264], ["oxygenfree radicals", "SIMPLE_CHEMICAL", 283, 302], ["collagen", "PROTEIN", 96, 104], ["elastin", "PROTEIN", 106, 113], ["extracellular components", "PROBLEM", 62, 86], ["collagen, elastin, and proteoglycans", "TREATMENT", 96, 132], ["monocyte recruitment", "TREATMENT", 164, 184], ["lipoprotein metabolism", "PROBLEM", 186, 208], ["bioactive lipids", "TREATMENT", 224, 240], ["prostaglandins", "TREATMENT", 250, 264], ["oxygenfree radicals", "TREATMENT", 283, 302], ["extracellular components", "OBSERVATION", 62, 86], ["vascular tone", "ANATOMY", 149, 162]]], ["These functions are regulated by a wide variety of biochemical mediators, such as various growth factors, cytokines, and inflammatory mediators.Disturbances of CirculationHemorrhage.", [["CirculationHemorrhage", "DISEASE", 160, 181], ["biochemical mediators", "PROTEIN", 51, 72], ["growth factors", "PROTEIN", 90, 104], ["cytokines", "PROTEIN", 106, 115], ["inflammatory mediators", "PROTEIN", 121, 143], ["various growth factors", "PROBLEM", 82, 104], ["cytokines", "TREATMENT", 106, 115], ["inflammatory mediators", "TREATMENT", 121, 143], ["CirculationHemorrhage", "PROBLEM", 160, 181], ["inflammatory", "OBSERVATION_MODIFIER", 121, 133], ["Circulation", "OBSERVATION_MODIFIER", 160, 171], ["Hemorrhage", "OBSERVATION", 171, 181]]], ["Hemorrhage resulting from vascular injury is a frequent lesion of the epicardium, endocardium, and myocardium.", [["vascular", "ANATOMY", 26, 34], ["lesion", "ANATOMY", 56, 62], ["epicardium", "ANATOMY", 70, 80], ["endocardium", "ANATOMY", 82, 93], ["myocardium", "ANATOMY", 99, 109], ["Hemorrhage", "DISEASE", 0, 10], ["vascular injury", "DISEASE", 26, 41], ["vascular", "MULTI-TISSUE_STRUCTURE", 26, 34], ["epicardium", "TISSUE", 70, 80], ["endocardium", "MULTI-TISSUE_STRUCTURE", 82, 93], ["myocardium", "MULTI-TISSUE_STRUCTURE", 99, 109], ["Hemorrhage", "PROBLEM", 0, 10], ["vascular injury", "PROBLEM", 26, 41], ["a frequent lesion of the epicardium, endocardium, and myocardium", "PROBLEM", 45, 109], ["vascular", "ANATOMY", 26, 34], ["injury", "OBSERVATION", 35, 41], ["frequent", "OBSERVATION_MODIFIER", 47, 55], ["lesion", "OBSERVATION", 56, 62], ["epicardium", "ANATOMY", 70, 80], ["endocardium", "ANATOMY", 82, 93], ["myocardium", "ANATOMY", 99, 109]]], ["Hemorrhages vary in size from petechiae (1-to 2-mm diameter) to ecchymoses (2-to 10-mm diameter) to suffusive (diffuse).", [["ecchymoses", "ANATOMY", 64, 74], ["Hemorrhages", "DISEASE", 0, 11], ["petechiae", "DISEASE", 30, 39], ["ecchymoses", "DISEASE", 64, 74], ["petechiae", "PATHOLOGICAL_FORMATION", 30, 39], ["Hemorrhages", "PROBLEM", 0, 11], ["petechiae", "TEST", 30, 39], ["ecchymoses", "PROBLEM", 64, 74], ["vary", "OBSERVATION_MODIFIER", 12, 16], ["size", "OBSERVATION_MODIFIER", 20, 24], ["petechiae", "OBSERVATION", 30, 39], ["1-to 2-mm diameter", "OBSERVATION_MODIFIER", 41, 59], ["ecchymoses", "OBSERVATION", 64, 74], ["2-to 10-mm diameter", "OBSERVATION_MODIFIER", 76, 95], ["diffuse", "OBSERVATION_MODIFIER", 111, 118]]], ["Animals dying from septicemia, endotoxemia, anoxia, or electrocution often have prominent epicardial (Fig. 10-24 ; E-Fig.", [["epicardial", "ANATOMY", 90, 100], ["septicemia", "DISEASE", 19, 29], ["endotoxemia", "DISEASE", 31, 42], ["anoxia", "DISEASE", 44, 50], ["electrocution", "DISEASE", 55, 68], ["Animals", "ORGANISM", 0, 7], ["epicardial", "MULTI-TISSUE_STRUCTURE", 90, 100], ["septicemia", "PROBLEM", 19, 29], ["endotoxemia", "PROBLEM", 31, 42], ["anoxia", "PROBLEM", 44, 50], ["septicemia", "OBSERVATION", 19, 29], ["endotoxemia", "OBSERVATION_MODIFIER", 31, 42], ["prominent", "OBSERVATION_MODIFIER", 80, 89], ["epicardial", "ANATOMY", 90, 100]]], ["10-18 and endocardial (see Fig. 10 -21) hemorrhages.", [["endocardial", "ANATOMY", 10, 21], ["hemorrhages", "DISEASE", 40, 51], ["endocardial", "MULTI-TISSUE_STRUCTURE", 10, 21], ["endocardial (see Fig.", "TEST", 10, 31], ["hemorrhages", "PROBLEM", 40, 51], ["endocardial", "ANATOMY", 10, 21], ["hemorrhages", "OBSERVATION", 40, 51]]], ["Horses dying of any cause usually have agonal hemorrhages on the epicardial and endocardial surfaces.", [["epicardial", "ANATOMY", 65, 75], ["endocardial surfaces", "ANATOMY", 80, 100], ["hemorrhages", "DISEASE", 46, 57], ["epicardial", "MULTI-TISSUE_STRUCTURE", 65, 75], ["endocardial surfaces", "TISSUE", 80, 100], ["agonal hemorrhages on the epicardial and endocardial surfaces", "PROBLEM", 39, 100], ["hemorrhages", "OBSERVATION", 46, 57], ["epicardial", "ANATOMY", 65, 75], ["endocardial", "ANATOMY", 80, 91], ["surfaces", "ANATOMY_MODIFIER", 92, 100]]], ["A distinctive example of a specific disease with cardiac hemorrhage is mulberry heart disease, associated with vitamin E-selenium deficiency in growing pigs.", [["cardiac", "ANATOMY", 49, 56], ["heart", "ANATOMY", 80, 85], ["cardiac hemorrhage", "DISEASE", 49, 67], ["mulberry heart disease", "DISEASE", 71, 93], ["vitamin E-selenium", "CHEMICAL", 111, 129], ["vitamin E", "CHEMICAL", 111, 120], ["selenium", "CHEMICAL", 121, 129], ["cardiac", "ORGAN", 49, 56], ["heart", "ORGAN", 80, 85], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 111, 129], ["pigs", "ORGANISM", 152, 156], ["pigs", "SPECIES", 152, 156], ["a specific disease", "PROBLEM", 25, 43], ["cardiac hemorrhage", "PROBLEM", 49, 67], ["mulberry heart disease", "PROBLEM", 71, 93], ["vitamin E", "TREATMENT", 111, 120], ["selenium deficiency", "PROBLEM", 121, 140], ["specific", "OBSERVATION_MODIFIER", 27, 35], ["disease", "OBSERVATION", 36, 43], ["cardiac", "ANATOMY", 49, 56], ["hemorrhage", "OBSERVATION", 57, 67], ["heart", "ANATOMY", 80, 85], ["disease", "OBSERVATION", 86, 93], ["selenium deficiency", "OBSERVATION", 121, 140]]], ["In these pigs, hydropericardium accompanies severe myocardial hemorrhage that results Arteritis and Vasculitis.", [["myocardial", "ANATOMY", 51, 61], ["hydropericardium", "DISEASE", 15, 31], ["myocardial hemorrhage", "DISEASE", 51, 72], ["Arteritis", "DISEASE", 86, 95], ["Vasculitis", "DISEASE", 100, 110], ["pigs", "ORGANISM", 9, 13], ["myocardial", "MULTI-TISSUE_STRUCTURE", 51, 61], ["pigs", "SPECIES", 9, 13], ["severe myocardial hemorrhage", "PROBLEM", 44, 72], ["Arteritis", "PROBLEM", 86, 95], ["Vasculitis", "PROBLEM", 100, 110], ["severe", "OBSERVATION_MODIFIER", 44, 50], ["myocardial", "ANATOMY", 51, 61], ["hemorrhage", "OBSERVATION", 62, 72], ["Arteritis", "OBSERVATION", 86, 95], ["Vasculitis", "OBSERVATION", 100, 110]]], ["Arteritis occurs as a feature of many infectious and immune-mediated diseases (Box 10-7).", [["Arteritis", "DISEASE", 0, 9], ["Arteritis", "PROBLEM", 0, 9], ["many infectious and immune-mediated diseases", "PROBLEM", 33, 77], ["Box", "TEST", 79, 82], ["many", "OBSERVATION_MODIFIER", 33, 37], ["infectious", "OBSERVATION", 38, 48]]], ["Often, all types of vessels are affected rather than only arteries, and then vasculitis or angiitis (a term that includes blood and lymphatic vessels) is the term applied to the lesions.", [["vessels", "ANATOMY", 20, 27], ["arteries", "ANATOMY", 58, 66], ["blood", "ANATOMY", 122, 127], ["lymphatic vessels", "ANATOMY", 132, 149], ["lesions", "ANATOMY", 178, 185], ["vasculitis", "DISEASE", 77, 87], ["angiitis", "DISEASE", 91, 99], ["vessels", "MULTI-TISSUE_STRUCTURE", 20, 27], ["arteries", "MULTI-TISSUE_STRUCTURE", 58, 66], ["blood", "ORGANISM_SUBSTANCE", 122, 127], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 132, 149], ["lesions", "PATHOLOGICAL_FORMATION", 178, 185], ["vasculitis", "PROBLEM", 77, 87], ["angiitis", "PROBLEM", 91, 99], ["the lesions", "PROBLEM", 174, 185], ["vessels", "ANATOMY", 20, 27], ["arteries", "ANATOMY", 58, 66], ["vasculitis", "OBSERVATION", 77, 87], ["angiitis", "OBSERVATION", 91, 99], ["lymphatic vessels", "ANATOMY", 132, 149], ["lesions", "OBSERVATION", 178, 185]]], ["The vascular system serves as the major mechanisms for transport of organisms-for example, Bacillus anthracis.", [["vascular system", "ANATOMY", 4, 19], ["vascular system", "MULTI-TISSUE_STRUCTURE", 4, 19], ["Bacillus anthracis", "ORGANISM", 91, 109], ["Bacillus anthracis", "SPECIES", 91, 109], ["Bacillus anthracis", "SPECIES", 91, 109], ["organisms", "PROBLEM", 68, 77], ["Bacillus anthracis", "PROBLEM", 91, 109], ["vascular system", "ANATOMY", 4, 19]]], ["In inflamed vessels, leukocytes are present within and surrounding the walls, and damage to the vessel wall is evident as fibrin deposits or necrotic endothelial and smooth muscle cells.", [["inflamed vessels", "ANATOMY", 3, 19], ["leukocytes", "ANATOMY", 21, 31], ["walls", "ANATOMY", 71, 76], ["vessel wall", "ANATOMY", 96, 107], ["necrotic endothelial", "ANATOMY", 141, 161], ["smooth muscle cells", "ANATOMY", 166, 185], ["necrotic", "DISEASE", 141, 149], ["vessels", "MULTI-TISSUE_STRUCTURE", 12, 19], ["leukocytes", "CELL", 21, 31], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 96, 107], ["fibrin", "GENE_OR_GENE_PRODUCT", 122, 128], ["necrotic endothelial", "CELL", 141, 161], ["smooth muscle cells", "CELL", 166, 185], ["leukocytes", "CELL_TYPE", 21, 31], ["necrotic endothelial", "CELL_TYPE", 141, 161], ["smooth muscle cells", "CELL_TYPE", 166, 185], ["leukocytes", "PROBLEM", 21, 31], ["damage to the vessel wall", "PROBLEM", 82, 107], ["fibrin deposits", "PROBLEM", 122, 137], ["necrotic endothelial and smooth muscle cells", "PROBLEM", 141, 185], ["inflamed", "ANATOMY_MODIFIER", 3, 11], ["vessels", "ANATOMY", 12, 19], ["leukocytes", "OBSERVATION", 21, 31], ["walls", "ANATOMY_MODIFIER", 71, 76], ["vessel", "ANATOMY", 96, 102], ["wall", "ANATOMY_MODIFIER", 103, 107], ["fibrin deposits", "OBSERVATION", 122, 137], ["necrotic endothelial", "OBSERVATION", 141, 161], ["smooth muscle cells", "OBSERVATION", 166, 185]]], ["As a result of endothelial damage, thrombosis, which can result in ischemic injury or infarction in the circulatory field, may be present.", [["endothelial", "ANATOMY", 15, 26], ["endothelial damage", "DISEASE", 15, 33], ["thrombosis", "DISEASE", 35, 45], ["ischemic injury", "DISEASE", 67, 82], ["infarction", "DISEASE", 86, 96], ["endothelial", "TISSUE", 15, 26], ["endothelial damage", "PROBLEM", 15, 33], ["thrombosis", "PROBLEM", 35, 45], ["ischemic injury", "PROBLEM", 67, 82], ["infarction in the circulatory field", "PROBLEM", 86, 121], ["endothelial", "ANATOMY", 15, 26], ["damage", "OBSERVATION", 27, 33], ["thrombosis", "OBSERVATION", 35, 45], ["ischemic", "OBSERVATION_MODIFIER", 67, 75], ["injury", "OBSERVATION", 76, 82], ["infarction", "OBSERVATION", 86, 96], ["circulatory field", "OBSERVATION", 104, 121], ["may be", "UNCERTAINTY", 123, 129]]], ["Arteritis and vasculitis can develop from endothelial injury caused by either infectious agents or immune-mediated mechanisms or may be caused by local extension of suppurative and necrotizing inflammatory processes in adjacent tissues.", [["endothelial", "ANATOMY", 42, 53], ["suppurative", "ANATOMY", 165, 176], ["tissues", "ANATOMY", 228, 235], ["Arteritis", "DISEASE", 0, 9], ["vasculitis", "DISEASE", 14, 24], ["endothelial injury", "DISEASE", 42, 60], ["endothelial", "TISSUE", 42, 53], ["tissues", "TISSUE", 228, 235], ["Arteritis", "PROBLEM", 0, 9], ["vasculitis", "PROBLEM", 14, 24], ["endothelial injury", "PROBLEM", 42, 60], ["immune-mediated mechanisms", "PROBLEM", 99, 125], ["suppurative and necrotizing inflammatory processes in adjacent tissues", "PROBLEM", 165, 235], ["vasculitis", "OBSERVATION", 14, 24], ["endothelial", "ANATOMY", 42, 53], ["injury", "OBSERVATION", 54, 60], ["infectious", "OBSERVATION_MODIFIER", 78, 88], ["may be caused", "UNCERTAINTY", 129, 142], ["suppurative", "OBSERVATION_MODIFIER", 165, 176], ["necrotizing", "OBSERVATION_MODIFIER", 181, 192], ["inflammatory", "OBSERVATION", 193, 205]]], ["Arteritis is a prominent feature of several parasitic diseases.Disturbances of CirculationSystemic infections with phlebitis as a lesion include salmonellosis in several species and feline infectious peritonitis.", [["lesion", "ANATOMY", 130, 136], ["Arteritis", "DISEASE", 0, 9], ["parasitic diseases", "DISEASE", 44, 62], ["CirculationSystemic infections", "DISEASE", 79, 109], ["phlebitis", "DISEASE", 115, 124], ["salmonellosis", "DISEASE", 145, 158], ["infectious peritonitis", "DISEASE", 189, 211], ["feline", "ORGANISM", 182, 188], ["feline", "SPECIES", 182, 188], ["Arteritis", "PROBLEM", 0, 9], ["several parasitic diseases", "PROBLEM", 36, 62], ["CirculationSystemic infections", "PROBLEM", 79, 109], ["phlebitis", "PROBLEM", 115, 124], ["a lesion", "PROBLEM", 128, 136], ["salmonellosis", "PROBLEM", 145, 158], ["several species", "PROBLEM", 162, 177], ["feline infectious peritonitis", "PROBLEM", 182, 211], ["prominent", "OBSERVATION_MODIFIER", 15, 24], ["several", "OBSERVATION_MODIFIER", 36, 43], ["parasitic diseases", "OBSERVATION", 44, 62], ["CirculationSystemic", "OBSERVATION_MODIFIER", 79, 98], ["infections", "OBSERVATION", 99, 109], ["phlebitis", "OBSERVATION", 115, 124], ["lesion", "OBSERVATION", 130, 136], ["salmonellosis", "OBSERVATION", 145, 158], ["several species", "OBSERVATION_MODIFIER", 162, 177], ["feline", "OBSERVATION_MODIFIER", 182, 188], ["infectious", "OBSERVATION_MODIFIER", 189, 199], ["peritonitis", "OBSERVATION", 200, 211]]], ["In pigs with various septicemias, such as salmonellosis and colibacillosis, the gastric fundic mucosa is often severely congested and hemorrhagic because of venous endothelial damage and thrombosis.", [["gastric fundic mucosa", "ANATOMY", 80, 101], ["venous endothelial", "ANATOMY", 157, 175], ["septicemias", "DISEASE", 21, 32], ["salmonellosis", "DISEASE", 42, 55], ["colibacillosis", "DISEASE", 60, 74], ["gastric fundic mucosa", "DISEASE", 80, 101], ["hemorrhagic", "DISEASE", 134, 145], ["venous endothelial damage", "DISEASE", 157, 182], ["thrombosis", "DISEASE", 187, 197], ["pigs", "ORGANISM", 3, 7], ["gastric fundic mucosa", "MULTI-TISSUE_STRUCTURE", 80, 101], ["venous endothelial", "TISSUE", 157, 175], ["pigs", "SPECIES", 3, 7], ["pigs", "SPECIES", 3, 7], ["salmonellosis", "SPECIES", 42, 55], ["various septicemias", "PROBLEM", 13, 32], ["salmonellosis", "PROBLEM", 42, 55], ["colibacillosis", "PROBLEM", 60, 74], ["severely congested", "PROBLEM", 111, 129], ["hemorrhagic", "PROBLEM", 134, 145], ["venous endothelial damage", "PROBLEM", 157, 182], ["thrombosis", "PROBLEM", 187, 197], ["various septicemias", "OBSERVATION", 13, 32], ["salmonellosis", "OBSERVATION", 42, 55], ["colibacillosis", "OBSERVATION", 60, 74], ["gastric", "ANATOMY", 80, 87], ["fundic mucosa", "ANATOMY", 88, 101], ["severely", "OBSERVATION_MODIFIER", 111, 119], ["congested", "OBSERVATION", 120, 129], ["hemorrhagic", "OBSERVATION_MODIFIER", 134, 145], ["venous endothelial", "ANATOMY", 157, 175], ["damage", "OBSERVATION", 176, 182], ["thrombosis", "OBSERVATION", 187, 197]]], ["In severe local infections, such as in metritis or hepatic abscesses, inflammation extends into the walls of adjacent veins and produces phlebitis, with or without thrombosis.", [["hepatic abscesses", "ANATOMY", 51, 68], ["walls", "ANATOMY", 100, 105], ["veins", "ANATOMY", 118, 123], ["infections", "DISEASE", 16, 26], ["metritis", "DISEASE", 39, 47], ["hepatic abscesses", "DISEASE", 51, 68], ["inflammation", "DISEASE", 70, 82], ["phlebitis", "DISEASE", 137, 146], ["thrombosis", "DISEASE", 164, 174], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 51, 68], ["veins", "MULTI-TISSUE_STRUCTURE", 118, 123], ["severe local infections", "PROBLEM", 3, 26], ["metritis", "PROBLEM", 39, 47], ["hepatic abscesses", "PROBLEM", 51, 68], ["inflammation", "PROBLEM", 70, 82], ["phlebitis", "PROBLEM", 137, 146], ["thrombosis", "PROBLEM", 164, 174], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["local", "OBSERVATION_MODIFIER", 10, 15], ["infections", "OBSERVATION", 16, 26], ["metritis", "OBSERVATION", 39, 47], ["hepatic", "ANATOMY", 51, 58], ["abscesses", "OBSERVATION", 59, 68], ["inflammation", "OBSERVATION", 70, 82], ["walls", "ANATOMY_MODIFIER", 100, 105], ["adjacent", "ANATOMY_MODIFIER", 109, 117], ["veins", "ANATOMY", 118, 123], ["phlebitis", "OBSERVATION", 137, 146], ["without", "UNCERTAINTY", 156, 163], ["thrombosis", "OBSERVATION", 164, 174]]], ["Intravenous injections of irritant solutions, injecting solutions into the vascular wall, or intimal trauma produced by indwelling venous catheters result in vascular damage and create an opportunity for localization and proliferation of infectious agents and development of phlebitis and thrombosis .", [["Intravenous", "ANATOMY", 0, 11], ["vascular wall", "ANATOMY", 75, 88], ["intimal", "ANATOMY", 93, 100], ["venous", "ANATOMY", 131, 137], ["vascular", "ANATOMY", 158, 166], ["intimal trauma", "DISEASE", 93, 107], ["vascular damage", "DISEASE", 158, 173], ["phlebitis", "DISEASE", 275, 284], ["thrombosis", "DISEASE", 289, 299], ["Intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 0, 11], ["vascular wall", "MULTI-TISSUE_STRUCTURE", 75, 88], ["intimal", "TISSUE", 93, 100], ["venous catheters", "PATHOLOGICAL_FORMATION", 131, 147], ["vascular", "MULTI-TISSUE_STRUCTURE", 158, 166], ["phlebitis", "PATHOLOGICAL_FORMATION", 275, 284], ["Intravenous injections of irritant solutions", "TREATMENT", 0, 44], ["intimal trauma", "PROBLEM", 93, 107], ["indwelling venous catheters", "TREATMENT", 120, 147], ["vascular damage", "PROBLEM", 158, 173], ["infectious agents", "TREATMENT", 238, 255], ["phlebitis", "PROBLEM", 275, 284], ["thrombosis", "PROBLEM", 289, 299], ["vascular wall", "ANATOMY", 75, 88], ["intimal", "ANATOMY", 93, 100], ["trauma", "OBSERVATION", 101, 107], ["indwelling", "OBSERVATION", 120, 130], ["venous", "ANATOMY", 131, 137], ["catheters", "OBSERVATION", 138, 147], ["vascular", "ANATOMY", 158, 166], ["damage", "OBSERVATION", 167, 173], ["infectious", "OBSERVATION", 238, 248], ["phlebitis", "OBSERVATION", 275, 284], ["thrombosis", "OBSERVATION", 289, 299]]], ["Animals with phlebitis complicated by thrombosis have the additional risk of septic embolism, which can cause endocarditis and pulmonary abscesses or pulmonary infarcts.Disturbances of CirculationMany reportable foreign animal diseases are viral diseases, which are endotheliotropic and result in vasculitis; examples include Hypertrophy.", [["pulmonary abscesses", "ANATOMY", 127, 146], ["pulmonary", "ANATOMY", 150, 159], ["phlebitis", "DISEASE", 13, 22], ["thrombosis", "DISEASE", 38, 48], ["septic embolism", "DISEASE", 77, 92], ["endocarditis", "DISEASE", 110, 122], ["pulmonary abscesses", "DISEASE", 127, 146], ["pulmonary infarcts", "DISEASE", 150, 168], ["animal diseases", "DISEASE", 220, 235], ["viral diseases", "DISEASE", 240, 254], ["vasculitis", "DISEASE", 297, 307], ["Hypertrophy", "DISEASE", 326, 337], ["pulmonary abscesses", "PATHOLOGICAL_FORMATION", 127, 146], ["pulmonary", "ORGAN", 150, 159], ["phlebitis", "PROBLEM", 13, 22], ["thrombosis", "PROBLEM", 38, 48], ["septic embolism", "PROBLEM", 77, 92], ["endocarditis", "PROBLEM", 110, 122], ["pulmonary abscesses", "PROBLEM", 127, 146], ["pulmonary infarcts", "PROBLEM", 150, 168], ["Disturbances of Circulation", "PROBLEM", 169, 196], ["foreign animal diseases", "PROBLEM", 212, 235], ["viral diseases", "PROBLEM", 240, 254], ["vasculitis", "PROBLEM", 297, 307], ["Hypertrophy", "PROBLEM", 326, 337], ["phlebitis", "OBSERVATION", 13, 22], ["thrombosis", "OBSERVATION", 38, 48], ["septic embolism", "OBSERVATION", 77, 92], ["can cause", "UNCERTAINTY", 100, 109], ["endocarditis", "OBSERVATION", 110, 122], ["pulmonary", "ANATOMY", 127, 136], ["abscesses", "OBSERVATION", 137, 146], ["pulmonary", "ANATOMY", 150, 159], ["infarcts", "OBSERVATION", 160, 168], ["Circulation", "ANATOMY", 185, 196], ["foreign animal diseases", "OBSERVATION", 212, 235], ["viral diseases", "OBSERVATION", 240, 254], ["vasculitis", "OBSERVATION", 297, 307], ["Hypertrophy", "OBSERVATION", 326, 337]]], ["Arterial hypertrophy is a response to sustained increases in pressure or volume loads.", [["Arterial", "ANATOMY", 0, 8], ["Arterial hypertrophy", "DISEASE", 0, 20], ["Arterial", "MULTI-TISSUE_STRUCTURE", 0, 8], ["Arterial hypertrophy", "PROBLEM", 0, 20], ["sustained increases in pressure or volume loads", "PROBLEM", 38, 85], ["hypertrophy", "OBSERVATION", 9, 20], ["sustained", "OBSERVATION_MODIFIER", 38, 47], ["increases", "OBSERVATION_MODIFIER", 48, 57], ["pressure", "OBSERVATION_MODIFIER", 61, 69], ["volume loads", "OBSERVATION", 73, 85]]], ["Affected vessels are generally muscular arteries, and the increase in wall thickness is predominantly caused by hypertrophy (and, to some degree, hyperplasia) of smooth muscle cells of the tunica media.", [["vessels", "ANATOMY", 9, 16], ["muscular arteries", "ANATOMY", 31, 48], ["wall", "ANATOMY", 70, 74], ["smooth muscle cells", "ANATOMY", 162, 181], ["hypertrophy", "DISEASE", 112, 123], ["hyperplasia", "DISEASE", 146, 157], ["vessels", "MULTI-TISSUE_STRUCTURE", 9, 16], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 31, 48], ["wall", "TISSUE", 70, 74], ["smooth muscle cells", "CELL", 162, 181], ["tunica", "TISSUE", 189, 195], ["smooth muscle cells", "CELL_TYPE", 162, 181], ["the increase in wall thickness", "PROBLEM", 54, 84], ["hypertrophy", "PROBLEM", 112, 123], ["hyperplasia", "PROBLEM", 146, 157], ["vessels", "ANATOMY", 9, 16], ["muscular arteries", "ANATOMY", 31, 48], ["increase", "OBSERVATION_MODIFIER", 58, 66], ["wall", "ANATOMY_MODIFIER", 70, 74], ["thickness", "OBSERVATION_MODIFIER", 75, 84], ["predominantly", "OBSERVATION_MODIFIER", 88, 101], ["hypertrophy", "OBSERVATION", 112, 123], ["some degree", "OBSERVATION_MODIFIER", 133, 144], ["hyperplasia", "OBSERVATION", 146, 157], ["smooth muscle cells", "OBSERVATION", 162, 181], ["tunica media", "ANATOMY", 189, 201]]], ["Muscular pulmonary arteries of cats are frequently affected, and the lesion has been associated with infection by several parasites, including Aelurostrongylus abstrusus (the lungworm of cats), Toxocara sp., and Dirofilaria immitis ( Fig. 10-25) .", [["Muscular pulmonary arteries", "ANATOMY", 0, 27], ["lesion", "ANATOMY", 69, 75], ["infection", "DISEASE", 101, 110], ["Aelurostrongylus abstrusus", "DISEASE", 143, 169], ["Toxocara sp.", "DISEASE", 194, 206], ["Dirofilaria immitis", "DISEASE", 212, 231], ["Muscular pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 0, 27], ["cats", "ORGANISM", 31, 35], ["Aelurostrongylus abstrusus", "ORGANISM", 143, 169], ["cats", "ORGANISM", 187, 191], ["Toxocara sp.", "ORGANISM", 194, 206], ["Dirofilaria immitis", "ORGANISM", 212, 231], ["cats", "SPECIES", 31, 35], ["Aelurostrongylus abstrusus", "SPECIES", 143, 169], ["cats", "SPECIES", 187, 191], ["Toxocara sp.", "SPECIES", 194, 206], ["Dirofilaria immitis", "SPECIES", 212, 231], ["Aelurostrongylus abstrusus", "SPECIES", 143, 169], ["Toxocara sp.", "SPECIES", 194, 206], ["Dirofilaria immitis", "SPECIES", 212, 231], ["the lesion", "PROBLEM", 65, 75], ["infection", "PROBLEM", 101, 110], ["several parasites", "PROBLEM", 114, 131], ["Aelurostrongylus abstrusus", "PROBLEM", 143, 169], ["Toxocara sp.", "PROBLEM", 194, 206], ["Dirofilaria immitis", "PROBLEM", 212, 231], ["pulmonary arteries", "ANATOMY", 9, 27], ["cats", "OBSERVATION", 31, 35], ["lesion", "OBSERVATION", 69, 75], ["associated with", "UNCERTAINTY", 85, 100], ["infection", "OBSERVATION", 101, 110], ["several", "OBSERVATION_MODIFIER", 114, 121], ["parasites", "OBSERVATION", 122, 131], ["Aelurostrongylus abstrusus", "OBSERVATION", 143, 169], ["Dirofilaria immitis", "OBSERVATION", 212, 231]]], ["However, the lesions often occur in the absence of parasitic infections ( Fig. 10-26) .", [["lesions", "ANATOMY", 13, 20], ["parasitic infections", "DISEASE", 51, 71], ["lesions", "PATHOLOGICAL_FORMATION", 13, 20], ["the lesions", "PROBLEM", 9, 20], ["parasitic infections", "PROBLEM", 51, 71], ["lesions", "OBSERVATION", 13, 20], ["parasitic", "OBSERVATION_MODIFIER", 51, 60], ["infections", "OBSERVATION", 61, 71]]], ["Often, no clinical disease is associated with the lesion in cats, but asthmatic signs have been seen in cats with these parasitic infections.", [["lesion", "ANATOMY", 50, 56], ["asthmatic signs", "DISEASE", 70, 85], ["parasitic infections", "DISEASE", 120, 140], ["cats", "ORGANISM", 60, 64], ["cats", "ORGANISM", 104, 108], ["cats", "SPECIES", 60, 64], ["cats", "SPECIES", 104, 108], ["clinical disease", "PROBLEM", 10, 26], ["the lesion in cats", "PROBLEM", 46, 64], ["asthmatic signs", "PROBLEM", 70, 85], ["these parasitic infections", "PROBLEM", 114, 140], ["no", "UNCERTAINTY", 7, 9], ["disease", "OBSERVATION", 19, 26], ["lesion", "OBSERVATION", 50, 56], ["parasitic", "OBSERVATION_MODIFIER", 120, 129], ["infections", "OBSERVATION", 130, 140]]], ["Similar hypertrophy of muscular pulmonary arteries occurs in cattle with hypoxia-induced pulmonary arterial vasoconstriction and subsequent pulmonary hypertension associated with right-sided heart failure from exposure to high altitudes (so-called high-altitude disease or \"brisket disease\") (see section on the stages of myocardial hypertrophy).", [["muscular pulmonary arteries", "ANATOMY", 23, 50], ["pulmonary arterial", "ANATOMY", 89, 107], ["pulmonary", "ANATOMY", 140, 149], ["heart", "ANATOMY", 191, 196], ["myocardial", "ANATOMY", 322, 332], ["hypertrophy", "DISEASE", 8, 19], ["hypoxia", "DISEASE", 73, 80], ["pulmonary hypertension", "DISEASE", 140, 162], ["heart failure", "DISEASE", 191, 204], ["high-altitude disease", "DISEASE", 248, 269], ["myocardial hypertrophy", "DISEASE", 322, 344], ["muscular pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 23, 50], ["pulmonary arterial", "MULTI-TISSUE_STRUCTURE", 89, 107], ["pulmonary", "ORGAN", 140, 149], ["heart", "ORGAN", 191, 196], ["myocardial", "MULTI-TISSUE_STRUCTURE", 322, 332], ["cattle", "SPECIES", 61, 67], ["cattle", "SPECIES", 61, 67], ["Similar hypertrophy of muscular pulmonary arteries", "PROBLEM", 0, 50], ["hypoxia", "PROBLEM", 73, 80], ["pulmonary arterial vasoconstriction", "PROBLEM", 89, 124], ["subsequent pulmonary hypertension", "PROBLEM", 129, 162], ["right-sided heart failure", "PROBLEM", 179, 204], ["high altitudes", "PROBLEM", 222, 236], ["high-altitude disease", "PROBLEM", 248, 269], ["\"brisket disease\"", "PROBLEM", 273, 290], ["myocardial hypertrophy", "PROBLEM", 322, 344], ["hypertrophy", "OBSERVATION", 8, 19], ["muscular", "ANATOMY_MODIFIER", 23, 31], ["pulmonary arteries", "ANATOMY", 32, 50], ["hypoxia", "OBSERVATION", 73, 80], ["pulmonary arterial", "ANATOMY", 89, 107], ["vasoconstriction", "OBSERVATION", 108, 124], ["pulmonary", "ANATOMY", 140, 149], ["hypertension", "OBSERVATION", 150, 162], ["right", "ANATOMY_MODIFIER", 179, 184], ["sided", "ANATOMY_MODIFIER", 185, 190], ["heart", "ANATOMY", 191, 196], ["failure", "OBSERVATION", 197, 204], ["high altitudes", "OBSERVATION", 222, 236], ["altitude disease", "OBSERVATION", 253, 269], ["myocardial", "ANATOMY", 322, 332], ["hypertrophy", "OBSERVATION", 333, 344]]], ["Also, cardiovascular anomalies that shunt blood left to right in animals result in pulmonary hypertension; these animals may have hypertrophy of the muscular pulmonary arteries, which can result in plexogenic pulmonary arteriopathy.", [["cardiovascular", "ANATOMY", 6, 20], ["blood", "ANATOMY", 42, 47], ["pulmonary", "ANATOMY", 83, 92], ["muscular pulmonary arteries", "ANATOMY", 149, 176], ["pulmonary", "ANATOMY", 209, 218], ["cardiovascular anomalies", "DISEASE", 6, 30], ["pulmonary hypertension", "DISEASE", 83, 105], ["hypertrophy", "DISEASE", 130, 141], ["plexogenic pulmonary arteriopathy", "DISEASE", 198, 231], ["cardiovascular", "ANATOMICAL_SYSTEM", 6, 20], ["blood", "ORGANISM_SUBSTANCE", 42, 47], ["pulmonary", "ORGAN", 83, 92], ["muscular pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 149, 176], ["pulmonary", "ORGAN", 209, 218], ["cardiovascular anomalies", "PROBLEM", 6, 30], ["shunt blood", "TEST", 36, 47], ["pulmonary hypertension", "PROBLEM", 83, 105], ["hypertrophy of the muscular pulmonary arteries", "PROBLEM", 130, 176], ["plexogenic pulmonary arteriopathy", "PROBLEM", 198, 231], ["cardiovascular", "ANATOMY", 6, 20], ["anomalies", "OBSERVATION", 21, 30], ["shunt", "OBSERVATION", 36, 41], ["left", "ANATOMY_MODIFIER", 48, 52], ["right", "ANATOMY_MODIFIER", 56, 61], ["pulmonary", "ANATOMY", 83, 92], ["hypertension", "OBSERVATION", 93, 105], ["hypertrophy", "OBSERVATION", 130, 141], ["muscular pulmonary arteries", "ANATOMY", 149, 176], ["plexogenic", "OBSERVATION_MODIFIER", 198, 208], ["pulmonary", "ANATOMY", 209, 218], ["arteriopathy", "OBSERVATION", 219, 231]]], ["Uterine arteries in pregnant animals are hypertrophic.Disturbances of CirculationInflammation.", [["Uterine arteries", "ANATOMY", 0, 16], ["Inflammation", "DISEASE", 81, 93], ["Uterine arteries", "MULTI-TISSUE_STRUCTURE", 0, 16], ["hypertrophic", "PROBLEM", 41, 53], ["CirculationInflammation", "PROBLEM", 70, 93], ["arteries", "ANATOMY", 8, 16], ["hypertrophic", "OBSERVATION", 41, 53], ["Circulation", "OBSERVATION_MODIFIER", 70, 81], ["Inflammation", "OBSERVATION", 81, 93]]], ["See Chapters 3 and 5 for discussion of the processes and mechanisms of acute and chronic inflammation.IMMUNE-MEDIATEDCanine systemic lupus erythematosus, rheumatoid arthritis, polyarteritis nodosa, lymphocytic choriomeningitis, druginduced hypersensitivityLymphatic VesselsInflammation.", [["Lymphatic Vessels", "ANATOMY", 256, 273], ["inflammation", "DISEASE", 89, 101], ["systemic lupus erythematosus", "DISEASE", 124, 152], ["rheumatoid arthritis", "DISEASE", 154, 174], ["polyarteritis nodosa", "DISEASE", 176, 196], ["lymphocytic choriomeningitis", "DISEASE", 198, 226], ["hypersensitivity", "DISEASE", 240, 256], ["Inflammation", "DISEASE", 273, 285], ["Lymphatic Vessels", "TISSUE", 256, 273], ["acute and chronic inflammation", "PROBLEM", 71, 101], ["MEDIATEDCanine systemic lupus erythematosus", "PROBLEM", 109, 152], ["rheumatoid arthritis", "PROBLEM", 154, 174], ["polyarteritis nodosa", "PROBLEM", 176, 196], ["lymphocytic choriomeningitis", "PROBLEM", 198, 226], ["druginduced hypersensitivity", "PROBLEM", 228, 256], ["Lymphatic VesselsInflammation", "PROBLEM", 256, 285], ["acute", "OBSERVATION_MODIFIER", 71, 76], ["chronic", "OBSERVATION_MODIFIER", 81, 88], ["inflammation", "OBSERVATION", 89, 101], ["systemic lupus erythematosus", "OBSERVATION", 124, 152], ["rheumatoid arthritis", "OBSERVATION", 154, 174], ["polyarteritis", "OBSERVATION_MODIFIER", 176, 189], ["nodosa", "OBSERVATION", 190, 196], ["lymphocytic choriomeningitis", "OBSERVATION", 198, 226], ["hypersensitivity", "OBSERVATION", 240, 256], ["Vessels", "ANATOMY", 266, 273], ["Inflammation", "OBSERVATION", 273, 285]]], ["The endothelial cells lining the lymphatic vessels are subject to the same reactions to injury and inflammation as the vascular system.", [["endothelial cells", "ANATOMY", 4, 21], ["lymphatic vessels", "ANATOMY", 33, 50], ["vascular system", "ANATOMY", 119, 134], ["inflammation", "DISEASE", 99, 111], ["endothelial cells", "CELL", 4, 21], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 33, 50], ["vascular system", "MULTI-TISSUE_STRUCTURE", 119, 134], ["endothelial cells", "CELL_TYPE", 4, 21], ["injury", "PROBLEM", 88, 94], ["inflammation", "PROBLEM", 99, 111], ["endothelial cells", "OBSERVATION", 4, 21], ["lining", "ANATOMY_MODIFIER", 22, 28], ["lymphatic vessels", "ANATOMY", 33, 50], ["injury", "OBSERVATION", 88, 94], ["inflammation", "OBSERVATION", 99, 111], ["vascular system", "ANATOMY", 119, 134]]], ["Inflammation of the lymphatic vessels is called lymphangitis and may be seen with specific diseases such as septicemias caused by bacteria like Salmonella spp.", [["lymphatic vessels", "ANATOMY", 20, 37], ["lymphangitis", "ANATOMY", 48, 60], ["Inflammation", "DISEASE", 0, 12], ["lymphangitis", "DISEASE", 48, 60], ["septicemias", "DISEASE", 108, 119], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 20, 37], ["Salmonella spp", "ORGANISM", 144, 158], ["Inflammation of the lymphatic vessels", "PROBLEM", 0, 37], ["lymphangitis", "PROBLEM", 48, 60], ["specific diseases", "PROBLEM", 82, 99], ["septicemias", "PROBLEM", 108, 119], ["bacteria", "PROBLEM", 130, 138], ["Salmonella spp", "PROBLEM", 144, 158], ["lymphatic vessels", "ANATOMY", 20, 37], ["lymphangitis", "OBSERVATION", 48, 60], ["may be seen", "UNCERTAINTY", 65, 76], ["bacteria", "OBSERVATION_MODIFIER", 130, 138], ["Salmonella spp", "OBSERVATION", 144, 158]]], ["Lymphangitis may be acute, subacute, granulomatous, or chronic resulting in lymphedema.", [["Lymphangitis", "DISEASE", 0, 12], ["lymphedema", "DISEASE", 76, 86], ["Lymphangitis", "PROBLEM", 0, 12], ["acute", "PROBLEM", 20, 25], ["granulomatous", "PROBLEM", 37, 50], ["lymphedema", "PROBLEM", 76, 86], ["may be", "UNCERTAINTY", 13, 19], ["acute", "OBSERVATION_MODIFIER", 20, 25], ["subacute", "OBSERVATION_MODIFIER", 27, 35], ["granulomatous", "OBSERVATION", 37, 50], ["chronic", "OBSERVATION_MODIFIER", 55, 62], ["lymphedema", "OBSERVATION", 76, 86]]], ["See Chapters 3 and 5, and also see the discussion on Glanders disease and other cutaneous lymphangitides in the section on Disorders of Horses.AgingAging changes are evident in the cardiovascular system.", [["cutaneous lymphangitides", "ANATOMY", 80, 104], ["cardiovascular system", "ANATOMY", 181, 202], ["Glanders disease", "DISEASE", 53, 69], ["cutaneous lymphangitides", "DISEASE", 80, 104], ["cardiovascular", "ANATOMICAL_SYSTEM", 181, 195], ["system", "ANATOMICAL_SYSTEM", 196, 202], ["Glanders disease", "PROBLEM", 53, 69], ["other cutaneous lymphangitides", "PROBLEM", 74, 104], ["Disorders of Horses", "PROBLEM", 123, 142], ["cutaneous", "OBSERVATION_MODIFIER", 80, 89], ["lymphangitides", "OBSERVATION", 90, 104], ["cardiovascular system", "ANATOMY", 181, 202]]], ["Lipofuscin granules, primarily perinuclear, increase in number with age of cardiac myocytes (see sections on Lipofuscinosis, Cell Degeneration and Death, Disturbances of Growth, and Responses to Injury: Myocardium).", [["Lipofuscin granules", "ANATOMY", 0, 19], ["perinuclear", "ANATOMY", 31, 42], ["cardiac myocytes", "ANATOMY", 75, 91], ["sections", "ANATOMY", 97, 105], ["Cell", "ANATOMY", 125, 129], ["Death", "DISEASE", 147, 152], ["Injury", "DISEASE", 195, 201], ["Lipofuscin", "GENE_OR_GENE_PRODUCT", 0, 10], ["granules", "ORGANISM_SUBSTANCE", 11, 19], ["perinuclear", "ORGANISM_SUBSTANCE", 31, 42], ["cardiac myocytes", "CELL", 75, 91], ["Cell", "CELL", 125, 129], ["Lipofuscin granules", "PROBLEM", 0, 19], ["cardiac myocytes", "PROBLEM", 75, 91], ["Lipofuscinosis", "PROBLEM", 109, 123], ["Cell Degeneration", "PROBLEM", 125, 142], ["Death", "PROBLEM", 147, 152], ["Disturbances of Growth", "PROBLEM", 154, 176], ["granules", "OBSERVATION", 11, 19], ["primarily", "OBSERVATION_MODIFIER", 21, 30], ["perinuclear", "OBSERVATION_MODIFIER", 31, 42], ["increase", "OBSERVATION_MODIFIER", 44, 52], ["cardiac myocytes", "ANATOMY", 75, 91], ["Cell Degeneration", "OBSERVATION", 125, 142], ["Myocardium", "ANATOMY", 203, 213]]], ["Fatty infiltration of the pericardium and myocardium increases with the age of the animal.", [["pericardium", "ANATOMY", 26, 37], ["myocardium", "ANATOMY", 42, 52], ["pericardium", "TISSUE", 26, 37], ["myocardium", "MULTI-TISSUE_STRUCTURE", 42, 52], ["Fatty infiltration of the pericardium", "PROBLEM", 0, 37], ["infiltration", "OBSERVATION", 6, 18], ["pericardium", "ANATOMY", 26, 37], ["myocardium", "ANATOMY", 42, 52], ["increases", "OBSERVATION_MODIFIER", 53, 62]]], ["Hearts from aged sheep often have abundant amounts of adipose tissue, particularly within the right ventricle (see sections on Fatty Degeneration, Cell Degeneration and Death, Disturbances of Growth, and Responses to Injury: Myocardium).", [["Hearts", "ANATOMY", 0, 6], ["adipose tissue", "ANATOMY", 54, 68], ["right ventricle", "ANATOMY", 94, 109], ["sections", "ANATOMY", 115, 123], ["Cell", "ANATOMY", 147, 151], ["Fatty Degeneration", "DISEASE", 127, 145], ["Death", "DISEASE", 169, 174], ["Injury", "DISEASE", 217, 223], ["Hearts", "MULTI-TISSUE_STRUCTURE", 0, 6], ["sheep", "ORGANISM", 17, 22], ["adipose tissue", "TISSUE", 54, 68], ["ventricle", "MULTI-TISSUE_STRUCTURE", 100, 109], ["sheep", "SPECIES", 17, 22], ["sheep", "SPECIES", 17, 22], ["adipose tissue", "PROBLEM", 54, 68], ["Fatty Degeneration", "PROBLEM", 127, 145], ["Cell Degeneration", "PROBLEM", 147, 164], ["Death", "PROBLEM", 169, 174], ["Disturbances of Growth", "PROBLEM", 176, 198], ["abundant", "OBSERVATION_MODIFIER", 34, 42], ["amounts", "OBSERVATION_MODIFIER", 43, 50], ["adipose tissue", "OBSERVATION", 54, 68], ["right ventricle", "ANATOMY", 94, 109], ["Fatty Degeneration", "OBSERVATION", 127, 145], ["Cell Degeneration", "OBSERVATION", 147, 164], ["Myocardium", "ANATOMY", 225, 235]]], ["Myxomatous valvular disease increases in incidence with age in small breed dogs (see section on Disorders of Dogs; also see Fig. 10 -83).", [["valvular", "ANATOMY", 11, 19], ["valvular disease", "DISEASE", 11, 27], ["valvular", "ORGAN", 11, 19], ["dogs", "SPECIES", 75, 79], ["Myxomatous valvular disease", "PROBLEM", 0, 27], ["small breed dogs", "PROBLEM", 63, 79], ["Disorders of Dogs", "PROBLEM", 96, 113], ["valvular", "ANATOMY", 11, 19], ["disease", "OBSERVATION", 20, 27], ["small", "OBSERVATION_MODIFIER", 63, 68]]], ["Degenerative vascular disease associated with aging includes arteriosclerosis, amyloidosis, and hyaline degeneration of cardiac arteries (see section on Hyaline Degeneration, Fibrinoid Necrosis, and Amyloidosis and section on Disorders of Domestic Animals: Blood and Lymphatic Vascular System).", [["vascular", "ANATOMY", 13, 21], ["hyaline", "ANATOMY", 96, 103], ["cardiac arteries", "ANATOMY", 120, 136], ["Blood", "ANATOMY", 257, 262], ["Vascular", "ANATOMY", 277, 285], ["Degenerative vascular disease", "DISEASE", 0, 29], ["arteriosclerosis", "DISEASE", 61, 77], ["amyloidosis", "DISEASE", 79, 90], ["Fibrinoid Necrosis", "DISEASE", 175, 193], ["Amyloidosis", "DISEASE", 199, 210], ["vascular", "MULTI-TISSUE_STRUCTURE", 13, 21], ["hyaline", "TISSUE", 96, 103], ["cardiac arteries", "MULTI-TISSUE_STRUCTURE", 120, 136], ["Blood", "ORGANISM_SUBSTANCE", 257, 262], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 267, 285], ["Degenerative vascular disease", "PROBLEM", 0, 29], ["arteriosclerosis", "PROBLEM", 61, 77], ["amyloidosis", "PROBLEM", 79, 90], ["hyaline degeneration of cardiac arteries", "PROBLEM", 96, 136], ["Hyaline Degeneration", "PROBLEM", 153, 173], ["Fibrinoid Necrosis", "PROBLEM", 175, 193], ["Amyloidosis", "PROBLEM", 199, 210], ["vascular", "ANATOMY", 13, 21], ["disease", "OBSERVATION", 22, 29], ["arteriosclerosis", "OBSERVATION", 61, 77], ["amyloidosis", "OBSERVATION", 79, 90], ["hyaline", "OBSERVATION_MODIFIER", 96, 103], ["degeneration", "OBSERVATION", 104, 116], ["cardiac arteries", "ANATOMY", 120, 136], ["Hyaline", "OBSERVATION_MODIFIER", 153, 160], ["Degeneration", "OBSERVATION", 161, 173], ["Fibrinoid", "OBSERVATION_MODIFIER", 175, 184], ["Necrosis", "OBSERVATION", 185, 193], ["Amyloidosis", "OBSERVATION", 199, 210], ["Lymphatic", "ANATOMY_MODIFIER", 267, 276], ["Vascular System", "ANATOMY", 277, 292]]], ["The incidence of neoplastic disease increases with age in the cardiovascular and lymphatic system.Portals of Entry/Pathways of SpreadRoutes used to enter the cardiovascular system and lymphatic vessels are numerous and listed in Box 10-9.", [["neoplastic", "ANATOMY", 17, 27], ["cardiovascular", "ANATOMY", 62, 76], ["lymphatic system", "ANATOMY", 81, 97], ["cardiovascular system", "ANATOMY", 158, 179], ["lymphatic vessels", "ANATOMY", 184, 201], ["neoplastic disease", "DISEASE", 17, 35], ["Box 10-9", "CHEMICAL", 229, 237], ["neoplastic disease", "CANCER", 17, 35], ["cardiovascular", "ANATOMICAL_SYSTEM", 62, 76], ["lymphatic system", "MULTI-TISSUE_STRUCTURE", 81, 97], ["cardiovascular", "ANATOMICAL_SYSTEM", 158, 172], ["system", "ANATOMICAL_SYSTEM", 173, 179], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 184, 201], ["neoplastic disease", "PROBLEM", 17, 35], ["SpreadRoutes", "TREATMENT", 127, 139], ["neoplastic", "OBSERVATION_MODIFIER", 17, 27], ["disease", "OBSERVATION", 28, 35], ["cardiovascular", "ANATOMY", 62, 76], ["lymphatic system", "ANATOMY", 81, 97], ["Entry", "OBSERVATION", 109, 114], ["cardiovascular system", "ANATOMY", 158, 179], ["lymphatic vessels", "ANATOMY", 184, 201], ["numerous", "OBSERVATION_MODIFIER", 206, 214]]], ["Toxic chemicals and pathogenic organisms can enter via ingestion, inhalation, cutaneous contact, trauma, or iatrogenic injection and gain access to the cardiovascular system.", [["cutaneous", "ANATOMY", 78, 87], ["cardiovascular system", "ANATOMY", 152, 173], ["trauma", "DISEASE", 97, 103], ["cardiovascular", "ANATOMICAL_SYSTEM", 152, 166], ["system", "ANATOMICAL_SYSTEM", 167, 173], ["Toxic chemicals", "PROBLEM", 0, 15], ["pathogenic organisms", "PROBLEM", 20, 40], ["trauma", "PROBLEM", 97, 103], ["iatrogenic injection", "TREATMENT", 108, 128], ["cardiovascular system", "ANATOMY", 152, 173]]], ["Microorganisms and toxins penetrate and enter deeper tissues, dermis, lamina propria, subcutis, or submucosa, triggering an acute inflammatory reaction.", [["tissues", "ANATOMY", 53, 60], ["dermis", "ANATOMY", 62, 68], ["lamina propria", "ANATOMY", 70, 84], ["subcutis", "ANATOMY", 86, 94], ["submucosa", "ANATOMY", 99, 108], ["tissues", "TISSUE", 53, 60], ["dermis", "TISSUE", 62, 68], ["lamina propria", "TISSUE", 70, 84], ["subcutis", "TISSUE", 86, 94], ["submucosa", "MULTI-TISSUE_STRUCTURE", 99, 108], ["Microorganisms", "PROBLEM", 0, 14], ["toxins penetrate", "PROBLEM", 19, 35], ["an acute inflammatory reaction", "PROBLEM", 121, 151], ["deeper tissues", "ANATOMY", 46, 60], ["dermis", "ANATOMY", 62, 68], ["lamina", "ANATOMY_MODIFIER", 70, 76], ["propria", "ANATOMY_MODIFIER", 77, 84], ["subcutis", "ANATOMY", 86, 94], ["submucosa", "ANATOMY", 99, 108], ["acute", "OBSERVATION_MODIFIER", 124, 129], ["inflammatory", "OBSERVATION", 130, 142]]], ["All three of the major components of acute inflammation may be responsible for entry of the toxin or organism into the vascular or lymphatic system.", [["vascular", "ANATOMY", 119, 127], ["lymphatic system", "ANATOMY", 131, 147], ["inflammation", "DISEASE", 43, 55], ["vascular", "MULTI-TISSUE_STRUCTURE", 119, 127], ["lymphatic system", "MULTI-TISSUE_STRUCTURE", 131, 147], ["acute inflammation", "PROBLEM", 37, 55], ["the toxin", "PROBLEM", 88, 97], ["major", "OBSERVATION_MODIFIER", 17, 22], ["components", "OBSERVATION_MODIFIER", 23, 33], ["acute", "OBSERVATION_MODIFIER", 37, 42], ["inflammation", "OBSERVATION", 43, 55], ["may be responsible for", "UNCERTAINTY", 56, 78], ["vascular", "ANATOMY", 119, 127], ["lymphatic system", "ANATOMY", 131, 147]]], ["The increase in the vascular caliber increasing blood flow increases the number of capillary beds exposed to the agent.", [["vascular", "ANATOMY", 20, 28], ["blood", "ANATOMY", 48, 53], ["capillary beds", "ANATOMY", 83, 97], ["vascular caliber", "MULTI-TISSUE_STRUCTURE", 20, 36], ["blood", "ORGANISM_SUBSTANCE", 48, 53], ["capillary beds", "TISSUE", 83, 97], ["the vascular caliber increasing blood flow", "PROBLEM", 16, 58], ["capillary beds", "TREATMENT", 83, 97], ["the agent", "TREATMENT", 109, 118], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["vascular", "ANATOMY", 20, 28], ["caliber", "OBSERVATION_MODIFIER", 29, 36], ["increasing", "OBSERVATION_MODIFIER", 37, 47], ["blood flow", "OBSERVATION", 48, 58], ["increases", "OBSERVATION_MODIFIER", 59, 68], ["number", "OBSERVATION_MODIFIER", 73, 79], ["capillary beds", "OBSERVATION", 83, 97]]], ["Changes in the classic swine fever (hog cholera), African horse sickness, and African swine fever (see the sections on disorders of specific animal species).Thrombosis and EmbolismCoronary and Other Arteries.", [["sections", "ANATOMY", 107, 115], ["Arteries", "ANATOMY", 199, 207], ["swine fever", "DISEASE", 23, 34], ["cholera", "DISEASE", 40, 47], ["horse sickness", "DISEASE", 58, 72], ["swine fever", "DISEASE", 86, 97], ["Thrombosis", "DISEASE", 157, 167], ["swine", "ORGANISM", 23, 28], ["hog", "ORGANISM", 36, 39], ["horse", "ORGANISM", 58, 63], ["Arteries", "MULTI-TISSUE_STRUCTURE", 199, 207], ["swine", "SPECIES", 23, 28], ["hog", "SPECIES", 36, 39], ["horse", "SPECIES", 58, 63], ["African swine fever", "SPECIES", 78, 97], ["hog", "SPECIES", 36, 39], ["African horse", "SPECIES", 50, 63], ["African swine fever", "SPECIES", 78, 97], ["the classic swine fever", "PROBLEM", 11, 34], ["African horse sickness", "PROBLEM", 50, 72], ["African swine fever", "PROBLEM", 78, 97], ["Thrombosis", "PROBLEM", 157, 167], ["EmbolismCoronary and Other Arteries", "PROBLEM", 172, 207], ["EmbolismCoronary", "ANATOMY_MODIFIER", 172, 188], ["Other Arteries", "ANATOMY", 193, 207]]], ["Thrombosis or embolism of the coronary arteries can result in myocardial infarction ( Fig. 10-28) and cardiac failure.", [["coronary arteries", "ANATOMY", 30, 47], ["myocardial", "ANATOMY", 62, 72], ["cardiac", "ANATOMY", 102, 109], ["Thrombosis", "DISEASE", 0, 10], ["embolism", "DISEASE", 14, 22], ["myocardial infarction", "DISEASE", 62, 83], ["cardiac failure", "DISEASE", 102, 117], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 30, 47], ["myocardial", "MULTI-TISSUE_STRUCTURE", 62, 72], ["cardiac", "ORGAN", 102, 109], ["Thrombosis", "PROBLEM", 0, 10], ["embolism of the coronary arteries", "PROBLEM", 14, 47], ["myocardial infarction", "PROBLEM", 62, 83], ["Fig.", "TEST", 86, 90], ["cardiac failure", "PROBLEM", 102, 117], ["embolism", "OBSERVATION", 14, 22], ["coronary arteries", "ANATOMY", 30, 47], ["myocardial", "ANATOMY", 62, 72], ["infarction", "OBSERVATION", 73, 83], ["cardiac", "ANATOMY", 102, 109], ["failure", "OBSERVATION", 110, 117]]], ["These lesions are much less common in animals than in human beings.", [["lesions", "ANATOMY", 6, 13], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["human", "ORGANISM", 54, 59], ["human", "SPECIES", 54, 59], ["human", "SPECIES", 54, 59], ["These lesions", "PROBLEM", 0, 13], ["lesions", "OBSERVATION", 6, 13], ["much", "OBSERVATION_MODIFIER", 18, 22], ["less common", "OBSERVATION_MODIFIER", 23, 34]]], ["Affected animals generally have one of several types of coronary arterial disease, including atherosclerosis, arteriosclerosis, or periarteritis.", [["coronary arterial", "ANATOMY", 56, 73], ["coronary arterial disease", "DISEASE", 56, 81], ["atherosclerosis", "DISEASE", 93, 108], ["arteriosclerosis", "DISEASE", 110, 126], ["periarteritis", "DISEASE", 131, 144], ["coronary arterial", "MULTI-TISSUE_STRUCTURE", 56, 73], ["coronary arterial disease", "PROBLEM", 56, 81], ["atherosclerosis", "PROBLEM", 93, 108], ["arteriosclerosis", "PROBLEM", 110, 126], ["periarteritis", "PROBLEM", 131, 144], ["coronary arterial", "ANATOMY", 56, 73], ["disease", "OBSERVATION", 74, 81], ["atherosclerosis", "OBSERVATION", 93, 108], ["arteriosclerosis", "OBSERVATION", 110, 126], ["periarteritis", "OBSERVATION", 131, 144]]], ["In atherosclerosis associated with hypothyroidism or diabetes mellitus (discussed previously), severe lesions are present in the extramural (epicardial) coronary arteries of dogs, but this only rarely leads to thrombosis and myocardial infarction.", [["lesions", "ANATOMY", 102, 109], ["epicardial) coronary arteries", "ANATOMY", 141, 170], ["myocardial", "ANATOMY", 225, 235], ["atherosclerosis", "DISEASE", 3, 18], ["hypothyroidism", "DISEASE", 35, 49], ["diabetes mellitus", "DISEASE", 53, 70], ["thrombosis", "DISEASE", 210, 220], ["myocardial infarction", "DISEASE", 225, 246], ["lesions", "PATHOLOGICAL_FORMATION", 102, 109], ["epicardial", "MULTI-TISSUE_STRUCTURE", 141, 151], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 153, 170], ["dogs", "ORGANISM", 174, 178], ["myocardial", "MULTI-TISSUE_STRUCTURE", 225, 235], ["dogs", "SPECIES", 174, 178], ["atherosclerosis", "PROBLEM", 3, 18], ["hypothyroidism", "PROBLEM", 35, 49], ["diabetes mellitus", "PROBLEM", 53, 70], ["severe lesions", "PROBLEM", 95, 109], ["thrombosis", "PROBLEM", 210, 220], ["myocardial infarction", "PROBLEM", 225, 246], ["atherosclerosis", "OBSERVATION", 3, 18], ["hypothyroidism", "OBSERVATION", 35, 49], ["diabetes", "OBSERVATION", 53, 61], ["severe", "OBSERVATION_MODIFIER", 95, 101], ["lesions", "OBSERVATION", 102, 109], ["extramural", "ANATOMY_MODIFIER", 129, 139], ["epicardial", "ANATOMY", 141, 151], ["coronary arteries", "ANATOMY", 153, 170], ["dogs", "OBSERVATION", 174, 178], ["thrombosis", "OBSERVATION", 210, 220], ["myocardial", "ANATOMY", 225, 235], ["infarction", "OBSERVATION", 236, 246]]], ["In contrast, severe arteriosclerosis of intramural cardiac arteries in aged dogs can cause small multifocal myocardial infarcts (see Fig. 10 -28).", [["intramural cardiac arteries", "ANATOMY", 40, 67], ["myocardial", "ANATOMY", 108, 118], ["arteriosclerosis", "DISEASE", 20, 36], ["myocardial infarcts", "DISEASE", 108, 127], ["cardiac arteries", "MULTI-TISSUE_STRUCTURE", 51, 67], ["dogs", "ORGANISM", 76, 80], ["myocardial infarcts", "PATHOLOGICAL_FORMATION", 108, 127], ["dogs", "SPECIES", 76, 80], ["severe arteriosclerosis of intramural cardiac arteries", "PROBLEM", 13, 67], ["small multifocal myocardial infarcts", "PROBLEM", 91, 127], ["severe", "OBSERVATION_MODIFIER", 13, 19], ["arteriosclerosis", "OBSERVATION", 20, 36], ["intramural", "ANATOMY_MODIFIER", 40, 50], ["cardiac arteries", "ANATOMY", 51, 67], ["small", "OBSERVATION_MODIFIER", 91, 96], ["multifocal", "OBSERVATION_MODIFIER", 97, 107], ["myocardial", "ANATOMY", 108, 118], ["infarcts", "OBSERVATION", 119, 127]]], ["Affected dogs often also have myxomatous valvular degeneration (valvular endocardiosis), which is also an age-related disease.", [["myxomatous valvular", "ANATOMY", 30, 49], ["valvular", "ANATOMY", 64, 72], ["valvular degeneration", "DISEASE", 41, 62], ["valvular endocardiosis", "DISEASE", 64, 86], ["dogs", "ORGANISM", 9, 13], ["myxomatous valvular", "PATHOLOGICAL_FORMATION", 30, 49], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["myxomatous valvular degeneration", "PROBLEM", 30, 62], ["valvular endocardiosis", "PROBLEM", 64, 86], ["related disease", "PROBLEM", 110, 125], ["myxomatous", "OBSERVATION_MODIFIER", 30, 40], ["valvular", "ANATOMY", 41, 49], ["degeneration", "OBSERVATION", 50, 62], ["valvular", "ANATOMY", 64, 72], ["endocardiosis", "OBSERVATION", 73, 86]]], ["Thrombosis of or embolism to other large arteries, such as the interlobular artery of the kidney, can lead to infarction of the tissue supplied by the artery (E- Fig. 10-19 ; also see Chapter 2). finally a rich network of capillaries in which there is nearly one vessel adjacent to each cardiac muscle cell.", [["arteries", "ANATOMY", 41, 49], ["interlobular artery", "ANATOMY", 63, 82], ["kidney", "ANATOMY", 90, 96], ["tissue", "ANATOMY", 128, 134], ["artery", "ANATOMY", 151, 157], ["capillaries", "ANATOMY", 222, 233], ["vessel", "ANATOMY", 263, 269], ["cardiac muscle cell", "ANATOMY", 287, 306], ["Thrombosis", "DISEASE", 0, 10], ["embolism", "DISEASE", 17, 25], ["infarction", "DISEASE", 110, 120], ["arteries", "MULTI-TISSUE_STRUCTURE", 41, 49], ["interlobular artery", "MULTI-TISSUE_STRUCTURE", 63, 82], ["kidney", "ORGAN", 90, 96], ["tissue", "TISSUE", 128, 134], ["artery", "MULTI-TISSUE_STRUCTURE", 151, 157], ["capillaries", "TISSUE", 222, 233], ["vessel", "MULTI-TISSUE_STRUCTURE", 263, 269], ["cardiac muscle cell", "CELL", 287, 306], ["cardiac muscle cell", "CELL_TYPE", 287, 306], ["Thrombosis", "PROBLEM", 0, 10], ["embolism to other large arteries", "PROBLEM", 17, 49], ["infarction of the tissue", "PROBLEM", 110, 134], ["embolism", "OBSERVATION", 17, 25], ["large arteries", "ANATOMY", 35, 49], ["interlobular", "ANATOMY_MODIFIER", 63, 75], ["artery", "ANATOMY", 76, 82], ["kidney", "ANATOMY", 90, 96], ["infarction", "OBSERVATION", 110, 120], ["tissue", "OBSERVATION", 128, 134], ["artery", "ANATOMY", 151, 157], ["capillaries", "OBSERVATION_MODIFIER", 222, 233], ["one", "ANATOMY_MODIFIER", 259, 262], ["vessel", "ANATOMY", 263, 269], ["each", "ANATOMY_MODIFIER", 282, 286], ["cardiac muscle", "ANATOMY", 287, 301], ["cell", "OBSERVATION", 302, 306]]], ["This rich network of capillaries provides an opportunity for bacteria or virus to gain entrance into the myocardium once they have entered the circulatory system.", [["capillaries", "ANATOMY", 21, 32], ["myocardium", "ANATOMY", 105, 115], ["circulatory system", "ANATOMY", 143, 161], ["capillaries", "TISSUE", 21, 32], ["myocardium", "ORGAN", 105, 115], ["circulatory system", "ANATOMICAL_SYSTEM", 143, 161], ["bacteria", "PROBLEM", 61, 69], ["virus", "PROBLEM", 73, 78], ["myocardium", "ANATOMY", 105, 115], ["circulatory system", "ANATOMY", 143, 161]]], ["As a result, many bacterial and viral infections may result in myocarditis.", [["infections", "DISEASE", 38, 48], ["myocarditis", "DISEASE", 63, 74], ["many bacterial and viral infections", "PROBLEM", 13, 48], ["myocarditis", "PROBLEM", 63, 74], ["bacterial", "OBSERVATION_MODIFIER", 18, 27], ["viral infections", "OBSERVATION", 32, 48], ["myocarditis", "OBSERVATION", 63, 74]]], ["Bacteria within fibrin and inflammatory debris loosely attached to affected valves (bacterial valvular endocarditis) may detach and lodge in coronary arteries.", [["fibrin", "ANATOMY", 16, 22], ["valves", "ANATOMY", 76, 82], ["valvular", "ANATOMY", 94, 102], ["coronary arteries", "ANATOMY", 141, 158], ["valvular endocarditis", "DISEASE", 94, 115], ["fibrin", "GENE_OR_GENE_PRODUCT", 16, 22], ["valves", "PATHOLOGICAL_FORMATION", 76, 82], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 141, 158], ["fibrin", "PROTEIN", 16, 22], ["Bacteria within fibrin", "PROBLEM", 0, 22], ["inflammatory debris", "PROBLEM", 27, 46], ["affected valves", "TREATMENT", 67, 82], ["bacterial valvular endocarditis", "PROBLEM", 84, 115], ["fibrin", "OBSERVATION", 16, 22], ["inflammatory", "OBSERVATION_MODIFIER", 27, 39], ["debris", "OBSERVATION", 40, 46], ["affected valves", "OBSERVATION", 67, 82], ["bacterial valvular endocarditis", "OBSERVATION", 84, 115], ["coronary arteries", "ANATOMY", 141, 158]]], ["This septic emboli damages endothelial cells and initiates acute inflammation resulting in myocarditis.", [["septic emboli", "ANATOMY", 5, 18], ["endothelial cells", "ANATOMY", 27, 44], ["septic", "DISEASE", 5, 11], ["inflammation", "DISEASE", 65, 77], ["myocarditis", "DISEASE", 91, 102], ["endothelial cells", "CELL", 27, 44], ["endothelial cells", "CELL_TYPE", 27, 44], ["This septic emboli damages endothelial cells", "PROBLEM", 0, 44], ["acute inflammation", "PROBLEM", 59, 77], ["myocarditis", "PROBLEM", 91, 102], ["septic", "OBSERVATION_MODIFIER", 5, 11], ["emboli", "OBSERVATION", 12, 18], ["endothelial cells", "OBSERVATION", 27, 44], ["acute", "OBSERVATION_MODIFIER", 59, 64], ["inflammation", "OBSERVATION", 65, 77], ["myocarditis", "OBSERVATION", 91, 102]]], ["Toxins or toxic by-products can directly damage endothelial cells or diffuse through the endothelium to affect myocardial fibers.", [["endothelial cells", "ANATOMY", 48, 65], ["endothelium", "ANATOMY", 89, 100], ["myocardial fibers", "ANATOMY", 111, 128], ["endothelial cells", "CELL", 48, 65], ["endothelium", "TISSUE", 89, 100], ["myocardial fibers", "TISSUE", 111, 128], ["endothelial cells", "CELL_TYPE", 48, 65], ["directly damage endothelial cells", "PROBLEM", 32, 65], ["diffuse through the endothelium", "PROBLEM", 69, 100], ["toxic", "OBSERVATION_MODIFIER", 10, 15], ["endothelial cells", "OBSERVATION", 48, 65], ["diffuse", "OBSERVATION_MODIFIER", 69, 76], ["endothelium", "ANATOMY", 89, 100]]], ["In addition, the myocardium is susceptible to direct extension of pathogens located within the endocardium or pericardium.Endocardium and Heart ValvesThe endocardium and the cardiac valves are in direct contact with any pathogen that enters the circulatory system, including parasites, bacterial and viral pathogens, and toxins.", [["myocardium", "ANATOMY", 17, 27], ["endocardium", "ANATOMY", 95, 106], ["pericardium", "ANATOMY", 110, 121], ["Endocardium", "ANATOMY", 122, 133], ["Heart Valves", "ANATOMY", 138, 150], ["endocardium", "ANATOMY", 154, 165], ["cardiac valves", "ANATOMY", 174, 188], ["circulatory system", "ANATOMY", 245, 263], ["myocardium", "ORGAN", 17, 27], ["endocardium", "MULTI-TISSUE_STRUCTURE", 95, 106], ["pericardium", "ORGAN", 110, 121], ["endocardium", "MULTI-TISSUE_STRUCTURE", 154, 165], ["cardiac valves", "TISSUE", 174, 188], ["circulatory system", "ANATOMICAL_SYSTEM", 245, 263], ["direct extension of pathogens", "PROBLEM", 46, 75], ["Endocardium and Heart Valves", "PROBLEM", 122, 150], ["any pathogen", "PROBLEM", 216, 228], ["parasites", "PROBLEM", 275, 284], ["bacterial and viral pathogens", "PROBLEM", 286, 315], ["toxins", "PROBLEM", 321, 327], ["myocardium", "ANATOMY", 17, 27], ["pathogens", "OBSERVATION", 66, 75], ["endocardium", "ANATOMY", 95, 106], ["pericardium", "ANATOMY", 110, 121], ["Heart Valves", "ANATOMY", 138, 150], ["endocardium", "ANATOMY", 154, 165], ["cardiac valves", "ANATOMY", 174, 188], ["pathogen", "OBSERVATION", 220, 228], ["circulatory system", "ANATOMY", 245, 263], ["parasites", "OBSERVATION", 275, 284], ["bacterial", "OBSERVATION_MODIFIER", 286, 295], ["viral pathogens", "OBSERVATION", 300, 315]]], ["The endocardium, especially the left atrial endocardium, is particularly susceptible to toxins resulting from renal failure in the dog.Epicardium and PericardiumBacteria and viruses can enter the pericardial sac via endothelial damage to capillaries on visceral (epicardium) and parietal (pericardium) surfaces.", [["endocardium", "ANATOMY", 4, 15], ["left atrial endocardium", "ANATOMY", 32, 55], ["renal", "ANATOMY", 110, 115], ["Epicardium", "ANATOMY", 135, 145], ["pericardial sac", "ANATOMY", 196, 211], ["endothelial", "ANATOMY", 216, 227], ["capillaries", "ANATOMY", 238, 249], ["visceral", "ANATOMY", 253, 261], ["epicardium", "ANATOMY", 263, 273], ["parietal", "ANATOMY", 279, 287], ["pericardium", "ANATOMY", 289, 300], ["renal failure", "DISEASE", 110, 123], ["endocardium", "MULTI-TISSUE_STRUCTURE", 4, 15], ["atrial endocardium", "MULTI-TISSUE_STRUCTURE", 37, 55], ["renal", "ORGAN", 110, 115], ["dog", "ORGANISM", 131, 134], ["PericardiumBacteria", "GENE_OR_GENE_PRODUCT", 150, 169], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 196, 211], ["endothelial", "TISSUE", 216, 227], ["capillaries", "TISSUE", 238, 249], ["visceral", "TISSUE", 253, 261], ["epicardium", "TISSUE", 263, 273], ["parietal (", "TISSUE", 279, 289], ["pericardium", "TISSUE", 289, 300], ["dog", "SPECIES", 131, 134], ["toxins", "PROBLEM", 88, 94], ["renal failure in the dog", "PROBLEM", 110, 134], ["Epicardium and PericardiumBacteria and viruses", "PROBLEM", 135, 181], ["endothelial damage", "PROBLEM", 216, 234], ["endocardium", "ANATOMY", 4, 15], ["left atrial endocardium", "ANATOMY", 32, 55], ["renal", "ANATOMY", 110, 115], ["failure", "OBSERVATION", 116, 123], ["PericardiumBacteria", "OBSERVATION", 150, 169], ["viruses", "OBSERVATION", 174, 181], ["pericardial sac", "ANATOMY", 196, 211], ["endothelial", "ANATOMY", 216, 227], ["damage", "OBSERVATION", 228, 234], ["capillaries", "ANATOMY_MODIFIER", 238, 249], ["visceral", "ANATOMY", 253, 261], ["epicardium", "ANATOMY", 263, 273], ["parietal", "ANATOMY_MODIFIER", 279, 287], ["pericardium", "ANATOMY", 289, 300], ["surfaces", "OBSERVATION_MODIFIER", 302, 310]]], ["Bacteria can enter by direct penetration.", [["Bacteria", "PROBLEM", 0, 8]]], ["In cattle, foreign bodies exiting the reticulum and penetrating the diaphragm carry bacterial pathogens into the pericardial cavity.", [["foreign bodies", "ANATOMY", 11, 25], ["reticulum", "ANATOMY", 38, 47], ["diaphragm", "ANATOMY", 68, 77], ["pericardial cavity", "ANATOMY", 113, 131], ["cattle", "ORGANISM", 3, 9], ["reticulum", "CELLULAR_COMPONENT", 38, 47], ["diaphragm", "ORGAN", 68, 77], ["pericardial cavity", "MULTI-TISSUE_STRUCTURE", 113, 131], ["cattle", "SPECIES", 3, 9], ["cattle", "SPECIES", 3, 9], ["foreign bodies", "PROBLEM", 11, 25], ["bacterial pathogens into the pericardial cavity", "PROBLEM", 84, 131], ["foreign bodies", "OBSERVATION", 11, 25], ["reticulum", "ANATOMY", 38, 47], ["penetrating", "OBSERVATION_MODIFIER", 52, 63], ["diaphragm", "ANATOMY", 68, 77], ["bacterial pathogens", "OBSERVATION", 84, 103], ["pericardial", "ANATOMY", 113, 124], ["cavity", "ANATOMY_MODIFIER", 125, 131]]], ["Direct entry from bacterial or viral infections in the pleural cavity or mediastinum can also occur.Blood and Lymphatic Vascular SystemsThe circulatory systems are intrinsically susceptible to microbial organisms and toxins because of the primary role of providing oxygen and nutrients to and removing waste from tissues.", [["pleural cavity", "ANATOMY", 55, 69], ["mediastinum", "ANATOMY", 73, 84], ["Blood", "ANATOMY", 100, 105], ["circulatory systems", "ANATOMY", 140, 159], ["tissues", "ANATOMY", 313, 320], ["infections", "DISEASE", 37, 47], ["oxygen", "CHEMICAL", 265, 271], ["oxygen", "CHEMICAL", 265, 271], ["pleural cavity", "MULTI-TISSUE_STRUCTURE", 55, 69], ["mediastinum", "ORGAN", 73, 84], ["Blood", "ORGANISM_SUBSTANCE", 100, 105], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 110, 128], ["oxygen", "SIMPLE_CHEMICAL", 265, 271], ["tissues", "TISSUE", 313, 320], ["bacterial or viral infections in the pleural cavity", "PROBLEM", 18, 69], ["mediastinum", "PROBLEM", 73, 84], ["Blood", "TEST", 100, 105], ["microbial organisms", "PROBLEM", 193, 212], ["toxins", "PROBLEM", 217, 223], ["oxygen and nutrients", "TREATMENT", 265, 285], ["bacterial", "OBSERVATION_MODIFIER", 18, 27], ["viral", "OBSERVATION_MODIFIER", 31, 36], ["infections", "OBSERVATION", 37, 47], ["pleural", "ANATOMY", 55, 62], ["cavity", "ANATOMY_MODIFIER", 63, 69], ["mediastinum", "ANATOMY", 73, 84], ["Lymphatic", "OBSERVATION", 110, 119], ["Vascular Systems", "ANATOMY", 120, 136], ["circulatory", "ANATOMY", 140, 151], ["microbial organisms", "OBSERVATION", 193, 212]]], ["Hematogenous and lymphogenous dissemination of microbial pathogens and toxins directly exposes the corresponding vasculature to these hazards.", [["Hematogenous", "ANATOMY", 0, 12], ["lymphogenous", "ANATOMY", 17, 29], ["vasculature", "ANATOMY", 113, 124], ["vasculature", "MULTI-TISSUE_STRUCTURE", 113, 124], ["Hematogenous", "PROBLEM", 0, 12], ["lymphogenous dissemination of microbial pathogens", "PROBLEM", 17, 66], ["toxins", "PROBLEM", 71, 77], ["lymphogenous", "OBSERVATION_MODIFIER", 17, 29], ["microbial pathogens", "OBSERVATION", 47, 66], ["vasculature", "ANATOMY", 113, 124]]], ["Parasitic migration and local extension of an inflammatory process can directly result in entry into the circulatory or lymphatic system and directly damage these tissues.Defense Mechanisms/Barrier SystemsDefense mechanisms used by the cardiovascular system and lymphatic vessels are listed in Box 10-10.", [["circulatory", "ANATOMY", 105, 116], ["lymphatic system", "ANATOMY", 120, 136], ["tissues", "ANATOMY", 163, 170], ["cardiovascular system", "ANATOMY", 236, 257], ["lymphatic vessels", "ANATOMY", 262, 279], ["circulatory", "ANATOMICAL_SYSTEM", 105, 116], ["lymphatic system", "ANATOMICAL_SYSTEM", 120, 136], ["tissues", "TISSUE", 163, 170], ["cardiovascular system", "MULTI-TISSUE_STRUCTURE", 236, 257], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 262, 279], ["Parasitic migration", "PROBLEM", 0, 19], ["an inflammatory process", "PROBLEM", 43, 66], ["Barrier Systems", "TREATMENT", 190, 205], ["migration", "OBSERVATION_MODIFIER", 10, 19], ["local", "OBSERVATION_MODIFIER", 24, 29], ["inflammatory", "OBSERVATION", 46, 58], ["circulatory", "ANATOMY_MODIFIER", 105, 116], ["lymphatic system", "ANATOMY", 120, 136], ["Barrier Systems", "OBSERVATION_MODIFIER", 190, 205], ["cardiovascular system", "ANATOMY", 236, 257], ["lymphatic vessels", "ANATOMY", 262, 279]]], ["These structures are fortunate microvasculature that allow the exit of plasma proteins and leukocytes also increase the entry of an agent.", [["microvasculature", "ANATOMY", 31, 47], ["plasma", "ANATOMY", 71, 77], ["leukocytes", "ANATOMY", 91, 101], ["microvasculature", "TISSUE", 31, 47], ["plasma", "ORGANISM_SUBSTANCE", 71, 77], ["leukocytes", "CELL", 91, 101], ["plasma proteins", "PROTEIN", 71, 86], ["leukocytes", "CELL_TYPE", 91, 101], ["plasma proteins", "TEST", 71, 86], ["an agent", "TREATMENT", 129, 137]]], ["Finally, the increase in leukocytes can result in vascular injury and phagocytosis of material.", [["leukocytes", "ANATOMY", 25, 35], ["vascular", "ANATOMY", 50, 58], ["leukocytes", "CELL", 25, 35], ["vascular", "MULTI-TISSUE_STRUCTURE", 50, 58], ["leukocytes", "CELL_TYPE", 25, 35], ["the increase in leukocytes", "PROBLEM", 9, 35], ["vascular injury", "PROBLEM", 50, 65], ["phagocytosis of material", "PROBLEM", 70, 94], ["increase", "OBSERVATION_MODIFIER", 13, 21], ["leukocytes", "OBSERVATION", 25, 35], ["vascular", "ANATOMY", 50, 58], ["injury", "OBSERVATION", 59, 65]]], ["Organisms that are not diluted, but are denatured by molecules from lysosomes of neutrophils, or restricted in movement by being trapped in fibrin at the site of inflammation can gain entry into the lymphatic vessels, thin-walled capillaries, or venules.", [["lysosomes", "ANATOMY", 68, 77], ["neutrophils", "ANATOMY", 81, 92], ["site", "ANATOMY", 154, 158], ["lymphatic vessels", "ANATOMY", 199, 216], ["thin-walled capillaries", "ANATOMY", 218, 241], ["venules", "ANATOMY", 246, 253], ["inflammation", "DISEASE", 162, 174], ["lysosomes", "CELLULAR_COMPONENT", 68, 77], ["neutrophils", "CELL", 81, 92], ["fibrin", "GENE_OR_GENE_PRODUCT", 140, 146], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 199, 216], ["walled capillaries", "TISSUE", 223, 241], ["venules", "MULTI-TISSUE_STRUCTURE", 246, 253], ["neutrophils", "CELL_TYPE", 81, 92], ["fibrin", "PROTEIN", 140, 146], ["Organisms", "PROBLEM", 0, 9], ["neutrophils", "PROBLEM", 81, 92], ["fibrin", "PROBLEM", 140, 146], ["inflammation", "PROBLEM", 162, 174], ["thin-walled capillaries", "PROBLEM", 218, 241], ["venules", "PROBLEM", 246, 253], ["fibrin", "OBSERVATION", 140, 146], ["inflammation", "OBSERVATION", 162, 174], ["lymphatic vessels", "ANATOMY", 199, 216], ["walled capillaries", "OBSERVATION", 223, 241], ["venules", "ANATOMY", 246, 253]]], ["Entry into lymphatic vessels allows invading microorganisms to be carried in lymph to draining regional and systemic lymph nodes and eventually via the thoracic duct to the circulatory system.", [["lymphatic vessels", "ANATOMY", 11, 28], ["lymph", "ANATOMY", 77, 82], ["lymph nodes", "ANATOMY", 117, 128], ["thoracic duct", "ANATOMY", 152, 165], ["circulatory system", "ANATOMY", 173, 191], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 11, 28], ["lymph", "ORGAN", 77, 82], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 117, 128], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 152, 165], ["circulatory system", "ANATOMICAL_SYSTEM", 173, 191], ["invading microorganisms", "PROBLEM", 36, 59], ["lymphatic vessels", "ANATOMY", 11, 28], ["lymph", "ANATOMY", 77, 82], ["regional", "ANATOMY_MODIFIER", 95, 103], ["systemic", "ANATOMY", 108, 116], ["lymph nodes", "OBSERVATION", 117, 128], ["thoracic duct", "ANATOMY", 152, 165], ["circulatory system", "ANATOMY", 173, 191]]], ["Microorganisms that gain access to veins spread with the circulation and can localize in the lungs.", [["veins", "ANATOMY", 35, 40], ["lungs", "ANATOMY", 93, 98], ["veins", "MULTI-TISSUE_STRUCTURE", 35, 40], ["lungs", "ORGAN", 93, 98], ["Microorganisms", "PROBLEM", 0, 14], ["veins", "ANATOMY", 35, 40], ["circulation", "OBSERVATION_MODIFIER", 57, 68], ["lungs", "ANATOMY", 93, 98]]], ["In occurrences in which severe pulmonary inflammation leads to the formation of AV fistulas, microorganisms can gain access to pulmonary veins, be pumped through the left heart, and enter the systemic arterial circulation.", [["pulmonary", "ANATOMY", 31, 40], ["AV fistulas", "ANATOMY", 80, 91], ["pulmonary veins", "ANATOMY", 127, 142], ["left heart", "ANATOMY", 166, 176], ["arterial", "ANATOMY", 201, 209], ["pulmonary inflammation", "DISEASE", 31, 53], ["AV fistulas", "DISEASE", 80, 91], ["pulmonary", "ORGAN", 31, 40], ["AV fistulas", "PATHOLOGICAL_FORMATION", 80, 91], ["pulmonary veins", "MULTI-TISSUE_STRUCTURE", 127, 142], ["heart", "ORGAN", 171, 176], ["arterial circulation", "MULTI-TISSUE_STRUCTURE", 201, 221], ["severe pulmonary inflammation", "PROBLEM", 24, 53], ["AV fistulas", "PROBLEM", 80, 91], ["microorganisms", "PROBLEM", 93, 107], ["severe", "OBSERVATION_MODIFIER", 24, 30], ["pulmonary", "ANATOMY", 31, 40], ["inflammation", "OBSERVATION", 41, 53], ["AV", "ANATOMY", 80, 82], ["fistulas", "OBSERVATION", 83, 91], ["pulmonary veins", "ANATOMY", 127, 142], ["left", "ANATOMY_MODIFIER", 166, 170], ["heart", "ANATOMY", 171, 176], ["systemic arterial", "ANATOMY", 192, 209]]], ["The circulatory system can distribute organisms and materials to other organs and tissues (see E- Fig. 10-2 ; also see Chapter 2).MyocardiumPathogens gain entry to the myocardium through the vascular system from the coronary arteries, which provide blood flow to the myocardium.", [["circulatory system", "ANATOMY", 4, 22], ["organs", "ANATOMY", 71, 77], ["tissues", "ANATOMY", 82, 89], ["myocardium", "ANATOMY", 168, 178], ["vascular system", "ANATOMY", 191, 206], ["coronary arteries", "ANATOMY", 216, 233], ["blood", "ANATOMY", 249, 254], ["myocardium", "ANATOMY", 267, 277], ["organs", "ORGAN", 71, 77], ["tissues", "TISSUE", 82, 89], ["myocardium", "ORGAN", 168, 178], ["vascular system", "MULTI-TISSUE_STRUCTURE", 191, 206], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 216, 233], ["blood", "ORGANISM_SUBSTANCE", 249, 254], ["myocardium", "MULTI-TISSUE_STRUCTURE", 267, 277], ["circulatory system", "ANATOMY", 4, 22], ["tissues", "ANATOMY", 82, 89], ["myocardium", "ANATOMY", 168, 178], ["vascular system", "ANATOMY", 191, 206], ["coronary arteries", "ANATOMY", 216, 233], ["myocardium", "ANATOMY", 267, 277]]], ["Coronary arteries originate in the sinus of Valsalva at the origin of the aorta and travel in the coronary grooves to the apex of the heart supplying blood to both ventricles.", [["Coronary arteries", "ANATOMY", 0, 17], ["sinus", "ANATOMY", 35, 40], ["aorta", "ANATOMY", 74, 79], ["coronary", "ANATOMY", 98, 106], ["heart", "ANATOMY", 134, 139], ["blood", "ANATOMY", 150, 155], ["ventricles", "ANATOMY", 164, 174], ["Coronary arteries", "MULTI-TISSUE_STRUCTURE", 0, 17], ["sinus", "ORGAN", 35, 40], ["aorta", "ORGAN", 74, 79], ["coronary grooves", "MULTI-TISSUE_STRUCTURE", 98, 114], ["heart", "ORGAN", 134, 139], ["blood", "ORGANISM_SUBSTANCE", 150, 155], ["ventricles", "MULTI-TISSUE_STRUCTURE", 164, 174], ["arteries", "ANATOMY", 9, 17], ["sinus of Valsalva", "ANATOMY", 35, 52], ["origin", "ANATOMY_MODIFIER", 60, 66], ["aorta", "ANATOMY", 74, 79], ["coronary", "ANATOMY", 98, 106], ["grooves", "ANATOMY_MODIFIER", 107, 114], ["apex", "ANATOMY_MODIFIER", 122, 126], ["heart", "ANATOMY", 134, 139], ["blood", "OBSERVATION", 150, 155], ["both", "ANATOMY_MODIFIER", 159, 163], ["ventricles", "ANATOMY", 164, 174]]], ["Branches of the coronary arteries bifurcate and send smaller arteries on the outer surface of the heart within the visceral pericardium.", [["coronary arteries", "ANATOMY", 16, 33], ["arteries", "ANATOMY", 61, 69], ["outer surface", "ANATOMY", 77, 90], ["heart", "ANATOMY", 98, 103], ["visceral pericardium", "ANATOMY", 115, 135], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 16, 33], ["arteries", "MULTI-TISSUE_STRUCTURE", 61, 69], ["outer surface", "CELLULAR_COMPONENT", 77, 90], ["heart", "ORGAN", 98, 103], ["visceral pericardium", "ORGAN", 115, 135], ["coronary arteries", "ANATOMY", 16, 33], ["bifurcate", "ANATOMY_MODIFIER", 34, 43], ["smaller arteries", "OBSERVATION", 53, 69], ["outer", "ANATOMY_MODIFIER", 77, 82], ["surface", "ANATOMY_MODIFIER", 83, 90], ["heart", "ANATOMY", 98, 103], ["visceral pericardium", "ANATOMY", 115, 135]]], ["These smaller arteries then penetrate the myocardium, becoming arterioles andCELL-MEDIATED RESPONSESBox 10-10 Defense Mechanisms side (pulmonic circulation, low pressure).", [["arteries", "ANATOMY", 14, 22], ["myocardium", "ANATOMY", 42, 52], ["arterioles", "ANATOMY", 63, 73], ["arteries", "MULTI-TISSUE_STRUCTURE", 14, 22], ["myocardium", "ORGAN", 42, 52], ["arterioles", "MULTI-TISSUE_STRUCTURE", 63, 73], ["RESPONSESBox", "TEST", 91, 103], ["smaller", "OBSERVATION_MODIFIER", 6, 13], ["arteries", "ANATOMY", 14, 22], ["myocardium", "ANATOMY", 42, 52], ["arterioles", "OBSERVATION_MODIFIER", 63, 73], ["pulmonic", "ANATOMY", 135, 143], ["circulation", "ANATOMY_MODIFIER", 144, 155], ["low pressure", "OBSERVATION", 157, 169]]], ["The consequence of blood shunting is overloading of the low-pressured pulmonary circulation, which results in increased volume of blood that enters the left cardiac compartment after returning from the lungs.", [["blood", "ANATOMY", 19, 24], ["pulmonary", "ANATOMY", 70, 79], ["blood", "ANATOMY", 130, 135], ["left cardiac compartment", "ANATOMY", 152, 176], ["lungs", "ANATOMY", 202, 207], ["blood shunting", "DISEASE", 19, 33], ["blood", "ORGANISM_SUBSTANCE", 19, 24], ["pulmonary", "ORGAN", 70, 79], ["blood", "ORGANISM_SUBSTANCE", 130, 135], ["cardiac compartment", "MULTI-TISSUE_STRUCTURE", 157, 176], ["lungs", "ORGAN", 202, 207], ["blood shunting", "PROBLEM", 19, 33], ["the low-pressured pulmonary circulation", "PROBLEM", 52, 91], ["increased volume of blood", "PROBLEM", 110, 135], ["blood shunting", "OBSERVATION", 19, 33], ["overloading", "OBSERVATION_MODIFIER", 37, 48], ["low", "OBSERVATION_MODIFIER", 56, 59], ["pressured", "OBSERVATION_MODIFIER", 60, 69], ["pulmonary circulation", "ANATOMY", 70, 91], ["increased", "OBSERVATION_MODIFIER", 110, 119], ["volume of blood", "OBSERVATION", 120, 135], ["left", "ANATOMY_MODIFIER", 152, 156], ["cardiac", "ANATOMY", 157, 164], ["compartment", "ANATOMY_MODIFIER", 165, 176], ["lungs", "ANATOMY", 202, 207]]], ["This in turn leads to eccentric hypertrophy of the left ventricle and atrium to accommodate the increased volume of blood.", [["left ventricle", "ANATOMY", 51, 65], ["atrium", "ANATOMY", 70, 76], ["blood", "ANATOMY", 116, 121], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 51, 65], ["atrium", "MULTI-TISSUE_STRUCTURE", 70, 76], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["eccentric hypertrophy of the left ventricle and atrium", "PROBLEM", 22, 76], ["the increased volume of blood", "PROBLEM", 92, 121], ["eccentric", "OBSERVATION_MODIFIER", 22, 31], ["hypertrophy", "OBSERVATION", 32, 43], ["left ventricle", "ANATOMY", 51, 65], ["atrium", "ANATOMY", 70, 76], ["increased", "OBSERVATION_MODIFIER", 96, 105], ["volume of blood", "OBSERVATION", 106, 121]]], ["Anomalies in the first category that lead to valvular regurgitation include mitral and tricuspid dysplasia and aortic and pulmonic insufficiency.", [["valvular", "ANATOMY", 45, 53], ["mitral", "ANATOMY", 76, 82], ["tricuspid dysplasia", "ANATOMY", 87, 106], ["aortic", "ANATOMY", 111, 117], ["valvular regurgitation", "DISEASE", 45, 67], ["mitral and tricuspid dysplasia", "DISEASE", 76, 106], ["aortic and pulmonic insufficiency", "DISEASE", 111, 144], ["valvular", "PATHOLOGICAL_FORMATION", 45, 53], ["mitral", "MULTI-TISSUE_STRUCTURE", 76, 82], ["tricuspid dysplasia", "PATHOLOGICAL_FORMATION", 87, 106], ["aortic", "MULTI-TISSUE_STRUCTURE", 111, 117], ["Anomalies in the first category", "PROBLEM", 0, 31], ["valvular regurgitation", "PROBLEM", 45, 67], ["mitral and tricuspid dysplasia", "PROBLEM", 76, 106], ["aortic and pulmonic insufficiency", "PROBLEM", 111, 144], ["valvular", "ANATOMY", 45, 53], ["regurgitation", "OBSERVATION", 54, 67], ["mitral", "OBSERVATION", 76, 82], ["tricuspid", "ANATOMY", 87, 96], ["dysplasia", "OBSERVATION", 97, 106], ["aortic", "ANATOMY", 111, 117], ["pulmonic", "ANATOMY", 122, 130], ["insufficiency", "OBSERVATION", 131, 144]]], ["The regurgitated blood from the ventricles to the atria leads to progressive atrial dilation and eccentric ventricular dilation.", [["blood", "ANATOMY", 17, 22], ["ventricles", "ANATOMY", 32, 42], ["atria", "ANATOMY", 50, 55], ["atrial", "ANATOMY", 77, 83], ["ventricular", "ANATOMY", 107, 118], ["atrial dilation", "DISEASE", 77, 92], ["blood", "ORGANISM_SUBSTANCE", 17, 22], ["ventricles", "MULTI-TISSUE_STRUCTURE", 32, 42], ["atria", "MULTI-TISSUE_STRUCTURE", 50, 55], ["atrial", "MULTI-TISSUE_STRUCTURE", 77, 83], ["ventricular", "MULTI-TISSUE_STRUCTURE", 107, 118], ["progressive atrial dilation", "PROBLEM", 65, 92], ["eccentric ventricular dilation", "PROBLEM", 97, 127], ["ventricles", "ANATOMY", 32, 42], ["atria", "ANATOMY", 50, 55], ["progressive", "OBSERVATION_MODIFIER", 65, 76], ["atrial", "ANATOMY", 77, 83], ["dilation", "OBSERVATION", 84, 92], ["eccentric", "OBSERVATION_MODIFIER", 97, 106], ["ventricular", "ANATOMY", 107, 118], ["dilation", "OBSERVATION", 119, 127]]], ["Anomalies in the second category that cause pressure overload include pulmonic and aortic stenosis and coarctation and interruption of the aorta.", [["aortic", "ANATOMY", 83, 89], ["aorta", "ANATOMY", 139, 144], ["pressure overload", "DISEASE", 44, 61], ["pulmonic and aortic stenosis", "DISEASE", 70, 98], ["coarctation", "DISEASE", 103, 114], ["pulmonic", "MULTI-TISSUE_STRUCTURE", 70, 78], ["aortic", "MULTI-TISSUE_STRUCTURE", 83, 89], ["aorta", "MULTI-TISSUE_STRUCTURE", 139, 144], ["Anomalies in the second category", "PROBLEM", 0, 32], ["pressure overload", "PROBLEM", 44, 61], ["pulmonic and aortic stenosis", "PROBLEM", 70, 98], ["coarctation", "PROBLEM", 103, 114], ["interruption of the aorta", "PROBLEM", 119, 144], ["pressure overload", "OBSERVATION", 44, 61], ["pulmonic", "ANATOMY", 70, 78], ["aortic", "ANATOMY", 83, 89], ["stenosis", "OBSERVATION", 90, 98], ["coarctation", "OBSERVATION", 103, 114], ["aorta", "ANATOMY", 139, 144]]], ["In these anomalies, ventricular outflow obstructions result in progressive and chronic increase in intraventricular pressure.", [["ventricular", "ANATOMY", 20, 31], ["intraventricular", "ANATOMY", 99, 115], ["ventricular outflow obstructions", "DISEASE", 20, 52], ["ventricular outflow obstructions", "PATHOLOGICAL_FORMATION", 20, 52], ["intraventricular", "IMMATERIAL_ANATOMICAL_ENTITY", 99, 115], ["these anomalies", "PROBLEM", 3, 18], ["ventricular outflow obstructions", "PROBLEM", 20, 52], ["progressive and chronic increase in intraventricular pressure", "PROBLEM", 63, 124], ["anomalies", "OBSERVATION", 9, 18], ["ventricular", "ANATOMY", 20, 31], ["outflow", "ANATOMY_MODIFIER", 32, 39], ["obstructions", "OBSERVATION", 40, 52], ["progressive", "OBSERVATION_MODIFIER", 63, 74], ["chronic", "OBSERVATION_MODIFIER", 79, 86], ["increase", "OBSERVATION_MODIFIER", 87, 95], ["intraventricular pressure", "OBSERVATION", 99, 124]]], ["The increased intraventricular pressure induces concentric ventricular hypertrophy that eventually results in a diastolic failure.CELL-MEDIATED RESPONSESAnomalies in the third category that cause cyanotic heart disease include tetralogy of Fallot, pulmonary to systemic (right to left) blood shunting (some VSD and PDA), tricuspid atresia/right ventricular hypoplasia, double-outlet right ventricle, transposition of the great vessels, truncus arteriosus, and aorticopulmonary window (see Disorders of Domestic Animals, Developmental Errors/ Congenital Anomalies).", [["intraventricular", "ANATOMY", 14, 30], ["ventricular", "ANATOMY", 59, 70], ["heart", "ANATOMY", 205, 210], ["pulmonary", "ANATOMY", 248, 257], ["right", "ANATOMY", 271, 276], ["left", "ANATOMY", 280, 284], ["blood", "ANATOMY", 286, 291], ["tricuspid", "ANATOMY", 321, 330], ["right ventricular", "ANATOMY", 339, 356], ["right ventricle", "ANATOMY", 383, 398], ["great vessels", "ANATOMY", 421, 434], ["truncus arteriosus", "ANATOMY", 436, 454], ["aorticopulmonary", "ANATOMY", 460, 476], ["ventricular hypertrophy", "DISEASE", 59, 82], ["diastolic failure", "DISEASE", 112, 129], ["cyanotic heart disease", "DISEASE", 196, 218], ["tetralogy of Fallot", "DISEASE", 227, 246], ["pulmonary to systemic (right to left) blood shunting", "DISEASE", 248, 300], ["tricuspid atresia", "DISEASE", 321, 338], ["ventricular hypoplasia", "DISEASE", 345, 367], ["truncus arteriosus", "DISEASE", 436, 454], ["Congenital Anomalies", "DISEASE", 542, 562], ["ventricular", "MULTI-TISSUE_STRUCTURE", 59, 70], ["heart", "ORGAN", 205, 210], ["pulmonary", "ORGAN", 248, 257], ["blood", "ORGANISM_SUBSTANCE", 286, 291], ["ventricular", "ORGAN", 345, 356], ["ventricle", "MULTI-TISSUE_STRUCTURE", 389, 398], ["vessels", "MULTI-TISSUE_STRUCTURE", 427, 434], ["arteriosus", "MULTI-TISSUE_STRUCTURE", 444, 454], ["The increased intraventricular pressure", "PROBLEM", 0, 39], ["concentric ventricular hypertrophy", "PROBLEM", 48, 82], ["a diastolic failure", "PROBLEM", 110, 129], ["cyanotic heart disease", "PROBLEM", 196, 218], ["tetralogy of Fallot", "PROBLEM", 227, 246], ["pulmonary to systemic (right to left) blood shunting", "PROBLEM", 248, 300], ["some VSD and PDA)", "PROBLEM", 302, 319], ["tricuspid atresia", "PROBLEM", 321, 338], ["right ventricular hypoplasia", "PROBLEM", 339, 367], ["double-outlet right ventricle", "TREATMENT", 369, 398], ["transposition of the great vessels", "TREATMENT", 400, 434], ["truncus arteriosus", "PROBLEM", 436, 454], ["aorticopulmonary window", "PROBLEM", 460, 483], ["Developmental Errors", "PROBLEM", 520, 540], ["Congenital Anomalies)", "PROBLEM", 542, 563], ["increased", "OBSERVATION_MODIFIER", 4, 13], ["intraventricular pressure", "OBSERVATION", 14, 39], ["concentric", "OBSERVATION_MODIFIER", 48, 58], ["ventricular", "ANATOMY", 59, 70], ["hypertrophy", "OBSERVATION", 71, 82], ["diastolic failure", "OBSERVATION", 112, 129], ["RESPONSESAnomalies", "OBSERVATION", 144, 162], ["cyanotic", "OBSERVATION", 196, 204], ["heart", "ANATOMY", 205, 210], ["disease", "OBSERVATION", 211, 218], ["Fallot", "OBSERVATION", 240, 246], ["pulmonary", "ANATOMY", 248, 257], ["systemic", "OBSERVATION_MODIFIER", 261, 269], ["right", "ANATOMY_MODIFIER", 271, 276], ["left", "ANATOMY_MODIFIER", 280, 284], ["blood shunting", "OBSERVATION", 286, 300], ["VSD", "OBSERVATION", 307, 310], ["PDA", "OBSERVATION", 315, 318], ["tricuspid", "ANATOMY", 321, 330], ["atresia", "OBSERVATION", 331, 338], ["right ventricular", "ANATOMY", 339, 356], ["hypoplasia", "OBSERVATION", 357, 367], ["double", "OBSERVATION", 369, 375], ["outlet", "ANATOMY_MODIFIER", 376, 382], ["right ventricle", "ANATOMY", 383, 398], ["transposition", "OBSERVATION", 400, 413], ["great vessels", "ANATOMY", 421, 434], ["truncus arteriosus", "ANATOMY", 436, 454], ["aorticopulmonary window", "OBSERVATION", 460, 483], ["Congenital Anomalies", "OBSERVATION", 542, 562]]], ["In these anomalies, nonoxygenated blood from the right cardiac compartment flows to the left compartment or bypasses the left compartment and flows directly into the systemic circulation.", [["blood", "ANATOMY", 34, 39], ["right cardiac compartment", "ANATOMY", 49, 74], ["left compartment", "ANATOMY", 88, 104], ["left compartment", "ANATOMY", 121, 137], ["blood", "ORGANISM_SUBSTANCE", 34, 39], ["cardiac compartment", "MULTI-TISSUE_STRUCTURE", 55, 74], ["nonoxygenated blood", "PROBLEM", 20, 39], ["anomalies", "OBSERVATION", 9, 18], ["nonoxygenated blood", "OBSERVATION", 20, 39], ["right", "ANATOMY_MODIFIER", 49, 54], ["cardiac", "ANATOMY", 55, 62], ["compartment", "ANATOMY_MODIFIER", 63, 74], ["flows", "ANATOMY_MODIFIER", 75, 80], ["left", "ANATOMY_MODIFIER", 88, 92], ["compartment", "ANATOMY_MODIFIER", 93, 104], ["bypasses", "OBSERVATION", 108, 116], ["left", "ANATOMY_MODIFIER", 121, 125], ["compartment", "ANATOMY_MODIFIER", 126, 137], ["flows", "OBSERVATION", 142, 147], ["systemic circulation", "OBSERVATION", 166, 186]]], ["This portion of nonoxygenated blood mixes and dilutes the oxygenated blood in the systemic circulation and induces cyanosis in multiple tissues.CELL-MEDIATED RESPONSESAnomalies in the fourth category include peritoneopericardial diaphragmatic hernias (PPDHs), persistent right aortic arch (PRAA), endocardial fibroelastosis, anomalous pulmonary venous return, double aortic arch, retroesophageal left subclavian artery, valvular hematomas, and situs inversus.CELL-MEDIATED RESPONSESin that most of the components of the innate and humoral immunity are present within the lumen.", [["blood", "ANATOMY", 30, 35], ["blood", "ANATOMY", 69, 74], ["tissues", "ANATOMY", 136, 143], ["peritoneopericardial diaphragmatic hernias", "ANATOMY", 208, 250], ["PPDHs", "ANATOMY", 252, 257], ["right aortic arch", "ANATOMY", 271, 288], ["PRAA", "ANATOMY", 290, 294], ["endocardial", "ANATOMY", 297, 308], ["pulmonary venous", "ANATOMY", 335, 351], ["aortic arch", "ANATOMY", 367, 378], ["retroesophageal left subclavian artery", "ANATOMY", 380, 418], ["valvular", "ANATOMY", 420, 428], ["situs", "ANATOMY", 444, 449], ["lumen", "ANATOMY", 571, 576], ["cyanosis", "DISEASE", 115, 123], ["diaphragmatic hernias", "DISEASE", 229, 250], ["PPDHs", "DISEASE", 252, 257], ["endocardial fibroelastosis", "DISEASE", 297, 323], ["valvular hematomas", "DISEASE", 420, 438], ["situs inversus", "DISEASE", 444, 458], ["blood", "ORGANISM_SUBSTANCE", 30, 35], ["blood", "ORGANISM_SUBSTANCE", 69, 74], ["tissues", "TISSUE", 136, 143], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 277, 288], ["pulmonary venous", "MULTI-TISSUE_STRUCTURE", 335, 351], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 367, 378], ["subclavian artery", "MULTI-TISSUE_STRUCTURE", 401, 418], ["valvular", "MULTI-TISSUE_STRUCTURE", 420, 428], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 571, 576], ["nonoxygenated blood mixes", "TREATMENT", 16, 41], ["the oxygenated blood in the systemic circulation", "PROBLEM", 54, 102], ["cyanosis in multiple tissues", "PROBLEM", 115, 143], ["peritoneopericardial diaphragmatic hernias", "PROBLEM", 208, 250], ["persistent right aortic arch (PRAA)", "PROBLEM", 260, 295], ["endocardial fibroelastosis", "PROBLEM", 297, 323], ["anomalous pulmonary venous return", "PROBLEM", 325, 358], ["double aortic arch", "TREATMENT", 360, 378], ["retroesophageal left subclavian artery", "PROBLEM", 380, 418], ["valvular hematomas", "PROBLEM", 420, 438], ["situs inversus", "PROBLEM", 444, 458], ["oxygenated blood", "OBSERVATION", 58, 74], ["systemic circulation", "ANATOMY", 82, 102], ["cyanosis", "OBSERVATION", 115, 123], ["multiple tissues", "OBSERVATION", 127, 143], ["RESPONSESAnomalies", "OBSERVATION", 158, 176], ["peritoneopericardial", "ANATOMY_MODIFIER", 208, 228], ["diaphragmatic", "ANATOMY", 229, 242], ["hernias", "OBSERVATION", 243, 250], ["persistent", "OBSERVATION_MODIFIER", 260, 270], ["right", "ANATOMY_MODIFIER", 271, 276], ["aortic arch", "ANATOMY", 277, 288], ["endocardial", "ANATOMY", 297, 308], ["fibroelastosis", "OBSERVATION", 309, 323], ["anomalous", "OBSERVATION", 325, 334], ["pulmonary venous", "ANATOMY", 335, 351], ["double", "OBSERVATION", 360, 366], ["aortic arch", "ANATOMY", 367, 378], ["retroesophageal", "ANATOMY_MODIFIER", 380, 395], ["left", "ANATOMY_MODIFIER", 396, 400], ["subclavian artery", "ANATOMY", 401, 418], ["valvular", "ANATOMY", 420, 428], ["hematomas", "OBSERVATION", 429, 438], ["situs inversus", "OBSERVATION", 444, 458], ["humoral immunity", "OBSERVATION", 531, 547], ["lumen", "ANATOMY_MODIFIER", 571, 576]]], ["A review of inflammation (see Chapter 3), immune function (see Chapter 5), and circulatory disturbances (see Chapter 2) is invaluable in understanding the defense mechanisms of the cardiovascular and lymphatic systems.", [["cardiovascular", "ANATOMY", 181, 195], ["lymphatic systems", "ANATOMY", 200, 217], ["inflammation", "DISEASE", 12, 24], ["circulatory disturbances", "DISEASE", 79, 103], ["cardiovascular", "ANATOMICAL_SYSTEM", 181, 195], ["lymphatic systems", "MULTI-TISSUE_STRUCTURE", 200, 217], ["inflammation", "PROBLEM", 12, 24], ["circulatory disturbances", "PROBLEM", 79, 103], ["inflammation", "OBSERVATION", 12, 24], ["cardiovascular", "ANATOMY", 181, 195], ["lymphatic systems", "ANATOMY", 200, 217]]], ["The constant flow of blood and lymph through intact circulatory and lymphatic systems, respectively, provides the surface endothelium of the chambers and vessels with constant exposure to nutrients, plasma proteins such as immunoglobulins, preformed chemical mediators, and circulating leukocytes.Developmental Errors/Congenital Anomalies 2The complex events involved in the embryologic development of the heart and great vessels allow substantial opportunities for congenital anomalies to develop (see E- Fig. 10-1) .", [["blood", "ANATOMY", 21, 26], ["lymph", "ANATOMY", 31, 36], ["circulatory", "ANATOMY", 52, 63], ["lymphatic systems", "ANATOMY", 68, 85], ["surface endothelium", "ANATOMY", 114, 133], ["chambers", "ANATOMY", 141, 149], ["vessels", "ANATOMY", 154, 161], ["plasma", "ANATOMY", 199, 205], ["leukocytes", "ANATOMY", 286, 296], ["heart", "ANATOMY", 406, 411], ["vessels", "ANATOMY", 422, 429], ["Congenital Anomalies", "DISEASE", 318, 338], ["congenital anomalies", "DISEASE", 466, 486], ["blood", "ORGANISM_SUBSTANCE", 21, 26], ["lymph", "ORGAN", 31, 36], ["circulatory", "ANATOMICAL_SYSTEM", 52, 63], ["lymphatic systems", "MULTI-TISSUE_STRUCTURE", 68, 85], ["surface endothelium", "TISSUE", 114, 133], ["vessels", "MULTI-TISSUE_STRUCTURE", 154, 161], ["plasma", "ORGANISM_SUBSTANCE", 199, 205], ["immunoglobulins", "GENE_OR_GENE_PRODUCT", 223, 238], ["leukocytes", "CELL", 286, 296], ["heart", "ORGAN", 406, 411], ["great vessels", "MULTI-TISSUE_STRUCTURE", 416, 429], ["plasma proteins", "PROTEIN", 199, 214], ["immunoglobulins", "PROTEIN", 223, 238], ["circulating leukocytes", "CELL_TYPE", 274, 296], ["plasma proteins", "TEST", 199, 214], ["immunoglobulins", "TEST", 223, 238], ["circulating leukocytes", "PROBLEM", 274, 296], ["Developmental Errors", "PROBLEM", 297, 317], ["Congenital Anomalies", "PROBLEM", 318, 338], ["The complex events", "PROBLEM", 340, 358], ["congenital anomalies", "PROBLEM", 466, 486], ["constant", "OBSERVATION_MODIFIER", 4, 12], ["flow", "OBSERVATION", 13, 17], ["blood", "ANATOMY", 21, 26], ["lymph", "OBSERVATION", 31, 36], ["circulatory", "ANATOMY_MODIFIER", 52, 63], ["lymphatic systems", "ANATOMY", 68, 85], ["surface", "ANATOMY_MODIFIER", 114, 121], ["endothelium", "ANATOMY_MODIFIER", 122, 133], ["chambers", "ANATOMY_MODIFIER", 141, 149], ["vessels", "ANATOMY", 154, 161], ["circulating leukocytes", "OBSERVATION", 274, 296], ["Congenital", "OBSERVATION_MODIFIER", 318, 328], ["Anomalies", "OBSERVATION", 329, 338], ["heart", "ANATOMY", 406, 411], ["great vessels", "ANATOMY", 416, 429]]], ["The functional significance of these anomalies varies widely.", [["these anomalies", "PROBLEM", 31, 46], ["anomalies", "OBSERVATION", 37, 46]]], ["Animals with the most extreme defects are unable to survive in utero, and those with the mildest lesions could have no clinical signs of disease during life.", [["lesions", "ANATOMY", 97, 104], ["Animals", "ORGANISM", 0, 7], ["lesions", "PATHOLOGICAL_FORMATION", 97, 104], ["the most extreme defects", "PROBLEM", 13, 37], ["the mildest lesions", "PROBLEM", 85, 104], ["disease", "PROBLEM", 137, 144], ["defects", "OBSERVATION", 30, 37], ["lesions", "OBSERVATION", 97, 104], ["disease", "OBSERVATION", 137, 144]]], ["However, animals with defects of intermediate severity are most likely to be presented to a veterinarian because of gradually developing signs of cardiac failure, including poor exercise tolerance, cyanosis, and stunted body growth.", [["cardiac", "ANATOMY", 146, 153], ["body", "ANATOMY", 220, 224], ["cardiac failure", "DISEASE", 146, 161], ["cyanosis", "DISEASE", 198, 206], ["cardiac", "ORGAN", 146, 153], ["body", "ORGANISM_SUBDIVISION", 220, 224], ["defects of intermediate severity", "PROBLEM", 22, 54], ["cardiac failure", "PROBLEM", 146, 161], ["poor exercise tolerance", "PROBLEM", 173, 196], ["cyanosis", "PROBLEM", 198, 206], ["stunted body growth", "PROBLEM", 212, 231], ["intermediate severity", "OBSERVATION_MODIFIER", 33, 54], ["most likely", "UNCERTAINTY", 59, 70], ["cardiac", "ANATOMY", 146, 153], ["failure", "OBSERVATION", 154, 161]]], ["Ectopia cordis is a congenital development of the heart at an abnormal site outside of the thoracic cavity.", [["heart", "ANATOMY", 50, 55], ["thoracic cavity", "ANATOMY", 91, 106], ["Ectopia cordis", "DISEASE", 0, 14], ["congenital development of the heart", "DISEASE", 20, 55], ["heart", "ORGAN", 50, 55], ["thoracic cavity", "MULTI-TISSUE_STRUCTURE", 91, 106], ["Ectopia cordis", "PROBLEM", 0, 14], ["a congenital development of the heart", "PROBLEM", 18, 55], ["an abnormal site", "PROBLEM", 59, 75], ["cordis", "OBSERVATION", 8, 14], ["congenital", "OBSERVATION", 20, 30], ["heart", "ANATOMY", 50, 55], ["abnormal", "OBSERVATION", 62, 70], ["thoracic cavity", "ANATOMY", 91, 106]]], ["In cattle, cases in healthy adult animals have been described in which the heart was located subcutaneously in the caudoventral neck area.", [["heart", "ANATOMY", 75, 80], ["subcutaneously", "ANATOMY", 93, 107], ["caudoventral neck area", "ANATOMY", 115, 137], ["cattle", "ORGANISM", 3, 9], ["heart", "ORGAN", 75, 80], ["caudoventral neck area", "CANCER", 115, 137], ["cattle", "SPECIES", 3, 9], ["cattle", "SPECIES", 3, 9], ["heart", "ANATOMY", 75, 80], ["caudoventral", "ANATOMY_MODIFIER", 115, 127], ["neck", "ANATOMY", 128, 132], ["area", "ANATOMY_MODIFIER", 133, 137]]], ["The most frequently observed cardiovascular anomalies in domestic animals are listed in Box 10-11.Developmental Errors/Congenital Anomalies 2The causes of congenital cardiovascular anomalies are varied.", [["cardiovascular", "ANATOMY", 29, 43], ["cardiovascular", "ANATOMY", 166, 180], ["cardiovascular anomalies", "DISEASE", 29, 53], ["Congenital Anomalies", "DISEASE", 119, 139], ["congenital cardiovascular anomalies", "DISEASE", 155, 190], ["cardiovascular", "ANATOMICAL_SYSTEM", 29, 43], ["cardiovascular", "ANATOMICAL_SYSTEM", 166, 180], ["The most frequently observed cardiovascular anomalies", "PROBLEM", 0, 53], ["Developmental Errors", "PROBLEM", 98, 118], ["Congenital Anomalies", "PROBLEM", 119, 139], ["congenital cardiovascular anomalies", "PROBLEM", 155, 190], ["most frequently", "OBSERVATION_MODIFIER", 4, 19], ["cardiovascular", "ANATOMY", 29, 43], ["anomalies", "OBSERVATION", 44, 53], ["Congenital", "OBSERVATION_MODIFIER", 119, 129], ["Anomalies", "OBSERVATION", 130, 139], ["congenital", "OBSERVATION_MODIFIER", 155, 165], ["cardiovascular", "ANATOMY", 166, 180], ["anomalies", "OBSERVATION", 181, 190]]], ["Most animal species have a low background frequency of spontaneous cardiac malformations.", [["cardiac", "ANATOMY", 67, 74], ["cardiac malformations", "DISEASE", 67, 88], ["cardiac malformations", "PATHOLOGICAL_FORMATION", 67, 88], ["spontaneous cardiac malformations", "PROBLEM", 55, 88], ["low background", "OBSERVATION_MODIFIER", 27, 41], ["spontaneous", "OBSERVATION_MODIFIER", 55, 66], ["cardiac", "ANATOMY", 67, 74], ["malformations", "OBSERVATION", 75, 88]]], ["In many species, especially in dogs, these defects are heritable and can be attributed to either single or multiple gene effects.", [["dogs", "ORGANISM", 31, 35], ["dogs", "SPECIES", 31, 35], ["these defects", "PROBLEM", 37, 50], ["single or multiple gene effects", "PROBLEM", 97, 128], ["many", "OBSERVATION_MODIFIER", 3, 7], ["species", "OBSERVATION_MODIFIER", 8, 15], ["defects", "OBSERVATION", 43, 50]]], ["Under experimental conditions, cardiovascular congenital defects can be elicited by exposure of pregnant dams to various chemicals and drugs, physical agents, toxins, or nutritional deficiencies.", [["cardiovascular", "ANATOMY", 31, 45], ["cardiovascular congenital defects", "DISEASE", 31, 64], ["nutritional deficiencies", "DISEASE", 170, 194], ["cardiovascular congenital defects", "PROBLEM", 31, 64], ["drugs", "TREATMENT", 135, 140], ["physical agents", "TREATMENT", 142, 157], ["toxins", "PROBLEM", 159, 165], ["nutritional deficiencies", "PROBLEM", 170, 194], ["congenital defects", "OBSERVATION", 46, 64], ["nutritional deficiencies", "OBSERVATION", 170, 194]]], ["Chemical compounds implicated include thalidomide, ethanol, salicylates, griseofulvin, and cortisone.", [["thalidomide", "CHEMICAL", 38, 49], ["ethanol", "CHEMICAL", 51, 58], ["griseofulvin", "CHEMICAL", 73, 85], ["cortisone", "CHEMICAL", 91, 100], ["thalidomide", "CHEMICAL", 38, 49], ["ethanol", "CHEMICAL", 51, 58], ["salicylates", "CHEMICAL", 60, 71], ["griseofulvin", "CHEMICAL", 73, 85], ["cortisone", "CHEMICAL", 91, 100], ["thalidomide", "SIMPLE_CHEMICAL", 38, 49], ["ethanol", "SIMPLE_CHEMICAL", 51, 58], ["salicylates", "SIMPLE_CHEMICAL", 60, 71], ["griseofulvin", "SIMPLE_CHEMICAL", 73, 85], ["cortisone", "SIMPLE_CHEMICAL", 91, 100], ["Chemical compounds", "TREATMENT", 0, 18], ["thalidomide", "TREATMENT", 38, 49], ["ethanol", "TREATMENT", 51, 58], ["salicylates", "TREATMENT", 60, 71], ["griseofulvin", "TREATMENT", 73, 85], ["cortisone", "TREATMENT", 91, 100]]], ["Prenatal exposure to x-irradiation or fetal hypoxia can induce defects.", [["fetal", "ANATOMY", 38, 43], ["hypoxia", "DISEASE", 44, 51], ["fetal", "ORGAN", 38, 43], ["fetal hypoxia", "PROBLEM", 38, 51], ["defects", "PROBLEM", 63, 70]]], ["Maternal nutritional deficiencies of vitamin A, pantothenic acid, riboflavin, or zinc and excess intake of vitamin A, retinoic acid, or copper can result in cardiovascular anomalies in newborn animals.", [["cardiovascular", "ANATOMY", 157, 171], ["vitamin A", "CHEMICAL", 37, 46], ["pantothenic acid", "CHEMICAL", 48, 64], ["riboflavin", "CHEMICAL", 66, 76], ["zinc", "CHEMICAL", 81, 85], ["vitamin A", "CHEMICAL", 107, 116], ["retinoic acid", "CHEMICAL", 118, 131], ["copper", "CHEMICAL", 136, 142], ["cardiovascular anomalies", "DISEASE", 157, 181], ["vitamin A", "CHEMICAL", 37, 46], ["pantothenic acid", "CHEMICAL", 48, 64], ["riboflavin", "CHEMICAL", 66, 76], ["zinc", "CHEMICAL", 81, 85], ["vitamin A", "CHEMICAL", 107, 116], ["retinoic acid", "CHEMICAL", 118, 131], ["copper", "CHEMICAL", 136, 142], ["vitamin A", "SIMPLE_CHEMICAL", 37, 46], ["pantothenic acid", "SIMPLE_CHEMICAL", 48, 64], ["riboflavin", "SIMPLE_CHEMICAL", 66, 76], ["zinc", "SIMPLE_CHEMICAL", 81, 85], ["vitamin A", "SIMPLE_CHEMICAL", 107, 116], ["retinoic acid", "SIMPLE_CHEMICAL", 118, 131], ["copper", "SIMPLE_CHEMICAL", 136, 142], ["cardiovascular", "ANATOMICAL_SYSTEM", 157, 171], ["Maternal nutritional deficiencies", "PROBLEM", 0, 33], ["vitamin A", "TREATMENT", 37, 46], ["pantothenic acid", "TREATMENT", 48, 64], ["riboflavin", "TREATMENT", 66, 76], ["zinc", "TREATMENT", 81, 85], ["vitamin A", "TREATMENT", 107, 116], ["retinoic acid", "TREATMENT", 118, 131], ["cardiovascular anomalies in newborn animals", "PROBLEM", 157, 200], ["nutritional deficiencies", "OBSERVATION", 9, 33], ["cardiovascular", "ANATOMY", 157, 171], ["anomalies", "OBSERVATION", 172, 181]]], ["Infectious diseases have been incriminated, but not confirmed, in cardiovascular defects; they include bluetongue infections in sheep, bovine virus diarrhea in cattle, and parvoviral infections in dogs and cats.Developmental Errors/Congenital Anomalies 2Congenital cardiac malformations may be grouped into four large categories according to their pathophysiology: (1) defects that cause volume overload (with subcategories of systemic to pulmonary shunting [left to right shunt] and valvular regurgitation), (2) defects that cause pressure overload, (3) defects that cause cyanosis, and (4) miscellaneous cardiac and vascular defects.Developmental Errors/Congenital Anomalies 2Anomalies in the first category that lead to left to right shunting include patent ductus arteriosus (PDA), ventricular septal defect (VSD), atrial septal defect (ASD), and endocardial cushion defects.", [["cardiovascular", "ANATOMY", 66, 80], ["cardiac", "ANATOMY", 265, 272], ["pulmonary", "ANATOMY", 439, 448], ["left", "ANATOMY", 459, 463], ["right shunt", "ANATOMY", 467, 478], ["valvular", "ANATOMY", 484, 492], ["cardiac", "ANATOMY", 606, 613], ["vascular", "ANATOMY", 618, 626], ["patent ductus arteriosus", "ANATOMY", 754, 778], ["ventricular septal", "ANATOMY", 786, 804], ["atrial septal", "ANATOMY", 819, 832], ["endocardial cushion", "ANATOMY", 851, 870], ["Infectious diseases", "DISEASE", 0, 19], ["cardiovascular defects", "DISEASE", 66, 88], ["bluetongue infections", "DISEASE", 103, 124], ["bovine virus diarrhea", "DISEASE", 135, 156], ["parvoviral infections", "DISEASE", 172, 193], ["Congenital Anomalies", "DISEASE", 232, 252], ["cardiac malformations", "DISEASE", 265, 286], ["volume overload", "DISEASE", 388, 403], ["valvular regurgitation", "DISEASE", 484, 506], ["pressure overload", "DISEASE", 532, 549], ["cyanosis", "DISEASE", 574, 582], ["cardiac and vascular defects", "DISEASE", 606, 634], ["Congenital Anomalies 2Anomalies", "DISEASE", 656, 687], ["patent ductus arteriosus", "DISEASE", 754, 778], ["ventricular septal defect", "DISEASE", 786, 811], ["atrial septal defect", "DISEASE", 819, 839], ["ASD", "DISEASE", 841, 844], ["endocardial cushion defects", "DISEASE", 851, 878], ["cardiovascular", "ANATOMICAL_SYSTEM", 66, 80], ["bluetongue", "ORGANISM", 103, 113], ["sheep", "ORGANISM", 128, 133], ["bovine virus diarrhea", "ORGANISM", 135, 156], ["dogs", "ORGANISM", 197, 201], ["cats", "ORGANISM", 206, 210], ["cardiac malformations", "PATHOLOGICAL_FORMATION", 265, 286], ["pulmonary", "ORGAN", 439, 448], ["valvular", "ORGAN", 484, 492], ["cardiac", "ORGAN", 606, 613], ["vascular", "MULTI-TISSUE_STRUCTURE", 618, 626], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 761, 778], ["ventricular septal", "MULTI-TISSUE_STRUCTURE", 786, 804], ["atrial septal", "MULTI-TISSUE_STRUCTURE", 819, 832], ["bluetongue", "SPECIES", 103, 113], ["sheep", "SPECIES", 128, 133], ["bovine", "SPECIES", 135, 141], ["virus diarrhea", "SPECIES", 142, 156], ["cattle", "SPECIES", 160, 166], ["dogs", "SPECIES", 197, 201], ["cats", "SPECIES", 206, 210], ["sheep", "SPECIES", 128, 133], ["bovine virus", "SPECIES", 135, 147], ["cattle", "SPECIES", 160, 166], ["cardiovascular defects", "PROBLEM", 66, 88], ["bluetongue infections in sheep", "PROBLEM", 103, 133], ["bovine virus diarrhea", "PROBLEM", 135, 156], ["parvoviral infections in dogs and cats", "PROBLEM", 172, 210], ["Developmental Errors", "PROBLEM", 211, 231], ["Congenital Anomalies", "PROBLEM", 232, 252], ["2Congenital cardiac malformations", "PROBLEM", 253, 286], ["defects", "PROBLEM", 369, 376], ["volume overload", "PROBLEM", 388, 403], ["systemic to pulmonary shunting", "TREATMENT", 427, 457], ["left to right shunt", "TREATMENT", 459, 478], ["valvular regurgitation", "PROBLEM", 484, 506], ["(2) defects", "PROBLEM", 509, 520], ["pressure overload", "PROBLEM", 532, 549], ["(3) defects", "PROBLEM", 551, 562], ["cyanosis", "PROBLEM", 574, 582], ["miscellaneous cardiac and vascular defects", "PROBLEM", 592, 634], ["Developmental Errors", "PROBLEM", 635, 655], ["Congenital Anomalies 2Anomalies", "PROBLEM", 656, 687], ["patent ductus arteriosus", "PROBLEM", 754, 778], ["ventricular septal defect (VSD)", "PROBLEM", 786, 817], ["atrial septal defect (ASD)", "PROBLEM", 819, 845], ["endocardial cushion defects", "PROBLEM", 851, 878], ["cardiovascular", "ANATOMY", 66, 80], ["defects", "OBSERVATION", 81, 88], ["bluetongue infections", "OBSERVATION", 103, 124], ["parvoviral", "ANATOMY", 172, 182], ["infections", "OBSERVATION", 183, 193], ["cardiac", "ANATOMY", 265, 272], ["malformations", "OBSERVATION", 273, 286], ["defects", "OBSERVATION", 369, 376], ["volume overload", "OBSERVATION", 388, 403], ["pulmonary", "ANATOMY", 439, 448], ["shunting", "OBSERVATION", 449, 457], ["left", "ANATOMY_MODIFIER", 459, 463], ["right", "ANATOMY_MODIFIER", 467, 472], ["shunt", "OBSERVATION", 473, 478], ["valvular", "ANATOMY", 484, 492], ["regurgitation", "OBSERVATION", 493, 506], ["pressure overload", "OBSERVATION", 532, 549], ["cyanosis", "OBSERVATION", 574, 582], ["cardiac", "ANATOMY", 606, 613], ["vascular", "ANATOMY", 618, 626], ["defects", "OBSERVATION", 627, 634], ["Congenital", "OBSERVATION_MODIFIER", 656, 666], ["Anomalies", "OBSERVATION", 667, 676], ["left", "ANATOMY_MODIFIER", 723, 727], ["right", "ANATOMY_MODIFIER", 731, 736], ["shunting", "OBSERVATION", 737, 745], ["patent", "OBSERVATION", 754, 760], ["ductus arteriosus", "ANATOMY", 761, 778], ["ventricular septal", "ANATOMY", 786, 804], ["defect", "OBSERVATION", 805, 811], ["VSD", "OBSERVATION", 813, 816], ["atrial septal", "ANATOMY", 819, 832], ["defect", "OBSERVATION", 833, 839], ["endocardial", "ANATOMY", 851, 862], ["cushion defects", "OBSERVATION", 863, 878]]], ["In this category, a defect between the right and left cardiac compartments leads to flow of cardiac blood according to a pressure gradient from the left side (systemic circulation, high pressure) to the right 2 See E-Box 10-2 for a list of inherited cardiovascular diseases of animals; E-Box 10-3 for a list of canine breed predilections for congenital cardiac anomalies; and E-Box 1-1 for a list of potential, suspected, or known genetic disorders.", [["right", "ANATOMY", 39, 44], ["left cardiac compartments", "ANATOMY", 49, 74], ["cardiac blood", "ANATOMY", 92, 105], ["left", "ANATOMY", 148, 152], ["cardiovascular", "ANATOMY", 250, 264], ["cardiac", "ANATOMY", 353, 360], ["cardiovascular diseases", "DISEASE", 250, 273], ["congenital cardiac anomalies", "DISEASE", 342, 370], ["blood", "ORGANISM_SUBSTANCE", 100, 105], ["cardiovascular", "ANATOMICAL_SYSTEM", 250, 264], ["E-Box 10-3", "GENE_OR_GENE_PRODUCT", 286, 296], ["canine", "ORGANISM", 311, 317], ["cardiac", "ORGAN", 353, 360], ["E-Box 1-1", "GENE_OR_GENE_PRODUCT", 376, 385], ["E-Box 1-1", "DNA", 376, 385], ["a defect between the right and left cardiac compartments", "PROBLEM", 18, 74], ["cardiac blood", "TEST", 92, 105], ["a pressure gradient", "TEST", 119, 138], ["systemic circulation", "TEST", 159, 179], ["inherited cardiovascular diseases of animals", "PROBLEM", 240, 284], ["canine breed predilections", "TREATMENT", 311, 337], ["congenital cardiac anomalies", "PROBLEM", 342, 370], ["known genetic disorders", "PROBLEM", 425, 448], ["defect", "OBSERVATION", 20, 26], ["right", "ANATOMY_MODIFIER", 39, 44], ["left", "ANATOMY_MODIFIER", 49, 53], ["cardiac", "ANATOMY", 54, 61], ["compartments", "ANATOMY_MODIFIER", 62, 74], ["flow", "OBSERVATION", 84, 88], ["cardiac", "ANATOMY", 92, 99], ["left", "ANATOMY_MODIFIER", 148, 152], ["high pressure", "OBSERVATION", 181, 194], ["right", "ANATOMY_MODIFIER", 203, 208], ["cardiovascular", "ANATOMY", 250, 264], ["diseases", "OBSERVATION", 265, 273], ["cardiac", "ANATOMY", 353, 360], ["anomalies", "OBSERVATION", 361, 370]]], ["Among breeds of dogs, the greatest frequency has been observed in the English bulldog, English springer spaniel, and West Highland white terrier.HORSESAtrial Septal Defect.", [["dogs", "ORGANISM", 16, 20], ["dogs", "SPECIES", 16, 20], ["HORSESAtrial Septal Defect", "PROBLEM", 145, 171], ["Septal", "ANATOMY_MODIFIER", 158, 164], ["Defect", "OBSERVATION", 165, 171]]], ["An atrial septal defect could represent the failure of closure of the foramen ovale, which is an interatrial septal shunt that allows blood to bypass the lungs of the fetus, or it can be the result of true septal defects at another site because of faulty development of the interatrial septum.", [["atrial septal", "ANATOMY", 3, 16], ["interatrial septal", "ANATOMY", 97, 115], ["blood", "ANATOMY", 134, 139], ["lungs", "ANATOMY", 154, 159], ["fetus", "ANATOMY", 167, 172], ["septal", "ANATOMY", 206, 212], ["interatrial septum", "ANATOMY", 274, 292], ["atrial septal defect", "DISEASE", 3, 23], ["septal defects", "DISEASE", 206, 220], ["atrial septal", "MULTI-TISSUE_STRUCTURE", 3, 16], ["interatrial septal", "MULTI-TISSUE_STRUCTURE", 97, 115], ["blood", "ORGANISM_SUBSTANCE", 134, 139], ["lungs", "ORGAN", 154, 159], ["fetus", "ORGAN", 167, 172], ["septal", "ORGAN", 206, 212], ["interatrial septum", "MULTI-TISSUE_STRUCTURE", 274, 292], ["An atrial septal defect", "PROBLEM", 0, 23], ["the failure of closure of the foramen ovale", "PROBLEM", 40, 83], ["an interatrial septal shunt", "PROBLEM", 94, 121], ["true septal defects", "PROBLEM", 201, 220], ["faulty development of the interatrial septum", "PROBLEM", 248, 292], ["atrial", "ANATOMY", 3, 9], ["septal", "ANATOMY_MODIFIER", 10, 16], ["defect", "OBSERVATION", 17, 23], ["could represent", "UNCERTAINTY", 24, 39], ["failure", "OBSERVATION", 44, 51], ["closure", "OBSERVATION", 55, 62], ["foramen ovale", "ANATOMY", 70, 83], ["interatrial", "ANATOMY", 97, 108], ["septal shunt", "OBSERVATION", 109, 121], ["lungs", "ANATOMY", 154, 159], ["fetus", "ANATOMY", 167, 172], ["septal defects", "OBSERVATION", 206, 220], ["faulty", "OBSERVATION", 248, 254], ["interatrial septum", "ANATOMY", 274, 292]]], ["Although this defect occurs in all domestic animal species, dog breeds with greatest frequency of this defect are the boxer, Doberman pinscher, and Samoyed.HORSESTetralogy of Fallot.", [["HORSESTetralogy of Fallot", "DISEASE", 156, 181], ["dog", "ORGANISM", 60, 63], ["dog", "SPECIES", 60, 63], ["this defect", "PROBLEM", 9, 20], ["dog breeds", "PROBLEM", 60, 70], ["this defect", "PROBLEM", 98, 109], ["Fallot", "PROBLEM", 175, 181], ["defect", "OBSERVATION", 14, 20], ["all", "OBSERVATION_MODIFIER", 31, 34], ["domestic", "OBSERVATION_MODIFIER", 35, 43], ["animal species", "OBSERVATION", 44, 58], ["dog breeds", "OBSERVATION", 60, 70], ["greatest", "OBSERVATION_MODIFIER", 76, 84], ["defect", "OBSERVATION", 103, 109], ["Fallot", "OBSERVATION", 175, 181]]], ["Tetralogy of Fallot is a complicated cardiac anomaly seen in all animal species with four lesions (Fig. 10-31) .", [["cardiac", "ANATOMY", 37, 44], ["lesions", "ANATOMY", 90, 97], ["Tetralogy of Fallot", "DISEASE", 0, 19], ["cardiac anomaly", "DISEASE", 37, 52], ["cardiac", "PATHOLOGICAL_FORMATION", 37, 44], ["lesions", "PATHOLOGICAL_FORMATION", 90, 97], ["Tetralogy of Fallot", "TREATMENT", 0, 19], ["a complicated cardiac anomaly", "PROBLEM", 23, 52], ["four lesions", "PROBLEM", 85, 97], ["Fallot", "OBSERVATION", 13, 19], ["complicated", "OBSERVATION_MODIFIER", 25, 36], ["cardiac", "ANATOMY", 37, 44], ["anomaly", "OBSERVATION", 45, 52], ["four", "OBSERVATION_MODIFIER", 85, 89], ["lesions", "OBSERVATION", 90, 97]]], ["The three primary defects are a ventricular septal defect located high in the septum, pulmonic stenosis (see later discussion), and dextroposition of the aorta (see later discussion).", [["ventricular septal", "ANATOMY", 32, 50], ["septum", "ANATOMY", 78, 84], ["pulmonic", "ANATOMY", 86, 94], ["aorta", "ANATOMY", 154, 159], ["ventricular septal defect", "DISEASE", 32, 57], ["pulmonic stenosis", "DISEASE", 86, 103], ["ventricular septal", "MULTI-TISSUE_STRUCTURE", 32, 50], ["septum", "MULTI-TISSUE_STRUCTURE", 78, 84], ["aorta", "MULTI-TISSUE_STRUCTURE", 154, 159], ["The three primary defects", "PROBLEM", 0, 25], ["a ventricular septal defect", "PROBLEM", 30, 57], ["pulmonic stenosis", "PROBLEM", 86, 103], ["three", "OBSERVATION_MODIFIER", 4, 9], ["primary", "OBSERVATION_MODIFIER", 10, 17], ["defects", "OBSERVATION", 18, 25], ["ventricular septal", "ANATOMY", 32, 50], ["defect", "OBSERVATION", 51, 57], ["high", "OBSERVATION_MODIFIER", 66, 70], ["septum", "ANATOMY", 78, 84], ["pulmonic", "ANATOMY", 86, 94], ["stenosis", "OBSERVATION", 95, 103], ["aorta", "ANATOMY", 154, 159]]], ["The fourth defect, which develops secondarily, is hypertrophy of the right ventricular myocardium.", [["right ventricular myocardium", "ANATOMY", 69, 97], ["hypertrophy of the right ventricular myocardium", "DISEASE", 50, 97], ["ventricular myocardium", "MULTI-TISSUE_STRUCTURE", 75, 97], ["The fourth defect", "PROBLEM", 0, 17], ["hypertrophy of the right ventricular myocardium", "PROBLEM", 50, 97], ["fourth", "OBSERVATION_MODIFIER", 4, 10], ["defect", "OBSERVATION", 11, 17], ["hypertrophy", "OBSERVATION", 50, 61], ["right ventricular myocardium", "ANATOMY", 69, 97]]], ["The major pathophysiologic significance in this condition is the increased pressure in the right side that shunts unoxygenated blood from the hypertrophic right side to the underdeveloped left side (systemic circulation) and results in systemic hypoxemia and secondary polycythemia.", [["blood", "ANATOMY", 127, 132], ["left side", "ANATOMY", 188, 197], ["hypoxemia", "DISEASE", 245, 254], ["polycythemia", "DISEASE", 269, 281], ["blood", "ORGANISM_SUBSTANCE", 127, 132], ["the increased pressure in the right side", "PROBLEM", 61, 101], ["shunts unoxygenated blood", "PROBLEM", 107, 132], ["the hypertrophic right side", "PROBLEM", 138, 165], ["systemic hypoxemia", "PROBLEM", 236, 254], ["secondary polycythemia", "PROBLEM", 259, 281], ["increased", "OBSERVATION_MODIFIER", 65, 74], ["pressure", "OBSERVATION_MODIFIER", 75, 83], ["right", "ANATOMY_MODIFIER", 91, 96], ["shunts", "OBSERVATION", 107, 113], ["hypertrophic", "OBSERVATION_MODIFIER", 142, 154], ["right", "ANATOMY_MODIFIER", 155, 160], ["left", "ANATOMY_MODIFIER", 188, 192], ["systemic circulation", "ANATOMY", 199, 219], ["systemic", "OBSERVATION_MODIFIER", 236, 244], ["hypoxemia", "OBSERVATION", 245, 254], ["secondary polycythemia", "OBSERVATION", 259, 281]]], ["Cyanosis is often an associated clinical sign.", [["Cyanosis", "DISEASE", 0, 8], ["Cyanosis", "PROBLEM", 0, 8]]], ["The anomaly is one of the most common cardiac abnormalities seen in hearts of human beings (so-called blue babies).", [["cardiac", "ANATOMY", 38, 45], ["hearts", "ANATOMY", 68, 74], ["cardiac abnormalities", "DISEASE", 38, 59], ["cardiac", "ORGAN", 38, 45], ["hearts", "ORGAN", 68, 74], ["human", "ORGANISM", 78, 83], ["blue babies", "ORGANISM", 102, 113], ["human", "SPECIES", 78, 83], ["human", "SPECIES", 78, 83], ["The anomaly", "PROBLEM", 0, 11], ["the most common cardiac abnormalities", "PROBLEM", 22, 59], ["anomaly", "OBSERVATION", 4, 11], ["one", "OBSERVATION_MODIFIER", 15, 18], ["cardiac", "ANATOMY", 38, 45], ["abnormalities", "OBSERVATION", 46, 59], ["hearts", "ANATOMY", 68, 74]]], ["This complex anomaly is inherited in keeshond dogs and is frequent in English bulldogs.", [["bulldogs", "CANCER", 78, 86], ["dogs", "SPECIES", 46, 50], ["This complex anomaly", "PROBLEM", 0, 20], ["complex", "OBSERVATION_MODIFIER", 5, 12], ["anomaly", "OBSERVATION", 13, 20], ["frequent", "OBSERVATION_MODIFIER", 58, 66]]], ["In genetic and pathologic studies of keeshond dogs, the basic defect has been determined to be hypoplasia and malpositioning of the conotruncal septum.", [["conotruncal septum", "ANATOMY", 132, 150], ["hypoplasia", "DISEASE", 95, 105], ["keeshond dogs", "ORGANISM", 37, 50], ["conotruncal septum", "MULTI-TISSUE_STRUCTURE", 132, 150], ["dogs", "SPECIES", 46, 50], ["keeshond dogs", "PROBLEM", 37, 50], ["the basic defect", "PROBLEM", 52, 68], ["hypoplasia", "PROBLEM", 95, 105], ["malpositioning of the conotruncal septum", "PROBLEM", 110, 150], ["defect", "OBSERVATION", 62, 68], ["determined to be", "UNCERTAINTY", 78, 94], ["hypoplasia", "OBSERVATION", 95, 105], ["malpositioning", "OBSERVATION", 110, 124], ["conotruncal septum", "ANATOMY", 132, 150]]], ["Wide variability in the severity of the lesions has been observed.", [["lesions", "ANATOMY", 40, 47], ["lesions", "PATHOLOGICAL_FORMATION", 40, 47], ["Wide variability", "PROBLEM", 0, 16], ["the lesions", "PROBLEM", 36, 47], ["variability", "OBSERVATION_MODIFIER", 5, 16], ["severity", "OBSERVATION_MODIFIER", 24, 32], ["lesions", "OBSERVATION", 40, 47]]], ["The inheritance pattern in keeshonds is a simple autosomal locus with partial penetration in heterozygotes and complete penetrance in homozygotes.Failure of Normal Valvular DevelopmentPulmonic Stenosis.", [["Valvular", "ANATOMY", 164, 172], ["Valvular DevelopmentPulmonic Stenosis", "DISEASE", 164, 201], ["keeshonds", "CANCER", 27, 36], ["a simple autosomal locus", "PROBLEM", 40, 64], ["partial penetration in heterozygotes", "PROBLEM", 70, 106], ["complete penetrance in homozygotes", "PROBLEM", 111, 145], ["Failure of Normal Valvular DevelopmentPulmonic Stenosis", "PROBLEM", 146, 201], ["inheritance", "OBSERVATION", 4, 15], ["simple", "OBSERVATION_MODIFIER", 42, 48], ["autosomal", "OBSERVATION_MODIFIER", 49, 58], ["locus", "OBSERVATION_MODIFIER", 59, 64], ["partial", "OBSERVATION_MODIFIER", 70, 77], ["penetration", "OBSERVATION_MODIFIER", 78, 89], ["complete", "OBSERVATION_MODIFIER", 111, 119], ["penetrance", "OBSERVATION", 120, 130], ["Normal", "OBSERVATION", 157, 163], ["Valvular", "OBSERVATION", 164, 172], ["DevelopmentPulmonic Stenosis", "OBSERVATION", 173, 201]]], ["Pulmonic stenosis has been recognized as a frequently occurring anomaly in dogs and is inherited in the beagle (Fig. 10-32 ).", [["Pulmonic stenosis", "DISEASE", 0, 17], ["dogs", "ORGANISM", 75, 79], ["beagle", "ORGANISM_SUBDIVISION", 104, 110], ["dogs", "SPECIES", 75, 79], ["Pulmonic stenosis", "PROBLEM", 0, 17], ["a frequently occurring anomaly in dogs", "PROBLEM", 41, 79], ["stenosis", "OBSERVATION", 9, 17]]], ["Other breeds in which this lesion is frequent are basset hound, boxer, Chihuahua, Chow Chow, cocker spaniel, English bulldog, Labrador retriever, mastiff, Newfoundland, Samoyed, schnauzer, and terrier.", [["lesion", "ANATOMY", 27, 33], ["Labrador retriever", "SPECIES", 126, 144], ["Labrador retriever", "SPECIES", 126, 144], ["Other breeds", "PROBLEM", 0, 12], ["this lesion", "PROBLEM", 22, 33], ["lesion", "OBSERVATION", 27, 33], ["frequent", "OBSERVATION_MODIFIER", 37, 45]]], ["Several types of valvular lesions have been described and include formation of a circumferential band of fibrous Sites of the major cardiovascular anomalies in the dog are shown in Fig. 10-29 .Developmental Errors/Congenital Anomalies: MyocardiumSee the following section on Developmental Errors/Congenital Anomalies: Endocardium and Heart Valves.Failure of Closure of Fetal Cardiovascular ShuntsInterventricular Septal Defect.", [["valvular lesions", "ANATOMY", 17, 33], ["cardiovascular", "ANATOMY", 132, 146], ["Heart", "ANATOMY", 334, 339], ["Cardiovascular", "ANATOMY", 375, 389], ["valvular lesions", "DISEASE", 17, 33], ["cardiovascular anomalies", "DISEASE", 132, 156], ["Congenital Anomalies", "DISEASE", 214, 234], ["Congenital Anomalies", "DISEASE", 296, 316], ["valvular lesions", "PATHOLOGICAL_FORMATION", 17, 33], ["cardiovascular", "ANATOMICAL_SYSTEM", 132, 146], ["dog", "ORGANISM", 164, 167], ["dog", "SPECIES", 164, 167], ["valvular lesions", "PROBLEM", 17, 33], ["a circumferential band of fibrous Sites", "PROBLEM", 79, 118], ["the major cardiovascular anomalies", "PROBLEM", 122, 156], ["Congenital Anomalies", "PROBLEM", 214, 234], ["Congenital Anomalies", "PROBLEM", 296, 316], ["Endocardium and Heart Valves", "TREATMENT", 318, 346], ["Failure of Closure", "PROBLEM", 347, 365], ["Fetal Cardiovascular ShuntsInterventricular Septal Defect", "PROBLEM", 369, 426], ["valvular", "ANATOMY", 17, 25], ["lesions", "OBSERVATION", 26, 33], ["circumferential", "OBSERVATION_MODIFIER", 81, 96], ["band", "OBSERVATION_MODIFIER", 97, 101], ["fibrous Sites", "OBSERVATION", 105, 118], ["major", "OBSERVATION_MODIFIER", 126, 131], ["cardiovascular anomalies", "OBSERVATION", 132, 156], ["Congenital Anomalies", "OBSERVATION", 214, 234], ["Congenital", "OBSERVATION", 296, 306], ["Endocardium", "ANATOMY", 318, 329], ["Heart Valves", "ANATOMY", 334, 346], ["Closure", "OBSERVATION", 358, 365], ["Fetal", "ANATOMY_MODIFIER", 369, 374], ["Cardiovascular Shunts", "OBSERVATION", 375, 396], ["Interventricular", "ANATOMY_MODIFIER", 396, 412], ["Septal", "ANATOMY_MODIFIER", 413, 419], ["Defect", "OBSERVATION", 420, 426]]], ["A ventricular septal defect indicates failure of complete development of the interventricular septum and allows the shunting of blood between the ventricles (Fig. 10-30) .", [["ventricular septal", "ANATOMY", 2, 20], ["interventricular septum", "ANATOMY", 77, 100], ["blood", "ANATOMY", 128, 133], ["ventricles", "ANATOMY", 146, 156], ["ventricular septal defect", "DISEASE", 2, 27], ["ventricular septal", "MULTI-TISSUE_STRUCTURE", 2, 20], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 77, 100], ["blood", "ORGANISM_SUBSTANCE", 128, 133], ["ventricles", "MULTI-TISSUE_STRUCTURE", 146, 156], ["A ventricular septal defect", "PROBLEM", 0, 27], ["the interventricular septum", "PROBLEM", 73, 100], ["the shunting of blood between the ventricles", "PROBLEM", 112, 156], ["ventricular", "ANATOMY", 2, 13], ["septal", "ANATOMY_MODIFIER", 14, 20], ["defect", "OBSERVATION", 21, 27], ["failure", "OBSERVATION", 38, 45], ["interventricular septum", "ANATOMY", 77, 100], ["shunting", "OBSERVATION", 116, 124], ["blood", "OBSERVATION", 128, 133], ["ventricles", "ANATOMY", 146, 156]]], ["The defect occurs in many species and more commonly in the upper interventricular septum-below the aortic valves (on the left), proximal to the crista supraventricularis (near the septal tri- (Fig. 10-34) .", [["upper interventricular septum", "ANATOMY", 59, 88], ["aortic valves", "ANATOMY", 99, 112], ["left", "ANATOMY", 121, 125], ["crista supraventricularis", "ANATOMY", 144, 169], ["septal tri", "ANATOMY", 180, 190], ["upper", "ORGANISM_SUBDIVISION", 59, 64], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 65, 88], ["aortic valves", "MULTI-TISSUE_STRUCTURE", 99, 112], ["crista supraventricularis", "CANCER", 144, 169], ["The defect", "PROBLEM", 0, 10], ["many species", "PROBLEM", 21, 33], ["defect", "OBSERVATION", 4, 10], ["many", "OBSERVATION_MODIFIER", 21, 25], ["species", "OBSERVATION_MODIFIER", 26, 33], ["upper", "ANATOMY_MODIFIER", 59, 64], ["interventricular septum", "ANATOMY", 65, 88], ["below", "ANATOMY_MODIFIER", 89, 94], ["aortic valves", "ANATOMY", 99, 112], ["left", "ANATOMY_MODIFIER", 121, 125], ["proximal", "ANATOMY_MODIFIER", 128, 136], ["crista", "ANATOMY_MODIFIER", 144, 150], ["supraventricularis", "ANATOMY_MODIFIER", 151, 169], ["septal", "ANATOMY_MODIFIER", 180, 186], ["tri", "ANATOMY_MODIFIER", 187, 190]]], ["Endocardial cushion defects are the most common congenital cardiac anomaly seen in cats.Failure of Closure of Fetal Cardiovascular ShuntsTricuspid Valve Dysplasia.", [["Endocardial cushion", "ANATOMY", 0, 19], ["cardiac", "ANATOMY", 59, 66], ["Cardiovascular", "ANATOMY", 116, 130], ["Endocardial cushion defects", "DISEASE", 0, 27], ["cardiac anomaly", "DISEASE", 59, 74], ["Dysplasia", "DISEASE", 153, 162], ["cardiac anomaly", "PATHOLOGICAL_FORMATION", 59, 74], ["cats", "ORGANISM", 83, 87], ["cats", "SPECIES", 83, 87], ["Endocardial cushion defects", "PROBLEM", 0, 27], ["congenital cardiac anomaly", "PROBLEM", 48, 74], ["Failure of Closure", "PROBLEM", 88, 106], ["Fetal Cardiovascular ShuntsTricuspid Valve Dysplasia", "PROBLEM", 110, 162], ["cushion defects", "OBSERVATION", 12, 27], ["most common", "OBSERVATION_MODIFIER", 36, 47], ["cardiac", "ANATOMY", 59, 66], ["anomaly", "OBSERVATION", 67, 74], ["Closure", "OBSERVATION", 99, 106], ["Fetal", "ANATOMY_MODIFIER", 110, 115], ["Cardiovascular Shunts", "OBSERVATION", 116, 137], ["Tricuspid Valve", "ANATOMY", 137, 152], ["Dysplasia", "OBSERVATION", 153, 162]]], ["Tricuspid valve dysplasia has a genetic basis in the Labrador retriever dog, in which it is an autosomal dominant trait with reduced penetrance that is mapped to chromosome 9.", [["Tricuspid valve dysplasia", "ANATOMY", 0, 25], ["chromosome 9", "ANATOMY", 162, 174], ["Tricuspid valve dysplasia", "DISEASE", 0, 25], ["Tricuspid valve dysplasia", "PATHOLOGICAL_FORMATION", 0, 25], ["Labrador retriever dog", "ORGANISM", 53, 75], ["chromosome 9", "CELLULAR_COMPONENT", 162, 174], ["chromosome 9", "DNA", 162, 174], ["Labrador retriever dog", "SPECIES", 53, 75], ["Labrador retriever dog", "SPECIES", 53, 75], ["Tricuspid valve dysplasia", "PROBLEM", 0, 25], ["an autosomal dominant trait", "PROBLEM", 92, 119], ["reduced penetrance", "PROBLEM", 125, 143], ["valve", "ANATOMY", 10, 15], ["dysplasia", "OBSERVATION", 16, 25], ["autosomal", "OBSERVATION_MODIFIER", 95, 104], ["dominant trait", "OBSERVATION", 105, 119], ["reduced", "OBSERVATION_MODIFIER", 125, 132], ["penetrance", "OBSERVATION", 133, 143]]], ["There is a wide spectrum of morphologic abnormalities that may include (1) shortening, rolling, notching, and thickening of or muscular tissue beneath the valve (subvalvular stenosis) or malformation of the valve (valvular stenosis), with a small central orifice in a dome of thickened valvular tissue.", [["muscular tissue", "ANATOMY", 127, 142], ["valve", "ANATOMY", 155, 160], ["subvalvular", "ANATOMY", 162, 173], ["valve", "ANATOMY", 207, 212], ["valvular", "ANATOMY", 214, 222], ["valvular tissue", "ANATOMY", 286, 301], ["subvalvular stenosis", "DISEASE", 162, 182], ["malformation of the valve", "DISEASE", 187, 212], ["valvular stenosis", "DISEASE", 214, 231], ["muscular tissue", "TISSUE", 127, 142], ["valve", "TISSUE", 155, 160], ["subvalvular", "MULTI-TISSUE_STRUCTURE", 162, 173], ["valve", "PATHOLOGICAL_FORMATION", 207, 212], ["valvular stenosis", "PATHOLOGICAL_FORMATION", 214, 231], ["valvular tissue", "TISSUE", 286, 301], ["morphologic abnormalities", "PROBLEM", 28, 53], ["shortening, rolling, notching", "PROBLEM", 75, 104], ["thickening of or muscular tissue", "PROBLEM", 110, 142], ["subvalvular stenosis)", "PROBLEM", 162, 183], ["malformation of the valve (valvular stenosis)", "PROBLEM", 187, 232], ["a small central orifice", "PROBLEM", 239, 262], ["thickened valvular tissue", "PROBLEM", 276, 301], ["wide", "OBSERVATION_MODIFIER", 11, 15], ["morphologic", "OBSERVATION_MODIFIER", 28, 39], ["abnormalities", "OBSERVATION", 40, 53], ["may include", "UNCERTAINTY", 59, 70], ["rolling", "OBSERVATION_MODIFIER", 87, 94], ["notching", "OBSERVATION_MODIFIER", 96, 104], ["thickening", "OBSERVATION", 110, 120], ["muscular tissue", "ANATOMY", 127, 142], ["valve", "ANATOMY", 155, 160], ["subvalvular", "ANATOMY_MODIFIER", 162, 173], ["stenosis", "OBSERVATION", 174, 182], ["malformation", "OBSERVATION", 187, 199], ["valve", "ANATOMY", 207, 212], ["valvular", "ANATOMY", 214, 222], ["stenosis", "OBSERVATION", 223, 231], ["small", "OBSERVATION_MODIFIER", 241, 246], ["central", "OBSERVATION_MODIFIER", 247, 254], ["orifice", "OBSERVATION_MODIFIER", 255, 262], ["dome", "OBSERVATION_MODIFIER", 268, 272], ["thickened", "OBSERVATION", 276, 285], ["valvular tissue", "OBSERVATION", 286, 301]]], ["A unique form of subvalvular pulmonic stenosis has been described in English bulldogs and boxers in which an anomalous development of a coronary artery obstructs the right ventricular outflow tract.", [["subvalvular pulmonic", "ANATOMY", 17, 37], ["coronary artery", "ANATOMY", 136, 151], ["right ventricular outflow tract", "ANATOMY", 166, 197], ["subvalvular pulmonic stenosis", "DISEASE", 17, 46], ["subvalvular pulmonic", "PATHOLOGICAL_FORMATION", 17, 37], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 136, 151], ["right ventricular", "MULTI-TISSUE_STRUCTURE", 166, 183], ["outflow tract", "ORGANISM_SUBDIVISION", 184, 197], ["subvalvular pulmonic stenosis", "PROBLEM", 17, 46], ["subvalvular pulmonic", "ANATOMY", 17, 37], ["stenosis", "OBSERVATION", 38, 46], ["anomalous", "OBSERVATION", 109, 118], ["coronary artery", "ANATOMY", 136, 151], ["obstructs", "OBSERVATION", 152, 161], ["right ventricular", "ANATOMY", 166, 183], ["outflow tract", "ANATOMY", 184, 197]]], ["Notable concentric hypertrophy (see the discussion on hypertrophy in the section on Responses to Injury: Myocardium, Disturbances of Growth) of the right ventricle develops from the resulting pressure overload.Failure of Closure of Fetal Cardiovascular ShuntsAortic and Subaortic Stenoses.", [["right ventricle", "ANATOMY", 148, 163], ["Cardiovascular", "ANATOMY", 238, 252], ["hypertrophy", "DISEASE", 19, 30], ["hypertrophy", "DISEASE", 54, 65], ["Injury", "DISEASE", 97, 103], ["pressure overload", "DISEASE", 192, 209], ["Fetal Cardiovascular ShuntsAortic and Subaortic Stenoses", "DISEASE", 232, 288], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 148, 163], ["Notable concentric hypertrophy", "PROBLEM", 0, 30], ["hypertrophy", "PROBLEM", 54, 65], ["Myocardium", "PROBLEM", 105, 115], ["the resulting pressure overload", "PROBLEM", 178, 209], ["Failure of Closure", "PROBLEM", 210, 228], ["Fetal Cardiovascular ShuntsAortic and Subaortic Stenoses", "PROBLEM", 232, 288], ["concentric", "OBSERVATION_MODIFIER", 8, 18], ["hypertrophy", "OBSERVATION", 19, 30], ["hypertrophy", "OBSERVATION", 54, 65], ["Myocardium", "ANATOMY", 105, 115], ["right ventricle", "ANATOMY", 148, 163], ["pressure overload", "OBSERVATION", 192, 209], ["Closure", "OBSERVATION", 221, 228], ["Fetal", "ANATOMY_MODIFIER", 232, 237], ["Cardiovascular", "ANATOMY", 238, 252], ["ShuntsAortic", "OBSERVATION_MODIFIER", 253, 265], ["Subaortic", "OBSERVATION_MODIFIER", 270, 279], ["Stenoses", "OBSERVATION", 280, 288]]], ["True stenoses of the aortic valve are uncommon.", [["aortic valve", "ANATOMY", 21, 33], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 21, 33], ["True stenoses of the aortic valve", "PROBLEM", 0, 33], ["stenoses", "OBSERVATION", 5, 13], ["aortic valve", "ANATOMY", 21, 33]]], ["Subaortic stenosis is a cardiac anomaly frequently observed in pigs and dogs.", [["Subaortic", "ANATOMY", 0, 9], ["cardiac", "ANATOMY", 24, 31], ["Subaortic stenosis", "DISEASE", 0, 18], ["cardiac anomaly", "DISEASE", 24, 39], ["Subaortic", "MULTI-TISSUE_STRUCTURE", 0, 9], ["pigs", "ORGANISM", 63, 67], ["dogs", "ORGANISM", 72, 76], ["pigs", "SPECIES", 63, 67], ["dogs", "SPECIES", 72, 76], ["pigs", "SPECIES", 63, 67], ["Subaortic stenosis", "PROBLEM", 0, 18], ["a cardiac anomaly", "PROBLEM", 22, 39], ["stenosis", "OBSERVATION", 10, 18], ["cardiac", "ANATOMY", 24, 31], ["anomaly", "OBSERVATION", 32, 39]]], ["Subvalvular aortic stenosis is the most common congenital cardiac anomaly of large-breed dogs.", [["aortic", "ANATOMY", 12, 18], ["cardiac", "ANATOMY", 58, 65], ["Subvalvular aortic stenosis", "DISEASE", 0, 27], ["cardiac anomaly", "DISEASE", 58, 73], ["aortic", "MULTI-TISSUE_STRUCTURE", 12, 18], ["cardiac", "ORGAN", 58, 65], ["dogs", "ORGANISM", 89, 93], ["dogs", "SPECIES", 89, 93], ["Subvalvular aortic stenosis", "PROBLEM", 0, 27], ["congenital cardiac anomaly", "PROBLEM", 47, 73], ["large-breed dogs", "PROBLEM", 77, 93], ["aortic", "ANATOMY", 12, 18], ["stenosis", "OBSERVATION", 19, 27], ["cardiac", "ANATOMY", 58, 65], ["anomaly", "OBSERVATION", 66, 73], ["large", "OBSERVATION_MODIFIER", 77, 82], ["breed dogs", "OBSERVATION", 83, 93]]], ["Bull terriers and boxers are predisposed, and a genetic basis is present in the Newfoundland dog, in which subvalvular aortic stenosis is inherited in an autosomal dominant pattern.", [["subvalvular aortic", "ANATOMY", 107, 125], ["subvalvular aortic stenosis", "DISEASE", 107, 134], ["boxers", "MULTI-TISSUE_STRUCTURE", 18, 24], ["dog", "ORGANISM", 93, 96], ["subvalvular aortic", "MULTI-TISSUE_STRUCTURE", 107, 125], ["Newfoundland dog", "SPECIES", 80, 96], ["Bull terriers", "PROBLEM", 0, 13], ["subvalvular aortic stenosis", "PROBLEM", 107, 134], ["an autosomal dominant pattern", "PROBLEM", 151, 180], ["terriers", "OBSERVATION", 5, 13], ["subvalvular aortic", "ANATOMY", 107, 125], ["stenosis", "OBSERVATION", 126, 134], ["autosomal", "OBSERVATION_MODIFIER", 154, 163], ["dominant", "OBSERVATION_MODIFIER", 164, 172], ["pattern", "OBSERVATION_MODIFIER", 173, 180]]], ["Obstruction of the left ventricular outflow tract (LVOT) results from a raised, partial or complete fibrous ring that arises from the endocardium below the aortic valve and may extend to involve the cranioventral leaflet of the mitral valve and the base of the aortic valve ( Fig. 10-33) .", [["left ventricular outflow tract", "ANATOMY", 19, 49], ["LVOT", "ANATOMY", 51, 55], ["fibrous ring", "ANATOMY", 100, 112], ["endocardium", "ANATOMY", 134, 145], ["aortic valve", "ANATOMY", 156, 168], ["cranioventral leaflet", "ANATOMY", 199, 220], ["mitral valve", "ANATOMY", 228, 240], ["aortic valve", "ANATOMY", 261, 273], ["ventricular outflow tract", "MULTI-TISSUE_STRUCTURE", 24, 49], ["fibrous ring", "TISSUE", 100, 112], ["endocardium", "TISSUE", 134, 145], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 156, 168], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 228, 240], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 261, 273], ["Obstruction of the left ventricular outflow tract", "PROBLEM", 0, 49], ["a raised, partial or complete fibrous ring", "PROBLEM", 70, 112], ["left ventricular", "ANATOMY", 19, 35], ["outflow tract", "ANATOMY", 36, 49], ["LVOT", "ANATOMY_MODIFIER", 51, 55], ["partial", "OBSERVATION_MODIFIER", 80, 87], ["complete", "OBSERVATION_MODIFIER", 91, 99], ["fibrous ring", "OBSERVATION", 100, 112], ["endocardium", "ANATOMY_MODIFIER", 134, 145], ["aortic valve", "ANATOMY", 156, 168], ["cranioventral", "ANATOMY_MODIFIER", 199, 212], ["leaflet", "ANATOMY_MODIFIER", 213, 220], ["mitral valve", "ANATOMY", 228, 240], ["base", "ANATOMY_MODIFIER", 249, 253], ["aortic valve", "ANATOMY", 261, 273]]], ["The lesion is also observed in the German shorthair pointer, golden retriever, Great Dane, Rottweiler, Samoyed, and bull terrier breeds.", [["lesion", "ANATOMY", 4, 10], ["golden retriever", "SPECIES", 61, 77], ["The lesion", "PROBLEM", 0, 10], ["bull terrier breeds", "PROBLEM", 116, 135], ["lesion", "OBSERVATION", 4, 10], ["golden retriever", "OBSERVATION", 61, 77], ["Great", "OBSERVATION_MODIFIER", 79, 84], ["terrier breeds", "OBSERVATION", 121, 135]]], ["In clinical cases, the stenosis is produced by the presence of a thick zone of endocardial fibrous tissue that encircles the LVOT below the valve.", [["endocardial fibrous tissue", "ANATOMY", 79, 105], ["LVOT", "ANATOMY", 125, 129], ["valve", "ANATOMY", 140, 145], ["stenosis", "DISEASE", 23, 31], ["endocardial fibrous tissue", "TISSUE", 79, 105], ["valve", "PATHOLOGICAL_FORMATION", 140, 145], ["the stenosis", "PROBLEM", 19, 31], ["a thick zone of endocardial fibrous tissue", "PROBLEM", 63, 105], ["stenosis", "OBSERVATION", 23, 31], ["thick", "OBSERVATION_MODIFIER", 65, 70], ["zone", "OBSERVATION_MODIFIER", 71, 75], ["endocardial", "ANATOMY", 79, 90], ["fibrous tissue", "OBSERVATION", 91, 105], ["LVOT", "OBSERVATION", 125, 129], ["valve", "ANATOMY", 140, 145]]], ["In mild cases, often subclinical, the lesion is limited to white nodules on the ventricular septum immediately below the valve.", [["lesion", "ANATOMY", 38, 44], ["white nodules", "ANATOMY", 59, 72], ["ventricular septum", "ANATOMY", 80, 98], ["valve", "ANATOMY", 121, 126], ["nodules", "CANCER", 65, 72], ["ventricular septum", "MULTI-TISSUE_STRUCTURE", 80, 98], ["valve", "PATHOLOGICAL_FORMATION", 121, 126], ["the lesion", "PROBLEM", 34, 44], ["white nodules", "PROBLEM", 59, 72], ["mild", "OBSERVATION_MODIFIER", 3, 7], ["cases", "OBSERVATION", 8, 13], ["lesion", "OBSERVATION", 38, 44], ["white", "OBSERVATION_MODIFIER", 59, 64], ["nodules", "OBSERVATION", 65, 72], ["ventricular septum", "ANATOMY", 80, 98], ["valve", "ANATOMY", 121, 126]]], ["Microscopically, the altered endocardial tissue contains loosely arranged elastic fibers, mucopolysaccharide ground substance, and collagen fibers admixed with fibroblasts and chondrocyte-like cells.", [["endocardial tissue", "ANATOMY", 29, 47], ["elastic fibers", "ANATOMY", 74, 88], ["collagen fibers", "ANATOMY", 131, 146], ["fibroblasts", "ANATOMY", 160, 171], ["chondrocyte-like cells", "ANATOMY", 176, 198], ["endocardial tissue", "TISSUE", 29, 47], ["elastic fibers", "CELLULAR_COMPONENT", 74, 88], ["mucopolysaccharide ground substance", "GENE_OR_GENE_PRODUCT", 90, 125], ["collagen", "GENE_OR_GENE_PRODUCT", 131, 139], ["fibroblasts", "CELL", 160, 171], ["chondrocyte-like cells", "CELL", 176, 198], ["fibroblasts", "CELL_TYPE", 160, 171], ["chondrocyte-like cells", "CELL_TYPE", 176, 198], ["the altered endocardial tissue", "PROBLEM", 17, 47], ["mucopolysaccharide ground substance", "PROBLEM", 90, 125], ["collagen fibers", "PROBLEM", 131, 146], ["fibroblasts and chondrocyte-like cells", "PROBLEM", 160, 198], ["altered", "OBSERVATION_MODIFIER", 21, 28], ["endocardial tissue", "OBSERVATION", 29, 47], ["loosely", "OBSERVATION_MODIFIER", 57, 64], ["elastic fibers", "OBSERVATION", 74, 88], ["mucopolysaccharide ground substance", "OBSERVATION", 90, 125], ["collagen fibers", "OBSERVATION_MODIFIER", 131, 146], ["chondrocyte", "ANATOMY", 176, 187], ["like cells", "OBSERVATION", 188, 198]]], ["Other cardiac lesions develop as a result of the altered left ventricular outflow; these include left ventricular concentric hypertrophy, disseminated foci of myocardial necrosis, fibrosis in the inner left ventricular wall, and thickening of the walls of intramyocardial arteries.Failure of Closure of Fetal Cardiovascular ShuntsValvular Dysplasias: Endocardial Cushion Defects.", [["cardiac lesions", "ANATOMY", 6, 21], ["left ventricular", "ANATOMY", 57, 73], ["left ventricular", "ANATOMY", 97, 113], ["foci", "ANATOMY", 151, 155], ["myocardial", "ANATOMY", 159, 169], ["inner left ventricular wall", "ANATOMY", 196, 223], ["walls", "ANATOMY", 247, 252], ["intramyocardial arteries", "ANATOMY", 256, 280], ["Cardiovascular", "ANATOMY", 309, 323], ["cardiac lesions", "DISEASE", 6, 21], ["hypertrophy", "DISEASE", 125, 136], ["myocardial necrosis", "DISEASE", 159, 178], ["fibrosis", "DISEASE", 180, 188], ["Cardiovascular ShuntsValvular Dysplasias", "DISEASE", 309, 349], ["cardiac lesions", "PATHOLOGICAL_FORMATION", 6, 21], ["left ventricular", "MULTI-TISSUE_STRUCTURE", 57, 73], ["ventricular", "MULTI-TISSUE_STRUCTURE", 102, 113], ["myocardial", "MULTI-TISSUE_STRUCTURE", 159, 169], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 207, 223], ["intramyocardial arteries", "MULTI-TISSUE_STRUCTURE", 256, 280], ["Other cardiac lesions", "PROBLEM", 0, 21], ["the altered left ventricular outflow", "PROBLEM", 45, 81], ["left ventricular concentric hypertrophy", "PROBLEM", 97, 136], ["disseminated foci", "PROBLEM", 138, 155], ["myocardial necrosis", "PROBLEM", 159, 178], ["fibrosis in the inner left ventricular wall", "PROBLEM", 180, 223], ["thickening of the walls of intramyocardial arteries", "PROBLEM", 229, 280], ["Failure of Closure", "PROBLEM", 281, 299], ["Fetal Cardiovascular ShuntsValvular Dysplasias", "PROBLEM", 303, 349], ["Endocardial Cushion Defects", "PROBLEM", 351, 378], ["cardiac", "ANATOMY", 6, 13], ["lesions", "OBSERVATION", 14, 21], ["altered", "OBSERVATION", 49, 56], ["left ventricular", "ANATOMY", 57, 73], ["outflow", "ANATOMY_MODIFIER", 74, 81], ["left ventricular", "ANATOMY", 97, 113], ["concentric", "OBSERVATION_MODIFIER", 114, 124], ["hypertrophy", "OBSERVATION", 125, 136], ["disseminated", "OBSERVATION_MODIFIER", 138, 150], ["foci", "OBSERVATION_MODIFIER", 151, 155], ["myocardial", "ANATOMY", 159, 169], ["necrosis", "OBSERVATION", 170, 178], ["fibrosis", "OBSERVATION", 180, 188], ["inner", "ANATOMY_MODIFIER", 196, 201], ["left ventricular", "ANATOMY", 202, 218], ["wall", "ANATOMY_MODIFIER", 219, 223], ["thickening", "OBSERVATION", 229, 239], ["walls", "ANATOMY_MODIFIER", 247, 252], ["intramyocardial arteries", "ANATOMY", 256, 280], ["Closure", "OBSERVATION", 292, 299], ["Fetal", "ANATOMY_MODIFIER", 303, 308], ["Cardiovascular ShuntsValvular", "ANATOMY", 309, 338], ["Dysplasias", "OBSERVATION", 339, 349], ["Endocardial", "ANATOMY", 351, 362], ["Cushion Defects", "OBSERVATION", 363, 378]]], ["Other valvular developmental anomalies include endocardial cushion defects (persistent AV canal and atrioventricular canal defect) in pigs, sheep, and cats; mitral dysplasia in cats and dogs; and tricuspid A incidental lesion that is rarely found during necropsy and has not been reported to have clinical significance during life.", [["valvular", "ANATOMY", 6, 14], ["endocardial cushion", "ANATOMY", 47, 66], ["AV canal", "ANATOMY", 87, 95], ["atrioventricular canal", "ANATOMY", 100, 122], ["sheep", "ANATOMY", 140, 145], ["mitral dysplasia", "ANATOMY", 157, 173], ["tricuspid A incidental lesion", "ANATOMY", 196, 225], ["valvular developmental anomalies", "DISEASE", 6, 38], ["endocardial cushion defects", "DISEASE", 47, 74], ["atrioventricular canal defect", "DISEASE", 100, 129], ["mitral dysplasia", "DISEASE", 157, 173], ["tricuspid A incidental lesion", "DISEASE", 196, 225], ["AV canal", "MULTI-TISSUE_STRUCTURE", 87, 95], ["atrioventricular canal", "MULTI-TISSUE_STRUCTURE", 100, 122], ["pigs", "ORGANISM", 134, 138], ["sheep", "ORGANISM_SUBDIVISION", 140, 145], ["cats", "ORGANISM", 151, 155], ["mitral dysplasia", "PATHOLOGICAL_FORMATION", 157, 173], ["cats", "ORGANISM", 177, 181], ["pigs", "SPECIES", 134, 138], ["sheep", "SPECIES", 140, 145], ["cats", "SPECIES", 151, 155], ["cats", "SPECIES", 177, 181], ["dogs", "SPECIES", 186, 190], ["pigs", "SPECIES", 134, 138], ["sheep", "SPECIES", 140, 145], ["Other valvular developmental anomalies", "PROBLEM", 0, 38], ["endocardial cushion defects", "PROBLEM", 47, 74], ["persistent AV canal", "PROBLEM", 76, 95], ["atrioventricular canal defect", "PROBLEM", 100, 129], ["mitral dysplasia in cats", "PROBLEM", 157, 181], ["dogs", "PROBLEM", 186, 190], ["tricuspid A incidental lesion", "PROBLEM", 196, 225], ["valvular", "ANATOMY", 6, 14], ["endocardial", "ANATOMY_MODIFIER", 47, 58], ["cushion defects", "OBSERVATION", 59, 74], ["persistent", "OBSERVATION_MODIFIER", 76, 86], ["AV canal", "ANATOMY", 87, 95], ["atrioventricular canal", "ANATOMY", 100, 122], ["defect", "OBSERVATION", 123, 129], ["mitral", "ANATOMY", 157, 163], ["dysplasia", "OBSERVATION", 164, 173], ["tricuspid", "ANATOMY", 196, 205], ["incidental", "OBSERVATION_MODIFIER", 208, 218], ["lesion", "OBSERVATION", 219, 225]]], ["However, there is one report of a dog with a partial tear in the pericardium that was associated with episodes of syncope.Failure of Closure of Fetal Cardiovascular ShuntsIntrapericardial Cysts.", [["pericardium", "ANATOMY", 65, 76], ["Cardiovascular", "ANATOMY", 150, 164], ["syncope", "DISEASE", 114, 121], ["dog", "ORGANISM", 34, 37], ["pericardium", "ORGAN", 65, 76], ["dog", "SPECIES", 34, 37], ["a partial tear in the pericardium", "PROBLEM", 43, 76], ["syncope", "PROBLEM", 114, 121], ["Failure of Closure", "PROBLEM", 122, 140], ["Fetal Cardiovascular ShuntsIntrapericardial Cysts", "PROBLEM", 144, 193], ["partial", "OBSERVATION_MODIFIER", 45, 52], ["tear", "OBSERVATION", 53, 57], ["pericardium", "ANATOMY", 65, 76], ["syncope", "OBSERVATION", 114, 121], ["Closure", "OBSERVATION", 133, 140], ["Fetal", "ANATOMY_MODIFIER", 144, 149], ["Cardiovascular", "ANATOMY", 150, 164], ["Shunts", "ANATOMY_MODIFIER", 165, 171], ["Intrapericardial", "ANATOMY", 171, 187], ["Cysts", "OBSERVATION", 188, 193]]], ["Benign intrapericardial cysts are rare, large fluid-filled masses within the pericardial space that originate from the pericardium and consist of encapsulated and hemorrhagic adipose tissue that possibly originated from congenital entrapment of the omentum or falciform ligament.", [["Benign intrapericardial cysts", "ANATOMY", 0, 29], ["masses", "ANATOMY", 59, 65], ["pericardial space", "ANATOMY", 77, 94], ["pericardium", "ANATOMY", 119, 130], ["adipose tissue", "ANATOMY", 175, 189], ["omentum", "ANATOMY", 249, 256], ["falciform ligament", "ANATOMY", 260, 278], ["intrapericardial cysts", "DISEASE", 7, 29], ["hemorrhagic", "DISEASE", 163, 174], ["congenital entrapment of the omentum", "DISEASE", 220, 256], ["intrapericardial cysts", "PATHOLOGICAL_FORMATION", 7, 29], ["masses", "CANCER", 59, 65], ["pericardial space", "MULTI-TISSUE_STRUCTURE", 77, 94], ["pericardium", "ORGAN", 119, 130], ["adipose tissue", "TISSUE", 175, 189], ["omentum", "TISSUE", 249, 256], ["falciform ligament", "TISSUE", 260, 278], ["Benign intrapericardial cysts", "PROBLEM", 0, 29], ["large fluid-filled masses within the pericardial space", "PROBLEM", 40, 94], ["encapsulated and hemorrhagic adipose tissue", "PROBLEM", 146, 189], ["congenital entrapment of the omentum or falciform ligament", "PROBLEM", 220, 278], ["intrapericardial", "ANATOMY", 7, 23], ["cysts", "OBSERVATION", 24, 29], ["rare", "OBSERVATION_MODIFIER", 34, 38], ["large", "OBSERVATION_MODIFIER", 40, 45], ["fluid", "OBSERVATION", 46, 51], ["filled", "OBSERVATION_MODIFIER", 52, 58], ["masses", "OBSERVATION", 59, 65], ["pericardial", "ANATOMY", 77, 88], ["space", "ANATOMY_MODIFIER", 89, 94], ["pericardium", "ANATOMY", 119, 130], ["encapsulated", "OBSERVATION_MODIFIER", 146, 158], ["hemorrhagic", "OBSERVATION_MODIFIER", 163, 174], ["adipose tissue", "OBSERVATION", 175, 189], ["congenital", "OBSERVATION_MODIFIER", 220, 230], ["entrapment", "OBSERVATION", 231, 241], ["omentum", "ANATOMY", 249, 256], ["falciform ligament", "ANATOMY", 260, 278]]], ["In other cases, these rare lesions are associated with PPDH.Failure of Closure of Fetal Cardiovascular ShuntsPortacaval Shunts.", [["lesions", "ANATOMY", 27, 34], ["Cardiovascular", "ANATOMY", 88, 102], ["PPDH", "DISEASE", 55, 59], ["Fetal Cardiovascular ShuntsPortacaval Shunts", "DISEASE", 82, 126], ["rare lesions", "CANCER", 22, 34], ["these rare lesions", "PROBLEM", 16, 34], ["PPDH", "PROBLEM", 55, 59], ["Failure of Closure", "PROBLEM", 60, 78], ["Fetal Cardiovascular ShuntsPortacaval Shunts", "TREATMENT", 82, 126], ["rare", "OBSERVATION_MODIFIER", 22, 26], ["lesions", "OBSERVATION", 27, 34], ["Closure", "OBSERVATION", 71, 78], ["Fetal", "ANATOMY_MODIFIER", 82, 87], ["Cardiovascular", "ANATOMY", 88, 102], ["ShuntsPortacaval Shunts", "OBSERVATION", 103, 126]]], ["Portacaval shunts occur in animals, particularly in the dog.", [["dog", "ORGANISM", 56, 59], ["dog", "SPECIES", 56, 59], ["Portacaval shunts", "TREATMENT", 0, 17], ["shunts", "OBSERVATION", 11, 17], ["dog", "ANATOMY", 56, 59]]], ["The normal flow from the portal vein is diverted, either partially or completely, to the systemic circulation, thus bypassing the liver (Fig. 10-35) .", [["portal vein", "ANATOMY", 25, 36], ["liver", "ANATOMY", 130, 135], ["portal vein", "MULTI-TISSUE_STRUCTURE", 25, 36], ["liver", "ORGAN", 130, 135], ["normal", "OBSERVATION", 4, 10], ["flow", "OBSERVATION_MODIFIER", 11, 15], ["portal vein", "ANATOMY", 25, 36], ["diverted", "OBSERVATION", 40, 48], ["systemic", "OBSERVATION_MODIFIER", 89, 97], ["circulation", "OBSERVATION_MODIFIER", 98, 109], ["liver", "ANATOMY", 130, 135]]], ["Normal hepatic detoxification of portal flow is incomplete and may result in neurologic signs and elevated circulating bile acids.", [["hepatic", "ANATOMY", 7, 14], ["portal", "ANATOMY", 33, 39], ["neurologic", "ANATOMY", 77, 87], ["bile", "ANATOMY", 119, 123], ["bile acids", "CHEMICAL", 119, 129], ["bile acids", "CHEMICAL", 119, 129], ["hepatic", "MULTI-TISSUE_STRUCTURE", 7, 14], ["portal", "MULTI-TISSUE_STRUCTURE", 33, 39], ["bile acids", "SIMPLE_CHEMICAL", 119, 129], ["neurologic signs", "TEST", 77, 93], ["elevated circulating bile acids", "PROBLEM", 98, 129], ["hepatic", "ANATOMY", 7, 14], ["detoxification", "OBSERVATION", 15, 29], ["portal", "ANATOMY", 33, 39], ["flow", "OBSERVATION", 40, 44], ["elevated", "OBSERVATION_MODIFIER", 98, 106], ["circulating", "OBSERVATION_MODIFIER", 107, 118], ["bile acids", "OBSERVATION", 119, 129]]], ["The resulting nervous system syndrome is termed hepatic encephalopathy.", [["nervous system", "ANATOMY", 14, 28], ["hepatic", "ANATOMY", 48, 55], ["nervous system syndrome", "DISEASE", 14, 37], ["hepatic encephalopathy", "DISEASE", 48, 70], ["nervous system", "ANATOMICAL_SYSTEM", 14, 28], ["hepatic", "ORGAN", 48, 55], ["The resulting nervous system syndrome", "PROBLEM", 0, 37], ["hepatic encephalopathy", "PROBLEM", 48, 70], ["nervous system syndrome", "OBSERVATION", 14, 37], ["hepatic", "ANATOMY", 48, 55], ["encephalopathy", "OBSERVATION", 56, 70]]], ["Specifically, the shunts represent retained fetal vascular structures, as in persistent ductus venosus, or arise from prominent dilation of various portosystemic shunts that normally are quite small vessels.", [["fetal vascular structures", "ANATOMY", 44, 69], ["ductus venosus", "ANATOMY", 88, 102], ["vessels", "ANATOMY", 199, 206], ["fetal vascular structures", "TISSUE", 44, 69], ["ductus venosus", "MULTI-TISSUE_STRUCTURE", 88, 102], ["small vessels", "MULTI-TISSUE_STRUCTURE", 193, 206], ["retained fetal vascular structures", "PROBLEM", 35, 69], ["persistent ductus venosus", "PROBLEM", 77, 102], ["prominent dilation of various portosystemic shunts", "PROBLEM", 118, 168], ["shunts", "OBSERVATION", 18, 24], ["retained", "OBSERVATION", 35, 43], ["fetal", "ANATOMY_MODIFIER", 44, 49], ["vascular structures", "ANATOMY", 50, 69], ["persistent", "OBSERVATION_MODIFIER", 77, 87], ["ductus venosus", "ANATOMY", 88, 102], ["prominent", "OBSERVATION_MODIFIER", 118, 127], ["dilation", "OBSERVATION", 128, 136], ["various", "OBSERVATION_MODIFIER", 140, 147], ["portosystemic shunts", "OBSERVATION", 148, 168], ["small vessels", "OBSERVATION", 193, 206]]], ["See Chapter 8 on diseases of the liver for further details.Failure of Closure of Fetal Cardiovascular ShuntsTetralogy of Fallot.", [["liver", "ANATOMY", 33, 38], ["Cardiovascular", "ANATOMY", 87, 101], ["diseases of the liver", "DISEASE", 17, 38], ["Fetal Cardiovascular ShuntsTetralogy of Fallot", "DISEASE", 81, 127], ["liver", "ORGAN", 33, 38], ["Failure of Closure", "PROBLEM", 59, 77], ["Fetal Cardiovascular ShuntsTetralogy of Fallot", "PROBLEM", 81, 127], ["liver", "ANATOMY", 33, 38], ["Closure", "OBSERVATION", 70, 77], ["Fetal", "ANATOMY_MODIFIER", 81, 86], ["Cardiovascular ShuntsTetralogy", "OBSERVATION", 87, 117], ["Fallot", "OBSERVATION", 121, 127]]], ["See Disorders of Domestic Animals; Developmental Errors/Congenital Anomalies; Developmental Errors/ Congenital Anomalies: Endocardium and Heart Valves, Failure of Closure of Fetal Cardiovascular Shunts, Tetralogy of Fallot.Failure of Closure of Fetal Cardiovascular ShuntsPatent Ductus Arteriosus.", [["Heart", "ANATOMY", 138, 143], ["Cardiovascular", "ANATOMY", 180, 194], ["Cardiovascular", "ANATOMY", 251, 265], ["Developmental Errors", "DISEASE", 35, 55], ["Congenital Anomalies", "DISEASE", 56, 76], ["Developmental Errors", "DISEASE", 78, 98], ["Congenital Anomalies", "DISEASE", 100, 120], ["Heart Valves", "DISEASE", 138, 150], ["Fetal Cardiovascular Shunts", "DISEASE", 174, 201], ["Tetralogy of Fallot", "DISEASE", 203, 222], ["Congenital Anomalies", "PROBLEM", 56, 76], ["Developmental Errors", "PROBLEM", 78, 98], ["Congenital Anomalies", "PROBLEM", 100, 120], ["Endocardium and Heart Valves", "TREATMENT", 122, 150], ["Failure of Closure", "PROBLEM", 152, 170], ["Fetal Cardiovascular Shunts", "TREATMENT", 174, 201], ["Tetralogy of Fallot", "PROBLEM", 203, 222], ["Failure of Closure", "PROBLEM", 223, 241], ["Fetal Cardiovascular ShuntsPatent Ductus Arteriosus", "PROBLEM", 245, 296], ["Endocardium", "ANATOMY", 122, 133], ["Heart Valves", "ANATOMY", 138, 150], ["Failure", "OBSERVATION", 152, 159], ["Closure", "OBSERVATION", 163, 170], ["Fetal", "ANATOMY_MODIFIER", 174, 179], ["Cardiovascular Shunts", "OBSERVATION", 180, 201], ["Fallot", "OBSERVATION", 216, 222], ["Closure", "OBSERVATION", 234, 241], ["Fetal", "ANATOMY_MODIFIER", 245, 250], ["Cardiovascular ShuntsPatent", "ANATOMY", 251, 278], ["Ductus Arteriosus", "ANATOMY", 279, 296]]], ["Patent ductus arteriosus is a frequent anomaly in poodle, collie, Pomeranian, Chihuahua, cocker spaniel, English springer spaniel, German shepherd, keeshond, Maltese, Yorkshire terrier, bichon frise, and Shetland sheepdog breeds ( Fig. 10-36) .", [["ductus arteriosus", "DISEASE", 7, 24], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 7, 24], ["Patent ductus arteriosus", "PROBLEM", 0, 24], ["a frequent anomaly in poodle", "PROBLEM", 28, 56], ["ductus arteriosus", "ANATOMY", 7, 24], ["frequent", "OBSERVATION_MODIFIER", 30, 38], ["anomaly", "OBSERVATION", 39, 46]]], ["In poodles, it is an inherited polygenic trait.", [["an inherited polygenic trait", "PROBLEM", 18, 46], ["inherited", "OBSERVATION_MODIFIER", 21, 30], ["polygenic trait", "OBSERVATION", 31, 46]]], ["Female dogs have a greater incidence.", [["dogs", "ORGANISM", 7, 11], ["dogs", "SPECIES", 7, 11]]], ["The ductus arteriosus is a fetal communication between the aorta and pulmonary artery that serves to divert blood from the right cardiac chamber to the fetal circulation in order to bypass the collapsed fetal lungs.", [["ductus arteriosus", "ANATOMY", 4, 21], ["fetal", "ANATOMY", 27, 32], ["aorta", "ANATOMY", 59, 64], ["pulmonary artery", "ANATOMY", 69, 85], ["blood", "ANATOMY", 108, 113], ["right cardiac chamber", "ANATOMY", 123, 144], ["fetal", "ANATOMY", 152, 157], ["fetal lungs", "ANATOMY", 203, 214], ["ductus arteriosus", "DISEASE", 4, 21], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 4, 21], ["fetal", "TISSUE", 27, 32], ["aorta", "MULTI-TISSUE_STRUCTURE", 59, 64], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 69, 85], ["blood", "ORGANISM_SUBSTANCE", 108, 113], ["cardiac", "ORGAN", 129, 136], ["fetal circulation", "MULTI-TISSUE_STRUCTURE", 152, 169], ["fetal lungs", "ORGAN", 203, 214], ["bypass", "TREATMENT", 182, 188], ["the collapsed fetal lungs", "PROBLEM", 189, 214], ["ductus arteriosus", "ANATOMY", 4, 21], ["fetal communication", "OBSERVATION", 27, 46], ["aorta", "ANATOMY", 59, 64], ["pulmonary artery", "ANATOMY", 69, 85], ["right", "ANATOMY_MODIFIER", 123, 128], ["cardiac", "ANATOMY", 129, 136], ["chamber", "ANATOMY_MODIFIER", 137, 144], ["fetal circulation", "OBSERVATION", 152, 169], ["bypass", "OBSERVATION", 182, 188], ["collapsed", "OBSERVATION", 193, 202], ["fetal", "ANATOMY_MODIFIER", 203, 208], ["lungs", "ANATOMY", 209, 214]]], ["Following parturition, the smooth leaflets; (2) incomplete separation of valvular components from the ventricular wall; (3) elongation, shortening, fusion, and thickening of chordae tendineae; (4) direct insertion of the valve edges into a papillary muscle; or (5) atrophy, fusion, and malpositioning of the papillary muscles and chordae tendineae.Failure of Closure of Fetal Cardiovascular ShuntsMitral Valve Dysplasia.", [["smooth leaflets", "ANATOMY", 27, 42], ["valvular components", "ANATOMY", 73, 92], ["ventricular wall", "ANATOMY", 102, 118], ["chordae tendineae", "ANATOMY", 174, 191], ["valve", "ANATOMY", 221, 226], ["papillary muscle", "ANATOMY", 240, 256], ["papillary muscles", "ANATOMY", 308, 325], ["chordae tendineae", "ANATOMY", 330, 347], ["Cardiovascular", "ANATOMY", 376, 390], ["papillary muscle", "DISEASE", 240, 256], ["atrophy", "DISEASE", 265, 272], ["Dysplasia", "DISEASE", 410, 419], ["smooth leaflets", "TISSUE", 27, 42], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 102, 118], ["papillary muscle", "TISSUE", 240, 256], ["papillary muscles", "TISSUE", 308, 325], ["chordae tendineae", "TISSUE", 330, 347], ["incomplete separation of valvular components", "PROBLEM", 48, 92], ["elongation", "PROBLEM", 124, 134], ["shortening, fusion", "PROBLEM", 136, 154], ["thickening of chordae tendineae", "PROBLEM", 160, 191], ["direct insertion of the valve edges", "TREATMENT", 197, 232], ["atrophy", "PROBLEM", 265, 272], ["fusion", "TREATMENT", 274, 280], ["malpositioning of the papillary muscles", "PROBLEM", 286, 325], ["chordae tendineae", "PROBLEM", 330, 347], ["Failure of Closure", "PROBLEM", 348, 366], ["Fetal Cardiovascular ShuntsMitral Valve Dysplasia", "PROBLEM", 370, 419], ["smooth leaflets", "ANATOMY", 27, 42], ["valvular", "OBSERVATION", 73, 81], ["ventricular wall", "ANATOMY", 102, 118], ["elongation", "OBSERVATION_MODIFIER", 124, 134], ["shortening", "OBSERVATION_MODIFIER", 136, 146], ["fusion", "OBSERVATION", 148, 154], ["thickening", "OBSERVATION", 160, 170], ["chordae tendineae", "ANATOMY", 174, 191], ["valve", "ANATOMY", 221, 226], ["edges", "ANATOMY_MODIFIER", 227, 232], ["papillary muscle", "ANATOMY", 240, 256], ["atrophy", "OBSERVATION", 265, 272], ["fusion", "OBSERVATION", 274, 280], ["malpositioning", "OBSERVATION", 286, 300], ["papillary muscles", "ANATOMY", 308, 325], ["chordae tendineae", "ANATOMY", 330, 347], ["Closure", "OBSERVATION", 359, 366], ["Fetal", "ANATOMY_MODIFIER", 370, 375], ["Cardiovascular Shunts", "OBSERVATION", 376, 397], ["Mitral Valve", "ANATOMY", 397, 409], ["Dysplasia", "OBSERVATION", 410, 419]]], ["Mitral valve dysplasia is often associated with other anomalies, such as ASD/VSD and tricuspid valve dysplasia.", [["Mitral valve dysplasia", "ANATOMY", 0, 22], ["tricuspid valve dysplasia", "ANATOMY", 85, 110], ["Mitral valve dysplasia", "DISEASE", 0, 22], ["ASD", "DISEASE", 73, 76], ["tricuspid valve dysplasia", "DISEASE", 85, 110], ["Mitral valve", "PATHOLOGICAL_FORMATION", 0, 12], ["tricuspid valve", "PATHOLOGICAL_FORMATION", 85, 100], ["dysplasia", "PATHOLOGICAL_FORMATION", 101, 110], ["Mitral valve dysplasia", "PROBLEM", 0, 22], ["other anomalies", "PROBLEM", 48, 63], ["ASD", "PROBLEM", 73, 76], ["VSD", "PROBLEM", 77, 80], ["tricuspid valve dysplasia", "PROBLEM", 85, 110], ["valve", "ANATOMY", 7, 12], ["dysplasia", "OBSERVATION", 13, 22], ["anomalies", "OBSERVATION", 54, 63], ["VSD", "OBSERVATION", 77, 80], ["tricuspid valve", "ANATOMY", 85, 100], ["dysplasia", "OBSERVATION", 101, 110]]], ["A similar spectrum of morphological valvular abnormalities is present in mitral valve dysplasia as described previously for tricuspid valve dysplasia.", [["valvular", "ANATOMY", 36, 44], ["mitral valve dysplasia", "ANATOMY", 73, 95], ["tricuspid valve dysplasia", "ANATOMY", 124, 149], ["valvular abnormalities", "DISEASE", 36, 58], ["mitral valve dysplasia", "DISEASE", 73, 95], ["tricuspid valve dysplasia", "DISEASE", 124, 149], ["valvular", "PATHOLOGICAL_FORMATION", 36, 44], ["mitral valve dysplasia", "PATHOLOGICAL_FORMATION", 73, 95], ["tricuspid valve dysplasia", "PATHOLOGICAL_FORMATION", 124, 149], ["morphological valvular abnormalities", "PROBLEM", 22, 58], ["mitral valve dysplasia", "PROBLEM", 73, 95], ["tricuspid valve dysplasia", "PROBLEM", 124, 149], ["morphological valvular abnormalities", "OBSERVATION", 22, 58], ["mitral valve", "ANATOMY", 73, 85], ["dysplasia", "OBSERVATION", 86, 95], ["tricuspid valve", "ANATOMY", 124, 139], ["dysplasia", "OBSERVATION", 140, 149]]], ["Dysplastic malformations in the atrioventricular valves that result in valvular insufficiency lead to volume overload with resultant atrial dilation and to eccentric ventricular hypertrophy.", [["atrioventricular valves", "ANATOMY", 32, 55], ["valvular", "ANATOMY", 71, 79], ["atrial", "ANATOMY", 133, 139], ["ventricular", "ANATOMY", 166, 177], ["Dysplastic malformations", "DISEASE", 0, 24], ["valvular insufficiency", "DISEASE", 71, 93], ["volume overload", "DISEASE", 102, 117], ["atrial dilation", "DISEASE", 133, 148], ["ventricular hypertrophy", "DISEASE", 166, 189], ["atrioventricular valves", "MULTI-TISSUE_STRUCTURE", 32, 55], ["valvular", "ORGAN", 71, 79], ["atrial", "MULTI-TISSUE_STRUCTURE", 133, 139], ["ventricular", "MULTI-TISSUE_STRUCTURE", 166, 177], ["Dysplastic malformations in the atrioventricular valves", "PROBLEM", 0, 55], ["valvular insufficiency", "PROBLEM", 71, 93], ["volume overload", "PROBLEM", 102, 117], ["resultant atrial dilation", "PROBLEM", 123, 148], ["eccentric ventricular hypertrophy", "PROBLEM", 156, 189], ["malformations", "OBSERVATION", 11, 24], ["atrioventricular valves", "ANATOMY", 32, 55], ["valvular", "ANATOMY", 71, 79], ["insufficiency", "OBSERVATION", 80, 93], ["volume overload", "OBSERVATION", 102, 117], ["resultant", "OBSERVATION_MODIFIER", 123, 132], ["atrial", "ANATOMY", 133, 139], ["dilation", "OBSERVATION", 140, 148], ["eccentric", "OBSERVATION_MODIFIER", 156, 165], ["ventricular", "ANATOMY", 166, 177], ["hypertrophy", "OBSERVATION", 178, 189]]], ["Dysplastic malformations in the atrioventricular valves that result in valvular stenosis lead to reduced ventricular filling with subsequent low cardiac output (history of syncope, collapse, and hypotension) and increased atrial pressure; in the case of mitral stenosis, increased atrial pressure can lead to pulmonary edema initially and dilation of the right ventricle (right-sided heart failure) from prolonged pulmonary hypertension.Developmental Errors/Congenital Anomalies: Pericardium and EpicardiumPeritoneopericardial Diaphragmatic Hernias.", [["atrioventricular valves", "ANATOMY", 32, 55], ["valvular", "ANATOMY", 71, 79], ["ventricular", "ANATOMY", 105, 116], ["cardiac", "ANATOMY", 145, 152], ["atrial", "ANATOMY", 222, 228], ["mitral", "ANATOMY", 254, 260], ["atrial", "ANATOMY", 281, 287], ["pulmonary", "ANATOMY", 309, 318], ["right ventricle", "ANATOMY", 355, 370], ["heart", "ANATOMY", 384, 389], ["pulmonary", "ANATOMY", 414, 423], ["Dysplastic malformations", "DISEASE", 0, 24], ["valvular stenosis", "DISEASE", 71, 88], ["low cardiac output", "DISEASE", 141, 159], ["syncope", "DISEASE", 172, 179], ["collapse", "DISEASE", 181, 189], ["hypotension", "DISEASE", 195, 206], ["mitral stenosis", "DISEASE", 254, 269], ["pulmonary edema", "DISEASE", 309, 324], ["heart failure", "DISEASE", 384, 397], ["pulmonary hypertension", "DISEASE", 414, 436], ["Congenital Anomalies", "DISEASE", 458, 478], ["Diaphragmatic Hernias", "DISEASE", 527, 548], ["Dysplastic malformations", "PATHOLOGICAL_FORMATION", 0, 24], ["atrioventricular valves", "MULTI-TISSUE_STRUCTURE", 32, 55], ["valvular stenosis", "PATHOLOGICAL_FORMATION", 71, 88], ["ventricular", "MULTI-TISSUE_STRUCTURE", 105, 116], ["cardiac", "ORGAN", 145, 152], ["atrial", "MULTI-TISSUE_STRUCTURE", 222, 228], ["mitral", "MULTI-TISSUE_STRUCTURE", 254, 260], ["atrial", "MULTI-TISSUE_STRUCTURE", 281, 287], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 309, 324], ["ventricle", "MULTI-TISSUE_STRUCTURE", 361, 370], ["heart", "ORGAN", 384, 389], ["pulmonary", "ORGAN", 414, 423], ["Dysplastic malformations in the atrioventricular valves", "PROBLEM", 0, 55], ["valvular stenosis", "PROBLEM", 71, 88], ["reduced ventricular filling", "PROBLEM", 97, 124], ["subsequent low cardiac output", "PROBLEM", 130, 159], ["syncope", "PROBLEM", 172, 179], ["collapse", "PROBLEM", 181, 189], ["hypotension", "PROBLEM", 195, 206], ["increased atrial pressure", "PROBLEM", 212, 237], ["mitral stenosis", "PROBLEM", 254, 269], ["increased atrial pressure", "PROBLEM", 271, 296], ["pulmonary edema", "PROBLEM", 309, 324], ["dilation of the right ventricle", "PROBLEM", 339, 370], ["right-sided heart failure", "PROBLEM", 372, 397], ["prolonged pulmonary hypertension", "PROBLEM", 404, 436], ["Developmental Errors", "PROBLEM", 437, 457], ["Congenital Anomalies", "PROBLEM", 458, 478], ["Pericardium and EpicardiumPeritoneopericardial Diaphragmatic Hernias", "PROBLEM", 480, 548], ["malformations", "OBSERVATION", 11, 24], ["atrioventricular valves", "ANATOMY", 32, 55], ["valvular", "ANATOMY", 71, 79], ["stenosis", "OBSERVATION", 80, 88], ["reduced", "OBSERVATION_MODIFIER", 97, 104], ["ventricular filling", "OBSERVATION", 105, 124], ["low", "OBSERVATION_MODIFIER", 141, 144], ["cardiac output", "OBSERVATION", 145, 159], ["syncope", "OBSERVATION", 172, 179], ["collapse", "OBSERVATION", 181, 189], ["hypotension", "OBSERVATION", 195, 206], ["increased", "OBSERVATION_MODIFIER", 212, 221], ["atrial pressure", "OBSERVATION", 222, 237], ["mitral", "ANATOMY", 254, 260], ["stenosis", "OBSERVATION", 261, 269], ["increased", "OBSERVATION_MODIFIER", 271, 280], ["atrial pressure", "OBSERVATION", 281, 296], ["pulmonary", "ANATOMY", 309, 318], ["edema", "OBSERVATION", 319, 324], ["dilation", "OBSERVATION", 339, 347], ["right ventricle", "ANATOMY", 355, 370], ["right", "ANATOMY_MODIFIER", 372, 377], ["sided", "ANATOMY_MODIFIER", 378, 383], ["heart", "ANATOMY", 384, 389], ["failure", "OBSERVATION", 390, 397], ["prolonged", "OBSERVATION_MODIFIER", 404, 413], ["pulmonary", "ANATOMY", 414, 423], ["hypertension", "OBSERVATION", 424, 436], ["Pericardium", "ANATOMY", 480, 491], ["EpicardiumPeritoneopericardial", "ANATOMY_MODIFIER", 496, 526], ["Diaphragmatic", "ANATOMY", 527, 540], ["Hernias", "OBSERVATION", 541, 548]]], ["Peritoneopericardial diaphragmatic hernias (PPDHs) occur in cats and dogs with incomplete development of the diaphragm.", [["Peritoneopericardial diaphragmatic hernias", "ANATOMY", 0, 42], ["PPDHs", "ANATOMY", 44, 49], ["diaphragm", "ANATOMY", 109, 118], ["diaphragmatic hernias", "DISEASE", 21, 42], ["PPDHs", "DISEASE", 44, 49], ["diaphragmatic hernias", "PATHOLOGICAL_FORMATION", 21, 42], ["cats", "ORGANISM", 60, 64], ["diaphragm", "ORGAN", 109, 118], ["cats", "SPECIES", 60, 64], ["dogs", "SPECIES", 69, 73], ["Peritoneopericardial diaphragmatic hernias (PPDHs)", "PROBLEM", 0, 50], ["diaphragmatic", "ANATOMY", 21, 34], ["hernias", "OBSERVATION", 35, 42], ["diaphragm", "ANATOMY", 109, 118]]], ["PPDHs are rare, but they are the most common congenital pericardial anomaly in cats; Persian and domestic longhair cats were overrepresented in two studies.", [["pericardial", "ANATOMY", 56, 67], ["PPDHs", "DISEASE", 0, 5], ["congenital pericardial anomaly", "DISEASE", 45, 75], ["PPDHs", "GENE_OR_GENE_PRODUCT", 0, 5], ["pericardial", "ORGAN", 56, 67], ["cats", "ORGANISM", 79, 83], ["cats", "ORGANISM", 115, 119], ["cats", "SPECIES", 79, 83], ["cats", "SPECIES", 115, 119], ["the most common congenital pericardial anomaly in cats", "PROBLEM", 29, 83], ["rare", "OBSERVATION", 10, 14], ["pericardial", "ANATOMY", 56, 67], ["anomaly", "OBSERVATION", 68, 75]]], ["PPDHs result from defective separation of the developing liver and septum transversum during embryogenesis that allows the peritoneal and pericardial cavities to communicate.", [["liver", "ANATOMY", 57, 62], ["septum transversum", "ANATOMY", 67, 85], ["peritoneal", "ANATOMY", 123, 133], ["pericardial cavities", "ANATOMY", 138, 158], ["PPDHs", "GENE_OR_GENE_PRODUCT", 0, 5], ["liver", "ORGAN", 57, 62], ["septum transversum", "MULTI-TISSUE_STRUCTURE", 67, 85], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 123, 133], ["pericardial cavities", "MULTI-TISSUE_STRUCTURE", 138, 158], ["defective separation", "PROBLEM", 18, 38], ["the developing liver and septum transversum", "PROBLEM", 42, 85], ["defective separation", "OBSERVATION", 18, 38], ["liver", "ANATOMY", 57, 62], ["septum", "ANATOMY_MODIFIER", 67, 73], ["transversum", "ANATOMY_MODIFIER", 74, 85], ["embryogenesis", "OBSERVATION", 93, 106], ["peritoneal", "ANATOMY", 123, 133], ["pericardial", "ANATOMY", 138, 149], ["cavities", "OBSERVATION", 150, 158]]], ["Hence, abdominal organs including omental fat may fill the pericardial sac and compress the heart.", [["abdominal organs", "ANATOMY", 7, 23], ["omental fat", "ANATOMY", 34, 45], ["pericardial sac", "ANATOMY", 59, 74], ["heart", "ANATOMY", 92, 97], ["abdominal organs", "MULTI-TISSUE_STRUCTURE", 7, 23], ["omental fat", "TISSUE", 34, 45], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 59, 74], ["heart", "ORGAN", 92, 97], ["abdominal", "ANATOMY_MODIFIER", 7, 16], ["organs", "ANATOMY", 17, 23], ["omental", "ANATOMY", 34, 41], ["fat", "OBSERVATION", 42, 45], ["pericardial", "ANATOMY", 59, 70], ["sac", "ANATOMY_MODIFIER", 71, 74], ["heart", "ANATOMY", 92, 97]]], ["Parts of the liver are often incarcerated in the pericardial sac and may develop intrahepatic myelolipomas.", [["liver", "ANATOMY", 13, 18], ["pericardial sac", "ANATOMY", 49, 64], ["intrahepatic myelolipomas", "ANATOMY", 81, 106], ["intrahepatic myelolipomas", "DISEASE", 81, 106], ["liver", "ORGAN", 13, 18], ["pericardial sac", "ORGAN", 49, 64], ["intrahepatic myelolipomas", "CANCER", 81, 106], ["intrahepatic myelolipomas", "PROBLEM", 81, 106], ["liver", "ANATOMY", 13, 18], ["often", "OBSERVATION_MODIFIER", 23, 28], ["incarcerated", "OBSERVATION", 29, 41], ["pericardial sac", "ANATOMY", 49, 64], ["intrahepatic", "ANATOMY", 81, 93], ["myelolipomas", "OBSERVATION", 94, 106]]], ["Partial/Complete Absence (Agenesis) of the Pericardial Sac.", [["Pericardial Sac.", "ANATOMY", 43, 59], ["Partial/Complete Absence (Agenesis) of the Pericardial Sac.", "PROBLEM", 0, 59], ["Agenesis", "OBSERVATION", 26, 34], ["Pericardial", "ANATOMY", 43, 54]]], ["Partial or complete absence of the pericardial sac is an proximal dilation (megaesophagus), which often results in aspiration pneumonia as the animal matures and consumes solid feed.", [["pericardial sac", "ANATOMY", 35, 50], ["megaesophagus", "ANATOMY", 76, 89], ["pneumonia", "DISEASE", 126, 135], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 35, 50], ["the pericardial sac", "PROBLEM", 31, 50], ["an proximal dilation (megaesophagus)", "PROBLEM", 54, 90], ["aspiration pneumonia", "PROBLEM", 115, 135], ["solid feed", "TREATMENT", 171, 181], ["complete", "OBSERVATION_MODIFIER", 11, 19], ["absence", "OBSERVATION", 20, 27], ["pericardial sac", "ANATOMY", 35, 50], ["proximal", "OBSERVATION_MODIFIER", 57, 65], ["dilation", "OBSERVATION", 66, 74], ["megaesophagus", "OBSERVATION", 76, 89], ["aspiration", "OBSERVATION_MODIFIER", 115, 125], ["pneumonia", "OBSERVATION", 126, 135], ["solid feed", "OBSERVATION", 171, 181]]], ["Transposition of the Aorta and Pulmonary Artery.", [["Pulmonary Artery", "ANATOMY", 31, 47], ["Aorta", "CANCER", 21, 26], ["Pulmonary Artery", "MULTI-TISSUE_STRUCTURE", 31, 47], ["Transposition of the Aorta and Pulmonary Artery", "TREATMENT", 0, 47], ["Aorta", "ANATOMY", 21, 26], ["Pulmonary Artery", "ANATOMY", 31, 47]]], ["Transposition of the aorta and pulmonary artery are severe anomalies, of which there are several types.", [["aorta", "ANATOMY", 21, 26], ["pulmonary artery", "ANATOMY", 31, 47], ["aorta", "MULTI-TISSUE_STRUCTURE", 21, 26], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 31, 47], ["severe anomalies", "PROBLEM", 52, 68], ["aorta", "ANATOMY", 21, 26], ["pulmonary artery", "ANATOMY", 31, 47], ["severe", "OBSERVATION_MODIFIER", 52, 58], ["anomalies", "OBSERVATION", 59, 68], ["several", "OBSERVATION_MODIFIER", 89, 96], ["types", "OBSERVATION_MODIFIER", 97, 102]]], ["In complete transposition, the aorta serves as the outflow from the right ventricle and the pulmonary artery is the left ventricle primary outflow.", [["aorta", "ANATOMY", 31, 36], ["right ventricle", "ANATOMY", 68, 83], ["pulmonary artery", "ANATOMY", 92, 108], ["left ventricle", "ANATOMY", 116, 130], ["aorta", "MULTI-TISSUE_STRUCTURE", 31, 36], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 68, 83], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 92, 108], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 116, 130], ["transposition", "OBSERVATION", 12, 25], ["aorta", "ANATOMY", 31, 36], ["outflow", "OBSERVATION", 51, 58], ["right ventricle", "ANATOMY", 68, 83], ["pulmonary artery", "ANATOMY", 92, 108], ["left ventricle", "ANATOMY", 116, 130], ["outflow", "ANATOMY_MODIFIER", 139, 146]]], ["Other congenital anomalies, including ventricular septal defect, often accompany this anomaly.Developmental Errors/Congenital Anomalies: Pericardium and EpicardiumTruncus Arteriosus.", [["ventricular septal", "ANATOMY", 38, 56], ["congenital anomalies", "DISEASE", 6, 26], ["ventricular septal defect", "DISEASE", 38, 63], ["Congenital Anomalies", "DISEASE", 115, 135], ["ventricular septal", "MULTI-TISSUE_STRUCTURE", 38, 56], ["Other congenital anomalies", "PROBLEM", 0, 26], ["ventricular septal defect", "PROBLEM", 38, 63], ["this anomaly", "PROBLEM", 81, 93], ["Developmental Errors", "PROBLEM", 94, 114], ["Congenital Anomalies", "PROBLEM", 115, 135], ["Pericardium and EpicardiumTruncus Arteriosus", "PROBLEM", 137, 181], ["congenital", "OBSERVATION_MODIFIER", 6, 16], ["anomalies", "OBSERVATION", 17, 26], ["ventricular septal", "ANATOMY", 38, 56], ["defect", "OBSERVATION", 57, 63], ["anomaly", "OBSERVATION", 86, 93], ["Congenital Anomalies", "OBSERVATION", 115, 135], ["Pericardium", "ANATOMY", 137, 148], ["EpicardiumTruncus Arteriosus", "ANATOMY", 153, 181]]], ["In this lesion, there is a large VSD that allows blood flow between the ventricles and a single large vessel that originates above the VSD.", [["lesion", "ANATOMY", 8, 14], ["blood", "ANATOMY", 49, 54], ["ventricles", "ANATOMY", 72, 82], ["vessel", "ANATOMY", 102, 108], ["lesion", "CANCER", 8, 14], ["blood", "ORGANISM_SUBSTANCE", 49, 54], ["ventricles", "MULTI-TISSUE_STRUCTURE", 72, 82], ["vessel", "MULTI-TISSUE_STRUCTURE", 102, 108], ["a large VSD", "PROBLEM", 25, 36], ["blood flow between the ventricles", "PROBLEM", 49, 82], ["a single large vessel", "PROBLEM", 87, 108], ["the VSD", "PROBLEM", 131, 138], ["lesion", "OBSERVATION", 8, 14], ["large", "OBSERVATION_MODIFIER", 27, 32], ["VSD", "OBSERVATION", 33, 36], ["blood flow", "OBSERVATION", 49, 59], ["ventricles", "ANATOMY", 72, 82], ["single", "OBSERVATION_MODIFIER", 89, 95], ["large", "OBSERVATION_MODIFIER", 96, 101], ["vessel", "OBSERVATION", 102, 108], ["VSD", "OBSERVATION", 135, 138]]], ["Hypoxemia and cyanosis develop, depending on the amount of mixture of nonoxygenated and oxygenated blood.Lymphatic VesselsLymphangiectasia.", [["blood", "ANATOMY", 99, 104], ["Lymphatic", "ANATOMY", 105, 114], ["Hypoxemia", "DISEASE", 0, 9], ["cyanosis", "DISEASE", 14, 22], ["Lymphatic VesselsLymphangiectasia", "DISEASE", 105, 138], ["nonoxygenated", "SIMPLE_CHEMICAL", 70, 83], ["blood", "ORGANISM_SUBSTANCE", 99, 104], ["Hypoxemia", "PROBLEM", 0, 9], ["cyanosis", "PROBLEM", 14, 22], ["Lymphatic VesselsLymphangiectasia", "PROBLEM", 105, 138], ["cyanosis", "OBSERVATION", 14, 22], ["VesselsLymphangiectasia", "OBSERVATION", 115, 138]]], ["Lymphangiectasia is dilation of lymphatic vessels.", [["lymphatic vessels", "ANATOMY", 32, 49], ["Lymphangiectasia", "DISEASE", 0, 16], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 32, 49], ["Lymphangiectasia", "PROBLEM", 0, 16], ["dilation of lymphatic vessels", "PROBLEM", 20, 49], ["dilation", "OBSERVATION", 20, 28], ["lymphatic vessels", "ANATOMY", 32, 49]]], ["The cause may be a congenital anomaly (Fig. 10-38 ) or obstruction of lymph drainage by invading masses of malignant neoplasms or inflammation ( Fig. 10-39) .Lymphatic VesselsHereditary Lymphedema.", [["lymph", "ANATOMY", 70, 75], ["masses", "ANATOMY", 97, 103], ["malignant neoplasms", "ANATOMY", 107, 126], ["Lymphatic", "ANATOMY", 158, 167], ["congenital anomaly", "DISEASE", 19, 37], ["malignant neoplasms", "DISEASE", 107, 126], ["inflammation", "DISEASE", 130, 142], ["Hereditary Lymphedema", "DISEASE", 175, 196], ["lymph", "MULTI-TISSUE_STRUCTURE", 70, 75], ["masses", "CANCER", 97, 103], ["malignant neoplasms", "CANCER", 107, 126], ["a congenital anomaly", "PROBLEM", 17, 37], ["obstruction of lymph drainage", "PROBLEM", 55, 84], ["invading masses", "PROBLEM", 88, 103], ["malignant neoplasms", "PROBLEM", 107, 126], ["inflammation", "PROBLEM", 130, 142], ["Lymphatic VesselsHereditary Lymphedema", "PROBLEM", 158, 196], ["may be", "UNCERTAINTY", 10, 16], ["congenital", "OBSERVATION_MODIFIER", 19, 29], ["anomaly", "OBSERVATION", 30, 37], ["obstruction", "OBSERVATION", 55, 66], ["lymph drainage", "OBSERVATION", 70, 84], ["malignant", "OBSERVATION_MODIFIER", 107, 116], ["neoplasms", "OBSERVATION", 117, 126], ["inflammation", "OBSERVATION", 130, 142], ["Vessels", "ANATOMY", 168, 175], ["Hereditary", "OBSERVATION_MODIFIER", 175, 185], ["Lymphedema", "OBSERVATION", 186, 196]]], ["Hereditary lymphedema has been described in dogs, Ayrshire and Angus calves, and pigs.", [["Hereditary lymphedema", "DISEASE", 0, 21], ["dogs", "ORGANISM", 44, 48], ["Angus calves", "ORGANISM", 63, 75], ["pigs", "ORGANISM", 81, 85], ["dogs", "SPECIES", 44, 48], ["calves", "SPECIES", 69, 75], ["pigs", "SPECIES", 81, 85], ["pigs", "SPECIES", 81, 85], ["Hereditary lymphedema", "PROBLEM", 0, 21], ["lymphedema", "OBSERVATION", 11, 21]]], ["Affected animals have prominent subcutaneous edema that, in calves, often causes severe swelling of the tips of the ears.", [["subcutaneous edema", "ANATOMY", 32, 50], ["ears", "ANATOMY", 116, 120], ["subcutaneous edema", "DISEASE", 32, 50], ["subcutaneous edema", "PATHOLOGICAL_FORMATION", 32, 50], ["calves", "ORGANISM", 60, 66], ["ears", "ORGAN", 116, 120], ["calves", "SPECIES", 60, 66], ["Affected animals", "PROBLEM", 0, 16], ["prominent subcutaneous edema", "PROBLEM", 22, 50], ["severe swelling of the tips of the ears", "PROBLEM", 81, 120], ["prominent", "OBSERVATION_MODIFIER", 22, 31], ["subcutaneous", "OBSERVATION_MODIFIER", 32, 44], ["edema", "OBSERVATION", 45, 50], ["calves", "ANATOMY", 60, 66], ["severe", "OBSERVATION_MODIFIER", 81, 87], ["swelling", "OBSERVATION", 88, 96], ["tips", "ANATOMY_MODIFIER", 104, 108], ["ears", "ANATOMY", 116, 120]]], ["Interference with lymph drainage results from defective development of the lymphatic vessels that are aplastic or hypoplastic.Disorders of Domestic Animals: MyocardiumThe most common cardiac diseases in horses, ruminants, pigs, dogs, and cats are summarized in Boxes 10-12 and 10-13.", [["lymph", "ANATOMY", 18, 23], ["lymphatic vessels", "ANATOMY", 75, 92], ["cardiac", "ANATOMY", 183, 190], ["aplastic", "DISEASE", 102, 110], ["hypoplastic", "DISEASE", 114, 125], ["cardiac diseases", "DISEASE", 183, 199], ["lymph", "MULTI-TISSUE_STRUCTURE", 18, 23], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 75, 92], ["cardiac", "ORGAN", 183, 190], ["horses", "ORGANISM_SUBDIVISION", 203, 209], ["pigs", "ORGANISM", 222, 226], ["dogs", "ORGANISM", 228, 232], ["cats", "ORGANISM", 238, 242], ["horses", "SPECIES", 203, 209], ["pigs", "SPECIES", 222, 226], ["dogs", "SPECIES", 228, 232], ["cats", "SPECIES", 238, 242], ["pigs", "SPECIES", 222, 226], ["lymph drainage", "TREATMENT", 18, 32], ["defective development of the lymphatic vessels", "PROBLEM", 46, 92], ["aplastic", "PROBLEM", 102, 110], ["hypoplastic", "PROBLEM", 114, 125], ["The most common cardiac diseases in horses", "PROBLEM", 167, 209], ["lymph drainage", "OBSERVATION", 18, 32], ["defective", "OBSERVATION_MODIFIER", 46, 55], ["lymphatic vessels", "ANATOMY", 75, 92], ["aplastic", "OBSERVATION", 102, 110], ["hypoplastic", "OBSERVATION", 114, 125], ["Myocardium", "ANATOMY", 157, 167], ["most", "OBSERVATION_MODIFIER", 171, 175], ["common", "OBSERVATION_MODIFIER", 176, 182], ["cardiac", "ANATOMY", 183, 190], ["diseases", "OBSERVATION", 191, 199]]], ["The most common locations of major neoplastic diseases in the heart are illustrated in Fig. 10 -40.", [["neoplastic", "ANATOMY", 35, 45], ["heart", "ANATOMY", 62, 67], ["neoplastic diseases", "DISEASE", 35, 54], ["heart", "ORGAN", 62, 67], ["major neoplastic diseases in the heart", "PROBLEM", 29, 67], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["major", "OBSERVATION_MODIFIER", 29, 34], ["neoplastic", "OBSERVATION", 35, 45], ["heart", "ANATOMY", 62, 67]]], ["Cardiovascular diseases with known or suspected heritability are listed in E-Boxes 10-2 and 10-3.Disturbances of CirculationHemorrhage: Trauma (Physical Injury).", [["Cardiovascular", "ANATOMY", 0, 14], ["Cardiovascular diseases", "DISEASE", 0, 23], ["CirculationHemorrhage", "DISEASE", 113, 134], ["Trauma", "DISEASE", 136, 142], ["Injury", "DISEASE", 153, 159], ["E-Boxes 10-2 and 10-3", "DNA", 75, 96], ["Cardiovascular diseases", "PROBLEM", 0, 23], ["suspected heritability", "PROBLEM", 38, 60], ["Disturbances of CirculationHemorrhage", "PROBLEM", 97, 134], ["Trauma (Physical Injury", "PROBLEM", 136, 159], ["diseases", "OBSERVATION", 15, 23], ["Circulation", "OBSERVATION_MODIFIER", 113, 124], ["Hemorrhage", "OBSERVATION", 124, 134], ["Trauma", "OBSERVATION", 136, 142]]], ["Blunt chest trauma may result in myocardial hemorrhage, which can lead to serious clinical consequences.", [["chest", "ANATOMY", 6, 11], ["myocardial", "ANATOMY", 33, 43], ["chest trauma", "DISEASE", 6, 18], ["myocardial hemorrhage", "DISEASE", 33, 54], ["myocardial", "MULTI-TISSUE_STRUCTURE", 33, 43], ["Blunt chest trauma", "PROBLEM", 0, 18], ["myocardial hemorrhage", "PROBLEM", 33, 54], ["serious clinical consequences", "PROBLEM", 74, 103], ["chest", "ANATOMY", 6, 11], ["trauma", "OBSERVATION", 12, 18], ["myocardial", "ANATOMY", 33, 43], ["hemorrhage", "OBSERVATION", 44, 54]]], ["Tears and rupture of tissue resulting from loss of structural integrity attributable to invasive and destructive properties of neoplasms may result in myocardial hemorrhage.", [["tissue", "ANATOMY", 21, 27], ["neoplasms", "ANATOMY", 127, 136], ["myocardial", "ANATOMY", 151, 161], ["rupture", "DISEASE", 10, 17], ["neoplasms", "DISEASE", 127, 136], ["myocardial hemorrhage", "DISEASE", 151, 172], ["tissue", "TISSUE", 21, 27], ["neoplasms", "CANCER", 127, 136], ["myocardial", "MULTI-TISSUE_STRUCTURE", 151, 161], ["Tears", "PROBLEM", 0, 5], ["rupture of tissue", "PROBLEM", 10, 27], ["loss of structural integrity", "PROBLEM", 43, 71], ["invasive and destructive properties of neoplasms", "PROBLEM", 88, 136], ["myocardial hemorrhage", "PROBLEM", 151, 172], ["rupture", "OBSERVATION", 10, 17], ["tissue", "ANATOMY", 21, 27], ["loss", "OBSERVATION_MODIFIER", 43, 47], ["structural integrity", "OBSERVATION", 51, 71], ["invasive", "OBSERVATION_MODIFIER", 88, 96], ["destructive", "OBSERVATION_MODIFIER", 101, 112], ["neoplasms", "OBSERVATION", 127, 136], ["myocardial", "ANATOMY", 151, 161], ["hemorrhage", "OBSERVATION", 162, 172]]], ["See discussion on hemorrhage in Chapter 2. muscle in the ductus arteriosus contracts, which results in its occlusion within 7 to 10 days after birth in the dog.", [["muscle", "ANATOMY", 43, 49], ["ductus arteriosus", "ANATOMY", 57, 74], ["hemorrhage", "DISEASE", 18, 28], ["muscle", "ORGAN", 43, 49], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 57, 74], ["dog", "ORGANISM", 156, 159], ["dog", "SPECIES", 156, 159], ["hemorrhage", "PROBLEM", 18, 28], ["its occlusion", "PROBLEM", 103, 116], ["hemorrhage", "OBSERVATION", 18, 28], ["ductus arteriosus", "ANATOMY", 57, 74], ["occlusion", "OBSERVATION", 107, 116]]], ["When this mechanism fails, the ductus arteriosus remains patent and allows for a portion of the blood from the left cardiac chamber to flow from the aorta into the pulmonary artery and results in overcirculation to the lungs, leading to pulmonary hypertension and increased preload to the left ventricle.", [["ductus arteriosus", "ANATOMY", 31, 48], ["blood", "ANATOMY", 96, 101], ["left cardiac chamber", "ANATOMY", 111, 131], ["aorta", "ANATOMY", 149, 154], ["pulmonary artery", "ANATOMY", 164, 180], ["lungs", "ANATOMY", 219, 224], ["pulmonary", "ANATOMY", 237, 246], ["left ventricle", "ANATOMY", 289, 303], ["ductus arteriosus", "DISEASE", 31, 48], ["hypertension", "DISEASE", 247, 259], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 31, 48], ["blood", "ORGANISM_SUBSTANCE", 96, 101], ["aorta", "MULTI-TISSUE_STRUCTURE", 149, 154], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 164, 180], ["lungs", "ORGAN", 219, 224], ["pulmonary", "ORGAN", 237, 246], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 289, 303], ["overcirculation to the lungs", "PROBLEM", 196, 224], ["pulmonary hypertension", "PROBLEM", 237, 259], ["increased preload to the left ventricle", "PROBLEM", 264, 303], ["ductus arteriosus", "ANATOMY", 31, 48], ["patent", "OBSERVATION", 57, 63], ["blood", "OBSERVATION", 96, 101], ["left", "ANATOMY_MODIFIER", 111, 115], ["cardiac", "ANATOMY", 116, 123], ["chamber", "ANATOMY_MODIFIER", 124, 131], ["flow", "OBSERVATION", 135, 139], ["aorta", "ANATOMY", 149, 154], ["pulmonary artery", "ANATOMY", 164, 180], ["overcirculation", "OBSERVATION", 196, 211], ["lungs", "ANATOMY", 219, 224], ["pulmonary", "ANATOMY", 237, 246], ["hypertension", "OBSERVATION", 247, 259], ["increased", "OBSERVATION_MODIFIER", 264, 273], ["preload", "OBSERVATION", 274, 281], ["left ventricle", "ANATOMY", 289, 303]]], ["Grossly, patent ductus arteriosus is a dilated funnel-shaped communication between the descending aorta and the main pulmonary artery.", [["patent ductus arteriosus", "ANATOMY", 9, 33], ["descending aorta", "ANATOMY", 87, 103], ["pulmonary artery", "ANATOMY", 117, 133], ["ductus arteriosus", "DISEASE", 16, 33], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 16, 33], ["aorta", "MULTI-TISSUE_STRUCTURE", 98, 103], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 117, 133], ["patent ductus arteriosus", "PROBLEM", 9, 33], ["a dilated funnel-shaped communication", "PROBLEM", 37, 74], ["patent", "OBSERVATION", 9, 15], ["ductus arteriosus", "ANATOMY", 16, 33], ["dilated", "OBSERVATION_MODIFIER", 39, 46], ["funnel", "OBSERVATION_MODIFIER", 47, 53], ["shaped", "OBSERVATION_MODIFIER", 54, 60], ["communication", "OBSERVATION", 61, 74], ["descending", "ANATOMY_MODIFIER", 87, 97], ["aorta", "ANATOMY", 98, 103], ["main pulmonary artery", "ANATOMY", 112, 133]]], ["This vascular channel between the pulmonary artery and aorta allows blood to bypass the lungs during fetal life.", [["vascular", "ANATOMY", 5, 13], ["pulmonary artery", "ANATOMY", 34, 50], ["aorta", "ANATOMY", 55, 60], ["blood", "ANATOMY", 68, 73], ["lungs", "ANATOMY", 88, 93], ["fetal", "ANATOMY", 101, 106], ["vascular", "MULTI-TISSUE_STRUCTURE", 5, 13], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 34, 50], ["aorta", "MULTI-TISSUE_STRUCTURE", 55, 60], ["blood", "ORGANISM_SUBSTANCE", 68, 73], ["lungs", "ORGAN", 88, 93], ["fetal", "DEVELOPING_ANATOMICAL_STRUCTURE", 101, 106], ["bypass the lungs", "TREATMENT", 77, 93], ["vascular channel", "ANATOMY", 5, 21], ["pulmonary artery", "ANATOMY", 34, 50], ["aorta", "ANATOMY", 55, 60], ["bypass", "OBSERVATION", 77, 83], ["lungs", "ANATOMY", 88, 93]]], ["Normally, the ductus arteriosus is converted to the solid ligamentum arteriosum postnatally.Malpositioning of Great VesselsPersistent Right Aortic Arch.", [["ductus arteriosus", "ANATOMY", 14, 31], ["solid ligamentum arteriosum", "ANATOMY", 52, 79], ["ductus arteriosus", "DISEASE", 14, 31], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 14, 31], ["ligamentum arteriosum", "MULTI-TISSUE_STRUCTURE", 58, 79], ["Malpositioning", "TREATMENT", 92, 106], ["Great VesselsPersistent Right Aortic Arch", "TREATMENT", 110, 151], ["ductus arteriosus", "ANATOMY", 14, 31], ["solid", "ANATOMY_MODIFIER", 52, 57], ["ligamentum arteriosum", "ANATOMY", 58, 79], ["Great", "OBSERVATION_MODIFIER", 110, 115], ["VesselsPersistent", "OBSERVATION", 116, 133], ["Right", "ANATOMY_MODIFIER", 134, 139], ["Aortic Arch", "ANATOMY", 140, 151]]], ["Persistent right aortic arch occurs in dogs; German shepherd, Irish setter, and Great Dane dogs are predisposed ( Fig. 10-37 ).", [["right aortic arch", "ANATOMY", 11, 28], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 17, 28], ["dogs", "ORGANISM", 39, 43], ["dogs", "ORGANISM", 91, 95], ["dogs", "SPECIES", 39, 43], ["Persistent right aortic arch occurs", "PROBLEM", 0, 35], ["right", "ANATOMY_MODIFIER", 11, 16], ["aortic arch", "ANATOMY", 17, 28]]], ["This defect arises because the right fourth aortic arch, rather than the normal left fourth aortic arch, develops and ascends on the right side of the midline so that the ligamentum arteriosum forms a vascular ring over the esophagus and trachea.", [["right fourth aortic arch", "ANATOMY", 31, 55], ["aortic arch", "ANATOMY", 92, 103], ["midline", "ANATOMY", 151, 158], ["ligamentum arteriosum", "ANATOMY", 171, 192], ["vascular ring", "ANATOMY", 201, 214], ["esophagus", "ANATOMY", 224, 233], ["trachea", "ANATOMY", 238, 245], ["ligamentum arteriosum", "DISEASE", 171, 192], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 44, 55], ["aortic arch", "MULTI-TISSUE_STRUCTURE", 92, 103], ["midline", "ORGAN", 151, 158], ["ligamentum arteriosum", "MULTI-TISSUE_STRUCTURE", 171, 192], ["vascular ring", "MULTI-TISSUE_STRUCTURE", 201, 214], ["esophagus", "ORGAN", 224, 233], ["trachea", "ORGAN", 238, 245], ["This defect", "PROBLEM", 0, 11], ["a vascular ring over the esophagus and trachea", "PROBLEM", 199, 245], ["defect", "OBSERVATION", 5, 11], ["right", "ANATOMY_MODIFIER", 31, 36], ["fourth", "ANATOMY_MODIFIER", 37, 43], ["aortic arch", "ANATOMY", 44, 55], ["normal", "OBSERVATION", 73, 79], ["left", "ANATOMY_MODIFIER", 80, 84], ["fourth", "ANATOMY_MODIFIER", 85, 91], ["aortic arch", "ANATOMY", 92, 103], ["right", "ANATOMY_MODIFIER", 133, 138], ["midline", "ANATOMY_MODIFIER", 151, 158], ["ligamentum arteriosum", "ANATOMY", 171, 192], ["vascular ring", "OBSERVATION", 201, 214], ["esophagus", "ANATOMY", 224, 233], ["trachea", "ANATOMY", 238, 245]]], ["This arrangement eventually results in esophageal obstruction and CHAPTER 10 Cardiovascular System and Lymphatic VesselsDisturbances of GrowthSee the discussion on anomalies and dysplasia in the section on Disorders of Domestic Animals, Developmental Errors/Congenital Anomalies: Endocardium and Heart Valves.Hypertrophy and AtrophyCardiomyopathies.", [["esophageal", "ANATOMY", 39, 49], ["Heart", "ANATOMY", 296, 301], ["esophageal obstruction", "DISEASE", 39, 61], ["dysplasia", "DISEASE", 178, 187], ["Developmental Errors", "DISEASE", 237, 257], ["Congenital Anomalies", "DISEASE", 258, 278], ["Hypertrophy", "DISEASE", 309, 320], ["AtrophyCardiomyopathies", "DISEASE", 325, 348], ["esophageal obstruction", "PATHOLOGICAL_FORMATION", 39, 61], ["dysplasia", "PATHOLOGICAL_FORMATION", 178, 187], ["Heart Valves", "CANCER", 296, 308], ["esophageal obstruction", "PROBLEM", 39, 61], ["Lymphatic VesselsDisturbances of GrowthSee", "PROBLEM", 103, 145], ["anomalies", "PROBLEM", 164, 173], ["dysplasia", "PROBLEM", 178, 187], ["Congenital Anomalies", "PROBLEM", 258, 278], ["Endocardium and Heart Valves", "TREATMENT", 280, 308], ["Hypertrophy", "PROBLEM", 309, 320], ["AtrophyCardiomyopathies", "PROBLEM", 325, 348], ["esophageal", "ANATOMY", 39, 49], ["obstruction", "OBSERVATION", 50, 61], ["Lymphatic Vessels", "ANATOMY", 103, 120], ["dysplasia", "OBSERVATION", 178, 187], ["Congenital Anomalies", "OBSERVATION", 258, 278], ["Endocardium", "ANATOMY", 280, 291], ["Heart Valves", "ANATOMY", 296, 308], ["AtrophyCardiomyopathies", "OBSERVATION", 325, 348]]], ["Categorization and causes of primary and secondary cardiomyopathies are listed in Box 10-14.", [["primary and secondary cardiomyopathies", "DISEASE", 29, 67], ["Box 10-14", "DNA", 82, 91], ["secondary cardiomyopathies", "PROBLEM", 41, 67], ["secondary cardiomyopathies", "OBSERVATION", 41, 67]]], ["These diseases are divided into five morphologic types: hypertrophic, dilated (congestive), restrictive, arrhythmogenic right ventricular, and unclassified cardiomyopathies.", [["right ventricular", "ANATOMY", 120, 137], ["arrhythmogenic right ventricular", "DISEASE", 105, 137], ["cardiomyopathies", "DISEASE", 156, 172], ["ventricular", "MULTI-TISSUE_STRUCTURE", 126, 137], ["These diseases", "PROBLEM", 0, 14], ["hypertrophic, dilated (congestive)", "PROBLEM", 56, 90], ["restrictive, arrhythmogenic right ventricular", "PROBLEM", 92, 137], ["unclassified cardiomyopathies", "PROBLEM", 143, 172], ["diseases", "OBSERVATION", 6, 14], ["five morphologic", "OBSERVATION_MODIFIER", 32, 48], ["hypertrophic", "OBSERVATION_MODIFIER", 56, 68], ["dilated", "OBSERVATION", 70, 77], ["congestive", "OBSERVATION_MODIFIER", 79, 89], ["restrictive", "OBSERVATION_MODIFIER", 92, 103], ["arrhythmogenic", "OBSERVATION", 105, 119], ["right ventricular", "ANATOMY", 120, 137], ["unclassified", "OBSERVATION_MODIFIER", 143, 155], ["cardiomyopathies", "OBSERVATION", 156, 172]]], ["Secondary cardiomyopathies (also termed specific heart muscle diseases) are generalized myocardial diseases of known cause.Hypertrophy and AtrophyHypertrophic Cardiomyopathy.", [["heart muscle", "ANATOMY", 49, 61], ["myocardial", "ANATOMY", 88, 98], ["Secondary cardiomyopathies", "DISEASE", 0, 26], ["heart muscle diseases", "DISEASE", 49, 70], ["myocardial diseases", "DISEASE", 88, 107], ["Hypertrophy", "DISEASE", 123, 134], ["Cardiomyopathy", "DISEASE", 159, 173], ["heart", "ORGAN", 49, 54], ["muscle", "ORGAN", 55, 61], ["myocardial", "MULTI-TISSUE_STRUCTURE", 88, 98], ["Secondary cardiomyopathies", "PROBLEM", 0, 26], ["specific heart muscle diseases", "PROBLEM", 40, 70], ["generalized myocardial diseases", "PROBLEM", 76, 107], ["Hypertrophy", "PROBLEM", 123, 134], ["AtrophyHypertrophic Cardiomyopathy", "PROBLEM", 139, 173], ["cardiomyopathies", "OBSERVATION", 10, 26], ["heart muscle", "ANATOMY", 49, 61], ["diseases", "OBSERVATION", 62, 70], ["generalized", "OBSERVATION_MODIFIER", 76, 87], ["myocardial", "ANATOMY", 88, 98], ["diseases", "OBSERVATION", 99, 107], ["AtrophyHypertrophic", "OBSERVATION_MODIFIER", 139, 158], ["Cardiomyopathy", "OBSERVATION", 159, 173]]], ["Hypertrophic cardiomyopathy (HCM) occurs frequently in cats, especially in young adult to middle-aged males (1 to 3 years old), and is seen infrequently in dogs, usually affecting males of large breeds.Hypertrophy and AtrophyHypertrophic cardiomyopathy is the most common feline primary myocardial disease, and it occurs frequently in cats (58% to 68% of all cardiomyopathy cases).", [["myocardial", "ANATOMY", 287, 297], ["Hypertrophic cardiomyopathy", "DISEASE", 0, 27], ["HCM", "DISEASE", 29, 32], ["Hypertrophy", "DISEASE", 202, 213], ["AtrophyHypertrophic cardiomyopathy", "DISEASE", 218, 252], ["primary myocardial disease", "DISEASE", 279, 305], ["cardiomyopathy", "DISEASE", 359, 373], ["cats", "ORGANISM", 55, 59], ["dogs", "ORGANISM", 156, 160], ["feline", "ORGANISM", 272, 278], ["myocardial", "MULTI-TISSUE_STRUCTURE", 287, 297], ["cats", "ORGANISM", 335, 339], ["cats", "SPECIES", 55, 59], ["dogs", "SPECIES", 156, 160], ["Hypertrophic cardiomyopathy", "PROBLEM", 0, 27], ["HCM", "PROBLEM", 29, 32], ["Hypertrophy", "PROBLEM", 202, 213], ["AtrophyHypertrophic cardiomyopathy", "PROBLEM", 218, 252], ["myocardial disease", "PROBLEM", 287, 305], ["all cardiomyopathy cases", "PROBLEM", 355, 379], ["cardiomyopathy", "OBSERVATION", 13, 27], ["HCM", "OBSERVATION", 29, 32], ["middle", "ANATOMY_MODIFIER", 90, 96], ["large", "OBSERVATION_MODIFIER", 189, 194], ["breeds", "OBSERVATION", 195, 201], ["AtrophyHypertrophic", "OBSERVATION_MODIFIER", 218, 237], ["cardiomyopathy", "OBSERVATION", 238, 252], ["most common", "OBSERVATION_MODIFIER", 260, 271], ["myocardial", "ANATOMY", 287, 297], ["disease", "OBSERVATION", 298, 305]]], ["There is familial heritability in Maine coon, ragdoll, and American shorthaired cats (in which it is transmitted in an autosomal dominant pattern) and breed predisposition in British shorthair, Norwegian forest, Turkish Van, Scottish fold, Bengal, Siberian, and Rex cats.", [["cats", "ORGANISM", 80, 84], ["cats", "ORGANISM", 266, 270], ["cats", "SPECIES", 80, 84], ["cats", "SPECIES", 266, 270], ["American shorthaired cats", "SPECIES", 59, 84], ["familial heritability", "PROBLEM", 9, 30], ["familial", "OBSERVATION_MODIFIER", 9, 17], ["heritability", "OBSERVATION", 18, 30]]], ["Young adult to middle-aged males (1 to 3 years old) are often affected.", [["males", "ORGANISM", 27, 32], ["middle", "OBSERVATION_MODIFIER", 15, 21]]], ["Hypertrophic cardiomyopathy is caused by sarcomeric defects in cardiomyocytes, of which two mutations in cardiac myosin-binding protein C (MYBPC) have been identified in Maine coon and ragdoll cats.", [["cardiomyocytes", "ANATOMY", 63, 77], ["Hypertrophic cardiomyopathy", "DISEASE", 0, 27], ["sarcomeric", "GENE_OR_GENE_PRODUCT", 41, 51], ["cardiomyocytes", "CELL", 63, 77], ["cardiac myosin-binding protein C", "GENE_OR_GENE_PRODUCT", 105, 137], ["MYBPC", "GENE_OR_GENE_PRODUCT", 139, 144], ["ragdoll cats", "ORGANISM", 185, 197], ["cardiomyocytes", "CELL_TYPE", 63, 77], ["cardiac myosin-binding protein C", "PROTEIN", 105, 137], ["MYBPC", "PROTEIN", 139, 144], ["cats", "SPECIES", 193, 197], ["Hypertrophic cardiomyopathy", "PROBLEM", 0, 27], ["sarcomeric defects in cardiomyocytes", "PROBLEM", 41, 77], ["two mutations", "PROBLEM", 88, 101], ["cardiac myosin", "TEST", 105, 119], ["cardiomyopathy", "OBSERVATION", 13, 27], ["sarcomeric defects", "OBSERVATION", 41, 59], ["cardiomyocytes", "ANATOMY", 63, 77], ["cardiac", "ANATOMY", 105, 112]]], ["Altered sarcomeric function ultimately results in myocytes hypertrophy, collagen synthesis, and myocytes disarray (defined as cellular disorientation of cardiomyocytes in which cardiomyocytes are oriented perpendicular or obliquely to each other forming tangled patterns and/or pinwheel configurations).", [["myocytes", "ANATOMY", 50, 58], ["myocytes", "ANATOMY", 96, 104], ["cellular", "ANATOMY", 126, 134], ["cardiomyocytes", "ANATOMY", 153, 167], ["cardiomyocytes", "ANATOMY", 177, 191], ["hypertrophy", "DISEASE", 59, 70], ["sarcomeric", "GENE_OR_GENE_PRODUCT", 8, 18], ["myocytes", "CELL", 50, 58], ["collagen", "GENE_OR_GENE_PRODUCT", 72, 80], ["cellular", "CELL", 126, 134], ["cardiomyocytes", "CELL", 153, 167], ["cardiomyocytes", "CELL", 177, 191], ["collagen", "PROTEIN", 72, 80], ["cardiomyocytes", "CELL_TYPE", 153, 167], ["cardiomyocytes", "CELL_TYPE", 177, 191], ["Altered sarcomeric function", "PROBLEM", 0, 27], ["myocytes hypertrophy", "PROBLEM", 50, 70], ["collagen synthesis", "PROBLEM", 72, 90], ["myocytes disarray", "PROBLEM", 96, 113], ["cellular disorientation of cardiomyocytes", "PROBLEM", 126, 167], ["sarcomeric function", "OBSERVATION", 8, 27], ["myocytes", "ANATOMY", 50, 58], ["hypertrophy", "OBSERVATION", 59, 70], ["collagen synthesis", "OBSERVATION", 72, 90], ["cardiomyocytes", "ANATOMY", 153, 167], ["cardiomyocytes", "ANATOMY", 177, 191]]], ["The left ventricle wall progressively thickens ( Fig. 10-41) , and its lumen narrows (nondilated concentric hypertrophy) (heart weight to body weight ratio of 7.0 \u00b1 0.3 g/kg compared to normal cats' heart weight to body weight ratio of 3.83 \u00b1 0.2 g/kg).", [["left ventricle wall", "ANATOMY", 4, 23], ["lumen", "ANATOMY", 71, 76], ["heart", "ANATOMY", 122, 127], ["body", "ANATOMY", 138, 142], ["heart", "ANATOMY", 199, 204], ["body", "ANATOMY", 215, 219], ["hypertrophy", "DISEASE", 108, 119], ["ventricle wall", "MULTI-TISSUE_STRUCTURE", 9, 23], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 71, 76], ["heart", "ORGAN", 122, 127], ["body", "ORGANISM_SUBDIVISION", 138, 142], ["heart", "ORGAN", 199, 204], ["body", "ORGANISM_SUBDIVISION", 215, 219], ["Fig.", "TEST", 49, 53], ["its lumen narrows (nondilated concentric hypertrophy", "PROBLEM", 67, 119], ["heart weight", "TEST", 122, 134], ["body weight ratio", "TEST", 138, 155], ["heart weight", "TEST", 199, 211], ["body weight ratio", "TEST", 215, 232], ["left ventricle", "ANATOMY", 4, 18], ["wall", "ANATOMY_MODIFIER", 19, 23], ["progressively", "OBSERVATION_MODIFIER", 24, 37], ["thickens", "OBSERVATION", 38, 46], ["lumen", "ANATOMY_MODIFIER", 71, 76], ["narrows", "OBSERVATION_MODIFIER", 77, 84], ["nondilated", "OBSERVATION_MODIFIER", 86, 96], ["concentric", "OBSERVATION_MODIFIER", 97, 107], ["hypertrophy", "OBSERVATION", 108, 119], ["heart", "ANATOMY", 122, 127]]], ["In addition, mild right ventricular enlargement is occasionally present.", [["right ventricular", "ANATOMY", 18, 35], ["ventricular enlargement", "DISEASE", 24, 47], ["right ventricular", "MULTI-TISSUE_STRUCTURE", 18, 35], ["mild right ventricular enlargement", "PROBLEM", 13, 47], ["mild", "OBSERVATION_MODIFIER", 13, 17], ["right ventricular", "ANATOMY", 18, 35], ["enlargement", "OBSERVATION", 36, 47], ["occasionally", "OBSERVATION_MODIFIER", 51, 63]]], ["Left ventricular concentric enlargement results in impairment of the left ventricle's ability to relax during diastole (diastolic failure).", [["Left ventricular", "ANATOMY", 0, 16], ["left ventricle", "ANATOMY", 69, 83], ["impairment of the left ventricle", "DISEASE", 51, 83], ["diastolic failure", "DISEASE", 120, 137], ["Left ventricular", "MULTI-TISSUE_STRUCTURE", 0, 16], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 69, 83], ["Left ventricular concentric enlargement", "PROBLEM", 0, 39], ["diastole (diastolic failure)", "PROBLEM", 110, 138], ["ventricular", "ANATOMY", 5, 16], ["concentric", "OBSERVATION_MODIFIER", 17, 27], ["enlargement", "OBSERVATION", 28, 39], ["impairment", "OBSERVATION_MODIFIER", 51, 61], ["left ventricle", "ANATOMY", 69, 83], ["diastolic failure", "OBSERVATION", 120, 137]]], ["Increased left ventricular diastolic filling pressure leads to enlargement of the left atrium with subsequent blood backing up to the lungs, resulting in congestive heart failure with pulmonary edema and/or pleural effusion.", [["left ventricular", "ANATOMY", 10, 26], ["left atrium", "ANATOMY", 82, 93], ["blood", "ANATOMY", 110, 115], ["lungs", "ANATOMY", 134, 139], ["heart", "ANATOMY", 165, 170], ["pulmonary", "ANATOMY", 184, 193], ["pleural", "ANATOMY", 207, 214], ["enlargement of the left atrium", "DISEASE", 63, 93], ["congestive heart failure", "DISEASE", 154, 178], ["pulmonary edema", "DISEASE", 184, 199], ["pleural effusion", "DISEASE", 207, 223], ["ventricular", "MULTI-TISSUE_STRUCTURE", 15, 26], ["atrium", "MULTI-TISSUE_STRUCTURE", 87, 93], ["blood", "ORGANISM_SUBSTANCE", 110, 115], ["lungs", "ORGAN", 134, 139], ["heart", "ORGAN", 165, 170], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 184, 199], ["pleural", "ORGAN", 207, 214], ["Increased left ventricular diastolic filling pressure", "PROBLEM", 0, 53], ["enlargement of the left atrium", "PROBLEM", 63, 93], ["subsequent blood backing", "PROBLEM", 99, 123], ["congestive heart failure", "PROBLEM", 154, 178], ["pulmonary edema", "PROBLEM", 184, 199], ["pleural effusion", "PROBLEM", 207, 223], ["left ventricular", "ANATOMY", 10, 26], ["diastolic", "ANATOMY_MODIFIER", 27, 36], ["filling pressure", "OBSERVATION", 37, 53], ["enlargement", "OBSERVATION", 63, 74], ["left atrium", "ANATOMY", 82, 93], ["blood backing", "OBSERVATION", 110, 123], ["lungs", "ANATOMY", 134, 139], ["congestive", "OBSERVATION_MODIFIER", 154, 164], ["heart", "ANATOMY", 165, 170], ["failure", "OBSERVATION", 171, 178], ["pulmonary", "ANATOMY", 184, 193], ["edema", "OBSERVATION", 194, 199], ["pleural", "ANATOMY", 207, 214], ["effusion", "OBSERVATION", 215, 223]]], ["In a subset of cases, in addition to concentric hypertrophy of the left ventricle, the interventricular septum contains hypertrophied, anteriorly displaced papillary muscles that pull the chordae tendineae and the anterior leaflet of the mitral valve into the left ventricular outflow tract (LVOT), resulting in a dynamic LVOT obstruction during systole (systolic anterior motion [SAM] of the mitral valve).", [["left ventricle", "ANATOMY", 67, 81], ["interventricular septum", "ANATOMY", 87, 110], ["hypertrophied", "ANATOMY", 120, 133], ["papillary muscles", "ANATOMY", 156, 173], ["chordae tendineae", "ANATOMY", 188, 205], ["anterior leaflet", "ANATOMY", 214, 230], ["mitral valve", "ANATOMY", 238, 250], ["left ventricular outflow tract", "ANATOMY", 260, 290], ["LVOT", "ANATOMY", 292, 296], ["LVOT", "ANATOMY", 322, 326], ["anterior", "ANATOMY", 364, 372], ["mitral valve", "ANATOMY", 393, 405], ["hypertrophy", "DISEASE", 48, 59], ["LVOT obstruction", "DISEASE", 322, 338], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 67, 81], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 87, 110], ["papillary muscles", "TISSUE", 156, 173], ["chordae tendineae", "TISSUE", 188, 205], ["anterior leaflet", "MULTI-TISSUE_STRUCTURE", 214, 230], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 238, 250], ["ventricular outflow tract", "ORGANISM_SUBDIVISION", 265, 290], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 393, 405], ["concentric hypertrophy of the left ventricle", "PROBLEM", 37, 81], ["hypertrophied, anteriorly displaced papillary muscles", "PROBLEM", 120, 173], ["a dynamic LVOT obstruction", "PROBLEM", 312, 338], ["systole", "TEST", 346, 353], ["the mitral valve", "TREATMENT", 389, 405], ["concentric", "OBSERVATION_MODIFIER", 37, 47], ["hypertrophy", "OBSERVATION", 48, 59], ["left ventricle", "ANATOMY", 67, 81], ["interventricular septum", "ANATOMY", 87, 110], ["hypertrophied", "OBSERVATION", 120, 133], ["anteriorly", "ANATOMY_MODIFIER", 135, 145], ["papillary muscles", "ANATOMY", 156, 173], ["chordae tendineae", "OBSERVATION", 188, 205], ["anterior", "ANATOMY_MODIFIER", 214, 222], ["leaflet", "ANATOMY_MODIFIER", 223, 230], ["mitral valve", "ANATOMY", 238, 250], ["left ventricular", "ANATOMY", 260, 276], ["outflow tract", "ANATOMY", 277, 290], ["LVOT obstruction", "OBSERVATION", 322, 338], ["anterior motion", "OBSERVATION", 364, 379], ["mitral valve", "ANATOMY", 393, 405]]], ["Therefore a unique kissing lesion forms in the LVOT, which has a diagnostic significanceRUMINANTS (CATTLE, SHEEP, AND GOATS)White muscle disease (vitamin E-selenium deficiency) Cardiotoxicity (ionophores, gossypol, Cassia occidentalis, Karwinskia humboldtiana) Brisket disease (high-altitude disease) Pericarditis Endocarditis Malignant lymphomaBox 10-12 Most Common Cardiac Diseases ofHorses and Production Animals myocytes, with interweaving rather than parallel arrangement of fibers ( Fig. 10-42 ).", [["lesion", "ANATOMY", 27, 33], ["muscle", "ANATOMY", 130, 136], ["Cardiac", "ANATOMY", 367, 374], ["myocytes", "ANATOMY", 416, 424], ["fibers", "ANATOMY", 480, 486], ["muscle disease", "DISEASE", 130, 144], ["vitamin E-selenium", "CHEMICAL", 146, 164], ["Cardiotoxicity", "DISEASE", 177, 191], ["ionophores", "CHEMICAL", 193, 203], ["gossypol", "CHEMICAL", 205, 213], ["Brisket disease", "DISEASE", 261, 276], ["high-altitude disease", "DISEASE", 278, 299], ["Pericarditis Endocarditis", "DISEASE", 301, 326], ["Cardiac Diseases ofHorses", "DISEASE", 367, 392], ["vitamin E", "CHEMICAL", 146, 155], ["selenium", "CHEMICAL", 156, 164], ["gossypol", "CHEMICAL", 205, 213], ["LVOT", "PATHOLOGICAL_FORMATION", 47, 51], ["muscle", "ORGAN", 130, 136], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 146, 164], ["ionophores", "SIMPLE_CHEMICAL", 193, 203], ["gossypol", "SIMPLE_CHEMICAL", 205, 213], ["Cassia occidentalis", "ORGANISM", 215, 234], ["high-altitude", "PATHOLOGICAL_FORMATION", 278, 291], ["fibers", "CELLULAR_COMPONENT", 480, 486], ["Cassia occidentalis", "SPECIES", 215, 234], ["Cassia occidentalis", "SPECIES", 215, 234], ["a unique kissing lesion forms in the LVOT", "PROBLEM", 10, 51], ["White muscle disease", "PROBLEM", 124, 144], ["vitamin E", "TEST", 146, 155], ["selenium deficiency)", "PROBLEM", 156, 176], ["Cardiotoxicity (ionophores", "PROBLEM", 177, 203], ["gossypol", "TREATMENT", 205, 213], ["Cassia occidentalis", "PROBLEM", 215, 234], ["Karwinskia humboldtiana", "PROBLEM", 236, 259], ["Brisket disease", "PROBLEM", 261, 276], ["high-altitude disease)", "PROBLEM", 278, 300], ["Pericarditis Endocarditis Malignant lymphomaBox", "PROBLEM", 301, 348], ["Common Cardiac Diseases ofHorses", "PROBLEM", 360, 392], ["Production Animals myocytes", "PROBLEM", 397, 424], ["kissing", "OBSERVATION_MODIFIER", 19, 26], ["lesion", "OBSERVATION", 27, 33], ["LVOT", "ANATOMY", 47, 51], ["White muscle", "ANATOMY", 124, 136], ["altitude disease", "OBSERVATION", 283, 299], ["Pericarditis", "OBSERVATION_MODIFIER", 301, 313], ["Endocarditis", "OBSERVATION", 314, 326], ["Malignant", "OBSERVATION_MODIFIER", 327, 336], ["Cardiac", "ANATOMY", 367, 374], ["Diseases", "OBSERVATION", 375, 383]]], ["Myocyte hypertrophy, various degenerative alterations in myocytes, and interstitial fibrosis are present.", [["Myocyte", "ANATOMY", 0, 7], ["myocytes", "ANATOMY", 57, 65], ["interstitial", "ANATOMY", 71, 83], ["hypertrophy", "DISEASE", 8, 19], ["fibrosis", "DISEASE", 84, 92], ["Myocyte", "CELL", 0, 7], ["myocytes", "CELL", 57, 65], ["interstitial", "MULTI-TISSUE_STRUCTURE", 71, 83], ["Myocyte hypertrophy", "PROBLEM", 0, 19], ["various degenerative alterations in myocytes", "PROBLEM", 21, 65], ["interstitial fibrosis", "PROBLEM", 71, 92], ["hypertrophy", "OBSERVATION", 8, 19], ["various", "OBSERVATION_MODIFIER", 21, 28], ["degenerative", "OBSERVATION_MODIFIER", 29, 41], ["alterations", "OBSERVATION", 42, 53], ["myocytes", "ANATOMY", 57, 65], ["interstitial", "ANATOMY_MODIFIER", 71, 83], ["fibrosis", "OBSERVATION", 84, 92]]], ["A second common histologic lesion includes remodeling of the coronary microcirculation associated with arteriosclerosis (\"small vessel disease\").", [["lesion", "ANATOMY", 27, 33], ["coronary", "ANATOMY", 61, 69], ["small vessel", "ANATOMY", 122, 134], ["arteriosclerosis", "DISEASE", 103, 119], ["coronary microcirculation", "MULTI-TISSUE_STRUCTURE", 61, 86], ["vessel", "MULTI-TISSUE_STRUCTURE", 128, 134], ["A second common histologic lesion", "PROBLEM", 0, 33], ["the coronary microcirculation", "PROBLEM", 57, 86], ["arteriosclerosis", "PROBLEM", 103, 119], ["small vessel disease\"", "PROBLEM", 122, 143], ["second", "OBSERVATION_MODIFIER", 2, 8], ["common", "OBSERVATION_MODIFIER", 9, 15], ["histologic", "OBSERVATION_MODIFIER", 16, 26], ["lesion", "OBSERVATION", 27, 33], ["coronary microcirculation", "ANATOMY", 61, 86], ["arteriosclerosis", "OBSERVATION", 103, 119], ["small vessel disease", "OBSERVATION", 122, 142]]], ["The lumen of small coronary vessels is severely narrowed due to smooth muscle proliferation and increased connective tissue elements.", [["lumen", "ANATOMY", 4, 9], ["small coronary vessels", "ANATOMY", 13, 35], ["smooth muscle", "ANATOMY", 64, 77], ["connective tissue", "ANATOMY", 106, 123], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 4, 9], ["coronary vessels", "MULTI-TISSUE_STRUCTURE", 19, 35], ["smooth muscle", "TISSUE", 64, 77], ["connective tissue", "TISSUE", 106, 123], ["severely narrowed", "PROBLEM", 39, 56], ["smooth muscle proliferation", "PROBLEM", 64, 91], ["increased connective tissue elements", "PROBLEM", 96, 132], ["lumen", "ANATOMY_MODIFIER", 4, 9], ["small", "OBSERVATION_MODIFIER", 13, 18], ["coronary vessels", "ANATOMY", 19, 35], ["severely", "OBSERVATION_MODIFIER", 39, 47], ["narrowed", "OBSERVATION", 48, 56], ["smooth muscle proliferation", "OBSERVATION", 64, 91], ["increased", "OBSERVATION_MODIFIER", 96, 105], ["connective tissue elements", "OBSERVATION", 106, 132]]], ["Replacement fibrosis due to myocardial infarction/necrosis is occasionally found in regions of remodeled coronary arterioles, implying a probable causal relationship (see Figs.", [["myocardial", "ANATOMY", 28, 38], ["coronary arterioles", "ANATOMY", 105, 124], ["fibrosis", "DISEASE", 12, 20], ["myocardial infarction", "DISEASE", 28, 49], ["necrosis", "DISEASE", 50, 58], ["myocardial", "MULTI-TISSUE_STRUCTURE", 28, 38], ["coronary arterioles", "MULTI-TISSUE_STRUCTURE", 105, 124], ["Replacement fibrosis", "PROBLEM", 0, 20], ["myocardial infarction", "PROBLEM", 28, 49], ["necrosis", "PROBLEM", 50, 58], ["fibrosis", "OBSERVATION", 12, 20], ["myocardial", "ANATOMY", 28, 38], ["infarction", "OBSERVATION", 39, 49], ["necrosis", "OBSERVATION", 50, 58], ["remodeled", "OBSERVATION", 95, 104], ["coronary arterioles", "ANATOMY", 105, 124], ["probable", "UNCERTAINTY", 137, 145]]], ["Idiopathic hypertrophic cardiomyopathy in dogs is an infrequent pathology, unlike in cats.", [["Idiopathic hypertrophic cardiomyopathy", "DISEASE", 0, 38], ["dogs", "ORGANISM", 42, 46], ["cats", "ORGANISM", 85, 89], ["dogs", "SPECIES", 42, 46], ["cats", "SPECIES", 85, 89], ["Idiopathic hypertrophic cardiomyopathy in dogs", "PROBLEM", 0, 46], ["an infrequent pathology", "PROBLEM", 50, 73], ["hypertrophic", "OBSERVATION_MODIFIER", 11, 23], ["cardiomyopathy", "OBSERVATION", 24, 38], ["infrequent", "OBSERVATION_MODIFIER", 53, 63], ["pathology", "OBSERVATION", 64, 73]]], ["It is defined as inappropriate concentric myocardial hypertrophy of a nondilated left ventricle in the absence of an identifiable stimulus for the hypertrophy.", [["myocardial", "ANATOMY", 42, 52], ["left ventricle", "ANATOMY", 81, 95], ["myocardial hypertrophy", "DISEASE", 42, 64], ["hypertrophy", "DISEASE", 147, 158], ["myocardial", "MULTI-TISSUE_STRUCTURE", 42, 52], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 81, 95], ["inappropriate concentric myocardial hypertrophy of a nondilated left ventricle", "PROBLEM", 17, 95], ["the hypertrophy", "PROBLEM", 143, 158], ["inappropriate", "OBSERVATION_MODIFIER", 17, 30], ["concentric", "OBSERVATION_MODIFIER", 31, 41], ["myocardial", "ANATOMY", 42, 52], ["hypertrophy", "OBSERVATION", 53, 64], ["nondilated", "OBSERVATION", 70, 80], ["left ventricle", "ANATOMY", 81, 95], ["identifiable stimulus", "OBSERVATION", 117, 138], ["hypertrophy", "OBSERVATION", 147, 158]]], ["Most reported cases have been in young males (<3 years old), and an inherited basis has been proposed in the pointer dog breed.", [["dog", "ORGANISM", 117, 120]]], ["Hypertrophy of the left ventricle has been reported to be symmetrical (i.e., both left ventricular free wall and interventricular septum) in most dogs.", [["left ventricle", "ANATOMY", 19, 33], ["left ventricular free wall", "ANATOMY", 82, 108], ["interventricular septum", "ANATOMY", 113, 136], ["Hypertrophy of the left ventricle", "DISEASE", 0, 33], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 19, 33], ["ventricular", "MULTI-TISSUE_STRUCTURE", 87, 98], ["wall", "MULTI-TISSUE_STRUCTURE", 104, 108], ["interventricular septum", "MULTI-TISSUE_STRUCTURE", 113, 136], ["dogs", "ORGANISM", 146, 150], ["dogs", "SPECIES", 146, 150], ["Hypertrophy of the left ventricle", "PROBLEM", 0, 33], ["left ventricle", "ANATOMY", 19, 33], ["symmetrical", "OBSERVATION", 58, 69], ["left ventricular", "ANATOMY", 82, 98], ["free", "ANATOMY_MODIFIER", 99, 103], ["wall", "ANATOMY_MODIFIER", 104, 108], ["interventricular septum", "ANATOMY", 113, 136], ["most dogs", "OBSERVATION", 141, 150]]], ["In addition, most dogs had an antemortem diagnosis of dynamic LVOT obstruction.", [["LVOT obstruction", "DISEASE", 62, 78], ["dogs", "ORGANISM", 18, 22], ["LVOT obstruction", "PATHOLOGICAL_FORMATION", 62, 78], ["dogs", "SPECIES", 18, 22], ["dynamic LVOT obstruction", "PROBLEM", 54, 78], ["dynamic LVOT", "OBSERVATION", 54, 66], ["obstruction", "OBSERVATION", 67, 78]]], ["In these dogs, a thickened opaque plaque of connective tissue was present opposite to the anterior mitral valve.", [["plaque", "ANATOMY", 34, 40], ["connective tissue", "ANATOMY", 44, 61], ["anterior mitral valve", "ANATOMY", 90, 111], ["dogs", "ORGANISM", 9, 13], ["connective tissue", "TISSUE", 44, 61], ["anterior mitral valve", "MULTI-TISSUE_STRUCTURE", 90, 111], ["dogs", "SPECIES", 9, 13], ["a thickened opaque plaque of connective tissue", "PROBLEM", 15, 61], ["thickened", "OBSERVATION_MODIFIER", 17, 26], ["opaque", "OBSERVATION_MODIFIER", 27, 33], ["plaque", "OBSERVATION", 34, 40], ["connective tissue", "OBSERVATION", 44, 61], ["anterior", "ANATOMY_MODIFIER", 90, 98], ["mitral valve", "ANATOMY", 99, 111]]], ["These dogs had an abnormally opposing thickened mitral valve leaflet and/or malpositioned papillary muscles, suggesting that hypertrophic cardiomyopathy in these dogs may not be just simply a disease of myocardium.", [["mitral valve leaflet", "ANATOMY", 48, 68], ["papillary muscles", "ANATOMY", 90, 107], ["myocardium", "ANATOMY", 203, 213], ["hypertrophic cardiomyopathy", "DISEASE", 125, 152], ["dogs", "ORGANISM", 6, 10], ["mitral valve leaflet", "TISSUE", 48, 68], ["papillary muscles", "TISSUE", 90, 107], ["dogs", "ORGANISM", 162, 166], ["myocardium", "ORGAN", 203, 213], ["dogs", "SPECIES", 6, 10], ["an abnormally opposing thickened mitral valve leaflet", "PROBLEM", 15, 68], ["malpositioned papillary muscles", "PROBLEM", 76, 107], ["hypertrophic cardiomyopathy", "PROBLEM", 125, 152], ["a disease of myocardium", "PROBLEM", 190, 213], ["abnormally", "OBSERVATION_MODIFIER", 18, 28], ["opposing", "OBSERVATION_MODIFIER", 29, 37], ["thickened", "OBSERVATION", 38, 47], ["mitral valve", "ANATOMY", 48, 60], ["leaflet", "ANATOMY_MODIFIER", 61, 68], ["malpositioned", "ANATOMY_MODIFIER", 76, 89], ["papillary muscles", "ANATOMY", 90, 107], ["hypertrophic", "OBSERVATION_MODIFIER", 125, 137], ["cardiomyopathy", "OBSERVATION", 138, 152], ["may not be", "UNCERTAINTY", 167, 177], ["disease", "OBSERVATION", 192, 199], ["myocardium", "ANATOMY", 203, 213]]], ["However, at least in one report, myofibers disarray and asymmetrical hypertrophy of the septum has been reported.", [["myofibers", "ANATOMY", 33, 42], ["septum", "ANATOMY", 88, 94], ["hypertrophy of the septum", "DISEASE", 69, 94], ["myofibers", "TISSUE", 33, 42], ["septum", "MULTI-TISSUE_STRUCTURE", 88, 94], ["myofibers disarray", "PROBLEM", 33, 51], ["asymmetrical hypertrophy of the septum", "PROBLEM", 56, 94], ["asymmetrical", "OBSERVATION_MODIFIER", 56, 68], ["hypertrophy", "OBSERVATION", 69, 80], ["septum", "ANATOMY_MODIFIER", 88, 94]]], ["Secondary changes in medium-sized coronary arteries that have been reported in cats with hypertrophic cardiomyopathy are also present in dogs with hypertrophic cardiomyopathy, and they include tunica intima hyperplasia with hypertrophy and hyaline degeneration of smooth muscle cells in the tunica media.Box 10-12 Most Common Cardiac Diseases ofDilated (Congestive) Cardiomyopathy.", [["coronary arteries", "ANATOMY", 34, 51], ["tunica intima", "ANATOMY", 193, 206], ["hyaline", "ANATOMY", 240, 247], ["smooth muscle cells", "ANATOMY", 264, 283], ["Cardiac", "ANATOMY", 326, 333], ["hypertrophic cardiomyopathy", "DISEASE", 89, 116], ["hypertrophic cardiomyopathy", "DISEASE", 147, 174], ["tunica intima hyperplasia", "DISEASE", 193, 218], ["hypertrophy", "DISEASE", 224, 235], ["Cardiac Diseases ofDilated", "DISEASE", 326, 352], ["Congestive) Cardiomyopathy", "DISEASE", 354, 380], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 34, 51], ["cats", "ORGANISM", 79, 83], ["dogs", "ORGANISM", 137, 141], ["tunica intima", "TISSUE", 193, 206], ["smooth muscle cells", "CELL", 264, 283], ["tunica", "TISSUE", 291, 297], ["smooth muscle cells", "CELL_TYPE", 264, 283], ["cats", "SPECIES", 79, 83], ["dogs", "SPECIES", 137, 141], ["Secondary changes in medium-sized coronary arteries", "PROBLEM", 0, 51], ["hypertrophic cardiomyopathy", "PROBLEM", 89, 116], ["hypertrophic cardiomyopathy", "PROBLEM", 147, 174], ["tunica intima hyperplasia", "PROBLEM", 193, 218], ["hypertrophy", "PROBLEM", 224, 235], ["hyaline degeneration of smooth muscle cells", "PROBLEM", 240, 283], ["Box", "TEST", 304, 307], ["Cardiac Diseases ofDilated (Congestive) Cardiomyopathy", "PROBLEM", 326, 380], ["medium", "OBSERVATION_MODIFIER", 21, 27], ["sized", "OBSERVATION_MODIFIER", 28, 33], ["coronary arteries", "ANATOMY", 34, 51], ["hypertrophic", "OBSERVATION_MODIFIER", 89, 101], ["cardiomyopathy", "OBSERVATION", 102, 116], ["hypertrophic", "OBSERVATION_MODIFIER", 147, 159], ["cardiomyopathy", "OBSERVATION", 160, 174], ["tunica intima", "ANATOMY", 193, 206], ["hyperplasia", "OBSERVATION", 207, 218], ["hypertrophy", "OBSERVATION", 224, 235], ["hyaline", "OBSERVATION_MODIFIER", 240, 247], ["degeneration", "OBSERVATION", 248, 260], ["smooth muscle cells", "OBSERVATION", 264, 283], ["tunica media", "ANATOMY", 291, 303], ["Cardiac", "ANATOMY", 326, 333], ["Diseases", "OBSERVATION", 334, 342], ["Congestive", "OBSERVATION_MODIFIER", 354, 364], ["Cardiomyopathy", "OBSERVATION", 366, 380]]], ["Dilated or congestive cardiomyopathy (DCM) is an important cause of congestive heart failure in cats, dogs, and cattle.Box 10-12 Most Common Cardiac Diseases ofAffected dogs often are males of large breed, such as Doberman pinschers, Portuguese water dogs, Dalmatians, Scottish deerhounds, Irish wolfhounds, Saint Bernards, Afghan hounds, Newfoundland dogs, Old English sheepdogs, Great Danes, and boxers.", [["heart", "ANATOMY", 79, 84], ["Cardiac", "ANATOMY", 141, 148], ["congestive cardiomyopathy", "DISEASE", 11, 36], ["DCM", "DISEASE", 38, 41], ["congestive heart failure", "DISEASE", 68, 92], ["Cardiac Diseases", "DISEASE", 141, 157], ["heart", "ORGAN", 79, 84], ["cats", "ORGANISM", 96, 100], ["dogs", "ORGANISM", 169, 173], ["cats", "SPECIES", 96, 100], ["dogs", "SPECIES", 102, 106], ["cattle", "SPECIES", 112, 118], ["dogs", "SPECIES", 169, 173], ["dogs", "SPECIES", 251, 255], ["dogs", "SPECIES", 352, 356], ["cattle", "SPECIES", 112, 118], ["Dilated or congestive cardiomyopathy", "PROBLEM", 0, 36], ["DCM", "PROBLEM", 38, 41], ["congestive heart failure in cats", "PROBLEM", 68, 100], ["congestive", "OBSERVATION_MODIFIER", 11, 21], ["cardiomyopathy", "OBSERVATION", 22, 36], ["important cause of", "UNCERTAINTY", 49, 67], ["congestive", "OBSERVATION_MODIFIER", 68, 78], ["heart", "ANATOMY", 79, 84], ["failure", "OBSERVATION", 85, 92], ["Cardiac", "ANATOMY", 141, 148], ["Diseases", "OBSERVATION", 149, 157], ["large", "OBSERVATION_MODIFIER", 193, 198]]], ["However, smaller breeds, such as English cocker spaniels and Manchester because it is seen only in this subset of cats with hypertrophic cardiomyopathy.", [["hypertrophic cardiomyopathy", "DISEASE", 124, 151], ["cats", "ORGANISM", 114, 118], ["cats", "SPECIES", 114, 118], ["hypertrophic cardiomyopathy", "PROBLEM", 124, 151], ["smaller", "OBSERVATION_MODIFIER", 9, 16], ["breeds", "OBSERVATION", 17, 23], ["hypertrophic", "OBSERVATION_MODIFIER", 124, 136], ["cardiomyopathy", "OBSERVATION", 137, 151]]], ["In addition, the systolic obstruction in the LVOT causes further increase in the left ventricular pressure that worsens its hypertrophy.", [["left ventricular", "ANATOMY", 81, 97], ["systolic obstruction", "DISEASE", 17, 37], ["hypertrophy", "DISEASE", 124, 135], ["left ventricular", "MULTI-TISSUE_STRUCTURE", 81, 97], ["the systolic obstruction in the LVOT", "PROBLEM", 13, 49], ["the left ventricular pressure", "TEST", 77, 106], ["its hypertrophy", "PROBLEM", 120, 135], ["systolic", "ANATOMY", 17, 25], ["obstruction", "OBSERVATION", 26, 37], ["LVOT", "ANATOMY", 45, 49], ["increase", "OBSERVATION_MODIFIER", 65, 73], ["left ventricular", "ANATOMY", 81, 97], ["pressure", "OBSERVATION_MODIFIER", 98, 106], ["hypertrophy", "OBSERVATION", 124, 135]]], ["Approximately 10% to 20% of cats with hypertrophic cardiomyopathy have a state of increased coagulability and develop posterior paresis from concurrent thromboembolism of the caudal abdominal aorta (\"saddle thrombosis\") (see Fig. 10-91) .", [["caudal abdominal aorta", "ANATOMY", 175, 197], ["hypertrophic cardiomyopathy", "DISEASE", 38, 65], ["paresis", "DISEASE", 128, 135], ["thromboembolism", "DISEASE", 152, 167], ["thrombosis", "DISEASE", 207, 217], ["cats", "ORGANISM", 28, 32], ["caudal abdominal aorta", "MULTI-TISSUE_STRUCTURE", 175, 197], ["cats", "SPECIES", 28, 32], ["hypertrophic cardiomyopathy", "PROBLEM", 38, 65], ["increased coagulability", "PROBLEM", 82, 105], ["posterior paresis", "PROBLEM", 118, 135], ["concurrent thromboembolism of the caudal abdominal aorta", "PROBLEM", 141, 197], ["saddle thrombosis\"", "PROBLEM", 200, 218], ["hypertrophic", "OBSERVATION_MODIFIER", 38, 50], ["cardiomyopathy", "OBSERVATION", 51, 65], ["increased", "OBSERVATION_MODIFIER", 82, 91], ["coagulability", "OBSERVATION", 92, 105], ["posterior", "ANATOMY_MODIFIER", 118, 127], ["paresis", "OBSERVATION", 128, 135], ["thromboembolism", "OBSERVATION", 152, 167], ["caudal", "ANATOMY_MODIFIER", 175, 181], ["abdominal aorta", "ANATOMY", 182, 197], ["saddle", "OBSERVATION_MODIFIER", 200, 206], ["thrombosis", "OBSERVATION", 207, 217]]], ["The aortic thrombus is first formed in the stagnant blood flow of the enlarged left atrium and is subsequently launched into the aorta.", [["aortic thrombus", "ANATOMY", 4, 19], ["blood", "ANATOMY", 52, 57], ["left atrium", "ANATOMY", 79, 90], ["aorta", "ANATOMY", 129, 134], ["aortic thrombus", "DISEASE", 4, 19], ["aortic thrombus", "PATHOLOGICAL_FORMATION", 4, 19], ["blood", "ORGANISM_SUBSTANCE", 52, 57], ["left atrium", "MULTI-TISSUE_STRUCTURE", 79, 90], ["aorta", "MULTI-TISSUE_STRUCTURE", 129, 134], ["The aortic thrombus", "PROBLEM", 0, 19], ["the stagnant blood flow of the enlarged left atrium", "PROBLEM", 39, 90], ["aortic", "ANATOMY", 4, 10], ["thrombus", "OBSERVATION", 11, 19], ["stagnant", "OBSERVATION_MODIFIER", 43, 51], ["blood flow", "OBSERVATION", 52, 62], ["enlarged", "OBSERVATION", 70, 78], ["left atrium", "ANATOMY", 79, 90], ["aorta", "ANATOMY", 129, 134]]], ["Some cats with hypertrophic cardiomyopathy die unexpectedly without premonitory clinical signs.", [["hypertrophic cardiomyopathy", "DISEASE", 15, 42], ["cats", "ORGANISM", 5, 9], ["cats", "SPECIES", 5, 9], ["hypertrophic cardiomyopathy", "PROBLEM", 15, 42], ["premonitory clinical signs", "PROBLEM", 68, 94], ["hypertrophic", "OBSERVATION_MODIFIER", 15, 27], ["cardiomyopathy", "OBSERVATION", 28, 42]]], ["Microscopically, the lesions of the myocardium are prominent disarray or disorganizations of terriers, may be affected.", [["lesions", "ANATOMY", 21, 28], ["myocardium", "ANATOMY", 36, 46], ["lesions", "PATHOLOGICAL_FORMATION", 21, 28], ["myocardium", "ORGAN", 36, 46], ["the lesions of the myocardium", "PROBLEM", 17, 46], ["prominent disarray", "PROBLEM", 51, 69], ["disorganizations of terriers", "PROBLEM", 73, 101], ["lesions", "OBSERVATION", 21, 28], ["myocardium", "ANATOMY", 36, 46], ["prominent", "OBSERVATION_MODIFIER", 51, 60], ["disarray", "OBSERVATION", 61, 69], ["may be", "UNCERTAINTY", 103, 109]]], ["The disease often has a familial pattern in the affected breeds, and it appears to be inherited as an autosomal recessive mode in the Portuguese water dog breed; as an autosomal dominant mode in the Irish wolfhound, Newfoundland, and Doberman pinscher dog breeds; and likely as an X-linked recessive mode in boxer dogs.", [["autosomal recessive", "DISEASE", 102, 121], ["boxer dogs", "ORGANISM", 308, 318], ["dog", "SPECIES", 252, 255], ["dogs", "SPECIES", 314, 318], ["Doberman pinscher dog", "SPECIES", 234, 255], ["The disease", "PROBLEM", 0, 11], ["a familial pattern in the affected breeds", "PROBLEM", 22, 63], ["an autosomal recessive mode", "PROBLEM", 99, 126], ["disease", "OBSERVATION", 4, 11], ["familial", "OBSERVATION_MODIFIER", 24, 32], ["pattern", "OBSERVATION_MODIFIER", 33, 40]]], ["At autopsy (syn: necropsy), lesions of congestive heart failure are present and the hearts are rounded because of biventricular dilation (Figs.", [["lesions", "ANATOMY", 28, 35], ["heart", "ANATOMY", 50, 55], ["hearts", "ANATOMY", 84, 90], ["biventricular", "ANATOMY", 114, 127], ["congestive heart failure", "DISEASE", 39, 63], ["biventricular dilation", "DISEASE", 114, 136], ["lesions", "PATHOLOGICAL_FORMATION", 28, 35], ["heart", "ORGAN", 50, 55], ["hearts", "ORGAN", 84, 90], ["lesions of congestive heart failure", "PROBLEM", 28, 63], ["biventricular dilation", "PROBLEM", 114, 136], ["lesions", "OBSERVATION", 28, 35], ["congestive", "OBSERVATION_MODIFIER", 39, 49], ["heart", "ANATOMY", 50, 55], ["failure", "OBSERVATION", 56, 63], ["hearts", "ANATOMY", 84, 90], ["rounded", "OBSERVATION_MODIFIER", 95, 102], ["biventricular", "ANATOMY", 114, 127], ["dilation", "OBSERVATION", 128, 136]]], ["10-43 and 10-44), whereas in some cases dilation of the left atrium and ventricle predominates.", [["left atrium", "ANATOMY", 56, 67], ["ventricle", "ANATOMY", 72, 81], ["left atrium", "MULTI-TISSUE_STRUCTURE", 56, 67], ["ventricle", "MULTI-TISSUE_STRUCTURE", 72, 81], ["dilation", "OBSERVATION", 40, 48], ["left atrium", "ANATOMY", 56, 67], ["ventricle", "ANATOMY", 72, 81]]], ["The ratio between the ventricular wall and chamber diameter is decreased (i.e., eccentric hypertrophy).", [["ventricular wall", "ANATOMY", 22, 38], ["hypertrophy", "DISEASE", 90, 101], ["ventricular wall", "MULTI-TISSUE_STRUCTURE", 22, 38], ["The ratio", "TEST", 0, 9], ["eccentric hypertrophy", "PROBLEM", 80, 101], ["ventricular", "ANATOMY", 22, 33], ["wall", "ANATOMY_MODIFIER", 34, 38], ["chamber", "OBSERVATION_MODIFIER", 43, 50], ["diameter", "OBSERVATION_MODIFIER", 51, 59], ["decreased", "OBSERVATION_MODIFIER", 63, 72], ["eccentric", "OBSERVATION_MODIFIER", 80, 89], ["hypertrophy", "OBSERVATION", 90, 101]]], ["The circumference of the annulus of the mitral and tricuspid valves is often increased, and the papillary muscles are often flattened and atrophic.", [["annulus", "ANATOMY", 25, 32], ["mitral", "ANATOMY", 40, 46], ["tricuspid valves", "ANATOMY", 51, 67], ["papillary muscles", "ANATOMY", 96, 113], ["annulus", "MULTI-TISSUE_STRUCTURE", 25, 32], ["mitral", "MULTI-TISSUE_STRUCTURE", 40, 46], ["tricuspid valves", "MULTI-TISSUE_STRUCTURE", 51, 67], ["papillary muscles", "TISSUE", 96, 113], ["atrophic", "PROBLEM", 138, 146], ["circumference", "OBSERVATION_MODIFIER", 4, 17], ["annulus", "ANATOMY_MODIFIER", 25, 32], ["mitral", "OBSERVATION", 40, 46], ["tricuspid valves", "ANATOMY", 51, 67], ["often", "OBSERVATION_MODIFIER", 71, 76], ["increased", "OBSERVATION", 77, 86], ["papillary muscles", "ANATOMY", 96, 113], ["often", "OBSERVATION_MODIFIER", 118, 123], ["flattened", "OBSERVATION_MODIFIER", 124, 133], ["atrophic", "OBSERVATION", 138, 146]]], ["Atrioventricular valvular leaflets are occasionally mildly to moderately thickened, and chordae tendineae are thickened and elongated.", [["Atrioventricular valvular leaflets", "ANATOMY", 0, 34], ["chordae tendineae", "ANATOMY", 88, 105], ["Atrioventricular valvular leaflets", "MULTI-TISSUE_STRUCTURE", 0, 34], ["occasionally mildly to moderately thickened", "PROBLEM", 39, 82], ["thickened", "PROBLEM", 110, 119], ["elongated", "PROBLEM", 124, 133], ["valvular leaflets", "ANATOMY", 17, 34], ["mildly", "OBSERVATION_MODIFIER", 52, 58], ["moderately", "OBSERVATION_MODIFIER", 62, 72], ["thickened", "OBSERVATION", 73, 82], ["chordae tendineae", "ANATOMY", 88, 105], ["thickened", "OBSERVATION", 110, 119], ["elongated", "OBSERVATION_MODIFIER", 124, 133]]], ["The dilated cardiac chambers often have a diffusely white, thickened endocardium.", [["cardiac chambers", "ANATOMY", 12, 28], ["endocardium", "ANATOMY", 69, 80], ["endocardium", "MULTI-TISSUE_STRUCTURE", 69, 80], ["The dilated cardiac chambers", "PROBLEM", 0, 28], ["a diffusely white, thickened endocardium", "PROBLEM", 40, 80], ["dilated", "OBSERVATION", 4, 11], ["cardiac", "ANATOMY", 12, 19], ["chambers", "ANATOMY_MODIFIER", 20, 28], ["diffusely", "OBSERVATION_MODIFIER", 42, 51], ["white", "OBSERVATION_MODIFIER", 52, 57], ["thickened", "OBSERVATION", 59, 68], ["endocardium", "ANATOMY", 69, 80]]], ["Myocardial hypertrophy is best demonstrated by calculating heart weight to body weight ratio.", [["Myocardial", "ANATOMY", 0, 10], ["heart", "ANATOMY", 59, 64], ["body", "ANATOMY", 75, 79], ["Myocardial hypertrophy", "DISEASE", 0, 22], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["heart", "ORGAN", 59, 64], ["body", "ORGANISM_SUBDIVISION", 75, 79], ["Myocardial hypertrophy", "PROBLEM", 0, 22], ["calculating heart weight", "TEST", 47, 71], ["body weight ratio", "TEST", 75, 92], ["hypertrophy", "OBSERVATION", 11, 22], ["heart", "ANATOMY", 59, 64]]], ["The term hypertrophy implies a pathologic process in which the weight of the organ is increased because of an increase in cell size rather than number.", [["organ", "ANATOMY", 77, 82], ["cell", "ANATOMY", 122, 126], ["hypertrophy", "DISEASE", 9, 20], ["organ", "ORGAN", 77, 82], ["cell", "CELL", 122, 126], ["The term hypertrophy", "PROBLEM", 0, 20], ["a pathologic process", "PROBLEM", 29, 49], ["an increase in cell size", "PROBLEM", 107, 131], ["term", "OBSERVATION_MODIFIER", 4, 8], ["hypertrophy", "OBSERVATION", 9, 20], ["pathologic", "OBSERVATION", 31, 41], ["organ", "ANATOMY", 77, 82], ["increased", "OBSERVATION_MODIFIER", 86, 95], ["increase", "OBSERVATION_MODIFIER", 110, 118], ["cell", "OBSERVATION", 122, 126], ["size", "OBSERVATION_MODIFIER", 127, 131]]], ["In myocardial eccentric hypertrophy, the sarcomeres are increased in numbers in series (rather than parallel as in concentric hypertrophy).", [["myocardial", "ANATOMY", 3, 13], ["sarcomeres", "ANATOMY", 41, 51], ["myocardial eccentric hypertrophy", "DISEASE", 3, 35], ["hypertrophy", "DISEASE", 126, 137], ["myocardial", "MULTI-TISSUE_STRUCTURE", 3, 13], ["sarcomeres", "CELLULAR_COMPONENT", 41, 51], ["myocardial eccentric hypertrophy", "PROBLEM", 3, 35], ["concentric hypertrophy", "PROBLEM", 115, 137], ["myocardial", "ANATOMY", 3, 13], ["eccentric", "OBSERVATION_MODIFIER", 14, 23], ["hypertrophy", "OBSERVATION", 24, 35], ["sarcomeres", "OBSERVATION_MODIFIER", 41, 51], ["increased", "OBSERVATION_MODIFIER", 56, 65], ["numbers", "OBSERVATION_MODIFIER", 69, 76], ["concentric", "OBSERVATION_MODIFIER", 115, 125], ["hypertrophy", "OBSERVATION", 126, 137]]], ["Two histological patterns have been described in dogs with dilated cardiomyopathy.", [["dilated cardiomyopathy", "DISEASE", 59, 81], ["dogs", "ORGANISM", 49, 53], ["dogs", "SPECIES", 49, 53], ["dilated cardiomyopathy", "PROBLEM", 59, 81], ["dilated", "OBSERVATION_MODIFIER", 59, 66], ["cardiomyopathy", "OBSERVATION", 67, 81]]], ["The attenuated wavy fiber type is seen in many giant, large and medium-sized dogs and the fatty infiltrationdegenerative type of dilated cardiomyopathy is seen in mainly boxers and Doberman pinschers.", [["wavy fiber", "ANATOMY", 15, 25], ["dilated cardiomyopathy", "DISEASE", 129, 151], ["dogs", "ORGANISM", 77, 81], ["dogs", "SPECIES", 77, 81], ["The attenuated wavy fiber type", "PROBLEM", 0, 30], ["large and medium-sized dogs", "PROBLEM", 54, 81], ["dilated cardiomyopathy", "PROBLEM", 129, 151], ["attenuated", "OBSERVATION_MODIFIER", 4, 14], ["wavy", "OBSERVATION_MODIFIER", 15, 19], ["fiber type", "OBSERVATION", 20, 30], ["many", "OBSERVATION_MODIFIER", 42, 46], ["giant", "OBSERVATION_MODIFIER", 47, 52], ["large", "OBSERVATION_MODIFIER", 54, 59], ["medium", "OBSERVATION_MODIFIER", 64, 70], ["sized", "OBSERVATION_MODIFIER", 71, 76], ["dogs", "OBSERVATION", 77, 81], ["fatty", "OBSERVATION_MODIFIER", 90, 95], ["infiltrationdegenerative type", "OBSERVATION_MODIFIER", 96, 125], ["dilated", "OBSERVATION_MODIFIER", 129, 136], ["cardiomyopathy", "OBSERVATION", 137, 151], ["Doberman pinschers", "OBSERVATION", 181, 199]]], ["Occasionally, there are additional nonspecific findings, such as necrosis, infarcts, fibrosis, vacuolization of myocytes, and hyperplasia of coronary arteries.", [["infarcts", "ANATOMY", 75, 83], ["myocytes", "ANATOMY", 112, 120], ["coronary arteries", "ANATOMY", 141, 158], ["necrosis", "DISEASE", 65, 73], ["infarcts", "DISEASE", 75, 83], ["fibrosis", "DISEASE", 85, 93], ["hyperplasia", "DISEASE", 126, 137], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 141, 158], ["additional nonspecific findings", "PROBLEM", 24, 55], ["necrosis", "PROBLEM", 65, 73], ["infarcts", "PROBLEM", 75, 83], ["fibrosis", "PROBLEM", 85, 93], ["vacuolization of myocytes", "PROBLEM", 95, 120], ["hyperplasia of coronary arteries", "PROBLEM", 126, 158], ["nonspecific", "OBSERVATION_MODIFIER", 35, 46], ["findings", "OBSERVATION", 47, 55], ["necrosis", "OBSERVATION", 65, 73], ["infarcts", "OBSERVATION", 75, 83], ["fibrosis", "OBSERVATION", 85, 93], ["vacuolization", "OBSERVATION_MODIFIER", 95, 108], ["myocytes", "ANATOMY", 112, 120], ["hyperplasia", "OBSERVATION", 126, 137], ["coronary arteries", "ANATOMY", 141, 158]]], ["In the attenuated wavy fiber type, the cardiomyocytes are less than 6 \u00b5m in diameter (normal myofiber diameter ranges from 10 to 20 \u00b5m) and have a wavy appearance.", [["wavy fiber type", "ANATOMY", 18, 33], ["cardiomyocytes", "ANATOMY", 39, 53], ["myofiber", "ANATOMY", 93, 101], ["cardiomyocytes", "CELL", 39, 53], ["myofiber", "TISSUE", 93, 101], ["cardiomyocytes", "CELL_TYPE", 39, 53], ["attenuated", "OBSERVATION_MODIFIER", 7, 17], ["wavy", "OBSERVATION_MODIFIER", 18, 22], ["fiber type", "OBSERVATION", 23, 33], ["cardiomyocytes", "ANATOMY", 39, 53], ["less", "OBSERVATION_MODIFIER", 58, 62], ["than 6 \u00b5m", "OBSERVATION_MODIFIER", 63, 72], ["diameter", "OBSERVATION_MODIFIER", 76, 84], ["normal", "OBSERVATION", 86, 92], ["myofiber", "OBSERVATION_MODIFIER", 93, 101], ["diameter", "OBSERVATION_MODIFIER", 102, 110], ["ranges", "OBSERVATION_MODIFIER", 111, 117], ["10 to 20 \u00b5m", "OBSERVATION_MODIFIER", 123, 134], ["wavy", "OBSERVATION_MODIFIER", 147, 151]]], ["The myocytes are separated by clear spaces (i.e., edema fluid), and there is minimal to absent cellular infiltrates.", [["myocytes", "ANATOMY", 4, 12], ["edema fluid", "ANATOMY", 50, 61], ["cellular", "ANATOMY", 95, 103], ["edema", "DISEASE", 50, 55], ["myocytes", "CELL", 4, 12], ["edema fluid", "TISSUE", 50, 61], ["cellular", "CELL", 95, 103], ["edema fluid", "PROBLEM", 50, 61], ["absent cellular infiltrates", "PROBLEM", 88, 115], ["myocytes", "ANATOMY", 4, 12], ["clear", "OBSERVATION_MODIFIER", 30, 35], ["spaces", "OBSERVATION_MODIFIER", 36, 42], ["edema", "OBSERVATION_MODIFIER", 50, 55], ["fluid", "OBSERVATION", 56, 61], ["minimal", "OBSERVATION_MODIFIER", 77, 84], ["absent", "OBSERVATION_MODIFIER", 88, 94], ["cellular", "OBSERVATION_MODIFIER", 95, 103], ["infiltrates", "OBSERVATION", 104, 115]]], ["The abnormal attenuated wavy fibers are most abundant in the lateral wall of the left ventricle and therefore this site should be sampled when dilated cardiomyopathy is suspected.", [["wavy fibers", "ANATOMY", 24, 35], ["lateral wall", "ANATOMY", 61, 73], ["left ventricle", "ANATOMY", 81, 95], ["dilated cardiomyopathy", "DISEASE", 143, 165], ["wavy fibers", "CELLULAR_COMPONENT", 24, 35], ["lateral wall", "MULTI-TISSUE_STRUCTURE", 61, 73], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 81, 95], ["The abnormal attenuated wavy fibers", "PROBLEM", 0, 35], ["dilated cardiomyopathy", "PROBLEM", 143, 165], ["abnormal", "OBSERVATION_MODIFIER", 4, 12], ["attenuated", "OBSERVATION_MODIFIER", 13, 23], ["wavy", "OBSERVATION_MODIFIER", 24, 28], ["fibers", "OBSERVATION_MODIFIER", 29, 35], ["most", "OBSERVATION_MODIFIER", 40, 44], ["abundant", "OBSERVATION_MODIFIER", 45, 53], ["lateral", "ANATOMY_MODIFIER", 61, 68], ["wall", "ANATOMY_MODIFIER", 69, 73], ["left ventricle", "ANATOMY", 81, 95], ["cardiomyopathy", "OBSERVATION", 151, 165]]], ["The sensitivity and specificity of attenuated wavy fibers of the myocardium of dogs for the diagnosis of dilated cardiomyopathy have been shown to be 98% and 100%, respectively.", [["wavy fibers", "ANATOMY", 46, 57], ["myocardium", "ANATOMY", 65, 75], ["dilated cardiomyopathy", "DISEASE", 105, 127], ["myocardium", "MULTI-TISSUE_STRUCTURE", 65, 75], ["dogs", "ORGANISM", 79, 83], ["dogs", "SPECIES", 79, 83], ["The sensitivity", "TEST", 0, 15], ["dilated cardiomyopathy", "PROBLEM", 105, 127], ["myocardium", "ANATOMY", 65, 75], ["dilated", "OBSERVATION", 105, 112]]], ["The attenuated wavy fibers form may represent an early pathologic change in the myocardium of dogs with dilated cardiomyopathy because it has been documented in dogs preceding clinical signs of dilated cardiomyopathy.", [["wavy fibers", "ANATOMY", 15, 26], ["myocardium", "ANATOMY", 80, 90], ["dilated cardiomyopathy", "DISEASE", 104, 126], ["dilated cardiomyopathy", "DISEASE", 194, 216], ["myocardium", "ORGAN", 80, 90], ["dogs", "ORGANISM", 94, 98], ["dogs", "ORGANISM", 161, 165], ["dogs", "SPECIES", 94, 98], ["dogs", "SPECIES", 161, 165], ["an early pathologic change", "PROBLEM", 46, 72], ["dilated cardiomyopathy", "PROBLEM", 104, 126], ["dilated cardiomyopathy", "PROBLEM", 194, 216], ["attenuated", "OBSERVATION_MODIFIER", 4, 14], ["wavy", "OBSERVATION_MODIFIER", 15, 19], ["fibers", "OBSERVATION", 20, 26], ["may represent", "UNCERTAINTY", 32, 45], ["early", "OBSERVATION_MODIFIER", 49, 54], ["pathologic", "OBSERVATION", 55, 65], ["myocardium", "ANATOMY", 80, 90], ["dilated", "OBSERVATION_MODIFIER", 104, 111], ["cardiomyopathy", "OBSERVATION", 112, 126], ["dilated", "OBSERVATION_MODIFIER", 194, 201], ["cardiomyopathy", "OBSERVATION", 202, 216]]], ["In the fatty infiltration-degenerative type of dilated cardiomyopathy, histopathology consists of myocytolysis, myofiber degeneration, vacuolization, and atrophy along with extensive fibrosis and fatty infiltration that replaces the myofibers.", [["myofiber", "ANATOMY", 112, 120], ["myofibers", "ANATOMY", 233, 242], ["fatty infiltration", "DISEASE", 7, 25], ["dilated cardiomyopathy", "DISEASE", 47, 69], ["myocytolysis", "DISEASE", 98, 110], ["myofiber degeneration", "DISEASE", 112, 133], ["atrophy", "DISEASE", 154, 161], ["fibrosis", "DISEASE", 183, 191], ["fatty infiltration", "DISEASE", 196, 214], ["myofiber", "TISSUE", 112, 120], ["myofibers", "TISSUE", 233, 242], ["the fatty infiltration", "PROBLEM", 3, 25], ["dilated cardiomyopathy", "PROBLEM", 47, 69], ["histopathology", "TEST", 71, 85], ["myocytolysis", "PROBLEM", 98, 110], ["myofiber degeneration", "PROBLEM", 112, 133], ["vacuolization", "PROBLEM", 135, 148], ["atrophy", "PROBLEM", 154, 161], ["extensive fibrosis", "PROBLEM", 173, 191], ["fatty infiltration", "PROBLEM", 196, 214], ["fatty infiltration", "OBSERVATION", 7, 25], ["degenerative", "OBSERVATION_MODIFIER", 26, 38], ["dilated", "OBSERVATION_MODIFIER", 47, 54], ["cardiomyopathy", "OBSERVATION", 55, 69], ["myofiber degeneration", "OBSERVATION", 112, 133], ["vacuolization", "OBSERVATION_MODIFIER", 135, 148], ["atrophy", "OBSERVATION", 154, 161], ["extensive", "OBSERVATION_MODIFIER", 173, 182], ["fibrosis", "OBSERVATION", 183, 191], ["fatty infiltration", "OBSERVATION", 196, 214], ["myofibers", "ANATOMY", 233, 242]]], ["It is proposed that the two histologically distinct forms of idiopathic canine dilated cardiomyopathy reflect different disease processes.", [["idiopathic canine dilated cardiomyopathy", "DISEASE", 61, 101], ["idiopathic canine dilated cardiomyopathy", "PROBLEM", 61, 101], ["different disease processes", "PROBLEM", 110, 137], ["histologically", "OBSERVATION_MODIFIER", 28, 42], ["distinct", "OBSERVATION_MODIFIER", 43, 51], ["idiopathic", "OBSERVATION_MODIFIER", 61, 71], ["canine", "OBSERVATION_MODIFIER", 72, 78], ["dilated", "OBSERVATION_MODIFIER", 79, 86], ["cardiomyopathy", "OBSERVATION", 87, 101], ["different", "OBSERVATION_MODIFIER", 110, 119], ["disease", "OBSERVATION", 120, 127]]], ["Cardiotoxicity leading to chamber dilation similar to DCM (i.e., secondary dilated cardiomyopathy) has been reported secondary to toxic/environmental (e.g., doxorubicin, irradiation, ethanol, cobalt, lead, catecholamines, histamine, and methylxanthines), infectious (e.g., canine parvovirus), and nutritional (taurine and carnitine deficiency) causes.", [["Cardiotoxicity", "DISEASE", 0, 14], ["DCM", "DISEASE", 54, 57], ["dilated cardiomyopathy", "DISEASE", 75, 97], ["doxorubicin", "CHEMICAL", 157, 168], ["ethanol", "CHEMICAL", 183, 190], ["cobalt", "CHEMICAL", 192, 198], ["catecholamines", "CHEMICAL", 206, 220], ["histamine", "CHEMICAL", 222, 231], ["methylxanthines", "CHEMICAL", 237, 252], ["infectious (e.g., canine parvovirus", "DISEASE", 255, 290], ["taurine", "CHEMICAL", 310, 317], ["carnitine", "CHEMICAL", 322, 331], ["doxorubicin", "CHEMICAL", 157, 168], ["ethanol", "CHEMICAL", 183, 190], ["cobalt", "CHEMICAL", 192, 198], ["catecholamines", "CHEMICAL", 206, 220], ["histamine", "CHEMICAL", 222, 231], ["methylxanthines", "CHEMICAL", 237, 252], ["taurine", "CHEMICAL", 310, 317], ["carnitine", "CHEMICAL", 322, 331], ["doxorubicin", "SIMPLE_CHEMICAL", 157, 168], ["ethanol", "SIMPLE_CHEMICAL", 183, 190], ["cobalt", "SIMPLE_CHEMICAL", 192, 198], ["lead", "SIMPLE_CHEMICAL", 200, 204], ["catecholamines", "SIMPLE_CHEMICAL", 206, 220], ["histamine", "SIMPLE_CHEMICAL", 222, 231], ["methylxanthines", "SIMPLE_CHEMICAL", 237, 252], ["canine parvovirus", "ORGANISM", 273, 290], ["taurine", "SIMPLE_CHEMICAL", 310, 317], ["carnitine", "SIMPLE_CHEMICAL", 322, 331], ["canine parvovirus", "SPECIES", 273, 290], ["canine parvovirus", "SPECIES", 273, 290], ["Cardiotoxicity", "PROBLEM", 0, 14], ["chamber dilation", "PROBLEM", 26, 42], ["DCM", "PROBLEM", 54, 57], ["secondary dilated cardiomyopathy", "PROBLEM", 65, 97], ["toxic/environmental (e.g.", "PROBLEM", 130, 155], ["doxorubicin", "TREATMENT", 157, 168], ["irradiation", "TREATMENT", 170, 181], ["ethanol", "TREATMENT", 183, 190], ["cobalt", "TREATMENT", 192, 198], ["catecholamines", "TREATMENT", 206, 220], ["histamine", "TREATMENT", 222, 231], ["methylxanthines", "TREATMENT", 237, 252], ["infectious (e.g., canine parvovirus)", "PROBLEM", 255, 291], ["nutritional (taurine and carnitine deficiency)", "PROBLEM", 297, 343], ["chamber dilation", "OBSERVATION", 26, 42], ["dilated", "OBSERVATION_MODIFIER", 75, 82], ["cardiomyopathy", "OBSERVATION", 83, 97], ["toxic", "OBSERVATION_MODIFIER", 130, 135], ["infectious", "OBSERVATION", 255, 265]]], ["Idiopathic dilated cardiomyopathy is a rare feline primary myocardial disease with a suggested complex genetic inheritance that results in a systolic heart failure rather than a diastolic heart failure as seen in cats with hypertrophic cardiomyopathy.", [["myocardial", "ANATOMY", 59, 69], ["heart", "ANATOMY", 150, 155], ["heart", "ANATOMY", 188, 193], ["Idiopathic dilated cardiomyopathy", "DISEASE", 0, 33], ["primary myocardial disease", "DISEASE", 51, 77], ["systolic heart failure", "DISEASE", 141, 163], ["diastolic heart failure", "DISEASE", 178, 201], ["hypertrophic cardiomyopathy", "DISEASE", 223, 250], ["myocardial", "MULTI-TISSUE_STRUCTURE", 59, 69], ["heart", "ORGAN", 150, 155], ["heart", "ORGAN", 188, 193], ["cats", "ORGANISM", 213, 217], ["Idiopathic dilated cardiomyopathy", "PROBLEM", 0, 33], ["a rare feline primary myocardial disease", "PROBLEM", 37, 77], ["complex genetic inheritance", "PROBLEM", 95, 122], ["a systolic heart failure", "PROBLEM", 139, 163], ["a diastolic heart failure", "PROBLEM", 176, 201], ["hypertrophic cardiomyopathy", "PROBLEM", 223, 250], ["dilated", "OBSERVATION_MODIFIER", 11, 18], ["cardiomyopathy", "OBSERVATION", 19, 33], ["myocardial", "ANATOMY", 59, 69], ["disease", "OBSERVATION", 70, 77], ["heart", "ANATOMY", 150, 155], ["failure", "OBSERVATION", 156, 163], ["diastolic", "OBSERVATION", 178, 187], ["heart", "ANATOMY", 188, 193], ["failure", "OBSERVATION", 194, 201], ["hypertrophic", "OBSERVATION_MODIFIER", 223, 235], ["cardiomyopathy", "OBSERVATION", 236, 250]]], ["Most cats develop secondary dilated cardiomyopathy because of nutritional deficiency (taurine), toxicity (doxorubicin), or severe volume overload (severe mitral insufficiency or congenital defects leading to severe left to right shunting) or, rarely, infection with feline panleukopenia virus.", [["mitral", "ANATOMY", 154, 160], ["left", "ANATOMY", 215, 219], ["dilated cardiomyopathy", "DISEASE", 28, 50], ["nutritional deficiency", "DISEASE", 62, 84], ["taurine", "CHEMICAL", 86, 93], ["toxicity", "DISEASE", 96, 104], ["doxorubicin", "CHEMICAL", 106, 117], ["volume overload", "DISEASE", 130, 145], ["mitral insufficiency", "DISEASE", 154, 174], ["congenital defects", "DISEASE", 178, 196], ["left to right shunting", "DISEASE", 215, 237], ["infection", "DISEASE", 251, 260], ["feline panleukopenia", "DISEASE", 266, 286], ["taurine", "CHEMICAL", 86, 93], ["doxorubicin", "CHEMICAL", 106, 117], ["cats", "ORGANISM", 5, 9], ["taurine", "SIMPLE_CHEMICAL", 86, 93], ["doxorubicin", "SIMPLE_CHEMICAL", 106, 117], ["mitral", "PATHOLOGICAL_FORMATION", 154, 160], ["feline panleukopenia virus", "ORGANISM", 266, 292], ["cats", "SPECIES", 5, 9], ["feline", "SPECIES", 266, 272], ["feline panleukopenia virus", "SPECIES", 266, 292], ["secondary dilated cardiomyopathy", "PROBLEM", 18, 50], ["nutritional deficiency", "PROBLEM", 62, 84], ["toxicity (doxorubicin", "TREATMENT", 96, 117], ["severe volume overload", "PROBLEM", 123, 145], ["severe mitral insufficiency", "PROBLEM", 147, 174], ["congenital defects", "PROBLEM", 178, 196], ["severe left to right shunting)", "PROBLEM", 208, 238], ["infection", "PROBLEM", 251, 260], ["feline panleukopenia virus", "PROBLEM", 266, 292], ["secondary", "OBSERVATION_MODIFIER", 18, 27], ["dilated", "OBSERVATION_MODIFIER", 28, 35], ["cardiomyopathy", "OBSERVATION", 36, 50], ["nutritional deficiency", "OBSERVATION", 62, 84], ["severe", "OBSERVATION_MODIFIER", 123, 129], ["volume overload", "OBSERVATION", 130, 145], ["severe", "OBSERVATION_MODIFIER", 147, 153], ["mitral insufficiency", "OBSERVATION", 154, 174], ["congenital defects", "OBSERVATION", 178, 196], ["severe", "OBSERVATION_MODIFIER", 208, 214], ["left", "ANATOMY_MODIFIER", 215, 219], ["right", "ANATOMY_MODIFIER", 223, 228], ["shunting", "OBSERVATION", 229, 237], ["infection", "OBSERVATION", 251, 260]]], ["The heart globally enlarges through dilation of all chambers (eccentric hypertrophy), and the heart to body weight ratio is increased (5.4 \u00b1 0.3 g/kg vs. 3.83 \u00b1 0.2 g/kg in normal control cats), although the walls of the ventricles are thinned.", [["heart", "ANATOMY", 4, 9], ["heart", "ANATOMY", 94, 99], ["body", "ANATOMY", 103, 107], ["walls", "ANATOMY", 208, 213], ["ventricles", "ANATOMY", 221, 231], ["hypertrophy", "DISEASE", 72, 83], ["heart", "ORGAN", 4, 9], ["heart", "ORGAN", 94, 99], ["body", "ORGANISM_SUBDIVISION", 103, 107], ["cats", "ORGANISM", 188, 192], ["ventricles", "MULTI-TISSUE_STRUCTURE", 221, 231], ["eccentric hypertrophy", "PROBLEM", 62, 83], ["the heart to body weight ratio", "TEST", 90, 120], ["thinned", "PROBLEM", 236, 243], ["heart", "ANATOMY", 4, 9], ["globally", "OBSERVATION_MODIFIER", 10, 18], ["enlarges", "OBSERVATION", 19, 27], ["dilation", "OBSERVATION", 36, 44], ["all", "OBSERVATION_MODIFIER", 48, 51], ["chambers", "OBSERVATION_MODIFIER", 52, 60], ["eccentric", "OBSERVATION_MODIFIER", 62, 71], ["hypertrophy", "OBSERVATION", 72, 83], ["heart", "ANATOMY", 94, 99], ["increased", "OBSERVATION_MODIFIER", 124, 133], ["walls", "ANATOMY_MODIFIER", 208, 213], ["ventricles", "ANATOMY", 221, 231], ["thinned", "OBSERVATION", 236, 243]]], ["This is due to addition of sarcomeres in series, rather than in parallel, which leads to a proportional increase in ventricular wall thickness and internal chamber diameter.", [["sarcomeres", "ANATOMY", 27, 37], ["ventricular wall", "ANATOMY", 116, 132], ["sarcomeres", "CELLULAR_COMPONENT", 27, 37], ["ventricular wall", "TISSUE", 116, 132], ["sarcomeres in series", "PROBLEM", 27, 47], ["a proportional increase in ventricular wall thickness and internal chamber diameter", "PROBLEM", 89, 172], ["sarcomeres", "OBSERVATION", 27, 37], ["proportional", "OBSERVATION_MODIFIER", 91, 103], ["increase", "OBSERVATION_MODIFIER", 104, 112], ["ventricular", "ANATOMY", 116, 127], ["wall", "ANATOMY_MODIFIER", 128, 132], ["thickness", "OBSERVATION_MODIFIER", 133, 142], ["internal", "ANATOMY_MODIFIER", 147, 155], ["chamber", "ANATOMY_MODIFIER", 156, 163], ["diameter", "OBSERVATION_MODIFIER", 164, 172]]], ["Hydrothorax, pulmonary congestion, and edema often accompany dilated cardiomyopathy when congestive heart failure ensues.", [["pulmonary", "ANATOMY", 13, 22], ["edema", "ANATOMY", 39, 44], ["heart", "ANATOMY", 100, 105], ["Hydrothorax", "DISEASE", 0, 11], ["pulmonary congestion", "DISEASE", 13, 33], ["edema", "DISEASE", 39, 44], ["dilated cardiomyopathy", "DISEASE", 61, 83], ["congestive heart failure", "DISEASE", 89, 113], ["pulmonary", "ORGAN", 13, 22], ["edema", "PATHOLOGICAL_FORMATION", 39, 44], ["heart", "ORGAN", 100, 105], ["Hydrothorax", "PROBLEM", 0, 11], ["pulmonary congestion", "PROBLEM", 13, 33], ["edema", "PROBLEM", 39, 44], ["dilated cardiomyopathy", "PROBLEM", 61, 83], ["congestive heart failure", "PROBLEM", 89, 113], ["pulmonary", "ANATOMY", 13, 22], ["congestion", "OBSERVATION", 23, 33], ["edema", "OBSERVATION", 39, 44], ["dilated", "OBSERVATION_MODIFIER", 61, 68], ["cardiomyopathy", "OBSERVATION", 69, 83], ["congestive", "OBSERVATION_MODIFIER", 89, 99], ["heart", "ANATOMY", 100, 105], ["failure", "OBSERVATION", 106, 113]]], ["Similar to cats with hypertrophic cardiomyopathy, arterial thromboembolism occasionally accompanies feline dilated cardiomyopathy, unlike in dogs with dilated cardiomyopathy.", [["arterial", "ANATOMY", 50, 58], ["hypertrophic cardiomyopathy", "DISEASE", 21, 48], ["arterial thromboembolism", "DISEASE", 50, 74], ["feline dilated cardiomyopathy", "DISEASE", 100, 129], ["dilated cardiomyopathy", "DISEASE", 151, 173], ["cats", "ORGANISM", 11, 15], ["arterial", "MULTI-TISSUE_STRUCTURE", 50, 58], ["feline", "ORGANISM", 100, 106], ["dogs", "ORGANISM", 141, 145], ["cats", "SPECIES", 11, 15], ["dogs", "SPECIES", 141, 145], ["hypertrophic cardiomyopathy", "PROBLEM", 21, 48], ["arterial thromboembolism", "PROBLEM", 50, 74], ["feline dilated cardiomyopathy", "PROBLEM", 100, 129], ["dilated cardiomyopathy", "PROBLEM", 151, 173], ["hypertrophic", "OBSERVATION_MODIFIER", 21, 33], ["cardiomyopathy", "OBSERVATION", 34, 48], ["arterial", "ANATOMY", 50, 58], ["thromboembolism", "OBSERVATION", 59, 74], ["feline", "OBSERVATION_MODIFIER", 100, 106], ["dilated", "OBSERVATION_MODIFIER", 107, 114], ["cardiomyopathy", "OBSERVATION", 115, 129], ["dilated", "OBSERVATION_MODIFIER", 151, 158], ["cardiomyopathy", "OBSERVATION", 159, 173]]], ["Cardiac histopathology consists of mild multifocal to severe and diffuse interstitial edema and fibrosis.", [["Cardiac", "ANATOMY", 0, 7], ["interstitial edema", "ANATOMY", 73, 91], ["interstitial edema", "DISEASE", 73, 91], ["fibrosis", "DISEASE", 96, 104], ["interstitial edema", "PATHOLOGICAL_FORMATION", 73, 91], ["Cardiac histopathology", "TEST", 0, 22], ["mild multifocal to severe and diffuse interstitial edema", "PROBLEM", 35, 91], ["fibrosis", "PROBLEM", 96, 104], ["histopathology", "OBSERVATION", 8, 22], ["mild", "OBSERVATION_MODIFIER", 35, 39], ["multifocal", "OBSERVATION_MODIFIER", 40, 50], ["severe", "OBSERVATION_MODIFIER", 54, 60], ["diffuse", "OBSERVATION_MODIFIER", 65, 72], ["interstitial", "ANATOMY_MODIFIER", 73, 85], ["edema", "OBSERVATION", 86, 91], ["fibrosis", "OBSERVATION", 96, 104]]], ["Myocardiocytes are thinner, attenuated, and wavier than normal, and they often exhibit myocytolysis.Box 10-12 Most Common Cardiac Diseases ofThree forms of bovine dilated cardiomyopathy are dilated cardiomyopathy in cattle of Canadian Holstein origin, cardiomyopathy occurs in newborn and infant calves.", [["Myocardiocytes", "ANATOMY", 0, 14], ["Cardiac", "ANATOMY", 122, 129], ["myocytolysis", "DISEASE", 87, 99], ["Cardiac Diseases", "DISEASE", 122, 138], ["dilated cardiomyopathy", "DISEASE", 163, 185], ["dilated cardiomyopathy", "DISEASE", 190, 212], ["cardiomyopathy", "DISEASE", 252, 266], ["Myocardiocytes", "CELL", 0, 14], ["bovine", "ORGANISM", 156, 162], ["calves", "ORGANISM", 296, 302], ["Myocardiocytes", "CELL_TYPE", 0, 14], ["bovine", "SPECIES", 156, 162], ["cattle", "SPECIES", 216, 222], ["infant", "SPECIES", 289, 295], ["calves", "SPECIES", 296, 302], ["cattle", "SPECIES", 216, 222], ["attenuated", "PROBLEM", 28, 38], ["myocytolysis", "PROBLEM", 87, 99], ["Box", "TEST", 100, 103], ["bovine dilated cardiomyopathy", "PROBLEM", 156, 185], ["dilated cardiomyopathy", "PROBLEM", 190, 212], ["cardiomyopathy", "PROBLEM", 252, 266], ["thinner", "OBSERVATION_MODIFIER", 19, 26], ["attenuated", "OBSERVATION_MODIFIER", 28, 38], ["myocytolysis", "OBSERVATION", 87, 99], ["Cardiac", "ANATOMY", 122, 129], ["Diseases", "OBSERVATION", 130, 138], ["bovine", "OBSERVATION_MODIFIER", 156, 162], ["dilated", "OBSERVATION_MODIFIER", 163, 170], ["cardiomyopathy", "OBSERVATION", 171, 185], ["dilated", "OBSERVATION_MODIFIER", 190, 197], ["cardiomyopathy", "OBSERVATION", 198, 212], ["Holstein origin", "OBSERVATION", 235, 250], ["cardiomyopathy", "OBSERVATION", 252, 266]]], ["Microscopically, myocardial degeneration and necrosis is marked.", [["myocardial", "ANATOMY", 17, 27], ["myocardial degeneration", "DISEASE", 17, 40], ["necrosis", "DISEASE", 45, 53], ["myocardial", "MULTI-TISSUE_STRUCTURE", 17, 27], ["myocardial degeneration", "PROBLEM", 17, 40], ["necrosis", "PROBLEM", 45, 53], ["myocardial", "ANATOMY", 17, 27], ["degeneration", "OBSERVATION", 28, 40], ["necrosis", "OBSERVATION", 45, 53], ["marked", "OBSERVATION_MODIFIER", 57, 63]]], ["A lethal, autosomal recessive gene is suspected.", [["autosomal recessive gene", "DISEASE", 10, 34], ["A lethal, autosomal recessive gene", "PROBLEM", 0, 34], ["lethal", "OBSERVATION_MODIFIER", 2, 8], ["autosomal", "OBSERVATION_MODIFIER", 10, 19], ["recessive gene", "OBSERVATION", 20, 34]]], ["Congenital cardiomyopathy occurs in Poll Hereford cattle in association with wooly haircoat syndrome.", [["Congenital cardiomyopathy", "DISEASE", 0, 25], ["haircoat syndrome", "DISEASE", 83, 100], ["cattle", "SPECIES", 50, 56], ["Poll Hereford cattle", "SPECIES", 36, 56], ["Congenital cardiomyopathy", "PROBLEM", 0, 25], ["wooly haircoat syndrome", "PROBLEM", 77, 100], ["cardiomyopathy", "OBSERVATION", 11, 25], ["haircoat syndrome", "OBSERVATION", 83, 100]]], ["Inherited as a lethal autosomal recessive trait, affected calves usually die from congestive heart failure by 12 weeks of age.Box 10-12 Most Common Cardiac Diseases ofRestrictive Cardiomyopathy.", [["calves", "ANATOMY", 58, 64], ["heart", "ANATOMY", 93, 98], ["Cardiac", "ANATOMY", 148, 155], ["autosomal recessive trait", "DISEASE", 22, 47], ["congestive heart failure", "DISEASE", 82, 106], ["Cardiac Diseases ofRestrictive Cardiomyopathy", "DISEASE", 148, 193], ["calves", "ORGANISM", 58, 64], ["heart", "ORGAN", 93, 98], ["calves", "SPECIES", 58, 64], ["a lethal autosomal recessive trait", "PROBLEM", 13, 47], ["congestive heart failure", "PROBLEM", 82, 106], ["Box", "TEST", 126, 129], ["Common Cardiac Diseases ofRestrictive Cardiomyopathy", "PROBLEM", 141, 193], ["congestive", "OBSERVATION", 82, 92], ["heart", "ANATOMY", 93, 98], ["failure", "OBSERVATION", 99, 106], ["Cardiac", "ANATOMY", 148, 155], ["Diseases", "OBSERVATION", 156, 164], ["Cardiomyopathy", "OBSERVATION", 179, 193]]], ["Restrictive cardiomyopathy occurs infrequently.", [["Restrictive cardiomyopathy", "DISEASE", 0, 26], ["Restrictive cardiomyopathy", "PROBLEM", 0, 26], ["cardiomyopathy", "OBSERVATION", 12, 26]]], ["Restrictive cardiomyopathy is a functional term rather than disease entity and consists of a spectrum of pathologic phenotype and pathophysiology.", [["Restrictive cardiomyopathy", "DISEASE", 0, 26], ["Restrictive cardiomyopathy", "PROBLEM", 0, 26], ["disease entity", "PROBLEM", 60, 74], ["pathologic phenotype", "PROBLEM", 105, 125], ["cardiomyopathy", "OBSERVATION", 12, 26], ["functional term", "OBSERVATION_MODIFIER", 32, 47], ["pathologic", "OBSERVATION", 105, 115]]], ["The hallmark of restrictive cardiomyopathy is increased stiffness of the myocardium that leads to diastolic heart failure.", [["myocardium", "ANATOMY", 73, 83], ["heart", "ANATOMY", 108, 113], ["cardiomyopathy", "DISEASE", 28, 42], ["diastolic heart failure", "DISEASE", 98, 121], ["myocardium", "ORGAN", 73, 83], ["heart", "ORGAN", 108, 113], ["restrictive cardiomyopathy", "PROBLEM", 16, 42], ["increased stiffness of the myocardium", "PROBLEM", 46, 83], ["diastolic heart failure", "PROBLEM", 98, 121], ["hallmark", "OBSERVATION_MODIFIER", 4, 12], ["restrictive", "OBSERVATION_MODIFIER", 16, 27], ["cardiomyopathy", "OBSERVATION", 28, 42], ["increased", "OBSERVATION_MODIFIER", 46, 55], ["stiffness", "OBSERVATION_MODIFIER", 56, 65], ["myocardium", "ANATOMY", 73, 83], ["diastolic", "ANATOMY_MODIFIER", 98, 107], ["heart", "ANATOMY", 108, 113], ["failure", "OBSERVATION", 114, 121]]], ["Stiffness is due to increased myocardial fibrosis and variable infiltration with leukocytes.", [["myocardial", "ANATOMY", 30, 40], ["leukocytes", "ANATOMY", 81, 91], ["fibrosis", "DISEASE", 41, 49], ["myocardial", "MULTI-TISSUE_STRUCTURE", 30, 40], ["leukocytes", "CELL", 81, 91], ["leukocytes", "CELL_TYPE", 81, 91], ["Stiffness", "PROBLEM", 0, 9], ["increased myocardial fibrosis", "PROBLEM", 20, 49], ["variable infiltration", "PROBLEM", 54, 75], ["leukocytes", "PROBLEM", 81, 91], ["due to", "UNCERTAINTY", 13, 19], ["increased", "OBSERVATION_MODIFIER", 20, 29], ["myocardial", "ANATOMY", 30, 40], ["fibrosis", "OBSERVATION", 41, 49], ["variable", "OBSERVATION_MODIFIER", 54, 62], ["infiltration", "OBSERVATION", 63, 75], ["leukocytes", "OBSERVATION_MODIFIER", 81, 91]]], ["Sometimes the endocardium is also involved (endomyocardial fibrosis), and it is thought to be a specific subtype of restrictive cardiomyopathy.", [["endocardium", "ANATOMY", 14, 25], ["endomyocardial", "ANATOMY", 44, 58], ["fibrosis", "DISEASE", 59, 67], ["cardiomyopathy", "DISEASE", 128, 142], ["endocardium", "MULTI-TISSUE_STRUCTURE", 14, 25], ["endomyocardial", "ORGAN", 44, 58], ["endomyocardial fibrosis", "PROBLEM", 44, 67], ["restrictive cardiomyopathy", "PROBLEM", 116, 142], ["endocardium", "ANATOMY", 14, 25], ["endomyocardial", "ANATOMY", 44, 58], ["fibrosis", "OBSERVATION", 59, 67], ["thought to be", "UNCERTAINTY", 80, 93], ["restrictive", "OBSERVATION_MODIFIER", 116, 127], ["cardiomyopathy", "OBSERVATION", 128, 142]]], ["When the endocardium is involved, there is extreme endocardial thickening secondary to fibrosis and granulation tissue.", [["endocardium", "ANATOMY", 9, 20], ["endocardial", "ANATOMY", 51, 62], ["granulation tissue", "ANATOMY", 100, 118], ["fibrosis", "DISEASE", 87, 95], ["endocardium", "MULTI-TISSUE_STRUCTURE", 9, 20], ["endocardial", "TISSUE", 51, 62], ["granulation tissue", "TISSUE", 100, 118], ["extreme endocardial thickening", "PROBLEM", 43, 73], ["fibrosis", "PROBLEM", 87, 95], ["granulation tissue", "PROBLEM", 100, 118], ["endocardium", "ANATOMY", 9, 20], ["extreme", "OBSERVATION_MODIFIER", 43, 50], ["endocardial", "ANATOMY", 51, 62], ["thickening", "OBSERVATION", 63, 73], ["fibrosis", "OBSERVATION", 87, 95], ["granulation tissue", "OBSERVATION", 100, 118]]], ["Restrictive cardiomyopathy in cats can have two types of endocardial changes resultant in impaired vascular filling.", [["endocardial", "ANATOMY", 57, 68], ["vascular", "ANATOMY", 99, 107], ["Restrictive cardiomyopathy", "DISEASE", 0, 26], ["impaired vascular filling", "DISEASE", 90, 115], ["cats", "ORGANISM", 30, 34], ["endocardial", "MULTI-TISSUE_STRUCTURE", 57, 68], ["vascular", "MULTI-TISSUE_STRUCTURE", 99, 107], ["cats", "SPECIES", 30, 34], ["Restrictive cardiomyopathy in cats", "PROBLEM", 0, 34], ["endocardial changes", "PROBLEM", 57, 76], ["impaired vascular filling", "PROBLEM", 90, 115], ["cardiomyopathy", "OBSERVATION", 12, 26], ["endocardial", "ANATOMY", 57, 68], ["changes", "OBSERVATION", 69, 76], ["impaired", "OBSERVATION_MODIFIER", 90, 98], ["vascular filling", "OBSERVATION", 99, 115]]], ["In one type, the left ventricular endocardium has diffuse notable fibrosis.", [["left ventricular endocardium", "ANATOMY", 17, 45], ["fibrosis", "DISEASE", 66, 74], ["ventricular endocardium", "MULTI-TISSUE_STRUCTURE", 22, 45], ["diffuse notable fibrosis", "PROBLEM", 50, 74], ["one type", "OBSERVATION_MODIFIER", 3, 11], ["left", "ANATOMY_MODIFIER", 17, 21], ["ventricular endocardium", "ANATOMY", 22, 45], ["diffuse", "OBSERVATION_MODIFIER", 50, 57], ["notable", "OBSERVATION_MODIFIER", 58, 65], ["fibrosis", "OBSERVATION", 66, 74]]], ["Evidence suggests that the fibrotic lesion is preceded by endomyocarditis.", [["fibrotic lesion", "ANATOMY", 27, 42], ["fibrotic lesion", "DISEASE", 27, 42], ["endomyocarditis", "DISEASE", 58, 73], ["the fibrotic lesion", "PROBLEM", 23, 42], ["endomyocarditis", "PROBLEM", 58, 73], ["fibrotic", "OBSERVATION_MODIFIER", 27, 35], ["lesion", "OBSERVATION", 36, 42], ["endomyocarditis", "OBSERVATION", 58, 73]]], ["The second type results from excessive moderator bands that traverse the left ventricular cavity.", [["left ventricular cavity", "ANATOMY", 73, 96], ["ventricular cavity", "MULTI-TISSUE_STRUCTURE", 78, 96], ["excessive moderator bands", "PROBLEM", 29, 54], ["excessive", "OBSERVATION_MODIFIER", 29, 38], ["moderator bands", "OBSERVATION", 39, 54], ["left ventricular cavity", "ANATOMY", 73, 96]]], ["Other examples of restrictive cardiomyopathy in animals include endocardial fibrosis in certain strains of aged rats and congenital endocardial fibroelastosis in Burmese cats (Fig. 10-45) .Box 10-12 Most Common Cardiac Diseases ofArrhythmogenic Right Ventricular Cardiomyopathy.", [["endocardial", "ANATOMY", 64, 75], ["endocardial fibroelastosis", "ANATOMY", 132, 158], ["Cardiac", "ANATOMY", 211, 218], ["Ventricular", "ANATOMY", 251, 262], ["cardiomyopathy", "DISEASE", 30, 44], ["endocardial fibrosis", "DISEASE", 64, 84], ["congenital endocardial fibroelastosis", "DISEASE", 121, 158], ["Cardiac Diseases", "DISEASE", 211, 227], ["Ventricular Cardiomyopathy", "DISEASE", 251, 277], ["endocardial", "MULTI-TISSUE_STRUCTURE", 64, 75], ["rats", "ORGANISM", 112, 116], ["cats", "ORGANISM", 170, 174], ["rats", "SPECIES", 112, 116], ["cats", "SPECIES", 170, 174], ["restrictive cardiomyopathy", "PROBLEM", 18, 44], ["endocardial fibrosis", "PROBLEM", 64, 84], ["congenital endocardial fibroelastosis", "PROBLEM", 121, 158], ["Box", "TEST", 189, 192], ["Common Cardiac Diseases", "PROBLEM", 204, 227], ["Right Ventricular Cardiomyopathy", "PROBLEM", 245, 277], ["restrictive", "OBSERVATION_MODIFIER", 18, 29], ["cardiomyopathy", "OBSERVATION", 30, 44], ["endocardial", "ANATOMY", 64, 75], ["fibrosis", "OBSERVATION", 76, 84], ["congenital", "OBSERVATION_MODIFIER", 121, 131], ["endocardial", "ANATOMY", 132, 143], ["fibroelastosis", "OBSERVATION", 144, 158], ["Cardiac", "ANATOMY", 211, 218], ["Diseases", "OBSERVATION", 219, 227], ["Right Ventricular", "ANATOMY", 245, 262], ["Cardiomyopathy", "OBSERVATION", 263, 277]]], ["Arrhythmogenic right ventricular cardiomyopathy is an important cardiac disease of middle-aged boxer dogs, and rare cases have been reported in cats.", [["right ventricular", "ANATOMY", 15, 32], ["cardiac", "ANATOMY", 64, 71], ["Arrhythmogenic right ventricular cardiomyopathy", "DISEASE", 0, 47], ["cardiac disease", "DISEASE", 64, 79], ["ventricular", "MULTI-TISSUE_STRUCTURE", 21, 32], ["cardiac", "ORGAN", 64, 71], ["dogs", "ORGANISM", 101, 105], ["cats", "ORGANISM", 144, 148], ["dogs", "SPECIES", 101, 105], ["cats", "SPECIES", 144, 148], ["Arrhythmogenic right ventricular cardiomyopathy", "PROBLEM", 0, 47], ["right ventricular", "ANATOMY", 15, 32], ["cardiomyopathy", "OBSERVATION", 33, 47], ["cardiac", "ANATOMY", 64, 71], ["disease", "OBSERVATION", 72, 79], ["middle", "ANATOMY_MODIFIER", 83, 89]]], ["Other names for the disease include boxer cardiomyopathy and familial ventricular arrhythmias of boxers.", [["ventricular", "ANATOMY", 70, 81], ["boxer cardiomyopathy", "DISEASE", 36, 56], ["ventricular arrhythmias", "DISEASE", 70, 93], ["ventricular", "ORGAN", 70, 81], ["the disease", "PROBLEM", 16, 27], ["boxer cardiomyopathy", "PROBLEM", 36, 56], ["familial ventricular arrhythmias of boxers", "PROBLEM", 61, 103], ["ventricular", "ANATOMY", 70, 81], ["arrhythmias", "OBSERVATION", 82, 93]]], ["It is inherited as an autosomal dominant trait in boxers, and it is associated with an 8-base pair deletion in the 3\u2032 untranslated region of the Striatin gene on chromosome 17, inhibition of trafficking of Wnt pathway proteins from the endoplasmic reticulum to their proper location within the cell, and potentially with Calstabin2 deficiency.", [["chromosome 17", "ANATOMY", 162, 175], ["endoplasmic reticulum", "ANATOMY", 236, 257], ["cell", "ANATOMY", 294, 298], ["Calstabin2", "CHEMICAL", 321, 331], ["Calstabin2", "CHEMICAL", 321, 331], ["Striatin", "GENE_OR_GENE_PRODUCT", 145, 153], ["chromosome 17", "CELLULAR_COMPONENT", 162, 175], ["Wnt", "GENE_OR_GENE_PRODUCT", 206, 209], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 236, 257], ["cell", "CELL", 294, 298], ["Calstabin2", "GENE_OR_GENE_PRODUCT", 321, 331], ["8-base pair deletion", "DNA", 87, 107], ["3\u2032 untranslated region", "DNA", 115, 137], ["Striatin gene", "DNA", 145, 158], ["chromosome 17", "DNA", 162, 175], ["Wnt pathway proteins", "PROTEIN", 206, 226], ["Calstabin2", "PROTEIN", 321, 331], ["an autosomal dominant trait in boxers", "PROBLEM", 19, 56], ["an 8-base pair deletion", "PROBLEM", 84, 107], ["Wnt pathway proteins", "PROBLEM", 206, 226], ["Calstabin2 deficiency", "PROBLEM", 321, 342], ["autosomal", "OBSERVATION_MODIFIER", 22, 31], ["dominant", "OBSERVATION_MODIFIER", 32, 40], ["trait", "OBSERVATION_MODIFIER", 41, 46], ["endoplasmic reticulum", "OBSERVATION", 236, 257], ["cell", "OBSERVATION", 294, 298], ["potentially with", "UNCERTAINTY", 304, 320], ["Calstabin2 deficiency", "OBSERVATION", 321, 342]]], ["Affected dogs have a high incidence of ventricular arrhythmias with in Japanese black cattle, and congenital cardiomyopathy in Hereford cattle.", [["ventricular", "ANATOMY", 39, 50], ["ventricular arrhythmias", "DISEASE", 39, 62], ["congenital cardiomyopathy", "DISEASE", 98, 123], ["dogs", "ORGANISM", 9, 13], ["ventricular", "ORGAN", 39, 50], ["dogs", "SPECIES", 9, 13], ["cattle", "SPECIES", 86, 92], ["cattle", "SPECIES", 136, 142], ["Japanese black cattle", "SPECIES", 71, 92], ["cattle", "SPECIES", 136, 142], ["Affected dogs", "PROBLEM", 0, 13], ["ventricular arrhythmias", "PROBLEM", 39, 62], ["congenital cardiomyopathy", "PROBLEM", 98, 123], ["ventricular", "ANATOMY", 39, 50], ["arrhythmias", "OBSERVATION", 51, 62], ["congenital", "OBSERVATION_MODIFIER", 98, 108], ["cardiomyopathy", "OBSERVATION", 109, 123]]], ["Cardiomyopathy in cattle of Canadian Holstein origin has been reported in Holsteins, Red Holstein-Friesian, and Red Danish dairy breed; it was first reported in Switzerland for Simmental-Red Holsteins, but is now reported from multiple countries.", [["Cardiomyopathy", "DISEASE", 0, 14], ["cattle", "SPECIES", 18, 24], ["cattle", "SPECIES", 18, 24], ["Red Holstein-Friesian", "SPECIES", 85, 106], ["Red Danish dairy breed", "SPECIES", 112, 134], ["Simmental-Red Holsteins", "SPECIES", 177, 200], ["Cardiomyopathy", "PROBLEM", 0, 14]]], ["Breeding studies have indicated an autosomal recessive mode of inheritance.", [["autosomal recessive mode of inheritance", "DISEASE", 35, 74], ["Breeding studies", "TEST", 0, 16], ["an autosomal recessive mode of inheritance", "PROBLEM", 32, 74]]], ["Affected cattle develop congestive heart failure with cardiac dilation.", [["heart", "ANATOMY", 35, 40], ["cardiac", "ANATOMY", 54, 61], ["congestive heart failure", "DISEASE", 24, 48], ["cardiac dilation", "DISEASE", 54, 70], ["cattle", "ORGANISM", 9, 15], ["heart", "ORGAN", 35, 40], ["cardiac", "ORGAN", 54, 61], ["cattle", "SPECIES", 9, 15], ["cattle", "SPECIES", 9, 15], ["Affected cattle", "PROBLEM", 0, 15], ["congestive heart failure", "PROBLEM", 24, 48], ["cardiac dilation", "PROBLEM", 54, 70], ["congestive", "OBSERVATION", 24, 34], ["heart", "ANATOMY", 35, 40], ["failure", "OBSERVATION", 41, 48], ["cardiac", "ANATOMY", 54, 61], ["dilation", "OBSERVATION", 62, 70]]], ["Histopathologic findings are loss of cardiac muscle cells and replacement fibrosis.", [["cardiac muscle cells", "ANATOMY", 37, 57], ["loss of cardiac muscle", "DISEASE", 29, 51], ["fibrosis", "DISEASE", 74, 82], ["cardiac muscle cells", "CELL", 37, 57], ["cardiac muscle cells", "CELL_TYPE", 37, 57], ["Histopathologic findings", "TEST", 0, 24], ["loss of cardiac muscle cells", "PROBLEM", 29, 57], ["replacement fibrosis", "PROBLEM", 62, 82], ["loss", "OBSERVATION_MODIFIER", 29, 33], ["cardiac muscle", "ANATOMY", 37, 51], ["cells", "OBSERVATION", 52, 57], ["replacement", "OBSERVATION_MODIFIER", 62, 73], ["fibrosis", "OBSERVATION", 74, 82]]], ["Japanese black cattle cardiomyopathy RV LV they may not have a documented history of ventricular premature complexes on electrocardiogram.", [["RV LV", "ANATOMY", 37, 42], ["ventricular", "ANATOMY", 85, 96], ["cardiomyopathy", "DISEASE", 22, 36], ["ventricular premature complexes", "DISEASE", 85, 116], ["ventricular", "ORGAN", 85, 96], ["cattle", "SPECIES", 15, 21], ["Japanese black cattle", "SPECIES", 0, 21], ["Japanese black cattle cardiomyopathy", "PROBLEM", 0, 36], ["ventricular premature complexes", "PROBLEM", 85, 116], ["electrocardiogram", "TEST", 120, 137], ["cardiomyopathy", "OBSERVATION", 22, 36], ["RV LV", "ANATOMY", 37, 42], ["ventricular", "ANATOMY", 85, 96], ["premature", "OBSERVATION", 97, 106]]], ["Therefore lack of documented arrhythmia and/or enlargement of the right cardiac chamber does not rule out this disease.", [["right cardiac chamber", "ANATOMY", 66, 87], ["arrhythmia", "DISEASE", 29, 39], ["cardiac", "ORGAN", 72, 79], ["documented arrhythmia", "PROBLEM", 18, 39], ["enlargement of the right cardiac chamber", "PROBLEM", 47, 87], ["this disease", "PROBLEM", 106, 118], ["arrhythmia", "OBSERVATION", 29, 39], ["enlargement", "OBSERVATION", 47, 58], ["right", "ANATOMY_MODIFIER", 66, 71], ["cardiac", "ANATOMY", 72, 79], ["chamber", "ANATOMY_MODIFIER", 80, 87], ["does not rule out", "UNCERTAINTY", 88, 105], ["disease", "OBSERVATION", 111, 118]]], ["The distinctive histopathologic findings are similar to those of the disease in human beings and include substantial replacement of right ventricular (RV) cardiac myocytes by adipose or fibrous tissue in a fatty or a fibro-fatty pattern.Box 10-12 Most Common Cardiac Diseases ofIt is a rare myocardial disease of cats.", [["right ventricular", "ANATOMY", 132, 149], ["RV) cardiac myocytes", "ANATOMY", 151, 171], ["adipose", "ANATOMY", 175, 182], ["fibrous tissue", "ANATOMY", 186, 200], ["fibro", "ANATOMY", 217, 222], ["Cardiac", "ANATOMY", 259, 266], ["myocardial", "ANATOMY", 291, 301], ["Cardiac Diseases", "DISEASE", 259, 275], ["myocardial disease", "DISEASE", 291, 309], ["human", "ORGANISM", 80, 85], ["ventricular", "MULTI-TISSUE_STRUCTURE", 138, 149], ["cardiac myocytes", "TISSUE", 155, 171], ["adipose", "TISSUE", 175, 182], ["fibrous tissue", "TISSUE", 186, 200], ["myocardial", "MULTI-TISSUE_STRUCTURE", 291, 301], ["cats", "ORGANISM", 313, 317], ["human", "SPECIES", 80, 85], ["cats", "SPECIES", 313, 317], ["human", "SPECIES", 80, 85], ["the disease in human beings", "PROBLEM", 65, 92], ["substantial replacement", "TREATMENT", 105, 128], ["right ventricular (RV) cardiac myocytes", "PROBLEM", 132, 171], ["fibrous tissue", "PROBLEM", 186, 200], ["a fibro-fatty pattern", "PROBLEM", 215, 236], ["Box", "TEST", 237, 240], ["a rare myocardial disease of cats", "PROBLEM", 284, 317], ["distinctive", "OBSERVATION_MODIFIER", 4, 15], ["histopathologic", "OBSERVATION", 16, 31], ["disease", "OBSERVATION", 69, 76], ["substantial", "OBSERVATION_MODIFIER", 105, 116], ["replacement", "OBSERVATION", 117, 128], ["right ventricular", "ANATOMY", 132, 149], ["RV", "ANATOMY_MODIFIER", 151, 153], ["cardiac myocytes", "ANATOMY", 155, 171], ["adipose", "ANATOMY", 175, 182], ["fibrous tissue", "OBSERVATION", 186, 200], ["fatty", "OBSERVATION_MODIFIER", 206, 211], ["fibro-", "OBSERVATION_MODIFIER", 217, 223], ["fatty pattern", "OBSERVATION", 223, 236], ["Cardiac", "ANATOMY", 259, 266], ["Diseases", "OBSERVATION", 267, 275], ["myocardial", "ANATOMY", 291, 301], ["disease", "OBSERVATION", 302, 309]]], ["Cats have moderate to severe RV eccentric hypertrophy and severe right atrial enlargement with segmental to diffuse wall thinning, and they develop atrial and ventricular arrhythmias from macroreentrant circuits that develop in regions of fibrofatty infiltration.Box 10-12 Most Common Cardiac Diseases ofUnclassified Cardiomyopathy.", [["right atrial", "ANATOMY", 65, 77], ["wall", "ANATOMY", 116, 120], ["atrial", "ANATOMY", 148, 154], ["ventricular", "ANATOMY", 159, 170], ["fibrofatty", "ANATOMY", 239, 249], ["Cardiac", "ANATOMY", 285, 292], ["hypertrophy", "DISEASE", 42, 53], ["atrial enlargement", "DISEASE", 71, 89], ["atrial and ventricular arrhythmias", "DISEASE", 148, 182], ["Cardiac Diseases", "DISEASE", 285, 301], ["Cardiomyopathy", "DISEASE", 317, 331], ["atrial", "ORGAN", 71, 77], ["wall", "TISSUE", 116, 120], ["atrial", "MULTI-TISSUE_STRUCTURE", 148, 154], ["ventricular", "MULTI-TISSUE_STRUCTURE", 159, 170], ["moderate to severe RV eccentric hypertrophy", "PROBLEM", 10, 53], ["severe right atrial enlargement", "PROBLEM", 58, 89], ["segmental to diffuse wall thinning", "PROBLEM", 95, 129], ["atrial and ventricular arrhythmias", "PROBLEM", 148, 182], ["macroreentrant circuits", "TREATMENT", 188, 211], ["fibrofatty infiltration", "PROBLEM", 239, 262], ["Box", "TEST", 263, 266], ["Cardiomyopathy", "PROBLEM", 317, 331], ["moderate", "OBSERVATION_MODIFIER", 10, 18], ["severe", "OBSERVATION_MODIFIER", 22, 28], ["RV", "ANATOMY", 29, 31], ["eccentric", "OBSERVATION_MODIFIER", 32, 41], ["hypertrophy", "OBSERVATION", 42, 53], ["severe", "OBSERVATION_MODIFIER", 58, 64], ["right", "ANATOMY_MODIFIER", 65, 70], ["atrial", "ANATOMY", 71, 77], ["enlargement", "OBSERVATION", 78, 89], ["segmental", "ANATOMY_MODIFIER", 95, 104], ["diffuse", "OBSERVATION_MODIFIER", 108, 115], ["wall", "ANATOMY_MODIFIER", 116, 120], ["thinning", "OBSERVATION", 121, 129], ["atrial", "ANATOMY", 148, 154], ["ventricular", "ANATOMY", 159, 170], ["arrhythmias", "OBSERVATION", 171, 182], ["macroreentrant circuits", "OBSERVATION", 188, 211], ["fibrofatty infiltration", "OBSERVATION", 239, 262], ["Cardiac", "ANATOMY", 285, 292], ["Diseases", "OBSERVATION", 293, 301], ["Cardiomyopathy", "OBSERVATION", 317, 331]]], ["This is a nebulous category that includes cases with left or bilateral atrial dilation, normal to near normal LV wall thickness, normal systolic function, and diastolic dysfunction.", [["left", "ANATOMY", 53, 57], ["atrial", "ANATOMY", 71, 77], ["LV wall", "ANATOMY", 110, 117], ["diastolic dysfunction", "DISEASE", 159, 180], ["atrial", "MULTI-TISSUE_STRUCTURE", 71, 77], ["LV wall", "TISSUE", 110, 117], ["a nebulous category", "PROBLEM", 8, 27], ["left or bilateral atrial dilation", "PROBLEM", 53, 86], ["diastolic dysfunction", "PROBLEM", 159, 180], ["left", "ANATOMY_MODIFIER", 53, 57], ["bilateral", "ANATOMY_MODIFIER", 61, 70], ["atrial", "ANATOMY", 71, 77], ["dilation", "OBSERVATION", 78, 86], ["normal", "OBSERVATION", 88, 94], ["LV", "ANATOMY", 110, 112], ["wall", "ANATOMY_MODIFIER", 113, 117], ["thickness", "OBSERVATION_MODIFIER", 118, 127], ["normal", "OBSERVATION", 129, 135], ["systolic function", "OBSERVATION", 136, 153], ["diastolic dysfunction", "OBSERVATION", 159, 180]]], ["Grossly and histologically, the distinction between restrictive cardiomyopathy and unclassified cardiomyopathy is not apparent unless endomyocardial fibrosis is present.", [["endomyocardial", "ANATOMY", 134, 148], ["restrictive cardiomyopathy", "DISEASE", 52, 78], ["cardiomyopathy", "DISEASE", 96, 110], ["fibrosis", "DISEASE", 149, 157], ["endomyocardial", "ORGAN", 134, 148], ["restrictive cardiomyopathy", "PROBLEM", 52, 78], ["unclassified cardiomyopathy", "PROBLEM", 83, 110], ["endomyocardial fibrosis", "PROBLEM", 134, 157], ["histologically", "OBSERVATION", 12, 26], ["restrictive", "OBSERVATION_MODIFIER", 52, 63], ["cardiomyopathy", "OBSERVATION", 64, 78], ["unclassified", "OBSERVATION_MODIFIER", 83, 95], ["cardiomyopathy", "OBSERVATION", 96, 110], ["not apparent", "UNCERTAINTY", 114, 126], ["fibrosis", "OBSERVATION", 149, 157]]], ["The separation between these two entities can sometimes be made antemortem via echocardiographic evaluation of a restrictive filling pattern on mitral inflow (E and A waves).Box 10-12 Most Common Cardiac Diseases ofMolecular Mechanisms of Hereditary Cardiomyopathies.", [["mitral", "ANATOMY", 144, 150], ["Cardiac", "ANATOMY", 196, 203], ["Cardiac Diseases", "DISEASE", 196, 212], ["Hereditary Cardiomyopathies", "DISEASE", 239, 266], ["mitral", "MULTI-TISSUE_STRUCTURE", 144, 150], ["echocardiographic evaluation", "TEST", 79, 107], ["a restrictive filling pattern", "PROBLEM", 111, 140], ["Box", "TEST", 174, 177], ["Hereditary Cardiomyopathies", "PROBLEM", 239, 266], ["restrictive", "OBSERVATION", 113, 124], ["filling pattern", "OBSERVATION", 125, 140], ["mitral inflow", "OBSERVATION", 144, 157], ["Cardiac", "ANATOMY", 196, 203], ["Diseases", "OBSERVATION", 204, 212], ["Hereditary", "OBSERVATION_MODIFIER", 239, 249], ["Cardiomyopathies", "OBSERVATION", 250, 266]]], ["Our understanding of the molecular mechanisms of the hereditary cardiomyopathies is developing rapidly.", [["hereditary cardiomyopathies", "DISEASE", 53, 80], ["the hereditary cardiomyopathies", "PROBLEM", 49, 80], ["hereditary", "OBSERVATION_MODIFIER", 53, 63], ["cardiomyopathies", "OBSERVATION", 64, 80], ["rapidly", "OBSERVATION_MODIFIER", 95, 102]]], ["In human beings with familial hypertrophic cardiomyopathy inherited in an autosomal dominant manner, a variety of single-gene mutations have been documented.", [["hypertrophic cardiomyopathy", "DISEASE", 30, 57], ["human", "ORGANISM", 3, 8], ["human", "SPECIES", 3, 8], ["human", "SPECIES", 3, 8], ["familial hypertrophic cardiomyopathy", "PROBLEM", 21, 57], ["single-gene mutations", "TREATMENT", 114, 135], ["hypertrophic", "OBSERVATION_MODIFIER", 30, 42], ["cardiomyopathy", "OBSERVATION", 43, 57], ["autosomal", "OBSERVATION_MODIFIER", 74, 83], ["dominant", "OBSERVATION", 84, 92]]], ["The mutations affect genes that encode sarcomere proteins of cardiac myocytes.", [["sarcomere", "ANATOMY", 39, 48], ["cardiac myocytes", "ANATOMY", 61, 77], ["cardiac myocytes", "CELL", 61, 77], ["sarcomere proteins", "PROTEIN", 39, 57], ["cardiac myocytes", "CELL_TYPE", 61, 77], ["The mutations affect genes", "PROBLEM", 0, 26], ["cardiac myocytes", "PROBLEM", 61, 77], ["cardiac myocytes", "ANATOMY", 61, 77]]], ["Hypertrophic cardiomyopathy-associated altered cardiac proteins include cardiac \u03b2-myosin heavy chain, cardiac troponin T and tropomyosin, and myosin-binding protein C. Dilated cardiomyopathy-associated mutated proteins include desmin, mitochondrial proteins, dystropin, titin (titin spans the sarcomere and connects the Z and M restricting the range of sarcomere stretching motion), and a subunit of the surface protein-dystropin-associated glycoproteins.", [["cardiac", "ANATOMY", 47, 54], ["mitochondrial", "ANATOMY", 235, 248], ["sarcomere", "ANATOMY", 293, 302], ["sarcomere", "ANATOMY", 353, 362], ["surface", "ANATOMY", 404, 411], ["Hypertrophic cardiomyopathy", "DISEASE", 0, 27], ["Dilated cardiomyopathy", "DISEASE", 168, 190], ["cardiac", "ORGAN", 47, 54], ["cardiac \u03b2-myosin heavy chain", "GENE_OR_GENE_PRODUCT", 72, 100], ["cardiac troponin T", "GENE_OR_GENE_PRODUCT", 102, 120], ["tropomyosin", "GENE_OR_GENE_PRODUCT", 125, 136], ["myosin-binding protein", "GENE_OR_GENE_PRODUCT", 142, 164], ["desmin", "GENE_OR_GENE_PRODUCT", 227, 233], ["mitochondrial", "CELLULAR_COMPONENT", 235, 248], ["dystropin", "GENE_OR_GENE_PRODUCT", 259, 268], ["titin", "GENE_OR_GENE_PRODUCT", 270, 275], ["sarcomere", "CELLULAR_COMPONENT", 293, 302], ["surface protein-dystropin-associated glycoproteins", "GENE_OR_GENE_PRODUCT", 404, 454], ["cardiac proteins", "PROTEIN", 47, 63], ["cardiac \u03b2-myosin heavy chain", "PROTEIN", 72, 100], ["cardiac troponin T", "PROTEIN", 102, 120], ["tropomyosin", "PROTEIN", 125, 136], ["myosin-binding protein", "PROTEIN", 142, 164], ["mutated proteins", "PROTEIN", 202, 218], ["desmin", "PROTEIN", 227, 233], ["mitochondrial proteins", "PROTEIN", 235, 257], ["dystropin", "PROTEIN", 259, 268], ["titin", "PROTEIN", 270, 275], ["titin", "PROTEIN", 277, 282], ["sarcomere", "PROTEIN", 293, 302], ["Z and M", "PROTEIN", 320, 327], ["surface protein", "PROTEIN", 404, 419], ["dystropin-associated glycoproteins", "PROTEIN", 420, 454], ["Hypertrophic cardiomyopathy", "PROBLEM", 0, 27], ["altered cardiac proteins", "PROBLEM", 39, 63], ["cardiac \u03b2-myosin heavy chain", "PROBLEM", 72, 100], ["cardiac troponin T", "TEST", 102, 120], ["tropomyosin", "TEST", 125, 136], ["myosin-binding protein C.", "PROBLEM", 142, 167], ["Dilated cardiomyopathy", "PROBLEM", 168, 190], ["mutated proteins", "PROBLEM", 202, 218], ["desmin, mitochondrial proteins", "PROBLEM", 227, 257], ["dystropin", "TREATMENT", 259, 268], ["titin (titin spans the sarcomere", "PROBLEM", 270, 302], ["sarcomere stretching motion", "TREATMENT", 353, 380], ["the surface protein", "TEST", 400, 419], ["associated glycoproteins", "PROBLEM", 430, 454], ["cardiomyopathy", "OBSERVATION", 13, 27], ["cardiac", "ANATOMY", 47, 54], ["proteins", "OBSERVATION", 55, 63], ["Dilated", "OBSERVATION_MODIFIER", 168, 175], ["cardiomyopathy", "OBSERVATION", 176, 190]]], ["It remains unclear how these mutant proteins result in functional and structural alterations of cardiac muscle cells.", [["cardiac muscle cells", "ANATOMY", 96, 116], ["cardiac muscle cells", "CELL", 96, 116], ["mutant proteins", "PROTEIN", 29, 44], ["cardiac muscle cells", "CELL_TYPE", 96, 116], ["these mutant proteins", "PROBLEM", 23, 44], ["functional and structural alterations of cardiac muscle cells", "PROBLEM", 55, 116], ["cardiac muscle", "ANATOMY", 96, 110], ["cells", "OBSERVATION", 111, 116]]], ["However, recent studies suggest hypertrophic cardiomyopathy may arise from defective energy transfer from the mitochondria to the sarcomere.", [["mitochondria", "ANATOMY", 110, 122], ["sarcomere", "ANATOMY", 130, 139], ["hypertrophic cardiomyopathy", "DISEASE", 32, 59], ["mitochondria", "CELLULAR_COMPONENT", 110, 122], ["sarcomere", "CELLULAR_COMPONENT", 130, 139], ["recent studies", "TEST", 9, 23], ["hypertrophic cardiomyopathy", "PROBLEM", 32, 59], ["defective energy", "PROBLEM", 75, 91], ["suggest", "UNCERTAINTY", 24, 31], ["hypertrophic", "OBSERVATION_MODIFIER", 32, 44], ["cardiomyopathy", "OBSERVATION", 45, 59], ["defective energy", "OBSERVATION", 75, 91]]], ["Dilated cardiomyopathy is believed to be associated with abnormalities in the cytoskeletal proteins resulting in abnormal force generation, force transmission, or myocyte signaling.", [["cytoskeletal", "ANATOMY", 78, 90], ["myocyte", "ANATOMY", 163, 170], ["Dilated cardiomyopathy", "DISEASE", 0, 22], ["cytoskeletal", "CELLULAR_COMPONENT", 78, 90], ["myocyte", "CELL", 163, 170], ["cytoskeletal proteins", "PROTEIN", 78, 99], ["Dilated cardiomyopathy", "PROBLEM", 0, 22], ["abnormalities in the cytoskeletal proteins", "PROBLEM", 57, 99], ["abnormal force generation", "PROBLEM", 113, 138], ["force transmission", "TEST", 140, 158], ["myocyte signaling", "PROBLEM", 163, 180], ["cardiomyopathy", "OBSERVATION", 8, 22], ["believed to be associated with", "UNCERTAINTY", 26, 56], ["abnormalities", "OBSERVATION", 57, 70], ["cytoskeletal proteins", "OBSERVATION", 78, 99], ["abnormal", "OBSERVATION_MODIFIER", 113, 121], ["force generation", "OBSERVATION", 122, 138], ["myocyte", "ANATOMY", 163, 170]]], ["Similar gene mutations and altered proteins were recently discovered in the various heritable cardiomyopathies of animals.Box 10-12 Most Common Cardiac Diseases ofNeoplastic Transformation.", [["Cardiac", "ANATOMY", 144, 151], ["cardiomyopathies", "DISEASE", 94, 110], ["Cardiac Diseases ofNeoplastic Transformation", "DISEASE", 144, 188], ["Similar gene mutations", "PROBLEM", 0, 22], ["altered proteins", "PROBLEM", 27, 43], ["the various heritable cardiomyopathies of animals", "PROBLEM", 72, 121], ["Box", "TEST", 122, 125], ["Common Cardiac Diseases ofNeoplastic Transformation", "PROBLEM", 137, 188], ["gene mutations", "OBSERVATION", 8, 22], ["heritable", "OBSERVATION_MODIFIER", 84, 93], ["cardiomyopathies", "OBSERVATION", 94, 110], ["Cardiac", "ANATOMY", 144, 151], ["Diseases", "OBSERVATION", 152, 160], ["ofNeoplastic Transformation", "OBSERVATION", 161, 188]]], ["Various primary and secondary neoplasms develop either in or near the heart.", [["neoplasms", "ANATOMY", 30, 39], ["heart", "ANATOMY", 70, 75], ["primary and secondary neoplasms", "DISEASE", 8, 39], ["neoplasms", "CANCER", 30, 39], ["heart", "ORGAN", 70, 75], ["Various primary and secondary neoplasms", "PROBLEM", 0, 39], ["secondary", "OBSERVATION_MODIFIER", 20, 29], ["neoplasms", "OBSERVATION", 30, 39], ["heart", "ANATOMY", 70, 75]]], ["Primary neoplasms include rhabdomyoma, rhabdomyosarcoma, schwannoma, and hemangiosarcoma.", [["Primary neoplasms", "ANATOMY", 0, 17], ["rhabdomyoma", "ANATOMY", 26, 37], ["rhabdomyosarcoma", "ANATOMY", 39, 55], ["schwannoma", "ANATOMY", 57, 67], ["hemangiosarcoma", "ANATOMY", 73, 88], ["Primary neoplasms", "DISEASE", 0, 17], ["rhabdomyoma", "DISEASE", 26, 37], ["rhabdomyosarcoma", "DISEASE", 39, 55], ["schwannoma", "DISEASE", 57, 67], ["hemangiosarcoma", "DISEASE", 73, 88], ["Primary neoplasms", "CANCER", 0, 17], ["rhabdomyoma", "CANCER", 26, 37], ["rhabdomyosarcoma", "CANCER", 39, 55], ["schwannoma", "CANCER", 57, 67], ["hemangiosarcoma", "CANCER", 73, 88], ["Primary neoplasms", "PROBLEM", 0, 17], ["rhabdomyoma", "PROBLEM", 26, 37], ["rhabdomyosarcoma", "PROBLEM", 39, 55], ["schwannoma", "PROBLEM", 57, 67], ["hemangiosarcoma", "PROBLEM", 73, 88], ["neoplasms", "OBSERVATION", 8, 17], ["rhabdomyoma", "OBSERVATION", 26, 37], ["rhabdomyosarcoma", "OBSERVATION", 39, 55], ["schwannoma", "OBSERVATION", 57, 67], ["hemangiosarcoma", "OBSERVATION", 73, 88]]], ["Rhabdomyomas and rhabdomyosarcomas are rare in animals and form white to gray nodules in the myocardium that often project into the cardiac chambers.", [["Rhabdomyomas", "ANATOMY", 0, 12], ["rhabdomyosarcomas", "ANATOMY", 17, 34], ["gray nodules", "ANATOMY", 73, 85], ["myocardium", "ANATOMY", 93, 103], ["cardiac chambers", "ANATOMY", 132, 148], ["Rhabdomyomas", "DISEASE", 0, 12], ["rhabdomyosarcomas", "DISEASE", 17, 34], ["Rhabdomyomas", "CANCER", 0, 12], ["rhabdomyosarcomas", "CANCER", 17, 34], ["gray nodules", "CANCER", 73, 85], ["myocardium", "ORGAN", 93, 103], ["cardiac chambers", "MULTI-TISSUE_STRUCTURE", 132, 148], ["Rhabdomyomas", "PROBLEM", 0, 12], ["rhabdomyosarcomas", "PROBLEM", 17, 34], ["white to gray nodules in the myocardium", "PROBLEM", 64, 103], ["rhabdomyosarcomas", "OBSERVATION", 17, 34], ["white to gray", "OBSERVATION_MODIFIER", 64, 77], ["nodules", "OBSERVATION", 78, 85], ["myocardium", "ANATOMY", 93, 103], ["cardiac", "ANATOMY", 132, 139], ["chambers", "ANATOMY_MODIFIER", 140, 148]]], ["Congenital rhabdomyomatosis in pigs and guinea pigs is a presumed nonneoplastic hamartoma (i.e., malformation often resembling a neoplasm that is composed of an overgrowth of mature cells and tissues that normally occur in the affected organ).", [["nonneoplastic hamartoma", "ANATOMY", 66, 89], ["neoplasm", "ANATOMY", 129, 137], ["cells", "ANATOMY", 182, 187], ["tissues", "ANATOMY", 192, 199], ["organ", "ANATOMY", 236, 241], ["Congenital rhabdomyomatosis", "DISEASE", 0, 27], ["hamartoma", "DISEASE", 80, 89], ["malformation", "DISEASE", 97, 109], ["neoplasm", "DISEASE", 129, 137], ["pigs", "ORGANISM", 31, 35], ["guinea pigs", "ORGANISM", 40, 51], ["nonneoplastic hamartoma", "CANCER", 66, 89], ["neoplasm", "CANCER", 129, 137], ["cells", "CELL", 182, 187], ["tissues", "TISSUE", 192, 199], ["organ", "ORGAN", 236, 241], ["mature cells", "CELL_TYPE", 175, 187], ["pigs", "SPECIES", 31, 35], ["guinea pigs", "SPECIES", 40, 51], ["Congenital rhabdomyomatosis", "PROBLEM", 0, 27], ["pigs and guinea pigs", "TREATMENT", 31, 51], ["nonneoplastic hamartoma", "PROBLEM", 66, 89], ["malformation", "PROBLEM", 97, 109], ["a neoplasm", "PROBLEM", 127, 137], ["an overgrowth of mature cells and tissues", "PROBLEM", 158, 199], ["rhabdomyomatosis", "OBSERVATION", 11, 27], ["presumed", "UNCERTAINTY", 57, 65], ["nonneoplastic", "OBSERVATION_MODIFIER", 66, 79], ["hamartoma", "OBSERVATION", 80, 89], ["neoplasm", "OBSERVATION", 129, 137], ["overgrowth", "OBSERVATION", 161, 171], ["mature cells", "OBSERVATION", 175, 187]]], ["Cardiac rhabdomyomatosis has been reported in cattle, sheep, and dogs.", [["Cardiac", "ANATOMY", 0, 7], ["Cardiac rhabdomyomatosis", "DISEASE", 0, 24], ["cattle", "ORGANISM", 46, 52], ["sheep", "ORGANISM", 54, 59], ["dogs", "ORGANISM", 65, 69], ["cattle", "SPECIES", 46, 52], ["sheep", "SPECIES", 54, 59], ["dogs", "SPECIES", 65, 69], ["cattle", "SPECIES", 46, 52], ["sheep", "SPECIES", 54, 59], ["Cardiac rhabdomyomatosis", "PROBLEM", 0, 24], ["rhabdomyomatosis", "OBSERVATION", 8, 24]]], ["Single or multiple, pale, poorly circumscribed areas are scattered in the myocardium and are composed of large glycogen-laden cells with morphologic features of cardiomyocytes and Purkinje cells.Box 10-12 Most Common Cardiac Diseases ofMalignant lymphoma (lymphosarcoma) is the most common secondary neoplasm occurring in the heart and often causes lesions in the hearts of cattle, which can be severe enough to cause death from cardiac failure.", [["myocardium", "ANATOMY", 74, 84], ["glycogen-laden cells", "ANATOMY", 111, 131], ["cardiomyocytes", "ANATOMY", 161, 175], ["Purkinje cells", "ANATOMY", 180, 194], ["Cardiac Diseases ofMalignant lymphoma", "ANATOMY", 217, 254], ["lymphosarcoma", "ANATOMY", 256, 269], ["neoplasm", "ANATOMY", 300, 308], ["heart", "ANATOMY", 326, 331], ["lesions", "ANATOMY", 349, 356], ["hearts", "ANATOMY", 364, 370], ["cardiac", "ANATOMY", 429, 436], ["Cardiac Diseases ofMalignant lymphoma", "DISEASE", 217, 254], ["lymphosarcoma", "DISEASE", 256, 269], ["neoplasm", "DISEASE", 300, 308], ["death", "DISEASE", 418, 423], ["cardiac failure", "DISEASE", 429, 444], ["myocardium", "ORGAN", 74, 84], ["glycogen", "SIMPLE_CHEMICAL", 111, 119], ["cells", "CELL", 126, 131], ["cardiomyocytes", "CELL", 161, 175], ["Purkinje cells", "CELL", 180, 194], ["Cardiac Diseases ofMalignant lymphoma", "CANCER", 217, 254], ["lymphosarcoma", "CANCER", 256, 269], ["neoplasm", "CANCER", 300, 308], ["heart", "ORGAN", 326, 331], ["lesions", "PATHOLOGICAL_FORMATION", 349, 356], ["hearts", "ORGAN", 364, 370], ["cattle", "ORGANISM", 374, 380], ["cardiac", "ORGAN", 429, 436], ["glycogen-laden cells", "CELL_TYPE", 111, 131], ["cardiomyocytes", "CELL_TYPE", 161, 175], ["Purkinje cells", "CELL_TYPE", 180, 194], ["cattle", "SPECIES", 374, 380], ["cattle", "SPECIES", 374, 380], ["Single or multiple, pale, poorly circumscribed areas", "PROBLEM", 0, 52], ["large glycogen-laden cells", "PROBLEM", 105, 131], ["cardiomyocytes", "PROBLEM", 161, 175], ["Purkinje cells", "PROBLEM", 180, 194], ["Box", "TEST", 195, 198], ["Common Cardiac Diseases ofMalignant lymphoma (lymphosarcoma", "PROBLEM", 210, 269], ["secondary neoplasm", "PROBLEM", 290, 308], ["lesions in the hearts of cattle", "PROBLEM", 349, 380], ["death", "PROBLEM", 418, 423], ["cardiac failure", "PROBLEM", 429, 444], ["multiple", "OBSERVATION_MODIFIER", 10, 18], ["pale", "OBSERVATION_MODIFIER", 20, 24], ["poorly", "OBSERVATION_MODIFIER", 26, 32], ["circumscribed", "OBSERVATION_MODIFIER", 33, 46], ["areas", "OBSERVATION", 47, 52], ["scattered", "OBSERVATION_MODIFIER", 57, 66], ["myocardium", "ANATOMY", 74, 84], ["large", "OBSERVATION_MODIFIER", 105, 110], ["glycogen-", "OBSERVATION", 111, 120], ["laden cells", "OBSERVATION", 120, 131], ["cardiomyocytes", "ANATOMY", 161, 175], ["Purkinje cells", "OBSERVATION", 180, 194], ["Cardiac", "ANATOMY", 217, 224], ["Diseases", "OBSERVATION", 225, 233], ["lymphoma", "OBSERVATION", 246, 254], ["lymphosarcoma", "OBSERVATION", 256, 269], ["most common", "OBSERVATION_MODIFIER", 278, 289], ["secondary", "OBSERVATION_MODIFIER", 290, 299], ["neoplasm", "OBSERVATION", 300, 308], ["heart", "ANATOMY", 326, 331], ["lesions", "OBSERVATION", 349, 356], ["hearts", "ANATOMY", 364, 370], ["cardiac", "ANATOMY", 429, 436], ["failure", "OBSERVATION", 437, 444]]], ["Cardiac lesions may be present in dogs and cats with malignant lymphoma.", [["Cardiac lesions", "ANATOMY", 0, 15], ["malignant lymphoma", "ANATOMY", 53, 71], ["Cardiac lesions", "DISEASE", 0, 15], ["malignant lymphoma", "DISEASE", 53, 71], ["Cardiac lesions", "PATHOLOGICAL_FORMATION", 0, 15], ["dogs", "ORGANISM", 34, 38], ["cats", "ORGANISM", 43, 47], ["malignant lymphoma", "CANCER", 53, 71], ["dogs", "SPECIES", 34, 38], ["cats", "SPECIES", 43, 47], ["Cardiac lesions", "PROBLEM", 0, 15], ["malignant lymphoma", "PROBLEM", 53, 71], ["lesions", "OBSERVATION", 8, 15], ["may be", "UNCERTAINTY", 16, 22], ["malignant lymphoma", "OBSERVATION", 53, 71]]], ["The neoplastic cell infiltration can be predominantly left bundle branch block morphology that originate from the right ventricle, and they often have enlargement of the right ventricular chamber; however, some dogs have normal-sized cardiac chambers, and because of the intermittent nature of the arrhythmia in arrhythmogenic right ventricular cardiomyopathy, polyhedral with vacuolated cytoplasm and are supported by a fine connective tissue stroma (see Fig. 12-47) .Cell Degeneration and DeathMyocardial Necrosis and Mineralization.", [["neoplastic cell", "ANATOMY", 4, 19], ["left bundle branch", "ANATOMY", 54, 72], ["right ventricle", "ANATOMY", 114, 129], ["right ventricular chamber", "ANATOMY", 170, 195], ["cardiac", "ANATOMY", 234, 241], ["right ventricular", "ANATOMY", 327, 344], ["vacuolated cytoplasm", "ANATOMY", 377, 397], ["connective tissue stroma", "ANATOMY", 426, 450], ["Cell", "ANATOMY", 469, 473], ["enlargement of the right ventricular chamber", "DISEASE", 151, 195], ["arrhythmia", "DISEASE", 298, 308], ["arrhythmogenic right ventricular cardiomyopathy", "DISEASE", 312, 359], ["neoplastic cell", "CELL", 4, 19], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 114, 129], ["ventricular", "MULTI-TISSUE_STRUCTURE", 176, 187], ["dogs", "ORGANISM", 211, 215], ["cardiac chambers", "MULTI-TISSUE_STRUCTURE", 234, 250], ["ventricular", "ORGAN", 333, 344], ["cytoplasm", "ORGANISM_SUBSTANCE", 388, 397], ["connective tissue stroma", "TISSUE", 426, 450], ["Cell", "CELL", 469, 473], ["dogs", "SPECIES", 211, 215], ["The neoplastic cell infiltration", "PROBLEM", 0, 32], ["enlargement of the right ventricular chamber", "PROBLEM", 151, 195], ["the arrhythmia", "PROBLEM", 294, 308], ["arrhythmogenic right ventricular cardiomyopathy", "PROBLEM", 312, 359], ["vacuolated cytoplasm", "PROBLEM", 377, 397], ["a fine connective tissue stroma", "PROBLEM", 419, 450], ["Cell Degeneration", "PROBLEM", 469, 486], ["DeathMyocardial Necrosis", "PROBLEM", 491, 515], ["Mineralization", "PROBLEM", 520, 534], ["neoplastic cell infiltration", "OBSERVATION", 4, 32], ["left", "ANATOMY_MODIFIER", 54, 58], ["bundle", "ANATOMY_MODIFIER", 59, 65], ["branch", "ANATOMY_MODIFIER", 66, 72], ["block morphology", "OBSERVATION", 73, 89], ["right ventricle", "ANATOMY", 114, 129], ["enlargement", "OBSERVATION", 151, 162], ["right ventricular", "ANATOMY", 170, 187], ["chamber", "ANATOMY_MODIFIER", 188, 195], ["normal", "OBSERVATION", 221, 227], ["sized", "OBSERVATION_MODIFIER", 228, 233], ["cardiac", "ANATOMY", 234, 241], ["chambers", "ANATOMY_MODIFIER", 242, 250], ["arrhythmia", "OBSERVATION", 298, 308], ["right ventricular", "ANATOMY", 327, 344], ["cardiomyopathy", "OBSERVATION", 345, 359], ["polyhedral", "OBSERVATION_MODIFIER", 361, 371], ["vacuolated cytoplasm", "OBSERVATION", 377, 397], ["fine", "OBSERVATION_MODIFIER", 421, 425], ["connective tissue stroma", "OBSERVATION", 426, 450], ["Degeneration", "OBSERVATION", 474, 486], ["DeathMyocardial", "OBSERVATION_MODIFIER", 491, 506], ["Necrosis", "OBSERVATION", 507, 515], ["Mineralization", "OBSERVATION", 520, 534]]], ["Myocardial necrosis and mineralization can result from a number of causes, including nutritional deficiencies, chemical and plant toxins, ischemia, metabolic disorders, heritable diseases, and physical injuries (see Box 10-5).", [["Myocardial", "ANATOMY", 0, 10], ["Myocardial necrosis", "DISEASE", 0, 19], ["nutritional deficiencies", "DISEASE", 85, 109], ["ischemia", "DISEASE", 138, 146], ["metabolic disorders", "DISEASE", 148, 167], ["heritable diseases", "DISEASE", 169, 187], ["physical injuries", "DISEASE", 193, 210], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["Myocardial necrosis", "PROBLEM", 0, 19], ["mineralization", "PROBLEM", 24, 38], ["nutritional deficiencies", "PROBLEM", 85, 109], ["chemical and plant toxins", "PROBLEM", 111, 136], ["ischemia", "PROBLEM", 138, 146], ["metabolic disorders", "PROBLEM", 148, 167], ["heritable diseases", "PROBLEM", 169, 187], ["physical injuries", "PROBLEM", 193, 210], ["necrosis", "OBSERVATION", 11, 19], ["mineralization", "OBSERVATION", 24, 38], ["nutritional deficiencies", "OBSERVATION", 85, 109], ["ischemia", "OBSERVATION", 138, 146], ["metabolic disorders", "OBSERVATION", 148, 167], ["heritable", "OBSERVATION_MODIFIER", 169, 178], ["diseases", "OBSERVATION", 179, 187]]], ["From this large list of causes of myocardial injury, some of the most frequently observed current examples are ionophore toxicity in horses and ruminants, vitamin E-selenium deficiency in the young of all species, \"heart-brain syndrome\" of dogs (see Fig. 10-82) , anthracycline toxicity in dogs, and gossypol toxicosis in pigs.", [["myocardial", "ANATOMY", 34, 44], ["heart", "ANATOMY", 215, 220], ["brain", "ANATOMY", 221, 226], ["myocardial injury", "DISEASE", 34, 51], ["ionophore", "CHEMICAL", 111, 120], ["toxicity", "DISEASE", 121, 129], ["vitamin E-selenium", "CHEMICAL", 155, 173], ["heart-brain syndrome", "DISEASE", 215, 235], ["anthracycline", "CHEMICAL", 264, 277], ["toxicity", "DISEASE", 278, 286], ["gossypol", "CHEMICAL", 300, 308], ["toxicosis", "DISEASE", 309, 318], ["ionophore", "CHEMICAL", 111, 120], ["vitamin E", "CHEMICAL", 155, 164], ["selenium", "CHEMICAL", 165, 173], ["anthracycline", "CHEMICAL", 264, 277], ["gossypol", "CHEMICAL", 300, 308], ["myocardial", "MULTI-TISSUE_STRUCTURE", 34, 44], ["ionophore", "SIMPLE_CHEMICAL", 111, 120], ["horses", "ORGANISM_SUBDIVISION", 133, 139], ["vitamin E", "SIMPLE_CHEMICAL", 155, 164], ["selenium", "SIMPLE_CHEMICAL", 165, 173], ["heart", "ORGAN", 215, 220], ["brain", "ORGAN", 221, 226], ["dogs", "ORGANISM", 240, 244], ["anthracycline", "SIMPLE_CHEMICAL", 264, 277], ["dogs", "ORGANISM", 290, 294], ["gossypol", "SIMPLE_CHEMICAL", 300, 308], ["pigs", "ORGANISM", 322, 326], ["dogs", "SPECIES", 240, 244], ["dogs", "SPECIES", 290, 294], ["pigs", "SPECIES", 322, 326], ["pigs", "SPECIES", 322, 326], ["myocardial injury", "PROBLEM", 34, 51], ["ionophore toxicity in horses", "PROBLEM", 111, 139], ["vitamin E", "TREATMENT", 155, 164], ["selenium deficiency", "PROBLEM", 165, 184], ["all species", "PROBLEM", 201, 212], ["heart-brain syndrome", "PROBLEM", 215, 235], ["dogs", "PROBLEM", 240, 244], ["anthracycline toxicity in dogs", "PROBLEM", 264, 294], ["gossypol toxicosis", "PROBLEM", 300, 318], ["myocardial", "ANATOMY", 34, 44], ["injury", "OBSERVATION", 45, 51], ["selenium deficiency", "OBSERVATION", 165, 184], ["heart", "ANATOMY", 215, 220], ["brain", "ANATOMY", 221, 226], ["syndrome", "OBSERVATION", 227, 235], ["gossypol toxicosis", "OBSERVATION", 300, 318]]], ["In various localized areas throughout the world, numerous deaths in ruminants have resulted from consumption of poisonous plants such as Acacia georginae and Dichapetalum cymosum.", [["deaths", "DISEASE", 58, 64], ["Acacia georginae", "ORGANISM", 137, 153], ["Dichapetalum cymosum", "ORGANISM", 158, 178], ["Acacia georginae", "SPECIES", 137, 153], ["Dichapetalum cymosum", "SPECIES", 158, 178], ["Acacia georginae", "SPECIES", 137, 153], ["Dichapetalum cymosum", "SPECIES", 158, 178], ["poisonous plants", "PROBLEM", 112, 128], ["Acacia georginae", "TREATMENT", 137, 153], ["various", "OBSERVATION_MODIFIER", 3, 10], ["localized", "OBSERVATION_MODIFIER", 11, 20], ["areas", "OBSERVATION_MODIFIER", 21, 26], ["numerous", "OBSERVATION_MODIFIER", 49, 57], ["deaths", "OBSERVATION", 58, 64], ["poisonous plants", "OBSERVATION", 112, 128], ["Acacia georginae", "OBSERVATION", 137, 153], ["Dichapetalum cymosum", "OBSERVATION", 158, 178]]], ["The macroscopic lesions are similar regardless of the specific toxin and include pale white to tan areas and linear streaks throughout the myocardium.", [["macroscopic lesions", "ANATOMY", 4, 23], ["myocardium", "ANATOMY", 139, 149], ["macroscopic lesions", "CANCER", 4, 23], ["myocardium", "ORGAN", 139, 149], ["The macroscopic lesions", "PROBLEM", 0, 23], ["the specific toxin", "TEST", 50, 68], ["pale white to tan areas", "PROBLEM", 81, 104], ["linear streaks throughout the myocardium", "PROBLEM", 109, 149], ["macroscopic", "OBSERVATION_MODIFIER", 4, 15], ["lesions", "OBSERVATION", 16, 23], ["linear", "OBSERVATION_MODIFIER", 109, 115], ["streaks", "OBSERVATION", 116, 123], ["myocardium", "ANATOMY", 139, 149]]], ["Microscopic lesions include multifocal myocardial degeneration and necrosis characterized by vacuolation of myocardial cytoplasm; loss of cross-striations; fragmentation of rhabdomyocytes; diffuse or nodular and involve the myocardium, endocardium, and pericardium.", [["lesions", "ANATOMY", 12, 19], ["myocardial", "ANATOMY", 39, 49], ["myocardial cytoplasm", "ANATOMY", 108, 128], ["rhabdomyocytes", "ANATOMY", 173, 187], ["nodular", "ANATOMY", 200, 207], ["myocardium", "ANATOMY", 224, 234], ["endocardium", "ANATOMY", 236, 247], ["pericardium", "ANATOMY", 253, 264], ["myocardial degeneration", "DISEASE", 39, 62], ["necrosis", "DISEASE", 67, 75], ["loss of cross-striations", "DISEASE", 130, 154], ["Microscopic lesions", "PATHOLOGICAL_FORMATION", 0, 19], ["myocardial", "MULTI-TISSUE_STRUCTURE", 39, 49], ["cytoplasm", "ORGANISM_SUBSTANCE", 119, 128], ["myocardium", "TISSUE", 224, 234], ["endocardium", "MULTI-TISSUE_STRUCTURE", 236, 247], ["pericardium", "ORGAN", 253, 264], ["Microscopic lesions", "PROBLEM", 0, 19], ["multifocal myocardial degeneration", "PROBLEM", 28, 62], ["necrosis", "PROBLEM", 67, 75], ["myocardial cytoplasm", "PROBLEM", 108, 128], ["loss of cross-striations", "PROBLEM", 130, 154], ["fragmentation of rhabdomyocytes", "PROBLEM", 156, 187], ["diffuse or nodular and involve the myocardium, endocardium, and pericardium", "PROBLEM", 189, 264], ["lesions", "OBSERVATION", 12, 19], ["multifocal", "OBSERVATION_MODIFIER", 28, 38], ["myocardial", "ANATOMY", 39, 49], ["degeneration", "OBSERVATION", 50, 62], ["necrosis", "OBSERVATION", 67, 75], ["vacuolation", "OBSERVATION_MODIFIER", 93, 104], ["myocardial", "ANATOMY", 108, 118], ["cytoplasm", "OBSERVATION", 119, 128], ["loss", "OBSERVATION_MODIFIER", 130, 134], ["fragmentation", "OBSERVATION_MODIFIER", 156, 169], ["diffuse", "OBSERVATION_MODIFIER", 189, 196], ["nodular", "OBSERVATION", 200, 207], ["myocardium", "ANATOMY", 224, 234], ["endocardium", "ANATOMY", 236, 247], ["pericardium", "ANATOMY", 253, 264]]], ["Lymphomatous tissue appears as white masses that may resemble deposits of fat ( Fig. 10-46) .", [["Lymphomatous tissue", "ANATOMY", 0, 19], ["white masses", "ANATOMY", 31, 43], ["fat", "ANATOMY", 74, 77], ["Lymphomatous tissue", "TISSUE", 0, 19], ["masses", "CANCER", 37, 43], ["fat", "TISSUE", 74, 77], ["Lymphomatous tissue", "PROBLEM", 0, 19], ["white masses", "PROBLEM", 31, 43], ["white", "OBSERVATION_MODIFIER", 31, 36], ["masses", "OBSERVATION", 37, 43], ["deposits", "OBSERVATION_MODIFIER", 62, 70], ["fat", "ANATOMY", 74, 77]]], ["Microscopically, extensive infiltrations of neoplastic lymphocytes are present between myocytes ( Fig. 10-47) .", [["neoplastic lymphocytes", "ANATOMY", 44, 66], ["myocytes", "ANATOMY", 87, 95], ["neoplastic lymphocytes", "CELL", 44, 66], ["myocytes", "CELL", 87, 95], ["neoplastic lymphocytes", "CELL_TYPE", 44, 66], ["extensive infiltrations of neoplastic lymphocytes", "PROBLEM", 17, 66], ["Fig.", "TEST", 98, 102], ["extensive", "OBSERVATION_MODIFIER", 17, 26], ["infiltrations", "OBSERVATION", 27, 40], ["neoplastic lymphocytes", "OBSERVATION", 44, 66], ["myocytes", "ANATOMY", 87, 95]]], ["Other neoplasms, such as malignant melanomas, occasionally have metastatic lesions in the heart.Cell Degeneration and DeathHeart-based tumors are primary neoplasms of extracardiac tissues in dogs and rarely cats.", [["neoplasms", "ANATOMY", 6, 15], ["malignant melanomas", "ANATOMY", 25, 44], ["metastatic lesions", "ANATOMY", 64, 82], ["heart", "ANATOMY", 90, 95], ["Cell", "ANATOMY", 96, 100], ["tumors", "ANATOMY", 135, 141], ["primary neoplasms", "ANATOMY", 146, 163], ["extracardiac tissues", "ANATOMY", 167, 187], ["neoplasms", "DISEASE", 6, 15], ["malignant melanomas", "DISEASE", 25, 44], ["tumors", "DISEASE", 135, 141], ["neoplasms", "DISEASE", 154, 163], ["neoplasms", "CANCER", 6, 15], ["malignant melanomas", "CANCER", 25, 44], ["metastatic lesions", "CANCER", 64, 82], ["heart", "ORGAN", 90, 95], ["Cell", "CELL", 96, 100], ["DeathHeart-based tumors", "CANCER", 118, 141], ["neoplasms", "CANCER", 154, 163], ["extracardiac tissues", "TISSUE", 167, 187], ["dogs", "ORGANISM", 191, 195], ["dogs", "SPECIES", 191, 195], ["Other neoplasms", "PROBLEM", 0, 15], ["malignant melanomas", "PROBLEM", 25, 44], ["metastatic lesions in the heart", "PROBLEM", 64, 95], ["Cell Degeneration", "PROBLEM", 96, 113], ["DeathHeart-based tumors", "PROBLEM", 118, 141], ["primary neoplasms of extracardiac tissues in dogs", "PROBLEM", 146, 195], ["neoplasms", "OBSERVATION", 6, 15], ["malignant", "OBSERVATION_MODIFIER", 25, 34], ["melanomas", "OBSERVATION", 35, 44], ["metastatic", "OBSERVATION", 64, 74], ["heart", "ANATOMY", 90, 95], ["Degeneration", "OBSERVATION", 101, 113], ["tumors", "OBSERVATION", 135, 141], ["primary", "OBSERVATION_MODIFIER", 146, 153], ["neoplasms", "OBSERVATION", 154, 163], ["extracardiac tissues", "OBSERVATION", 167, 187]]], ["They arise at the base of the heart and can produce vascular obstruction and cardiac failure.", [["heart", "ANATOMY", 30, 35], ["vascular", "ANATOMY", 52, 60], ["cardiac", "ANATOMY", 77, 84], ["vascular obstruction", "DISEASE", 52, 72], ["cardiac failure", "DISEASE", 77, 92], ["heart", "ORGAN", 30, 35], ["vascular", "MULTI-TISSUE_STRUCTURE", 52, 60], ["cardiac", "ORGAN", 77, 84], ["vascular obstruction", "PROBLEM", 52, 72], ["cardiac failure", "PROBLEM", 77, 92], ["base", "ANATOMY_MODIFIER", 18, 22], ["heart", "ANATOMY", 30, 35], ["vascular", "ANATOMY", 52, 60], ["obstruction", "OBSERVATION", 61, 72], ["cardiac", "ANATOMY", 77, 84], ["failure", "OBSERVATION", 85, 92]]], ["The most common neoplasm arising at this location is the aortic body tumor or paraganglioma (chemodectoma), but occasionally ectopic thyroid or parathyroid tissue gives origin to neoplasms in this area.", [["neoplasm", "ANATOMY", 16, 24], ["aortic body tumor", "ANATOMY", 57, 74], ["paraganglioma", "ANATOMY", 78, 91], ["chemodectoma", "ANATOMY", 93, 105], ["thyroid", "ANATOMY", 133, 140], ["parathyroid tissue", "ANATOMY", 144, 162], ["neoplasms", "ANATOMY", 179, 188], ["area", "ANATOMY", 197, 201], ["neoplasm", "DISEASE", 16, 24], ["tumor", "DISEASE", 69, 74], ["paraganglioma", "DISEASE", 78, 91], ["chemodectoma", "DISEASE", 93, 105], ["neoplasms", "DISEASE", 179, 188], ["neoplasm", "CANCER", 16, 24], ["aortic body tumor", "CANCER", 57, 74], ["paraganglioma", "CANCER", 78, 91], ["chemodectoma", "CANCER", 93, 105], ["thyroid", "ORGAN", 133, 140], ["parathyroid tissue", "TISSUE", 144, 162], ["neoplasms", "CANCER", 179, 188], ["The most common neoplasm", "PROBLEM", 0, 24], ["the aortic body tumor", "PROBLEM", 53, 74], ["paraganglioma", "PROBLEM", 78, 91], ["chemodectoma", "PROBLEM", 93, 105], ["occasionally ectopic thyroid", "PROBLEM", 112, 140], ["parathyroid tissue", "PROBLEM", 144, 162], ["neoplasms in this area", "PROBLEM", 179, 201], ["most", "OBSERVATION_MODIFIER", 4, 8], ["common", "OBSERVATION_MODIFIER", 9, 15], ["neoplasm", "OBSERVATION", 16, 24], ["aortic", "ANATOMY", 57, 63], ["body", "ANATOMY_MODIFIER", 64, 68], ["tumor", "OBSERVATION", 69, 74], ["paraganglioma", "OBSERVATION", 78, 91], ["chemodectoma", "OBSERVATION", 93, 105], ["occasionally", "OBSERVATION_MODIFIER", 112, 124], ["ectopic", "OBSERVATION_MODIFIER", 125, 132], ["thyroid", "ANATOMY", 133, 140], ["parathyroid tissue", "OBSERVATION", 144, 162], ["neoplasms", "OBSERVATION", 179, 188]]], ["The aortic body is a chemoreceptor organ.", [["aortic body", "ANATOMY", 4, 15], ["chemoreceptor organ", "ANATOMY", 21, 40], ["aortic body", "MULTI-TISSUE_STRUCTURE", 4, 15], ["organ", "ORGAN", 35, 40], ["aortic", "ANATOMY", 4, 10], ["body", "ANATOMY_MODIFIER", 11, 15], ["chemoreceptor organ", "OBSERVATION", 21, 40]]], ["In some cases, aortic body tumors become large, white, firm masses that surround and compress the great vessels and atria (Fig. 10-48) .", [["aortic body tumors", "ANATOMY", 15, 33], ["firm masses", "ANATOMY", 55, 66], ["great vessels", "ANATOMY", 98, 111], ["atria", "ANATOMY", 116, 121], ["tumors", "DISEASE", 27, 33], ["aortic body tumors", "CANCER", 15, 33], ["masses", "CANCER", 60, 66], ["great vessels", "MULTI-TISSUE_STRUCTURE", 98, 111], ["atria", "MULTI-TISSUE_STRUCTURE", 116, 121], ["aortic body tumors", "PROBLEM", 15, 33], ["large, white, firm masses", "PROBLEM", 41, 66], ["aortic", "ANATOMY", 15, 21], ["body", "ANATOMY_MODIFIER", 22, 26], ["tumors", "OBSERVATION", 27, 33], ["large", "OBSERVATION_MODIFIER", 41, 46], ["white", "OBSERVATION_MODIFIER", 48, 53], ["firm", "OBSERVATION_MODIFIER", 55, 59], ["masses", "OBSERVATION", 60, 66], ["great vessels", "ANATOMY", 98, 111], ["atria", "ANATOMY", 116, 121]]], ["Brachycephalic dog breeds are most frequently affected.", [["dog", "ORGANISM", 15, 18], ["dog", "SPECIES", 15, 18], ["Brachycephalic dog breeds", "PROBLEM", 0, 25], ["dog breeds", "OBSERVATION", 15, 25]]], ["Microscopically, the neoplastic cells are H L pale white to tan areas throughout a \"flabby\" myocardium; microscopic lesions include multifocal myocardial degeneration and necrosis.Cell Degeneration and DeathChemotherapeutic Agent-Induced Myocardial Degeneration.", [["neoplastic cells", "ANATOMY", 21, 37], ["flabby", "ANATOMY", 84, 90], ["myocardium", "ANATOMY", 92, 102], ["lesions", "ANATOMY", 116, 123], ["myocardial", "ANATOMY", 143, 153], ["Cell", "ANATOMY", 180, 184], ["Myocardial", "ANATOMY", 238, 248], ["myocardial degeneration", "DISEASE", 143, 166], ["necrosis", "DISEASE", 171, 179], ["Myocardial Degeneration", "DISEASE", 238, 261], ["neoplastic cells", "CELL", 21, 37], ["H L pale white", "TISSUE", 42, 56], ["myocardium", "ORGAN", 92, 102], ["lesions", "PATHOLOGICAL_FORMATION", 116, 123], ["myocardial", "MULTI-TISSUE_STRUCTURE", 143, 153], ["Cell", "CELL", 180, 184], ["Myocardial", "TISSUE", 238, 248], ["neoplastic cells", "CELL_TYPE", 21, 37], ["the neoplastic cells", "PROBLEM", 17, 37], ["H L pale white to tan areas", "PROBLEM", 42, 69], ["a \"flabby\" myocardium", "PROBLEM", 81, 102], ["microscopic lesions", "PROBLEM", 104, 123], ["multifocal myocardial degeneration", "PROBLEM", 132, 166], ["necrosis", "PROBLEM", 171, 179], ["Cell Degeneration", "PROBLEM", 180, 197], ["DeathChemotherapeutic Agent", "TREATMENT", 202, 229], ["Myocardial Degeneration", "PROBLEM", 238, 261], ["neoplastic cells", "OBSERVATION", 21, 37], ["L", "OBSERVATION_MODIFIER", 44, 45], ["pale", "OBSERVATION_MODIFIER", 46, 50], ["white", "OBSERVATION_MODIFIER", 51, 56], ["myocardium", "ANATOMY", 92, 102], ["lesions", "OBSERVATION", 116, 123], ["multifocal", "OBSERVATION_MODIFIER", 132, 142], ["myocardial", "ANATOMY", 143, 153], ["degeneration", "OBSERVATION", 154, 166], ["necrosis", "OBSERVATION", 171, 179], ["Degeneration", "OBSERVATION", 185, 197], ["DeathChemotherapeutic Agent", "OBSERVATION", 202, 229], ["Myocardial", "ANATOMY", 238, 248], ["Degeneration", "OBSERVATION", 249, 261]]], ["Cardiotoxicity has emerged as a significant clinical entity in veterinary medicine in recent years with the growing use of antineoplastic drugs in small animal practice and the widespread use of growth promotants in ruminants (see Fig. 10-49 ; also see E-Figs.", [["antineoplastic", "ANATOMY", 123, 137], ["Cardiotoxicity", "DISEASE", 0, 14], ["ruminants", "SPECIES", 216, 225], ["Cardiotoxicity", "PROBLEM", 0, 14], ["antineoplastic drugs", "TREATMENT", 123, 143], ["growth promotants", "PROBLEM", 195, 212]]], ["10-12 and 10-13).Neoplastic TransformationSchwannomas.", [["Neoplastic TransformationSchwannomas", "ANATOMY", 17, 53], ["Neoplastic TransformationSchwannomas", "DISEASE", 17, 53], ["Neoplastic TransformationSchwannomas", "CANCER", 17, 53], ["Neoplastic TransformationSchwannomas", "PROBLEM", 17, 53]]], ["Schwannomas involve cardiac nerves in cattle and appear as single or multiple white nodules detected as incidental findings at slaughter (see Fig. 14-115) .Cell Degeneration and DeathConduction system diseases have been described mainly in dogs and horses, probably because clinical cardiac evaluations are done most frequently in these species.", [["Schwannomas", "ANATOMY", 0, 11], ["cardiac nerves", "ANATOMY", 20, 34], ["white nodules", "ANATOMY", 78, 91], ["Cell", "ANATOMY", 156, 160], ["cardiac", "ANATOMY", 283, 290], ["Schwannomas", "DISEASE", 0, 11], ["cardiac nerves", "DISEASE", 20, 34], ["DeathConduction system diseases", "DISEASE", 178, 209], ["cardiac nerves", "MULTI-TISSUE_STRUCTURE", 20, 34], ["cattle", "ORGANISM", 38, 44], ["nodules", "CANCER", 84, 91], ["Cell", "CELL", 156, 160], ["dogs", "ORGANISM", 240, 244], ["cardiac", "ORGAN", 283, 290], ["cattle", "SPECIES", 38, 44], ["dogs", "SPECIES", 240, 244], ["cattle", "SPECIES", 38, 44], ["Schwannomas", "PROBLEM", 0, 11], ["multiple white nodules", "PROBLEM", 69, 91], ["Cell Degeneration", "PROBLEM", 156, 173], ["DeathConduction system diseases", "PROBLEM", 178, 209], ["clinical cardiac evaluations", "TEST", 274, 302], ["cardiac nerves", "ANATOMY", 20, 34], ["multiple", "OBSERVATION_MODIFIER", 69, 77], ["white", "OBSERVATION_MODIFIER", 78, 83], ["nodules", "OBSERVATION", 84, 91], ["Degeneration", "OBSERVATION", 161, 173]]], ["Secondary conduction system disorders result from myocardial disease (inflammation, neoplasia, or degeneration) near the conduction system.", [["conduction system", "ANATOMY", 10, 27], ["myocardial", "ANATOMY", 50, 60], ["neoplasia", "ANATOMY", 84, 93], ["Secondary conduction system disorders", "DISEASE", 0, 37], ["myocardial disease", "DISEASE", 50, 68], ["inflammation", "DISEASE", 70, 82], ["neoplasia", "DISEASE", 84, 93], ["myocardial", "MULTI-TISSUE_STRUCTURE", 50, 60], ["neoplasia", "CANCER", 84, 93], ["Secondary conduction system disorders", "PROBLEM", 0, 37], ["myocardial disease", "PROBLEM", 50, 68], ["inflammation", "PROBLEM", 70, 82], ["neoplasia", "PROBLEM", 84, 93], ["degeneration", "PROBLEM", 98, 110], ["conduction system", "OBSERVATION", 10, 27], ["myocardial", "ANATOMY", 50, 60], ["disease", "OBSERVATION", 61, 68], ["inflammation", "OBSERVATION_MODIFIER", 70, 82], ["neoplasia", "OBSERVATION", 84, 93], ["degeneration", "OBSERVATION", 98, 110], ["conduction system", "OBSERVATION", 121, 138]]], ["Specific presumably inherited diseases in dogs include (1) syncope in pug dogs with lesions of the bundle of His; (2) intermittent sinus arrest in deaf Dalmatian dogs, presumably associated with lesions in the sinus node; (3) sinoatrial syncope (sick sinus dysfunction) in female miniature schnauzers, West Highland white terriers, cocker spaniels, and dachshunds; (4) inherited ventricular arrhythmia and sudden unexpected death in German shepherds, and (5) widespread conduction pathology in Alaskan sled dogs that died suddenly and unexpectedly in a race.", [["lesions", "ANATOMY", 84, 91], ["bundle", "ANATOMY", 99, 105], ["sinus", "ANATOMY", 131, 136], ["lesions", "ANATOMY", 195, 202], ["sinus node", "ANATOMY", 210, 220], ["sinoatrial", "ANATOMY", 226, 236], ["sinus", "ANATOMY", 251, 256], ["cocker spaniels", "ANATOMY", 332, 347], ["dachshunds", "ANATOMY", 353, 363], ["ventricular", "ANATOMY", 379, 390], ["inherited diseases", "DISEASE", 20, 38], ["syncope", "DISEASE", 59, 66], ["sinus arrest", "DISEASE", 131, 143], ["sinoatrial syncope", "DISEASE", 226, 244], ["sick sinus dysfunction", "DISEASE", 246, 268], ["dachshunds", "DISEASE", 353, 363], ["ventricular arrhythmia", "DISEASE", 379, 401], ["death", "DISEASE", 424, 429], ["dogs", "ORGANISM", 42, 46], ["pug dogs", "ORGANISM", 70, 78], ["lesions", "PATHOLOGICAL_FORMATION", 84, 91], ["sinus", "ORGAN", 131, 136], ["lesions", "PATHOLOGICAL_FORMATION", 195, 202], ["sinus node", "MULTI-TISSUE_STRUCTURE", 210, 220], ["sinoatrial", "ORGAN", 226, 236], ["sinus", "MULTI-TISSUE_STRUCTURE", 251, 256], ["ventricular", "ORGAN", 379, 390], ["dogs", "SPECIES", 42, 46], ["dogs", "SPECIES", 74, 78], ["dogs", "SPECIES", 162, 166], ["dogs", "SPECIES", 507, 511], ["Alaskan sled dogs", "SPECIES", 494, 511], ["inherited diseases in dogs", "PROBLEM", 20, 46], ["syncope in pug dogs", "PROBLEM", 59, 78], ["lesions", "PROBLEM", 84, 91], ["intermittent sinus arrest", "PROBLEM", 118, 143], ["deaf Dalmatian dogs", "PROBLEM", 147, 166], ["lesions in the sinus node", "PROBLEM", 195, 220], ["sinoatrial syncope", "PROBLEM", 226, 244], ["sick sinus dysfunction", "PROBLEM", 246, 268], ["cocker spaniels", "PROBLEM", 332, 347], ["inherited ventricular arrhythmia", "PROBLEM", 369, 401], ["sudden unexpected death", "PROBLEM", 406, 429], ["widespread conduction pathology", "PROBLEM", 459, 490], ["presumably", "UNCERTAINTY", 9, 19], ["inherited", "OBSERVATION_MODIFIER", 20, 29], ["diseases", "OBSERVATION", 30, 38], ["lesions", "OBSERVATION", 84, 91], ["bundle", "ANATOMY_MODIFIER", 99, 105], ["sinus", "ANATOMY", 131, 136], ["arrest", "OBSERVATION", 137, 143], ["Dalmatian dogs", "OBSERVATION", 152, 166], ["presumably associated with", "UNCERTAINTY", 168, 194], ["lesions", "OBSERVATION", 195, 202], ["sinus node", "ANATOMY", 210, 220], ["sinoatrial", "ANATOMY", 226, 236], ["syncope", "OBSERVATION", 237, 244], ["ventricular", "ANATOMY", 379, 390], ["arrhythmia", "OBSERVATION", 391, 401], ["widespread", "OBSERVATION_MODIFIER", 459, 469], ["conduction pathology", "OBSERVATION", 470, 490]]], ["Other arrhythmias in dogs and horses are atrial fibrillation and heart block.", [["atrial", "ANATOMY", 41, 47], ["heart", "ANATOMY", 65, 70], ["arrhythmias", "DISEASE", 6, 17], ["atrial fibrillation", "DISEASE", 41, 60], ["heart block", "DISEASE", 65, 76], ["dogs", "ORGANISM", 21, 25], ["atrial", "MULTI-TISSUE_STRUCTURE", 41, 47], ["heart", "ORGAN", 65, 70], ["dogs", "SPECIES", 21, 25], ["Other arrhythmias in dogs", "PROBLEM", 0, 25], ["atrial fibrillation", "PROBLEM", 41, 60], ["heart block", "PROBLEM", 65, 76], ["arrhythmias", "OBSERVATION", 6, 17], ["atrial", "ANATOMY", 41, 47], ["fibrillation", "OBSERVATION", 48, 60], ["heart", "ANATOMY", 65, 70], ["block", "OBSERVATION", 71, 76]]], ["Dogs with atrial fibrillation often have concurrent congestive heart failure and have atrial dilation with AV valve insufficiency, but most horses live a normal or near-normal life span, may respond to cardioversion, and at necropsy have atrial myocardial fibrosis.", [["atrial", "ANATOMY", 10, 16], ["heart", "ANATOMY", 63, 68], ["atrial", "ANATOMY", 86, 92], ["AV valve", "ANATOMY", 107, 115], ["atrial myocardial", "ANATOMY", 238, 255], ["atrial fibrillation", "DISEASE", 10, 29], ["congestive heart failure", "DISEASE", 52, 76], ["atrial dilation", "DISEASE", 86, 101], ["AV valve insufficiency", "DISEASE", 107, 129], ["atrial myocardial fibrosis", "DISEASE", 238, 264], ["Dogs", "ORGANISM", 0, 4], ["heart", "ORGAN", 63, 68], ["atrial", "MULTI-TISSUE_STRUCTURE", 86, 92], ["valve", "MULTI-TISSUE_STRUCTURE", 110, 115], ["atrial myocardial", "MULTI-TISSUE_STRUCTURE", 238, 255], ["atrial fibrillation", "PROBLEM", 10, 29], ["concurrent congestive heart failure", "PROBLEM", 41, 76], ["atrial dilation", "PROBLEM", 86, 101], ["AV valve insufficiency", "PROBLEM", 107, 129], ["cardioversion", "TREATMENT", 202, 215], ["atrial myocardial fibrosis", "PROBLEM", 238, 264], ["atrial", "ANATOMY", 10, 16], ["fibrillation", "OBSERVATION", 17, 29], ["congestive", "OBSERVATION", 52, 62], ["heart", "ANATOMY", 63, 68], ["failure", "OBSERVATION", 69, 76], ["atrial", "ANATOMY", 86, 92], ["dilation", "OBSERVATION", 93, 101], ["AV valve", "ANATOMY", 107, 115], ["insufficiency", "OBSERVATION", 116, 129], ["normal", "OBSERVATION", 154, 160], ["atrial myocardial", "ANATOMY", 238, 255], ["fibrosis", "OBSERVATION", 256, 264]]], ["Heart block of the first degree (delay of impulse through the AV node), second degree (intermittent failure to conduct through the AV node with dropped beats), and third degree (complete) has been associated with myocardial lesions, such as areas of scarring, in horses and dogs.", [["Heart", "ANATOMY", 0, 5], ["AV node", "ANATOMY", 62, 69], ["AV node", "ANATOMY", 131, 138], ["myocardial lesions", "ANATOMY", 213, 231], ["myocardial lesions", "DISEASE", 213, 231], ["scarring", "DISEASE", 250, 258], ["Heart", "ORGAN", 0, 5], ["AV node", "MULTI-TISSUE_STRUCTURE", 62, 69], ["AV node", "MULTI-TISSUE_STRUCTURE", 131, 138], ["myocardial lesions", "PATHOLOGICAL_FORMATION", 213, 231], ["dogs", "SPECIES", 274, 278], ["Heart block", "PROBLEM", 0, 11], ["second degree (intermittent failure", "PROBLEM", 72, 107], ["the AV node", "TREATMENT", 127, 138], ["dropped beats)", "PROBLEM", 144, 158], ["myocardial lesions", "PROBLEM", 213, 231], ["scarring", "PROBLEM", 250, 258], ["block", "OBSERVATION", 6, 11], ["first degree", "OBSERVATION_MODIFIER", 19, 31], ["AV", "ANATOMY", 62, 64], ["node", "OBSERVATION", 65, 69], ["intermittent", "OBSERVATION_MODIFIER", 87, 99], ["failure", "OBSERVATION", 100, 107], ["AV node", "ANATOMY", 131, 138], ["associated with", "UNCERTAINTY", 197, 212], ["myocardial", "ANATOMY", 213, 223], ["lesions", "OBSERVATION", 224, 231], ["areas", "OBSERVATION_MODIFIER", 241, 246], ["scarring", "OBSERVATION", 250, 258]]], ["Second-degree heart block is considered to be a normal phenomenon in horses.Cell Degeneration and DeathPersistent atrial standstill (silent atria, AV myopathy) is a progressive cardiac disease of English springer spaniels and cats characterized by notable atrial dilation and fibrosis.Cell Degeneration and DeathAtrial fibrillation occurs in cattle in association with right atrial dilation and fibrosis and alterations in the SA mode.", [["heart", "ANATOMY", 14, 19], ["Cell", "ANATOMY", 76, 80], ["atrial", "ANATOMY", 114, 120], ["atria", "ANATOMY", 140, 145], ["cardiac", "ANATOMY", 177, 184], ["atrial", "ANATOMY", 256, 262], ["Cell", "ANATOMY", 285, 289], ["right atrial", "ANATOMY", 369, 381], ["heart block", "DISEASE", 14, 25], ["atrial standstill", "DISEASE", 114, 131], ["AV myopathy", "DISEASE", 147, 158], ["cardiac disease of English springer spaniels", "DISEASE", 177, 221], ["atrial dilation", "DISEASE", 256, 271], ["fibrosis", "DISEASE", 276, 284], ["DeathAtrial fibrillation", "DISEASE", 307, 331], ["fibrosis", "DISEASE", 395, 403], ["heart", "ORGAN", 14, 19], ["horses", "ORGANISM", 69, 75], ["Cell", "CELL", 76, 80], ["atria", "MULTI-TISSUE_STRUCTURE", 140, 145], ["cardiac", "ORGAN", 177, 184], ["cats", "ORGANISM", 226, 230], ["atrial", "MULTI-TISSUE_STRUCTURE", 256, 262], ["Cell", "CELL", 285, 289], ["cattle", "ORGANISM", 342, 348], ["atrial", "MULTI-TISSUE_STRUCTURE", 375, 381], ["cats", "SPECIES", 226, 230], ["cattle", "SPECIES", 342, 348], ["cattle", "SPECIES", 342, 348], ["Second-degree heart block", "PROBLEM", 0, 25], ["Cell Degeneration", "PROBLEM", 76, 93], ["DeathPersistent atrial standstill", "PROBLEM", 98, 131], ["silent atria", "PROBLEM", 133, 145], ["AV myopathy", "PROBLEM", 147, 158], ["a progressive cardiac disease", "PROBLEM", 163, 192], ["notable atrial dilation", "PROBLEM", 248, 271], ["fibrosis", "PROBLEM", 276, 284], ["Cell Degeneration", "PROBLEM", 285, 302], ["DeathAtrial fibrillation", "PROBLEM", 307, 331], ["right atrial dilation", "PROBLEM", 369, 390], ["fibrosis", "PROBLEM", 395, 403], ["alterations in the SA mode", "PROBLEM", 408, 434], ["heart", "ANATOMY", 14, 19], ["block", "OBSERVATION", 20, 25], ["considered to be", "UNCERTAINTY", 29, 45], ["normal", "OBSERVATION", 48, 54], ["Degeneration", "OBSERVATION", 81, 93], ["atrial standstill", "OBSERVATION", 114, 131], ["atria", "ANATOMY", 140, 145], ["AV", "ANATOMY", 147, 149], ["myopathy", "OBSERVATION", 150, 158], ["progressive", "OBSERVATION_MODIFIER", 165, 176], ["cardiac", "ANATOMY", 177, 184], ["disease", "OBSERVATION", 185, 192], ["notable", "OBSERVATION_MODIFIER", 248, 255], ["atrial", "ANATOMY", 256, 262], ["dilation", "OBSERVATION", 263, 271], ["fibrosis", "OBSERVATION", 276, 284], ["Degeneration", "OBSERVATION", 290, 302], ["DeathAtrial fibrillation", "OBSERVATION", 307, 331], ["right", "ANATOMY_MODIFIER", 369, 374], ["atrial", "ANATOMY", 375, 381], ["dilation", "OBSERVATION", 382, 390], ["fibrosis", "OBSERVATION", 395, 403]]], ["Also, sudden (unexpected) cardiac death is described in racehorses with right atrial myocardial fibrosis, fibrosis of the upper ventricular septum, and arteriosclerosis of intramyocardial arteries.Cell Degeneration and DeathAlso see the discussion on the cardiac conduction system in the section on Dysfunction/Responses to Injury; Responses: Cardiac Conduction System.InflammationSee the previous section on Cell Degeneration and Death.Disorders of Domestic Animals: Endocardium and Heart ValvesSee the discussion of the endocardium and heart valves in the section on Responses to Injury: Endocardium and Heart Valves.", [["cardiac", "ANATOMY", 26, 33], ["racehorses", "ANATOMY", 56, 66], ["right atrial myocardial", "ANATOMY", 72, 95], ["upper ventricular septum", "ANATOMY", 122, 146], ["intramyocardial arteries", "ANATOMY", 172, 196], ["Cell", "ANATOMY", 197, 201], ["cardiac", "ANATOMY", 255, 262], ["Cardiac", "ANATOMY", 343, 350], ["Cell", "ANATOMY", 409, 413], ["Heart Valves", "ANATOMY", 484, 496], ["endocardium", "ANATOMY", 522, 533], ["heart", "ANATOMY", 538, 543], ["Heart", "ANATOMY", 606, 611], ["cardiac death", "DISEASE", 26, 39], ["atrial myocardial fibrosis", "DISEASE", 78, 104], ["fibrosis", "DISEASE", 106, 114], ["arteriosclerosis", "DISEASE", 152, 168], ["Injury", "DISEASE", 324, 330], ["Death", "DISEASE", 431, 436], ["Injury", "DISEASE", 582, 588], ["cardiac", "ORGAN", 26, 33], ["racehorses", "ORGANISM_SUBDIVISION", 56, 66], ["atrial myocardial", "MULTI-TISSUE_STRUCTURE", 78, 95], ["upper", "ORGANISM_SUBDIVISION", 122, 127], ["ventricular septum", "MULTI-TISSUE_STRUCTURE", 128, 146], ["intramyocardial arteries", "MULTI-TISSUE_STRUCTURE", 172, 196], ["Cell", "CELL", 197, 201], ["Cell", "CELL", 409, 413], ["endocardium", "MULTI-TISSUE_STRUCTURE", 522, 533], ["heart valves", "MULTI-TISSUE_STRUCTURE", 538, 550], ["Heart Valves", "CANCER", 606, 618], ["sudden (unexpected) cardiac death", "PROBLEM", 6, 39], ["right atrial myocardial fibrosis", "PROBLEM", 72, 104], ["fibrosis of the upper ventricular septum", "PROBLEM", 106, 146], ["arteriosclerosis of intramyocardial arteries", "PROBLEM", 152, 196], ["Cell Degeneration", "PROBLEM", 197, 214], ["Dysfunction", "PROBLEM", 299, 310], ["Injury", "PROBLEM", 324, 330], ["Cell Degeneration", "PROBLEM", 409, 426], ["Death", "PROBLEM", 431, 436], ["Endocardium and Heart Valves", "TREATMENT", 468, 496], ["heart valves", "TREATMENT", 538, 550], ["Endocardium and Heart Valves", "TREATMENT", 590, 618], ["cardiac", "ANATOMY", 26, 33], ["death", "OBSERVATION", 34, 39], ["right", "ANATOMY_MODIFIER", 72, 77], ["atrial myocardial", "ANATOMY", 78, 95], ["fibrosis", "OBSERVATION", 96, 104], ["fibrosis", "OBSERVATION", 106, 114], ["upper ventricular septum", "ANATOMY", 122, 146], ["arteriosclerosis", "OBSERVATION", 152, 168], ["intramyocardial arteries", "ANATOMY", 172, 196], ["Cardiac", "ANATOMY", 343, 350], ["Cell Degeneration", "OBSERVATION", 409, 426], ["Endocardium", "ANATOMY", 468, 479], ["Heart", "ANATOMY", 484, 489], ["Valves", "OBSERVATION", 490, 496], ["endocardium", "ANATOMY", 522, 533], ["heart valves", "ANATOMY", 538, 550], ["Endocardium", "ANATOMY", 590, 601], ["Heart Valves", "ANATOMY", 606, 618]]], ["The major types of AV valvular diseases are shown in Fig. 10-50. hypereosinophilia, coagulation, and clumping of the sarcoplasm; and nuclear pyknosis and karyolysis (Fig. 10-49) .ToxicosesIonophore-Induced Myocardial Degeneration.", [["AV valvular", "ANATOMY", 19, 30], ["sarcoplasm", "ANATOMY", 117, 127], ["nuclear", "ANATOMY", 133, 140], ["Myocardial", "ANATOMY", 206, 216], ["AV valvular diseases", "DISEASE", 19, 39], ["hypereosinophilia", "DISEASE", 65, 82], ["clumping of the sarcoplasm", "DISEASE", 101, 127], ["karyolysis", "DISEASE", 154, 164], ["Ionophore", "CHEMICAL", 188, 197], ["Myocardial Degeneration", "DISEASE", 206, 229], ["AV valvular", "MULTI-TISSUE_STRUCTURE", 19, 30], ["sarcoplasm", "CANCER", 117, 127], ["nuclear", "CELLULAR_COMPONENT", 133, 140], ["Ionophore", "SIMPLE_CHEMICAL", 188, 197], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 206, 216], ["AV valvular diseases", "PROBLEM", 19, 39], ["hypereosinophilia", "PROBLEM", 65, 82], ["coagulation", "TEST", 84, 95], ["clumping of the sarcoplasm", "PROBLEM", 101, 127], ["nuclear pyknosis", "PROBLEM", 133, 149], ["karyolysis", "TEST", 154, 164], ["Fig.", "TEST", 166, 170], ["ToxicosesIonophore", "TREATMENT", 179, 197], ["Myocardial Degeneration", "PROBLEM", 206, 229], ["AV valvular", "ANATOMY", 19, 30], ["diseases", "OBSERVATION", 31, 39], ["coagulation", "OBSERVATION", 84, 95], ["clumping", "OBSERVATION_MODIFIER", 101, 109], ["sarcoplasm", "ANATOMY", 117, 127], ["nuclear", "OBSERVATION_MODIFIER", 133, 140], ["pyknosis", "OBSERVATION", 141, 149], ["Myocardial", "ANATOMY", 206, 216], ["Degeneration", "OBSERVATION", 217, 229]]], ["Ionophores (polyether antibiotics), such as monensin, lasalocid, salinomycin, and narasin, are toxic to horses and dogs at extremely low concentrations.", [["Ionophores", "CHEMICAL", 0, 10], ["polyether", "CHEMICAL", 12, 21], ["monensin", "CHEMICAL", 44, 52], ["lasalocid", "CHEMICAL", 54, 63], ["salinomycin", "CHEMICAL", 65, 76], ["narasin", "CHEMICAL", 82, 89], ["polyether", "CHEMICAL", 12, 21], ["monensin", "CHEMICAL", 44, 52], ["lasalocid", "CHEMICAL", 54, 63], ["salinomycin", "CHEMICAL", 65, 76], ["narasin", "CHEMICAL", 82, 89], ["Ionophores", "SIMPLE_CHEMICAL", 0, 10], ["polyether antibiotics", "SIMPLE_CHEMICAL", 12, 33], ["monensin", "SIMPLE_CHEMICAL", 44, 52], ["lasalocid", "SIMPLE_CHEMICAL", 54, 63], ["salinomycin", "SIMPLE_CHEMICAL", 65, 76], ["narasin", "SIMPLE_CHEMICAL", 82, 89], ["horses", "ORGANISM", 104, 110], ["dogs", "ORGANISM", 115, 119], ["dogs", "SPECIES", 115, 119], ["Ionophores (polyether antibiotics", "TREATMENT", 0, 33], ["monensin", "TREATMENT", 44, 52], ["lasalocid", "TREATMENT", 54, 63], ["salinomycin", "TREATMENT", 65, 76], ["narasin", "TREATMENT", 82, 89]]], ["They are used as feed additives to increase feed efficiency and weight gain of beef and dairy cattle and to control coccidiosis in poultry.", [["weight gain", "DISEASE", 64, 75], ["coccidiosis", "DISEASE", 116, 127], ["beef", "ORGANISM_SUBDIVISION", 79, 83], ["beef", "SPECIES", 79, 83], ["cattle", "SPECIES", 94, 100], ["beef", "SPECIES", 79, 83], ["cattle", "SPECIES", 94, 100], ["coccidiosis", "SPECIES", 116, 127], ["poultry", "SPECIES", 131, 138], ["increase feed efficiency", "TREATMENT", 35, 59], ["dairy cattle", "TREATMENT", 88, 100], ["coccidiosis", "PROBLEM", 116, 127], ["coccidiosis", "OBSERVATION", 116, 127]]], ["Horses gain access to ionophores when they consume (1) ruminant feed containing ionophores; (2) horse feed accidentally mixed with ionophores; and (3) horse and dog food accidentally contaminated in a mill producing poultry, cattle, horse, and dog feeds.", [["ionophores", "CHEMICAL", 80, 90], ["ionophores", "CHEMICAL", 131, 141], ["ionophores", "SIMPLE_CHEMICAL", 80, 90], ["horse", "ORGANISM", 96, 101], ["ionophores", "SIMPLE_CHEMICAL", 131, 141], ["horse", "ORGANISM", 151, 156], ["dog", "ORGANISM", 161, 164], ["cattle", "ORGANISM", 225, 231], ["horse", "ORGANISM_SUBDIVISION", 233, 238], ["dog", "ORGANISM", 244, 247], ["horse", "SPECIES", 96, 101], ["horse", "SPECIES", 151, 156], ["dog", "SPECIES", 161, 164], ["cattle", "SPECIES", 225, 231], ["horse", "SPECIES", 233, 238], ["dog", "SPECIES", 244, 247], ["dog", "SPECIES", 161, 164], ["poultry", "SPECIES", 216, 223], ["cattle", "SPECIES", 225, 231], ["horse", "SPECIES", 233, 238], ["dog", "SPECIES", 244, 247]]], ["Ionophores cause acute cardiac rhabdomyocyte degeneration and necrosis; this type of injury is discussed in detail in the section on Responses to Injury: Myocardium, Myocardial Necrosis.", [["cardiac rhabdomyocyte", "ANATOMY", 23, 44], ["Myocardial", "ANATOMY", 166, 176], ["cardiac rhabdomyocyte degeneration", "DISEASE", 23, 57], ["necrosis", "DISEASE", 62, 70], ["Injury", "DISEASE", 146, 152], ["Myocardial Necrosis", "DISEASE", 166, 185], ["cardiac rhabdomyocyte", "PATHOLOGICAL_FORMATION", 23, 44], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 166, 176], ["Ionophores", "TREATMENT", 0, 10], ["acute cardiac rhabdomyocyte degeneration", "PROBLEM", 17, 57], ["necrosis", "PROBLEM", 62, 70], ["injury", "PROBLEM", 85, 91], ["Myocardium", "PROBLEM", 154, 164], ["Myocardial Necrosis", "PROBLEM", 166, 185], ["acute", "OBSERVATION_MODIFIER", 17, 22], ["cardiac", "ANATOMY", 23, 30], ["rhabdomyocyte degeneration", "OBSERVATION", 31, 57], ["necrosis", "OBSERVATION", 62, 70], ["injury", "OBSERVATION", 85, 91], ["Myocardium", "ANATOMY", 154, 164], ["Myocardial", "ANATOMY", 166, 176], ["Necrosis", "OBSERVATION", 177, 185]]], ["Ionophores are lipophilic chelating agents that transport cations across phospholipid bilayer membranes and complexes with monovalent cations, such as Na + and Ca + , and cross cell membranes and enter the cell via ion transport systems in exchange for H + and K + ions.", [["phospholipid bilayer membranes", "ANATOMY", 73, 103], ["cell membranes", "ANATOMY", 177, 191], ["cell", "ANATOMY", 206, 210], ["Na", "CHEMICAL", 151, 153], ["Ca", "CHEMICAL", 160, 162], ["H", "CHEMICAL", 253, 254], ["K", "CHEMICAL", 261, 262], ["Na +", "CHEMICAL", 151, 155], ["Ca +", "CHEMICAL", 160, 164], ["H +", "CHEMICAL", 253, 256], ["K +", "CHEMICAL", 261, 264], ["Ionophores", "SIMPLE_CHEMICAL", 0, 10], ["lipophilic chelating agents", "SIMPLE_CHEMICAL", 15, 42], ["cations", "SIMPLE_CHEMICAL", 58, 65], ["phospholipid", "SIMPLE_CHEMICAL", 73, 85], ["bilayer membranes", "CELLULAR_COMPONENT", 86, 103], ["cations", "SIMPLE_CHEMICAL", 134, 141], ["Na +", "SIMPLE_CHEMICAL", 151, 155], ["Ca +", "SIMPLE_CHEMICAL", 160, 164], ["cell membranes", "CELLULAR_COMPONENT", 177, 191], ["cell", "CELL", 206, 210], ["H +", "SIMPLE_CHEMICAL", 253, 256], ["K + ions", "SIMPLE_CHEMICAL", 261, 269], ["Ionophores", "TREATMENT", 0, 10], ["lipophilic chelating agents", "TREATMENT", 15, 42], ["transport cations across phospholipid bilayer membranes", "TREATMENT", 48, 103], ["monovalent cations", "TREATMENT", 123, 141], ["Na", "TEST", 151, 153], ["Ca", "TEST", 160, 162], ["cross cell membranes", "TREATMENT", 171, 191], ["H", "TEST", 253, 254], ["lipophilic chelating", "OBSERVATION", 15, 35]]], ["Increases in the concentrations of intracellular Ca + and possibly Na + are thought to cause cell membrane injury and dysfunction, resulting in mitochondrial swelling and decreased adenosine triphosphate production.", [["intracellular", "ANATOMY", 35, 48], ["cell membrane", "ANATOMY", 93, 106], ["mitochondrial", "ANATOMY", 144, 157], ["Ca", "CHEMICAL", 49, 51], ["Na", "CHEMICAL", 67, 69], ["mitochondrial swelling", "DISEASE", 144, 166], ["adenosine triphosphate", "CHEMICAL", 181, 203], ["Ca +", "CHEMICAL", 49, 53], ["Na +", "CHEMICAL", 67, 71], ["adenosine triphosphate", "CHEMICAL", 181, 203], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 35, 48], ["Ca +", "SIMPLE_CHEMICAL", 49, 53], ["Na +", "SIMPLE_CHEMICAL", 67, 71], ["cell membrane", "CELLULAR_COMPONENT", 93, 106], ["mitochondrial", "CELLULAR_COMPONENT", 144, 157], ["adenosine triphosphate", "SIMPLE_CHEMICAL", 181, 203], ["intracellular Ca", "TEST", 35, 51], ["Na +", "PROBLEM", 67, 71], ["cell membrane injury", "PROBLEM", 93, 113], ["dysfunction", "PROBLEM", 118, 129], ["mitochondrial swelling", "PROBLEM", 144, 166], ["decreased adenosine triphosphate production", "PROBLEM", 171, 214], ["thought to cause", "UNCERTAINTY", 76, 92], ["cell membrane injury", "OBSERVATION", 93, 113], ["mitochondrial", "OBSERVATION_MODIFIER", 144, 157], ["swelling", "OBSERVATION", 158, 166], ["decreased", "OBSERVATION_MODIFIER", 171, 180], ["adenosine triphosphate production", "OBSERVATION", 181, 214]]], ["In addition, they cause lipid peroxidation of cell membranes leading to loss of cell membrane integrity, fluid and ion shifts, and oncotic necrosis.Gossypol-Induced MyocardialDegeneration.", [["cell membranes", "ANATOMY", 46, 60], ["cell membrane", "ANATOMY", 80, 93], ["fluid", "ANATOMY", 105, 110], ["oncotic", "ANATOMY", 131, 138], ["necrosis", "DISEASE", 139, 147], ["Gossypol", "CHEMICAL", 148, 156], ["MyocardialDegeneration", "DISEASE", 165, 187], ["Gossypol", "CHEMICAL", 148, 156], ["lipid", "SIMPLE_CHEMICAL", 24, 29], ["cell membranes", "CELLULAR_COMPONENT", 46, 60], ["cell membrane", "CELLULAR_COMPONENT", 80, 93], ["Gossypol", "SIMPLE_CHEMICAL", 148, 156], ["lipid peroxidation of cell membranes", "PROBLEM", 24, 60], ["loss of cell membrane integrity", "PROBLEM", 72, 103], ["fluid and ion shifts", "PROBLEM", 105, 125], ["oncotic necrosis", "PROBLEM", 131, 147], ["Gossypol", "TREATMENT", 148, 156], ["Induced MyocardialDegeneration", "PROBLEM", 157, 187], ["lipid peroxidation", "OBSERVATION", 24, 42], ["cell membranes", "OBSERVATION", 46, 60], ["loss of cell membrane integrity", "OBSERVATION", 72, 103], ["fluid", "OBSERVATION", 105, 110], ["ion shifts", "OBSERVATION_MODIFIER", 115, 125], ["oncotic", "OBSERVATION_MODIFIER", 131, 138], ["necrosis", "OBSERVATION", 139, 147], ["MyocardialDegeneration", "OBSERVATION", 165, 187]]], ["Gossypolinduced myocardial degeneration can follow the ingestion of cottonseed or cottonseed products that contain excess free gossypol.", [["myocardial", "ANATOMY", 16, 26], ["myocardial degeneration", "DISEASE", 16, 39], ["gossypol", "CHEMICAL", 127, 135], ["gossypol", "CHEMICAL", 127, 135], ["myocardial", "MULTI-TISSUE_STRUCTURE", 16, 26], ["cottonseed", "ORGANISM_SUBSTANCE", 68, 78], ["gossypol", "SIMPLE_CHEMICAL", 127, 135], ["Gossypolinduced myocardial degeneration", "PROBLEM", 0, 39], ["cottonseed products", "TREATMENT", 82, 101], ["excess free gossypol", "TREATMENT", 115, 135], ["myocardial", "ANATOMY", 16, 26], ["degeneration", "OBSERVATION", 27, 39]]], ["Gossypol is a potentially toxic pigment in the cotton plant; however, it is toxic only when in a free form (not bound to protein).", [["Gossypol", "CHEMICAL", 0, 8], ["Gossypol", "CHEMICAL", 0, 8], ["Gossypol", "SIMPLE_CHEMICAL", 0, 8], ["Gossypol", "TREATMENT", 0, 8], ["a potentially toxic pigment", "PROBLEM", 12, 39], ["potentially", "UNCERTAINTY", 14, 25], ["toxic", "OBSERVATION_MODIFIER", 26, 31], ["pigment", "OBSERVATION", 32, 39], ["cotton plant", "OBSERVATION", 47, 59], ["toxic", "OBSERVATION_MODIFIER", 76, 81]]], ["Gossypol causes myocardial degeneration and necrosis and cardiac conduction failure (see later discussion).", [["myocardial", "ANATOMY", 16, 26], ["cardiac", "ANATOMY", 57, 64], ["Gossypol", "CHEMICAL", 0, 8], ["myocardial degeneration", "DISEASE", 16, 39], ["necrosis", "DISEASE", 44, 52], ["cardiac conduction failure", "DISEASE", 57, 83], ["Gossypol", "CHEMICAL", 0, 8], ["Gossypol", "SIMPLE_CHEMICAL", 0, 8], ["myocardial", "MULTI-TISSUE_STRUCTURE", 16, 26], ["cardiac", "ORGAN", 57, 64], ["Gossypol", "TREATMENT", 0, 8], ["myocardial degeneration", "PROBLEM", 16, 39], ["necrosis", "PROBLEM", 44, 52], ["cardiac conduction failure", "PROBLEM", 57, 83], ["myocardial", "ANATOMY", 16, 26], ["degeneration", "OBSERVATION", 27, 39], ["necrosis", "OBSERVATION", 44, 52], ["cardiac", "ANATOMY", 57, 64], ["conduction failure", "OBSERVATION", 65, 83]]], ["The macroscopic and microscopic characteristics of the lesions are in many ways similar to those caused by ionophore-induced and white snakeroot-induced myocardial degeneration in horses.", [["lesions", "ANATOMY", 55, 62], ["myocardial", "ANATOMY", 153, 163], ["ionophore", "CHEMICAL", 107, 116], ["snakeroot", "CHEMICAL", 135, 144], ["myocardial degeneration", "DISEASE", 153, 176], ["ionophore", "CHEMICAL", 107, 116], ["lesions", "PATHOLOGICAL_FORMATION", 55, 62], ["ionophore", "SIMPLE_CHEMICAL", 107, 116], ["myocardial", "MULTI-TISSUE_STRUCTURE", 153, 163], ["the lesions", "PROBLEM", 51, 62], ["white snakeroot", "PROBLEM", 129, 144], ["myocardial degeneration in horses", "PROBLEM", 153, 186], ["macroscopic", "OBSERVATION_MODIFIER", 4, 15], ["lesions", "OBSERVATION", 55, 62], ["myocardial", "ANATOMY", 153, 163], ["degeneration", "OBSERVATION", 164, 176]]], ["In addition, acute rhabdomyocytic degeneration and necrosis are discussed in detail in the section on Responses to Injury: Myocardium, Myocardial Necrosis and also in Chapter 15.", [["rhabdomyocytic", "ANATOMY", 19, 33], ["Myocardial", "ANATOMY", 135, 145], ["necrosis", "DISEASE", 51, 59], ["Injury", "DISEASE", 115, 121], ["Myocardial Necrosis", "DISEASE", 135, 154], ["acute rhabdomyocytic degeneration", "PROBLEM", 13, 46], ["necrosis", "PROBLEM", 51, 59], ["Myocardium", "PROBLEM", 123, 133], ["Myocardial Necrosis", "PROBLEM", 135, 154], ["acute", "OBSERVATION_MODIFIER", 13, 18], ["rhabdomyocytic degeneration", "OBSERVATION", 19, 46], ["necrosis", "OBSERVATION", 51, 59], ["Myocardium", "ANATOMY", 123, 133], ["Myocardial", "ANATOMY", 135, 145], ["Necrosis", "OBSERVATION", 146, 154]]], ["Monogastric animals, particularly pigs and horses, are more sensitive to gossypol-induced myocardial degeneration and necrosis than ruminants.", [["myocardial", "ANATOMY", 90, 100], ["gossypol", "CHEMICAL", 73, 81], ["myocardial degeneration", "DISEASE", 90, 113], ["necrosis", "DISEASE", 118, 126], ["gossypol", "CHEMICAL", 73, 81], ["pigs", "ORGANISM", 34, 38], ["gossypol", "SIMPLE_CHEMICAL", 73, 81], ["myocardial", "MULTI-TISSUE_STRUCTURE", 90, 100], ["pigs", "SPECIES", 34, 38], ["pigs", "SPECIES", 34, 38], ["Monogastric animals", "PROBLEM", 0, 19], ["gossypol", "TREATMENT", 73, 81], ["myocardial degeneration", "PROBLEM", 90, 113], ["necrosis", "PROBLEM", 118, 126], ["myocardial", "ANATOMY", 90, 100], ["degeneration", "OBSERVATION", 101, 113], ["necrosis", "OBSERVATION", 118, 126]]], ["In summary, macroscopic lesions include Endocardial Mineralization.", [["macroscopic lesions", "ANATOMY", 12, 31], ["Endocardial", "ANATOMY", 40, 51], ["Endocardial Mineralization", "DISEASE", 40, 66], ["lesions", "PATHOLOGICAL_FORMATION", 24, 31], ["macroscopic lesions", "PROBLEM", 12, 31], ["Endocardial Mineralization", "PROBLEM", 40, 66], ["lesions", "OBSERVATION", 24, 31], ["Endocardial", "ANATOMY", 40, 51], ["Mineralization", "OBSERVATION", 52, 66]]], ["Endocardial mineralization occurs from intake of excessive amounts of vitamin D and from intoxication by calcinogenic plants (Cestrum diurnum, Trisetum flavescens, Solanum malacoxylon, and Solanum torvum) that contain vitamin D analogs.", [["Endocardial", "ANATOMY", 0, 11], ["vitamin D", "CHEMICAL", 70, 79], ["Cestrum diurnum, Trisetum flavescens, Solanum malacoxylon", "CHEMICAL", 126, 183], ["vitamin D", "CHEMICAL", 218, 227], ["vitamin D", "CHEMICAL", 70, 79], ["vitamin D", "CHEMICAL", 218, 227], ["Endocardial", "MULTI-TISSUE_STRUCTURE", 0, 11], ["vitamin D", "SIMPLE_CHEMICAL", 70, 79], ["calcinogenic plants", "ORGANISM", 105, 124], ["Cestrum diurnum", "ORGANISM", 126, 141], ["Trisetum flavescens", "ORGANISM", 143, 162], ["Solanum malacoxylon", "ORGANISM", 164, 183], ["Solanum torvum", "ORGANISM", 189, 203], ["vitamin D analogs", "SIMPLE_CHEMICAL", 218, 235], ["Cestrum diurnum", "SPECIES", 126, 141], ["Trisetum flavescens", "SPECIES", 143, 162], ["Solanum malacoxylon", "SPECIES", 164, 183], ["Solanum torvum", "SPECIES", 189, 203], ["Cestrum diurnum", "SPECIES", 126, 141], ["Trisetum flavescens", "SPECIES", 143, 162], ["Solanum malacoxylon", "SPECIES", 164, 183], ["Solanum torvum", "SPECIES", 189, 203], ["Endocardial mineralization", "PROBLEM", 0, 26], ["vitamin D", "TREATMENT", 70, 79], ["intoxication", "PROBLEM", 89, 101], ["calcinogenic plants", "TREATMENT", 105, 124], ["Cestrum diurnum", "TREATMENT", 126, 141], ["Trisetum flavescens", "TREATMENT", 143, 162], ["Solanum malacoxylon", "TREATMENT", 164, 183], ["Solanum torvum)", "TREATMENT", 189, 204], ["vitamin D analogs", "TREATMENT", 218, 235], ["mineralization", "OBSERVATION", 12, 26]]], ["These plant-induced syndromes of cattle have been called by different names in various areas of the world, such as \"Manchester wasting disease\" in Jamaica, \"enzootic calcinosis\" in Europe, \"Naalehu disease\" in Hawaii, \"enteque seco\" in Argentina, and \"espichamento\" in Brazil.", [["wasting disease", "DISEASE", 127, 142], ["calcinosis", "DISEASE", 166, 176], ["Naalehu disease", "DISEASE", 190, 205], ["cattle", "ORGANISM", 33, 39], ["cattle", "SPECIES", 33, 39], ["cattle", "SPECIES", 33, 39], ["Manchester wasting disease\"", "PROBLEM", 116, 143], ["enzootic calcinosis", "PROBLEM", 157, 176], ["enzootic", "OBSERVATION_MODIFIER", 157, 165], ["calcinosis", "OBSERVATION", 166, 176]]], ["Multiple, large, white, rough, firm plaques of mineralized fibroelastic tissue are present in the endocardium and intima of large elastic arteries.", [["plaques", "ANATOMY", 36, 43], ["fibroelastic tissue", "ANATOMY", 59, 78], ["endocardium", "ANATOMY", 98, 109], ["intima", "ANATOMY", 114, 120], ["elastic arteries", "ANATOMY", 130, 146], ["fibroelastic tissue", "TISSUE", 59, 78], ["endocardium", "MULTI-TISSUE_STRUCTURE", 98, 109], ["intima", "TISSUE", 114, 120], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 130, 146], ["Multiple, large, white, rough, firm plaques of mineralized fibroelastic tissue", "PROBLEM", 0, 78], ["large", "OBSERVATION_MODIFIER", 10, 15], ["white", "OBSERVATION_MODIFIER", 17, 22], ["rough", "OBSERVATION_MODIFIER", 24, 29], ["firm", "OBSERVATION_MODIFIER", 31, 35], ["plaques", "OBSERVATION", 36, 43], ["mineralized", "OBSERVATION_MODIFIER", 47, 58], ["fibroelastic tissue", "OBSERVATION", 59, 78], ["endocardium", "ANATOMY", 98, 109], ["intima", "ANATOMY_MODIFIER", 114, 120], ["large", "OBSERVATION_MODIFIER", 124, 129], ["elastic arteries", "ANATOMY", 130, 146]]], ["Fibrosis, with or without mineralization, occurs in chronically dilated hearts, in hearts of debilitated cattle with Johne's disease ( Fig. 10-53 ; also see , in dogs with healed lesions of left atrial ulcerative endocarditis associated with a prior uremic episode (see Fig. 10-52) , and in the so-called jet lesions produced by the trauma of refluxed blood in valvular insufficiencies.InflammationVegetative Valvular and Mural Endocarditis.", [["hearts", "ANATOMY", 72, 78], ["hearts", "ANATOMY", 83, 89], ["lesions", "ANATOMY", 179, 186], ["left atrial", "ANATOMY", 190, 201], ["lesions", "ANATOMY", 309, 316], ["blood", "ANATOMY", 352, 357], ["valvular", "ANATOMY", 361, 369], ["Valvular", "ANATOMY", 409, 417], ["Fibrosis", "DISEASE", 0, 8], ["Johne's disease", "DISEASE", 117, 132], ["atrial ulcerative endocarditis", "DISEASE", 195, 225], ["uremic", "DISEASE", 250, 256], ["trauma", "DISEASE", 333, 339], ["valvular insufficiencies", "DISEASE", 361, 385], ["Vegetative Valvular and Mural Endocarditis", "DISEASE", 398, 440], ["hearts", "ORGAN", 72, 78], ["hearts", "ORGAN", 83, 89], ["cattle", "ORGANISM", 105, 111], ["dogs", "ORGANISM", 162, 166], ["lesions", "PATHOLOGICAL_FORMATION", 179, 186], ["jet lesions", "PATHOLOGICAL_FORMATION", 305, 316], ["blood", "ORGANISM_SUBSTANCE", 352, 357], ["valvular", "ORGAN", 361, 369], ["Valvular", "MULTI-TISSUE_STRUCTURE", 409, 417], ["cattle", "SPECIES", 105, 111], ["dogs", "SPECIES", 162, 166], ["cattle", "SPECIES", 105, 111], ["Johne", "SPECIES", 117, 122], ["Fibrosis", "PROBLEM", 0, 8], ["mineralization", "PROBLEM", 26, 40], ["chronically dilated hearts", "PROBLEM", 52, 78], ["debilitated cattle", "PROBLEM", 93, 111], ["Johne's disease", "PROBLEM", 117, 132], ["healed lesions", "PROBLEM", 172, 186], ["left atrial ulcerative endocarditis", "PROBLEM", 190, 225], ["a prior uremic episode", "PROBLEM", 242, 264], ["jet lesions", "PROBLEM", 305, 316], ["refluxed blood in valvular insufficiencies", "PROBLEM", 343, 385], ["InflammationVegetative Valvular", "PROBLEM", 386, 417], ["Mural Endocarditis", "PROBLEM", 422, 440], ["without", "UNCERTAINTY", 18, 25], ["mineralization", "OBSERVATION", 26, 40], ["chronically", "OBSERVATION_MODIFIER", 52, 63], ["dilated", "OBSERVATION", 64, 71], ["hearts", "ANATOMY", 72, 78], ["hearts", "ANATOMY", 83, 89], ["debilitated", "OBSERVATION_MODIFIER", 93, 104], ["healed", "OBSERVATION_MODIFIER", 172, 178], ["lesions", "OBSERVATION", 179, 186], ["left atrial", "ANATOMY", 190, 201], ["ulcerative", "OBSERVATION_MODIFIER", 202, 212], ["endocarditis", "OBSERVATION", 213, 225], ["uremic", "OBSERVATION_MODIFIER", 250, 256], ["jet", "OBSERVATION_MODIFIER", 305, 308], ["lesions", "OBSERVATION", 309, 316], ["refluxed", "OBSERVATION", 343, 351], ["valvular", "ANATOMY", 361, 369], ["insufficiencies", "OBSERVATION", 370, 385], ["Valvular", "ANATOMY", 409, 417], ["Mural", "OBSERVATION_MODIFIER", 422, 427], ["Endocarditis", "OBSERVATION", 428, 440]]], ["Endocarditis is usually the result of bacterial infections, except for lesions produced by migrating Strongylus vulgaris larvae in horses and rarely in mycotic infections.", [["lesions", "ANATOMY", 71, 78], ["Endocarditis", "DISEASE", 0, 12], ["bacterial infections", "DISEASE", 38, 58], ["Strongylus vulgaris larvae", "DISEASE", 101, 127], ["mycotic infections", "DISEASE", 152, 170], ["lesions", "PATHOLOGICAL_FORMATION", 71, 78], ["Strongylus vulgaris larvae", "ORGANISM", 101, 127], ["horses", "ORGANISM_SUBDIVISION", 131, 137], ["Strongylus vulgaris", "SPECIES", 101, 120], ["Strongylus vulgaris", "SPECIES", 101, 120], ["Endocarditis", "PROBLEM", 0, 12], ["bacterial infections", "PROBLEM", 38, 58], ["lesions", "PROBLEM", 71, 78], ["migrating Strongylus vulgaris larvae", "PROBLEM", 91, 127], ["mycotic infections", "PROBLEM", 152, 170], ["bacterial", "OBSERVATION_MODIFIER", 38, 47], ["infections", "OBSERVATION", 48, 58], ["lesions", "OBSERVATION", 71, 78], ["migrating", "OBSERVATION_MODIFIER", 91, 100], ["Strongylus vulgaris larvae", "OBSERVATION", 101, 127], ["mycotic", "OBSERVATION_MODIFIER", 152, 159], ["infections", "OBSERVATION", 160, 170]]], ["The lesions are often very large by the time of death and are present on the valves (valvular endocarditis), although some lesions originate from the underlying myocardium or extend from the affected valve to the adjacent wall (mural endocarditis).", [["lesions", "ANATOMY", 4, 11], ["valves", "ANATOMY", 77, 83], ["valvular", "ANATOMY", 85, 93], ["lesions", "ANATOMY", 123, 130], ["myocardium", "ANATOMY", 161, 171], ["valve", "ANATOMY", 200, 205], ["wall", "ANATOMY", 222, 226], ["mural", "ANATOMY", 228, 233], ["death", "DISEASE", 48, 53], ["valvular endocarditis", "DISEASE", 85, 106], ["mural endocarditis", "DISEASE", 228, 246], ["lesions", "CANCER", 4, 11], ["valves", "TISSUE", 77, 83], ["lesions", "PATHOLOGICAL_FORMATION", 123, 130], ["myocardium", "ORGAN", 161, 171], ["valve", "PATHOLOGICAL_FORMATION", 200, 205], ["wall", "TISSUE", 222, 226], ["The lesions", "PROBLEM", 0, 11], ["death", "PROBLEM", 48, 53], ["the valves (valvular endocarditis", "PROBLEM", 73, 106], ["some lesions", "PROBLEM", 118, 130], ["mural endocarditis", "PROBLEM", 228, 246], ["lesions", "OBSERVATION", 4, 11], ["often", "OBSERVATION_MODIFIER", 16, 21], ["very", "OBSERVATION_MODIFIER", 22, 26], ["large", "OBSERVATION", 27, 32], ["valves", "ANATOMY", 77, 83], ["valvular", "ANATOMY", 85, 93], ["endocarditis", "OBSERVATION", 94, 106], ["some", "OBSERVATION_MODIFIER", 118, 122], ["lesions", "OBSERVATION", 123, 130], ["myocardium", "ANATOMY", 161, 171], ["affected valve", "ANATOMY", 191, 205], ["adjacent", "ANATOMY_MODIFIER", 213, 221], ["wall", "ANATOMY_MODIFIER", 222, 226], ["mural", "OBSERVATION_MODIFIER", 228, 233], ["endocarditis", "OBSERVATION", 234, 246]]], ["Grossly, the affected valves have large, adhering, friable, yellow-to-gray masses of fibrin termed vegetations, which can occlude the valvular orifice (Figs.", [["valves", "ANATOMY", 22, 28], ["vegetations", "ANATOMY", 99, 110], ["valvular orifice", "ANATOMY", 134, 150], ["valves", "PATHOLOGICAL_FORMATION", 22, 28], ["fibrin", "GENE_OR_GENE_PRODUCT", 85, 91], ["vegetations", "PATHOLOGICAL_FORMATION", 99, 110], ["valvular orifice", "MULTI-TISSUE_STRUCTURE", 134, 150], ["fibrin", "PROTEIN", 85, 91], ["the affected valves", "PROBLEM", 9, 28], ["large, adhering, friable, yellow-to-gray masses", "PROBLEM", 34, 81], ["fibrin termed vegetations", "PROBLEM", 85, 110], ["affected", "OBSERVATION_MODIFIER", 13, 21], ["valves", "OBSERVATION", 22, 28], ["large", "OBSERVATION_MODIFIER", 34, 39], ["friable", "OBSERVATION_MODIFIER", 51, 58], ["yellow", "OBSERVATION_MODIFIER", 60, 66], ["masses", "OBSERVATION", 75, 81], ["fibrin termed vegetations", "OBSERVATION", 85, 110], ["valvular", "ANATOMY", 134, 142], ["orifice", "ANATOMY_MODIFIER", 143, 150], ["Figs", "OBSERVATION_MODIFIER", 152, 156]]], ["In chronic lesions, the fibrin deposits are organized by fibrous connective tissue to produce irregular nodular masses termed verrucae (wartlike lesions).", [["lesions", "ANATOMY", 11, 18], ["fibrous connective tissue", "ANATOMY", 57, 82], ["nodular masses", "ANATOMY", 104, 118], ["verrucae", "ANATOMY", 126, 134], ["wartlike lesions", "ANATOMY", 136, 152], ["lesions", "PATHOLOGICAL_FORMATION", 11, 18], ["fibrin", "GENE_OR_GENE_PRODUCT", 24, 30], ["fibrous connective tissue", "TISSUE", 57, 82], ["nodular masses", "CANCER", 104, 118], ["verrucae", "CANCER", 126, 134], ["wartlike lesions", "CANCER", 136, 152], ["chronic lesions", "PROBLEM", 3, 18], ["the fibrin deposits", "PROBLEM", 20, 39], ["fibrous connective tissue", "PROBLEM", 57, 82], ["irregular nodular masses termed verrucae (wartlike lesions", "PROBLEM", 94, 152], ["chronic", "OBSERVATION_MODIFIER", 3, 10], ["lesions", "OBSERVATION", 11, 18], ["fibrin deposits", "OBSERVATION", 24, 39], ["fibrous", "OBSERVATION_MODIFIER", 57, 64], ["connective tissue", "OBSERVATION_MODIFIER", 65, 82], ["irregular", "OBSERVATION_MODIFIER", 94, 103], ["nodular", "OBSERVATION_MODIFIER", 104, 111], ["masses", "OBSERVATION", 112, 118], ["verrucae", "OBSERVATION", 126, 134]]], ["Microscopically, the lesion consists of accumulated layers of fibrin and numerous embedded bacterial colonies underlain by a zone of infiltrated leukocytes and granulation tissue (see Fig. 10-54, B) .", [["lesion", "ANATOMY", 21, 27], ["colonies", "ANATOMY", 101, 109], ["leukocytes", "ANATOMY", 145, 155], ["granulation tissue", "ANATOMY", 160, 178], ["fibrin", "GENE_OR_GENE_PRODUCT", 62, 68], ["leukocytes", "CELL", 145, 155], ["granulation tissue", "TISSUE", 160, 178], ["B", "CELL", 196, 197], ["fibrin", "PROTEIN", 62, 68], ["infiltrated leukocytes", "CELL_TYPE", 133, 155], ["the lesion", "PROBLEM", 17, 27], ["accumulated layers of fibrin", "PROBLEM", 40, 68], ["numerous embedded bacterial colonies", "PROBLEM", 73, 109], ["infiltrated leukocytes", "PROBLEM", 133, 155], ["granulation tissue", "PROBLEM", 160, 178], ["lesion", "OBSERVATION", 21, 27], ["accumulated", "OBSERVATION_MODIFIER", 40, 51], ["layers", "OBSERVATION_MODIFIER", 52, 58], ["fibrin", "OBSERVATION", 62, 68], ["numerous", "OBSERVATION_MODIFIER", 73, 81], ["embedded", "OBSERVATION_MODIFIER", 82, 90], ["bacterial colonies", "OBSERVATION", 91, 109], ["zone", "OBSERVATION_MODIFIER", 125, 129], ["infiltrated leukocytes", "OBSERVATION", 133, 155], ["granulation tissue", "OBSERVATION", 160, 178]]], ["The relative frequency of valvular involvement with endocarditis in animals is mitral > aortic > tricuspid > pulmonary.Disturbances of GrowthEndocardial Fibroelastosis.", [["valvular", "ANATOMY", 26, 34], ["mitral", "ANATOMY", 79, 85], ["aortic", "ANATOMY", 88, 94], ["tricuspid", "ANATOMY", 97, 106], ["pulmonary", "ANATOMY", 109, 118], ["endocarditis", "DISEASE", 52, 64], ["valvular", "ORGAN", 26, 34], ["mitral", "MULTI-TISSUE_STRUCTURE", 79, 85], ["aortic", "MULTI-TISSUE_STRUCTURE", 88, 94], ["tricuspid", "ORGAN", 97, 106], ["pulmonary", "ORGAN", 109, 118], ["valvular involvement", "PROBLEM", 26, 46], ["endocarditis", "PROBLEM", 52, 64], ["GrowthEndocardial Fibroelastosis", "PROBLEM", 135, 167], ["valvular", "ANATOMY", 26, 34], ["involvement", "OBSERVATION", 35, 46], ["endocarditis", "OBSERVATION", 52, 64], ["mitral", "OBSERVATION", 79, 85], ["aortic", "ANATOMY", 88, 94], ["tricuspid", "OBSERVATION", 97, 106], ["pulmonary", "ANATOMY", 109, 118], ["GrowthEndocardial", "OBSERVATION_MODIFIER", 135, 152], ["Fibroelastosis", "OBSERVATION", 153, 167]]], ["Endocardial fibroelastosis in animals was historically recognized as a primary cardiac defect in Burmese and Siamese cats.", [["Endocardial", "ANATOMY", 0, 11], ["cardiac", "ANATOMY", 79, 86], ["Endocardial fibroelastosis", "DISEASE", 0, 26], ["cardiac defect", "DISEASE", 79, 93], ["cardiac", "ORGAN", 79, 86], ["cats", "ORGANISM", 117, 121], ["cats", "SPECIES", 117, 121], ["Endocardial fibroelastosis in animals", "PROBLEM", 0, 37], ["a primary cardiac defect", "PROBLEM", 69, 93], ["fibroelastosis", "OBSERVATION", 12, 26], ["cardiac", "ANATOMY", 79, 86], ["defect", "OBSERVATION", 87, 93]]], ["Affected animals had prominent, white, thickened endocardium, especially of the left ventricle, because of the proliferation of fibroelastic tissue (see Fig. 10-45) .", [["endocardium", "ANATOMY", 49, 60], ["left ventricle", "ANATOMY", 80, 94], ["fibroelastic tissue", "ANATOMY", 128, 147], ["endocardium", "TISSUE", 49, 60], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 80, 94], ["fibroelastic tissue", "TISSUE", 128, 147], ["Affected animals", "PROBLEM", 0, 16], ["prominent, white, thickened endocardium", "PROBLEM", 21, 60], ["the proliferation of fibroelastic tissue", "PROBLEM", 107, 147], ["prominent", "OBSERVATION_MODIFIER", 21, 30], ["white", "OBSERVATION_MODIFIER", 32, 37], ["thickened", "OBSERVATION", 39, 48], ["endocardium", "ANATOMY_MODIFIER", 49, 60], ["left ventricle", "ANATOMY", 80, 94], ["proliferation", "OBSERVATION", 111, 124], ["fibroelastic tissue", "OBSERVATION", 128, 147]]], ["Endocardial fibroelastosis is a reaction of the endocardium to hypoxia and often associated with heart disease, which results in dilated cardiac chambers.", [["Endocardial", "ANATOMY", 0, 11], ["endocardium", "ANATOMY", 48, 59], ["heart", "ANATOMY", 97, 102], ["cardiac", "ANATOMY", 137, 144], ["Endocardial fibroelastosis", "DISEASE", 0, 26], ["hypoxia", "DISEASE", 63, 70], ["heart disease", "DISEASE", 97, 110], ["dilated cardiac chambers", "DISEASE", 129, 153], ["endocardium", "MULTI-TISSUE_STRUCTURE", 48, 59], ["heart", "ORGAN", 97, 102], ["cardiac chambers", "MULTI-TISSUE_STRUCTURE", 137, 153], ["Endocardial fibroelastosis", "PROBLEM", 0, 26], ["a reaction", "PROBLEM", 30, 40], ["hypoxia", "PROBLEM", 63, 70], ["heart disease", "PROBLEM", 97, 110], ["dilated cardiac chambers", "PROBLEM", 129, 153], ["fibroelastosis", "OBSERVATION", 12, 26], ["endocardium", "ANATOMY", 48, 59], ["hypoxia", "OBSERVATION", 63, 70], ["heart", "ANATOMY", 97, 102], ["disease", "OBSERVATION", 103, 110], ["dilated", "OBSERVATION", 129, 136], ["cardiac", "ANATOMY", 137, 144], ["chambers", "ANATOMY_MODIFIER", 145, 153]]], ["It is unclear whether this is a true congenital anomaly or a response to left atrial dilation.Miscellaneous Valvular AnomaliesValvular Hematomas.", [["left atrial", "ANATOMY", 73, 84], ["Valvular", "ANATOMY", 108, 116], ["Valvular", "ANATOMY", 126, 134], ["congenital anomaly", "DISEASE", 37, 55], ["Valvular Anomalies", "DISEASE", 108, 126], ["Valvular Hematomas", "DISEASE", 126, 144], ["atrial", "MULTI-TISSUE_STRUCTURE", 78, 84], ["a true congenital anomaly", "PROBLEM", 30, 55], ["left atrial dilation", "PROBLEM", 73, 93], ["Miscellaneous Valvular AnomaliesValvular Hematomas", "PROBLEM", 94, 144], ["unclear whether", "UNCERTAINTY", 6, 21], ["true", "OBSERVATION_MODIFIER", 32, 36], ["congenital", "OBSERVATION_MODIFIER", 37, 47], ["anomaly", "OBSERVATION", 48, 55], ["left", "ANATOMY_MODIFIER", 73, 77], ["atrial", "ANATOMY", 78, 84], ["dilation", "OBSERVATION", 85, 93], ["Valvular", "ANATOMY", 108, 116], ["Anomalies", "OBSERVATION", 117, 126], ["Valvular", "ANATOMY", 126, 134], ["Hematomas", "OBSERVATION", 135, 144]]], ["Valvular hematomas (hematocysts, valvular telangiectasia) frequently are observed on the AV valves of many species but are common in postnatal ruminants ( Fig. 10-51, A) .", [["Valvular", "ANATOMY", 0, 8], ["hematocysts", "ANATOMY", 20, 31], ["valvular", "ANATOMY", 33, 41], ["AV valves", "ANATOMY", 89, 98], ["Valvular hematomas", "DISEASE", 0, 18], ["valvular telangiectasia", "DISEASE", 33, 56], ["Valvular hematomas", "PATHOLOGICAL_FORMATION", 0, 18], ["AV valves", "MULTI-TISSUE_STRUCTURE", 89, 98], ["Valvular hematomas", "PROBLEM", 0, 18], ["hematocysts", "PROBLEM", 20, 31], ["valvular telangiectasia", "PROBLEM", 33, 56], ["the AV valves", "TREATMENT", 85, 98], ["many species", "PROBLEM", 102, 114], ["hematomas", "OBSERVATION", 9, 18], ["valvular", "ANATOMY", 33, 41], ["telangiectasia", "OBSERVATION", 42, 56], ["AV valves", "ANATOMY", 89, 98], ["many", "OBSERVATION_MODIFIER", 102, 106], ["species", "OBSERVATION", 107, 114]]], ["These lesions may regress and do not produce any functional abnormalities.", [["lesions", "ANATOMY", 6, 13], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["These lesions", "PROBLEM", 0, 13], ["any functional abnormalities", "PROBLEM", 45, 73], ["lesions", "OBSERVATION", 6, 13], ["abnormalities", "OBSERVATION", 60, 73]]], ["Lesions are bulging, blood-filled cysts, several millimeters in diameter, on the AV valves.Miscellaneous Valvular AnomaliesValvular Lymphocysts.", [["Lesions", "ANATOMY", 0, 7], ["blood", "ANATOMY", 21, 26], ["cysts", "ANATOMY", 34, 39], ["AV valves", "ANATOMY", 81, 90], ["Valvular", "ANATOMY", 105, 113], ["Valvular", "ANATOMY", 123, 131], ["Valvular AnomaliesValvular Lymphocysts", "DISEASE", 105, 143], ["blood", "ORGANISM_SUBSTANCE", 21, 26], ["cysts", "PATHOLOGICAL_FORMATION", 34, 39], ["AV valves", "MULTI-TISSUE_STRUCTURE", 81, 90], ["Lesions", "PROBLEM", 0, 7], ["bulging", "PROBLEM", 12, 19], ["blood-filled cysts", "PROBLEM", 21, 39], ["the AV valves", "TREATMENT", 77, 90], ["Miscellaneous Valvular AnomaliesValvular Lymphocysts", "PROBLEM", 91, 143], ["bulging", "OBSERVATION_MODIFIER", 12, 19], ["blood", "ANATOMY", 21, 26], ["filled", "OBSERVATION_MODIFIER", 27, 33], ["cysts", "OBSERVATION", 34, 39], ["several", "OBSERVATION_MODIFIER", 41, 48], ["millimeters", "OBSERVATION_MODIFIER", 49, 60], ["diameter", "OBSERVATION_MODIFIER", 64, 72], ["AV valves", "ANATOMY", 81, 90], ["Valvular", "ANATOMY", 105, 113], ["Anomalies", "OBSERVATION", 114, 123], ["Valvular", "ANATOMY", 123, 131], ["Lymphocysts", "OBSERVATION", 132, 143]]], ["Valvular lymphocysts may also occur and appear as yellow serum-filled cysts on the AV valve cusps (Fig. 10-51, B) .Cell Degeneration and DeathUlcerative Endocarditis (Uremic Endocarditis).", [["Valvular lymphocysts", "ANATOMY", 0, 20], ["serum", "ANATOMY", 57, 62], ["cysts", "ANATOMY", 70, 75], ["AV valve cusps", "ANATOMY", 83, 97], ["Cell", "ANATOMY", 115, 119], ["Valvular lymphocysts", "DISEASE", 0, 20], ["cysts", "DISEASE", 70, 75], ["DeathUlcerative Endocarditis", "DISEASE", 137, 165], ["Uremic Endocarditis", "DISEASE", 167, 186], ["Valvular lymphocysts", "CANCER", 0, 20], ["serum", "ORGANISM_SUBSTANCE", 57, 62], ["cysts", "CANCER", 70, 75], ["AV valve", "MULTI-TISSUE_STRUCTURE", 83, 91], ["Cell", "CELL", 115, 119], ["Valvular lymphocysts", "PROBLEM", 0, 20], ["yellow serum-filled cysts", "PROBLEM", 50, 75], ["the AV valve cusps", "TREATMENT", 79, 97], ["Cell Degeneration", "PROBLEM", 115, 132], ["DeathUlcerative Endocarditis", "PROBLEM", 137, 165], ["Uremic Endocarditis", "PROBLEM", 167, 186], ["lymphocysts", "OBSERVATION", 9, 20], ["filled", "OBSERVATION_MODIFIER", 63, 69], ["cysts", "OBSERVATION", 70, 75], ["AV valve", "ANATOMY", 83, 91], ["cusps", "ANATOMY_MODIFIER", 92, 97], ["DeathUlcerative", "OBSERVATION_MODIFIER", 137, 152], ["Endocarditis", "OBSERVATION", 153, 165], ["Uremic", "OBSERVATION_MODIFIER", 167, 173], ["Endocarditis", "OBSERVATION", 174, 186]]], ["Uremic endocarditis is most commonly a disorder in dogs that follows acute or repeated episodes of uremia.", [["Uremic endocarditis", "DISEASE", 0, 19], ["uremia", "DISEASE", 99, 105], ["dogs", "ORGANISM", 51, 55], ["dogs", "SPECIES", 51, 55], ["Uremic endocarditis", "PROBLEM", 0, 19], ["a disorder in dogs", "PROBLEM", 37, 55], ["uremia", "PROBLEM", 99, 105], ["endocarditis", "OBSERVATION", 7, 19], ["most commonly", "OBSERVATION_MODIFIER", 23, 36], ["uremia", "OBSERVATION", 99, 105]]], ["These episodes cause ulcerative endocarditis (injury of the endothelium) of the left atrium that is resolved via healing characterized by fibrosis, with or without mineralization and chronically dilated atria (Fig. 10-52 ).Myxomatous Valvular Degeneration (Valvular Endocardiosis).Degenerative changes in the valves are frequently seen in older dogs, and the process that leads to this lesion is termed myxomatous valvular degeneration (valvular endocardiosis).", [["ulcerative", "ANATOMY", 21, 31], ["endothelium", "ANATOMY", 60, 71], ["left atrium", "ANATOMY", 80, 91], ["atria", "ANATOMY", 203, 208], ["Valvular", "ANATOMY", 234, 242], ["Valvular", "ANATOMY", 257, 265], ["valves", "ANATOMY", 309, 315], ["lesion", "ANATOMY", 386, 392], ["myxomatous valvular", "ANATOMY", 403, 422], ["valvular", "ANATOMY", 437, 445], ["ulcerative endocarditis", "DISEASE", 21, 44], ["injury of the endothelium", "DISEASE", 46, 71], ["fibrosis", "DISEASE", 138, 146], ["Valvular Degeneration", "DISEASE", 234, 255], ["Valvular Endocardiosis", "DISEASE", 257, 279], ["valvular degeneration", "DISEASE", 414, 435], ["valvular endocardiosis", "DISEASE", 437, 459], ["ulcerative endocarditis", "PATHOLOGICAL_FORMATION", 21, 44], ["endothelium", "TISSUE", 60, 71], ["left atrium", "MULTI-TISSUE_STRUCTURE", 80, 91], ["atria", "MULTI-TISSUE_STRUCTURE", 203, 208], ["Valvular", "ORGAN", 234, 242], ["valves", "PATHOLOGICAL_FORMATION", 309, 315], ["dogs", "ORGANISM", 345, 349], ["myxomatous valvular", "PATHOLOGICAL_FORMATION", 403, 422], ["dogs", "SPECIES", 345, 349], ["ulcerative endocarditis", "PROBLEM", 21, 44], ["injury of the endothelium", "PROBLEM", 46, 71], ["fibrosis", "PROBLEM", 138, 146], ["mineralization", "PROBLEM", 164, 178], ["chronically dilated atria", "PROBLEM", 183, 208], ["Myxomatous Valvular Degeneration", "PROBLEM", 223, 255], ["Valvular Endocardiosis", "PROBLEM", 257, 279], ["Degenerative changes in the valves", "PROBLEM", 281, 315], ["this lesion", "PROBLEM", 381, 392], ["myxomatous valvular degeneration", "PROBLEM", 403, 435], ["valvular endocardiosis", "PROBLEM", 437, 459], ["ulcerative", "OBSERVATION_MODIFIER", 21, 31], ["endocarditis", "OBSERVATION", 32, 44], ["injury", "OBSERVATION", 46, 52], ["endothelium", "ANATOMY_MODIFIER", 60, 71], ["left atrium", "ANATOMY", 80, 91], ["resolved", "OBSERVATION_MODIFIER", 100, 108], ["healing", "OBSERVATION_MODIFIER", 113, 120], ["fibrosis", "OBSERVATION", 138, 146], ["without", "UNCERTAINTY", 156, 163], ["mineralization", "OBSERVATION", 164, 178], ["chronically", "OBSERVATION_MODIFIER", 183, 194], ["dilated", "OBSERVATION", 195, 202], ["atria", "ANATOMY", 203, 208], ["Valvular", "ANATOMY", 234, 242], ["Degeneration", "OBSERVATION", 243, 255], ["Valvular", "ANATOMY", 257, 265], ["Endocardiosis", "OBSERVATION", 266, 279], ["valves", "ANATOMY", 309, 315], ["lesion", "OBSERVATION", 386, 392], ["myxomatous", "OBSERVATION_MODIFIER", 403, 413], ["valvular", "ANATOMY", 414, 422], ["degeneration", "OBSERVATION", 423, 435], ["valvular", "ANATOMY", 437, 445], ["endocardiosis", "OBSERVATION", 446, 459]]], ["Atrial Thrombosis.", [["Atrial", "ANATOMY", 0, 6], ["Atrial Thrombosis", "DISEASE", 0, 17], ["Atrial", "MULTI-TISSUE_STRUCTURE", 0, 6], ["Atrial Thrombosis", "PROBLEM", 0, 17], ["Thrombosis", "OBSERVATION", 7, 17]]], ["Atrial thrombi may occur with valvular or myocardial disease and are the result of hemostatic abnormalities resulting from stasis or turbulence.", [["Atrial thrombi", "ANATOMY", 0, 14], ["valvular", "ANATOMY", 30, 38], ["myocardial", "ANATOMY", 42, 52], ["Atrial thrombi", "DISEASE", 0, 14], ["valvular or myocardial disease", "DISEASE", 30, 60], ["stasis", "DISEASE", 123, 129], ["Atrial thrombi", "PATHOLOGICAL_FORMATION", 0, 14], ["valvular", "MULTI-TISSUE_STRUCTURE", 30, 38], ["myocardial", "MULTI-TISSUE_STRUCTURE", 42, 52], ["Atrial thrombi", "PROBLEM", 0, 14], ["valvular or myocardial disease", "PROBLEM", 30, 60], ["hemostatic abnormalities", "PROBLEM", 83, 107], ["stasis", "PROBLEM", 123, 129], ["turbulence", "PROBLEM", 133, 143], ["thrombi", "OBSERVATION", 7, 14], ["valvular", "OBSERVATION", 30, 38], ["myocardial", "ANATOMY", 42, 52], ["disease", "OBSERVATION", 53, 60], ["stasis", "OBSERVATION", 123, 129], ["turbulence", "OBSERVATION_MODIFIER", 133, 143]]], ["Endothelial injury, turbulence, and hypercoagulability are involved in the pathogenesis of atrial thrombi.Disturbances of CirculationHemorrhage.", [["Endothelial", "ANATOMY", 0, 11], ["atrial thrombi", "ANATOMY", 91, 105], ["Endothelial injury", "DISEASE", 0, 18], ["hypercoagulability", "DISEASE", 36, 54], ["atrial thrombi", "DISEASE", 91, 105], ["CirculationHemorrhage", "DISEASE", 122, 143], ["Endothelial", "TISSUE", 0, 11], ["atrial thrombi", "MULTI-TISSUE_STRUCTURE", 91, 105], ["Endothelial injury", "PROBLEM", 0, 18], ["turbulence", "PROBLEM", 20, 30], ["hypercoagulability", "PROBLEM", 36, 54], ["atrial thrombi", "PROBLEM", 91, 105], ["CirculationHemorrhage", "PROBLEM", 122, 143], ["injury", "OBSERVATION", 12, 18], ["turbulence", "OBSERVATION_MODIFIER", 20, 30], ["hypercoagulability", "OBSERVATION", 36, 54], ["atrial", "ANATOMY", 91, 97], ["thrombi", "OBSERVATION", 98, 105], ["Circulation", "OBSERVATION_MODIFIER", 122, 133], ["Hemorrhage", "OBSERVATION", 133, 143]]], ["Hemorrhage involving the pericardium and epicardium (see Fig. 10-24 ; see E- Fig. 10-18 ) results from stretching, tearing, lacerating, or crushing blood vessels in these structures and may be caused by penetrating wounds (foreign objects, bullets, orDisturbances of CirculationThe pathogenesis of endocarditis is complicated and incompletely understood, but the components of Virchow's triad in thrombogenesis-endothelial injury, turbulence, and hypercoagulability-are involved.", [["pericardium", "ANATOMY", 25, 36], ["epicardium", "ANATOMY", 41, 51], ["blood vessels", "ANATOMY", 148, 161], ["structures", "ANATOMY", 171, 181], ["wounds", "ANATOMY", 215, 221], ["endothelial", "ANATOMY", 411, 422], ["Hemorrhage", "DISEASE", 0, 10], ["tearing", "DISEASE", 115, 122], ["endocarditis", "DISEASE", 298, 310], ["thrombogenesis", "DISEASE", 396, 410], ["hypercoagulability", "DISEASE", 447, 465], ["pericardium", "TISSUE", 25, 36], ["epicardium", "MULTI-TISSUE_STRUCTURE", 41, 51], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 148, 161], ["wounds", "PATHOLOGICAL_FORMATION", 215, 221], ["endothelial", "TISSUE", 411, 422], ["Hemorrhage involving the pericardium and epicardium", "PROBLEM", 0, 51], ["tearing", "PROBLEM", 115, 122], ["lacerating", "PROBLEM", 124, 134], ["crushing blood vessels in these structures", "PROBLEM", 139, 181], ["penetrating wounds", "PROBLEM", 203, 221], ["foreign objects", "PROBLEM", 223, 238], ["bullets", "PROBLEM", 240, 247], ["endocarditis", "PROBLEM", 298, 310], ["Virchow's triad", "PROBLEM", 377, 392], ["thrombogenesis", "PROBLEM", 396, 410], ["endothelial injury", "PROBLEM", 411, 429], ["turbulence", "PROBLEM", 431, 441], ["hypercoagulability", "PROBLEM", 447, 465], ["pericardium", "ANATOMY", 25, 36], ["epicardium", "ANATOMY", 41, 51], ["tearing", "OBSERVATION", 115, 122], ["vessels", "ANATOMY", 154, 161], ["may be caused", "UNCERTAINTY", 186, 199], ["penetrating", "OBSERVATION_MODIFIER", 203, 214], ["wounds", "OBSERVATION", 215, 221], ["foreign objects", "OBSERVATION", 223, 238], ["endocarditis", "OBSERVATION", 298, 310], ["endothelial", "ANATOMY", 411, 422], ["injury", "OBSERVATION", 423, 429], ["turbulence", "OBSERVATION_MODIFIER", 431, 441], ["hypercoagulability", "OBSERVATION", 447, 465]]], ["Affected animals often have preexisting extracardiac infections, such as gingivitis, mastitis, hepatic abscesses, or dermatitis, resulting in one or more bouts of bacteremia.", [["extracardiac", "ANATOMY", 40, 52], ["hepatic abscesses", "ANATOMY", 95, 112], ["extracardiac infections", "DISEASE", 40, 63], ["gingivitis", "DISEASE", 73, 83], ["mastitis", "DISEASE", 85, 93], ["hepatic abscesses", "DISEASE", 95, 112], ["dermatitis", "DISEASE", 117, 127], ["bacteremia", "DISEASE", 163, 173], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 95, 112], ["Affected animals", "PROBLEM", 0, 16], ["preexisting extracardiac infections", "PROBLEM", 28, 63], ["gingivitis", "PROBLEM", 73, 83], ["mastitis", "PROBLEM", 85, 93], ["hepatic abscesses", "PROBLEM", 95, 112], ["dermatitis", "PROBLEM", 117, 127], ["bacteremia", "PROBLEM", 163, 173], ["extracardiac", "ANATOMY", 40, 52], ["infections", "OBSERVATION", 53, 63], ["gingivitis", "OBSERVATION", 73, 83], ["mastitis", "OBSERVATION", 85, 93], ["hepatic", "ANATOMY", 95, 102], ["abscesses", "OBSERVATION", 103, 112], ["dermatitis", "OBSERVATION", 117, 127], ["bacteremia", "OBSERVATION", 163, 173]]], ["Turbulent intracardiac blood flow associated with congenital anomalies or the presence of intracardiac and vasculature devices, such as catheters, may contribute to initiation of the lesion.", [["intracardiac blood", "ANATOMY", 10, 28], ["intracardiac", "ANATOMY", 90, 102], ["vasculature", "ANATOMY", 107, 118], ["lesion", "ANATOMY", 183, 189], ["congenital anomalies", "DISEASE", 50, 70], ["blood", "ORGANISM_SUBSTANCE", 23, 28], ["intracardiac", "MULTI-TISSUE_STRUCTURE", 90, 102], ["vasculature", "MULTI-TISSUE_STRUCTURE", 107, 118], ["lesion", "PATHOLOGICAL_FORMATION", 183, 189], ["Turbulent intracardiac blood flow", "PROBLEM", 0, 33], ["congenital anomalies", "PROBLEM", 50, 70], ["intracardiac and vasculature devices", "PROBLEM", 90, 126], ["catheters", "TREATMENT", 136, 145], ["the lesion", "PROBLEM", 179, 189], ["intracardiac", "ANATOMY", 10, 22], ["blood flow", "OBSERVATION", 23, 33], ["congenital", "OBSERVATION_MODIFIER", 50, 60], ["anomalies", "OBSERVATION", 61, 70], ["intracardiac", "ANATOMY", 90, 102], ["vasculature", "ANATOMY", 107, 118], ["devices", "OBSERVATION", 119, 126], ["catheters", "OBSERVATION", 136, 145], ["lesion", "OBSERVATION", 183, 189]]], ["Focal trauma-induced endothelial disruption on the surface of the normally avascular valves allows bacteria to adhere, proliferate, and initiate an inflammatory reaction that results in subsequent deposition of masses of fibrin.", [["endothelial", "ANATOMY", 21, 32], ["surface", "ANATOMY", 51, 58], ["avascular valves", "ANATOMY", 75, 91], ["masses", "ANATOMY", 211, 217], ["trauma", "DISEASE", 6, 12], ["endothelial", "CELL", 21, 32], ["surface", "CELLULAR_COMPONENT", 51, 58], ["avascular valves", "TISSUE", 75, 91], ["fibrin", "GENE_OR_GENE_PRODUCT", 221, 227], ["fibrin", "PROTEIN", 221, 227], ["Focal trauma", "PROBLEM", 0, 12], ["endothelial disruption", "PROBLEM", 21, 43], ["bacteria", "PROBLEM", 99, 107], ["an inflammatory reaction", "PROBLEM", 145, 169], ["masses of fibrin", "PROBLEM", 211, 227], ["trauma", "OBSERVATION", 6, 12], ["endothelial disruption", "OBSERVATION", 21, 43], ["avascular valves", "OBSERVATION", 75, 91], ["inflammatory", "OBSERVATION_MODIFIER", 148, 160], ["deposition", "OBSERVATION_MODIFIER", 197, 207], ["masses", "OBSERVATION", 211, 217], ["fibrin", "OBSERVATION", 221, 227]]], ["Death is the result of cardiac failure from valvular dysfunction or the effects of bacteremia.", [["cardiac", "ANATOMY", 23, 30], ["valvular", "ANATOMY", 44, 52], ["Death", "DISEASE", 0, 5], ["cardiac failure", "DISEASE", 23, 38], ["valvular dysfunction", "DISEASE", 44, 64], ["bacteremia", "DISEASE", 83, 93], ["cardiac", "ORGAN", 23, 30], ["valvular", "ORGAN", 44, 52], ["Death", "PROBLEM", 0, 5], ["cardiac failure", "PROBLEM", 23, 38], ["valvular dysfunction", "PROBLEM", 44, 64], ["bacteremia", "PROBLEM", 83, 93], ["cardiac", "ANATOMY", 23, 30], ["failure", "OBSERVATION", 31, 38], ["valvular", "ANATOMY", 44, 52], ["dysfunction", "OBSERVATION", 53, 64], ["bacteremia", "OBSERVATION", 83, 93]]], ["In some animals, septic emboli lodge in organs such as the heart, synovium, bone, liver, kidneys, and meninges, leading to infarction and/or localized inflammation or abscess formation.", [["septic emboli", "ANATOMY", 17, 30], ["organs", "ANATOMY", 40, 46], ["heart", "ANATOMY", 59, 64], ["synovium", "ANATOMY", 66, 74], ["bone", "ANATOMY", 76, 80], ["liver", "ANATOMY", 82, 87], ["kidneys", "ANATOMY", 89, 96], ["meninges", "ANATOMY", 102, 110], ["abscess", "ANATOMY", 167, 174], ["septic emboli", "DISEASE", 17, 30], ["infarction", "DISEASE", 123, 133], ["inflammation", "DISEASE", 151, 163], ["abscess", "DISEASE", 167, 174], ["septic emboli", "PATHOLOGICAL_FORMATION", 17, 30], ["organs", "ORGAN", 40, 46], ["heart", "ORGAN", 59, 64], ["synovium", "TISSUE", 66, 74], ["bone", "TISSUE", 76, 80], ["liver", "ORGAN", 82, 87], ["kidneys", "ORGAN", 89, 96], ["meninges", "ORGAN", 102, 110], ["abscess", "PATHOLOGICAL_FORMATION", 167, 174], ["septic emboli lodge in organs such as the heart, synovium, bone, liver, kidneys, and meninges", "PROBLEM", 17, 110], ["infarction", "PROBLEM", 123, 133], ["localized inflammation", "PROBLEM", 141, 163], ["abscess formation", "PROBLEM", 167, 184], ["septic", "OBSERVATION_MODIFIER", 17, 23], ["emboli", "OBSERVATION", 24, 30], ["heart", "ANATOMY", 59, 64], ["synovium", "ANATOMY", 66, 74], ["bone", "ANATOMY", 76, 80], ["liver", "ANATOMY", 82, 87], ["kidneys", "ANATOMY", 89, 96], ["meninges", "ANATOMY", 102, 110], ["infarction", "OBSERVATION", 123, 133], ["localized", "OBSERVATION_MODIFIER", 141, 150], ["inflammation", "OBSERVATION", 151, 163], ["abscess", "OBSERVATION", 167, 174]]], ["See the discussion on vegetative valvular and mural endocarditis in the section on Disorders of Domestic Animals: Endocardium and Heart Valves, Inflammation and also Chapter 3.", [["vegetative valvular", "ANATOMY", 22, 41], ["Heart", "ANATOMY", 130, 135], ["vegetative valvular and mural endocarditis", "DISEASE", 22, 64], ["Inflammation", "DISEASE", 144, 156], ["valvular", "MULTI-TISSUE_STRUCTURE", 33, 41], ["vegetative valvular", "PROBLEM", 22, 41], ["mural endocarditis", "PROBLEM", 46, 64], ["Endocardium and Heart Valves", "PROBLEM", 114, 142], ["Inflammation", "PROBLEM", 144, 156], ["valvular", "ANATOMY", 33, 41], ["mural", "OBSERVATION_MODIFIER", 46, 51], ["endocarditis", "OBSERVATION", 52, 64], ["Endocardium", "ANATOMY", 114, 125], ["Heart Valves", "ANATOMY", 130, 142], ["Inflammation", "OBSERVATION", 144, 156]]], ["In cases associated with vascular injury, a few fibrin strands are present, and the fluid could clot after exposure to air.Disturbances of CirculationHydropericardium.", [["vascular", "ANATOMY", 25, 33], ["fibrin strands", "ANATOMY", 48, 62], ["fluid", "ANATOMY", 84, 89], ["clot", "ANATOMY", 96, 100], ["vascular injury", "DISEASE", 25, 40], ["vascular", "MULTI-TISSUE_STRUCTURE", 25, 33], ["fibrin", "GENE_OR_GENE_PRODUCT", 48, 54], ["fluid", "ORGANISM_SUBSTANCE", 84, 89], ["clot", "ORGANISM_SUBSTANCE", 96, 100], ["vascular injury", "PROBLEM", 25, 40], ["a few fibrin strands", "PROBLEM", 42, 62], ["the fluid could clot", "PROBLEM", 80, 100], ["Disturbances of CirculationHydropericardium", "PROBLEM", 123, 166], ["associated with", "UNCERTAINTY", 9, 24], ["vascular", "ANATOMY", 25, 33], ["injury", "OBSERVATION", 34, 40], ["few", "OBSERVATION_MODIFIER", 44, 47], ["fibrin strands", "OBSERVATION", 48, 62], ["fluid", "OBSERVATION", 84, 89], ["clot", "OBSERVATION", 96, 100], ["air", "OBSERVATION", 119, 122], ["CirculationHydropericardium", "OBSERVATION", 139, 166]]], ["Hydropericardium occurs in those diseases that have generalized edema (see Fig. 10-56) .", [["edema", "ANATOMY", 64, 69], ["Hydropericardium", "DISEASE", 0, 16], ["edema", "DISEASE", 64, 69], ["edema", "PATHOLOGICAL_FORMATION", 64, 69], ["Hydropericardium", "PROBLEM", 0, 16], ["those diseases", "PROBLEM", 27, 41], ["generalized edema", "PROBLEM", 52, 69], ["diseases", "OBSERVATION", 33, 41], ["generalized", "OBSERVATION_MODIFIER", 52, 63], ["edema", "OBSERVATION", 64, 69]]], ["Thus ascites and hydrothorax often occur concurrently with hydropericardium.", [["ascites", "ANATOMY", 5, 12], ["hydropericardium", "ANATOMY", 59, 75], ["ascites", "DISEASE", 5, 12], ["hydrothorax", "DISEASE", 17, 28], ["hydropericardium", "DISEASE", 59, 75], ["ascites", "PROBLEM", 5, 12], ["hydrothorax", "PROBLEM", 17, 28], ["hydropericardium", "PROBLEM", 59, 75], ["ascites", "OBSERVATION", 5, 12], ["hydrothorax", "OBSERVATION", 17, 28], ["hydropericardium", "OBSERVATION", 59, 75]]], ["Congestive heart failure is an important mechanism of hydropericardium and is usually the result of primary myocardial, valvular, congenital, or neoplastic diseases.", [["heart", "ANATOMY", 11, 16], ["hydropericardium", "ANATOMY", 54, 70], ["myocardial", "ANATOMY", 108, 118], ["valvular", "ANATOMY", 120, 128], ["neoplastic", "ANATOMY", 145, 155], ["Congestive heart failure", "DISEASE", 0, 24], ["hydropericardium", "DISEASE", 54, 70], ["primary myocardial, valvular, congenital, or neoplastic diseases", "DISEASE", 100, 164], ["heart", "ORGAN", 11, 16], ["hydropericardium", "CANCER", 54, 70], ["myocardial", "MULTI-TISSUE_STRUCTURE", 108, 118], ["Congestive heart failure", "PROBLEM", 0, 24], ["hydropericardium", "PROBLEM", 54, 70], ["primary myocardial, valvular, congenital", "PROBLEM", 100, 140], ["neoplastic diseases", "PROBLEM", 145, 164], ["heart", "ANATOMY", 11, 16], ["failure", "OBSERVATION", 17, 24], ["hydropericardium", "OBSERVATION", 54, 70], ["primary", "OBSERVATION_MODIFIER", 100, 107], ["myocardial", "OBSERVATION", 108, 118], ["valvular", "ANATOMY", 120, 128], ["congenital", "OBSERVATION", 130, 140], ["neoplastic", "OBSERVATION_MODIFIER", 145, 155]]], ["Common specific diseases include dilated cardiomyopathy of dogs and cats and \"ascites syndrome\" of poultry.", [["ascites", "ANATOMY", 78, 85], ["dilated cardiomyopathy", "DISEASE", 33, 55], ["ascites syndrome", "DISEASE", 78, 94], ["dogs", "ORGANISM", 59, 63], ["cats", "ORGANISM", 68, 72], ["dogs", "SPECIES", 59, 63], ["cats", "SPECIES", 68, 72], ["Common specific diseases", "PROBLEM", 0, 24], ["dilated cardiomyopathy of dogs and cats", "PROBLEM", 33, 72], ["\"ascites syndrome", "PROBLEM", 77, 94], ["diseases", "OBSERVATION", 16, 24], ["dilated", "OBSERVATION_MODIFIER", 33, 40], ["cardiomyopathy", "OBSERVATION", 41, 55], ["dogs", "OBSERVATION", 59, 63], ["ascites", "OBSERVATION", 78, 85], ["poultry", "OBSERVATION_MODIFIER", 99, 106]]], ["Hydropericardium can also accompany pulmonary hypertension (e.g., \"brisket disease\" or \"high-altitude disease\" of cattle), renal failure, and hypoproteinemia from various chronic debilitating knives), lacerations from fractured bone, shear forces that stretch and ultimately tear vessels in tissues (blunt force trauma), and tears and rupture of tissue resulting from loss of structural integrity attributable to invasive and destructive properties of neoplasms such as hemangiosarcomas (see Chapters 2 and 6).Disturbances of CirculationEffusions.", [["pulmonary", "ANATOMY", 36, 45], ["brisket", "ANATOMY", 67, 74], ["renal", "ANATOMY", 123, 128], ["bone", "ANATOMY", 228, 232], ["tear vessels", "ANATOMY", 275, 287], ["tissues", "ANATOMY", 291, 298], ["tissue", "ANATOMY", 346, 352], ["neoplasms", "ANATOMY", 452, 461], ["hemangiosarcomas", "ANATOMY", 470, 486], ["Hydropericardium", "CHEMICAL", 0, 16], ["pulmonary hypertension", "DISEASE", 36, 58], ["brisket disease", "DISEASE", 67, 82], ["high-altitude disease", "DISEASE", 88, 109], ["renal failure", "DISEASE", 123, 136], ["hypoproteinemia", "DISEASE", 142, 157], ["lacerations", "DISEASE", 201, 212], ["trauma", "DISEASE", 312, 318], ["tears", "DISEASE", 325, 330], ["rupture", "DISEASE", 335, 342], ["neoplasms", "DISEASE", 452, 461], ["hemangiosarcomas", "DISEASE", 470, 486], ["pulmonary", "ORGAN", 36, 45], ["renal", "ORGAN", 123, 128], ["bone", "TISSUE", 228, 232], ["tear vessels", "MULTI-TISSUE_STRUCTURE", 275, 287], ["tissues", "TISSUE", 291, 298], ["tissue", "TISSUE", 346, 352], ["neoplasms", "CANCER", 452, 461], ["hemangiosarcomas", "CANCER", 470, 486], ["cattle", "SPECIES", 114, 120], ["cattle", "SPECIES", 114, 120], ["pulmonary hypertension", "PROBLEM", 36, 58], ["\"brisket disease\"", "PROBLEM", 66, 83], ["\"high-altitude disease", "PROBLEM", 87, 109], ["renal failure", "PROBLEM", 123, 136], ["hypoproteinemia", "PROBLEM", 142, 157], ["various chronic debilitating knives", "PROBLEM", 163, 198], ["lacerations", "PROBLEM", 201, 212], ["fractured bone", "PROBLEM", 218, 232], ["shear forces", "PROBLEM", 234, 246], ["tear vessels in tissues", "PROBLEM", 275, 298], ["blunt force trauma", "PROBLEM", 300, 318], ["tears", "PROBLEM", 325, 330], ["rupture of tissue", "PROBLEM", 335, 352], ["loss of structural integrity", "PROBLEM", 368, 396], ["invasive and destructive properties of neoplasms", "PROBLEM", 413, 461], ["hemangiosarcomas", "PROBLEM", 470, 486], ["Disturbances of CirculationEffusions", "PROBLEM", 510, 546], ["pulmonary", "ANATOMY", 36, 45], ["hypertension", "OBSERVATION", 46, 58], ["high", "OBSERVATION_MODIFIER", 88, 92], ["altitude disease", "OBSERVATION", 93, 109], ["renal", "ANATOMY", 123, 128], ["failure", "OBSERVATION", 129, 136], ["hypoproteinemia", "OBSERVATION", 142, 157], ["various", "OBSERVATION_MODIFIER", 163, 170], ["chronic", "OBSERVATION_MODIFIER", 171, 178], ["debilitating", "OBSERVATION_MODIFIER", 179, 191], ["lacerations", "OBSERVATION", 201, 212], ["fractured", "OBSERVATION", 218, 227], ["bone", "ANATOMY", 228, 232], ["stretch", "OBSERVATION_MODIFIER", 252, 259], ["tear", "OBSERVATION", 275, 279], ["vessels", "ANATOMY", 280, 287], ["tissues", "ANATOMY", 291, 298], ["tears", "OBSERVATION", 325, 330], ["rupture", "OBSERVATION", 335, 342], ["tissue", "ANATOMY", 346, 352], ["loss", "OBSERVATION_MODIFIER", 368, 372], ["structural integrity", "OBSERVATION", 376, 396], ["invasive", "OBSERVATION_MODIFIER", 413, 421], ["destructive", "OBSERVATION_MODIFIER", 426, 437], ["neoplasms", "OBSERVATION", 452, 461], ["CirculationEffusions", "OBSERVATION", 526, 546]]], ["See the discussions on the mechanisms of edema formation and Figs.", [["edema", "ANATOMY", 41, 46], ["edema", "DISEASE", 41, 46], ["edema", "PATHOLOGICAL_FORMATION", 41, 46], ["edema formation", "PROBLEM", 41, 56], ["edema", "OBSERVATION", 41, 46]]], ["2-6 through 2-10 in Chapter 2 and on the formation of transudates and exudates and Fig. 3-3 in Chapter 3.Disturbances of CirculationPericardial Dilatation.", [["exudates", "ANATOMY", 70, 78], ["exudates", "TISSUE", 70, 78], ["transudates", "PROBLEM", 54, 65], ["exudates", "PROBLEM", 70, 78], ["CirculationPericardial Dilatation", "PROBLEM", 121, 154], ["transudates", "OBSERVATION", 54, 65], ["exudates", "OBSERVATION", 70, 78], ["CirculationPericardial", "OBSERVATION_MODIFIER", 121, 143], ["Dilatation", "OBSERVATION", 144, 154]]], ["The pericardium responds to excess fluid in the pericardial space by dilation.", [["pericardium", "ANATOMY", 4, 15], ["fluid", "ANATOMY", 35, 40], ["pericardial space", "ANATOMY", 48, 65], ["pericardium", "ORGAN", 4, 15], ["fluid", "ORGANISM_SUBSTANCE", 35, 40], ["pericardial space", "MULTI-TISSUE_STRUCTURE", 48, 65], ["excess fluid in the pericardial space", "PROBLEM", 28, 65], ["dilation", "PROBLEM", 69, 77], ["pericardium", "ANATOMY", 4, 15], ["excess", "OBSERVATION_MODIFIER", 28, 34], ["fluid", "OBSERVATION", 35, 40], ["pericardial", "ANATOMY", 48, 59], ["space", "ANATOMY_MODIFIER", 60, 65], ["dilation", "OBSERVATION", 69, 77]]], ["However, this outcome requires adequate time to allow adjustments in size.", [["size", "OBSERVATION_MODIFIER", 69, 73]]], ["In hemopericardium, blood rapidly fills the pericardial cavity and death often occurs unexpectedly from cardiac tamponade, a condition with compression of the heart caused by blood accumulation leading to reduced cardiac output.", [["hemopericardium", "ANATOMY", 3, 18], ["blood", "ANATOMY", 20, 25], ["pericardial cavity", "ANATOMY", 44, 62], ["cardiac", "ANATOMY", 104, 111], ["heart", "ANATOMY", 159, 164], ["blood", "ANATOMY", 175, 180], ["cardiac", "ANATOMY", 213, 220], ["death", "DISEASE", 67, 72], ["cardiac tamponade", "DISEASE", 104, 121], ["compression of the heart", "DISEASE", 140, 164], ["reduced cardiac output", "DISEASE", 205, 227], ["hemopericardium", "CANCER", 3, 18], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["pericardial cavity", "PATHOLOGICAL_FORMATION", 44, 62], ["cardiac", "ORGAN", 104, 111], ["heart", "ORGAN", 159, 164], ["blood", "ORGANISM_SUBSTANCE", 175, 180], ["cardiac", "ORGAN", 213, 220], ["hemopericardium", "PROBLEM", 3, 18], ["blood rapidly fills the pericardial cavity", "PROBLEM", 20, 62], ["death", "PROBLEM", 67, 72], ["cardiac tamponade", "PROBLEM", 104, 121], ["compression of the heart", "PROBLEM", 140, 164], ["blood accumulation", "PROBLEM", 175, 193], ["reduced cardiac output", "PROBLEM", 205, 227], ["hemopericardium", "OBSERVATION", 3, 18], ["blood", "OBSERVATION_MODIFIER", 20, 25], ["rapidly", "OBSERVATION_MODIFIER", 26, 33], ["pericardial", "ANATOMY", 44, 55], ["cavity", "OBSERVATION", 56, 62], ["cardiac", "ANATOMY", 104, 111], ["tamponade", "OBSERVATION", 112, 121], ["compression", "OBSERVATION", 140, 151], ["heart", "ANATOMY", 159, 164], ["blood accumulation", "OBSERVATION", 175, 193], ["reduced", "OBSERVATION_MODIFIER", 205, 212], ["cardiac", "ANATOMY", 213, 220], ["output", "OBSERVATION", 221, 227]]], ["Hydropericardium is the accumulation of clear, light yellow, watery, serous fluid (i.e., transudate) in the pericardial sac The thin-walled dilated pericardial sac contains serous fluid that has accumulated secondary to alterations in hydrostatic pressure between the pericardial cavity, circulatory system, and lymphatic system.", [["serous fluid", "ANATOMY", 69, 81], ["pericardial sac", "ANATOMY", 108, 123], ["pericardial sac", "ANATOMY", 148, 163], ["serous fluid", "ANATOMY", 173, 185], ["pericardial cavity", "ANATOMY", 268, 286], ["circulatory system", "ANATOMY", 288, 306], ["lymphatic system", "ANATOMY", 312, 328], ["Hydropericardium", "DISEASE", 0, 16], ["watery", "DISEASE", 61, 67], ["watery", "ORGANISM_SUBDIVISION", 61, 67], ["serous fluid", "ORGANISM_SUBSTANCE", 69, 81], ["pericardial sac", "ORGAN", 108, 123], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 148, 163], ["serous fluid", "ORGANISM_SUBSTANCE", 173, 185], ["pericardial cavity", "MULTI-TISSUE_STRUCTURE", 268, 286], ["lymphatic system", "MULTI-TISSUE_STRUCTURE", 312, 328], ["light yellow, watery, serous fluid", "PROBLEM", 47, 81], ["transudate) in the pericardial sac", "PROBLEM", 89, 123], ["The thin-walled dilated pericardial sac", "PROBLEM", 124, 163], ["serous fluid", "PROBLEM", 173, 185], ["hydrostatic pressure between the pericardial cavity, circulatory system, and lymphatic system", "PROBLEM", 235, 328], ["accumulation", "OBSERVATION_MODIFIER", 24, 36], ["clear", "OBSERVATION_MODIFIER", 40, 45], ["light", "OBSERVATION_MODIFIER", 47, 52], ["yellow", "OBSERVATION_MODIFIER", 53, 59], ["watery", "OBSERVATION_MODIFIER", 61, 67], ["serous", "OBSERVATION_MODIFIER", 69, 75], ["fluid", "OBSERVATION", 76, 81], ["transudate", "OBSERVATION", 89, 99], ["pericardial sac", "ANATOMY", 108, 123], ["thin", "OBSERVATION_MODIFIER", 128, 132], ["walled", "OBSERVATION_MODIFIER", 133, 139], ["dilated", "OBSERVATION", 140, 147], ["pericardial sac", "ANATOMY", 148, 163], ["serous fluid", "OBSERVATION", 173, 185], ["hydrostatic pressure", "OBSERVATION", 235, 255], ["pericardial cavity", "ANATOMY", 268, 286], ["circulatory system", "ANATOMY", 288, 306], ["lymphatic system", "ANATOMY", 312, 328]]], ["Serous Atrophy.", [["Serous", "ANATOMY", 0, 6], ["Serous Atrophy", "DISEASE", 0, 14], ["Serous", "ORGANISM_SUBSTANCE", 0, 6], ["Serous Atrophy", "PROBLEM", 0, 14], ["Atrophy", "OBSERVATION", 7, 14]]], ["Serous atrophy of fat is readily identified by the gray gelatinous appearance of epicardial fat deposits (Fig. 10-59) .", [["Serous", "ANATOMY", 0, 6], ["fat", "ANATOMY", 18, 21], ["epicardial fat deposits", "ANATOMY", 81, 104], ["Serous atrophy", "DISEASE", 0, 14], ["Serous", "ORGANISM_SUBSTANCE", 0, 6], ["fat", "TISSUE", 18, 21], ["epicardial fat deposits", "TISSUE", 81, 104], ["Serous atrophy of fat", "PROBLEM", 0, 21], ["epicardial fat deposits", "PROBLEM", 81, 104], ["atrophy", "OBSERVATION", 7, 14], ["fat", "ANATOMY", 18, 21], ["gray", "OBSERVATION_MODIFIER", 51, 55], ["gelatinous", "OBSERVATION_MODIFIER", 56, 66], ["epicardial", "ANATOMY", 81, 91], ["fat deposits", "OBSERVATION", 92, 104]]], ["Healthy animals normally have abundant white or yellow epicardial fat deposits, especially along the AV junction.", [["epicardial fat deposits", "ANATOMY", 55, 78], ["AV junction", "ANATOMY", 101, 112], ["animals", "ORGANISM", 8, 15], ["epicardial fat", "TISSUE", 55, 69], ["AV junction", "MULTI-TISSUE_STRUCTURE", 101, 112], ["abundant white or yellow epicardial fat deposits", "PROBLEM", 30, 78], ["abundant", "OBSERVATION_MODIFIER", 30, 38], ["white", "OBSERVATION_MODIFIER", 39, 44], ["yellow", "OBSERVATION_MODIFIER", 48, 54], ["epicardial", "ANATOMY", 55, 65], ["fat deposits", "OBSERVATION", 66, 78], ["AV junction", "ANATOMY", 101, 112]]], ["Microscopically, lipocytes are atrophic, and edema is present in the interstitial tissue.", [["lipocytes", "ANATOMY", 17, 26], ["edema", "ANATOMY", 45, 50], ["interstitial tissue", "ANATOMY", 69, 88], ["edema", "DISEASE", 45, 50], ["lipocytes", "CANCER", 17, 26], ["edema", "PATHOLOGICAL_FORMATION", 45, 50], ["interstitial tissue", "TISSUE", 69, 88], ["lipocytes", "CELL_TYPE", 17, 26], ["atrophic", "PROBLEM", 31, 39], ["edema", "PROBLEM", 45, 50], ["lipocytes", "ANATOMY", 17, 26], ["atrophic", "OBSERVATION", 31, 39], ["edema", "OBSERVATION", 45, 50], ["interstitial tissue", "ANATOMY", 69, 88]]], ["Serous atrophy of epicardial fat occurs rapidly during anorexia, starvation, or cachexia because fat is catabolized to maintain energy balance.Disturbances of Circulationdiseases.", [["Serous", "ANATOMY", 0, 6], ["epicardial fat", "ANATOMY", 18, 32], ["cachexia", "ANATOMY", 80, 88], ["fat", "ANATOMY", 97, 100], ["Serous atrophy", "DISEASE", 0, 14], ["anorexia", "DISEASE", 55, 63], ["cachexia", "DISEASE", 80, 88], ["Circulationdiseases", "DISEASE", 159, 178], ["Serous", "ORGANISM_SUBSTANCE", 0, 6], ["epicardial fat", "TISSUE", 18, 32], ["fat", "TISSUE", 97, 100], ["Serous atrophy of epicardial fat", "PROBLEM", 0, 32], ["anorexia", "PROBLEM", 55, 63], ["cachexia", "PROBLEM", 80, 88], ["Disturbances of Circulationdiseases", "PROBLEM", 143, 178], ["atrophy", "OBSERVATION", 7, 14], ["epicardial fat", "ANATOMY", 18, 32], ["rapidly", "OBSERVATION_MODIFIER", 40, 47], ["energy balance", "OBSERVATION", 128, 142], ["Circulationdiseases", "OBSERVATION", 159, 178]]], ["Hydropericardium can also occur in various systemic diseases with vascular injury, such as septicemia in pigs, \"heartwater\" (Cowdria ruminantium infection) in small ruminants, African horse sickness, and bovine ephemeral fever.Disturbances of CirculationHydropericardium is the accumulation of clear, light yellow, watery, serous fluid (i.e., transudate) in the pericardial sac (E- Fig. 10-21 ; also see Fig. 10-56 ; also see section on Disorders of Domestic Animals).", [["vascular", "ANATOMY", 66, 74], ["serous fluid", "ANATOMY", 323, 335], ["pericardial sac", "ANATOMY", 362, 377], ["Hydropericardium", "DISEASE", 0, 16], ["vascular injury", "DISEASE", 66, 81], ["septicemia", "DISEASE", 91, 101], ["Cowdria ruminantium infection", "DISEASE", 125, 154], ["horse sickness", "DISEASE", 184, 198], ["bovine ephemeral fever", "DISEASE", 204, 226], ["watery", "DISEASE", 315, 321], ["vascular", "MULTI-TISSUE_STRUCTURE", 66, 74], ["pigs", "ORGANISM", 105, 109], ["Cowdria ruminantium", "ORGANISM", 125, 144], ["horse", "ORGANISM", 184, 189], ["bovine", "ORGANISM", 204, 210], ["watery", "ORGANISM_SUBDIVISION", 315, 321], ["serous fluid", "ORGANISM_SUBSTANCE", 323, 335], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 362, 377], ["pigs", "SPECIES", 105, 109], ["Cowdria ruminantium", "SPECIES", 125, 144], ["horse", "SPECIES", 184, 189], ["bovine", "SPECIES", 204, 210], ["pigs", "SPECIES", 105, 109], ["Cowdria ruminantium", "SPECIES", 125, 144], ["African horse", "SPECIES", 176, 189], ["bovine", "SPECIES", 204, 210], ["Hydropericardium", "PROBLEM", 0, 16], ["various systemic diseases", "PROBLEM", 35, 60], ["vascular injury", "PROBLEM", 66, 81], ["septicemia", "PROBLEM", 91, 101], ["Cowdria ruminantium infection", "PROBLEM", 125, 154], ["African horse sickness", "PROBLEM", 176, 198], ["bovine ephemeral fever", "PROBLEM", 204, 226], ["Disturbances of CirculationHydropericardium", "PROBLEM", 227, 270], ["light yellow, watery, serous fluid", "PROBLEM", 301, 335], ["transudate", "PROBLEM", 343, 353], ["various", "OBSERVATION_MODIFIER", 35, 42], ["systemic", "OBSERVATION_MODIFIER", 43, 51], ["diseases", "OBSERVATION", 52, 60], ["vascular", "ANATOMY", 66, 74], ["injury", "OBSERVATION", 75, 81], ["septicemia", "OBSERVATION", 91, 101], ["small", "OBSERVATION_MODIFIER", 159, 164], ["bovine", "OBSERVATION_MODIFIER", 204, 210], ["ephemeral", "OBSERVATION_MODIFIER", 211, 220], ["fever", "OBSERVATION", 221, 226], ["CirculationHydropericardium", "OBSERVATION", 243, 270], ["accumulation", "OBSERVATION_MODIFIER", 278, 290], ["clear", "OBSERVATION_MODIFIER", 294, 299], ["light", "OBSERVATION_MODIFIER", 301, 306], ["yellow", "OBSERVATION_MODIFIER", 307, 313], ["watery", "OBSERVATION_MODIFIER", 315, 321], ["serous", "OBSERVATION_MODIFIER", 323, 329], ["fluid", "OBSERVATION", 330, 335], ["transudate", "OBSERVATION", 343, 353], ["pericardial sac", "ANATOMY", 362, 377]]], ["As examples, hydropericardium can occur in animals with (1) hypoproteinemia (decreased colloid osmotic pressure) caused by liver disease or protein-losing nephropathy/enteropathy;Disturbances of Circulation(2) heart failure (increased hydrostatic pressure) where there is poor venous return to the heart; and (3) vascular injury, where damage to the barrier function of the vascular wall can result in leakage of small quantities of plasma proteins.", [["liver", "ANATOMY", 123, 128], ["heart", "ANATOMY", 210, 215], ["venous", "ANATOMY", 277, 283], ["heart", "ANATOMY", 298, 303], ["vascular", "ANATOMY", 313, 321], ["barrier", "ANATOMY", 350, 357], ["vascular wall", "ANATOMY", 374, 387], ["plasma", "ANATOMY", 433, 439], ["hypoproteinemia", "DISEASE", 60, 75], ["liver disease", "DISEASE", 123, 136], ["nephropathy", "DISEASE", 155, 166], ["enteropathy", "DISEASE", 167, 178], ["heart failure", "DISEASE", 210, 223], ["vascular injury", "DISEASE", 313, 328], ["hydropericardium", "SIMPLE_CHEMICAL", 13, 29], ["liver", "ORGAN", 123, 128], ["heart", "ORGAN", 210, 215], ["venous", "MULTI-TISSUE_STRUCTURE", 277, 283], ["heart", "ORGAN", 298, 303], ["vascular", "MULTI-TISSUE_STRUCTURE", 313, 321], ["vascular wall", "MULTI-TISSUE_STRUCTURE", 374, 387], ["plasma", "ORGANISM_SUBSTANCE", 433, 439], ["plasma proteins", "PROTEIN", 433, 448], ["hydropericardium", "PROBLEM", 13, 29], ["hypoproteinemia (decreased colloid osmotic pressure", "PROBLEM", 60, 111], ["liver disease", "PROBLEM", 123, 136], ["protein-losing nephropathy", "PROBLEM", 140, 166], ["enteropathy", "PROBLEM", 167, 178], ["Disturbances of Circulation(2) heart failure", "PROBLEM", 179, 223], ["increased hydrostatic pressure)", "PROBLEM", 225, 256], ["poor venous return to the heart", "PROBLEM", 272, 303], ["vascular injury", "PROBLEM", 313, 328], ["damage", "PROBLEM", 336, 342], ["leakage of small quantities of plasma proteins", "PROBLEM", 402, 448], ["hypoproteinemia", "OBSERVATION", 60, 75], ["colloid osmotic pressure", "OBSERVATION", 87, 111], ["liver", "ANATOMY", 123, 128], ["disease", "OBSERVATION", 129, 136], ["losing nephropathy", "OBSERVATION", 148, 166], ["enteropathy", "OBSERVATION", 167, 178], ["Circulation", "OBSERVATION_MODIFIER", 195, 206], ["heart", "ANATOMY", 210, 215], ["failure", "OBSERVATION", 216, 223], ["increased", "OBSERVATION_MODIFIER", 225, 234], ["hydrostatic pressure", "OBSERVATION", 235, 255], ["poor venous return", "OBSERVATION", 272, 290], ["heart", "ANATOMY", 298, 303], ["vascular", "ANATOMY", 313, 321], ["injury", "OBSERVATION", 322, 328], ["vascular wall", "ANATOMY", 374, 387], ["leakage", "OBSERVATION", 402, 409], ["small", "OBSERVATION_MODIFIER", 413, 418]]], ["In this latter example, a few fibrin strands can be present and the fluid could clot after exposure to air.", [["fluid", "ANATOMY", 68, 73], ["clot", "ANATOMY", 80, 84], ["fibrin", "GENE_OR_GENE_PRODUCT", 30, 36], ["fluid", "ORGANISM_SUBSTANCE", 68, 73], ["clot", "ORGANISM_SUBSTANCE", 80, 84], ["a few fibrin strands", "PROBLEM", 24, 44], ["the fluid could clot", "PROBLEM", 64, 84], ["few", "OBSERVATION_MODIFIER", 26, 29], ["fibrin strands", "OBSERVATION", 30, 44], ["fluid", "OBSERVATION", 68, 73], ["air", "OBSERVATION", 103, 106]]], ["The pericardial surfaces are smooth and glistening in acute cases, but in chronic cases, the epicardium becomes opaque because of mild fibrous thickening and can appear roughened and granular when there is villous proliferation of fibrous tissue, especially over the atria.", [["pericardial surfaces", "ANATOMY", 4, 24], ["epicardium", "ANATOMY", 93, 103], ["fibrous", "ANATOMY", 135, 142], ["villous", "ANATOMY", 206, 213], ["fibrous tissue", "ANATOMY", 231, 245], ["atria", "ANATOMY", 267, 272], ["pericardial surfaces", "MULTI-TISSUE_STRUCTURE", 4, 24], ["epicardium", "MULTI-TISSUE_STRUCTURE", 93, 103], ["fibrous", "TISSUE", 135, 142], ["villous", "TISSUE", 206, 213], ["fibrous tissue", "TISSUE", 231, 245], ["atria", "ORGAN", 267, 272], ["acute cases", "PROBLEM", 54, 65], ["mild fibrous thickening", "PROBLEM", 130, 153], ["villous proliferation of fibrous tissue", "PROBLEM", 206, 245], ["pericardial", "ANATOMY", 4, 15], ["surfaces", "ANATOMY_MODIFIER", 16, 24], ["smooth", "OBSERVATION", 29, 35], ["glistening", "OBSERVATION_MODIFIER", 40, 50], ["acute", "OBSERVATION_MODIFIER", 54, 59], ["cases", "OBSERVATION", 60, 65], ["chronic", "OBSERVATION_MODIFIER", 74, 81], ["cases", "OBSERVATION", 82, 87], ["epicardium", "ANATOMY", 93, 103], ["opaque", "OBSERVATION_MODIFIER", 112, 118], ["mild", "OBSERVATION_MODIFIER", 130, 134], ["fibrous", "OBSERVATION_MODIFIER", 135, 142], ["thickening", "OBSERVATION", 143, 153], ["roughened", "OBSERVATION_MODIFIER", 169, 178], ["granular", "OBSERVATION_MODIFIER", 183, 191], ["villous proliferation", "OBSERVATION", 206, 227], ["fibrous tissue", "OBSERVATION", 231, 245], ["atria", "ANATOMY", 267, 272]]], ["The mechanisms involved in these fluid shifts are discussed in Chapters 2 and 3.Disturbances of CirculationHemopericardium.", [["fluid", "ANATOMY", 33, 38], ["these fluid shifts", "TEST", 27, 45], ["Disturbances of CirculationHemopericardium", "PROBLEM", 80, 122], ["fluid shifts", "OBSERVATION", 33, 45], ["Circulation", "OBSERVATION_MODIFIER", 96, 107], ["Hemopericardium", "OBSERVATION", 107, 122]]], ["Hemopericardium is an accumulation of whole blood in the pericardial sac (Figs.", [["whole blood", "ANATOMY", 38, 49], ["pericardial sac", "ANATOMY", 57, 72], ["Hemopericardium", "DISEASE", 0, 15], ["blood", "ORGANISM_SUBSTANCE", 44, 49], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 57, 72], ["Hemopericardium", "PROBLEM", 0, 15], ["whole blood in the pericardial sac", "PROBLEM", 38, 72], ["accumulation", "OBSERVATION_MODIFIER", 22, 34], ["whole blood", "OBSERVATION", 38, 49], ["pericardial sac", "ANATOMY", 57, 72], ["Figs", "OBSERVATION_MODIFIER", 74, 78]]], ["Death often occurs unexpectedly from cardiac tamponade, a condition in which the compression of the heart caused by the accumulation of blood in the pericardial sac leads to reduced cardiac output and poor perfusion of vascular beds in all organ systems.", [["cardiac", "ANATOMY", 37, 44], ["heart", "ANATOMY", 100, 105], ["blood", "ANATOMY", 136, 141], ["pericardial sac", "ANATOMY", 149, 164], ["cardiac", "ANATOMY", 182, 189], ["vascular", "ANATOMY", 219, 227], ["organ", "ANATOMY", 240, 245], ["Death", "DISEASE", 0, 5], ["cardiac tamponade", "DISEASE", 37, 54], ["reduced cardiac output", "DISEASE", 174, 196], ["cardiac", "ORGAN", 37, 44], ["heart", "ORGAN", 100, 105], ["blood", "ORGANISM_SUBSTANCE", 136, 141], ["pericardial sac", "ORGAN", 149, 164], ["cardiac", "ORGAN", 182, 189], ["vascular", "MULTI-TISSUE_STRUCTURE", 219, 227], ["organ", "ORGAN", 240, 245], ["Death", "PROBLEM", 0, 5], ["cardiac tamponade", "PROBLEM", 37, 54], ["the compression of the heart", "PROBLEM", 77, 105], ["the accumulation of blood in the pericardial sac", "PROBLEM", 116, 164], ["reduced cardiac output", "PROBLEM", 174, 196], ["poor perfusion of vascular beds in all organ systems", "PROBLEM", 201, 253], ["cardiac", "ANATOMY", 37, 44], ["tamponade", "OBSERVATION", 45, 54], ["compression", "OBSERVATION", 81, 92], ["heart", "ANATOMY", 100, 105], ["accumulation", "OBSERVATION_MODIFIER", 120, 132], ["blood", "OBSERVATION", 136, 141], ["pericardial sac", "ANATOMY", 149, 164], ["reduced", "OBSERVATION_MODIFIER", 174, 181], ["cardiac output", "OBSERVATION", 182, 196], ["poor perfusion", "OBSERVATION", 201, 215], ["vascular beds", "ANATOMY", 219, 232], ["all organ", "ANATOMY", 236, 245]]], ["As examples, hemopericardium may be caused by blunt force trauma (impact with an automobile) or from rupture of the wall of the right atrium after invasion by a hemangiosarcoma.Disturbances of CirculationBleeding into the pericardial sac can result from spontaneous atrial rupture in dogs, atrial rupture in dogs with hemangiosarcoma, rupture of the intrapericardial aorta or pulmonary artery in horses, or as a complication of intracardiac injections (see Figs.", [["hemopericardium", "ANATOMY", 13, 28], ["wall", "ANATOMY", 116, 120], ["right atrium", "ANATOMY", 128, 140], ["hemangiosarcoma", "ANATOMY", 161, 176], ["pericardial sac", "ANATOMY", 222, 237], ["atrial", "ANATOMY", 266, 272], ["atrial", "ANATOMY", 290, 296], ["hemangiosarcoma", "ANATOMY", 318, 333], ["intrapericardial aorta", "ANATOMY", 350, 372], ["pulmonary artery", "ANATOMY", 376, 392], ["intracardiac", "ANATOMY", 428, 440], ["hemopericardium", "DISEASE", 13, 28], ["trauma", "DISEASE", 58, 64], ["rupture", "DISEASE", 101, 108], ["hemangiosarcoma", "DISEASE", 161, 176], ["Bleeding", "DISEASE", 204, 212], ["pericardial sac", "DISEASE", 222, 237], ["atrial rupture", "DISEASE", 266, 280], ["atrial rupture", "DISEASE", 290, 304], ["hemangiosarcoma", "DISEASE", 318, 333], ["rupture", "DISEASE", 335, 342], ["hemopericardium", "CANCER", 13, 28], ["wall", "TISSUE", 116, 120], ["atrium", "MULTI-TISSUE_STRUCTURE", 134, 140], ["hemangiosarcoma", "CANCER", 161, 176], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 222, 237], ["atrial", "MULTI-TISSUE_STRUCTURE", 266, 272], ["atrial", "MULTI-TISSUE_STRUCTURE", 290, 296], ["dogs", "ORGANISM", 308, 312], ["hemangiosarcoma", "CANCER", 318, 333], ["intrapericardial aorta", "MULTI-TISSUE_STRUCTURE", 350, 372], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 376, 392], ["dogs", "SPECIES", 284, 288], ["dogs", "SPECIES", 308, 312], ["hemopericardium", "PROBLEM", 13, 28], ["blunt force trauma", "PROBLEM", 46, 64], ["rupture", "PROBLEM", 101, 108], ["a hemangiosarcoma", "PROBLEM", 159, 176], ["Disturbances of CirculationBleeding into the pericardial sac", "PROBLEM", 177, 237], ["spontaneous atrial rupture in dogs", "PROBLEM", 254, 288], ["atrial rupture in dogs", "PROBLEM", 290, 312], ["hemangiosarcoma", "PROBLEM", 318, 333], ["rupture of the intrapericardial aorta", "PROBLEM", 335, 372], ["pulmonary artery in horses", "PROBLEM", 376, 402], ["intracardiac injections", "TREATMENT", 428, 451], ["hemopericardium", "OBSERVATION", 13, 28], ["may be caused", "UNCERTAINTY", 29, 42], ["blunt", "OBSERVATION_MODIFIER", 46, 51], ["force trauma", "OBSERVATION", 52, 64], ["rupture", "OBSERVATION", 101, 108], ["wall", "ANATOMY_MODIFIER", 116, 120], ["right atrium", "ANATOMY", 128, 140], ["invasion", "OBSERVATION", 147, 155], ["hemangiosarcoma", "OBSERVATION", 161, 176], ["Circulation", "OBSERVATION_MODIFIER", 193, 204], ["Bleeding", "OBSERVATION", 204, 212], ["pericardial sac", "ANATOMY", 222, 237], ["spontaneous", "OBSERVATION_MODIFIER", 254, 265], ["atrial", "ANATOMY", 266, 272], ["rupture", "OBSERVATION", 273, 280], ["atrial", "ANATOMY", 290, 296], ["rupture", "OBSERVATION", 297, 304], ["hemangiosarcoma", "OBSERVATION", 318, 333], ["rupture", "OBSERVATION", 335, 342], ["intrapericardial aorta", "ANATOMY", 350, 372], ["pulmonary artery", "ANATOMY", 376, 392]]], ["10-57 and 10-58).597.e1CHAPTER 10 Cardiovascular System and Lymphatic Vessels E- Figure 10 -21 Hydropericardium, Chicken.", [["Chicken", "ORGANISM", 113, 120], ["Cardiovascular System", "TEST", 34, 55], ["Lymphatic Vessels E", "TEST", 60, 79], ["Figure", "TEST", 81, 87], ["Hydropericardium", "TREATMENT", 95, 111], ["Lymphatic Vessels", "ANATOMY", 60, 77]]], ["Note the accumulation of clear yellow fluid (transudate) in the pericardial cavity.", [["yellow fluid", "ANATOMY", 31, 43], ["pericardial cavity", "ANATOMY", 64, 82], ["fluid", "ORGANISM_SUBSTANCE", 38, 43], ["transudate", "CANCER", 45, 55], ["pericardial cavity", "MULTI-TISSUE_STRUCTURE", 64, 82], ["clear yellow fluid (transudate) in the pericardial cavity", "PROBLEM", 25, 82], ["accumulation", "OBSERVATION_MODIFIER", 9, 21], ["clear", "OBSERVATION_MODIFIER", 25, 30], ["yellow fluid", "OBSERVATION", 31, 43], ["transudate", "OBSERVATION_MODIFIER", 45, 55], ["pericardial", "ANATOMY", 64, 75], ["cavity", "ANATOMY_MODIFIER", 76, 82]]], ["This fluid may occur as a result of hypoproteinemia, heart failure, and vascular injury.", [["fluid", "ANATOMY", 5, 10], ["heart", "ANATOMY", 53, 58], ["vascular", "ANATOMY", 72, 80], ["hypoproteinemia", "DISEASE", 36, 51], ["heart failure", "DISEASE", 53, 66], ["vascular injury", "DISEASE", 72, 87], ["fluid", "ORGANISM_SUBSTANCE", 5, 10], ["heart", "ORGAN", 53, 58], ["vascular", "MULTI-TISSUE_STRUCTURE", 72, 80], ["hypoproteinemia", "PROBLEM", 36, 51], ["heart failure", "PROBLEM", 53, 66], ["vascular injury", "PROBLEM", 72, 87], ["fluid", "OBSERVATION", 5, 10], ["hypoproteinemia", "OBSERVATION", 36, 51], ["heart", "ANATOMY", 53, 58], ["failure", "OBSERVATION", 59, 66], ["vascular", "ANATOMY", 72, 80], ["injury", "OBSERVATION", 81, 87]]], ["If this accumulation is rapid, it compresses the heart (H) and great vessels, leading to a condition known as \"cardiac tamponade,\" which restricts venous return to the heart and reduces the end diastolic pumping volume of the heart.", [["heart", "ANATOMY", 49, 54], ["vessels", "ANATOMY", 69, 76], ["cardiac", "ANATOMY", 111, 118], ["venous", "ANATOMY", 147, 153], ["heart", "ANATOMY", 168, 173], ["heart", "ANATOMY", 226, 231], ["cardiac tamponade", "DISEASE", 111, 128], ["heart", "ORGAN", 49, 54], ["vessels", "MULTI-TISSUE_STRUCTURE", 69, 76], ["cardiac", "ORGAN", 111, 118], ["venous", "MULTI-TISSUE_STRUCTURE", 147, 153], ["heart", "ORGAN", 168, 173], ["heart", "ORGAN", 226, 231], ["this accumulation", "PROBLEM", 3, 20], ["a condition", "PROBLEM", 89, 100], ["\"cardiac tamponade", "PROBLEM", 110, 128], ["rapid", "OBSERVATION_MODIFIER", 24, 29], ["heart", "ANATOMY", 49, 54], ["great vessels", "ANATOMY", 63, 76], ["tamponade", "OBSERVATION", 119, 128], ["venous", "ANATOMY", 147, 153], ["heart", "ANATOMY", 168, 173], ["end diastolic", "OBSERVATION", 190, 203], ["pumping volume", "OBSERVATION", 204, 218], ["heart", "ANATOMY", 226, 231]]], ["H reticulum, occasionally penetrate the reticular wall and diaphragm, enter the adjacent pericardial sac, and introduce infection.", [["H reticulum", "ANATOMY", 0, 11], ["reticular wall", "ANATOMY", 40, 54], ["diaphragm", "ANATOMY", 59, 68], ["pericardial sac", "ANATOMY", 89, 104], ["infection", "DISEASE", 120, 129], ["H reticulum", "GENE_OR_GENE_PRODUCT", 0, 11], ["reticular wall", "TISSUE", 40, 54], ["diaphragm", "ORGAN", 59, 68], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 89, 104], ["infection", "PROBLEM", 120, 129], ["reticulum", "OBSERVATION", 2, 11], ["reticular", "ANATOMY_MODIFIER", 40, 49], ["wall", "ANATOMY_MODIFIER", 50, 54], ["diaphragm", "ANATOMY", 59, 68], ["adjacent", "ANATOMY_MODIFIER", 80, 88], ["pericardial sac", "ANATOMY", 89, 104], ["infection", "OBSERVATION", 120, 129]]], ["Some affected cattle survive for weeks to months until death ensues from congestive heart failure or septicemia.", [["heart", "ANATOMY", 84, 89], ["death", "DISEASE", 55, 60], ["congestive heart failure", "DISEASE", 73, 97], ["septicemia", "DISEASE", 101, 111], ["cattle", "ORGANISM", 14, 20], ["heart", "ORGAN", 84, 89], ["cattle", "SPECIES", 14, 20], ["cattle", "SPECIES", 14, 20], ["death", "PROBLEM", 55, 60], ["congestive heart failure", "PROBLEM", 73, 97], ["septicemia", "PROBLEM", 101, 111], ["congestive", "OBSERVATION_MODIFIER", 73, 83], ["heart", "ANATOMY", 84, 89], ["failure", "OBSERVATION", 90, 97], ["septicemia", "OBSERVATION", 101, 111]]], ["Grossly, the pericardial surfaces are notably thickened by white, often rough, shaggy-appearing masses of fibrous connective tissue that enclose an accumulation of white to gray, thick, foul-smelling, purulent exudate ( Fig. 10-62) .597.e1Constrictive pericarditis is a chronic inflammatory lesion of the pericardium accompanied by extensive fibrous proliferation and eventual formation of fibrous adhesions between the surfaces of the visceral and parietal pericardium.", [["pericardial surfaces", "ANATOMY", 13, 33], ["masses", "ANATOMY", 96, 102], ["fibrous connective tissue", "ANATOMY", 106, 131], ["purulent exudate", "ANATOMY", 201, 217], ["pericardium", "ANATOMY", 305, 316], ["fibrous", "ANATOMY", 342, 349], ["fibrous adhesions", "ANATOMY", 390, 407], ["visceral", "ANATOMY", 436, 444], ["parietal pericardium", "ANATOMY", 449, 469], ["Constrictive pericarditis", "DISEASE", 239, 264], ["pericardial surfaces", "PATHOLOGICAL_FORMATION", 13, 33], ["masses", "CANCER", 96, 102], ["fibrous connective tissue", "TISSUE", 106, 131], ["pericardium", "ORGAN", 305, 316], ["fibrous", "TISSUE", 342, 349], ["fibrous adhesions", "PATHOLOGICAL_FORMATION", 390, 407], ["visceral", "TISSUE", 436, 444], ["parietal pericardium", "MULTI-TISSUE_STRUCTURE", 449, 469], ["notably thickened", "PROBLEM", 38, 55], ["white, often rough", "PROBLEM", 59, 77], ["shaggy-appearing masses", "PROBLEM", 79, 102], ["fibrous connective tissue", "PROBLEM", 106, 131], ["an accumulation of white to gray, thick, foul-smelling, purulent exudate", "PROBLEM", 145, 217], ["Constrictive pericarditis", "PROBLEM", 239, 264], ["a chronic inflammatory lesion of the pericardium", "PROBLEM", 268, 316], ["extensive fibrous proliferation", "PROBLEM", 332, 363], ["fibrous adhesions", "PROBLEM", 390, 407], ["pericardial", "ANATOMY", 13, 24], ["surfaces", "ANATOMY_MODIFIER", 25, 33], ["notably", "OBSERVATION_MODIFIER", 38, 45], ["thickened", "OBSERVATION", 46, 55], ["white", "OBSERVATION_MODIFIER", 59, 64], ["often", "OBSERVATION_MODIFIER", 66, 71], ["rough", "OBSERVATION_MODIFIER", 72, 77], ["appearing", "OBSERVATION_MODIFIER", 86, 95], ["masses", "OBSERVATION", 96, 102], ["fibrous connective tissue", "OBSERVATION", 106, 131], ["accumulation", "OBSERVATION_MODIFIER", 148, 160], ["white to gray", "OBSERVATION_MODIFIER", 164, 177], ["thick", "OBSERVATION_MODIFIER", 179, 184], ["foul", "OBSERVATION_MODIFIER", 186, 190], ["-smelling", "OBSERVATION_MODIFIER", 190, 199], ["purulent", "OBSERVATION_MODIFIER", 201, 209], ["exudate", "OBSERVATION", 210, 217], ["Constrictive", "OBSERVATION_MODIFIER", 239, 251], ["pericarditis", "OBSERVATION", 252, 264], ["chronic", "OBSERVATION_MODIFIER", 270, 277], ["inflammatory", "OBSERVATION_MODIFIER", 278, 290], ["lesion", "OBSERVATION", 291, 297], ["pericardium", "ANATOMY", 305, 316], ["extensive", "OBSERVATION_MODIFIER", 332, 341], ["fibrous proliferation", "OBSERVATION", 342, 363], ["fibrous", "OBSERVATION_MODIFIER", 390, 397], ["adhesions", "OBSERVATION", 398, 407], ["surfaces", "ANATOMY_MODIFIER", 420, 428], ["visceral", "ANATOMY", 436, 444], ["parietal", "ANATOMY_MODIFIER", 449, 457], ["pericardium", "ANATOMY", 458, 469]]], ["The condition is seen in some cases of suppurative pericarditis in cattle and pigs with chronic fibrinous pericarditis.", [["pericarditis", "DISEASE", 51, 63], ["fibrinous pericarditis", "DISEASE", 96, 118], ["cattle", "ORGANISM", 67, 73], ["pigs", "ORGANISM", 78, 82], ["cattle", "SPECIES", 67, 73], ["pigs", "SPECIES", 78, 82], ["cattle", "SPECIES", 67, 73], ["pigs", "SPECIES", 78, 82], ["suppurative pericarditis", "PROBLEM", 39, 63], ["chronic fibrinous pericarditis", "PROBLEM", 88, 118], ["suppurative", "OBSERVATION_MODIFIER", 39, 50], ["pericarditis", "OBSERVATION", 51, 63], ["chronic", "OBSERVATION_MODIFIER", 88, 95], ["fibrinous", "OBSERVATION_MODIFIER", 96, 105], ["pericarditis", "OBSERVATION", 106, 118]]], ["Severe lesions obliterate the pericardial sac and constrict the heart with fibrous tissue and can interfere with cardiac filling and thus cardiac output.", [["lesions", "ANATOMY", 7, 14], ["pericardial sac", "ANATOMY", 30, 45], ["heart", "ANATOMY", 64, 69], ["fibrous tissue", "ANATOMY", 75, 89], ["cardiac", "ANATOMY", 113, 120], ["cardiac", "ANATOMY", 138, 145], ["lesions", "PATHOLOGICAL_FORMATION", 7, 14], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 30, 45], ["heart", "ORGAN", 64, 69], ["fibrous tissue", "TISSUE", 75, 89], ["cardiac", "ORGAN", 113, 120], ["cardiac", "ORGAN", 138, 145], ["Severe lesions obliterate the pericardial sac", "PROBLEM", 0, 45], ["fibrous tissue", "PROBLEM", 75, 89], ["cardiac filling", "TEST", 113, 128], ["cardiac output", "TEST", 138, 152], ["lesions", "OBSERVATION", 7, 14], ["pericardial sac", "ANATOMY", 30, 45], ["heart", "ANATOMY", 64, 69], ["fibrous tissue", "OBSERVATION", 75, 89], ["filling", "OBSERVATION", 121, 128], ["output", "OBSERVATION_MODIFIER", 146, 152]]], ["Compensatory myocardial hypertrophy can result in diminished ventricular chamber volumes and contribute to the eventual development of heart failure.Cell Degeneration and DeathEpicardial Calcification.", [["myocardial", "ANATOMY", 13, 23], ["ventricular chamber", "ANATOMY", 61, 80], ["heart", "ANATOMY", 135, 140], ["Cell", "ANATOMY", 149, 153], ["myocardial hypertrophy", "DISEASE", 13, 35], ["heart failure", "DISEASE", 135, 148], ["Calcification", "DISEASE", 187, 200], ["myocardial", "MULTI-TISSUE_STRUCTURE", 13, 23], ["ventricular chamber", "MULTI-TISSUE_STRUCTURE", 61, 80], ["heart", "ORGAN", 135, 140], ["Cell", "CELL", 149, 153], ["Compensatory myocardial hypertrophy", "PROBLEM", 0, 35], ["diminished ventricular chamber volumes", "PROBLEM", 50, 88], ["heart failure", "PROBLEM", 135, 148], ["Cell Degeneration", "PROBLEM", 149, 166], ["DeathEpicardial Calcification", "PROBLEM", 171, 200], ["myocardial", "ANATOMY", 13, 23], ["hypertrophy", "OBSERVATION", 24, 35], ["diminished", "OBSERVATION", 50, 60], ["ventricular", "OBSERVATION", 61, 72], ["chamber volumes", "OBSERVATION", 73, 88], ["heart", "ANATOMY", 135, 140], ["failure", "OBSERVATION", 141, 148], ["Degeneration", "OBSERVATION", 154, 166], ["DeathEpicardial", "OBSERVATION_MODIFIER", 171, 186], ["Calcification", "OBSERVATION", 187, 200]]], ["Epicardial calcification is a feature in hereditary calcinosis in mice and cardiomyopathy in hamsters (E- Fig. 10-22) .", [["Epicardial", "ANATOMY", 0, 10], ["Epicardial calcification", "DISEASE", 0, 24], ["hereditary calcinosis", "DISEASE", 41, 62], ["cardiomyopathy", "DISEASE", 75, 89], ["Epicardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["mice", "ORGANISM", 66, 70], ["hamsters", "ORGANISM", 93, 101], ["mice", "SPECIES", 66, 70], ["hamsters", "SPECIES", 93, 101], ["mice", "SPECIES", 66, 70], ["hamsters", "SPECIES", 93, 101], ["Epicardial calcification", "PROBLEM", 0, 24], ["hereditary calcinosis", "PROBLEM", 41, 62], ["cardiomyopathy in hamsters", "PROBLEM", 75, 101], ["calcification", "OBSERVATION", 11, 24], ["hereditary", "OBSERVATION_MODIFIER", 41, 51], ["calcinosis", "OBSERVATION", 52, 62], ["cardiomyopathy", "OBSERVATION", 75, 89]]], ["Myocardial mineralization (discussed later) may be visible on the epicardial surface in vitamin E-selenium deficiency in sheep and cattle, vitamin D toxicity in several species, calcinogenic plant toxicosis in cattle (\"Manchester wasting disease\"), and spontaneous myocardial calcification in aged rats and guinea pigs.Cell Degeneration and DeathGout.", [["Myocardial", "ANATOMY", 0, 10], ["epicardial surface", "ANATOMY", 66, 84], ["myocardial", "ANATOMY", 265, 275], ["Cell", "ANATOMY", 319, 323], ["vitamin E-selenium", "CHEMICAL", 88, 106], ["vitamin D", "CHEMICAL", 139, 148], ["toxicity", "DISEASE", 149, 157], ["toxicosis", "DISEASE", 197, 206], ["wasting disease", "DISEASE", 230, 245], ["myocardial calcification", "DISEASE", 265, 289], ["vitamin E", "CHEMICAL", 88, 97], ["selenium", "CHEMICAL", 98, 106], ["vitamin D", "CHEMICAL", 139, 148], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 0, 10], ["epicardial surface", "TISSUE", 66, 84], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 88, 106], ["sheep", "ORGANISM", 121, 126], ["vitamin D", "SIMPLE_CHEMICAL", 139, 148], ["cattle", "ORGANISM", 210, 216], ["myocardial", "MULTI-TISSUE_STRUCTURE", 265, 275], ["rats", "ORGANISM", 298, 302], ["guinea pigs", "ORGANISM", 307, 318], ["Cell", "CELL", 319, 323], ["sheep", "SPECIES", 121, 126], ["cattle", "SPECIES", 131, 137], ["cattle", "SPECIES", 210, 216], ["rats", "SPECIES", 298, 302], ["guinea pigs", "SPECIES", 307, 318], ["sheep", "SPECIES", 121, 126], ["cattle", "SPECIES", 131, 137], ["cattle", "SPECIES", 210, 216], ["guinea pigs", "SPECIES", 307, 318], ["Myocardial mineralization", "PROBLEM", 0, 25], ["the epicardial surface", "TEST", 62, 84], ["vitamin E", "TEST", 88, 97], ["selenium deficiency in sheep", "PROBLEM", 98, 126], ["vitamin D toxicity", "PROBLEM", 139, 157], ["several species", "PROBLEM", 161, 176], ["calcinogenic plant toxicosis", "PROBLEM", 178, 206], ["Manchester wasting disease\"", "PROBLEM", 219, 246], ["spontaneous myocardial calcification", "PROBLEM", 253, 289], ["guinea pigs", "TREATMENT", 307, 318], ["Cell Degeneration", "PROBLEM", 319, 336], ["DeathGout", "PROBLEM", 341, 350], ["mineralization", "OBSERVATION", 11, 25], ["epicardial", "ANATOMY", 66, 76], ["selenium deficiency", "OBSERVATION", 98, 117], ["plant toxicosis", "OBSERVATION", 191, 206], ["spontaneous", "OBSERVATION_MODIFIER", 253, 264], ["myocardial", "ANATOMY", 265, 275], ["calcification", "OBSERVATION", 276, 289], ["Degeneration", "OBSERVATION", 324, 336]]], ["Visceral gout has not been reported in domestic animals but does occur in birds and reptiles (E- Fig. 10-23 ; see Chapter 1).InflammationPericarditis.", [["Visceral gout", "DISEASE", 0, 13], ["InflammationPericarditis", "DISEASE", 125, 149], ["birds", "ORGANISM", 74, 79], ["Visceral gout", "PROBLEM", 0, 13], ["InflammationPericarditis", "PROBLEM", 125, 149], ["gout", "OBSERVATION", 9, 13]]], ["Inflammation of the pericardium is frequently seen with bacterial septicemias and typically results in fibrinous pericarditis.", [["pericardium", "ANATOMY", 20, 31], ["Inflammation of the pericardium", "DISEASE", 0, 31], ["bacterial septicemias", "DISEASE", 56, 77], ["pericarditis", "DISEASE", 113, 125], ["pericardium", "ORGAN", 20, 31], ["Inflammation of the pericardium", "PROBLEM", 0, 31], ["bacterial septicemias", "PROBLEM", 56, 77], ["fibrinous pericarditis", "PROBLEM", 103, 125], ["pericardium", "ANATOMY", 20, 31], ["bacterial septicemias", "OBSERVATION", 56, 77], ["fibrinous", "OBSERVATION_MODIFIER", 103, 112], ["pericarditis", "OBSERVATION", 113, 125]]], ["Grossly, both the visceral and parietal pericardial surfaces are covered by variable amounts of yellow fibrin deposits, which can result in adherence between the parietal and visceral layers.", [["visceral", "ANATOMY", 18, 26], ["parietal pericardial surfaces", "ANATOMY", 31, 60], ["parietal", "ANATOMY", 162, 170], ["visceral layers", "ANATOMY", 175, 190], ["visceral", "TISSUE", 18, 26], ["parietal pericardial surfaces", "TISSUE", 31, 60], ["fibrin", "GENE_OR_GENE_PRODUCT", 103, 109], ["parietal", "MULTI-TISSUE_STRUCTURE", 162, 170], ["visceral layers", "TISSUE", 175, 190], ["yellow fibrin deposits", "PROBLEM", 96, 118], ["both", "ANATOMY_MODIFIER", 9, 13], ["visceral", "ANATOMY_MODIFIER", 18, 26], ["parietal", "ANATOMY_MODIFIER", 31, 39], ["pericardial", "ANATOMY", 40, 51], ["surfaces", "ANATOMY_MODIFIER", 52, 60], ["variable", "OBSERVATION_MODIFIER", 76, 84], ["amounts", "OBSERVATION_MODIFIER", 85, 92], ["yellow fibrin deposits", "OBSERVATION", 96, 118], ["parietal", "ANATOMY_MODIFIER", 162, 170], ["visceral", "ANATOMY", 175, 183], ["layers", "ANATOMY_MODIFIER", 184, 190]]], ["When the pericardial sac is opened, the attachments are torn away (so-called bread-and-butter heart) ( Fig. 10-60) .", [["pericardial sac", "ANATOMY", 9, 24], ["heart", "ANATOMY", 94, 99], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 9, 24], ["heart", "ORGAN", 94, 99], ["pericardial", "ANATOMY", 9, 20], ["sac", "OBSERVATION", 21, 24], ["heart", "ANATOMY", 94, 99]]], ["Microscopically, an eosinophilic layer of fibrin with admixed neutrophils lies over a congested epicardium (Fig. 10-61) .InflammationThe outcome of fibrinous pericarditis varies.", [["eosinophilic layer", "ANATOMY", 20, 38], ["fibrin", "ANATOMY", 42, 48], ["neutrophils", "ANATOMY", 62, 73], ["epicardium", "ANATOMY", 96, 106], ["Inflammation", "DISEASE", 121, 133], ["pericarditis", "DISEASE", 158, 170], ["fibrin", "GENE_OR_GENE_PRODUCT", 42, 48], ["neutrophils", "CELL", 62, 73], ["epicardium", "TISSUE", 96, 106], ["fibrin", "PROTEIN", 42, 48], ["admixed neutrophils", "CELL_TYPE", 54, 73], ["an eosinophilic layer of fibrin", "PROBLEM", 17, 48], ["admixed neutrophils", "PROBLEM", 54, 73], ["Inflammation", "PROBLEM", 121, 133], ["fibrinous pericarditis varies", "PROBLEM", 148, 177], ["eosinophilic", "OBSERVATION_MODIFIER", 20, 32], ["layer", "OBSERVATION_MODIFIER", 33, 38], ["fibrin", "OBSERVATION", 42, 48], ["admixed neutrophils", "OBSERVATION", 54, 73], ["congested", "ANATOMY_MODIFIER", 86, 95], ["epicardium", "ANATOMY", 96, 106], ["fibrinous", "OBSERVATION_MODIFIER", 148, 157], ["pericarditis", "OBSERVATION", 158, 170]]], ["Early death is frequent because many of these lesions result from infection by highly virulent bacteria and concurrent septicemia.", [["lesions", "ANATOMY", 46, 53], ["death", "DISEASE", 6, 11], ["infection", "DISEASE", 66, 75], ["septicemia", "DISEASE", 119, 129], ["lesions", "PATHOLOGICAL_FORMATION", 46, 53], ["Early death", "PROBLEM", 0, 11], ["these lesions", "PROBLEM", 40, 53], ["infection", "PROBLEM", 66, 75], ["highly virulent bacteria", "PROBLEM", 79, 103], ["concurrent septicemia", "PROBLEM", 108, 129], ["death", "OBSERVATION", 6, 11], ["lesions", "OBSERVATION", 46, 53], ["infection", "OBSERVATION", 66, 75], ["virulent", "OBSERVATION_MODIFIER", 86, 94], ["bacteria", "OBSERVATION_MODIFIER", 95, 103], ["septicemia", "OBSERVATION", 119, 129]]], ["When survival is prolonged, adhesions form between the pericardial surfaces after fibrous organization of the exudate.InflammationSuppurative pericarditis is seen mainly in cattle as a complication of traumatic reticuloperitonitis (\"hardware disease\").", [["adhesions", "ANATOMY", 28, 37], ["pericardial surfaces", "ANATOMY", 55, 75], ["fibrous", "ANATOMY", 82, 89], ["exudate", "ANATOMY", 110, 117], ["Suppurative pericarditis", "DISEASE", 130, 154], ["traumatic reticuloperitonitis", "DISEASE", 201, 230], ["pericardial surfaces", "PATHOLOGICAL_FORMATION", 55, 75], ["exudate", "TISSUE", 110, 117], ["cattle", "SPECIES", 173, 179], ["cattle", "SPECIES", 173, 179], ["adhesions form between the pericardial surfaces", "PROBLEM", 28, 75], ["the exudate", "PROBLEM", 106, 117], ["Inflammation", "PROBLEM", 118, 130], ["Suppurative pericarditis", "PROBLEM", 130, 154], ["traumatic reticuloperitonitis", "PROBLEM", 201, 230], ["hardware disease\"", "PROBLEM", 233, 250], ["prolonged", "OBSERVATION_MODIFIER", 17, 26], ["adhesions", "OBSERVATION", 28, 37], ["pericardial", "ANATOMY", 55, 66], ["surfaces", "ANATOMY_MODIFIER", 67, 75], ["fibrous", "OBSERVATION", 82, 89], ["exudate", "OBSERVATION", 110, 117], ["Suppurative", "OBSERVATION_MODIFIER", 130, 141], ["pericarditis", "OBSERVATION", 142, 154], ["traumatic", "OBSERVATION_MODIFIER", 201, 210], ["reticuloperitonitis", "OBSERVATION", 211, 230], ["hardware disease", "OBSERVATION", 233, 249]]], ["Foreign bodies, such as nails or pieces of wire that accumulate in the deficiency in pigs (Fig. 10-64 ) because copper is necessary for normal development of elastic tissue and damage from infection with Spirocerca lupi in dogs or Strongylus vulgaris in horses.", [["bodies", "ANATOMY", 8, 14], ["nails", "ANATOMY", 24, 29], ["elastic tissue", "ANATOMY", 158, 172], ["copper", "CHEMICAL", 112, 118], ["infection", "DISEASE", 189, 198], ["Spirocerca lupi", "CHEMICAL", 204, 219], ["Strongylus vulgaris", "DISEASE", 231, 250], ["copper", "CHEMICAL", 112, 118], ["pigs", "ORGANISM", 85, 89], ["copper", "SIMPLE_CHEMICAL", 112, 118], ["elastic tissue", "TISSUE", 158, 172], ["Spirocerca lupi", "ORGANISM", 204, 219], ["dogs", "ORGANISM", 223, 227], ["Strongylus vulgaris", "ORGANISM", 231, 250], ["horses", "ORGANISM_SUBDIVISION", 254, 260], ["pigs", "SPECIES", 85, 89], ["Spirocerca lupi", "SPECIES", 204, 219], ["dogs", "SPECIES", 223, 227], ["Strongylus vulgaris", "SPECIES", 231, 250], ["Spirocerca lupi", "SPECIES", 204, 219], ["Strongylus vulgaris", "SPECIES", 231, 250], ["Foreign bodies", "PROBLEM", 0, 14], ["pieces of wire", "TREATMENT", 33, 47], ["the deficiency", "PROBLEM", 67, 81], ["elastic tissue", "PROBLEM", 158, 172], ["damage from infection", "PROBLEM", 177, 198], ["Strongylus vulgaris in horses", "PROBLEM", 231, 260], ["bodies", "OBSERVATION", 8, 14], ["wire", "OBSERVATION_MODIFIER", 43, 47], ["deficiency", "OBSERVATION", 71, 81], ["elastic tissue", "OBSERVATION_MODIFIER", 158, 172], ["infection", "OBSERVATION", 189, 198], ["vulgaris", "OBSERVATION", 242, 250]]], ["Most cases are idiopathic.", [["idiopathic", "PROBLEM", 15, 25], ["idiopathic", "OBSERVATION", 15, 25]]], ["Dissecting aneurysms are infrequent but have been seen in birds, most notably turkeys (Fig. 10-65 ).", [["aneurysms", "ANATOMY", 11, 20], ["aneurysms", "DISEASE", 11, 20], ["aneurysms", "PATHOLOGICAL_FORMATION", 11, 20], ["turkeys", "ORGANISM", 78, 85], ["turkeys", "SPECIES", 78, 85], ["Dissecting aneurysms", "PROBLEM", 0, 20], ["aneurysms", "OBSERVATION", 11, 20]]], ["They result from disruption of the intima, which allows entry of blood into the media, and this dissects along the wall.", [["intima", "ANATOMY", 35, 41], ["blood", "ANATOMY", 65, 70], ["wall", "ANATOMY", 115, 119], ["intima", "TISSUE", 35, 41], ["blood", "ORGANISM_SUBSTANCE", 65, 70], ["wall", "TISSUE", 115, 119], ["disruption of the intima", "PROBLEM", 17, 41], ["disruption", "OBSERVATION", 17, 27], ["intima", "ANATOMY", 35, 41], ["media", "ANATOMY", 80, 85], ["wall", "ANATOMY_MODIFIER", 115, 119]]], ["Aneurysms can rupture.", [["Aneurysms", "ANATOMY", 0, 9], ["Aneurysms", "DISEASE", 0, 9], ["Aneurysms", "PROBLEM", 0, 9], ["rupture", "PROBLEM", 14, 21], ["rupture", "OBSERVATION", 14, 21]]], ["Usually the consequences are rapidly fatal because rather large arteries typically are involved.", [["arteries", "ANATOMY", 64, 72], ["arteries", "MULTI-TISSUE_STRUCTURE", 64, 72], ["rapidly", "OBSERVATION_MODIFIER", 29, 36], ["fatal", "OBSERVATION", 37, 42], ["large", "OBSERVATION_MODIFIER", 58, 63], ["arteries", "ANATOMY", 64, 72]]], ["See the discussion on effusions in the section on Disorders of Domestic Animals: Pericardium and Epicardium, Disturbances of Circulation, Effusions and also Chapters 3, 7, and 9.", [["effusions", "DISEASE", 22, 31], ["effusions", "PROBLEM", 22, 31], ["Pericardium and Epicardium, Disturbances of Circulation", "PROBLEM", 81, 136], ["Effusions", "PROBLEM", 138, 147], ["effusions", "OBSERVATION", 22, 31], ["Pericardium", "ANATOMY", 81, 92], ["Epicardium", "ANATOMY", 97, 107], ["Circulation", "OBSERVATION_MODIFIER", 125, 136], ["Effusions", "OBSERVATION", 138, 147]]], ["Aortic Rupture and Rupture of Large Arteries.", [["Aortic", "ANATOMY", 0, 6], ["Arteries", "ANATOMY", 36, 44], ["Aortic", "MULTI-TISSUE_STRUCTURE", 0, 6], ["Arteries", "MULTI-TISSUE_STRUCTURE", 36, 44], ["Aortic Rupture", "PROBLEM", 0, 14], ["Rupture of Large Arteries", "PROBLEM", 19, 44], ["Rupture", "OBSERVATION", 7, 14], ["Rupture", "OBSERVATION", 19, 26], ["Large Arteries", "ANATOMY", 30, 44]]], ["Aortic rupture and rupture of large arteries can be the sequela of severe trauma or occur Fibrinous Pericarditis.", [["Aortic", "ANATOMY", 0, 6], ["arteries", "ANATOMY", 36, 44], ["Aortic rupture", "DISEASE", 0, 14], ["rupture", "DISEASE", 19, 26], ["trauma", "DISEASE", 74, 80], ["Pericarditis", "DISEASE", 100, 112], ["Aortic", "MULTI-TISSUE_STRUCTURE", 0, 6], ["arteries", "MULTI-TISSUE_STRUCTURE", 36, 44], ["Aortic rupture", "PROBLEM", 0, 14], ["rupture of large arteries", "PROBLEM", 19, 44], ["severe trauma", "PROBLEM", 67, 80], ["Fibrinous Pericarditis", "PROBLEM", 90, 112], ["rupture", "OBSERVATION", 7, 14], ["rupture", "OBSERVATION", 19, 26], ["large", "OBSERVATION_MODIFIER", 30, 35], ["arteries", "ANATOMY", 36, 44], ["severe", "OBSERVATION_MODIFIER", 67, 73], ["trauma", "OBSERVATION", 74, 80], ["Fibrinous", "OBSERVATION_MODIFIER", 90, 99], ["Pericarditis", "OBSERVATION", 100, 112]]], ["Hematogenous spread of specific organisms may result in fibrinous pericarditis.", [["pericarditis", "DISEASE", 66, 78], ["Hematogenous spread of specific organisms", "PROBLEM", 0, 41], ["fibrinous pericarditis", "PROBLEM", 56, 78], ["fibrinous", "OBSERVATION_MODIFIER", 56, 65], ["pericarditis", "OBSERVATION", 66, 78]]], ["Mannheimiosis, blackleg, coliform septicemias, contagious bovine pleuropneumonia, sporadic bovine encephalomyelitis, and in utero Brucella spp. and Arcanobacter pyogenesis fetal septicemias may all produce fibrinous pericarditis.", [["fetal", "ANATOMY", 172, 177], ["Mannheimiosis", "CHEMICAL", 0, 13], ["coliform septicemias", "DISEASE", 25, 45], ["bovine pleuropneumonia", "DISEASE", 58, 80], ["bovine encephalomyelitis", "DISEASE", 91, 115], ["septicemias", "DISEASE", 178, 189], ["pericarditis", "DISEASE", 216, 228], ["bovine", "ORGANISM", 58, 64], ["bovine", "ORGANISM", 91, 97], ["bovine", "SPECIES", 58, 64], ["bovine", "SPECIES", 91, 97], ["Brucella spp.", "SPECIES", 130, 143], ["bovine encephalomyelitis", "SPECIES", 91, 115], ["Brucella spp.", "SPECIES", 130, 143], ["Arcanobacter pyogenesis", "SPECIES", 148, 171], ["Mannheimiosis", "PROBLEM", 0, 13], ["blackleg", "PROBLEM", 15, 23], ["coliform septicemias", "PROBLEM", 25, 45], ["contagious bovine pleuropneumonia", "PROBLEM", 47, 80], ["sporadic bovine encephalomyelitis", "PROBLEM", 82, 115], ["utero Brucella spp.", "PROBLEM", 124, 143], ["Arcanobacter pyogenesis fetal septicemias", "PROBLEM", 148, 189], ["fibrinous pericarditis", "PROBLEM", 206, 228], ["coliform septicemias", "OBSERVATION", 25, 45], ["contagious", "OBSERVATION_MODIFIER", 47, 57], ["bovine pleuropneumonia", "OBSERVATION", 58, 80], ["sporadic", "OBSERVATION_MODIFIER", 82, 90], ["bovine encephalomyelitis", "OBSERVATION", 91, 115], ["Brucella spp.", "OBSERVATION", 130, 143], ["fibrinous", "OBSERVATION_MODIFIER", 206, 215], ["pericarditis", "OBSERVATION", 216, 228]]], ["In sheep, Mannheimiosis and streptococcal infections most commonly result in fibrinous pericarditis.", [["Mannheimiosis", "CHEMICAL", 10, 23], ["streptococcal infections", "DISEASE", 28, 52], ["pericarditis", "DISEASE", 87, 99], ["sheep", "ORGANISM", 3, 8], ["Mannheimiosis", "ORGANISM", 10, 23], ["sheep", "SPECIES", 3, 8], ["sheep", "SPECIES", 3, 8], ["Mannheimiosis", "PROBLEM", 10, 23], ["streptococcal infections", "PROBLEM", 28, 52], ["fibrinous pericarditis", "PROBLEM", 77, 99], ["streptococcal", "OBSERVATION_MODIFIER", 28, 41], ["infections", "OBSERVATION", 42, 52], ["fibrinous", "OBSERVATION_MODIFIER", 77, 86], ["pericarditis", "OBSERVATION", 87, 99]]], ["Sterile swabs of the pericardial exudates are recommended to identify the causative organism.Disorders of Domestic Animals: Blood and Lymphatic Vascular SystemsSee the discussion on blood and lymphatic vascular systems in the section on Responses to Injury: Blood and Lymphatic Vascular Systems.", [["swabs", "ANATOMY", 8, 13], ["pericardial exudates", "ANATOMY", 21, 41], ["Blood", "ANATOMY", 124, 129], ["Vascular", "ANATOMY", 144, 152], ["blood", "ANATOMY", 182, 187], ["lymphatic vascular systems", "ANATOMY", 192, 218], ["Blood", "ANATOMY", 258, 263], ["Vascular", "ANATOMY", 278, 286], ["Injury", "DISEASE", 250, 256], ["pericardial exudates", "MULTI-TISSUE_STRUCTURE", 21, 41], ["Blood", "ORGANISM_SUBSTANCE", 124, 129], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 134, 152], ["blood", "ORGANISM_SUBSTANCE", 182, 187], ["lymphatic vascular", "MULTI-TISSUE_STRUCTURE", 192, 210], ["Blood", "ORGANISM_SUBSTANCE", 258, 263], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 268, 286], ["Sterile swabs", "TREATMENT", 0, 13], ["the pericardial exudates", "PROBLEM", 17, 41], ["the causative organism", "PROBLEM", 70, 92], ["pericardial", "ANATOMY", 21, 32], ["exudates", "OBSERVATION", 33, 41], ["Blood", "ANATOMY", 124, 129], ["Lymphatic", "ANATOMY_MODIFIER", 134, 143], ["Vascular", "ANATOMY", 144, 152], ["lymphatic vascular", "ANATOMY", 192, 210], ["Injury", "OBSERVATION", 250, 256], ["Blood", "ANATOMY", 258, 263], ["Lymphatic Vascular", "ANATOMY", 268, 286]]], ["The major arterial diseases are shown in Fig. 10-63 .Disturbances of CirculationEffusions.", [["arterial", "ANATOMY", 10, 18], ["arterial diseases", "DISEASE", 10, 27], ["arterial", "MULTI-TISSUE_STRUCTURE", 10, 18], ["The major arterial diseases", "PROBLEM", 0, 27], ["Fig.", "TEST", 41, 45], ["Disturbances of CirculationEffusions", "PROBLEM", 53, 89], ["major", "OBSERVATION_MODIFIER", 4, 9], ["arterial", "ANATOMY", 10, 18], ["diseases", "OBSERVATION", 19, 27], ["CirculationEffusions", "OBSERVATION", 69, 89]]], ["See the previous discussion on disturbances of circulation in the sections on Pericardium and Epicardium.Disturbances of CirculationHemopericardium.", [["sections", "ANATOMY", 66, 74], ["Pericardium", "ANATOMY", 78, 89], ["Epicardium", "ANATOMY", 94, 104], ["Pericardium", "MULTI-TISSUE_STRUCTURE", 78, 89], ["Disturbances of CirculationHemopericardium", "PROBLEM", 105, 147], ["Pericardium", "ANATOMY", 78, 89], ["Epicardium", "ANATOMY", 94, 104], ["Circulation", "OBSERVATION_MODIFIER", 121, 132], ["Hemopericardium", "OBSERVATION", 132, 147]]], ["See the later discussion on the hemopericardium under Effusions in the section on Disorders of Domestic Animals: Pericardium and Epicardium; Disturbances of Circulation.Disturbances of CirculationHemothorax and Hemoabdomen.", [["hemopericardium", "DISEASE", 32, 47], ["Hemoabdomen", "DISEASE", 211, 222], ["hemopericardium", "CANCER", 32, 47], ["the hemopericardium under Effusions", "PROBLEM", 28, 63], ["Disturbances of Circulation", "PROBLEM", 141, 168], ["Disturbances of CirculationHemothorax", "PROBLEM", 169, 206], ["Hemoabdomen", "PROBLEM", 211, 222], ["hemopericardium", "OBSERVATION", 32, 47], ["Effusions", "OBSERVATION", 54, 63], ["Pericardium", "ANATOMY", 113, 124], ["Epicardium", "ANATOMY", 129, 139], ["Circulation", "OBSERVATION_MODIFIER", 157, 168], ["Circulation", "OBSERVATION_MODIFIER", 185, 196], ["Hemothorax", "OBSERVATION", 196, 206]]], ["Hemothorax and hemoabdomen arise from spontaneous or traumatic rupture of large arteries or veins or from rupture of aneurysms located in the thoracic or abdominal cavity, respectively.", [["hemoabdomen", "ANATOMY", 15, 26], ["arteries", "ANATOMY", 80, 88], ["veins", "ANATOMY", 92, 97], ["aneurysms", "ANATOMY", 117, 126], ["thoracic", "ANATOMY", 142, 150], ["abdominal cavity", "ANATOMY", 154, 170], ["Hemothorax", "DISEASE", 0, 10], ["hemoabdomen", "DISEASE", 15, 26], ["rupture", "DISEASE", 106, 113], ["aneurysms", "DISEASE", 117, 126], ["hemoabdomen", "CANCER", 15, 26], ["arteries", "MULTI-TISSUE_STRUCTURE", 80, 88], ["veins", "MULTI-TISSUE_STRUCTURE", 92, 97], ["thoracic", "ORGAN", 142, 150], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 154, 170], ["Hemothorax", "PROBLEM", 0, 10], ["hemoabdomen", "PROBLEM", 15, 26], ["spontaneous or traumatic rupture of large arteries or veins", "PROBLEM", 38, 97], ["rupture", "PROBLEM", 106, 113], ["aneurysms", "PROBLEM", 117, 126], ["spontaneous", "OBSERVATION_MODIFIER", 38, 49], ["traumatic", "OBSERVATION_MODIFIER", 53, 62], ["rupture", "OBSERVATION", 63, 70], ["large", "OBSERVATION_MODIFIER", 74, 79], ["arteries", "ANATOMY", 80, 88], ["veins", "ANATOMY", 92, 97], ["rupture", "OBSERVATION", 106, 113], ["aneurysms", "OBSERVATION", 117, 126], ["thoracic", "ANATOMY", 142, 150], ["abdominal cavity", "ANATOMY", 154, 170]]], ["An aneurysm is a localized dilation or outpouching of a thinned and weakened portion of a vessel.", [["aneurysm", "ANATOMY", 3, 11], ["vessel", "ANATOMY", 90, 96], ["aneurysm", "DISEASE", 3, 11], ["vessel", "MULTI-TISSUE_STRUCTURE", 90, 96], ["An aneurysm", "PROBLEM", 0, 11], ["a localized dilation", "PROBLEM", 15, 35], ["outpouching", "PROBLEM", 39, 50], ["a thinned and weakened portion of a vessel", "PROBLEM", 54, 96], ["aneurysm", "OBSERVATION", 3, 11], ["localized", "OBSERVATION_MODIFIER", 17, 26], ["dilation", "OBSERVATION", 27, 35], ["outpouching", "OBSERVATION_MODIFIER", 39, 50], ["thinned", "OBSERVATION_MODIFIER", 56, 63], ["weakened", "OBSERVATION_MODIFIER", 68, 76], ["portion", "OBSERVATION_MODIFIER", 77, 84], ["vessel", "ANATOMY", 90, 96]]], ["Usually, arteries are affected, especially large elastic arteries, but the lesion can also occur in veins.", [["arteries", "ANATOMY", 9, 17], ["elastic arteries", "ANATOMY", 49, 65], ["lesion", "ANATOMY", 75, 81], ["veins", "ANATOMY", 100, 105], ["arteries", "MULTI-TISSUE_STRUCTURE", 9, 17], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 49, 65], ["veins", "MULTI-TISSUE_STRUCTURE", 100, 105], ["large elastic arteries", "PROBLEM", 43, 65], ["the lesion", "PROBLEM", 71, 81], ["arteries", "ANATOMY", 9, 17], ["affected", "OBSERVATION", 22, 30], ["large", "OBSERVATION_MODIFIER", 43, 48], ["elastic", "OBSERVATION", 49, 56], ["arteries", "ANATOMY", 57, 65], ["lesion", "OBSERVATION", 75, 81], ["veins", "ANATOMY", 100, 105]]], ["Known causes include copper L involvement at arterial branching sites, in which blood flow is turbulent.", [["arterial branching sites", "ANATOMY", 45, 69], ["blood", "ANATOMY", 80, 85], ["copper", "CHEMICAL", 21, 27], ["copper L", "CHEMICAL", 21, 29], ["copper L", "SIMPLE_CHEMICAL", 21, 29], ["arterial branching sites", "MULTI-TISSUE_STRUCTURE", 45, 69], ["blood", "ORGANISM_SUBSTANCE", 80, 85], ["copper L involvement at arterial branching sites", "PROBLEM", 21, 69], ["blood flow", "TEST", 80, 90], ["copper L", "OBSERVATION_MODIFIER", 21, 29], ["involvement", "OBSERVATION", 30, 41], ["arterial", "ANATOMY_MODIFIER", 45, 53], ["branching", "ANATOMY_MODIFIER", 54, 63], ["blood flow", "OBSERVATION", 80, 90], ["turbulent", "OBSERVATION_MODIFIER", 94, 103]]], ["Grossly, the lesions are seen as slightly raised, firm, white plaques.", [["lesions", "ANATOMY", 13, 20], ["white plaques", "ANATOMY", 56, 69], ["white plaques", "DISEASE", 56, 69], ["lesions", "PATHOLOGICAL_FORMATION", 13, 20], ["the lesions", "PROBLEM", 9, 20], ["firm, white plaques", "PROBLEM", 50, 69], ["lesions", "OBSERVATION", 13, 20], ["slightly", "OBSERVATION_MODIFIER", 33, 41], ["raised", "OBSERVATION_MODIFIER", 42, 48], ["firm", "OBSERVATION_MODIFIER", 50, 54], ["white", "OBSERVATION_MODIFIER", 56, 61], ["plaques", "OBSERVATION", 62, 69]]], ["Microscopically, initially the intima is thickened by accumulation of mucopolysaccharides and later by the proliferation of smooth muscle cells in the tunica media and fibrous tissue infiltration into the intima.", [["intima", "ANATOMY", 31, 37], ["smooth muscle cells", "ANATOMY", 124, 143], ["tunica media", "ANATOMY", 151, 163], ["fibrous tissue", "ANATOMY", 168, 182], ["intima", "ANATOMY", 205, 211], ["intima", "TISSUE", 31, 37], ["mucopolysaccharides", "SIMPLE_CHEMICAL", 70, 89], ["smooth muscle cells", "CELL", 124, 143], ["tunica media", "TISSUE", 151, 163], ["fibrous tissue", "TISSUE", 168, 182], ["intima", "TISSUE", 205, 211], ["smooth muscle cells", "CELL_TYPE", 124, 143], ["thickened", "PROBLEM", 41, 50], ["accumulation of mucopolysaccharides", "PROBLEM", 54, 89], ["smooth muscle cells", "PROBLEM", 124, 143], ["fibrous tissue infiltration", "PROBLEM", 168, 195], ["intima", "ANATOMY", 31, 37], ["thickened", "OBSERVATION", 41, 50], ["accumulation of mucopolysaccharides", "OBSERVATION", 54, 89], ["proliferation", "OBSERVATION_MODIFIER", 107, 120], ["smooth muscle cells", "OBSERVATION", 124, 143], ["tunica media", "ANATOMY", 151, 163], ["fibrous tissue", "OBSERVATION", 168, 182], ["infiltration", "OBSERVATION", 183, 195], ["intima", "ANATOMY", 205, 211]]], ["Splitting and fragmentation of the internal elastic lamina are common Atherosclerosis.", [["elastic lamina", "ANATOMY", 44, 58], ["Atherosclerosis", "DISEASE", 70, 85], ["elastic lamina", "TISSUE", 44, 58], ["Atherosclerosis", "PROBLEM", 70, 85], ["fragmentation", "OBSERVATION_MODIFIER", 14, 27], ["internal", "ANATOMY_MODIFIER", 35, 43], ["elastic", "ANATOMY_MODIFIER", 44, 51], ["lamina", "ANATOMY", 52, 58], ["common", "OBSERVATION_MODIFIER", 63, 69], ["Atherosclerosis", "OBSERVATION", 70, 85]]], ["Atherosclerosis, the vascular disease of greatest importance in human beings, occurs only infrequently in animals and rarely leads to clinical disease such as infarction of the heart or brain.", [["vascular", "ANATOMY", 21, 29], ["heart", "ANATOMY", 177, 182], ["brain", "ANATOMY", 186, 191], ["Atherosclerosis", "DISEASE", 0, 15], ["vascular disease", "DISEASE", 21, 37], ["infarction of the heart or brain", "DISEASE", 159, 191], ["vascular", "MULTI-TISSUE_STRUCTURE", 21, 29], ["human", "ORGANISM", 64, 69], ["heart", "ORGAN", 177, 182], ["brain", "ORGAN", 186, 191], ["human", "SPECIES", 64, 69], ["human", "SPECIES", 64, 69], ["Atherosclerosis", "PROBLEM", 0, 15], ["the vascular disease", "PROBLEM", 17, 37], ["clinical disease", "PROBLEM", 134, 150], ["infarction of the heart or brain", "PROBLEM", 159, 191], ["vascular", "ANATOMY", 21, 29], ["disease", "OBSERVATION", 30, 37], ["greatest", "OBSERVATION_MODIFIER", 41, 49], ["infarction", "OBSERVATION", 159, 169], ["heart", "ANATOMY", 177, 182], ["brain", "ANATOMY", 186, 191]]], ["The principal alteration is accumulation of deposits (atheroma) of lipid, fibrous tissue, and calcium in vessel walls, which eventually results in luminal narrowing.", [["atheroma", "ANATOMY", 54, 62], ["fibrous tissue", "ANATOMY", 74, 88], ["vessel walls", "ANATOMY", 105, 117], ["luminal", "ANATOMY", 147, 154], ["atheroma", "DISEASE", 54, 62], ["calcium", "CHEMICAL", 94, 101], ["luminal", "CHEMICAL", 147, 154], ["calcium", "CHEMICAL", 94, 101], ["atheroma", "PATHOLOGICAL_FORMATION", 54, 62], ["lipid", "SIMPLE_CHEMICAL", 67, 72], ["fibrous tissue", "TISSUE", 74, 88], ["calcium", "SIMPLE_CHEMICAL", 94, 101], ["vessel walls", "MULTI-TISSUE_STRUCTURE", 105, 117], ["luminal", "IMMATERIAL_ANATOMICAL_ENTITY", 147, 154], ["accumulation of deposits (atheroma) of lipid, fibrous tissue", "PROBLEM", 28, 88], ["calcium in vessel walls", "PROBLEM", 94, 117], ["luminal narrowing", "PROBLEM", 147, 164], ["principal", "OBSERVATION_MODIFIER", 4, 13], ["alteration", "OBSERVATION", 14, 24], ["accumulation", "OBSERVATION_MODIFIER", 28, 40], ["deposits", "OBSERVATION_MODIFIER", 44, 52], ["atheroma", "OBSERVATION", 54, 62], ["lipid", "OBSERVATION_MODIFIER", 67, 72], ["fibrous tissue", "OBSERVATION", 74, 88], ["vessel", "ANATOMY", 105, 111], ["walls", "ANATOMY_MODIFIER", 112, 117], ["luminal", "ANATOMY_MODIFIER", 147, 154], ["narrowing", "OBSERVATION", 155, 164]]], ["Many studies have established that the pig, rabbit, and chicken are susceptible to the experimental disease produced by the feeding of a high-cholesterol diet; the dog, cat, cow, goat, and rat are resistant.", [["cholesterol", "CHEMICAL", 142, 153], ["cholesterol", "CHEMICAL", 142, 153], ["pig", "ORGANISM", 39, 42], ["rabbit", "ORGANISM", 44, 50], ["chicken", "ORGANISM", 56, 63], ["cholesterol", "SIMPLE_CHEMICAL", 142, 153], ["dog", "ORGANISM", 164, 167], ["cat", "ORGANISM", 169, 172], ["cow", "ORGANISM_SUBDIVISION", 174, 177], ["goat", "ORGANISM", 179, 183], ["rat", "ORGANISM", 189, 192], ["pig", "SPECIES", 39, 42], ["rabbit", "SPECIES", 44, 50], ["chicken", "SPECIES", 56, 63], ["dog", "SPECIES", 164, 167], ["cat", "SPECIES", 169, 172], ["cow", "SPECIES", 174, 177], ["goat", "SPECIES", 179, 183], ["rat", "SPECIES", 189, 192], ["pig", "SPECIES", 39, 42], ["rabbit", "SPECIES", 44, 50], ["chicken", "SPECIES", 56, 63], ["cow", "SPECIES", 174, 177], ["goat", "SPECIES", 179, 183], ["rat", "SPECIES", 189, 192], ["Many studies", "TEST", 0, 12], ["the pig, rabbit", "TREATMENT", 35, 50], ["the experimental disease", "PROBLEM", 83, 107], ["a high-cholesterol diet", "TREATMENT", 135, 158], ["experimental disease", "OBSERVATION", 87, 107]]], ["Lesions of the naturally occurring disease have been detected in aged pigs and birds (especially parrots) and in dogs with hypothyroidism and diabetes mellitus that develop an accompanying hypercholesterolemia.", [["hypothyroidism", "DISEASE", 123, 137], ["diabetes mellitus", "DISEASE", 142, 159], ["hypercholesterolemia", "DISEASE", 189, 209], ["pigs", "ORGANISM", 70, 74], ["birds", "ORGANISM", 79, 84], ["parrots", "ORGANISM", 97, 104], ["dogs", "ORGANISM", 113, 117], ["pigs", "SPECIES", 70, 74], ["dogs", "SPECIES", 113, 117], ["pigs", "SPECIES", 70, 74], ["Lesions of the naturally occurring disease", "PROBLEM", 0, 42], ["hypothyroidism", "PROBLEM", 123, 137], ["diabetes mellitus", "PROBLEM", 142, 159], ["an accompanying hypercholesterolemia", "PROBLEM", 173, 209], ["hypothyroidism", "OBSERVATION", 123, 137], ["diabetes mellitus", "OBSERVATION", 142, 159], ["hypercholesterolemia", "OBSERVATION", 189, 209]]], ["Arteries of the heart, mesentery, and kidneys are prominently thickened, firm, and yellow-white ( Fig. 10-66, A) .", [["Arteries", "ANATOMY", 0, 8], ["heart", "ANATOMY", 16, 21], ["mesentery", "ANATOMY", 23, 32], ["kidneys", "ANATOMY", 38, 45], ["Arteries", "MULTI-TISSUE_STRUCTURE", 0, 8], ["heart", "ORGAN", 16, 21], ["mesentery", "MULTI-TISSUE_STRUCTURE", 23, 32], ["kidneys", "ORGAN", 38, 45], ["prominently thickened", "PROBLEM", 50, 71], ["firm", "PROBLEM", 73, 77], ["Fig.", "TEST", 98, 102], ["heart", "ANATOMY", 16, 21], ["mesentery", "ANATOMY", 23, 32], ["kidneys", "ANATOMY", 38, 45], ["prominently", "OBSERVATION_MODIFIER", 50, 61], ["thickened", "OBSERVATION", 62, 71], ["firm", "OBSERVATION_MODIFIER", 73, 77], ["yellow", "OBSERVATION_MODIFIER", 83, 89]]], ["Microscopically, lipid globules accumulate in the cytoplasm of smooth muscle cells and macrophages, often termed foam cells, in the media and intima (see Fig. 10 -66, B and C).", [["lipid globules", "ANATOMY", 17, 31], ["cytoplasm", "ANATOMY", 50, 59], ["smooth muscle cells", "ANATOMY", 63, 82], ["macrophages", "ANATOMY", 87, 98], ["foam cells", "ANATOMY", 113, 123], ["intima", "ANATOMY", 142, 148], ["lipid globules", "CELLULAR_COMPONENT", 17, 31], ["cytoplasm", "ORGANISM_SUBSTANCE", 50, 59], ["smooth muscle cells", "CELL", 63, 82], ["macrophages", "CELL", 87, 98], ["foam cells", "CELL", 113, 123], ["intima", "TISSUE", 142, 148], ["smooth muscle cells", "CELL_TYPE", 63, 82], ["macrophages", "CELL_TYPE", 87, 98], ["foam cells", "CELL_TYPE", 113, 123], ["lipid globules", "TEST", 17, 31], ["macrophages", "PROBLEM", 87, 98], ["often termed foam cells", "PROBLEM", 100, 123], ["lipid globules", "OBSERVATION", 17, 31], ["cytoplasm", "ANATOMY_MODIFIER", 50, 59], ["smooth muscle cells", "OBSERVATION", 63, 82], ["macrophages", "OBSERVATION", 87, 98], ["foam cells", "OBSERVATION", 113, 123], ["media", "ANATOMY", 132, 137], ["intima", "ANATOMY", 142, 148]]], ["Necrosis and fibrosis develop in some arterial lesions.", [["arterial lesions", "ANATOMY", 38, 54], ["Necrosis", "DISEASE", 0, 8], ["fibrosis", "DISEASE", 13, 21], ["arterial lesions", "PATHOLOGICAL_FORMATION", 38, 54], ["Necrosis", "PROBLEM", 0, 8], ["fibrosis", "PROBLEM", 13, 21], ["some arterial lesions", "PROBLEM", 33, 54], ["fibrosis", "OBSERVATION", 13, 21], ["some", "OBSERVATION_MODIFIER", 33, 37], ["arterial", "ANATOMY", 38, 46], ["lesions", "OBSERVATION", 47, 54]]], ["The pathogenesis of atherosclerosis has been extensively studied in human beings.", [["atherosclerosis", "DISEASE", 20, 35], ["human", "ORGANISM", 68, 73], ["human", "SPECIES", 68, 73], ["human", "SPECIES", 68, 73], ["atherosclerosis", "PROBLEM", 20, 35], ["atherosclerosis", "OBSERVATION", 20, 35]]], ["The vascular response-to-injury hypothesis is the current proposed mechanism of injury.", [["vascular", "ANATOMY", 4, 12], ["vascular", "MULTI-TISSUE_STRUCTURE", 4, 12], ["The vascular response", "TEST", 0, 21], ["injury hypothesis", "PROBLEM", 25, 42], ["injury", "PROBLEM", 80, 86], ["vascular", "ANATOMY", 4, 12], ["injury", "OBSERVATION", 80, 86]]], ["The dyslipoproteinemia associated with diabetes or hypothyroidism in the dog results in endothelial injury.", [["endothelial", "ANATOMY", 88, 99], ["dyslipoproteinemia", "DISEASE", 4, 22], ["diabetes", "DISEASE", 39, 47], ["hypothyroidism", "DISEASE", 51, 65], ["endothelial injury", "DISEASE", 88, 106], ["dog", "ORGANISM", 73, 76], ["endothelial", "TISSUE", 88, 99], ["dog", "SPECIES", 73, 76], ["The dyslipoproteinemia", "PROBLEM", 0, 22], ["diabetes", "PROBLEM", 39, 47], ["hypothyroidism", "PROBLEM", 51, 65], ["endothelial injury", "PROBLEM", 88, 106], ["dyslipoproteinemia", "OBSERVATION", 4, 22], ["diabetes", "OBSERVATION", 39, 47], ["hypothyroidism", "OBSERVATION", 51, 65], ["endothelial", "ANATOMY", 88, 99], ["injury", "OBSERVATION", 100, 106]]], ["A variety of mechanisms, including oxygen free radical production, increase the decay of nitric oxide and decrease its vasodilator activity.", [["oxygen", "CHEMICAL", 35, 41], ["nitric oxide", "CHEMICAL", 89, 101], ["oxygen", "CHEMICAL", 35, 41], ["nitric oxide", "CHEMICAL", 89, 101], ["oxygen", "SIMPLE_CHEMICAL", 35, 41], ["nitric oxide", "SIMPLE_CHEMICAL", 89, 101], ["oxygen free radical production", "TREATMENT", 35, 65], ["nitric oxide", "TREATMENT", 89, 101], ["its vasodilator activity", "TREATMENT", 115, 139], ["variety", "OBSERVATION_MODIFIER", 2, 9], ["nitric oxide", "OBSERVATION", 89, 101], ["vasodilator activity", "OBSERVATION", 119, 139]]], ["The damaged endothelial cell allows lipoproteins to accumulate within the intima, where they are oxidized by free radicals generated by macrophages and endothelial cells.", [["endothelial cell", "ANATOMY", 12, 28], ["intima", "ANATOMY", 74, 80], ["macrophages", "ANATOMY", 136, 147], ["endothelial cells", "ANATOMY", 152, 169], ["endothelial cell", "CELL", 12, 28], ["intima", "TISSUE", 74, 80], ["macrophages", "CELL", 136, 147], ["endothelial cells", "CELL", 152, 169], ["damaged endothelial cell", "CELL_TYPE", 4, 28], ["lipoproteins", "PROTEIN", 36, 48], ["macrophages", "CELL_TYPE", 136, 147], ["endothelial cells", "CELL_TYPE", 152, 169], ["endothelial cell", "OBSERVATION", 12, 28], ["intima", "ANATOMY", 74, 80], ["free radicals", "OBSERVATION", 109, 122], ["macrophages", "OBSERVATION", 136, 147], ["endothelial cells", "OBSERVATION", 152, 169]]], ["The oxidized products are directly toxic to endothelium and smooth muscle cells.", [["endothelium", "ANATOMY", 44, 55], ["smooth muscle cells", "ANATOMY", 60, 79], ["endothelium", "CELL", 44, 55], ["smooth muscle cells", "CELL", 60, 79], ["smooth muscle cells", "CELL_TYPE", 60, 79], ["The oxidized products", "TREATMENT", 0, 21], ["oxidized products", "OBSERVATION", 4, 21], ["toxic", "OBSERVATION_MODIFIER", 35, 40], ["smooth muscle cells", "OBSERVATION", 60, 79]]], ["Cellular debris is ingested by macrophages and smooth muscle cells, resulting in the formation of \"foam cells.\"", [["Cellular debris", "ANATOMY", 0, 15], ["macrophages", "ANATOMY", 31, 42], ["smooth muscle cells", "ANATOMY", 47, 66], ["foam cells", "ANATOMY", 99, 109], ["macrophages", "CELL", 31, 42], ["smooth muscle cells", "CELL", 47, 66], ["foam cells", "CELL", 99, 109], ["macrophages", "CELL_TYPE", 31, 42], ["smooth muscle cells", "CELL_TYPE", 47, 66], ["foam cells", "CELL_TYPE", 99, 109], ["Cellular debris", "PROBLEM", 0, 15], ["smooth muscle cells", "PROBLEM", 47, 66], ["the formation of \"foam cells", "PROBLEM", 81, 109], ["debris", "OBSERVATION", 9, 15], ["macrophages", "OBSERVATION", 31, 42], ["smooth muscle cells", "OBSERVATION", 47, 66], ["foam cells", "OBSERVATION", 99, 109]]], ["The lesion in dogs differs from that of human beings with respect to the location of lipid, which is abundant throughout the wall of the artery in contrast to human beings, who have lipid accumulation in the tunica intima.", [["lesion", "ANATOMY", 4, 10], ["wall", "ANATOMY", 125, 129], ["artery", "ANATOMY", 137, 143], ["tunica intima", "ANATOMY", 208, 221], ["lesion", "CANCER", 4, 10], ["dogs", "ORGANISM", 14, 18], ["human", "ORGANISM", 40, 45], ["lipid", "SIMPLE_CHEMICAL", 85, 90], ["wall", "TISSUE", 125, 129], ["artery", "MULTI-TISSUE_STRUCTURE", 137, 143], ["human", "ORGANISM", 159, 164], ["lipid", "SIMPLE_CHEMICAL", 182, 187], ["tunica intima", "TISSUE", 208, 221], ["dogs", "SPECIES", 14, 18], ["human", "SPECIES", 40, 45], ["human", "SPECIES", 159, 164], ["human", "SPECIES", 40, 45], ["human", "SPECIES", 159, 164], ["The lesion", "PROBLEM", 0, 10], ["lipid accumulation in the tunica intima", "PROBLEM", 182, 221], ["lesion", "OBSERVATION", 4, 10], ["dogs", "OBSERVATION", 14, 18], ["lipid", "OBSERVATION", 85, 90], ["abundant", "OBSERVATION_MODIFIER", 101, 109], ["wall", "ANATOMY_MODIFIER", 125, 129], ["artery", "ANATOMY", 137, 143], ["lipid accumulation", "OBSERVATION", 182, 200], ["tunica intima", "ANATOMY", 208, 221]]], ["The chronic progression of atherosclerosis may result in narrowing of the lumen, ulceration and thrombosis, and hemorrhage or aneurysmal dilation.Disturbances of CirculationArterial Medial Calcification.", [["lumen", "ANATOMY", 74, 79], ["aneurysmal", "ANATOMY", 126, 136], ["atherosclerosis", "DISEASE", 27, 42], ["ulceration", "DISEASE", 81, 91], ["thrombosis", "DISEASE", 96, 106], ["hemorrhage", "DISEASE", 112, 122], ["aneurysmal dilation", "DISEASE", 126, 145], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 74, 79], ["atherosclerosis", "PROBLEM", 27, 42], ["narrowing of the lumen", "PROBLEM", 57, 79], ["ulceration", "PROBLEM", 81, 91], ["thrombosis", "PROBLEM", 96, 106], ["hemorrhage", "PROBLEM", 112, 122], ["aneurysmal dilation", "PROBLEM", 126, 145], ["CirculationArterial Medial Calcification", "PROBLEM", 162, 202], ["chronic", "OBSERVATION_MODIFIER", 4, 11], ["progression", "OBSERVATION_MODIFIER", 12, 23], ["atherosclerosis", "OBSERVATION", 27, 42], ["narrowing", "OBSERVATION", 57, 66], ["lumen", "ANATOMY_MODIFIER", 74, 79], ["ulceration", "OBSERVATION", 81, 91], ["thrombosis", "OBSERVATION", 96, 106], ["hemorrhage", "OBSERVATION", 112, 122], ["aneurysmal", "OBSERVATION_MODIFIER", 126, 136], ["dilation", "OBSERVATION", 137, 145], ["CirculationArterial", "OBSERVATION_MODIFIER", 162, 181], ["Medial", "OBSERVATION_MODIFIER", 182, 188], ["Calcification", "OBSERVATION", 189, 202]]], ["Arterial medial calcification is a frequent lesion in animals that often have concurrent endocardial mineralization and involves both elastic and muscular arteries.", [["Arterial", "ANATOMY", 0, 8], ["lesion", "ANATOMY", 44, 50], ["endocardial", "ANATOMY", 89, 100], ["elastic", "ANATOMY", 134, 141], ["muscular arteries", "ANATOMY", 146, 163], ["Arterial medial calcification", "DISEASE", 0, 29], ["Arterial medial", "MULTI-TISSUE_STRUCTURE", 0, 15], ["endocardial", "TISSUE", 89, 100], ["elastic", "TISSUE", 134, 141], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 146, 163], ["Arterial medial calcification", "PROBLEM", 0, 29], ["a frequent lesion", "PROBLEM", 33, 50], ["concurrent endocardial mineralization", "PROBLEM", 78, 115], ["medial", "OBSERVATION_MODIFIER", 9, 15], ["calcification", "OBSERVATION", 16, 29], ["frequent", "OBSERVATION_MODIFIER", 35, 43], ["lesion", "OBSERVATION", 44, 50], ["endocardial", "ANATOMY_MODIFIER", 89, 100], ["mineralization", "OBSERVATION", 101, 115], ["both", "ANATOMY_MODIFIER", 129, 133], ["elastic", "ANATOMY_MODIFIER", 134, 141], ["muscular arteries", "ANATOMY", 146, 163]]], ["The causes of arterial medial calcification include calcinogenic plant toxicosis, vitamin D toxicosis, renal insufficiency, and severe debilitation, as seen in cattle with Johne's disease (see Fig. 10-53) .", [["arterial medial", "ANATOMY", 14, 29], ["renal", "ANATOMY", 103, 108], ["arterial medial calcification", "DISEASE", 14, 43], ["toxicosis", "DISEASE", 71, 80], ["vitamin D", "CHEMICAL", 82, 91], ["toxicosis", "DISEASE", 92, 101], ["renal insufficiency", "DISEASE", 103, 122], ["debilitation", "DISEASE", 135, 147], ["Johne's disease", "DISEASE", 172, 187], ["vitamin D", "CHEMICAL", 82, 91], ["arterial medial", "MULTI-TISSUE_STRUCTURE", 14, 29], ["vitamin D", "SIMPLE_CHEMICAL", 82, 91], ["renal", "ORGAN", 103, 108], ["cattle", "SPECIES", 160, 166], ["cattle", "SPECIES", 160, 166], ["Johne", "SPECIES", 172, 177], ["arterial medial calcification", "PROBLEM", 14, 43], ["calcinogenic plant toxicosis", "PROBLEM", 52, 80], ["vitamin D toxicosis", "PROBLEM", 82, 101], ["renal insufficiency", "PROBLEM", 103, 122], ["severe debilitation", "PROBLEM", 128, 147], ["Johne's disease", "PROBLEM", 172, 187], ["arterial", "ANATOMY", 14, 22], ["medial", "ANATOMY_MODIFIER", 23, 29], ["calcification", "OBSERVATION", 30, 43], ["calcinogenic", "OBSERVATION_MODIFIER", 52, 64], ["plant toxicosis", "OBSERVATION", 65, 80], ["renal", "ANATOMY", 103, 108], ["insufficiency", "OBSERVATION", 109, 122], ["severe", "OBSERVATION_MODIFIER", 128, 134], ["debilitation", "OBSERVATION", 135, 147]]], ["Medial calcification occurs spontaneously in horses, rabbits, aged guinea pigs, and in rats with chronic renal disease.", [["renal", "ANATOMY", 105, 110], ["Medial calcification", "DISEASE", 0, 20], ["chronic renal disease", "DISEASE", 97, 118], ["horses", "ORGANISM_SUBDIVISION", 45, 51], ["rabbits", "ORGANISM", 53, 60], ["guinea pigs", "ORGANISM", 67, 78], ["rats", "ORGANISM", 87, 91], ["renal", "ORGAN", 105, 110], ["rabbits", "SPECIES", 53, 60], ["guinea pigs", "SPECIES", 67, 78], ["rats", "SPECIES", 87, 91], ["rabbits", "SPECIES", 53, 60], ["Medial calcification", "PROBLEM", 0, 20], ["chronic renal disease", "PROBLEM", 97, 118], ["calcification", "OBSERVATION", 7, 20], ["spontaneously", "OBSERVATION_MODIFIER", 28, 41], ["chronic", "OBSERVATION_MODIFIER", 97, 104], ["renal", "ANATOMY", 105, 110], ["disease", "OBSERVATION", 111, 118]]], ["Affected arteries, such as the aorta, have a unique gross appearance; they appear as solid, dense, pipelike structures with raised, white, solid intimal plaques (Fig. 10-67) .", [["arteries", "ANATOMY", 9, 17], ["aorta", "ANATOMY", 31, 36], ["pipelike structures", "ANATOMY", 99, 118], ["solid intimal plaques", "ANATOMY", 139, 160], ["arteries", "MULTI-TISSUE_STRUCTURE", 9, 17], ["aorta", "MULTI-TISSUE_STRUCTURE", 31, 36], ["solid intimal plaques", "PATHOLOGICAL_FORMATION", 139, 160], ["Affected arteries", "PROBLEM", 0, 17], ["solid, dense, pipelike structures", "PROBLEM", 85, 118], ["raised, white, solid intimal plaques", "PROBLEM", 124, 160], ["arteries", "ANATOMY", 9, 17], ["aorta", "ANATOMY", 31, 36], ["solid", "OBSERVATION_MODIFIER", 85, 90], ["dense", "OBSERVATION_MODIFIER", 92, 97], ["raised", "OBSERVATION_MODIFIER", 124, 130], ["white", "OBSERVATION_MODIFIER", 132, 137], ["solid", "OBSERVATION_MODIFIER", 139, 144], ["intimal", "OBSERVATION_MODIFIER", 145, 152], ["plaques", "OBSERVATION", 153, 160]]], ["Microscopically, in elastic arteries, prominent basophilic granular mineral deposits are present on elastic fibers of the media, but in muscular arteries, they can form a complete ring of mineralization in the tunica media ( Fig. 10-68) .", [["elastic arteries", "ANATOMY", 20, 36], ["basophilic granular mineral", "ANATOMY", 48, 75], ["elastic fibers", "ANATOMY", 100, 114], ["muscular arteries", "ANATOMY", 136, 153], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 20, 36], ["basophilic granular mineral", "PATHOLOGICAL_FORMATION", 48, 75], ["elastic fibers", "CELLULAR_COMPONENT", 100, 114], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 136, 153], ["tunica", "TISSUE", 210, 216], ["prominent basophilic granular mineral deposits", "PROBLEM", 38, 84], ["a complete ring of mineralization", "PROBLEM", 169, 202], ["elastic arteries", "ANATOMY", 20, 36], ["prominent", "OBSERVATION_MODIFIER", 38, 47], ["basophilic", "OBSERVATION_MODIFIER", 48, 58], ["granular mineral deposits", "OBSERVATION", 59, 84], ["elastic", "OBSERVATION_MODIFIER", 100, 107], ["fibers", "OBSERVATION_MODIFIER", 108, 114], ["media", "ANATOMY_MODIFIER", 122, 127], ["muscular arteries", "ANATOMY", 136, 153], ["complete", "OBSERVATION_MODIFIER", 171, 179], ["ring", "OBSERVATION_MODIFIER", 180, 184], ["mineralization", "OBSERVATION", 188, 202], ["tunica media", "ANATOMY", 210, 222]]], ["Siderocalcinosis (so-called iron rings), the result of deposition of both iron and calcium salts, occurs in the cerebral arteries of aged horses.", [["cerebral arteries", "ANATOMY", 112, 129], ["Siderocalcinosis", "DISEASE", 0, 16], ["iron", "CHEMICAL", 74, 78], ["calcium", "CHEMICAL", 83, 90], ["iron", "CHEMICAL", 28, 32], ["iron", "CHEMICAL", 74, 78], ["calcium", "CHEMICAL", 83, 90], ["iron rings", "SIMPLE_CHEMICAL", 28, 38], ["iron", "SIMPLE_CHEMICAL", 74, 78], ["calcium salts", "SIMPLE_CHEMICAL", 83, 96], ["cerebral arteries", "MULTI-TISSUE_STRUCTURE", 112, 129], ["horses", "ORGANISM_SUBDIVISION", 138, 144], ["Siderocalcinosis", "PROBLEM", 0, 16], ["iron rings", "TREATMENT", 28, 38], ["calcium salts", "TREATMENT", 83, 96], ["cerebral arteries", "ANATOMY", 112, 129]]], ["Lesions in the surrounding brain tissue are generally absent.", [["brain tissue", "ANATOMY", 27, 39], ["brain tissue", "TISSUE", 27, 39], ["Lesions in the surrounding brain tissue", "PROBLEM", 0, 39], ["surrounding", "ANATOMY_MODIFIER", 15, 26], ["brain tissue", "ANATOMY", 27, 39], ["generally", "OBSERVATION_MODIFIER", 44, 53], ["absent", "OBSERVATION", 54, 60]]], ["Siderocalcinosis lesions are considered incidental.Disturbances of CirculationHyaline Degeneration, Fibrinoid Necrosis, and Amyloidosis.", [["Siderocalcinosis lesions", "ANATOMY", 0, 24], ["Siderocalcinosis", "DISEASE", 0, 16], ["Fibrinoid Necrosis", "DISEASE", 100, 118], ["Amyloidosis", "DISEASE", 124, 135], ["Siderocalcinosis lesions", "CANCER", 0, 24], ["Siderocalcinosis lesions", "PROBLEM", 0, 24], ["CirculationHyaline Degeneration", "PROBLEM", 67, 98], ["Fibrinoid Necrosis", "PROBLEM", 100, 118], ["Amyloidosis", "PROBLEM", 124, 135], ["lesions", "OBSERVATION", 17, 24], ["Circulation", "OBSERVATION_MODIFIER", 67, 78], ["Hyaline Degeneration", "OBSERVATION", 78, 98], ["Fibrinoid", "OBSERVATION_MODIFIER", 100, 109], ["Necrosis", "OBSERVATION", 110, 118], ["Amyloidosis", "OBSERVATION", 124, 135]]], ["Hyaline degeneration, fibrinoid necrosis, and amyloidosis are vascular lesions of small muscular arteries and arterioles and occur spontaneously (see Figs.", [["fibrinoid", "ANATOMY", 22, 31], ["vascular lesions", "ANATOMY", 62, 78], ["muscular arteries", "ANATOMY", 88, 105], ["arterioles", "ANATOMY", 110, 120], ["Hyaline degeneration", "DISEASE", 0, 20], ["fibrinoid necrosis", "DISEASE", 22, 40], ["amyloidosis", "DISEASE", 46, 57], ["vascular lesions", "PATHOLOGICAL_FORMATION", 62, 78], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 88, 105], ["arterioles", "MULTI-TISSUE_STRUCTURE", 110, 120], ["Hyaline degeneration", "PROBLEM", 0, 20], ["fibrinoid necrosis", "PROBLEM", 22, 40], ["amyloidosis", "PROBLEM", 46, 57], ["vascular lesions of small muscular arteries", "PROBLEM", 62, 105], ["degeneration", "OBSERVATION", 8, 20], ["fibrinoid", "OBSERVATION_MODIFIER", 22, 31], ["necrosis", "OBSERVATION", 32, 40], ["amyloidosis", "OBSERVATION", 46, 57], ["vascular", "ANATOMY", 62, 70], ["lesions", "OBSERVATION", 71, 78], ["small", "ANATOMY_MODIFIER", 82, 87], ["muscular arteries", "ANATOMY", 88, 105], ["arterioles", "ANATOMY", 110, 120]]], ["Sudden rupture of the ascending aorta or pulmonary artery near the pulmonic valve in horses is associated with notable exertion and severe trauma to the ventral thorax from falling.", [["ascending aorta", "ANATOMY", 22, 37], ["pulmonary artery", "ANATOMY", 41, 57], ["pulmonic valve", "ANATOMY", 67, 81], ["ventral thorax", "ANATOMY", 153, 167], ["rupture of the ascending aorta", "DISEASE", 7, 37], ["trauma to the ventral thorax", "DISEASE", 139, 167], ["ascending aorta", "MULTI-TISSUE_STRUCTURE", 22, 37], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 41, 57], ["pulmonic valve", "PATHOLOGICAL_FORMATION", 67, 81], ["ventral thorax", "ORGAN", 153, 167], ["Sudden rupture of the ascending aorta", "PROBLEM", 0, 37], ["severe trauma to the ventral thorax", "PROBLEM", 132, 167], ["rupture", "OBSERVATION", 7, 14], ["ascending", "ANATOMY_MODIFIER", 22, 31], ["aorta", "ANATOMY", 32, 37], ["pulmonary artery", "ANATOMY", 41, 57], ["pulmonic valve", "ANATOMY", 67, 81], ["severe", "OBSERVATION_MODIFIER", 132, 138], ["trauma", "OBSERVATION", 139, 145], ["ventral", "ANATOMY_MODIFIER", 153, 160], ["thorax", "ANATOMY", 161, 167]]], ["Death ensues rapidly from cardiac tamponade because the tear is in that portion of the aorta or pulmonary artery within the pericardial sac.", [["cardiac", "ANATOMY", 26, 33], ["aorta", "ANATOMY", 87, 92], ["pulmonary artery", "ANATOMY", 96, 112], ["pericardial sac", "ANATOMY", 124, 139], ["Death", "DISEASE", 0, 5], ["cardiac tamponade", "DISEASE", 26, 43], ["cardiac", "ORGAN", 26, 33], ["aorta", "MULTI-TISSUE_STRUCTURE", 87, 92], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 96, 112], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 124, 139], ["cardiac tamponade", "PROBLEM", 26, 43], ["the tear", "PROBLEM", 52, 60], ["cardiac", "ANATOMY", 26, 33], ["tamponade", "OBSERVATION", 34, 43], ["tear", "OBSERVATION", 56, 60], ["portion", "ANATOMY_MODIFIER", 72, 79], ["aorta", "ANATOMY", 87, 92], ["pulmonary artery", "ANATOMY", 96, 112], ["pericardial sac", "ANATOMY", 124, 139]]], ["In horses, the internal carotid artery can rupture into the adjacent guttural pouch, with subsequent epistaxis.", [["internal carotid artery", "ANATOMY", 15, 38], ["guttural pouch", "ANATOMY", 69, 83], ["epistaxis", "DISEASE", 101, 110], ["internal carotid artery", "MULTI-TISSUE_STRUCTURE", 15, 38], ["guttural pouch", "ORGAN", 69, 83], ["rupture into the adjacent guttural pouch", "PROBLEM", 43, 83], ["subsequent epistaxis", "PROBLEM", 90, 110], ["internal carotid artery", "ANATOMY", 15, 38], ["rupture", "OBSERVATION", 43, 50], ["guttural pouch", "ANATOMY", 69, 83], ["epistaxis", "OBSERVATION", 101, 110]]], ["This is a consequence of deep mycotic infection of the guttural pouch.", [["guttural pouch", "ANATOMY", 55, 69], ["mycotic infection", "DISEASE", 30, 47], ["guttural pouch", "MULTI-TISSUE_STRUCTURE", 55, 69], ["deep mycotic infection of the guttural pouch", "PROBLEM", 25, 69], ["deep", "OBSERVATION_MODIFIER", 25, 29], ["mycotic", "OBSERVATION_MODIFIER", 30, 37], ["infection", "OBSERVATION", 38, 47], ["guttural pouch", "ANATOMY", 55, 69]]], ["Rupture of the middle uterine artery may occur during parturition in mares and with uterine torsion or prolapse in cows.", [["middle uterine artery", "ANATOMY", 15, 36], ["uterine", "ANATOMY", 84, 91], ["Rupture of the middle uterine artery", "DISEASE", 0, 36], ["uterine torsion", "DISEASE", 84, 99], ["prolapse", "DISEASE", 103, 111], ["uterine artery", "MULTI-TISSUE_STRUCTURE", 22, 36], ["mares", "ORGANISM_SUBDIVISION", 69, 74], ["uterine", "ORGAN", 84, 91], ["cows", "SPECIES", 115, 119], ["Rupture of the middle uterine artery", "PROBLEM", 0, 36], ["uterine torsion", "PROBLEM", 84, 99], ["prolapse in cows", "PROBLEM", 103, 119], ["middle uterine artery", "ANATOMY", 15, 36], ["uterine", "ANATOMY", 84, 91], ["torsion", "OBSERVATION", 92, 99], ["prolapse", "OBSERVATION", 103, 111]]], ["Aortic rupture, with or without dissection, is an important cause of death in male turkeys.", [["Aortic", "ANATOMY", 0, 6], ["Aortic rupture", "DISEASE", 0, 14], ["death", "DISEASE", 69, 74], ["Aortic", "MULTI-TISSUE_STRUCTURE", 0, 6], ["turkeys", "ORGANISM", 83, 90], ["turkeys", "SPECIES", 83, 90], ["turkeys", "SPECIES", 83, 90], ["Aortic rupture", "PROBLEM", 0, 14], ["dissection", "PROBLEM", 32, 42], ["death", "PROBLEM", 69, 74], ["rupture", "OBSERVATION", 7, 14], ["without", "UNCERTAINTY", 24, 31], ["dissection", "OBSERVATION", 32, 42]]], ["The most common vascular diseases with rupture are listed in Box 10-15.Disturbances of CirculationGastric Dilation and Volvulus.", [["vascular", "ANATOMY", 16, 24], ["vascular diseases", "DISEASE", 16, 33], ["rupture", "DISEASE", 39, 46], ["vascular", "MULTI-TISSUE_STRUCTURE", 16, 24], ["The most common vascular diseases", "PROBLEM", 0, 33], ["rupture", "PROBLEM", 39, 46], ["CirculationGastric Dilation", "PROBLEM", 87, 114], ["Volvulus", "PROBLEM", 119, 127], ["most", "OBSERVATION_MODIFIER", 4, 8], ["common", "OBSERVATION_MODIFIER", 9, 15], ["vascular", "ANATOMY", 16, 24], ["diseases", "OBSERVATION", 25, 33], ["rupture", "OBSERVATION", 39, 46], ["CirculationGastric Dilation", "OBSERVATION", 87, 114], ["Volvulus", "OBSERVATION", 119, 127]]], ["See the discussion on gastric dilation and volvulus in Chapter 7.Disturbances of Growth Neoplastic TransformationHemangiosarcoma.", [["gastric", "ANATOMY", 22, 29], ["gastric dilation and volvulus", "DISEASE", 22, 51], ["Hemangiosarcoma", "DISEASE", 113, 128], ["gastric", "ORGAN", 22, 29], ["gastric dilation", "TREATMENT", 22, 38], ["volvulus", "PROBLEM", 43, 51], ["Growth Neoplastic TransformationHemangiosarcoma", "PROBLEM", 81, 128], ["gastric", "ANATOMY", 22, 29], ["dilation", "OBSERVATION", 30, 38], ["volvulus", "OBSERVATION", 43, 51], ["Growth", "OBSERVATION_MODIFIER", 81, 87], ["Neoplastic", "OBSERVATION_MODIFIER", 88, 98], ["TransformationHemangiosarcoma", "OBSERVATION", 99, 128]]], ["Cardiac hemangiosarcoma is an important neoplasm of dogs and can arise either in the heart (primary) or by metastasis (secondary) from sites such as the spleen.", [["Cardiac hemangiosarcoma", "ANATOMY", 0, 23], ["neoplasm", "ANATOMY", 40, 48], ["heart", "ANATOMY", 85, 90], ["sites", "ANATOMY", 135, 140], ["spleen", "ANATOMY", 153, 159], ["Cardiac hemangiosarcoma", "DISEASE", 0, 23], ["Cardiac hemangiosarcoma", "CANCER", 0, 23], ["neoplasm", "CANCER", 40, 48], ["dogs", "ORGANISM", 52, 56], ["heart", "ORGAN", 85, 90], ["spleen", "ORGAN", 153, 159], ["dogs", "SPECIES", 52, 56], ["Cardiac hemangiosarcoma", "PROBLEM", 0, 23], ["an important neoplasm of dogs", "PROBLEM", 27, 56], ["metastasis", "PROBLEM", 107, 117], ["hemangiosarcoma", "OBSERVATION", 8, 23], ["important", "OBSERVATION_MODIFIER", 30, 39], ["neoplasm", "OBSERVATION", 40, 48], ["dogs", "OBSERVATION", 52, 56], ["heart", "ANATOMY", 85, 90], ["primary", "OBSERVATION_MODIFIER", 92, 99], ["metastasis", "OBSERVATION", 107, 117], ["spleen", "ANATOMY", 153, 159]]], ["This neoplasm is usually seen in the wall of the right atrium and only occasionally involves the right ventricle.", [["neoplasm", "ANATOMY", 5, 13], ["wall", "ANATOMY", 37, 41], ["right atrium", "ANATOMY", 49, 61], ["right ventricle", "ANATOMY", 97, 112], ["neoplasm", "DISEASE", 5, 13], ["neoplasm", "CANCER", 5, 13], ["wall", "TISSUE", 37, 41], ["atrium", "ORGAN", 55, 61], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 97, 112], ["This neoplasm", "PROBLEM", 0, 13], ["neoplasm", "OBSERVATION", 5, 13], ["wall", "ANATOMY_MODIFIER", 37, 41], ["right atrium", "ANATOMY", 49, 61], ["right ventricle", "ANATOMY", 97, 112]]], ["The tumor arises from neoplastic transformation of vascular endothelium.", [["tumor", "ANATOMY", 4, 9], ["neoplastic", "ANATOMY", 22, 32], ["vascular endothelium", "ANATOMY", 51, 71], ["tumor", "DISEASE", 4, 9], ["tumor", "CANCER", 4, 9], ["vascular endothelium", "TISSUE", 51, 71], ["The tumor", "PROBLEM", 0, 9], ["neoplastic transformation of vascular endothelium", "PROBLEM", 22, 71], ["tumor", "OBSERVATION", 4, 9], ["neoplastic transformation", "OBSERVATION", 22, 47], ["vascular endothelium", "ANATOMY", 51, 71]]], ["Also see Disorders of Dogs, Blood and Lymphatic Vascular Systems, Blood Vessels, Disturbances of Growth, Neoplastic Transformation, Hemangiosarcoma and Hemangioma.Disturbances of Growth Neoplastic TransformationVascular Melanosis.", [["Blood", "ANATOMY", 28, 33], ["Blood Vessels", "ANATOMY", 66, 79], ["Neoplastic", "ANATOMY", 105, 115], ["Hemangiosarcoma", "ANATOMY", 132, 147], ["Hemangioma", "ANATOMY", 152, 162], ["Vascular", "ANATOMY", 211, 219], ["Neoplastic Transformation", "DISEASE", 105, 130], ["Hemangiosarcoma", "DISEASE", 132, 147], ["Hemangioma", "DISEASE", 152, 162], ["Blood", "ORGANISM_SUBSTANCE", 28, 33], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 38, 56], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 66, 79], ["Hemangiosarcoma", "CANCER", 132, 147], ["Hemangioma", "CANCER", 152, 162], ["Dogs", "TEST", 22, 26], ["Blood", "TEST", 28, 33], ["Disturbances of Growth", "PROBLEM", 81, 103], ["Neoplastic Transformation", "PROBLEM", 105, 130], ["Hemangiosarcoma", "PROBLEM", 132, 147], ["Hemangioma", "PROBLEM", 152, 162], ["Disturbances of Growth Neoplastic TransformationVascular Melanosis", "PROBLEM", 163, 229], ["Blood", "ANATOMY", 28, 33], ["Lymphatic", "ANATOMY_MODIFIER", 38, 47], ["Vascular Systems", "ANATOMY", 48, 64], ["Blood Vessels", "ANATOMY", 66, 79], ["Growth", "OBSERVATION_MODIFIER", 97, 103], ["Neoplastic Transformation", "OBSERVATION", 105, 130], ["Hemangiosarcoma", "OBSERVATION", 132, 147], ["Hemangioma", "OBSERVATION", 152, 162], ["Growth", "OBSERVATION_MODIFIER", 179, 185], ["Neoplastic", "OBSERVATION_MODIFIER", 186, 196], ["Vascular", "ANATOMY", 211, 219], ["Melanosis", "OBSERVATION", 220, 229]]], ["See the discussion on vascular melanosis in Chapters 1 and 2.Disturbances of Growth Neoplastic TransformationCell Degeneration and Death.", [["vascular", "ANATOMY", 22, 30], ["Cell", "ANATOMY", 109, 113], ["vascular melanosis", "DISEASE", 22, 40], ["Death", "DISEASE", 131, 136], ["vascular", "MULTI-TISSUE_STRUCTURE", 22, 30], ["Cell", "CELL", 109, 113], ["Growth Neoplastic TransformationCell Degeneration", "PROBLEM", 77, 126], ["Death", "PROBLEM", 131, 136], ["vascular", "ANATOMY", 22, 30], ["melanosis", "OBSERVATION", 31, 40], ["Growth", "OBSERVATION_MODIFIER", 77, 83], ["Neoplastic TransformationCell Degeneration", "OBSERVATION", 84, 126]]], ["Toxicants that affect vessels are listed in E-Box 10-1.Disturbances of Growth Neoplastic TransformationSee Chapter 1.", [["vessels", "ANATOMY", 22, 29], ["vessels", "MULTI-TISSUE_STRUCTURE", 22, 29], ["E-Box 10-1", "GENE_OR_GENE_PRODUCT", 44, 54], ["E-Box 10-1", "DNA", 44, 54], ["vessels", "ANATOMY", 22, 29], ["Growth Neoplastic", "OBSERVATION", 71, 88]]], ["Generalized vascular degenerative diseases in animals are classified into the following three principal groups: \u2022 Arteriosclerosis \u2022 Atherosclerosis \u2022 Arterial medial calcification Hyaline degeneration, fibrinoid necrosis, and amyloidosis also occur in all animal species.Disturbances of Growth Neoplastic TransformationArteriosclerosis.", [["vascular", "ANATOMY", 12, 20], ["Arterial", "ANATOMY", 151, 159], ["fibrinoid", "ANATOMY", 203, 212], ["vascular degenerative diseases", "DISEASE", 12, 42], ["Arteriosclerosis", "DISEASE", 114, 130], ["Atherosclerosis", "DISEASE", 133, 148], ["calcification", "DISEASE", 167, 180], ["fibrinoid necrosis", "DISEASE", 203, 221], ["amyloidosis", "DISEASE", 227, 238], ["Neoplastic TransformationArteriosclerosis", "DISEASE", 295, 336], ["vascular", "MULTI-TISSUE_STRUCTURE", 12, 20], ["Generalized vascular degenerative diseases", "PROBLEM", 0, 42], ["Arteriosclerosis", "PROBLEM", 114, 130], ["Atherosclerosis", "PROBLEM", 133, 148], ["Arterial medial calcification", "PROBLEM", 151, 180], ["Hyaline degeneration", "PROBLEM", 181, 201], ["fibrinoid necrosis", "PROBLEM", 203, 221], ["amyloidosis", "PROBLEM", 227, 238], ["all animal species", "PROBLEM", 253, 271], ["Growth Neoplastic TransformationArteriosclerosis", "PROBLEM", 288, 336], ["vascular", "ANATOMY", 12, 20], ["degenerative", "OBSERVATION", 21, 33], ["Arteriosclerosis", "OBSERVATION", 114, 130], ["Atherosclerosis", "OBSERVATION", 133, 148], ["Arterial", "ANATOMY_MODIFIER", 151, 159], ["medial", "OBSERVATION_MODIFIER", 160, 166], ["calcification", "OBSERVATION_MODIFIER", 167, 180], ["Hyaline", "OBSERVATION_MODIFIER", 181, 188], ["degeneration", "OBSERVATION", 189, 201], ["fibrinoid", "OBSERVATION_MODIFIER", 203, 212], ["necrosis", "OBSERVATION", 213, 221], ["amyloidosis", "OBSERVATION", 227, 238], ["all animal", "OBSERVATION_MODIFIER", 253, 263], ["species", "OBSERVATION", 264, 271], ["Growth", "OBSERVATION_MODIFIER", 288, 294], ["Neoplastic TransformationArteriosclerosis", "OBSERVATION", 295, 336]]], ["Arteriosclerosis is characterized by intimal fibrosis of large elastic arteries, atherosclerosis is characterized by intimal and medial lipid deposits in elastic and muscular arteries, and arterial medial calcification has characteristic mineralization of the walls of elastic and muscular arteries.Disturbances of Growth Neoplastic TransformationArteriosclerosis is an age-related disease that occurs frequently in many animal species but rarely causes clinical signs.", [["intimal", "ANATOMY", 37, 44], ["elastic arteries", "ANATOMY", 63, 79], ["intimal", "ANATOMY", 117, 124], ["medial lipid", "ANATOMY", 129, 141], ["elastic", "ANATOMY", 154, 161], ["muscular arteries", "ANATOMY", 166, 183], ["arterial medial", "ANATOMY", 189, 204], ["walls", "ANATOMY", 260, 265], ["elastic", "ANATOMY", 269, 276], ["muscular arteries", "ANATOMY", 281, 298], ["Arteriosclerosis", "DISEASE", 0, 16], ["fibrosis", "DISEASE", 45, 53], ["atherosclerosis", "DISEASE", 81, 96], ["calcification", "DISEASE", 205, 218], ["Neoplastic TransformationArteriosclerosis", "DISEASE", 322, 363], ["intimal", "TISSUE", 37, 44], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 63, 79], ["intimal", "TISSUE", 117, 124], ["elastic", "TISSUE", 154, 161], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 166, 183], ["arterial medial", "MULTI-TISSUE_STRUCTURE", 189, 204], ["elastic", "TISSUE", 269, 276], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 281, 298], ["Arteriosclerosis", "PROBLEM", 0, 16], ["intimal fibrosis of large elastic arteries", "PROBLEM", 37, 79], ["atherosclerosis", "PROBLEM", 81, 96], ["intimal and medial lipid deposits in elastic and muscular arteries", "PROBLEM", 117, 183], ["arterial medial calcification", "PROBLEM", 189, 218], ["Disturbances of Growth Neoplastic TransformationArteriosclerosis", "PROBLEM", 299, 363], ["related disease", "PROBLEM", 374, 389], ["intimal", "OBSERVATION_MODIFIER", 37, 44], ["fibrosis", "OBSERVATION", 45, 53], ["large", "OBSERVATION_MODIFIER", 57, 62], ["elastic arteries", "ANATOMY", 63, 79], ["atherosclerosis", "OBSERVATION", 81, 96], ["intimal", "OBSERVATION_MODIFIER", 117, 124], ["medial", "OBSERVATION_MODIFIER", 129, 135], ["lipid deposits", "OBSERVATION", 136, 150], ["elastic", "ANATOMY_MODIFIER", 154, 161], ["muscular arteries", "ANATOMY", 166, 183], ["arterial", "ANATOMY_MODIFIER", 189, 197], ["medial", "ANATOMY_MODIFIER", 198, 204], ["calcification", "OBSERVATION", 205, 218], ["characteristic", "OBSERVATION_MODIFIER", 223, 237], ["mineralization", "OBSERVATION", 238, 252], ["walls", "ANATOMY_MODIFIER", 260, 265], ["elastic", "ANATOMY_MODIFIER", 269, 276], ["muscular arteries", "ANATOMY", 281, 298], ["Growth", "OBSERVATION_MODIFIER", 315, 321], ["Neoplastic", "OBSERVATION_MODIFIER", 322, 332], ["Transformation", "OBSERVATION_MODIFIER", 333, 347], ["Arteriosclerosis", "OBSERVATION", 347, 363]]], ["The disease develops as chronic degenerative and proliferative responses in the arterial wall and results in loss of elasticity (\"hardening of the arteries\") and, less often, luminal narrowing.", [["arterial wall", "ANATOMY", 80, 93], ["arteries", "ANATOMY", 147, 155], ["luminal", "ANATOMY", 175, 182], ["loss of elasticity", "DISEASE", 109, 127], ["luminal", "CHEMICAL", 175, 182], ["arterial wall", "MULTI-TISSUE_STRUCTURE", 80, 93], ["arteries", "MULTI-TISSUE_STRUCTURE", 147, 155], ["luminal", "IMMATERIAL_ANATOMICAL_ENTITY", 175, 182], ["The disease", "PROBLEM", 0, 11], ["chronic degenerative and proliferative responses in the arterial wall", "PROBLEM", 24, 93], ["loss of elasticity (\"hardening of the arteries\"", "PROBLEM", 109, 156], ["luminal narrowing", "PROBLEM", 175, 192], ["disease", "OBSERVATION", 4, 11], ["chronic", "OBSERVATION_MODIFIER", 24, 31], ["degenerative", "OBSERVATION", 32, 44], ["proliferative responses", "OBSERVATION", 49, 72], ["arterial", "ANATOMY", 80, 88], ["wall", "ANATOMY_MODIFIER", 89, 93], ["loss", "OBSERVATION_MODIFIER", 109, 113], ["elasticity", "OBSERVATION_MODIFIER", 117, 127], ["arteries", "ANATOMY", 147, 155], ["less", "OBSERVATION_MODIFIER", 163, 167], ["often", "OBSERVATION_MODIFIER", 168, 173], ["luminal", "ANATOMY_MODIFIER", 175, 182], ["narrowing", "OBSERVATION", 183, 192]]], ["The abdominal aorta is most frequently affected, but other elastic arteries and peripheral large muscular vessels may be involved.", [["abdominal aorta", "ANATOMY", 4, 19], ["elastic arteries", "ANATOMY", 59, 75], ["muscular vessels", "ANATOMY", 97, 113], ["abdominal aorta", "MULTI-TISSUE_STRUCTURE", 4, 19], ["elastic arteries", "MULTI-TISSUE_STRUCTURE", 59, 75], ["muscular vessels", "MULTI-TISSUE_STRUCTURE", 97, 113], ["abdominal aorta", "ANATOMY", 4, 19], ["frequently", "OBSERVATION_MODIFIER", 28, 38], ["affected", "OBSERVATION", 39, 47], ["elastic", "OBSERVATION", 59, 66], ["arteries", "ANATOMY", 67, 75], ["peripheral", "ANATOMY_MODIFIER", 80, 90], ["large", "OBSERVATION_MODIFIER", 91, 96], ["muscular vessels", "ANATOMY", 97, 113], ["may be", "UNCERTAINTY", 114, 120]]], ["Lesions are often localized around the orifices of arterial branches.", [["orifices", "ANATOMY", 39, 47], ["arterial branches", "ANATOMY", 51, 68], ["arterial branches", "MULTI-TISSUE_STRUCTURE", 51, 68], ["Lesions", "PROBLEM", 0, 7], ["orifices", "ANATOMY_MODIFIER", 39, 47], ["arterial", "ANATOMY", 51, 59], ["branches", "ANATOMY_MODIFIER", 60, 68]]], ["Etiologic factors in the development of arteriosclerosis are not well defined, but the significant role of hemodynamic influences is suggested by the frequent Fibrinoid necrosis of arteries is associated with endothelial damage and is characterized by entry and accumulation of serum proteins followed by fibrin polymerization in the vessel wall.", [["arteries", "ANATOMY", 181, 189], ["endothelial", "ANATOMY", 209, 220], ["serum", "ANATOMY", 278, 283], ["vessel wall", "ANATOMY", 334, 345], ["arteriosclerosis", "DISEASE", 40, 56], ["necrosis", "DISEASE", 169, 177], ["endothelial damage", "DISEASE", 209, 227], ["arteries", "MULTI-TISSUE_STRUCTURE", 181, 189], ["endothelial", "TISSUE", 209, 220], ["serum", "ORGANISM_SUBSTANCE", 278, 283], ["fibrin", "GENE_OR_GENE_PRODUCT", 305, 311], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 334, 345], ["serum proteins", "PROTEIN", 278, 292], ["fibrin", "PROTEIN", 305, 311], ["Etiologic factors", "PROBLEM", 0, 17], ["arteriosclerosis", "PROBLEM", 40, 56], ["the frequent Fibrinoid necrosis of arteries", "PROBLEM", 146, 189], ["endothelial damage", "PROBLEM", 209, 227], ["serum proteins", "PROBLEM", 278, 292], ["fibrin polymerization in the vessel wall", "PROBLEM", 305, 345], ["arteriosclerosis", "OBSERVATION", 40, 56], ["not", "UNCERTAINTY", 61, 64], ["well defined", "OBSERVATION_MODIFIER", 65, 77], ["significant", "OBSERVATION_MODIFIER", 87, 98], ["hemodynamic influences", "OBSERVATION", 107, 129], ["frequent", "OBSERVATION_MODIFIER", 150, 158], ["Fibrinoid", "OBSERVATION_MODIFIER", 159, 168], ["necrosis", "OBSERVATION", 169, 177], ["arteries", "ANATOMY", 181, 189], ["associated with", "UNCERTAINTY", 193, 208], ["endothelial damage", "OBSERVATION", 209, 227], ["serum proteins", "OBSERVATION", 278, 292], ["fibrin polymerization", "OBSERVATION", 305, 326], ["vessel", "ANATOMY", 334, 340], ["wall", "ANATOMY_MODIFIER", 341, 345]]], ["These materials form an intensely eosinophilic collar that obliterates cellular detail.", [["cellular", "ANATOMY", 71, 79], ["cellular", "CELL", 71, 79], ["an intensely eosinophilic collar", "TREATMENT", 21, 53], ["intensely", "OBSERVATION_MODIFIER", 24, 33], ["eosinophilic collar", "OBSERVATION", 34, 53], ["cellular detail", "OBSERVATION", 71, 86]]], ["This lesion is frequent in many acute degenerative and inflammatory diseases of small arteries and arterioles.", [["lesion", "ANATOMY", 5, 11], ["small arteries", "ANATOMY", 80, 94], ["arterioles", "ANATOMY", 99, 109], ["small arteries", "MULTI-TISSUE_STRUCTURE", 80, 94], ["arterioles", "MULTI-TISSUE_STRUCTURE", 99, 109], ["This lesion", "PROBLEM", 0, 11], ["many acute degenerative and inflammatory diseases of small arteries and arterioles", "PROBLEM", 27, 109], ["lesion", "OBSERVATION", 5, 11], ["frequent", "OBSERVATION_MODIFIER", 15, 23], ["many", "OBSERVATION_MODIFIER", 27, 31], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["degenerative", "OBSERVATION", 38, 50], ["inflammatory", "OBSERVATION", 55, 67], ["small arteries", "ANATOMY", 80, 94], ["arterioles", "ANATOMY", 99, 109]]], ["Fibrinoid necrosis is seen frequently in dogs with uremia and in dogs with hypertension, although hypertension is an uncommon finding in animals.Disturbances of Growth Neoplastic TransformationVitamin E-Selenium Deficiency.", [["necrosis", "DISEASE", 10, 18], ["uremia", "DISEASE", 51, 57], ["hypertension", "DISEASE", 75, 87], ["hypertension", "DISEASE", 98, 110], ["dogs", "ORGANISM", 41, 45], ["dogs", "ORGANISM", 65, 69], ["dogs", "SPECIES", 41, 45], ["dogs", "SPECIES", 65, 69], ["Fibrinoid necrosis", "PROBLEM", 0, 18], ["uremia", "PROBLEM", 51, 57], ["hypertension", "PROBLEM", 75, 87], ["hypertension", "PROBLEM", 98, 110], ["Disturbances of Growth Neoplastic TransformationVitamin E-Selenium Deficiency", "PROBLEM", 145, 222], ["necrosis", "OBSERVATION", 10, 18], ["uremia", "OBSERVATION", 51, 57], ["hypertension", "OBSERVATION", 75, 87], ["hypertension", "OBSERVATION", 98, 110], ["uncommon", "OBSERVATION_MODIFIER", 117, 125], ["Growth", "OBSERVATION_MODIFIER", 161, 167], ["Neoplastic", "OBSERVATION_MODIFIER", 168, 178], ["TransformationVitamin E-Selenium Deficiency", "OBSERVATION", 179, 222]]], ["See the discussion on vitamin E-selenium deficiency in the section on Disorders of Pigs. in all animal species.", [["vitamin E", "CHEMICAL", 22, 31], ["selenium", "CHEMICAL", 32, 40], ["vitamin E", "CHEMICAL", 22, 31], ["selenium", "CHEMICAL", 32, 40], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 22, 40], ["Pigs", "ORGANISM", 83, 87], ["Pigs", "SPECIES", 83, 87], ["vitamin E", "TREATMENT", 22, 31], ["selenium deficiency", "PROBLEM", 32, 51], ["Pigs", "TREATMENT", 83, 87], ["all", "OBSERVATION_MODIFIER", 92, 95], ["animal species", "OBSERVATION", 96, 110]]], ["These lesions are generally not detected grossly, but in some diseases with fibrinoid necrosis of vessels, hemorrhages and edema are seen in affected organs at necropsy.", [["lesions", "ANATOMY", 6, 13], ["vessels", "ANATOMY", 98, 105], ["edema", "ANATOMY", 123, 128], ["organs", "ANATOMY", 150, 156], ["necrosis", "DISEASE", 86, 94], ["hemorrhages", "DISEASE", 107, 118], ["edema", "DISEASE", 123, 128], ["lesions", "CANCER", 6, 13], ["vessels", "MULTI-TISSUE_STRUCTURE", 98, 105], ["edema", "PATHOLOGICAL_FORMATION", 123, 128], ["organs", "ORGAN", 150, 156], ["These lesions", "PROBLEM", 0, 13], ["some diseases", "PROBLEM", 57, 70], ["fibrinoid necrosis of vessels", "PROBLEM", 76, 105], ["hemorrhages", "PROBLEM", 107, 118], ["edema", "PROBLEM", 123, 128], ["lesions", "OBSERVATION", 6, 13], ["generally not", "UNCERTAINTY", 18, 31], ["fibrinoid", "OBSERVATION_MODIFIER", 76, 85], ["necrosis", "OBSERVATION", 86, 94], ["vessels", "ANATOMY", 98, 105], ["hemorrhages", "OBSERVATION", 107, 118], ["edema", "OBSERVATION", 123, 128]]], ["The microscopic feature shared by these lesions is the formation of a homogeneous eosinophilic zone in the vessel wall ( Fig. 10-69 ; also see Fig. 10-78) .", [["lesions", "ANATOMY", 40, 47], ["eosinophilic zone", "ANATOMY", 82, 99], ["vessel wall", "ANATOMY", 107, 118], ["lesions", "PATHOLOGICAL_FORMATION", 40, 47], ["eosinophilic zone", "PATHOLOGICAL_FORMATION", 82, 99], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 107, 118], ["these lesions", "PROBLEM", 34, 47], ["a homogeneous eosinophilic zone", "PROBLEM", 68, 99], ["lesions", "OBSERVATION", 40, 47], ["homogeneous", "OBSERVATION_MODIFIER", 70, 81], ["eosinophilic zone", "OBSERVATION", 82, 99], ["vessel", "ANATOMY", 107, 113], ["wall", "ANATOMY_MODIFIER", 114, 118]]], ["Special stains allow differentiation into three types:Disturbances of Growth Neoplastic Transformation(1) amyloid confirmed by Congo red and methyl violet; (2) fibrinoid deposits, positive by the periodic acid-Schiff technique; and (3) negative staining of hyaline deposits by these stains.", [["fibrinoid deposits", "ANATOMY", 160, 178], ["hyaline deposits", "ANATOMY", 257, 273], ["amyloid", "DISEASE", 106, 113], ["methyl violet", "CHEMICAL", 141, 154], ["Congo red", "CHEMICAL", 127, 136], ["methyl violet", "CHEMICAL", 141, 154], ["Congo red", "SIMPLE_CHEMICAL", 127, 136], ["methyl violet", "SIMPLE_CHEMICAL", 141, 154], ["fibrinoid", "TISSUE", 160, 169], ["Special stains", "TEST", 0, 14], ["Growth Neoplastic Transformation", "PROBLEM", 70, 102], ["amyloid", "PROBLEM", 106, 113], ["Congo red and methyl violet", "PROBLEM", 127, 154], ["fibrinoid deposits", "PROBLEM", 160, 178], ["the periodic acid-Schiff technique", "TEST", 192, 226], ["hyaline deposits", "PROBLEM", 257, 273], ["these stains", "TEST", 277, 289], ["Growth Neoplastic Transformation", "OBSERVATION", 70, 102], ["methyl violet", "OBSERVATION", 141, 154], ["fibrinoid deposits", "OBSERVATION", 160, 178], ["hyaline deposits", "OBSERVATION", 257, 273]]], ["Amyloidosis and hyaline degeneration are often observed in small muscular arteries of the myocardium, lungs, and spleen of old dogs.", [["hyaline", "ANATOMY", 16, 23], ["muscular arteries", "ANATOMY", 65, 82], ["myocardium", "ANATOMY", 90, 100], ["lungs", "ANATOMY", 102, 107], ["spleen", "ANATOMY", 113, 119], ["Amyloidosis", "DISEASE", 0, 11], ["hyaline degeneration", "DISEASE", 16, 36], ["hyaline", "TISSUE", 16, 23], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 65, 82], ["myocardium", "MULTI-TISSUE_STRUCTURE", 90, 100], ["lungs", "ORGAN", 102, 107], ["spleen", "ORGAN", 113, 119], ["dogs", "ORGANISM", 127, 131], ["dogs", "SPECIES", 127, 131], ["Amyloidosis", "PROBLEM", 0, 11], ["hyaline degeneration", "PROBLEM", 16, 36], ["old dogs", "PROBLEM", 123, 131], ["hyaline degeneration", "OBSERVATION", 16, 36], ["small", "ANATOMY_MODIFIER", 59, 64], ["muscular arteries", "ANATOMY", 65, 82], ["myocardium", "ANATOMY", 90, 100], ["lungs", "ANATOMY", 102, 107], ["spleen", "ANATOMY", 113, 119], ["dogs", "OBSERVATION", 127, 131]]], ["Lesions in the an osmotic pressure that allows fluid to be drawn into the interstitial compartment from tissues with a lower osmotic gradient (protein concentration).", [["fluid", "ANATOMY", 47, 52], ["interstitial compartment", "ANATOMY", 74, 98], ["tissues", "ANATOMY", 104, 111], ["interstitial compartment", "TISSUE", 74, 98], ["tissues", "TISSUE", 104, 111], ["Lesions", "PROBLEM", 0, 7], ["the an osmotic pressure", "TEST", 11, 34], ["fluid", "PROBLEM", 47, 52], ["a lower osmotic gradient (protein concentration", "TREATMENT", 117, 164], ["osmotic pressure", "OBSERVATION", 18, 34], ["fluid", "OBSERVATION", 47, 52], ["interstitial", "ANATOMY_MODIFIER", 74, 86], ["compartment", "ANATOMY_MODIFIER", 87, 98], ["tissues", "ANATOMY", 104, 111], ["lower", "OBSERVATION_MODIFIER", 119, 124], ["osmotic gradient", "OBSERVATION", 125, 141]]], ["Lymphedema can be divided into six etiologic categories: overload, inadequate collection, abnormal lymphatic contractility, insufficient lymphatic vessels, lymph node obstruction, and structural defects in lymphatic vessels.", [["lymphatic", "ANATOMY", 99, 108], ["lymphatic vessels", "ANATOMY", 137, 154], ["lymph node", "ANATOMY", 156, 166], ["lymphatic vessels", "ANATOMY", 206, 223], ["Lymphedema", "DISEASE", 0, 10], ["lymph node obstruction", "DISEASE", 156, 178], ["lymphatic", "MULTI-TISSUE_STRUCTURE", 99, 108], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 137, 154], ["lymph node", "MULTI-TISSUE_STRUCTURE", 156, 166], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 206, 223], ["Lymphedema", "PROBLEM", 0, 10], ["overload", "PROBLEM", 57, 65], ["inadequate collection", "PROBLEM", 67, 88], ["abnormal lymphatic contractility", "PROBLEM", 90, 122], ["insufficient lymphatic vessels", "PROBLEM", 124, 154], ["lymph node obstruction", "PROBLEM", 156, 178], ["structural defects in lymphatic vessels", "PROBLEM", 184, 223], ["overload", "OBSERVATION", 57, 65], ["inadequate", "OBSERVATION_MODIFIER", 67, 77], ["collection", "OBSERVATION", 78, 88], ["abnormal", "OBSERVATION_MODIFIER", 90, 98], ["lymphatic contractility", "OBSERVATION", 99, 122], ["insufficient", "OBSERVATION_MODIFIER", 124, 136], ["lymphatic vessels", "ANATOMY", 137, 154], ["lymph node obstruction", "OBSERVATION", 156, 178], ["structural", "OBSERVATION_MODIFIER", 184, 194], ["defects", "OBSERVATION", 195, 202], ["lymphatic vessels", "ANATOMY", 206, 223]]], ["Primary lymphedema is caused by aplasia, hypoplasia, or dysplasia of lymphatic ducts, vessels, and/or lymph nodes, whereas secondary lymphedema is an acquired defect due to various disease processes (e.g., neoplasia, radiation, parasites).", [["lymphatic ducts", "ANATOMY", 69, 84], ["vessels", "ANATOMY", 86, 93], ["lymph nodes", "ANATOMY", 102, 113], ["neoplasia", "ANATOMY", 206, 215], ["lymphedema", "DISEASE", 8, 18], ["aplasia", "DISEASE", 32, 39], ["hypoplasia", "DISEASE", 41, 51], ["dysplasia of lymphatic ducts", "DISEASE", 56, 84], ["lymphedema", "DISEASE", 133, 143], ["neoplasia", "DISEASE", 206, 215], ["lymphatic ducts", "MULTI-TISSUE_STRUCTURE", 69, 84], ["vessels", "MULTI-TISSUE_STRUCTURE", 86, 93], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 102, 113], ["neoplasia", "CANCER", 206, 215], ["Primary lymphedema", "PROBLEM", 0, 18], ["aplasia", "PROBLEM", 32, 39], ["hypoplasia", "PROBLEM", 41, 51], ["dysplasia of lymphatic ducts, vessels, and/or lymph nodes", "PROBLEM", 56, 113], ["secondary lymphedema", "PROBLEM", 123, 143], ["an acquired defect", "PROBLEM", 147, 165], ["various disease processes", "PROBLEM", 173, 198], ["neoplasia", "PROBLEM", 206, 215], ["parasites", "PROBLEM", 228, 237], ["lymphedema", "OBSERVATION", 8, 18], ["aplasia", "OBSERVATION", 32, 39], ["hypoplasia", "OBSERVATION", 41, 51], ["dysplasia", "OBSERVATION", 56, 65], ["lymphatic ducts", "ANATOMY", 69, 84], ["vessels", "ANATOMY", 86, 93], ["lymph nodes", "OBSERVATION", 102, 113], ["secondary", "OBSERVATION_MODIFIER", 123, 132], ["lymphedema", "OBSERVATION", 133, 143], ["defect", "OBSERVATION", 159, 165], ["various", "OBSERVATION_MODIFIER", 173, 180], ["disease", "OBSERVATION", 181, 188], ["neoplasia", "OBSERVATION", 206, 215]]], ["Primary lymphedema is rare in both dogs and cats, but it is more common in dogs.", [["Primary lymphedema", "DISEASE", 0, 18], ["dogs", "ORGANISM", 35, 39], ["cats", "ORGANISM", 44, 48], ["dogs", "ORGANISM", 75, 79], ["dogs", "SPECIES", 35, 39], ["cats", "SPECIES", 44, 48], ["dogs", "SPECIES", 75, 79], ["Primary lymphedema", "PROBLEM", 0, 18], ["lymphedema", "OBSERVATION", 8, 18], ["rare", "OBSERVATION_MODIFIER", 22, 26], ["both", "OBSERVATION_MODIFIER", 30, 34], ["dogs", "OBSERVATION", 35, 39]]], ["It can be temporary or permanent, and it usually affects the distal extremities, mainly of the hindlimbs.", [["distal extremities", "ANATOMY", 61, 79], ["hindlimbs", "ANATOMY", 95, 104], ["distal extremities", "ORGANISM_SUBDIVISION", 61, 79], ["hindlimbs", "ORGANISM_SUBDIVISION", 95, 104], ["temporary", "OBSERVATION_MODIFIER", 10, 19], ["permanent", "OBSERVATION", 23, 32], ["distal", "ANATOMY_MODIFIER", 61, 67], ["extremities", "ANATOMY", 68, 79], ["hindlimbs", "ANATOMY", 95, 104]]], ["Secondary lymphedema due to lymphatic filariasis in cats is common in tropical countries and is caused by Brugia spp., such as Brugia malayi and Brugia pahangi.", [["lymphatic", "ANATOMY", 28, 37], ["Secondary lymphedema", "DISEASE", 0, 20], ["lymphatic filariasis", "DISEASE", 28, 48], ["Brugia spp.", "DISEASE", 106, 117], ["Brugia malayi", "DISEASE", 127, 140], ["Brugia pahangi", "DISEASE", 145, 159], ["cats", "ORGANISM", 52, 56], ["Brugia spp.", "ORGANISM", 106, 117], ["Brugia malayi", "ORGANISM", 127, 140], ["Brugia pahangi", "ORGANISM", 145, 159], ["cats", "SPECIES", 52, 56], ["Brugia spp.", "SPECIES", 106, 117], ["Brugia malayi", "SPECIES", 127, 140], ["Brugia pahangi", "SPECIES", 145, 159], ["Brugia spp.", "SPECIES", 106, 117], ["Brugia malayi", "SPECIES", 127, 140], ["Brugia pahangi", "SPECIES", 145, 159], ["Secondary lymphedema", "PROBLEM", 0, 20], ["lymphatic filariasis in cats", "PROBLEM", 28, 56], ["Brugia spp.", "PROBLEM", 106, 117], ["Brugia malayi", "PROBLEM", 127, 140], ["Brugia pahangi", "PROBLEM", 145, 159], ["lymphedema", "OBSERVATION", 10, 20], ["lymphatic", "ANATOMY", 28, 37], ["filariasis", "OBSERVATION", 38, 48], ["Brugia", "OBSERVATION", 106, 112], ["Brugia pahangi", "OBSERVATION", 145, 159]]], ["Chronic lymphedema, regardless of its etiology, results in secondary fibrosis, which worsens edema and creates a vicious cycle that leads to chronic progressive lymphedema.Disturbances of Growth Neoplastic TransformationDisturbances of Growth.", [["edema", "ANATOMY", 93, 98], ["lymphedema", "DISEASE", 8, 18], ["fibrosis", "DISEASE", 69, 77], ["edema", "DISEASE", 93, 98], ["lymphedema", "DISEASE", 161, 171], ["edema", "PATHOLOGICAL_FORMATION", 93, 98], ["Chronic lymphedema", "PROBLEM", 0, 18], ["secondary fibrosis", "PROBLEM", 59, 77], ["edema", "PROBLEM", 93, 98], ["a vicious cycle", "PROBLEM", 111, 126], ["chronic progressive lymphedema", "PROBLEM", 141, 171], ["Growth Neoplastic TransformationDisturbances of Growth", "PROBLEM", 188, 242], ["lymphedema", "OBSERVATION", 8, 18], ["secondary", "OBSERVATION_MODIFIER", 59, 68], ["fibrosis", "OBSERVATION", 69, 77], ["worsens", "OBSERVATION_MODIFIER", 85, 92], ["edema", "OBSERVATION", 93, 98], ["chronic", "OBSERVATION_MODIFIER", 141, 148], ["progressive", "OBSERVATION_MODIFIER", 149, 160], ["lymphedema", "OBSERVATION", 161, 171], ["Growth", "OBSERVATION_MODIFIER", 188, 194], ["Neoplastic TransformationDisturbances", "OBSERVATION", 195, 232], ["Growth", "OBSERVATION_MODIFIER", 236, 242]]], ["See the discussion on anomalies and dysplasia in the section on Disorders of Domestic Animals, Developmental Errors/Congenital Anomalies: Blood and Lymphatic Vascular Systems.Disturbances of Growth Neoplastic TransformationNeoplastic Transformation.", [["Blood", "ANATOMY", 138, 143], ["Vascular", "ANATOMY", 158, 166], ["dysplasia", "DISEASE", 36, 45], ["Developmental Errors", "DISEASE", 95, 115], ["Congenital Anomalies", "DISEASE", 116, 136], ["dysplasia", "PATHOLOGICAL_FORMATION", 36, 45], ["Blood", "ORGANISM_SUBSTANCE", 138, 143], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 148, 166], ["anomalies", "PROBLEM", 22, 31], ["dysplasia", "PROBLEM", 36, 45], ["Congenital Anomalies", "PROBLEM", 116, 136], ["Disturbances of Growth Neoplastic TransformationNeoplastic Transformation", "PROBLEM", 175, 248], ["dysplasia", "OBSERVATION", 36, 45], ["Blood", "ANATOMY", 138, 143], ["Lymphatic Vascular", "ANATOMY", 148, 166], ["Growth Neoplastic Transformation", "OBSERVATION", 191, 223], ["Neoplastic Transformation", "OBSERVATION", 223, 248]]], ["Lymphangioma is a rare benign neoplasm composed of lymphatic channels.", [["Lymphangioma", "ANATOMY", 0, 12], ["benign neoplasm", "ANATOMY", 23, 38], ["lymphatic", "ANATOMY", 51, 60], ["Lymphangioma", "DISEASE", 0, 12], ["neoplasm", "DISEASE", 30, 38], ["Lymphangioma", "CANCER", 0, 12], ["benign neoplasm", "CANCER", 23, 38], ["lymphatic", "ORGAN", 51, 60], ["Lymphangioma", "PROBLEM", 0, 12], ["a rare benign neoplasm", "PROBLEM", 16, 38], ["lymphatic channels", "PROBLEM", 51, 69], ["rare", "OBSERVATION_MODIFIER", 18, 22], ["benign", "OBSERVATION_MODIFIER", 23, 29], ["neoplasm", "OBSERVATION", 30, 38], ["lymphatic channels", "OBSERVATION", 51, 69]]], ["Lymphangiosarcoma, the malignant counterpart, occurs more often than the benign neoplasm.", [["Lymphangiosarcoma", "ANATOMY", 0, 17], ["malignant counterpart", "ANATOMY", 23, 44], ["benign neoplasm", "ANATOMY", 73, 88], ["Lymphangiosarcoma", "DISEASE", 0, 17], ["neoplasm", "DISEASE", 80, 88], ["Lymphangiosarcoma", "CANCER", 0, 17], ["benign neoplasm", "CANCER", 73, 88], ["Lymphangiosarcoma", "PROBLEM", 0, 17], ["the malignant counterpart", "PROBLEM", 19, 44], ["the benign neoplasm", "PROBLEM", 69, 88], ["malignant", "OBSERVATION_MODIFIER", 23, 32], ["more often", "OBSERVATION_MODIFIER", 53, 63], ["benign", "OBSERVATION_MODIFIER", 73, 79], ["neoplasm", "OBSERVATION", 80, 88]]], ["Vascular spaces formed by neoplastic lymphatic endothelial cells contain lymph rather than blood.", [["Vascular spaces", "ANATOMY", 0, 15], ["neoplastic lymphatic endothelial cells", "ANATOMY", 26, 64], ["lymph", "ANATOMY", 73, 78], ["blood", "ANATOMY", 91, 96], ["Vascular", "MULTI-TISSUE_STRUCTURE", 0, 8], ["neoplastic lymphatic endothelial cells", "CELL", 26, 64], ["lymph", "ORGAN", 73, 78], ["blood", "ORGANISM_SUBSTANCE", 91, 96], ["neoplastic lymphatic endothelial cells", "CELL_TYPE", 26, 64], ["Vascular spaces", "TEST", 0, 15], ["neoplastic lymphatic endothelial cells", "PROBLEM", 26, 64], ["spaces", "OBSERVATION", 9, 15], ["neoplastic", "OBSERVATION_MODIFIER", 26, 36], ["lymphatic endothelial cells", "OBSERVATION", 37, 64], ["lymph", "OBSERVATION", 73, 78]]], ["Lymphatic vessels are frequently invaded by primary carcinomas and are a common route of metastasis (see the section on Disorders of Dogs).InflammationLymphangitis.", [["Lymphatic vessels", "ANATOMY", 0, 17], ["primary carcinomas", "ANATOMY", 44, 62], ["primary carcinomas", "DISEASE", 44, 62], ["InflammationLymphangitis", "DISEASE", 139, 163], ["Lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 0, 17], ["carcinomas", "CANCER", 52, 62], ["primary carcinomas", "PROBLEM", 44, 62], ["metastasis", "PROBLEM", 89, 99], ["InflammationLymphangitis", "PROBLEM", 139, 163], ["vessels", "ANATOMY", 10, 17], ["primary", "OBSERVATION_MODIFIER", 44, 51], ["carcinomas", "OBSERVATION", 52, 62], ["metastasis", "OBSERVATION", 89, 99]]], ["Lymphangitis is a feature of many diseases (see Box 10-8).", [["Lymphangitis", "DISEASE", 0, 12], ["Lymphangitis", "PROBLEM", 0, 12], ["many diseases", "PROBLEM", 29, 42], ["many", "OBSERVATION_MODIFIER", 29, 33], ["diseases", "OBSERVATION", 34, 42]]], ["The affected vessels are often located in the distal limbs and are thick, cordlike structures ( Fig. 10-70 ).", [["vessels", "ANATOMY", 13, 20], ["distal limbs", "ANATOMY", 46, 58], ["cordlike structures", "ANATOMY", 74, 93], ["vessels", "MULTI-TISSUE_STRUCTURE", 13, 20], ["limbs", "ORGANISM_SUBDIVISION", 53, 58], ["Fig.", "TEST", 96, 100], ["affected", "OBSERVATION", 4, 12], ["vessels", "ANATOMY", 13, 20], ["distal", "ANATOMY_MODIFIER", 46, 52], ["limbs", "ANATOMY", 53, 58], ["thick", "OBSERVATION", 67, 72]]], ["LymphedemaInflammationOmphalophlebitis (\"Navel Ill\").", [["LymphedemaInflammationOmphalophlebitis", "DISEASE", 0, 38], ["LymphedemaInflammationOmphalophlebitis", "PROBLEM", 0, 38]]], ["Omphalophlebitis (\"navel ill\") is inflammation of the umbilical vein that often occurs in neonatal farm animals because of bacterial contamination of the umbilicus immediately after parturition.", [["navel", "ANATOMY", 19, 24], ["umbilical vein", "ANATOMY", 54, 68], ["umbilicus", "ANATOMY", 154, 163], ["Omphalophlebitis", "DISEASE", 0, 16], ["navel ill", "DISEASE", 19, 28], ["inflammation of the umbilical vein", "DISEASE", 34, 68], ["navel", "ORGANISM_SUBDIVISION", 19, 24], ["umbilical vein", "MULTI-TISSUE_STRUCTURE", 54, 68], ["umbilicus", "ORGAN", 154, 163], ["Omphalophlebitis", "PROBLEM", 0, 16], ["inflammation of the umbilical vein", "PROBLEM", 34, 68], ["bacterial contamination of the umbilicus", "PROBLEM", 123, 163], ["inflammation", "OBSERVATION", 34, 46], ["umbilical vein", "ANATOMY", 54, 68], ["bacterial contamination", "OBSERVATION", 123, 146], ["umbilicus", "ANATOMY", 154, 163]]], ["Bacteria from this site can cause septicemia, suppurative polyarthritis, hepatic abscesses (the umbilical vein drains into the liver), and umbilical abscesses.InflammationJugular Thrombophlebitis.", [["site", "ANATOMY", 19, 23], ["hepatic abscesses", "ANATOMY", 73, 90], ["umbilical vein", "ANATOMY", 96, 110], ["liver", "ANATOMY", 127, 132], ["umbilical abscesses", "ANATOMY", 139, 158], ["septicemia", "DISEASE", 34, 44], ["polyarthritis", "DISEASE", 58, 71], ["hepatic abscesses", "DISEASE", 73, 90], ["umbilical abscesses", "DISEASE", 139, 158], ["Thrombophlebitis", "DISEASE", 179, 195], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 73, 90], ["umbilical vein", "MULTI-TISSUE_STRUCTURE", 96, 110], ["liver", "ORGAN", 127, 132], ["umbilical abscesses", "PATHOLOGICAL_FORMATION", 139, 158], ["Bacteria from this site", "PROBLEM", 0, 23], ["septicemia", "PROBLEM", 34, 44], ["suppurative polyarthritis", "PROBLEM", 46, 71], ["hepatic abscesses", "PROBLEM", 73, 90], ["the umbilical vein drains", "TREATMENT", 92, 117], ["umbilical abscesses", "PROBLEM", 139, 158], ["InflammationJugular Thrombophlebitis", "PROBLEM", 159, 195], ["septicemia", "OBSERVATION", 34, 44], ["suppurative", "OBSERVATION_MODIFIER", 46, 57], ["polyarthritis", "OBSERVATION", 58, 71], ["hepatic", "ANATOMY", 73, 80], ["abscesses", "OBSERVATION", 81, 90], ["umbilical vein", "ANATOMY", 96, 110], ["liver", "ANATOMY", 127, 132], ["umbilical", "ANATOMY", 139, 148], ["abscesses", "OBSERVATION", 149, 158], ["Thrombophlebitis", "OBSERVATION", 179, 195]]], ["Jugular thrombophlebitis may be associated with indwelling jugular catheters and is reported to be increased with several concurrent disease conditions, such as hypoproteinemia, salmonellosis, endotoxemia, and large intestinal disease (see Fig. 10-27) .", [["Jugular thrombophlebitis", "ANATOMY", 0, 24], ["indwelling jugular catheters", "ANATOMY", 48, 76], ["intestinal", "ANATOMY", 216, 226], ["Jugular thrombophlebitis", "DISEASE", 0, 24], ["hypoproteinemia", "DISEASE", 161, 176], ["salmonellosis", "DISEASE", 178, 191], ["endotoxemia", "DISEASE", 193, 204], ["intestinal disease", "DISEASE", 216, 234], ["jugular catheters", "MULTI-TISSUE_STRUCTURE", 59, 76], ["intestinal", "ORGAN", 216, 226], ["Jugular thrombophlebitis", "PROBLEM", 0, 24], ["indwelling jugular catheters", "TREATMENT", 48, 76], ["several concurrent disease conditions", "PROBLEM", 114, 151], ["hypoproteinemia", "PROBLEM", 161, 176], ["salmonellosis", "PROBLEM", 178, 191], ["endotoxemia", "PROBLEM", 193, 204], ["large intestinal disease", "PROBLEM", 210, 234], ["thrombophlebitis", "OBSERVATION", 8, 24], ["indwelling", "OBSERVATION", 48, 58], ["jugular", "ANATOMY", 59, 66], ["catheters", "OBSERVATION", 67, 76], ["increased", "OBSERVATION_MODIFIER", 99, 108], ["disease", "OBSERVATION", 133, 140], ["hypoproteinemia", "OBSERVATION", 161, 176], ["salmonellosis", "OBSERVATION", 178, 191], ["endotoxemia", "OBSERVATION_MODIFIER", 193, 204], ["large", "OBSERVATION_MODIFIER", 210, 215], ["intestinal", "ANATOMY", 216, 226], ["disease", "OBSERVATION", 227, 234]]], ["The most common diseases with thrombosis and embolism are listed in Box 10-16.Disturbances of Circulation EffusionsRupture of the Thoracic Duct.", [["thrombosis", "DISEASE", 30, 40], ["embolism", "DISEASE", 45, 53], ["Box 10-16", "DNA", 68, 77], ["The most common diseases", "PROBLEM", 0, 24], ["thrombosis", "PROBLEM", 30, 40], ["embolism", "PROBLEM", 45, 53], ["Disturbances of Circulation Effusions", "PROBLEM", 78, 115], ["Rupture of the Thoracic Duct", "PROBLEM", 115, 143], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["thrombosis", "OBSERVATION", 30, 40], ["embolism", "OBSERVATION", 45, 53], ["Circulation", "OBSERVATION_MODIFIER", 94, 105], ["Effusions", "OBSERVATION", 106, 115], ["Rupture", "OBSERVATION", 115, 122], ["Thoracic Duct", "ANATOMY", 130, 143]]], ["Rupture of the thoracic duct, either as a result of trauma or from spontaneous disruption, causes chylothorax in dogs and cats (see Fig. 9 -116).", [["thoracic duct", "ANATOMY", 15, 28], ["Rupture of the thoracic duct", "DISEASE", 0, 28], ["trauma", "DISEASE", 52, 58], ["chylothorax", "DISEASE", 98, 109], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 15, 28], ["dogs", "ORGANISM", 113, 117], ["cats", "ORGANISM", 122, 126], ["dogs", "SPECIES", 113, 117], ["cats", "SPECIES", 122, 126], ["Rupture of the thoracic duct", "PROBLEM", 0, 28], ["trauma", "PROBLEM", 52, 58], ["spontaneous disruption", "PROBLEM", 67, 89], ["chylothorax", "PROBLEM", 98, 109], ["thoracic duct", "ANATOMY", 15, 28], ["spontaneous", "OBSERVATION_MODIFIER", 67, 78], ["disruption", "OBSERVATION", 79, 89], ["chylothorax", "OBSERVATION", 98, 109]]], ["However, many cases of chylothorax occur without injury to the thoracic duct and have been attributed to lesions that interfere with central venous return or produce obstruction of the thoracic duct (right-sided heart failure, neoplasms, granulomas, cranial vena cava thrombosis, or dirofilariasis) or that are idiopathic.Disturbances of Circulation EffusionsLymphedema.", [["thoracic duct", "ANATOMY", 63, 76], ["lesions", "ANATOMY", 105, 112], ["venous", "ANATOMY", 141, 147], ["thoracic duct", "ANATOMY", 185, 198], ["heart", "ANATOMY", 212, 217], ["neoplasms", "ANATOMY", 227, 236], ["granulomas", "ANATOMY", 238, 248], ["cranial vena cava", "ANATOMY", 250, 267], ["dirofilariasis", "ANATOMY", 283, 297], ["chylothorax", "DISEASE", 23, 34], ["injury to the thoracic duct", "DISEASE", 49, 76], ["obstruction of the thoracic duct", "DISEASE", 166, 198], ["heart failure", "DISEASE", 212, 225], ["neoplasms", "DISEASE", 227, 236], ["granulomas", "DISEASE", 238, 248], ["cranial vena cava thrombosis", "DISEASE", 250, 278], ["dirofilariasis", "DISEASE", 283, 297], ["Lymphedema", "DISEASE", 359, 369], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 63, 76], ["lesions", "PATHOLOGICAL_FORMATION", 105, 112], ["venous", "MULTI-TISSUE_STRUCTURE", 141, 147], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 185, 198], ["heart", "ORGAN", 212, 217], ["neoplasms", "CANCER", 227, 236], ["cranial vena cava", "MULTI-TISSUE_STRUCTURE", 250, 267], ["chylothorax", "PROBLEM", 23, 34], ["injury to the thoracic duct", "PROBLEM", 49, 76], ["lesions", "PROBLEM", 105, 112], ["central venous return", "PROBLEM", 133, 154], ["obstruction of the thoracic duct", "PROBLEM", 166, 198], ["right-sided heart failure", "PROBLEM", 200, 225], ["neoplasms", "PROBLEM", 227, 236], ["granulomas", "PROBLEM", 238, 248], ["cranial vena cava thrombosis", "PROBLEM", 250, 278], ["dirofilariasis", "PROBLEM", 283, 297], ["idiopathic", "PROBLEM", 311, 321], ["Disturbances of Circulation EffusionsLymphedema", "PROBLEM", 322, 369], ["chylothorax", "OBSERVATION", 23, 34], ["without", "UNCERTAINTY", 41, 48], ["injury", "OBSERVATION", 49, 55], ["thoracic duct", "ANATOMY", 63, 76], ["lesions", "OBSERVATION", 105, 112], ["central", "ANATOMY_MODIFIER", 133, 140], ["venous", "ANATOMY", 141, 147], ["return", "OBSERVATION", 148, 154], ["obstruction", "OBSERVATION", 166, 177], ["thoracic duct", "ANATOMY", 185, 198], ["right", "ANATOMY_MODIFIER", 200, 205], ["sided", "ANATOMY_MODIFIER", 206, 211], ["heart", "ANATOMY", 212, 217], ["failure", "OBSERVATION", 218, 225], ["neoplasms", "OBSERVATION", 227, 236], ["granulomas", "OBSERVATION", 238, 248], ["cranial vena cava", "ANATOMY", 250, 267], ["thrombosis", "OBSERVATION", 268, 278], ["dirofilariasis", "OBSERVATION", 283, 297], ["idiopathic", "OBSERVATION_MODIFIER", 311, 321], ["Circulation", "OBSERVATION_MODIFIER", 338, 349], ["Effusions", "OBSERVATION", 350, 359], ["Lymphedema", "OBSERVATION", 359, 369]]], ["Lymphedema specifically refers to accumulation of fluid in interstitial space secondary to abnormal lymphatic absorption and should be differentiated from other causes of edema, such as hypoproteinemia, vasculitis, and increased hydrostatic pressure.", [["fluid", "ANATOMY", 50, 55], ["interstitial space", "ANATOMY", 59, 77], ["lymphatic", "ANATOMY", 100, 109], ["edema", "ANATOMY", 171, 176], ["Lymphedema", "DISEASE", 0, 10], ["edema", "DISEASE", 171, 176], ["hypoproteinemia", "DISEASE", 186, 201], ["vasculitis", "DISEASE", 203, 213], ["fluid", "ORGANISM_SUBSTANCE", 50, 55], ["lymphatic", "ORGAN", 100, 109], ["edema", "PATHOLOGICAL_FORMATION", 171, 176], ["Lymphedema", "PROBLEM", 0, 10], ["fluid in interstitial space", "PROBLEM", 50, 77], ["abnormal lymphatic absorption", "PROBLEM", 91, 120], ["edema", "PROBLEM", 171, 176], ["hypoproteinemia", "PROBLEM", 186, 201], ["vasculitis", "PROBLEM", 203, 213], ["increased hydrostatic pressure", "PROBLEM", 219, 249], ["accumulation", "OBSERVATION_MODIFIER", 34, 46], ["fluid", "OBSERVATION", 50, 55], ["interstitial", "ANATOMY_MODIFIER", 59, 71], ["abnormal", "OBSERVATION_MODIFIER", 91, 99], ["lymphatic absorption", "OBSERVATION", 100, 120], ["edema", "OBSERVATION", 171, 176], ["hypoproteinemia", "OBSERVATION", 186, 201], ["vasculitis", "OBSERVATION", 203, 213], ["increased", "OBSERVATION_MODIFIER", 219, 228], ["hydrostatic", "OBSERVATION_MODIFIER", 229, 240], ["pressure", "OBSERVATION_MODIFIER", 241, 249]]], ["Lymphatic fluid contains a variable amount of protein that may havePericardium and EpicardiumInflammation Fibrinous Pericarditis.", [["Lymphatic fluid", "ANATOMY", 0, 15], ["Pericarditis", "DISEASE", 116, 128], ["Lymphatic fluid", "TISSUE", 0, 15], ["Pericardium", "SIMPLE_CHEMICAL", 67, 78], ["Lymphatic fluid", "TEST", 0, 15], ["a variable amount of protein", "PROBLEM", 25, 53], ["Pericardium", "PROBLEM", 67, 78], ["EpicardiumInflammation Fibrinous Pericarditis", "PROBLEM", 83, 128], ["fluid", "OBSERVATION", 10, 15], ["variable", "OBSERVATION_MODIFIER", 27, 35], ["amount", "OBSERVATION_MODIFIER", 36, 42], ["Pericardium", "ANATOMY", 67, 78], ["EpicardiumInflammation", "OBSERVATION_MODIFIER", 83, 105], ["Fibrinous", "OBSERVATION_MODIFIER", 106, 115], ["Pericarditis", "OBSERVATION", 116, 128]]], ["Hematogenous spread of specific organisms may result in fibrinous pericarditis in the horse.", [["pericarditis", "DISEASE", 66, 78], ["horse", "ORGANISM_SUBDIVISION", 86, 91], ["horse", "SPECIES", 86, 91], ["Hematogenous spread of specific organisms", "PROBLEM", 0, 41], ["fibrinous pericarditis in the horse", "PROBLEM", 56, 91], ["fibrinous", "OBSERVATION_MODIFIER", 56, 65], ["pericarditis", "OBSERVATION", 66, 78]]], ["These include Actinobacillus, streptococcal, and mycoplasma infections.", [["mycoplasma infections", "DISEASE", 49, 70], ["Actinobacillus", "PROBLEM", 14, 28], ["streptococcal", "PROBLEM", 30, 43], ["mycoplasma infections", "PROBLEM", 49, 70], ["Actinobacillus", "OBSERVATION", 14, 28], ["streptococcal", "OBSERVATION", 30, 43], ["mycoplasma infections", "OBSERVATION", 49, 70]]], ["Sterile swabs of the pericardial exudates are recommended to identify the causative organism.", [["swabs", "ANATOMY", 8, 13], ["pericardial exudates", "ANATOMY", 21, 41], ["pericardial exudates", "MULTI-TISSUE_STRUCTURE", 21, 41], ["Sterile swabs", "TREATMENT", 0, 13], ["the pericardial exudates", "PROBLEM", 17, 41], ["the causative organism", "PROBLEM", 70, 92], ["pericardial", "ANATOMY", 21, 32], ["exudates", "OBSERVATION", 33, 41]]], ["Equine herpesvirus types 1 and 2 and influenza virus infections may result in fibrinous pericarditis.", [["influenza virus infections", "DISEASE", 37, 63], ["pericarditis", "DISEASE", 88, 100], ["Equine herpesvirus types 1", "ORGANISM", 0, 26], ["2", "GENE_OR_GENE_PRODUCT", 31, 32], ["influenza virus", "ORGANISM", 37, 52], ["Equine herpesvirus", "SPECIES", 0, 18], ["influenza virus", "SPECIES", 37, 52], ["Equine herpesvirus", "SPECIES", 0, 18], ["influenza virus", "SPECIES", 37, 52], ["Equine herpesvirus types", "TEST", 0, 24], ["influenza virus infections", "PROBLEM", 37, 63], ["fibrinous pericarditis", "PROBLEM", 78, 100], ["fibrinous", "OBSERVATION_MODIFIER", 78, 87], ["pericarditis", "OBSERVATION", 88, 100]]], ["Fibrinous pericarditis has been reported in horses with mare reproductive loss syndrome following exposure to the Eastern tent caterpillars.Blood VesselsInflammation Equine Viral Arteritis.", [["Blood", "ANATOMY", 140, 145], ["pericarditis", "DISEASE", 10, 22], ["mare reproductive loss syndrome", "DISEASE", 56, 87], ["Viral Arteritis", "DISEASE", 173, 188], ["horses", "ORGANISM_SUBDIVISION", 44, 50], ["Blood", "ORGANISM_SUBSTANCE", 140, 145], ["Fibrinous pericarditis", "PROBLEM", 0, 22], ["mare reproductive loss syndrome", "PROBLEM", 56, 87], ["the Eastern tent caterpillars", "TREATMENT", 110, 139], ["Blood VesselsInflammation", "PROBLEM", 140, 165], ["Viral Arteritis", "PROBLEM", 173, 188], ["pericarditis", "OBSERVATION", 10, 22], ["reproductive loss syndrome", "OBSERVATION", 61, 87], ["Vessels", "ANATOMY", 146, 153], ["Inflammation", "OBSERVATION", 153, 165], ["Viral Arteritis", "OBSERVATION", 173, 188]]], ["Equine viral arteritis is a systemic viral infection with a tropism for vascular endothelial cells.", [["vascular endothelial cells", "ANATOMY", 72, 98], ["Equine viral arteritis", "DISEASE", 0, 22], ["viral infection", "DISEASE", 37, 52], ["Equine", "ORGANISM", 0, 6], ["vascular endothelial cells", "CELL", 72, 98], ["vascular endothelial cells", "CELL_TYPE", 72, 98], ["Equine", "SPECIES", 0, 6], ["Equine viral arteritis", "PROBLEM", 0, 22], ["a systemic viral infection", "PROBLEM", 26, 52], ["vascular endothelial cells", "PROBLEM", 72, 98], ["viral arteritis", "OBSERVATION", 7, 22], ["systemic", "OBSERVATION_MODIFIER", 28, 36], ["viral infection", "OBSERVATION", 37, 52], ["vascular", "ANATOMY", 72, 80], ["endothelial cells", "OBSERVATION", 81, 98]]], ["In this disease, affected small muscular arteries have lesions of fibrinoid necrosis, extensive edema, and primarily mononuclear infiltration with thrombosis ( Fig. 10-72) .", [["small muscular arteries", "ANATOMY", 26, 49], ["lesions", "ANATOMY", 55, 62], ["fibrinoid", "ANATOMY", 66, 75], ["edema", "ANATOMY", 96, 101], ["mononuclear", "ANATOMY", 117, 128], ["necrosis", "DISEASE", 76, 84], ["edema", "DISEASE", 96, 101], ["mononuclear infiltration", "DISEASE", 117, 141], ["thrombosis", "DISEASE", 147, 157], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 32, 49], ["lesions", "PATHOLOGICAL_FORMATION", 55, 62], ["fibrinoid necrosis", "PATHOLOGICAL_FORMATION", 66, 84], ["edema", "PATHOLOGICAL_FORMATION", 96, 101], ["mononuclear", "CELL", 117, 128], ["this disease", "PROBLEM", 3, 15], ["affected small muscular arteries", "PROBLEM", 17, 49], ["fibrinoid necrosis", "PROBLEM", 66, 84], ["extensive edema", "PROBLEM", 86, 101], ["primarily mononuclear infiltration", "PROBLEM", 107, 141], ["thrombosis", "PROBLEM", 147, 157], ["Fig.", "TEST", 160, 164], ["disease", "OBSERVATION", 8, 15], ["affected", "OBSERVATION_MODIFIER", 17, 25], ["small", "OBSERVATION_MODIFIER", 26, 31], ["muscular arteries", "ANATOMY", 32, 49], ["lesions", "OBSERVATION", 55, 62], ["fibrinoid", "OBSERVATION_MODIFIER", 66, 75], ["necrosis", "OBSERVATION", 76, 84], ["extensive", "OBSERVATION_MODIFIER", 86, 95], ["edema", "OBSERVATION", 96, 101], ["primarily", "OBSERVATION_MODIFIER", 107, 116], ["mononuclear infiltration", "OBSERVATION", 117, 141], ["thrombosis", "OBSERVATION", 147, 157]]], ["Grossly, the vascular injury is reflected by hemorrhage and severe edema of the subcutaneous tissues, lymph nodes, and intestinal wall and mesentery accompanied by notable accumulation of serous fluids in body cavities and pulmonary edema.Blood VesselsAfrican Horse Sickness: Subacute Cardiac Form.", [["vascular", "ANATOMY", 13, 21], ["subcutaneous tissues", "ANATOMY", 80, 100], ["lymph nodes", "ANATOMY", 102, 113], ["intestinal wall", "ANATOMY", 119, 134], ["mesentery", "ANATOMY", 139, 148], ["serous fluids", "ANATOMY", 188, 201], ["body cavities", "ANATOMY", 205, 218], ["pulmonary edema", "ANATOMY", 223, 238], ["Blood", "ANATOMY", 239, 244], ["Cardiac", "ANATOMY", 285, 292], ["vascular injury", "DISEASE", 13, 28], ["hemorrhage", "DISEASE", 45, 55], ["edema", "DISEASE", 67, 72], ["pulmonary edema", "DISEASE", 223, 238], ["vascular", "MULTI-TISSUE_STRUCTURE", 13, 21], ["edema", "PATHOLOGICAL_FORMATION", 67, 72], ["subcutaneous tissues", "TISSUE", 80, 100], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 102, 113], ["intestinal wall", "MULTI-TISSUE_STRUCTURE", 119, 134], ["mesentery", "ORGAN", 139, 148], ["serous fluids", "ORGANISM_SUBSTANCE", 188, 201], ["body cavities", "TISSUE", 205, 218], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 223, 238], ["Blood", "ORGANISM_SUBSTANCE", 239, 244], ["the vascular injury", "PROBLEM", 9, 28], ["hemorrhage", "PROBLEM", 45, 55], ["severe edema of the subcutaneous tissues", "PROBLEM", 60, 100], ["lymph nodes", "PROBLEM", 102, 113], ["intestinal wall and mesentery", "PROBLEM", 119, 148], ["notable accumulation of serous fluids in body cavities", "PROBLEM", 164, 218], ["pulmonary edema", "PROBLEM", 223, 238], ["vascular", "ANATOMY", 13, 21], ["injury", "OBSERVATION", 22, 28], ["hemorrhage", "OBSERVATION", 45, 55], ["severe", "OBSERVATION_MODIFIER", 60, 66], ["edema", "OBSERVATION", 67, 72], ["subcutaneous tissues", "ANATOMY", 80, 100], ["lymph nodes", "OBSERVATION", 102, 113], ["intestinal wall", "ANATOMY", 119, 134], ["mesentery", "ANATOMY", 139, 148], ["notable", "OBSERVATION_MODIFIER", 164, 171], ["accumulation", "OBSERVATION_MODIFIER", 172, 184], ["serous fluids", "OBSERVATION", 188, 201], ["body", "ANATOMY", 205, 209], ["cavities", "ANATOMY_MODIFIER", 210, 218], ["pulmonary", "ANATOMY", 223, 232], ["edema", "OBSERVATION", 233, 238], ["Horse Sickness", "OBSERVATION", 260, 274], ["Subacute", "OBSERVATION_MODIFIER", 276, 284], ["Cardiac", "ANATOMY", 285, 292]]], ["African horse sickness is an insect-borne (Culicoides spp.) viral disease of Equidae that is endemic in Africa, the Middle East, India, and Spain.", [["horse sickness", "DISEASE", 8, 22], ["viral disease", "DISEASE", 60, 73], ["horse", "ORGANISM", 8, 13], ["Culicoides spp.", "ORGANISM", 43, 58], ["horse", "SPECIES", 8, 13], ["Culicoides spp.", "SPECIES", 43, 58], ["African horse", "SPECIES", 0, 13], ["Culicoides spp.", "SPECIES", 43, 58], ["African horse sickness", "PROBLEM", 0, 22], ["an insect", "PROBLEM", 26, 35], ["viral disease of Equidae", "PROBLEM", 60, 84], ["viral disease", "OBSERVATION", 60, 73], ["endemic", "OBSERVATION_MODIFIER", 93, 100], ["Middle", "ANATOMY_MODIFIER", 116, 122]]], ["The occurrence is seasonal because the insect vectors thrive in hot, wet conditions.", [["the insect vectors thrive", "PROBLEM", 35, 60]]], ["The febrile disease may produce high mortality (up to 95%) and appears in several clinical forms, including the subacute cardiac form described here, as well as an acute respiratory form with massive pulmonary edema.", [["cardiac", "ANATOMY", 121, 128], ["respiratory", "ANATOMY", 170, 181], ["pulmonary", "ANATOMY", 200, 209], ["febrile disease", "DISEASE", 4, 19], ["pulmonary edema", "DISEASE", 200, 215], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 200, 215], ["The febrile disease", "PROBLEM", 0, 19], ["high mortality", "PROBLEM", 32, 46], ["an acute respiratory form", "PROBLEM", 161, 186], ["massive pulmonary edema", "PROBLEM", 192, 215], ["febrile", "OBSERVATION_MODIFIER", 4, 11], ["disease", "OBSERVATION", 12, 19], ["high", "OBSERVATION_MODIFIER", 32, 36], ["mortality", "OBSERVATION_MODIFIER", 37, 46], ["subacute", "OBSERVATION_MODIFIER", 112, 120], ["acute", "OBSERVATION_MODIFIER", 164, 169], ["respiratory", "OBSERVATION", 170, 181], ["massive", "OBSERVATION_MODIFIER", 192, 199], ["pulmonary", "ANATOMY", 200, 209], ["edema", "OBSERVATION", 210, 215]]], ["The pathogenesis is initiated by the introduction of the virus by bites of the insect vector.", [["the virus", "TREATMENT", 53, 62]]], ["The virus proliferates in local lymph node, and viremia ensues.", [["lymph node", "ANATOMY", 32, 42], ["viremia", "DISEASE", 48, 55], ["lymph node", "MULTI-TISSUE_STRUCTURE", 32, 42], ["The virus proliferates in local lymph node", "PROBLEM", 0, 42], ["viremia", "PROBLEM", 48, 55], ["virus", "OBSERVATION_MODIFIER", 4, 9], ["proliferates", "OBSERVATION_MODIFIER", 10, 22], ["local", "OBSERVATION_MODIFIER", 26, 31], ["lymph node", "OBSERVATION", 32, 42], ["viremia", "OBSERVATION", 48, 55]]], ["The virus has a tropism for endothelial cells, monocytes, and macrophages, and increased vascular permeability, edema, hemorrhage, and microthrombosis are produced.", [["endothelial cells", "ANATOMY", 28, 45], ["monocytes", "ANATOMY", 47, 56], ["macrophages", "ANATOMY", 62, 73], ["vascular", "ANATOMY", 89, 97], ["edema", "ANATOMY", 112, 117], ["edema", "DISEASE", 112, 117], ["hemorrhage", "DISEASE", 119, 129], ["microthrombosis", "DISEASE", 135, 150], ["endothelial cells", "CELL", 28, 45], ["monocytes", "CELL", 47, 56], ["macrophages", "CELL", 62, 73], ["vascular", "MULTI-TISSUE_STRUCTURE", 89, 97], ["edema", "PATHOLOGICAL_FORMATION", 112, 117], ["endothelial cells", "CELL_TYPE", 28, 45], ["monocytes", "CELL_TYPE", 47, 56], ["macrophages", "CELL_TYPE", 62, 73], ["The virus", "PROBLEM", 0, 9], ["endothelial cells", "TEST", 28, 45], ["monocytes", "TEST", 47, 56], ["macrophages", "TEST", 62, 73], ["increased vascular permeability", "PROBLEM", 79, 110], ["edema", "PROBLEM", 112, 117], ["hemorrhage", "PROBLEM", 119, 129], ["microthrombosis", "PROBLEM", 135, 150], ["virus", "OBSERVATION", 4, 9], ["tropism", "OBSERVATION_MODIFIER", 16, 23], ["endothelial cells", "OBSERVATION", 28, 45], ["monocytes", "OBSERVATION_MODIFIER", 47, 56], ["macrophages", "OBSERVATION", 62, 73], ["increased", "OBSERVATION_MODIFIER", 79, 88], ["vascular", "ANATOMY", 89, 97], ["permeability", "OBSERVATION_MODIFIER", 98, 110], ["edema", "OBSERVATION", 112, 117], ["hemorrhage", "OBSERVATION", 119, 129]]], ["The gross lesions are extensive subcutaneous and intermuscular edematous swelling of the head and neck.", [["gross lesions", "ANATOMY", 4, 17], ["subcutaneous", "ANATOMY", 32, 44], ["intermuscular edematous", "ANATOMY", 49, 72], ["head", "ANATOMY", 89, 93], ["neck", "ANATOMY", 98, 102], ["gross lesions", "CANCER", 4, 17], ["head", "ORGAN", 89, 93], ["neck", "ORGAN", 98, 102], ["The gross lesions", "PROBLEM", 0, 17], ["extensive subcutaneous and intermuscular edematous swelling of the head and neck", "PROBLEM", 22, 102], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["extensive", "OBSERVATION_MODIFIER", 22, 31], ["subcutaneous", "OBSERVATION_MODIFIER", 32, 44], ["intermuscular", "ANATOMY_MODIFIER", 49, 62], ["edematous", "OBSERVATION_MODIFIER", 63, 72], ["swelling", "OBSERVATION", 73, 81], ["head", "ANATOMY", 89, 93], ["neck", "ANATOMY", 98, 102]]], ["Massive hydropericardium is present with accompanying epicardial and endocardial ecchymotic hemorrhages.", [["epicardial", "ANATOMY", 54, 64], ["endocardial", "ANATOMY", 69, 80], ["hemorrhages", "DISEASE", 92, 103], ["epicardial", "MULTI-TISSUE_STRUCTURE", 54, 64], ["Massive hydropericardium", "PROBLEM", 0, 24], ["accompanying epicardial and endocardial ecchymotic hemorrhages", "PROBLEM", 41, 103], ["hydropericardium", "OBSERVATION", 8, 24], ["epicardial", "ANATOMY", 54, 64], ["endocardial", "ANATOMY", 69, 80], ["ecchymotic", "OBSERVATION_MODIFIER", 81, 91], ["hemorrhages", "OBSERVATION", 92, 103]]], ["Histopathologically, endothelial degeneration and necrosis occur with the edema.", [["endothelial", "ANATOMY", 21, 32], ["edema", "ANATOMY", 74, 79], ["endothelial degeneration", "DISEASE", 21, 45], ["necrosis", "DISEASE", 50, 58], ["edema", "DISEASE", 74, 79], ["endothelial", "TISSUE", 21, 32], ["edema", "PATHOLOGICAL_FORMATION", 74, 79], ["endothelial degeneration", "PROBLEM", 21, 45], ["necrosis", "PROBLEM", 50, 58], ["the edema", "PROBLEM", 70, 79], ["endothelial", "ANATOMY", 21, 32], ["degeneration", "OBSERVATION", 33, 45], ["necrosis", "OBSERVATION", 50, 58], ["edema", "OBSERVATION", 74, 79]]], ["In the myocardium, hemorrhage, edema, and focal myocardial necrosis can be present.", [["myocardium", "ANATOMY", 7, 17], ["edema", "ANATOMY", 31, 36], ["myocardial", "ANATOMY", 48, 58], ["hemorrhage", "DISEASE", 19, 29], ["edema", "DISEASE", 31, 36], ["myocardial necrosis", "DISEASE", 48, 67], ["myocardium", "MULTI-TISSUE_STRUCTURE", 7, 17], ["edema", "PATHOLOGICAL_FORMATION", 31, 36], ["myocardial", "MULTI-TISSUE_STRUCTURE", 48, 58], ["hemorrhage", "PROBLEM", 19, 29], ["edema", "PROBLEM", 31, 36], ["focal myocardial necrosis", "PROBLEM", 42, 67], ["myocardium", "ANATOMY", 7, 17], ["hemorrhage", "OBSERVATION", 19, 29], ["edema", "OBSERVATION", 31, 36], ["focal", "OBSERVATION_MODIFIER", 42, 47], ["myocardial", "ANATOMY", 48, 58], ["necrosis", "OBSERVATION", 59, 67]]], ["Nodular suppurative lesions of lymphangitis often ulcerate and discharge pus onto the surface of the skin.", [["Nodular suppurative lesions", "ANATOMY", 0, 27], ["lymphangitis", "ANATOMY", 31, 43], ["pus", "ANATOMY", 73, 76], ["surface", "ANATOMY", 86, 93], ["skin", "ANATOMY", 101, 105], ["lymphangitis", "DISEASE", 31, 43], ["Nodular suppurative lesions", "PATHOLOGICAL_FORMATION", 0, 27], ["surface", "CELLULAR_COMPONENT", 86, 93], ["skin", "ORGAN", 101, 105], ["Nodular suppurative lesions", "PROBLEM", 0, 27], ["lymphangitis often ulcerate", "PROBLEM", 31, 58], ["discharge pus", "PROBLEM", 63, 76], ["suppurative", "OBSERVATION_MODIFIER", 8, 19], ["lesions", "OBSERVATION", 20, 27], ["lymphangitis", "OBSERVATION", 31, 43], ["discharge", "OBSERVATION_MODIFIER", 63, 72], ["pus", "OBSERVATION", 73, 76], ["surface", "ANATOMY_MODIFIER", 86, 93], ["skin", "ANATOMY", 101, 105]]], ["In Johne's disease, the mesenteric lymphatic vessels are often prominent because of granulomatous lymphangitis, an extension of the enteric infection producing a granulomatous enteritis and lymphangitis ( Fig. 10-71 ).WhiteSnakeroot-Induced Myocardial Degeneration.", [["mesenteric lymphatic vessels", "ANATOMY", 24, 52], ["granulomatous lymphangitis", "ANATOMY", 84, 110], ["Myocardial", "ANATOMY", 241, 251], ["Johne's disease", "DISEASE", 3, 18], ["lymphangitis", "DISEASE", 98, 110], ["enteric infection", "DISEASE", 132, 149], ["granulomatous enteritis", "DISEASE", 162, 185], ["lymphangitis", "DISEASE", 190, 202], ["WhiteSnakeroot", "CHEMICAL", 218, 232], ["Myocardial Degeneration", "DISEASE", 241, 264], ["mesenteric lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 24, 52], ["granulomatous lymphangitis", "PATHOLOGICAL_FORMATION", 84, 110], ["Myocardial", "TISSUE", 241, 251], ["Johne's disease", "PROBLEM", 3, 18], ["granulomatous lymphangitis", "PROBLEM", 84, 110], ["the enteric infection", "PROBLEM", 128, 149], ["a granulomatous enteritis", "PROBLEM", 160, 185], ["lymphangitis", "PROBLEM", 190, 202], ["WhiteSnakeroot", "PROBLEM", 218, 232], ["Myocardial Degeneration", "PROBLEM", 241, 264], ["disease", "OBSERVATION", 11, 18], ["mesenteric", "ANATOMY", 24, 34], ["lymphatic vessels", "ANATOMY", 35, 52], ["granulomatous", "OBSERVATION_MODIFIER", 84, 97], ["lymphangitis", "OBSERVATION", 98, 110], ["enteric", "ANATOMY", 132, 139], ["infection", "OBSERVATION", 140, 149], ["granulomatous", "OBSERVATION_MODIFIER", 162, 175], ["enteritis", "OBSERVATION", 176, 185], ["lymphangitis", "OBSERVATION", 190, 202], ["Myocardial", "ANATOMY", 241, 251], ["Degeneration", "OBSERVATION", 252, 264]]], ["After ingestion, white snakeroot (Eupatorium rugosum) causes myocardial degeneration and necrosis (acute injury) followed by fibrosis (reparative response).", [["myocardial", "ANATOMY", 61, 71], ["myocardial degeneration", "DISEASE", 61, 84], ["necrosis", "DISEASE", 89, 97], ["fibrosis", "DISEASE", 125, 133], ["Eupatorium rugosum", "ORGANISM", 34, 52], ["myocardial", "MULTI-TISSUE_STRUCTURE", 61, 71], ["Eupatorium rugosum", "SPECIES", 34, 52], ["white snakeroot", "SPECIES", 17, 32], ["Eupatorium rugosum", "SPECIES", 34, 52], ["white snakeroot (Eupatorium rugosum", "TREATMENT", 17, 52], ["myocardial degeneration", "PROBLEM", 61, 84], ["necrosis", "PROBLEM", 89, 97], ["acute injury", "PROBLEM", 99, 111], ["fibrosis", "PROBLEM", 125, 133], ["myocardial", "ANATOMY", 61, 71], ["degeneration", "OBSERVATION", 72, 84], ["necrosis", "OBSERVATION", 89, 97], ["acute", "OBSERVATION_MODIFIER", 99, 104], ["injury", "OBSERVATION", 105, 111], ["fibrosis", "OBSERVATION", 125, 133]]], ["Tremetol is the toxic compound in white snakeroot; it becomes toxic after microsomal activation of a precursor compound by cytochrome P450 enzymes in the liver.", [["microsomal", "ANATOMY", 74, 84], ["liver", "ANATOMY", 154, 159], ["Tremetol", "CHEMICAL", 0, 8], ["Tremetol", "CHEMICAL", 0, 8], ["Tremetol", "SIMPLE_CHEMICAL", 0, 8], ["microsomal", "SIMPLE_CHEMICAL", 74, 84], ["cytochrome P450 enzymes", "GENE_OR_GENE_PRODUCT", 123, 146], ["liver", "ORGAN", 154, 159], ["cytochrome P450 enzymes", "PROTEIN", 123, 146], ["white snakeroot", "SPECIES", 34, 49], ["the toxic compound in white snakeroot", "PROBLEM", 12, 49], ["a precursor compound", "PROBLEM", 99, 119], ["cytochrome P450 enzymes", "TEST", 123, 146], ["toxic", "OBSERVATION_MODIFIER", 16, 21], ["compound", "OBSERVATION_MODIFIER", 22, 30], ["white snakeroot", "OBSERVATION_MODIFIER", 34, 49], ["toxic", "OBSERVATION_MODIFIER", 62, 67], ["liver", "ANATOMY", 154, 159]]], ["The mechanism used by tremetol to cause injury is unclear, but dysfunction of mitochondrial oxidative phosphorylation by inhibiting the tricarboxylic acid cycle has been suggested.", [["mitochondrial", "ANATOMY", 78, 91], ["tremetol", "CHEMICAL", 22, 30], ["tricarboxylic acid", "CHEMICAL", 136, 154], ["tremetol", "CHEMICAL", 22, 30], ["tricarboxylic acid", "CHEMICAL", 136, 154], ["tremetol", "SIMPLE_CHEMICAL", 22, 30], ["mitochondrial", "CELLULAR_COMPONENT", 78, 91], ["tricarboxylic acid", "SIMPLE_CHEMICAL", 136, 154], ["injury", "PROBLEM", 40, 46], ["dysfunction of mitochondrial oxidative phosphorylation", "PROBLEM", 63, 117], ["the tricarboxylic acid cycle", "TEST", 132, 160], ["injury", "OBSERVATION", 40, 46]]], ["Acute cardiac rhabdomyocyte degeneration and necrosis are discussed in detail in the section on Responses to Injury: Myocardium, Myocardial Necrosis and also in Chapter 15.", [["cardiac rhabdomyocyte", "ANATOMY", 6, 27], ["Myocardial", "ANATOMY", 129, 139], ["cardiac rhabdomyocyte degeneration", "DISEASE", 6, 40], ["necrosis", "DISEASE", 45, 53], ["Injury", "DISEASE", 109, 115], ["Myocardial Necrosis", "DISEASE", 129, 148], ["Acute cardiac rhabdomyocyte degeneration", "PROBLEM", 0, 40], ["necrosis", "PROBLEM", 45, 53], ["Myocardium", "PROBLEM", 117, 127], ["Myocardial Necrosis", "PROBLEM", 129, 148], ["cardiac", "ANATOMY", 6, 13], ["rhabdomyocyte degeneration", "OBSERVATION", 14, 40], ["necrosis", "OBSERVATION", 45, 53], ["Myocardium", "ANATOMY", 117, 127], ["Myocardial", "ANATOMY", 129, 139], ["Necrosis", "OBSERVATION", 140, 148]]], ["Macroscopic lesions include pale white to tan areas and linear streaks throughout the myocardium; microscopic lesions include multifocal myocardial degeneration and necrosis with vacuolation of myocardial cytoplasm; loss of crossstriations; fragmentation of rhabdomyocytes; hypereosinophilia, coagulation, and clumping of the sarcoplasm; and nuclear pyknosis and karyolysis.", [["Macroscopic lesions", "ANATOMY", 0, 19], ["myocardium", "ANATOMY", 86, 96], ["lesions", "ANATOMY", 110, 117], ["myocardial", "ANATOMY", 137, 147], ["myocardial cytoplasm", "ANATOMY", 194, 214], ["rhabdomyocytes", "ANATOMY", 258, 272], ["sarcoplasm", "ANATOMY", 326, 336], ["nuclear", "ANATOMY", 342, 349], ["myocardial degeneration", "DISEASE", 137, 160], ["necrosis", "DISEASE", 165, 173], ["loss of crossstriations", "DISEASE", 216, 239], ["rhabdomyocytes", "DISEASE", 258, 272], ["hypereosinophilia", "DISEASE", 274, 291], ["coagulation", "DISEASE", 293, 304], ["clumping of the sarcoplasm", "DISEASE", 310, 336], ["karyolysis", "DISEASE", 363, 373], ["Macroscopic lesions", "PATHOLOGICAL_FORMATION", 0, 19], ["myocardium", "ORGAN", 86, 96], ["lesions", "PATHOLOGICAL_FORMATION", 110, 117], ["myocardial", "MULTI-TISSUE_STRUCTURE", 137, 147], ["cytoplasm", "ORGANISM_SUBSTANCE", 205, 214], ["nuclear", "CELLULAR_COMPONENT", 342, 349], ["Macroscopic lesions", "PROBLEM", 0, 19], ["pale white to tan areas", "PROBLEM", 28, 51], ["linear streaks throughout the myocardium", "PROBLEM", 56, 96], ["microscopic lesions", "PROBLEM", 98, 117], ["multifocal myocardial degeneration", "PROBLEM", 126, 160], ["necrosis", "PROBLEM", 165, 173], ["myocardial cytoplasm", "PROBLEM", 194, 214], ["loss of crossstriations", "PROBLEM", 216, 239], ["fragmentation of rhabdomyocytes", "PROBLEM", 241, 272], ["hypereosinophilia", "PROBLEM", 274, 291], ["coagulation", "PROBLEM", 293, 304], ["clumping of the sarcoplasm", "PROBLEM", 310, 336], ["nuclear pyknosis", "PROBLEM", 342, 358], ["karyolysis", "PROBLEM", 363, 373], ["lesions", "OBSERVATION", 12, 19], ["pale", "OBSERVATION_MODIFIER", 28, 32], ["white to tan", "OBSERVATION_MODIFIER", 33, 45], ["linear", "OBSERVATION_MODIFIER", 56, 62], ["streaks", "OBSERVATION", 63, 70], ["myocardium", "ANATOMY", 86, 96], ["microscopic", "OBSERVATION_MODIFIER", 98, 109], ["lesions", "OBSERVATION", 110, 117], ["multifocal", "OBSERVATION_MODIFIER", 126, 136], ["myocardial", "ANATOMY", 137, 147], ["degeneration", "OBSERVATION", 148, 160], ["necrosis", "OBSERVATION", 165, 173], ["vacuolation", "OBSERVATION_MODIFIER", 179, 190], ["myocardial", "ANATOMY", 194, 204], ["cytoplasm", "OBSERVATION", 205, 214], ["loss", "OBSERVATION_MODIFIER", 216, 220], ["fragmentation", "OBSERVATION_MODIFIER", 241, 254], ["hypereosinophilia", "OBSERVATION", 274, 291], ["clumping", "OBSERVATION_MODIFIER", 310, 318], ["sarcoplasm", "ANATOMY", 326, 336], ["nuclear pyknosis", "OBSERVATION", 342, 358]]], ["The pericardium may contain a modified transudate with fibrin.Ionophore-Induced Myocardial Degeneration.See the discussion on ionophore-induced myocardial degeneration in the section on Disorders of Domestic Animals.Lymphatic VesselsInflammation Glanders Disease (Farcy): Cutaneous Form.", [["pericardium", "ANATOMY", 4, 15], ["Myocardial", "ANATOMY", 80, 90], ["myocardial", "ANATOMY", 144, 154], ["Ionophore", "CHEMICAL", 62, 71], ["Myocardial Degeneration", "DISEASE", 80, 103], ["ionophore", "CHEMICAL", 126, 135], ["myocardial degeneration", "DISEASE", 144, 167], ["ionophore", "CHEMICAL", 126, 135], ["pericardium", "ORGAN", 4, 15], ["fibrin", "GENE_OR_GENE_PRODUCT", 55, 61], ["Ionophore", "SIMPLE_CHEMICAL", 62, 71], ["Myocardial", "MULTI-TISSUE_STRUCTURE", 80, 90], ["ionophore", "SIMPLE_CHEMICAL", 126, 135], ["myocardial", "MULTI-TISSUE_STRUCTURE", 144, 154], ["Lymphatic Vessels", "MULTI-TISSUE_STRUCTURE", 216, 233], ["fibrin", "PROTEIN", 55, 61], ["a modified transudate with fibrin", "PROBLEM", 28, 61], ["Ionophore", "TREATMENT", 62, 71], ["Myocardial Degeneration", "PROBLEM", 80, 103], ["ionophore", "TREATMENT", 126, 135], ["myocardial degeneration", "PROBLEM", 144, 167], ["Lymphatic VesselsInflammation Glanders Disease", "PROBLEM", 216, 262], ["pericardium", "ANATOMY", 4, 15], ["transudate", "OBSERVATION", 39, 49], ["fibrin", "OBSERVATION", 55, 61], ["Myocardial", "ANATOMY", 80, 90], ["Degeneration", "OBSERVATION", 91, 103], ["myocardial", "ANATOMY", 144, 154], ["degeneration", "OBSERVATION", 155, 167], ["Vessels", "ANATOMY", 226, 233], ["Inflammation", "OBSERVATION", 233, 245], ["Cutaneous", "ANATOMY", 272, 281]]], ["Glanders disease (Farcy) is a contagious disease of horses, donkeys, and mules caused by infection with Burkholderia (Pseudomonas) mallei.", [["Glanders disease", "DISEASE", 0, 16], ["infection", "DISEASE", 89, 98], ["horses", "ORGANISM", 52, 58], ["Pseudomonas) mallei", "ORGANISM", 118, 137], ["horses", "SPECIES", 52, 58], ["Pseudomonas) mallei", "SPECIES", 118, 137], ["Pseudomonas) mallei", "SPECIES", 118, 137], ["Glanders disease", "PROBLEM", 0, 16], ["a contagious disease of horses", "PROBLEM", 28, 58], ["infection", "PROBLEM", 89, 98], ["Burkholderia (Pseudomonas) mallei", "PROBLEM", 104, 137], ["contagious", "OBSERVATION_MODIFIER", 30, 40], ["infection", "OBSERVATION", 89, 98]]], ["Once worldwide in distribution, it is now seen in eastern Europe, Asia, and northern Africa.", [["distribution", "OBSERVATION_MODIFIER", 18, 30]]], ["The disease occurs in several clinical forms, and the cutaneous form with involvement of lymphatic vessels is described here.", [["cutaneous", "ANATOMY", 54, 63], ["lymphatic vessels", "ANATOMY", 89, 106], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 89, 106], ["The disease", "PROBLEM", 0, 11], ["involvement of lymphatic vessels", "PROBLEM", 74, 106], ["disease", "OBSERVATION", 4, 11], ["cutaneous", "ANATOMY", 54, 63], ["lymphatic vessels", "ANATOMY", 89, 106]]], ["The organisms enter through the pharynx and are disseminated to the skin hematogenously.", [["pharynx", "ANATOMY", 32, 39], ["skin", "ANATOMY", 68, 72], ["pharynx", "ORGAN", 32, 39], ["skin", "ORGAN", 68, 72], ["pharynx", "ANATOMY", 32, 39], ["disseminated", "OBSERVATION", 48, 60], ["skin", "ANATOMY", 68, 72], ["hematogenously", "ANATOMY_MODIFIER", 73, 87]]], ["The gross lesions of the skin appear as multiple ulcerated nodules that follow infected lymphatic vessels.", [["gross lesions", "ANATOMY", 4, 17], ["skin", "ANATOMY", 25, 29], ["ulcerated nodules", "ANATOMY", 49, 66], ["lymphatic vessels", "ANATOMY", 88, 105], ["gross lesions", "CANCER", 4, 17], ["skin", "ORGAN", 25, 29], ["ulcerated nodules", "PATHOLOGICAL_FORMATION", 49, 66], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 88, 105], ["The gross lesions of the skin", "PROBLEM", 0, 29], ["multiple ulcerated nodules", "PROBLEM", 40, 66], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["skin", "ANATOMY", 25, 29], ["multiple", "OBSERVATION_MODIFIER", 40, 48], ["ulcerated", "OBSERVATION_MODIFIER", 49, 58], ["nodules", "OBSERVATION", 59, 66], ["infected", "OBSERVATION_MODIFIER", 79, 87], ["lymphatic vessels", "ANATOMY", 88, 105]]], ["Most frequent in the limbs, the ulcerated lesions discharge suppurative exudate onto the skin surface.", [["limbs", "ANATOMY", 21, 26], ["ulcerated lesions", "ANATOMY", 32, 49], ["skin surface", "ANATOMY", 89, 101], ["limbs", "ORGANISM_SUBDIVISION", 21, 26], ["ulcerated lesions", "PATHOLOGICAL_FORMATION", 32, 49], ["skin surface", "MULTI-TISSUE_STRUCTURE", 89, 101], ["the ulcerated lesions discharge suppurative exudate", "PROBLEM", 28, 79], ["limbs", "ANATOMY", 21, 26], ["ulcerated", "OBSERVATION_MODIFIER", 32, 41], ["lesions", "OBSERVATION", 42, 49], ["suppurative", "OBSERVATION_MODIFIER", 60, 71], ["exudate", "OBSERVATION", 72, 79], ["skin", "ANATOMY", 89, 93], ["surface", "ANATOMY_MODIFIER", 94, 101]]], ["Swollen tortuous cutaneous lymphatic vessels are visible between the ulcerative lesions.", [["cutaneous lymphatic vessels", "ANATOMY", 17, 44], ["ulcerative lesions", "ANATOMY", 69, 87], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 27, 44], ["ulcerative lesions", "PATHOLOGICAL_FORMATION", 69, 87], ["Swollen tortuous cutaneous lymphatic vessels", "PROBLEM", 0, 44], ["the ulcerative lesions", "PROBLEM", 65, 87], ["tortuous", "OBSERVATION_MODIFIER", 8, 16], ["cutaneous", "ANATOMY_MODIFIER", 17, 26], ["lymphatic vessels", "ANATOMY", 27, 44], ["ulcerative", "OBSERVATION_MODIFIER", 69, 79], ["lesions", "OBSERVATION", 80, 87]]], ["Microscopically, the skin nodules represent pyogranulomatous inflammation extending from cutaneous lymphatic vessels with suppurative lymphangitis (see Fig. 4-25) .Lymphatic VesselsMiscellaneous Cutaneous Lymphangitides.", [["skin nodules", "ANATOMY", 21, 33], ["pyogranulomatous", "ANATOMY", 44, 60], ["cutaneous lymphatic vessels", "ANATOMY", 89, 116], ["suppurative lymphangitis", "ANATOMY", 122, 146], ["Lymphatic", "ANATOMY", 164, 173], ["inflammation", "DISEASE", 61, 73], ["suppurative lymphangitis", "DISEASE", 122, 146], ["skin nodules", "PATHOLOGICAL_FORMATION", 21, 33], ["pyogranulomatous inflammation", "PATHOLOGICAL_FORMATION", 44, 73], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 99, 116], ["the skin nodules", "PROBLEM", 17, 33], ["pyogranulomatous inflammation", "PROBLEM", 44, 73], ["suppurative lymphangitis", "PROBLEM", 122, 146], ["Cutaneous Lymphangitides", "PROBLEM", 195, 219], ["skin", "ANATOMY", 21, 25], ["nodules", "OBSERVATION", 26, 33], ["pyogranulomatous inflammation", "OBSERVATION", 44, 73], ["cutaneous", "ANATOMY_MODIFIER", 89, 98], ["lymphatic vessels", "ANATOMY", 99, 116], ["suppurative", "OBSERVATION_MODIFIER", 122, 133], ["lymphangitis", "OBSERVATION", 134, 146], ["Vessels", "ANATOMY", 174, 181], ["Miscellaneous", "OBSERVATION_MODIFIER", 181, 194], ["Cutaneous Lymphangitides", "OBSERVATION", 195, 219]]], ["The cutaneous lesions affecting lymphatic vessels in less common cutaneous lymphangitides are as follows (see Box 10-8): 1.", [["cutaneous lesions", "ANATOMY", 4, 21], ["lymphatic vessels", "ANATOMY", 32, 49], ["cutaneous lymphangitides", "ANATOMY", 65, 89], ["lymphangitides", "DISEASE", 75, 89], ["cutaneous lesions", "PATHOLOGICAL_FORMATION", 4, 21], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 32, 49], ["cutaneous lymphangitides", "CANCER", 65, 89], ["The cutaneous lesions", "PROBLEM", 0, 21], ["cutaneous", "ANATOMY", 4, 13], ["lesions", "OBSERVATION", 14, 21], ["lymphatic vessels", "ANATOMY", 32, 49], ["less", "OBSERVATION_MODIFIER", 53, 57], ["common", "OBSERVATION_MODIFIER", 58, 64], ["cutaneous lymphangitides", "OBSERVATION", 65, 89]]], ["Ulcerative (likely caused by Corynebacterium pseudotuberculosis and other cutaneous bacteria) 2.", [["Ulcerative", "DISEASE", 0, 10], ["Corynebacterium pseudotuberculosis", "DISEASE", 29, 63], ["Corynebacterium pseudotuberculosis", "ORGANISM", 29, 63], ["Corynebacterium pseudotuberculosis", "SPECIES", 29, 63], ["Corynebacterium pseudotuberculosis", "SPECIES", 29, 63], ["Ulcerative", "PROBLEM", 0, 10], ["Corynebacterium pseudotuberculosis", "PROBLEM", 29, 63], ["other cutaneous bacteria)", "PROBLEM", 68, 93], ["likely caused", "UNCERTAINTY", 12, 25], ["Corynebacterium pseudotuberculosis", "OBSERVATION", 29, 63]]], ["Epizootic lymphangitis (Histoplasma farciminosum) 4.", [["lymphangitis", "DISEASE", 10, 22], ["Histoplasma farciminosum", "ORGANISM", 24, 48], ["Histoplasma farciminosum", "SPECIES", 24, 48], ["Histoplasma farciminosum", "SPECIES", 24, 48], ["Epizootic lymphangitis (Histoplasma farciminosum)", "PROBLEM", 0, 49], ["lymphangitis", "OBSERVATION", 10, 22], ["Histoplasma farciminosum", "OBSERVATION", 24, 48]]], ["Melioidosis (Burkholderia pseudomallei) These lesions mimic those of Glanders disease, and differentiation occurs by impression smears and microbiologic cultures and analyses.", [["lesions", "ANATOMY", 46, 53], ["Melioidosis", "DISEASE", 0, 11], ["lesions", "PATHOLOGICAL_FORMATION", 46, 53], ["Melioidosis (Burkholderia pseudomallei)", "PROBLEM", 0, 39], ["These lesions", "PROBLEM", 40, 53], ["Glanders disease", "PROBLEM", 69, 85], ["impression smears", "TEST", 117, 134], ["microbiologic cultures", "TEST", 139, 161], ["analyses", "TEST", 166, 174], ["lesions", "OBSERVATION", 46, 53]]], ["The skin of the legs, head, neck, and/or flanks has raised firm nodules (\u22481 to 2 cm in diameter), draining nodules, and draining fistulous tracts, often arranged in linear bands (beaded appearance) that follow the flow of lymphatic vessels.", [["skin", "ANATOMY", 4, 8], ["legs", "ANATOMY", 16, 20], ["head", "ANATOMY", 22, 26], ["neck", "ANATOMY", 28, 32], ["flanks", "ANATOMY", 41, 47], ["firm nodules", "ANATOMY", 59, 71], ["draining nodules", "ANATOMY", 98, 114], ["draining fistulous tracts", "ANATOMY", 120, 145], ["lymphatic vessels", "ANATOMY", 222, 239], ["skin", "ORGAN", 4, 8], ["legs", "ORGANISM_SUBDIVISION", 16, 20], ["head", "ORGANISM_SUBDIVISION", 22, 26], ["neck", "ORGANISM_SUBDIVISION", 28, 32], ["flanks", "ORGANISM_SUBDIVISION", 41, 47], ["firm nodules", "CANCER", 59, 71], ["nodules", "CANCER", 107, 114], ["fistulous tracts", "PATHOLOGICAL_FORMATION", 129, 145], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 222, 239], ["The skin of the legs, head, neck, and/or flanks", "TEST", 0, 47], ["raised firm nodules", "PROBLEM", 52, 71], ["draining nodules", "PROBLEM", 98, 114], ["draining fistulous tracts", "PROBLEM", 120, 145], ["skin", "ANATOMY", 4, 8], ["legs", "ANATOMY", 16, 20], ["head", "ANATOMY", 22, 26], ["neck", "ANATOMY", 28, 32], ["flanks", "ANATOMY", 41, 47], ["firm", "OBSERVATION_MODIFIER", 59, 63], ["nodules", "OBSERVATION", 64, 71], ["\u22481 to 2 cm", "OBSERVATION_MODIFIER", 73, 83], ["draining", "OBSERVATION_MODIFIER", 98, 106], ["nodules", "OBSERVATION", 107, 114], ["draining", "OBSERVATION_MODIFIER", 120, 128], ["fistulous tracts", "OBSERVATION", 129, 145], ["linear bands", "OBSERVATION_MODIFIER", 165, 177], ["beaded", "OBSERVATION_MODIFIER", 179, 185], ["lymphatic vessels", "ANATOMY", 222, 239]]], ["These lesions contain or drain pus, which is often thick and white-yellow in color.", [["lesions", "ANATOMY", 6, 13], ["drain pus", "ANATOMY", 25, 34], ["lesions", "CANCER", 6, 13], ["pus", "ORGANISM_SUBSTANCE", 31, 34], ["These lesions", "PROBLEM", 0, 13], ["drain pus", "PROBLEM", 25, 34], ["lesions", "OBSERVATION", 6, 13], ["drain", "OBSERVATION_MODIFIER", 25, 30], ["pus", "OBSERVATION", 31, 34], ["often", "OBSERVATION_MODIFIER", 45, 50], ["thick", "OBSERVATION_MODIFIER", 51, 56], ["yellow", "OBSERVATION_MODIFIER", 67, 73]]], ["Microscopically, lesions are characterized by suppurative to pyogranulomatous inflammation.", [["lesions", "ANATOMY", 17, 24], ["pyogranulomatous", "ANATOMY", 61, 77], ["inflammation", "DISEASE", 78, 90], ["lesions", "PATHOLOGICAL_FORMATION", 17, 24], ["lesions", "PROBLEM", 17, 24], ["suppurative to pyogranulomatous inflammation", "PROBLEM", 46, 90], ["lesions", "OBSERVATION", 17, 24], ["suppurative", "OBSERVATION_MODIFIER", 46, 57], ["pyogranulomatous", "OBSERVATION_MODIFIER", 61, 77], ["inflammation", "OBSERVATION", 78, 90]]], ["Infectious microorganisms are often present in the exudate (see Fig. 4-25) .Lymphatic VesselsChronic Progressive Lymphedema in Draft Horses.", [["exudate", "ANATOMY", 51, 58], ["Lymphatic", "ANATOMY", 76, 85], ["Chronic Progressive Lymphedema", "DISEASE", 93, 123], ["exudate", "TISSUE", 51, 58], ["Infectious microorganisms", "PROBLEM", 0, 25], ["the exudate", "PROBLEM", 47, 58], ["Lymphatic VesselsChronic Progressive Lymphedema in Draft Horses", "PROBLEM", 76, 139], ["exudate", "OBSERVATION_MODIFIER", 51, 58], ["Vessels", "ANATOMY", 86, 93], ["Chronic", "OBSERVATION_MODIFIER", 93, 100], ["Progressive", "OBSERVATION_MODIFIER", 101, 112], ["Lymphedema", "OBSERVATION", 113, 123], ["Draft Horses", "OBSERVATION", 127, 139]]], ["Chronic progressive lymphedema (CPL) occurs in many draft horse breeds and is a debilitating condition.", [["lymphedema", "DISEASE", 20, 30], ["CPL", "DISEASE", 32, 35], ["horse", "ORGANISM", 58, 63], ["Chronic progressive lymphedema (CPL)", "PROBLEM", 0, 36], ["a debilitating condition", "PROBLEM", 78, 102], ["progressive", "OBSERVATION_MODIFIER", 8, 19], ["lymphedema", "OBSERVATION", 20, 30], ["CPL", "ANATOMY", 32, 35], ["horse breeds", "OBSERVATION", 58, 70], ["debilitating", "OBSERVATION_MODIFIER", 80, 92]]], ["A definitive cause is not known; however, a genetic disorder of elastin metabolism resulting in dysfunction of the lymphatic vessels in the distal extremities with multiple contributing factors including secondary bacterial infections is suspected.", [["lymphatic vessels", "ANATOMY", 115, 132], ["distal extremities", "ANATOMY", 140, 158], ["bacterial infections", "DISEASE", 214, 234], ["elastin", "GENE_OR_GENE_PRODUCT", 64, 71], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 115, 132], ["distal extremities", "ORGANISM_SUBDIVISION", 140, 158], ["a genetic disorder", "PROBLEM", 42, 60], ["elastin metabolism", "PROBLEM", 64, 82], ["dysfunction of the lymphatic vessels in the distal extremities", "PROBLEM", 96, 158], ["multiple contributing factors", "PROBLEM", 164, 193], ["secondary bacterial infections", "PROBLEM", 204, 234], ["not known", "UNCERTAINTY", 22, 31], ["elastin metabolism", "OBSERVATION", 64, 82], ["lymphatic vessels", "ANATOMY", 115, 132], ["distal", "ANATOMY_MODIFIER", 140, 146], ["extremities", "ANATOMY", 147, 158], ["multiple", "OBSERVATION_MODIFIER", 164, 172], ["secondary", "OBSERVATION_MODIFIER", 204, 213], ["bacterial", "OBSERVATION_MODIFIER", 214, 223], ["infections", "OBSERVATION", 224, 234]]], ["The distal limbs are swollen with pitting edema, thickened, scaling skin with exudation, erosions, and ulcerations.", [["distal limbs", "ANATOMY", 4, 16], ["edema", "ANATOMY", 42, 47], ["skin", "ANATOMY", 68, 72], ["edema", "DISEASE", 42, 47], ["erosions", "DISEASE", 89, 97], ["ulcerations", "DISEASE", 103, 114], ["limbs", "ORGANISM_SUBDIVISION", 11, 16], ["edema", "PATHOLOGICAL_FORMATION", 42, 47], ["skin", "ORGAN", 68, 72], ["ulcerations", "PATHOLOGICAL_FORMATION", 103, 114], ["swollen", "PROBLEM", 21, 28], ["pitting edema", "PROBLEM", 34, 47], ["thickened", "PROBLEM", 49, 58], ["scaling skin", "PROBLEM", 60, 72], ["exudation", "PROBLEM", 78, 87], ["erosions", "PROBLEM", 89, 97], ["ulcerations", "PROBLEM", 103, 114], ["distal", "ANATOMY_MODIFIER", 4, 10], ["limbs", "ANATOMY", 11, 16], ["swollen", "OBSERVATION", 21, 28], ["pitting", "OBSERVATION_MODIFIER", 34, 41], ["edema", "OBSERVATION", 42, 47], ["thickened", "OBSERVATION_MODIFIER", 49, 58], ["scaling", "OBSERVATION_MODIFIER", 60, 67], ["skin", "ANATOMY", 68, 72], ["exudation", "OBSERVATION_MODIFIER", 78, 87], ["erosions", "OBSERVATION", 89, 97], ["ulcerations", "OBSERVATION", 103, 114]]], ["Microscopically, dermal lymphatic vessels are markedly dilated within the edematous dermis.", [["dermal lymphatic vessels", "ANATOMY", 17, 41], ["edematous dermis", "ANATOMY", 74, 90], ["dermal lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 17, 41], ["edematous dermis", "TISSUE", 74, 90], ["markedly dilated within the edematous dermis", "PROBLEM", 46, 90], ["dermal", "ANATOMY_MODIFIER", 17, 23], ["lymphatic vessels", "ANATOMY", 24, 41], ["markedly", "OBSERVATION_MODIFIER", 46, 54], ["dilated", "OBSERVATION", 55, 62], ["edematous", "OBSERVATION_MODIFIER", 74, 83], ["dermis", "ANATOMY", 84, 90]]], ["In chronic cases, the dermis may become markedly thickened with fibrous connective tissue as a result of the chronic edema.", [["dermis", "ANATOMY", 22, 28], ["fibrous connective tissue", "ANATOMY", 64, 89], ["edema", "DISEASE", 117, 122], ["dermis", "TISSUE", 22, 28], ["fibrous connective tissue", "TISSUE", 64, 89], ["edema", "PATHOLOGICAL_FORMATION", 117, 122], ["markedly thickened", "PROBLEM", 40, 58], ["fibrous connective tissue", "PROBLEM", 64, 89], ["the chronic edema", "PROBLEM", 105, 122], ["chronic", "OBSERVATION_MODIFIER", 3, 10], ["cases", "OBSERVATION", 11, 16], ["dermis", "ANATOMY", 22, 28], ["may become", "UNCERTAINTY", 29, 39], ["markedly", "OBSERVATION_MODIFIER", 40, 48], ["thickened", "OBSERVATION", 49, 58], ["fibrous connective tissue", "OBSERVATION", 64, 89], ["chronic", "OBSERVATION_MODIFIER", 109, 116], ["edema", "OBSERVATION", 117, 122]]], ["The overlying epidermis may be acanthotic with intraepidermal pustules, erosions, and ulcerations.", [["overlying epidermis", "ANATOMY", 4, 23], ["intraepidermal pustules", "ANATOMY", 47, 70], ["pustules", "DISEASE", 62, 70], ["erosions", "DISEASE", 72, 80], ["ulcerations", "DISEASE", 86, 97], ["epidermis", "TISSUE", 14, 23], ["intraepidermal pustules", "PATHOLOGICAL_FORMATION", 47, 70], ["ulcerations", "PATHOLOGICAL_FORMATION", 86, 97], ["The overlying epidermis", "PROBLEM", 0, 23], ["acanthotic", "PROBLEM", 31, 41], ["intraepidermal pustules", "PROBLEM", 47, 70], ["erosions", "PROBLEM", 72, 80], ["ulcerations", "PROBLEM", 86, 97], ["overlying", "ANATOMY_MODIFIER", 4, 13], ["epidermis", "ANATOMY", 14, 23], ["may be", "UNCERTAINTY", 24, 30], ["intraepidermal", "OBSERVATION_MODIFIER", 47, 61], ["pustules", "OBSERVATION", 62, 70], ["erosions", "OBSERVATION", 72, 80], ["ulcerations", "OBSERVATION", 86, 97]]], ["Folliculitis and deep dermal abscesses may be present.", [["dermal abscesses", "ANATOMY", 22, 38], ["Folliculitis", "DISEASE", 0, 12], ["dermal abscesses", "DISEASE", 22, 38], ["dermal abscesses", "PATHOLOGICAL_FORMATION", 22, 38], ["Folliculitis", "PROBLEM", 0, 12], ["deep dermal abscesses", "PROBLEM", 17, 38], ["deep", "ANATOMY_MODIFIER", 17, 21], ["dermal", "ANATOMY", 22, 28], ["abscesses", "OBSERVATION", 29, 38]]], ["Staining for elastin fibers demonstrates a disorganized and excessive network of elastin fibers within the superficial dermis.", [["elastin fibers", "ANATOMY", 13, 27], ["elastin fibers", "ANATOMY", 81, 95], ["superficial dermis", "ANATOMY", 107, 125], ["elastin fibers", "GENE_OR_GENE_PRODUCT", 13, 27], ["elastin fibers", "CELLULAR_COMPONENT", 81, 95], ["superficial dermis", "TISSUE", 107, 125], ["elastin fibers", "PROBLEM", 13, 27], ["a disorganized", "PROBLEM", 41, 55], ["elastin fibers", "OBSERVATION", 13, 27], ["disorganized", "OBSERVATION_MODIFIER", 43, 55], ["excessive", "OBSERVATION_MODIFIER", 60, 69], ["elastin fibers", "OBSERVATION", 81, 95], ["superficial", "ANATOMY_MODIFIER", 107, 118], ["dermis", "ANATOMY", 119, 125]]], ["Lymphatic vessels within the deep dermis lack normal elastin fibers. with inflammatory cell infiltrates are present (see Chapter 4 and Fig. 4-40) .Disturbances of GrowthCranial Mesenteric Arteritis and Thrombosis.", [["Lymphatic vessels", "ANATOMY", 0, 17], ["deep dermis", "ANATOMY", 29, 40], ["elastin fibers", "ANATOMY", 53, 67], ["inflammatory cell", "ANATOMY", 74, 91], ["GrowthCranial Mesenteric Arteritis", "DISEASE", 163, 197], ["Thrombosis", "DISEASE", 202, 212], ["Lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 0, 17], ["deep dermis", "TISSUE", 29, 40], ["elastin fibers", "CELLULAR_COMPONENT", 53, 67], ["inflammatory cell", "CELL", 74, 91], ["inflammatory cell infiltrates", "CELL_TYPE", 74, 103], ["inflammatory cell infiltrates", "PROBLEM", 74, 103], ["GrowthCranial Mesenteric Arteritis", "PROBLEM", 163, 197], ["Thrombosis", "PROBLEM", 202, 212], ["vessels", "ANATOMY", 10, 17], ["deep", "ANATOMY_MODIFIER", 29, 33], ["dermis", "ANATOMY", 34, 40], ["normal", "OBSERVATION", 46, 52], ["elastin fibers", "OBSERVATION", 53, 67], ["inflammatory cell", "OBSERVATION", 74, 91], ["infiltrates", "OBSERVATION", 92, 103], ["GrowthCranial Mesenteric", "ANATOMY", 163, 187], ["Arteritis", "OBSERVATION", 188, 197], ["Thrombosis", "OBSERVATION", 202, 212]]], ["Cranial mesenteric arteritis and thrombosis results from fourth-stage larval migration from Strongylus vulgaris (Fig. 10-73 ).", [["Cranial mesenteric", "ANATOMY", 0, 18], ["Cranial mesenteric arteritis", "DISEASE", 0, 28], ["thrombosis", "DISEASE", 33, 43], ["Cranial mesenteric", "MULTI-TISSUE_STRUCTURE", 0, 18], ["Strongylus vulgaris", "ORGANISM", 92, 111], ["Strongylus vulgaris", "SPECIES", 92, 111], ["Strongylus vulgaris", "SPECIES", 92, 111], ["Cranial mesenteric arteritis", "PROBLEM", 0, 28], ["thrombosis", "PROBLEM", 33, 43], ["fourth-stage larval migration", "PROBLEM", 57, 86], ["Strongylus vulgaris", "PROBLEM", 92, 111], ["mesenteric", "ANATOMY", 8, 18], ["arteritis", "OBSERVATION", 19, 28], ["thrombosis", "OBSERVATION", 33, 43], ["fourth", "OBSERVATION_MODIFIER", 57, 63], ["stage", "OBSERVATION_MODIFIER", 64, 69], ["larval", "OBSERVATION_MODIFIER", 70, 76], ["migration", "OBSERVATION_MODIFIER", 77, 86], ["Strongylus", "OBSERVATION_MODIFIER", 92, 102], ["vulgaris", "OBSERVATION_MODIFIER", 103, 111]]], ["Infection of horses by Strongylus vulgaris is now less common because of widespread use of highly efficacious antiparasitic drugs.", [["Strongylus vulgaris", "DISEASE", 23, 42], ["horses", "ORGANISM", 13, 19], ["Strongylus vulgaris", "ORGANISM", 23, 42], ["Strongylus vulgaris", "SPECIES", 23, 42], ["Strongylus vulgaris", "SPECIES", 23, 42], ["Infection of horses", "PROBLEM", 0, 19], ["Strongylus vulgaris", "PROBLEM", 23, 42], ["antiparasitic drugs", "TREATMENT", 110, 129]]], ["During its larval development, the parasite migrates through the intestinal arteries, and the most severe lesions are generally found in the cranial mesenteric artery near its origin.", [["intestinal arteries", "ANATOMY", 65, 84], ["lesions", "ANATOMY", 106, 113], ["cranial mesenteric artery", "ANATOMY", 141, 166], ["intestinal arteries", "MULTI-TISSUE_STRUCTURE", 65, 84], ["lesions", "PATHOLOGICAL_FORMATION", 106, 113], ["cranial mesenteric artery", "MULTI-TISSUE_STRUCTURE", 141, 166], ["the parasite", "TREATMENT", 31, 43], ["the most severe lesions", "PROBLEM", 90, 113], ["larval", "OBSERVATION_MODIFIER", 11, 17], ["parasite", "OBSERVATION", 35, 43], ["intestinal arteries", "ANATOMY", 65, 84], ["most", "OBSERVATION_MODIFIER", 94, 98], ["severe", "OBSERVATION_MODIFIER", 99, 105], ["lesions", "OBSERVATION", 106, 113], ["cranial mesenteric artery", "ANATOMY", 141, 166], ["origin", "ANATOMY_MODIFIER", 176, 182]]], ["The affected vessel is enlarged, and its wall is firm and fibrotic.", [["vessel", "ANATOMY", 13, 19], ["wall", "ANATOMY", 41, 45], ["vessel", "MULTI-TISSUE_STRUCTURE", 13, 19], ["wall", "TISSUE", 41, 45], ["fibrotic", "PROBLEM", 58, 66], ["affected", "OBSERVATION_MODIFIER", 4, 12], ["vessel", "ANATOMY", 13, 19], ["enlarged", "OBSERVATION", 23, 31], ["wall", "ANATOMY_MODIFIER", 41, 45], ["firm", "OBSERVATION", 49, 53], ["fibrotic", "OBSERVATION", 58, 66]]], ["The intimal surface often has an adhering thrombus often admixed with larvae.", [["intimal surface", "ANATOMY", 4, 19], ["thrombus", "ANATOMY", 42, 50], ["thrombus", "DISEASE", 42, 50], ["intimal surface", "TISSUE", 4, 19], ["thrombus", "PATHOLOGICAL_FORMATION", 42, 50], ["an adhering thrombus", "PROBLEM", 30, 50], ["intimal", "OBSERVATION_MODIFIER", 4, 11], ["surface", "OBSERVATION_MODIFIER", 12, 19], ["adhering", "OBSERVATION_MODIFIER", 33, 41], ["thrombus", "OBSERVATION", 42, 50]]], ["Microscopically, the affected vessel has extensive infiltration of inflammatory cells and proliferation of fibroblasts throughout the wall.", [["vessel", "ANATOMY", 30, 36], ["inflammatory cells", "ANATOMY", 67, 85], ["fibroblasts", "ANATOMY", 107, 118], ["wall", "ANATOMY", 134, 138], ["vessel", "MULTI-TISSUE_STRUCTURE", 30, 36], ["inflammatory cells", "CELL", 67, 85], ["fibroblasts", "CELL", 107, 118], ["wall", "TISSUE", 134, 138], ["inflammatory cells", "CELL_TYPE", 67, 85], ["fibroblasts", "CELL_TYPE", 107, 118], ["extensive infiltration of inflammatory cells", "PROBLEM", 41, 85], ["proliferation of fibroblasts throughout the wall", "PROBLEM", 90, 138], ["affected", "OBSERVATION_MODIFIER", 21, 29], ["vessel", "ANATOMY", 30, 36], ["extensive", "OBSERVATION_MODIFIER", 41, 50], ["infiltration", "OBSERVATION", 51, 63], ["inflammatory cells", "OBSERVATION", 67, 85], ["proliferation", "OBSERVATION_MODIFIER", 90, 103], ["fibroblasts", "OBSERVATION", 107, 118], ["wall", "ANATOMY_MODIFIER", 134, 138]]], ["As a consequence, thromboembolism of the intestinal arteries frequently occurs and can produce colic, but the abundant collateral circulation to the equine intestinal tract makes intestinal infarction an unusual event.Disturbances of GrowthAortoiliac Thrombosis.", [["intestinal arteries", "ANATOMY", 41, 60], ["collateral", "ANATOMY", 119, 129], ["intestinal tract", "ANATOMY", 156, 172], ["intestinal", "ANATOMY", 179, 189], ["thromboembolism", "DISEASE", 18, 33], ["colic", "DISEASE", 95, 100], ["intestinal infarction", "DISEASE", 179, 200], ["Thrombosis", "DISEASE", 251, 261], ["intestinal arteries", "MULTI-TISSUE_STRUCTURE", 41, 60], ["collateral", "MULTI-TISSUE_STRUCTURE", 119, 129], ["equine", "ORGANISM", 149, 155], ["intestinal tract", "ORGANISM_SUBDIVISION", 156, 172], ["intestinal", "ORGAN", 179, 189], ["thromboembolism of the intestinal arteries", "PROBLEM", 18, 60], ["colic", "PROBLEM", 95, 100], ["intestinal infarction", "PROBLEM", 179, 200], ["GrowthAortoiliac Thrombosis", "PROBLEM", 234, 261], ["thromboembolism", "OBSERVATION", 18, 33], ["intestinal arteries", "ANATOMY", 41, 60], ["abundant", "OBSERVATION_MODIFIER", 110, 118], ["collateral circulation", "OBSERVATION", 119, 141], ["intestinal tract", "ANATOMY", 156, 172], ["intestinal", "ANATOMY", 179, 189], ["infarction", "OBSERVATION", 190, 200], ["GrowthAortoiliac Thrombosis", "OBSERVATION", 234, 261]]], ["Aortoiliac thrombosis is characterized by extensive and progressive thrombosis thought to be caused by migration of fourth-stage larval migration from Strongylus vulgaris.", [["Aortoiliac", "ANATOMY", 0, 10], ["Aortoiliac thrombosis", "DISEASE", 0, 21], ["thrombosis", "DISEASE", 68, 78], ["Strongylus vulgaris", "ORGANISM", 151, 170], ["Strongylus vulgaris", "SPECIES", 151, 170], ["Strongylus vulgaris", "SPECIES", 151, 170], ["Aortoiliac thrombosis", "PROBLEM", 0, 21], ["progressive thrombosis", "PROBLEM", 56, 78], ["fourth-stage larval migration", "PROBLEM", 116, 145], ["Strongylus vulgaris", "PROBLEM", 151, 170], ["thrombosis", "OBSERVATION", 11, 21], ["extensive", "OBSERVATION_MODIFIER", 42, 51], ["progressive", "OBSERVATION_MODIFIER", 56, 67], ["thrombosis", "OBSERVATION", 68, 78], ["thought to be caused", "UNCERTAINTY", 79, 99], ["migration", "OBSERVATION_MODIFIER", 103, 112], ["fourth", "OBSERVATION_MODIFIER", 116, 122], ["stage", "OBSERVATION_MODIFIER", 123, 128], ["larval migration", "OBSERVATION", 129, 145], ["Strongylus vulgaris", "OBSERVATION", 151, 170]]], ["Aortoiliac thrombosis results in posterior weakness following exercise with recovery following rest.", [["Aortoiliac", "ANATOMY", 0, 10], ["thrombosis", "DISEASE", 11, 21], ["posterior", "ORGANISM_SUBDIVISION", 33, 42], ["Aortoiliac thrombosis", "PROBLEM", 0, 21], ["posterior weakness", "PROBLEM", 33, 51], ["rest", "TREATMENT", 95, 99], ["thrombosis", "OBSERVATION", 11, 21], ["posterior", "ANATOMY_MODIFIER", 33, 42], ["weakness", "OBSERVATION", 43, 51]]], ["See the previous section on cranial mesenteric arteritis and thrombosis.", [["cranial mesenteric", "ANATOMY", 28, 46], ["cranial mesenteric arteritis", "DISEASE", 28, 56], ["thrombosis", "DISEASE", 61, 71], ["cranial mesenteric", "MULTI-TISSUE_STRUCTURE", 28, 46], ["cranial mesenteric arteritis", "PROBLEM", 28, 56], ["thrombosis", "PROBLEM", 61, 71], ["cranial mesenteric", "ANATOMY", 28, 46], ["arteritis", "OBSERVATION", 47, 56], ["thrombosis", "OBSERVATION", 61, 71]]], ["Jugular Thrombophlebitis.", [["Jugular Thrombophlebitis", "DISEASE", 0, 24], ["Jugular Thrombophlebitis", "PROBLEM", 0, 24], ["Thrombophlebitis", "OBSERVATION", 8, 24]]], ["See the discussion on jugular thrombophlebitis in the section on Disorders of Domestic Animals: Blood and Lymphatic Vessels, Blood Vessels, Inflammation.Cell Degeneration and DeathArterial Intimal Calcification.", [["jugular thrombophlebitis", "ANATOMY", 22, 46], ["Blood", "ANATOMY", 96, 101], ["Lymphatic Vessels", "ANATOMY", 106, 123], ["Blood Vessels", "ANATOMY", 125, 138], ["Cell", "ANATOMY", 153, 157], ["Intimal", "ANATOMY", 189, 196], ["jugular thrombophlebitis", "DISEASE", 22, 46], ["Inflammation", "DISEASE", 140, 152], ["jugular thrombophlebitis", "MULTI-TISSUE_STRUCTURE", 22, 46], ["Blood", "ORGANISM_SUBSTANCE", 96, 101], ["Lymphatic Vessels", "MULTI-TISSUE_STRUCTURE", 106, 123], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 125, 138], ["Cell", "CELL", 153, 157], ["Intimal", "TISSUE", 189, 196], ["jugular thrombophlebitis", "PROBLEM", 22, 46], ["Inflammation", "PROBLEM", 140, 152], ["Cell Degeneration", "PROBLEM", 153, 170], ["DeathArterial Intimal Calcification", "PROBLEM", 175, 210], ["jugular", "ANATOMY", 22, 29], ["thrombophlebitis", "OBSERVATION", 30, 46], ["Blood", "ANATOMY", 96, 101], ["Lymphatic Vessels", "ANATOMY", 106, 123], ["Blood Vessels", "ANATOMY", 125, 138], ["Inflammation", "OBSERVATION", 140, 152], ["DeathArterial", "OBSERVATION_MODIFIER", 175, 188], ["Intimal", "OBSERVATION_MODIFIER", 189, 196], ["Calcification", "OBSERVATION", 197, 210]]], ["Arterial intimal calcifications (intimal bodies) are distinctively small, mineralized masses within the subendothelium in small muscular arteries and arterioles of horses (E- Fig. 10-24) .", [["Arterial intimal", "ANATOMY", 0, 16], ["intimal bodies", "ANATOMY", 33, 47], ["masses", "ANATOMY", 86, 92], ["subendothelium", "ANATOMY", 104, 118], ["muscular arteries", "ANATOMY", 128, 145], ["arterioles", "ANATOMY", 150, 160], ["Arterial intimal calcifications", "PATHOLOGICAL_FORMATION", 0, 31], ["intimal bodies", "TISSUE", 33, 47], ["masses", "CANCER", 86, 92], ["subendothelium", "TISSUE", 104, 118], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 128, 145], ["arterioles", "MULTI-TISSUE_STRUCTURE", 150, 160], ["Arterial intimal calcifications (intimal bodies", "PROBLEM", 0, 47], ["distinctively small, mineralized masses", "PROBLEM", 53, 92], ["intimal", "OBSERVATION_MODIFIER", 9, 16], ["calcifications", "OBSERVATION", 17, 31], ["intimal", "ANATOMY", 33, 40], ["bodies", "ANATOMY_MODIFIER", 41, 47], ["distinctively", "OBSERVATION_MODIFIER", 53, 66], ["small", "OBSERVATION_MODIFIER", 67, 72], ["mineralized", "OBSERVATION_MODIFIER", 74, 85], ["masses", "OBSERVATION", 86, 92], ["subendothelium", "ANATOMY_MODIFIER", 104, 118], ["small", "ANATOMY_MODIFIER", 122, 127], ["muscular arteries", "ANATOMY", 128, 145], ["arterioles", "ANATOMY_MODIFIER", 150, 160], ["horses", "OBSERVATION_MODIFIER", 164, 170]]], ["They have no deleterious effect.Disturbances of GrowthValvular Hematomas.", [["Hematomas", "DISEASE", 63, 72], ["deleterious effect", "PROBLEM", 13, 31], ["GrowthValvular Hematomas", "PROBLEM", 48, 72], ["no", "UNCERTAINTY", 10, 12], ["deleterious", "OBSERVATION_MODIFIER", 13, 24], ["effect", "OBSERVATION_MODIFIER", 25, 31], ["GrowthValvular", "ANATOMY", 48, 62], ["Hematomas", "OBSERVATION", 63, 72]]], ["Valvular hematomas (hematocysts, valvular telangiectasia) frequently are observed on the AV valves of postnatal ruminants (see Fig. 10-51, A) .", [["Valvular", "ANATOMY", 0, 8], ["hematocysts", "ANATOMY", 20, 31], ["valvular", "ANATOMY", 33, 41], ["AV valves", "ANATOMY", 89, 98], ["Valvular hematomas", "DISEASE", 0, 18], ["valvular telangiectasia", "DISEASE", 33, 56], ["Valvular hematomas", "PATHOLOGICAL_FORMATION", 0, 18], ["AV valves", "MULTI-TISSUE_STRUCTURE", 89, 98], ["Valvular hematomas", "PROBLEM", 0, 18], ["hematocysts", "PROBLEM", 20, 31], ["valvular telangiectasia", "PROBLEM", 33, 56], ["postnatal ruminants", "PROBLEM", 102, 121], ["hematomas", "OBSERVATION", 9, 18], ["valvular", "ANATOMY", 33, 41], ["telangiectasia", "OBSERVATION", 42, 56], ["AV valves", "ANATOMY", 89, 98]]], ["These lesions, which may regress spontaneously by the time the animals are several months of age, do not produce any functional abnormalities.", [["lesions", "ANATOMY", 6, 13], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["These lesions", "PROBLEM", 0, 13], ["any functional abnormalities", "PROBLEM", 113, 141], ["lesions", "OBSERVATION", 6, 13], ["abnormalities", "OBSERVATION", 128, 141]]], ["Lesions are bulging, blood-filled cysts, several millimeters in diameter, on the AV valves.", [["Lesions", "ANATOMY", 0, 7], ["blood", "ANATOMY", 21, 26], ["cysts", "ANATOMY", 34, 39], ["AV valves", "ANATOMY", 81, 90], ["blood", "ORGANISM_SUBSTANCE", 21, 26], ["cysts", "PATHOLOGICAL_FORMATION", 34, 39], ["AV valves", "MULTI-TISSUE_STRUCTURE", 81, 90], ["Lesions", "PROBLEM", 0, 7], ["bulging", "PROBLEM", 12, 19], ["blood-filled cysts", "PROBLEM", 21, 39], ["the AV valves", "TREATMENT", 77, 90], ["bulging", "OBSERVATION_MODIFIER", 12, 19], ["blood", "ANATOMY", 21, 26], ["filled", "OBSERVATION_MODIFIER", 27, 33], ["cysts", "OBSERVATION", 34, 39], ["several", "OBSERVATION_MODIFIER", 41, 48], ["millimeters", "OBSERVATION_MODIFIER", 49, 60], ["diameter", "OBSERVATION_MODIFIER", 64, 72], ["AV valves", "ANATOMY", 81, 90]]], ["Valvular Lymphocysts.", [["Valvular Lymphocysts", "ANATOMY", 0, 20], ["Valvular Lymphocysts", "DISEASE", 0, 20], ["Valvular Lymphocysts", "PROBLEM", 0, 20], ["Lymphocysts", "OBSERVATION", 9, 20]]], ["Valvular lymphocysts may also occur and appear as yellow serum-filled cysts on the AV valve cusps (see Fig. 10-51, B) .InflammationVegetative Valvular Endocarditis.", [["Valvular lymphocysts", "ANATOMY", 0, 20], ["serum", "ANATOMY", 57, 62], ["cysts", "ANATOMY", 70, 75], ["AV valve cusps", "ANATOMY", 83, 97], ["Valvular", "ANATOMY", 142, 150], ["Valvular lymphocysts", "DISEASE", 0, 20], ["cysts", "DISEASE", 70, 75], ["Valvular Endocarditis", "DISEASE", 142, 163], ["Valvular lymphocysts", "CANCER", 0, 20], ["serum", "ORGANISM_SUBSTANCE", 57, 62], ["cysts", "CANCER", 70, 75], ["AV valve", "MULTI-TISSUE_STRUCTURE", 83, 91], ["Valvular lymphocysts", "PROBLEM", 0, 20], ["yellow serum-filled cysts", "PROBLEM", 50, 75], ["the AV valve cusps", "TREATMENT", 79, 97], ["InflammationVegetative Valvular Endocarditis", "PROBLEM", 119, 163], ["lymphocysts", "OBSERVATION", 9, 20], ["filled", "OBSERVATION_MODIFIER", 63, 69], ["cysts", "OBSERVATION", 70, 75], ["AV valve", "ANATOMY", 83, 91], ["cusps", "ANATOMY_MODIFIER", 92, 97], ["Valvular", "ANATOMY", 142, 150], ["Endocarditis", "OBSERVATION", 151, 163]]], ["Endocarditis is usually the result of bacterial infections in which the affected valves have large, adhering, friable, yellow-to-gray masses of fibrin termed vegetations, which can largely occlude the valvular orifice (see Fig. 10-54, A) .", [["valves", "ANATOMY", 81, 87], ["vegetations", "ANATOMY", 158, 169], ["valvular", "ANATOMY", 201, 209], ["Endocarditis", "DISEASE", 0, 12], ["infections", "DISEASE", 48, 58], ["valves", "PATHOLOGICAL_FORMATION", 81, 87], ["fibrin", "GENE_OR_GENE_PRODUCT", 144, 150], ["vegetations", "PATHOLOGICAL_FORMATION", 158, 169], ["valvular orifice", "MULTI-TISSUE_STRUCTURE", 201, 217], ["fibrin", "PROTEIN", 144, 150], ["Endocarditis", "PROBLEM", 0, 12], ["bacterial infections", "PROBLEM", 38, 58], ["the affected valves", "PROBLEM", 68, 87], ["friable, yellow-to-gray masses", "PROBLEM", 110, 140], ["fibrin termed vegetations", "PROBLEM", 144, 169], ["bacterial", "OBSERVATION_MODIFIER", 38, 47], ["infections", "OBSERVATION", 48, 58], ["affected", "OBSERVATION_MODIFIER", 72, 80], ["valves", "OBSERVATION", 81, 87], ["large", "OBSERVATION_MODIFIER", 93, 98], ["friable", "OBSERVATION_MODIFIER", 110, 117], ["yellow-to-gray", "OBSERVATION_MODIFIER", 119, 133], ["masses", "OBSERVATION", 134, 140], ["fibrin termed vegetations", "OBSERVATION", 144, 169], ["valvular", "ANATOMY", 201, 209], ["orifice", "ANATOMY_MODIFIER", 210, 217]]], ["Microscopically, the lesion consists of accumulated layers of fibrin and numerous embedded bacterial colonies underlain by a zone of infiltrated leukocytes and granulation tissue (see Fig. 10-54, B) .", [["lesion", "ANATOMY", 21, 27], ["colonies", "ANATOMY", 101, 109], ["leukocytes", "ANATOMY", 145, 155], ["granulation tissue", "ANATOMY", 160, 178], ["fibrin", "GENE_OR_GENE_PRODUCT", 62, 68], ["leukocytes", "CELL", 145, 155], ["granulation tissue", "TISSUE", 160, 178], ["B", "CELL", 196, 197], ["fibrin", "PROTEIN", 62, 68], ["infiltrated leukocytes", "CELL_TYPE", 133, 155], ["the lesion", "PROBLEM", 17, 27], ["accumulated layers of fibrin", "PROBLEM", 40, 68], ["numerous embedded bacterial colonies", "PROBLEM", 73, 109], ["infiltrated leukocytes", "PROBLEM", 133, 155], ["granulation tissue", "PROBLEM", 160, 178], ["lesion", "OBSERVATION", 21, 27], ["accumulated", "OBSERVATION_MODIFIER", 40, 51], ["layers", "OBSERVATION_MODIFIER", 52, 58], ["fibrin", "OBSERVATION", 62, 68], ["numerous", "OBSERVATION_MODIFIER", 73, 81], ["embedded", "OBSERVATION_MODIFIER", 82, 90], ["bacterial colonies", "OBSERVATION", 91, 109], ["zone", "OBSERVATION_MODIFIER", 125, 129], ["infiltrated leukocytes", "OBSERVATION", 133, 155], ["granulation tissue", "OBSERVATION", 160, 178]]], ["See the discussion on vegetative valvular and mural endocarditis in the section on Disorders of Domestic Animals: Endocardium and Heart Valves, Inflammation, and also Chapter 3.Cell Degeneration and DeathEndocardial Mineralization See the discussion on mineralization in the section on Disorders of Domestic Animals: Endocardium and Heart Valves, Cell Degeneration and Death, Endocardial Mineralization; in others sections of this chapter; and also Chapters 1 and 15.Pericardium and EpicardiumInflammation Fibrinous Pericarditis.", [["vegetative valvular", "ANATOMY", 22, 41], ["Heart", "ANATOMY", 130, 135], ["Cell", "ANATOMY", 177, 181], ["Heart", "ANATOMY", 333, 338], ["Cell", "ANATOMY", 347, 351], ["Pericardium", "ANATOMY", 467, 478], ["vegetative valvular and mural endocarditis", "DISEASE", 22, 64], ["Inflammation", "DISEASE", 144, 156], ["Heart Valves", "DISEASE", 333, 345], ["Death", "DISEASE", 369, 374], ["Pericardium", "DISEASE", 467, 478], ["Pericarditis", "DISEASE", 516, 528], ["valvular", "MULTI-TISSUE_STRUCTURE", 33, 41], ["Cell", "CELL", 177, 181], ["Cell", "CELL", 347, 351], ["vegetative valvular", "PROBLEM", 22, 41], ["mural endocarditis", "PROBLEM", 46, 64], ["Endocardium and Heart Valves", "PROBLEM", 114, 142], ["Inflammation", "PROBLEM", 144, 156], ["Cell Degeneration", "PROBLEM", 177, 194], ["DeathEndocardial Mineralization", "PROBLEM", 199, 230], ["Endocardium and Heart Valves", "PROBLEM", 317, 345], ["Cell Degeneration", "PROBLEM", 347, 364], ["Death", "PROBLEM", 369, 374], ["Endocardial Mineralization", "PROBLEM", 376, 402], ["Pericardium and EpicardiumInflammation Fibrinous Pericarditis", "PROBLEM", 467, 528], ["valvular", "ANATOMY", 33, 41], ["mural", "OBSERVATION_MODIFIER", 46, 51], ["endocarditis", "OBSERVATION", 52, 64], ["Endocardium", "ANATOMY", 114, 125], ["Heart Valves", "ANATOMY", 130, 142], ["Inflammation", "OBSERVATION", 144, 156], ["Degeneration", "OBSERVATION", 182, 194], ["DeathEndocardial Mineralization", "OBSERVATION", 199, 230], ["Endocardium", "ANATOMY", 317, 328], ["Heart Valves", "ANATOMY", 333, 345], ["Cell Degeneration", "OBSERVATION", 347, 364], ["Endocardial", "ANATOMY", 376, 387], ["Mineralization", "OBSERVATION", 388, 402], ["EpicardiumInflammation", "OBSERVATION_MODIFIER", 483, 505], ["Fibrinous", "OBSERVATION_MODIFIER", 506, 515], ["Pericarditis", "OBSERVATION", 516, 528]]], ["Hematogenous spread of specific organisms may result in fibrinous pericarditis.", [["pericarditis", "DISEASE", 66, 78], ["Hematogenous spread of specific organisms", "PROBLEM", 0, 41], ["fibrinous pericarditis", "PROBLEM", 56, 78], ["fibrinous", "OBSERVATION_MODIFIER", 56, 65], ["pericarditis", "OBSERVATION", 66, 78]]], ["Mannheimiosis, blackleg, coliform septicemias, contagious bovine pleuropneumonia, sporadic bovine encephalomyelitis, and in utero Brucella spp. and Arcanobacter pyogenesis fetal septicemias may all produce fibrinous pericarditis.", [["fetal", "ANATOMY", 172, 177], ["Mannheimiosis", "CHEMICAL", 0, 13], ["coliform septicemias", "DISEASE", 25, 45], ["bovine pleuropneumonia", "DISEASE", 58, 80], ["bovine encephalomyelitis", "DISEASE", 91, 115], ["septicemias", "DISEASE", 178, 189], ["pericarditis", "DISEASE", 216, 228], ["bovine", "ORGANISM", 58, 64], ["bovine", "ORGANISM", 91, 97], ["bovine", "SPECIES", 58, 64], ["bovine", "SPECIES", 91, 97], ["Brucella spp.", "SPECIES", 130, 143], ["bovine encephalomyelitis", "SPECIES", 91, 115], ["Brucella spp.", "SPECIES", 130, 143], ["Arcanobacter pyogenesis", "SPECIES", 148, 171], ["Mannheimiosis", "PROBLEM", 0, 13], ["blackleg", "PROBLEM", 15, 23], ["coliform septicemias", "PROBLEM", 25, 45], ["contagious bovine pleuropneumonia", "PROBLEM", 47, 80], ["sporadic bovine encephalomyelitis", "PROBLEM", 82, 115], ["utero Brucella spp.", "PROBLEM", 124, 143], ["Arcanobacter pyogenesis fetal septicemias", "PROBLEM", 148, 189], ["fibrinous pericarditis", "PROBLEM", 206, 228], ["coliform septicemias", "OBSERVATION", 25, 45], ["contagious", "OBSERVATION_MODIFIER", 47, 57], ["bovine pleuropneumonia", "OBSERVATION", 58, 80], ["sporadic", "OBSERVATION_MODIFIER", 82, 90], ["bovine encephalomyelitis", "OBSERVATION", 91, 115], ["Brucella spp.", "OBSERVATION", 130, 143], ["fibrinous", "OBSERVATION_MODIFIER", 206, 215], ["pericarditis", "OBSERVATION", 216, 228]]], ["In sheep, Mannheimiosis and streptococcal infections most commonly result in fibrinous pericarditis.", [["Mannheimiosis", "CHEMICAL", 10, 23], ["streptococcal infections", "DISEASE", 28, 52], ["pericarditis", "DISEASE", 87, 99], ["sheep", "ORGANISM", 3, 8], ["Mannheimiosis", "ORGANISM", 10, 23], ["sheep", "SPECIES", 3, 8], ["sheep", "SPECIES", 3, 8], ["Mannheimiosis", "PROBLEM", 10, 23], ["streptococcal infections", "PROBLEM", 28, 52], ["fibrinous pericarditis", "PROBLEM", 77, 99], ["streptococcal", "OBSERVATION_MODIFIER", 28, 41], ["infections", "OBSERVATION", 42, 52], ["fibrinous", "OBSERVATION_MODIFIER", 77, 86], ["pericarditis", "OBSERVATION", 87, 99]]], ["In goats, Mycoplasma Lymphoma (Lymphosarcoma).", [["Lymphoma", "ANATOMY", 21, 29], ["Mycoplasma Lymphoma", "DISEASE", 10, 29], ["goats", "ORGANISM", 3, 8], ["Mycoplasma Lymphoma", "CANCER", 10, 29], ["Lymphosarcoma", "CANCER", 31, 44], ["goats", "SPECIES", 3, 8], ["goats", "SPECIES", 3, 8], ["Mycoplasma Lymphoma (Lymphosarcoma)", "PROBLEM", 10, 45], ["goats", "ANATOMY", 3, 8], ["Mycoplasma Lymphoma", "OBSERVATION", 10, 29], ["Lymphosarcoma", "OBSERVATION", 31, 44]]], ["See the discussion on neoplastic transformation in the section on Disorders of Domestic Animals: Myocardium, Disturbances of Growth.InflammationBlackleg Myocarditis.", [["neoplastic", "ANATOMY", 22, 32], ["Myocarditis", "DISEASE", 153, 164], ["neoplastic transformation", "PROBLEM", 22, 47], ["Disturbances of Growth", "PROBLEM", 109, 131], ["InflammationBlackleg Myocarditis", "PROBLEM", 132, 164], ["neoplastic transformation", "OBSERVATION", 22, 47], ["Myocardium", "ANATOMY", 97, 107], ["Myocarditis", "OBSERVATION", 153, 164]]], ["Hemorrhagic myocarditis occurs together with the hemorrhagic inflammation typically found in skeletal muscle of cattle with blackleg (Clostridium chauvoei) (Fig. 10-74) .", [["skeletal muscle", "ANATOMY", 93, 108], ["Hemorrhagic myocarditis", "DISEASE", 0, 23], ["hemorrhagic inflammation", "DISEASE", 49, 73], ["skeletal muscle", "TISSUE", 93, 108], ["cattle", "ORGANISM", 112, 118], ["Clostridium chauvoei", "ORGANISM", 134, 154], ["cattle", "SPECIES", 112, 118], ["Clostridium chauvoei", "SPECIES", 134, 154], ["cattle", "SPECIES", 112, 118], ["Clostridium chauvoei", "SPECIES", 134, 154], ["Hemorrhagic myocarditis", "PROBLEM", 0, 23], ["the hemorrhagic inflammation", "PROBLEM", 45, 73], ["blackleg (Clostridium chauvoei)", "PROBLEM", 124, 155], ["myocarditis", "OBSERVATION", 12, 23], ["hemorrhagic", "OBSERVATION_MODIFIER", 49, 60], ["inflammation", "OBSERVATION", 61, 73], ["skeletal muscle", "ANATOMY", 93, 108]]], ["See the discussion on myocarditis in the section on Responses to Injury: Myocardium, Inflammation; sections on disorders of individual animal species; and also Chapter 15.InflammationEast Coast Fever (Theileria parva).", [["sections", "ANATOMY", 99, 107], ["myocarditis", "DISEASE", 22, 33], ["Injury", "DISEASE", 65, 71], ["Inflammation", "DISEASE", 85, 97], ["Fever", "DISEASE", 194, 199], ["Theileria parva", "ORGANISM", 201, 216], ["Theileria parva", "SPECIES", 201, 216], ["Theileria parva", "SPECIES", 201, 216], ["myocarditis", "PROBLEM", 22, 33], ["Myocardium", "PROBLEM", 73, 83], ["Inflammation", "PROBLEM", 85, 97], ["individual animal species", "PROBLEM", 124, 149], ["InflammationEast Coast Fever (Theileria parva)", "PROBLEM", 171, 217], ["myocarditis", "OBSERVATION", 22, 33], ["Myocardium", "ANATOMY", 73, 83], ["Inflammation", "OBSERVATION", 85, 97]]], ["East Coast fever is a tick-transmitted protozoal disease of cattle, sheep, and goats in Africa caused by Theileria parva, which causes myocardial necrosis and inflammation (E- Fig. 10-25) .", [["myocardial", "ANATOMY", 135, 145], ["fever", "DISEASE", 11, 16], ["protozoal disease", "DISEASE", 39, 56], ["Theileria parva", "DISEASE", 105, 120], ["myocardial necrosis", "DISEASE", 135, 154], ["inflammation", "DISEASE", 159, 171], ["cattle", "ORGANISM", 60, 66], ["sheep", "ORGANISM", 68, 73], ["goats", "ORGANISM", 79, 84], ["Theileria parva", "ORGANISM", 105, 120], ["myocardial", "MULTI-TISSUE_STRUCTURE", 135, 145], ["cattle", "SPECIES", 60, 66], ["sheep", "SPECIES", 68, 73], ["goats", "SPECIES", 79, 84], ["Theileria parva", "SPECIES", 105, 120], ["cattle", "SPECIES", 60, 66], ["sheep", "SPECIES", 68, 73], ["goats", "SPECIES", 79, 84], ["Theileria parva", "SPECIES", 105, 120], ["East Coast fever", "PROBLEM", 0, 16], ["a tick", "PROBLEM", 20, 26], ["transmitted protozoal disease of cattle", "PROBLEM", 27, 66], ["Theileria parva", "PROBLEM", 105, 120], ["myocardial necrosis", "PROBLEM", 135, 154], ["inflammation", "PROBLEM", 159, 171], ["protozoal disease", "OBSERVATION", 39, 56], ["Theileria parva", "OBSERVATION", 105, 120], ["myocardial", "ANATOMY", 135, 145], ["necrosis", "OBSERVATION", 146, 154], ["inflammation", "OBSERVATION", 159, 171]]], ["Anthrax.", [["Anthrax", "DISEASE", 0, 7], ["Anthrax", "PROBLEM", 0, 7]]], ["Anthrax in herbivores often occurs as an acute febrile highly fatal septicemic disease.", [["Anthrax", "DISEASE", 0, 7], ["Anthrax", "PROBLEM", 0, 7], ["an acute febrile highly fatal septicemic disease", "PROBLEM", 38, 86], ["acute", "OBSERVATION_MODIFIER", 41, 46], ["febrile", "OBSERVATION_MODIFIER", 47, 54], ["highly", "OBSERVATION_MODIFIER", 55, 61], ["fatal", "OBSERVATION_MODIFIER", 62, 67], ["septicemic", "OBSERVATION", 68, 78]]], ["Although global in distribution, the disease is enzootic in certain areas.", [["the disease", "PROBLEM", 33, 44], ["enzootic", "PROBLEM", 48, 56], ["global", "OBSERVATION_MODIFIER", 9, 15], ["distribution", "OBSERVATION_MODIFIER", 19, 31], ["disease", "OBSERVATION", 37, 44], ["enzootic", "OBSERVATION_MODIFIER", 48, 56]]], ["The etiology is Bacillus anthracis, a large rod-shaped spore-forming bacterium.", [["spore", "ANATOMY", 55, 60], ["Bacillus anthracis", "ORGANISM", 16, 34], ["Bacillus anthracis", "SPECIES", 16, 34], ["Bacillus anthracis", "SPECIES", 16, 34], ["Bacillus anthracis", "PROBLEM", 16, 34], ["a large rod-shaped spore-forming bacterium", "PROBLEM", 36, 78], ["Bacillus anthracis", "OBSERVATION", 16, 34], ["large", "OBSERVATION_MODIFIER", 38, 43], ["rod", "OBSERVATION_MODIFIER", 44, 47], ["shaped", "OBSERVATION_MODIFIER", 48, 54], ["spore", "OBSERVATION_MODIFIER", 55, 60], ["forming bacterium", "OBSERVATION", 61, 78]]], ["The pathogenesis of the disease in affected herbivores is exposure by ingestion of contaminated food (especially bone meal) and water.", [["bone", "ANATOMY", 113, 117], ["bone", "TISSUE", 113, 117], ["the disease in affected herbivores", "PROBLEM", 20, 54], ["disease", "OBSERVATION", 24, 31], ["affected", "OBSERVATION_MODIFIER", 35, 43], ["herbivores", "OBSERVATION", 44, 54]]], ["The organisms produce a variety of lethal toxins that provoke local edema and tissue necrosis and increased vascular permeability associated with lymphangitis and lymphadenitis.", [["edema", "ANATOMY", 68, 73], ["tissue", "ANATOMY", 78, 84], ["vascular", "ANATOMY", 108, 116], ["edema", "DISEASE", 68, 73], ["necrosis", "DISEASE", 85, 93], ["lymphangitis", "DISEASE", 146, 158], ["lymphadenitis", "DISEASE", 163, 176], ["edema", "PATHOLOGICAL_FORMATION", 68, 73], ["tissue", "TISSUE", 78, 84], ["vascular", "MULTI-TISSUE_STRUCTURE", 108, 116], ["The organisms", "PROBLEM", 0, 13], ["lethal toxins", "PROBLEM", 35, 48], ["local edema", "PROBLEM", 62, 73], ["tissue necrosis", "PROBLEM", 78, 93], ["increased vascular permeability", "PROBLEM", 98, 129], ["lymphangitis", "PROBLEM", 146, 158], ["lymphadenitis", "PROBLEM", 163, 176], ["variety", "OBSERVATION_MODIFIER", 24, 31], ["local", "OBSERVATION_MODIFIER", 62, 67], ["edema", "OBSERVATION", 68, 73], ["tissue", "OBSERVATION_MODIFIER", 78, 84], ["necrosis", "OBSERVATION", 85, 93], ["increased", "OBSERVATION_MODIFIER", 98, 107], ["vascular", "ANATOMY", 108, 116], ["permeability", "OBSERVATION_MODIFIER", 117, 129], ["lymphangitis", "OBSERVATION", 146, 158], ["lymphadenitis", "OBSERVATION", 163, 176]]], ["Herbivores that die from septicemic anthrax have dark, thick unclotted blood oozing from body orifices.", [["blood", "ANATOMY", 71, 76], ["body orifices", "ANATOMY", 89, 102], ["Herbivores", "DISEASE", 0, 10], ["anthrax", "DISEASE", 36, 43], ["blood", "ORGANISM_SUBSTANCE", 71, 76], ["body orifices", "MULTI-TISSUE_STRUCTURE", 89, 102], ["Herbivores", "TREATMENT", 0, 10], ["septicemic anthrax", "PROBLEM", 25, 43], ["thick unclotted blood oozing from body orifices", "PROBLEM", 55, 102], ["septicemic", "OBSERVATION_MODIFIER", 25, 35], ["oozing", "OBSERVATION", 77, 83], ["body", "ANATOMY_MODIFIER", 89, 93], ["orifices", "ANATOMY_MODIFIER", 94, 102]]], ["These cases should NOT be subjected to necropsy to avoid massive contamination of the environment by the spores of the organism.", [["necropsy", "TREATMENT", 39, 47], ["massive contamination of the environment", "PROBLEM", 57, 97], ["massive", "OBSERVATION_MODIFIER", 57, 64], ["contamination", "OBSERVATION", 65, 78]]], ["Instead, a blood smear should be collected and examined for the presence of the diagnostic bacilli.", [["blood", "ANATOMY", 11, 16], ["blood", "ORGANISM_SUBSTANCE", 11, 16], ["a blood smear", "TEST", 9, 22], ["the diagnostic bacilli", "TEST", 76, 98], ["bacilli", "OBSERVATION", 91, 98]]], ["If a case is necropsied by mistake, the diagnostic findings are massive splenomegaly (so-called blackberry jam spleen), disseminated serosal hemorrhages, and swollen edematous lymph nodes.", [["spleen", "ANATOMY", 111, 117], ["serosal", "ANATOMY", 133, 140], ["edematous lymph nodes", "ANATOMY", 166, 187], ["splenomegaly", "DISEASE", 72, 84], ["serosal hemorrhages", "DISEASE", 133, 152], ["splenomegaly", "PATHOLOGICAL_FORMATION", 72, 84], ["spleen", "ORGAN", 111, 117], ["serosal", "MULTI-TISSUE_STRUCTURE", 133, 140], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 176, 187], ["massive splenomegaly", "PROBLEM", 64, 84], ["disseminated serosal hemorrhages", "PROBLEM", 120, 152], ["swollen edematous lymph nodes", "PROBLEM", 158, 187], ["massive", "OBSERVATION_MODIFIER", 64, 71], ["splenomegaly", "OBSERVATION", 72, 84], ["spleen", "ANATOMY", 111, 117], ["disseminated", "OBSERVATION_MODIFIER", 120, 132], ["serosal hemorrhages", "OBSERVATION", 133, 152], ["swollen", "OBSERVATION_MODIFIER", 158, 165], ["edematous", "OBSERVATION_MODIFIER", 166, 175], ["lymph nodes", "OBSERVATION", 176, 187]]], ["Microscopic findings (histopathologic evaluation is NOT recommended) include massive numbers of typical large rod-shaped organisms in the blood, congestion, hemorrhage, lymphangitis, and lymphadenitis (see Chapter 4, Fig. 4 Bluetongue.", [["blood", "ANATOMY", 138, 143], ["congestion", "DISEASE", 145, 155], ["hemorrhage", "DISEASE", 157, 167], ["lymphangitis", "DISEASE", 169, 181], ["lymphadenitis", "DISEASE", 187, 200], ["blood", "ORGANISM_SUBSTANCE", 138, 143], ["Microscopic findings", "TEST", 0, 20], ["histopathologic evaluation", "TEST", 22, 48], ["massive numbers", "PROBLEM", 77, 92], ["typical large rod-shaped organisms", "PROBLEM", 96, 130], ["the blood", "PROBLEM", 134, 143], ["congestion", "PROBLEM", 145, 155], ["hemorrhage", "PROBLEM", 157, 167], ["lymphangitis", "PROBLEM", 169, 181], ["lymphadenitis", "PROBLEM", 187, 200], ["typical", "OBSERVATION_MODIFIER", 96, 103], ["large", "OBSERVATION_MODIFIER", 104, 109], ["rod", "OBSERVATION", 110, 113], ["-shaped", "OBSERVATION_MODIFIER", 113, 120], ["organisms", "OBSERVATION", 121, 130], ["blood", "ANATOMY", 138, 143], ["congestion", "OBSERVATION", 145, 155], ["hemorrhage", "OBSERVATION", 157, 167], ["lymphangitis", "OBSERVATION", 169, 181], ["lymphadenitis", "OBSERVATION", 187, 200], ["Bluetongue", "OBSERVATION", 224, 234]]], ["See the discussion on bluetongue in Chapters 4 and 7.Cell Degeneration and DeathMulberry Heart Disease.", [["Cell", "ANATOMY", 53, 57], ["bluetongue", "DISEASE", 22, 32], ["Heart Disease", "DISEASE", 89, 102], ["bluetongue", "ORGANISM", 22, 32], ["Cell", "CELL", 53, 57], ["Cell Degeneration", "PROBLEM", 53, 70], ["DeathMulberry Heart Disease", "PROBLEM", 75, 102], ["Degeneration", "OBSERVATION", 58, 70], ["Heart", "ANATOMY", 89, 94], ["Disease", "OBSERVATION", 95, 102]]], ["See the discussion on mulberry heart disease in the next section on Blood and Lymphatic Vascular Systems, Blood Vessels, Cell Degeneration and Death, Dietary Microangiopathy: Mulberry Heart Disease.Viral MyocarditisEncephalomyocarditis.", [["heart", "ANATOMY", 31, 36], ["Blood", "ANATOMY", 68, 73], ["Vascular", "ANATOMY", 88, 96], ["Blood Vessels", "ANATOMY", 106, 119], ["Cell", "ANATOMY", 121, 125], ["Heart", "ANATOMY", 184, 189], ["heart disease", "DISEASE", 31, 44], ["Death", "DISEASE", 143, 148], ["Dietary Microangiopathy", "DISEASE", 150, 173], ["Heart Disease", "DISEASE", 184, 197], ["Viral MyocarditisEncephalomyocarditis", "DISEASE", 198, 235], ["heart", "ORGAN", 31, 36], ["Blood", "ORGANISM_SUBSTANCE", 68, 73], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 78, 96], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 106, 119], ["Cell", "CELL", 121, 125], ["mulberry heart disease", "PROBLEM", 22, 44], ["Blood", "TEST", 68, 73], ["Cell Degeneration", "PROBLEM", 121, 138], ["Death", "PROBLEM", 143, 148], ["Dietary Microangiopathy", "PROBLEM", 150, 173], ["Mulberry Heart Disease", "PROBLEM", 175, 197], ["Viral MyocarditisEncephalomyocarditis", "PROBLEM", 198, 235], ["heart", "ANATOMY", 31, 36], ["disease", "OBSERVATION", 37, 44], ["Lymphatic", "ANATOMY", 78, 87], ["Vascular Systems", "ANATOMY", 88, 104], ["Blood Vessels", "ANATOMY", 106, 119], ["Cell Degeneration", "OBSERVATION", 121, 138], ["Mulberry", "OBSERVATION", 175, 183], ["Heart", "ANATOMY", 184, 189], ["Disease", "OBSERVATION", 190, 197], ["MyocarditisEncephalomyocarditis", "OBSERVATION", 204, 235]]], ["Encephalomyocarditis virus is a cardiovirus of the Picornaviridae.", [["Encephalomyocarditis", "DISEASE", 0, 20], ["Encephalomyocarditis virus", "ORGANISM", 0, 26], ["Encephalomyocarditis virus", "SPECIES", 0, 26], ["Encephalomyocarditis virus", "PROBLEM", 0, 26], ["the Picornaviridae", "TREATMENT", 47, 65]]], ["The type B strain can affect several species including human beings, but pigs are most often affected.", [["type B", "GENE_OR_GENE_PRODUCT", 4, 10], ["human", "ORGANISM", 55, 60], ["pigs", "ORGANISM", 73, 77], ["human", "SPECIES", 55, 60], ["pigs", "SPECIES", 73, 77], ["human", "SPECIES", 55, 60], ["pigs", "SPECIES", 73, 77], ["The type B strain", "PROBLEM", 0, 17]]], ["Pigs of any age can be affected.", [["Pigs", "ORGANISM", 0, 4], ["Pigs", "SPECIES", 0, 4]]], ["Gross lesions can include multifocal areas of pallor.", [["Gross lesions", "ANATOMY", 0, 13], ["pallor", "DISEASE", 46, 52], ["Gross lesions", "CANCER", 0, 13], ["Gross lesions", "PROBLEM", 0, 13], ["pallor", "PROBLEM", 46, 52], ["lesions", "OBSERVATION", 6, 13], ["multifocal", "OBSERVATION_MODIFIER", 26, 36], ["pallor", "OBSERVATION", 46, 52]]], ["Multifocal areas of myocardial necrosis with infiltrations of mononuclear inflammatory cells are observed microscopically.", [["myocardial", "ANATOMY", 20, 30], ["mononuclear inflammatory cells", "ANATOMY", 62, 92], ["myocardial necrosis", "DISEASE", 20, 39], ["myocardial", "MULTI-TISSUE_STRUCTURE", 20, 30], ["mononuclear inflammatory cells", "CELL", 62, 92], ["mononuclear inflammatory cells", "CELL_TYPE", 62, 92], ["myocardial necrosis", "PROBLEM", 20, 39], ["infiltrations of mononuclear inflammatory cells", "PROBLEM", 45, 92], ["areas", "OBSERVATION_MODIFIER", 11, 16], ["myocardial", "ANATOMY", 20, 30], ["necrosis", "OBSERVATION", 31, 39], ["infiltrations", "OBSERVATION", 45, 58], ["mononuclear", "OBSERVATION_MODIFIER", 62, 73], ["inflammatory cells", "OBSERVATION", 74, 92]]], ["Other viruses that can cause myocarditis in pigs include porcine parvovirus and porcine circovirus 2 associated with postweaning multisystemic wasting syndrome.Endocardium and Heart ValvesInflammation Endocarditis.", [["Endocardium", "ANATOMY", 160, 171], ["Heart", "ANATOMY", 176, 181], ["myocarditis", "DISEASE", 29, 40], ["porcine parvovirus", "DISEASE", 57, 75], ["multisystemic wasting syndrome", "DISEASE", 129, 159], ["Endocarditis", "DISEASE", 201, 213], ["pigs", "ORGANISM", 44, 48], ["porcine parvovirus", "ORGANISM", 57, 75], ["porcine circovirus 2", "ORGANISM", 80, 100], ["pigs", "SPECIES", 44, 48], ["porcine parvovirus", "SPECIES", 57, 75], ["porcine circovirus", "SPECIES", 80, 98], ["pigs", "SPECIES", 44, 48], ["porcine parvovirus", "SPECIES", 57, 75], ["porcine circovirus 2", "SPECIES", 80, 100], ["Other viruses", "PROBLEM", 0, 13], ["myocarditis", "PROBLEM", 29, 40], ["porcine parvovirus", "PROBLEM", 57, 75], ["porcine circovirus", "PROBLEM", 80, 98], ["postweaning multisystemic wasting syndrome", "PROBLEM", 117, 159], ["Endocardium and Heart ValvesInflammation Endocarditis", "PROBLEM", 160, 213], ["viruses", "OBSERVATION", 6, 13], ["myocarditis", "OBSERVATION", 29, 40], ["porcine parvovirus", "OBSERVATION", 57, 75], ["porcine circovirus", "OBSERVATION", 80, 98], ["multisystemic", "OBSERVATION_MODIFIER", 129, 142], ["wasting syndrome", "OBSERVATION", 143, 159], ["Heart Valves", "ANATOMY", 176, 188], ["Inflammation", "OBSERVATION_MODIFIER", 188, 200], ["Endocarditis", "OBSERVATION", 201, 213]]], ["Endocarditis is commonly found in pigs and results from a bacterial septicemia.", [["Endocarditis", "DISEASE", 0, 12], ["septicemia", "DISEASE", 68, 78], ["pigs", "ORGANISM", 34, 38], ["pigs", "SPECIES", 34, 38], ["pigs", "SPECIES", 34, 38], ["Endocarditis", "PROBLEM", 0, 12], ["a bacterial septicemia", "PROBLEM", 56, 78], ["bacterial", "OBSERVATION_MODIFIER", 58, 67], ["septicemia", "OBSERVATION", 68, 78]]], ["The most commonly isolated organisms are Streptococcus spp. and Erysipelothrix rhusiopathiae.", [["Streptococcus spp.", "ORGANISM", 41, 59], ["Erysipelothrix rhusiopathiae", "ORGANISM", 64, 92], ["Streptococcus spp.", "SPECIES", 41, 59], ["Erysipelothrix rhusiopathiae", "SPECIES", 64, 92], ["Streptococcus spp.", "SPECIES", 41, 59], ["Erysipelothrix rhusiopathiae", "SPECIES", 64, 92], ["Streptococcus spp.", "PROBLEM", 41, 59], ["Erysipelothrix rhusiopathiae", "PROBLEM", 64, 92], ["Streptococcus spp.", "OBSERVATION", 41, 59], ["Erysipelothrix", "OBSERVATION_MODIFIER", 64, 78], ["rhusiopathiae", "OBSERVATION", 79, 92]]], ["Confirmation of the definitive organism requires bacterial isolation.", [["the definitive organism", "PROBLEM", 16, 39], ["bacterial isolation", "TREATMENT", 49, 68], ["bacterial isolation", "OBSERVATION", 49, 68]]], ["Affected valves have large, adhering, friable, yellow-to-gray masses of fibrin termed vegetations, which can largely occlude the valvular orifice (see Fig. 10-54) .", [["valves", "ANATOMY", 9, 15], ["vegetations", "ANATOMY", 86, 97], ["valvular", "ANATOMY", 129, 137], ["valves", "MULTI-TISSUE_STRUCTURE", 9, 15], ["fibrin", "GENE_OR_GENE_PRODUCT", 72, 78], ["vegetations", "PATHOLOGICAL_FORMATION", 86, 97], ["valvular orifice", "MULTI-TISSUE_STRUCTURE", 129, 145], ["fibrin", "PROTEIN", 72, 78], ["Affected valves", "PROBLEM", 0, 15], ["friable, yellow-to-gray masses", "PROBLEM", 38, 68], ["fibrin termed vegetations", "PROBLEM", 72, 97], ["valves", "OBSERVATION", 9, 15], ["large", "OBSERVATION_MODIFIER", 21, 26], ["friable", "OBSERVATION_MODIFIER", 38, 45], ["yellow", "OBSERVATION_MODIFIER", 47, 53], ["masses", "OBSERVATION", 62, 68], ["fibrin termed vegetations", "OBSERVATION", 72, 97], ["valvular", "ANATOMY", 129, 137], ["orifice", "ANATOMY_MODIFIER", 138, 145]]], ["Microscopically, the lesion consists of accumulated layers of fibrin and numerous embedded bacterial colonies underlain by a zone of infiltrated leukocytes and granulation tissue mycoides subspecies mycoides produces a fibrinous pericarditis.", [["lesion", "ANATOMY", 21, 27], ["fibrin", "ANATOMY", 62, 68], ["colonies", "ANATOMY", 101, 109], ["leukocytes", "ANATOMY", 145, 155], ["fibrinous pericarditis", "DISEASE", 219, 241], ["fibrin", "GENE_OR_GENE_PRODUCT", 62, 68], ["leukocytes", "CELL", 145, 155], ["granulation tissue mycoides subspecies mycoides", "CELL", 160, 207], ["fibrin", "PROTEIN", 62, 68], ["infiltrated leukocytes", "CELL_TYPE", 133, 155], ["mycoides subspecies mycoides", "SPECIES", 179, 207], ["the lesion", "PROBLEM", 17, 27], ["accumulated layers of fibrin", "PROBLEM", 40, 68], ["numerous embedded bacterial colonies", "PROBLEM", 73, 109], ["infiltrated leukocytes", "PROBLEM", 133, 155], ["granulation tissue mycoides subspecies mycoides", "PROBLEM", 160, 207], ["a fibrinous pericarditis", "PROBLEM", 217, 241], ["lesion", "OBSERVATION", 21, 27], ["accumulated", "OBSERVATION_MODIFIER", 40, 51], ["layers", "OBSERVATION_MODIFIER", 52, 58], ["fibrin", "OBSERVATION", 62, 68], ["numerous", "OBSERVATION_MODIFIER", 73, 81], ["embedded", "OBSERVATION_MODIFIER", 82, 90], ["bacterial colonies", "OBSERVATION", 91, 109], ["zone", "OBSERVATION_MODIFIER", 125, 129], ["infiltrated leukocytes", "OBSERVATION", 133, 155], ["granulation tissue", "OBSERVATION", 160, 178], ["mycoides", "OBSERVATION_MODIFIER", 179, 187], ["subspecies mycoides", "OBSERVATION", 188, 207], ["fibrinous", "OBSERVATION_MODIFIER", 219, 228], ["pericarditis", "OBSERVATION", 229, 241]]], ["Sterile swabs of the pericardial exudates are recommended to identify the causative organism.", [["swabs", "ANATOMY", 8, 13], ["pericardial exudates", "ANATOMY", 21, 41], ["pericardial exudates", "MULTI-TISSUE_STRUCTURE", 21, 41], ["Sterile swabs", "TREATMENT", 0, 13], ["the pericardial exudates", "PROBLEM", 17, 41], ["the causative organism", "PROBLEM", 70, 92], ["pericardial", "ANATOMY", 21, 32], ["exudates", "OBSERVATION", 33, 41]]], ["See the discussion on pericarditis in Disorders of Domestic Animals: Pericardium and Epicardium, Inflammation and also Chapters 7 and 9.Endocardium and Heart ValvesSuppurative Pericarditis (Traumatic Reticulopericarditis).", [["pericarditis", "DISEASE", 22, 34], ["Inflammation", "DISEASE", 97, 109], ["Endocardium", "DISEASE", 136, 147], ["Heart ValvesSuppurative Pericarditis", "DISEASE", 152, 188], ["Traumatic Reticulopericarditis", "DISEASE", 190, 220], ["pericarditis", "PROBLEM", 22, 34], ["Pericardium and Epicardium", "PROBLEM", 69, 95], ["Inflammation", "PROBLEM", 97, 109], ["Endocardium and Heart ValvesSuppurative Pericarditis", "PROBLEM", 136, 188], ["Traumatic Reticulopericarditis", "PROBLEM", 190, 220], ["pericarditis", "OBSERVATION", 22, 34], ["Pericardium", "ANATOMY", 69, 80], ["Epicardium", "ANATOMY", 85, 95], ["Inflammation", "OBSERVATION", 97, 109], ["Heart", "ANATOMY", 152, 157], ["ValvesSuppurative", "OBSERVATION_MODIFIER", 158, 175], ["Pericarditis", "OBSERVATION", 176, 188], ["Traumatic", "OBSERVATION_MODIFIER", 190, 199]]], ["Suppurative pericarditis is seen mainly in cattle as a complication of traumatic reticuloperitonitis (\"hardware disease\").", [["pericarditis", "DISEASE", 12, 24], ["traumatic reticuloperitonitis", "DISEASE", 71, 100], ["cattle", "SPECIES", 43, 49], ["cattle", "SPECIES", 43, 49], ["Suppurative pericarditis", "PROBLEM", 0, 24], ["traumatic reticuloperitonitis", "PROBLEM", 71, 100], ["hardware disease\"", "PROBLEM", 103, 120], ["pericarditis", "OBSERVATION", 12, 24], ["traumatic", "OBSERVATION_MODIFIER", 71, 80], ["reticuloperitonitis", "OBSERVATION", 81, 100], ["hardware disease", "OBSERVATION", 103, 119]]], ["Foreign bodies, such as nails or pieces of wire that accumulate in the reticulum, occasionally penetrate the reticular wall and diaphragm, enter the adjacent pericardial sac, and introduce infection.", [["bodies", "ANATOMY", 8, 14], ["nails", "ANATOMY", 24, 29], ["reticulum", "ANATOMY", 71, 80], ["reticular wall", "ANATOMY", 109, 123], ["diaphragm", "ANATOMY", 128, 137], ["pericardial sac", "ANATOMY", 158, 173], ["infection", "DISEASE", 189, 198], ["reticulum", "CELLULAR_COMPONENT", 71, 80], ["reticular wall", "TISSUE", 109, 123], ["diaphragm", "ORGAN", 128, 137], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 158, 173], ["Foreign bodies", "PROBLEM", 0, 14], ["pieces of wire", "TREATMENT", 33, 47], ["infection", "PROBLEM", 189, 198], ["bodies", "OBSERVATION", 8, 14], ["nails", "OBSERVATION", 24, 29], ["wire", "OBSERVATION_MODIFIER", 43, 47], ["reticulum", "ANATOMY", 71, 80], ["reticular", "ANATOMY_MODIFIER", 109, 118], ["wall", "ANATOMY_MODIFIER", 119, 123], ["diaphragm", "ANATOMY", 128, 137], ["adjacent", "ANATOMY_MODIFIER", 149, 157], ["pericardial sac", "ANATOMY", 158, 173], ["infection", "OBSERVATION", 189, 198]]], ["Some affected cattle survive for weeks to months until death ensues from congestive heart failure and septicemia.", [["heart", "ANATOMY", 84, 89], ["death", "DISEASE", 55, 60], ["congestive heart failure", "DISEASE", 73, 97], ["septicemia", "DISEASE", 102, 112], ["cattle", "ORGANISM", 14, 20], ["heart", "ORGAN", 84, 89], ["cattle", "SPECIES", 14, 20], ["cattle", "SPECIES", 14, 20], ["death", "PROBLEM", 55, 60], ["congestive heart failure", "PROBLEM", 73, 97], ["septicemia", "PROBLEM", 102, 112], ["congestive", "OBSERVATION_MODIFIER", 73, 83], ["heart", "ANATOMY", 84, 89], ["failure", "OBSERVATION", 90, 97], ["septicemia", "OBSERVATION", 102, 112]]], ["Grossly, the pericardial surfaces are notably thickened by white, often rough, shaggy-appearing masses of fibrous connective tissue that enclose an accumulation of white to gray, thick, foul-smelling, purulent exudate (see Fig. 10-62) .", [["pericardial surfaces", "ANATOMY", 13, 33], ["masses", "ANATOMY", 96, 102], ["fibrous connective tissue", "ANATOMY", 106, 131], ["purulent exudate", "ANATOMY", 201, 217], ["pericardial surfaces", "PATHOLOGICAL_FORMATION", 13, 33], ["masses", "CANCER", 96, 102], ["fibrous connective tissue", "TISSUE", 106, 131], ["exudate", "TISSUE", 210, 217], ["notably thickened", "PROBLEM", 38, 55], ["white, often rough", "PROBLEM", 59, 77], ["shaggy-appearing masses", "PROBLEM", 79, 102], ["fibrous connective tissue", "PROBLEM", 106, 131], ["an accumulation of white to gray", "PROBLEM", 145, 177], ["thick, foul-smelling, purulent exudate", "PROBLEM", 179, 217], ["pericardial", "ANATOMY", 13, 24], ["surfaces", "ANATOMY_MODIFIER", 25, 33], ["notably", "OBSERVATION_MODIFIER", 38, 45], ["thickened", "OBSERVATION", 46, 55], ["white", "OBSERVATION_MODIFIER", 59, 64], ["often", "OBSERVATION_MODIFIER", 66, 71], ["rough", "OBSERVATION_MODIFIER", 72, 77], ["shaggy", "OBSERVATION_MODIFIER", 79, 85], ["appearing", "OBSERVATION_MODIFIER", 86, 95], ["masses", "OBSERVATION", 96, 102], ["fibrous connective tissue", "OBSERVATION", 106, 131], ["accumulation", "OBSERVATION_MODIFIER", 148, 160], ["white to gray", "OBSERVATION_MODIFIER", 164, 177], ["thick", "OBSERVATION_MODIFIER", 179, 184], ["foul", "OBSERVATION_MODIFIER", 186, 190], ["-smelling", "OBSERVATION_MODIFIER", 190, 199], ["purulent", "OBSERVATION_MODIFIER", 201, 209], ["exudate", "OBSERVATION", 210, 217]]], ["See the discussion on pericarditis in the section on Epicardium and Pericardium, Disorders of Domestic Animals, and also Chapters 7 and 9.Inflammation: Infectious DiseasesThrombotic Meningoencephalitis.", [["Epicardium", "ANATOMY", 53, 63], ["pericarditis", "DISEASE", 22, 34], ["Inflammation", "DISEASE", 138, 150], ["Thrombotic Meningoencephalitis", "DISEASE", 171, 201], ["pericarditis", "PROBLEM", 22, 34], ["Inflammation", "PROBLEM", 138, 150], ["Thrombotic Meningoencephalitis", "PROBLEM", 171, 201], ["pericarditis", "OBSERVATION", 22, 34], ["Epicardium", "ANATOMY", 53, 63], ["Pericardium", "ANATOMY", 68, 79], ["Infectious", "OBSERVATION_MODIFIER", 152, 162], ["Thrombotic", "OBSERVATION_MODIFIER", 171, 181], ["Meningoencephalitis", "OBSERVATION", 182, 201]]], ["Histophilus somni (formerly Haemophilus somnus) causes a systemic vasculitis in cattle resulting in meningoencephalitis.", [["Haemophilus somnus", "DISEASE", 28, 46], ["vasculitis", "DISEASE", 66, 76], ["meningoencephalitis", "DISEASE", 100, 119], ["Histophilus somni", "ORGANISM", 0, 17], ["Haemophilus somnus", "ORGANISM", 28, 46], ["cattle", "ORGANISM", 80, 86], ["Histophilus somni", "SPECIES", 0, 17], ["Haemophilus somnus", "SPECIES", 28, 46], ["cattle", "SPECIES", 80, 86], ["Histophilus somni", "SPECIES", 0, 17], ["Haemophilus somnus", "SPECIES", 28, 46], ["cattle", "SPECIES", 80, 86], ["Histophilus somni (formerly Haemophilus somnus", "PROBLEM", 0, 46], ["a systemic vasculitis", "PROBLEM", 55, 76], ["meningoencephalitis", "PROBLEM", 100, 119], ["systemic", "ANATOMY", 57, 65], ["vasculitis", "OBSERVATION", 66, 76], ["meningoencephalitis", "OBSERVATION", 100, 119]]], ["Mural thrombi from local vascular injury rather than thromboemboli from distal sites of vascular injury, such as the lungs, are the major type of thrombus in this disease.", [["Mural thrombi", "ANATOMY", 0, 13], ["vascular", "ANATOMY", 25, 33], ["distal sites", "ANATOMY", 72, 84], ["vascular", "ANATOMY", 88, 96], ["lungs", "ANATOMY", 117, 122], ["thrombus", "ANATOMY", 146, 154], ["thrombi", "DISEASE", 6, 13], ["vascular injury", "DISEASE", 25, 40], ["thromboemboli", "DISEASE", 53, 66], ["vascular injury", "DISEASE", 88, 103], ["thrombus", "DISEASE", 146, 154], ["Mural thrombi", "PATHOLOGICAL_FORMATION", 0, 13], ["vascular", "MULTI-TISSUE_STRUCTURE", 25, 33], ["vascular", "MULTI-TISSUE_STRUCTURE", 88, 96], ["lungs", "ORGAN", 117, 122], ["thrombus", "PATHOLOGICAL_FORMATION", 146, 154], ["Mural thrombi", "PROBLEM", 0, 13], ["local vascular injury", "PROBLEM", 19, 40], ["thromboemboli", "PROBLEM", 53, 66], ["vascular injury", "PROBLEM", 88, 103], ["thrombus", "PROBLEM", 146, 154], ["this disease", "PROBLEM", 158, 170], ["thrombi", "OBSERVATION", 6, 13], ["local", "OBSERVATION_MODIFIER", 19, 24], ["vascular", "ANATOMY", 25, 33], ["injury", "OBSERVATION", 34, 40], ["thromboemboli", "OBSERVATION", 53, 66], ["distal", "OBSERVATION_MODIFIER", 72, 78], ["sites", "OBSERVATION_MODIFIER", 79, 84], ["vascular", "ANATOMY", 88, 96], ["injury", "OBSERVATION", 97, 103], ["lungs", "ANATOMY", 117, 122], ["thrombus", "OBSERVATION", 146, 154], ["disease", "OBSERVATION", 163, 170]]], ["Gross lesions in the central nervous system (CNS) are characteristic of infarcts (see Fig. 14-89, A) .", [["Gross lesions", "ANATOMY", 0, 13], ["central nervous system", "ANATOMY", 21, 43], ["CNS", "ANATOMY", 45, 48], ["infarcts", "ANATOMY", 72, 80], ["Gross lesions in the central nervous system", "DISEASE", 0, 43], ["infarcts", "DISEASE", 72, 80], ["Gross lesions", "CANCER", 0, 13], ["central nervous system", "ANATOMICAL_SYSTEM", 21, 43], ["CNS", "ANATOMICAL_SYSTEM", 45, 48], ["Gross lesions in the central nervous system", "PROBLEM", 0, 43], ["infarcts", "PROBLEM", 72, 80], ["lesions", "OBSERVATION", 6, 13], ["central", "ANATOMY_MODIFIER", 21, 28], ["nervous system", "ANATOMY", 29, 43], ["CNS", "ANATOMY", 45, 48], ["infarcts", "OBSERVATION", 72, 80]]], ["Microscopic lesions are initially vasculitis and vascular necrosis, which are followed by thrombosis and infarction (see Fig. 14-89, B) .", [["lesions", "ANATOMY", 12, 19], ["vascular", "ANATOMY", 49, 57], ["vasculitis", "DISEASE", 34, 44], ["vascular necrosis", "DISEASE", 49, 66], ["thrombosis", "DISEASE", 90, 100], ["infarction", "DISEASE", 105, 115], ["Microscopic lesions", "PATHOLOGICAL_FORMATION", 0, 19], ["vascular", "MULTI-TISSUE_STRUCTURE", 49, 57], ["Microscopic lesions", "PROBLEM", 0, 19], ["vasculitis", "PROBLEM", 34, 44], ["vascular necrosis", "PROBLEM", 49, 66], ["thrombosis", "PROBLEM", 90, 100], ["infarction", "PROBLEM", 105, 115], ["Fig.", "TEST", 121, 125], ["lesions", "OBSERVATION", 12, 19], ["vasculitis", "OBSERVATION", 34, 44], ["vascular", "ANATOMY", 49, 57], ["necrosis", "OBSERVATION", 58, 66], ["thrombosis", "OBSERVATION", 90, 100], ["infarction", "OBSERVATION", 105, 115]]], ["Septic vasculitis, the initial event, is followed by edema and an influx of neutrophils and macrophages in and around vessel walls and adjacent parenchyma.", [["edema", "ANATOMY", 53, 58], ["neutrophils", "ANATOMY", 76, 87], ["macrophages", "ANATOMY", 92, 103], ["vessel walls", "ANATOMY", 118, 130], ["parenchyma", "ANATOMY", 144, 154], ["vasculitis", "DISEASE", 7, 17], ["edema", "DISEASE", 53, 58], ["edema", "PATHOLOGICAL_FORMATION", 53, 58], ["neutrophils", "CELL", 76, 87], ["macrophages", "CELL", 92, 103], ["vessel walls", "MULTI-TISSUE_STRUCTURE", 118, 130], ["parenchyma", "TISSUE", 144, 154], ["neutrophils", "CELL_TYPE", 76, 87], ["macrophages", "CELL_TYPE", 92, 103], ["Septic vasculitis", "PROBLEM", 0, 17], ["edema", "PROBLEM", 53, 58], ["an influx of neutrophils", "PROBLEM", 63, 87], ["macrophages", "PROBLEM", 92, 103], ["vasculitis", "OBSERVATION", 7, 17], ["edema", "OBSERVATION", 53, 58], ["influx of neutrophils", "OBSERVATION", 66, 87], ["macrophages", "OBSERVATION", 92, 103], ["vessel", "ANATOMY", 118, 124], ["walls", "ANATOMY_MODIFIER", 125, 130], ["adjacent", "ANATOMY_MODIFIER", 135, 143], ["parenchyma", "ANATOMY_MODIFIER", 144, 154]]], ["Colonies of small Gram-negative bacilli are frequent in thrombi, in and around affected vessels, and in areas of necrosis.", [["thrombi", "ANATOMY", 56, 63], ["vessels", "ANATOMY", 88, 95], ["thrombi", "DISEASE", 56, 63], ["necrosis", "DISEASE", 113, 121], ["Gram", "GENE_OR_GENE_PRODUCT", 18, 22], ["thrombi", "PATHOLOGICAL_FORMATION", 56, 63], ["vessels", "MULTI-TISSUE_STRUCTURE", 88, 95], ["small Gram-negative bacilli", "PROBLEM", 12, 39], ["thrombi", "PROBLEM", 56, 63], ["necrosis", "PROBLEM", 113, 121], ["small Gram", "OBSERVATION_MODIFIER", 12, 22], ["negative bacilli", "OBSERVATION", 23, 39], ["frequent", "OBSERVATION_MODIFIER", 44, 52], ["thrombi", "OBSERVATION", 56, 63], ["vessels", "ANATOMY", 88, 95], ["areas", "OBSERVATION_MODIFIER", 104, 109], ["necrosis", "OBSERVATION", 113, 121]]], ["Histophilus somni can also cause a necrotizing myocarditis, frequently in the left ventricular papillary myocardium.Inflammation: Infectious DiseasesThrombosis of the Caudal Vena Cava.", [["left ventricular papillary myocardium", "ANATOMY", 78, 115], ["Caudal Vena Cava", "ANATOMY", 167, 183], ["myocarditis", "DISEASE", 47, 58], ["Inflammation", "DISEASE", 116, 128], ["Infectious DiseasesThrombosis of the Caudal Vena Cava", "DISEASE", 130, 183], ["Histophilus somni", "ORGANISM", 0, 17], ["ventricular papillary myocardium", "TISSUE", 83, 115], ["Histophilus somni", "SPECIES", 0, 17], ["Histophilus somni", "SPECIES", 0, 17], ["a necrotizing myocarditis", "PROBLEM", 33, 58], ["Inflammation", "PROBLEM", 116, 128], ["Infectious DiseasesThrombosis of the Caudal Vena Cava", "PROBLEM", 130, 183], ["necrotizing", "OBSERVATION_MODIFIER", 35, 46], ["myocarditis", "OBSERVATION", 47, 58], ["left ventricular", "ANATOMY", 78, 94], ["papillary myocardium", "ANATOMY", 95, 115], ["Infectious", "OBSERVATION", 130, 140], ["Caudal Vena Cava", "ANATOMY", 167, 183]]], ["Thrombosis of the caudal vena cava occurs in association with rupture of hepatic abscesses into either the hepatic vein or the caudal vena cava.", [["caudal vena cava", "ANATOMY", 18, 34], ["hepatic abscesses", "ANATOMY", 73, 90], ["hepatic vein", "ANATOMY", 107, 119], ["caudal vena cava", "ANATOMY", 127, 143], ["Thrombosis of the caudal vena cava", "DISEASE", 0, 34], ["rupture of hepatic abscesses", "DISEASE", 62, 90], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 18, 34], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 73, 90], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 107, 119], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 127, 143], ["Thrombosis of the caudal vena cava", "PROBLEM", 0, 34], ["rupture of hepatic abscesses", "PROBLEM", 62, 90], ["caudal vena cava", "ANATOMY", 18, 34], ["rupture", "OBSERVATION", 62, 69], ["hepatic", "ANATOMY", 73, 80], ["abscesses", "OBSERVATION", 81, 90], ["hepatic vein", "ANATOMY", 107, 119], ["caudal vena cava", "ANATOMY", 127, 143]]], ["The hepatic abscess inflammation extends into the adjacent large hepatic veins and results in formation of a septic thrombus in the caudal vena cava.", [["hepatic abscess", "ANATOMY", 4, 19], ["hepatic veins", "ANATOMY", 65, 78], ["thrombus", "ANATOMY", 116, 124], ["caudal vena cava", "ANATOMY", 132, 148], ["hepatic abscess", "DISEASE", 4, 19], ["inflammation", "DISEASE", 20, 32], ["thrombus", "DISEASE", 116, 124], ["hepatic abscess", "PATHOLOGICAL_FORMATION", 4, 19], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 65, 78], ["thrombus", "PATHOLOGICAL_FORMATION", 116, 124], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 132, 148], ["The hepatic abscess inflammation", "PROBLEM", 0, 32], ["a septic thrombus in the caudal vena cava", "PROBLEM", 107, 148], ["hepatic", "ANATOMY", 4, 11], ["abscess", "OBSERVATION", 12, 19], ["adjacent", "ANATOMY_MODIFIER", 50, 58], ["large", "ANATOMY_MODIFIER", 59, 64], ["hepatic veins", "ANATOMY", 65, 78], ["septic", "OBSERVATION_MODIFIER", 109, 115], ["thrombus", "OBSERVATION", 116, 124], ["caudal vena cava", "ANATOMY", 132, 148]]], ["Rupture and release of the contents of the abscess into the lumen can cause multiple septic emboli in the pulmonary capillaries and unexpected death of the affected animal, often preceded by severe hemoptysis.Inflammation: Infectious DiseasesForeign Parasitic Diseases.", [["abscess", "ANATOMY", 43, 50], ["lumen", "ANATOMY", 60, 65], ["pulmonary capillaries", "ANATOMY", 106, 127], ["abscess", "DISEASE", 43, 50], ["septic emboli", "DISEASE", 85, 98], ["death", "DISEASE", 143, 148], ["hemoptysis", "DISEASE", 198, 208], ["Inflammation", "DISEASE", 209, 221], ["Parasitic Diseases", "DISEASE", 250, 268], ["abscess", "PATHOLOGICAL_FORMATION", 43, 50], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 60, 65], ["pulmonary capillaries", "TISSUE", 106, 127], ["Rupture", "PROBLEM", 0, 7], ["the abscess into the lumen", "PROBLEM", 39, 65], ["multiple septic emboli in the pulmonary capillaries", "PROBLEM", 76, 127], ["unexpected death", "PROBLEM", 132, 148], ["severe hemoptysis", "PROBLEM", 191, 208], ["Inflammation", "PROBLEM", 209, 221], ["Infectious Diseases", "PROBLEM", 223, 242], ["Foreign Parasitic Diseases", "PROBLEM", 242, 268], ["abscess", "OBSERVATION", 43, 50], ["lumen", "ANATOMY", 60, 65], ["can cause", "UNCERTAINTY", 66, 75], ["multiple", "OBSERVATION_MODIFIER", 76, 84], ["septic", "OBSERVATION_MODIFIER", 85, 91], ["emboli", "OBSERVATION", 92, 98], ["pulmonary capillaries", "ANATOMY", 106, 127], ["severe", "OBSERVATION_MODIFIER", 191, 197], ["hemoptysis", "OBSERVATION", 198, 208], ["Infectious", "OBSERVATION_MODIFIER", 223, 233], ["Parasitic Diseases", "OBSERVATION", 250, 268]]], ["Foreign parasitic diseases important in tropical regions of the world are characterized by the presence of parasites in the lumens of veins.", [["lumens", "ANATOMY", 124, 130], ["veins", "ANATOMY", 134, 139], ["parasitic diseases", "DISEASE", 8, 26], ["lumens of veins", "MULTI-TISSUE_STRUCTURE", 124, 139], ["Foreign parasitic diseases", "PROBLEM", 0, 26], ["parasites in the lumens of veins", "PROBLEM", 107, 139], ["parasitic diseases", "OBSERVATION", 8, 26], ["tropical", "OBSERVATION_MODIFIER", 40, 48], ["parasites", "OBSERVATION", 107, 116], ["lumens", "ANATOMY_MODIFIER", 124, 130], ["veins", "ANATOMY", 134, 139]]], ["These diseases in cattle and water buffalo include schistosomiasis (blood fluke infection-Schistosoma spp.) in which adult parasites are present in the mesenteric and portal veins, and the resulting phlebitis is characterized by intimal proliferation and thrombosis.Inflammation: Infectious DiseasesOmphalophlebitis (\"Navel Ill\") .", [["blood", "ANATOMY", 68, 73], ["mesenteric", "ANATOMY", 152, 162], ["portal veins", "ANATOMY", 167, 179], ["intimal", "ANATOMY", 229, 236], ["schistosomiasis", "DISEASE", 51, 66], ["blood fluke infection-Schistosoma spp.", "DISEASE", 68, 106], ["phlebitis", "DISEASE", 199, 208], ["thrombosis", "DISEASE", 255, 265], ["Inflammation", "DISEASE", 266, 278], ["Infectious DiseasesOmphalophlebitis", "DISEASE", 280, 315], ["cattle", "ORGANISM", 18, 24], ["water buffalo", "ORGANISM", 29, 42], ["blood fluke", "ORGANISM", 68, 79], ["Schistosoma spp.", "ORGANISM", 90, 106], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 152, 162], ["portal veins", "MULTI-TISSUE_STRUCTURE", 167, 179], ["intimal", "TISSUE", 229, 236], ["cattle", "SPECIES", 18, 24], ["Schistosoma spp.", "SPECIES", 90, 106], ["cattle", "SPECIES", 18, 24], ["buffalo", "SPECIES", 35, 42], ["Schistosoma spp.", "SPECIES", 90, 106], ["These diseases in cattle and water buffalo", "PROBLEM", 0, 42], ["schistosomiasis (blood fluke infection", "PROBLEM", 51, 89], ["Schistosoma spp.", "PROBLEM", 90, 106], ["adult parasites", "PROBLEM", 117, 132], ["the resulting phlebitis", "PROBLEM", 185, 208], ["intimal proliferation", "PROBLEM", 229, 250], ["thrombosis", "PROBLEM", 255, 265], ["Inflammation", "PROBLEM", 266, 278], ["Infectious DiseasesOmphalophlebitis", "PROBLEM", 280, 315], ["diseases", "OBSERVATION", 6, 14], ["schistosomiasis", "OBSERVATION", 51, 66], ["parasites", "OBSERVATION", 123, 132], ["mesenteric", "ANATOMY", 152, 162], ["portal veins", "ANATOMY", 167, 179], ["resulting", "OBSERVATION_MODIFIER", 189, 198], ["phlebitis", "OBSERVATION", 199, 208], ["intimal", "OBSERVATION_MODIFIER", 229, 236], ["proliferation", "OBSERVATION", 237, 250], ["thrombosis", "OBSERVATION", 255, 265], ["Infectious", "OBSERVATION", 280, 290]]], ["See the discussion on omphalophlebitis (\"navel ill\") in the section on Disorders of Domestic Animals: Blood and Lymphatic Vascular Systems, Blood Vessels, Inflammation, and also Chapter 8.Inflammation: Infectious DiseasesJohne's Disease.", [["Blood", "ANATOMY", 102, 107], ["Vascular", "ANATOMY", 122, 130], ["Blood Vessels", "ANATOMY", 140, 153], ["omphalophlebitis", "DISEASE", 22, 38], ["navel ill", "DISEASE", 41, 50], ["Inflammation", "DISEASE", 155, 167], ["Inflammation", "DISEASE", 188, 200], ["Infectious DiseasesJohne's Disease", "DISEASE", 202, 236], ["Blood", "ORGANISM_SUBSTANCE", 102, 107], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 112, 130], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 140, 153], ["omphalophlebitis", "PROBLEM", 22, 38], ["Blood and Lymphatic Vascular Systems", "PROBLEM", 102, 138], ["Inflammation", "PROBLEM", 155, 167], ["Inflammation", "PROBLEM", 188, 200], ["Infectious DiseasesJohne's Disease", "PROBLEM", 202, 236], ["Blood", "ANATOMY", 102, 107], ["Lymphatic", "ANATOMY_MODIFIER", 112, 121], ["Vascular Systems", "ANATOMY", 122, 138], ["Blood Vessels", "ANATOMY", 140, 153], ["Inflammation", "OBSERVATION", 155, 167], ["Infectious", "OBSERVATION_MODIFIER", 202, 212]]], ["Lesions of Johne's disease affecting blood and lymphatic vessels and characterized by intimal mineralization and granulomatous lymphangitis, respectively, are discussed in greater detail in Chapters 4, 7, and 13.", [["blood", "ANATOMY", 37, 42], ["lymphatic vessels", "ANATOMY", 47, 64], ["intimal", "ANATOMY", 86, 93], ["granulomatous lymphangitis", "ANATOMY", 113, 139], ["Johne's disease affecting blood and lymphatic vessels", "DISEASE", 11, 64], ["granulomatous lymphangitis", "DISEASE", 113, 139], ["blood", "ORGANISM_SUBSTANCE", 37, 42], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 47, 64], ["intimal", "TISSUE", 86, 93], ["Johne's disease affecting blood and lymphatic vessels", "PROBLEM", 11, 64], ["intimal mineralization", "PROBLEM", 86, 108], ["granulomatous lymphangitis", "PROBLEM", 113, 139], ["blood", "ANATOMY", 37, 42], ["lymphatic vessels", "ANATOMY", 47, 64], ["intimal", "OBSERVATION_MODIFIER", 86, 93], ["mineralization", "OBSERVATION", 94, 108], ["granulomatous", "OBSERVATION_MODIFIER", 113, 126], ["lymphangitis", "OBSERVATION", 127, 139]]], ["Fibrinoid Necrosis of Blood Vessels.", [["Blood Vessels", "ANATOMY", 22, 35], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 22, 35], ["Fibrinoid Necrosis of Blood Vessels", "PROBLEM", 0, 35], ["Necrosis", "OBSERVATION", 10, 18], ["Blood Vessels", "ANATOMY", 22, 35]]], ["Fibrinoid necrosis of arteries and veins (see Fig. 10 -69) is particularly frequent in pigs and is an important diagnostic feature in cases of vitamin E-selenium deficiency (heart), edema disease (gastric submucosa), cerebrospinal angiopathy, porcine circovirus II vasculopathy, and organic mercury toxicosis (meninges).", [["arteries", "ANATOMY", 22, 30], ["veins", "ANATOMY", 35, 40], ["heart", "ANATOMY", 174, 179], ["edema", "ANATOMY", 182, 187], ["gastric submucosa", "ANATOMY", 197, 214], ["cerebrospinal", "ANATOMY", 217, 230], ["meninges", "ANATOMY", 310, 318], ["necrosis", "DISEASE", 10, 18], ["vitamin E-selenium", "CHEMICAL", 143, 161], ["heart), edema disease", "DISEASE", 174, 195], ["gastric submucosa)", "DISEASE", 197, 215], ["cerebrospinal angiopathy", "DISEASE", 217, 241], ["porcine circovirus II vasculopathy", "DISEASE", 243, 277], ["organic mercury toxicosis", "DISEASE", 283, 308], ["vitamin E", "CHEMICAL", 143, 152], ["selenium", "CHEMICAL", 153, 161], ["mercury", "CHEMICAL", 291, 298], ["arteries", "MULTI-TISSUE_STRUCTURE", 22, 30], ["veins", "MULTI-TISSUE_STRUCTURE", 35, 40], ["pigs", "ORGANISM", 87, 91], ["vitamin E-selenium", "SIMPLE_CHEMICAL", 143, 161], ["heart", "ORGAN", 174, 179], ["edema", "PATHOLOGICAL_FORMATION", 182, 187], ["gastric submucosa", "MULTI-TISSUE_STRUCTURE", 197, 214], ["cerebrospinal", "ORGANISM_SUBSTANCE", 217, 230], ["porcine circovirus II", "ORGANISM", 243, 264], ["meninges", "ORGAN", 310, 318], ["pigs", "SPECIES", 87, 91], ["porcine circovirus", "SPECIES", 243, 261], ["pigs", "SPECIES", 87, 91], ["porcine circovirus II", "SPECIES", 243, 264], ["Fibrinoid necrosis of arteries and veins", "PROBLEM", 0, 40], ["vitamin E", "PROBLEM", 143, 152], ["selenium deficiency (heart)", "PROBLEM", 153, 180], ["edema disease (gastric submucosa)", "PROBLEM", 182, 215], ["cerebrospinal angiopathy", "PROBLEM", 217, 241], ["porcine circovirus II vasculopathy", "PROBLEM", 243, 277], ["organic mercury toxicosis", "PROBLEM", 283, 308], ["necrosis", "OBSERVATION", 10, 18], ["arteries", "ANATOMY", 22, 30], ["veins", "ANATOMY", 35, 40], ["selenium deficiency", "OBSERVATION", 153, 172], ["heart", "ANATOMY", 174, 179], ["edema", "OBSERVATION", 182, 187], ["gastric submucosa", "ANATOMY", 197, 214], ["cerebrospinal", "ANATOMY", 217, 230], ["angiopathy", "OBSERVATION", 231, 241], ["porcine circovirus II vasculopathy", "OBSERVATION", 243, 277], ["organic mercury toxicosis", "OBSERVATION", 283, 308]]], ["See the previous section on Dietary Microangiopathy: Mulberry Heart Disease.Inflammation: Infectious DiseasesEdema Disease (Cerebrospinal Angiopathy).", [["Heart", "ANATOMY", 62, 67], ["Dietary Microangiopathy", "DISEASE", 28, 51], ["Heart Disease", "DISEASE", 62, 75], ["Inflammation", "DISEASE", 76, 88], ["Infectious DiseasesEdema Disease", "DISEASE", 90, 122], ["Cerebrospinal Angiopathy", "DISEASE", 124, 148], ["Mulberry Heart Disease", "PROBLEM", 53, 75], ["Inflammation", "PROBLEM", 76, 88], ["Infectious DiseasesEdema Disease", "PROBLEM", 90, 122], ["Cerebrospinal Angiopathy)", "PROBLEM", 124, 149], ["Heart", "ANATOMY", 62, 67], ["Disease", "OBSERVATION", 68, 75], ["Infectious", "OBSERVATION_MODIFIER", 90, 100], ["Cerebrospinal", "ANATOMY", 124, 137], ["Angiopathy", "OBSERVATION", 138, 148]]], ["Infections with certain strains of hemolytic E. coli produce a cytotoxin that targets vascular endothelium, resulting in fibrinoid necrosis of arterioles and resultant edema.", [["vascular endothelium", "ANATOMY", 86, 106], ["fibrinoid", "ANATOMY", 121, 130], ["arterioles", "ANATOMY", 143, 153], ["edema", "ANATOMY", 168, 173], ["Infections", "DISEASE", 0, 10], ["hemolytic E. coli", "DISEASE", 35, 52], ["necrosis", "DISEASE", 131, 139], ["edema", "DISEASE", 168, 173], ["hemolytic E. coli", "ORGANISM", 35, 52], ["vascular endothelium", "TISSUE", 86, 106], ["fibrinoid", "TISSUE", 121, 130], ["arterioles", "MULTI-TISSUE_STRUCTURE", 143, 153], ["edema", "PATHOLOGICAL_FORMATION", 168, 173], ["E. coli", "SPECIES", 45, 52], ["E. coli", "SPECIES", 45, 52], ["Infections", "PROBLEM", 0, 10], ["hemolytic E. coli", "PROBLEM", 35, 52], ["a cytotoxin", "PROBLEM", 61, 72], ["fibrinoid necrosis of arterioles", "PROBLEM", 121, 153], ["resultant edema", "PROBLEM", 158, 173], ["hemolytic", "OBSERVATION_MODIFIER", 35, 44], ["coli", "OBSERVATION", 48, 52], ["vascular endothelium", "ANATOMY", 86, 106], ["fibrinoid", "OBSERVATION_MODIFIER", 121, 130], ["necrosis", "OBSERVATION", 131, 139], ["arterioles", "ANATOMY", 143, 153], ["resultant", "OBSERVATION_MODIFIER", 158, 167], ["edema", "OBSERVATION", 168, 173]]], ["Lesions are often prominent in the arterioles of the gastric submucosa ( Fig. 10-79) .", [["arterioles", "ANATOMY", 35, 45], ["gastric submucosa", "ANATOMY", 53, 70], ["arterioles", "MULTI-TISSUE_STRUCTURE", 35, 45], ["gastric submucosa", "MULTI-TISSUE_STRUCTURE", 53, 70], ["Lesions", "PROBLEM", 0, 7], ["often", "OBSERVATION_MODIFIER", 12, 17], ["prominent", "OBSERVATION_MODIFIER", 18, 27], ["arterioles", "ANATOMY_MODIFIER", 35, 45], ["gastric submucosa", "ANATOMY", 53, 70]]], ["Vascular changes occurring in the (see Fig. 10-54, B) .", [["Vascular", "ANATOMY", 0, 8], ["Vascular", "MULTI-TISSUE_STRUCTURE", 0, 8], ["Vascular changes", "PROBLEM", 0, 16], ["changes", "OBSERVATION", 9, 16]]], ["See the discussion on valvular and mural endocarditis in the section on Inflammation; Disorders of Domestic Animals: Endocardium and Heart Valves, and also Chapter 3.Inflammation: Infectious DiseasesFibrinous Pericarditis.", [["valvular", "ANATOMY", 22, 30], ["Heart", "ANATOMY", 133, 138], ["valvular and mural endocarditis", "DISEASE", 22, 53], ["Inflammation", "DISEASE", 72, 84], ["Inflammation", "DISEASE", 166, 178], ["DiseasesFibrinous Pericarditis", "DISEASE", 191, 221], ["valvular", "MULTI-TISSUE_STRUCTURE", 22, 30], ["valvular and mural endocarditis", "PROBLEM", 22, 53], ["Inflammation", "PROBLEM", 72, 84], ["Endocardium and Heart Valves", "TREATMENT", 117, 145], ["Inflammation", "PROBLEM", 166, 178], ["Fibrinous Pericarditis", "PROBLEM", 199, 221], ["valvular", "ANATOMY", 22, 30], ["mural", "OBSERVATION_MODIFIER", 35, 40], ["endocarditis", "OBSERVATION", 41, 53], ["Inflammation", "OBSERVATION", 72, 84], ["Endocardium", "ANATOMY", 117, 128], ["Heart Valves", "ANATOMY", 133, 145], ["Infectious", "OBSERVATION_MODIFIER", 180, 190], ["Fibrinous", "OBSERVATION_MODIFIER", 199, 208], ["Pericarditis", "OBSERVATION", 209, 221]]], ["Fibrinous pericarditis may accompany Glasser's disease (Haemophilus parasuis) (Fig. 10-75) , streptococcal infections, enzootic mycoplasma pneumonia, and salmonellosis.", [["pericarditis", "DISEASE", 10, 22], ["Glasser's disease", "DISEASE", 37, 54], ["Haemophilus parasuis", "DISEASE", 56, 76], ["streptococcal infections", "DISEASE", 93, 117], ["mycoplasma pneumonia", "DISEASE", 128, 148], ["salmonellosis", "DISEASE", 154, 167], ["Haemophilus parasuis", "ORGANISM", 56, 76], ["Fig. 10-75", "ORGANISM", 79, 89], ["Haemophilus parasuis", "SPECIES", 56, 76], ["Haemophilus parasuis", "SPECIES", 56, 76], ["Fibrinous pericarditis", "PROBLEM", 0, 22], ["Glasser's disease", "PROBLEM", 37, 54], ["Haemophilus parasuis", "PROBLEM", 56, 76], ["streptococcal infections", "PROBLEM", 93, 117], ["enzootic mycoplasma pneumonia", "PROBLEM", 119, 148], ["salmonellosis", "PROBLEM", 154, 167], ["pericarditis", "OBSERVATION", 10, 22], ["streptococcal", "OBSERVATION_MODIFIER", 93, 106], ["infections", "OBSERVATION", 107, 117], ["enzootic", "OBSERVATION_MODIFIER", 119, 127], ["mycoplasma pneumonia", "OBSERVATION", 128, 148], ["salmonellosis", "OBSERVATION", 154, 167]]], ["Sterile swabs of the pericardial exudates are recommended to identify the causative organism.", [["swabs", "ANATOMY", 8, 13], ["pericardial exudates", "ANATOMY", 21, 41], ["pericardial exudates", "MULTI-TISSUE_STRUCTURE", 21, 41], ["Sterile swabs", "TREATMENT", 0, 13], ["the pericardial exudates", "PROBLEM", 17, 41], ["the causative organism", "PROBLEM", 70, 92], ["pericardial", "ANATOMY", 21, 32], ["exudates", "OBSERVATION", 33, 41]]], ["See the discussion of pericarditis in the section on Disorders of Domestic Animals: Pericardium and Epicardium, Inflammation, and also Chapters 3, 7, and 9.Inflammation: Infectious DiseasesPorcine Polyserositis (Glasser's Disease, Streptococcus suis II).", [["pericarditis", "DISEASE", 22, 34], ["Inflammation", "DISEASE", 112, 124], ["Inflammation", "DISEASE", 156, 168], ["Infectious DiseasesPorcine Polyserositis", "DISEASE", 170, 210], ["Glasser's Disease", "DISEASE", 212, 229], ["Streptococcus suis II", "ORGANISM", 231, 252], ["Streptococcus suis", "SPECIES", 231, 249], ["Streptococcus suis II", "SPECIES", 231, 252], ["pericarditis", "PROBLEM", 22, 34], ["Pericardium and Epicardium", "PROBLEM", 84, 110], ["Inflammation", "PROBLEM", 112, 124], ["Inflammation", "PROBLEM", 156, 168], ["Infectious DiseasesPorcine Polyserositis", "PROBLEM", 170, 210], ["Glasser's Disease", "PROBLEM", 212, 229], ["Streptococcus suis II", "PROBLEM", 231, 252], ["pericarditis", "OBSERVATION", 22, 34], ["Pericardium", "ANATOMY", 84, 95], ["Epicardium", "ANATOMY", 100, 110], ["Inflammation", "OBSERVATION", 112, 124], ["Infectious", "OBSERVATION_MODIFIER", 170, 180], ["Polyserositis", "OBSERVATION_MODIFIER", 197, 210]]], ["See Fig. 10-75 ; also see the discussion of edema disease in the next section and in Chapters 4 and 7.Cell Degeneration and DeathDietary Microangiopathy: Mulberry Heart Disease.", [["edema", "ANATOMY", 44, 49], ["Cell", "ANATOMY", 102, 106], ["Heart", "ANATOMY", 163, 168], ["edema disease", "DISEASE", 44, 57], ["Heart Disease", "DISEASE", 163, 176], ["edema", "PATHOLOGICAL_FORMATION", 44, 49], ["Cell", "CELL", 102, 106], ["edema disease", "PROBLEM", 44, 57], ["Cell Degeneration", "PROBLEM", 102, 119], ["DeathDietary Microangiopathy", "PROBLEM", 124, 152], ["Mulberry Heart Disease", "PROBLEM", 154, 176], ["edema", "OBSERVATION", 44, 49], ["Degeneration", "OBSERVATION", 107, 119], ["Microangiopathy", "OBSERVATION", 137, 152], ["Mulberry", "OBSERVATION", 154, 162], ["Heart", "ANATOMY", 163, 168], ["Disease", "OBSERVATION", 169, 176]]], ["Dietary microangiopathy of pigs or \"mulberry heart disease\" is produced by a deficiency of vitamin E and/or selenium and the resultant effect on the microvasculature, which is characterized by fibrinoid necrosis, and thromboses of small vessels resulting in microhemorrhages.", [["heart", "ANATOMY", 45, 50], ["microvasculature", "ANATOMY", 149, 165], ["fibrinoid", "ANATOMY", 193, 202], ["small vessels", "ANATOMY", 231, 244], ["microangiopathy", "DISEASE", 8, 23], ["heart disease", "DISEASE", 45, 58], ["vitamin E", "CHEMICAL", 91, 100], ["selenium", "CHEMICAL", 108, 116], ["necrosis", "DISEASE", 203, 211], ["thromboses", "DISEASE", 217, 227], ["microhemorrhages", "DISEASE", 258, 274], ["vitamin E", "CHEMICAL", 91, 100], ["selenium", "CHEMICAL", 108, 116], ["pigs", "ORGANISM", 27, 31], ["heart", "ORGAN", 45, 50], ["vitamin E", "SIMPLE_CHEMICAL", 91, 100], ["selenium", "SIMPLE_CHEMICAL", 108, 116], ["microvasculature", "TISSUE", 149, 165], ["fibrinoid", "TISSUE", 193, 202], ["vessels", "MULTI-TISSUE_STRUCTURE", 237, 244], ["pigs", "SPECIES", 27, 31], ["Dietary microangiopathy of pigs", "PROBLEM", 0, 31], ["\"mulberry heart disease", "PROBLEM", 35, 58], ["a deficiency of vitamin E", "PROBLEM", 75, 100], ["selenium", "TREATMENT", 108, 116], ["the resultant effect on the microvasculature", "PROBLEM", 121, 165], ["fibrinoid necrosis", "PROBLEM", 193, 211], ["thromboses of small vessels", "PROBLEM", 217, 244], ["microhemorrhages", "PROBLEM", 258, 274], ["microangiopathy", "OBSERVATION", 8, 23], ["pigs", "OBSERVATION", 27, 31], ["heart", "ANATOMY", 45, 50], ["disease", "OBSERVATION", 51, 58], ["resultant effect", "OBSERVATION", 125, 141], ["microvasculature", "ANATOMY", 149, 165], ["fibrinoid", "OBSERVATION_MODIFIER", 193, 202], ["necrosis", "OBSERVATION", 203, 211], ["thromboses", "OBSERVATION", 217, 227], ["small", "OBSERVATION_MODIFIER", 231, 236], ["vessels", "ANATOMY", 237, 244], ["microhemorrhages", "OBSERVATION", 258, 274]]], ["The hemorrhage results in major discoloration of the epicardial surface of the heart, particularly the right atrium said to resemble a mulberry (Figs.", [["epicardial surface", "ANATOMY", 53, 71], ["heart", "ANATOMY", 79, 84], ["right atrium", "ANATOMY", 103, 115], ["hemorrhage", "DISEASE", 4, 14], ["epicardial surface", "MULTI-TISSUE_STRUCTURE", 53, 71], ["heart", "ORGAN", 79, 84], ["atrium", "ORGAN", 109, 115], ["mulberry", "ORGANISM_SUBDIVISION", 135, 143], ["The hemorrhage", "PROBLEM", 0, 14], ["major discoloration", "PROBLEM", 26, 45], ["hemorrhage", "OBSERVATION", 4, 14], ["major", "OBSERVATION_MODIFIER", 26, 31], ["discoloration", "OBSERVATION", 32, 45], ["epicardial", "ANATOMY_MODIFIER", 53, 63], ["surface", "ANATOMY_MODIFIER", 64, 71], ["heart", "ANATOMY", 79, 84], ["right atrium", "ANATOMY", 103, 115], ["mulberry", "OBSERVATION_MODIFIER", 135, 143]]], ["In addition to the epicardial hemorrhages, hydropericardium often ensues.", [["epicardial", "ANATOMY", 19, 29], ["hydropericardium", "ANATOMY", 43, 59], ["epicardial hemorrhages", "DISEASE", 19, 41], ["hydropericardium", "DISEASE", 43, 59], ["epicardial", "MULTI-TISSUE_STRUCTURE", 19, 29], ["the epicardial hemorrhages", "PROBLEM", 15, 41], ["hydropericardium", "PROBLEM", 43, 59], ["epicardial", "ANATOMY", 19, 29], ["hemorrhages", "OBSERVATION", 30, 41]]], ["Massive hemorrhagic hepatic necrosis (hepatosis dietetica) is also produced with vitamin E and/or selenium deficiency (see Fig. 8-74 ).", [["hepatic", "ANATOMY", 20, 27], ["hemorrhagic hepatic necrosis", "DISEASE", 8, 36], ["hepatosis dietetica", "DISEASE", 38, 57], ["vitamin E", "CHEMICAL", 81, 90], ["selenium", "CHEMICAL", 98, 106], ["vitamin E", "CHEMICAL", 81, 90], ["selenium", "CHEMICAL", 98, 106], ["hepatic", "ORGAN", 20, 27], ["vitamin E", "SIMPLE_CHEMICAL", 81, 90], ["selenium", "SIMPLE_CHEMICAL", 98, 106], ["Massive hemorrhagic hepatic necrosis", "PROBLEM", 0, 36], ["hepatosis dietetica", "PROBLEM", 38, 57], ["vitamin E", "TREATMENT", 81, 90], ["selenium deficiency", "PROBLEM", 98, 117], ["hemorrhagic", "OBSERVATION_MODIFIER", 8, 19], ["hepatic", "ANATOMY", 20, 27], ["necrosis", "OBSERVATION", 28, 36], ["selenium deficiency", "OBSERVATION", 98, 117]]], ["With either form of the disease, fibrinoid necrosis of small muscular arteries and arterioles is widespread and is accompanied by endothelial damage and fibrin thrombi in capillaries, especially capillaries of the myocardium (Fig. 10-78 ; E- Fig. 10-26 ).", [["fibrinoid", "ANATOMY", 33, 42], ["small muscular arteries", "ANATOMY", 55, 78], ["arterioles", "ANATOMY", 83, 93], ["endothelial", "ANATOMY", 130, 141], ["fibrin thrombi", "ANATOMY", 153, 167], ["capillaries", "ANATOMY", 171, 182], ["capillaries", "ANATOMY", 195, 206], ["myocardium", "ANATOMY", 214, 224], ["necrosis", "DISEASE", 43, 51], ["thrombi", "DISEASE", 160, 167], ["fibrinoid", "TISSUE", 33, 42], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 61, 78], ["arterioles", "MULTI-TISSUE_STRUCTURE", 83, 93], ["endothelial", "TISSUE", 130, 141], ["fibrin", "GENE_OR_GENE_PRODUCT", 153, 159], ["capillaries", "TISSUE", 171, 182], ["capillaries", "TISSUE", 195, 206], ["myocardium", "MULTI-TISSUE_STRUCTURE", 214, 224], ["the disease", "PROBLEM", 20, 31], ["fibrinoid necrosis of small muscular arteries and arterioles", "PROBLEM", 33, 93], ["endothelial damage", "PROBLEM", 130, 148], ["fibrin thrombi in capillaries", "PROBLEM", 153, 182], ["Fig.", "TEST", 226, 230], ["disease", "OBSERVATION", 24, 31], ["fibrinoid", "OBSERVATION_MODIFIER", 33, 42], ["necrosis", "OBSERVATION", 43, 51], ["small", "ANATOMY_MODIFIER", 55, 60], ["muscular arteries", "ANATOMY", 61, 78], ["arterioles", "ANATOMY", 83, 93], ["endothelial", "ANATOMY", 130, 141], ["damage", "OBSERVATION", 142, 148], ["fibrin", "OBSERVATION_MODIFIER", 153, 159], ["thrombi", "OBSERVATION", 160, 167], ["capillaries", "ANATOMY_MODIFIER", 171, 182], ["capillaries", "ANATOMY_MODIFIER", 195, 206], ["myocardium", "ANATOMY", 214, 224]]], ["This complex of vascular lesions has been termed dietary microangiopathy.", [["vascular lesions", "ANATOMY", 16, 32], ["vascular lesions", "DISEASE", 16, 32], ["microangiopathy", "DISEASE", 57, 72], ["vascular lesions", "PATHOLOGICAL_FORMATION", 16, 32], ["vascular lesions", "PROBLEM", 16, 32], ["dietary microangiopathy", "PROBLEM", 49, 72], ["vascular", "ANATOMY", 16, 24], ["lesions", "OBSERVATION", 25, 32], ["dietary microangiopathy", "OBSERVATION", 49, 72]]], ["The distinctive hemorrhagic lesions are attributed to disruption of the clotting mechanism and thrombocytopenia.", [["hemorrhagic lesions", "ANATOMY", 16, 35], ["hemorrhagic", "DISEASE", 16, 27], ["thrombocytopenia", "DISEASE", 95, 111], ["hemorrhagic lesions", "PATHOLOGICAL_FORMATION", 16, 35], ["The distinctive hemorrhagic lesions", "PROBLEM", 0, 35], ["the clotting mechanism", "PROBLEM", 68, 90], ["thrombocytopenia", "PROBLEM", 95, 111], ["distinctive", "OBSERVATION_MODIFIER", 4, 15], ["hemorrhagic", "OBSERVATION_MODIFIER", 16, 27], ["lesions", "OBSERVATION", 28, 35], ["clotting mechanism", "OBSERVATION", 72, 90], ["thrombocytopenia", "OBSERVATION", 95, 111]]], ["The gross lesions are characterized by widespread congestion, edema, and hemorrhage.", [["gross lesions", "ANATOMY", 4, 17], ["edema", "ANATOMY", 62, 67], ["congestion", "DISEASE", 50, 60], ["edema", "DISEASE", 62, 67], ["hemorrhage", "DISEASE", 73, 83], ["gross lesions", "CANCER", 4, 17], ["edema", "PATHOLOGICAL_FORMATION", 62, 67], ["The gross lesions", "PROBLEM", 0, 17], ["widespread congestion", "PROBLEM", 39, 60], ["edema", "PROBLEM", 62, 67], ["hemorrhage", "PROBLEM", 73, 83], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["widespread", "OBSERVATION_MODIFIER", 39, 49], ["congestion", "OBSERVATION", 50, 60], ["edema", "OBSERVATION", 62, 67], ["hemorrhage", "OBSERVATION", 73, 83]]], ["Hemorrhagic visceral lymph nodes and splenomegaly are present along with petechial hemorrhages of the renal cortices, epicardium, and other serosal surfaces.", [["visceral lymph nodes", "ANATOMY", 12, 32], ["splenomegaly", "ANATOMY", 37, 49], ["petechial", "ANATOMY", 73, 82], ["renal cortices", "ANATOMY", 102, 116], ["epicardium", "ANATOMY", 118, 128], ["serosal surfaces", "ANATOMY", 140, 156], ["splenomegaly", "DISEASE", 37, 49], ["hemorrhages", "DISEASE", 83, 94], ["visceral lymph nodes", "MULTI-TISSUE_STRUCTURE", 12, 32], ["renal cortices", "MULTI-TISSUE_STRUCTURE", 102, 116], ["epicardium", "MULTI-TISSUE_STRUCTURE", 118, 128], ["serosal surfaces", "MULTI-TISSUE_STRUCTURE", 140, 156], ["Hemorrhagic visceral lymph nodes", "PROBLEM", 0, 32], ["splenomegaly", "PROBLEM", 37, 49], ["petechial hemorrhages of the renal cortices", "PROBLEM", 73, 116], ["visceral", "ANATOMY", 12, 20], ["lymph nodes", "OBSERVATION", 21, 32], ["splenomegaly", "OBSERVATION", 37, 49], ["petechial", "OBSERVATION_MODIFIER", 73, 82], ["hemorrhages", "OBSERVATION", 83, 94], ["renal", "ANATOMY", 102, 107], ["cortices", "ANATOMY_MODIFIER", 108, 116], ["epicardium", "ANATOMY", 118, 128], ["serosal", "ANATOMY_MODIFIER", 140, 147], ["surfaces", "ANATOMY_MODIFIER", 148, 156]]], ["Pulmonary edema and hydrothorax also occur.", [["Pulmonary", "ANATOMY", 0, 9], ["Pulmonary edema", "DISEASE", 0, 15], ["hydrothorax", "DISEASE", 20, 31], ["Pulmonary", "ORGAN", 0, 9], ["Pulmonary edema", "PROBLEM", 0, 15], ["hydrothorax", "PROBLEM", 20, 31], ["edema", "OBSERVATION", 10, 15], ["hydrothorax", "OBSERVATION", 20, 31]]], ["Microscopically, viral-induced vascular alterations include congestion, hemorrhage, and edema with fibrin microthrombi (E- Fig. 10-28) .", [["vascular", "ANATOMY", 31, 39], ["edema", "ANATOMY", 88, 93], ["vascular alterations", "DISEASE", 31, 51], ["congestion", "DISEASE", 60, 70], ["hemorrhage", "DISEASE", 72, 82], ["edema", "DISEASE", 88, 93], ["vascular", "MULTI-TISSUE_STRUCTURE", 31, 39], ["edema", "PATHOLOGICAL_FORMATION", 88, 93], ["fibrin", "GENE_OR_GENE_PRODUCT", 99, 105], ["Microscopically", "TEST", 0, 15], ["viral-induced vascular alterations", "PROBLEM", 17, 51], ["congestion", "PROBLEM", 60, 70], ["hemorrhage", "PROBLEM", 72, 82], ["edema", "PROBLEM", 88, 93], ["fibrin microthrombi", "PROBLEM", 99, 118], ["viral", "OBSERVATION", 17, 22], ["vascular", "ANATOMY", 31, 39], ["congestion", "OBSERVATION", 60, 70], ["hemorrhage", "OBSERVATION", 72, 82], ["edema", "OBSERVATION", 88, 93], ["fibrin microthrombi", "OBSERVATION", 99, 118]]], ["The virus produces widespread necrosis of lymphocytes and macrophages (see Fig. 4-42) .Cell Degeneration and DeathHog Cholera/Classic Swine Fever (Swine Fever, Swine Plague, Schweinpest).", [["lymphocytes", "ANATOMY", 42, 53], ["macrophages", "ANATOMY", 58, 69], ["Cell", "ANATOMY", 87, 91], ["necrosis", "DISEASE", 30, 38], ["Cholera", "DISEASE", 118, 125], ["Swine Fever", "DISEASE", 134, 145], ["Swine Fever", "DISEASE", 147, 158], ["lymphocytes", "CELL", 42, 53], ["macrophages", "CELL", 58, 69], ["Cell", "CELL", 87, 91], ["lymphocytes", "CELL_TYPE", 42, 53], ["macrophages", "CELL_TYPE", 58, 69], ["Swine", "SPECIES", 134, 139], ["The virus", "PROBLEM", 0, 9], ["widespread necrosis of lymphocytes and macrophages", "PROBLEM", 19, 69], ["Cell Degeneration", "PROBLEM", 87, 104], ["DeathHog Cholera", "PROBLEM", 109, 125], ["Classic Swine Fever (Swine Fever", "PROBLEM", 126, 158], ["virus", "OBSERVATION", 4, 9], ["widespread", "OBSERVATION_MODIFIER", 19, 29], ["necrosis", "OBSERVATION", 30, 38], ["lymphocytes", "ANATOMY", 42, 53], ["macrophages", "OBSERVATION_MODIFIER", 58, 69], ["Degeneration", "OBSERVATION", 92, 104]]], ["Hog cholera (also termed classic swine fever) is a highly contagious febrile hemorrhagic disease of swine produced by an RNA virus.", [["cholera", "DISEASE", 4, 11], ["swine fever", "DISEASE", 33, 44], ["febrile hemorrhagic disease", "DISEASE", 69, 96], ["Hog cholera", "ORGANISM", 0, 11], ["swine", "ORGANISM", 100, 105], ["swine", "SPECIES", 33, 38], ["swine", "SPECIES", 100, 105], ["swine", "SPECIES", 100, 105], ["Hog cholera", "PROBLEM", 0, 11], ["classic swine fever", "PROBLEM", 25, 44], ["a highly contagious febrile hemorrhagic disease of swine", "PROBLEM", 49, 105], ["an RNA virus", "PROBLEM", 118, 130], ["highly", "OBSERVATION_MODIFIER", 51, 57], ["contagious", "OBSERVATION_MODIFIER", 58, 68], ["febrile", "OBSERVATION_MODIFIER", 69, 76], ["hemorrhagic", "OBSERVATION_MODIFIER", 77, 88], ["disease", "OBSERVATION", 89, 96], ["RNA virus", "OBSERVATION", 121, 130]]], ["The disease is enzootic in South America, Central America, Caribbean countries, Asia, and Europe.", [["The disease", "PROBLEM", 0, 11], ["disease", "OBSERVATION", 4, 11], ["enzootic", "OBSERVATION_MODIFIER", 15, 23]]], ["The pathogenesis of the disease is initiated by inhalation of the virus from direct contact with infected pigs or by ingestion of uncooked infected pork.", [["pigs", "ORGANISM", 106, 110], ["pork", "ORGANISM_SUBDIVISION", 148, 152], ["pigs", "SPECIES", 106, 110], ["pigs", "SPECIES", 106, 110], ["pork", "SPECIES", 148, 152], ["the disease", "PROBLEM", 20, 31], ["the virus", "PROBLEM", 62, 71], ["disease", "OBSERVATION", 24, 31], ["infected pork", "OBSERVATION", 139, 152]]], ["The virus traverses the oral mucosa, replicates in the tonsils, and initiates viremia.", [["oral mucosa", "ANATOMY", 24, 35], ["tonsils", "ANATOMY", 55, 62], ["viremia", "DISEASE", 78, 85], ["oral mucosa", "MULTI-TISSUE_STRUCTURE", 24, 35], ["tonsils", "ORGAN", 55, 62], ["The virus traverses the oral mucosa", "PROBLEM", 0, 35], ["viremia", "PROBLEM", 78, 85], ["virus", "OBSERVATION", 4, 9], ["oral mucosa", "ANATOMY", 24, 35], ["tonsils", "ANATOMY", 55, 62], ["viremia", "OBSERVATION", 78, 85]]], ["The virus selectively damages endothelial cells, cells of the immune system (lymphoreticular cells and macrophages), and epithelial cells.", [["endothelial cells", "ANATOMY", 30, 47], ["cells", "ANATOMY", 49, 54], ["immune system", "ANATOMY", 62, 75], ["lymphoreticular cells", "ANATOMY", 77, 98], ["macrophages", "ANATOMY", 103, 114], ["epithelial cells", "ANATOMY", 121, 137], ["endothelial cells", "CELL", 30, 47], ["cells", "CELL", 49, 54], ["immune system", "CELL", 62, 75], ["lymphoreticular cells", "CELL", 77, 98], ["macrophages", "CELL", 103, 114], ["epithelial cells", "CELL", 121, 137], ["endothelial cells", "CELL_TYPE", 30, 47], ["lymphoreticular cells", "CELL_TYPE", 77, 98], ["macrophages", "CELL_TYPE", 103, 114], ["epithelial cells", "CELL_TYPE", 121, 137], ["The virus selectively damages endothelial cells", "PROBLEM", 0, 47], ["the immune system", "TEST", 58, 75], ["macrophages", "TEST", 103, 114], ["epithelial cells", "PROBLEM", 121, 137], ["virus selectively", "OBSERVATION", 4, 21], ["damages endothelial cells", "OBSERVATION", 22, 47], ["lymphoreticular cells", "OBSERVATION", 77, 98], ["macrophages", "ANATOMY", 103, 114], ["epithelial cells", "OBSERVATION", 121, 137]]], ["The characteristic hemorrhagic lesions are associated with increased vascular permeability, thrombocytopenia, and DIC.", [["hemorrhagic lesions", "ANATOMY", 19, 38], ["vascular", "ANATOMY", 69, 77], ["hemorrhagic", "DISEASE", 19, 30], ["thrombocytopenia", "DISEASE", 92, 108], ["DIC", "DISEASE", 114, 117], ["hemorrhagic lesions", "PATHOLOGICAL_FORMATION", 19, 38], ["vascular", "MULTI-TISSUE_STRUCTURE", 69, 77], ["The characteristic hemorrhagic lesions", "PROBLEM", 0, 38], ["increased vascular permeability", "PROBLEM", 59, 90], ["thrombocytopenia", "PROBLEM", 92, 108], ["DIC", "PROBLEM", 114, 117], ["characteristic", "OBSERVATION_MODIFIER", 4, 18], ["hemorrhagic", "OBSERVATION_MODIFIER", 19, 30], ["lesions", "OBSERVATION", 31, 38], ["increased", "OBSERVATION_MODIFIER", 59, 68], ["vascular", "ANATOMY", 69, 77], ["permeability", "OBSERVATION_MODIFIER", 78, 90], ["thrombocytopenia", "OBSERVATION", 92, 108], ["DIC", "OBSERVATION_MODIFIER", 114, 117]]], ["The gross lesions are characterized by widespread petechial hemorrhages, especially of the renal cortices, urinary bladder, larynx, gastric mucosa, and epicardium with accompanying hemorrhage in lymph nodes and skin.", [["gross lesions", "ANATOMY", 4, 17], ["petechial", "ANATOMY", 50, 59], ["renal cortices", "ANATOMY", 91, 105], ["urinary bladder", "ANATOMY", 107, 122], ["larynx", "ANATOMY", 124, 130], ["gastric mucosa", "ANATOMY", 132, 146], ["epicardium", "ANATOMY", 152, 162], ["lymph nodes", "ANATOMY", 195, 206], ["skin", "ANATOMY", 211, 215], ["hemorrhages", "DISEASE", 60, 71], ["hemorrhage", "DISEASE", 181, 191], ["gross lesions", "CANCER", 4, 17], ["petechial hemorrhages", "PATHOLOGICAL_FORMATION", 50, 71], ["renal cortices", "MULTI-TISSUE_STRUCTURE", 91, 105], ["urinary bladder", "MULTI-TISSUE_STRUCTURE", 107, 122], ["larynx", "ORGAN", 124, 130], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 132, 146], ["epicardium", "ORGAN", 152, 162], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 195, 206], ["skin", "ORGAN", 211, 215], ["The gross lesions", "PROBLEM", 0, 17], ["widespread petechial hemorrhages", "PROBLEM", 39, 71], ["the renal cortices, urinary bladder, larynx, gastric mucosa", "PROBLEM", 87, 146], ["accompanying hemorrhage in lymph nodes", "PROBLEM", 168, 206], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["widespread", "OBSERVATION_MODIFIER", 39, 49], ["petechial", "OBSERVATION_MODIFIER", 50, 59], ["hemorrhages", "OBSERVATION", 60, 71], ["renal", "ANATOMY", 91, 96], ["cortices", "ANATOMY_MODIFIER", 97, 105], ["urinary bladder", "ANATOMY", 107, 122], ["larynx", "ANATOMY", 124, 130], ["gastric mucosa", "ANATOMY", 132, 146], ["epicardium", "ANATOMY", 152, 162], ["hemorrhage", "OBSERVATION", 181, 191], ["lymph nodes", "OBSERVATION", 195, 206], ["skin", "ANATOMY", 211, 215]]], ["A distinctive finding is hemorrhagic infarction of the spleen and \"button ulcers\" of the colonic mucosa.Cell Degeneration and DeathCNS are known as cerebrospinal angiopathy and can produce clinical signs of disease of the nervous system (E- Fig. 10-27 ; also see Chapters 4, 7, and 11; .", [["spleen", "ANATOMY", 55, 61], ["ulcers", "ANATOMY", 74, 80], ["colonic mucosa", "ANATOMY", 89, 103], ["Cell", "ANATOMY", 104, 108], ["cerebrospinal", "ANATOMY", 148, 161], ["nervous system", "ANATOMY", 222, 236], ["hemorrhagic infarction", "DISEASE", 25, 47], ["ulcers", "DISEASE", 74, 80], ["cerebrospinal angiopathy", "DISEASE", 148, 172], ["disease of the nervous system", "DISEASE", 207, 236], ["spleen", "ORGAN", 55, 61], ["ulcers", "PATHOLOGICAL_FORMATION", 74, 80], ["colonic mucosa", "MULTI-TISSUE_STRUCTURE", 89, 103], ["Cell", "CELL", 104, 108], ["cerebrospinal", "ORGANISM_SUBSTANCE", 148, 161], ["nervous system", "ANATOMICAL_SYSTEM", 222, 236], ["hemorrhagic infarction of the spleen", "PROBLEM", 25, 61], ["\"button ulcers", "PROBLEM", 66, 80], ["Cell Degeneration", "PROBLEM", 104, 121], ["DeathCNS", "PROBLEM", 126, 134], ["cerebrospinal angiopathy", "PROBLEM", 148, 172], ["disease of the nervous system", "PROBLEM", 207, 236], ["distinctive", "OBSERVATION_MODIFIER", 2, 13], ["hemorrhagic", "OBSERVATION_MODIFIER", 25, 36], ["infarction", "OBSERVATION", 37, 47], ["spleen", "ANATOMY", 55, 61], ["button ulcers", "OBSERVATION", 67, 80], ["colonic mucosa", "ANATOMY", 89, 103], ["Degeneration", "OBSERVATION", 109, 121], ["cerebrospinal", "ANATOMY", 148, 161], ["angiopathy", "OBSERVATION", 162, 172], ["disease", "OBSERVATION", 207, 214], ["nervous system", "ANATOMY", 222, 236]]], ["Erysipelosis (Erysipelothrix rhusiopathiae).", [["Erysipelothrix rhusiopathiae", "ORGANISM", 14, 42], ["Erysipelothrix rhusiopathiae", "SPECIES", 14, 42], ["Erysipelothrix rhusiopathiae", "SPECIES", 14, 42], ["Erysipelosis (Erysipelothrix rhusiopathiae", "PROBLEM", 0, 42], ["Erysipelothrix rhusiopathiae", "OBSERVATION", 14, 42]]], ["Cutaneous lesions in erysipelosis are caused by Erysipelothrix rhusiopathiae and are the result of bacterial embolization to the skin during sepsis.", [["Cutaneous lesions", "ANATOMY", 0, 17], ["erysipelosis", "ANATOMY", 21, 33], ["skin", "ANATOMY", 129, 133], ["erysipelosis", "DISEASE", 21, 33], ["sepsis", "DISEASE", 141, 147], ["Cutaneous lesions", "PATHOLOGICAL_FORMATION", 0, 17], ["erysipelosis", "CANCER", 21, 33], ["Erysipelothrix rhusiopathiae", "ORGANISM", 48, 76], ["skin", "ORGAN", 129, 133], ["Erysipelothrix rhusiopathiae", "SPECIES", 48, 76], ["Erysipelothrix rhusiopathiae", "SPECIES", 48, 76], ["Cutaneous lesions in erysipelosis", "PROBLEM", 0, 33], ["Erysipelothrix rhusiopathiae", "PROBLEM", 48, 76], ["bacterial embolization", "TREATMENT", 99, 121], ["sepsis", "PROBLEM", 141, 147], ["lesions", "OBSERVATION", 10, 17], ["erysipelosis", "OBSERVATION", 21, 33], ["Erysipelothrix", "OBSERVATION_MODIFIER", 48, 62], ["rhusiopathiae", "OBSERVATION", 63, 76], ["bacterial", "OBSERVATION_MODIFIER", 99, 108], ["embolization", "OBSERVATION", 109, 121], ["skin", "ANATOMY", 129, 133], ["sepsis", "OBSERVATION", 141, 147]]], ["Lesions consist of square to rhomboidal, firm, raised, pink to dark purple areas ( Fig. 10-80 ; see Fig. 17 -70) caused by vasculitis, thrombosis, and ischemia (infarction).", [["rhomboidal", "ANATOMY", 29, 39], ["vasculitis", "DISEASE", 123, 133], ["thrombosis", "DISEASE", 135, 145], ["ischemia", "DISEASE", 151, 159], ["infarction", "DISEASE", 161, 171], ["Lesions", "PROBLEM", 0, 7], ["firm", "PROBLEM", 41, 45], ["dark purple areas", "PROBLEM", 63, 80], ["Fig.", "TEST", 83, 87], ["vasculitis", "PROBLEM", 123, 133], ["thrombosis", "PROBLEM", 135, 145], ["ischemia (infarction)", "PROBLEM", 151, 172], ["square", "OBSERVATION_MODIFIER", 19, 25], ["rhomboidal", "ANATOMY", 29, 39], ["firm", "OBSERVATION_MODIFIER", 41, 45], ["pink", "OBSERVATION_MODIFIER", 55, 59], ["dark", "OBSERVATION_MODIFIER", 63, 67], ["purple", "OBSERVATION_MODIFIER", 68, 74], ["areas", "OBSERVATION_MODIFIER", 75, 80], ["vasculitis", "OBSERVATION", 123, 133], ["thrombosis", "OBSERVATION", 135, 145], ["ischemia", "OBSERVATION", 151, 159], ["infarction", "OBSERVATION", 161, 171]]], ["The rhomboidal shape likely represents an area of skin supplied by a thrombosed vessel (see Chapter 17).Cell Degeneration and DeathPorcine Polyserositis (Streptococcus suis II).", [["rhomboidal", "ANATOMY", 4, 14], ["skin", "ANATOMY", 50, 54], ["thrombosed vessel", "ANATOMY", 69, 86], ["Cell", "ANATOMY", 104, 108], ["skin", "ORGAN", 50, 54], ["thrombosed vessel", "MULTI-TISSUE_STRUCTURE", 69, 86], ["Cell", "CELL", 104, 108], ["Streptococcus suis II", "ORGANISM", 154, 175], ["Streptococcus suis", "SPECIES", 154, 172], ["Streptococcus suis II", "SPECIES", 154, 175], ["The rhomboidal shape", "PROBLEM", 0, 20], ["a thrombosed vessel", "PROBLEM", 67, 86], ["Cell Degeneration", "PROBLEM", 104, 121], ["DeathPorcine Polyserositis (Streptococcus suis II)", "PROBLEM", 126, 176], ["rhomboidal shape", "OBSERVATION", 4, 20], ["likely represents", "UNCERTAINTY", 21, 38], ["area", "OBSERVATION_MODIFIER", 42, 46], ["skin", "ANATOMY", 50, 54], ["thrombosed", "OBSERVATION", 69, 79], ["vessel", "ANATOMY", 80, 86], ["Degeneration", "OBSERVATION", 109, 121], ["DeathPorcine", "OBSERVATION_MODIFIER", 126, 138], ["Polyserositis", "OBSERVATION", 139, 152]]], ["Streptococcus suis II is one of several bacteria that can cause the disease porcine polyserositis.", [["porcine polyserositis", "DISEASE", 76, 97], ["Streptococcus suis II", "ORGANISM", 0, 21], ["porcine", "ORGANISM", 76, 83], ["Streptococcus suis", "SPECIES", 0, 18], ["porcine", "SPECIES", 76, 83], ["Streptococcus suis", "SPECIES", 0, 18], ["Streptococcus suis II", "PROBLEM", 0, 21], ["several bacteria", "PROBLEM", 32, 48], ["the disease porcine polyserositis", "PROBLEM", 64, 97], ["one of several", "OBSERVATION_MODIFIER", 25, 39], ["bacteria", "OBSERVATION", 40, 48], ["disease", "OBSERVATION", 68, 75], ["porcine", "OBSERVATION_MODIFIER", 76, 83], ["polyserositis", "OBSERVATION", 84, 97]]], ["Gross lesions include vasculitis leading to variable quantities of a gray-white friable material (fibrin) on serosal surfaces (fibrinous polyserositis) of the lungs (fibrinous pleuritis), heart (fibrinous pericarditis [see Fig. 10 -75]), and abdominal cavity (fibrinous peritonitis).", [["Gross lesions", "ANATOMY", 0, 13], ["serosal surfaces", "ANATOMY", 109, 125], ["lungs", "ANATOMY", 159, 164], ["fibrinous pleuritis", "ANATOMY", 166, 185], ["heart", "ANATOMY", 188, 193], ["abdominal cavity", "ANATOMY", 242, 258], ["vasculitis", "DISEASE", 22, 32], ["pleuritis", "DISEASE", 176, 185], ["fibrinous pericarditis", "DISEASE", 195, 217], ["abdominal cavity", "DISEASE", 242, 258], ["fibrinous peritonitis", "DISEASE", 260, 281], ["Gross lesions", "PATHOLOGICAL_FORMATION", 0, 13], ["fibrin", "GENE_OR_GENE_PRODUCT", 98, 104], ["serosal surfaces", "TISSUE", 109, 125], ["lungs", "ORGAN", 159, 164], ["heart", "ORGAN", 188, 193], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 242, 258], ["fibrin", "PROTEIN", 98, 104], ["Gross lesions", "PROBLEM", 0, 13], ["vasculitis", "PROBLEM", 22, 32], ["a gray-white friable material", "PROBLEM", 67, 96], ["fibrin) on serosal surfaces (fibrinous polyserositis) of the lungs (fibrinous pleuritis", "PROBLEM", 98, 185], ["heart (fibrinous pericarditis", "PROBLEM", 188, 217], ["abdominal cavity (fibrinous peritonitis", "PROBLEM", 242, 281], ["lesions", "OBSERVATION", 6, 13], ["vasculitis", "OBSERVATION", 22, 32], ["white", "OBSERVATION_MODIFIER", 74, 79], ["friable material", "OBSERVATION", 80, 96], ["fibrin", "OBSERVATION", 98, 104], ["serosal surfaces", "OBSERVATION_MODIFIER", 109, 125], ["fibrinous", "OBSERVATION_MODIFIER", 127, 136], ["polyserositis", "OBSERVATION", 137, 150], ["lungs", "ANATOMY", 159, 164], ["fibrinous", "OBSERVATION_MODIFIER", 166, 175], ["pleuritis", "OBSERVATION", 176, 185], ["heart", "ANATOMY", 188, 193], ["fibrinous", "OBSERVATION_MODIFIER", 195, 204], ["pericarditis", "OBSERVATION", 205, 217], ["abdominal cavity", "ANATOMY", 242, 258], ["fibrinous", "OBSERVATION_MODIFIER", 260, 269], ["peritonitis", "OBSERVATION", 270, 281]]], ["The bacterium gains access to and spreads systemically through the blood vascular system.", [["blood vascular system", "ANATOMY", 67, 88], ["blood vascular system", "MULTI-TISSUE_STRUCTURE", 67, 88], ["The bacterium gains access", "TREATMENT", 0, 26], ["bacterium gains", "OBSERVATION", 4, 19], ["blood", "ANATOMY", 67, 72], ["vascular system", "ANATOMY", 73, 88]]], ["Lesions suggest this bacterium may have a tropism for vascular endothelial cells of serosae, and bacterial endotoxins may contribute to vascular injury and permeability changes leading to the leakage of fibrinogen and its polymerization to fibrin on serosal surfaces and in some cases to microthrombus formation and disseminated intravascular coagulation (DIC) in other organ systems (see Chapters 4, 7, and 9).", [["vascular endothelial cells", "ANATOMY", 54, 80], ["serosae", "ANATOMY", 84, 91], ["vascular", "ANATOMY", 136, 144], ["serosal surfaces", "ANATOMY", 250, 266], ["microthrombus", "ANATOMY", 288, 301], ["intravascular", "ANATOMY", 329, 342], ["organ", "ANATOMY", 370, 375], ["vascular injury", "DISEASE", 136, 151], ["microthrombus", "DISEASE", 288, 301], ["intravascular coagulation", "DISEASE", 329, 354], ["DIC", "DISEASE", 356, 359], ["vascular endothelial cells", "CELL", 54, 80], ["serosae", "CELL", 84, 91], ["vascular", "MULTI-TISSUE_STRUCTURE", 136, 144], ["fibrinogen", "GENE_OR_GENE_PRODUCT", 203, 213], ["fibrin", "GENE_OR_GENE_PRODUCT", 240, 246], ["serosal surfaces", "MULTI-TISSUE_STRUCTURE", 250, 266], ["microthrombus", "CANCER", 288, 301], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 329, 342], ["organ", "ORGAN", 370, 375], ["vascular endothelial cells", "CELL_TYPE", 54, 80], ["fibrinogen", "PROTEIN", 203, 213], ["fibrin", "PROTEIN", 240, 246], ["Lesions", "PROBLEM", 0, 7], ["this bacterium", "PROBLEM", 16, 30], ["vascular endothelial cells of serosae", "PROBLEM", 54, 91], ["bacterial endotoxins", "PROBLEM", 97, 117], ["vascular injury", "PROBLEM", 136, 151], ["permeability changes", "PROBLEM", 156, 176], ["the leakage of fibrinogen", "PROBLEM", 188, 213], ["fibrin on serosal surfaces", "TREATMENT", 240, 266], ["microthrombus formation", "PROBLEM", 288, 311], ["disseminated intravascular coagulation", "PROBLEM", 316, 354], ["DIC) in other organ systems", "PROBLEM", 356, 383], ["vascular", "ANATOMY", 54, 62], ["endothelial cells", "OBSERVATION", 63, 80], ["bacterial endotoxins", "OBSERVATION", 97, 117], ["vascular", "ANATOMY", 136, 144], ["injury", "OBSERVATION", 145, 151], ["leakage", "OBSERVATION", 192, 199], ["fibrinogen", "OBSERVATION", 203, 213], ["fibrin", "OBSERVATION_MODIFIER", 240, 246], ["serosal surfaces", "OBSERVATION_MODIFIER", 250, 266], ["disseminated", "OBSERVATION_MODIFIER", 316, 328], ["intravascular coagulation", "OBSERVATION", 329, 354]]], ["Cardiac Neoplasms.", [["Cardiac Neoplasms", "ANATOMY", 0, 17], ["Cardiac Neoplasms", "DISEASE", 0, 17], ["Cardiac Neoplasms", "CANCER", 0, 17], ["Cardiac Neoplasms", "PROBLEM", 0, 17], ["Neoplasms", "OBSERVATION", 8, 17]]], ["Cardiac neoplasms comprise primary and secondary (metastatic) tumors.", [["Cardiac neoplasms", "ANATOMY", 0, 17], ["primary", "ANATOMY", 27, 34], ["metastatic) tumors", "ANATOMY", 50, 68], ["Cardiac neoplasms", "DISEASE", 0, 17], ["primary and secondary (metastatic) tumors", "DISEASE", 27, 68], ["Cardiac neoplasms", "CANCER", 0, 17], ["metastatic) tumors", "CANCER", 50, 68], ["Cardiac neoplasms", "PROBLEM", 0, 17], ["secondary (metastatic) tumors", "PROBLEM", 39, 68], ["neoplasms", "OBSERVATION", 8, 17], ["secondary", "OBSERVATION_MODIFIER", 39, 48], ["metastatic", "OBSERVATION_MODIFIER", 50, 60], ["tumors", "OBSERVATION", 62, 68]]], ["Primary cardiac tumors include hemangiosarcoma (most frequent), thyroid/parathyroid ectopic carcinomas, mesotheliomas, thymomas, granular cell tumor, sarcomas (osteosarcomas, chondrosarcomas, fibrosarcomas/ fibro mas, rhabdomyosarcomas/rhabdomyoma, neurofibrosarcomas/ neurofibroma, and malignant mixed mesenchymal tumor), and chemodectomas (heart-base tumors).", [["Primary cardiac tumors", "ANATOMY", 0, 22], ["hemangiosarcoma", "ANATOMY", 31, 46], ["thyroid", "ANATOMY", 64, 71], ["parathyroid ectopic carcinomas", "ANATOMY", 72, 102], ["mesotheliomas", "ANATOMY", 104, 117], ["thymomas", "ANATOMY", 119, 127], ["granular cell tumor", "ANATOMY", 129, 148], ["sarcomas", "ANATOMY", 150, 158], ["osteosarcomas", "ANATOMY", 160, 173], ["chondrosarcomas", "ANATOMY", 175, 190], ["fibrosarcomas", "ANATOMY", 192, 205], ["fibro mas", "ANATOMY", 207, 216], ["rhabdomyosarcomas", "ANATOMY", 218, 235], ["rhabdomyoma", "ANATOMY", 236, 247], ["neurofibrosarcomas", "ANATOMY", 249, 267], ["neurofibroma", "ANATOMY", 269, 281], ["malignant mixed mesenchymal tumor", "ANATOMY", 287, 320], ["chemodectomas", "ANATOMY", 327, 340], ["heart-base tumors", "ANATOMY", 342, 359], ["cardiac tumors", "DISEASE", 8, 22], ["hemangiosarcoma", "DISEASE", 31, 46], ["parathyroid ectopic carcinomas", "DISEASE", 72, 102], ["mesotheliomas", "DISEASE", 104, 117], ["thymomas", "DISEASE", 119, 127], ["granular cell tumor", "DISEASE", 129, 148], ["sarcomas", "DISEASE", 150, 158], ["osteosarcomas", "DISEASE", 160, 173], ["chondrosarcomas", "DISEASE", 175, 190], ["fibrosarcomas", "DISEASE", 192, 205], ["rhabdomyosarcomas", "DISEASE", 218, 235], ["rhabdomyoma", "DISEASE", 236, 247], ["neurofibrosarcomas", "DISEASE", 249, 267], ["neurofibroma", "DISEASE", 269, 281], ["malignant mixed mesenchymal tumor", "DISEASE", 287, 320], ["chemodectomas", "DISEASE", 327, 340], ["heart-base tumors", "DISEASE", 342, 359], ["Primary cardiac tumors", "CANCER", 0, 22], ["hemangiosarcoma", "CANCER", 31, 46], ["thyroid", "ORGAN", 64, 71], ["parathyroid ectopic carcinomas", "CANCER", 72, 102], ["mesotheliomas", "CANCER", 104, 117], ["thymomas", "CANCER", 119, 127], ["granular cell tumor", "CANCER", 129, 148], ["sarcomas", "CANCER", 150, 158], ["osteosarcomas", "CANCER", 160, 173], ["chondrosarcomas", "CANCER", 175, 190], ["fibrosarcomas", "CANCER", 192, 205], ["rhabdomyosarcomas", "CANCER", 218, 235], ["rhabdomyoma", "CANCER", 236, 247], ["neurofibrosarcomas", "CANCER", 249, 267], ["neurofibroma", "CANCER", 269, 281], ["malignant mixed mesenchymal tumor", "CANCER", 287, 320], ["chemodectomas", "CANCER", 327, 340], ["heart-base tumors", "CANCER", 342, 359], ["Primary cardiac tumors", "PROBLEM", 0, 22], ["hemangiosarcoma", "PROBLEM", 31, 46], ["thyroid/parathyroid ectopic carcinomas", "PROBLEM", 64, 102], ["mesotheliomas", "PROBLEM", 104, 117], ["thymomas", "PROBLEM", 119, 127], ["granular cell tumor", "PROBLEM", 129, 148], ["sarcomas (osteosarcomas", "PROBLEM", 150, 173], ["chondrosarcomas", "PROBLEM", 175, 190], ["fibrosarcomas", "PROBLEM", 192, 205], ["fibro mas", "PROBLEM", 207, 216], ["rhabdomyosarcomas", "PROBLEM", 218, 235], ["rhabdomyoma", "PROBLEM", 236, 247], ["neurofibrosarcomas", "PROBLEM", 249, 267], ["neurofibroma", "PROBLEM", 269, 281], ["malignant mixed mesenchymal tumor", "PROBLEM", 287, 320], ["chemodectomas (heart-base tumors", "PROBLEM", 327, 359], ["cardiac", "ANATOMY", 8, 15], ["tumors", "OBSERVATION", 16, 22], ["hemangiosarcoma", "OBSERVATION", 31, 46], ["thyroid", "ANATOMY", 64, 71], ["parathyroid", "ANATOMY", 72, 83], ["ectopic carcinomas", "OBSERVATION", 84, 102], ["mesotheliomas", "OBSERVATION", 104, 117], ["thymomas", "OBSERVATION", 119, 127], ["granular cell tumor", "OBSERVATION", 129, 148], ["sarcomas", "OBSERVATION", 150, 158], ["osteosarcomas", "OBSERVATION", 160, 173], ["chondrosarcomas", "OBSERVATION", 175, 190], ["fibrosarcomas", "OBSERVATION", 192, 205], ["fibro mas", "OBSERVATION", 207, 216], ["rhabdomyosarcomas", "OBSERVATION", 218, 235], ["rhabdomyoma", "OBSERVATION", 236, 247], ["neurofibroma", "OBSERVATION", 269, 281], ["malignant", "OBSERVATION_MODIFIER", 287, 296], ["mixed", "OBSERVATION_MODIFIER", 297, 302], ["mesenchymal tumor", "OBSERVATION", 303, 320], ["heart", "ANATOMY", 342, 347], ["base", "ANATOMY_MODIFIER", 348, 352], ["tumors", "OBSERVATION", 353, 359]]], ["Secondary cardiac neoplasms are metastases from distant, primary tumor sites.", [["cardiac neoplasms", "ANATOMY", 10, 27], ["metastases", "ANATOMY", 32, 42], ["primary tumor sites", "ANATOMY", 57, 76], ["cardiac neoplasms", "DISEASE", 10, 27], ["metastases", "DISEASE", 32, 42], ["tumor", "DISEASE", 65, 70], ["cardiac neoplasms", "CANCER", 10, 27], ["tumor", "CANCER", 65, 70], ["Secondary cardiac neoplasms", "PROBLEM", 0, 27], ["metastases", "PROBLEM", 32, 42], ["primary tumor sites", "PROBLEM", 57, 76], ["cardiac", "ANATOMY", 10, 17], ["neoplasms", "OBSERVATION", 18, 27], ["metastases", "OBSERVATION", 32, 42], ["distant", "OBSERVATION_MODIFIER", 48, 55], ["primary", "OBSERVATION_MODIFIER", 57, 64], ["tumor", "OBSERVATION", 65, 70]]], ["In a study that included 80 dogs with primary and/or secondary cardiac neoplasms, 36% of dogs had evidence of cardiac metastases.Inflammation: Infectious DiseasesCanine Parvovirus Myocarditis.", [["primary", "ANATOMY", 38, 45], ["cardiac neoplasms", "ANATOMY", 63, 80], ["cardiac metastases", "ANATOMY", 110, 128], ["cardiac neoplasms", "DISEASE", 63, 80], ["cardiac metastases", "DISEASE", 110, 128], ["Inflammation", "DISEASE", 129, 141], ["Parvovirus Myocarditis", "DISEASE", 169, 191], ["dogs", "ORGANISM", 28, 32], ["cardiac neoplasms", "CANCER", 63, 80], ["dogs", "ORGANISM", 89, 93], ["cardiac", "ORGAN", 110, 117], ["dogs", "SPECIES", 28, 32], ["dogs", "SPECIES", 89, 93], ["Canine", "SPECIES", 162, 168], ["a study", "TEST", 3, 10], ["secondary cardiac neoplasms", "PROBLEM", 53, 80], ["cardiac metastases", "PROBLEM", 110, 128], ["Inflammation", "PROBLEM", 129, 141], ["Infectious DiseasesCanine Parvovirus Myocarditis", "PROBLEM", 143, 191], ["cardiac", "ANATOMY", 63, 70], ["neoplasms", "OBSERVATION", 71, 80], ["cardiac", "ANATOMY", 110, 117], ["metastases", "OBSERVATION", 118, 128], ["Infectious", "OBSERVATION_MODIFIER", 143, 153], ["Parvovirus Myocarditis", "OBSERVATION", 169, 191]]], ["Lymphocytic myocarditis is usually a lesion of viral infections and is well illustrated by the lesions of parvoviral myocarditis of puppies.", [["lesion", "ANATOMY", 37, 43], ["lesions", "ANATOMY", 95, 102], ["Lymphocytic myocarditis", "DISEASE", 0, 23], ["viral infections", "DISEASE", 47, 63], ["myocarditis", "DISEASE", 117, 128], ["lesions", "PATHOLOGICAL_FORMATION", 95, 102], ["puppies", "ORGAN", 132, 139], ["Lymphocytic myocarditis", "PROBLEM", 0, 23], ["a lesion of viral infections", "PROBLEM", 35, 63], ["the lesions", "PROBLEM", 91, 102], ["parvoviral myocarditis of puppies", "PROBLEM", 106, 139], ["myocarditis", "OBSERVATION", 12, 23], ["lesion", "OBSERVATION", 37, 43], ["viral", "OBSERVATION_MODIFIER", 47, 52], ["infections", "OBSERVATION", 53, 63], ["lesions", "OBSERVATION", 95, 102], ["parvoviral", "ANATOMY", 106, 116], ["myocarditis", "OBSERVATION", 117, 128], ["puppies", "OBSERVATION", 132, 139]]], ["Dogs with parvoviral myocarditis die unexpectedly and have generalized lesions of acute congestive heart failure but lack lesions in the intestine, the primary site of viral damage in approximately 95% of clinical cases.", [["lesions", "ANATOMY", 71, 78], ["heart", "ANATOMY", 99, 104], ["lesions", "ANATOMY", 122, 129], ["intestine", "ANATOMY", 137, 146], ["primary site", "ANATOMY", 152, 164], ["parvoviral myocarditis", "DISEASE", 10, 32], ["congestive heart failure", "DISEASE", 88, 112], ["viral damage", "DISEASE", 168, 180], ["Dogs", "ORGANISM", 0, 4], ["lesions", "PATHOLOGICAL_FORMATION", 71, 78], ["heart", "ORGAN", 99, 104], ["lesions", "PATHOLOGICAL_FORMATION", 122, 129], ["intestine", "ORGAN", 137, 146], ["parvoviral myocarditis", "PROBLEM", 10, 32], ["generalized lesions", "PROBLEM", 59, 78], ["acute congestive heart failure", "PROBLEM", 82, 112], ["lack lesions in the intestine", "PROBLEM", 117, 146], ["viral damage", "PROBLEM", 168, 180], ["parvoviral", "ANATOMY", 10, 20], ["myocarditis", "OBSERVATION", 21, 32], ["generalized", "OBSERVATION_MODIFIER", 59, 70], ["lesions", "OBSERVATION", 71, 78], ["acute", "OBSERVATION_MODIFIER", 82, 87], ["congestive", "OBSERVATION_MODIFIER", 88, 98], ["heart", "ANATOMY", 99, 104], ["failure", "OBSERVATION", 105, 112], ["lack", "OBSERVATION_MODIFIER", 117, 121], ["lesions", "OBSERVATION", 122, 129], ["intestine", "ANATOMY", 137, 146], ["viral", "OBSERVATION_MODIFIER", 168, 173], ["damage", "OBSERVATION", 174, 180]]], ["The heart is pale and flabby and has disseminated interstitial lymphocytic infiltrations and scattered myocytes with large, basophilic, intranuclear viral inclusion bodies in dogs that survive fibrosis ( Fig. 10-81) .Inflammation: Infectious DiseasesTrypanosoma cruzi.", [["heart", "ANATOMY", 4, 9], ["interstitial lymphocytic", "ANATOMY", 50, 74], ["myocytes", "ANATOMY", 103, 111], ["basophilic", "ANATOMY", 124, 134], ["fibrosis", "DISEASE", 193, 201], ["Inflammation", "DISEASE", 217, 229], ["DiseasesTrypanosoma cruzi", "DISEASE", 242, 267], ["heart", "ORGAN", 4, 9], ["interstitial lymphocytic infiltrations", "PATHOLOGICAL_FORMATION", 50, 88], ["myocytes", "CELL", 103, 111], ["dogs", "ORGANISM", 175, 179], ["Trypanosoma cruzi", "ORGANISM", 250, 267], ["dogs", "SPECIES", 175, 179], ["Trypanosoma cruzi", "SPECIES", 250, 267], ["Trypanosoma cruzi", "SPECIES", 250, 267], ["flabby", "PROBLEM", 22, 28], ["disseminated interstitial lymphocytic infiltrations", "PROBLEM", 37, 88], ["scattered myocytes", "PROBLEM", 93, 111], ["large, basophilic, intranuclear viral inclusion bodies", "PROBLEM", 117, 171], ["survive fibrosis", "PROBLEM", 185, 201], ["Inflammation", "PROBLEM", 217, 229], ["Infectious DiseasesTrypanosoma cruzi", "PROBLEM", 231, 267], ["heart", "ANATOMY", 4, 9], ["pale", "OBSERVATION", 13, 17], ["disseminated", "OBSERVATION_MODIFIER", 37, 49], ["interstitial", "OBSERVATION_MODIFIER", 50, 62], ["lymphocytic infiltrations", "OBSERVATION", 63, 88], ["scattered", "OBSERVATION_MODIFIER", 93, 102], ["myocytes", "ANATOMY", 103, 111], ["large", "OBSERVATION_MODIFIER", 117, 122], ["basophilic", "OBSERVATION_MODIFIER", 124, 134], ["intranuclear", "OBSERVATION_MODIFIER", 136, 148], ["viral inclusion bodies", "OBSERVATION", 149, 171], ["survive", "OBSERVATION_MODIFIER", 185, 192], ["fibrosis", "OBSERVATION", 193, 201], ["Infectious", "OBSERVATION_MODIFIER", 231, 241]]], ["Trypanosoma cruzi is the protozoan hemoflagellate that causes American trypanosomiasis (Chagas' disease).", [["Trypanosoma cruzi", "DISEASE", 0, 17], ["protozoan hemoflagellate", "DISEASE", 25, 49], ["American trypanosomiasis", "DISEASE", 62, 86], ["Chagas' disease", "DISEASE", 88, 103], ["Trypanosoma cruzi", "ORGANISM", 0, 17], ["Chagas' disease", "CANCER", 88, 103], ["Trypanosoma cruzi", "SPECIES", 0, 17], ["Trypanosoma cruzi", "SPECIES", 0, 17], ["Trypanosoma cruzi", "PROBLEM", 0, 17], ["the protozoan hemoflagellate", "PROBLEM", 21, 49], ["American trypanosomiasis (Chagas' disease)", "PROBLEM", 62, 104]]], ["The kissing bug (family Reduviidae, subfamily Triatominae) transmits the disease.", [["the disease", "PROBLEM", 69, 80], ["disease", "OBSERVATION", 73, 80]]], ["Infection with Trypanosoma cruzi causes fatal chronic myocarditis.", [["Trypanosoma cruzi", "DISEASE", 15, 32], ["myocarditis", "DISEASE", 54, 65], ["Trypanosoma cruzi", "ORGANISM", 15, 32], ["Trypanosoma cruzi", "SPECIES", 15, 32], ["Trypanosoma cruzi", "SPECIES", 15, 32], ["Infection", "PROBLEM", 0, 9], ["Trypanosoma cruzi", "PROBLEM", 15, 32], ["fatal chronic myocarditis", "PROBLEM", 40, 65], ["Trypanosoma cruzi", "OBSERVATION", 15, 32], ["fatal", "OBSERVATION_MODIFIER", 40, 45], ["chronic", "OBSERVATION_MODIFIER", 46, 53], ["myocarditis", "OBSERVATION", 54, 65]]], ["Acute disease is characteristic in dogs younger than 1 year of age.", [["dogs", "ORGANISM", 35, 39], ["dogs", "SPECIES", 35, 39], ["Acute disease", "PROBLEM", 0, 13], ["disease", "OBSERVATION", 6, 13]]], ["Affected dogs develop lymphohistiocytic myocarditis resulting in right-sided congestive heart failure with ascites, lymphadenomegaly, and hepatosplenomegaly.", [["heart", "ANATOMY", 88, 93], ["ascites", "ANATOMY", 107, 114], ["myocarditis", "DISEASE", 40, 51], ["congestive heart failure", "DISEASE", 77, 101], ["ascites", "DISEASE", 107, 114], ["lymphadenomegaly", "DISEASE", 116, 132], ["hepatosplenomegaly", "DISEASE", 138, 156], ["dogs", "ORGANISM", 9, 13], ["heart", "ORGAN", 88, 93], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["lymphohistiocytic myocarditis", "PROBLEM", 22, 51], ["right-sided congestive heart failure", "PROBLEM", 65, 101], ["ascites", "PROBLEM", 107, 114], ["lymphadenomegaly", "PROBLEM", 116, 132], ["hepatosplenomegaly", "PROBLEM", 138, 156], ["lymphohistiocytic myocarditis", "OBSERVATION", 22, 51], ["right", "ANATOMY_MODIFIER", 65, 70], ["sided", "ANATOMY_MODIFIER", 71, 76], ["congestive", "OBSERVATION", 77, 87], ["heart", "ANATOMY", 88, 93], ["failure", "OBSERVATION", 94, 101], ["ascites", "OBSERVATION", 107, 114], ["lymphadenomegaly", "OBSERVATION", 116, 132], ["hepatosplenomegaly", "OBSERVATION", 138, 156]]], ["Grossly, the cardiac muscle contains multiple yellow-white myocardial streaks and spots that are often accompanied by hemorrhage.", [["cardiac muscle", "ANATOMY", 13, 27], ["myocardial", "ANATOMY", 59, 69], ["cardiac muscle", "DISEASE", 13, 27], ["myocardial streaks", "DISEASE", 59, 77], ["hemorrhage", "DISEASE", 118, 128], ["cardiac muscle", "TISSUE", 13, 27], ["myocardial streaks", "PATHOLOGICAL_FORMATION", 59, 77], ["multiple yellow-white myocardial streaks", "PROBLEM", 37, 77], ["spots", "PROBLEM", 82, 87], ["hemorrhage", "PROBLEM", 118, 128], ["cardiac muscle", "ANATOMY", 13, 27], ["multiple", "OBSERVATION_MODIFIER", 37, 45], ["yellow", "OBSERVATION_MODIFIER", 46, 52], ["white", "OBSERVATION_MODIFIER", 53, 58], ["myocardial", "ANATOMY", 59, 69], ["streaks", "OBSERVATION", 70, 77], ["hemorrhage", "OBSERVATION", 118, 128]]], ["Chronic lymphocytic and plasmacytic myocarditis that leads to right-sided congestive heart failure typically affects older dogs.", [["lymphocytic", "ANATOMY", 8, 19], ["heart", "ANATOMY", 85, 90], ["myocarditis", "DISEASE", 36, 47], ["congestive heart failure", "DISEASE", 74, 98], ["heart", "ORGAN", 85, 90], ["dogs", "ORGANISM", 123, 127], ["dogs", "SPECIES", 123, 127], ["Chronic lymphocytic", "PROBLEM", 0, 19], ["plasmacytic myocarditis", "PROBLEM", 24, 47], ["right-sided congestive heart failure", "PROBLEM", 62, 98], ["lymphocytic", "OBSERVATION", 8, 19], ["plasmacytic myocarditis", "OBSERVATION", 24, 47], ["right", "ANATOMY_MODIFIER", 62, 67], ["sided", "ANATOMY_MODIFIER", 68, 73], ["congestive", "OBSERVATION", 74, 84], ["heart", "ANATOMY", 85, 90], ["failure", "OBSERVATION", 91, 98]]], ["Grossly, the heart is bilaterally enlarged, thinned and flaccid, and contains fibrous plaques (areas of fibrosis).Inflammation: Infectious DiseasesMicroscopically, endothelial damage is evident as hydropic degeneration and cellular proliferation.", [["heart", "ANATOMY", 13, 18], ["flaccid", "ANATOMY", 56, 63], ["fibrous plaques", "ANATOMY", 78, 93], ["endothelial", "ANATOMY", 164, 175], ["cellular", "ANATOMY", 223, 231], ["flaccid", "DISEASE", 56, 63], ["fibrous plaques", "DISEASE", 78, 93], ["fibrosis", "DISEASE", 104, 112], ["Inflammation", "DISEASE", 114, 126], ["endothelial damage", "DISEASE", 164, 182], ["heart", "ORGAN", 13, 18], ["fibrous plaques", "PATHOLOGICAL_FORMATION", 78, 93], ["endothelial", "TISSUE", 164, 175], ["cellular", "CELL", 223, 231], ["bilaterally enlarged", "PROBLEM", 22, 42], ["thinned and flaccid", "PROBLEM", 44, 63], ["fibrous plaques", "PROBLEM", 78, 93], ["fibrosis", "PROBLEM", 104, 112], ["Inflammation", "PROBLEM", 114, 126], ["Infectious Diseases", "PROBLEM", 128, 147], ["endothelial damage", "PROBLEM", 164, 182], ["hydropic degeneration", "PROBLEM", 197, 218], ["cellular proliferation", "PROBLEM", 223, 245], ["heart", "ANATOMY", 13, 18], ["bilaterally", "ANATOMY_MODIFIER", 22, 33], ["enlarged", "OBSERVATION", 34, 42], ["thinned", "OBSERVATION_MODIFIER", 44, 51], ["flaccid", "OBSERVATION", 56, 63], ["fibrous", "OBSERVATION_MODIFIER", 78, 85], ["plaques", "OBSERVATION", 86, 93], ["areas", "OBSERVATION_MODIFIER", 95, 100], ["fibrosis", "OBSERVATION", 104, 112], ["Infectious", "OBSERVATION_MODIFIER", 128, 138], ["endothelial damage", "OBSERVATION", 164, 182], ["hydropic", "OBSERVATION_MODIFIER", 197, 205], ["degeneration", "OBSERVATION", 206, 218], ["cellular proliferation", "OBSERVATION", 223, 245]]], ["Affected vessels may have fibrinoid necrosis with fibrin deposition in the media and intima.", [["vessels", "ANATOMY", 9, 16], ["fibrinoid", "ANATOMY", 26, 35], ["intima", "ANATOMY", 85, 91], ["necrosis", "DISEASE", 36, 44], ["vessels", "MULTI-TISSUE_STRUCTURE", 9, 16], ["fibrinoid", "TISSUE", 26, 35], ["fibrin", "GENE_OR_GENE_PRODUCT", 50, 56], ["intima", "TISSUE", 85, 91], ["fibrin", "PROTEIN", 50, 56], ["Affected vessels", "PROBLEM", 0, 16], ["fibrinoid necrosis", "PROBLEM", 26, 44], ["fibrin deposition in the media and intima", "PROBLEM", 50, 91], ["vessels", "ANATOMY", 9, 16], ["fibrinoid", "OBSERVATION_MODIFIER", 26, 35], ["necrosis", "OBSERVATION", 36, 44], ["fibrin deposition", "OBSERVATION", 50, 67], ["media", "ANATOMY_MODIFIER", 75, 80], ["intima", "ANATOMY", 85, 91]]], ["Circulatory alterations include congestion, hemorrhage, thrombosis, and infarction.", [["Circulatory alterations", "DISEASE", 0, 23], ["congestion", "DISEASE", 32, 42], ["hemorrhage", "DISEASE", 44, 54], ["thrombosis", "DISEASE", 56, 66], ["infarction", "DISEASE", 72, 82], ["Circulatory alterations", "PROBLEM", 0, 23], ["congestion", "PROBLEM", 32, 42], ["hemorrhage", "PROBLEM", 44, 54], ["thrombosis", "PROBLEM", 56, 66], ["infarction", "PROBLEM", 72, 82], ["congestion", "OBSERVATION", 32, 42], ["hemorrhage", "OBSERVATION", 44, 54], ["thrombosis", "OBSERVATION", 56, 66], ["infarction", "OBSERVATION", 72, 82]]], ["The brain has a diffuse nonsuppurative encephalitis (see Fig. 4-41) .Inflammation: Infectious DiseasesPorcine Anthrax.", [["brain", "ANATOMY", 4, 9], ["encephalitis", "DISEASE", 39, 51], ["Inflammation", "DISEASE", 69, 81], ["Infectious DiseasesPorcine Anthrax", "DISEASE", 83, 117], ["brain", "ORGAN", 4, 9], ["a diffuse nonsuppurative encephalitis", "PROBLEM", 14, 51], ["Inflammation", "PROBLEM", 69, 81], ["Infectious DiseasesPorcine Anthrax", "PROBLEM", 83, 117], ["brain", "ANATOMY", 4, 9], ["diffuse", "OBSERVATION_MODIFIER", 16, 23], ["nonsuppurative", "OBSERVATION_MODIFIER", 24, 38], ["encephalitis", "OBSERVATION", 39, 51], ["Infectious", "OBSERVATION_MODIFIER", 83, 93]]], ["See the discussion on anthrax in the section on Disorders of Ruminants (Cattle, Sheep, and Goats), Blood and Lymphatic Vascular Systems, Blood Vessels, and also Chapter 4.", [["Blood", "ANATOMY", 99, 104], ["Vascular", "ANATOMY", 119, 127], ["Blood Vessels", "ANATOMY", 137, 150], ["anthrax", "DISEASE", 22, 29], ["Disorders of Ruminants", "DISEASE", 48, 70], ["Blood", "ORGANISM_SUBSTANCE", 99, 104], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 109, 127], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 137, 150], ["anthrax", "TREATMENT", 22, 29], ["Blood", "ANATOMY", 99, 104], ["Lymphatic", "ANATOMY_MODIFIER", 109, 118], ["Vascular Systems", "ANATOMY", 119, 135], ["Blood Vessels", "ANATOMY", 137, 150]]], ["Dilated (Congestive) Cardiomyopathy.", [["Congestive) Cardiomyopathy", "DISEASE", 9, 35], ["Dilated (Congestive) Cardiomyopathy", "PROBLEM", 0, 35], ["Congestive", "OBSERVATION_MODIFIER", 9, 19], ["Cardiomyopathy", "OBSERVATION", 21, 35]]], ["Dilated or congestive cardiomyopathy is an important cause of congestive heart failure in dogs.", [["heart", "ANATOMY", 73, 78], ["congestive cardiomyopathy", "DISEASE", 11, 36], ["congestive heart failure", "DISEASE", 62, 86], ["heart", "ORGAN", 73, 78], ["dogs", "ORGANISM", 90, 94], ["dogs", "SPECIES", 90, 94], ["Dilated or congestive cardiomyopathy", "PROBLEM", 0, 36], ["congestive heart failure in dogs", "PROBLEM", 62, 94], ["congestive cardiomyopathy", "OBSERVATION", 11, 36], ["important cause of", "UNCERTAINTY", 43, 61], ["congestive", "OBSERVATION_MODIFIER", 62, 72], ["heart", "ANATOMY", 73, 78], ["failure", "OBSERVATION", 79, 86]]], ["Some affected dogs have low tissue concentrations of taurine, but supplementation has not proved beneficial.", [["tissue", "ANATOMY", 28, 34], ["taurine", "CHEMICAL", 53, 60], ["taurine", "CHEMICAL", 53, 60], ["dogs", "ORGANISM", 14, 18], ["tissue", "TISSUE", 28, 34], ["taurine", "SIMPLE_CHEMICAL", 53, 60], ["dogs", "SPECIES", 14, 18], ["Some affected dogs", "PROBLEM", 0, 18], ["low tissue concentrations of taurine", "TREATMENT", 24, 60], ["low tissue", "OBSERVATION_MODIFIER", 24, 34]]], ["Affected dogs often are males of large breeds, such as Doberman pinschers, Portuguese water dogs, Dalmatians, Scottish deerhounds, Irish wolfhounds, Saint Bernards, Afghan hounds, Newfoundland dogs, Old English sheepdogs, Great Danes, and boxers, although smaller breeds, such as English cocker spaniels, may be affected.", [["dogs", "ORGANISM", 9, 13], ["dogs", "SPECIES", 9, 13], ["dogs", "SPECIES", 92, 96], ["dogs", "SPECIES", 193, 197], ["Affected dogs", "PROBLEM", 0, 13], ["large", "OBSERVATION_MODIFIER", 33, 38], ["breeds", "OBSERVATION", 39, 45]]], ["The disease often has a familial pattern in the affected breeds and appears to be inherited as an autosomal recessive or X-linked recessive trait.", [["autosomal recessive", "DISEASE", 98, 117], ["The disease", "PROBLEM", 0, 11], ["a familial pattern", "PROBLEM", 22, 40], ["the affected breeds", "PROBLEM", 44, 63], ["an autosomal recessive or X-linked recessive trait", "PROBLEM", 95, 145], ["disease", "OBSERVATION", 4, 11], ["familial", "OBSERVATION_MODIFIER", 24, 32], ["pattern", "OBSERVATION_MODIFIER", 33, 40]]], ["At necropsy, lesions of congestive heart failure are present and the hearts are rounded because of biventricular dilation (see Figs.", [["lesions", "ANATOMY", 13, 20], ["heart", "ANATOMY", 35, 40], ["hearts", "ANATOMY", 69, 75], ["biventricular", "ANATOMY", 99, 112], ["congestive heart failure", "DISEASE", 24, 48], ["lesions", "PATHOLOGICAL_FORMATION", 13, 20], ["heart", "ORGAN", 35, 40], ["hearts", "ORGAN", 69, 75], ["lesions", "PROBLEM", 13, 20], ["congestive heart failure", "PROBLEM", 24, 48], ["biventricular dilation", "PROBLEM", 99, 121], ["lesions", "OBSERVATION", 13, 20], ["congestive", "OBSERVATION_MODIFIER", 24, 34], ["heart", "ANATOMY", 35, 40], ["failure", "OBSERVATION", 41, 48], ["hearts", "ANATOMY", 69, 75], ["rounded", "OBSERVATION_MODIFIER", 80, 87], ["biventricular", "ANATOMY", 99, 112], ["dilation", "OBSERVATION", 113, 121]]], ["The dilated cardiac chambers often have a diffusely white, thickened endocardium.", [["cardiac chambers", "ANATOMY", 12, 28], ["endocardium", "ANATOMY", 69, 80], ["endocardium", "MULTI-TISSUE_STRUCTURE", 69, 80], ["The dilated cardiac chambers", "PROBLEM", 0, 28], ["a diffusely white, thickened endocardium", "PROBLEM", 40, 80], ["dilated", "OBSERVATION", 4, 11], ["cardiac", "ANATOMY", 12, 19], ["chambers", "ANATOMY_MODIFIER", 20, 28], ["diffusely", "OBSERVATION_MODIFIER", 42, 51], ["white", "OBSERVATION_MODIFIER", 52, 57], ["thickened", "OBSERVATION", 59, 68], ["endocardium", "ANATOMY", 69, 80]]], ["Microscopic and ultrastructural alterations are nonspecific, can be either mild or absent, and may include interstitial fibrosis and fatty infiltration and changes of myocyte degeneration, including the occurrence of so-called attenuated wavy fibers.", [["interstitial", "ANATOMY", 107, 119], ["myocyte", "ANATOMY", 167, 174], ["wavy fibers", "ANATOMY", 238, 249], ["fibrosis", "DISEASE", 120, 128], ["fatty infiltration", "DISEASE", 133, 151], ["myocyte", "CELL", 167, 174], ["wavy fibers", "CELLULAR_COMPONENT", 238, 249], ["Microscopic and ultrastructural alterations", "PROBLEM", 0, 43], ["interstitial fibrosis", "PROBLEM", 107, 128], ["fatty infiltration", "PROBLEM", 133, 151], ["myocyte degeneration", "PROBLEM", 167, 187], ["so-called attenuated wavy fibers", "PROBLEM", 217, 249], ["ultrastructural alterations", "OBSERVATION", 16, 43], ["nonspecific", "OBSERVATION_MODIFIER", 48, 59], ["mild", "OBSERVATION_MODIFIER", 75, 79], ["absent", "OBSERVATION", 83, 89], ["may include", "UNCERTAINTY", 95, 106], ["interstitial", "ANATOMY_MODIFIER", 107, 119], ["fibrosis", "OBSERVATION", 120, 128], ["fatty infiltration", "OBSERVATION", 133, 151], ["myocyte degeneration", "OBSERVATION", 167, 187], ["attenuated", "OBSERVATION_MODIFIER", 227, 237], ["wavy", "OBSERVATION_MODIFIER", 238, 242], ["fibers", "OBSERVATION_MODIFIER", 243, 249]]], ["See the discussion on cardiomyopathies in the section on A B by 10 years of age.", [["cardiomyopathies", "DISEASE", 22, 38], ["A B", "CELL", 57, 60], ["cardiomyopathies", "PROBLEM", 22, 38]]], ["Other breeds with high incidence include the cocker spaniel, Lhasa apsos, bichons, Yorkshire terriers, shih tzus, dachshund, poodle, Pomeranian, miniature schnauzer, Chihuahua, fox terrier, Boston terrier, and Pekingese.", [["shih tzus", "CELL", 103, 112], ["shih tzus", "SPECIES", 103, 112], ["Lhasa apsos", "SPECIES", 61, 72]]], ["At autopsies (syn: necropsies) of 3245 dogs, gross lesions occurred on the mitral valve alone (57.3%), mitral and tricuspid valves (26.6%), tricuspid valve alone (7.5%), aortic valve alone (2.1%), pulmonic valve alone (0.4%), and in combinations (6.1%).", [["gross lesions", "ANATOMY", 45, 58], ["mitral valve", "ANATOMY", 75, 87], ["mitral", "ANATOMY", 103, 109], ["tricuspid valves", "ANATOMY", 114, 130], ["tricuspid valve", "ANATOMY", 140, 155], ["aortic valve", "ANATOMY", 170, 182], ["pulmonic valve", "ANATOMY", 197, 211], ["dogs", "ORGANISM", 39, 43], ["gross lesions", "PATHOLOGICAL_FORMATION", 45, 58], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 75, 87], ["mitral", "MULTI-TISSUE_STRUCTURE", 103, 109], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 170, 182], ["dogs", "SPECIES", 39, 43], ["gross lesions", "PROBLEM", 45, 58], ["the mitral valve", "TREATMENT", 71, 87], ["mitral and tricuspid valves", "TEST", 103, 130], ["tricuspid valve alone", "TEST", 140, 161], ["aortic valve alone", "TREATMENT", 170, 188], ["pulmonic valve", "TREATMENT", 197, 211], ["gross", "OBSERVATION_MODIFIER", 45, 50], ["lesions", "OBSERVATION", 51, 58], ["mitral valve", "ANATOMY", 75, 87], ["mitral", "ANATOMY", 103, 109], ["tricuspid valves", "ANATOMY", 114, 130], ["tricuspid valve", "ANATOMY", 140, 155], ["aortic valve", "ANATOMY", 170, 182], ["pulmonic valve", "ANATOMY", 197, 211]]], ["The lesions in MVD become progressively worse with age.", [["lesions", "ANATOMY", 4, 11], ["MVD", "DISEASE", 15, 18], ["lesions", "PATHOLOGICAL_FORMATION", 4, 11], ["The lesions in MVD", "PROBLEM", 0, 18], ["lesions", "OBSERVATION", 4, 11], ["MVD", "OBSERVATION", 15, 18], ["progressively", "OBSERVATION_MODIFIER", 26, 39], ["worse", "OBSERVATION_MODIFIER", 40, 45]]], ["Affected valves are shortened and thickened (nodular), either focal or diffusely, and appear smooth and shiny ( Fig. 10-83 ) rather than rough and granular, as is usual in cases of valvular endocarditis.", [["valves", "ANATOMY", 9, 15], ["nodular", "ANATOMY", 45, 52], ["valvular", "ANATOMY", 181, 189], ["valvular endocarditis", "DISEASE", 181, 202], ["valves", "MULTI-TISSUE_STRUCTURE", 9, 15], ["valvular", "ORGAN", 181, 189], ["Affected valves", "PROBLEM", 0, 15], ["thickened (nodular)", "PROBLEM", 34, 53], ["shiny ( Fig.", "TEST", 104, 116], ["valvular endocarditis", "PROBLEM", 181, 202], ["valves", "ANATOMY", 9, 15], ["shortened", "OBSERVATION_MODIFIER", 20, 29], ["thickened", "OBSERVATION_MODIFIER", 34, 43], ["nodular", "OBSERVATION_MODIFIER", 45, 52], ["focal", "OBSERVATION_MODIFIER", 62, 67], ["diffusely", "OBSERVATION_MODIFIER", 71, 80], ["smooth", "OBSERVATION_MODIFIER", 93, 99], ["shiny", "OBSERVATION_MODIFIER", 104, 109], ["granular", "OBSERVATION_MODIFIER", 147, 155], ["valvular", "ANATOMY", 181, 189], ["endocarditis", "OBSERVATION", 190, 202]]], ["MVD is grossly classified into four groups as follows: type 1, a few small discrete nodules in the area of contact that are associated with areas of diffuse opacity in the proximal portion of the valve; type 2, larger nodules that are evident in the area of contact, which tend to coalesce with their neighbors, along with areas of diffuse opacity that may be present; type 3, large nodules that coalescedCell Degeneration and DeathNeurogenic Cardiomyopathy (Heart-Brain Syndrome).Cell Degeneration and DeathNeurogenic cardiomyopathy (heart-brain syndrome) is a syndrome in dogs characterized by unexpected death 5 to 10 days after diffuse CNS injury (usually hit by car).", [["nodules", "ANATOMY", 84, 91], ["valve", "ANATOMY", 196, 201], ["nodules", "ANATOMY", 218, 225], ["nodules", "ANATOMY", 383, 390], ["Cell", "ANATOMY", 405, 409], ["Cell", "ANATOMY", 481, 485], ["heart", "ANATOMY", 535, 540], ["brain", "ANATOMY", 541, 546], ["CNS", "ANATOMY", 640, 643], ["opacity", "DISEASE", 340, 347], ["Cardiomyopathy", "DISEASE", 443, 457], ["Heart-Brain Syndrome", "DISEASE", 459, 479], ["DeathNeurogenic cardiomyopathy", "DISEASE", 503, 533], ["heart-brain syndrome", "DISEASE", 535, 555], ["death", "DISEASE", 607, 612], ["nodules", "CANCER", 84, 91], ["valve", "PATHOLOGICAL_FORMATION", 196, 201], ["nodules", "CANCER", 218, 225], ["nodules", "CANCER", 383, 390], ["Cell", "CELL", 405, 409], ["Heart-Brain", "CANCER", 459, 470], ["Cell", "CELL", 481, 485], ["heart", "ORGAN", 535, 540], ["brain", "ORGAN", 541, 546], ["CNS", "ORGANISM_SUBDIVISION", 640, 643], ["dogs", "SPECIES", 574, 578], ["MVD", "PROBLEM", 0, 3], ["a few small discrete nodules", "PROBLEM", 63, 91], ["diffuse opacity", "PROBLEM", 149, 164], ["type 2", "PROBLEM", 203, 209], ["larger nodules", "PROBLEM", 211, 225], ["diffuse opacity", "PROBLEM", 332, 347], ["large nodules", "PROBLEM", 377, 390], ["Cell Degeneration", "PROBLEM", 405, 422], ["DeathNeurogenic Cardiomyopathy", "PROBLEM", 427, 457], ["Heart-Brain Syndrome", "PROBLEM", 459, 479], ["Cell Degeneration", "PROBLEM", 481, 498], ["DeathNeurogenic cardiomyopathy", "PROBLEM", 503, 533], ["heart-brain syndrome", "PROBLEM", 535, 555], ["a syndrome in dogs", "PROBLEM", 560, 578], ["unexpected death", "PROBLEM", 596, 612], ["diffuse CNS injury", "PROBLEM", 632, 650], ["grossly", "OBSERVATION_MODIFIER", 7, 14], ["few", "OBSERVATION_MODIFIER", 65, 68], ["small", "OBSERVATION_MODIFIER", 69, 74], ["discrete", "OBSERVATION_MODIFIER", 75, 83], ["nodules", "OBSERVATION", 84, 91], ["area", "OBSERVATION_MODIFIER", 99, 103], ["contact", "OBSERVATION", 107, 114], ["diffuse", "OBSERVATION_MODIFIER", 149, 156], ["opacity", "OBSERVATION", 157, 164], ["proximal", "ANATOMY_MODIFIER", 172, 180], ["portion", "ANATOMY_MODIFIER", 181, 188], ["valve", "ANATOMY", 196, 201], ["larger", "OBSERVATION_MODIFIER", 211, 217], ["nodules", "OBSERVATION", 218, 225], ["contact", "OBSERVATION", 258, 265], ["diffuse", "OBSERVATION_MODIFIER", 332, 339], ["opacity", "OBSERVATION", 340, 347], ["may be", "UNCERTAINTY", 353, 359], ["large", "OBSERVATION_MODIFIER", 377, 382], ["nodules", "OBSERVATION", 383, 390], ["coalesced", "OBSERVATION_MODIFIER", 396, 405], ["Degeneration", "OBSERVATION", 410, 422], ["DeathNeurogenic", "OBSERVATION_MODIFIER", 427, 442], ["Cardiomyopathy", "OBSERVATION", 443, 457], ["Heart", "ANATOMY", 459, 464], ["Brain", "ANATOMY", 465, 470], ["Syndrome", "OBSERVATION", 471, 479], ["DeathNeurogenic", "OBSERVATION_MODIFIER", 503, 518], ["cardiomyopathy", "OBSERVATION", 519, 533], ["heart", "ANATOMY", 535, 540], ["brain", "ANATOMY", 541, 546], ["syndrome", "OBSERVATION", 547, 555], ["diffuse", "OBSERVATION_MODIFIER", 632, 639], ["CNS", "ANATOMY", 640, 643], ["injury", "OBSERVATION", 644, 650]]], ["Affected dogs die of cardiac arrhythmias caused by myocardial degeneration and necrosis.", [["cardiac", "ANATOMY", 21, 28], ["myocardial", "ANATOMY", 51, 61], ["cardiac arrhythmias", "DISEASE", 21, 40], ["myocardial degeneration", "DISEASE", 51, 74], ["necrosis", "DISEASE", 79, 87], ["dogs", "ORGANISM", 9, 13], ["cardiac", "ORGAN", 21, 28], ["myocardial", "MULTI-TISSUE_STRUCTURE", 51, 61], ["dogs", "SPECIES", 9, 13], ["cardiac arrhythmias", "PROBLEM", 21, 40], ["myocardial degeneration", "PROBLEM", 51, 74], ["necrosis", "PROBLEM", 79, 87], ["cardiac", "ANATOMY", 21, 28], ["arrhythmias", "OBSERVATION", 29, 40], ["myocardial", "ANATOMY", 51, 61], ["degeneration", "OBSERVATION", 62, 74], ["necrosis", "OBSERVATION", 79, 87]]], ["Grossly, the myocardium has numerous discrete and coalescing pale white streaks and/or poorly defined areas of myocardial necrosis-most often involving the papillary muscles of the left ventricle ( Fig. 10-82) .", [["myocardium", "ANATOMY", 13, 23], ["pale white streaks", "ANATOMY", 61, 79], ["myocardial", "ANATOMY", 111, 121], ["papillary muscles", "ANATOMY", 156, 173], ["left ventricle", "ANATOMY", 181, 195], ["myocardial necrosis", "DISEASE", 111, 130], ["myocardium", "MULTI-TISSUE_STRUCTURE", 13, 23], ["myocardial", "MULTI-TISSUE_STRUCTURE", 111, 121], ["papillary muscles", "ORGAN", 156, 173], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 181, 195], ["numerous discrete and coalescing pale white streaks", "PROBLEM", 28, 79], ["myocardial necrosis", "PROBLEM", 111, 130], ["myocardium", "ANATOMY", 13, 23], ["numerous", "OBSERVATION_MODIFIER", 28, 36], ["discrete", "OBSERVATION_MODIFIER", 37, 45], ["coalescing", "OBSERVATION_MODIFIER", 50, 60], ["pale", "OBSERVATION_MODIFIER", 61, 65], ["white streaks", "OBSERVATION", 66, 79], ["poorly defined", "OBSERVATION_MODIFIER", 87, 101], ["areas", "OBSERVATION_MODIFIER", 102, 107], ["myocardial", "ANATOMY", 111, 121], ["necrosis", "OBSERVATION", 122, 130], ["papillary muscles", "ANATOMY", 156, 173], ["left ventricle", "ANATOMY", 181, 195]]], ["Neurogenic cardiomyopathy is thought to be caused by overstimulation of the heart by autonomic neurotransmitters and systemic catecholamines released at the time of trauma.", [["heart", "ANATOMY", 76, 81], ["Neurogenic cardiomyopathy", "DISEASE", 0, 25], ["catecholamines", "CHEMICAL", 126, 140], ["trauma", "DISEASE", 165, 171], ["catecholamines", "CHEMICAL", 126, 140], ["heart", "ORGAN", 76, 81], ["catecholamines", "SIMPLE_CHEMICAL", 126, 140], ["Neurogenic cardiomyopathy", "PROBLEM", 0, 25], ["overstimulation of the heart", "PROBLEM", 53, 81], ["autonomic neurotransmitters", "PROBLEM", 85, 112], ["systemic catecholamines", "PROBLEM", 117, 140], ["trauma", "PROBLEM", 165, 171], ["cardiomyopathy", "OBSERVATION", 11, 25], ["thought to be caused", "UNCERTAINTY", 29, 49], ["overstimulation", "OBSERVATION", 53, 68], ["heart", "ANATOMY", 76, 81], ["autonomic neurotransmitters", "OBSERVATION", 85, 112]]], ["It is unknown why there is a 5-to 10-day delay in the development of myocardial necrosis.", [["myocardial", "ANATOMY", 69, 79], ["myocardial necrosis", "DISEASE", 69, 88], ["myocardial", "MULTI-TISSUE_STRUCTURE", 69, 79], ["myocardial necrosis", "PROBLEM", 69, 88], ["5-to 10-", "OBSERVATION_MODIFIER", 29, 37], ["myocardial", "ANATOMY", 69, 79], ["necrosis", "OBSERVATION", 80, 88]]], ["See Chapter 14 for a discussion of heart-brain syndrome.Disturbances of GrowthValvular Anomalies and Dysplasia.", [["heart", "ANATOMY", 35, 40], ["brain", "ANATOMY", 41, 46], ["heart-brain syndrome", "DISEASE", 35, 55], ["GrowthValvular Anomalies", "DISEASE", 72, 96], ["Dysplasia", "DISEASE", 101, 110], ["heart", "ORGAN", 35, 40], ["brain", "ORGAN", 41, 46], ["heart-brain syndrome", "PROBLEM", 35, 55], ["GrowthValvular Anomalies", "PROBLEM", 72, 96], ["Dysplasia", "PROBLEM", 101, 110], ["heart", "ANATOMY", 35, 40], ["brain", "ANATOMY", 41, 46], ["syndrome", "OBSERVATION", 47, 55], ["GrowthValvular", "ANATOMY", 72, 86], ["Anomalies", "OBSERVATION", 87, 96], ["Dysplasia", "OBSERVATION", 101, 110]]], ["See the discussion on valvular anomalies and dysplasia in the section on Disorders of Domestic Animals, Developmental Errors/Congenital Anomalies: Endocardium and Heart Valves.Cell Degeneration and DeathMyxomatous Valvular Degeneration (Valvular Endocardiosis).", [["valvular", "ANATOMY", 22, 30], ["Heart", "ANATOMY", 163, 168], ["Cell", "ANATOMY", 176, 180], ["Valvular", "ANATOMY", 214, 222], ["Valvular", "ANATOMY", 237, 245], ["valvular anomalies", "DISEASE", 22, 40], ["dysplasia", "DISEASE", 45, 54], ["Developmental Errors", "DISEASE", 104, 124], ["Congenital Anomalies", "DISEASE", 125, 145], ["Valvular Degeneration", "DISEASE", 214, 235], ["Valvular Endocardiosis", "DISEASE", 237, 259], ["valvular", "PATHOLOGICAL_FORMATION", 22, 30], ["dysplasia", "PATHOLOGICAL_FORMATION", 45, 54], ["Cell", "CELL", 176, 180], ["valvular anomalies", "PROBLEM", 22, 40], ["dysplasia", "PROBLEM", 45, 54], ["Congenital Anomalies", "PROBLEM", 125, 145], ["Endocardium and Heart Valves", "TREATMENT", 147, 175], ["Cell Degeneration", "PROBLEM", 176, 193], ["DeathMyxomatous Valvular Degeneration", "PROBLEM", 198, 235], ["Valvular Endocardiosis)", "PROBLEM", 237, 260], ["valvular", "ANATOMY", 22, 30], ["anomalies", "OBSERVATION", 31, 40], ["dysplasia", "OBSERVATION", 45, 54], ["Congenital Anomalies", "OBSERVATION", 125, 145], ["Endocardium", "ANATOMY", 147, 158], ["Heart Valves", "ANATOMY", 163, 175], ["Degeneration", "OBSERVATION", 181, 193], ["DeathMyxomatous Valvular Degeneration", "OBSERVATION", 198, 235], ["Valvular", "ANATOMY", 237, 245], ["Endocardiosis", "OBSERVATION", 246, 259]]], ["Myxomatous valvular degeneration (valvular endocardiosis) is the most common cardiovascular disease in dogs, and it is the most common cause of congestive heart failure in old dogs.", [["valvular", "ANATOMY", 11, 19], ["valvular", "ANATOMY", 34, 42], ["cardiovascular", "ANATOMY", 77, 91], ["heart", "ANATOMY", 155, 160], ["valvular degeneration", "DISEASE", 11, 32], ["valvular endocardiosis", "DISEASE", 34, 56], ["cardiovascular disease", "DISEASE", 77, 99], ["congestive heart failure", "DISEASE", 144, 168], ["valvular", "MULTI-TISSUE_STRUCTURE", 11, 19], ["cardiovascular", "ANATOMICAL_SYSTEM", 77, 91], ["dogs", "ORGANISM", 103, 107], ["heart", "ORGAN", 155, 160], ["dogs", "ORGANISM", 176, 180], ["dogs", "SPECIES", 103, 107], ["dogs", "SPECIES", 176, 180], ["Myxomatous valvular degeneration", "PROBLEM", 0, 32], ["valvular endocardiosis", "PROBLEM", 34, 56], ["cardiovascular disease in dogs", "PROBLEM", 77, 107], ["congestive heart failure", "PROBLEM", 144, 168], ["old dogs", "PROBLEM", 172, 180], ["valvular", "ANATOMY", 11, 19], ["degeneration", "OBSERVATION", 20, 32], ["valvular", "ANATOMY", 34, 42], ["endocardiosis", "OBSERVATION", 43, 56], ["congestive", "OBSERVATION_MODIFIER", 144, 154], ["heart", "ANATOMY", 155, 160], ["failure", "OBSERVATION", 161, 168], ["dogs", "OBSERVATION", 176, 180]]], ["Other names for this disease include endocarditis valvularis chronica fibrosa (nodosa), chronic valvular endocarditis, chronic valvular disease, billowing sail distortion of the mitral valve, endocardiosis, chronic mitral valve fibrosis, senile nodular sclerosis, mucoid degeneration, chronic myxomatous valve disease, and degenerative mitral valve disease.", [["valvular", "ANATOMY", 96, 104], ["valvular", "ANATOMY", 127, 135], ["mitral valve", "ANATOMY", 178, 190], ["endocardiosis", "ANATOMY", 192, 205], ["mitral valve", "ANATOMY", 215, 227], ["mucoid", "ANATOMY", 264, 270], ["myxomatous valve", "ANATOMY", 293, 309], ["degenerative mitral valve", "ANATOMY", 323, 348], ["endocarditis valvularis chronica fibrosa (nodosa", "DISEASE", 37, 85], ["valvular endocarditis", "DISEASE", 96, 117], ["chronic valvular disease", "DISEASE", 119, 143], ["endocardiosis", "DISEASE", 192, 205], ["mitral valve fibrosis", "DISEASE", 215, 236], ["senile nodular sclerosis", "DISEASE", 238, 262], ["mucoid degeneration", "DISEASE", 264, 283], ["myxomatous valve disease", "DISEASE", 293, 317], ["mitral valve disease", "DISEASE", 336, 356], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 178, 190], ["mitral valve", "PATHOLOGICAL_FORMATION", 215, 227], ["mitral valve", "PATHOLOGICAL_FORMATION", 336, 348], ["valvularis chronica", "SPECIES", 50, 69], ["this disease", "PROBLEM", 16, 28], ["endocarditis valvularis chronica fibrosa (nodosa)", "PROBLEM", 37, 86], ["chronic valvular endocarditis", "PROBLEM", 88, 117], ["chronic valvular disease", "PROBLEM", 119, 143], ["billowing sail distortion of the mitral valve", "PROBLEM", 145, 190], ["endocardiosis", "PROBLEM", 192, 205], ["chronic mitral valve fibrosis", "PROBLEM", 207, 236], ["senile nodular sclerosis", "PROBLEM", 238, 262], ["mucoid degeneration", "PROBLEM", 264, 283], ["chronic myxomatous valve disease", "PROBLEM", 285, 317], ["degenerative mitral valve disease", "PROBLEM", 323, 356], ["endocarditis", "OBSERVATION", 37, 49], ["chronica", "OBSERVATION_MODIFIER", 61, 69], ["fibrosa", "OBSERVATION", 70, 77], ["nodosa", "OBSERVATION", 79, 85], ["chronic", "OBSERVATION_MODIFIER", 88, 95], ["valvular", "ANATOMY", 96, 104], ["endocarditis", "OBSERVATION", 105, 117], ["chronic", "OBSERVATION_MODIFIER", 119, 126], ["valvular", "ANATOMY", 127, 135], ["disease", "OBSERVATION", 136, 143], ["sail distortion", "OBSERVATION", 155, 170], ["mitral valve", "ANATOMY", 178, 190], ["chronic", "OBSERVATION_MODIFIER", 207, 214], ["mitral valve", "ANATOMY", 215, 227], ["fibrosis", "OBSERVATION", 228, 236], ["senile", "OBSERVATION_MODIFIER", 238, 244], ["nodular", "OBSERVATION_MODIFIER", 245, 252], ["sclerosis", "OBSERVATION", 253, 262], ["mucoid degeneration", "OBSERVATION", 264, 283], ["chronic", "OBSERVATION_MODIFIER", 285, 292], ["myxomatous valve disease", "OBSERVATION", 293, 317], ["degenerative", "OBSERVATION_MODIFIER", 323, 335], ["mitral valve disease", "OBSERVATION", 336, 356]]], ["Myxomatous valvular degeneration (MVD) is an age-related cardiac disease of middle-aged to old dogs, especially small, toy, and medium-sized breeds.", [["valvular", "ANATOMY", 11, 19], ["cardiac", "ANATOMY", 57, 64], ["Myxomatous valvular degeneration", "DISEASE", 0, 32], ["MVD", "DISEASE", 34, 37], ["cardiac disease", "DISEASE", 57, 72], ["valvular", "MULTI-TISSUE_STRUCTURE", 11, 19], ["cardiac", "ORGAN", 57, 64], ["dogs", "ORGANISM", 95, 99], ["dogs", "SPECIES", 95, 99], ["Myxomatous valvular degeneration", "PROBLEM", 0, 32], ["cardiac disease", "PROBLEM", 57, 72], ["old dogs", "PROBLEM", 91, 99], ["medium-sized breeds", "PROBLEM", 128, 147], ["valvular", "ANATOMY", 11, 19], ["degeneration", "OBSERVATION", 20, 32], ["MVD", "OBSERVATION", 34, 37], ["cardiac", "ANATOMY", 57, 64], ["disease", "OBSERVATION", 65, 72], ["middle", "ANATOMY_MODIFIER", 76, 82], ["dogs", "OBSERVATION", 95, 99], ["small", "OBSERVATION_MODIFIER", 112, 117], ["sized", "OBSERVATION_MODIFIER", 135, 140], ["breeds", "OBSERVATION", 141, 147]]], ["Males of affected breeds develop the disease at an earlier age than females.", [["affected breeds", "PROBLEM", 9, 24], ["the disease", "PROBLEM", 33, 44], ["disease", "OBSERVATION", 37, 44]]], ["MVD appears to have a polygenic inheritance in dachshunds and Cavalier King Charles spaniels.", [["MVD", "PROBLEM", 0, 3], ["a polygenic inheritance in dachshunds", "PROBLEM", 20, 57], ["polygenic", "OBSERVATION_MODIFIER", 22, 31], ["inheritance", "OBSERVATION", 32, 43]]], ["The Cavalier King Charles spaniel breed has a unique susceptibility, with more than 50% prevalence by 4 years of age and 100% prevalence into irregular, plaque-like deformities that extend to involve the proximal portions of the chordae tendineae; and type 4, there is gross distortion and \"ballooning\" of the valve cusp, and the chordae tendinea are thickened proximally ( Fig. 10-84 ).", [["plaque", "ANATOMY", 153, 159], ["chordae tendineae", "ANATOMY", 229, 246], ["valve cusp", "ANATOMY", 310, 320], ["chordae tendinea", "ANATOMY", 330, 346], ["plaque", "DISEASE", 153, 159], ["deformities", "DISEASE", 165, 176], ["chordae tendineae", "DISEASE", 229, 246], ["valve cusp", "MULTI-TISSUE_STRUCTURE", 310, 320], ["irregular, plaque-like deformities", "PROBLEM", 142, 176], ["gross distortion", "PROBLEM", 269, 285], ["\"ballooning\" of the valve cusp", "PROBLEM", 290, 320], ["thickened proximally", "PROBLEM", 351, 371], ["unique", "OBSERVATION_MODIFIER", 46, 52], ["susceptibility", "OBSERVATION_MODIFIER", 53, 67], ["irregular", "OBSERVATION_MODIFIER", 142, 151], ["plaque", "OBSERVATION", 153, 159], ["deformities", "OBSERVATION", 165, 176], ["proximal", "ANATOMY_MODIFIER", 204, 212], ["portions", "ANATOMY_MODIFIER", 213, 221], ["chordae tendineae", "ANATOMY", 229, 246], ["gross distortion", "OBSERVATION", 269, 285], ["ballooning", "OBSERVATION", 291, 301], ["valve", "ANATOMY", 310, 315], ["cusp", "ANATOMY_MODIFIER", 316, 320], ["chordae", "ANATOMY", 330, 337], ["thickened", "OBSERVATION", 351, 360], ["proximally", "OBSERVATION_MODIFIER", 361, 371]]], ["These lesions result in valvular insufficiency with subsequent atrial dilation and development of atrial \"jet lesions.\"", [["lesions", "ANATOMY", 6, 13], ["valvular", "ANATOMY", 24, 32], ["atrial", "ANATOMY", 63, 69], ["atrial \"jet lesions", "ANATOMY", 98, 117], ["valvular insufficiency", "DISEASE", 24, 46], ["atrial dilation", "DISEASE", 63, 78], ["atrial \"jet lesions", "DISEASE", 98, 117], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["valvular", "ORGAN", 24, 32], ["atrial", "MULTI-TISSUE_STRUCTURE", 63, 69], ["atrial", "MULTI-TISSUE_STRUCTURE", 98, 104], ["jet lesions", "PATHOLOGICAL_FORMATION", 106, 117], ["These lesions", "PROBLEM", 0, 13], ["valvular insufficiency", "PROBLEM", 24, 46], ["subsequent atrial dilation", "PROBLEM", 52, 78], ["atrial \"jet lesions", "PROBLEM", 98, 117], ["lesions", "OBSERVATION", 6, 13], ["valvular", "ANATOMY", 24, 32], ["insufficiency", "OBSERVATION", 33, 46], ["atrial", "ANATOMY", 63, 69], ["dilation", "OBSERVATION", 70, 78], ["atrial", "ANATOMY", 98, 104], ["\"", "OBSERVATION_MODIFIER", 105, 106], ["jet", "OBSERVATION_MODIFIER", 106, 109], ["lesions", "OBSERVATION", 110, 117]]], ["The jet lesion is a raised, rough, firm streak of endocardial fibrosis resulting from long-term trauma by a jet of blood leaking through the damaged valve in the closed position.", [["jet lesion", "ANATOMY", 4, 14], ["endocardial", "ANATOMY", 50, 61], ["blood", "ANATOMY", 115, 120], ["valve", "ANATOMY", 149, 154], ["endocardial fibrosis", "DISEASE", 50, 70], ["trauma", "DISEASE", 96, 102], ["jet lesion", "CANCER", 4, 14], ["endocardial", "TISSUE", 50, 61], ["blood", "ORGANISM_SUBSTANCE", 115, 120], ["valve", "PATHOLOGICAL_FORMATION", 149, 154], ["The jet lesion", "PROBLEM", 0, 14], ["endocardial fibrosis", "PROBLEM", 50, 70], ["long-term trauma", "PROBLEM", 86, 102], ["blood leaking", "PROBLEM", 115, 128], ["the damaged valve", "TREATMENT", 137, 154], ["jet", "OBSERVATION_MODIFIER", 4, 7], ["lesion", "OBSERVATION", 8, 14], ["raised", "OBSERVATION_MODIFIER", 20, 26], ["rough", "OBSERVATION_MODIFIER", 28, 33], ["firm", "OBSERVATION_MODIFIER", 35, 39], ["streak", "OBSERVATION_MODIFIER", 40, 46], ["endocardial", "ANATOMY", 50, 61], ["fibrosis", "OBSERVATION", 62, 70], ["long-term", "OBSERVATION_MODIFIER", 86, 95], ["trauma", "OBSERVATION", 96, 102], ["jet", "OBSERVATION_MODIFIER", 108, 111], ["blood leaking", "OBSERVATION", 115, 128], ["damaged valve", "OBSERVATION", 141, 154], ["closed", "OBSERVATION_MODIFIER", 162, 168], ["position", "OBSERVATION_MODIFIER", 169, 177]]], ["Histologically, the valves are divided into four layers: atrialis, ventricularis, spongiosa, and fibrosa.", [["valves", "ANATOMY", 20, 26], ["atrialis", "ANATOMY", 57, 65], ["ventricularis", "ANATOMY", 67, 80], ["spongiosa", "ANATOMY", 82, 91], ["fibrosa", "ANATOMY", 97, 104], ["fibrosa", "DISEASE", 97, 104], ["valves", "PATHOLOGICAL_FORMATION", 20, 26], ["layers", "TISSUE", 49, 55], ["atrialis", "CANCER", 57, 65], ["ventricularis", "MULTI-TISSUE_STRUCTURE", 67, 80], ["spongiosa", "TISSUE", 82, 91], ["the valves", "TREATMENT", 16, 26], ["fibrosa", "PROBLEM", 97, 104], ["valves", "ANATOMY", 20, 26], ["four", "OBSERVATION_MODIFIER", 44, 48], ["layers", "OBSERVATION_MODIFIER", 49, 55], ["atrialis", "ANATOMY", 57, 65], ["ventricularis", "ANATOMY", 67, 80], ["spongiosa", "ANATOMY", 82, 91], ["fibrosa", "OBSERVATION", 97, 104]]], ["The atrialis and ventricularis layers face the respective cardiac chambers and consist of endothelium and immediate subendothelial tissue containing fibroblasts, scattered collagen fibers, and a thin layer of elastic fibers.", [["atrialis", "ANATOMY", 4, 12], ["ventricularis layers", "ANATOMY", 17, 37], ["cardiac chambers", "ANATOMY", 58, 74], ["endothelium", "ANATOMY", 90, 101], ["subendothelial tissue", "ANATOMY", 116, 137], ["fibroblasts", "ANATOMY", 149, 160], ["collagen fibers", "ANATOMY", 172, 187], ["elastic fibers", "ANATOMY", 209, 223], ["atrialis", "CANCER", 4, 12], ["ventricularis layers", "TISSUE", 17, 37], ["endothelium", "TISSUE", 90, 101], ["subendothelial tissue", "TISSUE", 116, 137], ["fibroblasts", "CELL", 149, 160], ["collagen", "GENE_OR_GENE_PRODUCT", 172, 180], ["fibers", "CELLULAR_COMPONENT", 181, 187], ["elastic fibers", "CELLULAR_COMPONENT", 209, 223], ["fibroblasts", "CELL_TYPE", 149, 160], ["immediate subendothelial tissue containing fibroblasts", "PROBLEM", 106, 160], ["scattered collagen fibers", "PROBLEM", 162, 187], ["a thin layer of elastic fibers", "TREATMENT", 193, 223], ["atrialis", "ANATOMY_MODIFIER", 4, 12], ["ventricularis", "ANATOMY_MODIFIER", 17, 30], ["layers", "ANATOMY_MODIFIER", 31, 37], ["face", "ANATOMY_MODIFIER", 38, 42], ["respective", "ANATOMY_MODIFIER", 47, 57], ["cardiac", "ANATOMY", 58, 65], ["chambers", "ANATOMY_MODIFIER", 66, 74], ["endothelium", "OBSERVATION", 90, 101], ["immediate", "OBSERVATION_MODIFIER", 106, 115], ["subendothelial tissue", "OBSERVATION", 116, 137], ["fibroblasts", "OBSERVATION", 149, 160], ["scattered", "OBSERVATION_MODIFIER", 162, 171], ["collagen fibers", "OBSERVATION", 172, 187], ["thin", "OBSERVATION_MODIFIER", 195, 199], ["layer", "OBSERVATION_MODIFIER", 200, 205], ["elastic fibers", "OBSERVATION", 209, 223]]], ["The spongiosa layer is loose connective tissue with interstitial cells and minimal fibers.", [["spongiosa layer", "ANATOMY", 4, 19], ["connective tissue", "ANATOMY", 29, 46], ["interstitial cells", "ANATOMY", 52, 70], ["fibers", "ANATOMY", 83, 89], ["spongiosa layer", "TISSUE", 4, 19], ["connective tissue", "TISSUE", 29, 46], ["interstitial cells", "CELL", 52, 70], ["minimal fibers", "CELLULAR_COMPONENT", 75, 89], ["interstitial cells", "CELL_TYPE", 52, 70], ["loose connective tissue", "PROBLEM", 23, 46], ["interstitial cells", "PROBLEM", 52, 70], ["spongiosa", "ANATOMY", 4, 13], ["layer", "ANATOMY_MODIFIER", 14, 19], ["loose", "OBSERVATION_MODIFIER", 23, 28], ["connective tissue", "OBSERVATION", 29, 46], ["interstitial cells", "OBSERVATION", 52, 70], ["minimal", "OBSERVATION_MODIFIER", 75, 82], ["fibers", "OBSERVATION_MODIFIER", 83, 89]]], ["The fibrosa consists of dense collagen that is continuous with the collagen core of chordae tendineae.", [["fibrosa", "ANATOMY", 4, 11], ["chordae tendineae", "ANATOMY", 84, 101], ["fibrosa", "DISEASE", 4, 11], ["collagen", "GENE_OR_GENE_PRODUCT", 30, 38], ["collagen", "GENE_OR_GENE_PRODUCT", 67, 75], ["collagen", "PROTEIN", 30, 38], ["dense collagen", "PROBLEM", 24, 38], ["fibrosa", "OBSERVATION", 4, 11], ["dense", "OBSERVATION_MODIFIER", 24, 29], ["collagen", "OBSERVATION", 30, 38], ["chordae tendineae", "ANATOMY", 84, 101]]], ["Histopathologic lesions in MVD predominate in the distal third of the valve leaflets, and the incidence and severity increase with age.", [["lesions", "ANATOMY", 16, 23], ["distal third", "ANATOMY", 50, 62], ["valve leaflets", "ANATOMY", 70, 84], ["Histopathologic lesions", "CANCER", 0, 23], ["valve leaflets", "MULTI-TISSUE_STRUCTURE", 70, 84], ["Histopathologic lesions", "PROBLEM", 0, 23], ["MVD", "PROBLEM", 27, 30], ["lesions", "OBSERVATION", 16, 23], ["MVD", "OBSERVATION", 27, 30], ["distal", "ANATOMY_MODIFIER", 50, 56], ["third", "ANATOMY_MODIFIER", 57, 62], ["valve leaflets", "ANATOMY", 70, 84], ["severity", "OBSERVATION_MODIFIER", 108, 116], ["increase", "OBSERVATION_MODIFIER", 117, 125]]], ["Lesions include progressive expansion of the spongiosa layer and disruption of the fibrosa layer.Cell Degeneration and DeathMicroscopically, the thickened valves have notably increased myofibroblastic proliferation and deposition of acid mucopolysaccharides ( Fig. 10-85 ).", [["spongiosa layer", "ANATOMY", 45, 60], ["fibrosa layer", "ANATOMY", 83, 96], ["Cell", "ANATOMY", 97, 101], ["thickened valves", "ANATOMY", 145, 161], ["myofibroblastic", "ANATOMY", 185, 200], ["spongiosa layer", "TISSUE", 45, 60], ["Cell", "CELL", 97, 101], ["valves", "PATHOLOGICAL_FORMATION", 155, 161], ["mucopolysaccharides", "SIMPLE_CHEMICAL", 238, 257], ["Lesions", "PROBLEM", 0, 7], ["progressive expansion of the spongiosa layer", "PROBLEM", 16, 60], ["disruption of the fibrosa layer", "PROBLEM", 65, 96], ["Cell Degeneration", "PROBLEM", 97, 114], ["DeathMicroscopically", "TEST", 119, 139], ["the thickened valves", "PROBLEM", 141, 161], ["increased myofibroblastic proliferation", "PROBLEM", 175, 214], ["acid mucopolysaccharides", "TEST", 233, 257], ["Fig.", "TEST", 260, 264], ["progressive", "OBSERVATION_MODIFIER", 16, 27], ["expansion", "OBSERVATION_MODIFIER", 28, 37], ["spongiosa", "ANATOMY", 45, 54], ["layer", "ANATOMY_MODIFIER", 55, 60], ["disruption", "OBSERVATION_MODIFIER", 65, 75], ["fibrosa", "ANATOMY", 83, 90], ["layer", "ANATOMY_MODIFIER", 91, 96], ["Degeneration", "OBSERVATION", 102, 114], ["thickened", "OBSERVATION", 145, 154], ["valves", "ANATOMY", 155, 161], ["notably", "OBSERVATION_MODIFIER", 167, 174], ["increased", "OBSERVATION_MODIFIER", 175, 184], ["myofibroblastic proliferation", "OBSERVATION", 185, 214], ["deposition", "OBSERVATION_MODIFIER", 219, 229], ["acid mucopolysaccharides", "OBSERVATION", 233, 257]]], ["It is important not to confuse normal agerelated valve thickening in asymptomatic dogs with true pathologic thickening.", [["valve", "ANATOMY", 49, 54], ["valve", "TISSUE", 49, 54], ["dogs", "ORGANISM", 82, 86], ["dogs", "SPECIES", 82, 86], ["normal agerelated valve thickening", "PROBLEM", 31, 65], ["asymptomatic dogs", "PROBLEM", 69, 86], ["true pathologic thickening", "PROBLEM", 92, 118], ["important not to", "UNCERTAINTY", 6, 22], ["valve", "ANATOMY", 49, 54], ["thickening", "OBSERVATION", 55, 65], ["pathologic", "OBSERVATION_MODIFIER", 97, 107], ["thickening", "OBSERVATION", 108, 118]]], ["Therefore a \"clinical relevant diagnosis\" would be more certain when the mitral valve and chordae tendineae are thickened and/or ruptured or when left heart chambers are enlarged or there are left atrial jet lesions.", [["mitral valve", "ANATOMY", 73, 85], ["chordae tendineae", "ANATOMY", 90, 107], ["left heart chambers", "ANATOMY", 146, 165], ["left atrial jet lesions", "ANATOMY", 192, 215], ["mitral valve", "MULTI-TISSUE_STRUCTURE", 73, 85], ["chordae tendineae", "PATHOLOGICAL_FORMATION", 90, 107], ["heart", "ORGAN", 151, 156], ["atrial jet lesions", "PATHOLOGICAL_FORMATION", 197, 215], ["thickened", "PROBLEM", 112, 121], ["ruptured", "PROBLEM", 129, 137], ["left atrial jet lesions", "PROBLEM", 192, 215], ["mitral valve", "ANATOMY", 73, 85], ["chordae tendineae", "ANATOMY", 90, 107], ["thickened", "OBSERVATION", 112, 121], ["ruptured", "OBSERVATION", 129, 137], ["left", "ANATOMY_MODIFIER", 146, 150], ["heart", "ANATOMY", 151, 156], ["chambers", "ANATOMY_MODIFIER", 157, 165], ["enlarged", "OBSERVATION", 170, 178], ["left", "ANATOMY_MODIFIER", 192, 196], ["atrial", "ANATOMY", 197, 203], ["jet", "OBSERVATION_MODIFIER", 204, 207], ["lesions", "OBSERVATION", 208, 215]]], ["Severe complications of MVD include occasional rupture of chordae tendineae, occasional splitting or rupture of the left atrial wall that can result in hemopericardium, or acquired atrial septal defects.", [["chordae tendineae", "ANATOMY", 58, 75], ["left atrial wall", "ANATOMY", 116, 132], ["hemopericardium", "ANATOMY", 152, 167], ["atrial septal", "ANATOMY", 181, 194], ["MVD", "DISEASE", 24, 27], ["chordae tendineae", "DISEASE", 58, 75], ["hemopericardium", "DISEASE", 152, 167], ["atrial septal defects", "DISEASE", 181, 202], ["atrial wall", "MULTI-TISSUE_STRUCTURE", 121, 132], ["hemopericardium", "CANCER", 152, 167], ["atrial septal", "MULTI-TISSUE_STRUCTURE", 181, 194], ["Severe complications", "PROBLEM", 0, 20], ["MVD", "PROBLEM", 24, 27], ["occasional rupture of chordae tendineae", "PROBLEM", 36, 75], ["occasional splitting", "PROBLEM", 77, 97], ["rupture of the left atrial wall", "PROBLEM", 101, 132], ["hemopericardium", "PROBLEM", 152, 167], ["acquired atrial septal defects", "PROBLEM", 172, 202], ["MVD", "OBSERVATION", 24, 27], ["occasional", "OBSERVATION_MODIFIER", 36, 46], ["rupture", "OBSERVATION", 47, 54], ["chordae tendineae", "OBSERVATION", 58, 75], ["occasional", "OBSERVATION_MODIFIER", 77, 87], ["splitting", "OBSERVATION_MODIFIER", 88, 97], ["rupture", "OBSERVATION", 101, 108], ["left", "ANATOMY_MODIFIER", 116, 120], ["atrial wall", "ANATOMY", 121, 132], ["hemopericardium", "OBSERVATION", 152, 167], ["atrial", "ANATOMY", 181, 187], ["septal defects", "OBSERVATION", 188, 202]]], ["Frequent accompanying myocardial alterations include arteriosclerosis of intramyocardial arteries and multifocal myocardial necrosis and fibrosis.", [["myocardial", "ANATOMY", 22, 32], ["intramyocardial arteries", "ANATOMY", 73, 97], ["myocardial", "ANATOMY", 113, 123], ["myocardial alterations", "DISEASE", 22, 44], ["arteriosclerosis", "DISEASE", 53, 69], ["myocardial necrosis", "DISEASE", 113, 132], ["fibrosis", "DISEASE", 137, 145], ["myocardial", "MULTI-TISSUE_STRUCTURE", 22, 32], ["intramyocardial arteries", "MULTI-TISSUE_STRUCTURE", 73, 97], ["myocardial", "MULTI-TISSUE_STRUCTURE", 113, 123], ["Frequent accompanying myocardial alterations", "PROBLEM", 0, 44], ["arteriosclerosis of intramyocardial arteries", "PROBLEM", 53, 97], ["multifocal myocardial necrosis", "PROBLEM", 102, 132], ["fibrosis", "PROBLEM", 137, 145], ["myocardial", "ANATOMY", 22, 32], ["alterations", "OBSERVATION", 33, 44], ["arteriosclerosis", "OBSERVATION", 53, 69], ["intramyocardial arteries", "ANATOMY", 73, 97], ["multifocal", "OBSERVATION_MODIFIER", 102, 112], ["myocardial", "ANATOMY", 113, 123], ["necrosis", "OBSERVATION", 124, 132], ["fibrosis", "OBSERVATION", 137, 145]]], ["Progression of MVD is associated with an increase in plasma N-terminal pro-B-type natriuretic peptide concentration and an altered serotonin (5-hydroxytryptamine) signaling pathway.InflammationEndocarditis.", [["plasma", "ANATOMY", 53, 59], ["MVD", "DISEASE", 15, 18], ["serotonin", "CHEMICAL", 131, 140], ["5-hydroxytryptamine", "CHEMICAL", 142, 161], ["InflammationEndocarditis", "DISEASE", 181, 205], ["N", "CHEMICAL", 60, 61], ["serotonin", "CHEMICAL", 131, 140], ["5-hydroxytryptamine", "CHEMICAL", 142, 161], ["plasma", "ORGANISM_SUBSTANCE", 53, 59], ["pro-B-type natriuretic peptide", "GENE_OR_GENE_PRODUCT", 71, 101], ["serotonin", "SIMPLE_CHEMICAL", 131, 140], ["5-hydroxytryptamine", "SIMPLE_CHEMICAL", 142, 161], ["MVD", "PROBLEM", 15, 18], ["an increase", "PROBLEM", 38, 49], ["plasma N-terminal pro-B-type natriuretic peptide concentration", "TREATMENT", 53, 115], ["an altered serotonin", "PROBLEM", 120, 140], ["hydroxytryptamine", "TREATMENT", 144, 161], ["InflammationEndocarditis", "PROBLEM", 181, 205], ["MVD", "OBSERVATION", 15, 18], ["increase", "OBSERVATION_MODIFIER", 41, 49]]], ["Endocarditis is occasionally observed in dogs.", [["Endocarditis", "DISEASE", 0, 12], ["dogs", "ORGANISM", 41, 45], ["dogs", "SPECIES", 41, 45], ["Endocarditis", "PROBLEM", 0, 12]]], ["Bacterial septicemias result in inflammation of cardiac valves.", [["cardiac valves", "ANATOMY", 48, 62], ["septicemias", "DISEASE", 10, 21], ["inflammation", "DISEASE", 32, 44], ["cardiac valves", "MULTI-TISSUE_STRUCTURE", 48, 62], ["Bacterial septicemias", "PROBLEM", 0, 21], ["inflammation of cardiac valves", "PROBLEM", 32, 62], ["septicemias", "OBSERVATION", 10, 21], ["inflammation", "OBSERVATION", 32, 44], ["cardiac valves", "ANATOMY", 48, 62]]], ["Bacteria most commonly isolated include Streptococcus spp., Bartonella spp., and Escherichia coli.", [["Streptococcus spp.", "ORGANISM", 40, 58], ["Bartonella spp.", "ORGANISM", 60, 75], ["Escherichia coli", "ORGANISM", 81, 97], ["Streptococcus spp.", "SPECIES", 40, 58], ["Bartonella spp.", "SPECIES", 60, 75], ["Escherichia coli", "SPECIES", 81, 97], ["Streptococcus spp.", "SPECIES", 40, 58], ["Bartonella spp.", "SPECIES", 60, 75], ["Escherichia coli", "SPECIES", 81, 97], ["Bacteria", "PROBLEM", 0, 8], ["Streptococcus spp.", "PROBLEM", 40, 58], ["Bartonella spp.", "TEST", 60, 75], ["Escherichia coli", "PROBLEM", 81, 97], ["Escherichia coli", "OBSERVATION", 81, 97]]], ["The mitral valve is most commonly involved and is associated with polyarthritis.", [["mitral valve", "ANATOMY", 4, 16], ["polyarthritis", "DISEASE", 66, 79], ["mitral valve", "PATHOLOGICAL_FORMATION", 4, 16], ["polyarthritis", "PROBLEM", 66, 79], ["mitral valve", "ANATOMY", 4, 16], ["associated with", "UNCERTAINTY", 50, 65], ["polyarthritis", "OBSERVATION", 66, 79]]], ["Infections with Bartonellosis may only have inflammatory changes involving the aortic valve leaflets.", [["aortic valve leaflets", "ANATOMY", 79, 100], ["Infections", "DISEASE", 0, 10], ["Bartonellosis", "DISEASE", 16, 29], ["aortic valve", "MULTI-TISSUE_STRUCTURE", 79, 91], ["Infections", "PROBLEM", 0, 10], ["Bartonellosis", "PROBLEM", 16, 29], ["inflammatory changes involving the aortic valve leaflets", "PROBLEM", 44, 100], ["Bartonellosis", "OBSERVATION", 16, 29], ["inflammatory", "OBSERVATION", 44, 56], ["aortic valve", "ANATOMY", 79, 91], ["leaflets", "ANATOMY_MODIFIER", 92, 100]]], ["Erysipelothrix tonsillarum (formally known as Erysipelothrix serovar 7) is occasionally isolated.", [["Erysipelothrix tonsillarum", "ORGANISM", 0, 26], ["Erysipelothrix serovar 7", "ORGANISM", 46, 70], ["Erysipelothrix tonsillarum", "SPECIES", 0, 26], ["Erysipelothrix serovar", "SPECIES", 46, 68], ["Erysipelothrix tonsillarum", "SPECIES", 0, 26], ["Erysipelothrix serovar 7", "SPECIES", 46, 70], ["Erysipelothrix tonsillarum", "PROBLEM", 0, 26], ["Erysipelothrix serovar", "TREATMENT", 46, 68]]], ["Confirmation of the definitive organism requires bacterial isolation and/or identification by (1-4) .", [["the definitive organism", "PROBLEM", 16, 39], ["bacterial isolation", "TREATMENT", 49, 68], ["bacterial isolation", "OBSERVATION", 49, 68]]], ["Type 1 has a few discrete nodules (minimal changes); type 2 has larger nodules in contact areas (mild changes); type 3 has large, coalescing nodules forming plaquelike deformities (moderate changes); and type 4 has obvious distortions of the valve (severe changes).", [["nodules", "ANATOMY", 26, 33], ["nodules", "ANATOMY", 71, 78], ["nodules", "ANATOMY", 141, 148], ["valve", "ANATOMY", 242, 247], ["deformities", "DISEASE", 168, 179], ["nodules", "CANCER", 26, 33], ["nodules", "CANCER", 71, 78], ["nodules", "PATHOLOGICAL_FORMATION", 141, 148], ["valve", "PATHOLOGICAL_FORMATION", 242, 247], ["a few discrete nodules", "PROBLEM", 11, 33], ["minimal changes)", "PROBLEM", 35, 51], ["type 2", "PROBLEM", 53, 59], ["larger nodules in contact areas (mild changes)", "PROBLEM", 64, 110], ["type 3", "PROBLEM", 112, 118], ["large, coalescing nodules", "PROBLEM", 123, 148], ["plaquelike deformities", "PROBLEM", 157, 179], ["moderate changes)", "PROBLEM", 181, 198], ["obvious distortions of the valve (severe changes)", "PROBLEM", 215, 264], ["few", "OBSERVATION_MODIFIER", 13, 16], ["discrete", "OBSERVATION_MODIFIER", 17, 25], ["nodules", "OBSERVATION", 26, 33], ["minimal", "OBSERVATION_MODIFIER", 35, 42], ["larger", "OBSERVATION_MODIFIER", 64, 70], ["nodules", "OBSERVATION", 71, 78], ["contact areas", "OBSERVATION", 82, 95], ["mild", "OBSERVATION_MODIFIER", 97, 101], ["large", "OBSERVATION_MODIFIER", 123, 128], ["coalescing", "OBSERVATION_MODIFIER", 130, 140], ["nodules", "OBSERVATION", 141, 148], ["plaquelike", "OBSERVATION_MODIFIER", 157, 167], ["deformities", "OBSERVATION", 168, 179], ["moderate", "OBSERVATION_MODIFIER", 181, 189], ["obvious", "OBSERVATION_MODIFIER", 215, 222], ["distortions", "OBSERVATION", 223, 234], ["valve", "ANATOMY", 242, 247], ["severe", "OBSERVATION_MODIFIER", 249, 255]]], ["The lightcolored areas represent areas of nodular or diffuse thickening and ballooning of the valve cusp and proximal chordae tendineae.", [["nodular", "ANATOMY", 42, 49], ["valve cusp", "ANATOMY", 94, 104], ["proximal chordae tendineae", "ANATOMY", 109, 135], ["valve cusp", "MULTI-TISSUE_STRUCTURE", 94, 104], ["nodular or diffuse thickening", "PROBLEM", 42, 71], ["ballooning of the valve cusp", "PROBLEM", 76, 104], ["proximal chordae tendineae", "PROBLEM", 109, 135], ["areas", "OBSERVATION_MODIFIER", 33, 38], ["nodular", "OBSERVATION_MODIFIER", 42, 49], ["diffuse", "OBSERVATION_MODIFIER", 53, 60], ["thickening", "OBSERVATION", 61, 71], ["ballooning", "OBSERVATION", 76, 86], ["valve", "ANATOMY", 94, 99], ["cusp", "ANATOMY_MODIFIER", 100, 104], ["proximal", "ANATOMY_MODIFIER", 109, 117], ["chordae tendineae", "OBSERVATION", 118, 135]]], ["The dark-colored areas represent areas of diffuse opacity due to accumulation of neutral fat within the spongiosa layer.", [["fat", "ANATOMY", 89, 92], ["spongiosa layer", "ANATOMY", 104, 119], ["opacity", "DISEASE", 50, 57], ["fat", "TISSUE", 89, 92], ["spongiosa layer", "TISSUE", 104, 119], ["diffuse opacity", "PROBLEM", 42, 57], ["accumulation of neutral fat within the spongiosa layer", "PROBLEM", 65, 119], ["dark", "OBSERVATION_MODIFIER", 4, 8], ["colored", "OBSERVATION_MODIFIER", 9, 16], ["areas", "OBSERVATION_MODIFIER", 17, 22], ["areas", "OBSERVATION_MODIFIER", 33, 38], ["diffuse", "OBSERVATION_MODIFIER", 42, 49], ["opacity", "OBSERVATION", 50, 57], ["accumulation", "OBSERVATION_MODIFIER", 65, 77], ["neutral fat", "OBSERVATION", 81, 92], ["spongiosa", "ANATOMY", 104, 113], ["layer", "ANATOMY_MODIFIER", 114, 119]]], ["N, Normal valve.", [["valve", "PATHOLOGICAL_FORMATION", 10, 15], ["Normal valve", "OBSERVATION", 3, 15]]], ["(Redrawn from Figure 2Myxomatous degenerationThickening and bulging hemopericardium and cardiac tamponade.", [["bulging hemopericardium", "ANATOMY", 60, 83], ["cardiac", "ANATOMY", 88, 95], ["Thickening", "DISEASE", 45, 55], ["hemopericardium", "DISEASE", 68, 83], ["cardiac tamponade", "DISEASE", 88, 105], ["cardiac", "ORGAN", 88, 95], ["Figure 2Myxomatous degeneration", "PROBLEM", 14, 45], ["Thickening", "PROBLEM", 45, 55], ["bulging hemopericardium", "PROBLEM", 60, 83], ["cardiac tamponade", "PROBLEM", 88, 105], ["2Myxomatous degeneration", "OBSERVATION", 21, 45], ["bulging", "OBSERVATION_MODIFIER", 60, 67], ["hemopericardium", "OBSERVATION", 68, 83], ["cardiac", "ANATOMY", 88, 95], ["tamponade", "OBSERVATION", 96, 105]]], ["Microscopically, the neoplasms are composed of scattered, elongated, plump neoplastic endothelial cells, which may or may not form vascular spaces containing blood ( Fig. 10-87 ).", [["neoplasms", "ANATOMY", 21, 30], ["plump neoplastic endothelial cells", "ANATOMY", 69, 103], ["vascular", "ANATOMY", 131, 139], ["blood", "ANATOMY", 158, 163], ["neoplasms", "DISEASE", 21, 30], ["neoplasms", "CANCER", 21, 30], ["plump neoplastic endothelial cells", "CELL", 69, 103], ["vascular", "MULTI-TISSUE_STRUCTURE", 131, 139], ["blood", "ORGANISM_SUBSTANCE", 158, 163], ["plump neoplastic endothelial cells", "CELL_TYPE", 69, 103], ["the neoplasms", "PROBLEM", 17, 30], ["scattered, elongated, plump neoplastic endothelial cells", "PROBLEM", 47, 103], ["neoplasms", "OBSERVATION", 21, 30], ["scattered", "OBSERVATION_MODIFIER", 47, 56], ["elongated", "OBSERVATION_MODIFIER", 58, 67], ["plump", "OBSERVATION_MODIFIER", 69, 74], ["neoplastic endothelial cells", "OBSERVATION", 75, 103], ["may not form", "UNCERTAINTY", 118, 130], ["vascular", "ANATOMY", 131, 139]]], ["Pulmonary metastases are frequent.", [["Pulmonary metastases", "ANATOMY", 0, 20], ["Pulmonary metastases", "DISEASE", 0, 20], ["Pulmonary", "ORGAN", 0, 9], ["Pulmonary metastases", "PROBLEM", 0, 20], ["metastases", "OBSERVATION", 10, 20]]], ["Immunohistochemistry staining for factor VIII-related antigen or CD31 (an endothelial marker) confirms the tumor cells are endothelial inIdiopathic Pericardial Effusion (Hemorrhagic PericardialEffusion).", [["endothelial", "ANATOMY", 74, 85], ["tumor cells", "ANATOMY", 107, 118], ["endothelial", "ANATOMY", 123, 134], ["Pericardial", "ANATOMY", 148, 159], ["tumor", "DISEASE", 107, 112], ["factor VIII-related antigen", "GENE_OR_GENE_PRODUCT", 34, 61], ["CD31", "GENE_OR_GENE_PRODUCT", 65, 69], ["endothelial", "CELL", 74, 85], ["tumor cells", "CELL", 107, 118], ["endothelial", "CELL", 123, 134], ["factor VIII", "PROTEIN", 34, 45], ["CD31", "PROTEIN", 65, 69], ["tumor cells", "CELL_TYPE", 107, 118], ["Immunohistochemistry staining", "TEST", 0, 29], ["factor VIII", "TEST", 34, 45], ["related antigen", "PROBLEM", 46, 61], ["CD31", "PROBLEM", 65, 69], ["an endothelial marker", "TEST", 71, 92], ["the tumor cells", "PROBLEM", 103, 118], ["endothelial inIdiopathic Pericardial Effusion", "PROBLEM", 123, 168], ["Hemorrhagic PericardialEffusion", "PROBLEM", 170, 201], ["tumor cells", "OBSERVATION", 107, 118], ["endothelial", "OBSERVATION_MODIFIER", 123, 134], ["inIdiopathic", "OBSERVATION_MODIFIER", 135, 147], ["Pericardial", "ANATOMY", 148, 159], ["Effusion", "OBSERVATION", 160, 168], ["Hemorrhagic", "OBSERVATION_MODIFIER", 170, 181]]], ["Idiopathic pericardial effusion is one of the most common causes of canine pericardial effusion and accounts for approximately 19% of all canine pericardial effusions.", [["pericardial", "ANATOMY", 11, 22], ["pericardial", "ANATOMY", 75, 86], ["pericardial effusions", "ANATOMY", 145, 166], ["Idiopathic pericardial effusion", "DISEASE", 0, 31], ["pericardial effusion", "DISEASE", 75, 95], ["pericardial effusions", "DISEASE", 145, 166], ["canine", "ORGANISM", 68, 74], ["pericardial", "ORGAN", 75, 86], ["canine", "ORGANISM", 138, 144], ["pericardial effusions", "PATHOLOGICAL_FORMATION", 145, 166], ["canine", "SPECIES", 68, 74], ["canine", "SPECIES", 138, 144], ["Idiopathic pericardial effusion", "PROBLEM", 0, 31], ["canine pericardial effusion", "PROBLEM", 68, 95], ["all canine pericardial effusions", "PROBLEM", 134, 166], ["pericardial", "ANATOMY", 11, 22], ["effusion", "OBSERVATION", 23, 31], ["canine", "OBSERVATION_MODIFIER", 68, 74], ["pericardial", "ANATOMY", 75, 86], ["effusion", "OBSERVATION", 87, 95], ["all", "OBSERVATION_MODIFIER", 134, 137], ["canine", "OBSERVATION_MODIFIER", 138, 144], ["pericardial", "ANATOMY", 145, 156], ["effusions", "OBSERVATION", 157, 166]]], ["Large or giant breeds, such as the Great Dane, Saint Bernard, Great Pyrenees, German shepherd, and golden retriever, are most often affected.", [["golden retriever", "SPECIES", 99, 115], ["Large or giant breeds", "PROBLEM", 0, 21], ["giant breeds", "OBSERVATION", 9, 21], ["German shepherd", "OBSERVATION", 78, 93], ["golden retriever", "OBSERVATION", 99, 115]]], ["It is a diagnosis of exclusion after all other potential causes (neoplastic, traumatic, infectious, metabolic, cardiac, and coagulopathy) have been ruled out.", [["neoplastic", "ANATOMY", 65, 75], ["cardiac", "ANATOMY", 111, 118], ["traumatic", "DISEASE", 77, 86], ["infectious, metabolic, cardiac, and coagulopathy", "DISEASE", 88, 136], ["cardiac", "ORGAN", 111, 118], ["neoplastic, traumatic", "PROBLEM", 65, 86], ["infectious", "PROBLEM", 88, 98], ["coagulopathy", "PROBLEM", 124, 136], ["neoplastic", "OBSERVATION_MODIFIER", 65, 75], ["traumatic", "OBSERVATION_MODIFIER", 77, 86], ["infectious", "OBSERVATION_MODIFIER", 88, 98], ["cardiac", "ANATOMY", 111, 118], ["coagulopathy", "OBSERVATION", 124, 136]]], ["Idiopathic pericardial effusion can be hemorrhagic or serosanguinous.", [["pericardial", "ANATOMY", 11, 22], ["Idiopathic pericardial effusion", "DISEASE", 0, 31], ["hemorrhagic", "DISEASE", 39, 50], ["pericardial", "ORGAN", 11, 22], ["Idiopathic pericardial effusion", "PROBLEM", 0, 31], ["hemorrhagic", "PROBLEM", 39, 50], ["serosanguinous", "PROBLEM", 54, 68], ["pericardial", "ANATOMY", 11, 22], ["effusion", "OBSERVATION", 23, 31], ["hemorrhagic", "OBSERVATION_MODIFIER", 39, 50], ["serosanguinous", "OBSERVATION", 54, 68]]], ["The pericardium is thickened by diffuse fibrosis; neovascularization; areas of lymphocytic, plasmacytic, and histiocytic infiltrates; and areas of mesothelial hyperplasia alongside regions void of parietal mesothelium.", [["pericardium", "ANATOMY", 4, 15], ["lymphocytic", "ANATOMY", 79, 90], ["plasmacytic", "ANATOMY", 92, 103], ["histiocytic infiltrates", "ANATOMY", 109, 132], ["mesothelial hyperplasia", "ANATOMY", 147, 170], ["parietal mesothelium", "ANATOMY", 197, 217], ["fibrosis", "DISEASE", 40, 48], ["neovascularization", "DISEASE", 50, 68], ["mesothelial hyperplasia", "DISEASE", 147, 170], ["pericardium", "ORGAN", 4, 15], ["lymphocytic", "CANCER", 79, 90], ["plasmacytic", "CANCER", 92, 103], ["histiocytic infiltrates", "PATHOLOGICAL_FORMATION", 109, 132], ["mesothelial hyperplasia", "PATHOLOGICAL_FORMATION", 147, 170], ["parietal mesothelium", "TISSUE", 197, 217], ["thickened", "PROBLEM", 19, 28], ["diffuse fibrosis", "PROBLEM", 32, 48], ["neovascularization", "PROBLEM", 50, 68], ["lymphocytic, plasmacytic, and histiocytic infiltrates", "PROBLEM", 79, 132], ["mesothelial hyperplasia", "PROBLEM", 147, 170], ["pericardium", "ANATOMY", 4, 15], ["thickened", "OBSERVATION", 19, 28], ["diffuse", "OBSERVATION_MODIFIER", 32, 39], ["fibrosis", "OBSERVATION", 40, 48], ["neovascularization", "OBSERVATION", 50, 68], ["areas", "OBSERVATION_MODIFIER", 70, 75], ["lymphocytic", "OBSERVATION_MODIFIER", 79, 90], ["plasmacytic", "OBSERVATION_MODIFIER", 92, 103], ["histiocytic", "OBSERVATION_MODIFIER", 109, 120], ["infiltrates", "OBSERVATION", 121, 132], ["areas", "OBSERVATION_MODIFIER", 138, 143], ["mesothelial hyperplasia", "OBSERVATION", 147, 170], ["parietal", "ANATOMY_MODIFIER", 197, 205], ["mesothelium", "ANATOMY", 206, 217]]], ["See the discussion on effusions in the section on Disorders of Domestic Animals: Pericardium and Epicardium, Disturbances of Circulation, Effusions, and also Chapters 3, 7, and 9.Disturbances of GrowthAnomalies and Dysplasia.", [["effusions", "DISEASE", 22, 31], ["GrowthAnomalies", "DISEASE", 195, 210], ["Dysplasia", "DISEASE", 215, 224], ["effusions", "PROBLEM", 22, 31], ["Pericardium and Epicardium, Disturbances of Circulation", "PROBLEM", 81, 136], ["Effusions", "PROBLEM", 138, 147], ["Disturbances of GrowthAnomalies", "PROBLEM", 179, 210], ["Dysplasia", "PROBLEM", 215, 224], ["effusions", "OBSERVATION", 22, 31], ["Pericardium", "ANATOMY", 81, 92], ["Epicardium", "ANATOMY", 97, 107], ["Circulation", "OBSERVATION_MODIFIER", 125, 136], ["Effusions", "OBSERVATION", 138, 147], ["Dysplasia", "OBSERVATION", 215, 224]]], ["See the discussion on anomalies and dysplasia in the section on Disorders of Domestic Animals, Developmental Errors/Congenital Anomalies.Neoplastic TransformationHemangiosarcoma and Hemangioma.", [["Hemangioma", "ANATOMY", 182, 192], ["dysplasia", "DISEASE", 36, 45], ["Developmental Errors", "DISEASE", 95, 115], ["Congenital Anomalies", "DISEASE", 116, 136], ["Neoplastic TransformationHemangiosarcoma", "DISEASE", 137, 177], ["Hemangioma", "DISEASE", 182, 192], ["dysplasia", "PATHOLOGICAL_FORMATION", 36, 45], ["Neoplastic TransformationHemangiosarcoma", "CANCER", 137, 177], ["Hemangioma", "CANCER", 182, 192], ["anomalies", "PROBLEM", 22, 31], ["dysplasia", "PROBLEM", 36, 45], ["Congenital Anomalies", "PROBLEM", 116, 136], ["Neoplastic TransformationHemangiosarcoma", "PROBLEM", 137, 177], ["Hemangioma", "PROBLEM", 182, 192], ["dysplasia", "OBSERVATION", 36, 45], ["Congenital", "OBSERVATION_MODIFIER", 116, 126], ["Anomalies", "OBSERVATION", 127, 136], ["Hemangiosarcoma", "OBSERVATION", 162, 177], ["Hemangioma", "OBSERVATION", 182, 192]]], ["Cardiac hemangiosarcoma (HSA) is an important neoplasm of dogs and can arise either in the heart (primary) or via metastasis (secondary) from primary sites such as the spleen.", [["Cardiac hemangiosarcoma", "ANATOMY", 0, 23], ["HSA", "ANATOMY", 25, 28], ["neoplasm", "ANATOMY", 46, 54], ["heart", "ANATOMY", 91, 96], ["primary sites", "ANATOMY", 142, 155], ["spleen", "ANATOMY", 168, 174], ["Cardiac hemangiosarcoma", "DISEASE", 0, 23], ["Cardiac hemangiosarcoma", "CANCER", 0, 23], ["HSA", "CANCER", 25, 28], ["neoplasm", "CANCER", 46, 54], ["dogs", "ORGANISM", 58, 62], ["heart", "ORGAN", 91, 96], ["spleen", "ORGAN", 168, 174], ["dogs", "SPECIES", 58, 62], ["Cardiac hemangiosarcoma", "PROBLEM", 0, 23], ["an important neoplasm of dogs", "PROBLEM", 33, 62], ["via metastasis", "PROBLEM", 110, 124], ["primary sites", "PROBLEM", 142, 155], ["hemangiosarcoma", "OBSERVATION", 8, 23], ["important", "OBSERVATION_MODIFIER", 36, 45], ["neoplasm", "OBSERVATION", 46, 54], ["dogs", "OBSERVATION", 58, 62], ["heart", "ANATOMY", 91, 96], ["metastasis", "OBSERVATION", 114, 124], ["spleen", "ANATOMY", 168, 174]]], ["In a recent study, HSA frequently occurred in older golden retrievers, followed by Maltese dogs and miniature dachshunds.", [["HSA", "GENE_OR_GENE_PRODUCT", 19, 22], ["dogs", "SPECIES", 91, 95], ["golden retrievers", "SPECIES", 52, 69], ["a recent study", "TEST", 3, 17], ["golden retrievers", "OBSERVATION", 52, 69]]], ["Mass lesions of HSA were found more commonly in the right auricle and right atrium, and the right atrial masses were significantly larger than the right auricular masses, potentially accounting for their higher antemortem detection rate by echocardiography.", [["Mass lesions", "ANATOMY", 0, 12], ["HSA", "ANATOMY", 16, 19], ["right auricle", "ANATOMY", 52, 65], ["right atrium", "ANATOMY", 70, 82], ["right atrial masses", "ANATOMY", 92, 111], ["right auricular masses", "ANATOMY", 147, 169], ["Mass lesions", "CANCER", 0, 12], ["HSA", "GENE_OR_GENE_PRODUCT", 16, 19], ["auricle", "ORGAN", 58, 65], ["right atrium", "MULTI-TISSUE_STRUCTURE", 70, 82], ["right atrial masses", "CANCER", 92, 111], ["auricular masses", "CANCER", 153, 169], ["Mass lesions of HSA", "PROBLEM", 0, 19], ["the right atrial masses", "PROBLEM", 88, 111], ["echocardiography", "TEST", 240, 256], ["lesions", "OBSERVATION", 5, 12], ["HSA", "ANATOMY", 16, 19], ["right auricle", "ANATOMY", 52, 65], ["right atrium", "ANATOMY", 70, 82], ["right", "ANATOMY_MODIFIER", 92, 97], ["atrial", "ANATOMY", 98, 104], ["masses", "OBSERVATION", 105, 111], ["significantly", "OBSERVATION_MODIFIER", 117, 130], ["larger", "OBSERVATION_MODIFIER", 131, 137], ["right", "ANATOMY_MODIFIER", 147, 152], ["auricular", "ANATOMY", 153, 162], ["masses", "OBSERVATION", 163, 169], ["potentially accounting for", "UNCERTAINTY", 171, 197]]], ["Grossly, protruding red to red-black blood-containing masses are located on the epicardial surface ( Fig. 10-86) and may also protrude into the atrial lumen.", [["blood", "ANATOMY", 37, 42], ["masses", "ANATOMY", 54, 60], ["epicardial surface", "ANATOMY", 80, 98], ["atrial lumen", "ANATOMY", 144, 156], ["blood", "ORGANISM_SUBSTANCE", 37, 42], ["masses", "CANCER", 54, 60], ["epicardial surface", "TISSUE", 80, 98], ["atrial lumen", "MULTI-TISSUE_STRUCTURE", 144, 156], ["protruding red to red-black blood-containing masses", "PROBLEM", 9, 60], ["protruding", "OBSERVATION_MODIFIER", 9, 19], ["masses", "OBSERVATION", 54, 60], ["epicardial", "ANATOMY", 80, 90], ["surface", "ANATOMY_MODIFIER", 91, 98], ["atrial", "ANATOMY", 144, 150], ["lumen", "ANATOMY_MODIFIER", 151, 156]]], ["Rupture can produce fatal The high magnification (inset) shows these endothelial cells with large, round-to-oval nuclei forming poorly delineated and haphazardly arranged vascular channels.", [["endothelial cells", "ANATOMY", 69, 86], ["nuclei", "ANATOMY", 113, 119], ["vascular", "ANATOMY", 171, 179], ["endothelial cells", "CELL", 69, 86], ["nuclei", "CELLULAR_COMPONENT", 113, 119], ["vascular", "MULTI-TISSUE_STRUCTURE", 171, 179], ["endothelial cells", "CELL_TYPE", 69, 86], ["vascular channels", "PROTEIN", 171, 188], ["Rupture", "PROBLEM", 0, 7], ["these endothelial cells", "PROBLEM", 63, 86], ["large, round-to-oval nuclei", "PROBLEM", 92, 119], ["fatal", "OBSERVATION_MODIFIER", 20, 25], ["high", "OBSERVATION_MODIFIER", 30, 34], ["endothelial cells", "OBSERVATION", 69, 86], ["large", "OBSERVATION_MODIFIER", 92, 97], ["round", "OBSERVATION_MODIFIER", 99, 104], ["poorly delineated", "OBSERVATION_MODIFIER", 128, 145], ["vascular channels", "ANATOMY", 171, 188]]], ["These cells can also \"pile up\" and be arranged in clusters or solid sheets.", [["cells", "ANATOMY", 6, 11], ["cells", "CELL", 6, 11], ["solid sheets", "CANCER", 62, 74], ["These cells", "PROBLEM", 0, 11]]], ["Mitotic figures can be prominent and numerous (not shown here).", [["Mitotic figures", "PROBLEM", 0, 15], ["prominent", "OBSERVATION_MODIFIER", 23, 32]]], ["A golden-brown pigment (hemosiderin) can form secondary to erythrophagocytosis of damaged or effete erythrocytes (not shown here).", [["effete erythrocytes", "ANATOMY", 93, 112], ["brown pigment", "TISSUE", 9, 22], ["hemosiderin", "SIMPLE_CHEMICAL", 24, 35], ["erythrocytes", "CELL", 100, 112], ["damaged or effete erythrocytes", "CELL_TYPE", 82, 112], ["A golden-brown pigment (hemosiderin)", "PROBLEM", 0, 36], ["erythrophagocytosis", "PROBLEM", 59, 78], ["effete erythrocytes", "PROBLEM", 93, 112], ["golden", "OBSERVATION_MODIFIER", 2, 8], ["brown pigment", "OBSERVATION", 9, 22], ["erythrophagocytosis", "OBSERVATION", 59, 78], ["effete erythrocytes", "OBSERVATION", 93, 112]]], ["H&E stain.", [["H&E stain", "TEST", 0, 9]]], ["Pulmonary Artery Thromboembolism.", [["Pulmonary", "ANATOMY", 0, 9], ["Pulmonary Artery Thromboembolism", "DISEASE", 0, 32], ["Pulmonary Artery Thromboembolism", "PROBLEM", 0, 32], ["Artery", "ANATOMY", 10, 16], ["Thromboembolism", "OBSERVATION", 17, 32]]], ["Pulmonary artery thromboembolism ( Fig. 10-90) is often a life-threatening condition and in dogs has an incidence of 0.9% over a 10-year period.", [["Pulmonary artery", "ANATOMY", 0, 16], ["Pulmonary artery thromboembolism", "DISEASE", 0, 32], ["Pulmonary artery", "MULTI-TISSUE_STRUCTURE", 0, 16], ["dogs", "ORGANISM", 92, 96], ["dogs", "SPECIES", 92, 96], ["Pulmonary artery thromboembolism", "PROBLEM", 0, 32], ["Fig.", "TEST", 35, 39], ["artery", "ANATOMY", 10, 16], ["thromboembolism", "OBSERVATION", 17, 32]]], ["A wide variety of predisposing conditions may result in altered blood flow, hypercoagulability, or endothelial damage.", [["blood", "ANATOMY", 64, 69], ["endothelial", "ANATOMY", 99, 110], ["hypercoagulability", "DISEASE", 76, 94], ["endothelial damage", "DISEASE", 99, 117], ["blood", "ORGANISM_SUBSTANCE", 64, 69], ["endothelial", "TISSUE", 99, 110], ["predisposing conditions", "PROBLEM", 18, 41], ["altered blood flow", "PROBLEM", 56, 74], ["hypercoagulability", "PROBLEM", 76, 94], ["endothelial damage", "PROBLEM", 99, 117], ["wide", "OBSERVATION_MODIFIER", 2, 6], ["variety", "OBSERVATION_MODIFIER", 7, 14], ["altered", "OBSERVATION_MODIFIER", 56, 63], ["blood flow", "OBSERVATION", 64, 74], ["hypercoagulability", "OBSERVATION", 76, 94], ["endothelial damage", "OBSERVATION", 99, 117]]], ["These include sepsis, immune-mediated hemolytic anemia, neoplastic disease, proteinlosing nephropathy/amyloidosis, disseminated intravascular coagulation, cardiac disease, hyperadrenocorticism, dirofilariasis, and use of intravenous catheters.", [["neoplastic", "ANATOMY", 56, 66], ["intravascular", "ANATOMY", 128, 141], ["cardiac", "ANATOMY", 155, 162], ["intravenous", "ANATOMY", 221, 232], ["sepsis", "DISEASE", 14, 20], ["hemolytic anemia", "DISEASE", 38, 54], ["neoplastic disease", "DISEASE", 56, 74], ["nephropathy", "DISEASE", 90, 101], ["amyloidosis", "DISEASE", 102, 113], ["disseminated intravascular coagulation", "DISEASE", 115, 153], ["cardiac disease", "DISEASE", 155, 170], ["hyperadrenocorticism", "DISEASE", 172, 192], ["dirofilariasis", "DISEASE", 194, 208], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 128, 141], ["cardiac", "ORGAN", 155, 162], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 221, 232], ["sepsis", "PROBLEM", 14, 20], ["immune-mediated hemolytic anemia", "PROBLEM", 22, 54], ["neoplastic disease", "PROBLEM", 56, 74], ["proteinlosing nephropathy", "PROBLEM", 76, 101], ["amyloidosis", "PROBLEM", 102, 113], ["disseminated intravascular coagulation", "PROBLEM", 115, 153], ["cardiac disease", "PROBLEM", 155, 170], ["hyperadrenocorticism", "PROBLEM", 172, 192], ["dirofilariasis", "PROBLEM", 194, 208], ["intravenous catheters", "TREATMENT", 221, 242], ["sepsis", "OBSERVATION", 14, 20], ["hemolytic", "OBSERVATION_MODIFIER", 38, 47], ["anemia", "OBSERVATION", 48, 54], ["neoplastic disease", "OBSERVATION", 56, 74], ["nephropathy", "OBSERVATION", 90, 101], ["amyloidosis", "OBSERVATION", 102, 113], ["disseminated", "OBSERVATION_MODIFIER", 115, 127], ["intravascular coagulation", "OBSERVATION", 128, 153], ["cardiac", "ANATOMY", 155, 162], ["disease", "OBSERVATION", 163, 170], ["hyperadrenocorticism", "OBSERVATION", 172, 192], ["dirofilariasis", "OBSERVATION", 194, 208], ["intravenous catheters", "OBSERVATION", 221, 242]]], ["The thrombus in the pulmonary arteries lyses within a few hours and therefore may be absent at the time of autopsy (syn: necropsy) in approximately 15% of cases, as was indicated by one study.", [["thrombus", "ANATOMY", 4, 12], ["pulmonary arteries", "ANATOMY", 20, 38], ["thrombus", "DISEASE", 4, 12], ["thrombus", "PATHOLOGICAL_FORMATION", 4, 12], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 20, 38], ["The thrombus in the pulmonary arteries lyses", "PROBLEM", 0, 44], ["autopsy", "TEST", 107, 114], ["one study", "TEST", 182, 191], ["thrombus", "OBSERVATION", 4, 12], ["pulmonary arteries", "ANATOMY", 20, 38], ["few", "OBSERVATION_MODIFIER", 54, 57], ["may be", "UNCERTAINTY", 78, 84]]], ["Because of extensive collateral pulmonary arterial circulation, the presence of a large thrombus in the pulmonary artery or its main branches makes a clinically relevant diagnosis of pulmonary artery thromboembolism more certain, unless antemortem ancillary tests such as pulmonary angiography and ventilation/ perfusion scanning are strongly supportive of it.Neoplastic Transformationorigin.", [["collateral pulmonary arterial", "ANATOMY", 21, 50], ["thrombus", "ANATOMY", 88, 96], ["pulmonary artery", "ANATOMY", 104, 120], ["pulmonary artery", "ANATOMY", 183, 199], ["pulmonary", "ANATOMY", 272, 281], ["thrombus", "DISEASE", 88, 96], ["pulmonary artery thromboembolism", "DISEASE", 183, 215], ["collateral pulmonary arterial", "MULTI-TISSUE_STRUCTURE", 21, 50], ["thrombus", "PATHOLOGICAL_FORMATION", 88, 96], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 104, 120], ["pulmonary artery", "MULTI-TISSUE_STRUCTURE", 183, 199], ["pulmonary", "ORGAN", 272, 281], ["extensive collateral pulmonary arterial circulation", "PROBLEM", 11, 62], ["a large thrombus in the pulmonary artery", "PROBLEM", 80, 120], ["pulmonary artery thromboembolism", "PROBLEM", 183, 215], ["antemortem ancillary tests", "TEST", 237, 263], ["pulmonary angiography", "TEST", 272, 293], ["ventilation/ perfusion scanning", "TEST", 298, 329], ["Neoplastic Transformationorigin", "PROBLEM", 360, 391], ["extensive", "OBSERVATION_MODIFIER", 11, 20], ["collateral", "OBSERVATION", 21, 31], ["pulmonary arterial", "ANATOMY", 32, 50], ["large", "OBSERVATION_MODIFIER", 82, 87], ["thrombus", "OBSERVATION", 88, 96], ["pulmonary artery", "ANATOMY", 104, 120], ["main", "OBSERVATION_MODIFIER", 128, 132], ["branches", "ANATOMY_MODIFIER", 133, 141], ["pulmonary artery", "ANATOMY", 183, 199], ["thromboembolism", "OBSERVATION", 200, 215], ["pulmonary", "ANATOMY", 272, 281]]], ["Hemangiomas are benign neoplasms often found in the skin of dogs (Fig. 10-88) .", [["Hemangiomas", "ANATOMY", 0, 11], ["benign neoplasms", "ANATOMY", 16, 32], ["skin", "ANATOMY", 52, 56], ["Hemangiomas", "DISEASE", 0, 11], ["neoplasms", "DISEASE", 23, 32], ["Hemangiomas", "CANCER", 0, 11], ["benign neoplasms", "CANCER", 16, 32], ["skin", "ORGAN", 52, 56], ["dogs", "ORGANISM", 60, 64], ["dogs", "SPECIES", 60, 64], ["Hemangiomas", "PROBLEM", 0, 11], ["benign neoplasms", "PROBLEM", 16, 32], ["benign", "OBSERVATION_MODIFIER", 16, 22], ["neoplasms", "OBSERVATION", 23, 32], ["skin", "ANATOMY", 52, 56]]], ["These red, blood-filled masses are well circumscribed.Neoplastic TransformationHeart-Base Tumors.", [["blood", "ANATOMY", 11, 16], ["masses", "ANATOMY", 24, 30], ["Tumors", "ANATOMY", 90, 96], ["blood", "ORGANISM_SUBSTANCE", 11, 16], ["masses", "CANCER", 24, 30], ["Neoplastic TransformationHeart-Base Tumors", "CANCER", 54, 96], ["These red, blood-filled masses", "PROBLEM", 0, 30], ["Neoplastic TransformationHeart-Base Tumors", "PROBLEM", 54, 96], ["red", "OBSERVATION_MODIFIER", 6, 9], ["blood", "ANATOMY", 11, 16], ["filled", "OBSERVATION_MODIFIER", 17, 23], ["masses", "OBSERVATION", 24, 30], ["circumscribed", "OBSERVATION_MODIFIER", 40, 53], ["Base", "ANATOMY_MODIFIER", 85, 89], ["Tumors", "OBSERVATION", 90, 96]]], ["See the discussion on cardiac neoplasms in the section on Disorders of Dogs, Myocardium, Disturbances of Growth; on neoplastic transformation in the section on Disorders of Domestic Animals, Blood and Lymphatic Vascular Systems, Blood Vessels, Disturbances of Growth; and also see Fig. 10 -48.Cell Degeneration and DeathMedial Necrosis and Hemorrhage.", [["cardiac neoplasms", "ANATOMY", 22, 39], ["neoplastic", "ANATOMY", 116, 126], ["Blood", "ANATOMY", 191, 196], ["Vascular", "ANATOMY", 211, 219], ["Blood Vessels", "ANATOMY", 229, 242], ["Cell", "ANATOMY", 293, 297], ["cardiac neoplasms", "DISEASE", 22, 39], ["Necrosis", "DISEASE", 327, 335], ["Hemorrhage", "DISEASE", 340, 350], ["cardiac neoplasms", "CANCER", 22, 39], ["Blood", "ORGANISM_SUBSTANCE", 191, 196], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 201, 219], ["Blood Vessels", "MULTI-TISSUE_STRUCTURE", 229, 242], ["Cell", "CELL", 293, 297], ["cardiac neoplasms", "PROBLEM", 22, 39], ["Dogs", "PROBLEM", 71, 75], ["Myocardium", "PROBLEM", 77, 87], ["Disturbances of Growth", "PROBLEM", 89, 111], ["neoplastic transformation", "PROBLEM", 116, 141], ["Domestic Animals", "PROBLEM", 173, 189], ["Disturbances of Growth", "PROBLEM", 244, 266], ["Cell Degeneration", "PROBLEM", 293, 310], ["DeathMedial Necrosis", "PROBLEM", 315, 335], ["Hemorrhage", "PROBLEM", 340, 350], ["cardiac", "ANATOMY", 22, 29], ["neoplasms", "OBSERVATION", 30, 39], ["Myocardium", "ANATOMY", 77, 87], ["Growth", "OBSERVATION_MODIFIER", 105, 111], ["neoplastic transformation", "OBSERVATION", 116, 141], ["Lymphatic Vascular", "ANATOMY", 201, 219], ["Blood Vessels", "ANATOMY", 229, 242], ["Degeneration", "OBSERVATION", 298, 310], ["DeathMedial", "OBSERVATION_MODIFIER", 315, 326], ["Necrosis", "OBSERVATION", 327, 335], ["Hemorrhage", "OBSERVATION", 340, 350]]], ["Medial necrosis and hemorrhage is a distinctive lesion produced in muscular arteries and arterioles of dogs and rats by a wide variety of vasoactive drugs.", [["lesion", "ANATOMY", 48, 54], ["muscular arteries", "ANATOMY", 67, 84], ["arterioles", "ANATOMY", 89, 99], ["necrosis", "DISEASE", 7, 15], ["hemorrhage", "DISEASE", 20, 30], ["lesion", "CANCER", 48, 54], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 67, 84], ["arterioles", "MULTI-TISSUE_STRUCTURE", 89, 99], ["dogs", "ORGANISM", 103, 107], ["rats", "ORGANISM", 112, 116], ["dogs", "SPECIES", 103, 107], ["rats", "SPECIES", 112, 116], ["Medial necrosis", "PROBLEM", 0, 15], ["hemorrhage", "PROBLEM", 20, 30], ["a distinctive lesion", "PROBLEM", 34, 54], ["vasoactive drugs", "TREATMENT", 138, 154], ["necrosis", "OBSERVATION", 7, 15], ["hemorrhage", "OBSERVATION", 20, 30], ["distinctive", "OBSERVATION_MODIFIER", 36, 47], ["lesion", "OBSERVATION", 48, 54], ["muscular arteries", "ANATOMY", 67, 84], ["arterioles", "OBSERVATION_MODIFIER", 89, 99], ["vasoactive drugs", "OBSERVATION", 138, 154]]], ["These vascular lesions, detected during evaluations of new compounds, produce grossly apparent hemorrhage, especially in the epicardium.", [["vascular lesions", "ANATOMY", 6, 22], ["epicardium", "ANATOMY", 125, 135], ["vascular lesions", "DISEASE", 6, 22], ["hemorrhage", "DISEASE", 95, 105], ["vascular lesions", "PATHOLOGICAL_FORMATION", 6, 22], ["epicardium", "MULTI-TISSUE_STRUCTURE", 125, 135], ["These vascular lesions", "PROBLEM", 0, 22], ["new compounds", "PROBLEM", 55, 68], ["grossly apparent hemorrhage", "PROBLEM", 78, 105], ["vascular", "ANATOMY", 6, 14], ["lesions", "OBSERVATION", 15, 22], ["new", "OBSERVATION_MODIFIER", 55, 58], ["compounds", "OBSERVATION_MODIFIER", 59, 68], ["grossly", "OBSERVATION_MODIFIER", 78, 85], ["apparent", "OBSERVATION_MODIFIER", 86, 94], ["hemorrhage", "OBSERVATION", 95, 105], ["epicardium", "ANATOMY", 125, 135]]], ["Microscopically, acute damage is evident as necrosis of smooth muscle cells in the tunica media with surrounding erythrocytes.", [["smooth muscle cells", "ANATOMY", 56, 75], ["tunica media", "ANATOMY", 83, 95], ["erythrocytes", "ANATOMY", 113, 125], ["necrosis", "DISEASE", 44, 52], ["smooth muscle cells", "CELL", 56, 75], ["tunica", "TISSUE", 83, 89], ["erythrocytes", "CELL", 113, 125], ["smooth muscle cells", "CELL_TYPE", 56, 75], ["erythrocytes", "CELL_TYPE", 113, 125], ["acute damage", "PROBLEM", 17, 29], ["necrosis of smooth muscle cells", "PROBLEM", 44, 75], ["surrounding erythrocytes", "PROBLEM", 101, 125], ["acute", "OBSERVATION_MODIFIER", 17, 22], ["damage", "OBSERVATION", 23, 29], ["necrosis", "OBSERVATION", 44, 52], ["smooth muscle cells", "OBSERVATION", 56, 75], ["tunica media", "ANATOMY", 83, 95], ["surrounding erythrocytes", "OBSERVATION", 101, 125]]], ["Healing lesions have fibrosis of the vessel wall and perivascularly.Cell Degeneration and DeathSegmental Arterial Mediolysis.", [["lesions", "ANATOMY", 8, 15], ["vessel wall", "ANATOMY", 37, 48], ["perivascularly", "ANATOMY", 53, 67], ["Cell", "ANATOMY", 68, 72], ["Arterial", "ANATOMY", 105, 113], ["fibrosis", "DISEASE", 21, 29], ["lesions", "PATHOLOGICAL_FORMATION", 8, 15], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 37, 48], ["Cell", "CELL", 68, 72], ["Healing lesions", "PROBLEM", 0, 15], ["fibrosis of the vessel wall", "PROBLEM", 21, 48], ["Cell Degeneration", "PROBLEM", 68, 85], ["DeathSegmental Arterial Mediolysis", "PROBLEM", 90, 124], ["lesions", "OBSERVATION", 8, 15], ["fibrosis", "OBSERVATION", 21, 29], ["vessel", "ANATOMY", 37, 43], ["wall", "ANATOMY_MODIFIER", 44, 48], ["Degeneration", "OBSERVATION", 73, 85], ["DeathSegmental", "ANATOMY_MODIFIER", 90, 104], ["Arterial", "ANATOMY", 105, 113], ["Mediolysis", "OBSERVATION", 114, 124]]], ["Segmental arterial mediolysis is a distinctive lesion produced in muscular arteries and arterioles of dogs and rats that most often occurs in the splanchnic muscular and coronary arteries and causes catastrophic hemorrhages.", [["arterial", "ANATOMY", 10, 18], ["lesion", "ANATOMY", 47, 53], ["muscular arteries", "ANATOMY", 66, 83], ["arterioles", "ANATOMY", 88, 98], ["splanchnic muscular", "ANATOMY", 146, 165], ["coronary arteries", "ANATOMY", 170, 187], ["hemorrhages", "DISEASE", 212, 223], ["arterial", "MULTI-TISSUE_STRUCTURE", 10, 18], ["lesion", "CANCER", 47, 53], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 66, 83], ["arterioles", "MULTI-TISSUE_STRUCTURE", 88, 98], ["dogs", "ORGANISM", 102, 106], ["rats", "ORGANISM", 111, 115], ["splanchnic muscular", "MULTI-TISSUE_STRUCTURE", 146, 165], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 170, 187], ["dogs", "SPECIES", 102, 106], ["rats", "SPECIES", 111, 115], ["Segmental arterial mediolysis", "PROBLEM", 0, 29], ["a distinctive lesion", "PROBLEM", 33, 53], ["catastrophic hemorrhages", "PROBLEM", 199, 223], ["arterial", "ANATOMY", 10, 18], ["mediolysis", "OBSERVATION", 19, 29], ["distinctive", "OBSERVATION_MODIFIER", 35, 46], ["lesion", "OBSERVATION", 47, 53], ["muscular arteries", "ANATOMY", 66, 83], ["arterioles", "OBSERVATION_MODIFIER", 88, 98], ["dogs", "OBSERVATION", 102, 106], ["splanchnic muscular", "ANATOMY", 146, 165], ["coronary arteries", "ANATOMY", 170, 187], ["catastrophic", "OBSERVATION_MODIFIER", 199, 211], ["hemorrhages", "OBSERVATION", 212, 223]]], ["The pathology can be induced experimentally by administration of ractopamine, a synthetic \u03b2 2 -adrenoceptor agonist to dogs.", [["ractopamine", "CHEMICAL", 65, 76], ["ractopamine", "CHEMICAL", 65, 76], ["ractopamine", "SIMPLE_CHEMICAL", 65, 76], ["\u03b2 2 -adrenoceptor", "GENE_OR_GENE_PRODUCT", 90, 107], ["dogs", "ORGANISM", 119, 123], ["dogs", "SPECIES", 119, 123], ["ractopamine", "TREATMENT", 65, 76], ["a synthetic \u03b2", "TREATMENT", 78, 91], ["adrenoceptor agonist", "TREATMENT", 95, 115]]], ["Exposure to \u03b1 1 -adrenergic receptor agonists or \u03b2 2 agonists induces the release of norepinephrine from the peripheral nervous system.", [["peripheral nervous system", "ANATOMY", 109, 134], ["norepinephrine", "CHEMICAL", 85, 99], ["norepinephrine", "CHEMICAL", 85, 99], ["\u03b1 1 -adrenergic receptor", "GENE_OR_GENE_PRODUCT", 12, 36], ["\u03b2 2 agonists", "GENE_OR_GENE_PRODUCT", 49, 61], ["norepinephrine", "SIMPLE_CHEMICAL", 85, 99], ["peripheral nervous system", "ANATOMICAL_SYSTEM", 109, 134], ["\u03b1 1 -adrenergic receptor agonists", "TREATMENT", 12, 45], ["\u03b2 2 agonists", "TREATMENT", 49, 61], ["norepinephrine", "TREATMENT", 85, 99], ["peripheral", "ANATOMY_MODIFIER", 109, 119], ["nervous system", "ANATOMY", 120, 134]]], ["Epinephrine is thought to induce injury at the adventitial medial junction through medial muscle apoptosis.", [["adventitial medial junction", "ANATOMY", 47, 74], ["medial muscle", "ANATOMY", 83, 96], ["Epinephrine", "CHEMICAL", 0, 11], ["Epinephrine", "CHEMICAL", 0, 11], ["Epinephrine", "SIMPLE_CHEMICAL", 0, 11], ["adventitial medial junction", "TISSUE", 47, 74], ["medial muscle", "TISSUE", 83, 96], ["Epinephrine", "TREATMENT", 0, 11], ["injury", "PROBLEM", 33, 39], ["medial muscle apoptosis", "PROBLEM", 83, 106], ["thought to induce", "UNCERTAINTY", 15, 32], ["injury", "OBSERVATION", 33, 39], ["adventitial", "ANATOMY_MODIFIER", 47, 58], ["medial", "ANATOMY_MODIFIER", 59, 65], ["junction", "ANATOMY_MODIFIER", 66, 74], ["medial", "ANATOMY_MODIFIER", 83, 89], ["muscle", "ANATOMY", 90, 96], ["apoptosis", "OBSERVATION", 97, 106]]], ["Microscopically, acute damage is evident as necrosis of smooth muscle cells in the tunica media with surrounding erythrocytes.", [["smooth muscle cells", "ANATOMY", 56, 75], ["tunica media", "ANATOMY", 83, 95], ["erythrocytes", "ANATOMY", 113, 125], ["necrosis", "DISEASE", 44, 52], ["smooth muscle cells", "CELL", 56, 75], ["tunica", "TISSUE", 83, 89], ["erythrocytes", "CELL", 113, 125], ["smooth muscle cells", "CELL_TYPE", 56, 75], ["erythrocytes", "CELL_TYPE", 113, 125], ["acute damage", "PROBLEM", 17, 29], ["necrosis of smooth muscle cells", "PROBLEM", 44, 75], ["surrounding erythrocytes", "PROBLEM", 101, 125], ["acute", "OBSERVATION_MODIFIER", 17, 22], ["damage", "OBSERVATION", 23, 29], ["necrosis", "OBSERVATION", 44, 52], ["smooth muscle cells", "OBSERVATION", 56, 75], ["tunica media", "ANATOMY", 83, 95], ["surrounding erythrocytes", "OBSERVATION", 101, 125]]], ["Healing lesions have fibrosis of the vessel wall and perivascularly.Cell Degeneration and DeathFibrocartilaginous Embolism.", [["lesions", "ANATOMY", 8, 15], ["vessel wall", "ANATOMY", 37, 48], ["perivascularly", "ANATOMY", 53, 67], ["Cell", "ANATOMY", 68, 72], ["fibrosis", "DISEASE", 21, 29], ["lesions", "PATHOLOGICAL_FORMATION", 8, 15], ["vessel wall", "MULTI-TISSUE_STRUCTURE", 37, 48], ["Cell", "CELL", 68, 72], ["Healing lesions", "PROBLEM", 0, 15], ["fibrosis of the vessel wall", "PROBLEM", 21, 48], ["Cell Degeneration", "PROBLEM", 68, 85], ["DeathFibrocartilaginous Embolism", "PROBLEM", 90, 122], ["lesions", "OBSERVATION", 8, 15], ["fibrosis", "OBSERVATION", 21, 29], ["vessel", "ANATOMY", 37, 43], ["wall", "ANATOMY_MODIFIER", 44, 48], ["DeathFibrocartilaginous Embolism", "OBSERVATION", 90, 122]]], ["Fibrocartilaginous embolism of the spinal cord vasculature and resultant infarction of the spinal cord supplied or drained by the obstructed blood vessel lead to posterior paresis or paralysis.", [["spinal cord vasculature", "ANATOMY", 35, 58], ["spinal cord", "ANATOMY", 91, 102], ["blood vessel", "ANATOMY", 141, 153], ["embolism", "DISEASE", 19, 27], ["infarction", "DISEASE", 73, 83], ["paresis", "DISEASE", 172, 179], ["paralysis", "DISEASE", 183, 192], ["spinal cord vasculature", "MULTI-TISSUE_STRUCTURE", 35, 58], ["spinal cord", "ORGAN", 91, 102], ["blood vessel", "MULTI-TISSUE_STRUCTURE", 141, 153], ["Fibrocartilaginous embolism of the spinal cord vasculature", "PROBLEM", 0, 58], ["resultant infarction of the spinal cord", "PROBLEM", 63, 102], ["the obstructed blood vessel", "PROBLEM", 126, 153], ["posterior paresis", "PROBLEM", 162, 179], ["paralysis", "PROBLEM", 183, 192], ["embolism", "OBSERVATION", 19, 27], ["spinal cord", "ANATOMY", 35, 46], ["resultant", "OBSERVATION_MODIFIER", 63, 72], ["infarction", "OBSERVATION", 73, 83], ["spinal cord", "ANATOMY", 91, 102], ["drained", "OBSERVATION", 115, 122], ["obstructed", "OBSERVATION", 130, 140], ["blood vessel", "ANATOMY", 141, 153], ["posterior", "ANATOMY_MODIFIER", 162, 171], ["paresis", "OBSERVATION", 172, 179], ["paralysis", "OBSERVATION", 183, 192]]], ["Affected dogs are typically middle-aged large or giant breeds, but occurrence in young Irish wolfhounds has been reported.", [["dogs", "ORGANISM", 9, 13], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["giant breeds", "OBSERVATION", 49, 61]]], ["The mechanism of formation of the arterial or venous emboli is still unclear, but movement within the spinal vasculature of fibrocartilaginous fragments from degenerated intervertebral disks is generally considered to underlie the presence of these unusual emboli ( Fig. 10- Fig. 10-92) , and as the numbers increase, they are present in the right ventricle, then in the right atrium, and finally may occupy the vena cavae.", [["arterial", "ANATOMY", 34, 42], ["venous emboli", "ANATOMY", 46, 59], ["spinal vasculature", "ANATOMY", 102, 120], ["fibrocartilaginous fragments", "ANATOMY", 124, 152], ["intervertebral disks", "ANATOMY", 170, 190], ["right ventricle", "ANATOMY", 342, 357], ["right atrium", "ANATOMY", 371, 383], ["vena cavae", "ANATOMY", 412, 422], ["venous emboli", "DISEASE", 46, 59], ["arterial", "MULTI-TISSUE_STRUCTURE", 34, 42], ["venous emboli", "MULTI-TISSUE_STRUCTURE", 46, 59], ["spinal vasculature", "MULTI-TISSUE_STRUCTURE", 102, 120], ["intervertebral disks", "MULTI-TISSUE_STRUCTURE", 170, 190], ["right ventricle", "MULTI-TISSUE_STRUCTURE", 342, 357], ["atrium", "MULTI-TISSUE_STRUCTURE", 377, 383], ["vena cavae", "MULTI-TISSUE_STRUCTURE", 412, 422], ["the arterial or venous emboli", "PROBLEM", 30, 59], ["fibrocartilaginous fragments", "PROBLEM", 124, 152], ["degenerated intervertebral disks", "PROBLEM", 158, 190], ["these unusual emboli", "PROBLEM", 243, 263], ["arterial", "ANATOMY", 34, 42], ["venous", "ANATOMY", 46, 52], ["emboli", "OBSERVATION", 53, 59], ["movement", "OBSERVATION_MODIFIER", 82, 90], ["spinal", "ANATOMY_MODIFIER", 102, 108], ["vasculature", "ANATOMY", 109, 120], ["fibrocartilaginous fragments", "OBSERVATION", 124, 152], ["degenerated", "OBSERVATION_MODIFIER", 158, 169], ["intervertebral disks", "OBSERVATION", 170, 190], ["unusual", "OBSERVATION_MODIFIER", 249, 256], ["emboli", "OBSERVATION", 257, 263], ["numbers", "OBSERVATION_MODIFIER", 300, 307], ["increase", "OBSERVATION_MODIFIER", 308, 316], ["right ventricle", "ANATOMY", 342, 357], ["right atrium", "ANATOMY", 371, 383], ["vena cavae", "ANATOMY", 412, 422]]], ["Pulmonary hypertension results from vascular blockage and pulmonary vascular lesions produced by the parasites, and right ventricular hypertrophy follows.", [["Pulmonary", "ANATOMY", 0, 9], ["vascular", "ANATOMY", 36, 44], ["pulmonary vascular lesions", "ANATOMY", 58, 84], ["right ventricular", "ANATOMY", 116, 133], ["Pulmonary hypertension", "DISEASE", 0, 22], ["ventricular hypertrophy", "DISEASE", 122, 145], ["Pulmonary", "ORGAN", 0, 9], ["vascular", "MULTI-TISSUE_STRUCTURE", 36, 44], ["pulmonary vascular lesions", "PATHOLOGICAL_FORMATION", 58, 84], ["ventricular", "MULTI-TISSUE_STRUCTURE", 122, 133], ["Pulmonary hypertension", "PROBLEM", 0, 22], ["vascular blockage", "PROBLEM", 36, 53], ["pulmonary vascular lesions", "PROBLEM", 58, 84], ["the parasites", "PROBLEM", 97, 110], ["right ventricular hypertrophy", "PROBLEM", 116, 145], ["hypertension", "OBSERVATION", 10, 22], ["vascular", "ANATOMY", 36, 44], ["blockage", "OBSERVATION", 45, 53], ["pulmonary", "ANATOMY_MODIFIER", 58, 67], ["vascular", "ANATOMY", 68, 76], ["lesions", "OBSERVATION", 77, 84], ["parasites", "OBSERVATION", 101, 110], ["right ventricular", "ANATOMY", 116, 133], ["hypertrophy", "OBSERVATION", 134, 145]]], ["Right-sided heart failure may eventually develop.", [["heart", "ANATOMY", 12, 17], ["heart failure", "DISEASE", 12, 25], ["heart", "ORGAN", 12, 17], ["Right-sided heart failure", "PROBLEM", 0, 25], ["sided", "ANATOMY_MODIFIER", 6, 11], ["heart", "ANATOMY", 12, 17], ["failure", "OBSERVATION", 18, 25]]], ["The pulmonary arteries containing parasites initially have an infiltration of the intima (termed endarteritis) by eosinophils, with subsequent development of an irregular fibromuscular proliferation of the intima visible grossly as a rough granular or shaggy appearance of the luminal surface (see Fig. 10 -92; E-Figs.", [["pulmonary arteries", "ANATOMY", 4, 22], ["intima", "ANATOMY", 82, 88], ["endarteritis", "ANATOMY", 97, 109], ["eosinophils", "ANATOMY", 114, 125], ["fibromuscular", "ANATOMY", 171, 184], ["intima", "ANATOMY", 206, 212], ["luminal surface", "ANATOMY", 277, 292], ["endarteritis", "DISEASE", 97, 109], ["luminal", "CHEMICAL", 277, 284], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 4, 22], ["intima", "TISSUE", 82, 88], ["eosinophils", "CELL", 114, 125], ["fibromuscular", "PATHOLOGICAL_FORMATION", 171, 184], ["intima", "TISSUE", 206, 212], ["luminal surface", "CELLULAR_COMPONENT", 277, 292], ["eosinophils", "CELL_TYPE", 114, 125], ["parasites", "PROBLEM", 34, 43], ["an infiltration", "PROBLEM", 59, 74], ["the intima (termed endarteritis", "PROBLEM", 78, 109], ["eosinophils", "TEST", 114, 125], ["an irregular fibromuscular proliferation", "PROBLEM", 158, 198], ["a rough granular or shaggy appearance of the luminal surface", "PROBLEM", 232, 292], ["pulmonary arteries", "ANATOMY", 4, 22], ["parasites", "OBSERVATION", 34, 43], ["infiltration", "OBSERVATION", 62, 74], ["intima", "ANATOMY", 82, 88], ["endarteritis", "OBSERVATION", 97, 109], ["eosinophils", "OBSERVATION", 114, 125], ["irregular", "OBSERVATION_MODIFIER", 161, 170], ["fibromuscular", "OBSERVATION_MODIFIER", 171, 184], ["proliferation", "OBSERVATION", 185, 198], ["intima", "ANATOMY", 206, 212], ["visible", "OBSERVATION_MODIFIER", 213, 220], ["grossly", "OBSERVATION_MODIFIER", 221, 228], ["rough", "OBSERVATION_MODIFIER", 234, 239], ["granular", "OBSERVATION_MODIFIER", 240, 248], ["shaggy", "OBSERVATION_MODIFIER", 252, 258], ["luminal", "ANATOMY_MODIFIER", 277, 284], ["surface", "ANATOMY_MODIFIER", 285, 292]]], ["Live or dead parasites can be present within these vascular lesions and be accompanied by thromboembolism and pulmonary infarction.", [["vascular lesions", "ANATOMY", 51, 67], ["pulmonary", "ANATOMY", 110, 119], ["thromboembolism", "DISEASE", 90, 105], ["pulmonary infarction", "DISEASE", 110, 130], ["vascular lesions", "PATHOLOGICAL_FORMATION", 51, 67], ["pulmonary", "ORGAN", 110, 119], ["dead parasites", "PROBLEM", 8, 22], ["these vascular lesions", "PROBLEM", 45, 67], ["thromboembolism", "PROBLEM", 90, 105], ["pulmonary infarction", "PROBLEM", 110, 130], ["parasites", "OBSERVATION", 13, 22], ["vascular", "ANATOMY", 51, 59], ["lesions", "OBSERVATION", 60, 67], ["thromboembolism", "OBSERVATION", 90, 105], ["pulmonary", "ANATOMY", 110, 119], ["infarction", "OBSERVATION", 120, 130]]], ["The pleura of the caudal lung lobes may contain multifocal areas of hemorrhage, hemosiderosis, and fibrosis.", [["pleura", "ANATOMY", 4, 10], ["caudal lung lobes", "ANATOMY", 18, 35], ["hemorrhage", "DISEASE", 68, 78], ["hemosiderosis", "DISEASE", 80, 93], ["fibrosis", "DISEASE", 99, 107], ["pleura", "ORGAN", 4, 10], ["caudal lung lobes", "MULTI-TISSUE_STRUCTURE", 18, 35], ["hemorrhage", "PROBLEM", 68, 78], ["hemosiderosis", "PROBLEM", 80, 93], ["fibrosis", "PROBLEM", 99, 107], ["pleura", "ANATOMY", 4, 10], ["caudal", "ANATOMY_MODIFIER", 18, 24], ["lung", "ANATOMY", 25, 29], ["lobes", "ANATOMY_MODIFIER", 30, 35], ["multifocal", "OBSERVATION_MODIFIER", 48, 58], ["hemorrhage", "OBSERVATION", 68, 78], ["hemosiderosis", "OBSERVATION", 80, 93], ["fibrosis", "OBSERVATION", 99, 107]]], ["The presence of a massive number of adult worms may result in filling the right heart extending into venae cavae, resulting in venal caval syndrome.", [["right heart", "ANATOMY", 74, 85], ["venae cavae", "ANATOMY", 101, 112], ["venal caval", "ANATOMY", 127, 138], ["venal caval syndrome", "DISEASE", 127, 147], ["heart", "ORGAN", 80, 85], ["venae cavae", "ORGANISM", 101, 112], ["venal caval", "MULTI-TISSUE_STRUCTURE", 127, 138], ["worms", "SPECIES", 42, 47], ["venae cavae", "SPECIES", 101, 112], ["a massive number of adult worms", "PROBLEM", 16, 47], ["venal caval syndrome", "PROBLEM", 127, 147], ["massive", "OBSERVATION_MODIFIER", 18, 25], ["number", "OBSERVATION_MODIFIER", 26, 32], ["adult worms", "OBSERVATION", 36, 47], ["right", "ANATOMY_MODIFIER", 74, 79], ["heart", "ANATOMY", 80, 85], ["venae cavae", "ANATOMY", 101, 112], ["venal caval syndrome", "OBSERVATION", 127, 147]]], ["This syndrome results in sudden collapse, liver failure, intravascular hemolytic anemia, shock, and death if the adult worms are not removed surgically.Cell Degeneration and DeathPolyarteritis: \"Beagle Pain Syndrome. \"", [["liver", "ANATOMY", 42, 47], ["intravascular", "ANATOMY", 57, 70], ["Cell", "ANATOMY", 152, 156], ["sudden collapse", "DISEASE", 25, 40], ["liver failure", "DISEASE", 42, 55], ["intravascular hemolytic anemia", "DISEASE", 57, 87], ["shock", "DISEASE", 89, 94], ["death", "DISEASE", 100, 105], ["DeathPolyarteritis", "DISEASE", 174, 192], ["Pain", "DISEASE", 202, 206], ["liver", "ORGAN", 42, 47], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 57, 70], ["Cell", "CELL", 152, 156], ["worms", "SPECIES", 119, 124], ["This syndrome", "PROBLEM", 0, 13], ["sudden collapse", "PROBLEM", 25, 40], ["liver failure", "PROBLEM", 42, 55], ["intravascular hemolytic anemia", "PROBLEM", 57, 87], ["shock", "PROBLEM", 89, 94], ["death", "PROBLEM", 100, 105], ["the adult worms", "PROBLEM", 109, 124], ["Cell Degeneration", "PROBLEM", 152, 169], ["DeathPolyarteritis", "PROBLEM", 174, 192], ["Beagle Pain Syndrome", "PROBLEM", 195, 215], ["sudden", "OBSERVATION_MODIFIER", 25, 31], ["collapse", "OBSERVATION", 32, 40], ["liver", "ANATOMY", 42, 47], ["failure", "OBSERVATION", 48, 55], ["intravascular", "OBSERVATION_MODIFIER", 57, 70], ["hemolytic", "OBSERVATION_MODIFIER", 71, 80], ["shock", "OBSERVATION", 89, 94], ["Degeneration", "OBSERVATION", 157, 169], ["Pain Syndrome", "OBSERVATION", 202, 215]]], ["Polyarteritis is a disease that occurs sporadically in many animal species and is an important disease of aged rats called polyarteritis nodosa (E- Fig. 10-32 ).", [["Polyarteritis", "DISEASE", 0, 13], ["polyarteritis nodosa", "DISEASE", 123, 143], ["rats", "ORGANISM", 111, 115], ["rats", "SPECIES", 111, 115], ["Polyarteritis", "PROBLEM", 0, 13], ["a disease", "PROBLEM", 17, 26], ["polyarteritis nodosa", "PROBLEM", 123, 143], ["disease", "OBSERVATION", 19, 26], ["polyarteritis", "OBSERVATION", 123, 136]]], ["Many recent reports have described the occurrence of polyarteritis in a disease termed idiopathic necrotizing polyarteritis (idiopathic canine polyarteritis, juvenile polyarteritis syndrome) involving multiple arteries, including the coronary and meningeal arteries in dogs, most often pet and laboratory beagle dogs (\"beagle pain syndrome\").", [["arteries", "ANATOMY", 210, 218], ["coronary", "ANATOMY", 234, 242], ["meningeal arteries", "ANATOMY", 247, 265], ["polyarteritis", "DISEASE", 53, 66], ["idiopathic necrotizing polyarteritis", "DISEASE", 87, 123], ["idiopathic canine polyarteritis", "DISEASE", 125, 156], ["juvenile polyarteritis syndrome", "DISEASE", 158, 189], ["pain", "DISEASE", 326, 330], ["arteries", "MULTI-TISSUE_STRUCTURE", 210, 218], ["coronary", "MULTI-TISSUE_STRUCTURE", 234, 242], ["meningeal arteries", "MULTI-TISSUE_STRUCTURE", 247, 265], ["dogs", "ORGANISM", 269, 273], ["beagle", "ORGANISM_SUBDIVISION", 319, 325], ["dogs", "SPECIES", 269, 273], ["dogs", "SPECIES", 312, 316], ["polyarteritis", "PROBLEM", 53, 66], ["a disease termed idiopathic necrotizing polyarteritis", "PROBLEM", 70, 123], ["idiopathic canine polyarteritis", "PROBLEM", 125, 156], ["juvenile polyarteritis syndrome", "PROBLEM", 158, 189], ["multiple arteries", "PROBLEM", 201, 218], ["the coronary and meningeal arteries in dogs", "PROBLEM", 230, 273], ["laboratory beagle dogs", "PROBLEM", 294, 316], ["beagle pain syndrome", "PROBLEM", 319, 339], ["polyarteritis", "OBSERVATION", 53, 66], ["idiopathic", "OBSERVATION_MODIFIER", 87, 97], ["necrotizing", "OBSERVATION_MODIFIER", 98, 109], ["polyarteritis", "OBSERVATION", 110, 123], ["idiopathic", "OBSERVATION_MODIFIER", 125, 135], ["canine polyarteritis", "OBSERVATION", 136, 156], ["juvenile", "OBSERVATION_MODIFIER", 158, 166], ["polyarteritis syndrome", "OBSERVATION", 167, 189], ["multiple arteries", "ANATOMY", 201, 218], ["coronary", "ANATOMY", 234, 242], ["meningeal arteries", "ANATOMY", 247, 265], ["beagle dogs", "OBSERVATION", 305, 316]]], ["Clinically, affected dogs typically show recurrent episodes of fever, body weight loss, and occasionally cervical pain manifested by a stilted gait and stiff neck with a hunched body posture.", [["body", "ANATOMY", 70, 74], ["cervical", "ANATOMY", 105, 113], ["neck", "ANATOMY", 158, 162], ["body", "ANATOMY", 178, 182], ["fever", "DISEASE", 63, 68], ["weight loss", "DISEASE", 75, 86], ["cervical pain", "DISEASE", 105, 118], ["dogs", "ORGANISM", 21, 25], ["body", "ORGANISM_SUBDIVISION", 70, 74], ["cervical", "ORGANISM_SUBDIVISION", 105, 113], ["neck", "ORGANISM_SUBDIVISION", 158, 162], ["body", "ORGANISM_SUBDIVISION", 178, 182], ["dogs", "SPECIES", 21, 25], ["affected dogs", "PROBLEM", 12, 25], ["fever", "PROBLEM", 63, 68], ["body weight loss", "PROBLEM", 70, 86], ["occasionally cervical pain", "PROBLEM", 92, 118], ["a stilted gait", "PROBLEM", 133, 147], ["stiff neck", "PROBLEM", 152, 162], ["a hunched body posture", "PROBLEM", 168, 190], ["recurrent", "OBSERVATION_MODIFIER", 41, 50], ["fever", "OBSERVATION", 63, 68], ["cervical", "ANATOMY", 105, 113], ["pain", "OBSERVATION", 114, 118], ["neck", "ANATOMY", 158, 162]]], ["However, some affected dogs do not display clinical signs of disease.", [["dogs", "ORGANISM", 23, 27], ["dogs", "SPECIES", 23, 27], ["some affected dogs", "PROBLEM", 9, 27], ["disease", "PROBLEM", 61, 68], ["disease", "OBSERVATION", 61, 68]]], ["The lesions are usually attributed to an immune-mediated vascular injury.", [["lesions", "ANATOMY", 4, 11], ["vascular", "ANATOMY", 57, 65], ["vascular injury", "DISEASE", 57, 72], ["lesions", "PATHOLOGICAL_FORMATION", 4, 11], ["vascular", "MULTI-TISSUE_STRUCTURE", 57, 65], ["The lesions", "PROBLEM", 0, 11], ["an immune-mediated vascular injury", "PROBLEM", 38, 72], ["lesions", "OBSERVATION", 4, 11], ["usually attributed to", "UNCERTAINTY", 16, 37], ["immune", "OBSERVATION", 41, 47], ["vascular", "ANATOMY", 57, 65], ["injury", "OBSERVATION", 66, 72]]], ["Small and medium-sized muscular arteries in a wide variety of organs, including the heart, meninges, epididymis, and thymus, are selectively involved and grossly appear thick and tortuous, have associated focal hemorrhage, and develop aneurysms and thrombosis.", [["muscular arteries", "ANATOMY", 23, 40], ["organs", "ANATOMY", 62, 68], ["heart", "ANATOMY", 84, 89], ["meninges", "ANATOMY", 91, 99], ["epididymis", "ANATOMY", 101, 111], ["thymus", "ANATOMY", 117, 123], ["hemorrhage", "DISEASE", 211, 221], ["aneurysms", "DISEASE", 235, 244], ["thrombosis", "DISEASE", 249, 259], ["muscular arteries", "MULTI-TISSUE_STRUCTURE", 23, 40], ["organs", "ORGAN", 62, 68], ["heart", "ORGAN", 84, 89], ["meninges", "MULTI-TISSUE_STRUCTURE", 91, 99], ["epididymis", "ORGAN", 101, 111], ["thymus", "ORGAN", 117, 123], ["Small and medium-sized muscular arteries", "PROBLEM", 0, 40], ["thick and tortuous", "PROBLEM", 169, 187], ["focal hemorrhage", "PROBLEM", 205, 221], ["aneurysms", "PROBLEM", 235, 244], ["thrombosis", "PROBLEM", 249, 259], ["medium", "OBSERVATION_MODIFIER", 10, 16], ["sized", "OBSERVATION_MODIFIER", 17, 22], ["muscular arteries", "ANATOMY", 23, 40], ["wide", "OBSERVATION_MODIFIER", 46, 50], ["variety", "OBSERVATION_MODIFIER", 51, 58], ["organs", "ANATOMY", 62, 68], ["heart", "ANATOMY", 84, 89], ["meninges", "ANATOMY", 91, 99], ["epididymis", "ANATOMY", 101, 111], ["thymus", "ANATOMY", 117, 123], ["grossly", "OBSERVATION_MODIFIER", 154, 161], ["thick", "OBSERVATION_MODIFIER", 169, 174], ["tortuous", "OBSERVATION_MODIFIER", 179, 187], ["focal", "OBSERVATION_MODIFIER", 205, 210], ["hemorrhage", "OBSERVATION", 211, 221], ["aneurysms", "OBSERVATION", 235, 244], ["thrombosis", "OBSERVATION", 249, 259]]], ["Microscopically, the early lesions include fibrinoid necrosis and Arterial Thromboembolism and Thrombosis.", [["early lesions", "ANATOMY", 21, 34], ["fibrinoid", "ANATOMY", 43, 52], ["Arterial", "ANATOMY", 66, 74], ["necrosis", "DISEASE", 53, 61], ["Arterial Thromboembolism", "DISEASE", 66, 90], ["Thrombosis", "DISEASE", 95, 105], ["lesions", "PATHOLOGICAL_FORMATION", 27, 34], ["Arterial", "MULTI-TISSUE_STRUCTURE", 66, 74], ["the early lesions", "PROBLEM", 17, 34], ["fibrinoid necrosis", "PROBLEM", 43, 61], ["Arterial Thromboembolism", "PROBLEM", 66, 90], ["Thrombosis", "PROBLEM", 95, 105], ["early", "OBSERVATION_MODIFIER", 21, 26], ["lesions", "OBSERVATION", 27, 34], ["fibrinoid", "OBSERVATION_MODIFIER", 43, 52], ["necrosis", "OBSERVATION", 53, 61], ["Arterial", "ANATOMY", 66, 74], ["Thromboembolism", "OBSERVATION", 75, 90], ["Thrombosis", "OBSERVATION", 95, 105]]], ["Arterial thromboembolism and thrombosis occur in dogs and arise from injury to vascular endothelium, propagated via the coagulation cascade (see Chapter 2).", [["Arterial", "ANATOMY", 0, 8], ["vascular endothelium", "ANATOMY", 79, 99], ["Arterial thromboembolism", "DISEASE", 0, 24], ["thrombosis", "DISEASE", 29, 39], ["Arterial", "MULTI-TISSUE_STRUCTURE", 0, 8], ["dogs", "ORGANISM", 49, 53], ["vascular endothelium", "TISSUE", 79, 99], ["dogs", "SPECIES", 49, 53], ["Arterial thromboembolism", "PROBLEM", 0, 24], ["thrombosis", "PROBLEM", 29, 39], ["dogs", "PROBLEM", 49, 53], ["injury", "PROBLEM", 69, 75], ["the coagulation cascade", "TREATMENT", 116, 139], ["thromboembolism", "OBSERVATION", 9, 24], ["thrombosis", "OBSERVATION", 29, 39], ["injury", "OBSERVATION", 69, 75], ["vascular endothelium", "ANATOMY", 79, 99]]], ["In dogs, the most common site is the aortoiliac trifurcation ( Fig. 10-91 ), in which a thromboembolus extends from the caudal aorta distally to the external and internal iliac arteries.", [["site", "ANATOMY", 25, 29], ["aortoiliac", "ANATOMY", 37, 47], ["caudal aorta", "ANATOMY", 120, 132], ["internal iliac arteries", "ANATOMY", 162, 185], ["aortoiliac trifurcation", "DISEASE", 37, 60], ["thromboembolus", "DISEASE", 88, 102], ["dogs", "ORGANISM", 3, 7], ["thromboembolus", "CANCER", 88, 102], ["caudal aorta", "MULTI-TISSUE_STRUCTURE", 120, 132], ["iliac arteries", "MULTI-TISSUE_STRUCTURE", 171, 185], ["dogs", "SPECIES", 3, 7], ["a thromboembolus", "PROBLEM", 86, 102], ["dogs", "OBSERVATION", 3, 7], ["aortoiliac", "ANATOMY", 37, 47], ["trifurcation", "ANATOMY_MODIFIER", 48, 60], ["thromboembolus", "OBSERVATION", 88, 102], ["caudal", "ANATOMY_MODIFIER", 120, 126], ["aorta", "ANATOMY", 127, 132], ["distally", "ANATOMY_MODIFIER", 133, 141], ["external", "ANATOMY_MODIFIER", 149, 157], ["internal iliac arteries", "ANATOMY", 162, 185]]], ["Embolization of the subclavian and brachial arteries also results in lameness of the forelimb, albeit less commonly.", [["subclavian", "ANATOMY", 20, 30], ["brachial arteries", "ANATOMY", 35, 52], ["forelimb", "ANATOMY", 85, 93], ["lameness of the forelimb", "DISEASE", 69, 93], ["subclavian", "MULTI-TISSUE_STRUCTURE", 20, 30], ["brachial arteries", "MULTI-TISSUE_STRUCTURE", 35, 52], ["forelimb", "ORGANISM_SUBDIVISION", 85, 93], ["Embolization of the subclavian and brachial arteries", "TREATMENT", 0, 52], ["lameness of the forelimb", "PROBLEM", 69, 93], ["subclavian", "ANATOMY", 20, 30], ["brachial arteries", "ANATOMY", 35, 52], ["lameness", "OBSERVATION", 69, 77], ["forelimb", "ANATOMY_MODIFIER", 85, 93], ["less", "OBSERVATION_MODIFIER", 102, 106]]], ["Other sites include embolization of the coronary arteries in the heart, renal arteries, and intestinal arteries.", [["sites", "ANATOMY", 6, 11], ["coronary arteries", "ANATOMY", 40, 57], ["heart", "ANATOMY", 65, 70], ["renal arteries", "ANATOMY", 72, 86], ["intestinal arteries", "ANATOMY", 92, 111], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 40, 57], ["heart", "ORGAN", 65, 70], ["renal arteries", "MULTI-TISSUE_STRUCTURE", 72, 86], ["intestinal arteries", "MULTI-TISSUE_STRUCTURE", 92, 111], ["embolization", "TREATMENT", 20, 32], ["embolization", "OBSERVATION", 20, 32], ["coronary arteries", "ANATOMY", 40, 57], ["heart", "ANATOMY", 65, 70], ["renal arteries", "ANATOMY", 72, 86], ["intestinal arteries", "ANATOMY", 92, 111]]], ["Aortoiliac thromboembolism in dogs has been reported with infection by Spirocerca lupi and Blastomyces dermatitides and in association with various disease conditions, such as proteinlosing nephropathy, hypothyroidism, hypercortisolism, diabetes mellitus, and aortic neoplasia.Cell Degeneration and DeathThrombosis of the Femoral Artery.", [["Aortoiliac", "ANATOMY", 0, 10], ["aortic neoplasia", "ANATOMY", 260, 276], ["Cell", "ANATOMY", 277, 281], ["Femoral Artery", "ANATOMY", 322, 336], ["Aortoiliac thromboembolism", "DISEASE", 0, 26], ["infection", "DISEASE", 58, 67], ["nephropathy", "DISEASE", 190, 201], ["hypothyroidism", "DISEASE", 203, 217], ["hypercortisolism", "DISEASE", 219, 235], ["diabetes mellitus", "DISEASE", 237, 254], ["aortic neoplasia", "DISEASE", 260, 276], ["dogs", "ORGANISM", 30, 34], ["Spirocerca lupi", "ORGANISM", 71, 86], ["Blastomyces dermatitides", "ORGANISM", 91, 115], ["aortic neoplasia", "CANCER", 260, 276], ["Cell", "CELL", 277, 281], ["Femoral Artery", "MULTI-TISSUE_STRUCTURE", 322, 336], ["dogs", "SPECIES", 30, 34], ["Spirocerca lupi", "SPECIES", 71, 86], ["Blastomyces dermatitides", "SPECIES", 91, 115], ["Spirocerca lupi", "SPECIES", 71, 86], ["Blastomyces dermatitides", "SPECIES", 91, 115], ["Aortoiliac thromboembolism in dogs", "PROBLEM", 0, 34], ["infection", "PROBLEM", 58, 67], ["Spirocerca lupi", "TREATMENT", 71, 86], ["Blastomyces dermatitides", "PROBLEM", 91, 115], ["various disease conditions", "PROBLEM", 140, 166], ["proteinlosing nephropathy", "PROBLEM", 176, 201], ["hypothyroidism", "PROBLEM", 203, 217], ["hypercortisolism", "PROBLEM", 219, 235], ["diabetes mellitus", "PROBLEM", 237, 254], ["aortic neoplasia", "PROBLEM", 260, 276], ["Cell Degeneration", "PROBLEM", 277, 294], ["DeathThrombosis of the Femoral Artery", "PROBLEM", 299, 336], ["thromboembolism", "OBSERVATION", 11, 26], ["dogs", "OBSERVATION", 30, 34], ["infection", "OBSERVATION", 58, 67], ["Blastomyces", "OBSERVATION", 91, 102], ["disease", "OBSERVATION", 148, 155], ["nephropathy", "OBSERVATION", 190, 201], ["hypothyroidism", "OBSERVATION", 203, 217], ["hypercortisolism", "OBSERVATION", 219, 235], ["diabetes mellitus", "OBSERVATION", 237, 254], ["aortic", "ANATOMY", 260, 266], ["neoplasia", "OBSERVATION", 267, 276], ["Degeneration", "OBSERVATION", 282, 294], ["DeathThrombosis", "OBSERVATION", 299, 314], ["Femoral Artery", "ANATOMY", 322, 336]]], ["Thrombosis of the femoral artery, with resulting partial to complete occlusion, has been reported in Cavalier King Charles spaniels.", [["femoral artery", "ANATOMY", 18, 32], ["Thrombosis", "DISEASE", 0, 10], ["femoral artery", "MULTI-TISSUE_STRUCTURE", 18, 32], ["Thrombosis of the femoral artery", "PROBLEM", 0, 32], ["partial to complete occlusion", "PROBLEM", 49, 78], ["femoral artery", "ANATOMY", 18, 32], ["partial", "OBSERVATION_MODIFIER", 49, 56], ["complete", "OBSERVATION_MODIFIER", 60, 68], ["occlusion", "OBSERVATION", 69, 78]]], ["Affected dogs generally do not develop hindlimb ischemia, in contrast to human patients with this condition, because of extensive collateral circulation and thrombus recanalization.", [["hindlimb", "ANATOMY", 39, 47], ["collateral", "ANATOMY", 130, 140], ["thrombus", "ANATOMY", 157, 165], ["hindlimb ischemia", "DISEASE", 39, 56], ["thrombus", "DISEASE", 157, 165], ["dogs", "ORGANISM", 9, 13], ["hindlimb", "ORGANISM_SUBDIVISION", 39, 47], ["human", "ORGANISM", 73, 78], ["patients", "ORGANISM", 79, 87], ["collateral", "MULTI-TISSUE_STRUCTURE", 130, 140], ["thrombus", "PATHOLOGICAL_FORMATION", 157, 165], ["dogs", "SPECIES", 9, 13], ["human", "SPECIES", 73, 78], ["patients", "SPECIES", 79, 87], ["human", "SPECIES", 73, 78], ["Affected dogs", "PROBLEM", 0, 13], ["hindlimb ischemia", "PROBLEM", 39, 56], ["extensive collateral circulation", "PROBLEM", 120, 152], ["thrombus recanalization", "PROBLEM", 157, 180], ["hindlimb", "ANATOMY", 39, 47], ["ischemia", "OBSERVATION", 48, 56], ["extensive", "OBSERVATION_MODIFIER", 120, 129], ["collateral circulation", "OBSERVATION", 130, 152], ["thrombus", "OBSERVATION", 157, 165]]], ["It is a common but clinically insignificant pathology in Cavalier King Charles spaniels that is suspected to result from a probable weakness in the femoral artery wall.InflammationHeartworm Dirofilariasis (Dirofilaria immitis).", [["femoral artery wall", "ANATOMY", 148, 167], ["weakness", "DISEASE", 132, 140], ["Dirofilaria immitis", "DISEASE", 206, 225], ["femoral artery wall", "MULTI-TISSUE_STRUCTURE", 148, 167], ["Dirofilaria immitis", "ORGANISM", 206, 225], ["Dirofilaria immitis", "SPECIES", 206, 225], ["Dirofilaria immitis", "SPECIES", 206, 225], ["a probable weakness in the femoral artery wall", "PROBLEM", 121, 167], ["InflammationHeartworm Dirofilariasis (Dirofilaria immitis", "PROBLEM", 168, 225], ["insignificant", "OBSERVATION_MODIFIER", 30, 43], ["pathology", "OBSERVATION", 44, 53], ["probable", "UNCERTAINTY", 123, 131], ["weakness", "OBSERVATION", 132, 140], ["femoral artery", "ANATOMY", 148, 162], ["wall", "ANATOMY_MODIFIER", 163, 167], ["Dirofilariasis", "OBSERVATION", 190, 204], ["Dirofilaria immitis", "OBSERVATION", 206, 225]]], ["Dirofilariasis (heartworm disease) may occur in 35% to 45% of dogs and 2% of cats in areas of high infection rates, such as within 150 miles of the Atlantic and Gulf coasts from Texas to New Jersey and along the Mississippi River and its major tributaries.", [["Dirofilariasis", "DISEASE", 0, 14], ["heartworm disease", "DISEASE", 16, 33], ["infection", "DISEASE", 99, 108], ["heartworm", "ORGAN", 16, 25], ["dogs", "ORGANISM", 62, 66], ["cats", "ORGANISM", 77, 81], ["dogs", "SPECIES", 62, 66], ["cats", "SPECIES", 77, 81], ["Dirofilariasis (heartworm disease", "PROBLEM", 0, 33], ["dogs", "TEST", 62, 66], ["high infection rates", "PROBLEM", 94, 114], ["heartworm disease", "OBSERVATION", 16, 33], ["high", "OBSERVATION_MODIFIER", 94, 98], ["infection", "OBSERVATION", 99, 108], ["Mississippi River", "ANATOMY", 212, 229], ["major tributaries", "ANATOMY", 238, 255]]], ["The extent of cardiac alterations is related to the number of adult parasites present.", [["cardiac", "ANATOMY", 14, 21], ["cardiac alterations", "DISEASE", 14, 33], ["cardiac", "ORGAN", 14, 21], ["cardiac alterations", "PROBLEM", 14, 33], ["adult parasites", "PROBLEM", 62, 77], ["extent", "OBSERVATION_MODIFIER", 4, 10], ["cardiac", "ANATOMY", 14, 21], ["alterations", "OBSERVATION", 22, 33], ["adult", "OBSERVATION_MODIFIER", 62, 67], ["parasites", "OBSERVATION", 68, 77]]], ["Initially, the parasites accumulate in the pulmonary arteries with Gurltia paralysans have spinal cord damage from thrombophlebitis in the lumbar veins, associated with the presence of adult parasites in affected vessels.", [["pulmonary arteries", "ANATOMY", 43, 61], ["spinal cord", "ANATOMY", 91, 102], ["thrombophlebitis", "ANATOMY", 115, 131], ["lumbar veins", "ANATOMY", 139, 151], ["vessels", "ANATOMY", 213, 220], ["cord damage", "DISEASE", 98, 109], ["thrombophlebitis", "DISEASE", 115, 131], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 43, 61], ["Gurltia paralysans", "ORGANISM", 67, 85], ["spinal cord", "ORGAN", 91, 102], ["lumbar veins", "MULTI-TISSUE_STRUCTURE", 139, 151], ["vessels", "MULTI-TISSUE_STRUCTURE", 213, 220], ["Gurltia paralysans", "SPECIES", 67, 85], ["the parasites", "PROBLEM", 11, 24], ["Gurltia paralysans", "PROBLEM", 67, 85], ["spinal cord damage", "PROBLEM", 91, 109], ["thrombophlebitis in the lumbar veins", "PROBLEM", 115, 151], ["adult parasites in affected vessels", "PROBLEM", 185, 220], ["parasites", "OBSERVATION", 15, 24], ["pulmonary arteries", "ANATOMY", 43, 61], ["spinal cord", "ANATOMY", 91, 102], ["damage", "OBSERVATION", 103, 109], ["thrombophlebitis", "OBSERVATION", 115, 131], ["lumbar veins", "ANATOMY", 139, 151], ["adult", "OBSERVATION_MODIFIER", 185, 190], ["parasites", "OBSERVATION", 191, 200], ["affected", "OBSERVATION_MODIFIER", 204, 212], ["vessels", "ANATOMY", 213, 220]]], ["Brugia spp. infect lymphatic vessels and lead to secondary lymphedema.Disturbances of CirculationLymphedema.", [["lymphatic vessels", "ANATOMY", 19, 36], ["Brugia spp", "DISEASE", 0, 10], ["lymphedema", "DISEASE", 59, 69], ["Brugia spp", "ORGANISM", 0, 10], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 19, 36], ["Brugia spp", "PROBLEM", 0, 10], ["infect lymphatic vessels", "PROBLEM", 12, 36], ["secondary lymphedema", "PROBLEM", 49, 69], ["Disturbances of CirculationLymphedema", "PROBLEM", 70, 107], ["lymphatic vessels", "ANATOMY", 19, 36], ["secondary", "OBSERVATION_MODIFIER", 49, 58], ["lymphedema", "OBSERVATION", 59, 69], ["CirculationLymphedema", "OBSERVATION", 86, 107]]], ["See the section on Disorders of Domestic Animals, Disorders of Domestic Animals: Blood and Lymphatic Vascular Systems, Lymphatic Vessels, Disturbances of Circulation, Lymphedema.Suggested ReadingsSuggested Readings are available at www.expertconsult.com.Suggested Readingsleading to small areas of hemorrhage and necrosis in the lung and sudden death in some cats.", [["Blood", "ANATOMY", 81, 86], ["Lymphatic Vessels", "ANATOMY", 119, 136], ["lung", "ANATOMY", 329, 333], ["Lymphedema", "DISEASE", 167, 177], ["hemorrhage", "DISEASE", 298, 308], ["necrosis", "DISEASE", 313, 321], ["sudden death", "DISEASE", 338, 350], ["Blood", "ORGANISM_SUBSTANCE", 81, 86], ["Lymphatic Vascular", "MULTI-TISSUE_STRUCTURE", 91, 109], ["Lymphatic Vessels", "MULTI-TISSUE_STRUCTURE", 119, 136], ["lung", "ORGAN", 329, 333], ["cats", "ORGANISM", 359, 363], ["cats", "SPECIES", 359, 363], ["Blood and Lymphatic Vascular Systems", "PROBLEM", 81, 117], ["Disturbances of Circulation", "PROBLEM", 138, 165], ["Lymphedema", "PROBLEM", 167, 177], ["hemorrhage", "PROBLEM", 298, 308], ["necrosis in the lung", "PROBLEM", 313, 333], ["sudden death", "PROBLEM", 338, 350], ["Blood", "ANATOMY", 81, 86], ["Lymphatic Vascular", "ANATOMY", 91, 109], ["Lymphatic Vessels", "ANATOMY", 119, 136], ["Circulation", "OBSERVATION_MODIFIER", 154, 165], ["Lymphedema", "OBSERVATION", 167, 177], ["small", "OBSERVATION_MODIFIER", 283, 288], ["areas", "OBSERVATION_MODIFIER", 289, 294], ["hemorrhage", "OBSERVATION", 298, 308], ["necrosis", "OBSERVATION", 313, 321], ["lung", "ANATOMY", 329, 333], ["sudden", "OBSERVATION_MODIFIER", 338, 344], ["death", "OBSERVATION", 345, 350], ["some", "OBSERVATION_MODIFIER", 354, 358], ["cats", "OBSERVATION", 359, 363]]], ["Many cats that survive this initial phase develop collateral blood supply, but histologically they have multiple small pulmonary arteries with villus endarteritis and multifocal areas with type II pneumocyte hyperplasia, which is indicative of chronic alveolar injury.", [["collateral blood", "ANATOMY", 50, 66], ["pulmonary arteries", "ANATOMY", 119, 137], ["villus", "ANATOMY", 143, 149], ["alveolar", "ANATOMY", 252, 260], ["hyperplasia", "DISEASE", 208, 219], ["chronic alveolar injury", "DISEASE", 244, 267], ["cats", "ORGANISM", 5, 9], ["collateral", "MULTI-TISSUE_STRUCTURE", 50, 60], ["blood", "ORGANISM_SUBSTANCE", 61, 66], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 119, 137], ["villus endarteritis", "PATHOLOGICAL_FORMATION", 143, 162], ["alveolar", "ORGAN", 252, 260], ["cats", "SPECIES", 5, 9], ["collateral blood supply", "PROBLEM", 50, 73], ["multiple small pulmonary arteries", "PROBLEM", 104, 137], ["villus endarteritis", "PROBLEM", 143, 162], ["multifocal areas", "PROBLEM", 167, 183], ["type II pneumocyte hyperplasia", "PROBLEM", 189, 219], ["chronic alveolar injury", "PROBLEM", 244, 267], ["multiple", "OBSERVATION_MODIFIER", 104, 112], ["small", "OBSERVATION_MODIFIER", 113, 118], ["pulmonary arteries", "ANATOMY", 119, 137], ["villus", "ANATOMY", 143, 149], ["endarteritis", "OBSERVATION", 150, 162], ["multifocal", "OBSERVATION_MODIFIER", 167, 177], ["type II", "OBSERVATION_MODIFIER", 189, 196], ["pneumocyte hyperplasia", "OBSERVATION", 197, 219], ["indicative of", "UNCERTAINTY", 230, 243], ["chronic", "OBSERVATION_MODIFIER", 244, 251], ["alveolar", "ANATOMY_MODIFIER", 252, 260], ["injury", "OBSERVATION", 261, 267]]], ["The most common clinical manifestation is an asthma-like syndrome potentially from inflammatory mediators that are released by numerous eosinophils and other leukocytes that cuff affected small pulmonary arteries.Suggested ReadingsForeign Parasitic Diseases.", [["eosinophils", "ANATOMY", 136, 147], ["leukocytes", "ANATOMY", 158, 168], ["small pulmonary arteries", "ANATOMY", 188, 212], ["Parasitic Diseases", "DISEASE", 239, 257], ["eosinophils", "CELL", 136, 147], ["leukocytes", "CELL", 158, 168], ["pulmonary arteries", "MULTI-TISSUE_STRUCTURE", 194, 212], ["inflammatory mediators", "PROTEIN", 83, 105], ["eosinophils", "CELL_TYPE", 136, 147], ["leukocytes", "CELL_TYPE", 158, 168], ["an asthma-like syndrome", "PROBLEM", 42, 65], ["inflammatory mediators", "PROBLEM", 83, 105], ["numerous eosinophils", "PROBLEM", 127, 147], ["other leukocytes that cuff affected small pulmonary arteries", "PROBLEM", 152, 212], ["ReadingsForeign Parasitic Diseases", "PROBLEM", 223, 257], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["asthma-like syndrome", "OBSERVATION", 45, 65], ["inflammatory", "OBSERVATION_MODIFIER", 83, 95], ["numerous", "OBSERVATION_MODIFIER", 127, 135], ["eosinophils", "OBSERVATION", 136, 147], ["leukocytes", "OBSERVATION", 158, 168], ["cuff", "OBSERVATION_MODIFIER", 174, 178], ["affected", "OBSERVATION_MODIFIER", 179, 187], ["small", "OBSERVATION_MODIFIER", 188, 193], ["pulmonary arteries", "ANATOMY", 194, 212], ["Foreign Parasitic Diseases", "OBSERVATION", 231, 257]]], ["Foreign parasitic diseases important in tropical regions of the world are characterized by the presence of parasites in the lumens of veins and lymphatic vessels.", [["lumens", "ANATOMY", 124, 130], ["veins", "ANATOMY", 134, 139], ["lymphatic vessels", "ANATOMY", 144, 161], ["parasitic diseases", "DISEASE", 8, 26], ["lumens of veins", "MULTI-TISSUE_STRUCTURE", 124, 139], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 144, 161], ["Foreign parasitic diseases", "PROBLEM", 0, 26], ["parasites in the lumens of veins and lymphatic vessels", "PROBLEM", 107, 161], ["parasitic diseases", "OBSERVATION", 8, 26], ["tropical", "OBSERVATION_MODIFIER", 40, 48], ["parasites", "OBSERVATION", 107, 116], ["lumens", "ANATOMY_MODIFIER", 124, 130], ["veins", "ANATOMY", 134, 139], ["lymphatic vessels", "ANATOMY", 144, 161]]], ["These diseases include infection of cats in South America by Gurltia paralysans, infection of cats in tropical regions with Brugia spp., and infection of pulmonary vessels by Dirofilaria immitis.", [["pulmonary vessels", "ANATOMY", 154, 171], ["infection", "DISEASE", 23, 32], ["infection", "DISEASE", 81, 90], ["Brugia spp.", "DISEASE", 124, 135], ["infection of pulmonary vessels", "DISEASE", 141, 171], ["Dirofilaria immitis", "DISEASE", 175, 194], ["cats", "ORGANISM", 36, 40], ["Gurltia paralysans", "ORGANISM", 61, 79], ["cats", "ORGANISM", 94, 98], ["Brugia", "ORGANISM", 124, 130], ["pulmonary vessels", "MULTI-TISSUE_STRUCTURE", 154, 171], ["Dirofilaria immitis", "ORGANISM", 175, 194], ["cats", "SPECIES", 36, 40], ["cats", "SPECIES", 94, 98], ["Brugia spp.", "SPECIES", 124, 135], ["Dirofilaria immitis", "SPECIES", 175, 194], ["Gurltia paralysans", "SPECIES", 61, 79], ["Brugia spp.", "SPECIES", 124, 135], ["Dirofilaria immitis", "SPECIES", 175, 194], ["These diseases", "PROBLEM", 0, 14], ["infection of cats", "PROBLEM", 23, 40], ["infection of cats in tropical regions", "PROBLEM", 81, 118], ["Brugia spp.", "PROBLEM", 124, 135], ["infection of pulmonary vessels", "PROBLEM", 141, 171], ["Dirofilaria immitis", "PROBLEM", 175, 194], ["diseases", "OBSERVATION", 6, 14], ["infection", "OBSERVATION", 23, 32], ["infection", "OBSERVATION", 81, 90], ["Brugia spp.", "OBSERVATION", 124, 135], ["infection", "OBSERVATION", 141, 150], ["pulmonary vessels", "ANATOMY", 154, 171], ["Dirofilaria immitis", "OBSERVATION", 175, 194]]], ["Cats infected", [["Cats infected", "PROBLEM", 0, 13], ["infected", "OBSERVATION", 5, 13]]]], "6dda1fe5d6cffb0e287b8993e9a14b4abfc73600": [["This choice was supported by the importance of maintaining routine habits for patients with cognitive impairments.", [["cognitive impairments", "DISEASE", 92, 113], ["patients", "ORGANISM", 78, 86], ["patients", "SPECIES", 78, 86], ["cognitive impairments", "PROBLEM", 92, 113]]], ["The possibility to perform extra consultations was also introduced in order to contrast the risk of isolation and mood disorders and to support patients strained by the long period of social restrictions, especially in the case of quarantine in the personal room.", [["mood disorders", "DISEASE", 114, 128], ["patients", "ORGANISM", 144, 152], ["patients", "SPECIES", 144, 152], ["mood disorders", "PROBLEM", 114, 128]]], ["The patients were invited to give their personal mobile phone numbers in order to be called by the psychologists at set times.", [["patients", "ORGANISM", 4, 12], ["patients", "SPECIES", 4, 12]]], ["The audio modality was the preferred one because it only requires a phone, that usually is owned by patients.", [["patients", "ORGANISM", 100, 108], ["patients", "SPECIES", 100, 108]]], ["However, patients who do not have a personal mobile phone or for which it was preferable to have video-consultation modality, it was possible to use a mobile phone or a tablet freely made available by the administration of the nursing home (sanitised before and after each usage).", [["patients", "ORGANISM", 9, 17], ["patients", "SPECIES", 9, 17]]], ["The video-consultation modality, especially those with the tablet, was particularly useful for patients with hearing loss who need to read lips for better understanding the communication, or for facilitating the recognition of the psychologist by patients with moderate/severe cognitive impairment.", [["hearing loss", "DISEASE", 109, 121], ["cognitive impairment", "DISEASE", 277, 297], ["patients", "ORGANISM", 95, 103], ["lips", "ORGANISM_SUBDIVISION", 139, 143], ["patients", "ORGANISM", 247, 255], ["patients", "SPECIES", 95, 103], ["patients", "SPECIES", 247, 255], ["hearing loss", "PROBLEM", 109, 121], ["moderate/severe cognitive impairment", "PROBLEM", 261, 297], ["severe", "OBSERVATION_MODIFIER", 270, 276], ["cognitive", "OBSERVATION", 277, 286]]], ["In order to perform also cognitive stimulations, crucial in elderly people, several training schedules were sent to the head nurse by email, printed and handed over to the patients they were addressed to.", [["head", "ANATOMY", 120, 124], ["people", "ORGANISM", 68, 74], ["head", "ORGANISM_SUBDIVISION", 120, 124], ["patients", "ORGANISM", 172, 180], ["people", "SPECIES", 68, 74], ["patients", "SPECIES", 172, 180], ["cognitive stimulations", "TREATMENT", 25, 47], ["several training schedules", "TREATMENT", 76, 102], ["head", "ANATOMY", 120, 124]]], ["Specifically, patients presenting deficits in short-term memory, showed problems in remembering that they were experiencing a global health emergency with consequent social limitations.", [["patients", "ORGANISM", 14, 22], ["patients", "SPECIES", 14, 22], ["patients presenting deficits in short-term memory", "PROBLEM", 14, 63], ["short-term", "OBSERVATION_MODIFIER", 46, 56]]], ["Patients with a more preserved cognitive functioning, reported feelings of anxiety and fear for themselves and their loved ones that needed to be accepted and explored.", [["anxiety", "DISEASE", 75, 82], ["Patients", "ORGANISM", 0, 8], ["Patients", "SPECIES", 0, 8], ["anxiety", "PROBLEM", 75, 82]]]], "PMC7173509": [["Anatomy ::: IntroductionThe esophagus, stomach(s), small intestine, cecum, large intestine, colon, and rectum, the tubular portions of the gastrointestinal system, are potential spaces that expand to accommodate ingesta/digesta/excreta.", [["esophagus", "ANATOMY", 28, 37], ["stomach", "ANATOMY", 39, 46], ["small intestine", "ANATOMY", 51, 66], ["cecum", "ANATOMY", 68, 73], ["intestine", "ANATOMY", 81, 90], ["colon", "ANATOMY", 92, 97], ["rectum", "ANATOMY", 103, 109], ["tubular portions", "ANATOMY", 115, 131], ["gastrointestinal system", "ANATOMY", 139, 162], ["esophagus", "ORGAN", 28, 37], ["stomach", "ORGAN", 39, 46], ["small intestine", "MULTI-TISSUE_STRUCTURE", 51, 66], ["cecum", "MULTI-TISSUE_STRUCTURE", 68, 73], ["intestine", "MULTI-TISSUE_STRUCTURE", 81, 90], ["colon", "ORGAN", 92, 97], ["rectum", "ORGAN", 103, 109], ["tubular portions", "MULTI-TISSUE_STRUCTURE", 115, 131], ["gastrointestinal", "ORGAN", 139, 155], ["system", "ANATOMICAL_SYSTEM", 156, 162], ["digesta", "ORGANISM_SUBDIVISION", 220, 227], ["excreta", "ORGANISM_SUBSTANCE", 228, 235], ["small intestine, cecum, large intestine, colon, and rectum, the tubular portions of the gastrointestinal system", "PROBLEM", 51, 162], ["potential spaces", "PROBLEM", 168, 184], ["esophagus", "ANATOMY", 28, 37], ["stomach", "ANATOMY", 39, 46], ["small intestine", "ANATOMY", 51, 66], ["cecum", "ANATOMY", 68, 73], ["large intestine", "ANATOMY", 75, 90], ["colon", "ANATOMY", 92, 97], ["rectum", "ANATOMY", 103, 109], ["tubular", "ANATOMY_MODIFIER", 115, 122], ["portions", "ANATOMY_MODIFIER", 123, 131], ["gastrointestinal system", "ANATOMY", 139, 162]]], ["All portions of the digestive system contain mural smooth and/or striated muscle that propel luminal contents.", [["digestive system", "ANATOMY", 20, 36], ["mural smooth", "ANATOMY", 45, 57], ["striated muscle", "ANATOMY", 65, 80], ["luminal", "ANATOMY", 93, 100], ["luminal", "CHEMICAL", 93, 100], ["digestive system", "ANATOMICAL_SYSTEM", 20, 36], ["mural smooth", "TISSUE", 45, 57], ["striated muscle", "TISSUE", 65, 80], ["luminal", "IMMATERIAL_ANATOMICAL_ENTITY", 93, 100], ["portions", "ANATOMY_MODIFIER", 4, 12], ["digestive system", "ANATOMY", 20, 36], ["mural", "OBSERVATION_MODIFIER", 45, 50], ["smooth", "OBSERVATION", 51, 57], ["muscle", "ANATOMY", 74, 80], ["luminal contents", "OBSERVATION", 93, 109]]], ["There are three principal motility patterns of the gastrointestinal tract: storage, mixing, and propulsion.", [["gastrointestinal tract", "ANATOMY", 51, 73], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 51, 73], ["three", "OBSERVATION_MODIFIER", 10, 15], ["principal", "OBSERVATION_MODIFIER", 16, 25], ["motility patterns", "OBSERVATION", 26, 43], ["gastrointestinal tract", "ANATOMY", 51, 73]]], ["Each of these activities is associated with precise changes in muscle contractions.Anatomy ::: IntroductionThe length of the system varies among species, shorter tracts in carnivores, and longer more complicated tracts in herbivores.", [["muscle", "ANATOMY", 63, 69], ["muscle contractions", "DISEASE", 63, 82], ["muscle", "ORGAN", 63, 69], ["precise changes in muscle contractions", "PROBLEM", 44, 82], ["shorter tracts in carnivores", "PROBLEM", 154, 182], ["muscle", "ANATOMY", 63, 69], ["contractions", "OBSERVATION", 70, 82], ["length", "OBSERVATION_MODIFIER", 111, 117]]], ["In addition, herbivores require a fermentation chamber to digest cellulose, the forestomachs in ruminants and camelids or an enlarged cecum in equids, rodents, and lagomorphs.", [["forestomachs", "ANATOMY", 80, 92], ["camelids", "ANATOMY", 110, 118], ["cecum", "ANATOMY", 134, 139], ["cellulose", "SIMPLE_CHEMICAL", 65, 74], ["cecum", "ORGAN", 134, 139], ["a fermentation chamber", "TREATMENT", 32, 54], ["digest cellulose", "TREATMENT", 58, 74], ["the forestomachs in ruminants and camelids", "PROBLEM", 76, 118], ["an enlarged cecum in equids", "PROBLEM", 122, 149], ["enlarged", "OBSERVATION", 125, 133], ["cecum", "ANATOMY", 134, 139]]], ["A rendering of general gastrointestinal morphology is presented in Fig. 1.Oral Cavity ::: IntroductionVia \u201cmouth feel\u201d and taste, the oral cavity prevents many harmful substances from entering the body.", [["gastrointestinal", "ANATOMY", 23, 39], ["mouth", "ANATOMY", 107, 112], ["oral cavity", "ANATOMY", 134, 145], ["body", "ANATOMY", 197, 201], ["gastrointestinal", "ORGAN", 23, 39], ["mouth", "ORGANISM_SUBDIVISION", 107, 112], ["oral cavity", "ORGANISM_SUBDIVISION", 134, 145], ["body", "ORGANISM_SUBDIVISION", 197, 201], ["the oral cavity", "PROBLEM", 130, 145], ["gastrointestinal", "ANATOMY", 23, 39], ["Oral Cavity", "ANATOMY", 74, 85], ["oral cavity", "ANATOMY", 134, 145], ["harmful", "OBSERVATION_MODIFIER", 160, 167], ["substances", "OBSERVATION", 168, 178], ["body", "ANATOMY", 197, 201]]], ["Caustic substances, some pathogens, heat and electricity may result in thermal and chemical erosions or ulcerations of the oral mucosa, but mucus membranes heal rapidly.", [["oral mucosa", "ANATOMY", 123, 134], ["mucus membranes", "ANATOMY", 140, 155], ["erosions", "DISEASE", 92, 100], ["ulcerations", "DISEASE", 104, 115], ["oral mucosa", "MULTI-TISSUE_STRUCTURE", 123, 134], ["mucus membranes", "MULTI-TISSUE_STRUCTURE", 140, 155], ["Caustic substances", "PROBLEM", 0, 18], ["some pathogens", "PROBLEM", 20, 34], ["thermal and chemical erosions", "PROBLEM", 71, 100], ["ulcerations of the oral mucosa", "PROBLEM", 104, 134], ["mucus membranes heal", "PROBLEM", 140, 160], ["substances", "OBSERVATION", 8, 18], ["pathogens", "OBSERVATION_MODIFIER", 25, 34], ["chemical", "OBSERVATION_MODIFIER", 83, 91], ["erosions", "OBSERVATION", 92, 100], ["ulcerations", "OBSERVATION", 104, 115], ["oral mucosa", "ANATOMY", 123, 134], ["mucus membranes", "OBSERVATION", 140, 155]]], ["At various locations throughout the tract, extraintestinal substances are added to the ingesta.", [["tract", "ANATOMY", 36, 41], ["tract", "ORGANISM_SUBDIVISION", 36, 41], ["extraintestinal substances", "TREATMENT", 43, 69], ["extraintestinal substances", "OBSERVATION", 43, 69]]], ["These include saliva that contains electrolytes such as sodium, potassium, calcium, magnesium, chloride, bicarbonate, phosphate, and iodine, mucus, which serves as a lubricant, antibacterial compounds such as thiocyanate and hydrogen peroxide, secretory immunoglobulin A, epidermal growth factor (EGF) and the digestive enzymes \u03b1-amylase, lipase, and kallikrein.", [["mucus", "ANATOMY", 141, 146], ["sodium", "CHEMICAL", 56, 62], ["potassium", "CHEMICAL", 64, 73], ["calcium", "CHEMICAL", 75, 82], ["magnesium", "CHEMICAL", 84, 93], ["chloride", "CHEMICAL", 95, 103], ["bicarbonate", "CHEMICAL", 105, 116], ["phosphate", "CHEMICAL", 118, 127], ["iodine", "CHEMICAL", 133, 139], ["thiocyanate", "CHEMICAL", 209, 220], ["hydrogen peroxide", "CHEMICAL", 225, 242], ["sodium", "CHEMICAL", 56, 62], ["potassium", "CHEMICAL", 64, 73], ["calcium", "CHEMICAL", 75, 82], ["magnesium", "CHEMICAL", 84, 93], ["chloride", "CHEMICAL", 95, 103], ["bicarbonate", "CHEMICAL", 105, 116], ["phosphate", "CHEMICAL", 118, 127], ["iodine", "CHEMICAL", 133, 139], ["thiocyanate", "CHEMICAL", 209, 220], ["hydrogen peroxide", "CHEMICAL", 225, 242], ["saliva", "ORGANISM_SUBSTANCE", 14, 20], ["electrolytes", "SIMPLE_CHEMICAL", 35, 47], ["sodium", "SIMPLE_CHEMICAL", 56, 62], ["potassium", "SIMPLE_CHEMICAL", 64, 73], ["calcium", "SIMPLE_CHEMICAL", 75, 82], ["magnesium", "SIMPLE_CHEMICAL", 84, 93], ["chloride", "SIMPLE_CHEMICAL", 95, 103], ["bicarbonate", "SIMPLE_CHEMICAL", 105, 116], ["phosphate", "SIMPLE_CHEMICAL", 118, 127], ["iodine", "SIMPLE_CHEMICAL", 133, 139], ["mucus", "ORGANISM_SUBSTANCE", 141, 146], ["thiocyanate", "SIMPLE_CHEMICAL", 209, 220], ["hydrogen peroxide", "SIMPLE_CHEMICAL", 225, 242], ["secretory immunoglobulin A", "GENE_OR_GENE_PRODUCT", 244, 270], ["epidermal growth factor", "GENE_OR_GENE_PRODUCT", 272, 295], ["EGF", "GENE_OR_GENE_PRODUCT", 297, 300], ["\u03b1-amylase", "GENE_OR_GENE_PRODUCT", 328, 337], ["lipase", "GENE_OR_GENE_PRODUCT", 339, 345], ["kallikrein", "GENE_OR_GENE_PRODUCT", 351, 361], ["secretory immunoglobulin A", "PROTEIN", 244, 270], ["epidermal growth factor", "PROTEIN", 272, 295], ["EGF", "PROTEIN", 297, 300], ["digestive enzymes", "PROTEIN", 310, 327], ["\u03b1-amylase", "PROTEIN", 328, 337], ["lipase", "PROTEIN", 339, 345], ["kallikrein", "PROTEIN", 351, 361], ["electrolytes", "TEST", 35, 47], ["sodium", "TEST", 56, 62], ["potassium", "TREATMENT", 64, 73], ["calcium", "TEST", 75, 82], ["magnesium", "TREATMENT", 84, 93], ["chloride", "TREATMENT", 95, 103], ["bicarbonate", "TREATMENT", 105, 116], ["phosphate", "TREATMENT", 118, 127], ["iodine", "TREATMENT", 133, 139], ["a lubricant", "TREATMENT", 164, 175], ["antibacterial compounds", "TREATMENT", 177, 200], ["thiocyanate", "TREATMENT", 209, 220], ["hydrogen peroxide", "TREATMENT", 225, 242], ["secretory immunoglobulin", "TEST", 244, 268], ["epidermal growth factor", "PROBLEM", 272, 295], ["the digestive enzymes \u03b1-amylase", "TEST", 306, 337], ["lipase", "TEST", 339, 345], ["kallikrein", "TEST", 351, 361], ["lipase", "ANATOMY", 339, 345]]], ["Antimicrobial enzymes secreted include lysozyme, lactoperoxidase, proline-rich proteins, acid phosphatases A+B, N-acetylmuramoyl-l-alanine amidase, NAD(P)H dehydrogenase (quinone), superoxide dismutase (SOD), glutathione transferase, class 3 aldehyde dehydrogenase, and glucose-6-phosphate isomerase.", [["proline", "CHEMICAL", 66, 73], ["N-acetylmuramoyl-l-alanine", "CHEMICAL", 112, 138], ["NAD", "CHEMICAL", 148, 151], ["quinone", "CHEMICAL", 171, 178], ["superoxide", "CHEMICAL", 181, 191], ["glutathione", "CHEMICAL", 209, 220], ["aldehyde", "CHEMICAL", 242, 250], ["glucose-6-phosphate", "CHEMICAL", 270, 289], ["proline", "CHEMICAL", 66, 73], ["N-acetylmuramoyl-l-alanine", "CHEMICAL", 112, 138], ["NAD(P)H", "CHEMICAL", 148, 155], ["quinone", "CHEMICAL", 171, 178], ["superoxide", "CHEMICAL", 181, 191], ["glutathione", "CHEMICAL", 209, 220], ["aldehyde", "CHEMICAL", 242, 250], ["glucose-6-phosphate", "CHEMICAL", 270, 289], ["lysozyme", "GENE_OR_GENE_PRODUCT", 39, 47], ["lactoperoxidase", "SIMPLE_CHEMICAL", 49, 64], ["proline", "SIMPLE_CHEMICAL", 66, 73], ["acid phosphatases A+B", "SIMPLE_CHEMICAL", 89, 110], ["N-acetylmuramoyl-l-alanine amidase", "SIMPLE_CHEMICAL", 112, 146], ["NAD(P)H dehydrogenase", "GENE_OR_GENE_PRODUCT", 148, 169], ["quinone", "SIMPLE_CHEMICAL", 171, 178], ["superoxide dismutase", "GENE_OR_GENE_PRODUCT", 181, 201], ["SOD", "SIMPLE_CHEMICAL", 203, 206], ["glutathione transferase", "GENE_OR_GENE_PRODUCT", 209, 232], ["class 3 aldehyde dehydrogenase", "GENE_OR_GENE_PRODUCT", 234, 264], ["glucose-6-phosphate isomerase", "GENE_OR_GENE_PRODUCT", 270, 299], ["Antimicrobial enzymes", "PROTEIN", 0, 21], ["lysozyme", "PROTEIN", 39, 47], ["lactoperoxidase", "PROTEIN", 49, 64], ["proline-rich proteins", "PROTEIN", 66, 87], ["acid phosphatases A+B, N-acetylmuramoyl-l-alanine amidase", "PROTEIN", 89, 146], ["NAD(P)H dehydrogenase", "PROTEIN", 148, 169], ["superoxide dismutase", "PROTEIN", 181, 201], ["SOD", "PROTEIN", 203, 206], ["glutathione transferase", "PROTEIN", 209, 232], ["class 3 aldehyde dehydrogenase", "PROTEIN", 234, 264], ["glucose-6-phosphate isomerase", "PROTEIN", 270, 299], ["Antimicrobial enzymes", "TEST", 0, 21], ["lysozyme", "TEST", 39, 47], ["lactoperoxidase", "TREATMENT", 49, 64], ["proline-rich proteins", "TEST", 66, 87], ["acid phosphatases", "TEST", 89, 106], ["A+B", "TEST", 107, 110], ["N-acetylmuramoyl", "TEST", 112, 128], ["alanine amidase", "TREATMENT", 131, 146], ["NAD", "PROBLEM", 148, 151], ["dehydrogenase (quinone)", "TREATMENT", 156, 179], ["superoxide dismutase (SOD)", "TREATMENT", 181, 207], ["glutathione transferase", "TEST", 209, 232], ["aldehyde dehydrogenase", "TEST", 242, 264], ["glucose", "TEST", 270, 277], ["phosphate isomerase", "TEST", 280, 299]]], ["Saliva also contains a bacteria-rich flora and at least in humans, opiorphin, an analgesic.", [["opiorphin", "CHEMICAL", 67, 76], ["Saliva", "ORGANISM_SUBSTANCE", 0, 6], ["humans", "ORGANISM", 59, 65], ["opiorphin", "SIMPLE_CHEMICAL", 67, 76], ["humans", "SPECIES", 59, 65], ["humans", "SPECIES", 59, 65], ["a bacteria-rich flora", "PROBLEM", 21, 42], ["opiorphin", "TREATMENT", 67, 76], ["an analgesic", "TREATMENT", 78, 90]]], ["A partial list of gastrointestinal protective mechanisms is in Table 2.Esophagus ::: IntroductionThe esophagus is a muscular tube that passes through the neck and thorax and connects the oral cavity with the stomach.", [["gastrointestinal", "ANATOMY", 18, 34], ["esophagus", "ANATOMY", 101, 110], ["muscular tube", "ANATOMY", 116, 129], ["neck", "ANATOMY", 154, 158], ["thorax", "ANATOMY", 163, 169], ["oral cavity", "ANATOMY", 187, 198], ["stomach", "ANATOMY", 208, 215], ["gastrointestinal", "ORGAN", 18, 34], ["esophagus", "ORGAN", 101, 110], ["muscular tube", "TISSUE", 116, 129], ["neck", "ORGAN", 154, 158], ["thorax", "ORGAN", 163, 169], ["oral cavity", "ORGANISM_SUBDIVISION", 187, 198], ["stomach", "ORGAN", 208, 215], ["gastrointestinal protective mechanisms", "TREATMENT", 18, 56], ["a muscular tube", "TREATMENT", 114, 129], ["partial", "OBSERVATION_MODIFIER", 2, 9], ["gastrointestinal", "ANATOMY", 18, 34], ["esophagus", "ANATOMY", 101, 110], ["muscular tube", "OBSERVATION", 116, 129], ["neck", "ANATOMY", 154, 158], ["thorax", "ANATOMY", 163, 169], ["oral cavity", "ANATOMY", 187, 198], ["stomach", "ANATOMY", 208, 215]]], ["It secretes a lubricating mucus to aid in the passage of ingesta.", [["mucus", "ANATOMY", 26, 31], ["mucus", "ORGANISM_SUBSTANCE", 26, 31], ["ingesta", "GENE_OR_GENE_PRODUCT", 57, 64], ["a lubricating mucus", "TREATMENT", 12, 31], ["lubricating", "OBSERVATION_MODIFIER", 14, 25], ["mucus", "OBSERVATION", 26, 31], ["passage", "OBSERVATION_MODIFIER", 46, 53]]], ["The lining epithelium is keratinized in swine, equids, ruminants, rats, and mice and nonkeratinized in carnivores and humans.", [["lining epithelium", "ANATOMY", 4, 21], ["lining epithelium", "TISSUE", 4, 21], ["rats", "ORGANISM", 66, 70], ["mice", "ORGANISM", 76, 80], ["humans", "ORGANISM", 118, 124], ["swine", "SPECIES", 40, 45], ["rats", "SPECIES", 66, 70], ["mice", "SPECIES", 76, 80], ["humans", "SPECIES", 118, 124], ["swine", "SPECIES", 40, 45], ["mice", "SPECIES", 76, 80], ["humans", "SPECIES", 118, 124], ["lining", "OBSERVATION_MODIFIER", 4, 10], ["epithelium", "OBSERVATION_MODIFIER", 11, 21], ["keratinized", "OBSERVATION_MODIFIER", 25, 36]]], ["The epithelial cell turnover rate is 5\u20138 days.", [["epithelial cell", "ANATOMY", 4, 19], ["epithelial cell", "CELL", 4, 19], ["The epithelial cell turnover rate", "TEST", 0, 33], ["epithelial cell", "OBSERVATION", 4, 19]]], ["The muscularis is striated in ruminants and dogs, smooth in equids (distal third) that are unable to vomit, and variably mixed in other species.", [["muscularis", "ANATOMY", 4, 14], ["muscularis", "MULTI-TISSUE_STRUCTURE", 4, 14], ["dogs", "SPECIES", 44, 48], ["unable to vomit", "PROBLEM", 91, 106], ["variably mixed in other species", "PROBLEM", 112, 143], ["muscularis", "ANATOMY", 4, 14], ["striated", "OBSERVATION", 18, 26], ["ruminants", "OBSERVATION_MODIFIER", 30, 39], ["smooth", "OBSERVATION_MODIFIER", 50, 56], ["distal", "ANATOMY_MODIFIER", 68, 74], ["mixed", "OBSERVATION_MODIFIER", 121, 126], ["species", "OBSERVATION", 136, 143]]], ["Mice and rats, that have primarily striated muscle in their esophagus, are also unable to vomit (Treuting et al., 2011).", [["striated muscle", "ANATOMY", 35, 50], ["esophagus", "ANATOMY", 60, 69], ["Mice", "ORGANISM", 0, 4], ["rats", "ORGANISM", 9, 13], ["striated muscle", "ORGAN", 35, 50], ["esophagus", "ORGAN", 60, 69], ["Mice", "SPECIES", 0, 4], ["rats", "SPECIES", 9, 13], ["unable to vomit", "PROBLEM", 80, 95], ["striated muscle", "ANATOMY", 35, 50], ["esophagus", "ANATOMY", 60, 69]]], ["This is principally due to a limiting fold separating the nonglandular from the glandular stomach and diaphragmatic crura that cannot be contracted independently of each other to allow propulsion of contents.", [["glandular stomach", "ANATOMY", 80, 97], ["diaphragmatic crura", "ANATOMY", 102, 121], ["glandular stomach", "ORGAN", 80, 97], ["crura", "ORGAN", 116, 121], ["a limiting fold separating the nonglandular from the glandular stomach and diaphragmatic crura", "PROBLEM", 27, 121], ["glandular", "ANATOMY_MODIFIER", 80, 89], ["stomach", "ANATOMY", 90, 97], ["diaphragmatic crura", "ANATOMY", 102, 121]]], ["Submucosal mucus glands are present throughout the esophagus in swine, dogs, and humans and at the pharyngeal junction in cats, equids, and ruminants.", [["Submucosal mucus glands", "ANATOMY", 0, 23], ["esophagus", "ANATOMY", 51, 60], ["pharyngeal junction", "ANATOMY", 99, 118], ["mucus glands", "ORGAN", 11, 23], ["esophagus", "ORGAN", 51, 60], ["dogs", "ORGANISM", 71, 75], ["humans", "ORGANISM", 81, 87], ["pharyngeal junction", "MULTI-TISSUE_STRUCTURE", 99, 118], ["cats", "ORGANISM", 122, 126], ["swine", "SPECIES", 64, 69], ["dogs", "SPECIES", 71, 75], ["humans", "SPECIES", 81, 87], ["cats", "SPECIES", 122, 126], ["swine", "SPECIES", 64, 69], ["humans", "SPECIES", 81, 87], ["Submucosal mucus glands", "PROBLEM", 0, 23], ["mucus glands", "ANATOMY", 11, 23], ["esophagus", "ANATOMY", 51, 60], ["swine", "OBSERVATION_MODIFIER", 64, 69], ["dogs", "OBSERVATION", 71, 75], ["pharyngeal junction", "ANATOMY", 99, 118]]], ["A serosa is absent in all but the abdominal portion of the esophagus.", [["serosa", "ANATOMY", 2, 8], ["abdominal portion", "ANATOMY", 34, 51], ["esophagus", "ANATOMY", 59, 68], ["serosa", "MULTI-TISSUE_STRUCTURE", 2, 8], ["abdominal portion", "MULTI-TISSUE_STRUCTURE", 34, 51], ["esophagus", "ORGAN", 59, 68], ["serosa", "OBSERVATION", 2, 8], ["absent", "OBSERVATION", 12, 18], ["all", "ANATOMY_MODIFIER", 22, 25], ["abdominal", "ANATOMY", 34, 43], ["portion", "ANATOMY_MODIFIER", 44, 51], ["esophagus", "ANATOMY", 59, 68]]], ["Because the serosa is composed of collagen, it is crucial in holding sutures.", [["serosa", "ANATOMY", 12, 18], ["serosa", "MULTI-TISSUE_STRUCTURE", 12, 18], ["collagen", "GENE_OR_GENE_PRODUCT", 34, 42], ["collagen", "PROTEIN", 34, 42], ["holding sutures", "TREATMENT", 61, 76], ["serosa", "ANATOMY", 12, 18], ["crucial", "OBSERVATION_MODIFIER", 50, 57]]], ["Therefore, esophageal resection is seldom attempted and rarely successful.", [["esophageal", "ANATOMY", 11, 21], ["esophageal", "ORGAN", 11, 21], ["esophageal resection", "TREATMENT", 11, 31], ["esophageal", "ANATOMY", 11, 21], ["resection", "OBSERVATION", 22, 31]]], ["The strong muscular contractions of the esophagus, together with its poor blood supply and lack of serosa, mean that healing from caustic or penetrating wounds renders a poor prognosis for a functional return to normalcy.", [["muscular", "ANATOMY", 11, 19], ["esophagus", "ANATOMY", 40, 49], ["blood", "ANATOMY", 74, 79], ["serosa", "ANATOMY", 99, 105], ["wounds", "ANATOMY", 153, 159], ["esophagus", "ORGAN", 40, 49], ["blood", "ORGANISM_SUBSTANCE", 74, 79], ["serosa", "MULTI-TISSUE_STRUCTURE", 99, 105], ["wounds", "PATHOLOGICAL_FORMATION", 153, 159], ["The strong muscular contractions of the esophagus", "PROBLEM", 0, 49], ["its poor blood supply", "PROBLEM", 65, 86], ["lack of serosa", "PROBLEM", 91, 105], ["caustic or penetrating wounds", "PROBLEM", 130, 159], ["strong", "OBSERVATION_MODIFIER", 4, 10], ["muscular contractions", "OBSERVATION", 11, 32], ["esophagus", "ANATOMY", 40, 49], ["serosa", "ANATOMY", 99, 105], ["healing", "OBSERVATION_MODIFIER", 117, 124], ["caustic", "OBSERVATION_MODIFIER", 130, 137], ["penetrating", "OBSERVATION_MODIFIER", 141, 152], ["wounds", "OBSERVATION", 153, 159]]], ["Insofar as therapy for caustic toxin ingestion what burns going down will also burn coming back up, so generally speaking induction of vomition is contraindicated (Gelberg, 2013).Esophagus ::: IntroductionThe contracted musculature of the upper esophageal sphincter relaxes to permit movement of the swallowed bolus into the proximal portion of the esophagus.", [["musculature", "ANATOMY", 220, 231], ["upper esophageal sphincter", "ANATOMY", 239, 265], ["esophagus", "ANATOMY", 349, 358], ["burns", "DISEASE", 52, 57], ["vomition", "DISEASE", 135, 143], ["musculature", "ORGAN", 220, 231], ["upper esophageal", "ORGANISM_SUBDIVISION", 239, 255], ["sphincter", "ORGAN", 256, 265], ["esophagus", "ORGAN", 349, 358], ["therapy", "TREATMENT", 11, 18], ["caustic toxin ingestion", "PROBLEM", 23, 46], ["what burns", "PROBLEM", 47, 57], ["the swallowed bolus", "TREATMENT", 296, 315], ["contracted", "OBSERVATION", 209, 219], ["musculature", "ANATOMY_MODIFIER", 220, 231], ["upper", "ANATOMY_MODIFIER", 239, 244], ["esophageal sphincter", "ANATOMY", 245, 265], ["proximal", "ANATOMY_MODIFIER", 325, 333], ["portion", "ANATOMY_MODIFIER", 334, 341], ["esophagus", "ANATOMY", 349, 358]]], ["After the bolus passes, the sphincter regains its previous tone.", [["sphincter", "ANATOMY", 28, 37], ["sphincter", "ORGAN", 28, 37], ["the bolus passes", "TREATMENT", 6, 22], ["sphincter", "ANATOMY", 28, 37]]], ["Relaxation of the sphincter and subsequent restoration of tone require precise control by regulatory systems that may be disrupted by toxins.", [["sphincter", "ANATOMY", 18, 27], ["sphincter", "ORGAN", 18, 27], ["sphincter", "ANATOMY", 18, 27]]], ["When the bolus has entered the upper esophagus, an aborally progressing front of contraction of the circular muscle layer begins at the top of the esophageal body, seemingly as a continuation or extension of the forceful contraction of the upper esophageal sphincter that follows its relaxation (Conklin and Christensen, 1994).", [["upper esophagus", "ANATOMY", 31, 46], ["circular muscle layer", "ANATOMY", 100, 121], ["esophageal body", "ANATOMY", 147, 162], ["upper esophageal sphincter", "ANATOMY", 240, 266], ["upper esophagus", "ORGAN", 31, 46], ["muscle layer", "TISSUE", 109, 121], ["esophageal body", "MULTI-TISSUE_STRUCTURE", 147, 162], ["upper esophageal", "ORGANISM_SUBDIVISION", 240, 256], ["sphincter", "ORGAN", 257, 266], ["the bolus", "TREATMENT", 5, 14], ["the forceful contraction of the upper esophageal sphincter", "PROBLEM", 208, 266], ["upper", "ANATOMY_MODIFIER", 31, 36], ["esophagus", "ANATOMY", 37, 46], ["aborally", "OBSERVATION_MODIFIER", 51, 59], ["progressing", "OBSERVATION_MODIFIER", 60, 71], ["front", "OBSERVATION_MODIFIER", 72, 77], ["contraction", "OBSERVATION", 81, 92], ["circular", "ANATOMY_MODIFIER", 100, 108], ["muscle", "ANATOMY", 109, 115], ["layer", "ANATOMY_MODIFIER", 116, 121], ["top", "ANATOMY_MODIFIER", 136, 139], ["esophageal", "ANATOMY", 147, 157], ["body", "ANATOMY_MODIFIER", 158, 162], ["forceful contraction", "OBSERVATION", 212, 232], ["upper", "ANATOMY_MODIFIER", 240, 245], ["esophageal sphincter", "ANATOMY", 246, 266]]], ["A ring of contraction above the swallowed bolus moves down the esophagus, propelling the bolus toward the stomach.", [["esophagus", "ANATOMY", 63, 72], ["stomach", "ANATOMY", 106, 113], ["esophagus", "ORGAN", 63, 72], ["stomach", "ORGAN", 106, 113], ["A ring of contraction", "TREATMENT", 0, 21], ["the swallowed bolus", "TREATMENT", 28, 47], ["ring", "OBSERVATION_MODIFIER", 2, 6], ["contraction", "OBSERVATION", 10, 21], ["esophagus", "ANATOMY", 63, 72], ["stomach", "ANATOMY", 106, 113]]], ["While the bolus is still progressing through the mid-portion of the esophagus, the contracted ring of circular muscle that forms the lower esophageal sphincter relaxes and is completely relaxed by the time the bolus reaches the gastroesophageal junction.", [["esophagus", "ANATOMY", 68, 77], ["ring", "ANATOMY", 94, 98], ["muscle", "ANATOMY", 111, 117], ["lower esophageal sphincter", "ANATOMY", 133, 159], ["gastroesophageal junction", "ANATOMY", 228, 253], ["esophagus", "ORGAN", 68, 77], ["muscle", "ORGAN", 111, 117], ["lower", "ORGANISM_SUBDIVISION", 133, 138], ["esophageal sphincter", "ORGAN", 139, 159], ["gastroesophageal junction", "MULTI-TISSUE_STRUCTURE", 228, 253], ["the bolus", "TREATMENT", 6, 15], ["mid-portion", "ANATOMY_MODIFIER", 49, 60], ["esophagus", "ANATOMY", 68, 77], ["contracted ring", "OBSERVATION", 83, 98], ["circular muscle", "ANATOMY", 102, 117], ["lower", "ANATOMY_MODIFIER", 133, 138], ["esophageal sphincter", "ANATOMY", 139, 159], ["relaxes", "OBSERVATION_MODIFIER", 160, 167], ["completely", "OBSERVATION_MODIFIER", 175, 185], ["relaxed", "OBSERVATION", 186, 193], ["gastroesophageal junction", "ANATOMY", 228, 253]]], ["The bolus traverses the lower esophageal sphincter and drops into the stomach.", [["lower esophageal sphincter", "ANATOMY", 24, 50], ["stomach", "ANATOMY", 70, 77], ["lower esophageal", "ORGANISM_SUBDIVISION", 24, 40], ["sphincter", "ORGAN", 41, 50], ["stomach", "ORGAN", 70, 77], ["The bolus traverses the lower esophageal sphincter", "TREATMENT", 0, 50], ["lower", "ANATOMY_MODIFIER", 24, 29], ["esophageal sphincter", "ANATOMY", 30, 50], ["stomach", "ANATOMY", 70, 77]]], ["The proximal stomach (fundus and upper corpus) often relaxes, while the swallowed bolus is still in the esophageal body and has not yet passed the lower esophageal sphincter (receptive relaxation).", [["proximal stomach", "ANATOMY", 4, 20], ["fundus", "ANATOMY", 22, 28], ["upper corpus", "ANATOMY", 33, 45], ["esophageal body", "ANATOMY", 104, 119], ["lower esophageal sphincter", "ANATOMY", 147, 173], ["stomach", "ORGAN", 13, 20], ["fundus", "MULTI-TISSUE_STRUCTURE", 22, 28], ["upper corpus", "ORGANISM_SUBDIVISION", 33, 45], ["esophageal body", "ORGAN", 104, 119], ["lower esophageal sphincter", "MULTI-TISSUE_STRUCTURE", 147, 173], ["the swallowed bolus", "TREATMENT", 68, 87], ["proximal", "ANATOMY_MODIFIER", 4, 12], ["stomach", "ANATOMY", 13, 20], ["fundus", "ANATOMY", 22, 28], ["upper corpus", "ANATOMY", 33, 45], ["esophageal", "ANATOMY", 104, 114], ["body", "ANATOMY_MODIFIER", 115, 119], ["lower", "ANATOMY_MODIFIER", 147, 152], ["esophageal sphincter", "ANATOMY", 153, 173]]], ["After the bolus has entered the stomach, the fundus and corpus muscles relax so that a large volume can be stored in the upper stomach without significantly increasing intragastric pressure (accommodation).", [["stomach", "ANATOMY", 32, 39], ["fundus", "ANATOMY", 45, 51], ["corpus muscles", "ANATOMY", 56, 70], ["upper stomach", "ANATOMY", 121, 134], ["stomach", "ORGAN", 32, 39], ["fundus", "MULTI-TISSUE_STRUCTURE", 45, 51], ["corpus muscles", "ORGAN", 56, 70], ["upper stomach", "ORGAN", 121, 134], ["intragastric", "IMMATERIAL_ANATOMICAL_ENTITY", 168, 180], ["the bolus", "TREATMENT", 6, 15], ["a large volume", "TREATMENT", 85, 99], ["stomach", "ANATOMY", 32, 39], ["fundus", "ANATOMY", 45, 51], ["corpus muscles", "ANATOMY", 56, 70], ["large", "OBSERVATION_MODIFIER", 87, 92], ["volume", "OBSERVATION", 93, 99], ["upper", "ANATOMY_MODIFIER", 121, 126], ["stomach", "ANATOMY", 127, 134], ["significantly", "OBSERVATION_MODIFIER", 143, 156], ["increasing", "OBSERVATION_MODIFIER", 157, 167], ["intragastric pressure", "OBSERVATION", 168, 189]]], ["As the volume in the stomach increases, a subjective sensation of satiation develops (Burks and Villar, 1980).", [["stomach", "ANATOMY", 21, 28], ["stomach", "ORGAN", 21, 28], ["volume", "OBSERVATION_MODIFIER", 7, 13], ["stomach", "ANATOMY", 21, 28], ["increases", "OBSERVATION_MODIFIER", 29, 38]]], ["In view of the importance of loss of body weight as a sign of chemical toxicity, it is surprising that so little attention has been devoted to disordered sensory perception of gastric fullness as a mechanism of toxicity.Stomach(s) ::: IntroductionThe forestomachs in ruminants and camelids are esophageal dilations and modifications.", [["body", "ANATOMY", 37, 41], ["gastric", "ANATOMY", 176, 183], ["Stomach", "ANATOMY", 220, 227], ["forestomachs", "ANATOMY", 251, 263], ["camelids", "ANATOMY", 281, 289], ["esophageal", "ANATOMY", 294, 304], ["toxicity", "DISEASE", 71, 79], ["gastric fullness", "DISEASE", 176, 192], ["toxicity", "DISEASE", 211, 219], ["body", "ORGANISM_SUBDIVISION", 37, 41], ["gastric", "ORGAN", 176, 183], ["Stomach", "ORGAN", 220, 227], ["esophageal", "MULTI-TISSUE_STRUCTURE", 294, 304], ["loss of body weight", "PROBLEM", 29, 48], ["chemical toxicity", "PROBLEM", 62, 79], ["gastric fullness", "PROBLEM", 176, 192], ["toxicity", "PROBLEM", 211, 219], ["The forestomachs in ruminants", "TREATMENT", 247, 276], ["esophageal dilations", "TREATMENT", 294, 314], ["chemical toxicity", "OBSERVATION", 62, 79], ["gastric", "ANATOMY", 176, 183], ["fullness", "OBSERVATION", 184, 192], ["esophageal", "ANATOMY", 294, 304], ["dilations", "OBSERVATION", 305, 314]]], ["They house a digestive flora that produces short chain fatty acids from forage.", [["digestive flora", "ANATOMY", 13, 28], ["fatty acids", "CHEMICAL", 55, 66], ["short chain fatty acids", "CHEMICAL", 43, 66], ["digestive flora", "PATHOLOGICAL_FORMATION", 13, 28], ["fatty acids", "AMINO_ACID", 55, 66], ["a digestive flora", "PROBLEM", 11, 28], ["short chain fatty acids", "PROBLEM", 43, 66]]], ["These fatty acids are directly absorbed into the bloodstream along with sodium and chloride.", [["bloodstream", "ANATOMY", 49, 60], ["fatty acids", "CHEMICAL", 6, 17], ["sodium and chloride", "CHEMICAL", 72, 91], ["fatty acids", "CHEMICAL", 6, 17], ["sodium", "CHEMICAL", 72, 78], ["chloride", "CHEMICAL", 83, 91], ["fatty acids", "SIMPLE_CHEMICAL", 6, 17], ["sodium", "SIMPLE_CHEMICAL", 72, 78], ["chloride", "SIMPLE_CHEMICAL", 83, 91], ["These fatty acids", "PROBLEM", 0, 17], ["sodium and chloride", "TREATMENT", 72, 91], ["fatty acids", "OBSERVATION", 6, 17], ["bloodstream", "OBSERVATION_MODIFIER", 49, 60]]], ["Most clinical disease of the forestomachs relates to disruptions in coordinated motility and changes in pH.", [["forestomachs", "ANATOMY", 29, 41], ["forestomachs", "CANCER", 29, 41], ["Most clinical disease of the forestomachs", "PROBLEM", 0, 41], ["disruptions in coordinated motility", "PROBLEM", 53, 88], ["changes in pH", "PROBLEM", 93, 106], ["disease", "OBSERVATION", 14, 21], ["disruptions", "OBSERVATION", 53, 64], ["coordinated", "OBSERVATION_MODIFIER", 68, 79], ["motility", "OBSERVATION_MODIFIER", 80, 88]]], ["Camelid forestomachs have glandular sacculations.", [["forestomachs", "ANATOMY", 8, 20], ["glandular", "ANATOMY", 26, 35], ["glandular sacculations", "PATHOLOGICAL_FORMATION", 26, 48], ["glandular sacculations", "PROBLEM", 26, 48], ["glandular sacculations", "OBSERVATION", 26, 48]]], ["Equids and some rodents have stomachs that are divided into proximal stratified and aboral glandular portions.", [["stomachs", "ANATOMY", 29, 37], ["aboral glandular portions", "ANATOMY", 84, 109], ["stomachs", "ORGAN", 29, 37], ["aboral glandular portions", "TISSUE", 84, 109], ["stomachs", "ANATOMY", 29, 37], ["proximal", "ANATOMY_MODIFIER", 60, 68], ["aboral", "ANATOMY_MODIFIER", 84, 90], ["glandular", "ANATOMY", 91, 100], ["portions", "ANATOMY_MODIFIER", 101, 109]]], ["Swine have only a small stratified portion that directly surrounds the esophageal os.", [["esophageal", "ANATOMY", 71, 81], ["esophageal", "ORGAN", 71, 81], ["Swine", "SPECIES", 0, 5], ["a small stratified portion", "PROBLEM", 16, 42], ["small", "OBSERVATION_MODIFIER", 18, 23], ["esophageal", "ANATOMY", 71, 81], ["os", "OBSERVATION", 82, 84]]], ["The abomasum/C3 functions similar to the stomachs of monogastric mammals (Gelberg, 2016).Stomach(s) ::: IntroductionThe secretory gastric, small intestinal, and colonic mucosae are lined by a single layer of columnar epithelial cells.", [["stomachs", "ANATOMY", 41, 49], ["Stomach", "ANATOMY", 89, 96], ["secretory gastric", "ANATOMY", 120, 137], ["small intestinal", "ANATOMY", 139, 155], ["colonic mucosae", "ANATOMY", 161, 176], ["columnar epithelial cells", "ANATOMY", 208, 233], ["abomasum", "ORGAN", 4, 12], ["C3", "GENE_OR_GENE_PRODUCT", 13, 15], ["stomachs", "ORGAN", 41, 49], ["Stomach", "ORGAN", 89, 96], ["gastric", "ORGAN", 130, 137], ["small intestinal", "ORGAN", 139, 155], ["colonic mucosae", "TISSUE", 161, 176], ["columnar epithelial cells", "CELL", 208, 233], ["columnar epithelial cells", "CELL_TYPE", 208, 233], ["The abomasum/C3 functions", "PROBLEM", 0, 25], ["The secretory gastric, small intestinal, and colonic mucosae", "PROBLEM", 116, 176], ["abomasum", "ANATOMY", 4, 12], ["C3 functions", "OBSERVATION", 13, 25], ["stomachs", "ANATOMY", 41, 49], ["monogastric mammals", "ANATOMY", 53, 72], ["gastric", "ANATOMY", 130, 137], ["small intestinal", "ANATOMY", 139, 155], ["colonic mucosae", "ANATOMY", 161, 176], ["single layer", "OBSERVATION_MODIFIER", 192, 204], ["columnar epithelial cells", "OBSERVATION", 208, 233]]], ["The mucosal surface of the stomach is covered by mucus-secreting cells and, in the fundus and corpus, gastric crypts.", [["mucosal surface", "ANATOMY", 4, 19], ["stomach", "ANATOMY", 27, 34], ["mucus", "ANATOMY", 49, 54], ["cells", "ANATOMY", 65, 70], ["fundus", "ANATOMY", 83, 89], ["corpus", "ANATOMY", 94, 100], ["gastric crypts", "ANATOMY", 102, 116], ["mucosal surface", "MULTI-TISSUE_STRUCTURE", 4, 19], ["stomach", "ORGAN", 27, 34], ["mucus", "ORGANISM_SUBSTANCE", 49, 54], ["cells", "CELL", 65, 70], ["fundus", "MULTI-TISSUE_STRUCTURE", 83, 89], ["corpus", "MULTI-TISSUE_STRUCTURE", 94, 100], ["gastric crypts", "MULTI-TISSUE_STRUCTURE", 102, 116], ["mucus-secreting cells", "CELL_TYPE", 49, 70], ["mucosal", "ANATOMY_MODIFIER", 4, 11], ["surface", "ANATOMY_MODIFIER", 12, 19], ["stomach", "ANATOMY", 27, 34], ["mucus", "OBSERVATION", 49, 54], ["secreting cells", "OBSERVATION", 55, 70], ["fundus", "ANATOMY", 83, 89], ["corpus", "ANATOMY", 94, 100], ["gastric", "ANATOMY", 102, 109], ["crypts", "ANATOMY_MODIFIER", 110, 116]]], ["At the base of the crypts are branching gastric glands (Lloyd and Debas, 1994).Stomach(s) ::: IntroductionThe glandular stomach (abomasum, C3) is responsible for enzymatic and hydrolytic digestion of ingesta.", [["crypts", "ANATOMY", 19, 25], ["gastric glands", "ANATOMY", 40, 54], ["Stomach", "ANATOMY", 79, 86], ["glandular stomach", "ANATOMY", 110, 127], ["abomasum", "ANATOMY", 129, 137], ["crypts", "MULTI-TISSUE_STRUCTURE", 19, 25], ["gastric glands", "ORGAN", 40, 54], ["Stomach", "ORGAN", 79, 86], ["glandular stomach", "ORGAN", 110, 127], ["abomasum", "ORGAN", 129, 137], ["C3", "GENE_OR_GENE_PRODUCT", 139, 141], ["enzymatic and hydrolytic digestion of ingesta", "PROBLEM", 162, 207], ["base", "ANATOMY_MODIFIER", 7, 11], ["crypts", "ANATOMY_MODIFIER", 19, 25], ["branching", "ANATOMY_MODIFIER", 30, 39], ["gastric glands", "ANATOMY", 40, 54], ["glandular", "ANATOMY_MODIFIER", 110, 119], ["stomach", "ANATOMY", 120, 127], ["abomasum", "ANATOMY", 129, 137], ["hydrolytic digestion", "OBSERVATION", 176, 196]]], ["The glandular stomach is composed of a variety of cell types with bidirectional proliferation of cells from the neck of the gastric glands (Fig. 2).", [["glandular stomach", "ANATOMY", 4, 21], ["cell", "ANATOMY", 50, 54], ["cells", "ANATOMY", 97, 102], ["neck", "ANATOMY", 112, 116], ["gastric glands", "ANATOMY", 124, 138], ["glandular stomach", "ORGAN", 4, 21], ["cell", "CELL", 50, 54], ["cells", "CELL", 97, 102], ["neck", "ORGAN", 112, 116], ["gastric glands", "ORGAN", 124, 138], ["bidirectional proliferation of cells", "PROBLEM", 66, 102], ["glandular", "ANATOMY_MODIFIER", 4, 13], ["stomach", "ANATOMY", 14, 21], ["variety", "OBSERVATION_MODIFIER", 39, 46], ["cell types", "OBSERVATION", 50, 60], ["bidirectional proliferation", "OBSERVATION", 66, 93], ["of cells", "OBSERVATION", 94, 102], ["neck", "ANATOMY", 112, 116], ["gastric glands", "ANATOMY", 124, 138]]], ["The epithelial layer is one cell thick, and the turnover rate is 2\u20134 days.", [["epithelial layer", "ANATOMY", 4, 20], ["cell", "ANATOMY", 28, 32], ["epithelial layer", "TISSUE", 4, 20], ["cell", "CELL", 28, 32], ["epithelial", "ANATOMY_MODIFIER", 4, 14], ["layer", "OBSERVATION_MODIFIER", 15, 20], ["one cell", "OBSERVATION_MODIFIER", 24, 32], ["thick", "OBSERVATION_MODIFIER", 33, 38]]], ["There are three types of exocrine cells in the stomach: parietal, chief, and mucus.", [["exocrine cells", "ANATOMY", 25, 39], ["stomach", "ANATOMY", 47, 54], ["parietal", "ANATOMY", 56, 64], ["mucus", "ANATOMY", 77, 82], ["exocrine cells", "CELL", 25, 39], ["stomach", "ORGAN", 47, 54], ["parietal", "MULTI-TISSUE_STRUCTURE", 56, 64], ["mucus", "TISSUE", 77, 82], ["exocrine cells", "CELL_TYPE", 25, 39], ["exocrine cells", "OBSERVATION", 25, 39], ["stomach", "ANATOMY", 47, 54], ["parietal", "ANATOMY_MODIFIER", 56, 64], ["mucus", "ANATOMY", 77, 82]]], ["The parietal cells produce rennin that coagulates milk protein, intrinsic factor for vitamin B12 absorption, and HCL.", [["parietal cells", "ANATOMY", 4, 18], ["milk", "ANATOMY", 50, 54], ["vitamin B12", "CHEMICAL", 85, 96], ["HCL", "CHEMICAL", 113, 116], ["vitamin B12", "CHEMICAL", 85, 96], ["parietal cells", "CELL", 4, 18], ["rennin", "SIMPLE_CHEMICAL", 27, 33], ["milk", "ORGANISM_SUBSTANCE", 50, 54], ["vitamin B12", "SIMPLE_CHEMICAL", 85, 96], ["HCL", "CANCER", 113, 116], ["parietal cells", "CELL_TYPE", 4, 18], ["rennin", "PROTEIN", 27, 33], ["milk protein", "PROTEIN", 50, 62], ["intrinsic factor", "PROTEIN", 64, 80], ["vitamin B12 absorption", "TEST", 85, 107], ["HCL", "TREATMENT", 113, 116], ["parietal cells", "ANATOMY", 4, 18]]], ["Chief cells produce zymogen, pepsinogen, and gastric lipase.", [["cells", "ANATOMY", 6, 11], ["gastric", "ANATOMY", 45, 52], ["cells", "CELL", 6, 11], ["zymogen", "GENE_OR_GENE_PRODUCT", 20, 27], ["pepsinogen", "GENE_OR_GENE_PRODUCT", 29, 39], ["gastric lipase", "GENE_OR_GENE_PRODUCT", 45, 59], ["zymogen", "PROTEIN", 20, 27], ["pepsinogen", "PROTEIN", 29, 39], ["gastric lipase", "PROTEIN", 45, 59], ["zymogen", "TEST", 20, 27], ["pepsinogen", "TEST", 29, 39], ["gastric lipase", "TEST", 45, 59], ["gastric", "ANATOMY", 45, 52], ["lipase", "OBSERVATION", 53, 59]]], ["Mucus cells of the surface and gastric pits produce bicarbonate and an unstirred protective layer on the cell surface.", [["Mucus cells", "ANATOMY", 0, 11], ["surface", "ANATOMY", 19, 26], ["gastric pits", "ANATOMY", 31, 43], ["cell surface", "ANATOMY", 105, 117], ["bicarbonate", "CHEMICAL", 52, 63], ["bicarbonate", "CHEMICAL", 52, 63], ["Mucus cells", "CELL", 0, 11], ["surface", "CELLULAR_COMPONENT", 19, 26], ["gastric pits", "MULTI-TISSUE_STRUCTURE", 31, 43], ["bicarbonate", "SIMPLE_CHEMICAL", 52, 63], ["cell surface", "CELLULAR_COMPONENT", 105, 117], ["Mucus cells", "CELL_TYPE", 0, 11], ["Mucus cells", "PROBLEM", 0, 11], ["bicarbonate", "TREATMENT", 52, 63], ["an unstirred protective layer", "TREATMENT", 68, 97], ["surface", "OBSERVATION_MODIFIER", 19, 26], ["gastric", "ANATOMY", 31, 38], ["pits", "ANATOMY_MODIFIER", 39, 43], ["unstirred", "OBSERVATION_MODIFIER", 71, 80], ["protective", "OBSERVATION_MODIFIER", 81, 91], ["layer", "OBSERVATION_MODIFIER", 92, 97], ["cell surface", "OBSERVATION", 105, 117]]], ["Gastric gland output in humans is 2\u20133 L day\u2212 1.", [["Gastric gland", "ANATOMY", 0, 13], ["Gastric gland output", "DISEASE", 0, 20], ["Gastric gland", "MULTI-TISSUE_STRUCTURE", 0, 13], ["humans", "ORGANISM", 24, 30], ["humans", "SPECIES", 24, 30], ["humans", "SPECIES", 24, 30], ["Gastric gland output", "TEST", 0, 20], ["gland", "ANATOMY", 8, 13], ["output", "OBSERVATION", 14, 20]]], ["The low luminal pH destroys many ingested pathogens, but there is a resident bacterial flora that cannot be cultured by conventional methods.", [["luminal", "ANATOMY", 8, 15], ["luminal", "CHEMICAL", 8, 15], ["luminal", "IMMATERIAL_ANATOMICAL_ENTITY", 8, 15], ["The low luminal pH destroys", "PROBLEM", 0, 27], ["ingested pathogens", "PROBLEM", 33, 51], ["a resident bacterial flora", "PROBLEM", 66, 92], ["low luminal", "OBSERVATION_MODIFIER", 4, 15], ["pH destroys", "OBSERVATION_MODIFIER", 16, 27], ["ingested", "OBSERVATION_MODIFIER", 33, 41], ["pathogens", "OBSERVATION", 42, 51], ["bacterial flora", "OBSERVATION", 77, 92]]], ["Enteroendocrine cells (G cells) of the gastric pits produce serotonin, gastrin, ghrelin, somatostatin, endothelin, histamine, enteroglucagon, and other hormones.Stomach(s) ::: IntroductionGastric ulcers occur in all species.", [["Enteroendocrine cells", "ANATOMY", 0, 21], ["G cells", "ANATOMY", 23, 30], ["gastric pits", "ANATOMY", 39, 51], ["Stomach", "ANATOMY", 161, 168], ["IntroductionGastric ulcers", "ANATOMY", 176, 202], ["serotonin", "CHEMICAL", 60, 69], ["gastrin", "CHEMICAL", 71, 78], ["histamine", "CHEMICAL", 115, 124], ["ulcers", "DISEASE", 196, 202], ["serotonin", "CHEMICAL", 60, 69], ["somatostatin", "CHEMICAL", 89, 101], ["histamine", "CHEMICAL", 115, 124], ["Enteroendocrine cells", "CELL", 0, 21], ["G cells", "CELL", 23, 30], ["gastric pits", "MULTI-TISSUE_STRUCTURE", 39, 51], ["serotonin", "GENE_OR_GENE_PRODUCT", 60, 69], ["gastrin", "GENE_OR_GENE_PRODUCT", 71, 78], ["ghrelin", "GENE_OR_GENE_PRODUCT", 80, 87], ["somatostatin", "GENE_OR_GENE_PRODUCT", 89, 101], ["endothelin", "GENE_OR_GENE_PRODUCT", 103, 113], ["histamine", "SIMPLE_CHEMICAL", 115, 124], ["enteroglucagon", "SIMPLE_CHEMICAL", 126, 140], ["Stomach", "ORGAN", 161, 168], ["IntroductionGastric ulcers", "PATHOLOGICAL_FORMATION", 176, 202], ["Enteroendocrine cells", "CELL_TYPE", 0, 21], ["G cells", "CELL_TYPE", 23, 30], ["Enteroendocrine cells", "TEST", 0, 21], ["serotonin", "TEST", 60, 69], ["gastrin", "TREATMENT", 71, 78], ["somatostatin", "TREATMENT", 89, 101], ["endothelin", "TREATMENT", 103, 113], ["histamine", "TREATMENT", 115, 124], ["enteroglucagon", "TREATMENT", 126, 140], ["IntroductionGastric ulcers", "PROBLEM", 176, 202], ["gastric", "ANATOMY", 39, 46], ["pits", "ANATOMY_MODIFIER", 47, 51], ["ulcers", "OBSERVATION", 196, 202], ["all species", "OBSERVATION_MODIFIER", 212, 223]]], ["Although the cause of ulcers, other than caustic agents and those caused by bacteria that can survive the extremely low pH of the stomach (Helicobacter spp.), is imprecisely understood, conditions necessary for ulcer development include local disturbances or trauma to the mucosal epithelial barrier, normal or high gastric acidity, and local disturbances to blood flow, including stress-induced and sympathetic-nervous-system-mediated arteriovenous shunts leading to ischemia.", [["ulcers", "ANATOMY", 22, 28], ["stomach", "ANATOMY", 130, 137], ["ulcer", "ANATOMY", 211, 216], ["mucosal epithelial barrier", "ANATOMY", 273, 299], ["gastric", "ANATOMY", 316, 323], ["blood", "ANATOMY", 359, 364], ["sympathetic-nervous-system", "ANATOMY", 400, 426], ["arteriovenous", "ANATOMY", 436, 449], ["ulcers", "DISEASE", 22, 28], ["ulcer", "DISEASE", 211, 216], ["trauma", "DISEASE", 259, 265], ["ischemia", "DISEASE", 468, 476], ["ulcers", "PATHOLOGICAL_FORMATION", 22, 28], ["stomach", "ORGAN", 130, 137], ["Helicobacter spp.", "ORGANISM", 139, 156], ["ulcer", "PATHOLOGICAL_FORMATION", 211, 216], ["mucosal epithelial barrier", "TISSUE", 273, 299], ["gastric", "ORGAN", 316, 323], ["blood", "ORGANISM_SUBSTANCE", 359, 364], ["nervous", "ANATOMICAL_SYSTEM", 412, 419], ["arteriovenous shunts", "PATHOLOGICAL_FORMATION", 436, 456], ["Helicobacter spp.", "SPECIES", 139, 156], ["Helicobacter spp.", "SPECIES", 139, 156], ["ulcers", "PROBLEM", 22, 28], ["caustic agents", "TREATMENT", 41, 55], ["bacteria", "PROBLEM", 76, 84], ["ulcer development", "PROBLEM", 211, 228], ["local disturbances", "PROBLEM", 237, 255], ["trauma", "PROBLEM", 259, 265], ["the mucosal epithelial barrier", "PROBLEM", 269, 299], ["high gastric acidity", "PROBLEM", 311, 331], ["local disturbances", "PROBLEM", 337, 355], ["blood flow", "TEST", 359, 369], ["stress-induced and sympathetic-nervous-system", "PROBLEM", 381, 426], ["arteriovenous shunts", "TREATMENT", 436, 456], ["ischemia", "PROBLEM", 468, 476], ["ulcers", "OBSERVATION", 22, 28], ["stomach", "ANATOMY", 130, 137], ["mucosal epithelial", "ANATOMY", 273, 291], ["high", "OBSERVATION_MODIFIER", 311, 315], ["gastric acidity", "OBSERVATION", 316, 331], ["nervous", "ANATOMY", 412, 419], ["arteriovenous shunts", "OBSERVATION", 436, 456], ["ischemia", "OBSERVATION", 468, 476]]], ["These physiologic changes allow pepsin and HCl into the submucosa where they cause chemical erosion of the protective epithelium.", [["submucosa", "ANATOMY", 56, 65], ["epithelium", "ANATOMY", 118, 128], ["HCl", "CHEMICAL", 43, 46], ["HCl", "CHEMICAL", 43, 46], ["pepsin", "GENE_OR_GENE_PRODUCT", 32, 38], ["HCl", "SIMPLE_CHEMICAL", 43, 46], ["submucosa", "MULTI-TISSUE_STRUCTURE", 56, 65], ["epithelium", "TISSUE", 118, 128], ["These physiologic changes", "PROBLEM", 0, 25], ["pepsin and HCl", "TREATMENT", 32, 46], ["chemical erosion of the protective epithelium", "PROBLEM", 83, 128], ["submucosa", "ANATOMY", 56, 65], ["chemical", "OBSERVATION_MODIFIER", 83, 91], ["erosion", "OBSERVATION", 92, 99], ["protective epithelium", "OBSERVATION", 107, 128]]], ["In addition, exogenous or endogenous steroids and nonsteroidal antiinflammatory drugs (NSAIDs) depress prostaglandin (PG) E1 and E2 decreasing phospholipid secretions that are gastroprotective.", [["steroids", "CHEMICAL", 37, 45], ["prostaglandin (PG) E1", "CHEMICAL", 103, 124], ["E2", "CHEMICAL", 129, 131], ["steroids", "CHEMICAL", 37, 45], ["prostaglandin", "CHEMICAL", 103, 116], ["steroids", "SIMPLE_CHEMICAL", 37, 45], ["nonsteroidal antiinflammatory drugs", "SIMPLE_CHEMICAL", 50, 85], ["NSAIDs", "SIMPLE_CHEMICAL", 87, 93], ["prostaglandin", "SIMPLE_CHEMICAL", 103, 116], ["PG) E1", "SIMPLE_CHEMICAL", 118, 124], ["E2", "SIMPLE_CHEMICAL", 129, 131], ["phospholipid", "SIMPLE_CHEMICAL", 143, 155], ["endogenous steroids", "TREATMENT", 26, 45], ["nonsteroidal antiinflammatory drugs", "TREATMENT", 50, 85], ["NSAIDs)", "TREATMENT", 87, 94], ["prostaglandin (PG) E1", "TREATMENT", 103, 124], ["E2 decreasing phospholipid secretions", "TREATMENT", 129, 166], ["endogenous steroids", "OBSERVATION", 26, 45]]], ["Gastric ulcers induced by alcohol consumption are dose related with effects ranging from a decrease in mucus production and bicarbonate secretion to leakage of bicarbonate and electrolytes to vascular damage (Rousseaux and Haschek, 2010).", [["Gastric ulcers", "ANATOMY", 0, 14], ["mucus", "ANATOMY", 103, 108], ["vascular", "ANATOMY", 192, 200], ["Gastric ulcers", "DISEASE", 0, 14], ["alcohol", "CHEMICAL", 26, 33], ["bicarbonate", "CHEMICAL", 124, 135], ["bicarbonate", "CHEMICAL", 160, 171], ["vascular damage", "DISEASE", 192, 207], ["alcohol", "CHEMICAL", 26, 33], ["bicarbonate", "CHEMICAL", 124, 135], ["bicarbonate", "CHEMICAL", 160, 171], ["Gastric ulcers", "PATHOLOGICAL_FORMATION", 0, 14], ["alcohol", "SIMPLE_CHEMICAL", 26, 33], ["mucus", "TISSUE", 103, 108], ["bicarbonate", "SIMPLE_CHEMICAL", 124, 135], ["bicarbonate", "SIMPLE_CHEMICAL", 160, 171], ["vascular", "MULTI-TISSUE_STRUCTURE", 192, 200], ["Gastric ulcers", "PROBLEM", 0, 14], ["a decrease in mucus production", "PROBLEM", 89, 119], ["bicarbonate secretion", "PROBLEM", 124, 145], ["bicarbonate", "TREATMENT", 160, 171], ["electrolytes to vascular damage", "PROBLEM", 176, 207], ["ulcers", "OBSERVATION", 8, 14], ["alcohol consumption", "OBSERVATION", 26, 45], ["decrease", "OBSERVATION_MODIFIER", 91, 99], ["mucus production", "OBSERVATION", 103, 119], ["vascular", "ANATOMY", 192, 200], ["damage", "OBSERVATION", 201, 207]]], ["Anecdotal evidence suggests that a propensity towards ulcer formation may be hereditable (Gelberg, 2016).", [["ulcer", "ANATOMY", 54, 59], ["ulcer", "DISEASE", 54, 59], ["ulcer", "PATHOLOGICAL_FORMATION", 54, 59], ["a propensity towards ulcer formation", "PROBLEM", 33, 69], ["ulcer", "OBSERVATION", 54, 59], ["may be", "UNCERTAINTY", 70, 76]]], ["A partial listing of ulcerogenic chemicals is in Table 3.Stomach(s) ::: IntroductionTobacco products increase gastric reflux, pepsinogen-1, and basal acid output while decreasing mucus production and pancreatic bicarbonate secretion resulting in duodenal ulceration (Hojgaard et al., 1996, Maity et al., 2003).", [["Stomach", "ANATOMY", 57, 64], ["gastric", "ANATOMY", 110, 117], ["mucus", "ANATOMY", 179, 184], ["pancreatic", "ANATOMY", 200, 210], ["duodenal", "ANATOMY", 246, 254], ["gastric reflux", "DISEASE", 110, 124], ["bicarbonate", "CHEMICAL", 211, 222], ["bicarbonate", "CHEMICAL", 211, 222], ["Stomach", "ORGAN", 57, 64], ["Tobacco", "ORGANISM", 84, 91], ["gastric", "ORGAN", 110, 117], ["pepsinogen-1", "GENE_OR_GENE_PRODUCT", 126, 138], ["basal acid", "SIMPLE_CHEMICAL", 144, 154], ["mucus", "ORGANISM_SUBSTANCE", 179, 184], ["pancreatic", "ORGAN", 200, 210], ["bicarbonate", "SIMPLE_CHEMICAL", 211, 222], ["duodenal ulceration", "PATHOLOGICAL_FORMATION", 246, 265], ["gastric reflux", "PROBLEM", 110, 124], ["pepsinogen", "TEST", 126, 136], ["basal acid output", "TEST", 144, 161], ["decreasing mucus production", "PROBLEM", 168, 195], ["pancreatic bicarbonate secretion", "PROBLEM", 200, 232], ["duodenal ulceration", "PROBLEM", 246, 265], ["partial", "OBSERVATION_MODIFIER", 2, 9], ["ulcerogenic chemicals", "OBSERVATION", 21, 42], ["gastric", "ANATOMY", 110, 117], ["reflux", "OBSERVATION", 118, 124], ["basal", "ANATOMY_MODIFIER", 144, 149], ["acid output", "OBSERVATION", 150, 161], ["decreasing", "OBSERVATION_MODIFIER", 168, 178], ["mucus production", "OBSERVATION", 179, 195], ["pancreatic", "ANATOMY", 200, 210], ["bicarbonate secretion", "OBSERVATION", 211, 232], ["duodenal", "ANATOMY", 246, 254], ["ulceration", "OBSERVATION", 255, 265]]], ["Mucus secretion is reduced due to decreases in total mucus neck cell numbers and neck cell mucus volume.", [["Mucus", "ANATOMY", 0, 5], ["mucus neck cell", "ANATOMY", 53, 68], ["neck cell mucus", "ANATOMY", 81, 96], ["Mucus", "MULTI-TISSUE_STRUCTURE", 0, 5], ["mucus neck cell", "CELL", 53, 68], ["neck cell mucus", "TISSUE", 81, 96], ["Mucus secretion", "PROBLEM", 0, 15], ["decreases in total mucus neck cell numbers", "PROBLEM", 34, 76], ["neck cell mucus volume", "TEST", 81, 103], ["decreases", "OBSERVATION_MODIFIER", 34, 43], ["mucus neck", "ANATOMY", 53, 63], ["cell numbers", "OBSERVATION", 64, 76], ["neck", "ANATOMY", 81, 85], ["cell", "OBSERVATION", 86, 90], ["mucus volume", "OBSERVATION", 91, 103]]], ["Nicotine elevations in vasopressin, platelet-activating factor (PAF), and endothelin and reductions in EGF, PGs, and ornithine decarboxylase-related repair mechanisms contribute to the severity of the ulcerations along with tobacco nitriles and aniline derivatives (Florin et al., 1980).Stomach(s) ::: IntroductionGastric mucosa damaged by exposure to high concentrations of sodium chloride can be repaired over a period of 6 h by migration of epithelial cells from the glands (Svanes et al., 1982).", [["Stomach", "ANATOMY", 287, 294], ["Gastric mucosa", "ANATOMY", 314, 328], ["epithelial cells", "ANATOMY", 444, 460], ["glands", "ANATOMY", 470, 476], ["Nicotine", "CHEMICAL", 0, 8], ["vasopressin", "CHEMICAL", 23, 34], ["ornithine", "CHEMICAL", 117, 126], ["ulcerations", "DISEASE", 201, 212], ["aniline", "CHEMICAL", 245, 252], ["sodium chloride", "CHEMICAL", 375, 390], ["Nicotine", "CHEMICAL", 0, 8], ["ornithine", "CHEMICAL", 117, 126], ["nitriles", "CHEMICAL", 232, 240], ["aniline", "CHEMICAL", 245, 252], ["sodium chloride", "CHEMICAL", 375, 390], ["Nicotine", "SIMPLE_CHEMICAL", 0, 8], ["vasopressin", "SIMPLE_CHEMICAL", 23, 34], ["platelet-activating factor", "GENE_OR_GENE_PRODUCT", 36, 62], ["PAF", "GENE_OR_GENE_PRODUCT", 64, 67], ["endothelin", "GENE_OR_GENE_PRODUCT", 74, 84], ["EGF", "GENE_OR_GENE_PRODUCT", 103, 106], ["PGs", "GENE_OR_GENE_PRODUCT", 108, 111], ["ornithine decarboxylase", "GENE_OR_GENE_PRODUCT", 117, 140], ["ulcerations", "PATHOLOGICAL_FORMATION", 201, 212], ["tobacco nitriles", "SIMPLE_CHEMICAL", 224, 240], ["aniline derivatives", "SIMPLE_CHEMICAL", 245, 264], ["Stomach", "ORGAN", 287, 294], ["Gastric mucosa", "MULTI-TISSUE_STRUCTURE", 314, 328], ["sodium chloride", "SIMPLE_CHEMICAL", 375, 390], ["epithelial cells", "CELL", 444, 460], ["glands", "ORGAN", 470, 476], ["platelet-activating factor", "PROTEIN", 36, 62], ["PAF", "PROTEIN", 64, 67], ["EGF", "PROTEIN", 103, 106], ["ornithine decarboxylase", "PROTEIN", 117, 140], ["epithelial cells", "CELL_TYPE", 444, 460], ["Nicotine elevations", "TREATMENT", 0, 19], ["vasopressin", "TREATMENT", 23, 34], ["platelet", "TEST", 36, 44], ["PAF", "PROBLEM", 64, 67], ["endothelin and reductions in EGF", "TREATMENT", 74, 106], ["PGs", "TREATMENT", 108, 111], ["ornithine decarboxylase", "TREATMENT", 117, 140], ["repair mechanisms", "TREATMENT", 149, 166], ["the ulcerations", "PROBLEM", 197, 212], ["tobacco nitriles", "TREATMENT", 224, 240], ["aniline derivatives", "TREATMENT", 245, 264], ["sodium chloride", "TREATMENT", 375, 390], ["epithelial cells", "PROBLEM", 444, 460], ["elevations", "OBSERVATION_MODIFIER", 9, 19], ["ulcerations", "OBSERVATION", 201, 212], ["Gastric mucosa", "ANATOMY", 314, 328], ["epithelial cells", "OBSERVATION", 444, 460], ["glands", "ANATOMY", 470, 476]]], ["Rapid epithelial restitution of the superficial mucosa is one of the primary defense mechanisms of the stomach, small intestine, and colon (Feil et al., 1989).", [["epithelial", "ANATOMY", 6, 16], ["superficial mucosa", "ANATOMY", 36, 54], ["stomach", "ANATOMY", 103, 110], ["small intestine", "ANATOMY", 112, 127], ["colon", "ANATOMY", 133, 138], ["epithelial", "TISSUE", 6, 16], ["superficial mucosa", "MULTI-TISSUE_STRUCTURE", 36, 54], ["stomach", "ORGAN", 103, 110], ["small intestine", "MULTI-TISSUE_STRUCTURE", 112, 127], ["colon", "ORGAN", 133, 138], ["Rapid epithelial restitution of the superficial mucosa", "PROBLEM", 0, 54], ["epithelial restitution", "OBSERVATION", 6, 28], ["superficial mucosa", "ANATOMY", 36, 54], ["one", "OBSERVATION_MODIFIER", 58, 61], ["primary defense", "OBSERVATION", 69, 84], ["stomach", "ANATOMY", 103, 110], ["small intestine", "ANATOMY", 112, 127], ["colon", "ANATOMY", 133, 138]]], ["Preservation of the basement membrane in the area of damage is critical for prevention or repair of lesions.", [["basement membrane", "ANATOMY", 20, 37], ["area", "ANATOMY", 45, 49], ["lesions", "ANATOMY", 100, 107], ["basement membrane", "CELLULAR_COMPONENT", 20, 37], ["lesions", "PATHOLOGICAL_FORMATION", 100, 107], ["damage", "PROBLEM", 53, 59], ["repair", "TREATMENT", 90, 96], ["lesions", "PROBLEM", 100, 107], ["basement", "OBSERVATION_MODIFIER", 20, 28], ["membrane", "OBSERVATION_MODIFIER", 29, 37], ["area", "OBSERVATION_MODIFIER", 45, 49], ["damage", "OBSERVATION", 53, 59], ["repair", "OBSERVATION", 90, 96], ["lesions", "OBSERVATION", 100, 107]]], ["Indirect damage may occur when blood flow is compromised.Stomach(s) ::: IntroductionThe liquid component of a mixed meal usually empties faster than the solid component.", [["blood", "ANATOMY", 31, 36], ["Stomach", "ANATOMY", 57, 64], ["blood", "ORGANISM_SUBSTANCE", 31, 36], ["Stomach", "ORGAN", 57, 64], ["Indirect damage", "PROBLEM", 0, 15], ["blood flow", "TEST", 31, 41], ["The liquid component", "TREATMENT", 84, 104], ["a mixed meal", "TREATMENT", 108, 120], ["damage", "OBSERVATION", 9, 15], ["liquid component", "OBSERVATION_MODIFIER", 88, 104], ["mixed", "OBSERVATION_MODIFIER", 110, 115], ["solid component", "OBSERVATION_MODIFIER", 153, 168]]], ["Low pH or high osmolarity tends to decrease the rate of gastric emptying (Read, 1994).", [["gastric", "ANATOMY", 56, 63], ["gastric", "ORGAN", 56, 63], ["Low pH", "PROBLEM", 0, 6], ["high osmolarity", "PROBLEM", 10, 25], ["gastric emptying", "TEST", 56, 72], ["gastric", "ANATOMY", 56, 63]]], ["Effective gastric emptying requires coordinated propulsive contractions in the antrum that progress to the pyloric canal along with properly timed relaxation of the upper duodenum (Lin, 1994).", [["gastric", "ANATOMY", 10, 17], ["antrum", "ANATOMY", 79, 85], ["pyloric canal", "ANATOMY", 107, 120], ["upper duodenum", "ANATOMY", 165, 179], ["gastric", "MULTI-TISSUE_STRUCTURE", 10, 17], ["antrum", "MULTI-TISSUE_STRUCTURE", 79, 85], ["pyloric canal", "MULTI-TISSUE_STRUCTURE", 107, 120], ["upper duodenum", "ORGAN", 165, 179], ["Effective gastric emptying", "PROBLEM", 0, 26], ["coordinated propulsive contractions in the antrum", "PROBLEM", 36, 85], ["gastric", "ANATOMY", 10, 17], ["emptying", "OBSERVATION", 18, 26], ["propulsive contractions", "OBSERVATION", 48, 71], ["antrum", "ANATOMY", 79, 85], ["pyloric canal", "ANATOMY", 107, 120], ["relaxation", "OBSERVATION", 147, 157], ["upper", "ANATOMY_MODIFIER", 165, 170], ["duodenum", "ANATOMY", 171, 179]]], ["Some drugs and toxins reduce the rate of gastric emptying by producing contractions of the duodenum that abolish the antral\u2013duodenal pressure gradient required for effective emptying (Burks, 1994; Malbert et al., 1994).Stomach(s) ::: IntroductionBecause the alimentary lumen is markedly acidic in the stomach and slightly alkaline in the intestine, the degree of ionization of xenobiotics varies by the pKa(s) of the molecule.", [["gastric", "ANATOMY", 41, 48], ["duodenum", "ANATOMY", 91, 99], ["antral\u2013duodenal", "ANATOMY", 117, 132], ["Stomach", "ANATOMY", 219, 226], ["alimentary lumen", "ANATOMY", 258, 274], ["stomach", "ANATOMY", 301, 308], ["intestine", "ANATOMY", 338, 347], ["gastric", "ORGAN", 41, 48], ["duodenum", "ORGAN", 91, 99], ["Stomach", "ORGAN", 219, 226], ["alimentary lumen", "MULTI-TISSUE_STRUCTURE", 258, 274], ["stomach", "ORGAN", 301, 308], ["intestine", "ORGAN", 338, 347], ["Some drugs", "TREATMENT", 0, 10], ["toxins", "TREATMENT", 15, 21], ["gastric emptying", "PROBLEM", 41, 57], ["contractions of the duodenum", "PROBLEM", 71, 99], ["the antral\u2013duodenal pressure gradient", "TREATMENT", 113, 150], ["markedly acidic in the stomach", "PROBLEM", 278, 308], ["slightly alkaline in the intestine", "PROBLEM", 313, 347], ["ionization of xenobiotics", "TREATMENT", 363, 388], ["gastric", "ANATOMY", 41, 48], ["emptying", "OBSERVATION", 49, 57], ["duodenum", "ANATOMY", 91, 99], ["pressure gradient", "OBSERVATION", 133, 150], ["alimentary lumen", "OBSERVATION", 258, 274], ["markedly", "OBSERVATION_MODIFIER", 278, 286], ["acidic", "OBSERVATION", 287, 293], ["stomach", "ANATOMY", 301, 308], ["slightly", "OBSERVATION_MODIFIER", 313, 321], ["alkaline", "OBSERVATION", 322, 330], ["intestine", "ANATOMY", 338, 347], ["degree", "OBSERVATION_MODIFIER", 353, 359], ["ionization", "OBSERVATION", 363, 373], ["xenobiotics varies", "OBSERVATION", 377, 395]]], ["Nonionized forms cross cell membranes more readily and can pass into the mucosa depending on the local pH.", [["cell membranes", "ANATOMY", 23, 37], ["mucosa", "ANATOMY", 73, 79], ["cell membranes", "CELLULAR_COMPONENT", 23, 37], ["mucosa", "MULTI-TISSUE_STRUCTURE", 73, 79], ["Nonionized forms cross cell membranes", "PROBLEM", 0, 37], ["the local pH", "TEST", 93, 105], ["cross cell membranes", "OBSERVATION", 17, 37], ["mucosa", "ANATOMY", 73, 79]]], ["The gastric mucosa may therefore be a target for acidic compounds such as NSAIDs (Betton, 2013).Intestine ::: IntroductionThe small intestine functions in digestion, secretion, and absorption.", [["gastric mucosa", "ANATOMY", 4, 18], ["Intestine", "ANATOMY", 96, 105], ["intestine", "ANATOMY", 132, 141], ["NSAIDs", "CHEMICAL", 74, 80], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 4, 18], ["NSAIDs", "SIMPLE_CHEMICAL", 74, 80], ["Intestine", "ORGAN", 96, 105], ["intestine", "ORGAN", 132, 141], ["acidic compounds", "PROBLEM", 49, 65], ["NSAIDs", "TREATMENT", 74, 80], ["gastric mucosa", "ANATOMY", 4, 18], ["small", "OBSERVATION_MODIFIER", 126, 131], ["intestine", "ANATOMY", 132, 141]]], ["The small intestinal functional surface area is one cell thick but is markedly increased by the presence of numerous mucosal folds that contain finger-like villi (Fig. 3).", [["intestinal", "ANATOMY", 10, 20], ["surface area", "ANATOMY", 32, 44], ["cell", "ANATOMY", 52, 56], ["mucosal folds", "ANATOMY", 117, 130], ["finger-like villi", "ANATOMY", 144, 161], ["intestinal", "ORGAN", 10, 20], ["cell", "CELL", 52, 56], ["mucosal", "PATHOLOGICAL_FORMATION", 117, 124], ["villi", "MULTI-TISSUE_STRUCTURE", 156, 161], ["numerous mucosal folds", "PROBLEM", 108, 130], ["small", "OBSERVATION_MODIFIER", 4, 9], ["intestinal", "ANATOMY", 10, 20], ["functional", "OBSERVATION_MODIFIER", 21, 31], ["surface", "OBSERVATION_MODIFIER", 32, 39], ["area", "OBSERVATION_MODIFIER", 40, 44], ["one cell thick", "OBSERVATION", 48, 62], ["markedly", "OBSERVATION_MODIFIER", 70, 78], ["increased", "OBSERVATION_MODIFIER", 79, 88], ["numerous", "OBSERVATION_MODIFIER", 108, 116], ["mucosal folds", "ANATOMY", 117, 130], ["finger", "ANATOMY", 144, 150], ["like villi", "ANATOMY", 151, 161]]], ["Each villus consists of 2000\u20138000 epithelial cells and is surrounded by 6\u201314 crypts of Lieberkuhn.", [["villus", "ANATOMY", 5, 11], ["epithelial cells", "ANATOMY", 34, 50], ["crypts", "ANATOMY", 77, 83], ["villus", "MULTI-TISSUE_STRUCTURE", 5, 11], ["epithelial cells", "CELL", 34, 50], ["crypts", "MULTI-TISSUE_STRUCTURE", 77, 83], ["epithelial cells", "CELL_TYPE", 34, 50], ["villus", "ANATOMY", 5, 11], ["epithelial cells", "OBSERVATION", 34, 50]]], ["Each absorptive cell on these villi has a microvillus border that further increases surface area and has a glycocalyx housing the digestive enzymes (Fig. 3).", [["absorptive cell", "ANATOMY", 5, 20], ["villi", "ANATOMY", 30, 35], ["microvillus border", "ANATOMY", 42, 60], ["surface area", "ANATOMY", 84, 96], ["glycocalyx", "ANATOMY", 107, 117], ["absorptive cell", "CELL", 5, 20], ["villi", "MULTI-TISSUE_STRUCTURE", 30, 35], ["microvillus border", "CELLULAR_COMPONENT", 42, 60], ["digestive enzymes", "PROTEIN", 130, 147], ["a microvillus border", "PROBLEM", 40, 60], ["the digestive enzymes", "TEST", 126, 147], ["absorptive cell", "OBSERVATION", 5, 20], ["villi", "ANATOMY", 30, 35], ["increases", "OBSERVATION_MODIFIER", 74, 83], ["surface", "OBSERVATION_MODIFIER", 84, 91]]], ["Damage to any of these structures may result in dysfunction.", [["Damage", "PROBLEM", 0, 6], ["dysfunction", "PROBLEM", 48, 59], ["dysfunction", "OBSERVATION", 48, 59]]], ["In humans, it is estimated that the one cell thick surface area of the alimentary system is 300\u2013400 m2 (Corruzi, 2010).Intestine ::: IntroductionThe \u201cunstirred water layer\u201d adjacent to the GI lumen is a diffusion barrier.", [["cell", "ANATOMY", 40, 44], ["surface area", "ANATOMY", 51, 63], ["alimentary system", "ANATOMY", 71, 88], ["Intestine", "ANATOMY", 119, 128], ["GI lumen", "ANATOMY", 189, 197], ["humans", "ORGANISM", 3, 9], ["cell", "CELL", 40, 44], ["alimentary", "ORGAN", 71, 81], ["Intestine", "ORGAN", 119, 128], ["GI lumen", "MULTI-TISSUE_STRUCTURE", 189, 197], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["The \u201cunstirred water layer", "TREATMENT", 145, 171], ["a diffusion barrier", "TREATMENT", 201, 220], ["alimentary system", "ANATOMY", 71, 88], ["GI", "ANATOMY", 189, 191], ["lumen", "ANATOMY_MODIFIER", 192, 197]]], ["When a xenobiotic crosses this unstirred water layer and the acid mucolayer, it reaches the surface epithelium.", [["surface epithelium", "ANATOMY", 92, 110], ["surface epithelium", "TISSUE", 92, 110], ["a xenobiotic crosses this unstirred water layer", "TREATMENT", 5, 52], ["the acid mucolayer", "TREATMENT", 57, 75], ["acid mucolayer", "OBSERVATION", 61, 75], ["surface", "ANATOMY_MODIFIER", 92, 99], ["epithelium", "ANATOMY_MODIFIER", 100, 110]]], ["The two main pathways for substances to enter the membrane are transcellular (through the cells) and paracellular (between the cells) (Gad, 2007).Intestine ::: IntroductionTranscellular transport mechanisms may be passive such as in diffusion, filtration, osmosis, or facilitated diffusion.", [["membrane", "ANATOMY", 50, 58], ["cells", "ANATOMY", 90, 95], ["paracellular", "ANATOMY", 101, 113], ["cells", "ANATOMY", 127, 132], ["Intestine", "ANATOMY", 146, 155], ["Transcellular", "ANATOMY", 172, 185], ["membrane", "CELLULAR_COMPONENT", 50, 58], ["transcellular", "IMMATERIAL_ANATOMICAL_ENTITY", 63, 76], ["cells", "CELL", 90, 95], ["paracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 101, 113], ["cells", "CELL", 127, 132], ["Intestine", "ORGAN", 146, 155], ["substances", "TREATMENT", 26, 36], ["IntroductionTranscellular transport mechanisms", "TREATMENT", 160, 206], ["osmosis", "PROBLEM", 256, 263], ["facilitated diffusion", "PROBLEM", 268, 289], ["main", "OBSERVATION_MODIFIER", 8, 12], ["substances", "OBSERVATION", 26, 36], ["membrane", "ANATOMY_MODIFIER", 50, 58], ["transcellular", "OBSERVATION_MODIFIER", 63, 76], ["paracellular", "ANATOMY_MODIFIER", 101, 113]]], ["Active transcellular transport may be direct or indirect such as by endocytosis, pinocytosis, phagocytosis, receptor-mediated endocytosis, or exocytosis (Kapp, 2007).", [["transcellular", "ANATOMY", 7, 20], ["transcellular", "IMMATERIAL_ANATOMICAL_ENTITY", 7, 20], ["pinocytosis", "PROBLEM", 81, 92], ["phagocytosis", "PROBLEM", 94, 106], ["receptor-mediated endocytosis", "PROBLEM", 108, 137], ["exocytosis", "PROBLEM", 142, 152]]], ["Paracellular transport pathways allow the passive movement of substances through intercellular epithelial cell spaces regulated by apical tight junctions.", [["Paracellular", "ANATOMY", 0, 12], ["intercellular epithelial cell", "ANATOMY", 81, 110], ["apical tight junctions", "ANATOMY", 131, 153], ["intercellular epithelial cell", "CELL", 81, 110], ["apical tight junctions", "CELLULAR_COMPONENT", 131, 153], ["intercellular epithelial cell spaces", "CELL_TYPE", 81, 117], ["Paracellular transport pathways", "TREATMENT", 0, 31], ["intercellular epithelial cell spaces", "TREATMENT", 81, 117], ["passive movement", "OBSERVATION", 42, 58], ["intercellular", "ANATOMY_MODIFIER", 81, 94], ["epithelial cell spaces", "OBSERVATION", 95, 117], ["apical", "ANATOMY_MODIFIER", 131, 137], ["tight junctions", "OBSERVATION", 138, 153]]], ["These tight junctions permit ion but not large molecule passage.", [["tight junctions", "ANATOMY", 6, 21], ["tight junctions", "CELLULAR_COMPONENT", 6, 21], ["large molecule passage", "PROBLEM", 41, 63], ["large", "OBSERVATION_MODIFIER", 41, 46], ["molecule", "OBSERVATION_MODIFIER", 47, 55], ["passage", "OBSERVATION_MODIFIER", 56, 63]]], ["Passage through the tight junction is dependent on xenobiotic molecular size, net charge, intra- and extracellular calcium ion concentration, osmolarity, protein kinase inhibitors, and junctional complex proteins including claudin, occludin, and the junctional adhesion molecule (JAM) (Kapp, 2007).Intestine ::: IntroductionThe epithelial cells rest on a basement membrane subjacent to which is a mesenchymal lamina propria containing blood vessels and a central, blind-ended lymphatic or lacteal (Fig. 4).", [["tight junction", "ANATOMY", 20, 34], ["extracellular", "ANATOMY", 101, 114], ["Intestine", "ANATOMY", 298, 307], ["epithelial cells", "ANATOMY", 328, 344], ["basement membrane", "ANATOMY", 355, 372], ["mesenchymal lamina propria", "ANATOMY", 397, 423], ["blood vessels", "ANATOMY", 435, 448], ["lymphatic", "ANATOMY", 476, 485], ["lacteal", "ANATOMY", 489, 496], ["calcium", "CHEMICAL", 115, 122], ["calcium", "CHEMICAL", 115, 122], ["tight junction", "CELLULAR_COMPONENT", 20, 34], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 101, 114], ["calcium", "SIMPLE_CHEMICAL", 115, 122], ["claudin", "GENE_OR_GENE_PRODUCT", 223, 230], ["occludin", "GENE_OR_GENE_PRODUCT", 232, 240], ["junctional adhesion molecule", "GENE_OR_GENE_PRODUCT", 250, 278], ["JAM", "GENE_OR_GENE_PRODUCT", 280, 283], ["Intestine", "ORGAN", 298, 307], ["epithelial cells", "CELL", 328, 344], ["basement membrane", "CELLULAR_COMPONENT", 355, 372], ["mesenchymal lamina propria", "TISSUE", 397, 423], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 435, 448], ["lymphatic", "TISSUE", 476, 485], ["protein kinase inhibitors", "PROTEIN", 154, 179], ["junctional complex proteins", "PROTEIN", 185, 212], ["claudin", "PROTEIN", 223, 230], ["occludin", "PROTEIN", 232, 240], ["junctional adhesion molecule", "PROTEIN", 250, 278], ["JAM", "PROTEIN", 280, 283], ["epithelial cells", "CELL_TYPE", 328, 344], ["intra- and extracellular calcium ion concentration", "TEST", 90, 140], ["osmolarity", "TEST", 142, 152], ["protein kinase inhibitors", "TEST", 154, 179], ["junctional complex proteins", "PROBLEM", 185, 212], ["claudin, occludin", "TREATMENT", 223, 240], ["the junctional adhesion molecule", "PROBLEM", 246, 278], ["The epithelial cells", "PROBLEM", 324, 344], ["a basement membrane", "TREATMENT", 353, 372], ["a central, blind-ended lymphatic or lacteal (Fig.", "PROBLEM", 453, 502], ["tight junction", "OBSERVATION", 20, 34], ["dependent", "OBSERVATION_MODIFIER", 38, 47], ["xenobiotic molecular", "OBSERVATION_MODIFIER", 51, 71], ["size", "OBSERVATION_MODIFIER", 72, 76], ["net charge", "OBSERVATION", 78, 88], ["junctional adhesion", "OBSERVATION", 250, 269], ["epithelial cells", "OBSERVATION", 328, 344], ["mesenchymal", "ANATOMY_MODIFIER", 397, 408], ["lamina", "ANATOMY_MODIFIER", 409, 415], ["propria", "ANATOMY_MODIFIER", 416, 423], ["blood vessels", "ANATOMY", 435, 448], ["central", "OBSERVATION_MODIFIER", 455, 462], ["blind", "OBSERVATION", 464, 469], ["lymphatic", "ANATOMY", 476, 485]]], ["Villus height and crypt depth decrease aborally through the gut, while the number of goblet (mucus) cells increases.", [["Villus", "ANATOMY", 0, 6], ["crypt", "ANATOMY", 18, 23], ["gut", "ANATOMY", 60, 63], ["goblet (mucus) cells", "ANATOMY", 85, 105], ["Villus", "TISSUE", 0, 6], ["crypt", "TISSUE", 18, 23], ["gut", "ORGANISM_SUBDIVISION", 60, 63], ["goblet (mucus) cells", "CELL", 85, 105], ["goblet (mucus) cells", "CELL_TYPE", 85, 105], ["Villus height", "PROBLEM", 0, 13], ["crypt depth", "PROBLEM", 18, 29], ["goblet (mucus) cells", "PROBLEM", 85, 105], ["height", "OBSERVATION_MODIFIER", 7, 13], ["crypt depth", "OBSERVATION", 18, 29], ["decrease", "OBSERVATION_MODIFIER", 30, 38], ["gut", "ANATOMY", 60, 63]]], ["The submucosal duodenal (Brunner\u2019s) glands secrete an alkaline mucus that helps neutralize gastric acid.Intestine ::: IntroductionEnterocytes are rich in inducible cytochrome P450s (CYPs), microperoxisomes, UDP glucuronosyl transferase, glutathione S-transferases (microsomal GSTs), N-acetyl transferase, hydrolases of many types, azo-reductases (sulphasalazine is metabolized to 5-aminosalicylic acid in the colon), glucuronidases (metabolizing bile salts, thyroid hormone, drug glucuronides), nitro-reductases, glycosidase (cycasin is metabolized to methylazoxymethanol), and others (Fig. 5).", [["submucosal duodenal", "ANATOMY", 4, 23], ["Brunner\u2019s) glands", "ANATOMY", 25, 42], ["mucus", "ANATOMY", 63, 68], ["gastric", "ANATOMY", 91, 98], ["Intestine", "ANATOMY", 104, 113], ["Enterocytes", "ANATOMY", 130, 141], ["colon", "ANATOMY", 409, 414], ["UDP", "CHEMICAL", 207, 210], ["glutathione", "CHEMICAL", 237, 248], ["N-acetyl", "CHEMICAL", 283, 291], ["sulphasalazine", "CHEMICAL", 347, 361], ["5-aminosalicylic acid", "CHEMICAL", 380, 401], ["bile salts", "CHEMICAL", 446, 456], ["glucuronides", "CHEMICAL", 480, 492], ["nitro-", "CHEMICAL", 495, 501], ["cycasin", "CHEMICAL", 526, 533], ["methylazoxymethanol", "CHEMICAL", 552, 571], ["UDP", "CHEMICAL", 207, 210], ["glutathione", "CHEMICAL", 237, 248], ["S", "CHEMICAL", 249, 250], ["N-acetyl", "CHEMICAL", 283, 291], ["sulphasalazine", "CHEMICAL", 347, 361], ["5-aminosalicylic acid", "CHEMICAL", 380, 401], ["bile salts", "CHEMICAL", 446, 456], ["nitro-", "CHEMICAL", 495, 501], ["methylazoxymethanol", "CHEMICAL", 552, 571], ["submucosal duodenal", "MULTI-TISSUE_STRUCTURE", 4, 23], ["glands", "ORGAN", 36, 42], ["mucus", "ORGANISM_SUBSTANCE", 63, 68], ["gastric acid", "SIMPLE_CHEMICAL", 91, 103], ["Intestine", "ORGAN", 104, 113], ["Enterocytes", "GENE_OR_GENE_PRODUCT", 130, 141], ["cytochrome P450s", "GENE_OR_GENE_PRODUCT", 164, 180], ["CYPs", "GENE_OR_GENE_PRODUCT", 182, 186], ["microperoxisomes", "GENE_OR_GENE_PRODUCT", 189, 205], ["UDP glucuronosyl transferase", "GENE_OR_GENE_PRODUCT", 207, 235], ["glutathione S-transferases", "GENE_OR_GENE_PRODUCT", 237, 263], ["microsomal GSTs", "GENE_OR_GENE_PRODUCT", 265, 280], ["N-acetyl transferase", "GENE_OR_GENE_PRODUCT", 283, 303], ["azo-reductases", "SIMPLE_CHEMICAL", 331, 345], ["sulphasalazine", "SIMPLE_CHEMICAL", 347, 361], ["5-aminosalicylic acid", "SIMPLE_CHEMICAL", 380, 401], ["colon", "ORGAN", 409, 414], ["glucuronidases", "SIMPLE_CHEMICAL", 417, 431], ["bile salts", "SIMPLE_CHEMICAL", 446, 456], ["thyroid", "ORGAN", 458, 465], ["drug glucuronides", "SIMPLE_CHEMICAL", 475, 492], ["nitro-reductases", "SIMPLE_CHEMICAL", 495, 511], ["glycosidase", "SIMPLE_CHEMICAL", 513, 524], ["cycasin", "SIMPLE_CHEMICAL", 526, 533], ["methylazoxymethanol", "SIMPLE_CHEMICAL", 552, 571], ["cytochrome P450s", "PROTEIN", 164, 180], ["CYPs", "PROTEIN", 182, 186], ["microperoxisomes", "PROTEIN", 189, 205], ["UDP glucuronosyl transferase", "PROTEIN", 207, 235], ["glutathione S-transferases", "PROTEIN", 237, 263], ["microsomal GSTs", "PROTEIN", 265, 280], ["N-acetyl transferase", "PROTEIN", 283, 303], ["hydrolases", "PROTEIN", 305, 315], ["nitro-reductases", "PROTEIN", 495, 511], ["glycosidase", "PROTEIN", 513, 524], ["The submucosal duodenal (Brunner\u2019s) glands", "PROBLEM", 0, 42], ["an alkaline mucus", "PROBLEM", 51, 68], ["gastric acid", "TEST", 91, 103], ["IntroductionEnterocytes", "PROBLEM", 118, 141], ["inducible cytochrome P450s", "TEST", 154, 180], ["CYPs", "TEST", 182, 186], ["microperoxisomes", "TEST", 189, 205], ["UDP glucuronosyl transferase", "TEST", 207, 235], ["glutathione S-transferases (microsomal GSTs", "TEST", 237, 280], ["N-acetyl transferase", "TREATMENT", 283, 303], ["hydrolases of many types", "PROBLEM", 305, 329], ["azo-reductases (sulphasalazine", "TREATMENT", 331, 361], ["aminosalicylic acid in the colon", "TREATMENT", 382, 414], ["glucuronidases (metabolizing bile salts", "TREATMENT", 417, 456], ["thyroid hormone", "TREATMENT", 458, 473], ["drug glucuronides", "TREATMENT", 475, 492], ["nitro-reductases", "TREATMENT", 495, 511], ["glycosidase", "TREATMENT", 513, 524], ["cycasin", "TREATMENT", 526, 533], ["methylazoxymethanol", "TREATMENT", 552, 571], ["submucosal", "ANATOMY_MODIFIER", 4, 14], ["duodenal", "ANATOMY", 15, 23], ["alkaline mucus", "OBSERVATION", 54, 68], ["inducible cytochrome", "OBSERVATION", 154, 174], ["colon", "ANATOMY", 409, 414], ["bile", "ANATOMY", 446, 450], ["thyroid", "ANATOMY", 458, 465]]], ["Some of these metabolic activities are present in the gut microflora that can be modified by dietary manipulation (Betton, 2013).Intestinal Blood Flow ::: IntroductionThe vascular supply to the villi is from the mesenteric arteries.", [["gut microflora", "ANATOMY", 54, 68], ["Blood", "ANATOMY", 140, 145], ["vascular", "ANATOMY", 171, 179], ["villi", "ANATOMY", 194, 199], ["mesenteric arteries", "ANATOMY", 212, 231], ["gut microflora", "ORGANISM_SUBDIVISION", 54, 68], ["Intestinal", "ORGAN", 129, 139], ["Blood", "ORGANISM_SUBSTANCE", 140, 145], ["vascular", "MULTI-TISSUE_STRUCTURE", 171, 179], ["villi", "MULTI-TISSUE_STRUCTURE", 194, 199], ["mesenteric arteries", "MULTI-TISSUE_STRUCTURE", 212, 231], ["metabolic activities", "OBSERVATION", 14, 34], ["Blood", "ANATOMY", 140, 145], ["vascular", "ANATOMY", 171, 179], ["villi", "ANATOMY", 194, 199], ["mesenteric arteries", "ANATOMY", 212, 231]]], ["In the lamina propria, the arterioles generate resistance to blood flow, the precapillary sphincters determine perfusion, and molecular exchange occurs across capillaries.", [["lamina propria", "ANATOMY", 7, 21], ["arterioles", "ANATOMY", 27, 37], ["blood", "ANATOMY", 61, 66], ["precapillary sphincters", "ANATOMY", 77, 100], ["capillaries", "ANATOMY", 159, 170], ["lamina propria", "TISSUE", 7, 21], ["arterioles", "MULTI-TISSUE_STRUCTURE", 27, 37], ["blood", "ORGANISM_SUBSTANCE", 61, 66], ["precapillary sphincters", "MULTI-TISSUE_STRUCTURE", 77, 100], ["capillaries", "TISSUE", 159, 170], ["blood flow", "TEST", 61, 71], ["lamina", "ANATOMY_MODIFIER", 7, 13], ["propria", "ANATOMY_MODIFIER", 14, 21], ["arterioles", "ANATOMY", 27, 37], ["resistance", "OBSERVATION", 47, 57], ["blood flow", "OBSERVATION", 61, 71], ["precapillary sphincters", "ANATOMY", 77, 100], ["molecular exchange", "OBSERVATION", 126, 144]]], ["Venules are capacitance vessels (Tepperman and Jacobson, 1981).", [["Venules", "ANATOMY", 0, 7], ["capacitance vessels", "ANATOMY", 12, 31], ["Venules", "MULTI-TISSUE_STRUCTURE", 0, 7], ["capacitance vessels", "MULTI-TISSUE_STRUCTURE", 12, 31], ["capacitance vessels", "OBSERVATION", 12, 31]]], ["Arteriovenous anastomoses are not present; capillary networks cannot be bypassed (Jacobson, 1992).", [["Arteriovenous", "ANATOMY", 0, 13], ["capillary networks", "ANATOMY", 43, 61], ["Arteriovenous anastomoses", "PATHOLOGICAL_FORMATION", 0, 25], ["capillary networks", "MULTI-TISSUE_STRUCTURE", 43, 61], ["Arteriovenous anastomoses", "TREATMENT", 0, 25], ["anastomoses", "OBSERVATION", 14, 25]]], ["Constant delivery of oxygen and other nutrients to the villus and removal of absorbed materials are critical functions of the mesenteric circulation.", [["villus", "ANATOMY", 55, 61], ["mesenteric", "ANATOMY", 126, 136], ["oxygen", "CHEMICAL", 21, 27], ["oxygen", "CHEMICAL", 21, 27], ["oxygen", "SIMPLE_CHEMICAL", 21, 27], ["villus", "MULTI-TISSUE_STRUCTURE", 55, 61], ["mesenteric circulation", "MULTI-TISSUE_STRUCTURE", 126, 148], ["Constant delivery of oxygen", "TREATMENT", 0, 27], ["removal of absorbed materials", "TREATMENT", 66, 95], ["oxygen", "OBSERVATION_MODIFIER", 21, 27], ["villus", "ANATOMY", 55, 61], ["mesenteric", "ANATOMY", 126, 136], ["circulation", "ANATOMY_MODIFIER", 137, 148]]], ["Autoregulation of blood flow by villus vessels exceeds that of deeper mucosal or muscular vessels (Tepperman and Jacobson, 1981).Intestinal Blood Flow ::: IntroductionRegulation of mesenteric circulation is via the sympathetic, parasympathetic, and enteric nervous systems; by intrinsic sensory neurons; and by autoregulation (interstitial cells of Cajal).", [["blood", "ANATOMY", 18, 23], ["villus vessels", "ANATOMY", 32, 46], ["mucosal", "ANATOMY", 70, 77], ["muscular vessels", "ANATOMY", 81, 97], ["Blood", "ANATOMY", 140, 145], ["mesenteric", "ANATOMY", 181, 191], ["enteric nervous systems", "ANATOMY", 249, 272], ["sensory neurons", "ANATOMY", 287, 302], ["interstitial cells", "ANATOMY", 327, 345], ["Cajal", "ANATOMY", 349, 354], ["blood", "ORGANISM_SUBSTANCE", 18, 23], ["villus vessels", "MULTI-TISSUE_STRUCTURE", 32, 46], ["mucosal", "MULTI-TISSUE_STRUCTURE", 70, 77], ["muscular vessels", "MULTI-TISSUE_STRUCTURE", 81, 97], ["Intestinal", "ORGAN", 129, 139], ["Blood", "ORGANISM_SUBSTANCE", 140, 145], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 181, 191], ["parasympathetic", "ANATOMICAL_SYSTEM", 228, 243], ["enteric nervous systems", "ANATOMICAL_SYSTEM", 249, 272], ["sensory neurons", "CELL", 287, 302], ["interstitial cells", "CELL", 327, 345], ["Cajal", "MULTI-TISSUE_STRUCTURE", 349, 354], ["intrinsic sensory neurons", "CELL_TYPE", 277, 302], ["interstitial cells", "CELL_TYPE", 327, 345], ["blood flow", "TEST", 18, 28], ["villus vessels", "PROBLEM", 32, 46], ["the sympathetic, parasympathetic, and enteric nervous systems", "PROBLEM", 211, 272], ["blood flow", "OBSERVATION", 18, 28], ["villus", "ANATOMY_MODIFIER", 32, 38], ["vessels", "ANATOMY", 39, 46], ["deeper", "ANATOMY_MODIFIER", 63, 69], ["mucosal", "ANATOMY_MODIFIER", 70, 77], ["muscular vessels", "ANATOMY", 81, 97], ["Blood", "ANATOMY", 140, 145], ["mesenteric", "ANATOMY", 181, 191], ["parasympathetic", "ANATOMY", 228, 243], ["enteric nervous", "ANATOMY", 249, 264], ["sensory neurons", "OBSERVATION", 287, 302], ["interstitial cells", "OBSERVATION", 327, 345]]], ["Norepinephrine, adenosine triphosphate, and neuropeptide-Y are vasoconstrictors released directly onto blood vessels by the sympathetic nervous system.", [["blood vessels", "ANATOMY", 103, 116], ["sympathetic nervous system", "ANATOMY", 124, 150], ["Norepinephrine", "CHEMICAL", 0, 14], ["adenosine triphosphate", "CHEMICAL", 16, 38], ["Norepinephrine", "CHEMICAL", 0, 14], ["adenosine triphosphate", "CHEMICAL", 16, 38], ["Norepinephrine", "SIMPLE_CHEMICAL", 0, 14], ["adenosine triphosphate", "SIMPLE_CHEMICAL", 16, 38], ["neuropeptide-Y", "GENE_OR_GENE_PRODUCT", 44, 58], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 103, 116], ["sympathetic nervous system", "ANATOMICAL_SYSTEM", 124, 150], ["Norepinephrine", "TREATMENT", 0, 14], ["adenosine triphosphate", "TREATMENT", 16, 38], ["neuropeptide", "TREATMENT", 44, 56], ["vasoconstrictors", "TREATMENT", 63, 79], ["sympathetic nervous", "ANATOMY", 124, 143]]], ["Vasoactive intestinal polypeptide (VIP) and substance P may be the primary vasodilator substances released from enteric motor neurons.", [["enteric motor neurons", "ANATOMY", 112, 133], ["Vasoactive intestinal polypeptide", "GENE_OR_GENE_PRODUCT", 0, 33], ["VIP", "GENE_OR_GENE_PRODUCT", 35, 38], ["substance P", "SIMPLE_CHEMICAL", 44, 55], ["enteric motor neurons", "CELL", 112, 133], ["enteric motor neurons", "CELL_TYPE", 112, 133], ["Vasoactive intestinal polypeptide (VIP) and substance P", "TREATMENT", 0, 55], ["the primary vasodilator substances", "TREATMENT", 63, 97], ["intestinal", "ANATOMY", 11, 21]]], ["Calcitonin gene-related peptide (CGRP) and substance P are thought to be released from sensory neurons (Holzer et al., 1994).", [["sensory neurons", "ANATOMY", 87, 102], ["Calcitonin gene-related peptide", "CHEMICAL", 0, 31], ["CGRP", "CHEMICAL", 33, 37], ["Calcitonin gene-related peptide", "GENE_OR_GENE_PRODUCT", 0, 31], ["CGRP", "GENE_OR_GENE_PRODUCT", 33, 37], ["substance P", "GENE_OR_GENE_PRODUCT", 43, 54], ["sensory neurons", "CELL", 87, 102], ["sensory neurons", "CELL_TYPE", 87, 102], ["Calcitonin gene", "TREATMENT", 0, 15], ["sensory neurons", "ANATOMY", 87, 102]]], ["Capsaicin may cause initial release, then depletion, of the peptide neurotransmitters, substance P, and CGRP.", [["Capsaicin", "CHEMICAL", 0, 9], ["CGRP", "CHEMICAL", 104, 108], ["Capsaicin", "CHEMICAL", 0, 9], ["Capsaicin", "SIMPLE_CHEMICAL", 0, 9], ["substance P", "GENE_OR_GENE_PRODUCT", 87, 98], ["CGRP", "GENE_OR_GENE_PRODUCT", 104, 108], ["Capsaicin", "TREATMENT", 0, 9], ["the peptide neurotransmitters", "PROBLEM", 56, 85]]], ["At high concentrations, capsaicin causes neuronal degeneration (Buck and Burks, 1986, Buck et al., 1982b, Holzer, 1991).", [["neuronal", "ANATOMY", 41, 49], ["capsaicin", "CHEMICAL", 24, 33], ["neuronal degeneration", "DISEASE", 41, 62], ["capsaicin", "CHEMICAL", 24, 33], ["capsaicin", "SIMPLE_CHEMICAL", 24, 33], ["neuronal", "CELL", 41, 49], ["capsaicin", "TREATMENT", 24, 33], ["neuronal degeneration", "PROBLEM", 41, 62], ["neuronal degeneration", "OBSERVATION", 41, 62]]], ["Topical application of capsaicin to gastric mucosa causes dilation of submucosal arterioles, presumably by initial release of peptides from sensory neurons (Chen et al., 1992).", [["gastric mucosa", "ANATOMY", 36, 50], ["submucosal arterioles", "ANATOMY", 70, 91], ["sensory neurons", "ANATOMY", 140, 155], ["capsaicin", "CHEMICAL", 23, 32], ["capsaicin", "CHEMICAL", 23, 32], ["capsaicin", "SIMPLE_CHEMICAL", 23, 32], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 36, 50], ["submucosal arterioles", "MULTI-TISSUE_STRUCTURE", 70, 91], ["sensory neurons", "CELL", 140, 155], ["sensory neurons", "CELL_TYPE", 140, 155], ["Topical application of capsaicin", "TREATMENT", 0, 32], ["gastric mucosa", "PROBLEM", 36, 50], ["dilation of submucosal arterioles", "PROBLEM", 58, 91], ["sensory neurons", "PROBLEM", 140, 155], ["gastric mucosa", "ANATOMY", 36, 50], ["dilation", "OBSERVATION", 58, 66], ["submucosal arterioles", "ANATOMY", 70, 91]]], ["Prior treatment with a neurotoxic (peptide-depleting) dose of capsaicin blocks the vasodilator response.", [["neurotoxic", "DISEASE", 23, 33], ["capsaicin", "CHEMICAL", 62, 71], ["capsaicin", "CHEMICAL", 62, 71], ["capsaicin", "SIMPLE_CHEMICAL", 62, 71], ["Prior treatment", "TREATMENT", 0, 15], ["a neurotoxic (peptide-depleting)", "TREATMENT", 21, 53], ["capsaicin blocks", "TREATMENT", 62, 78], ["the vasodilator response", "TREATMENT", 79, 103]]], ["CGRP appears to be the principal neural mediator of gastric mucosal hyperemia (Holzer et al., 1994) and is therefore associated with alimentary mucosal protection (Lippe et al., 1989).", [["neural", "ANATOMY", 33, 39], ["gastric mucosal", "ANATOMY", 52, 67], ["alimentary mucosal", "ANATOMY", 133, 151], ["CGRP", "CHEMICAL", 0, 4], ["hyperemia", "DISEASE", 68, 77], ["CGRP", "GENE_OR_GENE_PRODUCT", 0, 4], ["gastric mucosal", "TISSUE", 52, 67], ["alimentary mucosal", "MULTI-TISSUE_STRUCTURE", 133, 151], ["gastric mucosal hyperemia", "PROBLEM", 52, 77], ["appears to be", "UNCERTAINTY", 5, 18], ["gastric mucosal", "ANATOMY", 52, 67], ["hyperemia", "OBSERVATION", 68, 77], ["alimentary mucosal", "ANATOMY", 133, 151]]], ["The vasodilator and hyperemic effects of CGRP appear to be mediated by nitric oxide (Holzer et al., 1993, Peskar et al., 1991).", [["CGRP", "CHEMICAL", 41, 45], ["nitric oxide", "CHEMICAL", 71, 83], ["nitric oxide", "CHEMICAL", 71, 83], ["CGRP", "GENE_OR_GENE_PRODUCT", 41, 45], ["nitric oxide", "SIMPLE_CHEMICAL", 71, 83], ["The vasodilator", "TREATMENT", 0, 15], ["hyperemic effects of CGRP", "TREATMENT", 20, 45], ["nitric oxide", "TREATMENT", 71, 83]]], ["Endogenous nitric oxide also mediates the vasodilation that accompanies acid secretion (Holzer et al., 1994).Intestinal Blood Flow ::: IntroductionOnce chyme passes into the upper small intestine, it is mixed with digestive enzymes.", [["Blood", "ANATOMY", 120, 125], ["upper small intestine", "ANATOMY", 174, 195], ["digestive", "ANATOMY", 214, 223], ["nitric oxide", "CHEMICAL", 11, 23], ["nitric oxide", "CHEMICAL", 11, 23], ["nitric oxide", "SIMPLE_CHEMICAL", 11, 23], ["Intestinal", "ORGAN", 109, 119], ["Blood", "ORGANISM_SUBSTANCE", 120, 125], ["upper", "ORGANISM_SUBDIVISION", 174, 179], ["small intestine", "ORGAN", 180, 195], ["digestive", "ORGAN", 214, 223], ["digestive enzymes", "PROTEIN", 214, 231], ["Endogenous nitric oxide", "TREATMENT", 0, 23], ["the vasodilation", "TREATMENT", 38, 54], ["acid secretion", "PROBLEM", 72, 86], ["digestive enzymes", "TEST", 214, 231], ["nitric oxide", "OBSERVATION", 11, 23], ["Blood", "ANATOMY", 120, 125], ["upper", "ANATOMY_MODIFIER", 174, 179], ["small intestine", "ANATOMY", 180, 195]]], ["Intimate contact with the absorptive surface of the intestinal mucosa is affected by segmenting or mixing contractions.", [["absorptive surface", "ANATOMY", 26, 44], ["intestinal mucosa", "ANATOMY", 52, 69], ["absorptive surface", "CELLULAR_COMPONENT", 26, 44], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 52, 69], ["mixing contractions", "PROBLEM", 99, 118], ["intestinal mucosa", "ANATOMY", 52, 69], ["mixing contractions", "OBSERVATION", 99, 118]]], ["Contractions of the circular muscle occur more or less randomly but are somewhat fixed by the electrical slow waves or electrical control activity generated in the interstitial cells of Cajal.", [["circular muscle", "ANATOMY", 20, 35], ["interstitial cells", "ANATOMY", 164, 182], ["Cajal", "ANATOMY", 186, 191], ["muscle", "ORGAN", 29, 35], ["interstitial cells", "CELL", 164, 182], ["Cajal", "CELL", 186, 191], ["interstitial cells", "CELL_TYPE", 164, 182], ["Contractions of the circular muscle", "PROBLEM", 0, 35], ["the electrical slow waves", "PROBLEM", 90, 115], ["circular muscle", "ANATOMY", 20, 35], ["interstitial cells", "ANATOMY", 164, 182], ["Cajal", "ANATOMY_MODIFIER", 186, 191]]], ["Propulsive contractions can occur, including random migrating clustered contractions associated with contractile rings that move distally from 5 to 30 cm propelling content aborad (Sarna and Otterson, 1989).", [["contractile rings", "ANATOMY", 101, 118], ["Propulsive contractions", "PROBLEM", 0, 23], ["random migrating clustered contractions", "PROBLEM", 45, 84], ["contractile rings", "PROBLEM", 101, 118], ["contractile rings", "OBSERVATION", 101, 118], ["Sarna", "ANATOMY", 181, 186]]], ["Toxic agents that induce excessive migrating clustered contractions may speed propulsion.Intestinal Blood Flow ::: IntroductionThe migrating motor complex (MMC) is a band of intense contractile activity that moves aborad over the stomach and small intestine during fasting (Szurszewski, 1969).", [["Blood", "ANATOMY", 100, 105], ["contractile", "ANATOMY", 182, 193], ["stomach", "ANATOMY", 230, 237], ["small intestine", "ANATOMY", 242, 257], ["Intestinal", "ORGAN", 89, 99], ["Blood", "ORGANISM_SUBSTANCE", 100, 105], ["migrating motor complex", "GENE_OR_GENE_PRODUCT", 131, 154], ["MMC", "CANCER", 156, 159], ["stomach", "ORGAN", 230, 237], ["small intestine", "ORGAN", 242, 257], ["migrating motor complex", "PROTEIN", 131, 154], ["Toxic agents", "TREATMENT", 0, 12], ["excessive migrating clustered contractions", "PROBLEM", 25, 67], ["a band of intense contractile activity", "PROBLEM", 164, 202], ["excessive", "OBSERVATION_MODIFIER", 25, 34], ["Blood Flow", "OBSERVATION", 100, 110], ["intense", "OBSERVATION_MODIFIER", 174, 181], ["contractile activity", "OBSERVATION", 182, 202], ["stomach", "ANATOMY", 230, 237], ["small intestine", "ANATOMY", 242, 257]]], ["The MMC sweeps debris from the stomach and intestine in preparation for the next meal.", [["stomach", "ANATOMY", 31, 38], ["intestine", "ANATOMY", 43, 52], ["MMC", "CHEMICAL", 4, 7], ["MMC", "CHEMICAL", 4, 7], ["stomach", "ORGAN", 31, 38], ["intestine", "ORGAN", 43, 52], ["The MMC sweeps debris from the stomach and intestine", "PROBLEM", 0, 52], ["MMC", "OBSERVATION_MODIFIER", 4, 7], ["sweeps", "OBSERVATION_MODIFIER", 8, 14], ["debris", "OBSERVATION", 15, 21], ["stomach", "ANATOMY", 31, 38], ["intestine", "ANATOMY", 43, 52]]], ["When food is ingested, motility reverts to the digestive pattern.", [["digestive", "ANATOMY", 47, 56], ["digestive", "ORGAN", 47, 56], ["digestive pattern", "ANATOMY", 47, 64]]], ["The central nervous system exerts some control of MMC activity, but the MMC cycle appears to be initiated in the enteric nervous system, principally the myenteric plexus (Sarna and Otterson, 1989, Gad, 2007).", [["central nervous system", "ANATOMY", 4, 26], ["enteric nervous system", "ANATOMY", 113, 135], ["myenteric plexus", "ANATOMY", 153, 169], ["MMC", "CHEMICAL", 50, 53], ["MMC", "CHEMICAL", 72, 75], ["central nervous system", "ANATOMICAL_SYSTEM", 4, 26], ["MMC", "GENE_OR_GENE_PRODUCT", 50, 53], ["enteric nervous system", "ANATOMICAL_SYSTEM", 113, 135], ["myenteric plexus", "MULTI-TISSUE_STRUCTURE", 153, 169], ["MMC activity", "PROBLEM", 50, 62], ["central", "ANATOMY_MODIFIER", 4, 11], ["nervous system", "ANATOMY", 12, 26], ["some", "OBSERVATION_MODIFIER", 34, 38], ["MMC activity", "OBSERVATION", 50, 62], ["enteric nervous system", "ANATOMY", 113, 135], ["myenteric plexus", "ANATOMY", 153, 169], ["Sarna", "ANATOMY", 171, 176]]], ["Premature MMC activity can be induced by opiates, erythromycin, and other agents.Cecum ::: IntroductionPatterns of motility in the cecum and colon are complex.", [["cecum", "ANATOMY", 131, 136], ["colon", "ANATOMY", 141, 146], ["MMC", "CHEMICAL", 10, 13], ["erythromycin", "CHEMICAL", 50, 62], ["erythromycin", "CHEMICAL", 50, 62], ["opiates", "SIMPLE_CHEMICAL", 41, 48], ["erythromycin", "SIMPLE_CHEMICAL", 50, 62], ["cecum", "ORGAN", 131, 136], ["colon", "ORGAN", 141, 146], ["Premature MMC activity", "PROBLEM", 0, 22], ["opiates", "TREATMENT", 41, 48], ["erythromycin", "TREATMENT", 50, 62], ["other agents", "TREATMENT", 68, 80], ["motility", "OBSERVATION_MODIFIER", 115, 123], ["cecum", "ANATOMY", 131, 136], ["colon", "ANATOMY", 141, 146], ["complex", "OBSERVATION_MODIFIER", 151, 158]]], ["In some species, especially in rodents and lapids, the cecum can store large amounts of content that is released intermittently, usually in response to a meal.", [["cecum", "ANATOMY", 55, 60], ["cecum", "ORGAN", 55, 60], ["some", "OBSERVATION_MODIFIER", 3, 7], ["species", "OBSERVATION", 8, 15], ["cecum", "ANATOMY", 55, 60], ["large", "OBSERVATION_MODIFIER", 71, 76], ["amounts", "OBSERVATION_MODIFIER", 77, 84], ["content", "OBSERVATION", 88, 95]]], ["Stress and corticotropin-releasing factor (CRF) also cause contraction and emptying of the cecum (Peterson and Burks, 1989, Williams et al., 1988).", [["cecum", "ANATOMY", 91, 96], ["CRF", "DISEASE", 43, 46], ["corticotropin-releasing factor", "GENE_OR_GENE_PRODUCT", 11, 41], ["CRF", "GENE_OR_GENE_PRODUCT", 43, 46], ["cecum", "ORGAN", 91, 96], ["corticotropin-releasing factor", "PROTEIN", 11, 41], ["CRF", "PROTEIN", 43, 46], ["Stress and corticotropin-releasing factor (CRF)", "PROBLEM", 0, 47], ["contraction and emptying of the cecum", "PROBLEM", 59, 96], ["contraction", "OBSERVATION", 59, 70], ["emptying", "OBSERVATION", 75, 83], ["cecum", "ANATOMY", 91, 96]]], ["Increased cecal emptying stimulated by CRF contributes to the excess of fecal excretion and diarrhea associated with psychological or chemical stress.", [["cecal", "ANATOMY", 10, 15], ["fecal", "ANATOMY", 72, 77], ["CRF", "DISEASE", 39, 42], ["diarrhea", "DISEASE", 92, 100], ["cecal", "ORGANISM_SUBDIVISION", 10, 15], ["CRF", "GENE_OR_GENE_PRODUCT", 39, 42], ["fecal", "ORGANISM_SUBSTANCE", 72, 77], ["Increased cecal emptying", "PROBLEM", 0, 24], ["CRF", "PROBLEM", 39, 42], ["fecal excretion", "PROBLEM", 72, 87], ["diarrhea", "PROBLEM", 92, 100], ["psychological or chemical stress", "PROBLEM", 117, 149], ["cecal", "ANATOMY", 10, 15], ["emptying", "OBSERVATION", 16, 24], ["fecal excretion", "OBSERVATION", 72, 87]]], ["Pharmaceuticals that alter intestinal motility include atropine, morphine, clonidine, papaverine, and isoproterenol (Gad, 2015).Colon ::: IntroductionThe colon absorbs water, electrolytes, short chain fatty acids, and bacterial metabolites.", [["intestinal", "ANATOMY", 27, 37], ["Colon", "ANATOMY", 128, 133], ["colon", "ANATOMY", 154, 159], ["atropine", "CHEMICAL", 55, 63], ["morphine", "CHEMICAL", 65, 73], ["clonidine", "CHEMICAL", 75, 84], ["papaverine", "CHEMICAL", 86, 96], ["isoproterenol", "CHEMICAL", 102, 115], ["fatty acids", "CHEMICAL", 201, 212], ["atropine", "CHEMICAL", 55, 63], ["morphine", "CHEMICAL", 65, 73], ["clonidine", "CHEMICAL", 75, 84], ["papaverine", "CHEMICAL", 86, 96], ["isoproterenol", "CHEMICAL", 102, 115], ["Gad", "CHEMICAL", 117, 120], ["fatty acids", "CHEMICAL", 201, 212], ["intestinal", "ORGAN", 27, 37], ["atropine", "SIMPLE_CHEMICAL", 55, 63], ["morphine", "SIMPLE_CHEMICAL", 65, 73], ["clonidine", "SIMPLE_CHEMICAL", 75, 84], ["papaverine", "SIMPLE_CHEMICAL", 86, 96], ["isoproterenol", "SIMPLE_CHEMICAL", 102, 115], ["Gad", "SIMPLE_CHEMICAL", 117, 120], ["Colon", "ORGAN", 128, 133], ["colon", "ORGAN", 154, 159], ["electrolytes", "SIMPLE_CHEMICAL", 175, 187], ["short chain fatty acids", "SIMPLE_CHEMICAL", 189, 212], ["Pharmaceuticals", "TREATMENT", 0, 15], ["atropine", "TREATMENT", 55, 63], ["morphine", "TREATMENT", 65, 73], ["clonidine", "TREATMENT", 75, 84], ["papaverine", "TREATMENT", 86, 96], ["isoproterenol (Gad", "TREATMENT", 102, 120], ["electrolytes", "TEST", 175, 187], ["short chain fatty acids", "TEST", 189, 212], ["bacterial metabolites", "PROBLEM", 218, 239], ["intestinal", "ANATOMY", 27, 37], ["colon", "ANATOMY", 154, 159], ["bacterial metabolites", "OBSERVATION", 218, 239]]], ["The cell junctions of the large intestinal epithelium are much tighter than those of the small intestine.", [["cell junctions", "ANATOMY", 4, 18], ["intestinal epithelium", "ANATOMY", 32, 53], ["small intestine", "ANATOMY", 89, 104], ["cell junctions", "CELLULAR_COMPONENT", 4, 18], ["intestinal epithelium", "TISSUE", 32, 53], ["small intestine", "ORGAN", 89, 104], ["cell junctions", "OBSERVATION", 4, 18], ["large", "OBSERVATION_MODIFIER", 26, 31], ["intestinal epithelium", "ANATOMY", 32, 53], ["much", "OBSERVATION_MODIFIER", 58, 62], ["tighter", "OBSERVATION", 63, 70], ["small intestine", "ANATOMY", 89, 104]]], ["As a result, large intestinal enterocytes absorb sodium ions more completely than in the small intestine (Spainhour, 2007).", [["intestinal enterocytes", "ANATOMY", 19, 41], ["small intestine", "ANATOMY", 89, 104], ["sodium ions", "CHEMICAL", 49, 60], ["sodium", "CHEMICAL", 49, 55], ["intestinal enterocytes", "MULTI-TISSUE_STRUCTURE", 19, 41], ["sodium ions", "SIMPLE_CHEMICAL", 49, 60], ["intestine", "ORGAN", 95, 104], ["intestinal enterocytes", "CELL_TYPE", 19, 41], ["large intestinal enterocytes absorb sodium ions", "PROBLEM", 13, 60], ["large", "OBSERVATION_MODIFIER", 13, 18], ["intestinal enterocytes", "ANATOMY", 19, 41], ["small intestine", "ANATOMY", 89, 104]]], ["The cecal and colonic walls do not have a continuous layer of longitudinal smooth muscle.", [["cecal", "ANATOMY", 4, 9], ["colonic walls", "ANATOMY", 14, 27], ["smooth muscle", "ANATOMY", 75, 88], ["cecal", "MULTI-TISSUE_STRUCTURE", 4, 9], ["colonic walls", "PATHOLOGICAL_FORMATION", 14, 27], ["smooth muscle", "TISSUE", 75, 88], ["cecal", "ANATOMY", 4, 9], ["colonic", "ANATOMY", 14, 21], ["walls", "ANATOMY_MODIFIER", 22, 27], ["continuous", "OBSERVATION_MODIFIER", 42, 52], ["layer", "OBSERVATION_MODIFIER", 53, 58], ["longitudinal", "ANATOMY_MODIFIER", 62, 74], ["smooth muscle", "ANATOMY", 75, 88]]], ["The proximal 85% of the colon is therefore incapable of peristaltic contractions.", [["colon", "ANATOMY", 24, 29], ["colon", "ORGAN", 24, 29], ["peristaltic contractions", "PROBLEM", 56, 80], ["proximal", "ANATOMY_MODIFIER", 4, 12], ["colon", "ANATOMY", 24, 29], ["peristaltic contractions", "OBSERVATION", 56, 80]]], ["Because the circular muscle is intact, rhythmic segmentation is present.", [["muscle", "ANATOMY", 21, 27], ["muscle", "ORGAN", 21, 27], ["rhythmic segmentation", "PROBLEM", 39, 60], ["circular muscle", "ANATOMY", 12, 27], ["intact", "OBSERVATION", 31, 37], ["rhythmic segmentation", "OBSERVATION", 39, 60]]], ["Rhythmic segmentation allows retropulsion but not peristalsis allowing the colon to function as a storage organ (Saur, 2010).", [["colon", "ANATOMY", 75, 80], ["organ", "ANATOMY", 106, 111], ["colon", "ORGAN", 75, 80], ["organ", "ORGAN", 106, 111], ["Rhythmic segmentation allows retropulsion", "PROBLEM", 0, 41], ["retropulsion", "OBSERVATION", 29, 41], ["peristalsis", "OBSERVATION", 50, 61], ["colon", "ANATOMY", 75, 80]]], ["Orthograde and retrograde contractions are thought to occur in the proximal and middle colon (Sarna, 1991).Colon ::: IntroductionThe colon of humans expresses some cytochrome P450 isozymes as well as uridine diphosphate (UDP)-glucuronosyltransferase (McKinnon et al., 1993: Peters et al., 1991).", [["middle colon", "ANATOMY", 80, 92], ["Colon", "ANATOMY", 107, 112], ["colon", "ANATOMY", 133, 138], ["uridine diphosphate", "CHEMICAL", 200, 219], ["UDP", "CHEMICAL", 221, 224], ["uridine diphosphate", "CHEMICAL", 200, 219], ["UDP", "CHEMICAL", 221, 224], ["colon", "ORGAN", 87, 92], ["Colon", "ORGAN", 107, 112], ["colon", "ORGAN", 133, 138], ["humans", "ORGANISM", 142, 148], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 164, 179], ["uridine diphosphate", "SIMPLE_CHEMICAL", 200, 219], ["UDP)-glucuronosyltransferase", "SIMPLE_CHEMICAL", 221, 249], ["cytochrome P450 isozymes", "PROTEIN", 164, 188], ["humans", "SPECIES", 142, 148], ["humans", "SPECIES", 142, 148], ["some cytochrome P450 isozymes", "PROBLEM", 159, 188], ["uridine diphosphate (UDP)", "TEST", 200, 225], ["retrograde contractions", "OBSERVATION", 15, 38], ["proximal", "ANATOMY_MODIFIER", 67, 75], ["middle", "ANATOMY_MODIFIER", 80, 86], ["colon", "ANATOMY", 87, 92], ["Sarna", "ANATOMY", 94, 99], ["colon", "ANATOMY", 133, 138]]], ["A number of drugs and therapeutic chemicals may alter the colon and or its functions by direct contact or systemic mechanisms (Ernest, 2010).Colon ::: IntroductionThe microbiota within the colon hydrolyzes some remaining digesta and xenobiotics via bacterial \u03b2-glucuronidase.", [["colon", "ANATOMY", 58, 63], ["Colon", "ANATOMY", 141, 146], ["colon", "ANATOMY", 189, 194], ["digesta", "ANATOMY", 221, 228], ["colon", "ORGAN", 58, 63], ["Colon", "ORGAN", 141, 146], ["colon", "ORGAN", 189, 194], ["digesta", "ORGANISM_SUBDIVISION", 221, 228], ["\u03b2-glucuronidase", "GENE_OR_GENE_PRODUCT", 259, 274], ["bacterial \u03b2-glucuronidase", "PROTEIN", 249, 274], ["drugs", "TREATMENT", 12, 17], ["therapeutic chemicals", "TREATMENT", 22, 43], ["xenobiotics via bacterial \u03b2-glucuronidase", "TREATMENT", 233, 274], ["colon", "ANATOMY", 58, 63], ["colon", "ANATOMY", 189, 194], ["bacterial \u03b2-glucuronidase", "OBSERVATION", 249, 274]]], ["Intestinal microbes facilitate enterohepatic circulation of phenytoin, phenacetin, diethylstilbestrol, digitoxin, and warfarin.", [["Intestinal", "ANATOMY", 0, 10], ["enterohepatic", "ANATOMY", 31, 44], ["phenytoin", "CHEMICAL", 60, 69], ["phenacetin", "CHEMICAL", 71, 81], ["diethylstilbestrol", "CHEMICAL", 83, 101], ["digitoxin", "CHEMICAL", 103, 112], ["warfarin", "CHEMICAL", 118, 126], ["phenytoin", "CHEMICAL", 60, 69], ["phenacetin", "CHEMICAL", 71, 81], ["diethylstilbestrol", "CHEMICAL", 83, 101], ["digitoxin", "CHEMICAL", 103, 112], ["warfarin", "CHEMICAL", 118, 126], ["Intestinal", "ORGAN", 0, 10], ["enterohepatic", "MULTI-TISSUE_STRUCTURE", 31, 44], ["phenytoin", "SIMPLE_CHEMICAL", 60, 69], ["phenacetin", "SIMPLE_CHEMICAL", 71, 81], ["diethylstilbestrol", "SIMPLE_CHEMICAL", 83, 101], ["digitoxin", "SIMPLE_CHEMICAL", 103, 112], ["warfarin", "SIMPLE_CHEMICAL", 118, 126], ["phenytoin", "TREATMENT", 60, 69], ["phenacetin", "TREATMENT", 71, 81], ["diethylstilbestrol", "TREATMENT", 83, 101], ["digitoxin", "TREATMENT", 103, 112], ["warfarin", "TREATMENT", 118, 126]]], ["These bacteria also convert methylmercury to its inorganic form (Gad, 2015).", [["methylmercury", "CHEMICAL", 28, 41], ["methylmercury", "CHEMICAL", 28, 41], ["methylmercury", "SIMPLE_CHEMICAL", 28, 41], ["These bacteria", "PROBLEM", 0, 14], ["bacteria", "OBSERVATION", 6, 14]]], ["The colon slowly propels its contents aborally, holds residual material in the distal colon, and expels its contents during defecation (Sarna, 1991).", [["colon", "ANATOMY", 4, 9], ["aborally", "ANATOMY", 38, 46], ["distal colon", "ANATOMY", 79, 91], ["colon", "ORGAN", 4, 9], ["colon", "ORGAN", 86, 91], ["holds residual material in the distal colon", "PROBLEM", 48, 91], ["colon", "ANATOMY", 4, 9], ["slowly", "OBSERVATION_MODIFIER", 10, 16], ["residual material", "OBSERVATION", 54, 71], ["distal", "ANATOMY_MODIFIER", 79, 85], ["colon", "ANATOMY", 86, 91]]], ["Since the colonic mucosa lacks villi, the absorptive area of the colon relative to the small intestine is small and absorption is slow.", [["colonic mucosa", "ANATOMY", 10, 24], ["villi", "ANATOMY", 31, 36], ["absorptive area", "ANATOMY", 42, 57], ["colon", "ANATOMY", 65, 70], ["small intestine", "ANATOMY", 87, 102], ["colonic mucosa", "MULTI-TISSUE_STRUCTURE", 10, 24], ["villi", "MULTI-TISSUE_STRUCTURE", 31, 36], ["colon", "ORGAN", 65, 70], ["small intestine", "ORGAN", 87, 102], ["colonic mucosa", "ANATOMY", 10, 24], ["villi", "ANATOMY_MODIFIER", 31, 36], ["absorptive", "OBSERVATION_MODIFIER", 42, 52], ["colon", "ANATOMY", 65, 70], ["small intestine", "ANATOMY", 87, 102], ["small", "OBSERVATION_MODIFIER", 106, 111], ["absorption", "OBSERVATION_MODIFIER", 116, 126], ["slow", "OBSERVATION_MODIFIER", 130, 134]]], ["Transit of contents through the colon is 2\u201310 h in small species and 30\u201350 h in humans.Intestinal Cell Types ::: IntroductionThere are a variety of epithelial cell types lining the intestine, all of which are produced by progenitor cells in the crypts (Fig. 6) via notch signaling (Sander and Powell, 2004).", [["colon", "ANATOMY", 32, 37], ["Cell", "ANATOMY", 98, 102], ["epithelial cell", "ANATOMY", 148, 163], ["intestine", "ANATOMY", 181, 190], ["progenitor cells", "ANATOMY", 221, 237], ["crypts", "ANATOMY", 245, 251], ["colon", "ORGAN", 32, 37], ["humans", "ORGANISM", 80, 86], ["Intestinal Cell", "CELL", 87, 102], ["epithelial cell", "CELL", 148, 163], ["intestine", "ORGAN", 181, 190], ["progenitor cells", "CELL", 221, 237], ["crypts", "TISSUE", 245, 251], ["notch", "GENE_OR_GENE_PRODUCT", 265, 270], ["epithelial cell types", "CELL_TYPE", 148, 169], ["progenitor cells", "CELL_TYPE", 221, 237], ["humans", "SPECIES", 80, 86], ["humans", "SPECIES", 80, 86], ["contents", "OBSERVATION", 11, 19], ["colon", "ANATOMY", 32, 37], ["small species", "OBSERVATION_MODIFIER", 51, 64], ["Cell Types", "OBSERVATION", 98, 108], ["variety", "OBSERVATION_MODIFIER", 137, 144], ["epithelial cell types", "OBSERVATION", 148, 169], ["intestine", "ANATOMY", 181, 190], ["progenitor cells", "OBSERVATION", 221, 237], ["crypts", "ANATOMY", 245, 251]]], ["Notch pathways are used by cells (i.e., cell\u2013cell communication) to regulate, via their genes, cell differentiation processes that occur during embryonic and adult life.", [["cells", "ANATOMY", 27, 32], ["cell\u2013cell", "ANATOMY", 40, 49], ["cell", "ANATOMY", 95, 99], ["embryonic", "ANATOMY", 144, 153], ["Notch", "GENE_OR_GENE_PRODUCT", 0, 5], ["cells", "CELL", 27, 32], ["cell\u2013cell", "CELL", 40, 49], ["cell", "CELL", 95, 99], ["embryonic", "DEVELOPING_ANATOMICAL_STRUCTURE", 144, 153], ["Notch pathways", "PROBLEM", 0, 14], ["cell differentiation processes", "PROBLEM", 95, 125], ["cell differentiation", "OBSERVATION", 95, 115]]], ["Enterocyte notch pathways influence whether intestinal epithelial stem cells differentiate into cells with secretory or absorptive functions.", [["intestinal epithelial stem cells", "ANATOMY", 44, 76], ["cells", "ANATOMY", 96, 101], ["secretory", "ANATOMY", 107, 116], ["intestinal epithelial stem cells", "CELL", 44, 76], ["cells", "CELL", 96, 101], ["intestinal epithelial stem cells", "CELL_TYPE", 44, 76], ["Enterocyte notch pathways", "PROBLEM", 0, 25], ["intestinal epithelial stem cells", "PROBLEM", 44, 76], ["intestinal", "ANATOMY", 44, 54], ["epithelial stem cells", "OBSERVATION", 55, 76], ["absorptive functions", "OBSERVATION", 120, 140]]], ["These pathways involve typical ligand\u2013receptor interactions where the ligand is a transmembrane protein expressed in one cell type that binds with a notch receptor (i.e., notch protein) present on/in the cell membrane of another cell type.", [["transmembrane", "ANATOMY", 82, 95], ["cell", "ANATOMY", 121, 125], ["cell membrane", "ANATOMY", 204, 217], ["cell", "ANATOMY", 229, 233], ["transmembrane", "CELLULAR_COMPONENT", 82, 95], ["cell type", "CELL", 121, 130], ["notch receptor", "GENE_OR_GENE_PRODUCT", 149, 163], ["notch", "GENE_OR_GENE_PRODUCT", 171, 176], ["cell membrane", "CELLULAR_COMPONENT", 204, 217], ["cell type", "CELL", 229, 238], ["transmembrane protein", "PROTEIN", 82, 103], ["notch receptor", "PROTEIN", 149, 163], ["notch protein", "PROTEIN", 171, 184], ["a transmembrane protein", "PROBLEM", 80, 103], ["a notch receptor", "TEST", 147, 163], ["notch protein)", "PROBLEM", 171, 185], ["one cell", "OBSERVATION_MODIFIER", 117, 125], ["cell membrane", "OBSERVATION", 204, 217], ["cell type", "OBSERVATION", 229, 238]]], ["This binding interaction results in modifications of gene expression in the cell expressing the receptor, such as facilitating its differentiation into an absorptive enterocyte.", [["cell", "ANATOMY", 76, 80], ["enterocyte", "ANATOMY", 166, 176], ["cell", "CELL", 76, 80], ["enterocyte", "CELLULAR_COMPONENT", 166, 176], ["This binding interaction", "PROBLEM", 0, 24], ["gene expression", "PROBLEM", 53, 68], ["absorptive enterocyte", "OBSERVATION", 155, 176]]], ["This ligand\u2013receptor binding appears to result in cells organizing into groups of cell types as needed for their differentiation into specific tissues and organs.", [["cells", "ANATOMY", 50, 55], ["cell", "ANATOMY", 82, 86], ["tissues", "ANATOMY", 143, 150], ["organs", "ANATOMY", 155, 161], ["ligand\u2013receptor", "GENE_OR_GENE_PRODUCT", 5, 20], ["cells", "CELL", 50, 55], ["cell", "CELL", 82, 86], ["tissues", "TISSUE", 143, 150], ["organs", "ORGAN", 155, 161], ["This ligand\u2013receptor binding", "PROBLEM", 0, 28], ["cell types", "TREATMENT", 82, 92], ["cell types", "OBSERVATION", 82, 92], ["organs", "ANATOMY", 155, 161]]], ["A combination of Notch and Wnt signals is necessary for proliferation of enterocyte precursors, but differentiation of cell types is independent of Wnt.", [["enterocyte precursors", "ANATOMY", 73, 94], ["cell", "ANATOMY", 119, 123], ["Notch", "GENE_OR_GENE_PRODUCT", 17, 22], ["Wnt", "GENE_OR_GENE_PRODUCT", 27, 30], ["enterocyte precursors", "CELL", 73, 94], ["cell", "CELL", 119, 123], ["enterocyte precursors", "CELL_TYPE", 73, 94], ["Notch and Wnt signals", "TEST", 17, 38], ["proliferation", "PROBLEM", 56, 69], ["enterocyte precursors", "PROBLEM", 73, 94], ["enterocyte", "ANATOMY", 73, 83], ["cell types", "OBSERVATION", 119, 129]]], ["Wnt and Notch synergy appears to induce intestinal adenomas (Fre et al., 2009).Intestinal Cell Types ::: IntroductionThe intestine has the fastest cell turnover of any of the body\u2019s fixed tissues.", [["intestinal adenomas", "ANATOMY", 40, 59], ["Cell", "ANATOMY", 90, 94], ["intestine", "ANATOMY", 121, 130], ["cell", "ANATOMY", 147, 151], ["body", "ANATOMY", 175, 179], ["tissues", "ANATOMY", 188, 195], ["intestinal adenomas", "DISEASE", 40, 59], ["Wnt", "GENE_OR_GENE_PRODUCT", 0, 3], ["Notch", "GENE_OR_GENE_PRODUCT", 8, 13], ["intestinal adenomas", "CANCER", 40, 59], ["Intestinal Cell", "CELL", 79, 94], ["intestine", "ORGAN", 121, 130], ["cell", "CELL", 147, 151], ["body\u2019s", "TISSUE", 175, 181], ["fixed tissues", "TISSUE", 182, 195], ["Notch synergy", "PROBLEM", 8, 21], ["intestinal adenomas", "PROBLEM", 40, 59], ["intestinal", "ANATOMY", 40, 50], ["adenomas", "OBSERVATION", 51, 59], ["Cell Types", "OBSERVATION", 90, 100], ["intestine", "ANATOMY", 121, 130], ["fastest cell turnover", "OBSERVATION", 139, 160], ["body", "ANATOMY", 175, 179], ["fixed tissues", "OBSERVATION", 182, 195]]], ["In a neonatal piglet that has not achieved climax flora, the epithelial turnover rate is approximately 7 days.", [["epithelial", "ANATOMY", 61, 71], ["piglet", "ORGANISM", 14, 20], ["epithelial", "TISSUE", 61, 71], ["piglet", "SPECIES", 14, 20], ["climax flora", "PROBLEM", 43, 55], ["the epithelial turnover rate", "TEST", 57, 85], ["neonatal piglet", "ANATOMY", 5, 20]]], ["In the mature gut, the turnover rate is 2\u20133 days.", [["gut", "ANATOMY", 14, 17], ["gut", "ORGAN", 14, 17], ["gut", "ANATOMY", 14, 17]]], ["The immature, recently produced cells, with the exception of the enteroendocrine and Paneth cells, mature as they slide along the basement membrane to the villous tip extrusion zone where senescent cells become part of the fecal mass by a process of apoptosis termed anoikis.Crypt Cells ::: IntroductionThe crypt or progenitor (stem) cells have short, sparse microvilli and little digestive or absorptive capacity.", [["cells", "ANATOMY", 32, 37], ["enteroendocrine", "ANATOMY", 65, 80], ["Paneth cells", "ANATOMY", 85, 97], ["basement membrane", "ANATOMY", 130, 147], ["villous tip", "ANATOMY", 155, 166], ["cells", "ANATOMY", 198, 203], ["fecal mass", "ANATOMY", 223, 233], ["Cells", "ANATOMY", 281, 286], ["crypt", "ANATOMY", 307, 312], ["progenitor (stem) cells", "ANATOMY", 316, 339], ["microvilli", "ANATOMY", 359, 369], ["digestive", "ANATOMY", 381, 390], ["cells", "CELL", 32, 37], ["enteroendocrine", "CELL", 65, 80], ["Paneth cells", "CELL", 85, 97], ["basement membrane", "CELLULAR_COMPONENT", 130, 147], ["villous tip extrusion zone", "CELLULAR_COMPONENT", 155, 181], ["senescent cells", "CELL", 188, 203], ["fecal", "ORGANISM_SUBDIVISION", 223, 228], ["Crypt Cells", "CELL", 275, 286], ["crypt", "CELL", 307, 312], ["progenitor (stem) cells", "CELL", 316, 339], ["microvilli", "CELLULAR_COMPONENT", 359, 369], ["digestive", "ORGAN", 381, 390], ["immature, recently produced cells", "CELL_TYPE", 4, 37], ["enteroendocrine and Paneth cells", "CELL_TYPE", 65, 97], ["senescent cells", "CELL_TYPE", 188, 203], ["crypt or progenitor (stem) cells", "CELL_TYPE", 307, 339], ["senescent cells", "PROBLEM", 188, 203], ["the fecal mass", "PROBLEM", 219, 233], ["apoptosis termed anoikis", "PROBLEM", 250, 274], ["Crypt Cells", "TEST", 275, 286], ["progenitor (stem) cells", "TEST", 316, 339], ["short, sparse microvilli", "PROBLEM", 345, 369], ["little digestive or absorptive capacity", "PROBLEM", 374, 413], ["immature", "OBSERVATION_MODIFIER", 4, 12], ["enteroendocrine", "ANATOMY", 65, 80], ["Paneth cells", "OBSERVATION", 85, 97], ["villous", "ANATOMY_MODIFIER", 155, 162], ["tip", "OBSERVATION_MODIFIER", 163, 166], ["extrusion", "OBSERVATION_MODIFIER", 167, 176], ["zone", "OBSERVATION_MODIFIER", 177, 181], ["senescent cells", "OBSERVATION", 188, 203], ["fecal", "ANATOMY", 223, 228], ["mass", "OBSERVATION", 229, 233], ["anoikis", "OBSERVATION", 267, 274], ["absorptive capacity", "OBSERVATION", 394, 413]]], ["They proliferate and migrate to replace absorptive cells.", [["absorptive cells", "ANATOMY", 40, 56], ["absorptive cells", "CELL", 40, 56], ["absorptive cells", "CELL_TYPE", 40, 56], ["absorptive cells", "TREATMENT", 40, 56], ["absorptive cells", "OBSERVATION", 40, 56]]], ["Each crypt produces 300\u2013400 cells day\u2212 1.", [["crypt", "ANATOMY", 5, 10], ["cells", "ANATOMY", 28, 33], ["crypt", "CELL", 5, 10], ["cells", "CELL", 28, 33]]], ["The migration rate is dependent on many factors, one of which is adaptation to gut microflora.", [["gut microflora", "ANATOMY", 79, 93], ["gut microflora", "MULTI-TISSUE_STRUCTURE", 79, 93], ["The migration rate", "PROBLEM", 0, 18], ["migration", "OBSERVATION_MODIFIER", 4, 13], ["dependent", "OBSERVATION_MODIFIER", 22, 31]]], ["Thus, in germ-free animals, the replacement rate is similar to neonates.", [["the replacement rate", "TREATMENT", 28, 48], ["free", "OBSERVATION_MODIFIER", 14, 18]]], ["Crypt cells have secretory functions (secretory component, NaCl) and may be involved in IgA and IgM transport.Enterocytes ::: IntroductionThe absorptive cells (enterocytes) are tall and columnar with approximately 600 luminal microvilli per cell.", [["Crypt cells", "ANATOMY", 0, 11], ["secretory", "ANATOMY", 17, 26], ["absorptive cells", "ANATOMY", 142, 158], ["enterocytes", "ANATOMY", 160, 171], ["luminal microvilli", "ANATOMY", 218, 236], ["cell", "ANATOMY", 241, 245], ["NaCl", "CHEMICAL", 59, 63], ["luminal", "CHEMICAL", 218, 225], ["NaCl", "CHEMICAL", 59, 63], ["Crypt cells", "CELL", 0, 11], ["NaCl", "SIMPLE_CHEMICAL", 59, 63], ["IgA", "GENE_OR_GENE_PRODUCT", 88, 91], ["IgM", "GENE_OR_GENE_PRODUCT", 96, 99], ["absorptive cells", "CELL", 142, 158], ["enterocytes", "CELL", 160, 171], ["luminal microvilli", "CELLULAR_COMPONENT", 218, 236], ["cell", "CELL", 241, 245], ["Crypt cells", "CELL_TYPE", 0, 11], ["IgA", "PROTEIN", 88, 91], ["IgM", "PROTEIN", 96, 99], ["Enterocytes", "CELL_TYPE", 110, 121], ["absorptive cells", "CELL_TYPE", 142, 158], ["enterocytes", "CELL_TYPE", 160, 171], ["Crypt cells", "PROBLEM", 0, 11], ["secretory functions", "PROBLEM", 17, 36], ["absorptive cells", "OBSERVATION", 142, 158], ["enterocytes", "ANATOMY", 160, 171], ["luminal", "ANATOMY_MODIFIER", 218, 225], ["microvilli per cell", "OBSERVATION", 226, 245]]], ["They harbor a surface glycocalyx that contains the digestive and absorptive enzymes.", [["surface glycocalyx", "ANATOMY", 14, 32], ["digestive", "ANATOMY", 51, 60], ["surface glycocalyx", "CELLULAR_COMPONENT", 14, 32], ["digestive", "ORGAN", 51, 60], ["digestive and absorptive enzymes", "PROTEIN", 51, 83], ["absorptive enzymes", "TEST", 65, 83], ["surface glycocalyx", "OBSERVATION_MODIFIER", 14, 32]]], ["Unilaminar membrane vesicles are shed into the lumen.", [["Unilaminar membrane vesicles", "ANATOMY", 0, 28], ["lumen", "ANATOMY", 47, 52], ["membrane vesicles", "CELLULAR_COMPONENT", 11, 28], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 47, 52], ["Unilaminar membrane vesicles", "TREATMENT", 0, 28], ["membrane vesicles", "OBSERVATION", 11, 28], ["lumen", "ANATOMY_MODIFIER", 47, 52]]], ["These vesicles contain alkaline phosphatase and catalase that are bacteriocidal as well as membrane attachment sites for some pathogens.", [["vesicles", "ANATOMY", 6, 14], ["membrane", "ANATOMY", 91, 99], ["vesicles", "CELLULAR_COMPONENT", 6, 14], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 23, 43], ["catalase", "GENE_OR_GENE_PRODUCT", 48, 56], ["membrane", "CELLULAR_COMPONENT", 91, 99], ["alkaline phosphatase", "PROTEIN", 23, 43], ["catalase", "PROTEIN", 48, 56], ["alkaline phosphatase", "TEST", 23, 43], ["catalase", "PROBLEM", 48, 56], ["bacteriocidal", "PROBLEM", 66, 79], ["membrane attachment sites", "PROBLEM", 91, 116], ["some pathogens", "PROBLEM", 121, 135], ["alkaline phosphatase", "OBSERVATION", 23, 43], ["pathogens", "OBSERVATION", 126, 135]]], ["Enterocytes are connected to each other by an apical junctional complex composed of more than 40 transmembrane proteins and other molecules.", [["Enterocytes", "ANATOMY", 0, 11], ["apical junctional", "ANATOMY", 46, 63], ["transmembrane", "ANATOMY", 97, 110], ["Enterocytes", "GENE_OR_GENE_PRODUCT", 0, 11], ["apical junctional", "CELLULAR_COMPONENT", 46, 63], ["Enterocytes", "CELL_TYPE", 0, 11], ["apical junctional complex", "PROTEIN", 46, 71], ["40 transmembrane proteins", "PROTEIN", 94, 119], ["an apical junctional complex", "PROBLEM", 43, 71], ["40 transmembrane proteins and other molecules", "PROBLEM", 94, 139], ["apical", "ANATOMY_MODIFIER", 46, 52], ["junctional complex", "OBSERVATION", 53, 71]]], ["Absorptive enterocytes are end stage cells that do not proliferate.", [["enterocytes", "ANATOMY", 11, 22], ["cells", "ANATOMY", 37, 42], ["enterocytes", "CELL", 11, 22], ["cells", "CELL", 37, 42], ["enterocytes", "CELL_TYPE", 11, 22], ["end stage cells", "CELL_TYPE", 27, 42], ["Absorptive enterocytes", "PROBLEM", 0, 22], ["end stage cells", "PROBLEM", 27, 42], ["enterocytes", "ANATOMY", 11, 22], ["end stage", "OBSERVATION_MODIFIER", 27, 36], ["cells", "OBSERVATION", 37, 42], ["not", "UNCERTAINTY", 51, 54], ["proliferate", "OBSERVATION_MODIFIER", 55, 66]]], ["They provide negative feedback inhibition to the progenitor cells by secreted chalones.", [["progenitor cells", "ANATOMY", 49, 65], ["progenitor cells", "CELL", 49, 65], ["chalones", "GENE_OR_GENE_PRODUCT", 78, 86], ["progenitor cells", "CELL_TYPE", 49, 65]]], ["The absorptive cells are pinocytotic early in life for colostrum absorption and passive transfer of antibody in some species.", [["absorptive cells", "ANATOMY", 4, 20], ["colostrum", "ANATOMY", 55, 64], ["absorptive cells", "CELL", 4, 20], ["colostrum", "ORGANISM_SUBSTANCE", 55, 64], ["absorptive cells", "CELL_TYPE", 4, 20], ["antibody", "PROTEIN", 100, 108], ["The absorptive cells", "PROBLEM", 0, 20], ["pinocytotic", "PROBLEM", 25, 36], ["colostrum absorption", "PROBLEM", 55, 75], ["passive transfer of antibody", "TREATMENT", 80, 108], ["some species", "PROBLEM", 112, 124], ["absorptive cells", "OBSERVATION", 4, 20], ["pinocytotic", "OBSERVATION_MODIFIER", 25, 36]]], ["In general, enterocytes are responsible for nutrient and xenobiotic absorption.", [["enterocytes", "ANATOMY", 12, 23], ["enterocytes", "CELL", 12, 23], ["enterocytes", "CELL_TYPE", 12, 23], ["enterocytes", "ANATOMY", 12, 23], ["xenobiotic absorption", "OBSERVATION", 57, 78]]], ["They contain Class II MHCs and a complement of biotransformation enzymes.", [["Class II MHCs", "GENE_OR_GENE_PRODUCT", 13, 26], ["Class II MHCs", "PROTEIN", 13, 26], ["biotransformation enzymes", "PROTEIN", 47, 72], ["biotransformation enzymes", "TEST", 47, 72]]], ["In humans with inflammatory bowel disease, there is downregulation of genes encoding enzymes such as cytochrome P450 on colonic enterocytes (Wilke et al., 2012).", [["bowel", "ANATOMY", 28, 33], ["colonic enterocytes", "ANATOMY", 120, 139], ["inflammatory bowel disease", "DISEASE", 15, 41], ["humans", "ORGANISM", 3, 9], ["bowel", "ORGAN", 28, 33], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 101, 116], ["colonic enterocytes", "MULTI-TISSUE_STRUCTURE", 120, 139], ["enzymes", "PROTEIN", 85, 92], ["cytochrome P450", "PROTEIN", 101, 116], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["inflammatory bowel disease", "PROBLEM", 15, 41], ["downregulation of genes encoding enzymes", "PROBLEM", 52, 92], ["cytochrome P450 on colonic enterocytes", "PROBLEM", 101, 139], ["inflammatory", "OBSERVATION_MODIFIER", 15, 27], ["bowel", "ANATOMY", 28, 33], ["disease", "OBSERVATION", 34, 41], ["colonic enterocytes", "ANATOMY", 120, 139]]], ["The colonic mucosa is covered by relatively flat mucus-secreting cells and crypts.Goblet Cells ::: IntroductionMucus producing goblet cells reside in villi and crypts.", [["colonic mucosa", "ANATOMY", 4, 18], ["mucus", "ANATOMY", 49, 54], ["cells", "ANATOMY", 65, 70], ["crypts", "ANATOMY", 75, 81], ["Goblet Cells", "ANATOMY", 82, 94], ["goblet cells", "ANATOMY", 127, 139], ["villi", "ANATOMY", 150, 155], ["crypts", "ANATOMY", 160, 166], ["colonic mucosa", "MULTI-TISSUE_STRUCTURE", 4, 18], ["mucus", "GENE_OR_GENE_PRODUCT", 49, 54], ["cells", "CELL", 65, 70], ["crypts", "TISSUE", 75, 81], ["Goblet Cells", "CELL", 82, 94], ["goblet cells", "CELL", 127, 139], ["villi", "MULTI-TISSUE_STRUCTURE", 150, 155], ["crypts", "TISSUE", 160, 166], ["mucus-secreting cells", "CELL_TYPE", 49, 70], ["IntroductionMucus producing goblet cells", "CELL_TYPE", 99, 139], ["relatively flat mucus-secreting cells", "PROBLEM", 33, 70], ["goblet cells", "PROBLEM", 127, 139], ["colonic mucosa", "ANATOMY", 4, 18], ["relatively", "OBSERVATION_MODIFIER", 33, 43], ["flat", "OBSERVATION_MODIFIER", 44, 48], ["mucus", "OBSERVATION", 49, 54], ["secreting cells", "OBSERVATION", 55, 70], ["goblet cells", "OBSERVATION", 127, 139], ["villi", "ANATOMY", 150, 155]]], ["They increase in number aborally.", [["increase", "OBSERVATION_MODIFIER", 5, 13]]], ["Mucus exerts a variety of protective effects including trapping of bacteria with resultant passage in the fecal mass, lessening of shear forces of particulate matter on the enterocytes, and housing bacteriophages that reduce the bacterial population of the intestine by 104.", [["Mucus", "ANATOMY", 0, 5], ["fecal mass", "ANATOMY", 106, 116], ["enterocytes", "ANATOMY", 173, 184], ["intestine", "ANATOMY", 257, 266], ["Mucus", "MULTI-TISSUE_STRUCTURE", 0, 5], ["fecal", "ORGANISM_SUBDIVISION", 106, 111], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 173, 184], ["intestine", "ORGAN", 257, 266], ["bacteria", "PROBLEM", 67, 75], ["resultant passage in the fecal mass", "PROBLEM", 81, 116], ["shear forces of particulate matter on the enterocytes", "PROBLEM", 131, 184], ["housing bacteriophages", "TREATMENT", 190, 212], ["the bacterial population of the intestine", "PROBLEM", 225, 266], ["variety", "OBSERVATION_MODIFIER", 15, 22], ["resultant", "OBSERVATION_MODIFIER", 81, 90], ["passage", "OBSERVATION_MODIFIER", 91, 98], ["fecal", "ANATOMY", 106, 111], ["mass", "OBSERVATION", 112, 116], ["lessening", "OBSERVATION_MODIFIER", 118, 127], ["shear", "OBSERVATION_MODIFIER", 131, 136], ["forces", "OBSERVATION_MODIFIER", 137, 143], ["particulate matter", "OBSERVATION", 147, 165], ["enterocytes", "ANATOMY", 173, 184], ["bacterial population", "OBSERVATION", 229, 249], ["intestine", "ANATOMY", 257, 266]]], ["Aspirin, NSAIDS, bile acids, and cigarette smoke are among the chemicals that decrease gastric and duodenal mucus production and bicarbonate secretion (Watkins and Klaassen, 2010).Paneth Cells ::: IntroductionPaneth cells are not present in cats, dogs, raccoons, or pigs.", [["gastric", "ANATOMY", 87, 94], ["duodenal mucus", "ANATOMY", 99, 113], ["Paneth Cells", "ANATOMY", 180, 192], ["Paneth cells", "ANATOMY", 209, 221], ["Aspirin", "CHEMICAL", 0, 7], ["NSAIDS, bile acids", "CHEMICAL", 9, 27], ["bicarbonate", "CHEMICAL", 129, 140], ["Aspirin", "CHEMICAL", 0, 7], ["NSAIDS", "CHEMICAL", 9, 15], ["bile acids", "CHEMICAL", 17, 27], ["bicarbonate", "CHEMICAL", 129, 140], ["Aspirin", "SIMPLE_CHEMICAL", 0, 7], ["NSAIDS", "SIMPLE_CHEMICAL", 9, 15], ["bile acids", "SIMPLE_CHEMICAL", 17, 27], ["cigarette", "ORGANISM", 33, 42], ["gastric", "MULTI-TISSUE_STRUCTURE", 87, 94], ["duodenal mucus", "MULTI-TISSUE_STRUCTURE", 99, 113], ["bicarbonate", "SIMPLE_CHEMICAL", 129, 140], ["Paneth Cells", "CELL", 180, 192], ["Paneth cells", "CELL", 209, 221], ["cats", "ORGANISM", 241, 245], ["dogs", "ORGANISM", 247, 251], ["pigs", "ORGANISM", 266, 270], ["Paneth cells", "CELL_TYPE", 209, 221], ["cats", "SPECIES", 241, 245], ["dogs", "SPECIES", 247, 251], ["pigs", "SPECIES", 266, 270], ["pigs", "SPECIES", 266, 270], ["Aspirin", "TREATMENT", 0, 7], ["NSAIDS", "TREATMENT", 9, 15], ["bile acids", "TREATMENT", 17, 27], ["gastric and duodenal mucus production", "PROBLEM", 87, 124], ["bicarbonate secretion", "PROBLEM", 129, 150], ["IntroductionPaneth cells", "TREATMENT", 197, 221], ["bile", "ANATOMY", 17, 21], ["gastric", "ANATOMY", 87, 94], ["duodenal", "ANATOMY", 99, 107], ["mucus production", "OBSERVATION", 108, 124], ["Paneth cells", "OBSERVATION", 209, 221]]], ["In other species they constitute a cellular mass similar to that of the pancreas.", [["cellular mass", "ANATOMY", 35, 48], ["pancreas", "ANATOMY", 72, 80], ["cellular", "CELL", 35, 43], ["pancreas", "ORGAN", 72, 80], ["a cellular mass", "PROBLEM", 33, 48], ["cellular", "OBSERVATION_MODIFIER", 35, 43], ["mass", "OBSERVATION", 44, 48], ["pancreas", "ANATOMY", 72, 80]]], ["They are believed to have phagocytic and secretory functions.", [["phagocytic and secretory functions", "PROBLEM", 26, 60], ["phagocytic", "OBSERVATION", 26, 36], ["secretory functions", "OBSERVATION", 41, 60]]], ["They secrete heavy metals and are injured during this process.", [["heavy", "OBSERVATION_MODIFIER", 13, 18], ["metals", "OBSERVATION", 19, 25]]], ["They produce bacteriocidal cryptdins, lysins, peptidases, and lysozymes that may serve to protect crypt cells.", [["crypt cells", "ANATOMY", 98, 109], ["cryptdins", "GENE_OR_GENE_PRODUCT", 27, 36], ["lysins", "GENE_OR_GENE_PRODUCT", 38, 44], ["crypt cells", "CELL", 98, 109], ["bacteriocidal cryptdins", "PROTEIN", 13, 36], ["lysins", "PROTEIN", 38, 44], ["peptidases", "PROTEIN", 46, 56], ["lysozymes", "PROTEIN", 62, 71], ["crypt cells", "CELL_TYPE", 98, 109], ["bacteriocidal cryptdins", "PROBLEM", 13, 36], ["lysins", "TREATMENT", 38, 44], ["peptidases", "PROBLEM", 46, 56], ["lysozymes", "TREATMENT", 62, 71], ["crypt cells", "PROBLEM", 98, 109], ["bacteriocidal cryptdins", "OBSERVATION", 13, 36], ["crypt cells", "OBSERVATION", 98, 109]]], ["They migrate toward the crypts rather than the villus tips.", [["crypts", "ANATOMY", 24, 30], ["villus", "ANATOMY", 47, 53], ["crypts", "MULTI-TISSUE_STRUCTURE", 24, 30], ["villus tips", "MULTI-TISSUE_STRUCTURE", 47, 58], ["the villus tips", "TREATMENT", 43, 58], ["crypts", "OBSERVATION", 24, 30], ["villus", "ANATOMY", 47, 53], ["tips", "OBSERVATION_MODIFIER", 54, 58]]], ["Paneth cell function and microbial composition vary among strains of mice suggesting a genetic influence of the host (Sonnenberg et al., 2012).", [["Paneth cell", "ANATOMY", 0, 11], ["Paneth cell", "CELL", 0, 11], ["mice", "ORGANISM", 69, 73], ["mice", "SPECIES", 69, 73], ["mice", "SPECIES", 69, 73], ["Paneth cell function", "TEST", 0, 20], ["microbial composition", "TEST", 25, 46], ["cell function", "OBSERVATION", 7, 20], ["microbial composition", "OBSERVATION_MODIFIER", 25, 46]]], ["Paneth cells reside in the lower portion of the crypt and have a life span of approximately 21 days.Enteroendocrine Cells ::: IntroductionThe gastrointestinal system is the largest endocrine organ in the body.", [["Paneth cells", "ANATOMY", 0, 12], ["lower portion", "ANATOMY", 27, 40], ["crypt", "ANATOMY", 48, 53], ["Cells", "ANATOMY", 116, 121], ["gastrointestinal system", "ANATOMY", 142, 165], ["endocrine organ", "ANATOMY", 181, 196], ["body", "ANATOMY", 204, 208], ["Paneth cells", "CELL", 0, 12], ["crypt", "CANCER", 48, 53], ["Enteroendocrine Cells", "CELL", 100, 121], ["gastrointestinal", "ORGAN", 142, 158], ["system", "ANATOMICAL_SYSTEM", 159, 165], ["endocrine organ", "ORGAN", 181, 196], ["body", "ORGANISM_SUBDIVISION", 204, 208], ["Paneth cells", "CELL_TYPE", 0, 12], ["Paneth cells", "TREATMENT", 0, 12], ["lower", "ANATOMY_MODIFIER", 27, 32], ["crypt", "ANATOMY", 48, 53], ["gastrointestinal system", "ANATOMY", 142, 165], ["largest", "OBSERVATION_MODIFIER", 173, 180], ["endocrine organ", "OBSERVATION", 181, 196], ["body", "ANATOMY", 204, 208]]], ["Enteroendocrine (argentaffin, enterochromaffin) cells produce a large variety of hormones that are delivered directly into the bloodstream (Table 4).", [["Enteroendocrine", "ANATOMY", 0, 15], ["argentaffin", "ANATOMY", 17, 28], ["enterochromaffin) cells", "ANATOMY", 30, 53], ["bloodstream", "ANATOMY", 127, 138], ["argentaffin", "CELL", 17, 28], ["enterochromaffin) cells", "CELL", 30, 53], ["Enteroendocrine (argentaffin, enterochromaffin) cells", "CELL_LINE", 0, 53], ["Enteroendocrine (argentaffin, enterochromaffin) cells", "TREATMENT", 0, 53], ["a large variety of hormones", "PROBLEM", 62, 89], ["large", "OBSERVATION_MODIFIER", 64, 69], ["variety", "OBSERVATION_MODIFIER", 70, 77], ["bloodstream", "ANATOMY", 127, 138]]], ["These hormones are generated via posttranslational processing of prohormones.", [["prohormones", "GENE_OR_GENE_PRODUCT", 65, 76], ["prohormones", "PROTEIN", 65, 76], ["posttranslational processing of prohormones", "TREATMENT", 33, 76]]], ["Often, more than one molecular form exhibits biological activity.", [["biological activity", "OBSERVATION", 45, 64]]], ["For example, human progastrin consists of 80 amino acids and is cleaved to two biologically active forms, gastrin-34 and gastrin-17.", [["progastrin", "CHEMICAL", 19, 29], ["amino acids", "CHEMICAL", 45, 56], ["gastrin-34 and gastrin-17", "CHEMICAL", 106, 131], ["progastrin", "CHEMICAL", 19, 29], ["amino acids", "CHEMICAL", 45, 56], ["human", "ORGANISM", 13, 18], ["progastrin", "GENE_OR_GENE_PRODUCT", 19, 29], ["amino acids", "AMINO_ACID", 45, 56], ["gastrin-34", "GENE_OR_GENE_PRODUCT", 106, 116], ["gastrin-17", "GENE_OR_GENE_PRODUCT", 121, 131], ["human progastrin", "PROTEIN", 13, 29], ["human", "SPECIES", 13, 18], ["human", "SPECIES", 13, 18], ["human progastrin", "TEST", 13, 29], ["80 amino acids", "TREATMENT", 42, 56], ["gastrin", "TEST", 106, 113], ["gastrin", "TEST", 121, 128]]], ["Even smaller fragments of gastrin retain biological activity.", [["fragments", "ANATOMY", 13, 22], ["gastrin", "GENE_OR_GENE_PRODUCT", 26, 33], ["gastrin", "PROTEIN", 26, 33], ["smaller", "OBSERVATION_MODIFIER", 5, 12], ["fragments", "OBSERVATION", 13, 22], ["gastrin retain biological activity", "OBSERVATION", 26, 60]]], ["Cholecystokinin (CCK) exists in even more biologically active forms.", [["Cholecystokinin", "CHEMICAL", 0, 15], ["CCK", "CHEMICAL", 17, 20], ["Cholecystokinin", "GENE_OR_GENE_PRODUCT", 0, 15], ["CCK", "GENE_OR_GENE_PRODUCT", 17, 20], ["Cholecystokinin (CCK)", "TEST", 0, 21]]], ["The 115 amino acid precursor peptide is cleaved by endopeptidases to produce CCK-58, CCK-39, CCK-33, CCK-22, CCK-11, and CCK-8, all of which have CCK activity (Reeve et al., 1986).", [["amino acid", "CHEMICAL", 8, 18], ["CCK-58, CCK-39, CCK-33, CCK-22, CCK-11", "CHEMICAL", 77, 115], ["amino acid", "CHEMICAL", 8, 18], ["amino acid", "AMINO_ACID", 8, 18], ["CCK-58", "GENE_OR_GENE_PRODUCT", 77, 83], ["CCK-39", "GENE_OR_GENE_PRODUCT", 85, 91], ["CCK-33", "GENE_OR_GENE_PRODUCT", 93, 99], ["CCK-22", "GENE_OR_GENE_PRODUCT", 101, 107], ["CCK-11", "GENE_OR_GENE_PRODUCT", 109, 115], ["CCK-8", "GENE_OR_GENE_PRODUCT", 121, 126], ["CCK", "GENE_OR_GENE_PRODUCT", 146, 149], ["endopeptidases", "PROTEIN", 51, 65], ["The 115 amino acid precursor peptide", "TEST", 0, 36], ["CCK", "TEST", 77, 80], ["CCK", "TEST", 85, 88], ["CCK", "TEST", 93, 96], ["CCK", "TEST", 101, 104], ["CCK", "TEST", 109, 112], ["CCK", "TEST", 121, 124]]], ["The C-terminal pentapeptide of CCK is identical to that of gastrin and retains gastrin-like activity.", [["CCK", "CHEMICAL", 31, 34], ["gastrin", "CHEMICAL", 59, 66], ["CCK", "GENE_OR_GENE_PRODUCT", 31, 34], ["gastrin", "GENE_OR_GENE_PRODUCT", 59, 66], ["gastrin", "GENE_OR_GENE_PRODUCT", 79, 86], ["CCK", "PROTEIN", 31, 34], ["gastrin", "PROTEIN", 59, 66], ["gastrin", "PROTEIN", 79, 86], ["The C-terminal pentapeptide of CCK", "PROBLEM", 0, 34], ["gastrin", "PROBLEM", 59, 66]]], ["Gastrin and CCK are released from gastric or intestinal mucosa, respectively, by ingestion of food.", [["gastric", "ANATOMY", 34, 41], ["intestinal mucosa", "ANATOMY", 45, 62], ["CCK", "CHEMICAL", 12, 15], ["Gastrin", "GENE_OR_GENE_PRODUCT", 0, 7], ["CCK", "GENE_OR_GENE_PRODUCT", 12, 15], ["gastric", "ORGAN", 34, 41], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 45, 62], ["Gastrin and CCK", "TEST", 0, 15], ["gastric", "ANATOMY", 34, 41], ["intestinal mucosa", "ANATOMY", 45, 62]]], ["Gastrin acts in the oxyntic area of the stomach to stimulate acid secretion.", [["oxyntic area", "ANATOMY", 20, 32], ["stomach", "ANATOMY", 40, 47], ["Gastrin", "GENE_OR_GENE_PRODUCT", 0, 7], ["oxyntic area", "MULTI-TISSUE_STRUCTURE", 20, 32], ["stomach", "ORGAN", 40, 47], ["Gastrin acts", "TREATMENT", 0, 12], ["stomach", "ANATOMY", 40, 47], ["acid secretion", "OBSERVATION", 61, 75]]], ["CCK acts at the gallbladder to produce contractions that stimulate bile flow into the intestinal lumen thus stimulating pancreatic enzyme secretion.", [["gallbladder", "ANATOMY", 16, 27], ["bile", "ANATOMY", 67, 71], ["intestinal lumen", "ANATOMY", 86, 102], ["pancreatic", "ANATOMY", 120, 130], ["CCK", "CHEMICAL", 0, 3], ["CCK", "GENE_OR_GENE_PRODUCT", 0, 3], ["gallbladder", "ORGAN", 16, 27], ["bile", "MULTI-TISSUE_STRUCTURE", 67, 71], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 86, 102], ["pancreatic enzyme", "GENE_OR_GENE_PRODUCT", 120, 137], ["CCK acts", "TEST", 0, 8], ["contractions", "PROBLEM", 39, 51], ["stimulating pancreatic enzyme secretion", "PROBLEM", 108, 147], ["gallbladder", "ANATOMY", 16, 27], ["contractions", "OBSERVATION", 39, 51], ["intestinal lumen", "ANATOMY", 86, 102], ["pancreatic", "ANATOMY", 120, 130], ["enzyme secretion", "OBSERVATION", 131, 147]]], ["CCK has been proposed as a major mediator of the satiety response that leads to cessation of feeding (Della-Fera and Baile, 1979).", [["CCK", "CHEMICAL", 0, 3], ["CCK", "GENE_OR_GENE_PRODUCT", 0, 3], ["CCK", "PROTEIN", 0, 3], ["CCK", "TEST", 0, 3]]], ["Endocrine disrupters and other toxicities resulting from increases or decreases in production, processing, gastrin, or CCK release may have effects on gastric acid secretion, digestion, fat absorption, gallbladder contraction, rate of gastric emptying, growth of gastrointestinal mucosa, or appetite.M Cells ::: IntroductionM (microfold, membranous) cells occur in most species except rats.", [["Endocrine", "ANATOMY", 0, 9], ["gastric", "ANATOMY", 151, 158], ["fat", "ANATOMY", 186, 189], ["gallbladder", "ANATOMY", 202, 213], ["gastric", "ANATOMY", 235, 242], ["gastrointestinal mucosa", "ANATOMY", 263, 286], ["Cells", "ANATOMY", 302, 307], ["membranous) cells", "ANATOMY", 338, 355], ["toxicities", "DISEASE", 31, 41], ["CCK", "CHEMICAL", 119, 122], ["gastrin", "GENE_OR_GENE_PRODUCT", 107, 114], ["CCK", "GENE_OR_GENE_PRODUCT", 119, 122], ["gastric acid", "SIMPLE_CHEMICAL", 151, 163], ["fat", "TISSUE", 186, 189], ["gallbladder", "MULTI-TISSUE_STRUCTURE", 202, 213], ["gastric", "ORGAN", 235, 242], ["gastrointestinal mucosa", "MULTI-TISSUE_STRUCTURE", 263, 286], ["Cells", "CELL", 302, 307], ["membranous) cells", "CELL", 338, 355], ["rats", "ORGANISM", 385, 389], ["IntroductionM (microfold, membranous) cells", "CELL_LINE", 312, 355], ["rats", "SPECIES", 385, 389], ["other toxicities", "PROBLEM", 25, 41], ["decreases in production", "PROBLEM", 70, 93], ["gastrin", "TREATMENT", 107, 114], ["gastric acid secretion", "PROBLEM", 151, 173], ["digestion", "PROBLEM", 175, 184], ["fat absorption", "PROBLEM", 186, 200], ["gallbladder contraction", "PROBLEM", 202, 225], ["gastric emptying", "PROBLEM", 235, 251], ["gastrointestinal mucosa", "PROBLEM", 263, 286], ["appetite", "PROBLEM", 291, 299], ["M Cells", "TEST", 300, 307], ["IntroductionM (microfold, membranous) cells", "PROBLEM", 312, 355], ["increases", "OBSERVATION_MODIFIER", 57, 66], ["decreases", "OBSERVATION_MODIFIER", 70, 79], ["gastric", "ANATOMY", 151, 158], ["acid secretion", "OBSERVATION", 159, 173], ["gallbladder", "ANATOMY", 202, 213], ["gastric", "ANATOMY", 235, 242], ["emptying", "OBSERVATION", 243, 251], ["gastrointestinal mucosa", "ANATOMY", 263, 286], ["most species", "OBSERVATION_MODIFIER", 365, 377]]], ["They are associated with the dome or follicle-associated epithelium of Peyer\u2019s patches or GALT.", [["dome", "ANATOMY", 29, 33], ["follicle", "ANATOMY", 37, 45], ["epithelium", "ANATOMY", 57, 67], ["Peyer\u2019s patches", "ANATOMY", 71, 86], ["GALT", "ANATOMY", 90, 94], ["follicle", "IMMATERIAL_ANATOMICAL_ENTITY", 37, 45], ["epithelium", "TISSUE", 57, 67], ["Peyer\u2019s patches", "TISSUE", 71, 86], ["GALT", "TISSUE", 90, 94], ["dome", "OBSERVATION", 29, 33]]], ["They play an important role in antigen uptake, including particulate toxins (e.g., asbestos), from the intestinal lumen and in transport to the lymphatic system.", [["intestinal lumen", "ANATOMY", 103, 119], ["lymphatic system", "ANATOMY", 144, 160], ["antigen", "GENE_OR_GENE_PRODUCT", 31, 38], ["asbestos", "SIMPLE_CHEMICAL", 83, 91], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 103, 119], ["lymphatic system", "MULTI-TISSUE_STRUCTURE", 144, 160], ["intestinal lumen", "ANATOMY", 103, 119], ["lymphatic system", "ANATOMY", 144, 160]]], ["M cells have basal recesses that house lymphoid cells.", [["M cells", "ANATOMY", 0, 7], ["lymphoid cells", "ANATOMY", 39, 53], ["M cells", "CELL", 0, 7], ["basal recesses", "CELLULAR_COMPONENT", 13, 27], ["lymphoid cells", "CELL", 39, 53], ["M cells", "CELL_LINE", 0, 7], ["house lymphoid cells", "CELL_TYPE", 33, 53], ["basal recesses", "PROBLEM", 13, 27], ["basal", "ANATOMY_MODIFIER", 13, 18], ["recesses", "OBSERVATION_MODIFIER", 19, 27], ["house lymphoid cells", "OBSERVATION", 33, 53]]], ["This spatial arrangement allows for more rapid interaction with phagocytosed antigens.", [["phagocytosed antigens", "PROTEIN", 64, 85]]], ["M cells allow bidirectional movement of lymphocytes between the lamina propria and intestinal lumen (Nicoletti, 2000).", [["M cells", "ANATOMY", 0, 7], ["lymphocytes", "ANATOMY", 40, 51], ["lamina propria", "ANATOMY", 64, 78], ["intestinal lumen", "ANATOMY", 83, 99], ["M cells", "CELL", 0, 7], ["lymphocytes", "CELL", 40, 51], ["lamina propria", "TISSUE", 64, 78], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 83, 99], ["M cells", "CELL_LINE", 0, 7], ["lymphocytes", "CELL_TYPE", 40, 51], ["M cells", "PROBLEM", 0, 7], ["bidirectional", "OBSERVATION_MODIFIER", 14, 27], ["movement", "OBSERVATION_MODIFIER", 28, 36], ["lymphocytes", "OBSERVATION", 40, 51], ["lamina", "ANATOMY_MODIFIER", 64, 70], ["propria", "ANATOMY_MODIFIER", 71, 78], ["intestinal", "ANATOMY", 83, 93], ["lumen", "ANATOMY_MODIFIER", 94, 99]]], ["These cells are exploited for the entry of a variety of pathogens such as Salmonella, Yersinia, Rhodococcus, and some viruses (bovine virus diarrhea).", [["cells", "ANATOMY", 6, 11], ["bovine virus diarrhea", "DISEASE", 127, 148], ["cells", "CELL", 6, 11], ["Salmonella", "ORGANISM", 74, 84], ["Yersinia, Rhodococcus", "ORGANISM", 86, 107], ["bovine virus diarrhea", "ORGANISM", 127, 148], ["bovine", "SPECIES", 127, 133], ["virus diarrhea", "SPECIES", 134, 148], ["pathogens", "PROBLEM", 56, 65], ["Salmonella", "PROBLEM", 74, 84], ["Yersinia", "PROBLEM", 86, 94], ["Rhodococcus", "PROBLEM", 96, 107], ["some viruses (bovine virus diarrhea", "PROBLEM", 113, 148]]], ["Fig. 7illustrates the anatomic and mechanistic relationships of M cells to the underlying lymphoid tissue.Submucosa/Lamina Propria ::: IntroductionThe gastrointestinal mucosa is the largest surface at which mammals interact with the external environment.", [["M cells", "ANATOMY", 64, 71], ["lymphoid tissue", "ANATOMY", 90, 105], ["gastrointestinal mucosa", "ANATOMY", 151, 174], ["surface", "ANATOMY", 190, 197], ["M cells", "CELL", 64, 71], ["lymphoid tissue", "TISSUE", 90, 105], ["gastrointestinal mucosa", "MULTI-TISSUE_STRUCTURE", 151, 174], ["surface", "CELLULAR_COMPONENT", 190, 197], ["M cells", "CELL_TYPE", 64, 71], ["M cells", "OBSERVATION", 64, 71], ["lymphoid tissue", "OBSERVATION", 90, 105], ["Lamina Propria", "ANATOMY", 116, 130], ["gastrointestinal mucosa", "ANATOMY", 151, 174], ["largest", "OBSERVATION_MODIFIER", 182, 189], ["surface", "OBSERVATION_MODIFIER", 190, 197]]], ["A single layer of epithelium separates the intestinal lumen from the systemic circulation (Shanahan and Johnson, 1994).", [["epithelium", "ANATOMY", 18, 28], ["intestinal lumen", "ANATOMY", 43, 59], ["epithelium", "TISSUE", 18, 28], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 43, 59], ["single", "OBSERVATION_MODIFIER", 2, 8], ["layer", "OBSERVATION_MODIFIER", 9, 14], ["epithelium", "OBSERVATION", 18, 28], ["intestinal", "ANATOMY", 43, 53], ["lumen", "ANATOMY_MODIFIER", 54, 59], ["systemic circulation", "ANATOMY", 69, 89]]], ["Immediately below the epithelial layer of the gastrointestinal mucosa is the loose connective tissue of the lamina propria.", [["epithelial layer", "ANATOMY", 22, 38], ["gastrointestinal mucosa", "ANATOMY", 46, 69], ["connective tissue", "ANATOMY", 83, 100], ["lamina propria", "ANATOMY", 108, 122], ["epithelial layer", "TISSUE", 22, 38], ["gastrointestinal mucosa", "MULTI-TISSUE_STRUCTURE", 46, 69], ["loose connective tissue", "TISSUE", 77, 100], ["lamina propria", "TISSUE", 108, 122], ["epithelial", "ANATOMY_MODIFIER", 22, 32], ["layer", "ANATOMY_MODIFIER", 33, 38], ["gastrointestinal mucosa", "ANATOMY", 46, 69], ["loose", "OBSERVATION_MODIFIER", 77, 82], ["connective tissue", "OBSERVATION", 83, 100], ["lamina propria", "ANATOMY", 108, 122]]], ["Many cellular components of the immune system are present in the lamina propria.", [["cellular", "ANATOMY", 5, 13], ["immune system", "ANATOMY", 32, 45], ["lamina propria", "ANATOMY", 65, 79], ["cellular", "CELL", 5, 13], ["immune system", "ANATOMICAL_SYSTEM", 32, 45], ["lamina propria", "TISSUE", 65, 79], ["cellular components", "OBSERVATION", 5, 24], ["immune system", "OBSERVATION", 32, 45], ["lamina", "ANATOMY_MODIFIER", 65, 71], ["propria", "ANATOMY", 72, 79]]], ["Among these is a resident population of lymphocytes that increase with exposure to antigens, especially the microbiota (Gulati et al., 2012).Immune Cells ::: IntroductionThe immune system and microbiota have profound influences on each other (Mueller et al., 2012).", [["lymphocytes", "ANATOMY", 40, 51], ["Cells", "ANATOMY", 148, 153], ["immune system", "ANATOMY", 174, 187], ["lymphocytes", "CELL", 40, 51], ["Immune Cells", "CELL", 141, 153], ["lymphocytes", "CELL_TYPE", 40, 51], ["antigens", "PROTEIN", 83, 91], ["lymphocytes", "PROBLEM", 40, 51], ["lymphocytes", "OBSERVATION", 40, 51], ["increase", "OBSERVATION_MODIFIER", 57, 65]]], ["The classification and functions of these innate immune cells are currently being elucidated (Sonnenberg et al., 2012, Walker et al., 2013; Figs.", [["immune cells", "ANATOMY", 49, 61], ["innate immune cells", "CELL", 42, 61], ["innate immune cells", "CELL_TYPE", 42, 61]]], ["These lymphocytes arise from the same progenitor cell as NK T-cells, do not contain T-cell receptors, and produce a plethora of interleukins and other soluble mediators that parallel those of the antigen-specific immune effector cells.", [["lymphocytes", "ANATOMY", 6, 17], ["progenitor cell", "ANATOMY", 38, 53], ["NK T-cells", "ANATOMY", 57, 67], ["T-cell", "ANATOMY", 84, 90], ["immune effector cells", "ANATOMY", 213, 234], ["lymphocytes", "CELL", 6, 17], ["progenitor cell", "CELL", 38, 53], ["NK T-cells", "CELL", 57, 67], ["T-cell", "CELL", 84, 90], ["interleukins", "GENE_OR_GENE_PRODUCT", 128, 140], ["antigen", "GENE_OR_GENE_PRODUCT", 196, 203], ["immune effector cells", "CELL", 213, 234], ["lymphocytes", "CELL_TYPE", 6, 17], ["progenitor cell", "CELL_TYPE", 38, 53], ["NK T-cells", "CELL_TYPE", 57, 67], ["T-cell receptors", "PROTEIN", 84, 100], ["interleukins", "PROTEIN", 128, 140], ["soluble mediators", "PROTEIN", 151, 168], ["immune effector cells", "CELL_TYPE", 213, 234], ["These lymphocytes", "TEST", 0, 17], ["interleukins", "TREATMENT", 128, 140], ["other soluble mediators", "TREATMENT", 145, 168], ["the antigen", "TEST", 192, 203], ["lymphocytes", "OBSERVATION", 6, 17], ["progenitor cell", "OBSERVATION", 38, 53], ["immune effector cells", "OBSERVATION", 213, 234]]], ["Current theory holds that the innate lymphoid cells hold infections in check until specific immune responses are generated (Leslie, 2012).", [["lymphoid cells", "ANATOMY", 37, 51], ["infections", "DISEASE", 57, 67], ["innate lymphoid cells", "CELL", 30, 51], ["innate lymphoid cells", "CELL_TYPE", 30, 51], ["the innate lymphoid cells", "TREATMENT", 26, 51], ["infections", "PROBLEM", 57, 67], ["lymphoid cells", "OBSERVATION", 37, 51]]], ["Dendritic cells may be ILC 3 cells and similar to macrophages have Toll-like receptors (TLRs).Immune Cells ::: IntroductionThe GALT is the largest mammalian lymphoid organ and houses approximately 80% of an individual\u2019s immunoglobulin-producing cells (Shanahan and Johnson, 1994).", [["Dendritic cells", "ANATOMY", 0, 15], ["ILC 3 cells", "ANATOMY", 23, 34], ["macrophages", "ANATOMY", 50, 61], ["Cells", "ANATOMY", 101, 106], ["lymphoid organ", "ANATOMY", 157, 171], ["cells", "ANATOMY", 245, 250], ["Dendritic cells", "CELL", 0, 15], ["ILC 3 cells", "CELL", 23, 34], ["macrophages", "CELL", 50, 61], ["Toll-like receptors", "GENE_OR_GENE_PRODUCT", 67, 86], ["TLRs", "GENE_OR_GENE_PRODUCT", 88, 92], ["Immune Cells", "CELL", 94, 106], ["GALT", "GENE_OR_GENE_PRODUCT", 127, 131], ["lymphoid organ", "TISSUE", 157, 171], ["immunoglobulin", "GENE_OR_GENE_PRODUCT", 220, 234], ["cells", "CELL", 245, 250], ["Dendritic cells", "CELL_TYPE", 0, 15], ["ILC 3 cells", "CELL_TYPE", 23, 34], ["macrophages", "CELL_TYPE", 50, 61], ["Toll-like receptors", "PROTEIN", 67, 86], ["TLRs", "PROTEIN", 88, 92], ["immunoglobulin-producing cells", "CELL_TYPE", 220, 250], ["Dendritic cells", "PROBLEM", 0, 15], ["ILC 3 cells", "PROBLEM", 23, 34], ["an individual\u2019s immunoglobulin", "TEST", 204, 234], ["GALT", "ANATOMY", 127, 131], ["largest", "OBSERVATION_MODIFIER", 139, 146], ["mammalian lymphoid organ", "OBSERVATION", 147, 171]]], ["Epithelial cells of the gastrointestinal mucosa are essential components of the immune response in the gut.", [["Epithelial cells", "ANATOMY", 0, 16], ["gastrointestinal mucosa", "ANATOMY", 24, 47], ["gut", "ANATOMY", 103, 106], ["Epithelial cells", "CELL", 0, 16], ["gastrointestinal mucosa", "MULTI-TISSUE_STRUCTURE", 24, 47], ["gut", "ORGANISM_SUBDIVISION", 103, 106], ["Epithelial cells", "CELL_TYPE", 0, 16], ["Epithelial cells of the gastrointestinal mucosa", "PROBLEM", 0, 47], ["cells", "OBSERVATION", 11, 16], ["gastrointestinal mucosa", "ANATOMY", 24, 47], ["immune response", "OBSERVATION", 80, 95], ["gut", "ANATOMY", 103, 106]]], ["The close spatial and functional associations between epithelial cells and lymphoid cells suggest that GALT should refer to gut-associated lymphoepithelial tissue (Bockman et al., 1983, Castro and Arntzen, 1993).Immune Cells ::: IntroductionImmune system-mediated inflammation is a common result of gastrointestinal toxicity.", [["epithelial cells", "ANATOMY", 54, 70], ["lymphoid cells", "ANATOMY", 75, 89], ["gut", "ANATOMY", 124, 127], ["lymphoepithelial tissue", "ANATOMY", 139, 162], ["Cells", "ANATOMY", 219, 224], ["gastrointestinal", "ANATOMY", 299, 315], ["inflammation", "DISEASE", 264, 276], ["gastrointestinal toxicity", "DISEASE", 299, 324], ["epithelial cells", "CELL", 54, 70], ["lymphoid cells", "CELL", 75, 89], ["GALT", "GENE_OR_GENE_PRODUCT", 103, 107], ["gut", "ORGANISM_SUBDIVISION", 124, 127], ["lymphoepithelial tissue", "TISSUE", 139, 162], ["Immune Cells", "CELL", 212, 224], ["gastrointestinal", "ORGAN", 299, 315], ["epithelial cells", "CELL_TYPE", 54, 70], ["lymphoid cells", "CELL_TYPE", 75, 89], ["epithelial cells and lymphoid cells", "PROBLEM", 54, 89], ["lymphoepithelial tissue", "PROBLEM", 139, 162], ["IntroductionImmune system", "PROBLEM", 229, 254], ["mediated inflammation", "PROBLEM", 255, 276], ["gastrointestinal toxicity", "PROBLEM", 299, 324], ["epithelial cells", "OBSERVATION", 54, 70], ["lymphoid cells", "OBSERVATION", 75, 89], ["lymphoepithelial tissue", "ANATOMY", 139, 162], ["inflammation", "OBSERVATION", 264, 276], ["gastrointestinal", "ANATOMY", 299, 315], ["toxicity", "OBSERVATION", 316, 324]]], ["These cells include lymphocytes, macrophages, neutrophils, eosinophils, basophils, and mast cells.", [["cells", "ANATOMY", 6, 11], ["lymphocytes", "ANATOMY", 20, 31], ["macrophages", "ANATOMY", 33, 44], ["neutrophils", "ANATOMY", 46, 57], ["eosinophils", "ANATOMY", 59, 70], ["basophils", "ANATOMY", 72, 81], ["mast cells", "ANATOMY", 87, 97], ["cells", "CELL", 6, 11], ["lymphocytes", "CELL", 20, 31], ["macrophages", "CELL", 33, 44], ["neutrophils", "CELL", 46, 57], ["eosinophils", "CELL", 59, 70], ["basophils", "CELL", 72, 81], ["mast cells", "CELL", 87, 97], ["lymphocytes", "CELL_TYPE", 20, 31], ["macrophages", "CELL_TYPE", 33, 44], ["neutrophils", "CELL_TYPE", 46, 57], ["eosinophils", "CELL_TYPE", 59, 70], ["basophils", "CELL_TYPE", 72, 81], ["mast cells", "CELL_TYPE", 87, 97], ["These cells", "TEST", 0, 11], ["lymphocytes", "TEST", 20, 31], ["macrophages", "TEST", 33, 44], ["neutrophils", "TEST", 46, 57], ["eosinophils", "TEST", 59, 70], ["basophils", "TEST", 72, 81], ["mast cells", "PROBLEM", 87, 97], ["lymphocytes", "OBSERVATION", 20, 31], ["macrophages", "ANATOMY", 33, 44], ["neutrophils", "ANATOMY", 46, 57], ["basophils", "ANATOMY", 72, 81], ["mast cells", "OBSERVATION", 87, 97]]], ["Some lymphocytes also occupy spaces between epithelial cells.", [["lymphocytes", "ANATOMY", 5, 16], ["epithelial cells", "ANATOMY", 44, 60], ["lymphocytes", "CELL", 5, 16], ["epithelial cells", "CELL", 44, 60], ["lymphocytes", "CELL_TYPE", 5, 16], ["epithelial cells", "CELL_TYPE", 44, 60], ["Some lymphocytes", "PROBLEM", 0, 16], ["lymphocytes", "OBSERVATION", 5, 16], ["occupy spaces", "OBSERVATION", 22, 35], ["epithelial cells", "OBSERVATION", 44, 60]]], ["Follicular lymphoid aggregates, Peyer\u2019s patches, are present in the mucosa.", [["Follicular lymphoid aggregates", "ANATOMY", 0, 30], ["Peyer\u2019s patches", "ANATOMY", 32, 47], ["mucosa", "ANATOMY", 68, 74], ["Follicular lymphoid aggregates", "CELL", 0, 30], ["Peyer\u2019s patches", "TISSUE", 32, 47], ["mucosa", "MULTI-TISSUE_STRUCTURE", 68, 74], ["Follicular lymphoid aggregates", "PROBLEM", 0, 30], ["Peyer\u2019s patches", "TREATMENT", 32, 47], ["lymphoid aggregates", "OBSERVATION", 11, 30], ["mucosa", "ANATOMY", 68, 74]]], ["The mucosal immune system is functionally and operationally distinct in several ways from the systemic immune system.", [["mucosal", "ANATOMY", 4, 11], ["mucosal", "MULTI-TISSUE_STRUCTURE", 4, 11], ["immune system", "ANATOMICAL_SYSTEM", 103, 116], ["mucosal immune", "ANATOMY", 4, 18], ["systemic immune system", "OBSERVATION", 94, 116]]], ["In contrast to systemic humoral immunity, IgA is the predominate immunoglobulin generated in the mucosa.", [["mucosa", "ANATOMY", 97, 103], ["IgA", "GENE_OR_GENE_PRODUCT", 42, 45], ["immunoglobulin", "GENE_OR_GENE_PRODUCT", 65, 79], ["mucosa", "MULTI-TISSUE_STRUCTURE", 97, 103], ["IgA", "PROTEIN", 42, 45], ["immunoglobulin", "PROTEIN", 65, 79], ["systemic humoral immunity", "TEST", 15, 40], ["systemic", "OBSERVATION_MODIFIER", 15, 23], ["humoral immunity", "OBSERVATION", 24, 40], ["predominate immunoglobulin", "OBSERVATION", 53, 79], ["mucosa", "ANATOMY", 97, 103]]], ["Additionally, mucosal lymphocytes have surface markers that are activated relative to the peripheral blood and the systemic immune system.Immune Cells ::: IntroductionMany immune system mediators are able to effect changes in cell function or viability associated with responses to toxic substances or conditions.", [["mucosal lymphocytes", "ANATOMY", 14, 33], ["surface", "ANATOMY", 39, 46], ["peripheral blood", "ANATOMY", 90, 106], ["Cells", "ANATOMY", 145, 150], ["immune system", "ANATOMY", 172, 185], ["cell", "ANATOMY", 226, 230], ["mucosal lymphocytes", "CELL", 14, 33], ["peripheral blood", "ORGANISM_SUBSTANCE", 90, 106], ["immune system", "ANATOMICAL_SYSTEM", 124, 137], ["Immune Cells", "CELL", 138, 150], ["cell", "CELL", 226, 230], ["mucosal lymphocytes", "CELL_TYPE", 14, 33], ["mucosal lymphocytes", "PROBLEM", 14, 33], ["surface markers", "PROBLEM", 39, 54], ["the peripheral blood", "TEST", 86, 106], ["changes in cell function", "PROBLEM", 215, 239], ["toxic substances", "TREATMENT", 282, 298], ["mucosal lymphocytes", "ANATOMY", 14, 33], ["surface markers", "OBSERVATION", 39, 54], ["peripheral", "ANATOMY_MODIFIER", 90, 100], ["blood", "ANATOMY", 101, 106], ["systemic immune system", "OBSERVATION", 115, 137]]], ["Immune mediators may alter local blood flow and vascular permeability, activate or inhibit intrinsic nerves, alter epithelial cell transport, or are cytotoxic.", [["blood", "ANATOMY", 33, 38], ["vascular", "ANATOMY", 48, 56], ["nerves", "ANATOMY", 101, 107], ["epithelial cell", "ANATOMY", 115, 130], ["blood", "ORGANISM_SUBSTANCE", 33, 38], ["vascular", "MULTI-TISSUE_STRUCTURE", 48, 56], ["nerves", "MULTI-TISSUE_STRUCTURE", 101, 107], ["epithelial cell", "CELL", 115, 130], ["Immune mediators", "PROTEIN", 0, 16], ["Immune mediators", "PROBLEM", 0, 16], ["local blood flow", "TEST", 27, 43], ["vascular permeability", "TEST", 48, 69], ["epithelial cell transport", "TEST", 115, 140], ["cytotoxic", "PROBLEM", 149, 158], ["vascular", "ANATOMY", 48, 56], ["nerves", "ANATOMY", 101, 107], ["epithelial cell", "OBSERVATION", 115, 130]]], ["Some of these immune mediators are cytokines, arachidonic acid derivatives, and amines (e.g., histamine and 5-hydroxytryptamine).", [["arachidonic acid", "CHEMICAL", 46, 62], ["amines", "CHEMICAL", 80, 86], ["histamine", "CHEMICAL", 94, 103], ["5-hydroxytryptamine", "CHEMICAL", 108, 127], ["arachidonic acid", "CHEMICAL", 46, 62], ["amines", "CHEMICAL", 80, 86], ["histamine", "CHEMICAL", 94, 103], ["5-hydroxytryptamine", "CHEMICAL", 108, 127], ["arachidonic acid derivatives", "SIMPLE_CHEMICAL", 46, 74], ["amines", "SIMPLE_CHEMICAL", 80, 86], ["histamine", "SIMPLE_CHEMICAL", 94, 103], ["5-hydroxytryptamine", "SIMPLE_CHEMICAL", 108, 127], ["immune mediators", "PROTEIN", 14, 30], ["cytokines", "PROTEIN", 35, 44], ["these immune mediators", "TREATMENT", 8, 30], ["cytokines", "TREATMENT", 35, 44], ["arachidonic acid derivatives", "TREATMENT", 46, 74], ["amines", "TREATMENT", 80, 86], ["histamine", "TREATMENT", 94, 103], ["hydroxytryptamine", "TREATMENT", 110, 127]]], ["Cytokines are peptide mediators released from immune and epithelial cells that activate other immune cells to release mediators, induce chemotaxis, or induce phagocytosis.", [["immune", "ANATOMY", 46, 52], ["epithelial cells", "ANATOMY", 57, 73], ["immune cells", "ANATOMY", 94, 106], ["immune", "CELL", 46, 52], ["epithelial cells", "CELL", 57, 73], ["immune cells", "CELL", 94, 106], ["Cytokines", "PROTEIN", 0, 9], ["immune and epithelial cells", "CELL_TYPE", 46, 73], ["immune cells", "CELL_TYPE", 94, 106], ["peptide mediators", "PROBLEM", 14, 31], ["epithelial cells", "PROBLEM", 57, 73], ["chemotaxis", "PROBLEM", 136, 146], ["phagocytosis", "PROBLEM", 158, 170], ["epithelial cells", "OBSERVATION", 57, 73]]], ["Macrophages and neutrophils are the cell types most often involved in phagocytosis.", [["Macrophages", "ANATOMY", 0, 11], ["neutrophils", "ANATOMY", 16, 27], ["cell", "ANATOMY", 36, 40], ["Macrophages", "CELL", 0, 11], ["neutrophils", "CELL", 16, 27], ["cell", "CELL", 36, 40], ["Macrophages", "CELL_TYPE", 0, 11], ["neutrophils", "CELL_TYPE", 16, 27], ["phagocytosis", "PROBLEM", 70, 82], ["neutrophils", "OBSERVATION", 16, 27], ["cell types", "OBSERVATION", 36, 46], ["phagocytosis", "OBSERVATION", 70, 82]]], ["The phagocytic activity of these cells is linked to the release of a number of catabolic enzymes (acid hydrolases, neutral proteases, acid phosphatase, lysozyme, and peroxidase), along with superoxide free radicals, arachidonic acid metabolites, and other cytotoxic molecules (Shanahan and Johnson, 1994, Tanner et al., 1984).", [["cells", "ANATOMY", 33, 38], ["superoxide", "CHEMICAL", 190, 200], ["arachidonic acid", "CHEMICAL", 216, 232], ["superoxide", "CHEMICAL", 190, 200], ["arachidonic acid", "CHEMICAL", 216, 232], ["cells", "CELL", 33, 38], ["acid phosphatase", "GENE_OR_GENE_PRODUCT", 134, 150], ["lysozyme", "GENE_OR_GENE_PRODUCT", 152, 160], ["peroxidase", "GENE_OR_GENE_PRODUCT", 166, 176], ["superoxide free radicals", "SIMPLE_CHEMICAL", 190, 214], ["arachidonic acid", "SIMPLE_CHEMICAL", 216, 232], ["catabolic enzymes", "PROTEIN", 79, 96], ["acid hydrolases", "PROTEIN", 98, 113], ["neutral proteases", "PROTEIN", 115, 132], ["acid phosphatase", "PROTEIN", 134, 150], ["lysozyme", "PROTEIN", 152, 160], ["peroxidase", "PROTEIN", 166, 176], ["catabolic enzymes", "TEST", 79, 96], ["acid hydrolases", "TEST", 98, 113], ["neutral proteases", "TEST", 115, 132], ["acid phosphatase", "TEST", 134, 150], ["lysozyme", "TREATMENT", 152, 160], ["peroxidase", "TREATMENT", 166, 176], ["superoxide free radicals", "TEST", 190, 214], ["arachidonic acid metabolites", "TEST", 216, 244], ["phagocytic activity", "OBSERVATION", 4, 23], ["arachidonic acid metabolites", "OBSERVATION", 216, 244], ["cytotoxic molecules", "OBSERVATION", 256, 275]]], ["An increase in intestinal macrophages is often present in inflammatory bowel disease (Shanahan and Johnson, 1994).", [["intestinal macrophages", "ANATOMY", 15, 37], ["bowel", "ANATOMY", 71, 76], ["inflammatory bowel disease", "DISEASE", 58, 84], ["intestinal macrophages", "CELL", 15, 37], ["bowel", "ORGAN", 71, 76], ["intestinal macrophages", "CELL_TYPE", 15, 37], ["An increase in intestinal macrophages", "PROBLEM", 0, 37], ["inflammatory bowel disease", "PROBLEM", 58, 84], ["increase", "OBSERVATION_MODIFIER", 3, 11], ["intestinal", "ANATOMY", 15, 25], ["macrophages", "OBSERVATION", 26, 37], ["inflammatory", "OBSERVATION_MODIFIER", 58, 70], ["bowel", "ANATOMY", 71, 76], ["disease", "OBSERVATION", 77, 84]]], ["Macrophages are abundant in granulomas and are a hallmark of Crohn\u2019s disease.Mast Cells ::: IntroductionMast cells are very important in maintaining intestinal integrity.", [["Macrophages", "ANATOMY", 0, 11], ["granulomas", "ANATOMY", 28, 38], ["Mast Cells", "ANATOMY", 77, 87], ["Mast cells", "ANATOMY", 104, 114], ["intestinal", "ANATOMY", 149, 159], ["granulomas", "DISEASE", 28, 38], ["Crohn\u2019s disease", "DISEASE", 61, 76], ["Macrophages", "CELL", 0, 11], ["Crohn\u2019s disease", "CANCER", 61, 76], ["Mast Cells", "CELL", 77, 87], ["Mast cells", "CELL", 104, 114], ["intestinal", "ORGAN", 149, 159], ["Macrophages", "CELL_TYPE", 0, 11], ["Mast cells", "CELL_TYPE", 104, 114], ["Macrophages", "PROBLEM", 0, 11], ["granulomas", "PROBLEM", 28, 38], ["Crohn\u2019s disease", "PROBLEM", 61, 76], ["IntroductionMast cells", "TREATMENT", 92, 114], ["abundant", "OBSERVATION_MODIFIER", 16, 24], ["granulomas", "OBSERVATION", 28, 38], ["hallmark", "OBSERVATION_MODIFIER", 49, 57], ["Crohn\u2019s disease", "OBSERVATION", 61, 76], ["Mast cells", "OBSERVATION", 104, 114], ["intestinal", "ANATOMY", 149, 159]]], ["They regulate the epithelial barrier; control blood flow, coagulation, smooth muscle contraction; stimulate the enteric nervous system and peristalsis; and play a role in antibody-dependent recognition of parasites and microorganisms.", [["epithelial barrier", "ANATOMY", 18, 36], ["blood", "ANATOMY", 46, 51], ["smooth muscle", "ANATOMY", 71, 84], ["enteric nervous system", "ANATOMY", 112, 134], ["epithelial barrier", "TISSUE", 18, 36], ["blood", "ORGANISM_SUBSTANCE", 46, 51], ["smooth muscle", "TISSUE", 71, 84], ["enteric nervous system", "ANATOMICAL_SYSTEM", 112, 134], ["the epithelial barrier", "TREATMENT", 14, 36], ["blood flow", "TEST", 46, 56], ["smooth muscle contraction", "PROBLEM", 71, 96], ["a role in antibody", "TEST", 161, 179], ["parasites", "PROBLEM", 205, 214], ["microorganisms", "PROBLEM", 219, 233], ["epithelial", "ANATOMY_MODIFIER", 18, 28], ["smooth muscle contraction", "OBSERVATION", 71, 96], ["enteric nervous", "ANATOMY", 112, 127]]], ["They release proinflammatory paracrine cytokines.", [["proinflammatory paracrine cytokines", "PROTEIN", 13, 48], ["proinflammatory paracrine cytokines", "OBSERVATION", 13, 48]]], ["Mucosal mast cells differ from mast cells at nonmucosal sites (Enerback, 1987).", [["Mucosal mast cells", "ANATOMY", 0, 18], ["mast cells", "ANATOMY", 31, 41], ["nonmucosal sites", "ANATOMY", 45, 61], ["Mucosal mast cells", "CELL", 0, 18], ["mast cells", "CELL", 31, 41], ["nonmucosal sites", "MULTI-TISSUE_STRUCTURE", 45, 61], ["Mucosal mast cells", "CELL_TYPE", 0, 18], ["mast cells", "CELL_TYPE", 31, 41], ["Mucosal mast cells", "PROBLEM", 0, 18], ["mast cells", "OBSERVATION", 8, 18], ["mast cells", "OBSERVATION", 31, 41]]], ["They lack membrane-bound IgE and contain chondroitin sulfate; peritoneal mast cells contain heparin proteoglycan (Shanahan and Johnson, 1994).", [["membrane", "ANATOMY", 10, 18], ["peritoneal mast cells", "ANATOMY", 62, 83], ["chondroitin sulfate", "CHEMICAL", 41, 60], ["heparin", "CHEMICAL", 92, 99], ["chondroitin sulfate", "CHEMICAL", 41, 60], ["membrane", "CELLULAR_COMPONENT", 10, 18], ["IgE", "GENE_OR_GENE_PRODUCT", 25, 28], ["chondroitin sulfate", "SIMPLE_CHEMICAL", 41, 60], ["peritoneal mast cells", "CELL", 62, 83], ["heparin proteoglycan", "SIMPLE_CHEMICAL", 92, 112], ["IgE", "PROTEIN", 25, 28], ["peritoneal mast cells", "CELL_TYPE", 62, 83], ["chondroitin sulfate", "TREATMENT", 41, 60], ["peritoneal mast cells", "TREATMENT", 62, 83], ["heparin proteoglycan", "TREATMENT", 92, 112], ["peritoneal", "ANATOMY", 62, 72], ["mast cells", "OBSERVATION", 73, 83]]], ["Activation of mast cells can lead to effects on mucus secretion, vascular permeability, muscle contraction, and inflammatory cell recruitment (Crowe and Perdue, 1992).Mast Cells ::: IntroductionWithin the mucosa there is bidirectional communication between intrinsic nerves and mast cells.", [["mast cells", "ANATOMY", 14, 24], ["mucus", "ANATOMY", 48, 53], ["vascular", "ANATOMY", 65, 73], ["muscle", "ANATOMY", 88, 94], ["cell", "ANATOMY", 125, 129], ["Mast Cells", "ANATOMY", 167, 177], ["mucosa", "ANATOMY", 205, 211], ["nerves", "ANATOMY", 267, 273], ["mast cells", "ANATOMY", 278, 288], ["mast cells", "CELL", 14, 24], ["mucus", "MULTI-TISSUE_STRUCTURE", 48, 53], ["vascular", "MULTI-TISSUE_STRUCTURE", 65, 73], ["muscle", "ORGAN", 88, 94], ["cell", "CELL", 125, 129], ["Mast Cells", "CELL", 167, 177], ["mucosa", "MULTI-TISSUE_STRUCTURE", 205, 211], ["nerves", "TISSUE", 267, 273], ["mast cells", "CELL", 278, 288], ["mast cells", "CELL_TYPE", 14, 24], ["mast cells", "CELL_TYPE", 278, 288], ["mast cells", "PROBLEM", 14, 24], ["mucus secretion", "PROBLEM", 48, 63], ["vascular permeability", "PROBLEM", 65, 86], ["muscle contraction", "PROBLEM", 88, 106], ["inflammatory cell recruitment", "PROBLEM", 112, 141], ["bidirectional communication between intrinsic nerves and mast cells", "PROBLEM", 221, 288], ["mast cells", "OBSERVATION", 14, 24], ["mucus secretion", "OBSERVATION", 48, 63], ["vascular", "ANATOMY", 65, 73], ["permeability", "OBSERVATION", 74, 86], ["muscle contraction", "ANATOMY", 88, 106], ["inflammatory cell recruitment", "OBSERVATION", 112, 141], ["mucosa", "ANATOMY", 205, 211], ["bidirectional communication", "OBSERVATION", 221, 248], ["nerves", "ANATOMY", 267, 273], ["mast cells", "OBSERVATION", 278, 288]]], ["In the guinea pig colon, histamine causes a recurrent pattern of chloride secretion mediated by activation of histamine receptors and stimulation of cholinergic secretomotor neurons (Cooke et al., 1993).", [["colon", "ANATOMY", 18, 23], ["cholinergic secretomotor neurons", "ANATOMY", 149, 181], ["histamine", "CHEMICAL", 25, 34], ["chloride", "CHEMICAL", 65, 73], ["histamine", "CHEMICAL", 110, 119], ["histamine", "CHEMICAL", 25, 34], ["chloride", "CHEMICAL", 65, 73], ["histamine", "CHEMICAL", 110, 119], ["pig", "ORGANISM", 14, 17], ["colon", "ORGAN", 18, 23], ["histamine", "SIMPLE_CHEMICAL", 25, 34], ["chloride", "SIMPLE_CHEMICAL", 65, 73], ["histamine receptors", "GENE_OR_GENE_PRODUCT", 110, 129], ["cholinergic secretomotor neurons", "CELL", 149, 181], ["histamine receptors", "PROTEIN", 110, 129], ["cholinergic secretomotor neurons", "CELL_TYPE", 149, 181], ["guinea pig", "SPECIES", 7, 17], ["guinea pig", "SPECIES", 7, 17], ["histamine", "TREATMENT", 25, 34], ["chloride secretion", "PROBLEM", 65, 83], ["histamine receptors", "TREATMENT", 110, 129], ["guinea", "ANATOMY_MODIFIER", 7, 13], ["pig colon", "ANATOMY", 14, 23], ["chloride secretion", "OBSERVATION", 65, 83]]], ["Antigen challenge in sensitized animals may result in release of substance P and CGRP from sensory nerves (Castro and Arntzen, 1993).", [["sensory nerves", "ANATOMY", 91, 105], ["CGRP", "CHEMICAL", 81, 85], ["substance P", "GENE_OR_GENE_PRODUCT", 65, 76], ["CGRP", "GENE_OR_GENE_PRODUCT", 81, 85], ["sensory nerves", "MULTI-TISSUE_STRUCTURE", 91, 105], ["Antigen challenge", "TEST", 0, 17], ["sensory nerves", "ANATOMY", 91, 105]]], ["These neurotransmitters can cause mast cells to release histamine.", [["mast cells", "ANATOMY", 34, 44], ["histamine", "CHEMICAL", 56, 65], ["histamine", "CHEMICAL", 56, 65], ["mast cells", "CELL", 34, 44], ["histamine", "SIMPLE_CHEMICAL", 56, 65], ["mast cells", "CELL_TYPE", 34, 44], ["mast cells", "PROBLEM", 34, 44], ["histamine", "TREATMENT", 56, 65], ["mast cells", "OBSERVATION", 34, 44]]], ["Histamine causes cholinergic motor neurons to induce muscle contractions or alterations in epithelial ion transport (Castro et al., 1994).", [["cholinergic motor neurons", "ANATOMY", 17, 42], ["muscle", "ANATOMY", 53, 59], ["epithelial", "ANATOMY", 91, 101], ["Histamine", "CHEMICAL", 0, 9], ["muscle contractions", "DISEASE", 53, 72], ["Histamine", "CHEMICAL", 0, 9], ["Histamine", "SIMPLE_CHEMICAL", 0, 9], ["cholinergic motor neurons", "CELL", 17, 42], ["muscle", "ORGAN", 53, 59], ["epithelial", "TISSUE", 91, 101], ["cholinergic motor neurons", "CELL_TYPE", 17, 42], ["Histamine", "TREATMENT", 0, 9], ["cholinergic motor neurons", "PROBLEM", 17, 42], ["muscle contractions", "PROBLEM", 53, 72], ["cholinergic motor", "OBSERVATION", 17, 34], ["muscle", "ANATOMY", 53, 59], ["epithelial", "ANATOMY_MODIFIER", 91, 101]]], ["Mast cell histamine release affects epithelial transport of water and electrolytes via direct actions on epithelial cells and indirectly by effects on intrinsic nerves (Castro et al., 1987).", [["Mast cell", "ANATOMY", 0, 9], ["epithelial", "ANATOMY", 36, 46], ["epithelial cells", "ANATOMY", 105, 121], ["nerves", "ANATOMY", 161, 167], ["histamine", "CHEMICAL", 10, 19], ["histamine", "CHEMICAL", 10, 19], ["Mast cell", "CELL", 0, 9], ["epithelial", "TISSUE", 36, 46], ["water", "SIMPLE_CHEMICAL", 60, 65], ["electrolytes", "SIMPLE_CHEMICAL", 70, 82], ["epithelial cells", "CELL", 105, 121], ["nerves", "MULTI-TISSUE_STRUCTURE", 161, 167], ["epithelial cells", "CELL_TYPE", 105, 121], ["Mast cell histamine release", "TREATMENT", 0, 27], ["epithelial transport of water and electrolytes", "TREATMENT", 36, 82], ["epithelial cells", "TREATMENT", 105, 121], ["epithelial cells", "OBSERVATION", 105, 121], ["nerves", "ANATOMY", 161, 167]]], ["Histamine induces a recurrent pattern of chloride secretion from mucosal crypt cells and contractions of smooth muscle (Cooke et al., 1993).", [["mucosal crypt cells", "ANATOMY", 65, 84], ["smooth muscle", "ANATOMY", 105, 118], ["Histamine", "CHEMICAL", 0, 9], ["chloride", "CHEMICAL", 41, 49], ["Histamine", "CHEMICAL", 0, 9], ["chloride", "CHEMICAL", 41, 49], ["Histamine", "SIMPLE_CHEMICAL", 0, 9], ["chloride", "SIMPLE_CHEMICAL", 41, 49], ["mucosal crypt cells", "CELL", 65, 84], ["smooth muscle", "TISSUE", 105, 118], ["mucosal crypt cells", "CELL_TYPE", 65, 84], ["Histamine", "TREATMENT", 0, 9], ["chloride secretion", "PROBLEM", 41, 59], ["mucosal crypt cells", "PROBLEM", 65, 84], ["recurrent", "OBSERVATION_MODIFIER", 20, 29], ["chloride secretion", "OBSERVATION", 41, 59], ["mucosal crypt cells", "OBSERVATION", 65, 84], ["smooth muscle", "ANATOMY", 105, 118]]], ["In addition to histamine, 5-hydroxy-tryptamine (5-HT) released from enterochromaffin cells and myenteric neurons, as well as mast cells in some rodents, may contribute to mucosal chloride secretion (Cooke et al., 1991).", [["enterochromaffin cells", "ANATOMY", 68, 90], ["myenteric neurons", "ANATOMY", 95, 112], ["mast cells", "ANATOMY", 125, 135], ["mucosal", "ANATOMY", 171, 178], ["histamine", "CHEMICAL", 15, 24], ["5-hydroxy-tryptamine", "CHEMICAL", 26, 46], ["5-HT", "CHEMICAL", 48, 52], ["chloride", "CHEMICAL", 179, 187], ["histamine", "CHEMICAL", 15, 24], ["5-hydroxy-tryptamine", "CHEMICAL", 26, 46], ["5-HT", "CHEMICAL", 48, 52], ["chloride", "CHEMICAL", 179, 187], ["histamine", "SIMPLE_CHEMICAL", 15, 24], ["5-hydroxy-tryptamine", "SIMPLE_CHEMICAL", 26, 46], ["5-HT", "SIMPLE_CHEMICAL", 48, 52], ["enterochromaffin cells", "CELL", 68, 90], ["myenteric neurons", "CELL", 95, 112], ["mast cells", "CELL", 125, 135], ["mucosal", "MULTI-TISSUE_STRUCTURE", 171, 178], ["chloride", "SIMPLE_CHEMICAL", 179, 187], ["enterochromaffin cells", "CELL_TYPE", 68, 90], ["myenteric neurons", "CELL_TYPE", 95, 112], ["mast cells", "CELL_TYPE", 125, 135], ["histamine", "TREATMENT", 15, 24], ["hydroxy-tryptamine", "TREATMENT", 28, 46], ["enterochromaffin cells", "TREATMENT", 68, 90], ["myenteric neurons", "PROBLEM", 95, 112], ["mast cells", "TREATMENT", 125, 135], ["mucosal chloride secretion", "PROBLEM", 171, 197], ["enterochromaffin cells", "OBSERVATION", 68, 90], ["myenteric neurons", "ANATOMY", 95, 112], ["mast cells", "OBSERVATION", 125, 135]]], ["Chloride secretion results in a net transfer of salt and water to the gastrointestinal lumen (Cooke et al., 1993).", [["gastrointestinal lumen", "ANATOMY", 70, 92], ["Chloride", "CHEMICAL", 0, 8], ["Chloride", "CHEMICAL", 0, 8], ["Chloride", "SIMPLE_CHEMICAL", 0, 8], ["salt", "SIMPLE_CHEMICAL", 48, 52], ["gastrointestinal lumen", "MULTI-TISSUE_STRUCTURE", 70, 92], ["Chloride secretion", "TEST", 0, 18], ["a net transfer of salt and water to the gastrointestinal lumen", "TREATMENT", 30, 92], ["gastrointestinal lumen", "ANATOMY", 70, 92]]], ["The actions of 5-HT appear to be indirect and result from release of acetylcholine that acts directly upon mucosal crypt cells.", [["mucosal crypt cells", "ANATOMY", 107, 126], ["5-HT", "CHEMICAL", 15, 19], ["acetylcholine", "CHEMICAL", 69, 82], ["5-HT", "CHEMICAL", 15, 19], ["acetylcholine", "CHEMICAL", 69, 82], ["5-HT", "SIMPLE_CHEMICAL", 15, 19], ["acetylcholine", "SIMPLE_CHEMICAL", 69, 82], ["mucosal crypt cells", "CELL", 107, 126], ["mucosal crypt cells", "CELL_TYPE", 107, 126], ["acetylcholine", "TREATMENT", 69, 82], ["mucosal", "ANATOMY", 107, 114], ["crypt cells", "OBSERVATION", 115, 126]]], ["Evidence indicates that 5-HT can induce electrogenic chloride secretion in human jejunal mucosa by direct effects on crypt cells (Kellum et al., 1994).", [["jejunal mucosa", "ANATOMY", 81, 95], ["crypt cells", "ANATOMY", 117, 128], ["5-HT", "CHEMICAL", 24, 28], ["chloride", "CHEMICAL", 53, 61], ["5-HT", "CHEMICAL", 24, 28], ["chloride", "CHEMICAL", 53, 61], ["5-HT", "SIMPLE_CHEMICAL", 24, 28], ["chloride", "SIMPLE_CHEMICAL", 53, 61], ["human", "ORGANISM", 75, 80], ["jejunal mucosa", "MULTI-TISSUE_STRUCTURE", 81, 95], ["crypt cells", "CELL", 117, 128], ["crypt cells", "CELL_TYPE", 117, 128], ["human", "SPECIES", 75, 80], ["human", "SPECIES", 75, 80], ["electrogenic chloride secretion in human jejunal mucosa", "PROBLEM", 40, 95], ["crypt cells", "PROBLEM", 117, 128], ["chloride secretion", "OBSERVATION", 53, 71], ["jejunal mucosa", "ANATOMY", 81, 95]]], ["Both the direct effects of 5-HT and histamine on epithelial cells and the indirect effects mediated by cholinergic motor neurons may be augmented and amplified by prostaglandins and other substances released during immune responses or inflammation (Sidhu and Cooke, 1995).Neutrophils ::: IntroductionNeutrophils in the lamina propria are transient as they pass through the intestine to become part of the fecal mass and expelled from the body.", [["epithelial cells", "ANATOMY", 49, 65], ["cholinergic motor neurons", "ANATOMY", 103, 128], ["Neutrophils", "ANATOMY", 272, 283], ["Neutrophils", "ANATOMY", 300, 311], ["lamina propria", "ANATOMY", 319, 333], ["intestine", "ANATOMY", 373, 382], ["fecal mass", "ANATOMY", 405, 415], ["body", "ANATOMY", 438, 442], ["5-HT", "CHEMICAL", 27, 31], ["histamine", "CHEMICAL", 36, 45], ["prostaglandins", "CHEMICAL", 163, 177], ["inflammation", "DISEASE", 235, 247], ["5-HT", "CHEMICAL", 27, 31], ["histamine", "CHEMICAL", 36, 45], ["prostaglandins", "CHEMICAL", 163, 177], ["5-HT", "SIMPLE_CHEMICAL", 27, 31], ["histamine", "SIMPLE_CHEMICAL", 36, 45], ["epithelial cells", "CELL", 49, 65], ["cholinergic motor neurons", "CELL", 103, 128], ["prostaglandins", "SIMPLE_CHEMICAL", 163, 177], ["Neutrophils", "CELL", 272, 283], ["Neutrophils", "CELL", 300, 311], ["lamina propria", "TISSUE", 319, 333], ["intestine", "ORGAN", 373, 382], ["fecal", "ORGANISM_SUBDIVISION", 405, 410], ["body", "ORGANISM_SUBDIVISION", 438, 442], ["epithelial cells", "CELL_TYPE", 49, 65], ["cholinergic motor neurons", "CELL_TYPE", 103, 128], ["Neutrophils", "CELL_TYPE", 272, 283], ["Neutrophils", "CELL_TYPE", 300, 311], ["5-HT and histamine on epithelial cells", "TREATMENT", 27, 65], ["inflammation", "PROBLEM", 235, 247], ["Neutrophils", "TEST", 272, 283], ["the fecal mass", "PROBLEM", 401, 415], ["epithelial cells", "OBSERVATION", 49, 65], ["lamina propria", "ANATOMY", 319, 333], ["transient", "OBSERVATION_MODIFIER", 338, 347], ["intestine", "ANATOMY", 373, 382], ["fecal", "ANATOMY", 405, 410], ["mass", "OBSERVATION", 411, 415], ["body", "ANATOMY", 438, 442]]], ["Human neutrophils spend about 5 days in the bloodstream and about 2 days in tissues.", [["neutrophils", "ANATOMY", 6, 17], ["bloodstream", "ANATOMY", 44, 55], ["tissues", "ANATOMY", 76, 83], ["Human", "ORGANISM", 0, 5], ["neutrophils", "CELL", 6, 17], ["tissues", "TISSUE", 76, 83], ["Human neutrophils", "CELL_TYPE", 0, 17], ["Human", "SPECIES", 0, 5], ["Human", "SPECIES", 0, 5], ["Human neutrophils", "PROBLEM", 0, 17], ["bloodstream", "ANATOMY", 44, 55]]], ["However, there is marked variation in neutrophil lifespan among species.", [["neutrophil", "ANATOMY", 38, 48], ["neutrophil", "CELL", 38, 48], ["marked variation in neutrophil lifespan among species", "PROBLEM", 18, 71], ["marked", "OBSERVATION_MODIFIER", 18, 24], ["variation", "OBSERVATION_MODIFIER", 25, 34], ["neutrophil lifespan", "OBSERVATION", 38, 57]]], ["In mice for example, neutrophil lifespan is approximately 0.75 days (Pillay et al., 2010).Globule Leukocytes ::: IntroductionGlobule leukocytes are present in a variety of submucosal locations including the lamina propria.", [["neutrophil", "ANATOMY", 21, 31], ["Leukocytes", "ANATOMY", 98, 108], ["Globule leukocytes", "ANATOMY", 125, 143], ["submucosal locations", "ANATOMY", 172, 192], ["lamina propria", "ANATOMY", 207, 221], ["mice", "ORGANISM", 3, 7], ["neutrophil", "CELL", 21, 31], ["Globule Leukocytes", "CELL", 90, 108], ["Globule leukocytes", "CELL", 125, 143], ["submucosal locations", "MULTI-TISSUE_STRUCTURE", 172, 192], ["lamina propria", "TISSUE", 207, 221], ["neutrophil", "CELL_TYPE", 21, 31], ["Leukocytes", "CELL_TYPE", 98, 108], ["Globule leukocytes", "CELL_TYPE", 125, 143], ["mice", "SPECIES", 3, 7], ["mice", "SPECIES", 3, 7], ["neutrophil lifespan", "TREATMENT", 21, 40], ["IntroductionGlobule leukocytes", "PROBLEM", 113, 143], ["Leukocytes", "OBSERVATION", 98, 108], ["Globule leukocytes", "OBSERVATION", 125, 143], ["variety", "OBSERVATION_MODIFIER", 161, 168], ["submucosal", "ANATOMY_MODIFIER", 172, 182], ["lamina propria", "ANATOMY", 207, 221]]], ["Their function is largely unknown but may be similar to those of Paneth cells.", [["Paneth cells", "ANATOMY", 65, 77], ["Paneth cells", "CELL", 65, 77], ["Paneth cells", "CELL_TYPE", 65, 77], ["Paneth cells", "OBSERVATION", 65, 77]]], ["Theories for their origin include derivation from mast cells, plasma cells, large granular lymphocyte lineages, or a distinct precursor (Spoor et al., 2011).", [["mast cells", "ANATOMY", 50, 60], ["plasma cells", "ANATOMY", 62, 74], ["granular lymphocyte", "ANATOMY", 82, 101], ["mast cells", "CELL", 50, 60], ["plasma cells", "CELL", 62, 74], ["large granular lymphocyte lineages", "CELL", 76, 110], ["mast cells", "CELL_TYPE", 50, 60], ["plasma cells", "CELL_TYPE", 62, 74], ["large granular lymphocyte lineages", "CELL_TYPE", 76, 110], ["mast cells", "PROBLEM", 50, 60], ["plasma cells", "PROBLEM", 62, 74], ["large granular lymphocyte lineages", "PROBLEM", 76, 110], ["a distinct precursor", "PROBLEM", 115, 135], ["mast cells", "OBSERVATION", 50, 60], ["plasma cells", "OBSERVATION", 62, 74], ["large", "OBSERVATION_MODIFIER", 76, 81], ["granular lymphocyte lineages", "OBSERVATION", 82, 110], ["distinct", "OBSERVATION_MODIFIER", 117, 125], ["precursor", "OBSERVATION_MODIFIER", 126, 135]]], ["They are most common in parasitic infections and rarely form neoplasms.Microbiota ::: IntroductionThe microbiota/microbiome of the lower GI system consists of 100 trillion bacteria which is 10 times the number of cells in an animal and 1.3 million times the number of genes in an animal.", [["neoplasms", "ANATOMY", 61, 70], ["lower GI system", "ANATOMY", 131, 146], ["cells", "ANATOMY", 213, 218], ["parasitic infections", "DISEASE", 24, 44], ["neoplasms", "DISEASE", 61, 70], ["neoplasms", "CANCER", 61, 70], ["cells", "CELL", 213, 218], ["parasitic infections", "PROBLEM", 24, 44], ["neoplasms", "PROBLEM", 61, 70], ["the lower GI system", "TEST", 127, 146], ["100 trillion bacteria", "PROBLEM", 159, 180], ["most common", "UNCERTAINTY", 9, 20], ["parasitic", "OBSERVATION_MODIFIER", 24, 33], ["infections", "OBSERVATION", 34, 44], ["neoplasms", "OBSERVATION", 61, 70], ["lower", "ANATOMY_MODIFIER", 131, 136], ["GI system", "ANATOMY", 137, 146], ["10 times", "OBSERVATION_MODIFIER", 190, 198]]], ["Due to the enterocytes\u2019 low expression of TLRs, such as lipopolysaccharide-responsive TLR4, they do not react to these resident bacteria (Abreu et al., 2003).Microbiota ::: IntroductionApproximately 30\u201340% of fecal dry matter is of bacterial origin.", [["enterocytes", "ANATOMY", 11, 22], ["lipopolysaccharide", "CHEMICAL", 56, 74], ["enterocytes", "CELL", 11, 22], ["TLRs", "GENE_OR_GENE_PRODUCT", 42, 46], ["lipopolysaccharide", "SIMPLE_CHEMICAL", 56, 74], ["TLR4", "GENE_OR_GENE_PRODUCT", 86, 90], ["fecal", "ORGANISM_SUBDIVISION", 209, 214], ["TLRs", "PROTEIN", 42, 46], ["TLR4", "PROTEIN", 86, 90], ["the enterocytes", "PROBLEM", 7, 22], ["lipopolysaccharide-responsive TLR4", "TREATMENT", 56, 90], ["IntroductionApproximately", "TREATMENT", 173, 198], ["fecal dry matter", "PROBLEM", 209, 225], ["bacterial origin", "PROBLEM", 232, 248], ["low expression", "OBSERVATION_MODIFIER", 24, 38], ["fecal dry matter", "OBSERVATION_MODIFIER", 209, 225], ["bacterial origin", "OBSERVATION", 232, 248]]], ["These bacteria secrete bacteriocins (i.e., proteinaceous toxins that inhibit the growth of other bacteria) and compete for nutrients and for attachment sites thus limiting potential pathogen growth.", [["These bacteria secrete bacteriocins", "PROBLEM", 0, 35], ["proteinaceous toxins", "PROBLEM", 43, 63], ["other bacteria", "PROBLEM", 91, 105], ["attachment sites", "PROBLEM", 141, 157], ["potential pathogen growth", "PROBLEM", 172, 197]]], ["The microbiome promotes immune system maturation and contains biotransformation enzymes such as \u03b2-glucuronidases, \u03b22-glycosidases, demethylases, hydrolases, and reductases.", [["immune system", "ANATOMY", 24, 37], ["\u03b2-glucuronidases", "GENE_OR_GENE_PRODUCT", 96, 112], ["\u03b22-glycosidases", "GENE_OR_GENE_PRODUCT", 114, 129], ["biotransformation enzymes", "PROTEIN", 62, 87], ["\u03b2-glucuronidases", "PROTEIN", 96, 112], ["\u03b22", "PROTEIN", 114, 116], ["glycosidases", "PROTEIN", 117, 129], ["demethylases", "PROTEIN", 131, 143], ["hydrolases", "PROTEIN", 145, 155], ["reductases", "PROTEIN", 161, 171], ["biotransformation enzymes", "TEST", 62, 87], ["\u03b2-glucuronidases", "TEST", 96, 112], ["demethylases", "PROBLEM", 131, 143], ["hydrolases", "PROBLEM", 145, 155], ["immune system", "OBSERVATION", 24, 37]]], ["There appear to be three enterotypes (i.e., type of bacteriologic ecosystem of the gastrointestinal microbiome) in animals, and these biotypes may be, in part, responsible for susceptibility or resistance to certain pathologic conditions.Mucosal Growth and Repair ::: IntroductionSeveral substances including gastrin, TGF-\u03b1, and TGF-\u03b2 are growth factors that stimulate epithelial growth from stem cells.", [["gastrointestinal microbiome", "ANATOMY", 83, 110], ["Mucosal", "ANATOMY", 238, 245], ["epithelial", "ANATOMY", 369, 379], ["stem cells", "ANATOMY", 392, 402], ["gastrin", "CHEMICAL", 309, 316], ["gastrointestinal microbiome", "MULTI-TISSUE_STRUCTURE", 83, 110], ["Mucosal", "MULTI-TISSUE_STRUCTURE", 238, 245], ["gastrin", "GENE_OR_GENE_PRODUCT", 309, 316], ["TGF-\u03b1", "GENE_OR_GENE_PRODUCT", 318, 323], ["TGF-\u03b2", "GENE_OR_GENE_PRODUCT", 329, 334], ["epithelial", "CELL", 369, 379], ["stem cells", "CELL", 392, 402], ["gastrin", "PROTEIN", 309, 316], ["TGF-\u03b1", "PROTEIN", 318, 323], ["TGF-\u03b2", "PROTEIN", 329, 334], ["growth factors", "PROTEIN", 339, 353], ["stem cells", "CELL_TYPE", 392, 402], ["three enterotypes", "PROBLEM", 19, 36], ["susceptibility or resistance to certain pathologic conditions", "PROBLEM", 176, 237], ["IntroductionSeveral substances", "TEST", 268, 298], ["gastrin", "TEST", 309, 316], ["TGF", "TEST", 318, 321], ["TGF", "TEST", 329, 332], ["growth factors", "PROBLEM", 339, 353], ["epithelial growth from stem cells", "PROBLEM", 369, 402], ["appear to be", "UNCERTAINTY", 6, 18], ["three", "OBSERVATION_MODIFIER", 19, 24], ["enterotypes", "OBSERVATION", 25, 36], ["gastrointestinal microbiome", "ANATOMY", 83, 110], ["Growth", "OBSERVATION_MODIFIER", 246, 252], ["Repair", "OBSERVATION", 257, 263], ["stem cells", "OBSERVATION", 392, 402]]], ["The ingestion and digestion of food are important in maintaining intestinal mucosal growth.", [["intestinal mucosal", "ANATOMY", 65, 83], ["intestinal mucosal", "MULTI-TISSUE_STRUCTURE", 65, 83], ["intestinal mucosal", "ANATOMY", 65, 83]]], ["Rats maintained on total parenteral nutrition gain body weight, but the weight of the stomach, small bowel, and colon is often only 30\u201340% of comparable tissues from control animals (Johnson et al., 1975).Mucosal Transport ::: IntroductionXenobiotics enter enterocytes primarily by diffusion.", [["parenteral", "ANATOMY", 25, 35], ["body", "ANATOMY", 51, 55], ["stomach", "ANATOMY", 86, 93], ["small bowel", "ANATOMY", 95, 106], ["colon", "ANATOMY", 112, 117], ["tissues", "ANATOMY", 153, 160], ["Mucosal", "ANATOMY", 205, 212], ["enterocytes", "ANATOMY", 257, 268], ["Rats", "ORGANISM", 0, 4], ["parenteral", "ORGANISM_SUBDIVISION", 25, 35], ["body", "ORGANISM_SUBDIVISION", 51, 55], ["stomach", "ORGAN", 86, 93], ["small bowel", "ORGAN", 95, 106], ["colon", "ORGAN", 112, 117], ["tissues", "TISSUE", 153, 160], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 257, 268], ["Rats", "SPECIES", 0, 4], ["total parenteral nutrition", "TREATMENT", 19, 45], ["body weight", "TEST", 51, 62], ["stomach", "ANATOMY", 86, 93], ["small bowel", "ANATOMY", 95, 106], ["colon", "ANATOMY", 112, 117], ["enterocytes", "ANATOMY", 257, 268]]], ["Entry into the systemic circulation is concentration dependent.", [["concentration dependent", "PROBLEM", 39, 62], ["systemic circulation", "ANATOMY", 15, 35], ["concentration", "OBSERVATION_MODIFIER", 39, 52], ["dependent", "OBSERVATION_MODIFIER", 53, 62]]], ["Transport of molecules with molecular weights < 200 is hydrostatic and is known as solvent drag.", [["molecular weights", "TEST", 28, 45], ["hydrostatic", "OBSERVATION", 55, 66]]], ["Facilitated diffusion utilizes carriers similar to active transport but does not occur against a concentration gradient.", [["a concentration gradient", "PROBLEM", 95, 119]]], ["Glucose transport into enterocytes utilizes the Na+\u2013K+ pump that generates a Na+ gradient across cell membranes via a glucose-Na+ symport protein (Brock and Hobson, 2007).Mucosal Transport ::: IntroductionIn order to cross a membrane, a xenobiotic must be lipid soluble; to enter and exit the membrane, it must be water soluble.", [["enterocytes", "ANATOMY", 23, 34], ["cell membranes", "ANATOMY", 97, 111], ["Mucosal", "ANATOMY", 171, 178], ["membrane", "ANATOMY", 225, 233], ["membrane", "ANATOMY", 293, 301], ["Glucose", "CHEMICAL", 0, 7], ["Na", "CHEMICAL", 48, 50], ["Na", "CHEMICAL", 77, 79], ["glucose", "CHEMICAL", 118, 125], ["Na", "CHEMICAL", 126, 128], ["Glucose", "CHEMICAL", 0, 7], ["Na+\u2013K+", "CHEMICAL", 48, 54], ["Na+", "CHEMICAL", 77, 80], ["glucose", "CHEMICAL", 118, 125], ["Na+", "CHEMICAL", 126, 129], ["Glucose", "SIMPLE_CHEMICAL", 0, 7], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 23, 34], ["Na+\u2013K+ pump", "GENE_OR_GENE_PRODUCT", 48, 59], ["Na+", "SIMPLE_CHEMICAL", 77, 80], ["cell membranes", "CELLULAR_COMPONENT", 97, 111], ["glucose", "SIMPLE_CHEMICAL", 118, 125], ["membrane", "CELLULAR_COMPONENT", 225, 233], ["membrane", "CELLULAR_COMPONENT", 293, 301], ["enterocytes", "CELL_TYPE", 23, 34], ["Na+\u2013K+ pump", "PROTEIN", 48, 59], ["glucose-Na+ symport protein", "PROTEIN", 118, 145], ["Glucose transport", "TEST", 0, 17], ["the Na+\u2013K+ pump", "TREATMENT", 44, 59], ["a Na", "TEST", 75, 79], ["a glucose", "TEST", 116, 125], ["a membrane", "TREATMENT", 223, 233], ["a xenobiotic", "TREATMENT", 235, 247], ["lipid soluble", "TREATMENT", 256, 269], ["cell membranes", "OBSERVATION", 97, 111]]], ["Many pharmaceuticals are polar or nonpolar.", [["pharmaceuticals", "OBSERVATION", 5, 20], ["polar", "OBSERVATION_MODIFIER", 25, 30], ["nonpolar", "ANATOMY_MODIFIER", 34, 42]]], ["For weak acids or bases, the pKa of the drug, the pH of the GI tract fluid, and the bloodstream control the solubility and rate of enterocyte absorption (pH partitioning).", [["GI tract fluid", "ANATOMY", 60, 74], ["bloodstream", "ANATOMY", 84, 95], ["enterocyte", "ANATOMY", 131, 141], ["GI tract", "ORGANISM_SUBDIVISION", 60, 68], ["enterocyte", "MULTI-TISSUE_STRUCTURE", 131, 141], ["weak acids or bases", "PROBLEM", 4, 23], ["the pH", "TEST", 46, 52], ["the GI tract fluid", "TEST", 56, 74], ["enterocyte absorption (pH partitioning", "TREATMENT", 131, 169], ["bases", "ANATOMY_MODIFIER", 18, 23], ["GI tract", "ANATOMY", 60, 68]]], ["Weak acids and weak bases are absorbed principally through the gastric mucosa because they are nonionized (Brock and Hobson, 2007).Mucosal Transport ::: IntroductionAbsorption is partly passive and dependent on the physiochemical properties of the xenobiotic.", [["gastric mucosa", "ANATOMY", 63, 77], ["Mucosal", "ANATOMY", 131, 138], ["Weak acids", "SIMPLE_CHEMICAL", 0, 10], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 63, 77], ["Weak acids and weak bases", "PROBLEM", 0, 25], ["acids", "OBSERVATION", 5, 10], ["weak", "OBSERVATION_MODIFIER", 15, 19], ["bases", "ANATOMY_MODIFIER", 20, 25], ["gastric mucosa", "ANATOMY", 63, 77]]], ["Active transport is by way of a family of active \u201ctransporter\u201d mechanisms in humans and most common laboratory species (Fig. 10).", [["humans", "ORGANISM", 77, 83], ["humans", "SPECIES", 77, 83], ["humans", "SPECIES", 77, 83]]], ["Transport is against concentration gradients using ATP as an energy source (Brock and Hobson, 2007).", [["ATP", "CHEMICAL", 51, 54], ["ATP", "CHEMICAL", 51, 54], ["ATP", "SIMPLE_CHEMICAL", 51, 54], ["ATP", "TREATMENT", 51, 54]]], ["Active transport of compounds into cells is complicated when structurally related toxicants (e.g., 5-fluorouracil) compete with a nutrient for a transporter protein.Mucosal Transport ::: IntroductionPeptide transporters are present on the brush border membrane of enterocytes and have broad substrate specificity for small peptides and peptidomimetic pharmaceuticals.", [["cells", "ANATOMY", 35, 40], ["Mucosal", "ANATOMY", 165, 172], ["brush border membrane", "ANATOMY", 239, 260], ["enterocytes", "ANATOMY", 264, 275], ["5-fluorouracil", "CHEMICAL", 99, 113], ["5-fluorouracil", "CHEMICAL", 99, 113], ["cells", "CELL", 35, 40], ["5-fluorouracil", "SIMPLE_CHEMICAL", 99, 113], ["brush border membrane", "CELLULAR_COMPONENT", 239, 260], ["enterocytes", "CELLULAR_COMPONENT", 264, 275], ["transporter protein", "PROTEIN", 145, 164], ["enterocytes", "CELL_TYPE", 264, 275], ["structurally related toxicants", "PROBLEM", 61, 91], ["a transporter protein", "TREATMENT", 143, 164], ["IntroductionPeptide transporters", "TREATMENT", 187, 219], ["small peptides", "PROBLEM", 317, 331], ["peptidomimetic pharmaceuticals", "TREATMENT", 336, 366], ["enterocytes", "ANATOMY", 264, 275], ["small peptides", "OBSERVATION", 317, 331], ["peptidomimetic pharmaceuticals", "OBSERVATION", 336, 366]]], ["Many lactam antibiotics and drugs such as cephalexin, ampicillin, amoxicillin, captopril, and other ACE inhibitors exploit this system (the amino acid prodrug of acyclovir has no peptide bond, suggesting a broader spectrum than just without energy input).", [["lactam", "CHEMICAL", 5, 11], ["cephalexin", "CHEMICAL", 42, 52], ["ampicillin", "CHEMICAL", 54, 64], ["amoxicillin", "CHEMICAL", 66, 77], ["captopril", "CHEMICAL", 79, 88], ["amino acid", "CHEMICAL", 140, 150], ["acyclovir", "CHEMICAL", 162, 171], ["lactam", "CHEMICAL", 5, 11], ["cephalexin", "CHEMICAL", 42, 52], ["ampicillin", "CHEMICAL", 54, 64], ["amoxicillin", "CHEMICAL", 66, 77], ["captopril", "CHEMICAL", 79, 88], ["amino acid", "CHEMICAL", 140, 150], ["acyclovir", "CHEMICAL", 162, 171], ["lactam antibiotics", "SIMPLE_CHEMICAL", 5, 23], ["cephalexin", "SIMPLE_CHEMICAL", 42, 52], ["ampicillin", "SIMPLE_CHEMICAL", 54, 64], ["amoxicillin", "SIMPLE_CHEMICAL", 66, 77], ["captopril", "SIMPLE_CHEMICAL", 79, 88], ["ACE", "GENE_OR_GENE_PRODUCT", 100, 103], ["amino acid", "AMINO_ACID", 140, 150], ["acyclovir", "SIMPLE_CHEMICAL", 162, 171], ["Many lactam antibiotics", "TREATMENT", 0, 23], ["drugs", "TREATMENT", 28, 33], ["cephalexin", "TREATMENT", 42, 52], ["ampicillin", "TREATMENT", 54, 64], ["amoxicillin", "TREATMENT", 66, 77], ["captopril", "TREATMENT", 79, 88], ["other ACE inhibitors", "TREATMENT", 94, 114], ["this system", "TREATMENT", 123, 134], ["the amino acid prodrug", "TREATMENT", 136, 158], ["acyclovir", "TREATMENT", 162, 171]]], ["Active transport requires energy and likely affects absorption of nucleoside analogs used in antiviral and anticancer therapeutics (Gad, 2007).Mucosal Transport ::: IntroductionThere are several types of sugar transporters with high affinities for d-glucose and d-fructose and low affinities for d-galactose and mannose.", [["anticancer", "ANATOMY", 107, 117], ["Mucosal", "ANATOMY", 143, 150], ["nucleoside", "CHEMICAL", 66, 76], ["d-fructose", "CHEMICAL", 262, 272], ["d-galactose", "CHEMICAL", 296, 307], ["mannose", "CHEMICAL", 312, 319], ["nucleoside", "CHEMICAL", 66, 76], ["sugar", "CHEMICAL", 204, 209], ["-glucose", "CHEMICAL", 249, 257], ["d-fructose", "CHEMICAL", 262, 272], ["d-galactose", "CHEMICAL", 296, 307], ["mannose", "CHEMICAL", 312, 319], ["nucleoside analogs", "SIMPLE_CHEMICAL", 66, 84], ["anticancer", "CANCER", 107, 117], ["sugar", "SIMPLE_CHEMICAL", 204, 209], ["d-glucose", "SIMPLE_CHEMICAL", 248, 257], ["d-fructose", "SIMPLE_CHEMICAL", 262, 272], ["d-galactose", "SIMPLE_CHEMICAL", 296, 307], ["mannose", "SIMPLE_CHEMICAL", 312, 319], ["nucleoside analogs", "TREATMENT", 66, 84], ["antiviral and anticancer therapeutics", "TREATMENT", 93, 130], ["sugar transporters", "TREATMENT", 204, 222], ["high affinities", "PROBLEM", 228, 243], ["d-glucose and d-fructose", "TREATMENT", 248, 272], ["d-galactose and mannose", "TREATMENT", 296, 319], ["low affinities", "OBSERVATION_MODIFIER", 277, 291]]], ["At least one type is facilitated transport. l-sugars affinities are 1000 times lower than d sugars.", [["l-sugars", "CHEMICAL", 44, 52], ["l-sugars", "CHEMICAL", 44, 52], ["sugars", "CHEMICAL", 92, 98], ["l-sugars", "SIMPLE_CHEMICAL", 44, 52], ["sugars affinities", "TEST", 46, 63], ["d sugars", "TEST", 90, 98], ["sugars affinities", "OBSERVATION_MODIFIER", 46, 63]]], ["Bile acid transporters are critical for enterohepatic recirculation (Gad, 2007).Mucosal Transport ::: IntroductionThere are many types of intestinal amino acid transporters.", [["enterohepatic", "ANATOMY", 40, 53], ["Mucosal", "ANATOMY", 80, 87], ["intestinal", "ANATOMY", 138, 148], ["Bile acid", "CHEMICAL", 0, 9], ["amino acid", "CHEMICAL", 149, 159], ["Bile acid", "CHEMICAL", 0, 9], ["amino acid", "CHEMICAL", 149, 159], ["Bile acid", "SIMPLE_CHEMICAL", 0, 9], ["enterohepatic", "MULTI-TISSUE_STRUCTURE", 40, 53], ["intestinal", "ORGAN", 138, 148], ["amino acid", "AMINO_ACID", 149, 159], ["intestinal amino acid transporters", "PROTEIN", 138, 172], ["Bile acid transporters", "TEST", 0, 22], ["intestinal amino acid transporters", "TREATMENT", 138, 172], ["enterohepatic", "ANATOMY", 40, 53], ["intestinal", "ANATOMY", 138, 148], ["amino acid", "OBSERVATION", 149, 159]]], ["Among the drugs utilizing these transporters are a-methyldopa, baclofen, and d-cyclosporin.", [["a-methyldopa", "CHEMICAL", 49, 61], ["baclofen", "CHEMICAL", 63, 71], ["d-cyclosporin", "CHEMICAL", 77, 90], ["a-methyldopa", "CHEMICAL", 49, 61], ["baclofen", "CHEMICAL", 63, 71], ["d-cyclosporin", "CHEMICAL", 77, 90], ["a-methyldopa", "SIMPLE_CHEMICAL", 49, 61], ["baclofen", "SIMPLE_CHEMICAL", 63, 71], ["d-cyclosporin", "SIMPLE_CHEMICAL", 77, 90], ["the drugs", "TREATMENT", 6, 15], ["these transporters", "TREATMENT", 26, 44], ["a-methyldopa", "TREATMENT", 49, 61], ["baclofen", "TREATMENT", 63, 71], ["d-cyclosporin", "TREATMENT", 77, 90]]], ["Organic anion transporters are exploited by carboxylic acids in neutral or basic media.", [["carboxylic acids", "CHEMICAL", 44, 60], ["carboxylic acids", "CHEMICAL", 44, 60], ["carboxylic acids", "SIMPLE_CHEMICAL", 44, 60], ["Organic anion transporters", "PROTEIN", 0, 26], ["Organic anion transporters", "TREATMENT", 0, 26], ["carboxylic acids", "TREATMENT", 44, 60]]], ["Vitamin transporters are specific such as those for thiamine, vitamin C, folic acid, and B12.", [["Vitamin", "CHEMICAL", 0, 7], ["thiamine", "CHEMICAL", 52, 60], ["vitamin C", "CHEMICAL", 62, 71], ["folic acid", "CHEMICAL", 73, 83], ["B12", "CHEMICAL", 89, 92], ["Vitamin", "CHEMICAL", 0, 7], ["thiamine", "CHEMICAL", 52, 60], ["vitamin C", "CHEMICAL", 62, 71], ["folic acid", "CHEMICAL", 73, 83], ["B12", "CHEMICAL", 89, 92], ["Vitamin", "SIMPLE_CHEMICAL", 0, 7], ["thiamine", "SIMPLE_CHEMICAL", 52, 60], ["vitamin C", "SIMPLE_CHEMICAL", 62, 71], ["folic acid", "SIMPLE_CHEMICAL", 73, 83], ["B12", "SIMPLE_CHEMICAL", 89, 92], ["Vitamin transporters", "TREATMENT", 0, 20], ["thiamine", "TREATMENT", 52, 60], ["vitamin C", "TREATMENT", 62, 71], ["folic acid", "TREATMENT", 73, 83], ["B12", "TREATMENT", 89, 92]]], ["The nicotinic acid transporter has affinity for valproic and salicylic acids and penicillins.", [["nicotinic acid", "CHEMICAL", 4, 18], ["valproic", "CHEMICAL", 48, 56], ["salicylic acids", "CHEMICAL", 61, 76], ["penicillins", "CHEMICAL", 81, 92], ["nicotinic acid", "CHEMICAL", 4, 18], ["valproic and salicylic acids", "CHEMICAL", 48, 76], ["penicillins", "CHEMICAL", 81, 92], ["nicotinic acid", "SIMPLE_CHEMICAL", 4, 18], ["valproic", "SIMPLE_CHEMICAL", 48, 56], ["salicylic acids", "SIMPLE_CHEMICAL", 61, 76], ["penicillins", "SIMPLE_CHEMICAL", 81, 92], ["nicotinic acid transporter", "PROTEIN", 4, 30], ["The nicotinic acid transporter", "TREATMENT", 0, 30], ["valproic and salicylic acids", "TREATMENT", 48, 76], ["penicillins", "TREATMENT", 81, 92]]], ["Foscarnet (antiviral) and fosfomycin (water-soluble antibiotic) utilize phosphate transporters.", [["Foscarnet", "CHEMICAL", 0, 9], ["fosfomycin", "CHEMICAL", 26, 36], ["phosphate", "CHEMICAL", 72, 81], ["Foscarnet", "CHEMICAL", 0, 9], ["fosfomycin", "CHEMICAL", 26, 36], ["phosphate", "CHEMICAL", 72, 81], ["Foscarnet", "SIMPLE_CHEMICAL", 0, 9], ["fosfomycin", "SIMPLE_CHEMICAL", 26, 36], ["water", "SIMPLE_CHEMICAL", 38, 43], ["phosphate transporters", "SIMPLE_CHEMICAL", 72, 94], ["Foscarnet (antiviral)", "TREATMENT", 0, 21], ["fosfomycin (water-soluble antibiotic", "TREATMENT", 26, 62], ["phosphate transporters", "TREATMENT", 72, 94]]], ["Bicarbonate transporters exchange bicarbonate, sodium, and chloride and are important regulators of cellular pH through acid\u2013base movement.", [["cellular", "ANATOMY", 100, 108], ["Bicarbonate", "CHEMICAL", 0, 11], ["bicarbonate", "CHEMICAL", 34, 45], ["sodium", "CHEMICAL", 47, 53], ["chloride", "CHEMICAL", 59, 67], ["Bicarbonate", "CHEMICAL", 0, 11], ["bicarbonate", "CHEMICAL", 34, 45], ["sodium", "CHEMICAL", 47, 53], ["chloride", "CHEMICAL", 59, 67], ["Bicarbonate", "SIMPLE_CHEMICAL", 0, 11], ["bicarbonate", "SIMPLE_CHEMICAL", 34, 45], ["sodium", "SIMPLE_CHEMICAL", 47, 53], ["chloride", "SIMPLE_CHEMICAL", 59, 67], ["cellular", "CELL", 100, 108], ["acid\u2013base", "SIMPLE_CHEMICAL", 120, 129], ["Bicarbonate transporters exchange bicarbonate", "TREATMENT", 0, 45], ["sodium", "TEST", 47, 53], ["chloride", "TREATMENT", 59, 67], ["cellular pH", "OBSERVATION", 100, 111]]], ["Choline is the substrate for organic cation transporters (Gad, 2007).Mucosal Transport ::: IntroductionHuman efflux transporters of P-glycoprotein are present on enterocyte brush borders.", [["Mucosal", "ANATOMY", 69, 76], ["enterocyte brush", "ANATOMY", 162, 178], ["Choline", "CHEMICAL", 0, 7], ["Choline", "CHEMICAL", 0, 7], ["Choline", "SIMPLE_CHEMICAL", 0, 7], ["Human", "ORGANISM", 103, 108], ["P-glycoprotein", "GENE_OR_GENE_PRODUCT", 132, 146], ["enterocyte brush", "MULTI-TISSUE_STRUCTURE", 162, 178], ["Human efflux transporters", "PROTEIN", 103, 128], ["P", "PROTEIN", 132, 133], ["glycoprotein", "PROTEIN", 134, 146], ["Human", "SPECIES", 103, 108], ["IntroductionHuman efflux transporters", "TREATMENT", 91, 128], ["P-glycoprotein", "TREATMENT", 132, 146]]], ["They exorb a large number of drugs and have broad substrate specificity that includes vincristine, taxol, digoxin, some fluoroquinolone antibacterials, quinidine, etoposide, cyclosporine, verapamil, and nifedipine (Gad, 2007).Mucosal Transport ::: IntroductionLong chain fatty acids (palmitate and oleate) can saturate the fatty acid transporter.", [["Mucosal", "ANATOMY", 226, 233], ["vincristine", "CHEMICAL", 86, 97], ["taxol", "CHEMICAL", 99, 104], ["digoxin", "CHEMICAL", 106, 113], ["fluoroquinolone", "CHEMICAL", 120, 135], ["quinidine", "CHEMICAL", 152, 161], ["etoposide", "CHEMICAL", 163, 172], ["cyclosporine", "CHEMICAL", 174, 186], ["verapamil", "CHEMICAL", 188, 197], ["nifedipine", "CHEMICAL", 203, 213], ["fatty acids", "CHEMICAL", 271, 282], ["palmitate", "CHEMICAL", 284, 293], ["oleate", "CHEMICAL", 298, 304], ["fatty acid", "CHEMICAL", 323, 333], ["vincristine", "CHEMICAL", 86, 97], ["taxol", "CHEMICAL", 99, 104], ["digoxin", "CHEMICAL", 106, 113], ["fluoroquinolone", "CHEMICAL", 120, 135], ["quinidine", "CHEMICAL", 152, 161], ["etoposide", "CHEMICAL", 163, 172], ["cyclosporine", "CHEMICAL", 174, 186], ["verapamil", "CHEMICAL", 188, 197], ["nifedipine", "CHEMICAL", 203, 213], ["fatty acids", "CHEMICAL", 271, 282], ["palmitate", "CHEMICAL", 284, 293], ["oleate", "CHEMICAL", 298, 304], ["fatty acid", "CHEMICAL", 323, 333], ["vincristine", "SIMPLE_CHEMICAL", 86, 97], ["taxol", "SIMPLE_CHEMICAL", 99, 104], ["digoxin", "SIMPLE_CHEMICAL", 106, 113], ["fluoroquinolone", "SIMPLE_CHEMICAL", 120, 135], ["quinidine", "SIMPLE_CHEMICAL", 152, 161], ["etoposide", "SIMPLE_CHEMICAL", 163, 172], ["cyclosporine", "SIMPLE_CHEMICAL", 174, 186], ["verapamil", "SIMPLE_CHEMICAL", 188, 197], ["nifedipine", "SIMPLE_CHEMICAL", 203, 213], ["Gad", "SIMPLE_CHEMICAL", 215, 218], ["Mucosal", "ORGAN", 226, 233], ["IntroductionLong chain fatty acids", "SIMPLE_CHEMICAL", 248, 282], ["palmitate", "SIMPLE_CHEMICAL", 284, 293], ["oleate", "SIMPLE_CHEMICAL", 298, 304], ["fatty acid", "SIMPLE_CHEMICAL", 323, 333], ["fatty acid transporter", "PROTEIN", 323, 345], ["drugs", "TREATMENT", 29, 34], ["broad substrate specificity", "PROBLEM", 44, 71], ["vincristine", "TREATMENT", 86, 97], ["taxol", "TREATMENT", 99, 104], ["digoxin", "TREATMENT", 106, 113], ["some fluoroquinolone antibacterials", "TREATMENT", 115, 150], ["quinidine", "TREATMENT", 152, 161], ["etoposide", "TREATMENT", 163, 172], ["cyclosporine", "TREATMENT", 174, 186], ["verapamil", "TREATMENT", 188, 197], ["nifedipine", "TREATMENT", 203, 213], ["IntroductionLong chain fatty acids (palmitate and oleate", "TREATMENT", 248, 304], ["the fatty acid transporter", "PROBLEM", 319, 345], ["large", "OBSERVATION_MODIFIER", 13, 18]]], ["Bile salts emulsify triglycerides and other fat-soluble molecules forming micelles for absorption into the lymphatics along with other nonpolar compounds.", [["Bile", "ANATOMY", 0, 4], ["lymphatics", "ANATOMY", 107, 117], ["Bile salts", "CHEMICAL", 0, 10], ["triglycerides", "CHEMICAL", 20, 33], ["Bile salts", "CHEMICAL", 0, 10], ["triglycerides", "CHEMICAL", 20, 33], ["Bile salts", "SIMPLE_CHEMICAL", 0, 10], ["triglycerides", "SIMPLE_CHEMICAL", 20, 33], ["fat", "SIMPLE_CHEMICAL", 44, 47], ["micelles", "SIMPLE_CHEMICAL", 74, 82], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 107, 117], ["Bile salts", "TEST", 0, 10], ["triglycerides", "TEST", 20, 33], ["other fat-soluble molecules forming micelles", "TREATMENT", 38, 82], ["salts emulsify", "OBSERVATION", 5, 19], ["lymphatics", "ANATOMY", 107, 117], ["nonpolar compounds", "OBSERVATION", 135, 153]]], ["Xenobiotics such as P-aminosalicylic acid, tetracycline, 3-methylcholanthrene, polychlorinated biphenyls, and benzpyrene may also be absorbed by this route (Gad, 2007).Mucosal Transport ::: IntroductionCells can transport macromolecular proteins, polysaccharides, and polynucleotides via phagocytosis or pinocytosis especially in areas of GALT.", [["Mucosal", "ANATOMY", 168, 175], ["P-aminosalicylic acid", "CHEMICAL", 20, 41], ["tetracycline", "CHEMICAL", 43, 55], ["3-methylcholanthrene", "CHEMICAL", 57, 77], ["polychlorinated biphenyls", "CHEMICAL", 79, 104], ["benzpyrene", "CHEMICAL", 110, 120], ["P-aminosalicylic acid", "CHEMICAL", 20, 41], ["tetracycline", "CHEMICAL", 43, 55], ["3-methylcholanthrene", "CHEMICAL", 57, 77], ["polychlorinated biphenyls", "CHEMICAL", 79, 104], ["benzpyrene", "CHEMICAL", 110, 120], ["Xenobiotics", "SIMPLE_CHEMICAL", 0, 11], ["P-aminosalicylic acid", "SIMPLE_CHEMICAL", 20, 41], ["tetracycline", "SIMPLE_CHEMICAL", 43, 55], ["3-methylcholanthrene", "SIMPLE_CHEMICAL", 57, 77], ["polychlorinated biphenyls", "SIMPLE_CHEMICAL", 79, 104], ["benzpyrene", "SIMPLE_CHEMICAL", 110, 120], ["Mucosal", "ORGAN", 168, 175], ["polysaccharides", "SIMPLE_CHEMICAL", 247, 262], ["GALT", "CELL", 339, 343], ["macromolecular proteins", "PROTEIN", 222, 245], ["Xenobiotics", "TREATMENT", 0, 11], ["P-aminosalicylic acid", "TREATMENT", 20, 41], ["tetracycline", "TREATMENT", 43, 55], ["methylcholanthrene", "TREATMENT", 59, 77], ["polychlorinated biphenyls", "TREATMENT", 79, 104], ["benzpyrene", "TREATMENT", 110, 120], ["polysaccharides", "PROBLEM", 247, 262], ["polynucleotides via phagocytosis", "PROBLEM", 268, 300], ["pinocytosis", "PROBLEM", 304, 315], ["pinocytosis", "OBSERVATION", 304, 315], ["GALT", "ANATOMY", 339, 343]]], ["Phagocytosis is the process of entering cells via cytoskeleton rearrangement forming phagosomes.", [["cells", "ANATOMY", 40, 45], ["cytoskeleton", "ANATOMY", 50, 62], ["phagosomes", "ANATOMY", 85, 95], ["cells", "CELL", 40, 45], ["cytoskeleton", "CELLULAR_COMPONENT", 50, 62], ["phagosomes", "CELLULAR_COMPONENT", 85, 95], ["Phagocytosis", "PROBLEM", 0, 12], ["cytoskeleton rearrangement", "OBSERVATION", 50, 76], ["forming phagosomes", "OBSERVATION", 77, 95]]], ["Phagosomes combine with lysosomes forming phagolysosomes.", [["lysosomes", "ANATOMY", 24, 33], ["phagolysosomes", "ANATOMY", 42, 56], ["lysosomes", "CELLULAR_COMPONENT", 24, 33], ["phagolysosomes", "CELLULAR_COMPONENT", 42, 56], ["Phagosomes", "TREATMENT", 0, 10], ["lysosomes forming phagolysosomes", "OBSERVATION", 24, 56]]], ["Pinocytosis is similar to phagocytosis and is selective or nonselective in transporting liquids into cells depending on the involvement of cell surface receptors.", [["cells", "ANATOMY", 101, 106], ["cell surface", "ANATOMY", 139, 151], ["Pinocytosis", "DISEASE", 0, 11], ["cells", "CELL", 101, 106], ["cell", "CELL", 139, 143], ["cell surface receptors", "PROTEIN", 139, 161], ["Pinocytosis", "PROBLEM", 0, 11], ["phagocytosis", "PROBLEM", 26, 38], ["nonselective in transporting liquids into cells", "TREATMENT", 59, 106], ["cell surface receptors", "TREATMENT", 139, 161], ["phagocytosis", "OBSERVATION", 26, 38]]], ["This method occurs in association with M cells and is especially effective in neonates and decreases with age.", [["M cells", "ANATOMY", 39, 46], ["M cells", "CELL", 39, 46], ["neonates", "ORGANISM", 78, 86], ["M cells", "CELL_TYPE", 39, 46], ["M cells", "PROBLEM", 39, 46], ["decreases", "OBSERVATION_MODIFIER", 91, 100]]], ["This process is useful for absorbing immunoglobulins but is exploited by some toxins, bacteria, and other xenobiotics.", [["immunoglobulins", "GENE_OR_GENE_PRODUCT", 37, 52], ["immunoglobulins", "PROTEIN", 37, 52], ["absorbing immunoglobulins", "PROBLEM", 27, 52], ["some toxins", "PROBLEM", 73, 84], ["bacteria", "PROBLEM", 86, 94]]], ["Cadmium, ferritin, and nutrients utilize this pathway.", [["Cadmium", "CHEMICAL", 0, 7], ["Cadmium", "CHEMICAL", 0, 7], ["Cadmium", "SIMPLE_CHEMICAL", 0, 7], ["ferritin", "GENE_OR_GENE_PRODUCT", 9, 17], ["Cadmium", "TEST", 0, 7], ["ferritin", "TEST", 9, 17], ["this pathway", "TREATMENT", 41, 53], ["ferritin", "OBSERVATION", 9, 17]]], ["To be absorbed, xenobiotics must survive low gastric pH, be of appropriate molecular structure, molecular size, ionization potential (pKa, pKb) and be hydrophilic or lipophilic (Brock and Hobson, 2007).Mucosal Transport ::: IntroductionXenobiotics with effects on absorption include acetazolamide, a carbonic anhydrase inhibitor involved in HCO3\u2212 production.", [["gastric", "ANATOMY", 45, 52], ["Mucosal", "ANATOMY", 202, 209], ["acetazolamide", "CHEMICAL", 283, 296], ["HCO3\u2212", "CHEMICAL", 341, 346], ["acetazolamide", "CHEMICAL", 283, 296], ["HCO3\u2212", "CHEMICAL", 341, 346], ["gastric", "ORGAN", 45, 52], ["Mucosal", "ORGAN", 202, 209], ["acetazolamide", "SIMPLE_CHEMICAL", 283, 296], ["carbonic anhydrase", "GENE_OR_GENE_PRODUCT", 300, 318], ["HCO3\u2212", "SIMPLE_CHEMICAL", 341, 346], ["xenobiotics", "TREATMENT", 16, 27], ["low gastric pH", "PROBLEM", 41, 55], ["pKa, pKb)", "TEST", 134, 143], ["IntroductionXenobiotics", "TREATMENT", 224, 247], ["acetazolamide", "TREATMENT", 283, 296], ["a carbonic anhydrase inhibitor", "TREATMENT", 298, 328], ["gastric", "ANATOMY", 45, 52], ["size", "OBSERVATION_MODIFIER", 106, 110]]], ["Belladonna (atropine), a competitive antagonist of acetylcholine at muscarinic receptors, is an antisecretory agent and decreases GI motility.", [["GI", "ANATOMY", 130, 132], ["Belladonna", "CHEMICAL", 0, 10], ["atropine", "CHEMICAL", 12, 20], ["acetylcholine", "CHEMICAL", 51, 64], ["Belladonna", "CHEMICAL", 0, 10], ["atropine", "CHEMICAL", 12, 20], ["acetylcholine", "CHEMICAL", 51, 64], ["Belladonna", "SIMPLE_CHEMICAL", 0, 10], ["atropine", "SIMPLE_CHEMICAL", 12, 20], ["acetylcholine", "SIMPLE_CHEMICAL", 51, 64], ["GI", "ORGANISM_SUBDIVISION", 130, 132], ["muscarinic receptors", "PROTEIN", 68, 88], ["Belladonna (atropine", "TREATMENT", 0, 20], ["acetylcholine at muscarinic receptors", "TREATMENT", 51, 88], ["an antisecretory agent", "TREATMENT", 93, 115]]], ["Clonidine is an adrenergic stimulator with antisecretory and antidiarrheal properties.", [["Clonidine", "CHEMICAL", 0, 9], ["Clonidine", "CHEMICAL", 0, 9], ["Clonidine", "SIMPLE_CHEMICAL", 0, 9], ["Clonidine", "TREATMENT", 0, 9], ["an adrenergic stimulator", "TREATMENT", 13, 37], ["antisecretory and antidiarrheal properties", "TREATMENT", 43, 85], ["antidiarrheal properties", "OBSERVATION_MODIFIER", 61, 85]]], ["Domperidone blocks the inhibitory effects of dopamine and increases GI motility, while ezetimibe inhibits cholesterol absorption and blocks the translocation of dietary and biliary cholesterol into the intracellular spaces of jejunal enterocytes (Toth and Davidson, 2005).", [["GI", "ANATOMY", 68, 70], ["biliary", "ANATOMY", 173, 180], ["intracellular", "ANATOMY", 202, 215], ["jejunal enterocytes", "ANATOMY", 226, 245], ["Domperidone", "CHEMICAL", 0, 11], ["dopamine", "CHEMICAL", 45, 53], ["ezetimibe", "CHEMICAL", 87, 96], ["cholesterol", "CHEMICAL", 106, 117], ["cholesterol", "CHEMICAL", 181, 192], ["Domperidone", "CHEMICAL", 0, 11], ["dopamine", "CHEMICAL", 45, 53], ["ezetimibe", "CHEMICAL", 87, 96], ["cholesterol", "CHEMICAL", 106, 117], ["cholesterol", "CHEMICAL", 181, 192], ["Domperidone", "SIMPLE_CHEMICAL", 0, 11], ["dopamine", "SIMPLE_CHEMICAL", 45, 53], ["GI", "ORGANISM_SUBDIVISION", 68, 70], ["ezetimibe", "SIMPLE_CHEMICAL", 87, 96], ["cholesterol", "SIMPLE_CHEMICAL", 106, 117], ["biliary", "SIMPLE_CHEMICAL", 173, 180], ["cholesterol", "SIMPLE_CHEMICAL", 181, 192], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 202, 215], ["jejunal enterocytes", "TISSUE", 226, 245], ["Domperidone blocks", "TREATMENT", 0, 18], ["dopamine", "TREATMENT", 45, 53], ["ezetimibe", "TREATMENT", 87, 96], ["cholesterol absorption", "PROBLEM", 106, 128], ["biliary", "ANATOMY", 173, 180], ["intracellular", "ANATOMY_MODIFIER", 202, 215], ["jejunal enterocytes", "ANATOMY", 226, 245]]], ["Cimetidine, ranitidine, and famotidine (H2 receptor antagonists) decrease production of gastric acid that may have downstream effects.", [["gastric", "ANATOMY", 88, 95], ["Cimetidine", "CHEMICAL", 0, 10], ["ranitidine", "CHEMICAL", 12, 22], ["famotidine", "CHEMICAL", 28, 38], ["Cimetidine", "CHEMICAL", 0, 10], ["ranitidine", "CHEMICAL", 12, 22], ["famotidine", "CHEMICAL", 28, 38], ["H2", "CHEMICAL", 40, 42], ["gastric acid", "CHEMICAL", 88, 100], ["Cimetidine", "SIMPLE_CHEMICAL", 0, 10], ["ranitidine", "SIMPLE_CHEMICAL", 12, 22], ["famotidine", "SIMPLE_CHEMICAL", 28, 38], ["H2 receptor antagonists", "GENE_OR_GENE_PRODUCT", 40, 63], ["gastric acid", "SIMPLE_CHEMICAL", 88, 100], ["Cimetidine", "TREATMENT", 0, 10], ["ranitidine", "TREATMENT", 12, 22], ["famotidine", "TREATMENT", 28, 38], ["H2 receptor antagonists", "TREATMENT", 40, 63], ["gastric acid", "TREATMENT", 88, 100], ["gastric", "ANATOMY", 88, 95]]], ["Loperamide is an opioid receptor agonist and acts as antisecretory agent that also slows colonic motility.", [["colonic", "ANATOMY", 89, 96], ["Loperamide", "CHEMICAL", 0, 10], ["Loperamide", "CHEMICAL", 0, 10], ["Loperamide", "SIMPLE_CHEMICAL", 0, 10], ["colonic", "MULTI-TISSUE_STRUCTURE", 89, 96], ["Loperamide", "TREATMENT", 0, 10], ["an opioid receptor agonist", "TREATMENT", 14, 40], ["antisecretory agent", "TREATMENT", 53, 72], ["colonic motility", "PROBLEM", 89, 105], ["colonic motility", "OBSERVATION", 89, 105]]], ["Opiates are antisecretory via relaxation of intestinal leiomyocytes.", [["intestinal leiomyocytes", "ANATOMY", 44, 67], ["Opiates", "SIMPLE_CHEMICAL", 0, 7], ["intestinal leiomyocytes", "MULTI-TISSUE_STRUCTURE", 44, 67], ["intestinal leiomyocytes", "CELL_TYPE", 44, 67], ["Opiates", "TREATMENT", 0, 7], ["intestinal leiomyocytes", "PROBLEM", 44, 67], ["antisecretory", "OBSERVATION_MODIFIER", 12, 25], ["intestinal", "ANATOMY", 44, 54], ["leiomyocytes", "OBSERVATION", 55, 67]]], ["Ouabain Inhibits enterocyte Na+\u2013K+\u2013ATPase pumps.", [["enterocyte", "ANATOMY", 17, 27], ["Ouabain", "CHEMICAL", 0, 7], ["Na", "CHEMICAL", 28, 30], ["Ouabain", "CHEMICAL", 0, 7], ["Na+", "CHEMICAL", 28, 31], ["\u2013K+", "CHEMICAL", 31, 34], ["Ouabain", "SIMPLE_CHEMICAL", 0, 7], ["enterocyte Na+\u2013K+\u2013ATPase", "GENE_OR_GENE_PRODUCT", 17, 41], ["enterocyte Na+\u2013K+\u2013ATPase", "PROTEIN", 17, 41], ["Ouabain", "TEST", 0, 7], ["enterocyte Na", "TEST", 17, 30], ["\u2013K", "TEST", 31, 33], ["ATPase pumps", "TREATMENT", 35, 47], ["enterocyte", "ANATOMY", 17, 27]]], ["Cisapride, metoclopramide, erythromycin, and bethanechol (prokinetic drugs) increase GI motility.", [["GI", "ANATOMY", 85, 87], ["Cisapride", "CHEMICAL", 0, 9], ["metoclopramide", "CHEMICAL", 11, 25], ["erythromycin", "CHEMICAL", 27, 39], ["bethanechol", "CHEMICAL", 45, 56], ["Cisapride", "CHEMICAL", 0, 9], ["metoclopramide", "CHEMICAL", 11, 25], ["erythromycin", "CHEMICAL", 27, 39], ["bethanechol", "CHEMICAL", 45, 56], ["Cisapride", "SIMPLE_CHEMICAL", 0, 9], ["metoclopramide", "SIMPLE_CHEMICAL", 11, 25], ["erythromycin", "SIMPLE_CHEMICAL", 27, 39], ["bethanechol", "SIMPLE_CHEMICAL", 45, 56], ["GI", "ORGANISM_SUBDIVISION", 85, 87], ["Cisapride", "TREATMENT", 0, 9], ["metoclopramide", "TREATMENT", 11, 25], ["erythromycin", "TREATMENT", 27, 39], ["bethanechol (prokinetic drugs", "TREATMENT", 45, 74], ["GI motility", "PROBLEM", 85, 96]]], ["Lansoprazole, rabeprazole, esomeprazole, omeprazole (proton pump inhibitors) downregulate gastric acid secretion and thus may affect intestinal absorption and motility (Hobson and Hobson, 2007).Mucosal Metabolism of Xenobiotics ::: IntroductionThe digestion of xenobiotics in preparation for absorption in the GI tract is by hydrolysis of primary organic structures (carbohydrates, lipids, proteins).", [["gastric", "ANATOMY", 90, 97], ["intestinal", "ANATOMY", 133, 143], ["Mucosal", "ANATOMY", 194, 201], ["GI tract", "ANATOMY", 310, 318], ["Lansoprazole", "CHEMICAL", 0, 12], ["rabeprazole", "CHEMICAL", 14, 25], ["esomeprazole", "CHEMICAL", 27, 39], ["omeprazole", "CHEMICAL", 41, 51], ["xenobiotics", "CHEMICAL", 261, 272], ["Lansoprazole", "CHEMICAL", 0, 12], ["rabeprazole", "CHEMICAL", 14, 25], ["esomeprazole", "CHEMICAL", 27, 39], ["omeprazole", "CHEMICAL", 41, 51], ["Xenobiotics", "CHEMICAL", 216, 227], ["carbohydrates", "CHEMICAL", 367, 380], ["Lansoprazole", "SIMPLE_CHEMICAL", 0, 12], ["rabeprazole", "SIMPLE_CHEMICAL", 14, 25], ["esomeprazole", "SIMPLE_CHEMICAL", 27, 39], ["omeprazole", "SIMPLE_CHEMICAL", 41, 51], ["proton pump inhibitors", "SIMPLE_CHEMICAL", 53, 75], ["gastric acid", "SIMPLE_CHEMICAL", 90, 102], ["intestinal", "ORGAN", 133, 143], ["Mucosal", "ORGAN", 194, 201], ["GI tract", "ORGANISM_SUBDIVISION", 310, 318], ["carbohydrates", "SIMPLE_CHEMICAL", 367, 380], ["lipids", "SIMPLE_CHEMICAL", 382, 388], ["Lansoprazole", "TREATMENT", 0, 12], ["rabeprazole", "TREATMENT", 14, 25], ["esomeprazole", "TREATMENT", 27, 39], ["omeprazole", "TREATMENT", 41, 51], ["proton pump inhibitors", "TREATMENT", 53, 75], ["gastric acid secretion", "PROBLEM", 90, 112], ["intestinal absorption", "PROBLEM", 133, 154], ["The digestion of xenobiotics", "TREATMENT", 244, 272], ["absorption in the GI tract", "PROBLEM", 292, 318], ["gastric", "ANATOMY", 90, 97], ["GI tract", "ANATOMY", 310, 318]]], ["Differences are in the enzymes required for each type of compound (Spainhour, 2007).", [["the enzymes", "TEST", 19, 30]]], ["Xenobiotics must be absorbed intact or bound to a substance that facilitates absorption by cotransport and metabolized followed by absorption or absorbed intact then metabolized (Brock and Hobson, 2007).", [["Xenobiotics", "CHEMICAL", 0, 11], ["Xenobiotics", "SIMPLE_CHEMICAL", 0, 11], ["Xenobiotics", "TREATMENT", 0, 11]]], ["Ingested xenobiotics can be metabolized intraluminally or extraluminally.", [["xenobiotics", "SIMPLE_CHEMICAL", 9, 20], ["Ingested xenobiotics", "TREATMENT", 0, 20]]], ["After transport to the portal blood and/or lymphatics, other forms of metabolism may take precedent (Brock and Hobson, 2007).Mucosal Metabolism of Xenobiotics ::: IntroductionThe majority of low-molecular-weight lipid-insoluble compounds including toxins and drugs enter mucosal epithelial cells by passive diffusion through aqueous membrane pores at epithelial tight junctions.", [["portal blood", "ANATOMY", 23, 35], ["lymphatics", "ANATOMY", 43, 53], ["Mucosal", "ANATOMY", 125, 132], ["mucosal epithelial cells", "ANATOMY", 271, 295], ["aqueous membrane pores", "ANATOMY", 325, 347], ["epithelial tight junctions", "ANATOMY", 351, 377], ["Xenobiotics", "CHEMICAL", 147, 158], ["portal", "MULTI-TISSUE_STRUCTURE", 23, 29], ["blood", "ORGANISM_SUBSTANCE", 30, 35], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 43, 53], ["Mucosal", "ORGAN", 125, 132], ["low-molecular-weight lipid-insoluble compounds", "SIMPLE_CHEMICAL", 191, 237], ["mucosal epithelial cells", "CELL", 271, 295], ["aqueous membrane pores", "CELLULAR_COMPONENT", 325, 347], ["epithelial tight junctions", "CELLULAR_COMPONENT", 351, 377], ["mucosal epithelial cells", "CELL_TYPE", 271, 295], ["insoluble compounds", "PROBLEM", 218, 237], ["toxins", "TREATMENT", 248, 254], ["drugs", "TREATMENT", 259, 264], ["passive diffusion through aqueous membrane pores", "PROBLEM", 299, 347], ["portal", "ANATOMY", 23, 29], ["lymphatics", "ANATOMY", 43, 53], ["mucosal", "ANATOMY", 271, 278], ["epithelial cells", "OBSERVATION", 279, 295], ["aqueous membrane", "OBSERVATION", 325, 341], ["epithelial", "ANATOMY_MODIFIER", 351, 361], ["tight junctions", "OBSERVATION", 362, 377]]], ["Enterocytes may metabolize pharmaceuticals to presystemic drugs or inactivate toxins.", [["Enterocytes", "ANATOMY", 0, 11], ["Enterocytes", "CELL", 0, 11], ["presystemic drugs", "TREATMENT", 46, 63], ["inactivate toxins", "PROBLEM", 67, 84]]], ["Conversely, they may convert inactive prodrugs or toxins to their active forms (Gad, 2007).Mucosal Metabolism of Xenobiotics ::: IntroductionEpithelial cell enzymes conduct oxidative, reductive, hydrolytic, and conjugation reactions.", [["Mucosal", "ANATOMY", 91, 98], ["Epithelial cell", "ANATOMY", 141, 156], ["Xenobiotics", "CHEMICAL", 113, 124], ["Mucosal", "ORGAN", 91, 98], ["Epithelial cell", "CELL", 141, 156], ["Epithelial cell enzymes", "PROTEIN", 141, 164], ["inactive prodrugs", "PROBLEM", 29, 46], ["toxins", "PROBLEM", 50, 56], ["IntroductionEpithelial cell enzymes", "TEST", 129, 164], ["reductive, hydrolytic", "TREATMENT", 184, 205], ["conjugation reactions", "TREATMENT", 211, 232], ["Epithelial cell", "OBSERVATION", 141, 156], ["reductive", "OBSERVATION_MODIFIER", 184, 193]]], ["The oxidative reactions are largely catalyzed by cytochrome P450 isozymes.", [["cytochrome P450", "GENE_OR_GENE_PRODUCT", 49, 64], ["cytochrome P450 isozymes", "PROTEIN", 49, 73], ["The oxidative reactions", "PROBLEM", 0, 23], ["oxidative reactions", "OBSERVATION", 4, 23]]], ["The intestinal mucosa also contains nonspecific esterases and amidases, UDP-glucuronosyltransferases, and reductases.", [["intestinal mucosa", "ANATOMY", 4, 21], ["UDP", "CHEMICAL", 72, 75], ["UDP", "CHEMICAL", 72, 75], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 4, 21], ["amidases", "GENE_OR_GENE_PRODUCT", 62, 70], ["UDP-glucuronosyltransferases", "SIMPLE_CHEMICAL", 72, 100], ["esterases", "PROTEIN", 48, 57], ["amidases", "PROTEIN", 62, 70], ["UDP-glucuronosyltransferases", "PROTEIN", 72, 100], ["reductases", "PROTEIN", 106, 116], ["nonspecific esterases", "PROBLEM", 36, 57], ["amidases", "TEST", 62, 70], ["UDP", "TEST", 72, 75], ["intestinal mucosa", "ANATOMY", 4, 21], ["nonspecific", "OBSERVATION_MODIFIER", 36, 47], ["esterases", "OBSERVATION_MODIFIER", 48, 57]]], ["Some enzyme activity, such as nitroreductase and dechlorinase, may be attributable to both mucosal enzymes and luminal microflora (Chadwick et al., 1990).", [["mucosal", "ANATOMY", 91, 98], ["luminal microflora", "ANATOMY", 111, 129], ["luminal", "CHEMICAL", 111, 118], ["nitroreductase", "GENE_OR_GENE_PRODUCT", 30, 44], ["dechlorinase", "SIMPLE_CHEMICAL", 49, 61], ["mucosal", "MULTI-TISSUE_STRUCTURE", 91, 98], ["luminal microflora", "TISSUE", 111, 129], ["nitroreductase", "PROTEIN", 30, 44], ["mucosal enzymes", "PROTEIN", 91, 106], ["Some enzyme activity", "PROBLEM", 0, 20], ["dechlorinase", "TREATMENT", 49, 61], ["both mucosal enzymes", "TEST", 86, 106], ["enzyme activity", "OBSERVATION", 5, 20], ["luminal microflora", "ANATOMY", 111, 129]]], ["In general, the cytochrome P450 oxidative enzymes are the most important in terms of chemical biotransformation.", [["cytochrome P450", "GENE_OR_GENE_PRODUCT", 16, 31], ["cytochrome P450 oxidative enzymes", "PROTEIN", 16, 49], ["the cytochrome P450 oxidative enzymes", "TEST", 12, 49], ["chemical biotransformation", "PROBLEM", 85, 111], ["chemical biotransformation", "OBSERVATION", 85, 111]]], ["While it is not known if all cytochrome P450 isozymes are present in enterocytes (Gelboin, 1993), it is clear that most isozymes occur in the intestine (Watkins, 1992).", [["enterocytes", "ANATOMY", 69, 80], ["intestine", "ANATOMY", 142, 151], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 29, 44], ["enterocytes", "CELL", 69, 80], ["intestine", "ORGAN", 142, 151], ["cytochrome P450 isozymes", "PROTEIN", 29, 53], ["isozymes", "PROTEIN", 120, 128], ["all cytochrome P450 isozymes", "TEST", 25, 53], ["enterocytes", "ANATOMY", 69, 80], ["intestine", "ANATOMY", 142, 151]]], ["Enterocytic cytochrome P450 activity increases as the cells mature during their migration from crypt to villus.", [["cells", "ANATOMY", 54, 59], ["crypt", "ANATOMY", 95, 100], ["villus", "ANATOMY", 104, 110], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 12, 27], ["cells", "CELL", 54, 59], ["crypt", "TISSUE", 95, 100], ["villus", "MULTI-TISSUE_STRUCTURE", 104, 110], ["Enterocytic cytochrome P450", "PROTEIN", 0, 27], ["Enterocytic cytochrome P450 activity increases", "PROBLEM", 0, 46], ["the cells", "PROBLEM", 50, 59], ["villus", "ANATOMY", 104, 110]]], ["Nearly all cytochrome P450 activity is attributable to villus cells.", [["villus cells", "ANATOMY", 55, 67], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 11, 26], ["villus cells", "CELL", 55, 67], ["cytochrome P450", "PROTEIN", 11, 26], ["villus cells", "CELL_TYPE", 55, 67], ["all cytochrome P450 activity", "TEST", 7, 35], ["villus cells", "PROBLEM", 55, 67], ["cytochrome P450", "OBSERVATION", 11, 26], ["villus cells", "OBSERVATION", 55, 67]]], ["NADPH cytochrome P450 reductase, a necessary component for the activity of all cytochrome P450 enzymes, is constitutively expressed only in villus cells (Traber et al., 1992).", [["villus cells", "ANATOMY", 140, 152], ["NADPH", "CHEMICAL", 0, 5], ["NADPH", "CHEMICAL", 0, 5], ["NADPH", "GENE_OR_GENE_PRODUCT", 0, 5], ["cytochrome P450 reductase", "GENE_OR_GENE_PRODUCT", 6, 31], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 79, 94], ["villus cells", "CELL", 140, 152], ["NADPH cytochrome P450 reductase", "PROTEIN", 0, 31], ["cytochrome P450 enzymes", "PROTEIN", 79, 102], ["villus cells", "CELL_TYPE", 140, 152], ["NADPH cytochrome P450 reductase", "PROBLEM", 0, 31], ["a necessary component", "TREATMENT", 33, 54], ["all cytochrome P450 enzymes", "TEST", 75, 102]]], ["Xenobiotic metabolizing activity is likely retained in enterocytes after they are shed from the villus tip.Mucosal Metabolism of Xenobiotics ::: IntroductionSome ingested alcohol is metabolized by gastric alcohol dehydrogenase, prior to systemic absorption.", [["enterocytes", "ANATOMY", 55, 66], ["villus tip", "ANATOMY", 96, 106], ["Mucosal", "ANATOMY", 107, 114], ["gastric", "ANATOMY", 197, 204], ["alcohol", "CHEMICAL", 171, 178], ["alcohol", "CHEMICAL", 205, 212], ["Xenobiotics", "CHEMICAL", 129, 140], ["alcohol", "CHEMICAL", 171, 178], ["alcohol", "CHEMICAL", 205, 212], ["Xenobiotic", "SIMPLE_CHEMICAL", 0, 10], ["enterocytes", "CELL", 55, 66], ["villus tip", "MULTI-TISSUE_STRUCTURE", 96, 106], ["Mucosal", "ORGAN", 107, 114], ["alcohol", "SIMPLE_CHEMICAL", 171, 178], ["gastric alcohol dehydrogenase", "GENE_OR_GENE_PRODUCT", 197, 226], ["enterocytes", "CELL_TYPE", 55, 66], ["gastric alcohol dehydrogenase", "PROTEIN", 197, 226], ["Xenobiotic metabolizing activity", "PROBLEM", 0, 32], ["metabolizing activity", "OBSERVATION", 11, 32], ["villus", "ANATOMY", 96, 102], ["tip", "OBSERVATION_MODIFIER", 103, 106], ["gastric", "ANATOMY", 197, 204]]], ["While metabolism in the gastric mucosa probably contributes little to overall alcohol metabolism, gastric alcohol dehydrogenase activity is affected by drugs and by chronic consumption of alcohol (Julkunen et al., 1985).Mucosal Metabolism of Xenobiotics ::: IntroductionXenobiotic metabolism is also a function of luminal microorganisms.", [["gastric mucosa", "ANATOMY", 24, 38], ["gastric", "ANATOMY", 98, 105], ["Mucosal", "ANATOMY", 220, 227], ["luminal microorganisms", "ANATOMY", 314, 336], ["alcohol", "CHEMICAL", 78, 85], ["alcohol", "CHEMICAL", 106, 113], ["alcohol", "CHEMICAL", 188, 195], ["luminal", "CHEMICAL", 314, 321], ["alcohol", "CHEMICAL", 78, 85], ["alcohol", "CHEMICAL", 106, 113], ["alcohol", "CHEMICAL", 188, 195], ["Xenobiotics", "CHEMICAL", 242, 253], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 24, 38], ["alcohol", "SIMPLE_CHEMICAL", 78, 85], ["gastric alcohol dehydrogenase", "GENE_OR_GENE_PRODUCT", 98, 127], ["alcohol", "SIMPLE_CHEMICAL", 188, 195], ["Mucosal", "ORGAN", 220, 227], ["gastric alcohol dehydrogenase", "PROTEIN", 98, 127], ["metabolism in the gastric mucosa", "PROBLEM", 6, 38], ["gastric alcohol dehydrogenase activity", "PROBLEM", 98, 136], ["IntroductionXenobiotic metabolism", "PROBLEM", 258, 291], ["gastric mucosa", "ANATOMY", 24, 38], ["alcohol metabolism", "OBSERVATION", 78, 96], ["gastric", "ANATOMY", 98, 105]]], ["The microbiota can affect mucosal enzyme activity.", [["mucosal", "ANATOMY", 26, 33], ["mucosal", "MULTI-TISSUE_STRUCTURE", 26, 33]]], ["The metabolic activity of the intestinal microflora must be taken into account in biotransformation studies (Rowland, 1988).", [["intestinal microflora", "ANATOMY", 30, 51], ["intestinal microflora", "MULTI-TISSUE_STRUCTURE", 30, 51], ["biotransformation studies", "TEST", 82, 107], ["metabolic activity", "OBSERVATION", 4, 22], ["intestinal microflora", "ANATOMY", 30, 51]]], ["There are marked animal species differences in microbial composition and metabolism with at least three biotypes.", [["marked animal species differences", "PROBLEM", 10, 43], ["marked", "OBSERVATION_MODIFIER", 10, 16], ["animal", "OBSERVATION_MODIFIER", 17, 23], ["species", "OBSERVATION_MODIFIER", 24, 31], ["differences", "OBSERVATION_MODIFIER", 32, 43], ["microbial composition", "OBSERVATION_MODIFIER", 47, 68], ["metabolism", "OBSERVATION_MODIFIER", 73, 83]]], ["The microbial population can be affected by age and is likely to differ at very young and very old ages.", [["microbial", "OBSERVATION_MODIFIER", 4, 13], ["population", "OBSERVATION", 14, 24]]], ["Environmental factors, such as drugs (especially antibiotics), gender, diet, and xenobiotics can modify microbial metabolism and thus the toxicity of foreign compounds.Mucosal Metabolism of Xenobiotics ::: IntroductionXenobiotics are transported from enterocytes to the bloodstream by multidrug resistance-associated monocarbohydrate transporter protein (MCT1), or equilibrative nucleoside transporter (ENT1 and ENT2) (Ciarimboli, 2008).", [["Mucosal", "ANATOMY", 168, 175], ["enterocytes", "ANATOMY", 251, 262], ["bloodstream", "ANATOMY", 270, 281], ["xenobiotics", "CHEMICAL", 81, 92], ["toxicity", "DISEASE", 138, 146], ["nucleoside", "CHEMICAL", 379, 389], ["Xenobiotics", "CHEMICAL", 190, 201], ["nucleoside", "CHEMICAL", 379, 389], ["Mucosal", "ORGAN", 168, 175], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 251, 262], ["multidrug resistance-associated monocarbohydrate transporter protein", "GENE_OR_GENE_PRODUCT", 285, 353], ["MCT1", "GENE_OR_GENE_PRODUCT", 355, 359], ["equilibrative nucleoside transporter", "GENE_OR_GENE_PRODUCT", 365, 401], ["ENT1", "GENE_OR_GENE_PRODUCT", 403, 407], ["multidrug resistance-associated monocarbohydrate transporter protein", "PROTEIN", 285, 353], ["MCT1", "PROTEIN", 355, 359], ["equilibrative nucleoside transporter", "PROTEIN", 365, 401], ["ENT1", "PROTEIN", 403, 407], ["ENT2", "PROTEIN", 412, 416], ["Environmental factors", "PROBLEM", 0, 21], ["drugs", "TREATMENT", 31, 36], ["antibiotics", "TREATMENT", 49, 60], ["xenobiotics", "TREATMENT", 81, 92], ["microbial metabolism", "PROBLEM", 104, 124], ["foreign compounds", "PROBLEM", 150, 167], ["IntroductionXenobiotics", "TREATMENT", 206, 229], ["multidrug resistance", "TEST", 285, 305], ["foreign compounds", "OBSERVATION", 150, 167], ["bloodstream", "ANATOMY", 270, 281], ["multidrug resistance", "OBSERVATION", 285, 305]]], ["Transport from the enterocytes into the GI lumen is via MRP2, MRP4, breast cancer-resistance protein (BCRP), and P-glycoprotein (Pgp) (Choudhuri and Klaassen, 2006, Toyoda et al., 2008) which are members of the ATP-binding cassette superfamily.Diseases of crypt enterocytes ::: Special Environment ::: IntroductionLoss or attrition of crypt enterocytes results in lack of replacement of normal absorptive epithelial cells.", [["enterocytes", "ANATOMY", 19, 30], ["GI lumen", "ANATOMY", 40, 48], ["breast cancer", "ANATOMY", 68, 81], ["crypt enterocytes", "ANATOMY", 256, 273], ["crypt enterocytes", "ANATOMY", 335, 352], ["absorptive epithelial cells", "ANATOMY", 394, 421], ["breast cancer", "DISEASE", 68, 81], ["ATP", "CHEMICAL", 211, 214], ["ATP", "CHEMICAL", 211, 214], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 19, 30], ["GI lumen", "MULTI-TISSUE_STRUCTURE", 40, 48], ["MRP2", "GENE_OR_GENE_PRODUCT", 56, 60], ["MRP4", "GENE_OR_GENE_PRODUCT", 62, 66], ["breast cancer-resistance protein", "GENE_OR_GENE_PRODUCT", 68, 100], ["BCRP", "GENE_OR_GENE_PRODUCT", 102, 106], ["P-glycoprotein", "GENE_OR_GENE_PRODUCT", 113, 127], ["Pgp", "GENE_OR_GENE_PRODUCT", 129, 132], ["ATP-binding cassette", "GENE_OR_GENE_PRODUCT", 211, 231], ["crypt enterocytes", "TISSUE", 256, 273], ["crypt enterocytes", "CELL", 335, 352], ["absorptive epithelial cells", "CELL", 394, 421], ["MRP2", "PROTEIN", 56, 60], ["MRP4", "PROTEIN", 62, 66], ["breast cancer-resistance protein", "PROTEIN", 68, 100], ["BCRP", "PROTEIN", 102, 106], ["P", "PROTEIN", 113, 114], ["glycoprotein", "PROTEIN", 115, 127], ["Pgp", "PROTEIN", 129, 132], ["ATP-binding cassette superfamily", "PROTEIN", 211, 243], ["crypt enterocytes", "CELL_TYPE", 256, 273], ["crypt enterocytes", "CELL_TYPE", 335, 352], ["normal absorptive epithelial cells", "CELL_TYPE", 387, 421], ["MRP4", "TEST", 62, 66], ["breast cancer", "PROBLEM", 68, 81], ["resistance protein", "TEST", 82, 100], ["BCRP", "TEST", 102, 106], ["IntroductionLoss", "TREATMENT", 302, 318], ["crypt enterocytes", "PROBLEM", 335, 352], ["replacement", "TREATMENT", 372, 383], ["normal absorptive epithelial cells", "PROBLEM", 387, 421], ["enterocytes", "ANATOMY", 19, 30], ["GI lumen", "ANATOMY", 40, 48], ["breast", "ANATOMY", 68, 74], ["cancer", "OBSERVATION", 75, 81], ["crypt enterocytes", "OBSERVATION", 256, 273], ["crypt enterocytes", "OBSERVATION", 335, 352], ["absorptive epithelial cells", "OBSERVATION", 394, 421]]], ["In 2\u20133 days the crypts and villi become depleted.", [["crypts", "ANATOMY", 16, 22], ["villi", "ANATOMY", 27, 32], ["crypts", "MULTI-TISSUE_STRUCTURE", 16, 22], ["villi", "MULTI-TISSUE_STRUCTURE", 27, 32], ["villi become depleted", "PROBLEM", 27, 48], ["villi", "ANATOMY", 27, 32], ["depleted", "OBSERVATION", 40, 48]]], ["Agents that attack mitotically active cells are termed radiomimetic since they act in a manner similar to radiation.", [["cells", "ANATOMY", 38, 43], ["cells", "CELL", 38, 43], ["mitotically active cells", "CELL_TYPE", 19, 43], ["attack mitotically active cells", "PROBLEM", 12, 43], ["active cells", "OBSERVATION", 31, 43], ["radiation", "OBSERVATION", 106, 115]]], ["A variety of chemotherapeutic agents, many of which are designed to destroy rapidly dividing neoplastic cells, cause this kind of injury.", [["neoplastic cells", "ANATOMY", 93, 109], ["neoplastic cells", "CELL", 93, 109], ["neoplastic cells", "CELL_TYPE", 93, 109], ["chemotherapeutic agents", "TREATMENT", 13, 36], ["rapidly dividing neoplastic cells", "PROBLEM", 76, 109], ["injury", "PROBLEM", 130, 136], ["variety", "OBSERVATION_MODIFIER", 2, 9], ["chemotherapeutic agents", "OBSERVATION", 13, 36], ["neoplastic cells", "OBSERVATION", 93, 109], ["injury", "OBSERVATION", 130, 136]]], ["Similarly, tyrosine kinase inhibitors (growth factor signaling) and cell cycle inhibitors cause apoptosis with resultant crypt necrosis and secondary enteritis (Betton, 2013).", [["cell", "ANATOMY", 68, 72], ["crypt", "ANATOMY", 121, 126], ["tyrosine", "CHEMICAL", 11, 19], ["necrosis", "DISEASE", 127, 135], ["enteritis", "DISEASE", 150, 159], ["tyrosine", "CHEMICAL", 11, 19], ["tyrosine kinase inhibitors", "SIMPLE_CHEMICAL", 11, 37], ["cell", "CELL", 68, 72], ["tyrosine kinase", "PROTEIN", 11, 26], ["growth factor", "PROTEIN", 39, 52], ["tyrosine kinase inhibitors", "TREATMENT", 11, 37], ["cell cycle inhibitors", "TREATMENT", 68, 89], ["apoptosis", "PROBLEM", 96, 105], ["resultant crypt necrosis", "PROBLEM", 111, 135], ["secondary enteritis", "PROBLEM", 140, 159], ["resultant", "OBSERVATION_MODIFIER", 111, 120], ["crypt necrosis", "OBSERVATION", 121, 135], ["secondary", "OBSERVATION_MODIFIER", 140, 149], ["enteritis", "OBSERVATION", 150, 159]]], ["In carnivores and pinnipeds, parvoviruses are radiomimetic.", [["parvoviruses", "ORGANISM", 29, 41], ["pinnipeds", "OBSERVATION_MODIFIER", 18, 27], ["parvoviruses", "OBSERVATION", 29, 41]]], ["Other tissues, such as those of neonates and hematopoietic precursors, also divide rapidly and are targets of these agents.", [["tissues", "ANATOMY", 6, 13], ["hematopoietic precursors", "ANATOMY", 45, 69], ["tissues", "TISSUE", 6, 13], ["neonates", "ORGANISM", 32, 40], ["hematopoietic precursors", "CELL_TYPE", 45, 69], ["hematopoietic precursors", "PROBLEM", 45, 69], ["these agents", "TREATMENT", 110, 122], ["hematopoietic precursors", "OBSERVATION", 45, 69]]], ["Conversely, some bacteria such as Lawsonia in pigs cause crypt cell proliferation.Diseases of absorptive enterocytes ::: Special Environment ::: IntroductionAgents targeting absorptive enterocytes may or may not be fatal depending on the number of cells affected and whether the basement membrane is intact.", [["crypt cell", "ANATOMY", 57, 67], ["absorptive enterocytes", "ANATOMY", 94, 116], ["absorptive enterocytes", "ANATOMY", 174, 196], ["cells", "ANATOMY", 248, 253], ["basement membrane", "ANATOMY", 279, 296], ["Lawsonia", "CHEMICAL", 34, 42], ["pigs", "ORGANISM", 46, 50], ["crypt cell", "CELL", 57, 67], ["absorptive enterocytes", "MULTI-TISSUE_STRUCTURE", 94, 116], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 185, 196], ["cells", "CELL", 248, 253], ["basement membrane", "CELLULAR_COMPONENT", 279, 296], ["absorptive enterocytes", "CELL_TYPE", 94, 116], ["absorptive enterocytes", "CELL_TYPE", 174, 196], ["pigs", "SPECIES", 46, 50], ["pigs", "SPECIES", 46, 50], ["some bacteria", "PROBLEM", 12, 25], ["Lawsonia", "PROBLEM", 34, 42], ["crypt cell proliferation", "PROBLEM", 57, 81], ["IntroductionAgents", "TREATMENT", 145, 163], ["absorptive enterocytes", "PROBLEM", 174, 196], ["bacteria", "OBSERVATION", 17, 25], ["Lawsonia", "OBSERVATION", 34, 42], ["crypt cell proliferation", "OBSERVATION", 57, 81], ["absorptive enterocytes", "OBSERVATION", 94, 116], ["may not be", "UNCERTAINTY", 204, 214], ["intact", "OBSERVATION", 300, 306]]], ["In the interim, surviving immature enterocytes elongate to cover basement membranes and prevent, among other undesired events, endotoxin absorption from the gut lumen.", [["enterocytes", "ANATOMY", 35, 46], ["basement membranes", "ANATOMY", 65, 83], ["gut lumen", "ANATOMY", 157, 166], ["endotoxin", "CHEMICAL", 127, 136], ["enterocytes", "CELL", 35, 46], ["basement membranes", "CELLULAR_COMPONENT", 65, 83], ["endotoxin", "SIMPLE_CHEMICAL", 127, 136], ["gut lumen", "MULTI-TISSUE_STRUCTURE", 157, 166], ["surviving immature enterocytes", "PROBLEM", 16, 46], ["basement membranes", "TREATMENT", 65, 83], ["undesired events", "PROBLEM", 109, 125], ["endotoxin absorption", "PROBLEM", 127, 147], ["the gut lumen", "TREATMENT", 153, 166], ["immature enterocytes", "OBSERVATION", 26, 46], ["elongate", "OBSERVATION_MODIFIER", 47, 55], ["basement membranes", "OBSERVATION_MODIFIER", 65, 83], ["gut", "ANATOMY", 157, 160], ["lumen", "ANATOMY_MODIFIER", 161, 166]]], ["The lost cells are rapidly replaced by migrating crypt cells, providing they have a basement membrane on which to orient and reconstruct villi.", [["cells", "ANATOMY", 9, 14], ["crypt cells", "ANATOMY", 49, 60], ["basement membrane", "ANATOMY", 84, 101], ["villi", "ANATOMY", 137, 142], ["cells", "CELL", 9, 14], ["crypt cells", "CELL", 49, 60], ["basement membrane", "CELLULAR_COMPONENT", 84, 101], ["villi", "MULTI-TISSUE_STRUCTURE", 137, 142], ["migrating crypt cells", "CELL_TYPE", 39, 60], ["The lost cells", "PROBLEM", 0, 14], ["migrating crypt cells", "PROBLEM", 39, 60], ["a basement membrane", "TREATMENT", 82, 101], ["lost cells", "OBSERVATION", 4, 14], ["rapidly", "OBSERVATION_MODIFIER", 19, 26], ["migrating", "OBSERVATION_MODIFIER", 39, 48], ["crypt cells", "OBSERVATION", 49, 60], ["villi", "ANATOMY", 137, 142]]], ["Once basement membranes touch, they fuse resulting in permanently stunted villi and loss of absorptive and digestive surface area.", [["basement membranes", "ANATOMY", 5, 23], ["villi", "ANATOMY", 74, 79], ["digestive surface area", "ANATOMY", 107, 129], ["basement membranes", "CELLULAR_COMPONENT", 5, 23], ["villi", "MULTI-TISSUE_STRUCTURE", 74, 79], ["permanently stunted villi", "PROBLEM", 54, 79], ["loss of absorptive and digestive surface area", "PROBLEM", 84, 129], ["stunted villi", "OBSERVATION", 66, 79], ["digestive surface", "OBSERVATION_MODIFIER", 107, 124]]], ["Many agents target absorptive enterocytes including viruses (rotavirus, transmissible gastroenteritis virus of swine, coronaviruses of most mammalian species), intracellular bacteria (Escherichia coli), and protozoal parasites such as coccidia and cryptosporidia.Diseases of the microvilli and glycocalyx ::: Special Environment ::: IntroductionAgents, including some toxins, selectively destroy the glycocalyx that results in specific or general enzyme deficiencies with a resultant lack of digestive capabilities.", [["absorptive enterocytes", "ANATOMY", 19, 41], ["intracellular", "ANATOMY", 160, 173], ["microvilli", "ANATOMY", 279, 289], ["glycocalyx", "ANATOMY", 294, 304], ["glycocalyx", "ANATOMY", 400, 410], ["digestive", "ANATOMY", 492, 501], ["transmissible gastroenteritis", "DISEASE", 72, 101], ["protozoal parasites", "DISEASE", 207, 226], ["coccidia and cryptosporidia", "DISEASE", 235, 262], ["absorptive enterocytes", "MULTI-TISSUE_STRUCTURE", 19, 41], ["rotavirus", "ORGANISM", 61, 70], ["transmissible gastroenteritis virus", "ORGANISM", 72, 107], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 160, 173], ["Escherichia coli", "ORGANISM", 184, 200], ["cryptosporidia", "CANCER", 248, 262], ["microvilli", "CELLULAR_COMPONENT", 279, 289], ["glycocalyx", "CELLULAR_COMPONENT", 294, 304], ["glycocalyx", "CELLULAR_COMPONENT", 400, 410], ["digestive", "ORGAN", 492, 501], ["swine", "SPECIES", 111, 116], ["Escherichia coli", "SPECIES", 184, 200], ["swine", "SPECIES", 111, 116], ["Escherichia coli", "SPECIES", 184, 200], ["absorptive enterocytes", "PROBLEM", 19, 41], ["viruses", "PROBLEM", 52, 59], ["rotavirus", "PROBLEM", 61, 70], ["transmissible gastroenteritis virus of swine", "PROBLEM", 72, 116], ["coronaviruses", "PROBLEM", 118, 131], ["most mammalian species", "PROBLEM", 135, 157], ["intracellular bacteria (Escherichia coli)", "PROBLEM", 160, 201], ["protozoal parasites", "PROBLEM", 207, 226], ["coccidia", "PROBLEM", 235, 243], ["cryptosporidia", "PROBLEM", 248, 262], ["Diseases of the microvilli and glycocalyx", "PROBLEM", 263, 304], ["IntroductionAgents", "TREATMENT", 333, 351], ["general enzyme deficiencies", "PROBLEM", 439, 466], ["digestive capabilities", "PROBLEM", 492, 514], ["absorptive enterocytes", "OBSERVATION", 19, 41], ["viruses", "OBSERVATION", 52, 59], ["bacteria", "OBSERVATION_MODIFIER", 174, 182], ["Escherichia coli", "OBSERVATION", 184, 200], ["protozoal parasites", "OBSERVATION", 207, 226], ["microvilli", "ANATOMY_MODIFIER", 279, 289], ["glycocalyx", "ANATOMY_MODIFIER", 294, 304], ["digestive capabilities", "OBSERVATION", 492, 514]]], ["An example of this is congenital lactase deficiency (lactose intolerance).", [["congenital lactase deficiency", "DISEASE", 22, 51], ["lactose intolerance", "DISEASE", 53, 72], ["lactose", "CHEMICAL", 53, 60], ["lactase", "GENE_OR_GENE_PRODUCT", 33, 40], ["lactose", "SIMPLE_CHEMICAL", 53, 60], ["congenital lactase deficiency", "PROBLEM", 22, 51], ["lactose intolerance", "PROBLEM", 53, 72], ["congenital", "OBSERVATION_MODIFIER", 22, 32], ["lactase deficiency", "OBSERVATION", 33, 51], ["lactose intolerance", "OBSERVATION", 53, 72]]], ["Undigested lactose ferments in the intestinal lumen with a resultant osmotic drain and diarrhea.", [["intestinal lumen", "ANATOMY", 35, 51], ["lactose", "CHEMICAL", 11, 18], ["diarrhea", "DISEASE", 87, 95], ["lactose", "CHEMICAL", 11, 18], ["lactose", "SIMPLE_CHEMICAL", 11, 18], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 35, 51], ["Undigested lactose ferments", "TREATMENT", 0, 27], ["a resultant osmotic drain", "PROBLEM", 57, 82], ["diarrhea", "PROBLEM", 87, 95], ["lactose ferments", "OBSERVATION", 11, 27], ["intestinal", "ANATOMY", 35, 45], ["lumen", "ANATOMY_MODIFIER", 46, 51], ["resultant", "OBSERVATION_MODIFIER", 59, 68], ["osmotic", "OBSERVATION_MODIFIER", 69, 76], ["drain", "OBSERVATION", 77, 82], ["diarrhea", "OBSERVATION", 87, 95]]], ["Pathogens such as attaching and effacing E. coli damage microvilli and disrupt enzyme systems.", [["microvilli", "ANATOMY", 56, 66], ["E. coli", "ORGANISM", 41, 48], ["microvilli", "CELLULAR_COMPONENT", 56, 66], ["E. coli", "SPECIES", 41, 48], ["E. coli", "SPECIES", 41, 48], ["Pathogens", "PROBLEM", 0, 9], ["effacing E. coli damage microvilli", "PROBLEM", 32, 66], ["disrupt enzyme systems", "PROBLEM", 71, 93], ["coli damage microvilli", "OBSERVATION", 44, 66]]], ["The antibiotic neomycin can cause reversible enzyme deficiency via fragmentation of microvilli and destruction of the glycocalyx.Separation of apical junctional complexes ::: Special Environment ::: IntroductionThis phenomenon is most common in parasitic and bacterial infections where opening of the apical junctional complexes results in transfer of large molecules such as antibody that helps clear the pathogen.", [["microvilli", "ANATOMY", 84, 94], ["glycocalyx", "ANATOMY", 118, 128], ["apical junctional complexes", "ANATOMY", 143, 170], ["apical junctional complexes", "ANATOMY", 301, 328], ["neomycin", "CHEMICAL", 15, 23], ["infections", "DISEASE", 269, 279], ["neomycin", "CHEMICAL", 15, 23], ["neomycin", "SIMPLE_CHEMICAL", 15, 23], ["microvilli", "CELLULAR_COMPONENT", 84, 94], ["glycocalyx", "CELLULAR_COMPONENT", 118, 128], ["apical junctional", "CELLULAR_COMPONENT", 143, 160], ["apical junctional complexes", "PROTEIN", 143, 170], ["apical junctional complexes", "PROTEIN", 301, 328], ["antibody", "PROTEIN", 376, 384], ["The antibiotic neomycin", "TREATMENT", 0, 23], ["reversible enzyme deficiency", "PROBLEM", 34, 62], ["fragmentation of microvilli", "PROBLEM", 67, 94], ["destruction of the glycocalyx", "PROBLEM", 99, 128], ["This phenomenon", "PROBLEM", 211, 226], ["parasitic and bacterial infections", "PROBLEM", 245, 279], ["the apical junctional complexes", "PROBLEM", 297, 328], ["large molecules", "PROBLEM", 352, 367], ["antibody", "TREATMENT", 376, 384], ["the pathogen", "PROBLEM", 402, 414], ["reversible", "OBSERVATION_MODIFIER", 34, 44], ["enzyme deficiency", "OBSERVATION", 45, 62], ["fragmentation", "OBSERVATION_MODIFIER", 67, 80], ["microvilli", "OBSERVATION_MODIFIER", 84, 94], ["destruction", "OBSERVATION_MODIFIER", 99, 110], ["glycocalyx", "ANATOMY_MODIFIER", 118, 128], ["apical", "ANATOMY_MODIFIER", 143, 149], ["junctional complexes", "OBSERVATION", 150, 170], ["most common", "OBSERVATION_MODIFIER", 230, 241], ["bacterial", "OBSERVATION_MODIFIER", 259, 268], ["infections", "OBSERVATION", 269, 279], ["apical", "ANATOMY_MODIFIER", 301, 307]]], ["This is sometimes called the leaky membrane concept of enteritis.Diseases in which epithelial targets are unknown or nonspecific ::: Special Environment ::: IntroductionIntestinal disease is often the result of bacterial or ingested toxins.", [["membrane", "ANATOMY", 35, 43], ["epithelial", "ANATOMY", 83, 93], ["Intestinal", "ANATOMY", 169, 179], ["enteritis", "DISEASE", 55, 64], ["Intestinal disease", "DISEASE", 169, 187], ["leaky membrane", "CELLULAR_COMPONENT", 29, 43], ["epithelial", "TISSUE", 83, 93], ["Intestinal", "ORGAN", 169, 179], ["enteritis", "PROBLEM", 55, 64], ["Diseases", "PROBLEM", 65, 73], ["IntroductionIntestinal disease", "PROBLEM", 157, 187], ["bacterial or ingested toxins", "PROBLEM", 211, 239], ["leaky membrane", "OBSERVATION", 29, 43], ["enteritis", "OBSERVATION", 55, 64], ["epithelial", "ANATOMY_MODIFIER", 83, 93], ["Intestinal", "ANATOMY", 169, 179], ["disease", "OBSERVATION", 180, 187], ["bacterial", "OBSERVATION_MODIFIER", 211, 220]]], ["Some bacteria colonize the small intestine overcoming the washout effect due to pilus antigens.", [["small intestine", "ANATOMY", 27, 42], ["small intestine", "ORGAN", 27, 42], ["pilus antigens", "GENE_OR_GENE_PRODUCT", 80, 94], ["pilus antigens", "PROTEIN", 80, 94], ["Some bacteria colonize the small intestine", "PROBLEM", 0, 42], ["pilus antigens", "PROBLEM", 80, 94], ["bacteria", "OBSERVATION", 5, 13], ["small", "OBSERVATION_MODIFIER", 27, 32], ["intestine", "ANATOMY", 33, 42]]], ["An example is enterotoxic E. coli where release of toxins causes the small intestine to secrete electrolytes and water.", [["small intestine", "ANATOMY", 69, 84], ["E. coli", "ORGANISM", 26, 33], ["intestine", "ORGAN", 75, 84], ["water", "SIMPLE_CHEMICAL", 113, 118], ["E. coli", "SPECIES", 26, 33], ["E. coli", "SPECIES", 26, 33], ["enterotoxic E. coli", "PROBLEM", 14, 33], ["toxins", "PROBLEM", 51, 57], ["the small intestine to secrete electrolytes", "PROBLEM", 65, 108], ["enterotoxic", "OBSERVATION_MODIFIER", 14, 25], ["E. coli", "OBSERVATION", 26, 33], ["small", "OBSERVATION_MODIFIER", 69, 74], ["intestine", "ANATOMY", 75, 84]]], ["When secretion exceeds colonic absorption, diarrhea results.", [["colonic", "ANATOMY", 23, 30], ["diarrhea", "DISEASE", 43, 51], ["colonic", "MULTI-TISSUE_STRUCTURE", 23, 30], ["colonic absorption", "PROBLEM", 23, 41], ["diarrhea", "PROBLEM", 43, 51]]], ["There is no histologic evidence of cell damage in these secretory diarrheas.", [["cell", "ANATOMY", 35, 39], ["secretory diarrheas", "ANATOMY", 56, 75], ["diarrheas", "DISEASE", 66, 75], ["cell", "CELL", 35, 39], ["cell damage", "PROBLEM", 35, 46], ["these secretory diarrheas", "PROBLEM", 50, 75], ["no histologic evidence of", "UNCERTAINTY", 9, 34], ["cell damage", "OBSERVATION", 35, 46], ["secretory diarrheas", "OBSERVATION", 56, 75]]], ["Hypersecretion is a net intestinal efflux of water and electrolytes independent of permeability changes, absorptive capacity, or endogenously generated osmotic gradients.", [["intestinal", "ANATOMY", 24, 34], ["Hypersecretion", "DISEASE", 0, 14], ["intestinal", "ORGAN", 24, 34], ["water", "SIMPLE_CHEMICAL", 45, 50], ["Hypersecretion", "PROBLEM", 0, 14], ["permeability changes", "PROBLEM", 83, 103], ["absorptive capacity", "TEST", 105, 124], ["osmotic gradients", "OBSERVATION", 152, 169]]], ["All Clostridia spp. produce enterotoxemia but unlike the case with E. coli, the toxins are markedly cytolytic causing necrosis of villus absorptive cells and subsequent extension into the lamina propria and blood vessels, much like caustic agents.", [["villus absorptive cells", "ANATOMY", 130, 153], ["lamina propria", "ANATOMY", 188, 202], ["blood vessels", "ANATOMY", 207, 220], ["enterotoxemia", "DISEASE", 28, 41], ["necrosis", "DISEASE", 118, 126], ["Clostridia spp.", "ORGANISM", 4, 19], ["E. coli", "ORGANISM", 67, 74], ["villus absorptive cells", "CELL", 130, 153], ["lamina propria", "TISSUE", 188, 202], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 207, 220], ["villus absorptive cells", "CELL_TYPE", 130, 153], ["E. coli", "SPECIES", 67, 74], ["Clostridia spp.", "SPECIES", 4, 19], ["E. coli", "SPECIES", 67, 74], ["All Clostridia spp.", "PROBLEM", 0, 19], ["enterotoxemia", "PROBLEM", 28, 41], ["E. coli", "PROBLEM", 67, 74], ["the toxins", "PROBLEM", 76, 86], ["markedly cytolytic", "PROBLEM", 91, 109], ["necrosis of villus absorptive cells", "PROBLEM", 118, 153], ["subsequent extension into the lamina propria and blood vessels", "PROBLEM", 158, 220], ["caustic agents", "TREATMENT", 232, 246], ["markedly", "OBSERVATION_MODIFIER", 91, 99], ["cytolytic", "OBSERVATION_MODIFIER", 100, 109], ["necrosis", "OBSERVATION", 118, 126], ["villus", "ANATOMY", 130, 136], ["absorptive cells", "OBSERVATION", 137, 153], ["lamina", "ANATOMY_MODIFIER", 188, 194], ["propria", "ANATOMY", 195, 202], ["blood vessels", "ANATOMY", 207, 220], ["caustic agents", "OBSERVATION", 232, 246]]], ["The result is ulceration and hemorrhage.Diseases of the lamina propria ::: Special Environment ::: IntroductionDiseases of the lamina propria include necrotizing processes and space occupying lesions.", [["lamina propria", "ANATOMY", 56, 70], ["lamina propria", "ANATOMY", 127, 141], ["lesions", "ANATOMY", 192, 199], ["hemorrhage", "DISEASE", 29, 39], ["lamina propria", "TISSUE", 56, 70], ["lamina propria", "TISSUE", 127, 141], ["space occupying lesions", "PATHOLOGICAL_FORMATION", 176, 199], ["ulceration", "PROBLEM", 14, 24], ["hemorrhage", "PROBLEM", 29, 39], ["necrotizing processes", "PROBLEM", 150, 171], ["space occupying lesions", "PROBLEM", 176, 199], ["ulceration", "OBSERVATION", 14, 24], ["hemorrhage", "OBSERVATION", 29, 39], ["lamina propria", "ANATOMY", 56, 70], ["lamina propria", "ANATOMY", 127, 141], ["necrotizing", "OBSERVATION_MODIFIER", 150, 161], ["space", "OBSERVATION_MODIFIER", 176, 181], ["occupying", "OBSERVATION_MODIFIER", 182, 191], ["lesions", "OBSERVATION", 192, 199]]], ["Often, necrosis of lymphoreticular tissue is how damage commences with extension to the overlying epithelium.", [["lymphoreticular tissue", "ANATOMY", 19, 41], ["overlying epithelium", "ANATOMY", 88, 108], ["necrosis", "DISEASE", 7, 15], ["lymphoreticular tissue", "TISSUE", 19, 41], ["overlying epithelium", "TISSUE", 88, 108], ["necrosis of lymphoreticular tissue", "PROBLEM", 7, 41], ["extension to the overlying epithelium", "PROBLEM", 71, 108], ["necrosis", "OBSERVATION", 7, 15], ["lymphoreticular tissue", "OBSERVATION", 19, 41], ["overlying", "ANATOMY_MODIFIER", 88, 97], ["epithelium", "ANATOMY_MODIFIER", 98, 108]]], ["This occurs in viral disease such as bovine virus diarrhea of cattle and bacterial diseases such as Rhodococcus equi of equids.Diseases of the lamina propria ::: Special Environment ::: IntroductionBy mechanisms that are poorly understood, space occupying lesions of the lamina propria interfere with mucosal diffusion of nutrients into the lacteals (malabsorption) resulting in diarrhea.", [["lamina propria", "ANATOMY", 143, 157], ["lesions", "ANATOMY", 256, 263], ["lamina propria", "ANATOMY", 271, 285], ["mucosal", "ANATOMY", 301, 308], ["lacteals", "ANATOMY", 341, 349], ["viral disease", "DISEASE", 15, 28], ["bovine virus diarrhea", "DISEASE", 37, 58], ["bacterial diseases", "DISEASE", 73, 91], ["Rhodococcus equi of equids", "DISEASE", 100, 126], ["malabsorption", "DISEASE", 351, 364], ["diarrhea", "DISEASE", 379, 387], ["bovine virus diarrhea", "ORGANISM", 37, 58], ["Rhodococcus equi", "ORGANISM", 100, 116], ["lamina propria", "TISSUE", 143, 157], ["lesions", "PATHOLOGICAL_FORMATION", 256, 263], ["lamina propria", "TISSUE", 271, 285], ["mucosal", "MULTI-TISSUE_STRUCTURE", 301, 308], ["bovine", "SPECIES", 37, 43], ["virus diarrhea", "SPECIES", 44, 58], ["cattle", "SPECIES", 62, 68], ["Rhodococcus equi", "SPECIES", 100, 116], ["bovine virus", "SPECIES", 37, 49], ["cattle", "SPECIES", 62, 68], ["Rhodococcus equi", "SPECIES", 100, 116], ["viral disease", "PROBLEM", 15, 28], ["bovine virus diarrhea of cattle", "PROBLEM", 37, 68], ["bacterial diseases", "PROBLEM", 73, 91], ["Rhodococcus equi of equids", "PROBLEM", 100, 126], ["space occupying lesions of the lamina propria", "PROBLEM", 240, 285], ["diarrhea", "PROBLEM", 379, 387], ["viral disease", "OBSERVATION", 15, 28], ["bovine virus", "OBSERVATION", 37, 49], ["bacterial diseases", "OBSERVATION", 73, 91], ["lamina propria", "ANATOMY", 143, 157], ["lesions", "OBSERVATION", 256, 263], ["lamina propria", "ANATOMY", 271, 285], ["diarrhea", "OBSERVATION", 379, 387]]], ["This occurs whether the lamina propria is filled with immune cells (inflammatory bowel disease), mycobacteria-filled macrophages (Johne\u2019s disease of cattle) or neoplastic infiltrates (intestinal lymphoma).Intestinal motility ::: Special Environment ::: IntroductionIntestinal motility changes are a part of many mechanisms of diarrhea production but are not considered to be a primary means.", [["lamina propria", "ANATOMY", 24, 38], ["immune cells", "ANATOMY", 54, 66], ["bowel", "ANATOMY", 81, 86], ["macrophages", "ANATOMY", 117, 128], ["neoplastic infiltrates", "ANATOMY", 160, 182], ["intestinal lymphoma", "ANATOMY", 184, 203], ["Intestinal", "ANATOMY", 205, 215], ["Intestinal", "ANATOMY", 265, 275], ["inflammatory bowel disease", "DISEASE", 68, 94], ["Johne\u2019s disease of cattle", "DISEASE", 130, 155], ["intestinal lymphoma", "DISEASE", 184, 203], ["diarrhea", "DISEASE", 326, 334], ["lamina propria", "TISSUE", 24, 38], ["immune cells", "CELL", 54, 66], ["bowel", "ORGAN", 81, 86], ["macrophages", "CELL", 117, 128], ["cattle", "ORGANISM", 149, 155], ["neoplastic infiltrates", "PATHOLOGICAL_FORMATION", 160, 182], ["intestinal lymphoma", "CANCER", 184, 203], ["Intestinal", "ORGAN", 205, 215], ["Intestinal", "ORGAN", 265, 275], ["immune cells", "CELL_TYPE", 54, 66], ["macrophages", "CELL_TYPE", 117, 128], ["cattle", "SPECIES", 149, 155], ["cattle", "SPECIES", 149, 155], ["immune cells", "PROBLEM", 54, 66], ["inflammatory bowel disease", "PROBLEM", 68, 94], ["mycobacteria", "PROBLEM", 97, 109], ["macrophages", "PROBLEM", 117, 128], ["Johne\u2019s disease of cattle)", "PROBLEM", 130, 156], ["neoplastic infiltrates", "PROBLEM", 160, 182], ["intestinal lymphoma", "PROBLEM", 184, 203], ["IntroductionIntestinal motility changes", "PROBLEM", 253, 292], ["diarrhea production", "PROBLEM", 326, 345], ["lamina propria", "ANATOMY", 24, 38], ["immune cells", "OBSERVATION", 54, 66], ["inflammatory", "OBSERVATION_MODIFIER", 68, 80], ["bowel", "ANATOMY", 81, 86], ["disease", "OBSERVATION", 87, 94], ["mycobacteria", "OBSERVATION", 97, 109], ["filled macrophages", "OBSERVATION", 110, 128], ["neoplastic", "OBSERVATION_MODIFIER", 160, 170], ["infiltrates", "OBSERVATION", 171, 182], ["intestinal", "ANATOMY", 184, 194], ["lymphoma", "OBSERVATION", 195, 203], ["motility", "OBSERVATION", 216, 224], ["Intestinal", "ANATOMY", 265, 275], ["motility", "OBSERVATION", 276, 284], ["diarrhea", "OBSERVATION", 326, 334]]], ["Decreased motility allows for bacterial overgrowth; increased motility hinders digestion and absorption.Vascular diseases ::: Special Environment ::: IntroductionEndotoxemia may result in injury to the enteric nervous system and the tunica muscularis secondary to vasoconstriction and vasospasm (Oikawa et al., 2007).", [["Vascular", "ANATOMY", 104, 112], ["enteric nervous system", "ANATOMY", 202, 224], ["tunica muscularis", "ANATOMY", 233, 250], ["Vascular diseases", "DISEASE", 104, 121], ["Endotoxemia", "DISEASE", 162, 173], ["injury to the enteric nervous system", "DISEASE", 188, 224], ["vasospasm", "DISEASE", 285, 294], ["Vascular", "MULTI-TISSUE_STRUCTURE", 104, 112], ["enteric nervous system", "ANATOMICAL_SYSTEM", 202, 224], ["tunica muscularis", "MULTI-TISSUE_STRUCTURE", 233, 250], ["Decreased motility", "PROBLEM", 0, 18], ["bacterial overgrowth", "PROBLEM", 30, 50], ["increased motility hinders digestion", "PROBLEM", 52, 88], ["Vascular diseases", "PROBLEM", 104, 121], ["IntroductionEndotoxemia", "PROBLEM", 150, 173], ["injury to the enteric nervous system", "PROBLEM", 188, 224], ["vasoconstriction", "PROBLEM", 264, 280], ["vasospasm", "PROBLEM", 285, 294], ["diseases", "OBSERVATION", 113, 121], ["injury", "OBSERVATION", 188, 194], ["enteric nervous", "ANATOMY", 202, 217], ["tunica muscularis", "ANATOMY", 233, 250], ["vasoconstriction", "OBSERVATION", 264, 280], ["vasospasm", "OBSERVATION", 285, 294]]], ["Lymphangiectasia may be congenital as a result of vascular malformations or acquired secondary to space occupying lesions of the lamina propria.", [["vascular", "ANATOMY", 50, 58], ["lesions", "ANATOMY", 114, 121], ["lamina propria", "ANATOMY", 129, 143], ["Lymphangiectasia", "DISEASE", 0, 16], ["vascular malformations", "DISEASE", 50, 72], ["vascular malformations", "PATHOLOGICAL_FORMATION", 50, 72], ["lesions", "PATHOLOGICAL_FORMATION", 114, 121], ["lamina propria", "TISSUE", 129, 143], ["Lymphangiectasia", "PROBLEM", 0, 16], ["congenital", "PROBLEM", 24, 34], ["vascular malformations", "PROBLEM", 50, 72], ["space occupying lesions of the lamina propria", "PROBLEM", 98, 143], ["may be", "UNCERTAINTY", 17, 23], ["congenital", "OBSERVATION", 24, 34], ["vascular", "ANATOMY", 50, 58], ["malformations", "OBSERVATION", 59, 72], ["space", "OBSERVATION_MODIFIER", 98, 103], ["occupying", "OBSERVATION_MODIFIER", 104, 113], ["lesions", "OBSERVATION", 114, 121], ["lamina propria", "ANATOMY", 129, 143]]], ["Most often it is idiopathic.", [["idiopathic", "DISEASE", 17, 27], ["idiopathic", "PROBLEM", 17, 27], ["idiopathic", "OBSERVATION", 17, 27]]], ["It results in malabsorption, steatorrhea, and protein-losing enteropathy.Problems with innervation ::: Special Environment ::: IntroductionThe alimentary system is second to the CNS in its number of neurons (108) and glial cells (4 \u00d7 108).", [["alimentary system", "ANATOMY", 143, 160], ["CNS", "ANATOMY", 178, 181], ["neurons", "ANATOMY", 199, 206], ["glial cells", "ANATOMY", 217, 228], ["malabsorption", "DISEASE", 14, 27], ["steatorrhea", "DISEASE", 29, 40], ["enteropathy", "DISEASE", 61, 72], ["alimentary system", "ANATOMICAL_SYSTEM", 143, 160], ["CNS", "ANATOMICAL_SYSTEM", 178, 181], ["neurons", "CELL", 199, 206], ["glial cells", "CELL", 217, 228], ["glial cells", "CELL_TYPE", 217, 228], ["malabsorption", "PROBLEM", 14, 27], ["steatorrhea", "PROBLEM", 29, 40], ["protein-losing enteropathy", "PROBLEM", 46, 72], ["glial cells", "TEST", 217, 228], ["malabsorption", "OBSERVATION", 14, 27], ["steatorrhea", "OBSERVATION", 29, 40], ["losing enteropathy", "OBSERVATION", 54, 72], ["alimentary system", "ANATOMY", 143, 160], ["CNS", "ANATOMY", 178, 181], ["neurons", "ANATOMY", 199, 206], ["glial cells", "ANATOMY", 217, 228]]], ["Agangliosis and dysautonomia, malfunctions of the cranial nerves, spinal nerves, ganglia, and/or autonomic nervous system may have profound influences on intestinal motility.", [["cranial nerves", "ANATOMY", 50, 64], ["spinal nerves", "ANATOMY", 66, 79], ["ganglia", "ANATOMY", 81, 88], ["autonomic nervous system", "ANATOMY", 97, 121], ["intestinal", "ANATOMY", 154, 164], ["Agangliosis", "DISEASE", 0, 11], ["dysautonomia", "DISEASE", 16, 28], ["cranial nerves", "MULTI-TISSUE_STRUCTURE", 50, 64], ["spinal nerves", "MULTI-TISSUE_STRUCTURE", 66, 79], ["ganglia", "ORGAN", 81, 88], ["autonomic nervous system", "ANATOMICAL_SYSTEM", 97, 121], ["intestinal", "ORGAN", 154, 164], ["Agangliosis", "PROBLEM", 0, 11], ["dysautonomia", "PROBLEM", 16, 28], ["malfunctions of the cranial nerves, spinal nerves, ganglia, and/or autonomic nervous system", "PROBLEM", 30, 121], ["profound influences on intestinal motility", "PROBLEM", 131, 173], ["dysautonomia", "OBSERVATION", 16, 28], ["cranial nerves", "ANATOMY", 50, 64], ["spinal nerves", "ANATOMY", 66, 79], ["ganglia", "ANATOMY", 81, 88], ["autonomic nervous", "ANATOMY", 97, 114], ["profound", "OBSERVATION_MODIFIER", 131, 139], ["intestinal motility", "OBSERVATION", 154, 173]]], ["There are a great variety of agents that cause these changes ranging from botulinum toxin to inflammatory diseases.", [["inflammatory diseases", "DISEASE", 93, 114], ["botulinum toxin", "SIMPLE_CHEMICAL", 74, 89], ["agents", "TREATMENT", 29, 35], ["these changes", "PROBLEM", 47, 60], ["botulinum toxin", "PROBLEM", 74, 89], ["inflammatory diseases", "PROBLEM", 93, 114], ["great", "OBSERVATION_MODIFIER", 12, 17], ["variety", "OBSERVATION_MODIFIER", 18, 25], ["inflammatory", "OBSERVATION_MODIFIER", 93, 105]]], ["Many cases are idiopathic or may be hereditary.", [["hereditary", "DISEASE", 36, 46], ["idiopathic", "PROBLEM", 15, 25], ["hereditary", "PROBLEM", 36, 46], ["idiopathic", "OBSERVATION", 15, 25]]], ["In addition, there is a bidirectional neurohormonal interchange between intestinal microbiota and the brain.", [["intestinal microbiota", "ANATOMY", 72, 93], ["brain", "ANATOMY", 102, 107], ["intestinal microbiota", "MULTI-TISSUE_STRUCTURE", 72, 93], ["brain", "ORGAN", 102, 107], ["a bidirectional neurohormonal interchange between intestinal microbiota and the brain", "PROBLEM", 22, 107], ["bidirectional", "OBSERVATION_MODIFIER", 24, 37], ["neurohormonal interchange", "OBSERVATION", 38, 63], ["intestinal microbiota", "ANATOMY", 72, 93], ["brain", "ANATOMY", 102, 107]]], ["Thus, alteration of the microbiota may result in changes in the gut\u2013brain axis (Collins et al., 2010).", [["gut\u2013brain axis", "ANATOMY", 64, 78]]], ["Dysbiosis has effects on early brain development in mice, irritable bowel syndrome, Crohn\u2019s disease, ulcerative colitis, demyelination in multiple sclerosis, hepatic encephalopathy, and psychiatric disorders such as early-onset autism.", [["brain", "ANATOMY", 31, 36], ["bowel", "ANATOMY", 68, 73], ["hepatic", "ANATOMY", 158, 165], ["Dysbiosis", "DISEASE", 0, 9], ["irritable bowel syndrome", "DISEASE", 58, 82], ["Crohn\u2019s disease", "DISEASE", 84, 99], ["ulcerative colitis", "DISEASE", 101, 119], ["demyelination", "DISEASE", 121, 134], ["multiple sclerosis", "DISEASE", 138, 156], ["hepatic encephalopathy", "DISEASE", 158, 180], ["psychiatric disorders", "DISEASE", 186, 207], ["autism", "DISEASE", 228, 234], ["brain", "ORGAN", 31, 36], ["mice", "ORGANISM", 52, 56], ["bowel", "ORGAN", 68, 73], ["ulcerative colitis", "PATHOLOGICAL_FORMATION", 101, 119], ["hepatic", "ORGAN", 158, 165], ["mice", "SPECIES", 52, 56], ["mice", "SPECIES", 52, 56], ["Dysbiosis", "PROBLEM", 0, 9], ["irritable bowel syndrome", "PROBLEM", 58, 82], ["Crohn\u2019s disease", "PROBLEM", 84, 99], ["ulcerative colitis", "PROBLEM", 101, 119], ["demyelination", "PROBLEM", 121, 134], ["multiple sclerosis", "PROBLEM", 138, 156], ["hepatic encephalopathy", "PROBLEM", 158, 180], ["psychiatric disorders", "PROBLEM", 186, 207], ["early-onset autism", "PROBLEM", 216, 234], ["brain", "ANATOMY", 31, 36], ["irritable bowel syndrome", "OBSERVATION", 58, 82], ["Crohn\u2019s", "OBSERVATION", 84, 91], ["ulcerative", "OBSERVATION_MODIFIER", 101, 111], ["colitis", "OBSERVATION", 112, 119], ["demyelination", "OBSERVATION", 121, 134], ["multiple", "OBSERVATION_MODIFIER", 138, 146], ["sclerosis", "OBSERVATION", 147, 156], ["hepatic", "ANATOMY", 158, 165], ["encephalopathy", "OBSERVATION", 166, 180]]], ["The interstitial cells of Cajal are of mesenchymal origin and are the pacemakers of the gut.", [["interstitial cells", "ANATOMY", 4, 22], ["Cajal", "ANATOMY", 26, 31], ["mesenchymal", "ANATOMY", 39, 50], ["gut", "ANATOMY", 88, 91], ["interstitial cells", "CELL", 4, 22], ["Cajal", "CELL", 26, 31], ["mesenchymal", "CELL", 39, 50], ["gut", "ORGANISM_SUBDIVISION", 88, 91], ["interstitial cells", "CELL_TYPE", 4, 22], ["interstitial cells", "OBSERVATION", 4, 22], ["Cajal", "ANATOMY_MODIFIER", 26, 31], ["mesenchymal origin", "OBSERVATION", 39, 57], ["pacemakers", "OBSERVATION", 70, 80], ["gut", "ANATOMY", 88, 91]]], ["Inflammation, neoplasia, or loss of these cells affect coordinated movement of the alimentary system.Problems with innervation ::: Special Environment ::: IntroductionThe digestive neuronal glial epithelial unit (Neunlist et al., 2013) is composed of enteric neurons, glial cells, and intestinal epithelial cells.", [["neoplasia", "ANATOMY", 14, 23], ["cells", "ANATOMY", 42, 47], ["alimentary system", "ANATOMY", 83, 100], ["digestive neuronal glial epithelial unit", "ANATOMY", 171, 211], ["enteric neurons", "ANATOMY", 251, 266], ["glial cells", "ANATOMY", 268, 279], ["intestinal epithelial cells", "ANATOMY", 285, 312], ["Inflammation", "DISEASE", 0, 12], ["neoplasia", "DISEASE", 14, 23], ["neoplasia", "CANCER", 14, 23], ["cells", "CELL", 42, 47], ["alimentary system", "ANATOMICAL_SYSTEM", 83, 100], ["digestive neuronal glial epithelial", "CELL", 171, 206], ["enteric neurons", "CELL", 251, 266], ["glial cells", "CELL", 268, 279], ["intestinal epithelial cells", "CELL", 285, 312], ["enteric neurons", "CELL_TYPE", 251, 266], ["glial cells", "CELL_TYPE", 268, 279], ["intestinal epithelial cells", "CELL_TYPE", 285, 312], ["Inflammation", "PROBLEM", 0, 12], ["neoplasia", "PROBLEM", 14, 23], ["loss of these cells", "PROBLEM", 28, 47], ["enteric neurons, glial cells", "PROBLEM", 251, 279], ["intestinal epithelial cells", "PROBLEM", 285, 312], ["neoplasia", "OBSERVATION", 14, 23], ["loss", "OBSERVATION_MODIFIER", 28, 32], ["movement", "OBSERVATION_MODIFIER", 67, 75], ["alimentary system", "ANATOMY", 83, 100], ["digestive neuronal", "ANATOMY", 171, 189], ["glial epithelial", "ANATOMY", 190, 206], ["enteric neurons", "ANATOMY", 251, 266], ["glial cells", "OBSERVATION", 268, 279], ["intestinal", "ANATOMY", 285, 295], ["epithelial cells", "OBSERVATION", 296, 312]]], ["Enteric neuromediators and gliomediators modulate intestinal epithelial barrier functions such as paracellular permeability, epithelial cell proliferation, and wound healing (Fig. 11).", [["intestinal epithelial barrier", "ANATOMY", 50, 79], ["paracellular", "ANATOMY", 98, 110], ["epithelial cell", "ANATOMY", 125, 140], ["wound", "ANATOMY", 160, 165], ["intestinal epithelial barrier", "TISSUE", 50, 79], ["paracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 98, 110], ["epithelial cell", "CELL", 125, 140], ["wound", "PATHOLOGICAL_FORMATION", 160, 165], ["epithelial cell", "CELL_TYPE", 125, 140], ["Enteric neuromediators", "TREATMENT", 0, 22], ["gliomediators modulate intestinal epithelial barrier functions", "TREATMENT", 27, 89], ["paracellular permeability", "PROBLEM", 98, 123], ["epithelial cell proliferation", "PROBLEM", 125, 154], ["wound healing", "PROBLEM", 160, 173], ["intestinal", "ANATOMY", 50, 60], ["epithelial", "ANATOMY_MODIFIER", 61, 71], ["paracellular", "ANATOMY_MODIFIER", 98, 110], ["permeability", "OBSERVATION_MODIFIER", 111, 123], ["epithelial cell proliferation", "OBSERVATION", 125, 154], ["wound", "OBSERVATION_MODIFIER", 160, 165], ["healing", "OBSERVATION_MODIFIER", 166, 173]]], ["Phenotypical changes in enteric neurons and glial cells are present in certain diseases, but the mechanisms are poorly understood.", [["enteric neurons", "ANATOMY", 24, 39], ["glial cells", "ANATOMY", 44, 55], ["enteric neurons", "CELL", 24, 39], ["glial cells", "CELL", 44, 55], ["enteric neurons", "CELL_TYPE", 24, 39], ["glial cells", "CELL_TYPE", 44, 55], ["Phenotypical changes in enteric neurons and glial cells", "PROBLEM", 0, 55], ["certain diseases", "PROBLEM", 71, 87], ["enteric neurons", "ANATOMY", 24, 39], ["glial cells", "OBSERVATION", 44, 55], ["certain", "OBSERVATION_MODIFIER", 71, 78], ["diseases", "OBSERVATION", 79, 87]]], ["The neurons and glial cells are organized into two plexi; myenteric (Auerbach\u2019s) and submucosal (Meissner\u2019s).", [["neurons", "ANATOMY", 4, 11], ["glial cells", "ANATOMY", 16, 27], ["plexi", "ANATOMY", 51, 56], ["myenteric", "ANATOMY", 58, 67], ["Auerbach\u2019s", "ANATOMY", 69, 79], ["submucosal", "ANATOMY", 85, 95], ["neurons", "CELL", 4, 11], ["glial cells", "CELL", 16, 27], ["myenteric", "MULTI-TISSUE_STRUCTURE", 58, 67], ["Auerbach\u2019s", "TISSUE", 69, 79], ["submucosal", "MULTI-TISSUE_STRUCTURE", 85, 95], ["neurons", "CELL_TYPE", 4, 11], ["glial cells", "CELL_TYPE", 16, 27], ["neurons", "ANATOMY", 4, 11], ["glial cells", "OBSERVATION", 16, 27], ["plexi", "ANATOMY_MODIFIER", 51, 56], ["myenteric", "ANATOMY", 58, 67], ["submucosal", "ANATOMY", 85, 95]]], ["Myenteric plexi regulate GI motor function, while submucosal plexi regulate mucosal processes.", [["Myenteric plexi", "ANATOMY", 0, 15], ["GI", "ANATOMY", 25, 27], ["submucosal plexi", "ANATOMY", 50, 66], ["mucosal", "ANATOMY", 76, 83], ["Myenteric plexi", "GENE_OR_GENE_PRODUCT", 0, 15], ["GI", "ORGAN", 25, 27], ["submucosal plexi", "MULTI-TISSUE_STRUCTURE", 50, 66], ["mucosal", "MULTI-TISSUE_STRUCTURE", 76, 83], ["submucosal plexi regulate mucosal processes", "PROBLEM", 50, 93], ["plexi", "ANATOMY_MODIFIER", 10, 15], ["motor function", "OBSERVATION", 28, 42], ["submucosal plexi", "ANATOMY", 50, 66], ["mucosal", "ANATOMY", 76, 83]]], ["Each villus and colonic unit is innervated by 70\u201392 submucosal neurons (Song et al., 1995).", [["villus", "ANATOMY", 5, 11], ["colonic unit", "ANATOMY", 16, 28], ["70\u201392 submucosal neurons", "ANATOMY", 46, 70], ["villus", "MULTI-TISSUE_STRUCTURE", 5, 11], ["colonic unit", "MULTI-TISSUE_STRUCTURE", 16, 28], ["submucosal neurons", "CELL", 52, 70], ["villus", "ANATOMY", 5, 11], ["colonic", "ANATOMY", 16, 23], ["submucosal neurons", "ANATOMY", 52, 70]]], ["The enteric nervous system can perform these functions in the absence of the CNS, but the CNS can have an effect on enteric neurons (Fig. 12).", [["enteric nervous system", "ANATOMY", 4, 26], ["CNS", "ANATOMY", 77, 80], ["CNS", "ANATOMY", 90, 93], ["enteric neurons", "ANATOMY", 116, 131], ["enteric nervous system", "ANATOMICAL_SYSTEM", 4, 26], ["CNS", "ANATOMICAL_SYSTEM", 77, 80], ["CNS", "ANATOMICAL_SYSTEM", 90, 93], ["enteric neurons", "CELL", 116, 131], ["enteric neurons", "CELL_TYPE", 116, 131], ["enteric nervous", "ANATOMY", 4, 19], ["CNS", "ANATOMY", 77, 80]]], ["The enteric nervous system along with the microflora, the immune system, and fibroblasts help maintain the integrity of the intestinal epithelial barrier.Emesis ::: Abnormal ConditionsEmesis is associated with rapidly progressive orad propulsion of small intestinal and gastric contents as well as coordinated respiratory, postural, and subjective correlates.", [["enteric nervous system", "ANATOMY", 4, 26], ["microflora", "ANATOMY", 42, 52], ["immune system", "ANATOMY", 58, 71], ["fibroblasts", "ANATOMY", 77, 88], ["intestinal epithelial barrier", "ANATOMY", 124, 153], ["orad", "ANATOMY", 230, 234], ["intestinal", "ANATOMY", 255, 265], ["gastric", "ANATOMY", 270, 277], ["respiratory", "ANATOMY", 310, 321], ["Emesis", "DISEASE", 154, 160], ["Emesis", "DISEASE", 184, 190], ["enteric nervous system", "ANATOMICAL_SYSTEM", 4, 26], ["fibroblasts", "CELL", 77, 88], ["intestinal epithelial barrier", "TISSUE", 124, 153], ["intestinal", "ORGAN", 255, 265], ["gastric", "ORGAN", 270, 277], ["fibroblasts", "CELL_TYPE", 77, 88], ["the microflora", "TREATMENT", 38, 52], ["Emesis", "PROBLEM", 154, 160], ["Abnormal Conditions", "PROBLEM", 165, 184], ["Emesis", "PROBLEM", 184, 190], ["rapidly progressive orad propulsion of small intestinal and gastric contents", "PROBLEM", 210, 286], ["enteric nervous", "ANATOMY", 4, 19], ["intestinal epithelial", "ANATOMY", 124, 145], ["Conditions", "OBSERVATION", 174, 184], ["rapidly", "OBSERVATION_MODIFIER", 210, 217], ["progressive", "OBSERVATION_MODIFIER", 218, 229], ["orad", "OBSERVATION_MODIFIER", 230, 234], ["propulsion", "OBSERVATION_MODIFIER", 235, 245], ["small", "OBSERVATION_MODIFIER", 249, 254], ["intestinal", "ANATOMY", 255, 265], ["gastric", "ANATOMY", 270, 277], ["contents", "OBSERVATION", 278, 286], ["coordinated", "OBSERVATION_MODIFIER", 298, 309], ["respiratory", "OBSERVATION_MODIFIER", 310, 321]]], ["Emesis is orchestrated by the diffuse vomiting center in the brainstem that initiates retrograde contractions that typically begin in the mid-portion of the small intestine and migrate orally at a rate of 8\u201310 cm s\u2212 1 (Lang et al., 1986, Stewart et al., 1977).", [["brainstem", "ANATOMY", 61, 70], ["small intestine", "ANATOMY", 157, 172], ["Emesis", "DISEASE", 0, 6], ["vomiting", "DISEASE", 38, 46], ["brainstem", "ORGAN", 61, 70], ["small intestine", "ORGAN", 157, 172], ["Emesis", "PROBLEM", 0, 6], ["the diffuse vomiting center in the brainstem", "PROBLEM", 26, 70], ["retrograde contractions", "PROBLEM", 86, 109], ["diffuse", "OBSERVATION_MODIFIER", 30, 37], ["vomiting", "OBSERVATION", 38, 46], ["brainstem", "ANATOMY", 61, 70], ["retrograde contractions", "OBSERVATION", 86, 109], ["mid-portion", "ANATOMY_MODIFIER", 138, 149], ["small intestine", "ANATOMY", 157, 172]]], ["Retching movements begin when the wave of retrograde propulsion reaches the stomach.", [["stomach", "ANATOMY", 76, 83], ["stomach", "ORGAN", 76, 83], ["Retching movements", "PROBLEM", 0, 18], ["stomach", "ANATOMY", 76, 83]]], ["Immediately afterward, the intercostal and diaphragmatic muscles contract to increase intraabdominal pressure, respiration is reflexively inhibited, and the gastric contents are expelled through the oral cavity.", [["intercostal", "ANATOMY", 27, 38], ["diaphragmatic muscles", "ANATOMY", 43, 64], ["intraabdominal", "ANATOMY", 86, 100], ["gastric", "ANATOMY", 157, 164], ["oral cavity", "ANATOMY", 199, 210], ["intercostal", "MULTI-TISSUE_STRUCTURE", 27, 38], ["muscles", "ORGAN", 57, 64], ["intraabdominal", "IMMATERIAL_ANATOMICAL_ENTITY", 86, 100], ["gastric", "ORGAN", 157, 164], ["oral cavity", "MULTI-TISSUE_STRUCTURE", 199, 210], ["increase intraabdominal pressure", "PROBLEM", 77, 109], ["intercostal", "ANATOMY", 27, 38], ["diaphragmatic muscles", "ANATOMY", 43, 64], ["increase", "OBSERVATION_MODIFIER", 77, 85], ["intraabdominal pressure", "OBSERVATION", 86, 109], ["gastric", "ANATOMY", 157, 164], ["contents", "OBSERVATION", 165, 173], ["oral cavity", "ANATOMY", 199, 210]]], ["While aspiration of vomitus does not often occur in conscious subjects, it can occur any time, especially in those with impaired consciousness such as those under anesthesia.", [["vomitus", "ANATOMY", 20, 27], ["impaired consciousness", "DISEASE", 120, 142], ["aspiration of vomitus", "PROBLEM", 6, 27], ["impaired consciousness", "PROBLEM", 120, 142], ["those under anesthesia", "TREATMENT", 151, 173]]], ["Aspiration is very hazardous particularly if the vomitus contains toxic substances (petroleum products, caustic materials) in addition to the usual potentially damaging content of acid, pepsin, bile, pancreatic enzymes, and microorganisms.", [["bile", "ANATOMY", 194, 198], ["pancreatic", "ANATOMY", 200, 210], ["vomitus", "DISEASE", 49, 56], ["petroleum products", "SIMPLE_CHEMICAL", 84, 102], ["pepsin", "GENE_OR_GENE_PRODUCT", 186, 192], ["bile", "SIMPLE_CHEMICAL", 194, 198], ["pancreatic", "MULTI-TISSUE_STRUCTURE", 200, 210], ["pancreatic enzymes", "PROTEIN", 200, 218], ["Aspiration", "PROBLEM", 0, 10], ["very hazardous", "PROBLEM", 14, 28], ["the vomitus", "PROBLEM", 45, 56], ["toxic substances", "PROBLEM", 66, 82], ["petroleum products", "TREATMENT", 84, 102], ["caustic materials", "PROBLEM", 104, 121], ["acid, pepsin, bile, pancreatic enzymes", "TEST", 180, 218], ["microorganisms", "PROBLEM", 224, 238], ["toxic", "OBSERVATION_MODIFIER", 66, 71], ["bile", "ANATOMY", 194, 198], ["pancreatic", "ANATOMY", 200, 210]]], ["Emesis and nausea, which may or may not accompany emesis, can be elicited by both peripheral and central stimuli.", [["Emesis", "DISEASE", 0, 6], ["nausea", "DISEASE", 11, 17], ["emesis", "DISEASE", 50, 56], ["peripheral", "TISSUE", 82, 92], ["Emesis", "PROBLEM", 0, 6], ["nausea", "PROBLEM", 11, 17], ["emesis", "PROBLEM", 50, 56], ["nausea", "OBSERVATION", 11, 17], ["emesis", "OBSERVATION", 50, 56], ["peripheral", "ANATOMY_MODIFIER", 82, 92], ["central stimuli", "OBSERVATION", 97, 112]]], ["In humans, unpleasant sights or smells may be sufficient to trigger emesis.", [["emesis", "DISEASE", 68, 74], ["humans", "ORGANISM", 3, 9], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["smells", "PROBLEM", 32, 38], ["emesis", "PROBLEM", 68, 74]]], ["Activation of dopamine D2 receptors in the chemoreceptor trigger zone or in the vomiting (emetic) center, activation of 5-HT3 receptors at peripheral vagal sensory pathways, gastritis or gastroenteritis, vection sickness, and other causes can initiate emesis.", [["chemoreceptor trigger zone", "ANATOMY", 43, 69], ["vagal sensory", "ANATOMY", 150, 163], ["dopamine", "CHEMICAL", 14, 22], ["vomiting", "DISEASE", 80, 88], ["emetic", "DISEASE", 90, 96], ["gastritis", "DISEASE", 174, 183], ["gastroenteritis", "DISEASE", 187, 202], ["vection sickness", "DISEASE", 204, 220], ["emesis", "DISEASE", 252, 258], ["dopamine", "CHEMICAL", 14, 22], ["dopamine D2 receptors", "GENE_OR_GENE_PRODUCT", 14, 35], ["5-HT3 receptors", "GENE_OR_GENE_PRODUCT", 120, 135], ["dopamine D2 receptors", "PROTEIN", 14, 35], ["5-HT3 receptors", "PROTEIN", 120, 135], ["dopamine D2 receptors", "TREATMENT", 14, 35], ["the vomiting", "PROBLEM", 76, 88], ["gastritis", "PROBLEM", 174, 183], ["gastroenteritis", "PROBLEM", 187, 202], ["vection sickness", "PROBLEM", 204, 220], ["emesis", "PROBLEM", 252, 258], ["gastritis", "OBSERVATION", 174, 183], ["gastroenteritis", "OBSERVATION", 187, 202]]], ["It is presumed that emesis is largely a protective reflex, designed to empty the upper gastrointestinal tract of toxic substances.", [["upper gastrointestinal tract", "ANATOMY", 81, 109], ["emesis", "DISEASE", 20, 26], ["upper gastrointestinal", "ORGANISM_SUBDIVISION", 81, 103], ["tract", "ORGANISM_SUBDIVISION", 104, 109], ["emesis", "PROBLEM", 20, 26], ["a protective reflex", "PROBLEM", 38, 57], ["presumed that", "UNCERTAINTY", 6, 19], ["emesis", "OBSERVATION", 20, 26], ["upper", "ANATOMY_MODIFIER", 81, 86], ["gastrointestinal tract", "ANATOMY", 87, 109], ["toxic substances", "OBSERVATION", 113, 129]]], ["Induction of emesis remains a mainstay of treatment of acute ingestion of poisons with the exception of caustic agents that burn mucosa.", [["mucosa", "ANATOMY", 129, 135], ["emesis", "DISEASE", 13, 19], ["mucosa", "MULTI-TISSUE_STRUCTURE", 129, 135], ["emesis", "PROBLEM", 13, 19], ["acute ingestion of poisons", "PROBLEM", 55, 81], ["caustic agents", "TREATMENT", 104, 118], ["burn mucosa", "PROBLEM", 124, 135], ["emesis", "OBSERVATION", 13, 19], ["acute", "OBSERVATION_MODIFIER", 55, 60], ["burn mucosa", "OBSERVATION", 124, 135]]], ["Examples of emetic agents are in Table 5.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsIt is unlikely that any one mechanism of diarrhea production is independent of other mechanisms.", [["diarrhea", "DISEASE", 55, 63], ["Diarrhea", "DISEASE", 79, 87], ["diarrhea", "DISEASE", 152, 160], ["emetic agents", "TREATMENT", 12, 25], ["diarrhea", "PROBLEM", 55, 63], ["Diarrhea", "PROBLEM", 79, 87], ["Abnormal Conditions", "PROBLEM", 92, 111], ["diarrhea production", "PROBLEM", 152, 171], ["diarrhea", "OBSERVATION", 55, 63], ["Conditions", "OBSERVATION", 101, 111], ["unlikely", "UNCERTAINTY", 117, 125], ["diarrhea", "OBSERVATION", 152, 160]]], ["Additionally, there are confounding variables in diarrhea production including pancreatic disease, liver disease, etc. Combinations of mechanisms are present in specific diseases as follows (Gelberg, 2016).Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsMalabsorption with or without fermentation leads to osmotic diarrhea whether the cause is loss of digestive enzymes secondary to microvillus disruption, crypt or villus enterocyte death, or space occupying lesions of the lamina propria.", [["pancreatic", "ANATOMY", 79, 89], ["liver", "ANATOMY", 99, 104], ["digestive", "ANATOMY", 374, 383], ["microvillus", "ANATOMY", 405, 416], ["crypt", "ANATOMY", 429, 434], ["villus enterocyte", "ANATOMY", 438, 455], ["lesions", "ANATOMY", 482, 489], ["lamina propria", "ANATOMY", 497, 511], ["diarrhea", "DISEASE", 49, 57], ["pancreatic disease", "DISEASE", 79, 97], ["liver disease", "DISEASE", 99, 112], ["diarrhea", "DISEASE", 220, 228], ["Diarrhea", "DISEASE", 244, 252], ["diarrhea", "DISEASE", 336, 344], ["death", "DISEASE", 456, 461], ["pancreatic", "ORGAN", 79, 89], ["liver", "ORGAN", 99, 104], ["digestive enzymes", "GENE_OR_GENE_PRODUCT", 374, 391], ["microvillus", "CELLULAR_COMPONENT", 405, 416], ["crypt", "PATHOLOGICAL_FORMATION", 429, 434], ["villus enterocyte", "CELLULAR_COMPONENT", 438, 455], ["lesions", "PATHOLOGICAL_FORMATION", 482, 489], ["lamina propria", "TISSUE", 497, 511], ["digestive enzymes", "PROTEIN", 374, 391], ["confounding variables", "PROBLEM", 24, 45], ["diarrhea production", "PROBLEM", 49, 68], ["pancreatic disease", "PROBLEM", 79, 97], ["liver disease", "PROBLEM", 99, 112], ["diarrhea", "PROBLEM", 220, 228], ["Diarrhea", "PROBLEM", 244, 252], ["Abnormal ConditionsMalabsorption", "PROBLEM", 257, 289], ["osmotic diarrhea", "PROBLEM", 328, 344], ["loss of digestive enzymes", "PROBLEM", 366, 391], ["microvillus disruption", "PROBLEM", 405, 427], ["crypt or villus enterocyte death", "PROBLEM", 429, 461], ["space occupying lesions of the lamina propria", "PROBLEM", 466, 511], ["confounding", "OBSERVATION_MODIFIER", 24, 35], ["variables", "OBSERVATION_MODIFIER", 36, 45], ["diarrhea", "OBSERVATION", 49, 57], ["pancreatic", "ANATOMY", 79, 89], ["disease", "OBSERVATION", 90, 97], ["liver", "ANATOMY", 99, 104], ["disease", "OBSERVATION", 105, 112], ["diarrhea", "OBSERVATION", 220, 228], ["Malabsorption", "OBSERVATION", 276, 289], ["microvillus disruption", "OBSERVATION", 405, 427], ["crypt", "ANATOMY_MODIFIER", 429, 434], ["villus enterocyte death", "OBSERVATION", 438, 461], ["space", "OBSERVATION_MODIFIER", 466, 471], ["occupying", "OBSERVATION_MODIFIER", 472, 481], ["lesions", "OBSERVATION", 482, 489], ["lamina propria", "ANATOMY", 497, 511]]], ["Generally, this is a problem of the small intestine, but secondary colonic malfunction can occur because of malabsorption of bile salts and fatty acids that stimulate fluid secretion in the large intestine.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsChloride (Cl\u2212) hypersecretion by the cystic fibrosis transmembrane regulator (CFTR) of a structurally intact mucosa.", [["small intestine", "ANATOMY", 36, 51], ["colonic", "ANATOMY", 67, 74], ["bile", "ANATOMY", 125, 129], ["fluid", "ANATOMY", 167, 172], ["intestine", "ANATOMY", 196, 205], ["mucosa", "ANATOMY", 385, 391], ["colonic malfunction", "DISEASE", 67, 86], ["malabsorption", "DISEASE", 108, 121], ["bile salts", "CHEMICAL", 125, 135], ["fatty acids", "CHEMICAL", 140, 151], ["diarrhea", "DISEASE", 220, 228], ["Diarrhea", "DISEASE", 244, 252], ["Chloride", "CHEMICAL", 276, 284], ["Cl\u2212", "CHEMICAL", 286, 289], ["fibrosis", "DISEASE", 320, 328], ["bile salts", "CHEMICAL", 125, 135], ["fatty acids", "CHEMICAL", 140, 151], ["Chloride", "CHEMICAL", 276, 284], ["small intestine", "ORGAN", 36, 51], ["colonic", "ORGAN", 67, 74], ["bile salts", "SIMPLE_CHEMICAL", 125, 135], ["fatty acids", "SIMPLE_CHEMICAL", 140, 151], ["fluid", "ORGANISM_SUBSTANCE", 167, 172], ["intestine", "ORGAN", 196, 205], ["Chloride", "SIMPLE_CHEMICAL", 276, 284], ["Cl\u2212", "SIMPLE_CHEMICAL", 286, 289], ["CFTR", "GENE_OR_GENE_PRODUCT", 354, 358], ["mucosa", "MULTI-TISSUE_STRUCTURE", 385, 391], ["cystic fibrosis transmembrane regulator", "PROTEIN", 313, 352], ["CFTR", "PROTEIN", 354, 358], ["a problem of the small intestine", "PROBLEM", 19, 51], ["secondary colonic malfunction", "PROBLEM", 57, 86], ["malabsorption of bile salts", "PROBLEM", 108, 135], ["fatty acids", "TREATMENT", 140, 151], ["fluid secretion in the large intestine", "PROBLEM", 167, 205], ["diarrhea", "PROBLEM", 220, 228], ["Diarrhea", "PROBLEM", 244, 252], ["Abnormal ConditionsChloride (Cl\u2212) hypersecretion", "PROBLEM", 257, 305], ["the cystic fibrosis transmembrane regulator", "PROBLEM", 309, 352], ["small intestine", "ANATOMY", 36, 51], ["colonic", "ANATOMY", 67, 74], ["malfunction", "OBSERVATION", 75, 86], ["bile", "ANATOMY", 125, 129], ["fluid secretion", "OBSERVATION", 167, 182], ["large", "ANATOMY_MODIFIER", 190, 195], ["intestine", "ANATOMY", 196, 205], ["diarrhea", "OBSERVATION", 220, 228], ["Abnormal", "OBSERVATION_MODIFIER", 257, 265], ["ConditionsChloride", "OBSERVATION_MODIFIER", 266, 284], ["hypersecretion", "OBSERVATION", 291, 305], ["cystic", "OBSERVATION_MODIFIER", 313, 319], ["fibrosis", "OBSERVATION", 320, 328], ["structurally", "OBSERVATION_MODIFIER", 365, 377], ["intact", "OBSERVATION", 378, 384], ["mucosa", "ANATOMY", 385, 391]]], ["CFTR is regulated by kinases which are dependent on cyclic adenosine monophosphate (cAMP) which acts as a second messenger.", [["cyclic adenosine monophosphate", "CHEMICAL", 52, 82], ["cAMP", "CHEMICAL", 84, 88], ["cyclic adenosine monophosphate", "CHEMICAL", 52, 82], ["cAMP", "CHEMICAL", 84, 88], ["CFTR", "GENE_OR_GENE_PRODUCT", 0, 4], ["cyclic adenosine monophosphate", "GENE_OR_GENE_PRODUCT", 52, 82], ["cAMP", "SIMPLE_CHEMICAL", 84, 88], ["CFTR", "PROTEIN", 0, 4], ["kinases", "PROTEIN", 21, 28], ["cyclic adenosine monophosphate (cAMP)", "TREATMENT", 52, 89]]], ["Prostanoids, bacterial toxins, and protein kinases all increase cAMP, thus increasing Cl\u2212 secretion.", [["cAMP", "CHEMICAL", 64, 68], ["cAMP", "CHEMICAL", 64, 68], ["Prostanoids", "SIMPLE_CHEMICAL", 0, 11], ["cAMP", "SIMPLE_CHEMICAL", 64, 68], ["Cl\u2212", "SIMPLE_CHEMICAL", 86, 89], ["protein kinases", "PROTEIN", 35, 50], ["Prostanoids", "TEST", 0, 11], ["bacterial toxins", "TEST", 13, 29], ["protein kinases", "TEST", 35, 50], ["cAMP", "TEST", 64, 68], ["increasing Cl\u2212 secretion", "PROBLEM", 75, 99], ["bacterial toxins", "OBSERVATION", 13, 29], ["increase", "OBSERVATION_MODIFIER", 55, 63], ["increasing", "OBSERVATION_MODIFIER", 75, 85], ["Cl\u2212 secretion", "OBSERVATION", 86, 99]]], ["Ca ion (Ca2 +) also plays a role in opening Cl\u2212 channels by increasing acetylcholine interaction with epithelial muscarinic receptors via cholinergic nerves in intestinal plexi.", [["epithelial", "ANATOMY", 102, 112], ["cholinergic nerves", "ANATOMY", 138, 156], ["intestinal plexi", "ANATOMY", 160, 176], ["Ca", "CHEMICAL", 0, 2], ["Ca2", "CHEMICAL", 8, 11], ["acetylcholine", "CHEMICAL", 71, 84], ["Ca", "CHEMICAL", 0, 2], ["Ca2 +)", "CHEMICAL", 8, 14], ["Cl\u2212", "CHEMICAL", 44, 47], ["acetylcholine", "CHEMICAL", 71, 84], ["Ca ion", "SIMPLE_CHEMICAL", 0, 6], ["Ca2 +", "SIMPLE_CHEMICAL", 8, 13], ["acetylcholine", "SIMPLE_CHEMICAL", 71, 84], ["epithelial muscarinic receptors", "GENE_OR_GENE_PRODUCT", 102, 133], ["cholinergic nerves", "MULTI-TISSUE_STRUCTURE", 138, 156], ["intestinal plexi", "MULTI-TISSUE_STRUCTURE", 160, 176], ["Cl\u2212 channels", "PROTEIN", 44, 56], ["epithelial muscarinic receptors", "PROTEIN", 102, 133], ["Ca ion (Ca2 +", "TEST", 0, 13], ["increasing acetylcholine interaction", "PROBLEM", 60, 96], ["epithelial muscarinic receptors", "TREATMENT", 102, 133], ["intestinal plexi", "PROBLEM", 160, 176], ["cholinergic nerves", "ANATOMY", 138, 156], ["intestinal plexi", "ANATOMY", 160, 176]]], ["Through a different mechanism but also involving the CFTR, bicarbonate secretion is also increased.", [["bicarbonate", "CHEMICAL", 59, 70], ["bicarbonate", "CHEMICAL", 59, 70], ["CFTR", "GENE_OR_GENE_PRODUCT", 53, 57], ["bicarbonate", "SIMPLE_CHEMICAL", 59, 70], ["CFTR", "PROTEIN", 53, 57], ["bicarbonate secretion", "PROBLEM", 59, 80], ["bicarbonate secretion", "OBSERVATION", 59, 80], ["increased", "OBSERVATION_MODIFIER", 89, 98]]], ["This osmotic activity results in a net efflux of fluid and electrolytes independent of permeability changes, absorptive capacity, or exogenously generated concentration gradients.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsExudation caused by an increased capillary permeability (protein-losing enteropathy) by leaky tight junctions between enterocytes.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsHypermotility generally is involved in diarrhea but usually not as a primary mechanism in domestic animals.", [["capillary", "ANATOMY", 282, 291], ["tight junctions", "ANATOMY", 343, 358], ["enterocytes", "ANATOMY", 367, 378], ["diarrhea", "DISEASE", 193, 201], ["Diarrhea", "DISEASE", 217, 225], ["Exudation", "DISEASE", 249, 258], ["enteropathy", "DISEASE", 321, 332], ["diarrhea", "DISEASE", 393, 401], ["Diarrhea", "DISEASE", 417, 425], ["Hypermotility", "DISEASE", 449, 462], ["diarrhea", "DISEASE", 488, 496], ["fluid", "ORGANISM_SUBSTANCE", 49, 54], ["capillary", "TISSUE", 282, 291], ["tight junctions", "CELLULAR_COMPONENT", 343, 358], ["enterocytes", "CELLULAR_COMPONENT", 367, 378], ["enterocytes", "CELL_TYPE", 367, 378], ["a net efflux of fluid", "PROBLEM", 33, 54], ["permeability changes", "PROBLEM", 87, 107], ["absorptive capacity", "PROBLEM", 109, 128], ["diarrhea", "PROBLEM", 193, 201], ["Diarrhea", "PROBLEM", 217, 225], ["Abnormal Conditions", "PROBLEM", 230, 249], ["Exudation", "PROBLEM", 249, 258], ["an increased capillary permeability", "PROBLEM", 269, 304], ["enteropathy", "PROBLEM", 321, 332], ["leaky tight junctions between enterocytes", "PROBLEM", 337, 378], ["diarrhea", "PROBLEM", 393, 401], ["Diarrhea", "PROBLEM", 417, 425], ["Abnormal ConditionsHypermotility", "PROBLEM", 430, 462], ["diarrhea", "PROBLEM", 488, 496], ["fluid", "OBSERVATION", 49, 54], ["diarrhea", "OBSERVATION", 193, 201], ["Conditions", "OBSERVATION", 239, 249], ["increased", "OBSERVATION_MODIFIER", 272, 281], ["capillary permeability", "OBSERVATION", 282, 304], ["leaky", "OBSERVATION_MODIFIER", 337, 342], ["tight junctions", "OBSERVATION", 343, 358], ["enterocytes", "ANATOMY", 367, 378], ["diarrhea", "OBSERVATION", 393, 401], ["Hypermotility", "OBSERVATION_MODIFIER", 449, 462]]], ["Hypermotility is defined as an increased rate, intensity, or frequency of peristalsis.", [["Hypermotility", "DISEASE", 0, 13], ["Hypermotility", "PROBLEM", 0, 13], ["an increased rate", "PROBLEM", 28, 45], ["increased", "OBSERVATION_MODIFIER", 31, 40], ["rate", "OBSERVATION_MODIFIER", 41, 45], ["peristalsis", "OBSERVATION", 74, 85]]], ["Theoretically, with decreased mucosal contact time, digestion and absorption of nutrients and water should be less efficient.", [["mucosal", "ANATOMY", 30, 37], ["water", "SIMPLE_CHEMICAL", 94, 99], ["decreased mucosal contact time", "PROBLEM", 20, 50], ["digestion", "PROBLEM", 52, 61], ["nutrients and water", "TREATMENT", 80, 99], ["decreased", "OBSERVATION_MODIFIER", 20, 29], ["mucosal contact", "OBSERVATION", 30, 45]]], ["It is suspected that decreased motility in some diseases allows for increased bacterial proliferation.", [["decreased motility", "PROBLEM", 21, 39], ["some diseases", "PROBLEM", 43, 56], ["increased bacterial proliferation", "PROBLEM", 68, 101], ["decreased", "OBSERVATION_MODIFIER", 21, 30], ["motility", "OBSERVATION_MODIFIER", 31, 39], ["increased", "OBSERVATION_MODIFIER", 68, 77], ["bacterial proliferation", "OBSERVATION", 78, 101]]], ["Conversely, some enterotoxins can stimulate intestinal motility in some motility disorders of humans such as achalasia, Hirschsprung\u2019s disease, and inflammatory bowel disease.", [["intestinal", "ANATOMY", 44, 54], ["bowel", "ANATOMY", 161, 166], ["motility disorders", "DISEASE", 72, 90], ["achalasia", "DISEASE", 109, 118], ["Hirschsprung\u2019s disease", "DISEASE", 120, 142], ["inflammatory bowel disease", "DISEASE", 148, 174], ["intestinal", "ORGAN", 44, 54], ["humans", "ORGANISM", 94, 100], ["bowel", "ORGAN", 161, 166], ["humans", "SPECIES", 94, 100], ["humans", "SPECIES", 94, 100], ["some enterotoxins", "PROBLEM", 12, 29], ["intestinal motility", "PROBLEM", 44, 63], ["some motility disorders of humans", "PROBLEM", 67, 100], ["achalasia", "PROBLEM", 109, 118], ["Hirschsprung\u2019s disease", "PROBLEM", 120, 142], ["inflammatory bowel disease", "PROBLEM", 148, 174], ["intestinal", "ANATOMY", 44, 54], ["achalasia", "OBSERVATION", 109, 118], ["inflammatory", "OBSERVATION_MODIFIER", 148, 160], ["bowel", "ANATOMY", 161, 166], ["disease", "OBSERVATION", 167, 174]]], ["Diarrhea occurs when there is an alteration in the network of interstitial cells of Cajal within the smooth muscle of the bowel wall.", [["interstitial cells", "ANATOMY", 62, 80], ["Cajal", "ANATOMY", 84, 89], ["smooth muscle", "ANATOMY", 101, 114], ["bowel wall", "ANATOMY", 122, 132], ["Diarrhea", "DISEASE", 0, 8], ["interstitial cells", "CELL", 62, 80], ["Cajal", "TISSUE", 84, 89], ["smooth muscle", "TISSUE", 101, 114], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 122, 132], ["interstitial cells", "CELL_TYPE", 62, 80], ["Diarrhea", "PROBLEM", 0, 8], ["an alteration", "PROBLEM", 30, 43], ["interstitial cells", "PROBLEM", 62, 80], ["alteration", "OBSERVATION", 33, 43], ["interstitial cells", "OBSERVATION", 62, 80], ["Cajal", "ANATOMY_MODIFIER", 84, 89], ["smooth muscle", "ANATOMY", 101, 114], ["bowel", "ANATOMY", 122, 127], ["wall", "ANATOMY_MODIFIER", 128, 132]]], ["Whether this is a cause or effect of bowel motility disorders is not known.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsTLRs and associated molecules produced by enterocytes and leukocytes are very important in the regulation of intestinal inflammation and in the host\u2019s response to intestinal pathogens.", [["bowel", "ANATOMY", 37, 42], ["enterocytes", "ANATOMY", 187, 198], ["leukocytes", "ANATOMY", 203, 213], ["intestinal", "ANATOMY", 254, 264], ["intestinal", "ANATOMY", 308, 318], ["bowel motility disorders", "DISEASE", 37, 61], ["diarrhea", "DISEASE", 89, 97], ["Diarrhea", "DISEASE", 113, 121], ["inflammation", "DISEASE", 265, 277], ["bowel", "ORGAN", 37, 42], ["enterocytes", "CELL", 187, 198], ["leukocytes", "CELL", 203, 213], ["intestinal", "ORGAN", 254, 264], ["intestinal", "ORGAN", 308, 318], ["ConditionsTLRs", "PROTEIN", 135, 149], ["enterocytes", "CELL_TYPE", 187, 198], ["leukocytes", "CELL_TYPE", 203, 213], ["bowel motility disorders", "PROBLEM", 37, 61], ["diarrhea", "PROBLEM", 89, 97], ["Diarrhea", "PROBLEM", 113, 121], ["Abnormal ConditionsTLRs", "PROBLEM", 126, 149], ["associated molecules", "PROBLEM", 154, 174], ["leukocytes", "PROBLEM", 203, 213], ["intestinal inflammation", "PROBLEM", 254, 277], ["intestinal pathogens", "PROBLEM", 308, 328], ["bowel", "ANATOMY", 37, 42], ["motility", "OBSERVATION", 43, 51], ["diarrhea", "OBSERVATION", 89, 97], ["molecules", "OBSERVATION", 165, 174], ["enterocytes", "ANATOMY", 187, 198], ["leukocytes", "OBSERVATION", 203, 213], ["intestinal", "ANATOMY", 254, 264], ["inflammation", "OBSERVATION", 265, 277], ["intestinal", "ANATOMY", 308, 318], ["pathogens", "OBSERVATION", 319, 328]]], ["Intestinal inflammation can lead to neoplasia (Arthur et al., 2012).Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsM cells regulate the presentation of antigens to GALT.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsOther factors (prostaglandins, leukotrienes, and PAF) act on enteric nerves to induce neurotransmitter-induced intestinal secretion by crypt cells.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsCell damage is possibly a consequence of inflammation mediated by T lymphocytes or proteases and oxidants produced by mast cells.", [["Intestinal", "ANATOMY", 0, 10], ["neoplasia", "ANATOMY", 36, 45], ["ConditionsM cells", "ANATOMY", 128, 145], ["enteric nerves", "ANATOMY", 323, 337], ["intestinal", "ANATOMY", 373, 383], ["crypt cells", "ANATOMY", 397, 408], ["Cell", "ANATOMY", 479, 483], ["T lymphocytes", "ANATOMY", 545, 558], ["mast cells", "ANATOMY", 597, 607], ["inflammation", "DISEASE", 11, 23], ["neoplasia", "DISEASE", 36, 45], ["diarrhea", "DISEASE", 82, 90], ["Diarrhea", "DISEASE", 106, 114], ["diarrhea", "DISEASE", 206, 214], ["Diarrhea", "DISEASE", 230, 238], ["prostaglandins", "CHEMICAL", 277, 291], ["leukotrienes", "CHEMICAL", 293, 305], ["PAF", "CHEMICAL", 311, 314], ["diarrhea", "DISEASE", 423, 431], ["Diarrhea", "DISEASE", 447, 455], ["inflammation", "DISEASE", 520, 532], ["prostaglandins", "CHEMICAL", 277, 291], ["leukotrienes", "CHEMICAL", 293, 305], ["Intestinal", "ORGAN", 0, 10], ["neoplasia", "CANCER", 36, 45], ["ConditionsM cells", "CELL", 128, 145], ["GALT", "GENE_OR_GENE_PRODUCT", 187, 191], ["prostaglandins", "SIMPLE_CHEMICAL", 277, 291], ["leukotrienes", "SIMPLE_CHEMICAL", 293, 305], ["PAF", "GENE_OR_GENE_PRODUCT", 311, 314], ["enteric nerves", "MULTI-TISSUE_STRUCTURE", 323, 337], ["intestinal", "ORGAN", 373, 383], ["crypt cells", "CELL", 397, 408], ["Cell", "CELL", 479, 483], ["T lymphocytes", "CELL", 545, 558], ["mast cells", "CELL", 597, 607], ["ConditionsM cells", "CELL_TYPE", 128, 145], ["antigens", "PROTEIN", 175, 183], ["ConditionsOther factors", "PROTEIN", 252, 275], ["leukotrienes", "PROTEIN", 293, 305], ["PAF", "PROTEIN", 311, 314], ["crypt cells", "CELL_TYPE", 397, 408], ["T lymphocytes", "CELL_TYPE", 545, 558], ["proteases", "PROTEIN", 562, 571], ["mast cells", "CELL_TYPE", 597, 607], ["Intestinal inflammation", "PROBLEM", 0, 23], ["neoplasia", "PROBLEM", 36, 45], ["diarrhea", "PROBLEM", 82, 90], ["Diarrhea", "PROBLEM", 106, 114], ["Abnormal ConditionsM cells", "PROBLEM", 119, 145], ["diarrhea", "PROBLEM", 206, 214], ["Diarrhea", "PROBLEM", 230, 238], ["Abnormal ConditionsOther factors", "PROBLEM", 243, 275], ["prostaglandins, leukotrienes", "TREATMENT", 277, 305], ["PAF", "PROBLEM", 311, 314], ["enteric nerves", "TREATMENT", 323, 337], ["neurotransmitter", "PROBLEM", 348, 364], ["intestinal secretion", "PROBLEM", 373, 393], ["crypt cells", "PROBLEM", 397, 408], ["diarrhea", "PROBLEM", 423, 431], ["Diarrhea", "PROBLEM", 447, 455], ["Abnormal Conditions", "PROBLEM", 460, 479], ["Cell damage", "PROBLEM", 479, 490], ["inflammation", "PROBLEM", 520, 532], ["T lymphocytes", "PROBLEM", 545, 558], ["proteases", "PROBLEM", 562, 571], ["mast cells", "PROBLEM", 597, 607], ["inflammation", "OBSERVATION", 11, 23], ["neoplasia", "OBSERVATION", 36, 45], ["diarrhea", "OBSERVATION", 82, 90], ["ConditionsM cells", "OBSERVATION", 128, 145], ["diarrhea", "OBSERVATION", 206, 214], ["enteric nerves", "ANATOMY", 323, 337], ["intestinal", "ANATOMY", 373, 383], ["secretion", "OBSERVATION", 384, 393], ["crypt cells", "OBSERVATION", 397, 408], ["diarrhea", "OBSERVATION", 423, 431], ["Conditions", "OBSERVATION", 469, 479], ["possibly a consequence of", "UNCERTAINTY", 494, 519], ["inflammation", "OBSERVATION", 520, 532], ["mast cells", "OBSERVATION", 597, 607]]], ["T lymphocytes also may affect epithelial cell maturation, causing villous atrophy and crypt hyperplasia.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsCell death can result from pathogen invasion into enterocytes, multiplication of the pathogen, and extrusion of the affected enterocytes.", [["T lymphocytes", "ANATOMY", 0, 13], ["epithelial cell", "ANATOMY", 30, 45], ["villous", "ANATOMY", 66, 73], ["crypt", "ANATOMY", 86, 91], ["Cell", "ANATOMY", 174, 178], ["enterocytes", "ANATOMY", 224, 235], ["enterocytes", "ANATOMY", 299, 310], ["villous atrophy", "DISEASE", 66, 81], ["hyperplasia", "DISEASE", 92, 103], ["diarrhea", "DISEASE", 118, 126], ["Diarrhea", "DISEASE", 142, 150], ["death", "DISEASE", 179, 184], ["T lymphocytes", "CELL", 0, 13], ["epithelial cell", "CELL", 30, 45], ["villous", "TISSUE", 66, 73], ["crypt hyperplasia", "PATHOLOGICAL_FORMATION", 86, 103], ["Cell", "CELL", 174, 178], ["enterocytes", "CELL", 224, 235], ["enterocytes", "CELL", 299, 310], ["T lymphocytes", "CELL_TYPE", 0, 13], ["T lymphocytes", "PROBLEM", 0, 13], ["epithelial cell maturation", "PROBLEM", 30, 56], ["villous atrophy", "PROBLEM", 66, 81], ["crypt hyperplasia", "PROBLEM", 86, 103], ["diarrhea", "PROBLEM", 118, 126], ["Diarrhea", "PROBLEM", 142, 150], ["Abnormal Conditions", "PROBLEM", 155, 174], ["Cell death", "PROBLEM", 174, 184], ["pathogen invasion into enterocytes", "PROBLEM", 201, 235], ["the pathogen", "PROBLEM", 255, 267], ["the affected enterocytes", "PROBLEM", 286, 310], ["lymphocytes", "OBSERVATION", 2, 13], ["may affect", "UNCERTAINTY", 19, 29], ["epithelial cell maturation", "OBSERVATION", 30, 56], ["villous atrophy", "OBSERVATION", 66, 81], ["crypt hyperplasia", "OBSERVATION", 86, 103], ["diarrhea", "OBSERVATION", 118, 126], ["Conditions", "OBSERVATION", 164, 174], ["pathogen", "OBSERVATION_MODIFIER", 201, 209], ["invasion", "OBSERVATION", 210, 218], ["enterocytes", "ANATOMY", 224, 235], ["pathogen", "OBSERVATION", 259, 267], ["extrusion", "OBSERVATION_MODIFIER", 273, 282], ["affected", "OBSERVATION_MODIFIER", 290, 298], ["enterocytes", "ANATOMY", 299, 310]]], ["These changes lead to notable distortion of villus architecture with a lack of mature absorptive enterocytes accompanied by nutrient malabsorption and osmotic diarrhea.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsMast cells of the lamina propria are in close association with enteric neurons and the enteric vasculature.", [["villus", "ANATOMY", 44, 50], ["enterocytes", "ANATOMY", 97, 108], ["Mast cells", "ANATOMY", 238, 248], ["lamina propria", "ANATOMY", 256, 270], ["enteric neurons", "ANATOMY", 301, 316], ["enteric vasculature", "ANATOMY", 325, 344], ["malabsorption", "DISEASE", 133, 146], ["diarrhea", "DISEASE", 159, 167], ["diarrhea", "DISEASE", 182, 190], ["Diarrhea", "DISEASE", 206, 214], ["villus", "TISSUE", 44, 50], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 97, 108], ["Mast cells", "CELL", 238, 248], ["lamina propria", "TISSUE", 256, 270], ["enteric neurons", "CELL", 301, 316], ["enteric vasculature", "MULTI-TISSUE_STRUCTURE", 325, 344], ["mature absorptive enterocytes", "CELL_TYPE", 79, 108], ["Mast cells", "CELL_TYPE", 238, 248], ["enteric neurons", "CELL_TYPE", 301, 316], ["These changes", "PROBLEM", 0, 13], ["notable distortion of villus architecture", "PROBLEM", 22, 63], ["mature absorptive enterocytes", "PROBLEM", 79, 108], ["nutrient malabsorption", "PROBLEM", 124, 146], ["osmotic diarrhea", "PROBLEM", 151, 167], ["diarrhea", "PROBLEM", 182, 190], ["Diarrhea", "PROBLEM", 206, 214], ["Abnormal Conditions", "PROBLEM", 219, 238], ["notable", "OBSERVATION_MODIFIER", 22, 29], ["distortion", "OBSERVATION", 30, 40], ["villus architecture", "OBSERVATION", 44, 63], ["mature", "OBSERVATION_MODIFIER", 79, 85], ["absorptive enterocytes", "OBSERVATION", 86, 108], ["nutrient malabsorption", "OBSERVATION", 124, 146], ["osmotic diarrhea", "OBSERVATION", 151, 167], ["diarrhea", "OBSERVATION", 182, 190], ["Conditions", "OBSERVATION", 228, 238], ["lamina propria", "ANATOMY", 256, 270], ["enteric neurons", "ANATOMY", 301, 316], ["enteric", "ANATOMY_MODIFIER", 325, 332], ["vasculature", "ANATOMY", 333, 344]]], ["They release histamine, prostaglandins, 5HT, and proteolytic enzymes that also play a role in diarrhea production.Mechanisms of diarrhea production ::: Diarrhea ::: Abnormal ConditionsThe nuts and bolts of the process are complicated.", [["nuts", "ANATOMY", 188, 192], ["histamine", "CHEMICAL", 13, 22], ["prostaglandins", "CHEMICAL", 24, 38], ["5HT", "CHEMICAL", 40, 43], ["diarrhea", "DISEASE", 94, 102], ["diarrhea", "DISEASE", 128, 136], ["Diarrhea", "DISEASE", 152, 160], ["histamine", "CHEMICAL", 13, 22], ["prostaglandins", "CHEMICAL", 24, 38], ["5HT", "CHEMICAL", 40, 43], ["histamine", "SIMPLE_CHEMICAL", 13, 22], ["prostaglandins", "SIMPLE_CHEMICAL", 24, 38], ["5HT", "SIMPLE_CHEMICAL", 40, 43], ["nuts", "ORGANISM_SUBDIVISION", 188, 192], ["proteolytic enzymes", "PROTEIN", 49, 68], ["prostaglandins", "TREATMENT", 24, 38], ["proteolytic enzymes", "TEST", 49, 68], ["diarrhea production", "PROBLEM", 94, 113], ["diarrhea", "PROBLEM", 128, 136], ["Diarrhea", "PROBLEM", 152, 160], ["Abnormal Conditions", "PROBLEM", 165, 184], ["diarrhea", "OBSERVATION", 128, 136], ["Conditions", "OBSERVATION", 174, 184], ["complicated", "OBSERVATION", 222, 233]]], ["Pathogens enter or attach to enterocytes, and may release enterotoxins.", [["enterocytes", "ANATOMY", 29, 40], ["enterocytes", "CELL", 29, 40], ["enterocytes", "CELL_TYPE", 29, 40], ["enterotoxins", "PROTEIN", 58, 70], ["Pathogens", "PROBLEM", 0, 9], ["enterotoxins", "PROBLEM", 58, 70], ["enterocytes", "ANATOMY", 29, 40], ["enterotoxins", "OBSERVATION", 58, 70]]], ["This triggers the enterocytes to release cytokines (IL-8) which activate resident macrophages and recruit new blood-borne macrophages into the lamina propria.", [["enterocytes", "ANATOMY", 18, 29], ["macrophages", "ANATOMY", 82, 93], ["blood", "ANATOMY", 110, 115], ["macrophages", "ANATOMY", 122, 133], ["lamina propria", "ANATOMY", 143, 157], ["enterocytes", "CELL", 18, 29], ["IL-8", "GENE_OR_GENE_PRODUCT", 52, 56], ["macrophages", "CELL", 82, 93], ["blood", "ORGANISM_SUBSTANCE", 110, 115], ["macrophages", "CELL", 122, 133], ["lamina propria", "TISSUE", 143, 157], ["cytokines", "PROTEIN", 41, 50], ["IL-8", "PROTEIN", 52, 56], ["resident macrophages", "CELL_TYPE", 73, 93], ["blood-borne macrophages", "CELL_TYPE", 110, 133], ["cytokines (IL", "TREATMENT", 41, 54], ["enterocytes", "ANATOMY", 18, 29], ["lamina propria", "ANATOMY", 143, 157]]], ["The activated macrophages release soluble factors (histamine, serotonin, and adenosine) that increase intestinal secretion of chloride and water and inhibit absorption.", [["macrophages", "ANATOMY", 14, 25], ["intestinal", "ANATOMY", 102, 112], ["histamine", "CHEMICAL", 51, 60], ["serotonin", "CHEMICAL", 62, 71], ["adenosine", "CHEMICAL", 77, 86], ["chloride", "CHEMICAL", 126, 134], ["histamine", "CHEMICAL", 51, 60], ["serotonin", "CHEMICAL", 62, 71], ["adenosine", "CHEMICAL", 77, 86], ["chloride", "CHEMICAL", 126, 134], ["macrophages", "CELL", 14, 25], ["histamine", "SIMPLE_CHEMICAL", 51, 60], ["serotonin", "SIMPLE_CHEMICAL", 62, 71], ["adenosine", "SIMPLE_CHEMICAL", 77, 86], ["intestinal", "ORGAN", 102, 112], ["chloride", "SIMPLE_CHEMICAL", 126, 134], ["water", "SIMPLE_CHEMICAL", 139, 144], ["activated macrophages", "CELL_TYPE", 4, 25], ["soluble factors", "PROTEIN", 34, 49], ["The activated macrophages release soluble factors", "TREATMENT", 0, 49], ["histamine", "TREATMENT", 51, 60], ["serotonin", "TREATMENT", 62, 71], ["adenosine", "TREATMENT", 77, 86], ["intestinal secretion of chloride", "TREATMENT", 102, 134], ["macrophages", "OBSERVATION", 14, 25]]], ["Other factors (prostaglandins, leukotrienes, and PAF) act on enteric nerves to induce neurotransmitter-mediated intestinal secretion.", [["enteric nerves", "ANATOMY", 61, 75], ["intestinal", "ANATOMY", 112, 122], ["prostaglandins", "CHEMICAL", 15, 29], ["leukotrienes", "CHEMICAL", 31, 43], ["PAF", "CHEMICAL", 49, 52], ["prostaglandins", "CHEMICAL", 15, 29], ["leukotrienes", "CHEMICAL", 31, 43], ["prostaglandins", "SIMPLE_CHEMICAL", 15, 29], ["leukotrienes", "SIMPLE_CHEMICAL", 31, 43], ["PAF", "SIMPLE_CHEMICAL", 49, 52], ["enteric nerves", "MULTI-TISSUE_STRUCTURE", 61, 75], ["intestinal", "ORGAN", 112, 122], ["PAF", "PROTEIN", 49, 52], ["Other factors", "PROBLEM", 0, 13], ["prostaglandins, leukotrienes", "TREATMENT", 15, 43], ["PAF", "PROBLEM", 49, 52], ["enteric nerves", "TREATMENT", 61, 75], ["intestinal secretion", "PROBLEM", 112, 132], ["enteric nerves", "ANATOMY", 61, 75], ["intestinal", "ANATOMY", 112, 122], ["secretion", "OBSERVATION", 123, 132]]], ["The subsequent cell damage is possibly a consequence of inflammation mediated by T-cells or proteases and oxidants secreted by mast cells (Fig. 15).", [["cell", "ANATOMY", 15, 19], ["T-cells", "ANATOMY", 81, 88], ["mast cells", "ANATOMY", 127, 137], ["inflammation", "DISEASE", 56, 68], ["cell", "CELL", 15, 19], ["T-cells", "CELL", 81, 88], ["mast cells", "CELL", 127, 137], ["T-cells", "CELL_TYPE", 81, 88], ["proteases", "PROTEIN", 92, 101], ["mast cells", "CELL_TYPE", 127, 137], ["The subsequent cell damage", "PROBLEM", 0, 26], ["inflammation", "PROBLEM", 56, 68], ["proteases", "PROBLEM", 92, 101], ["cell damage", "OBSERVATION", 15, 26], ["possibly a consequence of", "UNCERTAINTY", 30, 55], ["inflammation", "OBSERVATION", 56, 68], ["mast cells", "OBSERVATION", 127, 137]]], ["T-cells also affect epithelial cell growth producing villus atrophy and crypt hyperplasia.", [["T-cells", "ANATOMY", 0, 7], ["epithelial cell", "ANATOMY", 20, 35], ["villus", "ANATOMY", 53, 59], ["crypt hyperplasia", "ANATOMY", 72, 89], ["villus atrophy", "DISEASE", 53, 67], ["hyperplasia", "DISEASE", 78, 89], ["T-cells", "CELL", 0, 7], ["epithelial cell", "CELL", 20, 35], ["villus", "TISSUE", 53, 59], ["crypt hyperplasia", "PATHOLOGICAL_FORMATION", 72, 89], ["T-cells", "CELL_TYPE", 0, 7], ["T-cells", "TEST", 0, 7], ["epithelial cell growth", "PROBLEM", 20, 42], ["villus atrophy", "PROBLEM", 53, 67], ["crypt hyperplasia", "PROBLEM", 72, 89], ["epithelial cell", "OBSERVATION", 20, 35], ["growth", "OBSERVATION_MODIFIER", 36, 42], ["villus atrophy", "OBSERVATION", 53, 67], ["crypt hyperplasia", "OBSERVATION", 72, 89]]], ["Cell death results from pathogen invasion, multiplication, and extrusion.", [["Cell", "ANATOMY", 0, 4], ["death", "DISEASE", 5, 10], ["Cell", "CELL", 0, 4], ["Cell death", "PROBLEM", 0, 10], ["pathogen invasion", "PROBLEM", 24, 41], ["extrusion", "PROBLEM", 63, 72], ["pathogen", "OBSERVATION_MODIFIER", 24, 32], ["invasion", "OBSERVATION_MODIFIER", 33, 41], ["multiplication", "OBSERVATION_MODIFIER", 43, 57], ["extrusion", "OBSERVATION_MODIFIER", 63, 72]]], ["The end result is marked distortion of villus architecture accompanied by nutrient malabsorption and osmotic diarrhea (Gelberg, 2016).Consequences of diarrhea ::: Diarrhea ::: Abnormal ConditionsIntestinal fluid loss in the absence of replacement therapy gives rise to dehydration and acidosis secondary to electrolyte imbalances.", [["villus", "ANATOMY", 39, 45], ["Intestinal fluid", "ANATOMY", 195, 211], ["malabsorption", "DISEASE", 83, 96], ["diarrhea", "DISEASE", 109, 117], ["diarrhea", "DISEASE", 150, 158], ["Diarrhea", "DISEASE", 163, 171], ["fluid loss", "DISEASE", 206, 216], ["dehydration", "DISEASE", 269, 280], ["acidosis", "DISEASE", 285, 293], ["villus", "TISSUE", 39, 45], ["marked distortion of villus architecture", "PROBLEM", 18, 58], ["nutrient malabsorption", "PROBLEM", 74, 96], ["osmotic diarrhea", "PROBLEM", 101, 117], ["diarrhea", "PROBLEM", 150, 158], ["Diarrhea", "PROBLEM", 163, 171], ["Abnormal Conditions", "PROBLEM", 176, 195], ["Intestinal fluid loss", "PROBLEM", 195, 216], ["replacement therapy", "TREATMENT", 235, 254], ["dehydration", "PROBLEM", 269, 280], ["acidosis", "PROBLEM", 285, 293], ["electrolyte imbalances", "PROBLEM", 307, 329], ["marked", "OBSERVATION_MODIFIER", 18, 24], ["distortion", "OBSERVATION", 25, 35], ["villus architecture", "OBSERVATION", 39, 58], ["nutrient malabsorption", "OBSERVATION", 74, 96], ["osmotic diarrhea", "OBSERVATION", 101, 117], ["diarrhea", "OBSERVATION", 150, 158], ["Conditions", "OBSERVATION", 185, 195], ["fluid loss", "OBSERVATION", 206, 216], ["replacement", "OBSERVATION", 235, 246], ["dehydration", "OBSERVATION", 269, 280], ["acidosis", "OBSERVATION", 285, 293], ["electrolyte imbalances", "OBSERVATION", 307, 329]]], ["Dehydration also causes hypovolemia and hemoconcentration with inadequate tissue perfusion.", [["tissue", "ANATOMY", 74, 80], ["Dehydration", "DISEASE", 0, 11], ["hypovolemia", "DISEASE", 24, 35], ["hemoconcentration", "DISEASE", 40, 57], ["tissue", "TISSUE", 74, 80], ["Dehydration", "PROBLEM", 0, 11], ["hypovolemia", "PROBLEM", 24, 35], ["hemoconcentration", "PROBLEM", 40, 57], ["inadequate tissue perfusion", "PROBLEM", 63, 90], ["hypovolemia", "OBSERVATION", 24, 35], ["hemoconcentration", "OBSERVATION", 40, 57], ["inadequate tissue perfusion", "OBSERVATION", 63, 90]]], ["Energy generation shifts to anaerobic glycolysis leading to hypoglycemia and ketoacidosis.", [["hypoglycemia", "DISEASE", 60, 72], ["ketoacidosis", "DISEASE", 77, 89], ["Energy generation shifts", "PROBLEM", 0, 24], ["anaerobic glycolysis", "PROBLEM", 28, 48], ["hypoglycemia", "PROBLEM", 60, 72], ["ketoacidosis", "PROBLEM", 77, 89], ["anaerobic glycolysis", "OBSERVATION", 28, 48], ["ketoacidosis", "OBSERVATION", 77, 89]]], ["Acidosis, a lowering of blood and tissue pH, affects pH-dependent enzyme system function which is further exacerbated by HCO3\u2212 loss in fecal fluid and inadequate renal excretion of H+ and inadequate absorption of HCO3\u2212.", [["blood", "ANATOMY", 24, 29], ["tissue", "ANATOMY", 34, 40], ["fecal fluid", "ANATOMY", 135, 146], ["renal", "ANATOMY", 162, 167], ["Acidosis", "DISEASE", 0, 8], ["HCO3", "CHEMICAL", 121, 125], ["H", "CHEMICAL", 181, 182], ["HCO3\u2212", "CHEMICAL", 213, 218], ["HCO3", "CHEMICAL", 121, 125], ["H+", "CHEMICAL", 181, 183], ["HCO3", "CHEMICAL", 213, 217], ["blood", "ORGANISM_SUBSTANCE", 24, 29], ["tissue", "TISSUE", 34, 40], ["HCO3\u2212", "SIMPLE_CHEMICAL", 121, 126], ["fecal fluid", "ORGANISM_SUBSTANCE", 135, 146], ["renal", "ORGAN", 162, 167], ["H+", "SIMPLE_CHEMICAL", 181, 183], ["HCO3\u2212", "SIMPLE_CHEMICAL", 213, 218], ["Acidosis", "PROBLEM", 0, 8], ["a lowering of blood and tissue pH", "PROBLEM", 10, 43], ["pH", "TEST", 53, 55], ["dependent enzyme system function", "PROBLEM", 56, 88], ["HCO3\u2212 loss in fecal fluid", "PROBLEM", 121, 146], ["inadequate renal excretion", "PROBLEM", 151, 177], ["HCO3\u2212", "TREATMENT", 213, 218], ["lowering", "OBSERVATION_MODIFIER", 12, 20], ["fecal", "ANATOMY", 135, 140], ["fluid", "OBSERVATION", 141, 146], ["renal", "ANATOMY", 162, 167], ["excretion", "OBSERVATION", 168, 177]]], ["The increase in intracellular H+ and decrease in intracellular K+ lead to decreased neuromuscular control of myocardial contraction causing a further reduction in tissue perfusion and commencement of a vicious cycle (Gelberg, 2016).Intestinal models ::: Diarrhea ::: Abnormal ConditionsA variety of rodent and nonrodent animal models including knockouts have been employed for comparative toxicologic studies.", [["intracellular", "ANATOMY", 16, 29], ["intracellular", "ANATOMY", 49, 62], ["neuromuscular", "ANATOMY", 84, 97], ["myocardial", "ANATOMY", 109, 119], ["tissue", "ANATOMY", 163, 169], ["Intestinal", "ANATOMY", 232, 242], ["H", "CHEMICAL", 30, 31], ["K", "CHEMICAL", 63, 64], ["Diarrhea", "DISEASE", 254, 262], ["H+", "CHEMICAL", 30, 32], ["K+", "CHEMICAL", 63, 65], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 16, 29], ["H+", "SIMPLE_CHEMICAL", 30, 32], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 49, 62], ["K+", "SIMPLE_CHEMICAL", 63, 65], ["myocardial", "MULTI-TISSUE_STRUCTURE", 109, 119], ["tissue", "TISSUE", 163, 169], ["Intestinal", "ORGAN", 232, 242], ["rodent", "SPECIES", 299, 305], ["intracellular H", "TEST", 16, 31], ["decrease in intracellular K", "PROBLEM", 37, 64], ["myocardial contraction", "PROBLEM", 109, 131], ["a further reduction in tissue perfusion", "PROBLEM", 140, 179], ["Diarrhea", "PROBLEM", 254, 262], ["Abnormal ConditionsA variety of rodent", "PROBLEM", 267, 305], ["comparative toxicologic studies", "TEST", 377, 408], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["intracellular H+", "OBSERVATION", 16, 32], ["decrease", "OBSERVATION_MODIFIER", 37, 45], ["intracellular K", "OBSERVATION", 49, 64], ["myocardial contraction", "OBSERVATION", 109, 131], ["reduction", "OBSERVATION_MODIFIER", 150, 159], ["tissue perfusion", "OBSERVATION", 163, 179]]], ["Among these species, pigs are omnivorous like humans.", [["pigs", "ORGANISM", 21, 25], ["humans", "ORGANISM", 46, 52], ["pigs", "SPECIES", 21, 25], ["humans", "SPECIES", 46, 52], ["pigs", "SPECIES", 21, 25], ["humans", "SPECIES", 46, 52], ["species", "OBSERVATION", 12, 19]]], ["Their digestive physiology is also similar to that of humans.", [["digestive", "ANATOMY", 6, 15], ["digestive", "ORGAN", 6, 15], ["humans", "ORGANISM", 54, 60], ["humans", "SPECIES", 54, 60], ["humans", "SPECIES", 54, 60]]], ["While monogastric, their stomach has a species specific feature, the torus pyloricus, a prominent muscular outpouching of uncertain function.", [["stomach", "ANATOMY", 25, 32], ["torus pyloricus", "ANATOMY", 69, 84], ["muscular", "ANATOMY", 98, 106], ["pyloricus", "DISEASE", 75, 84], ["stomach", "ORGAN", 25, 32], ["torus pyloricus", "ORGANISM", 69, 84], ["muscular", "ORGAN", 98, 106], ["a prominent muscular outpouching", "PROBLEM", 86, 118], ["stomach", "ANATOMY", 25, 32], ["species", "OBSERVATION", 39, 46], ["torus pyloricus", "OBSERVATION", 69, 84], ["prominent", "OBSERVATION_MODIFIER", 88, 97], ["muscular", "OBSERVATION_MODIFIER", 98, 106], ["outpouching", "OBSERVATION", 107, 118], ["uncertain function", "OBSERVATION", 122, 140]]], ["Porcine Peyer\u2019s patches occur in a continuous band along the antimesenteric length of the small and large intestine; a 2-cm-wide lymphoid aggregation is at the ileocecal valve (i.e., cecal tonsil).", [["Peyer\u2019s patches", "ANATOMY", 8, 23], ["intestine", "ANATOMY", 106, 115], ["lymphoid", "ANATOMY", 129, 137], ["ileocecal valve", "ANATOMY", 160, 175], ["cecal tonsil", "ANATOMY", 183, 195], ["lymphoid aggregation", "DISEASE", 129, 149], ["intestine", "ORGAN", 106, 115], ["lymphoid", "CELL", 129, 137], ["ileocecal valve", "MULTI-TISSUE_STRUCTURE", 160, 175], ["cecal tonsil", "MULTI-TISSUE_STRUCTURE", 183, 195], ["Porcine", "SPECIES", 0, 7], ["Porcine Peyer\u2019s patches", "TREATMENT", 0, 23], ["a continuous band", "TREATMENT", 33, 50], ["wide lymphoid aggregation", "PROBLEM", 124, 149], ["antimesenteric length", "ANATOMY_MODIFIER", 61, 82], ["small", "OBSERVATION_MODIFIER", 90, 95], ["large", "ANATOMY_MODIFIER", 100, 105], ["intestine", "ANATOMY", 106, 115], ["2-cm", "OBSERVATION_MODIFIER", 119, 123], ["wide", "OBSERVATION_MODIFIER", 124, 128], ["lymphoid aggregation", "OBSERVATION", 129, 149], ["ileocecal valve", "ANATOMY", 160, 175], ["cecal tonsil", "ANATOMY", 183, 195]]], ["Xenobiotic-induced injury to the porcine stomach or intestine often results in degeneration, ulceration, or hemorrhage, as in other species.", [["stomach", "ANATOMY", 41, 48], ["intestine", "ANATOMY", 52, 61], ["Xenobiotic", "CHEMICAL", 0, 10], ["injury to the porcine stomach", "DISEASE", 19, 48], ["ulceration", "DISEASE", 93, 103], ["hemorrhage", "DISEASE", 108, 118], ["porcine", "ORGANISM", 33, 40], ["stomach", "ORGAN", 41, 48], ["intestine", "ORGAN", 52, 61], ["porcine", "SPECIES", 33, 40], ["Xenobiotic-induced injury to the porcine stomach", "PROBLEM", 0, 48], ["degeneration", "PROBLEM", 79, 91], ["ulceration", "PROBLEM", 93, 103], ["hemorrhage", "PROBLEM", 108, 118], ["injury", "OBSERVATION", 19, 25], ["porcine", "ANATOMY_MODIFIER", 33, 40], ["stomach", "ANATOMY", 41, 48], ["intestine", "ANATOMY", 52, 61], ["degeneration", "OBSERVATION", 79, 91], ["ulceration", "OBSERVATION", 93, 103], ["hemorrhage", "OBSERVATION", 108, 118]]], ["The P450 system of swine has been partially characterized, and its metabolic pathways are similar to humans, with significant overlap in substrate specificity.", [["P450", "GENE_OR_GENE_PRODUCT", 4, 8], ["swine", "ORGANISM", 19, 24], ["humans", "ORGANISM", 101, 107], ["swine", "SPECIES", 19, 24], ["humans", "SPECIES", 101, 107], ["swine", "SPECIES", 19, 24], ["humans", "SPECIES", 101, 107], ["significant overlap in substrate specificity", "PROBLEM", 114, 158], ["swine", "OBSERVATION", 19, 24], ["partially characterized", "OBSERVATION_MODIFIER", 34, 57], ["metabolic pathways", "OBSERVATION", 67, 85], ["significant", "OBSERVATION_MODIFIER", 114, 125]]], ["Total P450 in conventional pigs is similar to that of humans (Swindle et al., 2012).Intestinal models ::: Diarrhea ::: Abnormal ConditionsIntestinal xenografts have been proven to mimic the anatomy, physiology, and disease production of the host species (Thulin et al., 1991).", [["Intestinal", "ANATOMY", 84, 94], ["Intestinal xenografts", "ANATOMY", 138, 159], ["Diarrhea", "DISEASE", 106, 114], ["P450", "GENE_OR_GENE_PRODUCT", 6, 10], ["pigs", "ORGANISM", 27, 31], ["humans", "ORGANISM", 54, 60], ["Intestinal", "ORGAN", 84, 94], ["Intestinal xenografts", "CANCER", 138, 159], ["P450", "PROTEIN", 6, 10], ["pigs", "SPECIES", 27, 31], ["humans", "SPECIES", 54, 60], ["pigs", "SPECIES", 27, 31], ["humans", "SPECIES", 54, 60], ["Total P450 in conventional pigs", "TREATMENT", 0, 31], ["Diarrhea", "PROBLEM", 106, 114], ["Abnormal Conditions", "PROBLEM", 119, 138], ["Intestinal xenografts", "TREATMENT", 138, 159], ["disease production of the host species", "PROBLEM", 215, 253], ["Conditions", "OBSERVATION", 128, 138]]], ["Other models include exfoliated enterocytes (Rolsma et al., 1994), intestinal loops/explants, Ussing chambers, human colonic carcinoma (Caco-2) cell culture (Hidalgo et al., 1989) with high-throughput screening and Parallel Artificial Membrane Permeability Assay (PAMPA) (Avdeef et al., 2004) among others.Alcohol ::: Direct Effects on Cell Membranes ::: Toxic MechanismsA number of ingested substances can induce toxic effects by direct actions on gastrointestinal epithelial cell membranes.", [["enterocytes", "ANATOMY", 32, 43], ["intestinal", "ANATOMY", 67, 77], ["explants", "ANATOMY", 84, 92], ["colonic carcinoma", "ANATOMY", 117, 134], ["Caco-2) cell culture", "ANATOMY", 136, 156], ["Cell", "ANATOMY", 336, 340], ["gastrointestinal epithelial cell membranes", "ANATOMY", 449, 491], ["colonic carcinoma", "DISEASE", 117, 134], ["Alcohol", "CHEMICAL", 306, 313], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 32, 43], ["intestinal loops", "MULTI-TISSUE_STRUCTURE", 67, 83], ["human", "ORGANISM", 111, 116], ["colonic carcinoma", "CANCER", 117, 134], ["Caco-2) cell culture", "CELL", 136, 156], ["Cell", "CELL", 336, 340], ["gastrointestinal epithelial cell membranes", "CELLULAR_COMPONENT", 449, 491], ["exfoliated enterocytes", "CELL_TYPE", 21, 43], ["human colonic carcinoma (Caco-2) cell culture", "CELL_LINE", 111, 156], ["human", "SPECIES", 111, 116], ["human", "SPECIES", 111, 116], ["exfoliated enterocytes", "PROBLEM", 21, 43], ["intestinal loops/explants", "TREATMENT", 67, 92], ["Ussing chambers", "TREATMENT", 94, 109], ["human colonic carcinoma", "PROBLEM", 111, 134], ["Caco", "TEST", 136, 140], ["cell culture", "TEST", 144, 156], ["high-throughput screening", "PROBLEM", 185, 210], ["Parallel Artificial Membrane Permeability Assay", "TEST", 215, 262], ["toxic effects", "PROBLEM", 414, 427], ["gastrointestinal epithelial cell membranes", "TREATMENT", 449, 491], ["exfoliated enterocytes", "OBSERVATION", 21, 43], ["intestinal loops", "ANATOMY", 67, 83], ["colonic", "ANATOMY", 117, 124], ["carcinoma", "OBSERVATION", 125, 134], ["Cell Membranes", "OBSERVATION", 336, 350], ["gastrointestinal epithelial", "ANATOMY", 449, 476], ["cell membranes", "OBSERVATION", 477, 491]]], ["Examples include alcohol (Fig. 16) and other organic solvents, aspirin-like drugs (Fig. 17), bile acids, sodium chloride, and certain constituents of edible plants.", [["alcohol", "CHEMICAL", 17, 24], ["aspirin", "CHEMICAL", 63, 70], ["bile acids", "CHEMICAL", 93, 103], ["sodium chloride", "CHEMICAL", 105, 120], ["alcohol", "CHEMICAL", 17, 24], ["aspirin", "CHEMICAL", 63, 70], ["bile acids", "CHEMICAL", 93, 103], ["sodium chloride", "CHEMICAL", 105, 120], ["alcohol", "SIMPLE_CHEMICAL", 17, 24], ["aspirin-like drugs", "SIMPLE_CHEMICAL", 63, 81], ["Fig. 17", "SIMPLE_CHEMICAL", 83, 90], ["bile acids", "SIMPLE_CHEMICAL", 93, 103], ["sodium chloride", "SIMPLE_CHEMICAL", 105, 120], ["other organic solvents", "TREATMENT", 39, 61], ["aspirin", "TREATMENT", 63, 70], ["bile acids", "TREATMENT", 93, 103], ["sodium chloride", "TREATMENT", 105, 120], ["bile", "ANATOMY", 93, 97], ["edible plants", "OBSERVATION", 150, 163]]], ["High concentrations of ethyl alcohol (> 40%) can cause direct damage to esophageal and gastric epithelial cell membranes.", [["esophageal", "ANATOMY", 72, 82], ["gastric epithelial cell membranes", "ANATOMY", 87, 120], ["ethyl alcohol", "CHEMICAL", 23, 36], ["ethyl alcohol", "CHEMICAL", 23, 36], ["ethyl alcohol", "SIMPLE_CHEMICAL", 23, 36], ["esophageal", "CELL", 72, 82], ["gastric epithelial cell membranes", "CELLULAR_COMPONENT", 87, 120], ["ethyl alcohol", "TREATMENT", 23, 36], ["direct damage to esophageal and gastric epithelial cell membranes", "PROBLEM", 55, 120], ["concentrations", "OBSERVATION_MODIFIER", 5, 19], ["esophageal", "ANATOMY", 72, 82], ["gastric epithelial", "ANATOMY", 87, 105], ["cell membranes", "OBSERVATION", 106, 120]]], ["Alcohol disorders the lipids in the outer bilayer of membranes and may increase their fluidity (Geall et al., 1970).", [["outer bilayer", "ANATOMY", 36, 49], ["membranes", "ANATOMY", 53, 62], ["Alcohol disorders", "DISEASE", 0, 17], ["Alcohol", "CHEMICAL", 0, 7], ["Alcohol", "SIMPLE_CHEMICAL", 0, 7], ["outer bilayer", "CELLULAR_COMPONENT", 36, 49], ["membranes", "CELLULAR_COMPONENT", 53, 62], ["Alcohol disorders", "PROBLEM", 0, 17], ["the lipids in the outer bilayer of membranes", "TREATMENT", 18, 62], ["outer", "ANATOMY_MODIFIER", 36, 41], ["bilayer", "ANATOMY_MODIFIER", 42, 49], ["membranes", "OBSERVATION", 53, 62], ["may", "UNCERTAINTY", 67, 70], ["increase", "OBSERVATION_MODIFIER", 71, 79]]], ["Changes in membrane order lead to cell damage that can be measured as a decrease of transmucosal potential difference (Svanes et al., 1982).", [["membrane", "ANATOMY", 11, 19], ["cell", "ANATOMY", 34, 38], ["transmucosal", "ANATOMY", 84, 96], ["membrane", "CELLULAR_COMPONENT", 11, 19], ["cell", "CELL", 34, 38], ["transmucosal", "IMMATERIAL_ANATOMICAL_ENTITY", 84, 96], ["cell damage", "PROBLEM", 34, 45], ["cell damage", "OBSERVATION", 34, 45]]], ["Bile acids, aspirin, and salicylate exhibit similar effects (Black et al., 1973, Kasbekar, 1973).", [["Bile acids", "CHEMICAL", 0, 10], ["aspirin", "CHEMICAL", 12, 19], ["salicylate", "CHEMICAL", 25, 35], ["Bile acids", "CHEMICAL", 0, 10], ["aspirin", "CHEMICAL", 12, 19], ["salicylate", "CHEMICAL", 25, 35], ["Bile acids", "SIMPLE_CHEMICAL", 0, 10], ["aspirin", "SIMPLE_CHEMICAL", 12, 19], ["salicylate", "SIMPLE_CHEMICAL", 25, 35], ["Bile acids", "TREATMENT", 0, 10], ["aspirin", "TREATMENT", 12, 19], ["salicylate", "TREATMENT", 25, 35], ["acids", "OBSERVATION_MODIFIER", 5, 10]]], ["Aspirin and salicylate can alter production of prostanoids, products of the cyclooxygenase pathway of arachidonic acid metabolism (Fig. 18).", [["Aspirin", "CHEMICAL", 0, 7], ["salicylate", "CHEMICAL", 12, 22], ["arachidonic acid", "CHEMICAL", 102, 118], ["Aspirin", "CHEMICAL", 0, 7], ["salicylate", "CHEMICAL", 12, 22], ["prostanoids", "CHEMICAL", 47, 58], ["arachidonic acid", "CHEMICAL", 102, 118], ["Aspirin", "SIMPLE_CHEMICAL", 0, 7], ["salicylate", "SIMPLE_CHEMICAL", 12, 22], ["prostanoids", "SIMPLE_CHEMICAL", 47, 58], ["cyclooxygenase", "GENE_OR_GENE_PRODUCT", 76, 90], ["arachidonic acid", "SIMPLE_CHEMICAL", 102, 118], ["cyclooxygenase", "PROTEIN", 76, 90], ["Aspirin", "TREATMENT", 0, 7], ["salicylate", "TREATMENT", 12, 22], ["prostanoids", "TREATMENT", 47, 58], ["the cyclooxygenase pathway", "TREATMENT", 72, 98], ["arachidonic acid metabolism", "TREATMENT", 102, 129], ["arachidonic acid", "OBSERVATION", 102, 118]]], ["Exposure of the gastric mucosa to a high concentration of alcohol is associated with increased synthesis of prostaglandins and prostacyclin (Smith et al., 1991).", [["gastric mucosa", "ANATOMY", 16, 30], ["alcohol", "CHEMICAL", 58, 65], ["prostaglandins", "CHEMICAL", 108, 122], ["prostacyclin", "CHEMICAL", 127, 139], ["alcohol", "CHEMICAL", 58, 65], ["prostaglandins", "CHEMICAL", 108, 122], ["prostacyclin", "CHEMICAL", 127, 139], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 16, 30], ["alcohol", "SIMPLE_CHEMICAL", 58, 65], ["prostaglandins", "SIMPLE_CHEMICAL", 108, 122], ["prostacyclin", "SIMPLE_CHEMICAL", 127, 139], ["the gastric mucosa", "PROBLEM", 12, 30], ["increased synthesis of prostaglandins", "TREATMENT", 85, 122], ["prostacyclin", "TREATMENT", 127, 139], ["gastric mucosa", "ANATOMY", 16, 30], ["high concentration", "OBSERVATION_MODIFIER", 36, 54], ["increased", "OBSERVATION_MODIFIER", 85, 94], ["synthesis", "OBSERVATION", 95, 104]]], ["However, the prostanoid substances may help counteract alcohol-induced injury because treatment with indomethacin exacerbates alcohol-induced damage.", [["alcohol", "CHEMICAL", 55, 62], ["indomethacin", "CHEMICAL", 101, 113], ["alcohol", "CHEMICAL", 126, 133], ["prostanoid", "CHEMICAL", 13, 23], ["alcohol", "CHEMICAL", 55, 62], ["indomethacin", "CHEMICAL", 101, 113], ["alcohol", "CHEMICAL", 126, 133], ["prostanoid", "SIMPLE_CHEMICAL", 13, 23], ["alcohol", "SIMPLE_CHEMICAL", 55, 62], ["indomethacin", "SIMPLE_CHEMICAL", 101, 113], ["alcohol", "SIMPLE_CHEMICAL", 126, 133], ["the prostanoid substances", "TREATMENT", 9, 34], ["induced injury", "PROBLEM", 63, 77], ["indomethacin", "TREATMENT", 101, 113], ["induced damage", "PROBLEM", 134, 148], ["prostanoid substances", "OBSERVATION", 13, 34]]], ["Other eicosanoids such as leukotriene A4 may participate in alcohol-induced cell damage since inhibitors of leukotriene synthesis reduce the disruption caused by alcohol (French, 1991).", [["cell", "ANATOMY", 76, 80], ["leukotriene A4", "CHEMICAL", 26, 40], ["alcohol", "CHEMICAL", 60, 67], ["leukotriene", "CHEMICAL", 108, 119], ["alcohol", "CHEMICAL", 162, 169], ["eicosanoids", "CHEMICAL", 6, 17], ["alcohol", "CHEMICAL", 60, 67], ["alcohol", "CHEMICAL", 162, 169], ["leukotriene A4", "GENE_OR_GENE_PRODUCT", 26, 40], ["alcohol", "SIMPLE_CHEMICAL", 60, 67], ["cell", "CELL", 76, 80], ["leukotriene", "SIMPLE_CHEMICAL", 108, 119], ["alcohol", "SIMPLE_CHEMICAL", 162, 169], ["Other eicosanoids", "PROBLEM", 0, 17], ["leukotriene A4", "TREATMENT", 26, 40], ["induced cell damage", "PROBLEM", 68, 87], ["inhibitors of leukotriene synthesis", "TREATMENT", 94, 129], ["cell damage", "OBSERVATION", 76, 87]]], ["Thus, prostaglandins may protect the gastric mucosa from ethanol damage, while leukotrienes contribute to the damage.", [["gastric mucosa", "ANATOMY", 37, 51], ["prostaglandins", "CHEMICAL", 6, 20], ["ethanol", "CHEMICAL", 57, 64], ["leukotrienes", "CHEMICAL", 79, 91], ["prostaglandins", "CHEMICAL", 6, 20], ["ethanol", "CHEMICAL", 57, 64], ["prostaglandins", "SIMPLE_CHEMICAL", 6, 20], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 37, 51], ["ethanol", "SIMPLE_CHEMICAL", 57, 64], ["leukotrienes", "SIMPLE_CHEMICAL", 79, 91], ["prostaglandins", "TREATMENT", 6, 20], ["the gastric mucosa", "PROBLEM", 33, 51], ["ethanol damage", "PROBLEM", 57, 71], ["leukotrienes", "TREATMENT", 79, 91], ["the damage", "PROBLEM", 106, 116], ["gastric mucosa", "ANATOMY", 37, 51], ["ethanol damage", "OBSERVATION", 57, 71], ["damage", "OBSERVATION", 110, 116]]], ["Depletion of intracellular glutathione (GSH) has also been implicated in alcohol injury to mucosal cells (Hauser and Szabo, 1991, Victor et al., 1991).", [["intracellular", "ANATOMY", 13, 26], ["mucosal cells", "ANATOMY", 91, 104], ["glutathione", "CHEMICAL", 27, 38], ["GSH", "CHEMICAL", 40, 43], ["alcohol", "CHEMICAL", 73, 80], ["glutathione", "CHEMICAL", 27, 38], ["GSH", "CHEMICAL", 40, 43], ["alcohol", "CHEMICAL", 73, 80], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 13, 26], ["glutathione", "SIMPLE_CHEMICAL", 27, 38], ["GSH", "SIMPLE_CHEMICAL", 40, 43], ["alcohol", "SIMPLE_CHEMICAL", 73, 80], ["mucosal cells", "CELL", 91, 104], ["mucosal cells", "CELL_TYPE", 91, 104], ["intracellular glutathione (GSH", "PROBLEM", 13, 43], ["intracellular glutathione", "OBSERVATION", 13, 38], ["alcohol injury", "OBSERVATION", 73, 87], ["mucosal cells", "ANATOMY", 91, 104]]], ["The levels of GSH decline in proportion to the degree of alcohol injury and treatment with prostaglandin E2 can mitigate alcohol injury.", [["GSH", "CHEMICAL", 14, 17], ["alcohol", "CHEMICAL", 57, 64], ["prostaglandin E2", "CHEMICAL", 91, 107], ["alcohol injury", "DISEASE", 121, 135], ["GSH", "CHEMICAL", 14, 17], ["alcohol", "CHEMICAL", 57, 64], ["prostaglandin E2", "CHEMICAL", 91, 107], ["alcohol", "CHEMICAL", 121, 128], ["GSH", "SIMPLE_CHEMICAL", 14, 17], ["alcohol", "SIMPLE_CHEMICAL", 57, 64], ["prostaglandin E2", "SIMPLE_CHEMICAL", 91, 107], ["alcohol", "SIMPLE_CHEMICAL", 121, 128], ["GSH decline", "PROBLEM", 14, 25], ["alcohol injury", "PROBLEM", 57, 71], ["treatment", "TREATMENT", 76, 85], ["prostaglandin E2", "TREATMENT", 91, 107], ["alcohol injury", "PROBLEM", 121, 135], ["GSH decline", "OBSERVATION", 14, 25], ["alcohol injury", "OBSERVATION", 57, 71]]], ["N-ethylmaleimide prevents prostaglandin-induced protection against alcohol injury.Alcohol ::: Direct Effects on Cell Membranes ::: Toxic MechanismsA single alcohol drinking binge causes a rapid increase in serum endotoxin, bacterial translocation from the intestine, and a prolonged increase in circulation of acute phase proteins.", [["Cell", "ANATOMY", 112, 116], ["serum", "ANATOMY", 206, 211], ["intestine", "ANATOMY", 256, 265], ["N-ethylmaleimide", "CHEMICAL", 0, 16], ["prostaglandin", "CHEMICAL", 26, 39], ["alcohol", "CHEMICAL", 67, 74], ["Alcohol", "CHEMICAL", 82, 89], ["alcohol", "CHEMICAL", 156, 163], ["binge", "CHEMICAL", 173, 178], ["endotoxin", "CHEMICAL", 212, 221], ["N-ethylmaleimide", "CHEMICAL", 0, 16], ["prostaglandin", "CHEMICAL", 26, 39], ["alcohol", "CHEMICAL", 67, 74], ["alcohol", "CHEMICAL", 156, 163], ["N-ethylmaleimide", "SIMPLE_CHEMICAL", 0, 16], ["prostaglandin", "SIMPLE_CHEMICAL", 26, 39], ["alcohol", "SIMPLE_CHEMICAL", 67, 74], ["Cell", "CELL", 112, 116], ["alcohol", "SIMPLE_CHEMICAL", 156, 163], ["serum", "ORGANISM_SUBSTANCE", 206, 211], ["endotoxin", "SIMPLE_CHEMICAL", 212, 221], ["intestine", "ORGAN", 256, 265], ["serum endotoxin", "PROTEIN", 206, 221], ["acute phase proteins", "PROTEIN", 310, 330], ["-ethylmaleimide", "TREATMENT", 1, 16], ["prostaglandin", "TREATMENT", 26, 39], ["alcohol injury", "PROBLEM", 67, 81], ["a rapid increase in serum endotoxin", "PROBLEM", 186, 221], ["bacterial translocation from the intestine", "PROBLEM", 223, 265], ["a prolonged increase", "PROBLEM", 271, 291], ["acute phase proteins", "PROBLEM", 310, 330], ["Cell Membranes", "OBSERVATION", 112, 126], ["rapid", "OBSERVATION_MODIFIER", 188, 193], ["increase", "OBSERVATION_MODIFIER", 194, 202], ["bacterial translocation", "OBSERVATION", 223, 246], ["intestine", "ANATOMY", 256, 265], ["prolonged", "OBSERVATION_MODIFIER", 273, 282], ["increase", "OBSERVATION_MODIFIER", 283, 291], ["acute phase", "OBSERVATION", 310, 321]]], ["The increased endotoxin levels are associated with increased levels of inflammatory cytokines such TNF-\u03b1 and IL-6, and the chemokine (monocyte chemotactic protein) MCP-1 (Bala et al., 2014).", [["endotoxin", "CHEMICAL", 14, 23], ["endotoxin", "SIMPLE_CHEMICAL", 14, 23], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 99, 104], ["IL-6", "GENE_OR_GENE_PRODUCT", 109, 113], ["monocyte chemotactic protein) MCP-1", "GENE_OR_GENE_PRODUCT", 134, 169], ["inflammatory cytokines", "PROTEIN", 71, 93], ["TNF", "PROTEIN", 99, 102], ["IL-6", "PROTEIN", 109, 113], ["chemokine", "PROTEIN", 123, 132], ["monocyte chemotactic protein", "PROTEIN", 134, 162], ["MCP", "PROTEIN", 164, 167], ["The increased endotoxin levels", "PROBLEM", 0, 30], ["increased levels of inflammatory cytokines", "PROBLEM", 51, 93], ["TNF", "TEST", 99, 102], ["IL", "TEST", 109, 111], ["the chemokine (monocyte chemotactic protein", "TEST", 119, 162], ["MCP", "TEST", 164, 167], ["increased", "OBSERVATION_MODIFIER", 4, 13], ["endotoxin levels", "OBSERVATION", 14, 30], ["increased", "OBSERVATION_MODIFIER", 51, 60], ["inflammatory", "OBSERVATION_MODIFIER", 71, 83]]], ["Chronic administration of alcohol is associated with enhanced expression of a number of growth factors, including EGF and transforming growth factor-alpha (TGF-\u03b1).", [["alcohol", "CHEMICAL", 26, 33], ["alcohol", "CHEMICAL", 26, 33], ["alcohol", "SIMPLE_CHEMICAL", 26, 33], ["EGF", "GENE_OR_GENE_PRODUCT", 114, 117], ["transforming growth factor-alpha", "GENE_OR_GENE_PRODUCT", 122, 154], ["TGF-\u03b1", "GENE_OR_GENE_PRODUCT", 156, 161], ["growth factors", "PROTEIN", 88, 102], ["EGF", "PROTEIN", 114, 117], ["transforming growth factor-alpha", "PROTEIN", 122, 154], ["TGF-\u03b1", "PROTEIN", 156, 161], ["growth factors", "PROBLEM", 88, 102], ["EGF", "TEST", 114, 117], ["transforming growth factor", "PROBLEM", 122, 148], ["alpha (TGF", "TEST", 149, 159]]], ["These growth factors are thought to protect the gastric mucosa against acute injury and may explain the observation that adaptation of the gastric mucosa to chronic alcohol administration is associated with increased cell proliferation and increased expression of mucosal EGF and TGF-\u03b1 (Tarnawski et al., 1992).", [["gastric mucosa", "ANATOMY", 48, 62], ["gastric mucosa", "ANATOMY", 139, 153], ["cell", "ANATOMY", 217, 221], ["mucosal", "ANATOMY", 264, 271], ["acute injury", "DISEASE", 71, 83], ["alcohol", "CHEMICAL", 165, 172], ["alcohol", "CHEMICAL", 165, 172], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 48, 62], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 139, 153], ["alcohol", "SIMPLE_CHEMICAL", 165, 172], ["cell", "CELL", 217, 221], ["mucosal EGF", "GENE_OR_GENE_PRODUCT", 264, 275], ["TGF-\u03b1", "GENE_OR_GENE_PRODUCT", 280, 285], ["growth factors", "PROTEIN", 6, 20], ["mucosal EGF", "PROTEIN", 264, 275], ["TGF", "PROTEIN", 280, 283], ["These growth factors", "PROBLEM", 0, 20], ["the gastric mucosa", "PROBLEM", 44, 62], ["acute injury", "PROBLEM", 71, 83], ["the gastric mucosa", "PROBLEM", 135, 153], ["chronic alcohol administration", "TREATMENT", 157, 187], ["increased cell proliferation", "PROBLEM", 207, 235], ["increased expression of mucosal EGF", "PROBLEM", 240, 275], ["gastric mucosa", "ANATOMY", 48, 62], ["acute", "OBSERVATION_MODIFIER", 71, 76], ["injury", "OBSERVATION", 77, 83], ["gastric mucosa", "ANATOMY", 139, 153], ["chronic", "OBSERVATION_MODIFIER", 157, 164], ["alcohol", "OBSERVATION", 165, 172], ["increased cell proliferation", "OBSERVATION", 207, 235], ["increased", "OBSERVATION_MODIFIER", 240, 249], ["mucosal EGF", "ANATOMY", 264, 275]]], ["The ability of chronic alcohol exposure to lead to hyperregeneration of the gastric mucosa could be responsible for the suspected carcinogenic effect of alcohol (Simanowski et al., 1995).", [["gastric mucosa", "ANATOMY", 76, 90], ["alcohol", "CHEMICAL", 23, 30], ["hyperregeneration", "DISEASE", 51, 68], ["alcohol", "CHEMICAL", 153, 160], ["alcohol", "CHEMICAL", 23, 30], ["alcohol", "CHEMICAL", 153, 160], ["alcohol", "SIMPLE_CHEMICAL", 23, 30], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 76, 90], ["alcohol", "SIMPLE_CHEMICAL", 153, 160], ["chronic alcohol exposure", "PROBLEM", 15, 39], ["hyperregeneration of the gastric mucosa", "PROBLEM", 51, 90], ["chronic", "OBSERVATION_MODIFIER", 15, 22], ["alcohol exposure", "OBSERVATION", 23, 39], ["gastric mucosa", "ANATOMY", 76, 90]]], ["Generation of acetaldehyde, in addition to elaboration of growth factors, has also been implicated suggesting a potential role of gastric mucosal alcohol dehydrogenase (ADH) in the deleterious effects of alcohol on gastrointestinal mucosa.", [["gastric mucosal", "ANATOMY", 130, 145], ["gastrointestinal mucosa", "ANATOMY", 215, 238], ["acetaldehyde", "CHEMICAL", 14, 26], ["alcohol", "CHEMICAL", 146, 153], ["alcohol", "CHEMICAL", 204, 211], ["acetaldehyde", "CHEMICAL", 14, 26], ["alcohol", "CHEMICAL", 146, 153], ["alcohol", "CHEMICAL", 204, 211], ["acetaldehyde", "SIMPLE_CHEMICAL", 14, 26], ["gastric mucosal alcohol dehydrogenase", "GENE_OR_GENE_PRODUCT", 130, 167], ["ADH", "GENE_OR_GENE_PRODUCT", 169, 172], ["alcohol", "SIMPLE_CHEMICAL", 204, 211], ["gastrointestinal mucosa", "MULTI-TISSUE_STRUCTURE", 215, 238], ["growth factors", "PROTEIN", 58, 72], ["gastric mucosal alcohol dehydrogenase", "PROTEIN", 130, 167], ["ADH", "PROTEIN", 169, 172], ["acetaldehyde", "TREATMENT", 14, 26], ["gastric mucosal alcohol dehydrogenase (ADH)", "PROBLEM", 130, 173], ["acetaldehyde", "OBSERVATION", 14, 26], ["gastric mucosal", "ANATOMY", 130, 145], ["gastrointestinal mucosa", "ANATOMY", 215, 238]]], ["The human gastric mucosa contains three isoforms of ADH, and enzyme activity is inversely correlated with age and is higher in males than in females (Moreno and Pares, 1991, Moreno et al., 1994).", [["gastric mucosa", "ANATOMY", 10, 24], ["human", "ORGANISM", 4, 9], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 10, 24], ["ADH", "GENE_OR_GENE_PRODUCT", 52, 55], ["ADH", "PROTEIN", 52, 55], ["human", "SPECIES", 4, 9], ["human", "SPECIES", 4, 9], ["ADH", "PROBLEM", 52, 55], ["enzyme activity", "TEST", 61, 76], ["human", "ANATOMY_MODIFIER", 4, 9], ["gastric mucosa", "ANATOMY", 10, 24], ["three", "OBSERVATION_MODIFIER", 34, 39], ["isoforms", "OBSERVATION_MODIFIER", 40, 48], ["higher", "OBSERVATION_MODIFIER", 117, 123]]], ["However the overall contribution of gastric ADH to metabolism of alcohol and generation of acetaldehyde is thought to be slight (Brown et al., 1995, Gugler, 1994, Levitt et al., 1994).Lectins ::: Direct Effects on Cell Membranes ::: Toxic MechanismsLectins are plant glycoproteins that can interact specifically with certain carbohydrates on cell membranes, including intestinal epithelial cells (Gelberg et al.,1992).", [["gastric", "ANATOMY", 36, 43], ["Cell", "ANATOMY", 214, 218], ["cell membranes", "ANATOMY", 342, 356], ["intestinal epithelial cells", "ANATOMY", 368, 395], ["alcohol", "CHEMICAL", 65, 72], ["acetaldehyde", "CHEMICAL", 91, 103], ["alcohol", "CHEMICAL", 65, 72], ["acetaldehyde", "CHEMICAL", 91, 103], ["carbohydrates", "CHEMICAL", 325, 338], ["gastric", "ORGAN", 36, 43], ["ADH", "GENE_OR_GENE_PRODUCT", 44, 47], ["alcohol", "SIMPLE_CHEMICAL", 65, 72], ["acetaldehyde", "SIMPLE_CHEMICAL", 91, 103], ["Cell", "CELL", 214, 218], ["MechanismsLectins", "GENE_OR_GENE_PRODUCT", 239, 256], ["cell membranes", "CELLULAR_COMPONENT", 342, 356], ["intestinal epithelial cells", "CELL", 368, 395], ["MechanismsLectins", "PROTEIN", 239, 256], ["intestinal epithelial cells", "CELL_TYPE", 368, 395], ["gastric ADH", "PROBLEM", 36, 47], ["Toxic MechanismsLectins", "PROBLEM", 233, 256], ["plant glycoproteins", "PROBLEM", 261, 280], ["cell membranes", "TREATMENT", 342, 356], ["gastric", "ANATOMY", 36, 43], ["thought to be", "UNCERTAINTY", 107, 120], ["slight", "OBSERVATION_MODIFIER", 121, 127], ["Cell Membranes", "OBSERVATION", 214, 228], ["plant glycoproteins", "OBSERVATION", 261, 280], ["cell membranes", "OBSERVATION", 342, 356], ["intestinal", "ANATOMY", 368, 378], ["epithelial cells", "OBSERVATION", 379, 395]]], ["The toxic effects of lectins are dependent on their source, species, and dose.", [["lectins", "GENE_OR_GENE_PRODUCT", 21, 28], ["The toxic effects of lectins", "PROBLEM", 0, 28], ["toxic", "OBSERVATION_MODIFIER", 4, 9]]], ["Their potential effects range from depression of growth to lethality (Reddy and Hayes, 1989).", [["depression", "DISEASE", 35, 45], ["depression of growth to lethality", "PROBLEM", 35, 68], ["growth", "OBSERVATION_MODIFIER", 49, 55]]], ["The toxicity of ingested lectins often involves their binding to the luminal surface of mucosal epithelial cells where they disturb the function of the brush border membrane (Nakata and Kimura, 1985).", [["luminal surface", "ANATOMY", 69, 84], ["mucosal epithelial cells", "ANATOMY", 88, 112], ["brush border membrane", "ANATOMY", 152, 173], ["toxicity", "DISEASE", 4, 12], ["luminal", "CHEMICAL", 69, 76], ["luminal surface", "CELLULAR_COMPONENT", 69, 84], ["mucosal epithelial cells", "CELL", 88, 112], ["brush border membrane", "CELLULAR_COMPONENT", 152, 173], ["mucosal epithelial cells", "CELL_TYPE", 88, 112], ["The toxicity of ingested lectins", "PROBLEM", 0, 32], ["luminal", "ANATOMY_MODIFIER", 69, 76], ["mucosal", "ANATOMY", 88, 95], ["epithelial cells", "OBSERVATION", 96, 112]]], ["Binding of lectins to crypt cells is followed by nonspecific inhibition of both active and passive absorption of all nutrients, including water, across the intestinal mucosa.", [["crypt cells", "ANATOMY", 22, 33], ["intestinal mucosa", "ANATOMY", 156, 173], ["lectins", "GENE_OR_GENE_PRODUCT", 11, 18], ["crypt cells", "CELL", 22, 33], ["water", "SIMPLE_CHEMICAL", 138, 143], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 156, 173], ["lectins", "PROTEIN", 11, 18], ["crypt cells", "CELL_TYPE", 22, 33], ["crypt cells", "PROBLEM", 22, 33], ["all nutrients", "TREATMENT", 113, 126], ["crypt cells", "OBSERVATION", 22, 33], ["active", "OBSERVATION_MODIFIER", 80, 86], ["intestinal mucosa", "ANATOMY", 156, 173]]], ["Inhibition of absorption appears to account for growth depression.", [["depression", "DISEASE", 55, 65], ["Inhibition of absorption", "TREATMENT", 0, 24], ["growth depression", "PROBLEM", 48, 65], ["appears to account for", "UNCERTAINTY", 25, 47]]], ["Lectins can also cause necrosis of intestinal epithelial cells (King et al., 1980).", [["intestinal epithelial cells", "ANATOMY", 35, 62], ["necrosis", "DISEASE", 23, 31], ["intestinal epithelial cells", "CELL", 35, 62], ["intestinal epithelial cells", "CELL_TYPE", 35, 62], ["Lectins", "TREATMENT", 0, 7], ["necrosis of intestinal epithelial cells", "PROBLEM", 23, 62], ["can also cause", "UNCERTAINTY", 8, 22], ["necrosis", "OBSERVATION", 23, 31], ["intestinal epithelial cells", "OBSERVATION", 35, 62]]], ["The mitogenic effects of lectins on lymphocytes can be inhibited by several neuropeptides, including VIP, \u03b2-endorphin, and somatostatin.", [["lymphocytes", "ANATOMY", 36, 47], ["somatostatin", "CHEMICAL", 123, 135], ["lectins", "GENE_OR_GENE_PRODUCT", 25, 32], ["lymphocytes", "CELL", 36, 47], ["VIP", "GENE_OR_GENE_PRODUCT", 101, 104], ["\u03b2-endorphin", "GENE_OR_GENE_PRODUCT", 106, 117], ["somatostatin", "GENE_OR_GENE_PRODUCT", 123, 135], ["lymphocytes", "CELL_TYPE", 36, 47], ["\u03b2-endorphin", "PROTEIN", 106, 117], ["lectins on lymphocytes", "PROBLEM", 25, 47], ["VIP", "TREATMENT", 101, 104], ["\u03b2-endorphin", "TREATMENT", 106, 117], ["somatostatin", "TREATMENT", 123, 135]]], ["It is not known whether these peptides protect mucosal cells (Krco et al., 1986).Cholesterol transport inhibitors ::: Direct Effects on Cell Membranes ::: Toxic MechanismsCholesterol transport inhibitors, such as ezetimibe, reduce circulating cholesterol esters by blocking NPC1L1 receptor essential for lipid micelle uptake and by inhibiting transport across the intestinal epithelium (Hui et al., 2008).Dioxins ::: Stimulation of Mucosal Proliferation ::: Toxic MechanismsGastrin, EGF, TGF-\u03b1, and other endogenous growth factors can stimulate gastrointestinal crypt cell proliferation.", [["mucosal cells", "ANATOMY", 47, 60], ["Cell", "ANATOMY", 136, 140], ["intestinal epithelium", "ANATOMY", 364, 385], ["Mucosal", "ANATOMY", 432, 439], ["gastrointestinal crypt cell", "ANATOMY", 545, 572], ["Cholesterol", "CHEMICAL", 171, 182], ["ezetimibe", "CHEMICAL", 213, 222], ["cholesterol esters", "CHEMICAL", 243, 261], ["Dioxins", "CHEMICAL", 405, 412], ["Cholesterol", "CHEMICAL", 81, 92], ["Cholesterol", "CHEMICAL", 171, 182], ["ezetimibe", "CHEMICAL", 213, 222], ["cholesterol esters", "CHEMICAL", 243, 261], ["Dioxins", "CHEMICAL", 405, 412], ["mucosal cells", "CELL", 47, 60], ["Cholesterol", "SIMPLE_CHEMICAL", 81, 92], ["Cell", "CELL", 136, 140], ["Cholesterol", "SIMPLE_CHEMICAL", 171, 182], ["ezetimibe", "SIMPLE_CHEMICAL", 213, 222], ["cholesterol esters", "SIMPLE_CHEMICAL", 243, 261], ["NPC1L1 receptor", "GENE_OR_GENE_PRODUCT", 274, 289], ["lipid micelle", "SIMPLE_CHEMICAL", 304, 317], ["intestinal epithelium", "TISSUE", 364, 385], ["Dioxins", "SIMPLE_CHEMICAL", 405, 412], ["MechanismsGastrin", "GENE_OR_GENE_PRODUCT", 464, 481], ["EGF", "GENE_OR_GENE_PRODUCT", 483, 486], ["TGF-\u03b1", "GENE_OR_GENE_PRODUCT", 488, 493], ["gastrointestinal crypt cell", "CELL", 545, 572], ["mucosal cells", "CELL_TYPE", 47, 60], ["NPC1L1 receptor", "PROTEIN", 274, 289], ["MechanismsGastrin", "PROTEIN", 464, 481], ["EGF", "PROTEIN", 483, 486], ["TGF-\u03b1", "PROTEIN", 488, 493], ["endogenous growth factors", "PROTEIN", 505, 530], ["Toxic Mechanisms", "PROBLEM", 155, 171], ["Cholesterol transport inhibitors", "TREATMENT", 171, 203], ["ezetimibe", "TREATMENT", 213, 222], ["circulating cholesterol esters", "TREATMENT", 231, 261], ["blocking NPC1L1 receptor", "TREATMENT", 265, 289], ["lipid micelle uptake", "PROBLEM", 304, 324], ["Toxic MechanismsGastrin", "TEST", 458, 481], ["EGF", "TEST", 483, 486], ["TGF", "TEST", 488, 491], ["other endogenous growth factors", "PROBLEM", 499, 530], ["gastrointestinal crypt cell proliferation", "PROBLEM", 545, 586], ["not known", "UNCERTAINTY", 6, 15], ["Cell Membranes", "OBSERVATION", 136, 150], ["intestinal epithelium", "ANATOMY", 364, 385], ["Mucosal", "ANATOMY", 432, 439], ["gastrointestinal", "ANATOMY", 545, 561], ["crypt cell proliferation", "OBSERVATION", 562, 586]]], ["Mucosal hyperplasia can also be associated with ingested chemicals, such as 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) and probably other related polychlorinated dioxins (Pohjanvirta and Tuomisto, 1994).", [["Mucosal", "ANATOMY", 0, 7], ["Mucosal hyperplasia", "DISEASE", 0, 19], ["2,3,7,8-tetra-chlorodibenzo-p-dioxin", "CHEMICAL", 76, 112], ["TCDD", "CHEMICAL", 114, 118], ["polychlorinated dioxins", "CHEMICAL", 147, 170], ["Pohjanvirta", "CHEMICAL", 172, 183], ["2,3,7,8-tetra-chlorodibenzo-p-dioxin", "CHEMICAL", 76, 112], ["TCDD", "CHEMICAL", 114, 118], ["polychlorinated dioxins", "CHEMICAL", 147, 170], ["Pohjanvirta", "CHEMICAL", 172, 183], ["Mucosal", "PATHOLOGICAL_FORMATION", 0, 7], ["2,3,7,8-tetra-chlorodibenzo-p-dioxin", "SIMPLE_CHEMICAL", 76, 112], ["TCDD", "SIMPLE_CHEMICAL", 114, 118], ["polychlorinated dioxins", "SIMPLE_CHEMICAL", 147, 170], ["Pohjanvirta", "SIMPLE_CHEMICAL", 172, 183], ["Mucosal hyperplasia", "PROBLEM", 0, 19], ["chlorodibenzo", "TREATMENT", 90, 103], ["dioxin (TCDD", "TREATMENT", 106, 118], ["hyperplasia", "OBSERVATION", 8, 19]]], ["TCDD binds to a cytosolic protein called the Ah receptor (Burbach et al., 1992).", [["cytosolic", "ANATOMY", 16, 25], ["TCDD", "CHEMICAL", 0, 4], ["TCDD", "CHEMICAL", 0, 4], ["TCDD", "SIMPLE_CHEMICAL", 0, 4], ["Ah receptor", "GENE_OR_GENE_PRODUCT", 45, 56], ["cytosolic protein", "PROTEIN", 16, 33], ["Ah receptor", "PROTEIN", 45, 56]]], ["TCDD binding converts the receptor to its activated, functional form that binds to the DNA of the CYP 1A1 gene for cytochrome P450.", [["TCDD", "CHEMICAL", 0, 4], ["TCDD", "CHEMICAL", 0, 4], ["TCDD", "SIMPLE_CHEMICAL", 0, 4], ["DNA", "CELLULAR_COMPONENT", 87, 90], ["CYP 1A1", "GENE_OR_GENE_PRODUCT", 98, 105], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 115, 130], ["CYP 1A1 gene", "DNA", 98, 110], ["cytochrome P450", "PROTEIN", 115, 130], ["TCDD binding", "PROBLEM", 0, 12], ["cytochrome P450", "TREATMENT", 115, 130]]], ["Binding of TCDD to the DNA increases the rate of transcription of the cytochrome P450 gene.", [["TCDD", "CHEMICAL", 11, 15], ["TCDD", "CHEMICAL", 11, 15], ["TCDD", "SIMPLE_CHEMICAL", 11, 15], ["DNA", "CELLULAR_COMPONENT", 23, 26], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 70, 85], ["cytochrome P450 gene", "DNA", 70, 90], ["the DNA", "PROBLEM", 19, 26], ["the cytochrome P450 gene", "TREATMENT", 66, 90]]], ["The intestinal mucosa contains significant levels of Ah receptors and cytochrome P450 CYP 1A1 (Mason and Okey, 1982).", [["intestinal mucosa", "ANATOMY", 4, 21], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 4, 21], ["Ah receptors", "GENE_OR_GENE_PRODUCT", 53, 65], ["cytochrome P450 CYP 1A1", "GENE_OR_GENE_PRODUCT", 70, 93], ["Ah receptors", "PROTEIN", 53, 65], ["cytochrome P450 CYP 1A1", "PROTEIN", 70, 93], ["Ah receptors", "TREATMENT", 53, 65], ["intestinal mucosa", "ANATOMY", 4, 21], ["significant", "OBSERVATION_MODIFIER", 31, 42], ["levels", "OBSERVATION_MODIFIER", 43, 49], ["Ah receptors", "OBSERVATION", 53, 65]]], ["TCDD can induce mucosal hyperplasia in some animal species.", [["mucosal", "ANATOMY", 16, 23], ["TCDD", "CHEMICAL", 0, 4], ["mucosal hyperplasia", "DISEASE", 16, 35], ["TCDD", "CHEMICAL", 0, 4], ["TCDD", "SIMPLE_CHEMICAL", 0, 4], ["mucosal hyperplasia", "PATHOLOGICAL_FORMATION", 16, 35], ["mucosal hyperplasia", "PROBLEM", 16, 35], ["some animal species", "PROBLEM", 39, 58], ["mucosal", "ANATOMY", 16, 23], ["hyperplasia", "OBSERVATION", 24, 35], ["some", "OBSERVATION_MODIFIER", 39, 43], ["animal species", "OBSERVATION", 44, 58]]], ["It has been suggested to exert a disinhibitory effect on gastrin release, which may explain the mucosal hyperplasia (Potter et al., 1983).", [["mucosal", "ANATOMY", 96, 103], ["gastrin", "GENE_OR_GENE_PRODUCT", 57, 64], ["mucosal hyperplasia", "PATHOLOGICAL_FORMATION", 96, 115], ["a disinhibitory effect on gastrin release", "PROBLEM", 31, 72], ["the mucosal hyperplasia", "PROBLEM", 92, 115], ["gastrin release", "OBSERVATION", 57, 72], ["may explain", "UNCERTAINTY", 80, 91], ["mucosal", "ANATOMY", 96, 103], ["hyperplasia", "OBSERVATION", 104, 115]]], ["It also induces a \u201cwasting syndrome\u201d that is characterized by failure of appetite (Pohjanvirta and Tuomisto, 1994).", [["wasting syndrome", "DISEASE", 19, 35], ["a \u201cwasting syndrome", "PROBLEM", 16, 35], ["failure of appetite", "PROBLEM", 62, 81], ["wasting syndrome", "OBSERVATION", 19, 35]]], ["Hypophagia and severe weight loss are the principal signs in most species of TCDD intoxication.", [["Hypophagia", "DISEASE", 0, 10], ["weight loss", "DISEASE", 22, 33], ["TCDD", "CHEMICAL", 77, 81], ["TCDD", "CHEMICAL", 77, 81], ["TCDD", "SIMPLE_CHEMICAL", 77, 81], ["Hypophagia", "PROBLEM", 0, 10], ["severe weight loss", "PROBLEM", 15, 33], ["TCDD intoxication", "PROBLEM", 77, 94], ["severe", "OBSERVATION_MODIFIER", 15, 21], ["weight loss", "OBSERVATION", 22, 33], ["most species", "OBSERVATION_MODIFIER", 61, 73]]], ["Most animals given lethal doses of TCDD die within 2 weeks.", [["TCDD", "CHEMICAL", 35, 39], ["TCDD", "CHEMICAL", 35, 39], ["animals", "ORGANISM", 5, 12], ["TCDD", "SIMPLE_CHEMICAL", 35, 39]]], ["Those that live longer often develop tumors (Pohjanvirta and Tuomisto, 1994).Alcohol ::: Stimulation of Mucosal Proliferation ::: Toxic MechanismsChronic ingestion of alcohol can lead to proliferation of mucosal epithelium.", [["tumors", "ANATOMY", 37, 43], ["Mucosal", "ANATOMY", 104, 111], ["mucosal epithelium", "ANATOMY", 204, 222], ["tumors", "DISEASE", 37, 43], ["Alcohol", "CHEMICAL", 77, 84], ["alcohol", "CHEMICAL", 167, 174], ["alcohol", "CHEMICAL", 167, 174], ["tumors", "CANCER", 37, 43], ["alcohol", "SIMPLE_CHEMICAL", 167, 174], ["mucosal epithelium", "TISSUE", 204, 222], ["tumors", "PROBLEM", 37, 43], ["Toxic MechanismsChronic ingestion", "PROBLEM", 130, 163], ["proliferation of mucosal epithelium", "PROBLEM", 187, 222], ["tumors", "OBSERVATION", 37, 43], ["Mucosal", "ANATOMY", 104, 111], ["mucosal epithelium", "OBSERVATION", 204, 222]]], ["The effect of alcohol is likely mediated by peptide growth factors.Pancreatic enzyme preparations ::: Stimulation of Mucosal Proliferation ::: Toxic MechanismsFibrosing colonopathy is a proliferative disorder of the colonic submucosa associated with high doses of pancreatic enzymes (lipase, amylase, and protease) required for management of pancreatic insufficiency in children with cystic fibrosis (Borowitz et al., 1995, Smyth et al., 1995).", [["Pancreatic", "ANATOMY", 67, 77], ["Mucosal", "ANATOMY", 117, 124], ["colonic submucosa", "ANATOMY", 216, 233], ["pancreatic", "ANATOMY", 264, 274], ["pancreatic", "ANATOMY", 342, 352], ["cystic", "ANATOMY", 384, 390], ["alcohol", "CHEMICAL", 14, 21], ["MechanismsFibrosing colonopathy", "DISEASE", 149, 180], ["disorder of the colonic submucosa", "DISEASE", 200, 233], ["pancreatic insufficiency", "DISEASE", 342, 366], ["cystic fibrosis", "DISEASE", 384, 399], ["alcohol", "CHEMICAL", 14, 21], ["alcohol", "SIMPLE_CHEMICAL", 14, 21], ["Pancreatic", "ORGAN", 67, 77], ["colonic submucosa", "MULTI-TISSUE_STRUCTURE", 216, 233], ["pancreatic enzymes", "GENE_OR_GENE_PRODUCT", 264, 282], ["lipase", "GENE_OR_GENE_PRODUCT", 284, 290], ["amylase", "GENE_OR_GENE_PRODUCT", 292, 299], ["pancreatic", "ORGAN", 342, 352], ["children", "ORGANISM", 370, 378], ["peptide growth factors", "PROTEIN", 44, 66], ["pancreatic enzymes", "PROTEIN", 264, 282], ["lipase", "PROTEIN", 284, 290], ["amylase", "PROTEIN", 292, 299], ["protease", "PROTEIN", 305, 313], ["children", "SPECIES", 370, 378], ["peptide growth factors", "PROBLEM", 44, 66], ["Toxic MechanismsFibrosing colonopathy", "PROBLEM", 143, 180], ["a proliferative disorder of the colonic submucosa", "PROBLEM", 184, 233], ["pancreatic enzymes", "TEST", 264, 282], ["lipase", "TEST", 284, 290], ["amylase", "TEST", 292, 299], ["protease", "TREATMENT", 305, 313], ["management", "TREATMENT", 328, 338], ["pancreatic insufficiency", "PROBLEM", 342, 366], ["cystic fibrosis", "PROBLEM", 384, 399], ["Mucosal Proliferation", "OBSERVATION", 117, 138], ["MechanismsFibrosing colonopathy", "OBSERVATION", 149, 180], ["proliferative disorder", "OBSERVATION", 186, 208], ["colonic submucosa", "ANATOMY", 216, 233], ["high doses", "OBSERVATION_MODIFIER", 250, 260], ["pancreatic", "ANATOMY", 264, 274], ["pancreatic", "ANATOMY", 342, 352], ["insufficiency", "OBSERVATION", 353, 366], ["cystic", "OBSERVATION_MODIFIER", 384, 390], ["fibrosis", "OBSERVATION", 391, 399]]], ["Inadequate enzyme therapy may be associated with various abdominal symptoms (bloating, abdominal pain), frequent stools or overt diarrhea.", [["abdominal", "ANATOMY", 57, 66], ["abdominal", "ANATOMY", 87, 96], ["stools", "ANATOMY", 113, 119], ["bloating", "DISEASE", 77, 85], ["abdominal pain", "DISEASE", 87, 101], ["diarrhea", "DISEASE", 129, 137], ["abdominal", "ORGANISM_SUBDIVISION", 57, 66], ["abdominal", "ORGANISM_SUBDIVISION", 87, 96], ["Inadequate enzyme therapy", "TREATMENT", 0, 25], ["various abdominal symptoms", "PROBLEM", 49, 75], ["bloating", "PROBLEM", 77, 85], ["abdominal pain", "PROBLEM", 87, 101], ["frequent stools", "PROBLEM", 104, 119], ["overt diarrhea", "PROBLEM", 123, 137], ["enzyme therapy", "OBSERVATION", 11, 25], ["abdominal", "ANATOMY", 57, 66], ["abdominal", "ANATOMY", 87, 96], ["overt", "OBSERVATION_MODIFIER", 123, 128], ["diarrhea", "OBSERVATION", 129, 137]]], ["Often steatorrhea (excess fat in feces) is a major sign of inadequate enzyme (specifically lipase) treatment.", [["fat", "ANATOMY", 26, 29], ["feces", "ANATOMY", 33, 38], ["steatorrhea", "DISEASE", 6, 17], ["fat", "TISSUE", 26, 29], ["feces", "ORGANISM_SUBSTANCE", 33, 38], ["lipase", "GENE_OR_GENE_PRODUCT", 91, 97], ["lipase", "PROTEIN", 91, 97], ["Often steatorrhea (excess fat in feces", "PROBLEM", 0, 38], ["inadequate enzyme", "PROBLEM", 59, 76], ["lipase) treatment", "TREATMENT", 91, 108], ["steatorrhea", "OBSERVATION", 6, 17]]], ["Continued poor digestion leads to retarded weight gain and growth.", [["weight gain", "DISEASE", 43, 54], ["retarded weight gain", "PROBLEM", 34, 54], ["poor digestion", "OBSERVATION", 10, 24]]], ["If signs of poor digestion and malabsorption persist, the practice has been to increase enzyme doses until proper digestion is achieved.", [["malabsorption", "DISEASE", 31, 44], ["poor digestion", "PROBLEM", 12, 26], ["malabsorption", "PROBLEM", 31, 44], ["enzyme doses", "TREATMENT", 88, 100], ["poor", "OBSERVATION_MODIFIER", 12, 16], ["digestion", "OBSERVATION", 17, 26], ["malabsorption", "OBSERVATION", 31, 44]]], ["Fibrosing colonopathy seems to occur only in children under 12 years receiving > 2 mg kg\u2212 1, equivalent to 6000 lipase units kg\u2212 1, per meal (Borowitz et al., 1995).Pancreatic enzyme preparations ::: Stimulation of Mucosal Proliferation ::: Toxic MechanismsFibrosing colonopathy is characterized by fusiform, long-segment stenosis of the colon that can lead to obstruction.", [["Pancreatic", "ANATOMY", 165, 175], ["Mucosal", "ANATOMY", 215, 222], ["colon", "ANATOMY", 338, 343], ["colonopathy", "DISEASE", 10, 21], ["MechanismsFibrosing colonopathy", "DISEASE", 247, 278], ["stenosis of the colon", "DISEASE", 322, 343], ["obstruction", "DISEASE", 361, 372], ["children", "ORGANISM", 45, 53], ["Pancreatic", "ORGAN", 165, 175], ["colon", "ORGAN", 338, 343], ["children", "SPECIES", 45, 53], ["Fibrosing colonopathy", "PROBLEM", 0, 21], ["Toxic MechanismsFibrosing colonopathy", "PROBLEM", 241, 278], ["fusiform, long-segment stenosis of the colon", "PROBLEM", 299, 343], ["obstruction", "PROBLEM", 361, 372], ["Mucosal Proliferation", "OBSERVATION", 215, 236], ["MechanismsFibrosing colonopathy", "OBSERVATION", 247, 278], ["fusiform", "OBSERVATION_MODIFIER", 299, 307], ["long-segment", "OBSERVATION_MODIFIER", 309, 321], ["stenosis", "OBSERVATION", 322, 330], ["colon", "ANATOMY", 338, 343], ["obstruction", "OBSERVATION", 361, 372]]], ["There is submucosal thickening caused by excessive proliferation of fibroblasts resulting in a thick layer of fibrous tissue (Borowitz et al., 1995).", [["submucosal", "ANATOMY", 9, 19], ["fibroblasts", "ANATOMY", 68, 79], ["fibrous tissue", "ANATOMY", 110, 124], ["submucosal", "PATHOLOGICAL_FORMATION", 9, 19], ["fibroblasts", "CELL", 68, 79], ["fibrous tissue", "TISSUE", 110, 124], ["fibroblasts", "CELL_TYPE", 68, 79], ["submucosal thickening", "PROBLEM", 9, 30], ["excessive proliferation of fibroblasts", "PROBLEM", 41, 79], ["a thick layer of fibrous tissue", "PROBLEM", 93, 124], ["submucosal", "ANATOMY", 9, 19], ["thickening", "OBSERVATION", 20, 30], ["excessive", "OBSERVATION_MODIFIER", 41, 50], ["proliferation", "OBSERVATION_MODIFIER", 51, 64], ["fibroblasts", "OBSERVATION_MODIFIER", 68, 79], ["thick", "OBSERVATION_MODIFIER", 95, 100], ["layer", "OBSERVATION_MODIFIER", 101, 106], ["fibrous tissue", "OBSERVATION", 110, 124]]], ["The condition may be manifest as colonic obstruction with abdominal pain and may be more common in patients with histories of meconium ileus, distal intestinal obstruction syndrome, and prior colonic surgery.", [["colonic", "ANATOMY", 33, 40], ["abdominal", "ANATOMY", 58, 67], ["meconium", "ANATOMY", 126, 134], ["intestinal", "ANATOMY", 149, 159], ["colonic", "ANATOMY", 192, 199], ["colonic obstruction", "DISEASE", 33, 52], ["abdominal pain", "DISEASE", 58, 72], ["meconium ileus", "DISEASE", 126, 140], ["intestinal obstruction syndrome", "DISEASE", 149, 180], ["colonic obstruction", "PATHOLOGICAL_FORMATION", 33, 52], ["abdominal", "ORGANISM_SUBDIVISION", 58, 67], ["patients", "ORGANISM", 99, 107], ["intestinal", "ORGAN", 149, 159], ["colonic", "ORGAN", 192, 199], ["patients", "SPECIES", 99, 107], ["colonic obstruction", "PROBLEM", 33, 52], ["abdominal pain", "PROBLEM", 58, 72], ["meconium ileus", "PROBLEM", 126, 140], ["distal intestinal obstruction syndrome", "PROBLEM", 142, 180], ["prior colonic surgery", "TREATMENT", 186, 207], ["may be manifest", "UNCERTAINTY", 14, 29], ["colonic", "ANATOMY", 33, 40], ["obstruction", "OBSERVATION", 41, 52], ["abdominal", "ANATOMY", 58, 67], ["pain", "OBSERVATION", 68, 72], ["meconium ileus", "OBSERVATION", 126, 140], ["distal", "ANATOMY_MODIFIER", 142, 148], ["intestinal", "ANATOMY", 149, 159], ["obstruction syndrome", "OBSERVATION", 160, 180], ["colonic", "ANATOMY", 192, 199], ["surgery", "OBSERVATION", 200, 207]]], ["The strictures associated with fibrosing colonopathy require surgical resection.Pancreatic enzyme preparations ::: Stimulation of Mucosal Proliferation ::: Toxic MechanismsMany delayed release pancreatic enzyme products are coated with methacrylic acid copolymer, which has been implicated in the toxicity.", [["Pancreatic", "ANATOMY", 80, 90], ["Mucosal", "ANATOMY", 130, 137], ["pancreatic", "ANATOMY", 193, 203], ["strictures", "DISEASE", 4, 14], ["fibrosing colonopathy", "DISEASE", 31, 52], ["methacrylic acid", "CHEMICAL", 236, 252], ["toxicity", "DISEASE", 297, 305], ["methacrylic acid", "CHEMICAL", 236, 252], ["strictures", "PATHOLOGICAL_FORMATION", 4, 14], ["Pancreatic", "ORGAN", 80, 90], ["pancreatic", "ORGAN", 193, 203], ["methacrylic acid copolymer", "SIMPLE_CHEMICAL", 236, 262], ["pancreatic enzyme products", "PROTEIN", 193, 219], ["The strictures", "PROBLEM", 0, 14], ["fibrosing colonopathy", "PROBLEM", 31, 52], ["surgical resection", "TREATMENT", 61, 79], ["Toxic MechanismsMany delayed release pancreatic enzyme products", "TREATMENT", 156, 219], ["methacrylic acid copolymer", "TREATMENT", 236, 262], ["the toxicity", "PROBLEM", 293, 305], ["strictures", "OBSERVATION", 4, 14], ["fibrosing", "OBSERVATION_MODIFIER", 31, 40], ["surgical resection", "OBSERVATION", 61, 79], ["Mucosal Proliferation", "OBSERVATION", 130, 151], ["pancreatic", "ANATOMY", 193, 203]]], ["Theoretically, undissolved plastic polymer migrates across the mucosa, a process that is perhaps facilitated by the presence of sodium lauryl sulfate present in many formulations.", [["mucosa", "ANATOMY", 63, 69], ["sodium lauryl sulfate", "CHEMICAL", 128, 149], ["sodium lauryl sulfate", "CHEMICAL", 128, 149], ["mucosa", "MULTI-TISSUE_STRUCTURE", 63, 69], ["sodium lauryl sulfate", "SIMPLE_CHEMICAL", 128, 149], ["undissolved plastic polymer", "TREATMENT", 15, 42], ["sodium lauryl sulfate", "TREATMENT", 128, 149], ["many formulations", "TREATMENT", 161, 178], ["plastic polymer", "OBSERVATION", 27, 42], ["mucosa", "ANATOMY", 63, 69]]], ["Once in the lamina propria, the small particles of plastic stimulate proliferation of fibroblasts that attempt to encapsulate the fragments of methacrylate.", [["lamina propria", "ANATOMY", 12, 26], ["fibroblasts", "ANATOMY", 86, 97], ["fragments", "ANATOMY", 130, 139], ["methacrylate", "CHEMICAL", 143, 155], ["lamina propria", "TISSUE", 12, 26], ["fibroblasts", "CELL", 86, 97], ["methacrylate", "SIMPLE_CHEMICAL", 143, 155], ["fibroblasts", "CELL_TYPE", 86, 97], ["plastic stimulate proliferation of fibroblasts", "TREATMENT", 51, 97], ["the fragments of methacrylate", "TREATMENT", 126, 155], ["lamina", "ANATOMY_MODIFIER", 12, 18], ["propria", "ANATOMY", 19, 26], ["small", "OBSERVATION_MODIFIER", 32, 37], ["particles", "OBSERVATION_MODIFIER", 38, 47], ["plastic stimulate proliferation", "OBSERVATION", 51, 82], ["fibroblasts", "OBSERVATION", 86, 97], ["fragments", "OBSERVATION_MODIFIER", 130, 139]]], ["The plastic-induced fibrosis eventually results in stricture formation and colonic obstruction.", [["stricture", "ANATOMY", 51, 60], ["colonic", "ANATOMY", 75, 82], ["fibrosis", "DISEASE", 20, 28], ["stricture", "DISEASE", 51, 60], ["colonic obstruction", "DISEASE", 75, 94], ["stricture", "PATHOLOGICAL_FORMATION", 51, 60], ["colonic obstruction", "PATHOLOGICAL_FORMATION", 75, 94], ["The plastic-induced fibrosis", "PROBLEM", 0, 28], ["stricture formation", "PROBLEM", 51, 70], ["colonic obstruction", "PROBLEM", 75, 94], ["fibrosis", "OBSERVATION", 20, 28], ["stricture", "OBSERVATION", 51, 60], ["colonic", "ANATOMY", 75, 82], ["obstruction", "OBSERVATION", 83, 94]]], ["Ironically, the putative fragments cannot easily be visualized by microscopic examination of pathological specimens because the copolymer is crystal-clear.Inhibition of Mucosal Proliferation ::: Toxic MechanismsThe most notable substances that inhibit normal proliferation and turnover of mucosal epithelial cells are the antineoplastic or anticancer drugs.", [["fragments", "ANATOMY", 25, 34], ["specimens", "ANATOMY", 106, 115], ["Mucosal", "ANATOMY", 169, 176], ["mucosal epithelial cells", "ANATOMY", 289, 313], ["antineoplastic", "ANATOMY", 322, 336], ["anticancer", "ANATOMY", 340, 350], ["specimens", "CANCER", 106, 115], ["mucosal epithelial cells", "CELL", 289, 313], ["anticancer", "CANCER", 340, 350], ["putative fragments", "DNA", 16, 34], ["mucosal epithelial cells", "CELL_TYPE", 289, 313], ["the putative fragments", "PROBLEM", 12, 34], ["microscopic examination", "TEST", 66, 89], ["pathological specimens", "TEST", 93, 115], ["Toxic Mechanisms", "PROBLEM", 195, 211], ["mucosal epithelial cells", "PROBLEM", 289, 313], ["anticancer drugs", "TREATMENT", 340, 356], ["clear", "OBSERVATION", 149, 154], ["Mucosal Proliferation", "OBSERVATION", 169, 190], ["most notable", "OBSERVATION_MODIFIER", 215, 227], ["substances", "OBSERVATION", 228, 238], ["normal proliferation", "OBSERVATION", 252, 272], ["mucosal epithelial cells", "OBSERVATION", 289, 313]]], ["Antineoplastic agents are used in clinical oncology because the drugs are inherently toxic and are designed to kill host cells (O\u2019Keefe and Harris, 1990).", [["cells", "ANATOMY", 121, 126], ["host cells", "CELL", 116, 126], ["O\u2019Keefe", "CELL", 128, 135], ["host cells", "CELL_TYPE", 116, 126], ["Antineoplastic agents", "TREATMENT", 0, 21], ["inherently toxic", "PROBLEM", 74, 90]]], ["The toxic effects of many members of this class of agents occur in tissues with high growth fractions, such as gastrointestinal epithelium.", [["tissues", "ANATOMY", 67, 74], ["gastrointestinal epithelium", "ANATOMY", 111, 138], ["tissues", "TISSUE", 67, 74], ["gastrointestinal epithelium", "TISSUE", 111, 138], ["agents", "TREATMENT", 51, 57], ["high growth fractions", "PROBLEM", 80, 101], ["gastrointestinal epithelium", "PROBLEM", 111, 138], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["high growth", "OBSERVATION_MODIFIER", 80, 91], ["gastrointestinal epithelium", "ANATOMY", 111, 138]]], ["In general, the alkylating agents, such as nitrogen mustards (melphalan, cyclophosphamide, and chlorambucil) are the most highly toxic to dividing mucosal cells.", [["mucosal cells", "ANATOMY", 147, 160], ["alkylating agents", "CHEMICAL", 16, 33], ["nitrogen mustards", "CHEMICAL", 43, 60], ["melphalan", "CHEMICAL", 62, 71], ["cyclophosphamide", "CHEMICAL", 73, 89], ["chlorambucil", "CHEMICAL", 95, 107], ["nitrogen", "CHEMICAL", 43, 51], ["melphalan", "CHEMICAL", 62, 71], ["cyclophosphamide", "CHEMICAL", 73, 89], ["chlorambucil", "CHEMICAL", 95, 107], ["nitrogen mustards", "SIMPLE_CHEMICAL", 43, 60], ["melphalan", "SIMPLE_CHEMICAL", 62, 71], ["cyclophosphamide", "SIMPLE_CHEMICAL", 73, 89], ["chlorambucil", "SIMPLE_CHEMICAL", 95, 107], ["mucosal cells", "CELL", 147, 160], ["dividing mucosal cells", "CELL_TYPE", 138, 160], ["the alkylating agents", "TREATMENT", 12, 33], ["nitrogen mustards", "TREATMENT", 43, 60], ["melphalan", "TREATMENT", 62, 71], ["cyclophosphamide", "TREATMENT", 73, 89], ["chlorambucil", "TREATMENT", 95, 107], ["mucosal cells", "OBSERVATION", 147, 160]]], ["These agents cause mitotic arrest, cellular hypertrophy, disintegration of epithelial cells, and sloughing of the epithelium.", [["cellular", "ANATOMY", 35, 43], ["epithelial cells", "ANATOMY", 75, 91], ["epithelium", "ANATOMY", 114, 124], ["mitotic arrest", "DISEASE", 19, 33], ["hypertrophy", "DISEASE", 44, 55], ["cellular", "CELL", 35, 43], ["epithelial cells", "CELL", 75, 91], ["epithelium", "TISSUE", 114, 124], ["epithelial cells", "CELL_TYPE", 75, 91], ["mitotic arrest", "PROBLEM", 19, 33], ["cellular hypertrophy", "PROBLEM", 35, 55], ["epithelial cells", "PROBLEM", 75, 91], ["sloughing of the epithelium", "PROBLEM", 97, 124], ["mitotic arrest", "OBSERVATION", 19, 33], ["cellular hypertrophy", "OBSERVATION", 35, 55], ["epithelial cells", "OBSERVATION", 75, 91], ["sloughing", "OBSERVATION_MODIFIER", 97, 106], ["epithelium", "ANATOMY_MODIFIER", 114, 124]]], ["In high-dose chemotherapy protocols they can predispose to bacterial sepsis of the gastrointestinal tract.", [["gastrointestinal tract", "ANATOMY", 83, 105], ["sepsis of the gastrointestinal tract", "DISEASE", 69, 105], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 83, 105], ["high-dose chemotherapy protocols", "TREATMENT", 3, 35], ["bacterial sepsis of the gastrointestinal tract", "PROBLEM", 59, 105], ["bacterial", "OBSERVATION_MODIFIER", 59, 68], ["sepsis", "OBSERVATION", 69, 75], ["gastrointestinal tract", "ANATOMY", 83, 105]]], ["The nitrogen mustard drugs alkylate DNA and thereby interfere with DNA synthesis and cell division (Chabner et al., 1996).", [["cell", "ANATOMY", 85, 89], ["nitrogen mustard", "CHEMICAL", 4, 20], ["alkylate", "CHEMICAL", 27, 35], ["nitrogen", "CHEMICAL", 4, 12], ["alkylate", "CHEMICAL", 27, 35], ["nitrogen mustard", "SIMPLE_CHEMICAL", 4, 20], ["DNA", "CELLULAR_COMPONENT", 36, 39], ["DNA", "CELLULAR_COMPONENT", 67, 70], ["cell", "CELL", 85, 89], ["The nitrogen mustard drugs alkylate DNA", "TREATMENT", 0, 39], ["DNA synthesis", "TREATMENT", 67, 80]]], ["These drugs are most cytotoxic to rapidly proliferating tissues in which a large proportion of the cells are dividing.Inhibition of Mucosal Proliferation ::: Toxic MechanismsAntifolate drugs, such as methotrexate, also produce significant toxicity to the gastrointestinal epithelium.", [["tissues", "ANATOMY", 56, 63], ["cells", "ANATOMY", 99, 104], ["Mucosal", "ANATOMY", 132, 139], ["gastrointestinal epithelium", "ANATOMY", 255, 282], ["MechanismsAntifolate", "CHEMICAL", 164, 184], ["methotrexate", "CHEMICAL", 200, 212], ["toxicity", "DISEASE", 239, 247], ["MechanismsAntifolate", "CHEMICAL", 164, 184], ["methotrexate", "CHEMICAL", 200, 212], ["tissues", "TISSUE", 56, 63], ["cells", "CELL", 99, 104], ["MechanismsAntifolate drugs", "SIMPLE_CHEMICAL", 164, 190], ["methotrexate", "SIMPLE_CHEMICAL", 200, 212], ["gastrointestinal epithelium", "TISSUE", 255, 282], ["These drugs", "TREATMENT", 0, 11], ["Toxic MechanismsAntifolate drugs", "TREATMENT", 158, 190], ["methotrexate", "TREATMENT", 200, 212], ["significant toxicity to the gastrointestinal epithelium", "PROBLEM", 227, 282], ["rapidly", "OBSERVATION_MODIFIER", 34, 41], ["proliferating tissues", "OBSERVATION", 42, 63], ["large", "OBSERVATION_MODIFIER", 75, 80], ["Mucosal Proliferation", "OBSERVATION", 132, 153], ["significant", "OBSERVATION_MODIFIER", 227, 238], ["toxicity", "OBSERVATION", 239, 247], ["gastrointestinal epithelium", "ANATOMY", 255, 282]]], ["Methotrexate inhibits dihydrofolate reductase and interferes with folate-dependent enzymes required for synthesis of purines and thymidylate.", [["Methotrexate", "CHEMICAL", 0, 12], ["dihydrofolate", "CHEMICAL", 22, 35], ["folate", "CHEMICAL", 66, 72], ["purines", "CHEMICAL", 117, 124], ["thymidylate", "CHEMICAL", 129, 140], ["Methotrexate", "CHEMICAL", 0, 12], ["dihydrofolate", "CHEMICAL", 22, 35], ["folate", "CHEMICAL", 66, 72], ["purines", "CHEMICAL", 117, 124], ["thymidylate", "CHEMICAL", 129, 140], ["Methotrexate", "SIMPLE_CHEMICAL", 0, 12], ["dihydrofolate reductase", "GENE_OR_GENE_PRODUCT", 22, 45], ["folate", "SIMPLE_CHEMICAL", 66, 72], ["purines", "SIMPLE_CHEMICAL", 117, 124], ["thymidylate", "SIMPLE_CHEMICAL", 129, 140], ["dihydrofolate reductase", "PROTEIN", 22, 45], ["folate-dependent enzymes", "PROTEIN", 66, 90], ["Methotrexate inhibits dihydrofolate reductase", "TREATMENT", 0, 45], ["folate-dependent enzymes", "TREATMENT", 66, 90], ["synthesis of purines", "TREATMENT", 104, 124], ["thymidylate", "TREATMENT", 129, 140]]], ["Methotrexate is toxic to all rapidly dividing normal cells including those of the intestinal epithelium.", [["cells", "ANATOMY", 53, 58], ["intestinal epithelium", "ANATOMY", 82, 103], ["Methotrexate", "CHEMICAL", 0, 12], ["Methotrexate", "CHEMICAL", 0, 12], ["Methotrexate", "SIMPLE_CHEMICAL", 0, 12], ["cells", "CELL", 53, 58], ["intestinal epithelium", "TISSUE", 82, 103], ["normal cells", "CELL_TYPE", 46, 58], ["Methotrexate", "TREATMENT", 0, 12], ["toxic", "PROBLEM", 16, 21], ["toxic", "OBSERVATION_MODIFIER", 16, 21], ["normal cells", "OBSERVATION", 46, 58], ["intestinal epithelium", "ANATOMY", 82, 103]]], ["The drug can induce swelling and cytoplasmic vacuolation of epithelial cells within 6 h followed by enterocyte loss and leukocyte infiltration into the submucosa.", [["cytoplasmic", "ANATOMY", 33, 44], ["epithelial cells", "ANATOMY", 60, 76], ["enterocyte", "ANATOMY", 100, 110], ["leukocyte", "ANATOMY", 120, 129], ["submucosa", "ANATOMY", 152, 161], ["swelling", "DISEASE", 20, 28], ["cytoplasmic", "ORGANISM_SUBSTANCE", 33, 44], ["epithelial cells", "CELL", 60, 76], ["enterocyte", "CELL", 100, 110], ["leukocyte", "CELL", 120, 129], ["submucosa", "MULTI-TISSUE_STRUCTURE", 152, 161], ["epithelial cells", "CELL_TYPE", 60, 76], ["swelling", "PROBLEM", 20, 28], ["cytoplasmic vacuolation of epithelial cells", "PROBLEM", 33, 76], ["enterocyte loss", "PROBLEM", 100, 115], ["leukocyte infiltration into the submucosa", "PROBLEM", 120, 161], ["swelling", "OBSERVATION", 20, 28], ["cytoplasmic vacuolation", "OBSERVATION", 33, 56], ["epithelial cells", "OBSERVATION", 60, 76], ["enterocyte loss", "OBSERVATION", 100, 115], ["leukocyte infiltration", "OBSERVATION", 120, 142], ["submucosa", "ANATOMY", 152, 161]]], ["Mucositis (inflammation) peaks several days after drug administration.", [["Mucositis", "DISEASE", 0, 9], ["inflammation", "DISEASE", 11, 23], ["Mucositis (inflammation) peaks", "PROBLEM", 0, 30], ["drug administration", "TREATMENT", 50, 69], ["inflammation", "OBSERVATION", 11, 23]]], ["Animal studies indicate that methotrexate is extremely toxic to the gastrointestinal tract if elemental liquid diets are the only source of enteral nutrition.", [["gastrointestinal tract", "ANATOMY", 68, 90], ["methotrexate", "CHEMICAL", 29, 41], ["toxic to the gastrointestinal tract", "DISEASE", 55, 90], ["methotrexate", "CHEMICAL", 29, 41], ["methotrexate", "SIMPLE_CHEMICAL", 29, 41], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 68, 90], ["Animal studies", "TEST", 0, 14], ["methotrexate", "TREATMENT", 29, 41], ["extremely toxic", "PROBLEM", 45, 60], ["elemental liquid diets", "TREATMENT", 94, 116], ["enteral nutrition", "TREATMENT", 140, 157], ["gastrointestinal tract", "ANATOMY", 68, 90]]], ["It is believed that elemental diets change the pharmacokinetics of methotrexate or further diminish epithelial cell turnover rates (McAnena et al., 1987).", [["epithelial cell", "ANATOMY", 100, 115], ["methotrexate", "CHEMICAL", 67, 79], ["methotrexate", "CHEMICAL", 67, 79], ["methotrexate", "SIMPLE_CHEMICAL", 67, 79], ["epithelial cell", "CELL", 100, 115], ["methotrexate", "TREATMENT", 67, 79], ["further diminish epithelial cell turnover rates", "PROBLEM", 83, 130], ["epithelial cell", "OBSERVATION", 100, 115]]], ["Methotrexate-induced gastrointestinal toxicity is also enhanced dramatically in mice by aspirin-like drugs (Badr and Chen, 1985).", [["gastrointestinal", "ANATOMY", 21, 37], ["Methotrexate", "CHEMICAL", 0, 12], ["gastrointestinal toxicity", "DISEASE", 21, 46], ["aspirin", "CHEMICAL", 88, 95], ["Methotrexate", "CHEMICAL", 0, 12], ["aspirin", "CHEMICAL", 88, 95], ["Methotrexate", "SIMPLE_CHEMICAL", 0, 12], ["gastrointestinal", "ORGAN", 21, 37], ["mice", "ORGANISM", 80, 84], ["aspirin", "SIMPLE_CHEMICAL", 88, 95], ["mice", "SPECIES", 80, 84], ["mice", "SPECIES", 80, 84], ["Methotrexate", "TREATMENT", 0, 12], ["gastrointestinal toxicity", "PROBLEM", 21, 46], ["aspirin", "TREATMENT", 88, 95], ["gastrointestinal", "ANATOMY", 21, 37], ["toxicity", "OBSERVATION", 38, 46]]], ["Interestingly, transgenic mice carrying a mutant dihydrofolate reductase gene display resistance to methotrexate toxicity to the gastrointestinal tract (Isola and Gordon, 1986).Inhibition of Mucosal Proliferation ::: Toxic MechanismsThe pyrimidine analog, 5-fluorouracil (5-FU), and related drugs are less likely than alkylating agents or antifolate drugs to induce gastrointestinal toxicity.", [["gastrointestinal tract", "ANATOMY", 129, 151], ["Mucosal", "ANATOMY", 191, 198], ["gastrointestinal", "ANATOMY", 366, 382], ["methotrexate", "CHEMICAL", 100, 112], ["toxicity", "DISEASE", 113, 121], ["pyrimidine", "CHEMICAL", 237, 247], ["5-fluorouracil", "CHEMICAL", 256, 270], ["5-FU", "CHEMICAL", 272, 276], ["alkylating agents", "CHEMICAL", 318, 335], ["gastrointestinal toxicity", "DISEASE", 366, 391], ["methotrexate", "CHEMICAL", 100, 112], ["pyrimidine", "CHEMICAL", 237, 247], ["5-fluorouracil", "CHEMICAL", 256, 270], ["5-FU", "CHEMICAL", 272, 276], ["transgenic mice", "ORGANISM", 15, 30], ["dihydrofolate reductase", "GENE_OR_GENE_PRODUCT", 49, 72], ["methotrexate", "SIMPLE_CHEMICAL", 100, 112], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 129, 151], ["pyrimidine", "SIMPLE_CHEMICAL", 237, 247], ["5-fluorouracil", "SIMPLE_CHEMICAL", 256, 270], ["5-FU", "SIMPLE_CHEMICAL", 272, 276], ["antifolate drugs", "SIMPLE_CHEMICAL", 339, 355], ["gastrointestinal", "ORGAN", 366, 382], ["mutant dihydrofolate reductase gene", "DNA", 42, 77], ["mice", "SPECIES", 26, 30], ["mice", "SPECIES", 26, 30], ["a mutant dihydrofolate reductase gene", "TREATMENT", 40, 77], ["methotrexate toxicity", "PROBLEM", 100, 121], ["Toxic Mechanisms", "PROBLEM", 217, 233], ["The pyrimidine analog", "TREATMENT", 233, 254], ["fluorouracil", "TREATMENT", 258, 270], ["drugs", "TREATMENT", 291, 296], ["alkylating agents", "TREATMENT", 318, 335], ["antifolate drugs", "TREATMENT", 339, 355], ["gastrointestinal toxicity", "PROBLEM", 366, 391], ["methotrexate toxicity", "OBSERVATION", 100, 121], ["gastrointestinal tract", "ANATOMY", 129, 151], ["Mucosal Proliferation", "OBSERVATION", 191, 212], ["gastrointestinal", "ANATOMY", 366, 382]]], ["However, 5-FU is frequently associated with mucosal ulceration and diarrhea.", [["mucosal", "ANATOMY", 44, 51], ["5-FU", "CHEMICAL", 9, 13], ["diarrhea", "DISEASE", 67, 75], ["5-FU", "CHEMICAL", 9, 13], ["5-FU", "SIMPLE_CHEMICAL", 9, 13], ["mucosal ulceration", "PATHOLOGICAL_FORMATION", 44, 62], ["mucosal ulceration", "PROBLEM", 44, 62], ["diarrhea", "PROBLEM", 67, 75], ["mucosal", "ANATOMY", 44, 51], ["ulceration", "OBSERVATION", 52, 62], ["diarrhea", "OBSERVATION", 67, 75]]], ["In animal studies, the major toxicity is gastrointestinal disturbance, including decreases in brush border enzyme activity, that requires up to 72 h for recovery after 5-FU administration (Au et al., 1987, Kralovanszky et al., 1993).", [["gastrointestinal", "ANATOMY", 41, 57], ["toxicity", "DISEASE", 29, 37], ["gastrointestinal disturbance", "DISEASE", 41, 69], ["5-FU", "CHEMICAL", 168, 172], ["5-FU", "CHEMICAL", 168, 172], ["Au", "CHEMICAL", 189, 191], ["gastrointestinal", "ORGAN", 41, 57], ["5-FU", "SIMPLE_CHEMICAL", 168, 172], ["animal studies", "TEST", 3, 17], ["the major toxicity", "PROBLEM", 19, 37], ["gastrointestinal disturbance", "PROBLEM", 41, 69], ["decreases in brush border enzyme activity", "PROBLEM", 81, 122], ["gastrointestinal", "ANATOMY", 41, 57], ["disturbance", "OBSERVATION", 58, 69], ["decreases", "OBSERVATION_MODIFIER", 81, 90]]], ["5-FU also causes gastrointestinal toxicity, nausea, vomiting, and diarrhea in humans (Palmeri et al., 1990).", [["gastrointestinal", "ANATOMY", 17, 33], ["5-FU", "CHEMICAL", 0, 4], ["gastrointestinal toxicity", "DISEASE", 17, 42], ["nausea", "DISEASE", 44, 50], ["vomiting", "DISEASE", 52, 60], ["diarrhea", "DISEASE", 66, 74], ["5-FU", "CHEMICAL", 0, 4], ["5-FU", "SIMPLE_CHEMICAL", 0, 4], ["gastrointestinal", "ORGAN", 17, 33], ["humans", "ORGANISM", 78, 84], ["humans", "SPECIES", 78, 84], ["humans", "SPECIES", 78, 84], ["gastrointestinal toxicity", "PROBLEM", 17, 42], ["nausea", "PROBLEM", 44, 50], ["vomiting", "PROBLEM", 52, 60], ["diarrhea", "PROBLEM", 66, 74], ["gastrointestinal", "ANATOMY", 17, 33], ["toxicity", "OBSERVATION", 34, 42], ["diarrhea", "OBSERVATION", 66, 74]]], ["5-FU is a biochemical mimic of uracil that blocks thymidylate synthase by preventing thymidylate synthase-mediated methylation.", [["5-FU", "CHEMICAL", 0, 4], ["uracil", "CHEMICAL", 31, 37], ["thymidylate", "CHEMICAL", 50, 61], ["thymidylate", "CHEMICAL", 85, 96], ["5-FU", "CHEMICAL", 0, 4], ["uracil", "CHEMICAL", 31, 37], ["5-FU", "SIMPLE_CHEMICAL", 0, 4], ["uracil", "SIMPLE_CHEMICAL", 31, 37], ["thymidylate synthase", "GENE_OR_GENE_PRODUCT", 50, 70], ["thymidylate synthase", "GENE_OR_GENE_PRODUCT", 85, 105], ["thymidylate synthase", "PROTEIN", 50, 70], ["thymidylate synthase", "PROTEIN", 85, 105], ["uracil that blocks thymidylate synthase", "TREATMENT", 31, 70], ["thymidylate synthase", "TREATMENT", 85, 105], ["mediated methylation", "TREATMENT", 106, 126]]], ["5-FU also inhibits RNA processing and can be incorporated into DNA as flurodeoxyuridine triphosphate.Inhibition of Mucosal Proliferation ::: Toxic Mechanisms", [["Mucosal", "ANATOMY", 115, 122], ["5-FU", "CHEMICAL", 0, 4], ["flurodeoxyuridine triphosphate", "CHEMICAL", 70, 100], ["5-FU", "CHEMICAL", 0, 4], ["flurodeoxyuridine triphosphate", "CHEMICAL", 70, 100], ["5-FU", "SIMPLE_CHEMICAL", 0, 4], ["DNA", "CELLULAR_COMPONENT", 63, 66], ["flurodeoxyuridine triphosphate", "SIMPLE_CHEMICAL", 70, 100], ["RNA processing", "TREATMENT", 19, 33], ["flurodeoxyuridine triphosphate", "TREATMENT", 70, 100], ["Toxic Mechanisms", "PROBLEM", 141, 157], ["Mucosal Proliferation", "OBSERVATION", 115, 136]]]]}